PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ni, GY; Moser, G; Wray, NR; Lee, SH				Ni, Guiyan; Moser, Gerhard; Wray, Naomi R.; Lee, S. Hong		Psychiat Genomics Consortium	Estimation of Genetic Correlation via Linkage Disequilibrium Score Regression and Genomic Restricted Maximum Likelihood	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX HUMAN TRAITS; BODY-MASS INDEX; WIDE ASSOCIATION; PARTITIONING HERITABILITY; SUSCEPTIBILITY LOCI; SNP HERITABILITY; HUMAN HEIGHT; SCHIZOPHRENIA; INFORMATION; STATISTICS	Genetic correlation is a key population parameter that describes the shared genetic architecture of complex traits and diseases. It can be estimated by current state-of-art methods, i.e., linkage disequilibrium score regression (LDSC) and genomic restricted maximum likelihood (GREML). The massively reduced computing burden of LDSC compared to GREML makes it an attractive tool, although the accuracy (i.e., magnitude of standard errors) of LDSC estimates has not been thoroughly studied. In simulation, we show that the accuracy of GREML is generally higher than that of LDSC. When there is genetic heterogeneity between the actual sample and reference data from which LD scores are estimated, the accuracy of LDSC decreases further. In real data analyses estimating the genetic correlation between schizophrenia (SCZ) and body mass index, we show that GREML estimates based on similar to 150,000 individuals give a higher accuracy than LDSC estimates based on similar to 400,000 individuals (from combinedmeta-data). A GREML genomic partitioning analysis reveals that the genetic correlation between SCZ and height is significantly negative for regulatory regions, which whole genome or LDSC approach has less power to detect. We conclude that LDSC estimates should be carefully interpreted as there can be uncertainty about homogeneity among combined meta-datasets. We suggest that any interesting findings from massive LDSC analysis for a large number of complex traits should be followed up, where possible, with more detailed analyses with GREML methods, even if sample sizes are lesser.	[Ni, Guiyan; Moser, Gerhard; Lee, S. Hong] Univ South Australia, Sch Hlth Sci, Ctr Populat Hlth Res, Adelaide, SA 5000, Australia; [Ni, Guiyan; Moser, Gerhard; Lee, S. Hong] Univ South Australia, Sansom Inst Hlth Res, Adelaide, SA 5000, Australia; [Ni, Guiyan; Moser, Gerhard; Lee, S. Hong] Univ New England, Sch Environm & Rural Sci, Armidale, NSW 2351, Australia; [Wray, Naomi R.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Wray, Naomi R.; Lee, S. Hong] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia	University of South Australia; University of South Australia; University of New England; University of Queensland; University of Queensland	Lee, SH (corresponding author), Univ South Australia, Sch Hlth Sci, Ctr Populat Hlth Res, Adelaide, SA 5000, Australia.; Lee, SH (corresponding author), Univ South Australia, Sansom Inst Hlth Res, Adelaide, SA 5000, Australia.; Lee, SH (corresponding author), Univ New England, Sch Environm & Rural Sci, Armidale, NSW 2351, Australia.; Lee, SH (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	hong.lee@unisa.edu.au	Mattheisen, Manuel/B-4949-2012; Wray, Naomi/C-8639-2015; Pantelis, Christos/H-7722-2014; Lee, Sang Hong/A-2569-2011; Mattheisen, Manuel/S-3725-2019; Reichenberg, Abraham/GQB-1227-2022; Konte, Bettina/AAT-1142-2021; Hartmann, Annette/AAS-6331-2021; Hansen, Thomas Folkmann/O-5965-2014; KUČINSKAS, Vaidutis/A-4798-2013; Webb, Bradley T/B-1459-2009; Lee, Jimmy/ABB-2919-2020; O'Donovan, Michael C/P-7005-2018; Bramon, Elvira/HHC-3809-2022; Golimbet, V/E-2328-2016; McQuillin, Andrew/C-1623-2008; Meier, Sandra/AAB-1242-2021; McIntosh, Andrew M/B-9379-2008; Bergen, Sarah/I-8313-2012; Mowry, Bryan/G-5046-2010; Domenici, Enrico/K-8194-2016; Scott, Rodney/B-2827-2013; Sigurdsson, Engilbert/D-2486-2014; Moser, Gerhard/H-7054-2012; Collier, David/D-1649-2011; Agerbo, Esben/A-2645-2012; Magnusson, Patrik/C-4458-2017; Zimprich, Fritz/W-1738-2017	Mattheisen, Manuel/0000-0002-8442-493X; Wray, Naomi/0000-0001-7421-3357; Pantelis, Christos/0000-0002-9565-0238; Lee, Sang Hong/0000-0001-9701-2718; Mattheisen, Manuel/0000-0002-8442-493X; Konte, Bettina/0000-0001-5287-308X; Hansen, Thomas Folkmann/0000-0001-6703-7762; Webb, Bradley T/0000-0002-0576-5366; Lee, Jimmy/0000-0002-7724-7445; O'Donovan, Michael C/0000-0001-7073-2379; Bramon, Elvira/0000-0003-1369-5983; Golimbet, V/0000-0002-9960-7114; McQuillin, Andrew/0000-0003-1567-2240; McIntosh, Andrew M/0000-0002-0198-4588; Bergen, Sarah/0000-0002-5888-0034; Bacanu, Silviu-Alin/0000-0002-4364-1583; Curtis, David/0000-0002-4089-9183; IWATA, Nakao/0000-0003-3189-6076; Buxbaum, Joseph/0000-0001-8898-8313; O'Neill, Francis Anthony/0000-0002-7531-7657; Borglum, Anders/0000-0001-8627-7219; Posthuma, Danielle/0000-0001-7582-2365; Mowry, Bryan/0000-0002-4115-5645; Walters, James/0000-0002-6980-4053; Domenici, Enrico/0000-0001-7436-6919; Petryshen, Tracey/0000-0002-7972-4612; Buccola, Nancy/0000-0003-1378-4636; Scott, Rodney/0000-0001-7724-3404; Sigurdsson, Engilbert/0000-0001-9404-7982; TOSATO, Sarah/0000-0002-9665-7538; Moser, Gerhard/0000-0003-3104-5730; Myin-Germeys, Inez/0000-0002-3731-4930; Perkins, Diana/0000-0001-9396-2206; Collier, David/0000-0003-4087-1559; Freedman, Robert/0000-0002-2181-2898; Agerbo, Esben/0000-0002-2849-524X; So, Hon-Cheong/0000-0002-7102-833X; Demontis, Ditte/0000-0001-9124-2766; Djurovic, Srdjan/0000-0002-8140-8061; Schall, Ulrich/0000-0001-9041-4562; Klovins, Janis/0000-0001-8362-5505; Magnusson, Patrik/0000-0002-7315-7899; Zimprich, Fritz/0000-0002-6998-5480; Gopal, Srihari/0000-0001-5254-2192; Sim, Kang/0000-0003-3209-9626; Black, Donald/0000-0001-8038-1971; Ehrenreich, Hannelore/0000-0001-8371-5711; Moran, Jennifer/0000-0002-5664-4716; Knight, Joanne/0000-0002-7148-1660; Quested, Digby/0000-0001-6155-3336; Stogmann, Elisabeth/0000-0003-4688-8482; Julia Cano, Antonio/0000-0001-6064-3620; Giusti-Rodriguez, Paola/0000-0002-1921-1305; Lubinski, Jan/0000-0003-2931-3003; Legge, Sophie/0000-0001-6617-0289; Milovancevic, Milos/0000-0002-7891-1010; Liu, Jianjun/0000-0002-3255-3019; Pocklington, Andrew/0000-0002-2137-0452; Ikeda, Masashi/0000-0001-6237-2449; Pejovic Milovancevic, Milica/0000-0001-8902-2668; marsal, sara/0000-0001-5515-3854; Zai, Clement C/0000-0003-0496-7262	Australian National Health and Medical Research Council [1080157, 1087889]; Australian Research Council [DP160102126, FT160100229]; Resource for Genetic Epidemiology Research in Adult Health and Aging [RC2 AG033067]; Robert Wood Johnson Foundation; Wayne and Gladys Valley Foundation; Ellison Medical Foundation; Kaiser Permanente Northern California; Kaiser Permanente National and Northern California Community Benefit Programs; Wellcome Trust [076113, 085475, 090355]; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH101367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033067] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Resource for Genetic Epidemiology Research in Adult Health and Aging; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Wayne and Gladys Valley Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); Kaiser Permanente Northern California; Kaiser Permanente National and Northern California Community Benefit Programs; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research is supported by the Australian National Health and Medical Research Council (1080157, 1087889) and the Australian Research Council (DP160102126, FT160100229). This research has been conducted using the UK Biobank Resource. UK Biobank Research Ethics Committee (REC) approval number is 11/NW/0382. Our reference number approved by UK Biobank is 14575. GERA data came from a grant, the Resource for Genetic Epidemiology Research in Adult Health and Aging (RC2 AG033067; Schaefer and Risch, PIs) awarded to the Kaiser Permanente Research Program on Genes, Environment, and Health (RPGEH) and the UCSF Institute for Human Genetics. The RPGEH was supported by grants from the Robert Wood Johnson Foundation, the Wayne and Gladys Valley Foundation, the Ellison Medical Foundation, Kaiser Permanente Northern California, and the Kaiser Permanente National and Northern California Community Benefit Programs. The RPGEH and the Resource for Genetic Epidemiology Research in Adult Health and Aging are described in the GERA website (see Web Resources). This study makes use of data generated by the Wellcome Trust Case-Control Consortium. A full list of the investigators who contributed to the generation of the WTCCC data is available online. Funding for the WTCCC project was provided by the Wellcome Trust under awards 076113, 085475, and 090355.	[Anonymous], 2013, AM J HUM GENET, V93, P1151, DOI 10.1016/j.ajhg.2013.10.015; Bacanu SA, 2013, SCHIZOPHR RES, V151, P226, DOI 10.1016/j.schres.2013.10.016; Banda Y, 2015, GENETICS, V200, P1285, DOI 10.1534/genetics.115.178616; Bellenguez C, 2012, NAT GENET, V44, P328, DOI 10.1038/ng.1081; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; de los Campos G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003608; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Gunnell D, 2005, SCHIZOPHR RES, V79, P315, DOI 10.1016/j.schres.2005.07.022; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; HARVILLE DA, 1977, J AM STAT ASSOC, V72, P320, DOI 10.2307/2286796; Lee SH, 2016, BIOINFORMATICS, V32, P1420, DOI 10.1093/bioinformatics/btw012; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; Lee SH, 2017, SCI REP-UK, V7, DOI 10.1038/srep42091; Lee SH, 2015, INT J EPIDEMIOL, V44, P1706, DOI 10.1093/ije/dyv136; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Lu QS, 2017, AM J HUM GENET, V101, P939, DOI 10.1016/j.ajhg.2017.11.001; Lynch M, 1998, GENETICS ANAL QUANTI; Maier R, 2015, AM J HUM GENET, V96, P283, DOI 10.1016/j.ajhg.2014.12.006; Mehta D, 2016, JAMA PSYCHIAT, V73, P497, DOI 10.1001/jamapsychiatry.2016.0129; Mells GF, 2011, NAT GENET, V43, P329, DOI 10.1038/ng.789; Neale M., 2013, METHODOLOGY GENETIC; Pasaniuc B, 2017, NAT REV GENET, V18, P117, DOI 10.1038/nrg.2016.142; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.2307/2334389; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Shi HWB, 2017, AM J HUM GENET, V101, P737, DOI 10.1016/j.ajhg.2017.09.022; Speed D, 2017, NAT GENET, V49, P986, DOI 10.1038/ng.3865; Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Yang J, 2015, NAT GENET, V47, P1114, DOI 10.1038/ng.3390; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zheng J, 2017, BIOINFORMATICS, V33, P272, DOI 10.1093/bioinformatics/btw613	37	52	52	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 7	2018	102	6					1185	1194		10.1016/j.ajhg.2018.03.021	http://dx.doi.org/10.1016/j.ajhg.2018.03.021			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GJ0LP	29754766	Green Submitted, Green Published, Green Accepted, Bronze			2022-12-18	WOS:000434946200014
J	Schick, UM; Jain, D; Hodonsky, CJ; Morrison, JV; Davis, JP; Brown, L; Sofer, T; Conomos, MP; Schurmann, C; McHugh, CP; Nelson, SC; Vadlamudi, S; Stilp, A; Plantinga, A; Baier, L; Bien, SA; Gogarten, SM; Laurie, CA; Taylor, KD; Liu, YM; Auer, PL; Franceschini, N; Szpiro, A; Rice, K; Kerr, KF; Rotter, JI; Hanson, RL; Papanicolaou, G; Rich, SS; Loos, RJF; Browning, BL; Browning, SR; Weir, BS; Laurie, CC; Mohlke, KL; North, KE; Thornton, TA; Reiner, AP				Schick, Ursula M.; Jain, Deepti; Hodonsky, Chani J.; Morrison, Jean V.; Davis, James P.; Brown, Lisa; Sofer, Tamar; Conomos, Matthew P.; Schurmann, Claudia; McHugh, Caitlin P.; Nelson, Sarah C.; Vadlamudi, Swarooparani; Stilp, Adrienne; Plantinga, Anna; Baier, Leslie; Bien, Stephanie A.; Gogarten, Stephanie M.; Laurie, Cecelia A.; Taylor, Kent D.; Liu, Yongmei; Auer, Paul L.; Franceschini, Nora; Szpiro, Adam; Rice, Ken; Kerr, Kathleen F.; Rotter, Jerome I.; Hanson, Robert L.; Papanicolaou, George; Rich, Stephen S.; Loos, Ruth J. F.; Browning, Brian L.; Browning, Sharon R.; Weir, Bruce S.; Laurie, Cathy C.; Mohlke, Karen L.; North, Kari E.; Thornton, Timothy A.; Reiner, Alex P.			Genome-wide Association Study of Platelet Count Identifies Ancestry-Specific Loci in Hispanic/Latino Americans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSCRIPTION FACTOR GATA-1; GENETIC-VARIATION; AFRICAN-AMERICAN; SEQUENCE; THROMBOCYTOPENIA; POPULATION; INFERENCE; VARIANTS; MUTATIONS; BINDING	Platelets play an essential role in hemostasis and thrombosis. We performed a genome-wide association study of platelet count in 12,491 participants of the Hispanic Community Health Study/Study of Latinos by using a mixed-model method that accounts for admixture and family relationships. We discovered and replicated associations with five genes (ACTN1, ETV7, GABBR1-MOG, MEF2C, and ZBTB9-BAK1). Our strongest association was with Amerindian-specific variant rs117672662 (p value = 1.16 x 10 (28)) in ACTN1, a gene implicated in congenital macrothrombocytopenia. rs117672662 exhibited allelic differences in transcriptional activity and protein binding in hematopoietic cells. Our results underscore the value of diverse populations to extend insights into the allelic architecture of complex traits.	[Schick, Ursula M.; Bien, Stephanie A.; Reiner, Alex P.] Univ Washington, Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98195 USA; [Schick, Ursula M.; Schurmann, Claudia; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Schick, Ursula M.; Schurmann, Claudia; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Genet Obes & Related Metab Traits Program, New York, NY 10029 USA; [Jain, Deepti; Morrison, Jean V.; Brown, Lisa; Sofer, Tamar; Conomos, Matthew P.; McHugh, Caitlin P.; Nelson, Sarah C.; Stilp, Adrienne; Plantinga, Anna; Gogarten, Stephanie M.; Laurie, Cecelia A.; Szpiro, Adam; Rice, Ken; Kerr, Kathleen F.; Browning, Brian L.; Browning, Sharon R.; Weir, Bruce S.; Laurie, Cathy C.; Thornton, Timothy A.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Hodonsky, Chani J.; Franceschini, Nora; North, Kari E.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27514 USA; [Davis, James P.; Vadlamudi, Swarooparani; Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Baier, Leslie; Hanson, Robert L.] NIDDK, Phoenix Epidemiol & Clin Res Branch, NIH, 445 North 5th St, Phoenix, AZ 85004 USA; [Taylor, Kent D.; Rotter, Jerome I.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Inst Translat Genom & Populat Sci, Torrance, CA 90502 USA; [Taylor, Kent D.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Dept Pediat, Torrance, CA 90502 USA; [Liu, Yongmei] Wake Forest Univ, Sch Med, Winston Salem, NC 27157 USA; [Auer, Paul L.] Univ Wisconsin, Joseph J Zilber Sch Publ Hlth, Milwaukee, WI 53201 USA; [Papanicolaou, George] NHLBI, Div Cardiovasc Sci, NIH, Bldg 10, Bethesda, MD 20892 USA; [Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA; [Rich, Stephen S.] Univ Virginia, Dept Med, Div Endocrinol, Charlottesville, VA 22908 USA; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Wake Forest University; University of Wisconsin System; University of Wisconsin Milwaukee; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Virginia; University of Virginia; Icahn School of Medicine at Mount Sinai	Reiner, AP (corresponding author), Univ Washington, Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98195 USA.	apreiner@uw.edu	Browning, Sharon/B-1530-2008; Kerr, Kathleen F./A-2893-2013; Nelson, Sarah Catherine/AAN-9814-2020; Conomos, Matthew P./A-8136-2019; Loos, Ruth J F/Q-2862-2016; Hodonsky, Chani/AAC-8429-2020; Rotter, Jerome/AAY-6598-2021; Weir, Bruce S/A-2894-2013; Auer, Paul/AAC-5060-2019; Schurmann, Claudia/L-1204-2016; Loos, Ruth/GON-5877-2022; Browning, Brian L/A-1178-2010	Browning, Sharon/0000-0001-7251-9715; Kerr, Kathleen F./0000-0002-6438-9583; Nelson, Sarah Catherine/0000-0002-2109-6465; Conomos, Matthew P./0000-0001-9744-0851; Loos, Ruth J F/0000-0002-8532-5087; Hodonsky, Chani/0000-0001-8566-5877; Schurmann, Claudia/0000-0003-4158-9192; Browning, Brian L/0000-0001-6454-6633; Gogarten, Stephanie/0000-0002-7231-9745; Davis, James/0000-0002-8715-7857; Rich, Stephen/0000-0003-3872-7793; Sofer, Tamar/0000-0001-8520-8860	National Heart, Lung, and Blood Institute (NHLBI) [N01-HC65233]; University of Miami [N01-HC65234]; Albert Einstein College of Medicine [N01-HC65235]; Northwestern University [N01-HC65236]; San Diego State University [N01-HC65237]; National Institute on Minority Health and Health Disparities; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research (NIDCR); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK063491]; National Institute of Neurological Disorders and Stroke; NIH Office of Dietary; NHLBI; NIDCR [HHSN268201300005C AM03, MOD03]; National Center for Advancing Translational Sciences [UL1TR000124]; Intramural Research Program of the NIDDK [HHSB268201200054C]; Illumina; Andrea and Charles Bronfman Philanthropies [R01-GM110068];  [1R01DK101855-01];  [13GRNT16490017];  [R01 DK072193]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC065233] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K01CA148958] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065234, U01HL065233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075071, R01DK101855, R01DK072193, P30DK063491, ZIADK069071, ZIADK075012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110068, P01GM099568] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Miami; Albert Einstein College of Medicine; Northwestern University; San Diego State University; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH Office of Dietary; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Intramural Research Program of the NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Illumina; Andrea and Charles Bronfman Philanthropies; ; ; ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the participants and staff of the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). The baseline examination of HCHS/SOL was supported by contracts from the National Heart, Lung, and Blood Institute (NHLBI) to the University of North Carolina (N01-HC65233), University of Miami (N01-HC65234), Albert Einstein College of Medicine (N01-HC65235), Northwestern University (N01-HC65236), and San Diego State University (N01-HC65237). The National Institute on Minority Health and Health Disparities, National Institute on Deafness and Other Communication Disorders, National Institute of Dental and Craniofacial Research (NIDCR), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Neurological Disorders and Stroke, and NIH Office of Dietary Supplements additionally contributed funding to HCHS/SOL. The Genetic Analysis Center at the University of Washington was supported by NHLBI and NIDCR contracts (HHSN268201300005C AM03 and MOD03). Additional analysis support was provided by 1R01DK101855-01 and 13GRNT16490017. Genotyping was also supported by National Center for Advancing Translational Sciences UL1TR000124 and NIDDK DK063491 to the Southern California Diabetes Endocrinology Research Center. Additional support for rs117672662 functional studies was provided by R01 DK072193. This research was also supported in part by the Intramural Research Program of the NIDDK, contract no. HHSB268201200054C, and Illumina. S.R.B. was supported by R01-GM110068. We thank Dr. Nick Patterson and the Simons Genome Diversity Project for kindly providing Australo-Melanesian sequence data. The Mount Sinai IPM Biobank Program is supported by the Andrea and Charles Bronfman Philanthropies.	Ablain J, 2015, DEV CELL, V32, P756, DOI 10.1016/j.devcel.2015.01.032; Adams D, 2012, NAT BIOTECHNOL, V30, P224, DOI 10.1038/nbt.2153; Alharbi RA, 2013, LEUKEMIA, V27, P1000, DOI 10.1038/leu.2012.356; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; [Anonymous], 2014, R LANG ENV STAT COMP; Bain BJ, 1996, J CLIN PATHOL, V49, P664, DOI 10.1136/jcp.49.8.664; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Biino G, 2011, HAEMATOL-HEMATOL J, V96, P96, DOI 10.3324/haematol.2010.029934; Bottega R, 2015, BLOOD, V125, P869, DOI 10.1182/blood-2014-08-594531; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Buckley MF, 2000, THROMB HAEMOSTASIS, V83, P480; Cavalli-Sforza LL, 2005, NAT REV GENET, V6, P333, DOI 10.1038/nrg1579; Chen W, 2015, ANN AM THORAC SOC, V12, P340, DOI 10.1513/AnnalsATS.201408-380OC; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Conomos M.P., 2014, THESIS U WASHINGTON; Conomos MP, 2016, AM J HUM GENET, V98, P127, DOI 10.1016/j.ajhg.2015.11.022; Conomos MP, 2016, AM J HUM GENET, V98, P165, DOI 10.1016/j.ajhg.2015.12.001; Conomos MP, 2015, GENET EPIDEMIOL, V39, P276, DOI 10.1002/gepi.21896; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Evans D M, 1999, Twin Res, V2, P250, DOI 10.1375/136905299320565735; Fogarty MP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004633; Freson K, 2014, INT J LAB HEMATOL, V36, P313, DOI 10.1111/ijlh.12213; Gekas C, 2009, BLOOD, V113, P3461, DOI 10.1182/blood-2008-07-167577; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gu XS, 2001, J BIOL CHEM, V276, P9421, DOI 10.1074/jbc.M010070200; Gueguen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074728; Hamill KJ, 2015, J INVEST DERMATOL, V135, P1043, DOI 10.1038/jid.2014.505; Heller R., 2015, ARXIV150302278; Heller R, 2014, P NATL ACAD SCI USA, V111, P16262, DOI 10.1073/pnas.1314814111; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Knowler WC, 2005, J DIABETES COMPLICAT, V19, P1, DOI 10.1016/j.jdiacomp.2003.12.007; Kunishima S, 2013, AM J HUM GENET, V92, P431, DOI 10.1016/j.ajhg.2013.01.015; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Lavange LM, 2010, ANN EPIDEMIOL, V20, P642, DOI 10.1016/j.annepidem.2010.05.006; Lee D, 2015, NAT GENET, V47, P955, DOI 10.1038/ng.3331; Li J, 2013, HUM MOL GENET, V22, P1457, DOI 10.1093/hmg/dds534; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lizio M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0560-6; Magnusson M, 2007, BLOOD, V109, P3687, DOI 10.1182/blood-2006-10-054676; Manichaikul A, 2012, PLOS GENET, V8, P285, DOI 10.1371/journal.pgen.1002640; Maples BK, 2013, AM J HUM GENET, V93, P278, DOI 10.1016/j.ajhg.2013.06.020; Martens JHA, 2013, HAEMATOLOGICA, V98, P1487, DOI 10.3324/haematol.2013.094243; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Msaouel P, 2014, HAEMATOLOGICA, V99, P930, DOI 10.3324/haematol.2013.101949; Noetzli L, 2015, NAT GENET, V47, P535, DOI 10.1038/ng.3253; Nurnberg ST, 2012, BLOOD, V120, P4859, DOI 10.1182/blood-2012-01-401893; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Potter MD, 2000, BLOOD, V95, P3341, DOI 10.1182/blood.V95.11.3341.011k44_3341_3348; Qayyum R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002491; Raslova H, 2007, BLOOD, V109, P3225, DOI 10.1182/blood-2006-07-037838; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Reiner AP, 2012, AM J HUM GENET, V91, P502, DOI 10.1016/j.ajhg.2012.07.023; Ritchie GRS, 2014, NAT METHODS, V11, P294, DOI 10.1038/nmeth.2832; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Segal JB, 2006, ANN EPIDEMIOL, V16, P123, DOI 10.1016/j.annepidem.2005.06.052; Shameer K, 2014, HUM GENET, V133, P95, DOI 10.1007/s00439-013-1355-7; Shivdasani RA, 1997, EMBO J, V16, P3965, DOI 10.1093/emboj/16.13.3965; Skoglund P, 2015, NATURE, V525, P104, DOI 10.1038/nature14895; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Sorlie PD, 2010, ANN EPIDEMIOL, V20, P629, DOI 10.1016/j.annepidem.2010.03.015; Tayo BO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019166; Thon JN, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1838; Tian C, 2007, AM J HUM GENET, V80, P1014, DOI 10.1086/513522; Tijssen MR, 2011, DEV CELL, V20, P597, DOI 10.1016/j.devcel.2011.04.008; Topka S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005262; Wang CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124191; Wang QR, 2014, HAEMATOLOGICA, V99, pE176, DOI 10.3324/haematol.2014.104406; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Westbury SK, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0151-5; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Williams AL, 2014, NATURE, V506, P97, DOI 10.1038/nature12828; Witkop C J, 1990, Bol Asoc Med P R, V82, P333; Woo AJ, 2013, J CLIN INVEST, V123, P3292, DOI 10.1172/JCI40609; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zhang MY, 2015, NAT GENET, V47, P180, DOI 10.1038/ng.3177; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	85	52	53	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 4	2016	98	2					229	242		10.1016/j.ajhg.2015.12.003	http://dx.doi.org/10.1016/j.ajhg.2015.12.003			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DE3BR	26805783	Green Published, Bronze			2022-12-18	WOS:000370502300001
J	Davidson, AE; Liskova, P; Evans, CJ; Dudakova, L; Noskova, L; Pontikos, N; Hartmannova, H; Hodanova, K; Stranecky, V; Kozmik, Z; Levis, HJ; Idigo, N; Sasai, N; Maher, GJ; Bellingham, J; Veli, N; Ebenezer, ND; Cheetham, ME; Daniels, JT; Thaung, CMH; Jirsova, K; Plagnol, V; Filipec, M; Kmoch, S; Tuft, SJ; Hardcastle, AJ				Davidson, Alice E.; Liskova, Petra; Evans, Cerys J.; Dudakova, Lubica; Noskova, Lenka; Pontikos, Nikolas; Hartmannova, Hana; Hodanova, Katerina; Stranecky, Viktor; Kozmik, Zbynek; Levis, Hannah J.; Idigo, Nwamaka; Sasai, Noriaki; Maher, Geoffrey J.; Bellingham, James; Veli, Neyme; Ebenezer, Neil D.; Cheetham, Michael E.; Daniels, Julie T.; Thaung, Caroline M. H.; Jirsova, Katerina; Plagnol, Vincent; Filipec, Martin; Kmoch, Stanislav; Tuft, Stephen J.; Hardcastle, Alison J.			Autosomal-Dominant Corneal Endothelial Dystrophies CHED1 and PPCD1 Are Allelic Disorders Caused by Non-coding Mutations in the Promoter of OVOL2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE; CELLS; CHROMOSOME-20; LINKAGE; DIFFERENTIATION; IDENTIFICATION; EXPRESSION; MANAGEMENT; MEMBRANE; ADHESION	Congenital hereditary endothelial dystrophy 1 (CHED1) and posterior polymorphous corneal dystrophy 1 (PPCD1) are autosomal-dominant corneal endothelial dystrophies that have been genetically mapped to overlapping loci on the short arm of chromosome 20. We combined genetic and genomic approaches to identify the cause of disease in extensive pedigrees comprising over 100 affected individuals. After exclusion of pathogenic coding, splice-site, and copy-number variations, a parallel approach using targeted and whole-genome sequencing facilitated the identification of pathogenic variants in a conserved region of the OVOL2 proximal promoter sequence in the index families (c.-339_361dup for CHED1 and c.-370T>C for PPCD1). Direct sequencing of the OVOL2 promoter in other unrelated affected individuals identified two additional mutations within the conserved proximal promoter sequence (c.-274T>G and c.-307T>C). OVOL2 encodes ovo-like zinc finger 2, a C2H2 zinc-finger transcription factor that regulates mesenchymal-to-epithelial transition and acts as a direct transcriptional repressor of the established PPCD-associated gene ZEB1. Interestingly, we did not detect OVOL2 expression in the normal corneal endothelium. Our in vitro data demonstrate that all four mutated OVOL2 promoters exhibited more transcriptional activity than the corresponding wild-type promoter, and we postulate that the mutations identified create cryptic cis-acting regulatory sequence binding sites that drive aberrant OVOL2 expression during endothelial cell development. Our data establish CHED1 and PPCD1 as allelic conditions and show that CHED1 represents the extreme of what can be considered a disease spectrum. They also implicate transcriptional dysregulation of OVOL2 as a common cause of dominantly inherited corneal endothelial dystrophies.	[Davidson, Alice E.; Liskova, Petra; Evans, Cerys J.; Pontikos, Nikolas; Levis, Hannah J.; Idigo, Nwamaka; Sasai, Noriaki; Bellingham, James; Ebenezer, Neil D.; Cheetham, Michael E.; Daniels, Julie T.; Thaung, Caroline M. H.; Tuft, Stephen J.; Hardcastle, Alison J.] UCL, UCL Inst Ophthalmol, London EC1V 9EL, England; [Liskova, Petra; Dudakova, Lubica; Noskova, Lenka; Hartmannova, Hana; Hodanova, Katerina; Stranecky, Viktor; Jirsova, Katerina; Kmoch, Stanislav] Charles Univ Prague, Fac Med 1, Inst Inherited Metab Disorders, Prague 12808, Czech Republic; [Liskova, Petra; Dudakova, Lubica; Noskova, Lenka; Hartmannova, Hana; Hodanova, Katerina; Stranecky, Viktor; Jirsova, Katerina; Kmoch, Stanislav] Gen Univ Hosp Prague, Prague 12808, Czech Republic; [Liskova, Petra] Charles Univ Prague, Fac Med 1, Dept Ophthalmol, Prague 12808, Czech Republic; [Pontikos, Nikolas; Plagnol, Vincent] UCL, UCL Genet Inst, London WC1E 6BT, England; [Kozmik, Zbynek] Inst Mol Genet, Prague 14220, Czech Republic; [Maher, Geoffrey J.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Veli, Neyme; Thaung, Caroline M. H.; Tuft, Stephen J.] Moorfields Eye Hosp, London EC1V 2PD, England; [Filipec, Martin] European Eye Clin Lexum, Prague 14000, Czech Republic	University of London; University College London; Charles University Prague; General University Hospital Prague; Charles University Prague; University of London; University College London; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; University of Oxford; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Liskova, P (corresponding author), UCL, UCL Inst Ophthalmol, London EC1V 9EL, England.	petra.liskova@lfl.cuni.cz; a.hardcastle@ucl.ac.uk	Kmoch, Stanislav/C-1575-2010; Dudakova, Lubica/F-4781-2017; Noskova, Lenka/F-6564-2017; Stranecky, Viktor/I-8524-2017; Hartmannova, Hana/H-4735-2017; Kozmik, Zbynek/I-8807-2014; Jirsova, Katerina/B-8301-2012; Pontikos, Nikolas/U-3642-2018; Levis, Hannah/AAH-6556-2019; Bellingham, James/GVS-8955-2022; Hodaňová, Kateřina/I-4727-2017; Liskova, Petra/C-9680-2011; Thaung, Caroline/C-2180-2008	Kmoch, Stanislav/0000-0002-6239-707X; Dudakova, Lubica/0000-0003-4718-8955; Noskova, Lenka/0000-0001-7011-4327; Stranecky, Viktor/0000-0002-2599-6479; Hartmannova, Hana/0000-0001-7787-832X; Jirsova, Katerina/0000-0002-4625-6701; Pontikos, Nikolas/0000-0003-1782-4711; Bellingham, James/0000-0003-3368-5221; Hodaňová, Kateřina/0000-0001-9172-9945; Liskova, Petra/0000-0001-7834-8486; Thaung, Caroline/0000-0002-8318-046X; Cheetham, Michael/0000-0001-6429-654X; Levis, Hannah/0000-0002-3923-1178; Sasai, Noriaki/0000-0003-0360-1138; Idigo, Nwamaka/0000-0002-0723-3793; Kozmik, Zbynek/0000-0002-5850-2105; Hardcastle, Alison/0000-0002-0038-6770; Daniels, Julie/0000-0003-2099-9360; Evans, Cerys/0000-0001-6989-889X	National Health Service (NHS); Fight for Sight; Lanvern Foundation; Rosetrees Trust; Moorfields Eye Charity; Moorfields Special Trustees; Wellcome Trust [092621]; Charles University in Prague [UNCE 204011, PRVOUK-P24/LF1/3, SVV-UK 260148/2015]; BIOCEV (Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University) [CZ.1.05/1.1.00/02.0109]; European Regional Development Fund; Czech Ministry of Health [NT13116-4/2012, 15-28208A]; Czech-Norwegian Research Programme of the Czech Ministry of Education [7F14156]; National Institute for Health Research Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust and University College London Institute of Ophthalmology; Medical Research Council [1125070] Funding Source: researchfish; Rosetrees Trust [M311] Funding Source: researchfish; Fight for Sight [1588/89, 1415/16] Funding Source: researchfish	National Health Service (NHS); Fight for Sight; Lanvern Foundation; Rosetrees Trust(Rosetrees Trust); Moorfields Eye Charity; Moorfields Special Trustees; Wellcome Trust(Wellcome TrustEuropean Commission); Charles University in Prague; BIOCEV (Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University); European Regional Development Fund(European Commission); Czech Ministry of Health(Ministry of Health, Czech Republic); Czech-Norwegian Research Programme of the Czech Ministry of Education; National Institute for Health Research Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust and University College London Institute of Ophthalmology; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust); Fight for Sight	We would like to thank all the families for participating in this research. The diagnostic service is acknowledged for specimens provided by the Department of Eye Pathology, which is part of the National Health Service (NHS)-funded National Specialist Ophthalmic Pathology Service (UK subjects). We were supported by funding from Fight for Sight, the Lanvern Foundation, the Rosetrees Trust, the Moorfields Eye Charity, Moorfields Special Trustees (A.J.H., A.E.D., and C.J.E.), and the Wellcome Trust (092621 to M.E.C.). P.L. and L.D. were supported by the UNCE 204011, PRVOUK-P24/LF1/3, and SVV-UK 260148/2015 programs of Charles University in Prague. S.K., H.H., K.H., V.S., and L.N. were supported by BIOCEV (Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University; CZ.1.05/1.1.00/02.0109), the European Regional Development Fund, and grants NT13116-4/2012 and 15-28208A from the Czech Ministry of Health. K.J. was supported by the Czech-Norwegian Research Programme (7F14156) of the Czech Ministry of Education. S.J.T., V.P., N.P., and A.J.H. were supported by the National Institute for Health Research Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust and University College London Institute of Ophthalmology. The pGL3-Control vector was a kind gift from Dr. Stephanie Halford.	Aldave AJ, 2013, CLIN GENET, V84, P109, DOI 10.1111/cge.12191; Aldave AJ, 2007, AM J MED GENET A, V143A, P2549, DOI 10.1002/ajmg.a.31978; Aldave AJ, 2009, CORNEA, V28, P801, DOI 10.1097/ICO.0b013e31819672fb; Biswas S, 2001, HUM MOL GENET, V10, P2415, DOI 10.1093/hmg/10.21.2415; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen YY, 2013, HUM MOL GENET, V22, P1271, DOI 10.1093/hmg/dds527; Chung DWD, 2014, INVEST OPHTH VIS SCI, V55, P6159, DOI 10.1167/iovs.14-15247; CIBIS GW, 1977, ARCH OPHTHALMOL-CHIC, V95, P1529; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; de Vooght KMK, 2009, CLIN CHEM, V55, P698, DOI 10.1373/clinchem.2008.120931; Duband JL, 1996, CURR TOP MICROBIOL, V212, P207; Dudakova L, 2012, EXP EYE RES, V104, P74, DOI 10.1016/j.exer.2012.09.005; Gwilliam R, 2005, INVEST OPHTH VIS SCI, V46, P4480, DOI 10.1167/iovs.05-0269; HEON E, 1995, HUM MOL GENET, V4, P485, DOI 10.1093/hmg/4.3.485; Jirsova K, 2007, EXP EYE RES, V84, P680, DOI 10.1016/j.exer.2006.12.006; KIRKNESS CM, 1987, BRIT J OPHTHALMOL, V71, P130, DOI 10.1136/bjo.71.2.130; Krachmer J H, 1985, Trans Am Ophthalmol Soc, V83, P413; Krafchak CM, 2005, AM J HUM GENET, V77, P694, DOI 10.1086/497348; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lai IN, 2010, MOL VIS, V16, P2829; Lee B, 2014, DEV CELL, V29, P47, DOI 10.1016/j.devcel.2014.03.005; Li B, 2002, GENOMICS, V80, P319, DOI 10.1006/geno.2002.6831; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767; Liskova P, 2015, EUR J HUM GENET; Liskova P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045495; Mackay DR, 2006, DEV BIOL, V291, P38, DOI 10.1016/j.ydbio.2005.12.003; Massie I, 2015, METHODS MOL BIOL, V1235, P179, DOI 10.1007/978-1-4939-1785-3_15; Menendez L, 2013, NAT PROTOC, V8, P203, DOI 10.1038/nprot.2012.156; Merjava S, 2011, HISTOCHEM CELL BIOL, V136, P93, DOI 10.1007/s00418-011-0830-2; MURPHY C, 1984, INVEST OPHTH VIS SCI, V25, P312; Notara M, 2010, BRAIN RES BULL, V81, P279, DOI 10.1016/j.brainresbull.2009.08.009; Paila U, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003153; PEARCE WG, 1969, BRIT J OPHTHALMOL, V53, P577, DOI 10.1136/bjo.53.9.577; Peh GSL, 2011, TRANSPLANTATION, V91, P811, DOI 10.1097/TP.0b013e3182111f01; Plagnol V, 2012, BIOINFORMATICS, V28, P2747, DOI 10.1093/bioinformatics/bts526; Roca H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076773; Sanchez-Tillo E, 2010, ONCOGENE, V29, P3490, DOI 10.1038/onc.2010.102; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; SHERRARD ES, 1987, EYE, V1, P197, DOI 10.1038/eye.1987.37; Stranecky V, 2013, AM J HUM GENET, V92, P792, DOI 10.1016/j.ajhg.2013.03.023; Studeny P, 2012, INDIAN J OPHTHALMOL, V60, P59, DOI 10.4103/0301-4738.91350; Teng A, 2007, BBA-MOL BASIS DIS, V1772, P89, DOI 10.1016/j.bbadis.2006.08.012; TOMA NMG, 1995, HUM MOL GENET, V4, P2395, DOI 10.1093/hmg/4.12.2395; Valtink M, 2008, CELLS TISSUES ORGANS, V187, P286, DOI 10.1159/000113406; van de Steeg E, 2012, J CLIN INVEST, V122, P519, DOI 10.1172/JCI59526; Weiss JS, 2015, CORNEA, V34, P117, DOI 10.1097/ICO.0000000000000307; WULLE KG, 1969, OPHTHALMOLOGICA, V157, P451, DOI 10.1159/000305709; Yellore VS, 2007, GENET MED, V9, P228, DOI 10.1097/GIM.0b013e31803c4dc2	49	52	55	3	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 7	2016	98	1					75	89		10.1016/j.ajhg.2015.11.018	http://dx.doi.org/10.1016/j.ajhg.2015.11.018			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DA8JL	26749309	Green Published, hybrid			2022-12-18	WOS:000368050800006
J	Vasileiou, G; Ekici, AB; Urebe, S; Zweier, C; Hoyer, J; Engels, H; Behrens, J; Reis, A; Hadjihannas, MV				Vasileiou, Georgia; Ekici, Arif B.; Urebe, Steffen; Zweier, Christiane; Hoyer, Juliane; Engels, Hartmut; Behrens, Juergen; Reis, Andre; Hadjihannas, Michel V.			Chromatin-Remodeling-Factor ARID1 B Represses Wnt/beta-Catenin Signaling	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SWI/SNF-RELATED COMPLEXES; CELL-CYCLE CONTROL; BETA-CATENIN; UP-REGULATION; TARGET; GENE; MUTATIONS; SUBUNITS; CONDUCTIN/AXIN2; COMPARABILITY	The link of chromatin remodeling to both neurodevelopment and cancer has recently been highlighted by the identification of mutations affecting BAF chromatin-remodeling components, such as ARID1B, in individuals with intellectual disability and cancer. However, the underlying molecular mechanism(s) remains unknown. Here, we show that ARID1B is a repressor of Wnt/beta-catenin signaling. Through whole-transcriptome analysis, we find that in individuals with intellectual disability and ARID1B loss-of-function mutations, Wnt/beta-catenin target genes are upregulated. Using cellular models of low and high Wnt/beta-catenin activity, we demonstrate that knockdown of ARID1B activates Wnt/beta-catenin target genes and Wnt/beta-catenin-dependent transcriptional reporters in a beta-catenin-dependent manner. Reciprocally, forced expression of ARID 1B inhibits Wnt/beta-catenin signaling downstream of the beta-catenin destruction complex. Both endogenous and exogenous ARID1B associate with beta-catenin and repress Wnt/beta-catenin-mediated transcription through the BAF core subunit BRG1. Accordingly, mutations in ARID1B leading to partial or complete deletion of its BRG1-binding domain, as is often observed in intellectual disability and cancers, compromise association with P-catenin, and the resultant ARID1B mutant proteins fail to suppress Wnt/beta-catenin signaling. Finally, knockdown of ARID1B in mouse neuroblastoma cells leads to neurite outgrowth through beta-catenin. The data suggest that aberrations in chromatin-remodeling factors, such as ARID1B, might contribute to neurodevelopmental abnormalities and cancer through deregulation of developmental and oncogenic pathways, such as the Wnt/beta-catenin signaling pathway.	[Vasileiou, Georgia; Ekici, Arif B.; Urebe, Steffen; Zweier, Christiane; Hoyer, Juliane; Reis, Andre; Hadjihannas, Michel V.] Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; [Engels, Hartmut] Univ Bonn, Inst Human Genet, D-53105 Bonn, Germany; [Behrens, Juergen; Hadjihannas, Michel V.] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Bonn; University of Erlangen Nuremberg	Reis, A (corresponding author), Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany.	andre.reis@uk-erlangen.de	Reis, André/D-2309-2009; Ekici, Arif B/C-3971-2013; Zweier, Christiane/F-2202-2015	Reis, André/0000-0002-6301-6363; Ekici, Arif B/0000-0001-6099-7066; Zweier, Christiane/0000-0001-8002-2020; Vasileiou, Georgia/0000-0002-1993-1134	German Intellectual Disability Network (MRNET) from the German Ministry of Education and Research [01GS08160]; Interdisciplinary Center for Clinical Research Erlangen [E16]	German Intellectual Disability Network (MRNET) from the German Ministry of Education and Research; Interdisciplinary Center for Clinical Research Erlangen	We thank the affected individuals and their families for their cooperation. We also thank Andreas Winterpacht for reagents and Sabine Endele, Christian Thiel, Katharina Brauburger, Francesca Pasutto, and Kristin Kessler for their useful advice. We are indebted to Martina Bruckner, Angelika Diem, Petra Rothe, and Olga Zwenger for excellent technical assistance. This work was supported in part by the German Intellectual Disability Network (MRNET) through a grant from the German Ministry of Education and Research to A.R. (01GS08160) and by the Interdisciplinary Center for Clinical Research Erlangen, project E16.	Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brault V, 2001, DEVELOPMENT, V128, P1253; Cajuso T, 2014, INT J CANCER, V135, P611, DOI 10.1002/ijc.28705; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Codina-Sola M, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0017-0; Collins RT, 1999, EMBO J, V18, P7029, DOI 10.1093/emboj/18.24.7029; Davidson G, 2009, DEV CELL, V17, P788, DOI 10.1016/j.devcel.2009.11.006; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dehner M, 2008, J BIOL CHEM, V283, P19201, DOI 10.1074/jbc.M710366200; Endo Y, 2007, CANCER SCI, V98, P1311, DOI 10.1111/j.1349-7006.2007.00536.x; Flores-Alcantar A, 2011, CELL TISSUE RES, V345, P137, DOI 10.1007/s00441-011-1182-x; Gavert N, 2005, J CELL BIOL, V168, P633, DOI 10.1083/jcb.200408051; Gregor A, 2013, AM J HUM GENET, V93, P124, DOI 10.1016/j.ajhg.2013.05.007; Griffin CT, 2011, P NATL ACAD SCI USA, V108, P2282, DOI 10.1073/pnas.1013751108; Hadjihannas MV, 2012, EMBO REP, V13, P347, DOI 10.1038/embor.2012.12; Hadjihannas MV, 2010, EMBO REP, V11, P317, DOI 10.1038/embor.2010.23; Halgren C, 2012, CLIN GENET, V82, P248, DOI 10.1111/j.1399-0004.2011.01755.x; Helming KC, 2014, NAT MED, V20, P251, DOI 10.1038/nm.3480; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Holik AZ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004453; Hurlstone AFL, 2002, BIOCHEM J, V364, P255, DOI 10.1042/bj3640255; Inoue H, 2002, J BIOL CHEM, V277, P41674, DOI 10.1074/jbc.M205961200; Inoue H, 2011, BIOCHEM J, V434, P83, DOI 10.1042/BJ20101358; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Mora-Blanco EL, 2014, ONCOGENE, V33, P933, DOI 10.1038/onc.2013.37; Nagl NG, 2006, CANCER RES, V66, P1289, DOI 10.1158/0008-5472.CAN-05-3427; Nagl NG, 2005, CANCER RES, V65, P9236, DOI 10.1158/0008-5472.CAN-05-1225; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Ruijtenberg S, 2015, CELL, V162, P300, DOI 10.1016/j.cell.2015.06.013; Sangkhathat S, 2006, ONCOL REP, V16, P1197; Santen GWE, 2012, NAT GENET, V44, P379, DOI 10.1038/ng.2217; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Son EY, 2014, AM J MED GENET C, V166, P333, DOI 10.1002/ajmg.c.31416; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; Tylee DS, 2013, AM J MED GENET B, V162, P595, DOI 10.1002/ajmg.b.32150; Wang L, 2008, MOL CELL BIOL, V28, P6262, DOI 10.1128/MCB.00923-08; Wang XM, 2004, BIOCHEM J, V383, P319, DOI 10.1042/BJ20040524; Wisniewska MB, 2013, NEUROCHEM RES, V38, P1144, DOI 10.1007/s11064-013-0980-9; Yan Z, 2008, STEM CELLS, V26, P1155, DOI 10.1634/stemcells.2007-0846	47	52	53	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 3	2015	97	3					445	456		10.1016/j.ajhg.2015.08.002	http://dx.doi.org/10.1016/j.ajhg.2015.08.002			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CR1KW	26340334	Bronze, Green Published			2022-12-18	WOS:000361084700007
J	Xiong, DH; Wang, Y; Kupert, E; Simpson, C; Pinney, SM; Gaba, CR; Mandal, D; Schwartz, AG; Yang, P; de Andrade, M; Pikielny, C; Byun, J; Li, YF; Stambolian, D; Spitz, MR; Liu, YH; Amos, CI; Bailey-Wilson, JE; Anderson, M; You, M				Xiong, Donghai; Wang, Yian; Kupert, Elena; Simpson, Claire; Pinney, Susan M.; Gaba, Colette R.; Mandal, Diptasri; Schwartz, Ann G.; Yang, Ping; de Andrade, Mariza; Pikielny, Claudio; Byun, Jinyoung; Li, Yafang; Stambolian, Dwight; Spitz, Margaret R.; Liu, Yanhong; Amos, Christopher I.; Bailey-Wilson, Joan E.; Anderson, Marshall; You, Ming			A Recurrent Mutation in PARK2 Is Associated with Familial Lung Cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							UBIQUITIN-PROTEASOME SYSTEM; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCUS; RISK; LOCALIZATION; IMPAIRMENT; VARIANTS; SMOKING	PARK2, a gene associated with Parkinson disease, is a tumor suppressor in human malignancies. Here, we show that c.823C>T (p.Arg275Trp), a germline mutation in PARK2, is present in a family with eight cases of lung cancer. The resulting amino acid change, p.Arg275Trp, is located in the highly conserved RING finger 1 domain of PARK2, which encodes an E3 ubiquitin ligase. Upon further analysis, the c.823C>T mutation was detected in three additional families affected by lung cancer. The effect size for PARK2 c.823C>T (odds ratio = 5.24) in white individuals was larger than those reported for variants from lung cancer genome-wide association studies. These data implicate this PARK2 germline mutation as a genetic susceptibility factor for lung cancer. Our results provide a rationale for further investigations of this specific mutation and gene for evaluation of the possibility of developing targeted therapies against lung cancer in individuals with PARK2 variants by compensating for the loss-of-function effect caused by the associated variation.	[Xiong, Donghai; Wang, Yian; You, Ming] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Xiong, Donghai; Wang, Yian; Kupert, Elena; Anderson, Marshall; You, Ming] Med Coll Wisconsin, Ctr Canc, Milwaukee, WI 53226 USA; [Kupert, Elena; Anderson, Marshall] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; [Simpson, Claire; Bailey-Wilson, Joan E.] NHGRI, Computat & Stat Genom Branch, NIH, Baltimore, MD 20892 USA; [Pinney, Susan M.] Univ Cincinnati, Dept Environm Hlth, Coll Med, Cincinnati, OH 45267 USA; [Gaba, Colette R.] Univ Toledo, Coll Med, Toledo, OH 43614 USA; [Mandal, Diptasri] Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA 70112 USA; [Schwartz, Ann G.] Karmanos Canc Inst, Detroit, MI 48201 USA; [Yang, Ping; de Andrade, Mariza] Mayo Clin, Rochester, MN 55905 USA; [Pikielny, Claudio; Byun, Jinyoung; Li, Yafang; Amos, Christopher I.] Dartmouth Coll, Geisel Sch Med, Dept Community & Family Med, Lebanon, NH 03755 USA; [Stambolian, Dwight] Univ Penn, Dept Ophthalmol & Genet, Philadelphia, PA 19104 USA; [Spitz, Margaret R.; Liu, Yanhong] Baylor Coll Med, Houston, TX 77030 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; University System of Ohio; University of Cincinnati; University System of Ohio; University of Toledo; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Barbara Ann Karmanos Cancer Institute; Mayo Clinic; Dartmouth College; University of Pennsylvania; Baylor College of Medicine	You, M (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA.	myou@mcw.edu	liu, yan/HCI-5542-2022; liu, yan/HGV-1365-2022	Simpson, Claire/0000-0003-2244-7690; de Andrade, Mariza/0000-0003-2329-2686; Bailey-Wilson, Joan/0000-0002-9153-2920; Pinney, Susan/0000-0003-3491-1980	NIH [R01CA134433, R01CA134682, R01CA113793, R01CA129533, U01CA76293, P30-ES006096, RO1CA127219, N01-HG-65404, U19CA148127, P30CA023108, K07CA181480, HHSN268201200007C]; NIH National Human Genome Research Institute; Advancing a Healthier Wisconsin fund; National Lung Cancer Partnership, Free to Breathe; Lung Cancer Initiative of North Carolina; NATIONAL CANCER INSTITUTE [R01CA127219, P30CA015083, R01CA134433, P30CA023108, U19CA148127, U01CA076293, K07CA181480, R01CA113793, R01CA129533, R01CA134682, R25CA134286] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY001583] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065404, ZIAHG200331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Advancing a Healthier Wisconsin fund; National Lung Cancer Partnership, Free to Breathe; Lung Cancer Initiative of North Carolina; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by grants and contracts from the NIH (R01CA134433, R01CA134682, R01CA113793, R01CA129533, U01CA76293, P30-ES006096, RO1CA127219, N01-HG-65404, U19CA148127, P30CA023108, K07CA181480, and HHSN268201200007C), the Intramural Research Program of the NIH National Human Genome Research Institute, and the Advancing a Healthier Wisconsin fund. C.S. is supported in part by the National Lung Cancer Partnership, Free to Breathe, and the Lung Cancer Initiative of North Carolina.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Amos CI, 2010, CANCER RES, V70, P2359, DOI 10.1158/0008-5472.CAN-09-3096; Bartek J, 2014, NAT GENET, V46, P527, DOI 10.1038/ng.2992; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cookson MR, 2003, HUM MOL GENET, V12, P2957, DOI 10.1093/hmg/ddg328; Driver JA, 2007, CANCER EPIDEM BIOMAR, V16, P1260, DOI 10.1158/1055-9965.EPI-07-0038; Gong YX, 2014, NAT GENET, V46, P588, DOI 10.1038/ng.2981; Hernan MA, 2002, ANN NEUROL, V52, P276, DOI 10.1002/ana.10277; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McNaught KS, 2002, J NEUROCHEM, V81, P301, DOI 10.1046/j.1471-4159.2002.00821.x; MOLLER H, 1995, BRIT MED J, V310, P1500, DOI 10.1136/bmj.310.6993.1500; NEFZGER MD, 1968, AM J EPIDEMIOL, V88, P149, DOI 10.1093/oxfordjournals.aje.a120874; Olsen JH, 2005, BRIT J CANCER, V92, P201, DOI 10.1038/sj.bjc.6602279; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Quinn N, 1987, Mov Disord, V2, P73, DOI 10.1002/mds.870020201; Sriram SR, 2005, HUM MOL GENET, V14, P2571, DOI 10.1093/hmg/ddi292; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Veeriah S, 2010, NAT GENET, V42, P77, DOI 10.1038/ng.491; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang YF, 2014, NAT GENET, V46, P736, DOI 10.1038/ng.3002; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6; Xiong DH, 2012, CARCINOGENESIS, V33, P1797, DOI 10.1093/carcin/bgs210; Xu L, 2014, J MOL MED, V92, P31, DOI 10.1007/s00109-013-1107-0; Yokoyama S, 2011, NATURE, V480, P99, DOI 10.1038/nature10630; You M, 2009, CLIN CANCER RES, V15, P2666, DOI 10.1158/1078-0432.CCR-08-2335	33	52	53	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 5	2015	96	2					301	308		10.1016/j.ajhg.2014.12.016	http://dx.doi.org/10.1016/j.ajhg.2014.12.016			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CA9WY	25640678	Green Published, Bronze			2022-12-18	WOS:000349276700012
J	Glubb, DM; Maranian, MJ; Michailidou, K; Pooley, KA; Meyer, KB; Kar, S; Carlebur, S; O'Reilly, M; Betts, JA; Hillman, KM; Kaufmann, S; Beesley, J; Canisius, S; Hopper, JL; Southey, MC; Tsimiklis, H; Apicella, C; Schmidt, MK; Broeks, A; Hogervorst, FB; van der Schoot, CE; Muir, K; Lophatananon, A; Stewart-Brown, S; Siriwanarangsan, P; Fasching, PA; Ruebner, M; Ekici, AB; Beckmann, MW; Peto, J; Dos-Santos-Silva, I; Fletcher, O; Johnson, N; Pharoah, PDP; Bolla, MK; Wang, Q; Dennis, J; Sawyer, EJ; Tomlinson, I; Kerin, MJ; Miller, N; Burwinkel, B; Marme, F; Yang, RX; Surowy, H; Guenel, P; Truong, T; Menegaux, F; Sanchez, M; Bojesen, SE; Nordestgaard, BG; Nielsen, SF; Flyger, H; Gonzelez-Neira, A; Benitez, J; Zamora, MP; Perez, JIA; Anton-Culver, H; Neuhausen, SL; Brenner, H; Dieffenbach, AK; Arndt, V; Stegmaier, C; Meindl, A; Schmutzler, RK; Brauch, H; Ko, YD; Bruning, T; Nevanlinna, H; Muranen, TA; Aittomaki, K; Blomqvist, C; Matsuo, K; Ito, H; Iwata, H; Tanaka, H; Dork, T; Bogdanova, NV; Helbig, S; Lindblom, A; Margolin, S; Mannermaa, A; Kataja, V; Kosma, VM; Hartikainen, JM; Wu, AH; Tseng, CC; Van den Berg, D; Stram, DO; Lambrechts, D; Zhao, H; Weltens, C; van Limbergen, E; Chang-Claude, J; Flesch-Janys, D; Rudolph, A; Seibold, P; Radice, P; Peterlongo, P; Barile, M; Capra, F; Couch, FJ; Olson, JE; Hallberg, E; Vachon, C; Giles, GG; Milne, RL; McLean, C; Haiman, CA; Henderson, BE; Schumacher, F; Le Marchand, L; Simard, J; Goldberg, MS; Labreche, F; Dumont, M; Teo, SH; Yip, CH; See, MH; Cornes, B; Cheng, CY; Ikram, MK; Kristensen, V; Zheng, W; Halverson, SL; Shrubsole, M; Long, J; Winqvist, R; Pylkas, K; Jukkola-Vuorinen, A; Kauppila, S; Andrulis, IL; Knight, JA; Glendon, G; Tchatchou, S; Devilee, P; Tollenaar, RAEM; Seynaeve, C; Van Asperen, CJ; Garcia-Closas, M; Figueroa, J; Chanock, SJ; Lissowska, J; Czene, K; Klevebring, D; Darabi, H; Eriksson, M; Hooning, MJ; Hollestelle, A; Martens, JWM; Collee, JM; Hall, P; Li, JM; Humphreys, K; Shu, XO; Lu, W; Gao, YT; Cai, H; Cox, A; Cross, SS; Reed, MWR; Blot, W; Signorello, LB; Cai, QY; Shah, M; Ghoussaini, M; Kang, D; Choi, JY; Park, SK; Noh, DY; Hartman, M; Miao, H; Lim, WY; Tang, A; Hamann, U; Torres, D; Jakubowska, A; Lubinski, J; Jaworska, K; Durda, K; Sangrajrang, S; Gaborieau, V; Brennan, P; McKay, J; Olswold, C; Slager, S; Toland, AE; Yannoukakos, D; Shen, CY; Wu, PE; Yu, JC; Hou, MF; Swerdlow, A; Ashworth, A; Orr, N; Jones, M; Pita, G; Alonso, MR; Alvarez, N; Herrero, D; Tessier, DC; Vincent, D; Bacot, F; Luccarini, C; Baynes, C; Ahmed, S; Healey, CS; Brown, MA; Ponder, BAJ; Chenevix-Trench, G; Thompson, DJ; Edwards, SL; Easton, DF; Dunning, AM; French, JD				Glubb, Dylan M.; Maranian, Mel J.; Michailidou, Kyriaki; Pooley, Karen A.; Meyer, Kerstin B.; Kar, Siddhartha; Carlebur, Saskia; O'Reilly, Martin; Betts, Joshua A.; Hillman, Kristine M.; Kaufmann, Susanne; Beesley, Jonathan; Canisius, Sander; Hopper, John L.; Southey, Melissa C.; Tsimiklis, Helen; Apicella, Carmel; Schmidt, Marjanka K.; Broeks, Annegien; Hogervorst, Frans B.; van der Schoot, C. Ellen; Muir, Kenneth; Lophatananon, Artitaya; Stewart-Brown, Sarah; Siriwanarangsan, Pornthep; Fasching, Peter A.; Ruebner, Matthias; Ekici, Arif B.; Beckmann, Matthias W.; Peto, Julian; Dos-Santos-Silva, Isabel; Fletcher, Olivia; Johnson, Nichola; Pharoah, Paul D. P.; Bolla, Manjeet K.; Wang, Qin; Dennis, Joe; Sawyer, Elinor J.; Tomlinson, Ian; Kerin, Michael J.; Miller, Nicola; Burwinkel, Barbara; Marme, Frederik; Yang, Rongxi; Surowy, Harald; Guenel, Pascal; Truong, Therese; Menegaux, Florence; Sanchez, Marie; Bojesen, Stig E.; Nordestgaard, Borge G.; Nielsen, Sune F.; Flyger, Henrik; Gonzalez-Neira, Anna; Benitez, Javier; Pilar Zamora, M.; Arias Perez, Jose Ignacio; Anton-Culver, Hoda; Neuhausen, Susan L.; Brenner, Hermann; Dieffenbach, Aida Karina; Arndt, Volker; Stegmaier, Christa; Meindl, Alfons; Schmutzler, Rita K.; Brauch, Hiltrud; Ko, Yon-Dschun; Bruening, Thomas; Nevanlinna, Heli; Muranen, Taru A.; Aittomaeki, Kristiina; Blomqvist, Carl; Matsuo, Keitaro; Ito, Hidemi; Iwata, Hiroji; Tanaka, Hideo; Doerk, Thilo; Bogdanova, Natalia V.; Helbig, Sonja; Lindblom, Annika; Margolin, Sara; Mannermaa, Arto; Kataja, Vesa; Kosma, Veli-Matti; Hartikainen, Jaana M.; Wu, Anna H.; Tseng, Chiu-chen; Van den Berg, David; Stram, Daniel O.; Lambrechts, Diether; Zhao, Hui; Weltens, Caroline; van Limbergen, Erik; Chang-Claude, Jenny; Flesch-Janys, Dieter; Rudolph, Anja; Seibold, Petra; Radice, Paolo; Peterlongo, Paolo; Barile, Monica; Capra, Fabio; Couch, Fergus J.; Olson, Janet E.; Hallberg, Emily; Vachon, Celine; Giles, Graham G.; Milne, Roger L.; McLean, Catriona; Haiman, Christopher A.; Henderson, Brian E.; Schumacher, Fredrick; Le Marchand, Loic; Simard, Jacques; Goldberg, Mark S.; Labreche, France; Dumont, Martine; Teo, Soo Hwang; Yip, Cheng Har; See, Mee-Hoong; Cornes, Belinda; Cheng, Ching-Yu; Ikram, M. Kamran; Kristensen, Vessela; Zheng, Wei; Halverson, Sandra L.; Shrubsole, Martha; Long, Jirong; Winqvist, Robert; Pylkaes, Katri; Jukkola-Vuorinen, Arja; Kauppila, Saila; Andrulis, Irene L.; Knight, Julia A.; Glendon, Gord; Tchatchou, Sandrine; Devilee, Peter; Tollenaar, Robert A. E. M.; Seynaeve, Caroline; Van Asperen, Christi J.; Garcia-Closas, Montserrat; Figueroa, Jonine; Chanock, Stephen J.; Lissowska, Jolanta; Czene, Kamila; Klevebring, Daniel; Darabi, Hatef; Eriksson, Mikael; Hooning, Maartje J.; Hollestelle, Antoinette; Martens, John W. M.; Collee, J. Margriet; Hall, Per; Li, Jingmei; Humphreys, Keith; Shu, Xiao-Ou; Lu, Wei; Gao, Yu-Tang; Cai, Hui; Cox, Angela; Cross, Simon S.; Reed, Malcolm W. R.; Blot, William; Signorello, Lisa B.; Cai, Qiuyin; Shah, Mitul; Ghoussaini, Maya; Kang, Daehee; Choi, Ji-Yeob; Park, Sue K.; Noh, Dong-Young; Hartman, Mikael; Miao, Hui; Lim, Wei Yen; Tang, Anthony; Hamann, Ute; Torres, Diana; Jakubowska, Anna; Lubinski, Jan; Jaworska, Katarzyna; Durda, Katarzyna; Sangrajrang, Suleeporn; Gaborieau, Valerie; Brennan, Paul; McKay, James; Olswold, Curtis; Slager, Susan; Toland, Amanda E.; Yannoukakos, Drakoulis; Shen, Chen-Yang; Wu, Pei-Ei; Yu, Jyh-Cherng; Hou, Ming-Feng; Swerdlow, Anthony; Ashworth, Alan; Orr, Nick; Jones, Michael; Pita, Guillermo; Rosario Alonso, M.; Alvarez, Nuria; Herrero, Daniel; Tessier, Daniel C.; Vincent, Daniel; Bacot, Francois; Luccarini, Craig; Baynes, Caroline; Ahmed, Shahana; Healey, Catherine S.; Brown, Melissa A.; Ponder, Bruce A. J.; Chenevix-Trench, Georgia; Thompson, Deborah J.; Edwards, Stacey L.; Easton, Douglas F.; Dunning, Alison M.; French, Juliet D.		GENICA Network; KConFab Investigators; Norwegian Breast Canc Study	Fine-Scale Mapping of the 5q11.2 Breast Cancer Locus Reveals at Least Three Independent Risk Variants Regulating MAP3K1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CYCLIN D1 EXPRESSION; FUNCTIONAL VARIANTS; SUSCEPTIBILITY LOCI; GENES; PROMOTER; ACTIVATION; APOPTOSIS; SUBTYPES; TUMORS	Genome-wide association studies (GWASs) have revealed SNP rs889312 on 5q11.2 to be associated with breast cancer risk in women of European ancestry. In an attempt to identify the biologically relevant variants, we analyzed 909 genetic variants across 5q11.2 in 103,991 breast cancer individuals and control individuals from 52 studies in the Breast Cancer Association Consortium. Multiple logistic regression analyses identified three independent risk signals: the strongest associations were with 15 correlated variants (iCHAV1), where the minor allele of the best candidate, rs62355902, associated with significantly increased risks of both estrogen-receptor-positive (ER-: odds ratio [OR] = 1.24, 95% confidence interval [CI] = 1.21-1.27, p(trend) = 5.7 3 10(-44)) and estrogen-receptor-negative (ER-: OR = 1.10, 95% CI = 1.05-1.15, p(trend) = 3.0 x 10(-4)) tumors. After adjustment for rs62355902, we found evidence of association of a further 173 variants (iCHAV2) containing three subsets with a range of effects (the strongest was rs113317823 [p(cond) = 1.61 x 10(-5)]) and five variants composing iCHAV3 (lead rs11949391; ER-: OR = 0.90, 95% CI = 0.87-0.93, p(cond) = 1.4 x 10(-4)). Twenty-six percent of the prioritized candidate variants coincided with four putative regulatory elements that interact with the MAP3K1 promoter through chromatin looping and affect MAP3K1 promoter activity. Functional analysis indicated that the cancer risk alleles of four candidates (rs74345699 and rs62355900 [iCHAV1], rs16886397 [iCHAV2a], and rs17432750 [iCHAV3]) increased MAP3K1 transcriptional activity. Chromatin immunoprecipitation analysis revealed diminished GATA3 binding to the minor (cancer-protective) allele of rs17432750, indicating a mechanism for its action. We propose that the cancer risk alleles act to increase MAP3K1 expression in vivo and might promote breast cancer cell survival.	[Glubb, Dylan M.; Betts, Joshua A.; Hillman, Kristine M.; Kaufmann, Susanne; Beesley, Jonathan; Chenevix-Trench, Georgia; Edwards, Stacey L.; French, Juliet D.] QIMR Berghofer Med Res Inst, Canc Div, Brisbane, Qld 4029, Australia; [Maranian, Mel J.; Pooley, Karen A.; Pharoah, Paul D. P.; Shah, Mitul; Ghoussaini, Maya; Luccarini, Craig; Baynes, Caroline; Ahmed, Shahana; Healey, Catherine S.; Easton, Douglas F.; Dunning, Alison M.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Oncol, Cambridge CB1 8RN, England; [Michailidou, Kyriaki; Kar, Siddhartha; Pharoah, Paul D. P.; Bolla, Manjeet K.; Wang, Qin; Dennis, Joe; Thompson, Deborah J.; Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge CB1 8RN, England; [Meyer, Kerstin B.; Carlebur, Saskia; O'Reilly, Martin; Ponder, Bruce A. J.] Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Meyer, Kerstin B.; Carlebur, Saskia; O'Reilly, Martin; Ponder, Bruce A. J.] Univ Cambridge, Dept Oncol, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Betts, Joshua A.; Brown, Melissa A.; Edwards, Stacey L.; French, Juliet D.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Canisius, Sander; Schmidt, Marjanka K.; Broeks, Annegien; Hogervorst, Frans B.; Giles, Graham G.; Milne, Roger L.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [Hopper, John L.] Univ Melbourne, Ctr Epidemiol & Biostat, Melbourne Sch Populat & Global Hlth, Melbourne, Vic 3010, Australia; [Southey, Melissa C.; Tsimiklis, Helen; Apicella, Carmel] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [van der Schoot, C. Ellen] Sanquin Res, NL-1066 CX Amsterdam, Netherlands; [Muir, Kenneth; Lophatananon, Artitaya; Stewart-Brown, Sarah] Univ Warwick, Warwick Med Sch, Div Hlth Sci, Coventry CV4 7AL, W Midlands, England; [Muir, Kenneth] Univ Manchester, Inst Populat Hlth, Manchester M13 9PL, Lancs, England; [Siriwanarangsan, Pornthep] Minist Publ Hlth, Nonthaburi 11000, Thailand; [Fasching, Peter A.; Ruebner, Matthias; Beckmann, Matthias W.] Univ Erlangen Nurnberg, Univ Breast Ctr Franconia, Dept Gynecol & Obstet, Univ Hosp Erlangen,Comprehens Canc Ctr Erlangen E, D-91054 Erlangen, Germany; [Fasching, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Ekici, Arif B.] Univ Erlangen Nurnberg, Inst Human Genet, Univ Hosp Erlangen, Comprehens Canc Ctr Erlangen EMN, D-91054 Erlangen, Germany; [Peto, Julian; Dos-Santos-Silva, Isabel] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England; [Fletcher, Olivia; Johnson, Nichola; Garcia-Closas, Montserrat; Ashworth, Alan; Orr, Nick] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Sawyer, Elinor J.] Kings Coll London, Guys Hosp, Div Canc Studies, London SE1 9RT, England; [Tomlinson, Ian] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Tomlinson, Ian] Univ Oxford, Oxford Biomed Res Ctr, Oxford OX3 7BN, England; [Kerin, Michael J.; Miller, Nicola] Univ Hosp Galway, Inst Clin Sci, Galway, Ireland; [Burwinkel, Barbara; Marme, Frederik; Yang, Rongxi; Surowy, Harald] Heidelberg Univ, Dept Obstet & Gynecol, D-69115 Heidelberg, Germany; [Marme, Frederik] Heidelberg Univ, Natl Ctr Tumor Dis, D-69120 Heidelberg, Germany; [Yang, Rongxi; Surowy, Harald; Hamann, Ute; Torres, Diana] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Guenel, Pascal; Truong, Therese; Menegaux, Florence; Sanchez, Marie] INSERM, U1018, Ctr Rech Epidemiol & Sante Populat, F-94807 Villejuif, France; [Guenel, Pascal; Truong, Therese; Menegaux, Florence; Sanchez, Marie] Univ Paris Sud, UMRS 1018, F-94807 Villejuif, France; [Bojesen, Stig E.; Nordestgaard, Borge G.; Nielsen, Sune F.] Copenhagen Univ Hosp, Herlev Hosp, Copenhagen Gen Populat Study, DK-2730 Herlev, Denmark; [Bojesen, Stig E.; Nordestgaard, Borge G.; Nielsen, Sune F.] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; [Bojesen, Stig E.; Nordestgaard, Borge G.] Univ Copenhagen, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark; [Flyger, Henrik] Copenhagen Univ Hosp, Herlev Hosp, Dept Breast Surg, DK-2730 Herlev, Denmark; [Gonzalez-Neira, Anna; Pita, Guillermo; Rosario Alonso, M.; Alvarez, Nuria; Herrero, Daniel] Spanish Natl Canc Res Ctr, Human Canc Genet Program, Ctr Nacl Genotipado, Human Genotyping Unit, Madrid 28029, Spain; [Benitez, Javier] Ctr Invest Red Enfermedades Raras, Valencia 46010, Spain; [Benitez, Javier] Spanish Natl Canc Ctr, Human Genet Grp, Madrid 28029, Spain; [Benitez, Javier] Biomed Network Rare Dis, Madrid 28029, Spain; [Pilar Zamora, M.] Hosp Univ La Paz, Med Oncol Serv, Madrid 28029, Spain; [Arias Perez, Jose Ignacio] Hosp Monte Naranco, Serv Cirugia Gen & Especialidades, Oviedo 33012, Spain; [Anton-Culver, Hoda] Univ Calif Irvine, Dept Epidemiol, Irvine, CA 92697 USA; [Neuhausen, Susan L.] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA; [Brenner, Hermann; Dieffenbach, Aida Karina; Arndt, Volker] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-69120 Heidelberg, Germany; [Brenner, Hermann; Dieffenbach, Aida Karina] German Canc Consortium, D-69120 Heidelberg, Germany; [Stegmaier, Christa] Saarland Canc Registry, D-66024 Saarbrucken, Germany; [Meindl, Alfons] Tech Univ Munich, Div Gynaecol & Obstet, D-81675 Munich, Germany; [Schmutzler, Rita K.] Univ Hosp Cologne, Dept Obstet & Gynaecol, Div Mol Gynecooncol, D-50931 Cologne, Germany; [Schmutzler, Rita K.] Univ Hosp Cologne, Ctr Familial Breast & Ovarian Canc, Dept Obstet & Gynaecol, D-50937 Cologne, Germany; [Schmutzler, Rita K.] Univ Hosp Cologne, Ctr Integrated Oncol, Ctr Mol Med, D-50937 Cologne, Germany; [Schmutzler, Rita K.] Univ Cologne, Ctr Mol Med Cologne, D-50923 Cologne, Germany; [Schmutzler, Rita K.] Univ Hosp Cologne, Fac Med, Ctr Integrated Oncol, D-50937 Cologne, Germany; [Brauch, Hiltrud] Univ Tubingen, D-72074 Tubingen, Germany; [Brauch, Hiltrud] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany; [Ko, Yon-Dschun] Evangel Kliniken Bonn gGmbH, Johanniter Krankenhaus, Dept Internal Med, D-53113 Bonn, Germany; [Bruening, Thomas] German Social Accid Insurance, Inst Prevent & Occupat Med, Inst Ruhr Univ Bochum, D-44789 Bochum, Germany; [GENICA Network] Univ Med Ctr Hamburg Eppendorf, Inst Occupat Med & Maritime Med, D-20246 Hamburg, Germany; [Nevanlinna, Heli; Muranen, Taru A.] Univ Helsinki, Dept Obstet & Gynecol, Helsinki 00029, Finland; [Nevanlinna, Heli; Muranen, Taru A.] Univ Helsinki, Cent Hosp, Hosp Dist Helsinki & Uusimaa, Helsinki 00029, Finland; [Aittomaeki, Kristiina] Univ Helsinki, Cent Hosp, Dept Clin Genet, Helsinki 00029, Finland; [Blomqvist, Carl] Univ Helsinki, Dept Oncol, Helsinki 00029, Finland; [Blomqvist, Carl] Univ Helsinki, Cent Hosp, Helsinki 00029, Finland; [Matsuo, Keitaro] Kyushu Univ, Fac Med Sci, Dept Prevent Med, Fukuoka 8128582, Japan; [Ito, Hidemi; Tanaka, Hideo] Aichi Canc Ctr Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 4648681, Japan; [Iwata, Hiroji] Aichi Canc Ctr Hosp, Dept Breast Oncol, Nagoya, Aichi 4648681, Japan; [Doerk, Thilo; Helbig, Sonja] Hannover Med Sch, Gynaecol Res Unit, D-30625 Hannover, Germany; [Bogdanova, Natalia V.] Hannover Med Sch, Dept Radiat Oncol, D-30625 Hannover, Germany; [Lindblom, Annika] Karolinska Inst, Dept Mol Med & Surg, S-17177 Stockholm, Sweden; [Margolin, Sara] Karolinska Inst, Dept Oncol Pathol, S-17177 Stockholm, Sweden; [Mannermaa, Arto; Kataja, Vesa; Kosma, Veli-Matti; Hartikainen, Jaana M.] Univ Eastern Finland, Canc Ctr Eastern Finland, Kuopio 70211, Finland; [Mannermaa, Arto; Kataja, Vesa; Kosma, Veli-Matti; Hartikainen, Jaana M.] Kuopio Univ Hosp, Dept Clin Pathol, Imaging Ctr, Kuopio 70211, Finland; [Mannermaa, Arto; Kataja, Vesa; Kosma, Veli-Matti; Hartikainen, Jaana M.] Univ Eastern Finland, Sch Med, Inst Clin Med Pathol & Forens Med, Kuopio 70211, Finland; [Kataja, Vesa] Kuopio Univ Hosp, Ctr Canc, Kuopio 70211, Finland; [KConFab Investigators] Peter MacCallum Canc Inst, East Melbourne, Vic 3002, Australia; [Wu, Anna H.; Tseng, Chiu-chen; Van den Berg, David; Stram, Daniel O.; Haiman, Christopher A.; Henderson, Brian E.; Schumacher, Fredrick] Univ So Calif, Keck Sch Med, Dept Prevent Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Lambrechts, Diether; Zhao, Hui] Univ Leuven, Dept Oncol, Lab Translat Genet, B-3000 Leuven, Belgium; [Lambrechts, Diether; Zhao, Hui] VIB, Vesalius Res Ctr, B-3000 Leuven, Belgium; [Weltens, Caroline; van Limbergen, Erik] Univ Hosp Gashuisberg, B-3000 Leuven, Belgium; [Chang-Claude, Jenny; Rudolph, Anja; Seibold, Petra] German Canc Res Ctr, Div Canc Epidemiol, D-69120 Heidelberg, Germany; [Flesch-Janys, Dieter] Univ Clin Hamburg Eppendorf, Dept Canc Epidemiol, Clin Canc Registry, D-20246 Hamburg, Germany; [Flesch-Janys, Dieter] Univ Clin Hamburg Eppendorf, Inst Med Biometr & Epidemiol, D-20246 Hamburg, Germany; [Radice, Paolo] Ist Nazl Tumori, Fdn Ist Neurologico Carlo Besta, Dept Prevent & Predict Med, Unit Mol Bases Genet Risk & Genet Testing, I-20133 Milan, Italy; [Peterlongo, Paolo; Capra, Fabio] Ist Fdn Italiana Ric Canc Oncol Mol, I-20139 Milan, Italy; [Barile, Monica] Ist Europeo Oncol, Div Canc Prevent & Genet, I-20141 Milan, Italy; [Capra, Fabio] Cogentech Canc Genet Test Lab, I-20139 Milan, Italy; [Couch, Fergus J.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Olson, Janet E.; Hallberg, Emily; Vachon, Celine; Olswold, Curtis; Slager, Susan] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Giles, Graham G.; Milne, Roger L.] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic 3053, Australia; [McLean, Catriona] The Alfred, Anat Pathol, Melbourne, Vic 3004, Australia; [Le Marchand, Loic] Univ Hawaii, Ctr Canc, Honolulu, HI 96813 USA; [Simard, Jacques; Dumont, Martine] Ctr Hosp Univ Quebec, Res Ctr, Quebec City, PQ G1V 4G2, Canada; [Simard, Jacques; Dumont, Martine] Univ Laval, Quebec City, PQ G1V 4G2, Canada; [Goldberg, Mark S.] McGill Univ, Ctr Hlth, Royal Victoria Hosp, Div Clin Epidemiol, Montreal, PQ H3A 1A1, Canada; [Goldberg, Mark S.] McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada; [Labreche, France] Univ Montreal, Dept Sante Environm & Sante Travail, Dept Med Sociale & Prevent, Montreal, PQ H3A 3C2, Canada; [Teo, Soo Hwang] Canc Res Initiat Fdn, Sime Darby Med Ctr, Subang Jaya 47500, Malaysia; [Teo, Soo Hwang; Yip, Cheng Har; See, Mee-Hoong] Univ Malaya, Breast Canc Res Unit, Canc Res Inst, Med Ctr, Kuala Lumpur 50603, Malaysia; [Cornes, Belinda; Cheng, Ching-Yu; Ikram, M. Kamran] Natl Univ Singapore, Singapore Eye Res Inst, Singapore 168751, Singapore; [Kristensen, Vessela] Univ Oslo, Inst Clin Med, N-0450 Oslo, Norway; [Kristensen, Vessela] Radiumhospitalet, Oslo Univ Hosp, Inst Canc Res, Dept Genet, N-0310 Oslo, Norway; [Kristensen, Vessela] Univ Oslo, Dept Clin Mol Biol, N-0450 Oslo, Norway; Univ Bergen, Inst Med, Sect Oncol, N-5020 Bergen, Norway; Univ Hosp North Norway, Norwegian Ctr Integrated Care & Telemedicine, N-9038 Tromso, Norway; Radiumhospitalet, Rikshosp, Natl Resource Ctr Long Term Studies Canc, Canc Clin, N-0310 Oslo, Norway; Radiumhospitalet, Oslo Univ Hosp, Div Canc Med & Radiotherapy, N-0310 Oslo, Norway; Akershus Univ Hosp, Dept Surg, N-1478 Lorenskog, Norway; Radiumhospitalet, Oslo Univ Hosp, Dept Radiol, N-0310 Oslo, Norway; Akershus Univ Hosp, Dept Pathol, N-1478 Lorenskog, Norway; Radiumhospitalet, Oslo Univ Hosp, Dept Oncol, N-0310 Oslo, Norway; Haukeland Hosp, Dept Oncol, N-5021 Bergen, Norway; Arctic Univ Norway, Univ Tromso, Fac Hlth Sci, Dept Community Med, N-9019 Tromso, Norway; Univ Oslo, Akershus Univ Hosp, Inst Clin Med, Dept Clin Mol Biol, N-1478 Lorenskog, Norway; [Norwegian Breast Canc Study] Oslo Univ Hosp, Ullevaal Univ Hosp, Inst Clin Med, Dept Breast & Endocrine Surg, N-0450 Oslo, Norway; [Zheng, Wei; Halverson, Sandra L.; Shrubsole, Martha; Long, Jirong; Shu, Xiao-Ou; Cai, Hui; Blot, William; Signorello, Lisa B.; Cai, Qiuyin] Vanderbilt Univ, Sch Med, Div Epidemiol, Dept Med,Vanderbilt Epidemiol Ctr, Nashville, TN 37203 USA; [Zheng, Wei; Halverson, Sandra L.; Shrubsole, Martha; Long, Jirong; Shu, Xiao-Ou; Cai, Hui; Blot, William; Signorello, Lisa B.; Cai, Qiuyin] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37203 USA; [Winqvist, Robert; Pylkaes, Katri] Univ Oulu, Lab Canc Genet & Tumor Biol, Dept Clin Chem, NordLab Oulu,Oulu Univ Hosp, Oulu 90210, Finland; [Winqvist, Robert; Pylkaes, Katri] Univ Oulu, Bioctr Oulu, NordLab Oulu, Oulu Univ Hosp, Oulu 90210, Finland; [Jukkola-Vuorinen, Arja] Univ Oulu, Dept Oncol, Oulu Univ Hosp, Oulu 90014, Finland; [Kauppila, Saila] Univ Oulu, Dept Pathol, Oulu Univ Hosp, Oulu 90014, Finland; [Andrulis, Irene L.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Andrulis, Irene L.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1X5, Canada; [Knight, Julia A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON M5T 3M7, Canada; [Knight, Julia A.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Prosserman Ctr Hlth Res, Toronto, ON M5G 1X5, Canada; [Glendon, Gord; Tchatchou, Sandrine] Mt Sinai Hosp, Ontario Canc Genet Network, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Devilee, Peter; Tollenaar, Robert A. E. M.] Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RC Leiden, Netherlands; [Devilee, Peter; Tollenaar, Robert A. E. M.] Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RC Leiden, Netherlands; [Seynaeve, Caroline] Netherlands Canc Inst, Family Canc Clin, NL-1066 CX Amsterdam, Netherlands; [Van Asperen, Christi J.] Leiden Univ, Med Ctr, Dept Clin Genet, NL-2300 RC Leiden, Netherlands; [Garcia-Closas, Montserrat; Swerdlow, Anthony; Jones, Michael] Inst Canc Res, Div Genet & Epidemiol, Sutton SM2 5NG, Surrey, England; [Figueroa, Jonine; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, Rockville, MD 20892 USA; [Lissowska, Jolanta] Maria Sklodowska Curie Mem Canc Ctr, Dept Canc Epidemiol & Prevent, PL-02781 Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol, PL-02781 Warsaw, Poland; [Czene, Kamila; Klevebring, Daniel; Darabi, Hatef; Eriksson, Mikael; Hall, Per; Humphreys, Keith] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Hooning, Maartje J.; Hollestelle, Antoinette; Martens, John W. M.] Erasmus Univ, Med Ctr, Dept Med Oncol, NL-3075 EA Rotterdam, Netherlands; [Collee, J. Margriet] Erasmus Univ, Med Ctr, Dept Clin Genet, NL-3008 AE Rotterdam, Netherlands; [Li, Jingmei] Genome Inst Singapore, Div Human Genet, Singapore 138672, Singapore; [Lu, Wei] Shanghai Ctr Dis Control & Prevent, Shanghai 200336, Peoples R China; [Gao, Yu-Tang] Shanghai Canc Inst, Dept Epidemiol, Shanghai 200032, Peoples R China; [Cox, Angela; Reed, Malcolm W. R.] Univ Sheffield, Dept Oncol, Sheffield Canc Res Ctr, Sheffield S10 2RX, S Yorkshire, England; [Cross, Simon S.] Univ Sheffield, Acad Unit Pathol, Dept Neurosci, Sheffield S10 2RX, S Yorkshire, England; [Blot, William; Signorello, Lisa B.] Int Epidemiol Inst, Rockville, MD 20850 USA; [Kang, Daehee; Park, Sue K.] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul 110799, South Korea; [Kang, Daehee; Park, Sue K.] Seoul Natl Univ, Canc Res Inst, Seoul 110799, South Korea; [Kang, Daehee; Choi, Ji-Yeob; Park, Sue K.] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul 151742, South Korea; [Kang, Daehee; Choi, Ji-Yeob; Park, Sue K.] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul 110799, South Korea; [Noh, Dong-Young] Seoul Natl Univ, Bundang Hosp, Dept Surg, Songnam 110744, South Korea; [Hartman, Mikael; Miao, Hui; Lim, Wei Yen] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117597, Singapore; [Hartman, Mikael; Miao, Hui; Lim, Wei Yen] Natl Univ Hlth Syst, Singapore 117597, Singapore; [Hartman, Mikael] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 119228, Singapore; [Hartman, Mikael] Natl Univ Hlth Syst, Singapore 119228, Singapore; [Tang, Anthony] Natl Univ Hlth Syst, Div Gen Surg, Singapore 119228, Singapore; [Torres, Diana] Pontificia Univ Javeriana, Inst Human Genet, Bogota 11001000, Colombia; [Jakubowska, Anna; Lubinski, Jan; Jaworska, Katarzyna; Durda, Katarzyna] Pomeranian Med Univ, Dept Genet & Pathol, PL-70115 Szczecin, Poland; [Sangrajrang, Suleeporn] Natl Canc Inst, Bangkok 10400, Thailand; [Gaborieau, Valerie; Brennan, Paul; McKay, James] Int Agcy Res Canc, F-69372 Lyon, France; [Toland, Amanda E.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Yannoukakos, Drakoulis] Natl Ctr Sci Res Demokritos, Mol Diagnost Lab, Inst Radioisotopes & Radiodiagnost Prod, Athens 15310, Greece; [Shen, Chen-Yang; Wu, Pei-Ei] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Shen, Chen-Yang] China Med Univ, Sch Publ Hlth, Taichung 40402, Taiwan; [Shen, Chen-Yang; Wu, Pei-Ei] Acad Sinica, Inst Biomed Sci, Taiwan Biobank, Taipei 115, Taiwan; [Yu, Jyh-Cherng] Tri Serv Gen Hosp, Dept Surg, Taipei 114, Taiwan; [Hou, Ming-Feng] Kaohsiung Med Univ, Ctr Canc, Chung Ho Mem Hosp, Kaohsiung 807, Taiwan; [Hou, Ming-Feng] Kaohsiung Med Univ, Dept Surg, Chung Ho Mem Hosp, Kaohsiung 807, Taiwan; [Swerdlow, Anthony] Inst Canc Res, Div Breast Canc Res, Sutton SM2 5NG, Surrey, England; [Tessier, Daniel C.; Vincent, Daniel; Bacot, Francois] McGill Univ, Montreal, PQ H3A 0G1, Canada; [Tessier, Daniel C.; Vincent, Daniel; Bacot, Francois] Genome Quebec Innovat Ctr, Montreal, PQ H3A 0G1, Canada	QIMR Berghofer Medical Research Institute; University of Cambridge; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; CRUK Cambridge Institute; University of Cambridge; University of Queensland; Netherlands Cancer Institute; University of Melbourne; University of Melbourne; University of Warwick; University of Manchester; Ministry of Public Health - Thailand; University of Erlangen Nuremberg; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Erlangen Nuremberg; University of London; London School of Hygiene & Tropical Medicine; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Ollscoil na Gaillimhe-University of Galway; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario La Paz; University of California System; University of California Irvine; City of Hope; Beckman Research Institute of City of Hope; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Technical University of Munich; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Ruhr University Bochum; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Kyushu University; Aichi Cancer Center; Aichi Cancer Center; Hannover Medical School; Hannover Medical School; Karolinska Institutet; Karolinska Institutet; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Peter Maccallum Cancer Center; University of Southern California; KU Leuven; Flanders Institute for Biotechnology (VIB); Helmholtz Association; German Cancer Research Center (DKFZ); University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS European Institute of Oncology (IEO); Mayo Clinic; Mayo Clinic; Cancer Council Victoria; Cancer Research Center of Hawaii; University of Hawaii System; Laval University; Laval University; McGill University; Royal Victoria Hospital; McGill University; Universite de Montreal; Universiti Malaya; National University of Singapore; Singapore National Eye Center; University of Oslo; University of Oslo; University of Oslo; University of Bergen; UiT The Arctic University of Tromso; University Hospital of North Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Bergen; Haukeland University Hospital; UiT The Arctic University of Tromso; University of Oslo; University of Oslo; Vanderbilt University; Vanderbilt University; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University Health Network Toronto; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of London; Institute of Cancer Research - UK; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Karolinska Institutet; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Shanghai Center for Disease Control & Prevention; Shanghai Jiao Tong University; University of Sheffield; University of Sheffield; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Pontificia Universidad Javeriana; Pomeranian Medical University; National Cancer Institute - Thailand; World Health Organization; International Agency for Research on Cancer (IARC); University System of Ohio; Ohio State University; National Centre of Scientific Research "Demokritos"; Academia Sinica - Taiwan; China Medical University Taiwan; Academia Sinica - Taiwan; Tri-Service General Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; University of London; Institute of Cancer Research - UK; McGill University	Dunning, AM (corresponding author), Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Oncol, Cambridge CB1 8RN, England.	amd24@medschl.cam.ac.uk; juliet.french@qimrberghofer.edu.au	Guenel, Pascal/H-3728-2018; Bogdanova, Natalia V./Y-2205-2019; Ekici, Arif B/C-3971-2013; Gao, Yu/HGE-1937-2022; Van Den Berg, David J/G-8598-2017; Lissowska, Jolanta/AAH-3252-2020; Guenel, Pascal/AAS-7688-2021; Matsuo, Keitaro/H-6758-2019; Schmidt, Marjanka K/G-9058-2011; Brüning, Thomas/G-8120-2015; Garcia-Closas, Montserrat/F-3871-2015; Nordestgaard, Borge Gronne/ABF-1310-2020; Arndt, Volker/B-4999-2014; Dörk, Thilo/J-8620-2012; van Asperen, Christi J/D-3970-2012; Figueroa, Jonine/AAG-1065-2022; Figueroa, Jonine/GWD-1322-2022; Shrubsole, Martha J/K-5052-2015; Brenner, Hermann/ABE-6383-2020; Knight, Julia/R-5617-2019; Lambrechts, Diether/AAJ-3167-2020; Pharoah, Paul/V-6658-2019; Jakubowska, Anna/O-8050-2014; Edwards, Stacey/A-4980-2011; Radice, Paolo/O-3119-2013; Muranen, Taru/AAC-8418-2019; See, Mee-Hoong/P-8440-2014; Hartikainen, Jaana M/E-6256-2015; See, Mee Hoong/AAO-9275-2021; Teo, Soo-hwang/H-2353-2014; Garcia-Closas, Montserrat/AAZ-6930-2021; Tanaka, Hideo/A-8145-2016; Li, Jingmei/I-2904-2012; Arndt, Volker/AAI-7282-2020; Michailidou, Kyriaki/ABD-5122-2020; /AAM-5330-2020; Gonzalez-Neira, Anna/C-5791-2015; Cheng, Ching-Yu/Y-2229-2019; DEVILEE, PETER/ABR-2140-2022; Yip, Cheng-Har/B-1909-2010; Schumacher, Fredrick/R-6043-2019; Menegaux, Florence/H-4261-2018; Figueroa, Jonine/AFK-2752-2022; zhang, weihua/GXV-1334-2022; Reed, Malcolm Walter/AAG-9219-2020; Miller, Nicola/F-4009-2018; Peterlongo, Paolo/Q-4717-2018; Brenner, Hermann/B-4627-2017; French, Juliet/AAV-4435-2020; Lu, Wei/AAE-2921-2022; Flyger, Henrik/AAM-6494-2021; Knight, Julia/A-6843-2012; gao, yi/HCI-8298-2022; Zheng, Wei/O-3351-2013; Fasching, Peter A/ABH-9912-2020; truong, therese/A-2837-2013; Gao, Y./GWZ-3665-2022; Glubb, Dylan/M-7514-2016; Brown, Melissa A/F-1451-2010; Margolin, Sara/AAX-9034-2020; Devilee, Peter/GXV-8005-2022; Chenevix-Trench, Georgia/AAV-2014-2020; Andrulis, Irene L./E-7267-2013; Hartman, Mikael/B-4324-2011; benitez, javier/H-5232-2015	Guenel, Pascal/0000-0002-8359-518X; Ekici, Arif B/0000-0001-6099-7066; Van Den Berg, David J/0000-0002-5404-5218; Lissowska, Jolanta/0000-0003-2695-5799; Guenel, Pascal/0000-0002-8359-518X; Matsuo, Keitaro/0000-0003-1761-6314; Schmidt, Marjanka K/0000-0002-2228-429X; Brüning, Thomas/0000-0001-9560-5464; Garcia-Closas, Montserrat/0000-0003-1033-2650; Arndt, Volker/0000-0001-9320-8684; Dörk, Thilo/0000-0002-9458-0282; van Asperen, Christi J/0000-0002-1436-7650; Figueroa, Jonine/0000-0002-5100-623X; Figueroa, Jonine/0000-0002-5100-623X; Shrubsole, Martha J/0000-0002-5591-7575; Brenner, Hermann/0000-0002-6129-1572; Knight, Julia/0000-0002-7610-7635; Lambrechts, Diether/0000-0002-3429-302X; Pharoah, Paul/0000-0001-8494-732X; Jakubowska, Anna/0000-0002-5650-0501; Radice, Paolo/0000-0001-6298-4111; Muranen, Taru/0000-0002-5895-1808; See, Mee-Hoong/0000-0002-7197-5759; Hartikainen, Jaana M/0000-0001-8267-1905; See, Mee Hoong/0000-0002-3966-3368; Garcia-Closas, Montserrat/0000-0003-1033-2650; Li, Jingmei/0000-0001-8587-7511; Arndt, Volker/0000-0001-9320-8684; Michailidou, Kyriaki/0000-0001-7065-1237; Gonzalez-Neira, Anna/0000-0002-5421-2020; Cheng, Ching-Yu/0000-0003-0655-885X; Schumacher, Fredrick/0000-0002-3073-7463; Menegaux, Florence/0000-0003-3363-6411; Figueroa, Jonine/0000-0002-5100-623X; Reed, Malcolm Walter/0000-0001-7442-2132; Miller, Nicola/0000-0002-5416-7047; Peterlongo, Paolo/0000-0001-6951-6855; Brenner, Hermann/0000-0002-6129-1572; French, Juliet/0000-0002-9770-0198; Lu, Wei/0000-0002-4150-8674; Zheng, Wei/0000-0003-1226-070X; Fasching, Peter A/0000-0003-4885-8471; truong, therese/0000-0002-2943-6786; Glubb, Dylan/0000-0002-2184-7708; Chenevix-Trench, Georgia/0000-0002-1878-2587; Blomqvist, Carl/0000-0003-3041-1938; Fletcher, Olivia/0000-0001-9387-7116; Brauch, Hiltrud/0000-0001-7531-2736; Hartman, Mikael/0000-0001-5726-9965; Dunning, Alison Margaret/0000-0001-6651-7166; Ikram, Mohammad Kamran/0000-0003-0173-9571; Long, Jirong/0000-0002-7433-9766; Lubinski, Jan/0000-0003-2931-3003; Southey, Melissa/0000-0002-6313-9005; Hou, Ming-Feng/0000-0001-6030-9702; Kar, Siddhartha P./0000-0002-2314-1426; eriksson, mikael/0000-0001-8135-4270; Cross, Simon/0000-0003-2044-1754; Surowy, Harald/0000-0002-3595-9188; Thorne, Heather/0000-0003-3610-2511; Winqvist, Robert/0000-0003-0932-9104; Devilee, Peter/0000-0002-8023-2009; Pylkas, Katri/0000-0002-2449-0521; Simard, Jacques/0000-0001-6906-3390; Brown, Melissa/0000-0002-2830-9259; Nordestgaard, Borge/0000-0002-1954-7220; Swerdlow, Anthony/0000-0001-5550-4159; Czene, Kamila/0000-0002-3233-5695; Giles, Graham/0000-0003-4946-9099; Kang, Daehee/0000-0003-4031-5878; Beesley, Jonathan/0000-0003-1942-325X; Margolin, Sara/0000-0002-5526-5570; Yannoukakos, Drakoulis/0000-0001-7509-3510; Durocher, Francine/0000-0001-8012-4641; Torres-Lopez, Diana Maria/0000-0002-9879-9775; Sawyer, Elinor/0000-0001-8285-4111; Kataja, Vesa/0000-0003-4846-4843; Hollestelle, Antoinette/0000-0003-1166-1966; Bojesen, Stig/0000-0002-4061-4133; benitez, javier/0000-0002-0923-7202; Kerin, Michael/0000-0003-4164-5561; Pita, Guillermo/0000-0003-2393-0510; Jones, Michael/0000-0001-7479-3451; Cox, Angela/0000-0002-5138-1099; McLean, Catriona/0000-0002-0302-5727	Cancer Research UK [16561, 16563, 16565] Funding Source: researchfish; National Institute for Health Research [03/DHCS/03/G121/51] Funding Source: researchfish; National Breast Cancer Foundation [IF-12-06, ECF-12-04] Funding Source: researchfish; Cancer Foundation Finland sr [130168] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish; MRC [MC_PC_14105] Funding Source: UKRI; Cancer Research UK [10124, C1287/A10710, C8197/A16565, C1287/A12014, C1287/A10118, C490/A10124] Funding Source: Medline; CIHR [CRN-87521] Funding Source: Medline; Intramural NIH HHS Funding Source: Medline; Medical Research Council [MC_PC_14105] Funding Source: Medline; NCI NIH HHS [R01CA148667, R01 CA092447, P30 CA68485, CA098758, R01CA64277, CA116201, CA63464, R01 CA176785, N01CN25403, R37CA70867, CA132839, R01 CA148667, CA128978, CA54281, U01 CA116167, CA116167, UM1 CA164920, CA176785, R01 CA77398, P30 CA015083, U19 CA148065] Funding Source: Medline; DIVISION OF CANCER PREVENTION AND CONTROL [N01CN025403] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA063464, R37CA054281, U01CA098758, R01CA063464, P30CA068485, R01CA092447, R01CA176785, R01CA054281, R01CA132839, P30CA015083, R01CA128978, U19CA148065, P50CA116201, R01CA116167, ZIACP010126, UM1CA164920, R37CA070867, U01CA116167, R01CA064277, R01CA148667, R01CA077398] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [221S0001] Funding Source: KAKEN	Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); National Breast Cancer Foundation; Cancer Foundation Finland sr; The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); CIHR(Canadian Institutes of Health Research (CIHR)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Alarcon-Vargas D, 2002, ONCOGENE, V21, P4384, DOI 10.1038/sj.onc.1205543; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Antoniou AC, 2008, AM J HUM GENET, V82, P937, DOI 10.1016/j.ajhg.2008.02.008; Arnold A, 2005, J CLIN ONCOL, V23, P4215, DOI 10.1200/JCO.2005.05.064; Bojesen SE, 2013, NAT GENET, V45, P371, DOI 10.1038/ng.2566; Broeks A, 2011, HUM MOL GENET, V20, P3289, DOI 10.1093/hmg/ddr228; Cao Y, 2008, CANCER SCI, V99, P1092, DOI 10.1111/j.1349-7006.2008.00815.x; Clarke N, 1998, MOL CELL BIOL, V18, P1065, DOI 10.1128/MCB.18.2.1065; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; Cuevas BD, 2006, ONCOGENE, V25, P4998, DOI 10.1038/sj.onc.1209507; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; denDekker AD, 2012, CANCER RES, V72, P6002, DOI 10.1158/0008-5472.CAN-12-0748; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Fletcher MNC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3464; French JD, 2013, AM J HUM GENET, V92, P489, DOI 10.1016/j.ajhg.2013.01.002; Fuchs SY, 1998, P NATL ACAD SCI USA, V95, P10541, DOI 10.1073/pnas.95.18.10541; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Ghoussaini M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5999; Godde NJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004323; Hirano T, 2002, ONCOGENE, V21, P5923, DOI 10.1038/sj.onc.1205643; Keshet Y, 2010, METHODS MOL BIOL, V661, P3, DOI 10.1007/978-1-60761-795-2_1; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Meyer KB, 2013, AM J HUM GENET, V93, P1046, DOI 10.1016/j.ajhg.2013.10.026; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Nawata R, 2003, ONCOGENE, V22, P7774, DOI 10.1038/sj.onc.1206901; Nordgard SH, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1784; Prall OWJ, 1997, J BIOL CHEM, V272, P10882; Schlesinger TK, 2002, J BIOL CHEM, V277, P10283, DOI 10.1074/jbc.M106885200; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Smith CL, 1997, J BIOL CHEM, V272, P27493, DOI 10.1074/jbc.272.44.27493; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Tan-Wong SM, 2008, P NATL ACAD SCI USA, V105, P5160, DOI 10.1073/pnas.0801048105; Theodorou V, 2013, GENOME RES, V23, P12, DOI 10.1101/gr.139469.112; Widmann C, 1998, MOL CELL BIOL, V18, P2416, DOI 10.1128/MCB.18.4.2416	38	52	54	0	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 8	2015	96	1					5	20		10.1016/j.ajhg.2014.11.009	http://dx.doi.org/10.1016/j.ajhg.2014.11.009			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AY6YE	25529635	Green Published, Green Accepted, hybrid			2022-12-18	WOS:000347707800001
J	Slavotinek, A; Kaylor, J; Pierce, H; Cahr, M; DeWard, SJ; Schneidman-Duhovny, D; Alsadah, A; Salem, F; Schmajuk, G; Mehta, L				Slavotinek, Anne; Kaylor, Julie; Pierce, Heather; Cahr, Michelle; DeWard, Stephanie J.; Schneidman-Duhovny, Dina; Alsadah, Adnan; Salem, Fadi; Schmajuk, Gabriela; Mehta, Lakshmi			CRB2 Mutations Produce a Phenotype Resembling Congenital Nephrosis, Finnish Type, with Cerebral Ventriculomegaly and Raised Alpha-Fetoprotein	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RETINITIS-PIGMENTOSA; NEPHRIN MUTATIONS; CRUMBS; PROTEIN; DROSOPHILA; CHILDHOOD; POLARITY; GENE; ORGANIZATION; EPITHELIA	We report five fetuses and a child from three families who shared a phenotype comprising cerebral ventriculomegaly and echogenic kidneys with histopathological findings of congenital nephrosis. The presenting features were greatly elevated maternal serum alpha-fetoprotein (MSAFP) or amniotic fluid alpha-fetoprotein (AFAFP) levels or abnormalities visualized on ultrasound scan during the second trimester of pregnancy. Exome sequencing revealed deleterious sequence variants in Crumbs, Drosophila, Homolog of, 2 (CRB2) consistent with autosomal-recessive inheritance. Two fetuses with cerebral ventriculomegaly and renal microcysts were compound heterozygotes for p.Asn800Lys and p.Trp759Ter, one fetus with renal microcysts was a compound heterozygote for p.Glu643Ala and p.Asn800Lys, and one child with cerebral ventriculomegaly, periventricular heterotopias, echogenic kidneys, and renal failure was homozygous for p.Arg633Trp in CRB2. Examination of the kidneys in one fetus showed tubular cysts at the corticomedullary junction and diffuse effacement of the epithelial foot processes and microvillous transformation of the renal podocytes, findings that were similar to those reported in congenital nephrotic syndrome, Finnish type, that is caused by mutations in nephrin (NPHS1). Loss of function for crb2b and nphs1 in Danio rerio were previously shown to result in loss of the slit diaphragms of the podocytes, leading to the hypothesis that nephrosis develops from an inability to develop a functional glomerular barrier. We conclude that the phenotype associated with CRB2 mutations is pleiotropic and that the condition is an important consideration in the evaluation of high MSAFP/AFAFP where a renal cause is suspected.	[Slavotinek, Anne; Alsadah, Adnan] Univ Calif San Francisco, Dept Pediat, Div Genet, San Francisco, CA 94143 USA; [Slavotinek, Anne] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Kaylor, Julie] Arkansas Childrens Hosp, Mol Genet Pathol Lab, Little Rock, AR 72202 USA; [Pierce, Heather; DeWard, Stephanie J.] GeneDx Inc, Gaithersburg, MD 20877 USA; [Cahr, Michelle; Mehta, Lakshmi] Icahn Sch Med Mt Sinai, Div Med Genet, New York, NY 10029 USA; [Cahr, Michelle; Salem, Fadi; Mehta, Lakshmi] Mt Sinai Med Ctr, New York, NY 10029 USA; [Schneidman-Duhovny, Dina] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Schneidman-Duhovny, Dina] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Salem, Fadi] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Schmajuk, Gabriela] UCSF, Div Rheumatol, Dept Med, San Francisco, CA 94121 USA; [Schmajuk, Gabriela] San Francisco VA Hosp, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Arkansas Children's Hospital; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Icahn School of Medicine at Mount Sinai; University of California System; University of California San Francisco	Slavotinek, A (corresponding author), Univ Calif San Francisco, Dept Pediat, Div Genet, San Francisco, CA 94143 USA.	slavotia@ucsf.edu	Schneidman, Dina/ABH-6654-2020; Slavotinek, Anne/AAK-6794-2020; Salem, Fadi/AAP-9399-2020	Schneidman, Dina/0000-0003-0480-0438; Salem, Fadi/0000-0002-2603-2778				Alves CH, 2014, HUM MOL GENET, V23, P3384, DOI 10.1093/hmg/ddu048; Alves CH, 2013, HUM MOL GENET, V22, P35, DOI 10.1093/hmg/dds398; Chen CL, 2010, P NATL ACAD SCI USA, V107, P15810, DOI 10.1073/pnas.1004060107; den Hollander AI, 2004, HUM MUTAT, V24, P355, DOI 10.1002/humu.20093; Ebarasi L, 2009, DEV BIOL, V334, P1, DOI 10.1016/j.ydbio.2009.04.017; Fukuyo Y, 2014, MOL MED REP, V9, P457, DOI 10.3892/mmr.2013.1844; Gosens I, 2008, EXP EYE RES, V86, P713, DOI 10.1016/j.exer.2008.02.005; Hinkes BG, 2007, PEDIATRICS, V119, pE907, DOI 10.1542/peds.2006-2164; Ichimura K, 2012, DEV DYNAM, V241, P1922, DOI 10.1002/dvdy.23877; Jacobson SG, 2003, HUM MOL GENET, V12, P1073, DOI 10.1093/hmg/ddg117; Jolly M, 2003, PRENATAL DIAG, V23, P48, DOI 10.1002/pd.447; Katoh M, 2004, INT J ONCOL, V24, P743; Khan AO, 2014, OPHTHALMIC GENET, V35, P130, DOI 10.3109/13816810.2013.804097; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liapis H, 2008, PEDIATR DEVEL PATHOL, V11, P254, DOI 10.2350/07-11-0375.1; Machuca E, 2010, J AM SOC NEPHROL, V21, P1209, DOI 10.1681/ASN.2009121309; Machuca E, 2009, HUM MOL GENET, V18, pR185, DOI 10.1093/hmg/ddp328; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Pellissier LP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003976; Philippe A, 2008, J AM SOC NEPHROL, V19, P1871, DOI 10.1681/ASN.2008010059; Pieczynski J, 2011, AM J PHYSIOL-RENAL, V300, pF589, DOI 10.1152/ajprenal.00615.2010; Pocha SM, 2013, CURR BIOL, V23, pR289, DOI 10.1016/j.cub.2013.03.001; REUSS A, 1989, AM J MED GENET, V33, P385, DOI 10.1002/ajmg.1320330319; Roh MH, 2002, J CELL BIOL, V157, P161, DOI 10.1083/jcb.200109010; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santin S, 2009, KIDNEY INT, V76, P1268, DOI 10.1038/ki.2009.381; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; TEPASS U, 1993, DEV BIOL, V159, P311, DOI 10.1006/dbio.1993.1243; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tiab L, 2013, MOL VIS, V19, P829; Tsang SH, 2014, OPHTHALMOLOGY, V121, P1773, DOI 10.1016/j.ophtha.2014.03.010; van den Hurk JAJM, 2005, MOL VIS, V11, P263; Watanabe T, 2004, BIOCHEM BIOPH RES CO, V313, P263, DOI 10.1016/j.bbrc.2003.11.122; Xiao ZJ, 2011, DEV DYNAM, V240, P2646, DOI 10.1002/dvdy.22778; Zou J, 2013, INT J DEV NEUROSCI, V31, P770, DOI 10.1016/j.ijdevneu.2013.09.005	37	52	56	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 8	2015	96	1					162	169		10.1016/j.ajhg.2014.11.013	http://dx.doi.org/10.1016/j.ajhg.2014.11.013			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AY6YE	25557780	Bronze, Green Published			2022-12-18	WOS:000347707800013
J	Ganesh, SK; Chasman, DI; Larson, MG; Guo, X; Verwoert, G; Bis, JC; Gu, XJ; Smith, AV; Yang, ML; Zhang, Y; Ehret, G; Rose, LM; Hwang, SJ; Papanicolau, GJ; Sijbrands, EJ; Rice, K; Eiriksdottir, G; Pihur, V; Ridker, PM; Vasan, RS; Newton-Cheh, C; Raffel, LJ; Amin, N; Rotter, JI; Liu, K; Launer, LJ; Xu, M; Caulfield, M; Morrison, AC; Johnson, AD; Vaidya, D; Dehghan, A; Li, G; Bouchard, C; Harris, TB; Zhang, H; Boerwinkle, E; Siscovick, DS; Gao, W; Uitterlinden, AG; Rivadeneira, F; Hofman, A; Willer, CJ; Franco, OH; Huo, Y; Witteman, JCM; Munroe, PB; Gudnason, V; Palmas, W; van Duijn, C; Fornage, M; Levy, D; Psaty, BM; Chakravarti, A				Ganesh, Santhi K.; Chasman, Daniel I.; Larson, Martin G.; Guo, Xiuqing; Verwoert, Germain; Bis, Joshua C.; Gu, Xiangjun; Smith, Albert V.; Yang, Min-Lee; Zhang, Yan; Ehret, Georg; Rose, Lynda M.; Hwang, Shih-Jen; Papanicolau, George J.; Sijbrands, Eric J.; Rice, Kenneth; Eiriksdottir, Gudny; Pihur, Vasyl; Ridker, Paul M.; Vasan, Ramachandran S.; Newton-Cheh, Christopher; Raffel, Leslie J.; Amin, Najaf; Rotter, Jerome I.; Liu, Kiang; Launer, Lenore J.; Xu, Ming; Caulfield, Mark; Morrison, Alanna C.; Johnson, Andrew D.; Vaidya, Dhananjay; Dehghan, Abbas; Li, Guo; Bouchard, Claude; Harris, Tamara B.; Zhang, He; Boerwinkle, Eric; Siscovick, David S.; Gao, Wei; Uitterlinden, Andre G.; Rivadeneira, Fernando; Hofman, Albert; Willer, Cristen J.; Franco, Oscar H.; Huo, Yong; Witteman, Jacqueline C. M.; Munroe, Patricia B.; Gudnason, Vilmundur; Palmas, Walter; van Duijn, Cornelia; Fornage, Myriam; Levy, Daniel; Psaty, Bruce M.; Chakravarti, Aravinda		Global Blood Pressure Genetics Con	Effects of Long-Term Averaging of Quantitative Blood Pressure Traits on the Detection of Genetic Associations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GROWTH-FACTOR-I; CARDIOVASCULAR-DISEASE; EXPRESSION; CHILDHOOD; TRACKING; RISK; HEART; VARIABILITY; REVEALS	Blood pressure (BP) is a heritable, quantitative trait with intraindividual variability and susceptibility to measurement error. Genetic studies of BP generally use single-visit measurements and thus cannot remove variability occurring over months or years. We leveraged the idea that averaging BP measured across time would improve phenotypic accuracy and thereby increase statistical power to detect genetic associations. We studied systolic BP (SBP), diastolic BP (DBP), mean arterial pressure (MAP), and pulse pressure (PP) averaged over multiple years in 46,629 individuals of European ancestry. We identified 39 trait-variant associations across 19 independent loci (p < 5 x 10(-8)); five associations (in four loci) uniquely identified by our LTA analyses included those of SBP and MAP at 2p23 (rs1275988, near KCNK3), DBP at 2q11.2 (rs7599598, in FER1L5), and PP at 6p21 (rs10948071, near CRIP3) and 7p13 (rs2949837, near IGEBP3). Replication analyses conducted in cohorts with single-visit BP data showed positive replication of associations and a nominal association (p <0.05). We estimated a 20% gain in statistical power with long-term average (LTA) as compared to single-visit BP association studies. Using LTA analysis, we identified genetic loci influencing BP. LTA might be one way of increasing the power of genetic associations for continuous traits in extant samples for other phenotypes that are measured serially over time.	[Ganesh, Santhi K.; Yang, Min-Lee; Zhang, He; Willer, Cristen J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Ganesh, Santhi K.; Yang, Min-Lee; Zhang, He; Willer, Cristen J.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Chasman, Daniel I.; Rose, Lynda M.; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; [Chasman, Daniel I.; Ridker, Paul M.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Larson, Martin G.; Hwang, Shih-Jen; Vasan, Ramachandran S.; Johnson, Andrew D.; Levy, Daniel] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; [Larson, Martin G.] Boston Univ, Dept Math, Boston, MA 02215 USA; [Guo, Xiuqing; Rotter, Jerome I.] Los Angeles Biomed Res Inst, Inst Translat Genom & Populat Sci, Torrance, CA 90502 USA; [Guo, Xiuqing; Rotter, Jerome I.] Harbor UCLA Med Ctr, Dept Pediat, Torrance, CA 90502 USA; [Verwoert, Germain; Amin, Najaf; Dehghan, Abbas; Uitterlinden, Andre G.; Rivadeneira, Fernando; Hofman, Albert; Franco, Oscar H.; Witteman, Jacqueline C. M.; van Duijn, Cornelia] Erasmus Univ, Med Ctr, Dept Epidemiol, NL-3015 Rotterdam, Netherlands; [Verwoert, Germain; Sijbrands, Eric J.; Uitterlinden, Andre G.; Rivadeneira, Fernando] Erasmus Univ, Med Ctr, Dept Internal Med, NL-3015 Rotterdam, Netherlands; [Bis, Joshua C.; Li, Guo; Siscovick, David S.; Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Gu, Xiangjun; Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Res Ctr Human Genet, Brown Fdn Inst Mol Med, Houston, TX 77030 USA; [Smith, Albert V.; Eiriksdottir, Gudny; Gudnason, Vilmundur] Iceland Heart Assoc, IS-201 Kopavogur, Iceland; [Smith, Albert V.; Gudnason, Vilmundur] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Zhang, Yan; Huo, Yong] Peking Univ, Dept Cardiol, Hosp 1, Beijing 100034, Peoples R China; [Ehret, Georg; Pihur, Vasyl; Chakravarti, Aravinda] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Ctr Complex Dis Genom, Sch Med, Baltimore, MD 21205 USA; [Ehret, Georg] Univ Hosp Geneva, Dept Specialties Internal Med, CH-1211 Geneva, Switzerland; [Hwang, Shih-Jen; Levy, Daniel] NHLBI, Ctr Populat Studies, Bethesda, MD 20892 USA; [Papanicolau, George J.] NHLBI, Div Cardiovasc Sci, Bethesda, MD 20892 USA; [Rice, Kenneth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Div Epidemiol, Boston, MA 02118 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Div Cardiol, Dept Med, Boston, MA 02118 USA; [Newton-Cheh, Christopher] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Newton-Cheh, Christopher] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Raffel, Leslie J.] Cedars Sinai Med Ctr, Med Genet Res Inst, Los Angeles, CA 90048 USA; [Liu, Kiang] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Launer, Lenore J.; Harris, Tamara B.] NIA, Lab Epidemiol & Populat Sci, Bethesda, MD 20892 USA; [Xu, Ming; Gao, Wei] Peking Univ, Hosp 3, Dept Cardiol, Beijing 100191, Peoples R China; [Caulfield, Mark; Munroe, Patricia B.] Queen Mary Univ London, Clin Pharmacol & Genome Ctr, William Harvey Res Inst, Barts & London Sch Med & Dent, London EC1M 6BQ, England; [Caulfield, Mark; Munroe, Patricia B.] Queen Mary Univ London, NIHR Barts Cardiovasc Biomed Res Unit, London EC1M 6BQ, England; [Morrison, Alanna C.; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Johnson, Andrew D.] NHLBI, Cardiovasc Epidemiol & Human Genom Branch, Bethesda, MD 20892 USA; [Vaidya, Dhananjay] Johns Hopkins Univ, Dept Med, Baltimore, MD 21287 USA; [Bouchard, Claude] Pennington Biomed Res Ctr, Human Genom Lab, Baton Rouge, LA 70808 USA; [Siscovick, David S.; Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98101 USA; [Uitterlinden, Andre G.; van Duijn, Cornelia] Netherlands Genom Initiat, Netherlands Consortium Healthy Aging, NL-2593 The Hague, Netherlands; [Palmas, Walter] Columbia Univ, Dept Med, New York, NY 10032 USA; [van Duijn, Cornelia] Netherlands Genom Initiat, Ctr Med Syst Biol, NL-2593 The Hague, Netherlands; [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Sch Publ Hlth, Houston, TX 77030 USA; [Levy, Daniel] Boston Univ, Sch Med, Boston, MA 02118 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Group Hlth Res Inst, Seattle, WA 98101 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Health Science Center Houston; Icelandic Heart Association; University of Iceland; Peking University; Johns Hopkins University; University of Geneva; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Washington; University of Washington Seattle; Boston University; Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Cedars Sinai Medical Center; Northwestern University; Feinberg School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Peking University; University of London; Queen Mary University London; University of London; Queen Mary University London; University of Texas System; University of Texas Health Science Center Houston; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johns Hopkins University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of Washington; University of Washington Seattle; Columbia University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Boston University; Group Health Cooperative	Ganesh, SK (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.	sganesh@umich.edu; aravinda@jhmi.edu	Smith, Albert Vernon/K-5150-2015; Newhouse, Stephen J/C-9330-2011; Dominiczak, Anna F/P-9390-2017; Gudnason, Vilmundur/K-6885-2015; Rivadeneira, Fernando/O-5385-2015; Meitinger, Thomas/O-1318-2015; Bouchard, Claude/A-7637-2009; Colaus, PsyColaus/K-6607-2013; EHRET, Georg B/A-9532-2009; Beckmann, Jacques S/A-9772-2008; Sijbrands, Eric/A-1065-2009; Pfeufer, Arne/B-6634-2013; Vaidya, Dhananjay/AAL-5684-2020; Matullo, Giuseppe/K-6383-2016; Levy, Daniel/ABF-6873-2021; Dehghan, Abbas/ABE-7377-2020; Heath, Simon C/J-4138-2012; Levy, Daniel/ABB-2752-2021; Deloukas, Panos/B-2922-2013; Dörr, Marcus/F-1919-2010; Onland-Moret, N. Charlotte/G-9185-2011; Laan, Maris/A-4100-2011; Uda, Manuela/AAC-2645-2019; Bochud, Murielle/A-3981-2010; Bouchard, Claude/AAE-2035-2019; Johnson, Andrew D/G-6520-2013; Gudnason, Vilmundur/AAE-7126-2019; Franco, Óscar H/ABE-2305-2020; Ramachandran, Vasan/Y-2527-2019; Rotter, Jerome/AAY-6598-2021; Hwang, Shih-Jen/HGU-5826-2022; McCarthy, Mark/M-3763-2015; Paterson, Andrew/A-4088-2011; Coin, Lachlan/A-9001-2014; Hemingway, Harry/C-1219-2009; Luben, Robert/H-5519-2015; Dehghan, Abbas/B-9896-2008; Loos, Ruth/Q-2862-2016	Smith, Albert Vernon/0000-0003-1942-5845; Newhouse, Stephen J/0000-0002-1843-9842; Dominiczak, Anna F/0000-0003-4913-3608; Gudnason, Vilmundur/0000-0001-5696-0084; Rivadeneira, Fernando/0000-0001-9435-9441; Bouchard, Claude/0000-0002-0048-491X; EHRET, Georg B/0000-0002-5730-0675; Beckmann, Jacques S/0000-0002-9741-1900; Sijbrands, Eric/0000-0001-8857-7389; Vaidya, Dhananjay/0000-0002-7164-1601; Matullo, Giuseppe/0000-0003-0674-7757; Levy, Daniel/0000-0003-1843-8724; Heath, Simon C/0000-0002-9550-0897; Deloukas, Panos/0000-0001-9251-070X; Dörr, Marcus/0000-0001-7471-475X; Onland-Moret, N. Charlotte/0000-0002-2360-913X; Laan, Maris/0000-0002-8519-243X; Uda, Manuela/0000-0002-4890-6456; Bochud, Murielle/0000-0002-5727-0218; Johnson, Andrew D/0000-0001-6369-5178; Gudnason, Vilmundur/0000-0001-5696-0084; Franco, Óscar H/0000-0002-4606-4929; Ramachandran, Vasan/0000-0001-7357-5970; Voight, Benjamin/0000-0002-6205-9994; Amin, Najaf/0000-0002-8944-1771; Waeber, Gerard/0000-0003-4193-788X; Caulfield, Mark/0000-0001-9295-3594; McCarthy, Mark/0000-0002-4393-0510; Munroe, Patricia/0000-0002-4176-2947; Meitinger, Thomas/0000-0002-8838-8403; Tobin, Martin/0000-0002-3596-7874; Elliott, Paul/0000-0002-7511-5684; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Morrison, Alanna/0000-0001-6381-4296; Gut, Ivo/0000-0001-7219-632X; Org, Elin/0000-0001-8688-9717; Forouhi, Nita/0000-0002-5041-248X; Paterson, Andrew/0000-0002-9169-118X; Eyheramendy, Susana/0000-0003-4723-9660; Volker, Uwe/0000-0002-5689-3448; Melander, Olle/0000-0002-2581-484X; Wallace, Chris/0000-0001-9755-1703; Zeggini, Eleftheria/0000-0003-4238-659X; Yang, Min-Lee/0000-0003-2823-8320; Coin, Lachlan/0000-0002-4300-455X; Hemingway, Harry/0000-0003-2279-0624; Soranzo, Nicole/0000-0003-1095-3852; ELOSUA, ROBERTO/0000-0001-8235-0095; Luben, Robert/0000-0002-5088-6343; Marrugat, Jaume/0000-0003-3320-554X; Lucas, Gavin/0000-0003-4166-9416; Dehghan, Abbas/0000-0001-6403-016X; Sacerdote, Carlotta/0000-0002-8008-5096; Lakatta, Edward/0000-0002-4772-0035; Loos, Ruth/0000-0002-8532-5087; Van Duijn, Cornelia/0000-0002-2374-9204; Org, Elin/0000-0003-1451-9375; Wain, Louise/0000-0003-4951-1867; Polidoro, Silvia/0000-0003-2968-0575; Zhang, He/0000-0001-9198-6503; Bandinelli, Stefania/0000-0002-6491-0850; SCUTERI, ANGELO/0000-0003-4784-5441	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006170, ZIAHL006001, R01HL105756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG007380] Funding Source: NIH RePORTER; MRC [G9521010] Funding Source: UKRI; Cancer Research UK [14136] Funding Source: researchfish; Medical Research Council [G1000143, G9521010, MR/K006584/1, G0401527] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10113, NF-SI-0512-10114] Funding Source: researchfish	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))		[Anonymous], 1978, J Chronic Dis, V31, P651; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; BECKETT LA, 1992, AM J EPIDEMIOL, V135, P1166, DOI 10.1093/oxfordjournals.aje.a116217; Benton MC, 2013, AM J HUM GENET, V93, P1087, DOI 10.1016/j.ajhg.2013.11.004; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CAREY RM, 1976, JAMA-J AM MED ASSOC, V236, P847, DOI 10.1001/jama.236.7.847; Chasman DI, 2009, CLIN CHEM, V55, P39, DOI 10.1373/clinchem.2008.107243; Chen MH, 2010, BIOINFORMATICS, V26, P580, DOI 10.1093/bioinformatics/btp710; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; Chen X, 2008, HYPERTENSION, V51, P642, DOI 10.1161/HYPERTENSIONAHA.107.102145; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Cook NR, 2004, STAT MED, V23, P3421, DOI 10.1002/sim.1921; Cusanovich DA, 2012, HUM MOL GENET, V21, P2111, DOI 10.1093/hmg/dds021; Davies LA, 2008, P NATL ACAD SCI USA, V105, P2203, DOI 10.1073/pnas.0712000105; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Ding J, 2010, AM J HUM GENET, V87, P779, DOI 10.1016/j.ajhg.2010.10.024; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Franklin SS, 1997, CIRCULATION, V96, P308; Gamazon ER, 2013, MOL PSYCHIATR, V18, P340, DOI 10.1038/mp.2011.174; Ganesh SK, 2013, HUM MOL GENET, V22, P1663, DOI 10.1093/hmg/dds555; Gao C, 2014, BIOINFORMATICS, V30, P369, DOI 10.1093/bioinformatics/btt690; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; GILLMAN MW, 1992, EPIDEMIOLOGY, V3, P40, DOI 10.1097/00001648-199201000-00008; GILLMAN MW, 1991, PEDIATRICS, V87, P708; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Greenawalt DM, 2011, GENOME RES, V21, P1008, DOI 10.1101/gr.112821.110; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Grundberg E, 2009, GENOME RES, V19, P1942, DOI 10.1101/gr.095224.109; Gutierrez-Arcelus M, 2013, ELIFE, V2, DOI 10.7554/eLife.00523; Hao K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003029; Heap GA, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-1; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Idaghdour Y, 2010, NAT GENET, V42, P62, DOI 10.1038/ng.495; Innocenti F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002078; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kabakchiev B, 2013, GASTROENTEROLOGY, V144, P1488, DOI 10.1053/j.gastro.2013.03.001; KANNEL WB, 1971, AM J CARDIOL, V27, P335, DOI 10.1016/0002-9149(71)90428-0; Kaplan RC, 2011, HUM MOL GENET, V20, P1241, DOI 10.1093/hmg/ddq560; Keildson S, 2014, DIABETES, V63, P1154, DOI 10.2337/db13-1301; Kim S, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.42; Kollias A, 2012, EUR J PUBLIC HEALTH, V22, P389, DOI 10.1093/eurpub/ckr082; Kompass KS, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-6; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Lam CSP, 2010, ARTERIOSCL THROM VAS, V30, P1479, DOI 10.1161/ATVBAHA.110.203943; Landmark-Hoyvik H, 2013, GENOMICS, V102, P278, DOI 10.1016/j.ygeno.2013.07.006; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; Liang LM, 2013, GENOME RES, V23, P716, DOI 10.1101/gr.142521.112; Lin HH, 2014, HEART RHYTHM, V11, P266, DOI 10.1016/j.hrthm.2013.10.051; Liu C, 2010, MOL PSYCHIATR, V15, P779, DOI 10.1038/mp.2009.128; Lofqvist C, 2007, P NATL ACAD SCI USA, V104, P10589, DOI 10.1073/pnas.0702031104; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Ma L, 2013, NEW ENGL J MED, V369, P351, DOI 10.1056/NEJMoa1211097; Mehta D, 2013, EUR J HUM GENET, V21, P48, DOI 10.1038/ejhg.2012.106; Muhammad S, 2010, NEUROSCIENCE, V167, P758, DOI 10.1016/j.neuroscience.2010.02.024; Murphy A, 2010, HUM MOL GENET, V19, P4745, DOI 10.1093/hmg/ddq392; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qiu WL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024395; Quigley DA, 2014, MOL ONCOL, V8, P273, DOI 10.1016/j.molonc.2013.11.008; Rantalainen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027338; ROSNER B, 1979, J CHRON DIS, V32, P451, DOI 10.1016/0021-9681(79)90105-X; ROSNER B, 1981, J CHRON DIS, V34, P135, DOI 10.1016/0021-9681(81)90023-0; ROSNER B, 1989, STAT MED, V8, P1051, DOI 10.1002/sim.4780080905; Rossignol P, 2012, HYPERTENSION, V60, P339, DOI 10.1161/HYPERTENSIONAHA.111.190397; Sasayama D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054967; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schroder A, 2013, PHARMACOGENOMICS J, V13, P12, DOI 10.1038/tpj.2011.44; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Sundstrom J, 2005, HYPERTENSION, V45, P28, DOI 10.1161/01.HYP.0000150784.92944.9a; van Eijk KR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-636; Vasan RS, 2002, CIRCULATION, V105, P48, DOI 10.1161/hc0102.101774; Wang TD, 2011, HYPERTENS RES, V34, P49, DOI 10.1038/hr.2010.204; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wilson PWF, 1997, NEW ENGL J MED, V337, P516, DOI 10.1056/NEJM199708213370802; WOLFE BL, 1993, J BIOL CHEM, V268, P12418; Zachariah JP, 2012, HYPERTENSION, V59, P773, DOI 10.1161/HYPERTENSIONAHA.111.179242; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhernakova DV, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003594; ZINNER SH, 1978, CIRCULATION, V58, P908, DOI 10.1161/01.CIR.58.5.908; Zou FG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002707; 1977, J AM MED ASS, V237, P2385	91	52	52	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 13	2014	95	1					49	65		10.1016/j.ajhg.2014.06.002	http://dx.doi.org/10.1016/j.ajhg.2014.06.002			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AL1RP	24975945	Green Published, Bronze			2022-12-18	WOS:000338904100004
J	Kulzer, JR; Stitzel, ML; Morken, MA; Huyghe, JR; Fuchsberger, C; Kuusisto, J; Laakso, M; Boehnke, M; Collins, FS; Mohlke, KL				Kulzer, Jennifer R.; Stitzel, Michael L.; Morken, Mario A.; Huyghe, Jeroen R.; Fuchsberger, Christian; Kuusisto, Johanna; Laakso, Markku; Boehnke, Michael; Collins, Francis S.; Mohlke, Karen L.			A Common Functional Regulatory Variant at a Type 2 Diabetes Locus Upregulates ARAP1 Expression in the Pancreatic Beta Cell	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; TRANSCRIPTIONAL REPRESSOR; INSULIN-SECRETION; GENE-EXPRESSION; SUSCEPTIBILITY LOCUS; PROVIDES INSIGHTS; PAX4; ARF; IDENTIFICATION; DATABASE	Genome-wide association studies (GWASs) have identified more than 70 loci associated with type 2 diabetes (T2D), but for most, the underlying causal variants, associated genes, and functional mechanisms remain unknown. At a T2D- and fasting-proinsulin-associated locus on 11q13.4, we have identified a functional regulatory DNA variant, a candidate target gene, and a plausible underlying molecular mechanism. Fine mapping, conditional analyses, and exome array genotyping in 8,635 individuals from the Metabolic Syndrome in Men study confirmed a single major association signal between fasting proinsulin and noncoding variants (p = 7.4 x 10(-5)). Measurement of allele-specific mRNA levels in human pancreatic islet samples heterozygous for rs11603334 showed that the T2D-risk and proinsulin-decreasing allele (C) is associated with increased ARAP1 expression (p < 0.02). We evaluated four candidate functional SNPs for allelic effects on transcriptional activity by performing reporter assays in rodent pancreatic beta cell lines. The C allele of rs11603334, located near one of the ARAPI promoters, exhibited 2-fold higher transcriptional activity than did the T allele (p < 0.0001); three other candidate SNPs showed no allelic differences. Electrophoretic mobility shift assays demonstrated decreased binding of pancreatic beta cell transcriptional regulators PAX6 and PAX4 to the rs11603334 C allele. Collectively, these data suggest that the T2D-risk allele of rs11603334 could abrogate binding of a complex containing PAX6 and PAX4 and thus lead to increased promoter activity and ARAP1 expression in human pancreatic islets. This work suggests that increased ARAP1 expression might contribute to T2D susceptibility at this GWAS locus.	[Kulzer, Jennifer R.; Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Stitzel, Michael L.; Morken, Mario A.; Collins, Francis S.] NHGRI, NIH, Bethesda, MD 20892 USA; [Stitzel, Michael L.] Jackson Lab Genom Med, Farmington, CT 06030 USA; [Huyghe, Jeroen R.; Fuchsberger, Christian; Boehnke, Michael] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Huyghe, Jeroen R.; Fuchsberger, Christian; Boehnke, Michael] Univ Michigan, Sch Publ Hlth, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Kuusisto, Johanna; Laakso, Markku] Univ Eastern Finland, Dept Med, Kuopio 70210, Finland; [Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, SF-70210 Kuopio, Finland	University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Jackson Laboratory; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Mohlke, KL (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA.	mohlke@med.unc.edu	Fuchsberger, Christian/ABD-7127-2021	Fuchsberger, Christian/0000-0002-5918-8947	National Institutes of Health (NIH) [R01DK072193, R21DA027040, R01DK093757, K99DK092251, R01DK062370]; NIH National Human Genome Research Institute (NHGRI) Division of Intramural Research project [Z01HG000024]; Academy of Finland [77299, 124243]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000024] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Human Genome Research Institute (NHGRI) Division of Intramural Research project; Academy of Finland(Academy of Finland); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank first and foremost the human organ donors whose pancreatic islets were used in this study. Islets were obtained from the Islet Cell Resource Center Basic Science Islet Distribution Program and Integrated Islet Distribution Program and the National Disease Research Interchange. This study was supported by National Institutes of Health (NIH) grants R01DK072193 (K.L.M.), R21DA027040 (K.L.M.), R01DK093757 (K.L.M.), K99DK092251 (M.L.S.), and R01DK062370 (M.B.), NIH National Human Genome Research Institute (NHGRI) Division of Intramural Research project number Z01HG000024 (F.S.C.), and Academy of Finland grants 77299 and 124243 (M.L.). The authors gratefully acknowledge the Genetics of Type 2 Diabetes Consortium for access to the reference Panel used for imputation, Michael R. Erdos (NHGRI) for assistance coordinating and preparing human islet samples, Yun Li (University of North Carolina at Chapel Hill) for providing linkage-disequilibrium data from the 1000 Genomes Project, Praveen Sethupathy (University of North Carolina at Chapel Hill) for helpful discussion and assistance generating motif prediction scores via PWM-Scan, Leslie Lange and Ethan Lange (University of North Carolina at Chapel Hill) for statistical advice, and Marie Fogarty (University of North Carolina at Chapel Hill) for helpful discussions.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Cho YS, 2012, CURR DIABETES REP, V12, P686, DOI 10.1007/s11892-012-0326-z; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Cuthbert EJ, 2008, AM J PHYSIOL-CELL PH, V294, pC263, DOI 10.1152/ajpcell.00292.2007; Daniele T, 2008, TRAFFIC, V9, P2221, DOI 10.1111/j.1600-0854.2008.00823.x; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Duncan MK, 1998, MOL CELL BIOL, V18, P5579, DOI 10.1128/MCB.18.9.5579; Fogarty MP, 2010, HUM MOL GENET, V19, P1921, DOI 10.1093/hmg/ddq067; Fujitani Y, 1999, MOL CELL BIOL, V19, P8281; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Ghosh D, 2000, NUCLEIC ACIDS RES, V28, P308, DOI 10.1093/nar/28.1.308; Greenawalt DM, 2011, GENOME RES, V21, P1008, DOI 10.1101/gr.112821.110; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Huyghe JR, 2013, NAT GENET, V45, P197, DOI 10.1038/ng.2507; Ichii H, 2005, AM J TRANSPLANT, V5, P1635, DOI 10.1111/j.1600-6143.2005.00913.x; Imamura M, 2012, HUM MOL GENET, V21, P3042, DOI 10.1093/hmg/dds113; Jayaram B, 2011, BIOCHEM PHARMACOL, V81, P1016, DOI 10.1016/j.bcp.2011.01.006; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Katoh M, 2004, INT J MOL MED, V13, P749; Lawrence JTR, 2003, P NATL ACAD SCI USA, V100, P13320, DOI 10.1073/pnas.2232129100; Levy S, 2002, MAMM GENOME, V13, P510, DOI 10.1007/s00335-002-2175-6; Li HX, 2013, DIABETES, V62, P291, DOI 10.2337/db12-0454; Liu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046934; Ma RCW, 2013, DIABETOLOGIA, V56, P1291, DOI 10.1007/s00125-013-2874-4; Matsushita M, 2007, J BIOL CHEM, V282, P6763, DOI 10.1074/jbc.M609876200; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mauvais-Jarvis F, 2004, HUM MOL GENET, V13, P3151, DOI 10.1093/hmg/ddh341; Miura K, 2002, MOL CELL, V9, P109, DOI 10.1016/S1097-2765(02)00428-8; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nielsen T, 2011, DIABETOLOGIA, V54, P1052, DOI 10.1007/s00125-011-2054-3; Olayioye MA, 2005, J BIOL CHEM, V280, P27436, DOI 10.1074/jbc.M413330200; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Pastinen T, 2010, NAT REV GENET, V11, P533, DOI 10.1038/nrg2815; Perry JRB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002741; Petersen Helle V., 2000, Molecular Cell Biology Research Communications, V3, P249, DOI 10.1006/mcbr.2000.0220; Pisania A, 2010, LAB INVEST, V90, P1661, DOI 10.1038/labinvest.2010.124; Plengvidhya N, 2007, J CLIN ENDOCR METAB, V92, P2821, DOI 10.1210/jc.2006-1927; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Ritz-Laser B, 2002, DIABETOLOGIA, V45, P97, DOI 10.1007/s125-002-8249-9; Rosman GJ, 1997, GENE, V191, P89, DOI 10.1016/S0378-1119(97)00046-2; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Saxena R, 2013, DIABETES, V62, P1746, DOI 10.2337/db12-1077; Shimajiri Y, 2001, DIABETES, V50, P2864, DOI 10.2337/diabetes.50.12.2864; Shyr CR, 2010, PROSTATE, V70, P190, DOI 10.1002/pros.21052; Simova S, 2008, APOPTOSIS, V13, P423, DOI 10.1007/s10495-007-0171-8; Smith SB, 1999, MOL CELL BIOL, V19, P8272; Stancakova A, 2009, DIABETES, V58, P1212, DOI 10.2337/db08-1607; Stitzel ML, 2010, CELL METAB, V12, P443, DOI 10.1016/j.cmet.2010.09.012; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tabassum R, 2013, DIABETES, V62, P977, DOI 10.2337/db12-0406; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang ZX, 2007, J BIOL CHEM, V282, P9536, DOI 10.1074/jbc.M610553200; Wen JH, 2009, DIABETOLOGIA, V52, P504, DOI 10.1007/s00125-008-1210-x; Wethmar K, 2010, BIOESSAYS, V32, P885, DOI 10.1002/bies.201000037; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Yasuda T, 2002, DIABETES, V51, P224, DOI 10.2337/diabetes.51.1.224; Yoon HY, 2008, TRAFFIC, V9, P2236, DOI 10.1111/j.1600-0854.2008.00839.x	66	52	55	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 6	2014	94	2					186	197		10.1016/j.ajhg.2013.12.011	http://dx.doi.org/10.1016/j.ajhg.2013.12.011			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA9NF	24439111	Green Published, Bronze			2022-12-18	WOS:000331419500003
J	Han, SZ; Yang, BZ; Kranzler, HR; Liu, XM; Zhao, HY; Farrer, LA; Boerwinkle, E; Potash, JB; Gelemter, J				Han, Shizhong; Yang, Bao-Zhu; Kranzler, Henry R.; Liu, Xiaoming; Zhao, Hongyu; Farrer, Lindsay A.; Boerwinkle, Eric; Potash, James B.; Gelemter, Joel			Integrating GWASs and Human Protein Interaction Networks Identifies a Gene Subnetwork Underlying Alcohol Dependence	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; ENVIRONMENTAL CONTRIBUTIONS; SEMISTRUCTURED ASSESSMENT; SUSCEPTIBILITY LOCI; HAPLOTYPIC VARIANTS; QUANTITATIVE-TRAIT; DRUG-DEPENDENCE; RISK; LINKAGE; SAMPLE	Despite a significant genetic contribution to alcohol dependence (AD), few AD-risk genes have been identified to date. In the current study, we aimed to integrate genome-wide association studies (GWASs) and human protein interaction networks to investigate whether a subnetwork of genes whose protein products interact with one another might collectively contribute to AD. By using two discovery GWAS data sets of the Study of Addiction: Genetics and Environment (SAGE) and the Collaborative Study on the Genetics of Alcoholism (COGA), we identified a subnetwork of 39 genes that not only was enriched for genes associated with AD, but also collectively associated with AD in both European Americans (p < 0.0001) and African Americans (p = 0.0008). We replicated the association of the gene subnetwork with AD in three independent samples, including two samples of European descent (p = 0.001 and p = 0.006) and one sample of African descent (p = 0.0069). To evaluate whether the significant associations are likely to be false-positive findings and to ascertain their specificity, we examined the same gene subnetwork in three other human complex disorders (bipolar disorder, major depressive disorder, and type 2 diabetes) and found no significant associations. Functional enrichment, analysis revealed that the gene subnetwork was enriched for genes involved in cation transport, synaptic transmission, and transmission of nerve impulses, all of which are biologically meaningful processes that may underlie the risk for AD. In conclusion, we identified a gene subnetwork underlying AD that is biologically meaningful and highly reproducible, providing important clues for future research into AD etiology and treatment.	[Han, Shizhong; Yang, Bao-Zhu; Gelemter, Joel] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA; [Han, Shizhong; Potash, James B.] Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA; [Kranzler, Henry R.] Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Kranzler, Henry R.] Philadelphia VAMC, VISN MIRECC 4, Philadelphia, PA 19104 USA; [Liu, Xiaoming] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, Houston, TX 77030 USA; [Zhao, Hongyu] Yale Univ, Sch Med, Dept Biostat, New Haven, CT 06510 USA; [Zhao, Hongyu] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Med, Boston, MA USA; [Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Biomed Genet, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Biomed Genet, Boston, MA USA; [Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Genet & Genom, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Biostat, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Epidemiol, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Neurol, Boston, MA USA; [Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Ophthalmol, Boston, MA USA; [Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Genet & Genom, Boston, MA USA; [Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Gelemter, Joel] Yale Univ, Dept Genet, Sch Med, New Haven, CT 06510 USA; [Gelemter, Joel] Yale Univ, Dept Neurobiol, Sch Med, New Haven, CT 06510 USA	Yale University; University of Iowa; University of Pennsylvania; University of Texas System; University of Texas Health Science Center Houston; Yale University; Yale University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Baylor College of Medicine; Yale University; Yale University	Han, SZ (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA.	shizhong-han@uiowa.edu	kranzler, henry/AAS-1113-2020; Farrer, Lindsay/AAS-1035-2020; Liu, Xiaoming/C-2743-2008	kranzler, henry/0000-0002-1018-0450; Liu, Xiaoming/0000-0001-8285-5528; Farrer, Lindsay/0000-0001-5533-4225; Han, Shizhong/0000-0002-5114-6742; Gelernter, Joel/0000-0002-4067-1859	National Institutes of Health [R01 DA12690, R01 DA12849, RC2 DA028909, R01 DA18432, R01 AA11330, R01 AA017535, K01 DA24758, N01-HG-65403]; VA Connecticut REAP center; VA MERIT grant; VA National Center for PTSD Research; VA Connecticut; VISN4 MIRECC Centers; AbbVie; Lilly; Lundbeck; Pfizer; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017535, R01AA011330, P50AA011998, R01AA013320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RC2DA028909, R01DA018432, K01DA024758, R01DA012690, R01DA012849] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Connecticut REAP center; VA MERIT grant; VA National Center for PTSD Research; VA Connecticut; VISN4 MIRECC Centers; AbbVie(AbbVie); Lilly(Eli Lilly); Lundbeck(Lundbeck Corporation); Pfizer(Pfizer); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors are grateful to the volunteer families and individuals who participated in this research study. The authors would like to thank Peilin Jia for helping in the use of dmGWAS R package. The authors are indebted to the two anonymous reviewers for their constructive comments. This study was supported by the Alcoholic Beverage Medical Research Foundation (ABMRF) grant (S.H.). This study was also supported by National Institutes of Health grants R01 DA12690, R01 DA12849, RC2 DA028909, R01 DA18432, R01 AA11330, R01 AA017535, and K01 DA24758, and by the VA Connecticut REAP center, a VA MERIT grant, VA National Center for PTSD Research, and the VA Connecticut and VISN4 MIRECC Centers. Genotyping services for a part of the Yale-Penn GWAS were provided by the Center for Inherited Disease Research (CIDR) and Yale University (Center for Genome Analysis). CIDR is fully funded through a federal contract from the National Institutes of Health to The Johns Hopkins University (contract number N01-HG-65403). The SAGE, COGA, and OZ-ALC GWAS data sets in this study were obtained from dbGaP. Detailed funding and support information for these GWAS data sets are in Supplemental Acknowledgements. H.R.K. has been a paid consultant or advisory board member for Alkermes, Lilly, Lundbeck, Pfizer, and Roche and is a member of the Alcohol Clinical Trials Initiative (ACTIVE) of the American Society of Clinical Psychopharmacology, which is supported by AbbVie, Lilly, Lundbeck, and Pfizer.	Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bierut LJ, 2010, P NATL ACAD SCI USA, V107, P5082, DOI 10.1073/pnas.0911109107; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Edenberg HJ, 2010, ALCOHOL CLIN EXP RES, V34, P840, DOI 10.1111/j.1530-0277.2010.01156.x; Frank J, 2012, ADDICT BIOL, V17, P171, DOI 10.1111/j.1369-1600.2011.00395.x; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Gelernter J, 2013, BIOL PSYCHIAT; Gelernter J, 2013, MOL PSYCHIAT; Gelernter J, 2009, HUM GENET, V126, P91, DOI 10.1007/s00439-009-0701-2; Guo AY, 2009, NUCLEIC ACIDS RES, V37, pD840, DOI 10.1093/nar/gkn816; Hansell NK, 2010, ALCOHOL CLIN EXP RES, V34, P158, DOI 10.1111/j.1530-0277.2009.01077.x; Heath AC, 1997, PSYCHOL MED, V27, P1381, DOI 10.1017/S0033291797005643; Heath AC, 2011, BIOL PSYCHIAT, V70, P513, DOI 10.1016/j.biopsych.2011.02.028; Ishiguro H, 2000, AM J MED GENET, V96, P716, DOI 10.1002/1096-8628(20001204)96:6<716::AID-AJMG3>3.0.CO;2-N; Jia PL, 2011, BIOINFORMATICS, V27, P95, DOI 10.1093/bioinformatics/btq615; Kendler KS, 2011, ALCOHOL CLIN EXP RES, V35, P963, DOI 10.1111/j.1530-0277.2010.01427.x; Kendler KS, 1997, ARCH GEN PSYCHIAT, V54, P178; KENDLER KS, 1992, JAMA-J AM MED ASSOC, V268, P1877, DOI 10.1001/jama.268.14.1877; Nikpay M, 2012, HYPERTENS RES, V35, P585, DOI 10.1038/hr.2011.233; Pastor IJ, 2009, EUR PSYCHIAT, V24, P191, DOI 10.1016/j.eurpsy.2008.08.007; Pierucci-Lagha A, 2005, DRUG ALCOHOL DEPEN, V80, P303, DOI 10.1016/j.drugalcdep.2005.04.005; Pierucci-Lagha A, 2007, DRUG ALCOHOL DEPEN, V91, P85, DOI 10.1016/j.drugalcdep.2007.04.014; Prescott CA, 1999, AM J PSYCHIAT, V156, P34, DOI 10.1176/ajp.156.1.34; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reich T, 1998, AM J MED GENET, V81, P207, DOI 10.1002/(SICI)1096-8628(19980508)81:3<207::AID-AJMG1>3.3.CO;2-X; Saccone SF, 2007, AM J HUM GENET, V80, P856, DOI 10.1086/513703; Schumann G, 2003, BIOL PSYCHIAT, V54, P1422, DOI 10.1016/S0006-3223(03)00635-8; Shi J, 2011, MOL PSYCHIATR, V16, P193, DOI 10.1038/mp.2009.124; Smith EN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002134; Treistman SN, 2009, TRENDS NEUROSCI, V32, P629, DOI 10.1016/j.tins.2009.08.001; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wu JM, 2009, NAT METHODS, V6, P75, DOI [10.1038/NMETH.1282, 10.1038/nmeth.1282]; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Xie PX, 2013, BIOL PSYCHIAT, V74, P656, DOI 10.1016/j.biopsych.2013.04.013; Xu JZ, 2006, BIOINFORMATICS, V22, P2800, DOI 10.1093/bioinformatics/btl467; Yang BZ, 2007, HUM MOL GENET, V16, P2844, DOI 10.1093/hmg/ddm240; Yang BZ, 2008, ALCOHOL CLIN EXP RES, V32, P2117, DOI 10.1111/j.1530-0277.2008.00800.x	43	52	53	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 5	2013	93	6					1027	1034		10.1016/j.ajhg.2013.10.021	http://dx.doi.org/10.1016/j.ajhg.2013.10.021			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	273FS	24268660	Green Published, Bronze			2022-12-18	WOS:000328521300003
J	Merrill, AE; Sarukhanov, A; Krejci, P; Idoni, B; Camacho, N; Estrada, KD; Lyons, KM; Deixler, H; Robinson, H; Chitayat, D; Curry, CJ; Lachman, RS; Wilcox, WR; Krakow, D				Merrill, Amy E.; Sarukhanov, Anna; Krejci, Pavel; Idoni, Brian; Camacho, Natalia; Estrada, Kristine D.; Lyons, Karen M.; Deixler, Hannah; Robinson, Haynes; Chitayat, David; Curry, Cynthia J.; Lachman, Ralph S.; Wilcox, William R.; Krakow, Deborah			Bent Bone Dysplasia-FGFR2 type, a Distinct Skeletal Disorder, Has Deficient Canonical FGF Signaling	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							APERT-SYNDROME; LADD SYNDROME; GROWTH; MUTATIONS; RECEPTOR-2; ACTIVATION; INDUCTION; CROUZON; MOUSE; DISRUPTION	Fibroblast growth factor receptor 2 (FGFR2) is a crucial regulator of bone formation during embryonic development. Both gain and loss-of-function studies in mice have shown that FGFR2 maintains a critical balance between the proliferation and differentiation of osteoprogenitor cells. We have identified de novo FGFR2 mutations in a sporadically occurring perinatal lethal skeletal dysplasia characterized by poor mineralization of the calvarium, craniosynostosis, dysmorphic facial features, prenatal teeth, hypoplastic pubis and clavicles, osteopenia, and bent long bones. Histological analysis of the long bones revealed that the growth plate contained smaller hypertrophic chondrocytes and a thickened hypercellular periosteum. Four unrelated affected individuals were found to be heterozygous for missense mutations that introduce a polar amino acid into the hydrophobic transmembrane domain of FGFR2. Using diseased chondrocytes and a cell-based assay, we determined that these mutations selectively reduced plasma-membrane levels of FGFR2 and markedly diminished the receptor's responsiveness to extracellular FGF. All together, these clinical and molecular findings are separate from previously characterized FGFR2 disorders and represent a distinct skeletal dysplasia.	[Merrill, Amy E.; Sarukhanov, Anna; Camacho, Natalia; Lyons, Karen M.; Deixler, Hannah; Krakow, Deborah] Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthoped Surg, Los Angeles, CA 90048 USA; [Merrill, Amy E.; Krejci, Pavel; Lachman, Ralph S.; Wilcox, William R.; Krakow, Deborah] Cedars Sinai Med Ctr, Med Genet Res Inst, Los Angeles, CA 90048 USA; [Merrill, Amy E.; Idoni, Brian] Univ So Calif, Ctr Craniofacial Mol Biol, Ostrow Sch Dent, Los Angeles, CA 90033 USA; [Merrill, Amy E.] Univ So Calif, Keck Sch Med, Dept Biochem, Los Angeles, CA 90033 USA; [Krejci, Pavel] Masaryk Univ, Inst Expt Biol, Dept Anim Physiol & Immunol, Brno 61265, Czech Republic; [Krejci, Pavel] Acad Sci Czech Republic, Inst Biophys, Dept Cytokinet, CS-61265 Brno, Czech Republic; [Robinson, Haynes] Akron Childrens Hosp, Akron, OH 44308 USA; [Chitayat, David] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Curry, Cynthia J.] Genet Med Cent Calif, Fresno, CA 93701 USA; [Chitayat, David] Mt Sinai Hosp, Prenatal Diag & Med Genet Program, Dept Obstet & Gynecol, Toronto, ON M5G 1X8, Canada	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; University of Southern California; University of Southern California; Masaryk University Brno; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Akron Children's Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Krakow, D (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthoped Surg, Los Angeles, CA 90048 USA.	dkrakow@mednet.ucla.edu	Krakow, Deborah/B-5778-2009; Krejčí, Pavel/I-4285-2014	Krakow, Deborah/0000-0001-9906-4968; Krejci, Pavel/0000-0003-0618-9134; Merrill-Brugger, Amy/0000-0002-3660-1575	US National Institute of Health [HD22657]; Friedman Family Foundation; National Institute of Dental and Craniofacial Research [5 P30 DE020750-02]; University of Southern California Ostrow School of Dentistry and Keck School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P30DE020750] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Friedman Family Foundation; National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); University of Southern California Ostrow School of Dentistry and Keck School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank David Ornitz for providing BaF3 cells and Nan Hatch for providing the FGFR2-pcDNA3.1 plasmid. We also thank Sean Brugger, Robert Maxson, Richard Schneider, Malcolm Snead, Daniel Cohn, and Larry Zipursky for helpful discussions. The work presented here was supported by the US National Institute of Health award HD22657 (to D.K., W.R.W., and R.S.L.), the Friedman Family Foundation, the National Institute of Dental and Craniofacial Research award 5 P30 DE020750-02 (to Yang Chai in support of A.E.M), and start-up funds from the University of Southern California Ostrow School of Dentistry and Keck School of Medicine (to A.E.M.).	Arman E, 1998, P NATL ACAD SCI USA, V95, P5082, DOI 10.1073/pnas.95.9.5082; Celli G, 1998, EMBO J, V17, P1642, DOI 10.1093/emboj/17.6.1642; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Dode C, 2003, NAT GENET, V33, P463, DOI 10.1038/ng1122; Eswarakumar VP, 2004, P NATL ACAD SCI USA, V101, P12555, DOI 10.1073/pnas.0405031101; Eswarakumar VP, 2002, DEVELOPMENT, V129, P3783; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Galvin BD, 1996, P NATL ACAD SCI USA, V93, P7894, DOI 10.1073/pnas.93.15.7894; Haraguchi R, 2000, DEVELOPMENT, V127, P2471; Hatch NE, 2006, J BIOL CHEM, V281, P27292, DOI 10.1074/jbc.M600448200; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lajeunie E, 2006, EUR J HUM GENET, V14, P289, DOI 10.1038/sj.ejhg.5201558; Lew ED, 2007, P NATL ACAD SCI USA, V104, P19802, DOI 10.1073/pnas.0709905104; Mangasarian K, 1997, J CELL PHYSIOL, V172, P117, DOI 10.1002/(SICI)1097-4652(199707)172:1<117::AID-JCP13>3.3.CO;2-S; MATHIEU M, 1995, J BIOL CHEM, V270, P24197, DOI 10.1074/jbc.270.41.24197; McAtee PA, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-5; Meyers GA, 1996, AM J HUM GENET, V58, P491; Myers JM, 2003, J CELL BIOCHEM, V88, P1273, DOI 10.1002/jcb.10476; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Revest JM, 2001, DEV BIOL, V231, P47, DOI 10.1006/dbio.2000.0144; Robertson SC, 1998, P NATL ACAD SCI USA, V95, P4567, DOI 10.1073/pnas.95.8.4567; Rohmann E, 2006, NAT GENET, V38, P414, DOI 10.1038/ng1757; Wang YL, 2005, DEVELOPMENT, V132, P3537, DOI 10.1242/dev.01914; Xu XL, 1998, DEVELOPMENT, V125, P753; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Yu K, 2000, P NATL ACAD SCI USA, V97, P14536, DOI 10.1073/pnas.97.26.14536	26	52	62	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR 9	2012	90	3					550	557		10.1016/j.ajhg.2012.02.005	http://dx.doi.org/10.1016/j.ajhg.2012.02.005			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911ZI	22387015	Green Published, Bronze			2022-12-18	WOS:000301762800022
J	Abouzeid, H; Boisset, G; Favez, T; Youssef, M; Marzouk, I; Shakankiry, N; Bayoumi, N; Descombes, P; Agosti, C; Munier, FL; Schorderet, DE				Abouzeid, Hana; Boisset, Gaelle; Favez, Tatiana; Youssef, Mohamed; Marzouk, Iman; Shakankiry, Nihal; Bayoumi, Nader; Descombes, Patrick; Agosti, Celine; Munier, Francis L.; Schorderet, Daniel E.			Mutations in the SPARC-Related Modular Calcium-Binding Protein 1 Gene, SMOC1, Cause Waardenburg Anophthalmia Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OPHTHALMO-ACROMELIC SYNDROME; RECESSIVE ANOPHTHALMIA; HOMEOBOX GENE; MICROPHTHALMIA; EYE; ABNORMALITIES; ANOMALIES; FIBULIN-1; SOX2	Waardenburg anophthalmia syndrome, also known as microphthalmia with limb anomalies, ophthalmoacromelic syndrome, and anophthalmia-syndactyly, is a rare autosomal-recessive developmental disorder that has been mapped to 10p11.23. Here we show that this disease is heterogeneous by reporting on a consanguineous family, not linked to the 10p11.23 locus, whose two affected children have a homozygous mutation in SMOC1. Knockdown experiments of the zebrafish smoc1 revealed that smoc1 is important in eye development and that it is expressed in many organs, including brain and somites.	[Abouzeid, Hana; Boisset, Gaelle; Favez, Tatiana; Agosti, Celine; Munier, Francis L.; Schorderet, Daniel E.] IRO, CH-1950 Sion, Switzerland; [Abouzeid, Hana; Munier, Francis L.; Schorderet, Daniel E.] Univ Lausanne, Jules Gonin Eye Hosp, CH-1003 Lausanne, Switzerland; [Youssef, Mohamed; Marzouk, Iman] Univ Alexandria, Genet Unit, Dept Paediat, Alexandria 21526, Egypt; [Shakankiry, Nihal; Bayoumi, Nader] Univ Alexandria, Dept Ophthalmol, Alexandria 21526, Egypt; [Descombes, Patrick] Univ Geneva, NCCR Frontiers Genet, CH-1211 Geneva, Switzerland; [Schorderet, Daniel E.] Ecole Polytech Fed Lausanne, Fed Sch Technol Lausanne, CH-1015 Lausanne, Switzerland	University of Lausanne; Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Alexandria University; University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Schorderet, DE (corresponding author), IRO, CH-1950 Sion, Switzerland.	daniel.schorderet@irovision.ch	ABOUZEID, HANA/AFR-1918-2022; Al-Inany, Hesham/AAF-1089-2020; Bayoumi, Nader/R-7266-2018	ABOUZEID, HANA/0000-0003-3915-3285; Bayoumi, Nader/0000-0002-3140-5073				al Gazali L I, 1994, Clin Dysmorphol, V3, P258; Asai-Coakwell M, 2009, HUM MOL GENET, V18, P1110, DOI 10.1093/hmg/ddp008; Bakrania P, 2008, AM J HUM GENET, V82, P304, DOI 10.1016/j.ajhg.2007.09.023; BENNETT CP, 1991, J MED GENET, V28, P280, DOI 10.1136/jmg.28.4.280; Chao R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010565; Choi YA, 2010, J PROTEOME RES, V9, P2946, DOI 10.1021/pr901110q; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Fuhrmann S, 2010, CURR TOP DEV BIOL, V93, P61, DOI [10.1016/B978-0-12-385044-7.00003-5, 10.1016/S0070-2153(10)93003-2]; Fuhrmann Sabine, 2008, Organogenesis, V4, P60; Gallardo ME, 2004, AM J MED GENET A, V129A, P92, DOI 10.1002/ajmg.a.30126; Garavelli L, 2006, GENET COUNSEL, V17, P449; Gilmour DT, 1998, EMBO J, V17, P1860, DOI 10.1093/emboj/17.7.1860; GRAHAM CA, 1991, OPHTHALMIC PAED GEN, V12, P43, DOI 10.3109/13816819109023084; Graw J, 2003, NAT REV GENET, V4, P876, DOI 10.1038/nrg1202; Hamanoue H, 2009, AM J MED GENET A, V149A, P336, DOI 10.1002/ajmg.a.32656; Hever AM, 2006, CLIN GENET, V69, P459, DOI 10.1111/j.1399-0004.2006.00619.x; Kim JI, 1999, P NATL ACAD SCI USA, V96, P3781, DOI 10.1073/pnas.96.7.3781; LEMERRER M, 1988, ANN GENET-PARIS, V31, P226; LENZ W, 1955, Z Kinderheilkd, V77, P384, DOI 10.1007/BF00437927; Megarbane A, 1998, GENET COUNSEL, V9, P195; Ng D, 2004, NAT GENET, V36, P411, DOI 10.1038/ng1321; Novinec M, 2008, PROTEIN EXPRES PURIF, V62, P75, DOI 10.1016/j.pep.2008.07.009; OSTOR AG, 1978, PATHOLOGY, V10, P243; Percin EF, 2000, NAT GENET, V25, P397, DOI 10.1038/78071; Polok B, 2009, AM J HUM GENET, V84, P259, DOI 10.1016/j.ajhg.2009.01.006; Ragge NK, 2005, AM J HUM GENET, V76, P1008, DOI 10.1086/430721; RICHIERICOSTA A, 1983, AM J MED GENET, V14, P607, DOI 10.1002/ajmg.1320140403; SAYLI BS, 1995, AM J MED GENET, V58, P18, DOI 10.1002/ajmg.1320580105; Stone EM, 1999, NAT GENET, V22, P199, DOI 10.1038/9722; Suyugul Z, 1996, AM J MED GENET, V62, P391, DOI 10.1002/(SICI)1096-8628(19960424)62:4<391::AID-AJMG12>3.3.CO;2-D; TACHIBANA M, 1994, HUM MOL GENET, V3, P553, DOI 10.1093/hmg/3.4.553; Tekin M, 2000, AM J MED GENET, V90, P150, DOI 10.1002/(SICI)1096-8628(20000117)90:2<150::AID-AJMG12>3.0.CO;2-C; TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4; TRABOULSI EI, 1984, OPHTHALMIC PAED GEN, V4, P13, DOI 10.3109/13816818409009888; Vannahme C, 2002, J BIOL CHEM, V277, P37977, DOI 10.1074/jbc.M203830200; Viljoen D L, 1993, Clin Dysmorphol, V2, P274; Voronina VA, 2004, HUM MOL GENET, V13, P315, DOI 10.1093/hmg/ddh025; WAARDENBURG PJ, 1961, GENET OPHTHALMOL, P773; Ye M, 2010, HUM MOL GENET, V19, P287, DOI 10.1093/hmg/ddp496; Zhang H, 2008, ACTA BIOCH BIOPH SIN, V40, P375, DOI 10.1111/j.1745-7270.2008.00420.x; Zhang HY, 1996, DEV DYNAM, V205, P348, DOI 10.1002/(SICI)1097-0177(199603)205:3<348::AID-AJA13>3.0.CO;2-0	41	52	55	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 7	2011	88	1					92	98		10.1016/j.ajhg.2010.12.002	http://dx.doi.org/10.1016/j.ajhg.2010.12.002			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	710HJ	21194680	Bronze, Green Published			2022-12-18	WOS:000286501500009
J	Riazuddin, SA; Shahzadi, A; Zeitz, C; Ahmed, ZM; Ayyagari, R; Chavali, VRM; Ponferrada, VG; Audo, I; Michiels, C; Lancelot, ME; Nasir, IA; Zafar, AU; Khan, SN; Husnain, T; Jiao, XD; MacDonald, IM; Riazuddin, S; Sieving, PA; Katsanis, N; Hejtmancik, JF				Riazuddin, S. Amer; Shahzadi, Amber; Zeitz, Christina; Ahmed, Zubair M.; Ayyagari, Radha; Chavali, Venkata R. M.; Ponferrada, Virgilio G.; Audo, Isabelle; Michiels, Christelle; Lancelot, Marie-Elise; Nasir, Idrees A.; Zafar, Ahmad U.; Khan, Shaheen N.; Husnain, Tayyab; Jiao, Xiaodong; MacDonald, Ian M.; Riazuddin, Sheikh; Sieving, Paul A.; Katsanis, Nicholas; Hejtmancik, J. Fielding			A Mutation in SLC24A1 Implicated in Autosomal-Recessive Congenital Stationary Night Blindness	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RHODOPSIN MUTATION; MISSENSE MUTATION; PAKISTANI FAMILY; GENE; EXCHANGER; ROD; ELECTRORETINOGRAM; IDENTIFICATION; MEMBRANE; PROTEIN	Congenital stationary night blindness (CSNB) is a nonprogressive retinal disorder that can be associated with impaired night vision The last decade has witnessed huge progress in ophthalmic genetics, including the identification of three genes implicated in the pathogenicity of autosomal-recessive CSNB. However, not all patients studied could be associated with mutations in these genes and thus other genes certainly underlie this disorder. Here, we report a large multigeneration family with five affected individuals manifesting symptoms of night blindness A genome-wide scan localized the disease interval to chromosome 15q, and recombination events in affected individuals refined the critical interval to a 10.41 cM (6 53 Mb) region that harbors SLC24A1, a member of the solute carrier protein superfamily Sequencing of all the coding exons identified a 2 bp deletion in exon 2. c 1613_1614del, which is predicted to result in a frame shift that leads to premature termination of SLC24A1 (p 17538Cf5X23) and segregates with the disorder under an autosomal-recessive model. Expression analysis using mouse ocular tissues shows that Slc24a1 is expressed in the retina around postnatal day 7 In situ and immunohistological studies localized both SLC24A1 and S1c24a1 to the inner segment, outer and inner nuclear layers, and ganglion cells of the retina, respectively Our data expand the genetic basis of CSNB and highlight the indispensible function of SLC24A1 in retinal function and/or maintenance in humans.	[Riazuddin, S. Amer; Shahzadi, Amber; Nasir, Idrees A.; Zafar, Ahmad U.; Khan, Shaheen N.; Husnain, Tayyab; Riazuddin, Sheikh] Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore 53700, Pakistan; [Riazuddin, S. Amer; Katsanis, Nicholas] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21287 USA; [Zeitz, Christina; Audo, Isabelle; Michiels, Christelle; Lancelot, Marie-Elise] INSERM, U968, F-75012 Paris, France; [Zeitz, Christina; Audo, Isabelle; Michiels, Christelle; Lancelot, Marie-Elise] CNRS, UMR_7210, F-75012 Paris, France; [Zeitz, Christina; Audo, Isabelle; Michiels, Christelle; Lancelot, Marie-Elise] Univ Paris 06, UMR S 968, Dept Genet, Inst Vis, F-75012 Paris, France; [Ahmed, Zubair M.; Ponferrada, Virgilio G.] Cincinnati Childrens Hosp, Med Ctr, Div Pediat Ophthalmol, Cincinnati, OH 45229 USA; [Ahmed, Zubair M.] Coll Med, Dept Ophthalmol, Cincinnati, OH 45229 USA; [Ayyagari, Radha; Chavali, Venkata R. M.] Univ Calif San Diego, Shiley Eye Ctr, La Jolla, CA 92037 USA; [Audo, Isabelle] INSERM DHOS CIC 503, Ctr Hosp Natl Ophtalmol Quinze Vingts, F-75012 Paris, France; [Audo, Isabelle] Inst Ophthalmol, Dept Mol Genet, London EC1V 9EL, England; [Jiao, Xiaodong; MacDonald, Ian M.; Sieving, Paul A.; Hejtmancik, J. Fielding] NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 21850 USA; [MacDonald, Ian M.] Univ Alberta, Dept Ophthalmol, Edmonton, AB T5H 3V9, Canada; [Riazuddin, Sheikh] Allama Iqbal Med Coll, Lahore 54550, Pakistan; [Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Durham, NC 27710 USA	National Center of Excellence in Molecular Biology - Pakistan; University of Punjab; Johns Hopkins University; Johns Hopkins Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Cincinnati Children's Hospital Medical Center; University of California System; University of California San Diego; CHNO des Quinze-Vingts; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Alberta; Duke University	Riazuddin, SA (corresponding author), Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore 53700, Pakistan.		Nasir, Idrees Ahmad/T-7695-2019; Husnain, Tayyab/AAE-9033-2019; Zeitz, Christina/F-2757-2017; Nasim Khan, Shaheen/F-2135-2015; Husnain, Tayyab/G-3805-2015; Katsanis, Nicholas/E-1837-2012	Zeitz, Christina/0000-0002-3510-1712; Katsanis, Nicholas/0000-0002-2480-0171; MacDonald, Ian/0000-0001-7472-8385; Audo, Isabelle/0000-0003-0698-5309	Higher Education Commission (H E.C.), Islamabad, Pakistan; Ministry of Science and Technology, Islamabad, Pakistan; Foundation Fighting Blindness, USA; Research to Prevent Blindness;  [NIH-R00-DC009287-03];  [NIH-EY013198]; NATIONAL EYE INSTITUTE [R01EY013198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R00DC009287] Funding Source: NIH RePORTER	Higher Education Commission (H E.C.), Islamabad, Pakistan(Higher Education Commission of Pakistan); Ministry of Science and Technology, Islamabad, Pakistan; Foundation Fighting Blindness, USA; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors are grateful to all family members for their participation in this study None of the contributing authors have any financial interest related to this work This work was supported in part by Higher Education Commission (H E.C.), Islamabad, Pakistan, Ministry of Science and Technology, Islamabad, Pakistan, NIH-R00-DC009287-03 (Z A.); Research to Prevent Blindness (Z A), Foundation Fighting Blindness, USA (PA), Research to prevent blindness (R A) and NIH-EY013198 (R.A.) N K is a Distinguished George W. Brumley Professor.	Audo I, 2008, SURV OPHTHALMOL, V53, P16, DOI 10.1016/j.survophthal.2007.10.010; Audo I, 2009, AM J HUM GENET, V85, P720, DOI 10.1016/j.ajhg.2009.10.013; Ayyagari R, 2005, INVEST OPHTH VIS SCI, V46, P3363, DOI 10.1167/iovs.05-0159; Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; Dryja TP, 2005, P NATL ACAD SCI USA, V102, P4884, DOI 10.1073/pnas.0501233102; DRYJA TP, 1993, NAT GENET, V4, P280, DOI 10.1038/ng0793-280; Dryja TP, 1996, NAT GENET, V13, P358, DOI 10.1038/ng0796-358; GAL A, 1994, NAT GENET, V7, P551, DOI 10.1038/ng0894-551c; He L, 1998, Mol Vis, V4, P32; Kaul H, 2010, MOL VIS, V16, P511; Kaul H, 2010, MOL VIS, V16, P240; Kimura M, 1999, AM J PHYSIOL-HEART C, V277, pH911, DOI 10.1152/ajpheart.1999.277.3.H911; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Li Z, 2009, AM J HUM GENET, V85, P711, DOI 10.1016/j.ajhg.2009.10.003; Mandal MNA, 2006, INVEST OPHTH VIS SCI, V47, P5505, DOI 10.1167/iovs.06-0312; Nieto MA, 1996, METHOD CELL BIOL, V51, P219, DOI 10.1016/S0091-679X(08)60630-5; Pusch CM, 2000, NAT GENET, V26, P324, DOI 10.1038/81627; REID DM, 1990, BIOCHEMISTRY-US, V29, P1601, DOI 10.1021/bi00458a035; RIGGS LA, 1954, AM J OPHTHALMOL, V38, P70, DOI 10.1016/0002-9394(54)90011-2; ROSENBERG T, 1991, ACTA OPHTHALMOL, V69, P694; SANDBERG MA, 1995, INVEST OPHTH VIS SCI, V36, P1934; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Schnetkamp PPM, 2004, PFLUG ARCH EUR J PHY, V447, P683, DOI 10.1007/s00424-003-1069-0; SCHUBERT G, 1952, OPHTHALMOLOGICA, V123, P396, DOI 10.1159/000301211; Sharon D, 2002, INVEST OPHTH VIS SCI, V43, P1971; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; van Genderen MM, 2009, AM J HUM GENET, V85, P730, DOI 10.1016/j.ajhg.2009.10.012; Zeitz C, 2005, INVEST OPHTH VIS SCI, V46, P4328, DOI 10.1167/iovs.05-0526; Zeitz C, 2007, EXPERT REV OPHTHALMO, V2, P467, DOI 10.1586/17469899.2.3.467; Zeitz C, 2008, INVEST OPHTH VIS SCI, V49, P4105, DOI 10.1167/iovs.08-1717; Zeitz C, 2006, AM J HUM GENET, V79, P657, DOI 10.1086/508067	32	52	53	1	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT 8	2010	87	4					523	531		10.1016/j.ajhg.2010.08.013	http://dx.doi.org/10.1016/j.ajhg.2010.08.013			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	665LU	20850105	Green Published, Bronze			2022-12-18	WOS:000283037600008
J	Dvir, L; Srour, G; Abu-Ras, R; Miller, B; Shalev, SA; Ben-Yosef, T				Dvir, Liron; Srour, Gassoub; Abu-Ras, Rasmi; Miller, Benjamin; Shalev, Stavit A.; Ben-Yosef, Tamar			Autosomal-Recessive Early-Onset Retinitis Pigmentosa Caused by a Mutation in PDE6G, the Gene Encoding the Gamma Subunit of Rod cGMP Phosphodiesterase	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STATIONARY NIGHT BLINDNESS; BETA-SUBUNIT; INHIBITION; PROTEIN	Retinitis pigmentosa (RP) is the most common form of hereditary retinal degeneration, with a worldwide prevalence of 1 in 4000. Over 30 genes and loci have been implicated in nonsyndromic autosomal-recessive (ar) RR Genome-wide homozygosity mapping was conducted in two sibships from an extended consanguineous Muslim Arab Israeli family segregating ar severe early-onset RP. A shared homozygous region on chromosome 17q25.3 was identified in both sibships, with an overlap of 4.7 Mb. One of the genes located in this interval is PDE6G, encoding for the inhibitory gamma subunit of rod photoreceptor cyclic GMP-phosphodiesterase. Mutations in the genes encoding for the catalytic subunits of this holoenzyme, PDE6A and PDE6B, cause arRP. Sequencing of all coding exons, including exon-intron boundaries, revealed a homozygous single base change (c.187+1G>T) located in the conserved intron 3 donor splice site of PDE6G. This mutation cosegregated with the disease in the extended family. We used an in vitro splicing assay to demonstrate that this mutation leads to incorrect splicing. Affected individuals had markedly constricted visual fields. Both scotopic and photopic electroretinograms were severely reduced or completely extinct. Funduscopy showed typical bone spicule-type pigment deposits spread mainly at the midperiphery, as well as pallor of the optic disk. Macular involvement was indicated by the lack of foveal reflex and typical cystoid macular edema, proved by optical coherence tomography. These findings demonstrate the positive role of the gamma subunit in maintaining phosphodiesterase activity and confirm the contribution of PDE6G to the etiology of RP in humans.	[Dvir, Liron; Ben-Yosef, Tamar] Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, IL-31096 Haifa, Israel; [Dvir, Liron; Miller, Benjamin; Shalev, Stavit A.; Ben-Yosef, Tamar] Technion Israel Inst Technol, Fac Med, IL-31096 Haifa, Israel; [Abu-Ras, Rasmi] Hlth Serv, Clalit, IL-17106 Nazareth, Israel; [Miller, Benjamin] Rambam Med Ctr, Alberto Moscona Dept Ophthalmol, IL-31096 Haifa, Israel; [Shalev, Stavit A.] HaEmek Med Ctr, Genet Inst, IL-18101 Afula, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Clalit Health Services; Rambam Health Care Campus; Technion Israel Institute of Technology; Emek Medical Center	Ben-Yosef, T (corresponding author), Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, IL-31096 Haifa, Israel.	benyosef@tx.technion.ac.il		Miller, Benjamin/0000-0003-1647-0122	Israel Science Foundation; R.L. Kohns Eye Research Fund	Israel Science Foundation(Israel Science Foundation); R.L. Kohns Eye Research Fund	We are grateful to the patients and their relatives for their participation in this study. We thank Karl Skorecki and Dror Sharon for DNA samples and Liliana Mizrahi-Meissonnier for technical help. This work was supported by research grants from the Legacy Heritage Bio-Medical program of the Israel Science Foundation (to T.B.-Y.) and from the R.L. Kohns Eye Research Fund (to T.B.-Y. and S.A.S.).	Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Barren B, 2009, EMBO J, V28, P3613, DOI 10.1038/emboj.2009.284; Chang B, 2007, VISION RES, V47, P624, DOI 10.1016/j.visres.2006.11.020; COTRAN PR, 1991, EXP EYE RES, V53, P557, DOI 10.1016/0014-4835(91)90213-X; GAL A, 1994, NAT GENET, V7, P64, DOI 10.1038/ng0594-64; Guo LW, 2010, J BIOL CHEM, V285, P15209, DOI 10.1074/jbc.M109.086116; HAHN LB, 1994, INVEST OPHTH VIS SCI, V35, P1077; Hamel C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-40; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; HUANG SH, 1995, NAT GENET, V11, P468, DOI 10.1038/ng1295-468; Ionita MA, 2007, EXP EYE RES, V84, P1, DOI 10.1016/j.exer.2005.12.012; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; Morin F, 2003, MOL VIS, V9, P449; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; Muradov KG, 2003, BIOCHEMISTRY-US, V42, P3305, DOI 10.1021/bi027095x; Nevet MJ, 2010, J MED GENET, V47, P533, DOI 10.1136/jmg.2009.073619; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; ROSNER M, 1993, AM J OPHTHALMOL, V116, P373, DOI 10.1016/S0002-9394(14)71358-3; Sakamoto K, 2009, HUM MOL GENET, V18, P178, DOI 10.1093/hmg/ddn327; Salchow DJ, 1999, INVEST OPHTH VIS SCI, V40, P3262; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; Song J, 2008, P NATL ACAD SCI USA, V105, P1505, DOI 10.1073/pnas.0709558105; Tate Rothwelle J., 1998, Cell Biochemistry and Biophysics, V29, P133, DOI 10.1007/BF02737832; Tsang SH, 1996, SCIENCE, V272, P1026, DOI 10.1126/science.272.5264.1026; Tsang SH, 2002, VISION RES, V42, P439, DOI 10.1016/S0042-6989(01)00213-9; Tsang SH, 2008, AM J OPHTHALMOL, V146, P780, DOI 10.1016/j.ajo.2008.06.017; Tuntivanich N, 2009, INVEST OPHTH VIS SCI, V50, P801, DOI 10.1167/iovs.08-2562; Wada Y, 2001, INVEST OPHTH VIS SCI, V42, P2395; Wan KF, 2001, J BIOL CHEM, V276, P37802; Zlotogora J, 2002, AM J MED GENET, V109, P176, DOI 10.1002/ajmg.10328	30	52	54	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 13	2010	87	2					258	264		10.1016/j.ajhg.2010.06.016	http://dx.doi.org/10.1016/j.ajhg.2010.06.016			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641EG	20655036	Bronze, Green Published			2022-12-18	WOS:000281107000010
J	Riazuddin, S; Anwar, S; Fischer, M; Ahmed, ZM; Khan, SY; Janssen, AGH; Zafar, AU; Scholl, U; Husnain, T; Belyantseva, IA; Friedman, PL; Riazuddin, S; Friedman, TB; Fahlke, C				Riazuddin, Saima; Anwar, Saima; Fischer, Martin; Ahmed, Zubair M.; Khan, Shahid Y.; Janssen, Audrey G. H.; Zafar, Ahmad U.; Scholl, Ute; Husnain, Tayyab; Belyantseva, Inna A.; Friedman, Penelope L.; Riazuddin, Sheikh; Friedman, Thomas B.; Fahlke, Christoph			Molecular Basis of DFNB73: Mutations of BSND Can Cause Nonsyndromic Deafness or Bartter Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLC-K CHANNELS; SENSORINEURAL DEAFNESS; CHLORIDE CHANNELS; BETA-SUBUNIT; MECHANISMS; FAILURE; DISEASE; VARIANT; IV	BSND encodes barttin, an accessory Subunit of renal and inner ear chloride channels. To date, all Mutations of BSND have been shown to cause Bartter syndrome type IV, characterized by significant renal abnormalities and deafness. We identified a BSND mutation (p.I12T) in four kindreds segregating nonsyndromic deafness linked to a 4.04-cM interval on chromosome 1p32.3. The functional consequences of p.I12T differ from BSND Mutations that cause renal failure and deafness in Bartter syndrome type IV. p.I12T leaves chloride channel function unaffected and only interferes with chaperone function of barttin in intracellular trafficking. This study provides functional data implicating a hypomorphic allele of BSND as a cause of apparent nonsyndromic deafness. We demonstrate that BSND mutations with different functional consequences are the basis for either syndromic or nonsyndromic deafness.	[Fischer, Martin; Janssen, Audrey G. H.; Scholl, Ute; Fahlke, Christoph] Hannover Med Sch, Inst Neurophysiol, D-30625 Hannover, Germany; [Riazuddin, Saima; Ahmed, Zubair M.; Belyantseva, Inna A.; Friedman, Thomas B.] Natl Inst Deafness & Other Commun Disorders, Sect Human Genet, Mol Genet Lab, NIH, Rockville, MD 20850 USA; [Riazuddin, Saima; Ahmed, Zubair M.] Childrens Hosp Res Fdn, Div Pediat Otolaryngol Head & Neck Surg, Cincinnati, OH 45229 USA; [Riazuddin, Saima; Ahmed, Zubair M.] Childrens Hosp Res Fdn, Div Ophthalmol, Cincinnati, OH 45229 USA; [Anwar, Saima; Khan, Shahid Y.; Zafar, Ahmad U.; Husnain, Tayyab; Riazuddin, Sheikh] Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore 54700, Pakistan; [Friedman, Penelope L.] NIH, Internal Med Consult Serv, Hatfield Clin Res Ctr, Bethesda, MD 21224 USA; [Fahlke, Christoph] Zentrum Syst Neurowissensch Hannover ZSN, D-30559 Hannover, Germany	Hannover Medical School; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; National Center of Excellence in Molecular Biology - Pakistan; University of Punjab; National Institutes of Health (NIH) - USA	Fahlke, C (corresponding author), Hannover Med Sch, Inst Neurophysiol, D-30625 Hannover, Germany.	fahlke.christoph@mh-hannover.de	Fahlke, Christoph/G-3635-2013; Husnain, Tayyab/G-3805-2015; Anwar, Saima/C-7477-2016; Husnain, Tayyab/AAE-9033-2019	Fahlke, Christoph/0000-0001-8602-9952; Scholl, Ute/0000-0002-0309-8045	Higher Education Commission; Ministry of Science and Technology in Pakistan; Intramural Program of the NICD/National Institutes of Health [1 ZO1 DC000039-12]; DFG [301/8, 301/10]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000039] Funding Source: NIH RePORTER	Higher Education Commission(Ministry of Higher Education & Scientific Research (MHESR)); Ministry of Science and Technology in Pakistan; Intramural Program of the NICD/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank the families for their participation and J. Ehrich, D. Ewers, E. Miranda, D. Nothmann, and D. Wojchiechowski, for helpful discussions. This study was supported by the Higher Education Commission and the Ministry of Science and Technology in Pakistan to S.R., the Intramural Program of the NICD/National Institutes of Health 1 ZO1 DC000039-12 to T.B.F. and the DFG (FA 301/8 and FA 301/10) to C.F.	BARTTER FC, 1962, AM J MED, V33, P811, DOI 10.1016/0002-9343(62)90214-0; Birkenhager R, 2001, NAT GENET, V29, P310, DOI 10.1038/ng752; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Garcia-Olivares J, 2008, J PHYSIOL-LONDON, V586, P5325, DOI 10.1113/jphysiol.2008.158097; Hayama A, 2003, HISTOCHEM CELL BIOL, V119, P485, DOI 10.1007/s00418-003-0535-2; Hebert SC, 2003, CURR OPIN NEPHROL HY, V12, P527, DOI 10.1097/00041552-200309000-00008; Janssen AGH, 2009, J AM SOC NEPHROL, V20, P145, DOI 10.1681/ASN.2008010102; Jeck N, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e5; Kramer BK, 2008, NAT CLIN PRACT NEPHR, V4, P38, DOI 10.1038/ncpneph0689; LANDAU D, 1995, AM J MED GENET, V59, P454, DOI 10.1002/ajmg.1320590411; Miyamura N, 2003, J CLIN ENDOCR METAB, V88, P781, DOI 10.1210/jc.2002-021398; Papadopoulos S, 2004, J BIOL CHEM, V279, P44046, DOI 10.1074/jbc.M405317200; Rickheit G, 2008, EMBO J, V27, P2907, DOI 10.1038/emboj.2008.203; Schlingmann KP, 2004, NEW ENGL J MED, V350, P1314, DOI 10.1056/NEJMoa032843; Scholl U, 2006, P NATL ACAD SCI USA, V103, P11411, DOI 10.1073/pnas.0601631103; Sesti F, 1998, J GEN PHYSIOL, V112, P651, DOI 10.1085/jgp.112.6.651; Shalev H, 2003, PEDIATRICS, V112, P628, DOI 10.1542/peds.112.3.628; SIGWORTH FJ, 1992, METHOD ENZYMOL, V207, P746; Torres-Salazar D, 2007, J BIOL CHEM, V282, P34719, DOI 10.1074/jbc.M704118200; Waldegger S, 2002, PFLUG ARCH EUR J PHY, V444, P411, DOI 10.1007/s00424-002-0819-8	21	52	54	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 14	2009	85	2					273	280		10.1016/j.ajhg.2009.07.003	http://dx.doi.org/10.1016/j.ajhg.2009.07.003			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488EV	19646679	Green Published, Bronze			2022-12-18	WOS:000269332900016
J	Theusch, E; Basu, A; Gitschier, J				Theusch, Elizabeth; Basu, Analabha; Gitschier, Jane			Genome-wide Study of Families with Absolute Pitch Reveals Linkage to 8q24.21 and Locus Heterogeneity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETICALLY COMPLEX TRAITS; AFFECTED RELATIVE PAIRS; IDENTIFICATION; MEMORY; GENE; DISEQUILIBRIUM; STRATEGIES; TESTS; SCAN	Absolute pitch (AP) is the rare ability to instantaneously recognize and label tones with their musical note names without using a reference pitch for comparison. The etiology of AP is complex. Prior studies have implicated both genetic and environmental factors in its genesis, yet the molecular basis for AP remains unknown. To locate regions of the human genome that may harbor AP-predisposing genetic variants, we performed a genome-wide linkage study on 73 multiplex AP families by genotyping them with 6090 SNP markers. Nonparametric multipoint linkage analyses were conducted, and the strongest evidence for linkage was observed on chromosome 8q24.21 in the subset of 45 families with European ancestry (exponential LOD score = 3.464, empirical genome-wide p = 0.03). Other regions with suggestive LOD scores included chromosomes 7q22.3, 8q21.11, and 9p21.3. Of these four regions, only the 7q22.3 linkage peak was also evident when 19 families with East Asian ancestry were analyzed separately. Though only one of these regions has yet reached statistical significance individually, we detected a larger number of independent linkage peaks than expected by chance overall, indicating that AP is genetically heterogeneous.	[Theusch, Elizabeth; Basu, Analabha; Gitschier, Jane] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Theusch, Elizabeth; Gitschier, Jane] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Gitschier, Jane] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Gitschier, Jane] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Gitschier, J (corresponding author), Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA.	jane.gitschier@ucsf.edu		Theusch, Elizabeth/0000-0002-5678-759X	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Abecasis GR, 2004, AM J HUM GENET, V74, P403, DOI 10.1086/381713; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Athos EA, 2007, P NATL ACAD SCI USA, V104, P14795, DOI 10.1073/pnas.0703868104; BACHEM A, 1940, J ACOUST SOC AM, V11, P434, DOI DOI 10.1121/1.1916056; Baharloo S, 1998, AM J HUM GENET, V62, P224, DOI 10.1086/301704; Baharloo S, 2000, AM J HUM GENET, V67, P755, DOI 10.1086/303057; Boyles AL, 2005, HUM HERED, V59, P220, DOI 10.1159/000087122; Brown MT, 1998, MOL CELL BIOL, V18, P7038, DOI 10.1128/MCB.18.12.7038; Camp NJ, 2001, ANN HUM GENET, V65, P577, DOI [10.1046/j.1469-1809.2001.6560577.x, 10.1017/S0003480001008922]; de Quervain DJF, 2006, P NATL ACAD SCI USA, V103, P4270, DOI 10.1073/pnas.0510212103; Deutsch D, 2009, J ACOUST SOC AM, V125, P2398, DOI 10.1121/1.3081389; Granota RY, 2007, EVOL HUM BEHAV, V28, P313, DOI 10.1016/j.evolhumbehav.2007.05.003; Gregersen PK, 1999, AM J HUM GENET, V65, P911, DOI 10.1086/302541; Gregersen PK, 2001, AM J MED GENET, V98, P280, DOI 10.1002/1096-8628(20010122)98:3<280::AID-AJMG1083>3.0.CO;2-6; Gregersen PK, 1998, AM J HUM GENET, V62, P221, DOI 10.1086/301734; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Ludwig MG, 2002, J RECEPT SIGNAL TR R, V22, P79, DOI 10.1081/RRS-120014589; MIYAZAKI K, 1988, PERCEPT PSYCHOPHYS, V44, P501, DOI 10.3758/BF03207484; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; PROFITA J, 1988, AM J MED GENET, V29, P763, DOI 10.1002/ajmg.1320290405; Pulli K, 2008, J MED GENET, V45, P451, DOI 10.1136/jmg.2007.056366; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P242; Saffran JR, 2001, DEV PSYCHOL, V37, P74, DOI 10.1037//0012-1649.37.1.74; SERGEANT D, 1969, J RES MUSIC EDUC, V17, P135, DOI 10.2307/3344200; TAKEUCHI AH, 1993, PSYCHOL BULL, V113, P345, DOI 10.1037/0033-2909.113.2.345; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Wiltshire S, 2002, AM J HUM GENET, V71, P1175, DOI 10.1086/342976; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2	32	52	56	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 10	2009	85	1					112	119		10.1016/j.ajhg.2009.06.010	http://dx.doi.org/10.1016/j.ajhg.2009.06.010			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	470RO	19576568	Green Published, Bronze			2022-12-18	WOS:000267997600013
J	Pala, M; Achilli, A; Olivieri, A; Kashani, BH; Perego, UA; Sanna, D; Metspalu, E; Tambets, K; Tamm, E; Accetturo, M; Carossa, V; Lancioni, H; Panara, F; Zimmermann, B; Huber, G; Al-Zahery, N; Brisighelli, F; Woodward, SR; Francalacci, P; Parson, W; Salas, A; Behar, DM; Villems, R; Semino, O; Bandelt, HJ; Torroni, A				Pala, Maria; Achilli, Alessandro; Olivieri, Anna; Kashani, Baharak Hooshiar; Perego, Ugo A.; Sanna, Daria; Metspalu, Ene; Tambets, Kristiina; Tamm, Erika; Accetturo, Matteo; Carossa, Valeria; Lancioni, Hovirag; Panara, Fausto; Zimmermann, Bettina; Huber, Gabriela; Al-Zahery, Nadia; Brisighelli, Francesca; Woodward, Scott R.; Francalacci, Paolo; Parson, Walther; Salas, Antonio; Behar, Doron M.; Villems, Richard; Semino, Ornella; Bandelt, Hans-Juergen; Torroni, Antonio			Mitochondrial Haplogroup U5b3: A Distant Echo of the Epipaleolithic in Italy and the Legacy of the Early Sardinians	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ABRUPT CLIMATE-CHANGE; MODERN HUMANS; PHYLOGENETIC NETWORK; MTDNA VARIATION; Y-CHROMOSOMES; GENE FLOW; EUROPE; POPULATION; DNA; PHYLOGEOGRAPHY	There are extensive data indicating that some glacial refuge zones of southern Europe (Franco-Cantabria, Balkans, and Ukraine) were major genetic sources for the human recolonization of the continent at the beginning of the Holocene. Intriguingly, there is no genetic evidence that the refuge area located in the Italian Peninsula contributed to this process. Here we show, through phylogeographic analyses of mitochondrial DNA (mtDNA) variation performed at the highest level of molecular resolution (52 entire mitochondrial genomes), that the most likely homeland for U5b3-a haplogroup present at a very low frequency across Europe-was the Italian Peninsula. In contrast to mtDNA haplogroups that expanded from other refugia, the Holocene expansion of haplogroup U5b3 toward the North was restricted by the Alps and occurred only along the Mediterranean coasts, mainly toward nearby Provence (southern France). From there, similar to 7,000-9,000 years ago, a subdade of this haplogroup moved to Sardinia, possibly as a result of the obsidian trade that linked the two regions, leaving a distinctive signature in the modern people of the island. This scenario strikingly matches the age, distribution, and postulated geographic source of a Sardinian Y chromosome haplogroup (12a2-M26), a paradigmatic case in the European context of a founder event marking both female and male lineages.	[Pala, Maria; Achilli, Alessandro; Olivieri, Anna; Kashani, Baharak Hooshiar; Perego, Ugo A.; Accetturo, Matteo; Carossa, Valeria; Al-Zahery, Nadia; Semino, Ornella; Torroni, Antonio] Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; [Achilli, Alessandro; Lancioni, Hovirag; Panara, Fausto] Univ Perugia, Dipartimento Biol Cellulare & Ambientale, I-06123 Perugia, Italy; [Perego, Ugo A.; Woodward, Scott R.] Sorenson Mol Geneal Fdn, Salt Lake City, UT 84115 USA; [Sanna, Daria; Francalacci, Paolo] Univ Sassari, Dipartimento Zool & Genet Evoluzionist, I-07100 Sassari, Italy; [Metspalu, Ene; Tambets, Kristiina; Tamm, Erika; Villems, Richard] Univ Tartu, Dept Evolutionary Biol, EE-51010 Tartu, Estonia; [Metspalu, Ene; Tambets, Kristiina; Tamm, Erika; Villems, Richard] Estonian Bioctr, EE-51010 Tartu, Estonia; [Zimmermann, Bettina; Huber, Gabriela; Parson, Walther] Innsbruck Med Univ, Inst Legal Med, A-6020 Innsbruck, Austria; [Al-Zahery, Nadia] Univ Baghdad, Dept Biotechnol, Coll Sci, Baghdad, Iraq; [Brisighelli, Francesca; Salas, Antonio] Univ Santiago de Compostela, Unidad Xenet, Dept Anat Patol & Ciencias Forenses, Fac Med, Santiago De Compostela 15782, Galicia, Spain; [Brisighelli, Francesca; Salas, Antonio] Univ Santiago de Compostela, Inst Med Legal, Fac Med, Santiago De Compostela 15782, Galicia, Spain; [Behar, Doron M.] Mol Med Lab, IL-31096 Haifa, Israel; [Bandelt, Hans-Juergen] Univ Hamburg, Dept Math, D-20146 Hamburg, Germany	University of Pavia; University of Perugia; University of Sassari; University of Tartu; Estonian Biocentre; Medical University of Innsbruck; University of Baghdad; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Rambam Health Care Campus; University of Hamburg	Torroni, A (corresponding author), Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy.	torroni@ipvgen.unipv.it	OLIVIERI, ANNA/I-9235-2012; Perego, Ugo/AAG-9327-2019; Parson, Walther/AAD-6845-2020; Tambets, Kristiina/M-2568-2019; Al-Zahery, Nadia/AAV-5878-2020; Salas, Antonio/U-2029-2019; Achilli, Alessandro/I-9236-2012; Salas, Antonio/E-3977-2012; Tamm, Erika/G-2818-2017; Torroni, Antonio/E-1557-2011; Lancioni, Hovirag/F-9067-2014	OLIVIERI, ANNA/0000-0002-3941-8098; Tambets, Kristiina/0000-0002-8173-6380; Salas, Antonio/0000-0002-2336-702X; Achilli, Alessandro/0000-0001-6871-3451; Salas, Antonio/0000-0002-2336-702X; Tamm, Erika/0000-0003-0694-3598; Torroni, Antonio/0000-0002-4163-4478; Lancioni, Hovirag/0000-0001-5514-1853; FRANCALACCI, Paolo/0000-0001-7912-162X; Pala, Maria/0000-0001-9202-8331; Brisighelli, Francesca/0000-0001-5469-4413; SEMINO, Ornella/0000-0002-9675-9403; Parson, Walther/0000-0002-5692-2392	Fondazione Cassa di Risparrnio di Foligno; Fondazione Cassa di Risparmio di Perugia; European Union; Estonian Biocentre; Estonian Science Foundation [7858, 6040]; Swedish Collegium of Advanced Studies; Osterreichische Forschungsforderungsgesellschaft; KIRAS Sicherheitsforschung DNATOX; Ministerio de Ciencia e Innovacion [SAF2008-02971]; Landau Network-Centro Volta; Progetti Ricerca Interesse Nazionale 2007 (Italian Ministry of the University); Ministero degli Affari Esteri; Compagnia di San Paolo; Fondazione Cariplo	Fondazione Cassa di Risparrnio di Foligno; Fondazione Cassa di Risparmio di Perugia(Fondazione Cassa Risparmio Perugia); European Union(European Commission); Estonian Biocentre; Estonian Science Foundation; Swedish Collegium of Advanced Studies; Osterreichische Forschungsforderungsgesellschaft; KIRAS Sicherheitsforschung DNATOX; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Landau Network-Centro Volta; Progetti Ricerca Interesse Nazionale 2007 (Italian Ministry of the University)(Ministry of Education, Universities and Research (MIUR)); Ministero degli Affari Esteri(Ministry of Foreign Affairs and International Cooperation (Italy)); Compagnia di San Paolo(Compagnia di San Paolo); Fondazione Cariplo(Fondazione Cariplo)	This research received support from Fondazione Cassa di Risparrnio di Foligno (to A.A. and F.P.), Fondazione Cassa di Risparmio di Perugia (to A.A. and ER), the European Union (European Regional Development Fund through the Centre of Excellence in Genomics), Estonian Biocentre, Estonian Science Foundation grants 7858 (to E.M.) and 6040 (to K.T.), the Swedish Collegium of Advanced Studies (to R.V.), Osterreichische Forschungsforderungsgesellschaft, KIRAS Sicherheitsforschung DNATOX (to W.P.), Ministerio de Ciencia e Innovacion (SAF2008-02971; to A.S.), Landau Network-Centro Volta (to N.A.-Z.), Progetti Ricerca Interesse Nazionale 2007 (Italian Ministry of the University) (to O.S. and A.T.), Ministero degli Affari Esteri (to O.S.), Compagnia di San Paolo (to O.S. and A.T.), and Fondazione Cariplo (to A.T.). We are grateful to all the donors for providing blood samples and to Cristian Capelli and the other people who helped collecting the samples.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; ALLEY RB, 1993, NATURE, V362, P527, DOI 10.1038/362527a0; Alley RB, 2003, SCIENCE, V299, P2005, DOI 10.1126/science.1081056; Alvarez-Iglesias V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005112; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Anikovich MV, 2007, SCIENCE, V315, P223, DOI 10.1126/science.1133376; Banks WE, 2008, J ARCHAEOL SCI, V35, P481, DOI 10.1016/j.jas.2007.05.011; Barac L, 2003, EUR J HUM GENET, V11, P535, DOI 10.1038/sj.ejhg.5200992; BATTAGLIA V, 2008, EUR J HUM GENET, V17, P820, DOI DOI 10.1038/EJHG.2008.249; Bjorck S, 1996, SCIENCE, V274, P1155, DOI 10.1126/science.274.5290.1155; Cinnioglu C, 2004, HUM GENET, V114, P127, DOI 10.1007/s00439-003-1031-4; Contu D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001430; Dimo-Simonin N, 2000, INT J LEGAL MED, V113, P89, DOI 10.1007/PL00007715; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; Fraumene C, 2006, MOL BIOL EVOL, V23, P2101, DOI 10.1093/molbev/msl084; Gamble C, 2004, PHILOS T R SOC B, V359, P243, DOI 10.1098/rstb.2003.1396; Goebel T, 2007, SCIENCE, V315, P194, DOI 10.1126/science.1137564; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Loogvali EL, 2004, MOL BIOL EVOL, V21, P2012, DOI 10.1093/molbev/msh209; Mellars P, 2006, NATURE, V439, P931, DOI 10.1038/nature04521; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Mussi M., 2001, EARLIEST ITALY OVERV; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Passarino G, 2001, HUM IMMUNOL, V62, P922, DOI 10.1016/S0198-8859(01)00291-9; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Pereira L, 2005, GENOME RES, V15, P19, DOI 10.1101/gr.3182305; Pericic M, 2005, MOL BIOL EVOL, V22, P1964, DOI 10.1093/molbev/msi185; Peteet D, 2000, P NATL ACAD SCI USA, V97, P1359, DOI 10.1073/pnas.97.4.1359; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; SHACKLETON JC, 1984, J FIELD ARCHAEOL, V11, P307, DOI 10.1179/009346984791535476; SONDAAR PY, 1998, SARDINIAN AEGEAN CHR, P45; Straus LG, 2005, EVOL ANTHROPOL, V14, P145, DOI 10.1002/evan.20067; Street M, 1999, ANTIQUITY, V73, P259, DOI 10.1017/S0003598X00088232; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Tambets K, 2004, AM J HUM GENET, V74, P661, DOI 10.1086/383203; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Turchi C, 2008, INT J LEGAL MED, V122, P199, DOI 10.1007/s00414-007-0207-1; Tykot RH, 2002, ACCOUNTS CHEM RES, V35, P618, DOI 10.1021/ar000208p; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Zei G, 2003, EUR J HUM GENET, V11, P802, DOI 10.1038/sj.ejhg.5201040	50	52	53	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 12	2009	84	6					814	821		10.1016/j.ajhg.2009.05.004	http://dx.doi.org/10.1016/j.ajhg.2009.05.004			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Genetics & Heredity	458SC	19500771	Green Published, Bronze			2022-12-18	WOS:000267042800012
J	Yngvadottir, B; Xue, Y; Searle, S; Hunt, S; Delgado, M; Morrison, J; Whittaker, P; Deloukas, P; Tyler-Smith, C				Yngvadottir, Bryndis; Xue, Yali; Searle, Steve; Hunt, Sarah; Delgado, Marcos; Morrison, Jonathan; Whittaker, Pamela; Deloukas, Panos; Tyler-Smith, Chris			A Genome-wide Survey of the Prevalence and Evolutionary Forces Acting on Human Nonsense SNPs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MESSENGER-RNA DECAY; HAPLOTYPE RECONSTRUCTION; POSITIVE SELECTION; STATISTICAL-METHOD; POPULATION-GROWTH; NATURAL-SELECTION; GENE; MUTATIONS; DIVERSITY; GENOTYPE	Nonsense SNPs introduce premature termination codons into genes and can result in the absence of a gene product or in a truncated and potentially harmful protein, so they are often considered disadvantageous and are associated with disease susceptibility. As such, we might expect the disrupted allele to be rare and, in healthy people, observed only in a heterozygous state. However, some, like those in the CASP12 and ACTN3 genes, are known to be present at high frequencies and to occur often in a homozygous state and seem to have been advantageous in recent human evolution. To evaluate the selective forces acting on nonsense SNPs as a class, we have carried out a large-scale experimental survey of nonsense SNPs in the human genome by genotyping 805 of them (plus control synonymous SNPs) in 1,151 individuals from 56 worldwide populations. We identified 169 genes containing nonsense SNPs that were variable in our samples, of which 99 were found with both copies inactivated in at least one individual. We found that the sampled humans differ on average by 24 genes (out of about 20,000) because of these nonsense SNPs alone. As might be expected, nonsense SNPs as a class were found to be slightly disadvantageous over evolutionary timescales, but a few nevertheless showed signs of being possibly advantageous, as indicated by unusually high levels of population differentiation, long haplotypes, and/or high frequencies of derived alleles. This study underlines the extent of variation in gene content within humans and emphasizes the importance of understanding this type of variation.	[Yngvadottir, Bryndis; Xue, Yali; Searle, Steve; Hunt, Sarah; Delgado, Marcos; Morrison, Jonathan; Whittaker, Pamela; Deloukas, Panos; Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England	Wellcome Trust Sanger Institute	Tyler-Smith, C (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.	cts@sanger.ac.uk	Deloukas, Panos/B-2922-2013	Deloukas, Panos/0000-0001-9251-070X; Hunt, Sarah/0000-0002-8350-1235	The Wellcome Trust	The Wellcome Trust(Wellcome TrustEuropean Commission)	We thank all the sample donors for making this work possible, Howard M. Cann for providing the HGDP-CEPH DNA panel, John Burton, Alison J Coffey, Sanjeev Bhaskar, and Jonathan Bailey at the Sanger Large-Scale Sequencing Pipeline Group for generating the sequence data, William C. Amos, Alex Bateman, and Matthew E. Hurles for input throughout the study, Alex Kondrashov for his suggestions about calculating the selection coefficient, Matthew E. Hurles for the template used to prepare Figure 1, and an anonymous reviewer for helpful comments. This work was supported by The Wellcome Trust.	Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Angata T, 2004, P NATL ACAD SCI USA, V101, P13251, DOI 10.1073/pnas.0404833101; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashurst JL, 2005, NUCLEIC ACIDS RES, V33, pD459, DOI 10.1093/nar/gki135; Bahlo M, 2000, THEOR POPUL BIOL, V57, P79, DOI 10.1006/tpbi.1999.1447; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Cann HM, 2002, SCIENCE, V296, P261; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Chomez P, 2001, CANCER RES, V61, P5544; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dolphin CT, 1998, J BIOL CHEM, V273, P30599, DOI 10.1074/jbc.273.46.30599; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Fay JC, 2000, GENETICS, V155, P1405; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Gilad Y, 2003, P NATL ACAD SCI USA, V100, P3324, DOI 10.1073/pnas.0535697100; Gilad Y, 2003, MOL BIOL EVOL, V20, P307, DOI 10.1093/molbev/msg013; Gorlov IP, 2006, HUM MOL GENET, V15, P1143, DOI 10.1093/hmg/ddl029; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Han A, 2007, BIOINFORMATICS, V23, P397, DOI 10.1093/bioinformatics/btl593; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Kingman J, 1982, STOCHASTIC PROCESS A, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Krueger SK, 2004, DRUG METAB DISPOS, V32, P1337, DOI 10.1124/dmd.104.001099; MacArthur DG, 2007, NAT GENET, V39, P1261, DOI 10.1038/ng2122; MacArthur DG, 2004, BIOESSAYS, V26, P786, DOI 10.1002/bies.20061; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Mort M, 2008, HUM MUTAT, V29, P1037, DOI 10.1002/humu.20763; Murata M, 2003, J EXP MED, V197, P1279, DOI 10.1084/jem.20030044; Nachman MW, 2000, GENETICS, V156, P297; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; NEEL JV, 1962, AM J HUM GENET, V14, P353; Nei M., 1987, MOL EVOLUTIONARY GEN; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Ohno S., 1970, EVOLUTION GENE DUPLI; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rubattu S, 2004, STROKE, V35, P814, DOI 10.1161/01.STR.0000119381.52589.AB; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Saleh M, 2004, NATURE, V429, P75, DOI 10.1038/nature02451; Savas Sevtap, 2006, Human Genomics, V2, P274; Sawyer SL, 2003, HUM MUTAT, V22, P252, DOI 10.1002/humu.10256; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; TAJIMA F, 1989, GENETICS, V123, P585; VEERAMAH KR, 2008, GENOMICS, V18, P877; Wang XX, 2006, PLOS BIOL, V4, P366, DOI 10.1371/journal.pbio.0040052; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; Williamson SH, 2005, P NATL ACAD SCI USA, V102, P7882, DOI 10.1073/pnas.0502300102; Xue YL, 2006, AM J HUM GENET, V78, P659, DOI 10.1086/503116; Yamaguchi-Kabata Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003393; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590	66	52	53	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 13	2009	84	2					224	234		10.1016/j.ajhg.2009.01.008	http://dx.doi.org/10.1016/j.ajhg.2009.01.008			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	413NL	19200524	Green Published, Bronze			2022-12-18	WOS:000263799700012
J	Ho, SYW; EndiCott, P				Ho, Simon Y. W.; EndiCott, Phillip			The crucial role of calibration in molecular date estimates for the peopling of the Americas	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							TIME DEPENDENCY; MTDNA VARIATION; SETTLEMENT; SELECTION; HUMANS; ORIGIN; DNA		[EndiCott, Phillip] Univ Oxford Magdalen Coll, Oxford OX1 4AU, England; [Ho, Simon Y. W.] Australian Natl Univ, Ctr Macroevolut & Macroecol, Sch Bot & Zool, Canberra, ACT 0200, Australia	University of Oxford; Australian National University	EndiCott, P (corresponding author), Univ Oxford Magdalen Coll, Oxford OX1 4AU, England.	phillip.endicott@gmail.com	Ho, Simon YW/A-8417-2008	Ho, Simon YW/0000-0002-0361-2307; Endicott, Phillip/0000-0003-2452-8507				Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Atkinson QD, 2008, MOL BIOL EVOL, V25, P468, DOI 10.1093/molbev/msm277; Bandelt HJ, 2006, NUCL ACID M, V18, P47; Burridge CP, 2008, MOL BIOL EVOL, V25, P624, DOI 10.1093/molbev/msm271; DILLEHAY TD, 1997, M VERDE LATE PLEISTO; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Endicott P, 2008, AM J HUM GENET, V82, P895, DOI 10.1016/j.ajhg.2008.01.019; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Gamble C, 2004, PHILOS T R SOC B, V359, P243, DOI 10.1098/rstb.2003.1396; Gilbert MTP, 2008, SCIENCE, V320, P786, DOI 10.1126/science.1154116; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Ho SYW, 2007, SYST BIOL, V56, P515, DOI 10.1080/10635150701435401; Ho SYW, 2006, TRENDS GENET, V22, P79, DOI 10.1016/j.tig.2005.11.006; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Hudjashov G, 2007, P NATL ACAD SCI USA, V104, P8726, DOI 10.1073/pnas.0702928104; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kemp BM, 2007, AM J PHYS ANTHROPOL, V132, P605, DOI 10.1002/ajpa.20543; Kitchen A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001596; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; STONEKING M, 1992, PHILOS T ROY SOC B, V337, P167, DOI 10.1098/rstb.1992.0094; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829	25	52	52	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2008	83	1					142	146		10.1016/j.ajhg.2008.06.014	http://dx.doi.org/10.1016/j.ajhg.2008.06.014			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	328FO	18606310	Green Published, Bronze			2022-12-18	WOS:000257784000024
J	Nousbeck, J; Spiegel, R; Ishida-Yamamoto, A; Indelman, M; Shani-Adir, A; Adir, N; Lipkin, E; Bercovici, S; Geiger, D; van Steensel, MA; Steijlen, PM; Bergman, R; Bindereif, A; Choder, M; Shalev, S; Sprecher, E				Nousbeck, Janna; Spiegel, Ronen; Ishida-Yamamoto, Akemi; Indelman, Margarita; Shani-Adir, Ayelet; Adir, Noam; Lipkin, Ehud; Bercovici, Sivan; Geiger, Dan; van Steensel, Maurice A.; Steijlen, Peter M.; Bergman, Reuven; Bindereif, Albrecht; Choder, Mordechai; Shalev, Stavit; Sprecher, Eli			Alopecia, neurological defects, and endocrinopathy syndrome caused by decreased expression of RBM28, a nucleolar protein associated with ribosome biogenesis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RNA RECOGNITION MOTIFS; HAIR; HYPOGONADISM; DISORDER	Single-gene disorders offer unique opportunities to shed light upon fundamental physiological processes in humans. We investigated an autosomal-recessive phenotype characterized by alopecia, progressive neurological defects, and endocrinopathy (ANE syndrome). By using homozygosity mapping and candidate-gene analysis, we identified a loss-of-function mutation in RBM28, encoding a nucleolar protein. RBM28 yeast ortholog, Nop4p, was previously found to regulate ribosome biogenesis. Accordingly, electron microscopy revealed marked ribosome depletion and structural abnormalities of the rough endoplasmic reticulum in patient cells, ascribing ANE syndrome to the restricted group of inherited disorders associated with ribosomal dysfunction.	[Nousbeck, Janna; Indelman, Margarita; Bergman, Reuven; Sprecher, Eli] Rambam Hlth Care Campus, Lab Mol Dermatol, IL-31096 Haifa, Israel; [Nousbeck, Janna; Spiegel, Ronen; Lipkin, Ehud; Bergman, Reuven; Choder, Mordechai; Shalev, Stavit; Sprecher, Eli] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel; [Adir, Noam] Technion Israel Inst Technol, Schulich Fac Chem, IL-31096 Haifa, Israel; [Bercovici, Sivan; Geiger, Dan] Technion Israel Inst Technol, Dept Comp Sci, IL-31096 Haifa, Israel; [Spiegel, Ronen; Shalev, Stavit] Haemek Med Ctr, Inst Genet, IL-18101 Afula, Israel; [Shani-Adir, Ayelet] Haemek Med Ctr, Dept Dermatol, IL-18101 Afula, Israel; [Ishida-Yamamoto, Akemi] Asahikawa Med Coll, Dept Dermatol, Asahikawa, Hokkaido 0788510, Japan; [van Steensel, Maurice A.; Steijlen, Peter M.] Univ Hosp Maastricht, Dept Dermatol, NL-6202 AZ Maastricht, Netherlands; [Bindereif, Albrecht] Univ Giessen, Dept Biol & Chem, Inst Biochem, D-35390 Giessen, Germany	Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Emek Medical Center; Emek Medical Center; Asahikawa Medical College; Maastricht University; Maastricht University Medical Centre (MUMC); Justus Liebig University Giessen	Sprecher, E (corresponding author), Rambam Hlth Care Campus, Lab Mol Dermatol, IL-31096 Haifa, Israel.	e_sprecher@rambam.health.gov.il	van Steensel, Maurice A.M./V-3852-2019; Adir, Noam/ABE-6990-2020; Lipkin, Ehud/AAE-9034-2020; Steijlen, Peter/X-2729-2019	van Steensel, Maurice/0000-0002-7507-2442; Lipkin, Ehud/0000-0003-2624-6765				Al-Semari A, 2007, AM J MED GENET A, V143A, P149, DOI 10.1002/ajmg.a.31497; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Antonarakis SE, 2006, NAT REV GENET, V7, P277, DOI 10.1038/nrg1826; Bae E, 2007, J MOL BIOL, V367, P1447, DOI 10.1016/j.jmb.2007.01.078; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Choesmel V, 2007, BLOOD, V109, P1275, DOI 10.1182/blood-2006-07-038372; Combs DJ, 2006, MOL CELL BIOL, V26, P523, DOI 10.1128/MCB.26.2.523-534.2006; Cushman LJ, 2005, BIRTH DEFECTS RES A, V73, P638, DOI 10.1002/bdra.20178; Damianov A, 2006, BIOL CHEM, V387, P1455, DOI 10.1515/BC.2006.182; Devriendt K, 1996, AM J MED GENET, V62, P54, DOI 10.1002/(SICI)1096-8628(19960301)62:1<54::AID-AJMG11>3.0.CO;2-U; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Jones NC, 2008, NAT MED, V14, P125, DOI 10.1038/nm1725; Kantaputra PN, 2006, AM J MED GENET A, V140A, P2598, DOI 10.1002/ajmg.a.31386; Kazantseva A, 2006, SCIENCE, V314, P982, DOI 10.1126/science.1133276; Liu JM, 2006, BLOOD, V107, P4583, DOI 10.1182/blood-2005-12-4831; Olson LE, 2006, CELL, V125, P593, DOI 10.1016/j.cell.2006.02.046; Pellizzoni L, 2007, EMBO REP, V8, P340, DOI 10.1038/sj.embor.7400941; Ropers HH, 2007, AM J HUM GENET, V81, P199, DOI 10.1086/520679; Scherl A, 2002, MOL BIOL CELL, V13, P4100, DOI 10.1091/mbc.E02-05-0271; Schneider SA, 2008, MOVEMENT DISORD, V23, P592, DOI 10.1002/mds.21886; Silberstein M, 2006, AM J HUM GENET, V78, P922, DOI 10.1086/504158; Sprecher E, 2005, CLIN DERMATOL, V23, P47, DOI 10.1016/j.clindermatol.2004.09.009; Sun C, 1997, J BIOL CHEM, V272, P25345, DOI 10.1074/jbc.272.40.25345; Thompson CC, 2006, CELL CYCLE, V5, P1913, DOI 10.4161/cc.5.17.3189; Wali A, 2006, CLIN GENET, V70, P233, DOI 10.1111/j.1399-0004.2006.00661.x	26	52	54	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2008	82	5					1114	1121		10.1016/j.ajhg.2008.03.014	http://dx.doi.org/10.1016/j.ajhg.2008.03.014			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	301VJ	18439547	Green Published, Bronze			2022-12-18	WOS:000255923600010
J	Chanda, P; Zhang, A; Brazeau, D; Sucheston, L; Freudenheim, JL; Ambrosone, C; Ramanathan, M				Chanda, Pritam; Zhang, Aidong; Brazeau, Daniel; Sucheston, Lara; Freudenheim, Jo L.; Ambrosone, Christine; Ramanathan, Murali			Information-theoretic metrics for visualizing gene-environment interactions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIFACTOR-DIMENSIONALITY REDUCTION; SINGLE-NUCLEOTIDE POLYMORPHISMS; HUMAN GENOME; MUTUAL INFORMATION; SEQUENCE VARIATION; BREAST-CANCER; ASSOCIATION; MAP; DISEQUILIBRIUM; SUSCEPTIBILITY	The purpose of our work was to develop heuristics for visualizing and interpreting gene-environment interactions (GEIs) and to assess the dependence of candidate visualization metrics on biological and study-design factors. Two information-theoretic metrics, the k-way interaction information (KWII) and the total correlation information (TCI), were investigated. The effectiveness of the KWII and TCI to detect GEIs in a diverse range of simulated data sets and a Crohn disease data set was assessed. The sensitivity of the KWII and TCI spectra to biological and study-design variables was determined. Head-to-head comparisons with the relevance-chain, multifactor dimensionality reduction, and the pedigree disequilibrium test (PDT) methods were obtained. The KWII and TCI spectra, which are graphical summaries of the KWII and TCI for each subset of environmental and genotype variables, were found to detect each known GEI in the simulated data sets. The patterns in the KWII and TCI spectra were informative for factors such as case-control misassignment, locus heterogeneity, allele frequencies, and linkage disequilibrium. The KWII and TCI spectra were found to have excellent sensitivity for identifying the key disease-associated genetic variations in the Crohn disease data set. In head-to-head comparisons with the relevance-chain, multifactor dimensionality reduction, and PDT methods, the results from visual interpretation of the KWII and TCI spectra performed satisfactorily. The KWII and TCI are promising metrics for visualizing GEIs. They are capable of detecting interactions among numerous single-nucleotide polymorphisms and environmental variables for a diverse range of GEI models.	SUNY Buffalo, Dept Pharmaceut Sci, Buffalo, NY 14260 USA; SUNY Buffalo, Dept Comp Sci & Engn, Buffalo, NY 14260 USA; SUNY Buffalo, Dept Biostat, Buffalo, NY 14260 USA; SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14260 USA; Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute	Ramanathan, M (corresponding author), SUNY Buffalo, Dept Pharmaceut Sci, 427 Cooke Hall, Buffalo, NY 14260 USA.	Murali@Buffalo.edu		Freudenheim, Jo/0000-0002-9301-0499	CSR NIH HHS [RG3743] Funding Source: Medline	CSR NIH HHS		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Ambrosone CB, 2007, JNCI-J NATL CANCER I, V99, P487, DOI 10.1093/jnci/djk097; Andrew AS, 2006, CARCINOGENESIS, V27, P1030, DOI 10.1093/carcin/bgi284; BELL AJ, 2003, 4 INT S IND COMP AN; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhasi K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl520; Bhasi K, 2006, BIOINFORMATICS, V22, P1569, DOI 10.1093/bioinformatics/btl144; Bush WS, 2006, BIOINFORMATICS, V22, P2173, DOI 10.1093/bioinformatics/btl347; Cho YM, 2004, DIABETOLOGIA, V47, P549, DOI 10.1007/s00125-003-1321-3; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Dawy Z, 2006, IEEE ACM T COMPUT BI, V3, P47, DOI 10.1109/TCBB.2006.9; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Fano R. M., 1961, TRANSMISSION INFORM; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Jakulin A., 2004, P 21 INT C MACH LEAR; Jakulin A, 2005, MACHINE LEARNING BAS; Jakulin A., 2003, P 9 C ART INT MED EU; Jakulin A., 2003, P 7 EUR C PRINC PRAC; Liu ZQ, 2005, GENET EPIDEMIOL, V29, P353, DOI 10.1002/gepi.20092; Ma DQ, 2005, AM J HUM GENET, V77, P377, DOI 10.1086/433195; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; McGill WJ., 1954, PSYCHOMETRIKA, V19, P97, DOI 10.1007/BF02289159; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; MOTSINGER AA, 2006, PAC S BIOCOMPUT, V11, P584; Olivier M, 2001, SCIENCE, V291, P1298, DOI 10.1126/science.1057437; Onnie C, 2006, GENES IMMUN, V7, P359, DOI 10.1038/sj.gene.6364307; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Tsai CT, 2004, CIRCULATION, V109, P1640, DOI 10.1161/01.CIR.0000124487.36586.26; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WATANABE S, 1960, IBM J RES DEV, V4, P66, DOI 10.1147/rd.41.0066; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zhang L, 2004, BIOINFORMATICS, V20, P85, DOI 10.1093/bioinformatics/btg377	36	52	52	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2007	81	5					939	963		10.1086/521878	http://dx.doi.org/10.1086/521878			25	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	224XE	17924337	Green Published, Bronze			2022-12-18	WOS:000250480900007
J	Kawashima, M; Tamiya, G; Oka, A; Hohjoh, H; Juji, T; Ebisawa, T; Honda, Y; Inoko, H; Tokunaga, K				Kawashima, Minae; Tamiya, Gen; Oka, Akira; Hohjoh, Hirohiko; Juji, Takeo; Ebisawa, Takashi; Honda, Yutaka; Inoko, Hidetoshi; Tokunaga, Katsushi			Genomewide association analysis of human narcolepsy and a new resistance gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OREXIN; POLYMORPHISMS; LINKAGE; POWER; HYPOCRETIN/OREXIN; RECEPTORS; FREQUENCY; HAPLOTYPE; CATAPLEXY; PROMOTER	Human narcolepsy is a hypersomnia that is affected by multiple genetic and environmental factors. One genetic factor strongly associated with narcolepsy is the HLA-DRB1*1501-DQB1*0602 haplotype in the human leukocyte antigen region on chromosome 6, whereas the other genetic factors are not clear. To discover additional candidate regions for susceptibility or resistance to human narcolepsy, we performed a genomewide association study, using 23,244 microsatellite markers. Two rounds of screening with the use of pooled DNAs yielded 96 microsatellite markers (including 16 markers on chromosome 6) with significantly different estimated frequencies in case and control pools. Markers not located on chromosome 6 were evaluated by the individual typing of 95 cases and 95 controls; 30 markers still showed significant associations. A strong association was displayed by a marker on chromosome 21 (21q22.3). The surrounding region was subjected to high-density association mapping with 14 additional microsatellite markers and 74 SNPs. One microsatellite marker (D21S0012m) and two SNPs (rs13048981 and rs13046884) showed strong associations (P < .0005 odds ratios 0.19 - 0.33). These polymorphisms were in a strong linkage disequilibrium, and no other polymorphism in the region showed a stronger association with narcolepsy. The region contains three predicted genes - NLC1- A, NLC1- B, and NLC1- C tentatively named " narcolepsy candidate- region 1 genes," and NLC1- A and NLC1- C were expressed in human hypothalamus. Reporter- gene assays showed that the marker D21S0012m in the promoter region and the SNP rs13046884 in the intron of NLC1- A significantly affected expression levels. Therefore, NLC1- A is considered to be a new resistance gene for human narcolepsy.	Univ Tokyo, Grad Sch Med, Dept Human Genet, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Med, Dept Sleep Disorder Res, Tokyo 1130033, Japan; Tokai Univ, Sch Med, Dept Mol Life Sci, Kanagawa, Japan; Japanese Red Cross Cent Blood Ctr, Tokyo, Japan; Neuropsychiat Res Inst, Tokyo, Japan	University of Tokyo; University of Tokyo; Tokai University; Japanese Red Cross Medical Center	Tokunaga, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Human Genet, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	tokunaga@m.u-tokyo.ac.jp		Tamiya, Gen/0000-0002-0597-415X				Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; ALDRICH MS, 1990, NEW ENGL J MED, V323, P389; Barcellos LF, 1997, AM J HUM GENET, V61, P734, DOI 10.1086/515512; Black JL, 2005, SLEEP, V28, P1191; Chabas D, 2003, ANNU REV GENOM HUM G, V4, P459, DOI 10.1146/annurev.genom.4.070802.110432; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Collins HE, 2000, HUM GENET, V106, P218, DOI 10.1007/s004390051031; Dauvilliers Y, 2004, ANN NEUROL, V56, P382, DOI 10.1002/ana.20208; Hagan JJ, 1999, P NATL ACAD SCI USA, V96, P10911, DOI 10.1073/pnas.96.19.10911; HIGGINS CF, 1990, J BIOENERG BIOMEMBR, V22, P571, DOI 10.1007/BF00762962; Hohjoh H, 2001, IMMUNOGENETICS, V52, P299, DOI 10.1007/s002510000269; Hohjoh H, 1999, TISSUE ANTIGENS, V54, P138, DOI 10.1034/j.1399-0039.1999.540204.x; Hohjoh H, 2000, TISSUE ANTIGENS, V56, P446, DOI 10.1034/j.1399-0039.2000.560508.x; Honda Y., 1979, SLEEP RES, V8, P191; Hungs M, 2001, NEUROLOGY, V57, P1893, DOI 10.1212/WNL.57.10.1893; JAMES JW, 1971, ANN HUM GENET, V35, P47, DOI 10.1111/j.1469-1809.1956.tb01377.x; JUJI T, 1984, TISSUE ANTIGENS, V24, P316, DOI 10.1111/j.1399-0039.1984.tb02144.x; Kawashima M, 2001, KOREAN J GENETIC, V23, P365; KAWASHIMA M, 2004, HLA 2004 IMM HUM MHC; Kirov G, 2000, GENOME RES, V10, P105; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; LEWONTIN RC, 1964, GENETICS, V50, P757; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; MATSUKI K, 1985, J CLIN INVEST, V76, P2078, DOI 10.1172/JCI112211; Mignot E, 1998, NEUROLOGY, V50, pS16, DOI 10.1212/WNL.50.2_Suppl_1.S16; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; Nakayama J, 2000, GENOMICS, V65, P84, DOI 10.1006/geno.2000.6143; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; Ohashi J, 2003, J HUM GENET, V48, P487, DOI 10.1007/s10038-003-0058-7; Ohashi J, 2001, J HUM GENET, V46, P478, DOI 10.1007/s100380170048; Ohashi J, 2001, ANN HUM GENET, V65, P197, DOI 10.1017/S000348000100851X; Olafsdottir BR, 2001, NEUROLOGY, V57, P1896, DOI 10.1212/WNL.57.10.1896; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; RISCH N, 1987, AM J HUM GENET, V40, P1; Sakurai T, 1999, J BIOL CHEM, V274, P17771, DOI 10.1074/jbc.274.25.17771; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Smith AJF, 2004, LANCET, V364, P2122, DOI 10.1016/S0140-6736(04)17553-3; Tamiya G, 2005, HUM MOL GENET, V14, P2305, DOI 10.1093/hmg/ddi234; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; Wieczorek S, 2004, J MOL MED-JMM, V82, P696, DOI 10.1007/s00109-004-0569-5; Wieczorek S, 2003, J MOL MED-JMM, V81, P87, DOI 10.1007/s00109-002-0405-8; Wieczorek S, 2003, TISSUE ANTIGENS, V61, P437, DOI 10.1034/j.1399-0039.2003.00068.x	44	52	55	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2006	79	2					252	263		10.1086/505539	http://dx.doi.org/10.1086/505539			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	063SR	16826516	Green Published, Bronze			2022-12-18	WOS:000239040400007
J	Vander Molen, J; Frisse, LM; Fullerton, SM; Qian, Y; del Bosque-Plata, L; Hudson, RR; Di Rienzo, A				Vander Molen, J; Frisse, LM; Fullerton, SM; Qian, Y; del Bosque-Plata, L; Hudson, RR; Di Rienzo, A			Population genetics of CAPN10 and GPR35: Implications for the evolution of type 2 diabetes variants	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							APOLIPOPROTEIN-E POLYMORPHISM; THRIFTY-GENOTYPE HYPOTHESIS; RECENT COMMON ANCESTRY; HUMAN-Y-CHROMOSOMES; X-LINKED LOCI; LINKAGE-DISEQUILIBRIUM; RECOMBINATION RATES; HUMAN GENOME; HAPLOTYPE RECONSTRUCTION; CARNIVORE CONNECTION	`1A positional cloning study of type 2 diabetes in Mexican Americans identified a region, termed "NIDDM1," on chromosome 2q37 with significant linkage evidence. Haplotype combinations at the calpain-10 gene (CAPN10) within this region were shown to increase diabetes risk in several populations. On the basis of the thrifty genotype hypothesis, variants that increase susceptibility to type 2 diabetes under modern lifestyle conditions provided a survival advantage in past environments by increasing the efficiency of energy use and storage. Here, our goal is to make inferences about the evolutionary forces shaping variation in genes in the NIDDM1 region and to investigate the population genetics models that may underlie the thrifty genotype hypothesis. To this end, we surveyed sequence variation in CAPN10 and in an adjacent gene, G-protein - coupled receptor 35 (GPR35), in four population samples from different ethnic groups. These data revealed two distinct deviations from the standard neutral model in CAPN10, whereas GPR35 variation was largely consistent with neutrality. CAPN10 showed a significant deficit of variation in the haplotype class defined by the derived allele at SNP44, a polymorphism that is significantly associated with diabetes in meta-analysis studies. This suggests that this haplotype class was quickly driven to high frequency by positive natural selection. Interestingly, the derived allele at SNP44 is protective against diabetes. CAPN10 also showed a local excess of polymorphism and linkage disequilibrium decay in intron 13. Simulations show that this pattern may be explained by long-standing balancing selection that maintains multiple selected alleles. Alternatively, it is possible that the local mutation and recombination rates changed since the divergence of human and chimpanzee; this scenario does not require the action of natural selection on intron 13 variation.	Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Di Rienzo, A (corresponding author), 920 E 58th St,CLSC 507F, Chicago, IL 60637 USA.	dirienzo@genetics.uchicago.edu	Fullerton, Stephanie Malia/H-8696-2019	Fullerton, Stephanie Malia/0000-0002-0938-6048; Di Rienzo, Anna/0000-0002-8982-9098; del Bosque-Plata, Laura/0000-0003-3224-378X	NHGRI NIH HHS [F32 HG000219, HG00219] Funding Source: Medline; NIDDK NIH HHS [R01 DK055889, R01 DK056670, DK55889, DK56670] Funding Source: Medline; NIGMS NIH HHS [GM07197, T32 GM007197] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055889, R01DK056670] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Colagiuri S, 2002, EUR J CLIN NUTR, V56, pS30, DOI 10.1038/sj.ejcn.1601351; Corbo RM, 1999, ANN HUM GENET, V63, P301, DOI 10.1046/j.1469-1809.1999.6340301.x; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cox NJ, 2004, DIABETES, V53, pS19, DOI 10.2337/diabetes.53.2007.S19; Crawford DC, 2004, AM J HUM GENET, V74, P610, DOI 10.1086/382227; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; CULLEN M, 1995, AM J HUM GENET, V56, P1350; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; DEKNIJFF P, 1994, HUM MUTAT, V4, P178, DOI 10.1002/humu.1380040303; Ebersberger I, 2002, AM J HUM GENET, V70, P1490, DOI 10.1086/340787; Frisse L, 2001, AM J HUM GENET, V69, P831, DOI 10.1086/323612; Fullerton SM, 2000, AM J HUM GENET, V67, P881, DOI 10.1086/303070; Fullerton SM, 2002, AM J HUM GENET, V70, P1096, DOI 10.1086/339930; GILLESPIE JH, 1991, CAUSES MOL EVOLUTION, P142; Hamblin MT, 2002, AM J HUM GENET, V70, P369, DOI 10.1086/338628; Hammer MF, 2004, GENETICS, V167, P1841, DOI 10.1534/genetics.103.025361; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; Harding RM, 1997, AM J HUM GENET, V60, P772; Hedrick PW, 2002, EVOLUTION, V56, P1902, DOI 10.1111/j.0014-3820.2002.tb00116.x; Hellmann I, 2003, AM J HUM GENET, V72, P1527, DOI 10.1086/375657; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; HUDSON RR, 1994, GENETICS, V136, P1329; HUDSON RR, 1988, GENETICS, V120, P831; Hudson RR, 2001, GENETICS, V159, P1805; HUDSON RR, 1987, GENETICS, V116, P153; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Jeffreys AJ, 2000, HUM MOL GENET, V9, P725, DOI 10.1093/hmg/9.5.725; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Lercher MJ, 2002, TRENDS GENET, V18, P337, DOI 10.1016/S0168-9525(02)02669-0; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; MILLER JCB, 1994, DIABETOLOGIA, V37, P1280, DOI 10.1007/s001250050246; Mulligan CJ, 2004, ANNU REV GENOM HUM G, V5, P295, DOI 10.1146/annurev.genom.5.061903.175920; Nachman MW, 1998, GENETICS, V150, P1133; NEEL JV, 1962, AM J HUM GENET, V14, P353; Neel JV, 1998, PERSPECT BIOL MED, V42, P44; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Pluzhnikov A, 2002, GENETICS, V161, P1209; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Ptak SE, 2004, PLOS BIOL, V2, P849, DOI 10.1371/journal.pbio.0020155; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Schierup MH, 2001, GENETICS, V159, P1833; Sharma AM, 1998, J MOL MED-JMM, V76, P568, DOI 10.1007/s001090050251; Slatkin M, 1998, GENET RES, V71, P155, DOI 10.1017/S001667239800319X; Song YQ, 2004, AM J HUM GENET, V74, P208, DOI 10.1086/381400; Sreenan SK, 2001, DIABETES, V50, P2013, DOI 10.2337/diabetes.50.9.2013; Stajich JE, 2005, MOL BIOL EVOL, V22, P63, DOI 10.1093/molbev/msh252; STENGARD JH, 1995, CIRCULATION, V91, P265, DOI 10.1161/01.CIR.91.2.265; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; TAJIMA F, 1989, GENETICS, V123, P585; TAKAHATA N, 1990, P NATL ACAD SCI USA, V87, P2419, DOI 10.1073/pnas.87.7.2419; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Wall JD, 2003, AM J HUM GENET, V73, P1330, DOI 10.1086/380311; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Weedon MN, 2003, AM J HUM GENET, V73, P1208, DOI 10.1086/379285; WEISS KM, 1984, YEARB PHYS ANTHROPOL, V27, P153; Zietkiewicz E, 1998, J MOL EVOL, V47, P146, DOI 10.1007/PL00006371	65	52	52	0	12	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2005	76	4					548	560		10.1086/428784	http://dx.doi.org/10.1086/428784			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	904RS	15696418	Green Published, Bronze			2022-12-18	WOS:000227516000002
J	Zenker, M; Rauch, A; Winterpacht, A; Tagariello, A; Kraus, C; Rupprecht, T; Sticht, H; Reis, A				Zenker, M; Rauch, A; Winterpacht, A; Tagariello, A; Kraus, C; Rupprecht, T; Sticht, H; Reis, A			A dual phenotype of periventricular nodular heterotopia and frontometaphyseal dysplasia in one patient caused by a single FLNA mutation leading to two functionally different aberrant transcripts	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE; INACTIVATION; METHYLATION; MIGRATION; FILAMINS; SITES	Two disorders, periventricular nodular heterotopia (PVNH) and a group of skeletal dysplasias belonging to the oto-palato-digital (OPD) spectrum, are caused by FLNA mutations. They are considered mutually exclusive because of the different presumed effects of the respective FLNA gene mutations, leading to loss of function ( PVNH) and gain of function ( OPD), respectively. We describe here the first patient manifesting PVNH in combination with frontometaphyseal dysplasia, a skeletal dysplasia of the OPD-spectrum. A novel de novo mutation, 7315C-->A in exon 45 of the FLNA gene, was identified. It leads to two aberrant transcripts, one full-length transcript with the point mutation causing a substitution of a highly conserved leucine residue (L2439M) and a second shortened transcript lacking 21 bp due to the creation of an ectopic splice donor site in exon 45. We propose that the dual phenotype is caused by two functionally different, aberrant filamin A proteins and therefore represents an exceptional model case of allelic gain-of-function and loss-of-function phenotypes due to a single mutational event.	Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; Univ Erlangen Nurnberg, Dept Pediat Radiol, Childrens Hosp, D-91054 Erlangen, Germany; Univ Erlangen Nurnberg, Inst Biochem, Dept Bioinformat, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Zenker, M (corresponding author), Univ Erlangen Nurnberg, Inst Human Genet, Schwabachanlage 10, D-91054 Erlangen, Germany.	mzenker@humgenet.uni-erlangen.de	Rauch, Anita/C-5568-2014; Reis, André/D-2309-2009	Rauch, Anita/0000-0003-2930-3163; Reis, André/0000-0002-6301-6363; Sticht, Heinrich/0000-0001-5644-045X				ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Carrel L, 1996, AM J MED GENET, V64, P27, DOI 10.1002/(SICI)1096-8628(19960712)64:1<27::AID-AJMG3>3.0.CO;2-O; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Fucini P, 1997, NAT STRUCT BIOL, V4, P223, DOI 10.1038/nsb0397-223; GELLMAN SH, 1991, BIOCHEMISTRY-US, V30, P6633, DOI 10.1021/bi00241a001; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Ketterling RP, 1999, HUM MUTAT, V13, P221, DOI 10.1002/(SICI)1098-1004(1999)13:3<221::AID-HUMU6>3.3.CO;2-L; McCoy AJ, 1999, NAT STRUCT BIOL, V6, P836; Moro F, 2002, NEUROLOGY, V58, P916, DOI 10.1212/WNL.58.6.916; Nagano T, 2002, NAT CELL BIOL, V4, P495, DOI 10.1038/ncb808; PATROSSO MC, 1994, GENOMICS, V21, P71, DOI 10.1006/geno.1994.1226; Robertson SP, 2003, NAT GENET, V33, P487, DOI 10.1038/ng1119; Robertson SP, 2001, AM J HUM GENET, V69, P223, DOI 10.1086/321280; Roca X, 2003, NUCLEIC ACIDS RES, V31, P6321, DOI 10.1093/nar/gkg830; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Sheen VL, 2001, HUM MOL GENET, V10, P1775, DOI 10.1093/hmg/10.17.1775; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Verloes A, 2000, AM J MED GENET, V90, P407, DOI 10.1002/(SICI)1096-8628(20000228)90:5<407::AID-AJMG11>3.0.CO;2-D	20	52	53	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2004	74	4					731	737		10.1086/383094	http://dx.doi.org/10.1086/383094			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	804EA	14988809	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000220280800012
J	Zhang, AJ; Zheng, CY; Hou, M; Lindvall, C; Li, KJ; Erlandsson, F; Bjorkholm, M; Gruber, A; Blennow, E; Xu, DW				Zhang, AJ; Zheng, CY; Hou, M; Lindvall, C; Li, KJ; Erlandsson, F; Bjorkholm, M; Gruber, A; Blennow, E; Xu, DW			Deletion of the telomerase reverse transcriptase gene and haploinsufficiency of telomere maintenance in Cri du chat syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CATALYTIC SUBUNIT GENE; IN-SITU HYBRIDIZATION; MOUSE CELLS LACKING; DYSKERATOSIS-CONGENITA; HUMAN FIBROBLASTS; FLOW-CYTOMETRY; RNA COMPONENT; TUMOR-CELLS; HTERT GENE; EST GENES	Cri du chat syndrome (CdCS) results from loss of the distal portion of chromosome 5p, where the telomerase reverse transcriptase (hTERT) gene is localized (5p15.33). hTERT is the rate-limiting component for telomerase activity that is essential for telomere-length maintenance and sustained cell proliferation. Here, we show that a concomitant deletion of the hTERT allele occurs in all 10 patients with CdCS whom we examined. Induction of hTERT mRNA in proliferating lymphocytes derived from five of seven patients was lower than that in unaffected control individuals (P < .05). The patient lymphocytes exhibited shorter telomeres than age-matched unaffected individuals (P < .0001). A reduction in replicative life span and a high rate of chromosome fusions were observed in cultured patient fibroblasts. Reconstitution of telomerase activity by ectopic expression of hTERT extended the telomere length, increased the population doublings, and prevented the end-to-end fusion of chromosomes. We conclude that hTERT is limiting and haploinsufficient for telomere maintenance in humans in vivo. Accordingly, the hTERT deletion may be one genetic element contributing to the phenotypic changes in CdCS.	Karolinska Hosp & Inst, Dept Pathol & Oncol, Stockholm, Sweden; Karolinska Hosp & Inst, Dept Med, Div Hematol, Stockholm, Sweden; Karolinska Hosp & Inst, Dept Mol Med, Stockholm, Sweden; Karolinska Hosp & Inst, Dept Biosci Novum, Stockholm, Sweden; Shaanxi Prov Hosp, Xian, Peoples R China	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Xi'an Medical University	Xu, DW (corresponding author), Karolinska Hosp, Hematol Lab, CMM, L8 03, SE-17176 Stockholm, Sweden.			Lindvall, Charlotta/0000-0003-2090-2039; Hou, Mi/0000-0002-4573-7028; Xu, Dawei/0000-0003-3141-4524				ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Artandi SE, 2002, P NATL ACAD SCI USA, V99, P8191, DOI 10.1073/pnas.112515399; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; BREG WR, 1970, J PEDIATR-US, V77, P782, DOI 10.1016/S0022-3476(70)80236-0; Bryce LA, 2000, NEOPLASIA, V2, P197, DOI 10.1038/sj.neo.7900092; Collins MSR, 2001, ARCH DIS CHILD, V85, P337, DOI 10.1136/adc.85.4.337; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ducrest AL, 2002, ONCOGENE, V21, P541, DOI 10.1038/sj.onc.1205081; Forsyth NR, 2002, DIFFERENTIATION, V69, P188, DOI 10.1046/j.1432-0436.2002.690412.x; Gonzalez-Suarez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Harrington L, 1997, GENE DEV, V11, P3109, DOI 10.1101/gad.11.23.3109; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; Hathcock KS, 2002, P NATL ACAD SCI USA, V99, P3591, DOI 10.1073/pnas.012549799; Hultdin M, 1998, NUCLEIC ACIDS RES, V26, P3651, DOI 10.1093/nar/26.16.3651; Kilian A, 1997, HUM MOL GENET, V6, P2011, DOI 10.1093/hmg/6.12.2011; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Lendvay TS, 1996, GENETICS, V144, P1399; Lingner J, 1997, P NATL ACAD SCI USA, V94, P11190, DOI 10.1073/pnas.94.21.11190; Liu JP, 1999, FASEB J, V13, P2091, DOI 10.1096/fasebj.13.15.2091; Liu Y, 2002, P NATL ACAD SCI USA, V99, P3597, DOI 10.1073/pnas.062549199; Liu Y, 2000, CURR BIOL, V10, P1459, DOI 10.1016/S0960-9822(00)00805-8; Mainardi PC, 2001, J MED GENET, V38, P151, DOI 10.1136/jmg.38.3.151; MARTINEZ JE, 1993, CLIN GENET, V43, P212, DOI 10.1111/j.1399-0004.1993.tb04467.x; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; NIEBUHR E, 1978, HUM GENET, V44, P227, DOI 10.1007/BF00394291; Niida H, 1998, NAT GENET, V19, P203, DOI 10.1038/580; Rufer N, 1998, NAT BIOTECHNOL, V16, P743, DOI 10.1038/nbt0898-743; Saretzki G, 2002, CANCER LETT, V176, P81, DOI 10.1016/S0304-3835(01)00644-9; Van Buggenhout GJCM, 2000, AM J MED GENET, V90, P203, DOI 10.1002/(SICI)1096-8628(20000131)90:3<203::AID-AJMG5>3.0.CO;2-A; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Xu D, 1999, BRIT J CANCER, V80, P1156, DOI 10.1038/sj.bjc.6690480; Yuan XM, 1999, GENES CELLS, V4, P563, DOI 10.1046/j.1365-2443.1999.00284.x; Zhang AJ, 2002, GENE CHROMOSOME CANC, V34, P269, DOI 10.1002/gcc.10071; Zhang AJ, 2000, CANCER RES, V60, P6230	43	52	58	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2003	72	4					940	948		10.1086/374565	http://dx.doi.org/10.1086/374565			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662WT	12629597	Bronze, Green Published			2022-12-18	WOS:000181972600014
J	Yu, CE; Dawson, G; Munson, J; D'Souza, I; Osterling, J; Estes, A; Leutenegger, AL; Flodman, P; Smith, M; Raskind, WH; Spence, MA; McMahon, W; Wijsman, EM; Schellenberg, GD				Yu, CE; Dawson, G; Munson, J; D'Souza, I; Osterling, J; Estes, A; Leutenegger, AL; Flodman, P; Smith, M; Raskind, WH; Spence, MA; McMahon, W; Wijsman, EM; Schellenberg, GD			Presence of large deletions in kindreds with autism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSLOCATION BREAKPOINT; FAMILY-HISTORY; GENOMIC SCREEN; GENE; SUSCEPTIBILITY; IDENTIFICATION; DISORDER; TWIN; INDIVIDUALS; DUPLICATION	Autism is caused, in part, by inheritance of multiple interacting susceptibility alleles. To identify these inherited factors, linkage analysis of multiplex families is being performed on a sample of 105 families with two or more affected sibs. Segregation patterns of short tandem repeat polymorphic markers from four chromosomes revealed null alleles at four marker sites in 12 families that were the result of deletions ranging in size from 5 to >260 kb. In one family, a deletion at marker D7S630 was complex, with two segments deleted (37 kb and 18 kb) and two retained (2,836 bp and 38 bp). Three families had deletions at D7S517, with each family having a different deletion (96 kb, 183 kb, and 1 69 kb). Another three families had deletions at D8S264, again with each family having a different deletion, ranging in size from <5.9 kb to >260 kb. At a fourth marker, D8S272, a 192-kb deletion was found in five families. Unrelated subjects and additional families without autism were screened for deletions at these four sites. Families screened included 40 families from Centre d'Etude du Polymorphisme Humaine and 28 families affected with learning disabilities. Unrelated samples were 299 elderly control subjects, 121 younger control subjects, and 248 subjects with Alzheimer disease. The deletion allele at D8S272 was found in all populations screened. For the other three sites, no additional deletions were identified in any of the groups without autism. Thus, these deletions appear to be specific to autism kindreds and are potential autism-susceptibility alleles. An alternative hypothesis is that autism-susceptibility alleles elsewhere cause the deletions detected here, possibly by inducing errors during meiosis.	Puget Sound Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Seattle, WA USA; Univ Washington, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA; Univ Washington, Dept Psychol, Seattle, WA 98195 USA; Univ Washington, Ctr Human Dev & Disabil, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; Univ Washington, Dept Neurol, Seattle, WA 98195 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA; Univ Utah, Dept Psychiat, Div Child & Adolescent Psychiat, Salt Lake City, UT 84112 USA	Geriatric Research Education & Clinical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California Irvine; Utah System of Higher Education; University of Utah	Schellenberg, GD (corresponding author), Vet Affairs Med Ctr 182B, 1660 S Columbian Rd, Seattle, WA 98108 USA.	zachdad@u.washington.edu	Leutenegger, Anne-Louise/B-5597-2009	Leutenegger, Anne-Louise/0000-0002-1302-4357; Munson, Jeffrey A/0000-0003-1798-8927; Dawson, Geraldine/0000-0003-1410-2764; Estes, Annette/0000-0003-2687-4155; Wijsman, Ellen/0000-0002-2725-6669	NCRR NIH HHS [M01 RR000064] Funding Source: Medline; NICHD NIH HHS [P50 HD033812, U19 HD035476, P01 HD035476] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		American Psychiatric Association, 1994, DIAGN STAT MAN MENT, P65; Asano E, 2001, J CHILD NEUROL, V16, P357, DOI 10.1177/088307380101600509; Ashley-Koch A, 1999, GENOMICS, V61, P227, DOI 10.1006/geno.1999.5968; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; BAKER P, 1994, J AUTISM DEV DISORD, V24, P529, DOI 10.1007/BF02172133; Barrett S, 1999, AM J MED GENET, V88, P609; Bass MP, 2000, NEUROGENETICS, V2, P219, DOI 10.1007/s100489900081; BOLTON P, 1994, J CHILD PSYCHOL PSYC, V35, P877, DOI 10.1111/j.1469-7610.1994.tb02300.x; BURD L, 1988, CLIN GENET, V33, P356; Buxbaum JD, 2001, AM J HUM GENET, V68, P1514, DOI 10.1086/320588; Cook EH, 1997, AM J HUM GENET, V60, P928; Cook EH, 1997, MOL PSYCHIATR, V2, P247; Cook PJ, 1998, ISSUES SCI TECHNOL, V15, P12; Das M, 2001, GENOMICS, V77, P71, DOI 10.1006/geno.2001.6620; Deloukas P, 2001, NATURE, V414, P865, DOI 10.1038/414865a; Ewen KR, 2000, AM J HUM GENET, V67, P727, DOI 10.1086/303048; FOLSTEIN S, 1977, NATURE, V265, P726, DOI 10.1038/265726a0; FOLSTEIN S, 1977, J CHILD PSYCHOL PSYC, V18, P297, DOI 10.1111/j.1469-7610.1977.tb00443.x; Ghaziuddin M, 1999, J AUTISM DEV DISORD, V29, P259, DOI 10.1023/A:1023088207468; GILLBERG C, 1991, J AM ACAD CHILD PSY, V30, P489, DOI 10.1097/00004583-199105000-00022; Gilles F, 2000, GENOMICS, V70, P364, DOI 10.1006/geno.2000.6388; GOY A, 1995, GENOMICS, V26, P327, DOI 10.1016/0888-7543(95)80217-A; Gratacos M, 2001, CELL, V106, P367, DOI 10.1016/S0092-8674(01)00447-0; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Harrington JJ, 2001, NAT BIOTECHNOL, V19, P440, DOI 10.1038/88107; Ingram JL, 2000, TERATOLOGY, V62, P393, DOI 10.1002/1096-9926(200012)62:6<393::AID-TERA6>3.3.CO;2-M; Khan SG, 1998, J INVEST DERMATOL, V111, P791, DOI 10.1046/j.1523-1747.1998.00391.x; LeCouteur A, 1996, J CHILD PSYCHOL PSYC, V37, P785; Liu JJ, 2001, AM J HUM GENET, V69, P327, DOI 10.1086/321980; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Michaelis RC, 1997, AM J MED GENET, V71, P298, DOI 10.1002/(SICI)1096-8628(19970822)71:3<298::AID-AJMG10>3.0.CO;2-F; Nurmi EL, 2001, GENOMICS, V77, P105, DOI 10.1006/geno.2001.6617; Palferman S, 2001, HUM MOL GENET, V10, P973; Palferman S, 2001, AM J HUM GENET, V69, P570; Persico AM, 2001, MOL PSYCHIATR, V6, P150, DOI 10.1038/sj.mp.4000850; PETIT E, 1995, J MED GENET, V32, P269, DOI 10.1136/jmg.32.4.269; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; PICKLES A, 1995, AM J HUM GENET, V57, P717; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; RITVO ER, 1985, AM J PSYCHIAT, V142, P74; Robinson Wendy P., 1993, European Journal of Human Genetics, V1, P37; Silverstein S, 2001, AM J HUM GENET, V68, P261, DOI 10.1086/316943; Smith M, 2000, AM J MED GENET, V96, P765, DOI 10.1002/1096-8628(20001204)96:6<765::AID-AJMG13>3.0.CO;2-L; Smith M, 2001, CYTOGENET CELL GENET, V94, P15, DOI 10.1159/000048775; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; SULTANA R, IN PRESS GENOMICS; Thomas NS, 1999, HUM GENET, V104, P43, DOI 10.1007/s004390050908; Vincent JB, 2000, AM J HUM GENET, V67, P510, DOI 10.1086/303005; Vostanis P., 1994, Psychiatric Genetics, V4, P109, DOI 10.1097/00041444-199422000-00008; Wassink TH, 2001, AM J MED GENET, V105, P406, DOI 10.1002/ajmg.1401; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Yan WL, 2000, AM J MED GENET, V96, P749, DOI 10.1002/1096-8628(20001204)96:6<749::AID-AJMG10>3.0.CO;2-K	54	52	56	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2002	71	1					100	115		10.1086/341291	http://dx.doi.org/10.1086/341291			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	564GY	12058345	Bronze, Green Published			2022-12-18	WOS:000176307700010
J	Beaudet, AL; Jiang, YH				Beaudet, AL; Jiang, YH			A rheostat model for a rapid and reversible form of imprinting-dependent evolution	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA METHYLATION; GENE-EXPRESSION; PATTERNS; INHERITANCE; EPIGENETICS; MECHANISMS; GENOME; RNA	The evolutionary advantages of genomic imprinting are puzzling. We propose that genomic imprinting evolved as a mechanism that maximizes the interindividual variability in the rates of gene expression for dosage-sensitive loci that, with minimal unrelated deleterious effects, can alter the phenotype over a wide continuum. We hypothesize (1) that genomic imprinting provides a previously suggested haploid selective advantage (HSA); (2) that many imprinted genes have evolved mechanisms that facilitate quantitative hypervariability (QH) of gene expression; (3) that the combination of HSA and QH makes possible a rapid and reversible form of imprinting-dependent evolution (IDE) that can mediate changes in phenotype; and (4) that this enhanced adaptability to a changing environment provides selective advantage to the population, as an assisted form of evolution. These mechanisms may have provided at least one of the driving forces for the evolution of genomic imprinting in mammals. The rheostat model suggests that both genetic and epigenetic variants can contribute to an integrated mechanism of mixed Mendelian and non-Mendelian inheritance and suggests the possibility that the majority of variants are not intrinsically deleterious but, depending on the environment, are each potentially advantageous. Moreover, this would be a reversible form of evolution, with the ability not only to protect a silent allele from selection for many generations but to reactivate and expand it in the population quickly.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine	Beaudet, AL (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,Room T619, Houston, TX 77030 USA.	abeaudet@bcm.tmc.edu			NICHD NIH HHS [R01 HD037283, P30 HD024064, HD 37283, HD 24064] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037283, P30HD024064] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Balter M, 2000, SCIENCE, V288, P38, DOI 10.1126/science.288.5463.38; BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; Bartolomei MS, 1997, ANNU REV GENET, V31, P493, DOI 10.1146/annurev.genet.31.1.493; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bird A, 2001, SCIENCE, V294, P2113, DOI 10.1126/science.1066726; Boerkoel CF, 1999, ANN NY ACAD SCI, V883, P22, DOI 10.1111/j.1749-6632.1999.tb08563.x; CHAILLET JR, 1994, MUTAT RES, V307, P441, DOI 10.1016/0027-5107(94)90255-0; Chicurel M, 2001, SCIENCE, V292, P1824, DOI 10.1126/science.292.5523.1824; Dover G, 2000, NATURE, V408, P17, DOI 10.1038/35040756; Gould SJ, 1999, P NATL ACAD SCI USA, V96, P11904, DOI 10.1073/pnas.96.21.11904; Gray TA, 1999, P NATL ACAD SCI USA, V96, P5616, DOI 10.1073/pnas.96.10.5616; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hastings PJ, 2000, CELL, V103, P723, DOI 10.1016/S0092-8674(00)00176-8; Henikoff S, 1997, TRENDS GENET, V13, P293, DOI 10.1016/S0168-9525(97)01219-5; Hurst L. D., 1997, GENOMIC IMPRINTING, P211; Hurst LD, 1998, CURR OPIN GENET DEV, V8, P701, DOI 10.1016/S0959-437X(98)80040-3; Hurst LD, 1998, NAT GENET, V20, P315, DOI 10.1038/3776; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KONDRASHOV AS, 1991, NATURE, V351, P314, DOI 10.1038/351314a0; Lindquist S, 2000, NATURE, V408, P17, DOI 10.1038/35040758; Lloyd V, 2000, GENETICA, V109, P35, DOI 10.1023/A:1026592318341; Lloyd VK, 1999, GENETICS, V151, P1503; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; Mayr E, 1997, P NATL ACAD SCI USA, V94, P2091, DOI 10.1073/pnas.94.6.2091; McGowan RA, 1997, BIOCHEM CELL BIOL, V75, P499, DOI 10.1139/bcb-75-5-499; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Pembrey M., 1996, Acta Geneticae Medicae et Gemellologiae, V45, P111; Rakyan VK, 2001, BIOCHEM J, V356, P1, DOI 10.1042/0264-6021:3560001; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Reik W, 2001, ELECTROPHORESIS, V22, P2838, DOI 10.1002/1522-2683(200108)22:14&lt;2838::AID-ELPS2838&gt;3.0.CO;2-M; Rosenberg SM, 2001, NAT REV GENET, V2, P504, DOI 10.1038/35080556; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Seidman JG, 2002, J CLIN INVEST, V109, P451, DOI 10.1172/JC1200215043; SHIBATA H, 1995, ELECTROPHORESIS, V16, P210, DOI 10.1002/elps.1150160136; SILVA AJ, 1988, CELL, V54, P145, DOI 10.1016/0092-8674(88)90546-6; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Sommer SS, 2001, MUTAT RES-DNA REPAIR, V487, P1, DOI 10.1016/S0921-8777(01)00108-2; Sutherland HGE, 2000, MAMM GENOME, V11, P347, DOI 10.1007/s003350010066; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; VARMUZA S, 1993, J THEOR BIOL, V164, P1, DOI 10.1006/jtbi.1993.1137; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Wolffe AP, 2000, CURR BIOL, V10, pR463, DOI 10.1016/S0960-9822(00)00534-0; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; Xin ZH, 2001, AM J HUM GENET, V69, P1389, DOI 10.1086/324469	50	52	53	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2002	70	6					1389	1397		10.1086/340969	http://dx.doi.org/10.1086/340969			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549LP	11992247	Green Published, Bronze			2022-12-18	WOS:000175445700001
J	Merz, JF; Magnus, D; Cho, MK; Caplan, AL				Merz, JF; Magnus, D; Cho, MK; Caplan, AL			Protecting subjects' interests in genetics research	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CAUSE PSEUDOXANTHOMA ELASTICUM; BIOMEDICAL-RESEARCH; CANAVAN DISEASE; OF-INTEREST; MUTATIONS; COMMUNITIES; INNOVATION; PATENTS	Biomedical researchers often assume that sponsors, subjects, families, and disease-associated advocacy groups contribute to research solely because of altruism. This view fails to capture the diverse interests of many participants in the emerging research enterprise. In the past two decades, patient groups have become increasingly active in the promotion and facilitation of genetics research. Simultaneously, a significant shift of academic biomedical science toward commercialization has occurred, spurred by U. S. federal policy changes. The concurrent rise in both the roles that subjects play and the commercial interests they have presents numerous ethical challenges. We examine the interests of different research participants, finding that these interests are not addressed by current policies and practices. We conclude that all participants should be given a voice in decisions affecting ownership, access to, and use of commercialized products and services, and that researchers and institutions should negotiate issues relating to control of research results and the sharing of benefits before the research is performed.	Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA; Stanford Univ, Ctr Biomed Eth, Palo Alto, CA 94304 USA	University of Pennsylvania; Pennsylvania Medicine; Stanford University	Merz, JF (corresponding author), Univ Penn, Ctr Bioeth, 3401 Market St,Suite 320, Philadelphia, PA 19104 USA.			Merz, Jon/0000-0002-0612-7104	NHGRI NIH HHS [R01 HG002034-01A1S1, R01 HG002034-02, R01 HG002034-01A1, R01 HG002034-03, R01 HG002034, HG 02034, R01 HG002034-01A1S2] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002034] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Angell M, 2000, NEW ENGL J MED, V342, P1516, DOI 10.1056/NEJM200005183422009; Berg K, 2001, CLIN GENET, V59, P240, DOI 10.1034/j.1399-0004.2001.590404.x; Bergen AAB, 2000, NAT GENET, V25, P228, DOI 10.1038/76109; Beskow LM, 2001, JAMA-J AM MED ASSOC, V286, P2315, DOI 10.1001/jama.286.18.2315; Brody B, 1996, HASTINGS CENT REP, V26, P5, DOI 10.2307/3528570; Cho MK, 2000, JAMA-J AM MED ASSOC, V284, P2203, DOI 10.1001/jama.284.17.2203; DeAngelis CD, 2000, JAMA-J AM MED ASSOC, V284, P2237, DOI 10.1001/jama.284.17.2237; Eisenberg RS, 1996, VA LAW REV, V82, P1663, DOI 10.2307/1073686; Gupta A. K., 1998, PROTECTION GLOBAL BI, P180; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; KATZ D, 2000, ENCY ETHICAL LEGAL P, P854; KAUL R, 1993, NAT GENET, V5, P118, DOI 10.1038/ng1093-118; KAUL R, 1994, AM J HUM GENET, V55, P34; Knoppers BM, 2000, CLIN GENET, V58, P364; KOLATA G, 2000, NY TIMES        0317, pA1; KOLATA G, 2000, NY TIMES        1229, pA19; KREEGER KY, 2001, SCIENTIST, V14, P35; Krimsky S, 1996, Sci Eng Ethics, V2, P395, DOI 10.1007/BF02583927; Le Saux O, 2000, NAT GENET, V25, P223, DOI 10.1038/76102; Lindee MS, 2000, NAT REV GENET, V1, P236, DOI 10.1038/35042097; Marshall E, 2000, SCIENCE, V290, P1062, DOI 10.1126/science.290.5494.1062; Pennisi E, 2000, SCIENCE, V288, P1565, DOI 10.1126/science.288.5471.1565; ROSENBERG R, 2001, BOSTON GLOBE    1221, pD1; Smaglik P, 2000, NATURE, V407, P821, DOI 10.1038/35038209; Weijer C, 2000, CLIN GENET, V58, P367, DOI 10.1034/j.1399-0004.2000.580506.x; Weijer C, 2000, SCIENCE, V289, P1142, DOI 10.1126/science.289.5482.1142; WEIR RF, 1995, IRB, V17, P1	27	52	53	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2002	70	4					965	971		10.1086/339767	http://dx.doi.org/10.1086/339767			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	528PL	11870592	Green Published, Bronze			2022-12-18	WOS:000174252100013
J	Kelley, MJ; Korczak, JF; Sheridan, E; Yang, XH; Goldstein, AM; Parry, DM				Kelley, MJ; Korczak, JF; Sheridan, E; Yang, XH; Goldstein, AM; Parry, DM			Familial chordoma, a tumor of notochordal remnants, is linked to chromosome 7q33	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; INHERITANCE; LOCUS	Chordoma is a rare tumor originating from notochordal remnants that is usually diagnosed during midlife. We performed a genomewide analysis for linkage in a family with 10 individuals affected by chordoma. The maximum two-point LOD score based on only the affected individuals was 2.21, at recombination fraction 0, at marker D7S2195 on chromosome 7q. Combined analysis of additional members of this family (11 affected individuals) and of two unrelated families (one with 2 affected individuals and the other with 3 affected individuals), with 20 markers on 7q, showed a maximum two-point LOD score of 4.05 at marker D7S500. Multipoint analysis based on only the affected individuals gave a maximum LOD score of 4.78, with an approximate 2-LOD support interval from marker D7S512 to marker D7S684. Haplotype analysis of the three families showed a minimal disease-gene region from D7S512 to D7S684, a distance of 11.1 cM and similar to7.1 Mb. No loss of heterozygosity was found at markers D7S1804, D7S1824, and D7S2195 in four tumor samples from affected family members. These results map a locus for familial chordoma to 7q33. Further analysis of this region, to identify this gene, is ongoing.	NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; Duke Univ, Dept Med, Durham, NC USA; Vet Affairs Hosp, Durham, NC USA; Karmanos Canc Inst, Epidemiol Sect, Detroit, MI USA; Wayne State Univ, Sch Med, Dept Internal Med, Detroit, MI 48201 USA; St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Duke University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Saint James's University Hospital	Parry, DM (corresponding author), NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, Execut Plaza S,Room 7124,6120 Execut Blvd,MSC 723, Bethesda, MD 20892 USA.		Kelley, Michael/AAC-8939-2019; Pillay, Nischalan/F-9536-2012	Kelley, Michael/0000-0001-9523-6080; 	VA [5I01BX000458-03] Funding Source: Federal RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000458] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR003655, RR03655] Funding Source: Medline; PHS HHS [263-MQ-013900] Funding Source: Medline	VA(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Veterans Affairs(US Department of Veterans Affairs); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bouffard GG, 1997, GENOME RES, V7, P673, DOI 10.1101/gr.7.7.673; Dalpra L, 1999, INT J CANCER, V81, P24, DOI 10.1002/(SICI)1097-0215(19990331)81:1<24::AID-IJC5>3.3.CO;2-F; ENIN IP, 1963, VESTN OTORINOLARYNG, V26, P88; FOOTE R F, 1958, Calif Med, V88, P383; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HEALEY JH, 1989, ORTHOP CLIN N AM, V20, P417; KERR WA, 1975, S AFR MED J, V49, P1584; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MALAWER MM, 1997, CANC PRINCIPLES PRAC, P1844; MCMAHON PJ, 1995, HAND UPP E, V12, P1; Miozzo M, 2000, INT J CANCER, V87, P68, DOI 10.1002/1097-0215(20000701)87:1<68::AID-IJC10>3.0.CO;2-V; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; RICH TA, 1985, CANCER, V56, P182, DOI 10.1002/1097-0142(19850701)56:1<182::AID-CNCR2820560131>3.0.CO;2-J; *SAGE, 1994, STAT AN GEN EP; SAWYER JR, 2001, NEUROSURG FOCUS, V10; Stepanek J, 1998, AM J MED GENET, V75, P335, DOI 10.1002/(SICI)1096-8628(19980123)75:3<335::AID-AJMG23>3.0.CO;2-P; TAI PTH, 1995, CANCER, V75, P749, DOI 10.1002/1097-0142(19950201)75:3<749::AID-CNCR2820750302>3.0.CO;2-D	18	52	53	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2001	69	2					454	460		10.1086/321982	http://dx.doi.org/10.1086/321982			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XN	11452362	Green Published, Bronze			2022-12-18	WOS:000170108200021
J	Bonnen, PE; Story, MD; Ashorn, CL; Buchholz, TA; Weil, MM; Nelson, DL				Bonnen, PE; Story, MD; Ashorn, CL; Buchholz, TA; Weil, MM; Nelson, DL			Haplotypes at ATM identify coding-sequence variation and indicate a region of extensive linkage disequilibrium	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; HUMAN LIPOPROTEIN-LIPASE; ATAXIA-TELANGIECTASIA; GENE; FAMILIES; DISEASE; CANCER; POPULATION; GENOME; BREAST	Genetic variation in the human population may lead to functional variants of genes that contribute to risk for common chronic diseases such as cancer. In an effort to detect such possible predisposing variants, we constructed haplotypes for a candidate gene and tested their efficacy in association studies. We developed haplotypes consisting of 14 biallelic neutral-sequence variants that span 142 kb of the ATM locus. ATM is the gene responsible for the autosomal recessive disease ataxia-telangiectasia (AT). These ATM noncoding single-nucleotide polymorphisms (SNPs) were genotyped in nine CEPH families (89 individuals) and in 260 DNA samples from four different ethnic origins. Analysis of these data with an expectation-maximization algorithm revealed 22 haplotypes at this locus, with three major haplotypes having frequencies greater than or equal to .10. Tests for recombination and linkage disequilibrium (LD) show reduced recombination and extensive LD at the ATM locus, in all four ethnic groups studied. The most striking example was found in the study population of European ancestry, in which no evidence for recombination could be discerned. The potential of ATM haplotypes for detection of genetic variants through association studies was tested by analysis of 84 individuals carrying one of three ATM coding SNPs. Each coding SNP was detected by association with an ATM haplotype. We demonstrate that association studies with haplotypes for candidate genes have significant potential for the detection of genetic backgrounds that contribute to disease.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Nelson, DL (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.		Story, Michael/AAX-2864-2021	Story, Michael/0000-0001-6522-4169; Ashorn, Cheryl/0000-0003-1207-7323	NCI NIH HHS [CA75432, R01 CA075432] Funding Source: Medline; NLM NIH HHS [1T15LM07093, T15 LM007093] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA075432] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007093] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Boerwinkle E, 1996, HUM MOL GENET, V5, P1405, DOI 10.1093/hmg/5.Supplement_1.1405; Cargill M, 1999, NAT GENET, V23, P373, DOI 10.1038/15564; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; DEMARCHI JM, 1994, HUM MUTAT, V4, P281, DOI 10.1002/humu.1380040409; Eaves IA, 2000, NAT GENET, V25, P320; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Gatti RA, 1999, MOL GENET METAB, V68, P419, DOI 10.1006/mgme.1999.2942; GATTI RA, 1991, MEDICINE, V70, P99, DOI 10.1097/00005792-199103000-00003; Goddard KAB, 2000, AM J HUM GENET, V66, P216, DOI 10.1086/302727; Hacia JG, 1999, NAT GENET, V22, P164, DOI 10.1038/9674; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; HUDSON RR, 1985, GENETICS, V111, P147; Josefsson AM, 1998, NATURE, V396, P531, DOI 10.1038/25037; Kraft HG, 1998, HUM MOL GENET, V7, P257, DOI 10.1093/hmg/7.2.257; Kruglyak L, 1997, NAT GENET, V17, P21, DOI 10.1038/ng0997-21; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Lai E, 1998, GENOMICS, V54, P31, DOI 10.1006/geno.1998.5581; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; LEWONTIN RC, 1995, GENETICS, V140, P377; Li AR, 1999, AM J MED GENET, V86, P140, DOI 10.1002/(SICI)1096-8628(19990910)86:2<140::AID-AJMG10>3.3.CO;2-O; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; Moffatt MF, 2000, HUM MOL GENET, V9, P1011, DOI 10.1093/hmg/9.7.1011; MORRELL D, 1990, CANCER GENET CYTOGEN, V50, P119, DOI 10.1016/0165-4608(90)90245-6; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Rotman G, 1999, ONCOGENE, V18, P6135, DOI 10.1038/sj.onc.1203124; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Stankovic T, 1998, AM J HUM GENET, V62, P334, DOI 10.1086/301706; Storey A, 1998, NATURE, V393, P229, DOI 10.1038/30400; STRITTMATTER WJ, 1995, P NATL ACAD SCI USA, V92, P4725, DOI 10.1073/pnas.92.11.4725; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; SWIFT M, 1986, AM J HUM GENET, V39, P573; SWIFT M, 1991, NEW ENGL J MED, V325, P1831, DOI 10.1056/NEJM199112263252602; Taillon-Miller P, 2000, NAT GENET, V25, P324, DOI 10.1038/77100; Weir BS, 1996, SINAUER ASS SUNDERL; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	41	52	61	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2000	67	6					1437	1451		10.1086/316908	http://dx.doi.org/10.1086/316908			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	378WE	11078475	Bronze, Green Published			2022-12-18	WOS:000165607600009
J	Mears, AJ; Hiriyanna, S; Vervoort, R; Yashar, B; Gieser, L; Fahrner, S; Daiger, SP; Heckenlively, JR; Sieving, PA; Wright, AF; Swaroop, A				Mears, AJ; Hiriyanna, S; Vervoort, R; Yashar, B; Gieser, L; Fahrner, S; Daiger, SP; Heckenlively, JR; Sieving, PA; Wright, AF; Swaroop, A			Remapping of the RP15 locus for X-linked cone-rod degeneration to Xp11.4-p21.1, and identification of a de novo insertion in the RPGR exon ORF15	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; RETINITIS-PIGMENTOSA; GENE; RP3; MUTATIONS; DYSTROPHY; FAMILIES; HOMOLOGY; RCC1	X-linked forms of retinitis pigmentosa (XLRP) are among the most severe, because of their early onset, often leading to significant vision loss before the 4th decade. Previously, the RP15 locus was assigned to Xp22, by linkage analysis of a single pedigree with "X-linked dominant cone-rod degeneration." After clinical reevaluation of a female in this pedigree identified her as affected, we remapped the disease to a 19.5-cM interval (DXS1219-DXS993) at Xp11.4-p21.1. This new interval overlapped both RP3 (RPGR) and COD1. Sequencing of the previously published exons of RPGR revealed no mutations, but a de novo insertion was detected in the new RPGR exon, ORF15. The identification of an RPGR mutation in a family with a severe form of cone and rod degeneration suggests that RPGR mutations may encompass a broader phenotypic spectrum than has previously been recognized in "typical" retinitis pigmentosa.	Univ Michigan, WK Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48105 USA; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Texas, Hlth Sci Ctr, Dept Ophthalmol & Visual Sci, Houston, TX USA; Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90024 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Edinburgh; University of Texas System; University of Texas Health Science Center Houston; University of California System; University of California Los Angeles	Swaroop, A (corresponding author), Univ Michigan, WK Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, 1000 Wall St, Ann Arbor, MI 48105 USA.			Swaroop, Anand/0000-0002-1975-1141; Yashar, Beverly M./0000-0003-0807-3258	NATIONAL EYE INSTITUTE [R01EY007142, R29EY007961, R01EY007961] Funding Source: NIH RePORTER; NEI NIH HHS [F31 EY007003, P30 EY007003, R01 EY007961, R01 EY007142, EY07003, EY07961, R01 EY006094, EY07142] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BIRD AC, 1975, BRIT J OPHTHALMOL, V59, P177, DOI 10.1136/bjo.59.4.177; Buraczynska M, 1997, AM J HUM GENET, V61, P1287, DOI 10.1086/301646; Daiger SP, 1996, AM J HUM GENET, V58, P435; FISHMAN GA, 1988, ARCH OPHTHALMOL-CHIC, V106, P369; Fujita R, 1997, AM J HUM GENET, V61, P571, DOI 10.1086/515523; Hong DH, 2000, P NATL ACAD SCI USA, V97, P3649, DOI 10.1073/pnas.060037497; Inglehearn CF, 1996, AM J HUM GENET, V58, P433; KEITH CG, 1991, OPHTHALMIC PAED GEN, V12, P91, DOI 10.3109/13816819109023680; MCGUIRE RE, 1995, AM J HUM GENET, V57, P87; Meindl A, 1996, NAT GENET, V13, P35, DOI 10.1038/ng0596-35; OTT J, 1990, P NATL ACAD SCI USA, V87, P701, DOI 10.1073/pnas.87.2.701; Roepman R, 1996, HUM MOL GENET, V5, P1035, DOI 10.1093/hmg/5.7.1035; Seymour AB, 1998, AM J HUM GENET, V62, P122, DOI 10.1086/301667; Souied E, 1997, J MED GENET, V34, P793, DOI 10.1136/jmg.34.10.793; Vervoort R, 2000, NAT GENET, V25, P462, DOI 10.1038/78182	15	52	55	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4					1000	1003		10.1086/303091	http://dx.doi.org/10.1086/303091			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	360DL	10970770	Bronze, Green Published			2022-12-18	WOS:000089651100024
J	Keicho, N; Ohashi, J; Tamiya, G; Nakata, K; Taguchi, Y; Azuma, A; Ohishi, N; Emi, M; Park, MH; Inoko, H; Tokunaga, K; Kudoh, S				Keicho, N; Ohashi, J; Tamiya, G; Nakata, K; Taguchi, Y; Azuma, A; Ohishi, N; Emi, M; Park, MH; Inoko, H; Tokunaga, K; Kudoh, S			Fine localization of a major disease-susceptibility locus for diffuse panbronchiolitis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMORPHIC MICROSATELLITE MARKERS; CLASS-I REGION; CYSTIC-FIBROSIS; HLA ANTIGENS; JAPANESE; ALLELES; GENE	Diffuse panbronchiolitis affecting East Asians is strongly associated with the class I human leukocyte antigen (HLA) alleles. Recent observations suggest that a major disease-susceptibility gene may be located between the HLA-B and HLA-A loci in the class I region of the major histocompatibility complex on chromosome 6. To test this possibility, we analyzed 14 polymorphic markers in 92 Japanese patients and 93 healthy controls. Of these, seven marker alleles, including HLA-B54 and HLA-A11, were significantly associated with the disease. Maximum-likelihood haplotype analysis and subsequent direct determination of individual haplotypes identified a group of disease-associated haplotypes, one of which contained all seven disease-associated marker alleles. Another haplotype, containing HLA-B*5504, was also associated with the disease. All these haplotypes seem to have diverged from a common ancestral haplotype in East Asians and share a specific segment containing three consecutive markers between the S and TFIIH loci in the class I region. Furthermore, one of the markers within the candidate region showed the highest delta value, indicating the strongest association. Of 20 Korean patients with diffuse panbronchiolitis, 17 also shared the combination of the disease-associated marker alleles within the candidate region. These results indicate that an HLA-associated major susceptibility gene for diffuse panbronchiolitis is probably located within the 200 kb in the class I region 300 kb telomeric of the HLA-B locus on the chromosome 6p21.3.	Univ Tokyo, Grad Sch Med, Dept Resp Med, Bunkyo Ku, Tokyo 1138655, Japan; Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo 1138655, Japan; Nippon Med Sch, Dept Internal Med 4, Tokyo 113, Japan; Nippon Med Sch, Inst Gerontol, Dept Mol Biol, Tokyo 113, Japan; Toranomon Gen Hosp, Div Resp Dis, Tokyo, Japan; Tokai Univ, Sch Med, Dept Genet Informat, Div Mol Life Sci, Kanagawa 2591100, Japan; Tenri Hosp, Dept Resp Med, Nara, Japan; Seoul Natl Univ, Coll Med, Dept Clin Pathol, Seoul, South Korea	University of Tokyo; University of Tokyo; Nippon Medical School; Nippon Medical School; Toranomon Hospital; Tokai University; Tenri Hospital; Seoul National University (SNU)	Keicho, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Resp Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.		Keicho, Naoto/GQZ-0301-2022; OHASHI, JUN/G-5907-2015	Azuma, Arata/0000-0003-0506-9966; Keicho, Naoto/0000-0001-8232-9448; Tamiya, Gen/0000-0002-0597-415X				Bannai M, 1997, TISSUE ANTIGENS, V49, P376, DOI 10.1111/j.1399-0039.1997.tb02765.x; BENGTSSON BO, 1981, TISSUE ANTIGENS, V18, P356, DOI 10.1111/j.1399-0039.1981.tb01404.x; Chu Ya-Chiung, 1992, Journal of the Formosan Medical Association, V91, P912; Corne J, 1996, LANCET, V348, P1465, DOI 10.1016/S0140-6736(05)65888-6; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; FRASER RG, 1990, DIAGNOSIS DIS CHEST, V3, P2224; GERAGHTY DE, 1992, HUM IMMUNOL, V33, P174, DOI 10.1016/0198-8859(92)90069-Y; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; HOIBY N, 1994, THORAX, V49, P531, DOI 10.1136/thx.49.6.531; HOMMA H, 1983, CHEST, V83, P63, DOI 10.1378/chest.83.1.63; Imanish T, 1992, HLA 1991, V1, P1065; Keicho N, 1998, AM J RESP CRIT CARE, V158, P846, DOI 10.1164/ajrccm.158.3.9712125; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KIM YW, 1992, INTERNAL MED, V31, P695, DOI 10.2169/internalmedicine.31.695; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Park MH, 1999, AM J RESP CRIT CARE, V159, P526, DOI 10.1164/ajrccm.159.2.9805047; Park MH, 1998, TISSUE ANTIGENS, V51, P347; Sasazuki T., 1992, HLA 1991, P76; SUGIYAMA Y, 1990, AM REV RESPIR DIS, V141, P1459, DOI 10.1164/ajrccm/141.6.1459; Tamiya G, 1999, TISSUE ANTIGENS, V54, P221, DOI 10.1034/j.1399-0039.1999.540302.x; Tamiya G, 1998, TISSUE ANTIGENS, V51, P337; Tokunaga K, 1996, PREHISTORIC MONGOLOI, P187; Tsang KWT, 1998, THORAX, V53, P274, DOI 10.1136/thx.53.4.274	24	52	57	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					501	507		10.1086/302786	http://dx.doi.org/10.1086/302786			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677310	Bronze, Green Published			2022-12-18	WOS:000088373100017
J	Anderson, CL; Brown, CJ				Anderson, CL; Brown, CJ			Polymorphic X-chromosome inactivation of the human TIMP1 gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AGE-RELATED REACTIVATION; LINKED GENE; BIOLOGICAL FUNCTIONS; DOSAGE COMPENSATION; FEMALE MAMMALS; SYNAPSIN-I; XIST GENE; SMCX GENE; EXPRESSION; MOUSE	X inactivation silences most but not all of the genes on one of the two X chromosomes in mammalian females. The human X chromosome preserves its activation status when isolated in rodent/human somatic-cell hybrids, and hybrids retaining either the active or inactive X chromosome have been used to assess the inactivation status of many X-linked genes. Surprisingly, the X-linked gene for human tissue inhibitor of metalloproteinases (TIMP1) is expressed in some but not all inactive X-containing somatic-cell hybrids, suggesting that this gene is either prone to reactivation or variable in its inactivation. Since many genes that escape X inactivation are clustered, we examined the expression of four genes (ARAF1, ELK1, ZNF41, and ZNF157) within similar to 100 kb of TIMP1. All four genes were expressed only from the active X chromosome, demonstrating that the factors allowing TIMP1 expression from the inactive X chromosome are specific to the TIMP1 gene. To determine if this variable inactivation of TIMP1 is a function of the hybrid-cell environment or also is observed in human cells, we developed an allele-specific assay to assess TIMP1 expression in human females. Expression of two alleles was detected in some female cells with previously demonstrated extreme skewing of X inactivation, indicating TIMP1 expression from the inactive chromosome. However, in other cells, no expression of TIMP1 was observed from the inactive X chromosome, suggesting that TIMP1 inactivation is polymorphic in human females.	Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Brown, CJ (corresponding author), Room 222,6174 Univ Blvd, Vancouver, BC V6T 1Z3, Canada.		Brown, Carolyn J/A-5159-2014	Brown, Carolyn J/0000-0002-8959-0101				ALLEN RC, 1992, AM J HUM GENET, V51, P1229; [Anonymous], ADV DEV BIO; Brandau O, 1998, EUR J HUM GENET, V6, P459, DOI 10.1038/sj.ejhg.5200207; BROWN CJ, 1991, NATURE, V349, P82, DOI 10.1038/349082a0; BROWN CJ, 1989, AM J HUM GENET, V45, P592; BROWN CJ, 1990, NUCLEIC ACIDS RES, V18, P4191, DOI 10.1093/nar/18.14.4191; Brown CJ, 1997, AM J HUM GENET, V60, P1333, DOI 10.1086/515488; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; BROWN S, 1988, GENET RES, V52, P151, DOI 10.1017/S0016672300027531; Carrel L, 1996, HUM MOL GENET, V5, P1361, DOI 10.1093/hmg/5.9.1361; Carrel L, 1999, P NATL ACAD SCI USA, V96, P7364, DOI 10.1073/pnas.96.13.7364; Carrel L, 1996, AM J MED GENET, V64, P27, DOI 10.1002/(SICI)1096-8628(19960712)64:1<27::AID-AJMG3>3.0.CO;2-O; CATTANACH BM, 1974, GENET RES, V23, P291, DOI 10.1017/S0016672300014932; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COLEMAN MP, 1994, GENOMICS, V21, P337, DOI 10.1006/geno.1994.1274; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; DAVIDSON RG, 1963, P NATL ACAD SCI USA, V50, P481, DOI 10.1073/pnas.50.3.481; DENHARDT DT, 1993, PHARMACOL THERAPEUT, V59, P329, DOI 10.1016/0163-7258(93)90074-N; DERRY JMJ, 1992, GENOMICS, V12, P632, DOI 10.1016/0888-7543(92)90286-2; DERRY JMJ, 1995, GENOMICS, V30, P361, DOI 10.1006/geno.1995.0031; DISTECHE CM, 1995, TRENDS GENET, V11, P17, DOI 10.1016/S0168-9525(00)88981-7; DUNCAN AM, 1993, AM J MED GENET, V47, P1151; ELLIS N, 1987, SOMAT CELL MOLEC GEN, V13, P191, DOI 10.1007/BF01535202; Esposito T, 1997, GENOMICS, V43, P183, DOI 10.1006/geno.1997.4797; FISHER EMC, 1990, CELL, V63, P1205, DOI 10.1016/0092-8674(90)90416-C; GARTLER SM, 1994, DEV GENET, V15, P504, DOI 10.1002/dvg.1020150609; Giannoukakis N, 1996, BIOCHEM BIOPH RES CO, V220, P1014, DOI 10.1006/bbrc.1996.0524; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; HANSEN RS, 1988, MOL CELL BIOL, V8, P4692, DOI 10.1128/MCB.8.11.4692; Hardcastle AJ, 1997, INVEST OPHTH VIS SCI, V38, P1893; Hardcastle AJ, 1998, INVEST OPHTH VIS SCI, V39, P219; JEPPESEN P, 1993, CELL, V74, P281, DOI 10.1016/0092-8674(93)90419-Q; JINNO Y, 1995, NAT GENET, V10, P318, DOI 10.1038/ng0795-318; KAHAN B, 1975, P NATL ACAD SCI USA, V72, P1510, DOI 10.1073/pnas.72.4.1510; KASLOW DC, 1987, P NATL ACAD SCI USA, V84, P6210, DOI 10.1073/pnas.84.17.6210; KNIGHT JC, 1994, GENOMICS, V21, P180, DOI 10.1006/geno.1994.1240; LEPPIG KA, 1993, HUM MOL GENET, V2, P883, DOI 10.1093/hmg/2.7.883; LINDER D, 1965, SCIENCE, V150, P67, DOI 10.1126/science.150.3692.67; Lingenfelter PA, 1998, NAT GENET, V18, P212, DOI 10.1038/ng0398-212; LYON MF, 1962, AM J HUM GENET, V14, P135; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MIGEON BR, 1982, NATURE, V299, P838, DOI 10.1038/299838a0; MIGEON BR, 1972, NATURE, V239, P87, DOI 10.1038/239087a0; MIGEON BR, 1985, P NATL ACAD SCI USA, V82, P3390, DOI 10.1073/pnas.82.10.3390; MIGEON BR, 1988, AM J HUM GENET, V42, P742; MIGEON BR, 1988, NATURE, V335, P93, DOI 10.1038/335093a0; Milleding P, 1998, INT J PROSTHODONT, V11, P21; OHLSSON R, 1994, DEVELOPMENT, V120, P361; Plenge RM, 1997, NAT GENET, V17, P353, DOI 10.1038/ng1197-353; Rupert JL, 1995, EUR J HUM GENET, V3, P333; SCHEMPP W, 1983, HUM GENET, V63, P171, DOI 10.1007/BF00291539; SCHNEIDERGADICKE A, 1989, CELL, V57, P1247, DOI 10.1016/0092-8674(89)90061-5; Sheardown S, 1996, HUM MOL GENET, V5, P1355, DOI 10.1093/hmg/5.9.1355; Tilghman SM, 1995, CHROMATIN STRUCTURE, P197; WAREHAM KA, 1987, NATURE, V327, P725, DOI 10.1038/327725a0; WILLARD HF, 1993, COLD SPRING HARB SYM, V58, P315, DOI 10.1101/SQB.1993.058.01.037; YANGFENG TL, 1986, P NATL ACAD SCI USA, V83, P8679, DOI 10.1073/pnas.83.22.8679	57	52	53	1	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					699	708		10.1086/302556	http://dx.doi.org/10.1086/302556			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441576	Green Published, Bronze			2022-12-18	WOS:000082426400014
J	Liu, YF; Bjorkman, J; Urquhart, A; Wanders, RJA; Crane, DI; Gould, SJ				Liu, YF; Bjorkman, J; Urquhart, A; Wanders, RJA; Crane, DI; Gould, SJ			PEX13 is mutated in complementation group 13 of the peroxisome-biogenesis disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RHIZOMELIC CHONDRODYSPLASIA PUNCTATA; ZELLWEGER-SYNDROME; PTS1 RECEPTOR; MEMBRANE-PROTEIN; PICHIA-PASTORIS; SACCHAROMYCES-CEREVISIAE; TARGETING SIGNAL; REFSUM-DISEASE; COMMON-CAUSE; GENE	The peroxisome-biogenesis disorders (PBDs) are a genetically and phenotypically diverse group of diseases caused by defects in peroxisome assembly. One of the milder clinical variants within the PBDs is neonatal adrenoleukodystrophy (NALD), a disease that is usually associated with partial defects in the import of peroxisomal matrix proteins that carry the type 1 or type 2 peroxisomal targeting signals. Here, we characterize the sole representative of complementation group 13 of the PBDs, a patient with NALD (patient PBD222). Skin fibroblasts from patient PBD222 display defects in the import of multiple peroxisomal matrix proteins. However, residual matrix-protein import can be detected in cells from patient PBD222, consistent with the relatively mild phenotypes of the patient. PEX13 encodes a peroxisomal membrane protein with a cytoplasmically exposed SH3 domain, and we find that expression of human PEX13 restores peroxisomal matrix-protein import in cells from patient PBD222. Furthermore, these cells are homozygous for a missense mutation at a conserved position in the PEX13 SH3 domain. This mutation attenuated the activity of human PEX13, and an analogous mutation in yeast PEX13 also reduced its activity. The mutation was absent in >100 control alleles, indicating that it is not a common polymorphism. previous studies have demonstrated extragenic suppression in the PBDs, but the phenotypes of patient PBD222 cells could not be rescued by expression of any other human PEX genes. Taken together, these results provide strong evidence that mutations in PEX13 are responsible for disease in patient PBD222 and, by extension, in complementation group 13 of the PBDs.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Griffith Univ, Sch Biomol & Biomed Sci, Nathan, Qld 4111, Australia; Univ Amsterdam, Acad Med Ctr, Dept Clin Biochem, NL-1105 AZ Amsterdam, Netherlands; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA	Johns Hopkins University; Griffith University; University of Amsterdam; Academic Medical Center Amsterdam; Johns Hopkins University	Gould, SJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.		Crane, Denis I/A-7887-2011	Crane, Denis I/0000-0002-5696-1906	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD010981] Funding Source: NIH RePORTER; NICHD NIH HHS [HD10981] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; BELL GI, 1986, NUCLEIC ACIDS RES, V14, P5561; Bjorkman J, 1998, GENOMICS, V54, P521, DOI 10.1006/geno.1998.5520; BRAUN A, 1994, GENE, V146, P291, DOI 10.1016/0378-1119(94)90308-5; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; Chang CC, 1998, AM J HUM GENET, V63, P1294, DOI 10.1086/302103; Chang CC, 1999, J CELL SCI, V112, P1579; Chang CC, 1997, NAT GENET, V15, P385, DOI 10.1038/ng0497-385; Collins CS, 1999, HUM MUTAT, V14, P45, DOI 10.1002/(SICI)1098-1004(1999)14:1<45::AID-HUMU6>3.3.CO;2-A; CRANE DI, 1994, J BIOL CHEM, V269, P21835; CRANE DI, 1994, CURR GENET, V26, P443, DOI 10.1007/BF00309932; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Elgersma Y, 1996, J CELL BIOL, V135, P97, DOI 10.1083/jcb.135.1.97; Erdmann R, 1996, J CELL BIOL, V135, P111, DOI 10.1083/jcb.135.1.111; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Fransen M, 1998, P NATL ACAD SCI USA, V95, P8087, DOI 10.1073/pnas.95.14.8087; Fukuda S, 1996, AM J HUM GENET, V59, P1210; GARTNER J, 1992, NAT GENET, V1, P16, DOI 10.1038/ng0492-16; Geisbrecht BV, 1998, P NATL ACAD SCI USA, V95, P8630, DOI 10.1073/pnas.95.15.8630; Geisbrecht BV, 1999, J BIOL CHEM, V274, P21797, DOI 10.1074/jbc.274.31.21797; Girzalsky W, 1999, J CELL BIOL, V144, P1151, DOI 10.1083/jcb.144.6.1151; GOULD SJ, 1990, J CELL BIOL, V110, P27, DOI 10.1083/jcb.110.1.27; GOULD SJ, 1992, YEAST, V8, P613, DOI 10.1002/yea.320080805; Gould SJ, 1996, J CELL BIOL, V135, P85, DOI 10.1083/jcb.135.1.85; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Honsho M, 1998, AM J HUM GENET, V63, P1622, DOI 10.1086/302161; Huhse B, 1998, J CELL BIOL, V140, P49, DOI 10.1083/jcb.140.1.49; Jones JM, 1999, J BIOL CHEM, V274, P9216, DOI 10.1074/jbc.274.14.9216; KAMIJO K, 1990, J BIOL CHEM, V265, P4534; Kammerer S, 1998, FEBS LETT, V429, P53, DOI 10.1016/S0014-5793(98)00557-2; KOZAK M, 1992, ANNU REV CELL BIOL, V8, P197, DOI 10.1146/annurev.cb.08.110192.001213; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; Kunau WH, 1998, CURR BIOL, V8, pR299, DOI 10.1016/S0960-9822(98)70191-5; Lazarow P. B., 1995, METABOLIC MOL BASES, P2287; LAZAROW PB, 1982, ANN NY ACAD SCI, V386, P285, DOI 10.1111/j.1749-6632.1982.tb21423.x; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; Matsuzono Y, 1999, P NATL ACAD SCI USA, V96, P2116, DOI 10.1073/pnas.96.5.2116; Mihalik SJ, 1997, NAT GENET, V17, P185, DOI 10.1038/ng1097-185; Motley AM, 1997, NAT GENET, V15, P377, DOI 10.1038/ng0497-377; MUSACCHIO A, 1994, NAT STRUCT BIOL, V1, P546, DOI 10.1038/nsb0894-546; Okumoto K, 1998, HUM MOL GENET, V7, P1399, DOI 10.1093/hmg/7.9.1399; Okumoto K, 1998, MOL CELL BIOL, V18, P4324, DOI 10.1128/MCB.18.7.4324; Porter TL, 1997, RRD POLYM SCI, V1, P1; Purdue PE, 1997, NAT GENET, V15, P381, DOI 10.1038/ng0497-381; Purdue PE, 1996, J CELL BIOL, V134, P849, DOI 10.1083/jcb.134.4.849; Reuber BE, 1997, NAT GENET, V17, P445, DOI 10.1038/ng1297-445; SANTOS MJ, 1988, SCIENCE, V239, P1536, DOI 10.1126/science.3281254; Schrader M, 1998, J BIOL CHEM, V273, P29607, DOI 10.1074/jbc.273.45.29607; Shimozawa N, 1998, BIOCHEM BIOPH RES CO, V243, P368, DOI 10.1006/bbrc.1997.8067; SHIMOZAWA N, 1992, SCIENCE, V255, P1132, DOI 10.1126/science.1546315; South ST, 1999, J CELL BIOL, V144, P255, DOI 10.1083/jcb.144.2.255; SUBRAMANI S, 1993, ANNU REV CELL BIOL, V9, P445, DOI 10.1146/annurev.cb.09.110193.002305; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; Warren DS, 1998, AM J HUM GENET, V63, P347, DOI 10.1086/301963; Yahraus T, 1996, EMBO J, V15, P2914, DOI 10.1002/j.1460-2075.1996.tb00654.x	57	52	54	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					621	634		10.1086/302534	http://dx.doi.org/10.1086/302534			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441568	Bronze, Green Published			2022-12-18	WOS:000082426400006
J	Kaukonen, J; Zeviani, M; Comi, GP; Piscaglia, MG; Peltonen, L; Suomalainen, A				Kaukonen, J; Zeviani, M; Comi, GP; Piscaglia, MG; Peltonen, L; Suomalainen, A			A third locus predisposing to multiple deletions of mtDNA in autosomal dominant progressive external ophthalmoplegia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							ADENINE-NUCLEOTIDE TRANSLOCATOR; MITOCHONDRIAL-DNA; WOLFRAM-SYNDROME; LINKAGE ANALYSIS; GENE; MYOPATHY; DISEASE; GENOME		Natl Publ Hlth Inst, Dept Human Mol Genet, SF-00300 Helsinki, Finland; Univ Milan, Inst Ric & Cura Carattere Sci, Osped Maggiore Policlin,Natl Neurol Inst Carlo Be, Ist Clin Neurol,Div Biochem & Genet, Milan, Italy; Univ Milan, Inst Ric & Cura Carattere Sci, Osped Maggiore Policlin, Ist Clin Neurol,Ctr Dino Ferrari, Milan, Italy; Osped Infermi, Div Neurol, Rimini, Italy	Finland National Institute for Health & Welfare; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Hospital of Rimini	Kaukonen, J (corresponding author), Natl Publ Hlth Inst, Dept Human Mol Genet, Mannerheimintie 166, SF-00300 Helsinki, Finland.		Zeviani, Massimo/AAU-2632-2021; Comi, Giacomo P/K-5702-2016; Zeviani, Massimo/K-2891-2014	Zeviani, Massimo/0000-0002-9067-5508; Comi, Giacomo P/0000-0002-1383-5248; Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195				Barrientos A, 1996, AM J HUM GENET, V58, P963; Barrientos A, 1996, J CLIN INVEST, V97, P1570, DOI 10.1172/JCI118581; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FAN YS, 1992, CYTOGENET CELL GENET, V60, P29, DOI 10.1159/000133288; Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226; Hirano M, 1998, AM J HUM GENET, V63, P526, DOI 10.1086/301979; Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441; Kaukonen JA, 1996, AM J HUM GENET, V58, P763; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Melberg A, 1996, MUSCLE NERVE, V19, P751; Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; POLYMEROPOULOS MH, 1994, NAT GENET, V8, P95, DOI 10.1038/ng0994-95; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053; Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244; SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856; SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146; Weeks DE., 1990, AM J HUM GENET, V47, pA203; Wijmenga C, 1990, LANCET, V336, P651, DOI 10.1016/0140-6736(90)92148-B; ZEVIANI M, 1988, NEUROLOGY, V38, P1339; ZEVIANI M, 1990, AM J HUM GENET, V47, P904; ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0	24	52	52	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1999	65	1					256	261		10.1086/302445	http://dx.doi.org/10.1086/302445			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	212NZ	10364542	Green Published, Bronze			2022-12-18	WOS:000081224300034
J	Mohammad-Panah, R; Demolombe, S; Neyroud, N; Guicheney, P; Kyndt, F; van den Hoff, M; Baro, I; Escande, D				Mohammad-Panah, R; Demolombe, S; Neyroud, N; Guicheney, P; Kyndt, F; van den Hoff, M; Baro, I; Escande, D			Mutations in a dominant-negative isoform correlate with phenotype in inherited cardiac arrhythmias	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LONG-QT SYNDROME; POTASSIUM CHANNEL GENE; LANGE-NIELSEN-SYNDROME; KVLQT1 CAUSES; ROMANO-WARD; RECEPTOR; JERVELL; FORM; ISK; MECHANISMS	The long QT syndrome is characterized by prolonged cardiac repolarization and a high risk of sudden death. Mutations in the KCNQ1 gene, which encodes the cardiac KvLQT1 potassium ion (KC) channel, cause both the autosomal dominant Romano-Ward (RW) syndrome and the recessive Jervell and Lange-Nielsen (JLN) syndrome. JLN presents with cardiac arrhythmias and congenital deafness, and heterozygous carriers of JLN mutations exhibit a very mild cardiac phenotype. Despite the phenotypic differences between heterozygotes with RW and those with JLN mutations, both classes of variant protein fail to produce K+ currents in cultured cells. We have shown that an N-terminus-truncated KvLQT1 isoform endogenously expressed in the human heart exerts strong dominant-negative effects on the full-length KvLQT1 protein. Because RW and JLN mutations concern both truncated and full-length KvLQT1 isoforms, we investigated whether RW or JLN mutations would have different impacts on the dominant-negative properties of the truncated KvLQT1 splice variant. In a mammalian expression system, we found that JLN, but not RW, mutations suppress the dominant-negative effects of the truncated KvLQT1. Thus, in JLN heterozygous carriers, the full-length KvLQT1 protein encoded by the unaffected allele should not be subject to the negative influence of the mutated truncated isoform, leaving some cardiac K+ current available for repolarization. This is the first report of a genetic disease in which the impact of a mutation on a dominant-negative isoform correlates with the phenotype.	Grp Hosp Pitie Salpetriere, Inst Mycol, INSERM, U153, F-75634 Paris, France; Univ Amsterdam, Acad Med Ctr, Dept Anat & Embryol, NL-1105 AZ Amsterdam, Netherlands; Hop Hotel Dieu, INSERM, Lab Physiopathol & Pharmacol Cellulaires & Mol, CJF9601, F-44093 Nantes, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Amsterdam; Academic Medical Center Amsterdam; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Escande, D (corresponding author), Hop Hotel Dieu, INSERM, Lab Physiopathol & Pharmacol Cellulaires & Mol, CJF9601, Bat HBN,BP 1005, F-44093 Nantes, France.		Baró, Isabelle/D-3604-2015; KYNDT, Florence/D-6370-2015; Neyroud, Nathalie/D-1013-2017; Baró, Isabelle/ABH-5667-2020; Guicheney, Pascale/D-1034-2017	Baró, Isabelle/0000-0003-4850-4171; KYNDT, Florence/0000-0001-6651-1696; Neyroud, Nathalie/0000-0003-3382-7680; Baró, Isabelle/0000-0003-4850-4171; Guicheney, Pascale/0000-0002-7663-2050; van den Hoff, Maurice/0000-0002-3837-8055				Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Chouabe C, 1997, EMBO J, V16, P5472, DOI 10.1093/emboj/16.17.5472; Demolombe S, 1998, J BIOL CHEM, V273, P6837, DOI 10.1074/jbc.273.12.6837; Donger C, 1997, CIRCULATION, V96, P2778, DOI 10.1161/01.CIR.96.9.2778; Duggal P, 1998, CIRCULATION, V97, P142, DOI 10.1161/01.CIR.97.2.142; Ebihara K, 1996, MOL CELL BIOL, V16, P3393; FRASER GR, 1964, ANN HUM GENET, V28, P133, DOI 10.1111/j.1469-1809.1964.tb00469.x; Jiang M, 1997, J BIOL CHEM, V272, P24109, DOI 10.1074/jbc.272.39.24109; Li H, 1998, CIRCULATION, V97, P1264, DOI 10.1161/01.CIR.97.13.1264; Mohammad-Panah R, 1998, AM J PHYSIOL-CELL PH, V274, pC310, DOI 10.1152/ajpcell.1998.274.2.C310; Neyroud N, 1998, EUR J HUM GENET, V6, P129, DOI 10.1038/sj.ejhg.5200165; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; Oakley RH, 1997, ENDOCRINOLOGY, V138, P5028, DOI 10.1210/en.138.11.5028; Patel BKR, 1998, P NATL ACAD SCI USA, V95, P172, DOI 10.1073/pnas.95.1.172; Roden DM, 1996, CIRCULATION, V94, P1996, DOI 10.1161/01.CIR.94.8.1996; Ross RJM, 1997, MOL ENDOCRINOL, V11, P265, DOI 10.1210/me.11.3.265; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; SchulzeBahr E, 1997, HUM GENET, V100, P573, DOI 10.1007/s004390050554; Shalaby FY, 1997, CIRCULATION, V96, P1733, DOI 10.1161/01.CIR.96.6.1733; Tyson J, 1997, HUM MOL GENET, V6, P2179, DOI 10.1093/hmg/6.12.2179; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; WANG YL, 1991, MOL ENDOCRINOL, V5, P1707, DOI 10.1210/mend-5-11-1707; Wollnik B, 1997, HUM MOL GENET, V6, P1943, DOI 10.1093/hmg/6.11.1943; Zhu XG, 1997, ENDOCRINOLOGY, V138, P1456, DOI 10.1210/en.138.4.1456	24	52	54	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					1015	1023		10.1086/302346	http://dx.doi.org/10.1086/302346			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	10090886	Green Published, Bronze			2022-12-18	WOS:000079632900012
J	Speer, MC; Vance, JM; Grubber, JM; Graham, FL; Stajich, JM; Viles, KD; Rogala, A; McMichael, R; Chutkow, J; Goldsmith, C; Tim, RW; Pericak-Vance, MA				Speer, MC; Vance, JM; Grubber, JM; Graham, FL; Stajich, JM; Viles, KD; Rogala, A; McMichael, R; Chutkow, J; Goldsmith, C; Tim, RW; Pericak-Vance, MA			Identification of a new autosomal dominant limb-girdle muscular dystrophy locus on chromosome 7	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROPOSED LINKAGE; HETEROGENEITY; SARCOGLYCAN; MUTATIONS; COMPLEX; POWER; GENE; MAPS; FORM	We report the identification of a new locus for autosomal dominant limb-girdle muscular dystrophy (LGMD1) on 7q. Two of five families (1047 and 1701) demonstrate evidence in favor of linkage to this region. The maximum two-point LOD score for family 1047 was 3.76 for D7S427, and that for family 1701 was 2.63 for D7S3058, Flanking markers place the LGMD1 locus between D7S2423 and D7S427, with multipoint analysis slightly favoring the 9-cM interval spanned by D7S2546 and D7S2423. Three of five families appear to be unlinked to this new locus on chromosome 7, thus establishing further heterogeneity within the LGMD1 diagnostic classification.	Duke Univ, Med Ctr, Durham, NC 27710 USA; Univ Texas, SW Med Ctr, Dallas, TX USA; SUNY Buffalo, Buffalo, NY 14260 USA; Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada	Duke University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Ottawa; Children's Hospital of Eastern Ontario	Speer, MC (corresponding author), Duke Univ, Med Ctr, Box 3455, Durham, NC 27710 USA.			Vance, Jeffery/0000-0003-3815-8199	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS026630] Funding Source: NIH RePORTER; NINDS NIH HHS [NS26630] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BASHIR R, 1994, HUM MOL GENET, V3, P455, DOI 10.1093/hmg/3.3.455; BECKMANN JS, 1991, CR ACAD SCI III-VIE, V312, P141; BOEHNKE M, 1986, AM J HUM GENET, V39, P513; BONNEMANN CG, 1995, NAT GENET, V11, P266, DOI 10.1038/ng1195-266; CHURKOW JG, 1986, ANN NEUROL, V20, P240; GILCHRIST JM, 1988, NEUROLOGY, V38, P5, DOI 10.1212/WNL.38.1.5; Haynes C., 1995, American Journal of Human Genetics, V57, pA193; JACKSON CE, 1968, PEDIATRICS, V41, P495; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; McNally EM, 1998, HUM MOL GENET, V7, P871, DOI 10.1093/hmg/7.5.871; Messina DN, 1997, AM J HUM GENET, V61, P909, DOI 10.1086/514896; Minetti C, 1998, NAT GENET, V18, P365, DOI 10.1038/ng0498-365; Moreira ES, 1997, AM J HUM GENET, V61, P151, DOI 10.1086/513889; MORTON NE, 1959, AM J HUM GENET, V11, P360; NOGUCHI S, 1995, SCIENCE, V270, P819, DOI 10.1126/science.270.5237.819; Ott J., 1991, ANAL HUMAN GENETIC L; PLOUGHMAN LM, 1989, AM J HUM GENET, V44, P543; SCHNEIDERMAN LJ, 1969, AM J MED, V46, P380, DOI 10.1016/0002-9343(69)90040-0; SHOKEIR MHK, 1976, CLIN GENET, V9, P197; SPEER MC, 1992, AM J HUM GENET, V50, P1211; SPEER MC, 1995, AM J HUM GENET, V57, P1371; VANCE JM, 1998, DESIGN IMPLEMENTATIO; vanderKooi AJ, 1997, AM J HUM GENET, V60, P891; WEEKS DE, 1995, AM J HUM GENET, V56, P1506; YATES JRW, 1985, J MED GENET, V22, P250, DOI 10.1136/jmg.22.4.250	25	52	53	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					556	562		10.1086/302252	http://dx.doi.org/10.1086/302252			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973293	Bronze, Green Published			2022-12-18	WOS:000078740600025
J	Juengst, ET				Juengst, ET			Group identity and human diversity: Keeping biology straight from culture	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material									Case Western Reserve Univ, Ctr Biomed Eth, Cleveland, OH 44106 USA	Case Western Reserve University	Juengst, ET (corresponding author), Case Western Reserve Univ, Ctr Biomed Eth, 10900 Euclid Ave, Cleveland, OH 44106 USA.			Juengst, Eric/0000-0002-8374-5774				Barbujani G, 1997, AM J HUM GENET, V61, P1011, DOI 10.1086/301620; CAPLAN AL, 1994, JUSTICE HUMAN GENOME, P30; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; EDLIN GJ, 1987, PERSPECT BIOL MED, V31, P47; Foster MW, 1997, NAT GENET, V17, P277, DOI 10.1038/ng1197-277; GILMOUR JS, 1939, NATURE, V144, P33; Hall Andrew J, 1989, IRB, V11, P8, DOI 10.2307/3564470; Haller John S., 1971, OUTCASTS EVOLUTION S; KNOPPERS B, 1996, GENOMICS, V34, P271; Marks J., 1995, HUMAN BIODIVERSITY G; MOORE JH, 1996, CULT SURVIVAL, V20, P60; *N AM REG COMM HUM, 1995, MOD ETH PROT COLL DN; *NAT RES COUNC COM, 1997, EV HUM GEN DIV; Petersen W, 1980, HARVARD ENCY AM ETHN, P234; RECER P, 1996, CLEVELAND PLAIN 0114, pF5; WELLS JV, 1995, WILDLIFE SOC B, V23, P458; [No title captured]	17	52	52	0	3	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1998	63	3					673	677		10.1086/302032	http://dx.doi.org/10.1086/302032			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	119VN	9718361	Green Published, Bronze			2022-12-18	WOS:000075919000001
J	Allayee, H; Aouizerat, BE; Cantor, RM; Dallinga-Thie, GM; Krauss, RM; Lanning, CD; Rotter, JI; Lusis, AJ; de Bruin, TWA				Allayee, H; Aouizerat, BE; Cantor, RM; Dallinga-Thie, GM; Krauss, RM; Lanning, CD; Rotter, JI; Lusis, AJ; de Bruin, TWA			Families with familial combined hyperlipidemia and families enriched for coronary artery disease share genetic determinants for the atherogenic lipoprotein phenotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX SEGREGATION ANALYSIS; SERUM TRIGLYCERIDE LEVELS; SUBCLASS PATTERNS; APOLIPOPROTEIN-B; COMBINED HYPERLIPEMIA; STABLE ISOTOPES; HEART-DISEASE; PARTICLE-SIZE; DENSITY; SUSCEPTIBILITY	Small, dense LDL particles consistently have been associated with hypertriglyceridemia, premature coronary artery disease (CAD), and familial combined hyperlipidemia (FCH). previously, we have observed linkage of LDL particle size with four separate candidate-gene loci in a study of families enriched for CAD. These loci contain the genes for manganese superoxide dismutase (MnSOD), on chromosome 6q; for apolipoprotein AI-CIII-AIV, on chromosome 11q; for cholesteryl ester transfer protein (CETP) and lecithin:cholesterol acyltransferase (LCAT), on chromosome 16q; and for the LDL receptor (LDLR), on chromosome 19p. We have now tested whether these loci also contribute to LDL particle size in families ascertained for FCH. The members of 18 families (481 individuals) were typed for genetic markers at the four loci, and linkage to LDL particle size was assessed by nonparametric sib-pair linkage analysis. The presence of small, dense LDL (pattern B) was much more frequent in the FCH probands (39%) than in the spouse controls (4%). Evidence for linkage was observed at the MnSOD (P = .02), CETP/LCAT (P = .03), and apolipoprotein AI-CIII-AIV loci (P = .005) but not at the LDLR locus. We conclude that there is a genetically based association between FCH and small, dense LDL and that the genetic determinants for LDL particle size are shared, at least in part, among FCH families and the more general population at risk for CAD.	Univ Calif Los Angeles, Dept Microbiol & Mol Genet, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; Cedars Sinai Res Inst, Dept Med, Div Med Genet, Los Angeles, CA USA; Cedars Sinai Res Inst, Dept Pediat, Los Angeles, CA USA; Univ Utrecht Hosp, Dept Med, Utrecht, Netherlands; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; Univ Hosp Maastricht, Dept Med, Maastricht, Netherlands; Univ Hosp Maastricht, Dept Endocrinol, Maastricht, Netherlands	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Utrecht University; Utrecht University Medical Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC)	Lusis, AJ (corresponding author), Univ Calif Los Angeles, Sch Med, Ctr Hlth Sci, Dept Med,Div Cardiol 47 123, Los Angeles, CA 90095 USA.			dallinga-thie, geesje/0000-0001-5412-5923	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028481, P01HL018574] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR03655] Funding Source: Medline; NHLBI NIH HHS [HL 18574, HL-28481] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AMOS CI, 1989, GENET EPIDEMIOL, V6, P435, DOI 10.1002/gepi.1370060306; AUSTIN MA, 1988, AM J HUM GENET, V43, P838; AUSTIN MA, 1990, ARTERIOSCLEROSIS, V10, P520, DOI 10.1161/01.ATV.10.4.520; AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917; AUSTIN MA, 1990, CIRCULATION, V82, P495, DOI 10.1161/01.CIR.82.2.495; Bredie SJH, 1996, AM J HUM GENET, V58, P812; Bredie SJH, 1997, EUR J CLIN INVEST, V27, P802, DOI 10.1046/j.1365-2362.1997.1850734.x; BRUNZELL JD, 1983, J LIPID RES, V24, P147; CABEZAS MC, 1993, J CLIN INVEST, V92, P160, DOI 10.1172/JCI116544; CORTNER JA, 1991, J INHERIT METAB DIS, V14, P915, DOI 10.1007/BF01800473; CULLEN P, 1994, ARTERIOSCLER THROMB, V14, P1233, DOI 10.1161/01.ATV.14.8.1233; DallingaThie GM, 1996, J LIPID RES, V37, P136; DallingaThie GM, 1997, J CLIN INVEST, V99, P953, DOI 10.1172/JCI119260; DEGRAAF J, 1991, ARTERIOSCLER THROMB, V11, P298, DOI 10.1161/01.ATV.11.2.298; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; GRUNDY SM, 1987, ARTERIOSCLEROSIS, V7, P203; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; JARVIK GP, 1994, ARTERIOSCLER THROMB, V14, P1687, DOI 10.1161/01.ATV.14.11.1687; Kwiterovich Peter O. Jr., 1993, Current Opinion in Lipidology, V4, P133, DOI 10.1097/00041433-199304000-00009; Naggert JK, 1997, CLIN GENET, V51, P236; NICHOLS AV, 1986, METHOD ENZYMOL, V128, P417; NISHINA PM, 1992, P NATL ACAD SCI USA, V89, P708, DOI 10.1073/pnas.89.2.708; Rotter JI, 1996, AM J HUM GENET, V58, P585; *SAGE, 1997, STAT AN GEN EP VER 3; SAKAI N, 1995, ATHEROSCLEROSIS, V114, P139, DOI 10.1016/0021-9150(94)05477-Z; SKRETTING G, 1992, BIOCHEM BIOPH RES CO, V182, P583, DOI 10.1016/0006-291X(92)91772-I; SNIDERMAN A, 1980, P NATL ACAD SCI-BIOL, V77, P604, DOI 10.1073/pnas.77.1.604; TALL AR, 1986, J LIPID RES, V27, P361; TRIBBLE DL, 1992, ATHEROSCLEROSIS, V93, P189, DOI 10.1016/0021-9150(92)90255-F; VENKATESAN S, 1993, ARTERIOSCLER THROMB, V13, P1110, DOI 10.1161/01.ATV.13.7.1110; WALTER MA, 1994, NAT GENET, V7, P22, DOI 10.1038/ng0594-22; Weinstock PH, 1997, J LIPID RES, V38, P1782; WILLIAMS WR, 1982, HUM HERED, V32, P24, DOI 10.1159/000153254; WOJCIECHOWSKI AP, 1991, NATURE, V349, P161, DOI 10.1038/349161a0; WONG GHW, 1989, CELL, V58, P923, DOI 10.1016/0092-8674(89)90944-6; ZULIANI G, 1990, NUCLEIC ACIDS RES, V18, P4300, DOI 10.1093/nar/18.14.4300	36	52	56	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					577	585		10.1086/301983	http://dx.doi.org/10.1086/301983			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683614	Green Published, Bronze			2022-12-18	WOS:000075360800034
J	Becker, JA; Vlach, J; Raben, N; Nagaraju, K; Adams, EM; Hermans, MM; Reuser, AJJ; Brooks, SS; Tifft, CJ; Hirschhorn, R; Huie, ML; Nicolino, M; Plotz, PH				Becker, JA; Vlach, J; Raben, N; Nagaraju, K; Adams, EM; Hermans, MM; Reuser, AJJ; Brooks, SS; Tifft, CJ; Hirschhorn, R; Huie, ML; Nicolino, M; Plotz, PH			The African origin of the common mutation in African American patients with glycogen-storage disease type II	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							LYSOSOMAL ALPHA-GLUCOSIDASE; MISSENSE MUTATION; POMPE DISEASE; POINT MUTATION; MESSENGER-RNA; ONE ALLELE; IDENTIFICATION; EXPRESSION; DELETION; SUBSTITUTION		George Washington Univ, Childrens Natl Med Ctr, Washington, DC 20010 USA; George Washington Univ, Dept Amer Studies & Anthropol, Washington, DC 20010 USA; NIAMSD, Arthrit & Rheumatism Branch, NIH, Bethesda, MD 20892 USA; Erasmus Univ, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands; New York State Inst Basic Res Dev Disabil, Staten Isl, NY 10314 USA; NYU, Med Ctr, Div Med Genet, New York, NY 10016 USA; Hop Debrousse, Dept Endocrinol Pediat, Lyon, France	Children's National Health System; George Washington University; George Washington University; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Erasmus University Rotterdam; Institute for Basic Research in Developmental Disabilities; New York University; CHU Lyon	Plotz, PH (corresponding author), NIAMSD, Arthrit & Rheumatism Branch, NIH, Bethesda, MD 20892 USA.	pplotz@box-p.nih.gov	Nagaraju, Kanneboyina/ABA-6525-2021; Nagaraju, Kanneboyina/AAV-7684-2021					Adams EM, 1997, HUM MUTAT, V10, P128, DOI 10.1002/(SICI)1098-1004(1997)10:2<128::AID-HUMU5>3.3.CO;2-S; Boerkoel C., 1992, American Journal of Human Genetics, V51, pA347; CURTIN PD, 1988, AFRICA AFRICANS; Curtin PD, 1969, ATLANTIC SLAVE TRADE, Vxix; HERMANS MMP, 1994, HUM MOL GENET, V3, P2213, DOI 10.1093/hmg/3.12.2213; HERMANS MMP, 1993, BIOCHEM J, V289, P687, DOI 10.1042/bj2890687; HERMANS MMP, 1993, GENOMICS, V16, P300, DOI 10.1006/geno.1993.1185; HIRSCHHORN R, 1997, METABOLIC MOL BASIS; HUIE ML, 1994, HUM MOL GENET, V3, P1081, DOI 10.1093/hmg/3.7.1081; HUIE ML, 1994, HUM MUTAT, V4, P291, DOI 10.1002/humu.1380040410; KROOS MA, 1995, J MED GENET, V32, P836, DOI 10.1136/jmg.32.10.836-a; Lin Ching-Yuang, 1996, Acta Paediatrica Sinica, V37, P115; LIN CY, 1995, BIOCHEM BIOPH RES CO, V208, P886, DOI 10.1006/bbrc.1995.1418; MARTINIUK F, 1991, DNA CELL BIOL, V10, P681, DOI 10.1089/dna.1991.10.681; MARTINIUK F, 1986, P NATL ACAD SCI USA, V83, P9641, DOI 10.1073/pnas.83.24.9641; Parish Peter J, 1989, SLAVERY HIST HIST; RABEN N, 1995, MUSCLE NERVE, pS70; RAWLEY JA, 1985, TRANSATLANTIC SLAVE; REUSER AJJ, 1995, MUSCLE NERVE, pS61; SHIEH JJ, 1994, J INHERIT METAB DIS, V17, P145, DOI 10.1007/BF00735421; Thornton J., 1992, AFRICA AFRICANS MAKI; Tsunoda H, 1996, HUM GENET, V97, P496, DOI 10.1007/s004390050080; TURNBULL CM, 1977, MAN AFRICA; VANDERKRAAN M, 1994, BIOCHEM BIOPH RES CO, V203, P1535, DOI 10.1006/bbrc.1994.2360; VANDERPLOEG AT, 1989, AM J HUM GENET, V44, P787; WISSELAAR HA, 1993, J BIOL CHEM, V268, P2223; ZHONG N, 1991, AM J HUM GENET, V49, P635	27	52	59	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1998	62	4					991	994		10.1086/301788	http://dx.doi.org/10.1086/301788			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZM197	9529346	Green Published, Bronze			2022-12-18	WOS:000073514400034
J	Carrozzo, R; Rossi, E; Christian, SL; Kittikamron, K; Livieri, C; Corrias, A; Pucci, L; Fois, A; Simi, P; Bosio, L; Beccaria, L; Zuffardi, O; Ledbetter, DH				Carrozzo, R; Rossi, E; Christian, SL; Kittikamron, K; Livieri, C; Corrias, A; Pucci, L; Fois, A; Simi, P; Bosio, L; Beccaria, L; Zuffardi, O; Ledbetter, DH			Inter- and intrachromosomal rearrangements are both involved in the origin of 15q11-q13 deletions in Prader-Willi syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							ALU-ALU RECOMBINATION; SEVERE HEMOPHILIA-A; FACTOR-VIII GENE; ANGELMAN-SYNDROME; REGION 15Q11-13; DUPLICATION; PATIENT		UNIV CHICAGO,CTR MED GENET,CHICAGO,IL 60637; UNIV MILAN,OSPED SAN RAFFAELE,SERV GENET MED,I-20127 MILAN,ITALY; UNIV MILAN,OSPED SAN RAFFAELE,LAB CITOGENET,I-20127 MILAN,ITALY; UNIV MILAN,OSPED SAN RAFFAELE,CLIN PEDIAT 3,I-20127 MILAN,ITALY; TIGEM,MILAN,ITALY; UNIV PAVIA,PEDIAT CLIN,I-27100 PAVIA,ITALY; OSPED INFANTILE REGINA MARGHERITA,DIV ENDOCRINOL PEDIAT,TURIN,ITALY; UNIV SIENA,PEDIAT CLIN,I-53100 SIENA,ITALY; UO AZIENDA OSPED PISANA,PISA,ITALY	University of Chicago; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Pavia; A.O.U. Citta della Salute e della Scienza di Torino; University of Siena; University of Pisa; Azienda Ospedaliero Universitaria Pisana			Rossi, Elena/O-1664-2016	Rossi, Elena/0000-0001-9152-435X; zuffardi, orsetta/0000-0002-1466-4559	Telethon [TGM97000, TGM06S01] Funding Source: Medline	Telethon(Fondazione Telethon)		CHANCE PF, 1994, HUM MOL GENET, V3, P223, DOI 10.1093/hmg/3.2.223; CHRISTIAN SI, 1995, AM J HUM GENET, V57, P40; CLAYTONSMITH J, 1993, J MED GENET, V30, P529, DOI 10.1136/jmg.30.6.529; Dutly F, 1996, HUM MOL GENET, V5, P1893, DOI 10.1093/hmg/5.12.1893; Huang B, 1997, HUM GENET, V99, P11; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; Ji Y., 1996, American Journal of Human Genetics, V59, pA32; KNOLL JHM, 1993, AM J MED GENET, V46, P2, DOI 10.1002/ajmg.1320460103; Kuwano Akira, 1992, Human Molecular Genetics, V1, P417, DOI 10.1093/hmg/1.6.417; LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236; LEHRMAN MA, 1987, CELL, V48, P827, DOI 10.1016/0092-8674(87)90079-1; MARCUS S, 1993, HUM GENET, V90, P477; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; Reiter LT, 1996, NAT GENET, V12, P288, DOI 10.1038/ng0396-288; ROBINSON WP, 1991, AM J HUM GENET, V49, P1219; ROBINSON WP, 1995, HUM MOL GENET, V4, P801, DOI 10.1093/hmg/4.5.801; ROSSITER JP, 1994, HUM MOL GENET, V3, P1035, DOI 10.1093/hmg/3.7.1035; WEATHERALL DJ, 1995, METABOLIC MOL BASES, P3417	19	52	52	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1997	61	1					228	231		10.1086/513907	http://dx.doi.org/10.1086/513907			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM728	9246004	Green Published, Bronze			2022-12-18	WOS:A1997XM72800031
J	Goellner, GM; Tester, D; Thibodeau, S; Almqvist, E; Goldberg, YP; Hayden, MR; McMurray, CT				Goellner, GM; Tester, D; Thibodeau, S; Almqvist, E; Goldberg, YP; Hayden, MR; McMurray, CT			Different mechanisms underlie DNA instability in Huntington disease and colorectal cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NONPOLYPOSIS COLON-CANCER; MISMATCH REPAIR DEFICIENCY; HUMAN ENKEPHALIN ENHANCER; HUMAN GENETIC-DISEASE; CAG REPEAT; FRAGILE-X; TRINUCLEOTIDE REPEATS; INTERMEDIATE ALLELES; GENOMIC INSTABILITY; GENERAL-POPULATION	Two recent lines of evidence raise the possibility that instability in germ-line or somatic cells arises by a common mechanism that involves defective mismatch repair. Mutations in mismatch-repair proteins are known to cause instability in hereditary nonpolyposis colorectal cancer, instability that is physically similar to germ-line instability observed in Huntington disease (HD). Furthermore, both germ-line and somatic-cell instability are likely to be mitotic defects, the former occurring early in embryogenesis. To test the hypothesis that defective repair is a common prerequisite for instability, we have utilized two disease groups that represent different instability ''conditions.'' Germ-line instability within simple tandem repeats (STR) at 10 loci in 29 HD families were compared with somatic instability at the same loci in 26 colon cancer (CC) patients with identified or suspected defects in mismatch-repair enzymes. HD is known to be caused by expansion within the CAG repeat of the locus, but the extent or pattern of STR instability outside this region has not been examined systematically. We find a distinctly different pattern of STR mutation in the two disease groups, suggesting different mechanisms. Instability in HD is generally confined to a single locus, whereas instability is widespread for the same loci in CC. Our data do not support a causative role for defective mismatch-repair enzymes in instability associated with HD; rather, our data are consistent with a model in which DNA structure may inhibit normal mismatch repair at the expansion site.	MAYO CLIN & MAYO FDN,DEPT PHARMACOL,ROCHESTER,MN 55905; MAYO CLIN & MAYO FDN,DEPT BIOCHEM & MOL BIOL,ROCHESTER,MN 55905; MAYO CLIN & MAYO FDN,MOL NEUROSCI PROGRAM,ROCHESTER,MN 55905; MAYO CLIN & MAYO FDN,DEPT LAB MED & PATHOL,ROCHESTER,MN 55905; UNIV BRITISH COLUMBIA,DEPT MED GENET,VANCOUVER,BC,CANADA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of British Columbia			Hayden, Michael R/D-8581-2011	Hayden, Michael R/0000-0001-5159-1419	NIDDK NIH HHS [DK 43694-01A2] Funding Source: Medline; PHS HHS [NIH 60117] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Ashley CT, 1995, ANNU REV GENET, V29, P703, DOI 10.1146/annurev.ge.29.120195.003415; BAKER SM, 1995, CELL, V82, P309, DOI 10.1016/0092-8674(95)90318-6; BATES G, 1994, BIOESSAYS, V16, P277, DOI 10.1002/bies.950160411; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BROWN T, 1995, CURRENT PROTOCOLS MO, V1; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; CARBONNAUX C, 1991, BIOCHEMISTRY-US, V30, P5449, DOI 10.1021/bi00236a018; CHEN XA, 1995, P NATL ACAD SCI USA, V92, P5199, DOI 10.1073/pnas.92.11.5199; CUNNINGHAM J, 1992, CANCER RES, V52, P1974; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; DOLINNAYA NG, 1992, P NATL ACAD SCI USA, V89, P9242, DOI 10.1073/pnas.89.19.9242; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; FRANKKAMENETSKII MD, 1995, ANNU REV BIOCHEM, V64, P65, DOI 10.1146/annurev.bi.64.070195.000433; GACY AM, 1994, BIOCHEMISTRY-US, V33, P11951, DOI 10.1021/bi00205a034; GACY AM, 1995, CELL, V81, P533; GOLDBERG YP, 1993, NAT GENET, V5, P174, DOI 10.1038/ng1093-174; GOLDBERG YP, 1995, HUM MOL GENET, V4, P1911, DOI 10.1093/hmg/4.10.1911; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GREENE KL, 1994, BIOCHEMISTRY-US, V33, P1053, DOI 10.1021/bi00171a003; HEALE SM, 1995, CELL, V83, P539, DOI 10.1016/0092-8674(95)90093-4; HONCHEL R, 1995, SEMIN CELL BIOL, V6, P45, DOI 10.1016/1043-4682(95)90014-4; *HUNT DIS COLL RES, 1993, CELL, V72, P971; Igarashi S, 1996, HUM MOL GENET, V5, P923, DOI 10.1093/hmg/5.7.923; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; JAWORSKI A, 1995, P NATL ACAD SCI USA, V92, P11019, DOI 10.1073/pnas.92.24.11019; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; KANG S, 1992, J BIOL CHEM, V267, P1259; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; Kramer PR, 1996, HUM GENET, V98, P151, DOI 10.1007/s004390050179; KREMER B, 1995, AM J HUM GENET, V57, P343; KREMER B, 1994, NEW ENGL J MED, V330, P1450; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; KUNKEL TA, 1993, NATURE, V365, P207, DOI 10.1038/365207a0; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LEEFLANG EP, 1995, HUM MOL GENET, V4, P1519; LITT M, 1989, AM J HUM GENET, V44, P397; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; MCMURRAY CT, 1995, CHROMOSOMA, V104, P2; MITAS M, 1995, NUCLEIC ACIDS RES, V23, P1050, DOI 10.1093/nar/23.6.1050; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; Paulson HL, 1996, ANNU REV NEUROSCI, V19, P79; REYNIERS E, 1993, NAT GENET, V4, P107; SEARS LE, 1992, BIOTECHNIQUES, V13, P626; SHIBATA D, 1994, NAT GENET, V6, P273, DOI 10.1038/ng0394-273; SNOW K, 1993, AM J HUM GENET, V53, P1217; SPIRO C, 1993, P NATL ACAD SCI USA, V90, P4606, DOI 10.1073/pnas.90.10.4606; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; SUTHERLAND GR, 1995, P NATL ACAD SCI USA, V92, P3636, DOI 10.1073/pnas.92.9.3636; TABOR S, 1995, CURRENT PROTOCOLS MO, V1; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WOHRLE D, 1992, HUM GENET, V89, P114, DOI 10.1007/BF00207057; ZHU LM, 1995, NAT STRUCT BIOL, V2, P1012, DOI 10.1038/nsb1195-1012	63	52	52	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1997	60	4					879	890						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WT614	9106534				2022-12-18	WOS:A1997WT61400017
J	Oruc, L; Lindblad, K; Verheyen, GR; Ahlberg, S; Jakovljevic, M; Ivezic, S; Raeymaekers, P; Van Broeckhoven, C; Schalling, M				Oruc, L; Lindblad, K; Verheyen, GR; Ahlberg, S; Jakovljevic, M; Ivezic, S; Raeymaekers, P; Van Broeckhoven, C; Schalling, M			CAG repeat expansions in bipolar and unipolar disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							ANTICIPATION		UNIV ANTWERP VIB, DEPT BIOCHEM, NEUROGENET LAB, BORN BUNGE FDN, B-2610 ANTWERP, BELGIUM; KAROLINSKA HOSP, DEPT MOL MED, NEUROGENET UNIT, S-10401 STOCKHOLM, SWEDEN; UNIV ZAGREB, UNIV HOSP REBRO, DEPT PSYCHIAT, ZAGREB, CROATIA; UNIV ZAGREB, VRAPCE SCH MED, HOSP PSYCHIAT, ZAGREB 41000, CROATIA	Flanders Institute for Biotechnology (VIB); University of Antwerp; Karolinska Institutet; Karolinska University Hospital; University of Zagreb; University of Zagreb			Van Broeckhoven, Christine/G-8362-2017; Van Broeckhoven, Christine/M-7853-2019; Schalling, Martin/F-1518-2015	Van Broeckhoven, Christine/0000-0003-0183-7665; Van Broeckhoven, Christine/0000-0003-0183-7665; Verheyen, Geert/0000-0001-9268-9228; Schalling, Martin/0000-0001-5011-2922				ENDICOTT J, 1978, SCHEDULE SCHIZOPHREN; ENGSTROM C, 1995, J AFFECT DISORDERS, V35, P31, DOI 10.1016/0165-0327(95)00035-L; HALL JG, 1990, AM J HUM GENET, V46, P857; LINDBLAD K, 1995, NEUROBIOL DIS, V2, P55, DOI 10.1006/nbdi.1995.0006; Lindblad K, 1996, ACTA PAEDIATR, V85, P265, DOI 10.1111/j.1651-2227.1996.tb14011.x; MCINNIS MG, 1993, AM J HUM GENET, V53, P385; Morrison PJ, 1996, LANCET, V347, P1132, DOI 10.1016/S0140-6736(96)90605-4; Mott FW, 1910, BRIT MED J, V1910, P1013, DOI 10.1136/bmj.2.2597.1013; NYLANDER PO, 1994, J MED GENET, V31, P686, DOI 10.1136/jmg.31.9.686; ODONOVAN MC, 1995, NAT GENET, V10, P380, DOI 10.1038/ng0895-380; PENROSE LS, 1948, ANN EUGENIC, V14, P125; PETRONIS A, 1995, AM J PSYCHIAT, V152, P164; SCHALLING M, 1993, NAT GENET, V4, P135, DOI 10.1038/ng0693-135; WILLEMS PJ, 1994, NAT GENET, V8, P213, DOI 10.1038/ng1194-213	14	52	53	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1997	60	3					730	732						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK403	9042934				2022-12-18	WOS:A1997WK40300031
J	Lunetta, KL; Boehnke, M; Lange, K; Cox, DR				Lunetta, KL; Boehnke, M; Lange, K; Cox, DR			Selected locus and multiple panel models for radiation hybrid mapping	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STATISTICAL-METHODS; EM ALGORITHM	We develop two new types of models for whole-genome radiation hybrid mapping using the general multipoint framework. The first, selected locus models, are appropriate for mapping markers in the region of a selectable locus that was used in creation of the hybrids. The models allow for strong retention of the selectable locus, with retention rates decreasing with increasing distance from the selectable locus in both directions. We illustrate the application of these models with 10 chromosome 17 sequence-tagged site (STS) markers and the thymidine kinase (TK) locus typed on a whole-genome hybrid panel in which TK was used in the selection process. The second set of models are appropriate when loci typed on two or more independent panels are to be used to build maps. Maps can be built assuming interlocus distances are independent or proportional between the panels, and the hypothesis of proportional distances can be tested. We illustrate the application of these models by using 27 chromosome 21 STS markers typed on two hybrid panels created with radiation doses of similar to 10,000 and similar to 50,000 Rads.	UNIV MICHIGAN,SCH PUBL HLTH,DEPT BIOSTAT,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT MATH,ANN ARBOR,MI 48109; STANFORD UNIV,SCH MED,DEPT GENET,STANFORD,CA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Stanford University				Lunetta, Kathryn/0000-0002-9268-810X	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R29HG000376, T32HG000040, R01HG000376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053275] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00376, T32 HG00040] Funding Source: Medline; NIGMS NIH HHS [GM53275] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baum LE, 1972, INEQUALITIES, V3, P1; BOEHNKE M, 1991, AM J HUM GENET, V49, P1174; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Gyapay G, 1996, HUM MOL GENET, V5, P339, DOI 10.1093/hmg/5.3.339; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; LANGE K, 1995, GENOME RES, V5, P136, DOI 10.1101/gr.5.2.136; LANGE K, 1996, SEARCH FORTRAN PROGR; LUNETTA KL, 1994, GENOMICS, V21, P92, DOI 10.1006/geno.1994.1229; WEEKS DE, 1989, IMA J MATH APPL MED, V6, P209	9	52	52	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1996	59	3					717	725						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN625	8751873				2022-12-18	WOS:A1996VN62500026
J	Ion, A; Telvi, L; Chaussain, JL; Galacteros, F; Valayer, J; Fellous, M; McElreavey, K				Ion, A; Telvi, L; Chaussain, JL; Galacteros, F; Valayer, J; Fellous, M; McElreavey, K			Novel mutation in the putative DNA helicase XH2 is responsible for male-to-female sex reversal associated with an atypical form of the ATR-X syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; MENTAL-RETARDATION; SRY	We describe a pedigree presenting X-linked severe mental retardation associated with multiple congenital abnormalities and 46,XY gonadal dysgenesis, leading in one family member to female gender assignment. Female carriers are unaffected. The dysmorphic features are similar to those described in the alpha-thalassemia and mental retardation (ATR-X) syndrome, although there is no clinical evidence of alpha-thalassemia in this family. In addition, the family had other clinical features not previously observed in the ATR-X syndrome, including partial optic-nerve atrophy and partial ocular albinism. Mutations in a putative DNA helicase, termed XH2, have been reported to give rise to the ATR-X syndrome. We screened the XH2 gene for mutations in affected members of the family and identified a 4-bp deletion at an intron/exon boundary that removes an invariant 3' splice-acceptor site. The mutation cosegregates with the syndrome. The genomic deletion causes missplicing of the pre-mRNA, which results in the loss of 8 bp of coding sequence, thereby generating a frameshift and a downstream premature stop codon. Our finding increases the range of clinical features associated with mutations in the XH2 gene.	HOP ST VINCENT DE PAUL,SERV ENDOCRINOL PEDIAT,F-75014 PARIS 14,FRANCE; INST PASTEUR,PARIS,FRANCE; HOP HENRI MONDOR,SERV BIOCHIM,F-94010 CRETEIL,FRANCE; HOP BICETRE,SERV CHIRURG INFANTILE,LE KREMLIN BICETR,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP	Ion, A (corresponding author), HOP ST VINCENT DE PAUL,LAB CYTOGENET CONSTITUT,82 AVE DENFERT ROCHEREAU,F-75014 PARIS 14,FRANCE.							CARLSON M, 1994, CURR OPIN CELL BIOL, V6, P396, DOI 10.1016/0955-0674(94)90032-9; CLEGG JB, 1983, METHODS HAEMATOLOGY, P54; COLE GM, 1987, MOL CELL BIOL, V7, P1078, DOI 10.1128/MCB.7.3.1078; COLE GM, 1989, MOL CELL BIOL, V9, P3101, DOI 10.1128/MCB.9.7.3101; GECZ J, 1994, HUM MOL GENET, V3, P39, DOI 10.1093/hmg/3.1.39; GIBBONS RJ, 1995, HUM MOL GENET, V4, P1705, DOI 10.1093/hmg/4.suppl_1.1705; GIBBONS RJ, 1992, AM J HUM GENET, V51, P1136; GIBBONS RJ, 1995, AM J MED GENET, V55, P288, DOI 10.1002/ajmg.1320550309; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; HAWKINS JR, 1992, HUM GENET, V88, P471, DOI 10.1007/BF00215684; JUBERG RC, 1980, AM J HUM GENET, V32, P714; KOLSTO AB, 1993, J MOL BIOL, V230, P684, DOI 10.1006/jmbi.1993.1185; MCELREAVY K, 1992, P NATL ACAD SCI USA, V89, P11016, DOI 10.1073/pnas.89.22.11016; MCPHERSON EW, 1995, AM J MED GENET, V55, P302, DOI 10.1002/ajmg.1320550311; SAUGIERVEBER P, 1993, AM J HUM GENET, V52, P1040; STAYTON CL, 1994, HUM MOL GENET, V3, P1957, DOI 10.1093/hmg/3.11.1957; TELVI L, 1995, AM J MED GENET, V57, P598, DOI 10.1002/ajmg.1320570416	17	52	53	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1996	58	6					1185	1191						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UM271	8651295				2022-12-18	WOS:A1996UM27100011
J	MANNIKKO, M; KESTILA, M; HOLMBERG, C; NORIO, R; RYYNANEN, M; OLSEN, A; PELTONEN, L; TRYGGVASON, K				MANNIKKO, M; KESTILA, M; HOLMBERG, C; NORIO, R; RYYNANEN, M; OLSEN, A; PELTONEN, L; TRYGGVASON, K			FINE MAPPING AND HAPLOTYPE ANALYSIS OF THE LOCUS FOR CONGENITAL NEPHROTIC SYNDROME ON CHROMOSOME 19Q13.1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; OXIDASE SUBUNIT-VIB; FINNISH TYPE; INSITU HYBRIDIZATION; REPEAT-POLYMORPHISM; GENE; CLONING; POPULATIONS; ASSIGNMENT; PRECURSOR	We have recently localized the gene for congenital nephrotic syndrome of the Finnish type (CNF) to chromosome 19q12-13.1. On the basis of observed recombination events, the gene was localized between markers D19S416/D19S425/D19S213/D19S208/D19S191 and D19S224. Here we have extended the mapping efforts, on the basis of a detailed physical map of the region. By means of three new polymorphic markers-D19S608, D19S609, and D19S610-developed in this study, the critical candidate region could be further restricted, Significant linkage disequilibrium was observed with markers D19S610, D19S608, D19S224, and D19S220, the strongest allelic association being 84% with marker D19S610 at 19q13.1. This suggests that the CNF gene locus lies in close proximity to marker D19S610. Combination of the informative markers revealed four main haplotype categories. Different geographic distribution was observed between these haplotype groups when they were placed on the map of Finland according to the birthplaces of grandparents.	UNIV OULU, BIOCTR, SF-90570 OULU, FINLAND; UNIV OULU, DEPT BIOCHEM, SF-90570 OULU, FINLAND; UNIV HELSINKI, CHILDRENS HOSP, HELSINKI, FINLAND; FAMILY FEDERAT FINLAND, HELSINKI, FINLAND; NATL PUBL HLTH INST, DEPT HUMAN MOLEC GENET, HELSINKI, FINLAND; KUOPIO UNIV HOSP, DEPT OBSTET & GYNECOL, DIV PRENATAL DIAGNOST, SF-70210 KUOPIO, FINLAND; LAWRENCE LIVERMORE NATL LAB, CTR HUMAN GENOME, LIVERMORE, CA USA	University of Oulu; Finland National Institute for Health & Welfare; University of Oulu; University of Helsinki; Family Federation of Finland; Finland National Institute for Health & Welfare; Kuopio University Hospital; University of Eastern Finland; United States Department of Energy (DOE); Lawrence Livermore National Laboratory			Mannikko, Minna/C-5877-2008	Mannikko, Minna/0000-0002-6857-6423				BRANDRIFF BF, 1994, GENOMICS, V23, P582, DOI 10.1006/geno.1994.1546; BROWNE DL, 1992, NUCLEIC ACIDS RES, V20, P141, DOI 10.1093/nar/20.1.141; CANFIELD VA, 1990, J BIOL CHEM, V265, P19878; CARREROVALENZUELA RD, 1991, GENE, V102, P229, DOI 10.1016/0378-1119(91)90082-M; DEJONG PJ, 1989, CYTOGENET CELL GENET, V51, P985; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; DIMAURO S, 1980, NEUROLOGY, V30, P795, DOI 10.1212/WNL.30.8.795; Farquhar M. G., 1981, CELL BIOL EXTRACELLU, V1981, P335; GORDON LA, IN PRESS GENOMICS; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; Higuchi R, 1989, PCR TECHNOLOGY PRINC, P31; HOLMBERG C, 1995, PEDIATR NEPHROL, V9, P87, DOI 10.1007/BF00858984; HOLMBERG C, 1991, TRANSPLANT P, V23, P1378; HUTTUNEN NP, 1976, ARCH DIS CHILD, V51, P344, DOI 10.1136/adc.51.5.344; ILES DE, 1992, NUCLEIC ACIDS RES, V20, P1170; KESTILA M, 1994, GENOMICS, V19, P570, DOI 10.1006/geno.1994.1109; KESTILA M, 1994, KIDNEY INT, V45, P986, DOI 10.1038/ki.1994.133; KESTILA M, 1994, AM J HUM GENET, V54, P757; KOSKIMIES O, 1990, INHERITANCE KIDNEY U, P131; LAINE J, 1993, KIDNEY INT, V44, P867, DOI 10.1038/ki.1993.324; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; NIKALI K, 1995, AM J HUM GENET, V56, P1088; Norio R., 1966, ANN PAEDIAT FENN S27, V12, P1; RAPOLA J, 1987, PEDIATR NEPHROL, V1, P441, DOI 10.1007/BF00849252; SATO S, 1989, BIOCHEM BIOPH RES CO, V163, P1473, DOI 10.1016/0006-291X(89)91145-5; SAVUKOSKI M, 1994, AM J HUM GENET, V55, P695; SHIBATA DK, 1988, J EXP MED, V167, P225, DOI 10.1084/jem.167.1.225; SONG I, 1992, GENOMICS, V14, P547, DOI 10.1016/S0888-7543(05)80266-6; SPAGNOL G, 1989, J NEUROSCI RES, V24, P137, DOI 10.1002/jnr.490240203; SULISALO T, 1994, AM J HUM GENET, V55, P937; TAANMAN JW, 1991, HUM GENET, V87, P325, DOI 10.1007/BF00200913; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; VERNIER RL, 1983, NEW ENGL J MED, V309, P1001, DOI 10.1056/NEJM198310273091701; WASCO W, 1993, GENOMICS, V15, P237, DOI 10.1006/geno.1993.1047; WASCO W, 1992, P NATL ACAD SCI USA, V89, P10758, DOI 10.1073/pnas.89.22.10758; WEBER JL, 1993, AM J HUM GENET, V53, P1079	38	52	56	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1995	57	6					1377	1383						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TE655	8533767				2022-12-18	WOS:A1995TE65500015
J	MAW, MA; ALLENPOWELL, DR; GOODEY, RJ; STEWART, IA; NANCARROW, DJ; HAYWARD, NK; GARDNER, RJM				MAW, MA; ALLENPOWELL, DR; GOODEY, RJ; STEWART, IA; NANCARROW, DJ; HAYWARD, NK; GARDNER, RJM			THE CONTRIBUTION OF THE DFNB1 LOCUS TO NEUROSENSORY DEAFNESS IN A CAUCASIAN POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								Classical studies have demonstrated genetic heterogeneity for nonsyndromic autosomal recessive congenital neurosensory deafness, with at least six loci postulated. Linkage analysis in two consanguineous Tunisian kindreds has demonstrated that one such deafness locus, DFNB1, maps near chromosome 13 markers D13S175, D13S143, and D13S115. We tested these markers for cosegregation with deafness in 18 New Zealand and 1 Australian nonconsanguineous kindreds, each of which included at least two siblings with nonsyndromic presumed congenital sensorineural deafness and that had a pedigree structure consistent with autosomal recessive inheritance. When all families were combined, a peak two-point lod score of 2.547 (theta = .1) was obtained for D13S175, 0.780 (theta = .2) for D13S143, and 0.664 (theta = .3) for D13S115. While there was no statistically significant evidence for heterogeneity at any of the three loci tested, nine families showed cosegregation of marker haplotypes with deafness. These observations suggest that the DFNB1 locus may make an important contribution to autosomal recessive neurosensory deafness in a Caucasian population. In the nine cosegregating families, phenotypic variation was observed both within sibships (in four families), which indicates that variable expressivity characterizes some genotypes at the DFNB1 locus, and between generations (in two families), which suggests allelic heterogeneity.	ROYAL CHILDRENS HOSP,MURDOCH INST,MELBOURNE,VIC 3052,AUSTRALIA; UNIV OTAGO,DEPT BIOCHEM,DUNEDIN,NEW ZEALAND; UNIV OTAGO,DEPT PAEDIAT & CHILD HLTH,DUNEDIN,NEW ZEALAND; UNIV OTAGO,DEPT SURG,DUNEDIN,NEW ZEALAND; DILWORTH CLIN,AUCKLAND,NEW ZEALAND; QUEENSLAND INST MED RES,QUEENSLAND CANC FUND RES UNIT,BRISBANE,QLD 4006,AUSTRALIA	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Otago; University of Otago; University of Otago; QIMR Berghofer Medical Research Institute			hayward, nicholas k/C-1367-2015; hayward, nick/AAV-8802-2020	hayward, nicholas k/0000-0003-4760-1033; 				Brown K. A., 1994, American Journal of Human Genetics, V55, pA181; BROWNSTEIN Z, 1991, AM J MED GENET, V41, P306, DOI 10.1002/ajmg.1320410309; CHAI, 1994, HUM MOL GENET, V3, P2219; Fraser G. R, 1976, BIG 4 CAUSES POVERTY; FRIEDMAN TB, 1995, NAT GENET, V9, P86, DOI 10.1038/ng0195-86; GUILFORD P, 1994, HUM MOL GENET, V3, P989, DOI 10.1093/hmg/3.6.989; GUILFORD P, 1994, NAT GENET, V6, P24, DOI 10.1038/ng0194-24; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MCGILL JJ, 1991, MED J AUSTRALIA, V154, P572, DOI 10.5694/j.1326-5377.1991.tb121212.x; MORTON NE, 1960, AM J HUM GENET, V12, P348; NANCE WE, 1975, OTOLARYNG CLIN N AM, V8, P19; Ott J., 1991, ANAL HUMAN GENETIC L; STEVENSON AC, 1956, ANN HUM GENET, V20, P177	13	52	55	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1995	57	3					629	635						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR605	7668291				2022-12-18	WOS:A1995RR60500012
J	ALLAMAND, V; BROUX, O; RICHARD, I; FOUGEROUSSE, F; CHIANNILKULCHAI, N; BOURG, N; BRENGUIER, L; DEVAUD, C; PASTURAUD, P; DESOUZA, AP; ROUDAUT, C; TISCHFIELD, JA; CONNEALLY, PM; FARDEAU, M; COHEN, D; JACKSON, CE; BECKMANN, JS				ALLAMAND, V; BROUX, O; RICHARD, I; FOUGEROUSSE, F; CHIANNILKULCHAI, N; BOURG, N; BRENGUIER, L; DEVAUD, C; PASTURAUD, P; DESOUZA, AP; ROUDAUT, C; TISCHFIELD, JA; CONNEALLY, PM; FARDEAU, M; COHEN, D; JACKSON, CE; BECKMANN, JS			PREFERENTIAL LOCALIZATION OF THE LIMB-GIRDLE MUSCULAR-DYSTROPHY TYPE 2A GENE IN THE PROXIMAL PART OF A 1-CM 15Q15.1-Q15.3 INTERVAL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BRAZILIAN FAMILIES; LINKAGE ANALYSIS; CHROMOSOME-15; GENOME; MAP	A gene for a recessive form of limb-girdle muscular dystrophy (LGMD2A) has been localized to chromosome 15. A physical map of the 7-cM candidate 15q15.1-q21.1 region has been constructed by means of a 10-12-Mb continuum of overlapping YAC clones. New microsatellite markers developed from these YACs were genotyped on large, consanguineous LGMD2A pedigrees from different origins. The identification of recombination events in these families allowed the restriction of the LGMD2A region to an estimated 1-cM interval, equivalent to similar to 3-4 Mb. Linkage disequilibrium data on genetic isolates from the island of Reunion and from the Amish community suggest a preferential location of the LGMD2A gene in the proximal part of this region. Analysis of the interrelated pedigrees from Reunion revealed the existence of at least six different carrier haplotypes. This allelic heterogeneity is incompatible with the presumed existence of a founder effect and suggests that multiple LGMD2A mutations may segregate in this population.	CNRS,URA 1922,F-91002 EVRY,FRANCE; FDN JEAN DAUSSET,CTR ETUD POLYMORPHISME HUMAIN,PARIS,FRANCE; INSERM,U153,PARIS,FRANCE; INDIANA UNIV,SCH MED,DEPT MED & MOLEC GENET,INDIANAPOLIS,IN 46202; HENRY FORD HOSP,DIV CLIN & MOLEC GENET,DETROIT,MI	Centre National de la Recherche Scientifique (CNRS); Foundation Jean Dausset-CEPH; Institut National de la Sante et de la Recherche Medicale (Inserm); Indiana University System; Indiana University-Purdue University Indianapolis; Henry Ford Health System; Henry Ford Hospital			Beckmann, Jacques S/A-9772-2008; DE SOUZA, ANETE PEREIRA/B-8663-2012; Allamand, Valerie/M-4333-2017; Richard, isabelle/J-8298-2013; Allamand, Valérie/AAH-6272-2021	Beckmann, Jacques S/0000-0002-9741-1900; DE SOUZA, ANETE PEREIRA/0000-0003-3831-9829; Allamand, Valérie/0000-0001-8997-9742; Tischfield, Jay/0000-0003-3217-8287				ALLAMAND V, 1995, HUM MOL GENET, V4, P459, DOI 10.1093/hmg/4.3.459; BACH G, 1994, AM J HUM GENET, V53, P330; BASHIR R, 1994, HUM MOL GENET, V3, P455, DOI 10.1093/hmg/3.3.455; BECKMANN JS, 1991, CR ACAD SCI III-VIE, V312, P141; BECKMANN JS, 1993, HUM MOL GENET, V2, P2019, DOI 10.1093/hmg/2.12.2019; BENHAMIDA C, 1993, NAT GENET, V5, P195; BOWCOCK AM, 1994, AM J HUM GENET, V54, P79; CHIANNILKULCHAI N, 1995, HUM MOL GENET, V4, P717, DOI 10.1093/hmg/4.4.717; DESOUZA AP, 1994, GENOMICS, V19, P391, DOI 10.1006/geno.1994.1079; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; FOUGEROUSSE F, 1994, HUM MOL GENET, V3, P285, DOI 10.1093/hmg/3.2.285; FOUGEROUSSE F, 1992, GENOMICS, V13, P903, DOI 10.1016/0888-7543(92)90184-T; HAMMOND DT, 1958, AM J HUM GENET, V10, P61; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HEINISCH U, 1995, AM J HUM GENET, V56, P51; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; JACKSON CE, 1968, PEDIATRICS, V41, P495; JORDE LB, 1994, AM J HUM GENET, V54, P884; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; LITT M, 1986, AM J HUM GENET, V39, P166; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; PASSOSBUENO MR, 1993, J MED GENET, V30, P385, DOI 10.1136/jmg.30.5.385; PASSOSBUENO MR, 1991, J NEUROL SCI, V103, P65; POLLAK MR, 1993, NAT GENET, V5, P201, DOI 10.1038/ng1093-201; PUFFENBERGER EG, 1994, HUM MOL GENET, V3, P1217; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; RODIUS F, 1994, AM J HUM GENET, V54, P1050; SIRUGO G, 1992, AM J HUM GENET, V50, P559; SNAREY A, 1994, AM J HUM GENET, V55, P365; STAM P, 1981, EUPHYTICA, V30, P227, DOI 10.1007/BF00033982; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; Vignal Alain, 1993, V1, P211; Weir BS, 1990, GENETIC DATA ANAL; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; YOUNG K, 1992, GENOMICS, V13, P1370, DOI 10.1016/0888-7543(92)90074-3; 1993, CELL, V72, P971	40	52	52	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1995	56	6					1417	1430						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA794	7762565				2022-12-18	WOS:A1995RA79400021
J	JESUDASAN, RA; RAHMAN, RA; CHANDRASHEKHARAPPA, S; EVANS, GA; SRIVATSAN, ES				JESUDASAN, RA; RAHMAN, RA; CHANDRASHEKHARAPPA, S; EVANS, GA; SRIVATSAN, ES			DELETION AND TRANSLOCATION OF CHROMOSOME 11Q13 SEQUENCES IN CERVICAL-CARCINOMA CELL-LINES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE CHAIN-REACTION; SQUAMOUS-CELL; HUMAN PAPILLOMAVIRUSES; UTERINE CERVIX; CANCER; LOCUS; GENE; HETEROZYGOSITY; NEOPLASIA; ONCOGENE	Molecular genetic studies on HeLa cell-derived nontumorigenic and tumorigenic hybrids have previously localized the HeLa cell tumor-suppressor gene to the long arm of chromosome 11. Extensive molecular and cytogenetic studies on HeLa cells have shown chromosome band 11q13 to be rearranged in this cell line. To determine whether q13 rearrangement is a nonrandom event in cervical carcinomas, six different human papilloma virus (HPV)-positive (HeLa, SiHa, Caski, C4-I, Me180, and Ms751) and two different HPV-negative (C33A and HT3) cell lines were studied. Long-range restriction mapping using a number of q13-specific probes showed molecular rearrangements within 75 kb of INT2 probe in three HPV-positive cell lines (HeLa, SiHa, and Caski) and in an HPV-negative cell line (HT3). FISH using an INT2 YAC identified a breakpoint within the sequences spanned by this YAC in two of the cell lines, HeLa and Caski. INT2 cosmid derived from this YAC showed deletion of cosmid sequences in two other cell lines, SiHa and C33A. These two cell lines, however, retained cosmid sequences of Cyclin D1, a probe localized 100 kb proximal to INT2. Deletions being the hallmark of a tumor-suppressor gene, we conclude that the 100-kb interval between the two cosmids might contain sequences of the cervical carcinoma tumor-suppressor gene.	UNIV CALIF LOS ANGELES,SCH MED,VET ADM MED CTR,DEPT SURG,LOS ANGELES,CA 90073; SPECIAL DIAGNOST,CLIN GENET CTR,LA MIRADA,CA; NATL CTR HUMAN GENOME RES,GENE TRANSFER LAB,BETHESDA,MD; UNIV TEXAS,SW MED CTR,MCDERMOTT CTR,DALLAS,TX	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas			Chandrashekharappa, Dr. Sandeep/V-8205-2018; Jesudasan, Rachel/AHE-4743-2022	Chandrashekharappa, Dr. Sandeep/0000-0003-2475-7270; Jesudasan, Rachel/0000-0001-9459-832X	NATIONAL CANCER INSTITUTE [R29CA047206] Funding Source: NIH RePORTER; NCI NIH HHS [CA47206] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AHSEE KW, 1994, CANCER RES, V54, P1617; BROOKES S, 1992, GENE CHROMOSOME CANC, V4, P290, DOI 10.1002/gcc.2870040404; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; HAMPTON GM, 1994, P NATL ACAD SCI USA, V91, P6953, DOI 10.1073/pnas.91.15.6953; HIGGINS MJ, 1989, MOL CELL BIOL, V9, P1; JANSON M, 1991, P NATL ACAD SCI USA, V88, P10609, DOI 10.1073/pnas.88.23.10609; JESUDASAN RA, 1994, ANTICANCER RES, V14, P1727; JIN YH, 1990, GENE CHROMOSOME CANC, V2, P198, DOI 10.1002/gcc.2870020306; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; KNUDSON AG, 1985, CANCER RES, V45, P1437; KOI M, 1989, MOL CARCINOGEN, V2, P12, DOI 10.1002/mc.2940020103; LAMMIE GA, 1991, CANCER CELL-MON REV, V3, P413; LAMMIE GA, 1991, ONCOGENE, V6, P439; LARSSON C, 1988, NATURE, V332, P85, DOI 10.1038/332085a0; MISRA BC, 1989, AM J HUM GENET, V45, P565; MOTOKURA T, 1993, CURR OPIN GENET DEV, V3, P5, DOI 10.1016/S0959-437X(05)80334-X; MOTOKURA T, 1992, J BIOL CHEM, V267, P20412; NELSON DL, 1991, P NATL ACAD SCI USA, V88, P6157, DOI 10.1073/pnas.88.14.6157; OCADIZ R, 1987, CANCER RES, V47, P4173; PATER MM, 1986, VIROLOGY, V155, P13, DOI 10.1016/0042-6822(86)90163-7; PFISTER H, 1987, ADV CANCER RES, V48, P113, DOI 10.1016/S0065-230X(08)60691-0; RIOU G, 1988, ONCOGENE, V3, P329; ROSL F, 1988, EMBO J, V7, P1321, DOI 10.1002/j.1460-2075.1988.tb02947.x; SAXON PJ, 1986, EMBO J, V5, P3461, DOI 10.1002/j.1460-2075.1986.tb04670.x; SRIVATSAN ES, 1993, GENE CHROMOSOME CANC, V7, P32, DOI 10.1002/gcc.2870070106; SRIVATSAN ES, 1991, AM J HUM GENET, V49, P868; WILCZYNSKI SP, 1988, HUM PATHOL, V19, P697, DOI 10.1016/S0046-8177(88)80176-X; YOKOTA J, 1989, CANCER RES, V49, P3598	28	52	54	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1995	56	3					705	715						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QK918	7887426				2022-12-18	WOS:A1995QK91800021
J	KAWADA, Y; HATTORI, M; DAI, XY; NANKO, S				KAWADA, Y; HATTORI, M; DAI, XY; NANKO, S			POSSIBLE ASSOCIATION BETWEEN MONOAMINE-OXIDASE A GENE AND BIPOLAR AFFECTIVE-DISORDER	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									TEIKYO UNIV,SCH MED,DEPT PSYCHIAT,TOKYO,JAPAN	Teikyo University	KAWADA, Y (corresponding author), JUNTENDO UNIV,SCH MED,DEPT PSYCHIAT,TOKYO 113,JAPAN.							BLACK GCM, 1991, NUCLEIC ACIDS RES, V19, P689; HATTORI M, 1993, PSYCHIATR GENET, V3, P27; LIM LCC, 1994, AM J HUM GENET, V54, P1122	3	52	55	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					335	335						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7880306				2022-12-18	WOS:A1995QC10100044
J	RICE, T; PROVINCE, M; PERUSSE, L; BOUCHARD, C; RAO, DC				RICE, T; PROVINCE, M; PERUSSE, L; BOUCHARD, C; RAO, DC			CROSS-TRAIT FAMILIAL RESEMBLANCE FOR BODY-FAT AND BLOOD-PRESSURE - FAMILIAL CORRELATIONS IN THE QUEBEC FAMILY STUDY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMMINGLING ANALYSIS; OBESITY; INSULIN	Cross-trait resemblance between body fat and blood pressure (BP) was examined among families in the Quebec Family Study by using a bivariate familial correlation model assessing both intraindividual (e.g., comparison of father's body fat with his own BP) and interindividual (e.g., comparison of father's body fat with son's BP) cross-trait correlations. Each of six body-fat measures-(i) percent body fat, (ii) body-mass index, (iii) the sum of six skinfolds, (iv) the ratio of the sum of six skinfolds to total fat mass, (v) the ratio of the trunk skinfold sum to the extremity skinfold sum, and (vi) the regression of the trunk-extremity skinfold ratio on the sum of six skinfolds-was analyzed separately with systolic BP and with diastolic BP. Results showed that (1) upper-body fat was the strongest interindividual correlate of BP (especially the correlation of trunk-extremity ratio with diastolic BP), suggesting shared pleiotropic genetic and/or common familial environmental effects; (2) summary body-fat measures either were inconsistent (in the case of both percent body fat and sum of six skinfolds) or gave no evidence of interindividual cross-trait resemblance skinfolds and BP largely vanished once the skinfold sum was adjusted for fat mass, suggesting that the intraindividual association may be mediated largely by the absolute amount of subcutaneous fat rather than by the subcutaneous proportion. Finally, the magnitude of the spouse resemblance for the trunk-extremity ratio with diastolic BP suggests that a significant proportion of the resemblance may be due to environmental influences, In summary, our investigation confirms a heritable link between BP and truncal-abdominal fat as predicted by the metabolic-syndrome hypothesis. That this result is obtained in primarily normotensive, nonobese families, suggests the connection involves normal metabolic paths.	WASHINGTON UNIV,SCH MED,DEPT PSYCHIAT,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT GENET,ST LOUIS,MO 63110; UNIV LAVAL,PEPS,PHYS ACT SCI LAB,ST FOY,PQ,CANADA	Washington University (WUSTL); Washington University (WUSTL); Laval University	RICE, T (corresponding author), WASHINGTON UNIV,SCH MED,DIV BIOSTAT,BOX 8067,660 S EUCLID AVE,ST LOUIS,MO 63110, USA.		Rice, Treva K/D-1385-2009; Bouchard, Claude/A-7637-2009; Perusse, Louis/A-3444-2012; Bouchard, Claude/AAE-2035-2019	Bouchard, Claude/0000-0002-0048-491X; Perusse, Louis/0000-0001-6440-9698; Rice, Treva/0000-0001-7452-2600	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028719] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-18281] Funding Source: Medline; NIGMS NIH HHS [GM-28719] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BJORNTORP P, 1992, ANN MED, V24, P465, DOI 10.3109/07853899209166997; BLISHEN BR, 1976, CAN REV SOC ANTHROP, V13, P71, DOI 10.1111/j.1755-618X.1976.tb00759.x; BLISHEN BR, 1970, CAN REV SOCIOL ANTHR, V7, P110; BORECKI IB, 1991, INT J OBESITY, V15, P763; BORECKI IB, IN PRESS OBES RES; BOUCHARD C, 1991, INT J OBESITY, V15, P9; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; BOUCHARD C, 1985, 6 ROSS C MED RES COL, P9; DESPRES JP, 1988, J CLIN EPIDEMIOL, V41, P889, DOI 10.1016/0895-4356(88)90106-0; HIMES JH, 1985, AM J PUBLIC HEALTH, V75, P1076, DOI 10.2105/AJPH.75.9.1076; KIRKENDALL WM, 1967, CIRCULATION, V36, P980, DOI 10.1161/01.CIR.36.6.980; LANDSBERG L, 1986, Q J MED, V61, P1081; Lourie JA., 1969, HUMAN BIOL GUIDE FIE; PERUSSE L, 1989, AM J HUM GENET, V45, P240; PROVINCE MA, IN PRESS GENET EPIDE; PROVINCE MA, 1992, 1ST INT GEN EP SOC M; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; RICE T, 1992, INT J OBESITY, V16, P831; SCHORK NJ, 1994, AM J HUM GENET, V54, P361; SIMS EAH, 1982, JAMA-J AM MED ASSOC, V24, P49; VAGUE J, 1956, AM J CLIN NUTR, V4, P20, DOI 10.1093/ajcn/4.1.20	21	52	52	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1994	55	5					1019	1029						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB682	7977339				2022-12-18	WOS:A1994QB68200022
J	SPINNER, NB; RAND, EB; FORTINA, P; GENIN, A; TAUB, R; SEMERARO, A; PICCOLI, DA				SPINNER, NB; RAND, EB; FORTINA, P; GENIN, A; TAUB, R; SEMERARO, A; PICCOLI, DA			CYTOLOGICALLY BALANCED T(2,20) IN A 2-GENERATION FAMILY WITH ALAGILLE-SYNDROME - CYTOGENETIC AND MOLECULAR STUDIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ARTERIOHEPATIC DYSPLASIA; LINKAGE MAP; CHROMOSOME-20; GENE; DELETION; NEUROFIBROMATOSIS; MARKERS; 20P; ARM	Alagille syndrome is a clinically defined, dominantly inherited disorder affecting the liver, heart, face, eye, and vertebrae. Alagille syndrome has previously been localized to the short arm of chromosome 20, on the basis of reports of a small number of patients with chromosomal deletions of 20p. We undertook a cytogenetic study of patients with Alagille syndrome and identified a family in which a cytologically balanced translocation between chromosomes 2 and 20, 46,XX/XY,t(2;20)(q21.3;p12), is segregating concordantly with the disease. The breakpoint on chromosome 20p in this t(2;20) is consistent with the shortest region of overlap demonstrated in the reported deletion patients. This is the first report of a translocation associated with 20p and Alagille syndrome, and this rearrangement confirms the location of the Alagille disease gene at 20p12. We have established a somatic cell hybrid from a lymphoblastoid cell line from one of the affected individuals that contains the derivative chromosome 20 (20qter-->p12::2q21.3-->qter) but not the derivative chromosome 2, the normal chromosome 2, or the normal chromosome 20. Southern blot and PCR analysis of probes and sequences from 20p have been studied to define the location of the translocation breakpoint. Our results show that the breakpoint lies distal to D20S61 and D20S56 within band 20p12.	CHILDRENS HOSP PHILADELPHIA,DIV GASTROENTEROL & NUTR,PHILADELPHIA,PA 19104; CHILDRENS HOSP PHILADELPHIA,DIV HEMATOL,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,HOWARD HUGHES MED INST,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT GENET,PHILADELPHIA,PA 19104	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania	SPINNER, NB (corresponding author), CHILDRENS HOSP PHILADELPHIA,DIV HUMAN GENET & MOLEC BIOL,34TH ST & CIVIC CTR BLVD,PHILADELPHIA,PA 19104, USA.		Fortina, Paolo/ABE-8350-2020	Fortina, Paolo/0000-0002-5898-2081				ALAGILLE D, 1987, J PEDIATR-US, V110, P195, DOI 10.1016/S0022-3476(87)80153-1; ALAGILLE D, 1975, J PEDIATR-US, V86, P63, DOI 10.1016/S0022-3476(75)80706-2; ANAD F, 1990, J MED GENET, V27, P729, DOI 10.1136/jmg.27.12.729; BYRNE JLB, 1986, AM J MED GENET, V24, P673, DOI 10.1002/ajmg.1320240411; COLLINS FS, 1992, NAT GENET, V1, P3, DOI 10.1038/ng0492-3; DAVIS LM, 1988, SCIENCE, V241, P840, DOI 10.1126/science.2841760; DESMAZE C, 1992, J MED GENET, V29, P233, DOI 10.1136/jmg.29.4.233; DRISCOLL DA, 1993, AM J MED GENET, V44, P261; FOUNTAIN JW, 1989, SCIENCE, V244, P1085, DOI 10.1126/science.2543076; GOODFELLOW PJ, 1987, CYTOGENET CELL GENET, V454, P112; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HANSMANN I, 1993, AM J HUM GENET, V53, P1299; HAZAN J, 1992, GENOMICS, V12, P183, DOI 10.1016/0888-7543(92)90364-X; LABRECQUE DR, 1982, HEPATOLOGY, V2, P467; LEGIUS E, 1990, AM J MED GENET, V35, P532, DOI 10.1002/ajmg.1320350419; LITT M, 1987, CYTOGENET CELL GENET, V46, P651; MELIS R, 1993, GENOMICS, V16, P56, DOI 10.1006/geno.1993.1140; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; NICHOLLS RD, 1989, AM J MED GENET, V33, P66, DOI 10.1002/ajmg.1320330109; OHAGI S, 1992, P NATL ACAD SCI USA, V89, P4977, DOI 10.1073/pnas.89.11.4977; PICCOLI DA, 1991, GASTROINTESTINAL DIS, P1124; PYERITZ RE, 1979, NEW ENGL J MED, V300, P722; RICCARDI VM, 1981, NEW ENGL J MED, V305, P1617, DOI 10.1056/NEJM198112313052704; ROBAKIS NK, 1986, BIOCHEM BIOPH RES CO, V140, P758, DOI 10.1016/0006-291X(86)90796-5; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; SCHNITTGER S, 1989, HUM GENET, V83, P239, DOI 10.1007/BF00285164; SHULMAN SA, 1984, AM J MED GENET, V19, P325, DOI 10.1002/ajmg.1320190215; SPURR NK, 1991, CYTOGENET CELL GENET, V58, P142, DOI 10.1159/000133162; SPURR NK, 1991, CYTOGENET CELL GENET, V58, P785; TEEBI AS, 1992, AM J MED GENET, V42, P35, DOI 10.1002/ajmg.1320420109; WATSON GH, 1973, ARCH DIS CHILD, V48, P459, DOI 10.1136/adc.48.6.459; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; ZHANG FR, 1990, J PEDIATR-US, V116, P73, DOI 10.1016/S0022-3476(05)81648-8; [No title captured]	34	52	54	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1994	55	2					238	243						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NZ336	8037203				2022-12-18	WOS:A1994NZ33600003
J	SPURDLE, AB; HAMMER, MF; JENKINS, T				SPURDLE, AB; HAMMER, MF; JENKINS, T			THE Y-ALU POLYMORPHISM IN SOUTHERN AFRICAN POPULATIONS AND ITS RELATIONSHIP TO OTHER Y-SPECIFIC POLYMORPHISMS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; FRAGMENT LENGTH POLYMORPHISM; HUMAN-EVOLUTION; CHROMOSOME; HAPLOTYPES; SEARCH; SITES	Y-linked polymorphisms were studied in a number of African populations. The frequency of the alleles of a Y-specific Alu insertion polymorphism, termed the ''Y Alu polymorphism,'' was determined in 883 individuals from 23 different African population groups. A trend in frequency was observed, with the insert largely absent in Caucasoid populations, at intermediate frequency in the Khoisan, and at high frequency in Negroids. The insert predates diversification of Home sapiens, since it occurs in all groups. The Alu insertion is believed to result from a unique mutation event, and comparisons between this and several other Y-linked polymorphisms were carried out in an attempt to validate their usefulness in population and evolutionary studies. The p21A1/TaqI and pDP31/EcoRI polymorphisms and 49a/TaqI alleles were all shown to have arisen on more than one occasion, and evidence exists for a preraciation crossover event between the Y-linked pseudoautosomal XY275 locus and the Y chromosome pseudoautosomal boundary.	UNIV ARIZONA,DIV BIOTECHNOL,TUCSON,AZ; UNIV WITWATERSRAND,JOHANNESBURG,SOUTH AFRICA	University of Arizona; University of Witwatersrand	SPURDLE, AB (corresponding author), S AFRICAN INST MED RES,SCH PATHOL,DEPT HUMAN GENET,MRC,HUMAN ECOGENET RES UNIT,POB 1038,JOHANNESBURG 2000,SOUTH AFRICA.		Spurdle, Amanda B/A-4978-2011	Spurdle, Amanda B/0000-0003-1337-7897				BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BATZER MA, 1991, NUCLEIC ACIDS RES, V19, P3619, DOI 10.1093/nar/19.13.3619; BOWCOCK A, 1984, THESIS U WITWATERSRA; Bowcock A M, 1987, Gene Geogr, V1, P47; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; CANN RL, 1984, GENETICS, V106, P479; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; CAVALLISFORZA LL, 1989, 2ND HOM P INT C HUM, P401; DEBENEDICTIS G, 1989, ANN HUM GENET, V53, P311, DOI 10.1111/j.1469-1809.1989.tb01800.x; ELLIS N, 1990, AM J HUM GENET, V46, P950; ELLIS N, AM J HUM GENET, V49, P908; GRUN R, 1990, NATURE, V344, P537, DOI 10.1038/344537a0; GUERIN P, 1988, NUCLEIC ACIDS RES, V156, P7759; JAKUBICZKA S, 1989, HUM GENET, V84, P86, DOI 10.1007/BF00210680; Lucotte G, 1990, Gene Geogr, V4, P21; MALASPINA P, 1990, ANN HUM GENET, V54, P297, DOI 10.1111/j.1469-1809.1990.tb00385.x; Mourant AE, 1978, BLOOD GROUPS DIS; Nei M., 1987, MOL EVOLUTIONARY GEN; NGO KY, 1986, AM J HUM GENET, V38, P407; Nurse GT., 1985, PEOPLES SO AFRICA TH; OLIVER R, 1975, AFRICA IRON AGE; PAGE D, 1982, P NATL ACAD SCI-BIOL, V79, P5352, DOI 10.1073/pnas.79.17.5352; PERSICHETTI F, 1992, ANN HUM GENET, V56, P303, DOI 10.1111/j.1469-1809.1992.tb01157.x; SEMINO O, 1989, ANN HUM GENET, V53, P193, DOI 10.1111/j.1469-1809.1989.tb01784.x; SPURDLE A, 1992, AM J HUM GENET, V50, P107; SPURDLE A, 1992, HUM MOL GENET, V1, P169, DOI 10.1093/hmg/1.3.169; SPURDLE A, 1992, AM J HUM GENET, V50, P1301; SPURDLE AB, 1992, THESIS U WITWATERSRA; Spurdle AB, 1992, CURR OPIN GENET DEV, V2, P487, DOI 10.1016/S0959-437X(05)80162-5; TORRONI A, 1990, ANN HUM GENET, V54, P287; Van Warmelo N. J., 1974, BANTU SPEAKING PEOPL, P56; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WAINSCOAT JS, 1986, NATURE, V319, P491, DOI 10.1038/319491a0	34	52	60	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1994	54	2					319	330						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU315	8304348				2022-12-18	WOS:A1994MU31500016
J	WILKIE, AOM				WILKIE, AOM			DETECTION OF CRYPTIC CHROMOSOMAL-ABNORMALITIES IN UNEXPLAINED MENTAL-RETARDATION - A GENERAL STRATEGY USING HYPERVARIABLE SUBTELOMERIC DNA POLYMORPHISMS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRADER-WILLI SYNDROME; FLUORESCENCE INSITU HYBRIDIZATION; UNIPARENTAL PATERNAL DISOMY; WOLF-HIRSCHHORN SYNDROME; GENETIC-LINKAGE MAP; HUMAN GENOME; REDUCED RECOMBINATION; MOLECULAR ANALYSIS; SHORT ARM; ISODISOMY	Given the availability of DNA from both parents, unusual segregation of hypervariable DNA polymorphisms (HVPs) in the offspring may be attributable to deletion, unbalanced chromosomal translocation, or uniparental disomy. The telomeric regions of chromosomes are rich in both genes and hypervariable minisatellite sequences and may also be particularly prone to cryptic breakage events. Here I describe and analyze a general approach to the detection of subtelomeric abnormalities and uniparental disomy in patients with unexplained mental retardation. With 29 available polymorphic systems, approximately 50%-70% of these abnormalities could currently be detected. Development of subtelomeric HVPs physically localized with respect to their telomeres should provide a valuable resource in routine diagnostics.			WILKIE, AOM (corresponding author), UNIV HOSP WALES,INST MED GENET,HEATH PK,CARDIFF CF4 4XW,S GLAM,WALES.		Wilkie, Andrew/AAC-3820-2020	Wilkie, Andrew/0000-0002-2972-5481				ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; ALTHERR MR, 1991, AM J HUM GENET, V49, P1235; [Anonymous], 1985, INT SYSTEM HUMAN CYT; ANTONARAKIS SE, 1993, NAT GENET, V3, P146, DOI 10.1038/ng0293-146; BATES GP, 1991, AM J HUM GENET, V49, P7; BELDJORD C, 1992, BLOOD, V80, P287; BENNETT P, 1992, LANCET, V340, P1284, DOI 10.1016/0140-6736(92)92980-T; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BOWCOCK AM, 1984, BRIT J HAEMATOL, V56, P69, DOI 10.1111/j.1365-2141.1984.tb01272.x; CASSIDY SB, 1992, AM J HUM GENET, V51, P701; CATTANACH BM, 1990, DEVELOPMENT, P63; CHAKRAVARTI A, 1987, Genomics, V1, P35, DOI 10.1016/0888-7543(87)90102-9; CHAKRAVARTI A, 1989, AM J HUM GENET, V44, P639; CHAO LY, 1993, NAT GENET, V3, P127, DOI 10.1038/ng0293-127; COX DR, 1991, CYTOGENET CELL GENET, V58, P800, DOI 10.1159/000133181; DAIGER SP, 1983, AM J MED GENET, V14, P43, DOI 10.1002/ajmg.1320140108; DANIEL A, 1985, CLIN GENET, V28, P216; DAUWERSE JG, 1992, HUM MOL GENET, V1, P593, DOI 10.1093/hmg/1.8.593; DEKA R, 1990, AM J HUM GENET, V47, P644; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; DWORNICZAK B, 1992, LANCET, V340, P1285; ENGEL E, 1991, AM J MED GENET, V40, P432, DOI 10.1002/ajmg.1320400411; GOODSHIP J, 1992, J MED GENET, V29, P451; GRUNDY P, 1991, LANCET, V338, P1079, DOI 10.1016/0140-6736(91)91937-P; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HASSOLD TJ, 1991, J MED GENET, V28, P159, DOI 10.1136/jmg.28.3.159; HELMS C, 1992, GENOMICS, V14, P1041, DOI 10.1016/S0888-7543(05)80128-4; Henry I., 1993, European Journal of Human Genetics, V1, P19; HENRY I, 1991, NATURE, V351, P665, DOI 10.1038/351665a0; HIGGS DR, 1989, BLOOD, V73, P1081; KALOUSEK DK, 1993, AM J HUM GENET, V52, P8; KIDD KK, 1989, CYTOGENET CELL GENET, V51, P622, DOI 10.1159/000132810; KUWANO A, 1991, AM J HUM GENET, V49, P707; LAMB J, 1989, LANCET, V2, P819; LAMB J, 1993, AM J HUM GENET, V52, P668; LAURIE DA, 1985, ANN HUM GENET, V49, P203, DOI 10.1111/j.1469-1809.1985.tb01694.x; LEDBETTER DH, 1992, AM J HUM GENET, V51, P451; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; MASCARI MJ, 1992, NEW ENGL J MED, V326, P1599, DOI 10.1056/NEJM199206113262404; MUTIRANGURA A, 1993, HUM MOL GENET, V2, P143, DOI 10.1093/hmg/2.2.143; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; OVERHAUSER J, 1989, AM J HUM GENET, V45, P296; PENTAO L, 1992, AM J HUM GENET, V50, P690; PETERSEN MB, 1992, GENOMICS, V13, P269, DOI 10.1016/0888-7543(92)90242-K; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; PURVISSMITH SG, 1992, AM J HUM GENET, V50, P1348; RIED T, 1992, P NATL ACAD SCI USA, V89, P1388, DOI 10.1073/pnas.89.4.1388; ROBINSON WP, 1991, AM J HUM GENET, V49, P1219; ROSENBERG C, 1992, AM J HUM GENET, V50, P700; ROYLE NJ, 1988, GENOMICS, V3, P352, DOI 10.1016/0888-7543(88)90127-9; SACCONE S, 1992, P NATL ACAD SCI USA, V89, P4913, DOI 10.1073/pnas.89.11.4913; Schinzel A, 1983, CATALOGUE UNBALANCED; SHERMAN SL, 1991, AM J HUM GENET, V49, P608; SPENCE JE, 1988, AM J HUM GENET, V42, P217; SPOTILA LD, 1992, AM J HUM GENET, V51, P1396; STALLINGS RL, 1990, P NATL ACAD SCI USA, V87, P6218, DOI 10.1073/pnas.87.16.6218; STALLINGS RL, 1991, GENOMICS, V10, P807, DOI 10.1016/0888-7543(91)90467-S; STOLL C, 1980, HUM GENET, V56, P89; SUTCLIFFE JG, 1988, ANNU REV NEUROSCI, V11, P157, DOI 10.1146/annurev.ne.11.030188.001105; VASARHELYI K, 1989, ANN HUM GENET, V53, P375, DOI 10.1111/j.1469-1809.1989.tb01805.x; VOSS R, 1989, AM J HUM GENET, V45, P373; WAHLSTROM J, 1990, J MENT DEFIC RES, V34, P11; WANG D, 1992, P NATL ACAD SCI USA, V89, P3222, DOI 10.1073/pnas.89.8.3222; WANG JCC, 1991, AM J HUM GENET, V48, P1069; WAPENAAR MC, 1992, GENOMICS, V13, P167, DOI 10.1016/0888-7543(92)90217-G; WARREN AC, 1987, SCIENCE, V237, P652, DOI 10.1126/science.2955519; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WELCH TR, 1990, J CLIN INVEST, V86, P675, DOI 10.1172/JCI114760; WILKIE AOM, 1991, CELL, V64, P595, DOI 10.1016/0092-8674(91)90243-R; WILKIE AOM, 1990, AM J HUM GENET, V46, P1112; WILKIE AOM, 1991, NATURE, V353, P802, DOI 10.1038/353802b0; WILLIAMSON R, 1990, CYTOGENET CELL GENET, V55, P457, DOI 10.1159/000133027; WILLIAMSON R, 1991, CYTOGENET CELL GENET, V58, P1190, DOI 10.1159/000133727	73	52	52	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1993	53	3					688	701						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LU559	8352277				2022-12-18	WOS:A1993LU55900013
J	FARRER, LA; CUPPLES, LA; WIATER, P; CONNEALLY, PM; GUSELLA, JF; MYERS, RH				FARRER, LA; CUPPLES, LA; WIATER, P; CONNEALLY, PM; GUSELLA, JF; MYERS, RH			THE NORMAL HUNTINGTON DISEASE (HD) ALLELE, OR A CLOSELY LINKED GENE, INFLUENCES AGE AT ONSET OF HD	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRION PROTEIN; CHOREA; HETEROGENEITY; INHERITANCE; TRANSMISSION; CHROMOSOME-4; RELIABILITY; FAMILIES; HISTORY	We evaluated the hypothesis that Huntington disease (HD) is influenced by the normal HD allele by comparing transmission patterns of genetically linked markers at the D4S10 locus in the normal parent against age at onset in the affected offspring. Analysis of information from 21 sibships in 14 kindreds showed a significant tendency for sibs who have similar onset ages to share the same D4S10 allele from the normal parent. Affected sibs who inherited different D4S10 alleles from the normal parent tended to have more variable ages at onset. These findings suggest that the expression of HD is modulated by the normal HD allele or by a closely linked locus.	BOSTON UNIV,SCH PUBL HLTH,DEPT EPIDEMIOL & BIOSTAT,BOSTON,MA 02215; HARVARD UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02115; MASSACHUSETTS GEN HOSP,MOLEC NEUROGENET LAB,BOSTON,MA 02114; INDIANA UNIV,SCH MED,DEPT MED GENET,INDIANAPOLIS,IN 46202	Boston University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Indiana University System; Indiana University-Purdue University Indianapolis	FARRER, LA (corresponding author), BOSTON UNIV,SCH MED,DEPT NEUROL,80 E CONCORD ST,BOSTON,MA 02118, USA.		Farrer, Lindsay/AAS-1035-2020	Farrer, Lindsay/0000-0001-5533-4225; Myers, Richard/0000-0002-8365-2674				BAKER HF, 1991, LANCET, V337, P1286, DOI 10.1016/0140-6736(91)92953-Y; BELL J, 1934, TREASURY HUMAN INHER, V4, P1; BOEHNKE M, 1983, AM J HUM GENET, V35, P845; COLLINGE J, 1989, LANCET, V2, P15, DOI 10.1016/S0140-6736(89)90256-0; CONNEALLY PM, 1984, AM J HUM GENET, V36, P506; CONNEALLY PM, 1989, GENOMICS, V5, P304, DOI 10.1016/0888-7543(89)90062-1; ERICKSON RP, 1985, AM J HUM GENET, V37, P827; FARRER LA, 1984, AM J MED GENET, V18, P115, DOI 10.1002/ajmg.1320180115; FARRER LA, 1985, AM J HUM GENET, V37, P350; FARRER LA, 1992, AM J HUM GENET, V50, P528; FARRER LA, 1989, J PSYCHIAT RES, V23, P35, DOI 10.1016/0022-3956(89)90015-0; FARRER LA, 1987, ARCH NEUROL-CHICAGO, V44, P109, DOI 10.1001/archneur.1987.00520130083023; FAUGHT E, 1983, SOUTHERN MED J, V76, P1266, DOI 10.1097/00007611-198310000-00018; GILLIAM TC, 1987, CELL, V50, P565, DOI 10.1016/0092-8674(87)90029-8; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HALL JG, 1983, AM J MED GENET, V16, P289, DOI 10.1002/ajmg.1320160218; Hayden MR., 1981, HUNTINGTONS CHOREA, P45; LAIRD CD, 1990, TRENDS GENET, V6, P242, DOI 10.1016/0168-9525(90)90206-L; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MERRITT AD, 1969, PROGR NEUROGENETICS, P645; MYERS RH, 1991, ARCH NEUROL-CHICAGO, V48, P800, DOI 10.1001/archneur.1991.00530200036015; MYERS RH, 1983, LANCET, V1, P208; MYERS RH, 1982, AM J HUM GENET, V34, P481; MYERS RH, 1985, AM J HUM GENET, V37, P511; MYERS RH, 1985, J NEUROL NEUROSUR PS, V48, P530, DOI 10.1136/jnnp.48.6.530; NEWCOMBE RG, 1981, ANN HUM GENET, V45, P387, DOI 10.1111/j.1469-1809.1981.tb00352.x; PERICAKVANCE MA, 1983, AM J MED GENET, V14, P49, DOI 10.1002/ajmg.1320140109; REIK W, 1988, J MED GENET, V25, P805, DOI 10.1136/jmg.25.12.805; RIDLEY RM, 1991, J MED GENET, V28, P224, DOI 10.1136/jmg.28.4.224; RIDLEY RM, 1988, J MED GENET, V25, P589, DOI 10.1136/jmg.25.9.589; RIDLEY RM, 1992, AM J HUM GENET, V50, P536; SAX DS, 1989, NEUROLOGY, V39, P1332, DOI 10.1212/WNL.39.10.1332; SILVERMAN JM, 1986, AM J PSYCHIAT, V143, P1279; STEVENS DL, 1976, THESIS U LONDON LOND; SUDARSKY L, 1983, J MED GENET, V20, P408, DOI 10.1136/jmg.20.6.408; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; WALLACE DC, 1972, J NEUROL NEUROSUR PS, V35, P789, DOI 10.1136/jnnp.35.6.789; ZWEIG RM, 1989, ANN NEUROL, V26, P778	38	52	53	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1993	53	1					125	130						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ385	8317477				2022-12-18	WOS:A1993LJ38500016
J	LI, L; BRAY, PF				LI, L; BRAY, PF			HOMOLOGOUS RECOMBINATION AMONG 3 INTRAGENE ALU SEQUENCES CAUSES AN INVERSION-DELETION RESULTING IN THE HEREDITARY BLEEDING DISORDER GLANZMANN THROMBASTHENIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DENSITY LIPOPROTEIN RECEPTOR; PLATELET GLYCOPROTEIN-IIIA; VITRONECTIN-RECEPTOR; FAMILIAL HYPERCHOLESTEROLEMIA; ALPHA-SUBUNITS; GENE; IIB; DISEASE; EXON; IDENTIFICATION	The crucial role of the human platelet fibrinogen receptor in maintaining normal hemostasis is best exemplified by the autosomal recessive bleeding disorder Glanzmann thrombasthenia (GT). The platelet fibrinogen receptor is a heterodimer composed of glycoproteins IIb (GPIIb) and IIIa (GPIIIa). Platelets from patients with GT have a quantitative or qualitative abnormality in GPIIb and GPIIIa and can neither bind fibrinogen nor aggregate. Very few genetic defects have been identified that cause this disorder. We describe a kindred with GT in which the affected individuals have a unique inversion-deletion mutation in the gene for GPIIIa. Patient platelets lacked both GPIIIa protein and mRNA. Southern blots of patient genomic DNA probed with an internal 1.0-kb GPIIIa cDNA suggested a large rearrangement of this gene but were normal when probed with small GPIIIa cDNA fragments that were outside the mutation. Cytogenetics and pulsed-field gel analysis of the GPIIIa gene were normal, making a translocation or a very large rearrangement unlikely. Additional Southern analyses suggested that the abnormality was not a small insertion. We constructed a patient genomic DNA library and isolated fragments containing the 5' and 3' breakpoints of the mutation. The nucleotide sequence from these genomic clones was determined and revealed that, relative to the normal gene, the mutant allele contained a 1-kb deletion immediately preceding a 15-kb inversion. The DNA breaks occurred in two inverted and one forward Alu sequence within the gene for GPIIIa and in the left, right, and left arms, respectively, of these sequences. There was a 5-bp repeat at the 3' terminus of the inversion. One copy of the repeat remained in the mutant allele breakpoint junction. The alignment and orientation of the different Alu sequences, as well as the position of the breakpoints, suggest that the inversion preceded the deletion in this complex rearrangement. This is a highly unusual inversion-deletion causing a human disease. We are unaware of a previously described inversion-deletion recombination event with all three breakpoints occurring in Alu sequences.	JOHNS HOPKINS UNIV,SCH MED,DEPT MED,720 RUTLAND AVE,ROSS 1015,BALTIMORE,MD 21205	Johns Hopkins University					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL043020] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL43020] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BENNETT JS, 1979, J CLIN INVEST, V64, P1393, DOI 10.1172/JCI109597; BOTCHAN M, 1980, CELL, V20, P143, DOI 10.1016/0092-8674(80)90242-1; BRAY PF, 1990, J BIOL CHEM, V265, P9587; BRAY PF, 1990, BLOOD, V75, P881; BRAY PF, 1988, P NATL ACAD SCI USA, V85, P8683, DOI 10.1073/pnas.85.22.8683; BRAY PF, 1987, J CLIN INVEST, V80, P1812, DOI 10.1172/JCI113277; BURK CD, 1991, J CLIN INVEST, V87, P270, DOI 10.1172/JCI114982; DAVIES J, 1989, J CELL BIOL, V109, P1817, DOI 10.1083/jcb.109.4.1817; DEININGER PL, 1981, J MOL BIOL, V151, P17, DOI 10.1016/0022-2836(81)90219-9; DEVLIN RH, 1990, AM J HUM GENET, V46, P112; FITZGERALD LA, 1987, J BIOL CHEM, V262, P3936; GEORGE JN, 1990, BLOOD, V75, P1383; GILTAY JC, 1988, BLOOD, V72, P230; GINSBERG MH, 1987, J BIOL CHEM, V262, P5437; Glanzmann E, 1918, J KINDERKR, V88, P113; HEIDENREICH R, 1990, BIOCHEMISTRY-US, V29, P1232, DOI 10.1021/bi00457a020; HUANG LS, 1989, J BIOL CHEM, V264, P11394; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; JELINEK WR, 1980, P NATL ACAD SCI-BIOL, V77, P1398, DOI 10.1073/pnas.77.3.1398; JENNINGS MW, 1985, NUCLEIC ACIDS RES, V13, P2897, DOI 10.1093/nar/13.8.2897; KATO A, 1992, BLOOD, V79, P3212; KORNREICH R, 1990, J BIOL CHEM, V265, P9319; LEHRMAN MA, 1986, P NATL ACAD SCI USA, V83, P3679, DOI 10.1073/pnas.83.11.3679; LEHRMAN MA, 1987, J BIOL CHEM, V262, P3354; LOFTUS JC, 1990, SCIENCE, V249, P915, DOI 10.1126/science.2392682; MARKERT ML, 1988, J CLIN INVEST, V81, P1323, DOI 10.1172/JCI113458; NEOTE K, 1990, J CLIN INVEST, V86, P1524, DOI 10.1172/JCI114871; NEWMAN PJ, 1991, P NATL ACAD SCI USA, V88, P3160, DOI 10.1073/pnas.88.8.3160; NURDEN AT, 1974, BRIT J HAEMATOL, V28, P253, DOI 10.1111/j.1365-2141.1974.tb06660.x; OTOOLE TE, 1989, BLOOD, V74, P14; PAOLELLA G, 1983, EMBO J, V2, P691, DOI 10.1002/j.1460-2075.1983.tb01486.x; PONCZ M, 1987, J BIOL CHEM, V262, P8476; PYTELA R, 1986, SCIENCE, V231, P1559, DOI 10.1126/science.2420006; ROSA JP, 1988, BLOOD, V72, P593; RULEY HE, 1983, NATURE, V304, P181, DOI 10.1038/304181a0; RUSSELL ME, 1988, P NATL ACAD SCI USA, V72, P1833; Sambrook J., 1989, MOL CLONING LAB MANU; STOPPALYONNET D, 1990, P NATL ACAD SCI USA, V87, P1551, DOI 10.1073/pnas.87.4.1551; VANDERPUYE OA, 1991, BIOCHEM J, V280, P9, DOI 10.1042/bj2800009; WILLARD C, 1987, J MOL EVOL, V26, P180, DOI 10.1007/BF02099850; ZIMRIN AB, 1990, J BIOL CHEM, V265, P8590	41	52	52	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1993	53	1					140	149						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ385	8317479				2022-12-18	WOS:A1993LJ38500018
J	SINNETT, D; WAGSTAFF, J; GLATT, K; WOOLF, E; KIRKNESS, EJ; LALANDE, M				SINNETT, D; WAGSTAFF, J; GLATT, K; WOOLF, E; KIRKNESS, EJ; LALANDE, M			HIGH-RESOLUTION MAPPING OF THE GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT-BETA-3 AND ALPHA-5 GENE-CLUSTER ON CHROMOSOME-15Q11-Q13, AND LOCALIZATION OF BREAKPOINTS IN 2 ANGELMAN SYNDROME PATIENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRADER-WILLI SYNDROME; NICOTINIC ACETYLCHOLINE-RECEPTOR; PARENTAL ORIGIN; 15Q DELETIONS; PROXIMAL 15Q; DNA STRANDS; LOCUS; REGION; EXPRESSION; ORGANIZATION	The gamma-aminobutyric acid (GABA(A)) receptors are a family of ligand-gated chloride channels constituting the major inhibitory neurotransmitter receptors in the nervous system. In order to determine the genomic organization of the GABA(A) receptor beta3 subunit gene (GABRB3) and alpha5 subunit gene (GABRA5) in chromosome 15q11-q13, we have constructed a high-resolution physical map using the combined techniques of field-inversion gel electrophoresis and phage genomic library screening. This map, which covers nearly 1.0 Mb, shows that GABRB3 and GABRA5 are separated by less than 100 kb and are arranged in a head-to-head configuration. GABRB3 encompasses approximately 250 kb, while GABRA5 is contained within 70 kb. This difference in size is due in large part to an intron of 150 kb within GABRB3. We have also identified seven putative CpG islands within a 600-kb interval. Chromosomal rearrangement breakpoints-in one Angelman syndrome (AS) patient with an unbalanced translocation and in another patient with a submicroscopic deletion-are located within the large GABRB3 intron. These findings will facilitate chromosomal walking strategies for cloning the regions disrupted by the DNA rearrangements in these AS patients and will be valuable for mapping new genes to the AS chromosomal region.	CHILDRENS HOSP MED CTR,DIV GENET,300 LONGWOOD AVE,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02115; HOWARD HUGHES MED INST,BOSTON,MA; NIAAA,MOLEC NEUROBIOL SECT,NEUROGENET LAB,ROCKVILLE,MD 20852	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)			sinnett, daniel/S-4589-2017	sinnett, daniel/0000-0003-3625-6676	NINDS NIH HHS [R01NS30628-01] Funding Source: Medline; PHS HHS [P01H018658-11] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030628] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADELMAN JP, 1987, SCIENCE, V235, P1514, DOI 10.1126/science.3547652; ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; BETZ H, 1990, NEURON, V5, P383, DOI 10.1016/0896-6273(90)90077-S; BIRD PA, 1987, TRENDS GENET, V3, P324; BOULTER J, 1990, J BIOL CHEM, V265, P4472; BRUNK CF, 1979, ANAL BIOCHEM, V92, P497, DOI 10.1016/0003-2697(79)90690-0; BUCKLE VJ, 1989, NEURON, V3, P647, DOI 10.1016/0896-6273(89)90275-4; BUITING K, 1990, GENOMICS, V6, P521, DOI 10.1016/0888-7543(90)90481-9; BUTLER MG, 1983, LANCET, V1, P1285; BUTLER MG, 1990, AM J MED GENET, V35, P319, DOI 10.1002/ajmg.1320350306; CATTANACH BM, 1992, NAT GENET, V2, P270, DOI 10.1038/ng1292-270; Clayton-Smith J., 1992, HUM GENET, V88, P376; CUTTING GR, 1992, GENOMICS, V12, P801, DOI 10.1016/0888-7543(92)90312-G; DELOREY TM, 1992, J BIOL CHEM, V267, P16747; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FORRESTER WC, 1990, GENE DEV, V4, P1637, DOI 10.1101/gad.4.10.1637; FORUS A, 1992, GENOMICS, V14, P117, DOI 10.1016/S0888-7543(05)80292-7; GARDINER K, 1986, SOMAT CELL MOLEC GEN, V12, P185, DOI 10.1007/BF01560665; GREENBERG F, 1987, AM J MED GENET, V28, P813, DOI 10.1002/ajmg.1320280405; HAMABE J, 1991, AM J MED GENET, V41, P64, DOI 10.1002/ajmg.1320410117; HAMABE J, 1991, AM J MED GENET, V41, P54, DOI 10.1002/ajmg.1320410116; HENTSCHEL CC, 1981, CELL, V25, P301, DOI 10.1016/0092-8674(81)90048-9; HIGGINS MJ, 1989, MOL CELL BIOL, V9, P1; HOHEISEL JD, 1989, NUCLEIC ACIDS RES, V17, P8571; KAPLAN LC, 1987, AM J MED GENET, V28, P45, DOI 10.1002/ajmg.1320280107; KIRKNESS EF, 1993, J BIOL CHEM, V268, P4420; KNOLL JHM, 1990, AM J HUM GENET, V47, P149; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; KNOLL JHM, 1993, HUM MOL GENET, V2, P183, DOI 10.1093/hmg/2.2.183; KOFUJI P, 1991, J NEUROCHEM, V56, P713, DOI 10.1111/j.1471-4159.1991.tb08209.x; Kuwano Akira, 1992, Human Molecular Genetics, V1, P417, DOI 10.1093/hmg/1.6.417; LALANDE M, 1984, CANCER GENET CYTOGEN, V13, P283, DOI 10.1016/0165-4608(84)90073-6; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; LASHAM A, 1991, J NEUROCHEM, V57, P352, DOI 10.1111/j.1471-4159.1991.tb02135.x; LEDBETTER DH, 1981, NEW ENGL J MED, V304, P325, DOI 10.1056/NEJM198102053040604; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; LEVINSON B, 1992, GENOMICS, V14, P585, DOI 10.1016/S0888-7543(05)80155-7; LINDSAY S, 1987, NATURE, V327, P336, DOI 10.1038/327336a0; MAGENIS RE, 1990, AM J MED GENET, V35, P333, DOI 10.1002/ajmg.1320350307; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; MIYAJIMA N, 1989, CELL, V57, P31, DOI 10.1016/0092-8674(89)90169-4; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; NEF P, 1984, P NATL ACAD SCI-BIOL, V81, P7975, DOI 10.1073/pnas.81.24.7975; NICHOLLS RD, 1989, AM J MED GENET, V33, P66, DOI 10.1002/ajmg.1320330109; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; OZCELIK T, 1992, NAT GENET, V2, P265, DOI 10.1038/ng1292-265; PEMBREY M, 1989, J MED GENET, V26, P73, DOI 10.1136/jmg.26.2.73; POSCHL E, 1988, EMBO J, V7, P2687, DOI 10.1002/j.1460-2075.1988.tb03122.x; REIS A, 1993, LANCET, V341, P122, DOI 10.1016/0140-6736(93)92606-T; ROBINSON WP, 1991, AM J HUM GENET, V49, P1219; SAITOH S, 1992, LANCET, V339, P366, DOI 10.1016/0140-6736(92)91686-3; Sambrook J., 1989, MOL CLONING LAB MANU; SMEETS DFCM, 1992, NEW ENGL J MED, V326, P807, DOI 10.1056/NEJM199203193261206; SOMMER B, 1990, DNA CELL BIOL, V9, P561, DOI 10.1089/dna.1990.9.561; TANTRAVAHI U, 1989, AM J MED GENET, V33, P78, DOI 10.1002/ajmg.1320330110; WAGSTAFF J, 1992, NAT GENET, V1, P291, DOI 10.1038/ng0792-291; WAGSTAFF J, 1991, AM J HUM GENET, V49, P330; WAGSTAFF J, 1991, GENOMICS, V11, P1071, DOI 10.1016/0888-7543(91)90034-C; WHITING P, 1990, P NATL ACAD SCI USA, V87, P9966, DOI 10.1073/pnas.87.24.9966; WILCOX AS, 1992, P NATL ACAD SCI USA, V89, P5857, DOI 10.1073/pnas.89.13.5857; WILLIAMS CA, 1990, AM J MED GENET, V35, P350, DOI 10.1002/ajmg.1320350308; WILLIAMS CA, 1989, AM J MED GENET, V32, P339, DOI 10.1002/ajmg.1320320313; WILLIAMS T, 1986, NATURE, V322, P275, DOI 10.1038/322275a0	64	52	53	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1993	52	6					1216	1229						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LG133	8389098				2022-12-18	WOS:A1993LG13300023
J	CHAMBERLAIN, JS; BOEHNKE, M; FRANK, TS; KIOUSIS, S; XU, JX; GUO, SW; HAUSER, ER; NORUM, RA; HELMBOLD, EA; MARKEL, DS; KESHAVARZI, SM; JACKSON, CE; CALZONE, K; GARBER, J; COLLINS, FS; WEBER, BL				CHAMBERLAIN, JS; BOEHNKE, M; FRANK, TS; KIOUSIS, S; XU, JX; GUO, SW; HAUSER, ER; NORUM, RA; HELMBOLD, EA; MARKEL, DS; KESHAVARZI, SM; JACKSON, CE; CALZONE, K; GARBER, J; COLLINS, FS; WEBER, BL			BRCA1 MAPS PROXIMAL TO D17S579 ON CHROMOSOME-17Q21 BY GENETIC-ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BREAST-CANCER; RISK	Previous studies have demonstrated linkage between early-onset breast cancer and ovarian cancer and genetic markers on chromosome 17q21. These markers define the location of a gene (BRCA1) which appears to be inherited as an autosomal dominant susceptibility allele. We analyzed five families with multiple affected individuals for evidence of linkage to the BRCA1 region. Two of the five families appear to be linked to BRCA1. One apparently linked family contains critical recombinants, suggesting that the gene is proximal to the marker D17S579 (Mfd188). These findings are consistent with the maximum-likelihood position estimated by the Breast Cancer Linkage Consortium and with recombination events detected in other linked families. Linkage analysis was greatly aided by PCR-based analysis of paraffin-embedded normal breast tissue from deceased family members, demonstrating the feasibility and importance of this approach. One of the two families with evidence of linkage between breast cancer and genetic markers flanking BRCA1 represents the first such family of African-American descent to be reported in detail.	UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,ANN ARBOR,MI 48104; UNIV MICHIGAN,SCH MED,DEPT INTERNAL MED,ANN ARBOR,MI 48104; UNIV MICHIGAN,SCH MED,DEPT PATHOL,ANN ARBOR,MI 48104; UNIV NANCY 1,SCH PUBL HLTH,DEPT BIOSTAT,F-54506 VANDOEUVRE NANCY,FRANCE; UNIV MICHIGAN,CTR HUMAN GENOME,ANN ARBOR,MI 48109; HOWARD HUGHES MED INST,ANN ARBOR,MI; HARVARD UNIV,SCH MED,DANA FARBER CANC INST,BOSTON,MA 02115; HENRY FORD HOSP,DETROIT,MI 48202	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Universite de Lorraine; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Henry Ford Health System; Henry Ford Hospital				Hauser, Elizabeth/0000-0003-0367-9189; Calzone, Kathleen/0000-0002-2354-6810; Chamberlain, Jeffrey/0000-0001-5299-0059; Markel, Dorene/0000-0002-3382-6779	NATIONAL CANCER INSTITUTE [R01CA057601] Funding Source: NIH RePORTER; NCI NIH HHS [CA57601, CA32280] Funding Source: Medline; NHGRI NIH HHS [HG00209] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BOEHNKE M, 1991, AM J HUM GENET, V48, P22; BOWCOCK AM, 1993, AM J HUM GENET, V52, P718; CLAUS EB, 1991, AM J HUM GENET, V48, P232; EASTON DF, 1993, AM J HUM GENET, V52, P678; HALL JM, 1992, AM J HUM GENET, V50, P1235; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LEDBETTER SA, 1990, GENOMICS, V7, P264, DOI 10.1016/0888-7543(90)90549-A; MORTON NE, 1955, AM J HUM GENET, V7, P277; NAROD SA, 1991, LANCET, V338, P82; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P3044, DOI 10.1073/pnas.85.9.3044; SATTIN RW, 1985, JAMA-J AM MED ASSOC, V253, P1908, DOI 10.1001/jama.253.13.1908; SMITH SA, 1992, NAT GENET, V2, P128, DOI 10.1038/ng1092-128; WALLACE MR, 1989, NUCLEIC ACIDS RES, V17, P1665, DOI 10.1093/nar/17.4.1665; WHITE R, 1992, 3RD INT WORKSH HUM C	16	52	55	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1993	52	4					792	798						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KY059	8460646				2022-12-18	WOS:A1993KY05900020
J	BAKER, E; GUO, XH; ORSBORN, AM; SUTHERLAND, GR; CALLEN, DF; HOPWOOD, JJ; MORRIS, CP				BAKER, E; GUO, XH; ORSBORN, AM; SUTHERLAND, GR; CALLEN, DF; HOPWOOD, JJ; MORRIS, CP			THE MORQUIO-A SYNDROME (MUCOPOLYSACCHARIDOSIS IVA) GENE MAPS TO 16Q24.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOMAL LOCALIZATION	The gene for N-acetylgalactosamine-6-sulfatase, the deficiency of which results in Morquio A syndrome (mucopolysaccharidosis type IVA), was assigned to chromosome 16 at band q24.3 by fluorescence in situ hybridization. Localization to this band was confirmed by PCR analysis of a somatic cell hybrid panel used for fine mapping of chromosome 16.	ADELAIDE CHILDRENS HOSP INC,DEPT CYTOGENET & MOLEC GENET,ADELAIDE,SA 5006,AUSTRALIA; ADELAIDE CHILDRENS HOSP INC,DEPT CHEM PATHOL,LYSOSOMAL DIS RES UNIT,ADELAIDE,SA 5006,AUSTRALIA				Callen, David F/G-1975-2012; Sutherland, Grant Robert/D-2606-2012	Callen, David/0000-0002-6189-9991; Morris, Phillip/0000-0001-8976-619X				ALLANSON JE, 1988, AM J MED GENET, V29, P517, DOI 10.1002/ajmg.1320290307; CALLEN DF, 1992, GENOMICS, V13, P1178, DOI 10.1016/0888-7543(92)90035-Q; CALLEN DF, 1990, ANN GENET-PARIS, V33, P219; LITJENS T, 1989, HUM GENET, V82, P67, DOI 10.1007/BF00288275; Neufeld EF, 1989, METABOLIC BASIS INHE, P1565; REEDERS ST, 1991, CYTOGENET CELL GENET, V58, P643, DOI 10.1159/000133176; ROBERTSON DA, 1988, HUM GENET, V79, P175, DOI 10.1007/BF00280560; Roden L., 1980, BIOCH GLYCOPROTEINS, P267; SCOTT HS, 1990, AM J HUM GENET, V47, P802; SHOWS TB, 1979, SOMAT CELL GENET, V5, P147, DOI 10.1007/BF01539157; TOMATSU S, 1991, BIOCHEM BIOPH RES CO, V181, P677, DOI 10.1016/0006-291X(91)91244-7; WILSON PJ, 1991, HUM GENET, V86, P505	12	52	54	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1993	52	1					96	98						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KK908	8434612				2022-12-18	WOS:A1993KK90800012
J	SPURDLE, A; JENKINS, T				SPURDLE, A; JENKINS, T			Y-CHROMOSOME PROBE P49A DETECTS COMPLEX PVUII HAPLOTYPES AND MANY NEW TAQI HAPLOTYPES IN SOUTHERN AFRICAN POPULATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA POLYMORPHISMS; EVOLUTION; SEQUENCES; DISTANCE; FAMILIES	Y-specific 49a/TaqI haplotypes were determined for 831 individuals drawn from 21 different southern African populations. A total of 31 new haplotypes were observed, some of which contained new alleles or allelic variants. Duplication, in addition to CpG mutation, is implicated in the generation of certain allelic variants. Cluster analysis of genetic distances between the populations, calculated using the 49a/TaqI haplotype frequencies, revealed a basic split between African and non-African populations. Hybrid groups cluster with the caucasoid groups, indicating that male gene flow has occurred from the latter into the former. Clustering of the negroid and Khoisan groups is not what might have been expected from the known linguistic affinities. It is suggested that the 49a/TaqI haplotype analysis of these populations is not sufficiently sensitive to distinguish between many of the populations. The Y-specific 49a/PvuII polymorphism was studied in 127 individuals from southern African populations, and 17 polymorphic fragments ranging in size from 3.6 kb to > 48 kb were identified. A total of 53 PvuII haplotypes were observed, corresponding to only 30 TaqI haplotypes. There appears to be poor correlation between the two polymorphisms.	UNIV WITWATERSRAND,JOHANNESBURG 2001,SOUTH AFRICA	University of Witwatersrand	SPURDLE, A (corresponding author), S AFRICAN INST MED RES,SCH PATHOL,DEPT HUMAN GENET,MRC,HUMAN ECOGENET RES UNIT,POB 1038,JOHANNESBURG 2000,SOUTH AFRICA.		Spurdle, Amanda B/A-4978-2011	Spurdle, Amanda B/0000-0003-1337-7897				ARNEMANN J, 1985, CYTOGENET CELL GENET, V40, P571; BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BISHOP CE, 1983, NATURE, V303, P831, DOI 10.1038/303831a0; BREUIL S, 1987, ANN GENET-PARIS, V30, P209; CASANOVA M, 1985, SCIENCE, V230, P1403, DOI 10.1126/science.2999986; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; CAVALLISFORZA LL, 1986, COLD SPRING HARB SYM, V51, P411, DOI 10.1101/SQB.1986.051.01.049; CAVALLISFORZA LL, 1974, BIOL ANTHR READINGS, P265; COHENHAGUENAUER O, 1987, CYTOGENET CELL GENET, V46, P596; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GUERIN P, 1988, NUCLEIC ACIDS RES, V156, P7759; HARDING RM, 1988, P NATL ACAD SCI USA, V85, P9370, DOI 10.1073/pnas.85.23.9370; HARPENDING HC, 1973, METHODS THEORIES ANT, P177; Hartl D. L., 1989, PRINCIPLES POPULATIO; HUFFMAN TN, 1982, ANNU REV ANTHROPOL, V11, P133, DOI 10.1146/annurev.an.11.100182.001025; JAKUBICZKA S, 1989, HUM GENET, V84, P86, DOI 10.1007/BF00210680; JENKINS T, 1970, AM J PHYS ANTHROPOL, V32, P197, DOI 10.1002/ajpa.1330320206; Jenkins T, 1982, HUMAN GENETICS A, P227; LEROY P, 1987, CYTOGENET CELL GENET, V46, P649; LUCOTTE G, 1990, BIOCHEM SYST ECOL, V18, P199, DOI 10.1016/0305-1978(90)90057-M; Lucotte G, 1990, Gene Geogr, V4, P21; LUCOTTE G, 1989, AM J HUM GENET, V45, P16; MAEDA N, 1986, ANNU REV GENET, V20, P81; Malan J.S., 1980, PEOPLES S W AFRICA; Maniatis T., 1982, MOL CLONING; Murdock G.P., 1959, AFRICA ITS PEOPLES T; Nei M., 1987, MOL EVOLUTIONARY GEN; NGO KY, 1986, AM J HUM GENET, V38, P407; NURSE GT, 1977, HLTH HUNTER GATHERER; Nurse GT., 1985, PEOPLES SO AFRICA TH; OAKEY R, 1990, GENOMICS, V7, P325, DOI 10.1016/0888-7543(90)90165-Q; Oliver RA, 1975, AFRICA IRON AGE C 50; RAMSAY M, 1988, AM J HUM GENET, V43, P527; SOUTHERN E, 1975, J MOL BIOL, V19, P503; SPURDLE AB, 1989, CYTOGENET CELL GENET, V51, P1084; SPURDLE AB, 1989, 3RD C S AFR SOC HUM; SYKES BC, 1983, LANCET, V2, P787; TORRONI A, 1990, ANN HUM GENET, V54, P287; Van Warmelo N. J., 1974, BANTU SPEAKING PEOPL, P56; WAINSCOAT JS, 1986, NATURE, V319, P491, DOI 10.1038/319491a0; WOLFF RK, 1988, GENOMICS, V3, P347, DOI 10.1016/0888-7543(88)90126-7	41	52	53	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1992	50	1					107	125						19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HA040	1729883				2022-12-18	WOS:A1992HA04000012
J	FLUHARTY, AL; FLUHARTY, CB; BOHNE, W; VONFIGURA, K; GIESELMANN, V				FLUHARTY, AL; FLUHARTY, CB; BOHNE, W; VONFIGURA, K; GIESELMANN, V			2 NEW ARYLSULFATASE-A (ARSA) MUTATIONS IN A JUVENILE METACHROMATIC LEUKODYSTROPHY (MLD) PATIENT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EXPRESSION	Fragments of the arylsulfatase A (ARSA) gene from a patient with juvenile-onset metachromatic leukodystrophy (MLD) were amplified by PCR and ligated into MP13 cloning vectors. Clones hybridizing with cDNA for human ARSA were selected, examined for appropriate size inserts, and used to prepare single-stranded phage DNA. Examination of the entire coding and most of the intronic sequence revealed two putative disease-related mutations. One, a point mutation in exon 3, resulted in the substitution of isoleucine by serine. Introduction of this alteration into the normal ARSA cDNA sequence resulted in a substantial decrease in ARSA activity on transient expression in cultured baby hamster kidney cells. About 5% of the control expression was observed, suggesting a small residual activity in the mutated ARSA. The second mutation, a G-to-A transition, occurred in the other allele and resulted an altered splice-recognition sequence between exon 7 and the following intron. The mutation also resulted in the loss of a restriction site. Apparently normal levels of mRNA were generated from this allele, but no ARSA activity or immuno-cross-reactive material could be detected. A collection of DNA samples from known or suspected MLD patients, members of their families, and normal controls was screened for these mutations. Four additional individuals carrying each of the mutations were found among the nearly 100 MLD patients in the sample. Gene segregation in the original patient's family was consistent with available clinical and biochemical data. No individuals homozygous for either of these two mutations were identified. However, combinations with other MLD mutations suggest that the point mutation in exon 3 does result in some residual enzyme activity and is associated with late-onset forms of the disease. The splice-site mutation following exon 7 produces late-infantile MLD when combined with other enzyme-null mutations, implying that it is completely silent enzymatically.	UNIV GOTTINGEN,W-3400 GOTTINGEN,GERMANY	University of Gottingen	FLUHARTY, AL (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,MENTAL RETARDAT RES CTR,LANTERMAN DEV CTR RES GRP,POB 100R,POMONA,CA 91769, USA.			Bohne, Wolfgang/0000-0002-5554-131X	FIC NIH HHS [TW-1520] Funding Source: Medline; NINDS NIH HHS [NS-11665] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [F06TW001520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011665] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARTELT P, 1988, GENE, V68, P213, DOI 10.1016/0378-1119(88)90023-6; BAUM H, 1959, CLIN CHIM ACTA, V4, P453, DOI 10.1016/0009-8981(59)90119-6; DUBOIS G, 1975, NEW ENGL J MED, V293, P302; FLUHARTY AL, 1978, J PEDIATR-US, V92, P782, DOI 10.1016/S0022-3476(78)80153-X; FLUHARTY AL, 1970, BIOCHEM MED METAB B, V4, P110, DOI 10.1016/0006-2944(70)90088-8; GEISELMANN V, 1989, P NAT ACAD SCI, V86, P9436; KIHARA H, 1980, PEDIATR RES, V14, P224, DOI 10.1203/00006450-198003000-00009; KINGSTON RE, 1987, CURRENT PROTOCOLS MO; KOLODNY EH, 1989, METABOLIC BASIS INHE, P1721; KREYSING J, 1990, EUR J BIOCHEM, V191, P627, DOI 10.1111/j.1432-1033.1990.tb19167.x; LOTT IT, 1976, J PEDIATR-US, V89, P438, DOI 10.1016/S0022-3476(76)80546-X; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NAKAMAYE KL, 1986, NUCLEIC ACIDS RES, V14, P9679, DOI 10.1093/nar/14.24.9679; POLTEN A, 1991, NEW ENGL J MED, V324, P18, DOI 10.1056/NEJM199101033240104; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STEIN C, 1989, J BIOL CHEM, V264, P1252	17	52	54	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1991	49	6					1340	1350						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GU672	1684088				2022-12-18	WOS:A1991GU67200021
J	STOPPALYONNET, D; DUPONCHEL, C; MEO, T; LAURENT, J; CARTER, PE; ARALACHAVES, M; COHEN, JHM; DEWALD, G; GOETZ, J; HAUPTMANN, G; LAGRUE, G; LESAVRE, P; LOPEZTRASCASA, M; MISIANO, G; MORAINE, C; SOBEL, A; SPATH, PJ; TOSI, M				STOPPALYONNET, D; DUPONCHEL, C; MEO, T; LAURENT, J; CARTER, PE; ARALACHAVES, M; COHEN, JHM; DEWALD, G; GOETZ, J; HAUPTMANN, G; LAGRUE, G; LESAVRE, P; LOPEZTRASCASA, M; MISIANO, G; MORAINE, C; SOBEL, A; SPATH, PJ; TOSI, M			RECOMBINATIONAL BIASES IN THE REARRANGED C1-INHIBITOR GENES OF HEREDITARY ANGIOEDEMA PATIENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALU-ALU RECOMBINATION; DENSITY-LIPOPROTEIN-RECEPTOR; HUMAN C1BAR INHIBITOR; FAMILIAL HYPERCHOLESTEROLEMIA; HOMOLOGOUS RECOMBINATION; REPEAT SEQUENCES; DELETION; SUBJECT; EXON; DNA	DNA structural changes responsible for hereditary angioedema were sought in the C1-inhibitor gene, which contains unusually dense clusters of Alu repeats in various orientations. Among patients belonging to 45 unrelated families, eight partial C1-inhibitor gene deletions and a partial duplication were found. Four deletions had one of the boundaries within the gene and the other in extragenic regions-in three cases 5' of the gene and in one case 3' of the gene. The boundaries of the partial duplication and of the remaining four deletions mapped instead within a few kilobases of exon 4. The same element-Alu 1-the first of three tandem Alu repeats preceding exon 4, contained one of the breakpoints of each of these five rearrangements. Moreover, these recombination breakpoints spread over the entire length of Alu 1, in contrast with the tight clustering observed near the 5' end of Alu sequences rearranged in other human genes. Thus, two uncommon recombinational biases are observed in the Alu rearrangements of hereditary angioedema patients; one promotes the occurrence of intragenic breakpoints in a single Alu repeat, and the other allows the breaks to be distributed over the entire Alu structure rather than within the hot spot of the left Alu monomer. A region of potential Z-DNA structure, located 1.7 kb upstream of Alu 1, may contribute to both peculiarities.	INST PASTEUR,UNITE IMMUNOGENET,25 RUE DOCTEUR ROUX,F-75724 PARIS 15,FRANCE; INST PASTEUR,INSERM,U276,F-75724 PARIS 15,FRANCE; HOP NECKER ENFANTS MALAD,INSERM,U25,UNITE RECH IMMUNOPATHOL & NEPHROL,F-75730 PARIS 15,FRANCE; HOP HENRI MONDOR,DEPT ENSEIGNEMENT & RECH IMMUNOL,F-94010 CRETEIL,FRANCE; HOP HENRI MONDOR,INSERM,U139,F-94010 CRETEIL,FRANCE; CHU REIMS,HOP ROBERT DEBRE,F-51100 REIMS,FRANCE; CTR RECH IMMUNOL & HEMATOL,STRASBOURG,FRANCE; CHR UNIV TOURS,HOP BRETONNEAU,TOURS,FRANCE; UNIV ABERDEEN,DEPT MOLEC & CELL BIOL,ABERDEEN AB9 1FX,SCOTLAND; INST CIENCIAS BIOMED ABEL SALAZAR,OPORTO,PORTUGAL; UNIV BONN,INST HUMANGENET,W-5300 BONN,GERMANY; INMUNOL HOSP LA PAZ,MADRID,SPAIN; UNIV PALERMO,IST PATOL GEN,I-90134 PALERMO,ITALY; RED CROSS FDN,CENT LAB,BERN,SWITZERLAND	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Reims; CHU Tours; University of Aberdeen; Universidade do Porto; University of Bonn; University of Palermo			Cohen, Jacques/AAI-4637-2020; López-Trascasa, Margarita/L-2699-2014	López-Trascasa, Margarita/0000-0001-8594-282X; Cohen, Jacques HM/0000-0003-4214-4419				ARIGA T, 1990, GENOMICS, V8, P607, DOI 10.1016/0888-7543(90)90246-Q; BERKVENS TM, 1990, GENOMICS, V7, P486, DOI 10.1016/0888-7543(90)90190-6; BOCK SC, 1986, BIOCHEMISTRY-US, V25, P4292, DOI 10.1021/bi00363a018; BOEHM T, 1989, EMBO J, V8, P2621, DOI 10.1002/j.1460-2075.1989.tb08402.x; CARTER PE, 1991, EUR J BIOCHEM, V197, P301, DOI 10.1111/j.1432-1033.1991.tb15911.x; DAVIS AE, 1988, ANNU REV IMMUNOL, V6, P595, DOI 10.1146/annurev.iy.06.040188.003115; DEVLIN RH, 1990, AM J HUM GENET, V46, P112; ECONOMOU EP, 1990, P NATL ACAD SCI USA, V87, P2951, DOI 10.1073/pnas.87.8.2951; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FLANAGAN JG, 1984, CELL, V36, P681, DOI 10.1016/0092-8674(84)90348-9; HOBBS HH, 1986, J BIOL CHEM, V261, P3114; HOLLIDAY R, 1989, TRENDS GENET, V5, P355, DOI 10.1016/0168-9525(89)90150-9; HORSTHEMKE B, 1987, EUR J BIOCHEM, V164, P77, DOI 10.1111/j.1432-1033.1987.tb10995.x; HUANG LS, 1989, J BIOL CHEM, V264, P11394; KUDO S, 1989, P NATL ACAD SCI USA, V86, P4619, DOI 10.1073/pnas.86.12.4619; LEHRMAN MA, 1987, J BIOL CHEM, V262, P3354; LEHRMAN MA, 1987, CELL, V48, P827, DOI 10.1016/0092-8674(87)90079-1; MARKERT ML, 1988, J CLIN INVEST, V81, P1323, DOI 10.1172/JCI113458; MCPHADEN A, IN PRESS HUM GENET; NICHOLLS RD, 1987, CELL, V49, P369, DOI 10.1016/0092-8674(87)90289-3; PAOLELLA G, 1983, EMBO J, V2, P691, DOI 10.1002/j.1460-2075.1983.tb01486.x; ROSEN FS, 1971, J CLIN INVEST, V50, P2142; ROUYER F, 1987, CELL, V51, P417, DOI 10.1016/0092-8674(87)90637-4; SKRIVER K, 1989, J BIOL CHEM, V264, P3066; STOPPALYONNET D, 1990, P NATL ACAD SCI USA, V87, P1551, DOI 10.1073/pnas.87.4.1551; STOPPALYONNET D, 1987, NEW ENGL J MED, V317, P1, DOI 10.1056/NEJM198707023170101; STRANG CJ, 1986, J IMMUNOL, V137, P631	27	52	52	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1991	49	5					1055	1062						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GM873	1656734				2022-12-18	WOS:A1991GM87300016
J	DEVLIN, B; RISCH, N; ROEDER, K				DEVLIN, B; RISCH, N; ROEDER, K			ESTIMATION OF ALLELE FREQUENCIES FOR VNTR LOCI	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGMENT LENGTH POLYMORPHISMS; DNA	VNTR loci provide valuable information for a number of fields of study involving human genetics, ranging from forensics (DNA fingerprinting and paternity testing) to linkage analysis and population genetics. Alleles of a VNTR locus are simply fragments obtained from a particular portion of the DNA molecule and are defined in terms of their length. The essential element of a VNTR fragment is the repeat, which is a short sequence of basepairs. The core of the fragment is composed of a variable number of identical repeats that are linked in tandem. A sample of fragments from a population of individuals exhibits substantial variation in length because of variation in the number of repeats. Each distinct fragment length defines an allele, but any given fragment is measured with error. Therefore the observed distribution of fragment lengths is not discrete but is continuous, and determination of distinct allele classes is not straightforward. A mixture model is the natural statistical method for estimating the allele frequencies of VNTR loci. In this article we develop nonparametric methods for obtaining the distribution of allele sizes and estimates of their frequencies. Methods for obtaining maximum-likelihood estimates are developed. In addition, we suggest an empirical Bayes method to improve the maximum-likelihood estimates of the gene frequencies; the empirical Bayes procedure effects a local smoothing. The latter method works particularly well when measurement error is large relative to the repeat size, because the estimated distribution of allele frequencies when maximum likelihood is used is unreliable because of an alternating pattern of over- and underestimation. We define alleles and estimate the allele frequencies for two VNTR loci from the human genome (D17S79 and D2S44), from data obtained from Lifecodes, Inc.	YALE UNIV,DEPT EPIDEMIOL & PUBL HLTH,60 COLL ST,POB 3333,NEW HAVEN,CT 06510; YALE UNIV,DEPT HUMAN GENET,NEW HAVEN,CT 06510; YALE UNIV,DEPT STAT,NEW HAVEN,CT 06510	Yale University; Yale University; Yale University				Roeder, Kathryn/0000-0002-8869-6254	NCI NIH HHS [CA45052] Funding Source: Medline; NHGRI NIH HHS [HG00648] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA045052] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000648] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BALAZS I, 1989, AM J HUM GENET, V44, P182; Berger J. O., 1985, STAT DECISION THEORY, P74; BUDOWLE B, UNPUB FIXE BIN ANAL; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; DEVLIN B, 1990, SCIENCE, V249, P1416, DOI 10.1126/science.2205919; DEVLIN B, UNPUB FORENSIC INFER; EFRON B, 1973, J AM STAT ASSOC, V68, P117, DOI 10.2307/2284155; Efron B, 1982, JACKKNIFE BOOTSTRAP; GUISTI A, 1986, J FORENSIC SCI, V31, P409; GUTMANN S, 1982, ANN STAT, V10, P1017, DOI 10.1214/aos/1176345893; ITO H, 1985, JPN J HUM GENET, V30, P261, DOI 10.1007/BF01907963; JAMES W, 1961, 4TH P BERK S MATH ST, V1, P361; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; KANTER E, 1986, J FORENSIC SCI, V31, P403; LYNCH M, 1988, MOL BIOL EVOL, V5, P584; Marriott FHC., 1979, APPLIED STATISTICS, V28, P75, DOI [DOI 10.2307/2346816, 10.2307/2346816]; MENDELL NR, 1984, ANN HUM GENET, V48, P283, DOI 10.1111/j.1469-1809.1984.tb01026.x; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; Nei M., 1987, MOL EVOLUTIONARY GEN; Prakasa Rao B. L. S, 1983, NONPARAMETRIC FUNCTI; RISCH N, 1990, AM J HUM GENET, V46, P242; WAYE JS, 1989, INT S HUMAN IDENTIFI	23	52	52	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1991	48	4					662	676						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK478	2014794				2022-12-18	WOS:A1991FK47800004
J	BROWN, KW; WILLIAMS, JC; MAITLAND, NJ; MOTT, MG				BROWN, KW; WILLIAMS, JC; MAITLAND, NJ; MOTT, MG			GENOMIC IMPRINTING AND THE BECKWITH-WIEDEMANN SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									ROYAL HOSP SICK CHILDREN,PAEDIAT ONCOL UNIT,BRISTOL,ENGLAND	Bristol Royal Hospital For Children	BROWN, KW (corresponding author), UNIV BRISTOL,SCH MED,DEPT PATHOL,CANC LEUKAEMIA CHILDHOOD TRUST RES UNIT,BRISTOL BS8 1TH,AVON,ENGLAND.		Brown, Keith/C-3355-2009	Brown, Keith/0000-0002-4258-5129				HENRY I, 1989, HUM GENET, V81, P273, DOI 10.1007/BF00279003; JOURNEL H, 1985, ANN GENET-PARIS, V28, P97; KOUFOS A, 1989, AM J HUM GENET, V44, P711; MANNENS M, 1988, HUM GENET, V81, P41, DOI 10.1007/BF00283727; PING AJ, 1989, AM J HUM GENET, V44, P720; REEVE AE, 1989, MOL CELL BIOL, V9, P1799, DOI 10.1128/MCB.9.4.1799; SCHROEDER WT, 1987, AM J HUM GENET, V40, P413; TURLEAU C, 1984, HUM GENET, V67, P219, DOI 10.1007/BF00273006; WALES JKH, 1986, EUR J PEDIATR, V145, P141, DOI 10.1007/BF00441878; WAZIRI M, 1983, J PEDIATR-US, V102, P873, DOI 10.1016/S0022-3476(83)80014-6; WILKINS RJ, 1988, LANCET, V1, P329; WILLIAMS JC, 1989, LANCET, V1, P283	12	52	52	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1990	46	5					1000	1001						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DD896	2339685				2022-12-18	WOS:A1990DD89600021
J	SMEETS, H; BACHINSKI, L; COERWINKEL, M; SCHEPENS, J; HOEIJMAKERS, J; VANDUIN, M; GRZESCHIK, KH; WEBER, CA; DEJONG, P; SICILIANO, MJ; WIERINGA, B				SMEETS, H; BACHINSKI, L; COERWINKEL, M; SCHEPENS, J; HOEIJMAKERS, J; VANDUIN, M; GRZESCHIK, KH; WEBER, CA; DEJONG, P; SICILIANO, MJ; WIERINGA, B			A LONG-RANGE RESTRICTION MAP OF THE HUMAN-CHROMOSOME 19Q13 REGION - CLOSE PHYSICAL LINKAGE BETWEEN CKMM AND THE ERCCI AND ERCC2 GENES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT GENET,HOUSTON,TX 77030; ERASMUS UNIV,DEPT CELL BIOL & GENET,3000 DR ROTTERDAM,NETHERLANDS; UNIV MARBURG,INST HUMAN GENET,W-3550 MARBURG,GERMANY; UNIV CALIF LAWRENCE LIVERMORE NATL LAB,DIV BIOMED SCI,LIVERMORE,CA 94550	University of Texas System; UTMD Anderson Cancer Center; Erasmus University Rotterdam; Philipps University Marburg; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System	SMEETS, H (corresponding author), CATHOLIC UNIV NIJMEGEN,DEPT HUMAN GENET,POB 9101,6500 HB NIJMEGEN,NETHERLANDS.		Wieringa, Berend/A-5346-2011; Hoeijmakers, Jan/AAX-6972-2021	Wieringa, Berend/0000-0001-9192-8020; 	NATIONAL CANCER INSTITUTE [P01CA034936] Funding Source: NIH RePORTER; NCI NIH HHS [CA 34936] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADHYA S, 1982, CELL, V29, P939, DOI 10.1016/0092-8674(82)90456-1; BRUNNER HG, 1989, GENOMICS, V5, P589, DOI 10.1016/0888-7543(89)90027-X; BRUNNER HG, 1989, HUM GENET, V81, P308, DOI 10.1007/BF00283680; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; COERWINKELDRIESSEN M, 1988, NUCLEIC ACIDS RES, V16, P8743, DOI 10.1093/nar/16.17.8743; COLLINS FS, 1984, P NATL ACAD SCI-BIOL, V81, P6812, DOI 10.1073/pnas.81.21.6812; CREMERS FPM, 1989, GENOMICS, V4, P41, DOI 10.1016/0888-7543(89)90312-1; CULLEN BR, 1984, NATURE, V307, P241, DOI 10.1038/307241a0; DEJONG PJ, 1989, CYTOGENET CELL GENET, V51, P985; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GARDINER K, 1986, SOMAT CELL MOLEC GEN, V12, P185, DOI 10.1007/BF01560665; HELLKUHL B, 1978, CYTOGENET CELL GENET, V22, P527, DOI 10.1159/000131016; HULSEBOS T, 1986, CYTOGENET CELL GENET, V43, P47, DOI 10.1159/000132297; HULSEBOS T, 1988, CYTOGENET CELL GENET, V47, P144, DOI 10.1159/000132533; KADESCH T, 1986, MOL CELL BIOL, V6, P2593, DOI 10.1128/MCB.6.7.2593; LAWRENCE JB, 1988, CELL, V52, P51; LEBEAU MM, 1989, CYTOGENET CELL GENET, V51, P338, DOI 10.1159/000132798; LYON MF, 1987, MOUSE NEWS LETT, V787, P12; MACKENZIE AE, 1989, CYTOGENET CELL GENET, V51, P1036; Maniatis T., 1982, MOL CLONING; MARIMAN E C M, 1987, Genomics, V1, P126, DOI 10.1016/0888-7543(87)90004-8; MOHANDAS T, 1980, P NATL ACAD SCI-BIOL, V77, P6759, DOI 10.1073/pnas.77.11.6759; MOHRENWEISER HW, IN PRESS CYTOGENET C; Myotonic Dystrophy Foundation, 2017, VOIC PAT REP MYOT DY; NAKAMURA Y, 1988, Genomics, V3, P67, DOI 10.1016/0888-7543(88)90161-9; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; POUSTKA A, 1986, TRENDS GENET, V2, P174, DOI 10.1016/0168-9525(86)90219-2; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHONK D, 1989, GENOMICS, V4, P384, DOI 10.1016/0888-7543(89)90346-7; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; SMEETS HJM, 1989, HUM GENET, V83, P245, DOI 10.1007/BF00285165; STALLINGS RL, 1988, AM J HUM GENET, V43, P144; THOMPSON LH, IN PRESS GENOMICS; VANDUIN M, 1988, THESIS U ROTTERDAM; WEBER CA, 1988, MOL CELL BIOL, V8, P1137, DOI 10.1128/MCB.8.3.1137; WESTERVELD A, 1984, NATURE, V310, P425, DOI 10.1038/310425a0; Wieringa B, 1988, Adv Neurol, V48, P47	38	52	52	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1990	46	3					492	501						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CT668	2309701				2022-12-18	WOS:A1990CT66800012
J	HUEBNER, K; NAGARAJAN, L; BESA, E; ANGERT, E; LANGE, BJ; CANNIZZARO, LA; VANDENBERGHE, H; SANTOLI, D; FINAN, J; CROCE, CM; NOWELL, PC				HUEBNER, K; NAGARAJAN, L; BESA, E; ANGERT, E; LANGE, BJ; CANNIZZARO, LA; VANDENBERGHE, H; SANTOLI, D; FINAN, J; CROCE, CM; NOWELL, PC			ORDER OF GENES ON HUMAN CHROMOSOME-5Q WITH RESPECT TO 5Q INTERSTITIAL DELETIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MED COLL PENN,PHILADELPHIA,PA 19129; CHILDRENS HOSP,PHILADELPHIA,PA 19104; WISTAR INST,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT PATHOL & LAB MED,PHILADELPHIA,PA 19104; UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT HEMATOL,HOUSTON,TX 77030; CATHOLIC UNIV LEUVEN,CTR HUMAN GENET,B-3000 LOUVAIN,BELGIUM; SW RES BIOMED INST,CTR GENET,SCOTTSDALE,AZ	Drexel University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; The Wistar Institute; University of Pennsylvania; University of Texas System; UTMD Anderson Cancer Center; KU Leuven	HUEBNER, K (corresponding author), TEMPLE UNIV,HLTH SCI CTR,SCH MED,FELS INST CANC RES & MOLEC BIOL,3420 N BROAD ST,PHILADELPHIA,PA 19140, USA.		Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647	NATIONAL CANCER INSTITUTE [R35CA039860, P01CA025875, P01CA021124] Funding Source: NIH RePORTER; NCI NIH HHS [CA 39860, CA 25875, CA 21124] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANAGNOU NP, 1985, CYTOGENET CELL GENET, V40, P568; ANAGNOU NP, 1989, GENOMICS, V5, P354, DOI 10.1016/0888-7543(89)90069-4; ANGERT E, 1989, NUCLEIC ACIDS RES, V17, P2153, DOI 10.1093/nar/17.5.2153; BARLOW DP, 1987, EMBO J, V6, P617, DOI 10.1002/j.1460-2075.1987.tb04799.x; BAUER SR, 1988, IMMUNOGENETICS, V28, P328, DOI 10.1007/BF00364231; CANNIZZARO LA, IN PRESS GENOMICS; COUSSENS L, 1986, NATURE, V320, P277, DOI 10.1038/320277a0; DALTON WT, 1988, BLOOD, V71, P242; ERIKSON J, 1983, P NATL ACAD SCI-BIOL, V80, P7581, DOI 10.1073/pnas.80.24.7581; GARDINER K, 1986, SOMAT CELL MOLEC GEN, V12, P185, DOI 10.1007/BF01560665; HOLLENBERG SM, 1985, NATURE, V318, P635, DOI 10.1038/318635a0; HUEBNER K, 1988, ONCOGENE, V3, P449; HUEBNER K, 1985, SCIENCE, V230, P1282, DOI 10.1126/science.2999978; JAYE M, 1986, SCIENCE, V233, P541, DOI 10.1126/science.3523756; KAWASAKI ES, 1985, SCIENCE, V230, P291, DOI 10.1126/science.2996129; KENNEDY JL, 1988, NATURE, V336, P167, DOI 10.1038/336167a0; KOBILKA BK, 1987, P NATL ACAD SCI USA, V84, P46, DOI 10.1073/pnas.84.1.46; LEBEAU MM, 1987, P NATL ACAD SCI USA, V84, P5913; LEBEAU MM, 1989, BLOOD, V73, P647; MECUCCI C, 1987, CANCER GENET CYTOGEN, V29, P171, DOI 10.1016/0165-4608(87)90046-X; MURRAY JC, 1987, NUCLEIC ACIDS RES, V15, P6765, DOI 10.1093/nar/15.16.6765; NAGARAJAN L, 1989, NUCLEIC ACIDS RES, V17, P2154, DOI 10.1093/nar/17.5.2154; NAGARAJAN L, IN PRESS BLOOD; NIENHUIS AW, 1985, CELL, V42, P421, DOI 10.1016/0092-8674(85)90099-6; NOWELL P, 1983, NATURE, V306, P494, DOI 10.1038/306494a0; ODOWD BF, 1985, P NATL ACAD SCI USA, V82, P1184, DOI 10.1073/pnas.82.4.1184; OLAISEN B, 1987, CYTOGENET CELL GENET, V46, P147, DOI 10.1159/000132475; PETTENATI MJ, 1987, P NATL ACAD SCI USA, V84, P2970, DOI 10.1073/pnas.84.9.2970; ROBERTS WM, 1988, CELL, V55, P655, DOI 10.1016/0092-8674(88)90224-3; STEWART GD, 1987, NUCLEIC ACIDS RES, V15, P3939, DOI 10.1093/nar/15.9.3939; SUTHERLAND GR, 1988, BLOOD, V71, P1150; SUTHERLAND GR, IN PRESS HUMAN GENET; VANDENBERGHE H, 1985, CANCER GENET CYTOGEN, V17, P189, DOI 10.1016/0165-4608(85)90016-0; VANLEEUWEN BH, 1989, BLOOD, V73, P1142; XU DQ, 1985, P NATL ACAD SCI USA, V82, P2862, DOI 10.1073/pnas.82.9.2862; YANG YC, 1986, CELL, V47, P3, DOI 10.1016/0092-8674(86)90360-0; YANG YC, 1988, BLOOD, V71, P958; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0; YOKOTA T, 1986, P NATL ACAD SCI USA, V83, P5894, DOI 10.1073/pnas.83.16.5894; YOKOTA T, 1987, P NATL ACAD SCI USA, V84, P7388, DOI 10.1073/pnas.84.21.7388	40	52	52	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1990	46	1					26	36						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ043	2294753				2022-12-18	WOS:A1990CJ04300005
J	BERGMANN, JE; GRABOWSKI, GA				BERGMANN, JE; GRABOWSKI, GA			POSTTRANSLATIONAL PROCESSING OF HUMAN LYSOSOMAL ACID BETA-GLUCOSIDASE - A CONTINUUM OF DEFECTS IN GAUCHER DISEASE TYPE-1 AND TYPE-2 FIBROBLASTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CUNY MT SINAI SCH MED,DIV MED & MOLEC GENET,DEPT PEDIAT,NEW YORK,NY 10029	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	BERGMANN, JE (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,DEPT ANAT & CELL BIOL,630 W 168TH ST,NEW YORK,NY 10032, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032617] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-71] Funding Source: Medline; NIDDK NIH HHS [DK36729] Funding Source: Medline; NIGMS NIH HHS [GM32617] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEUTLER E, 1984, P NATL ACAD SCI-BIOL, V81, P6506, DOI 10.1073/pnas.81.20.6506; BEUTLER E, 1986, P NATL ACAD SCI USA, V83, P7472, DOI 10.1073/pnas.83.19.7472; BRADY RO, 1965, BIOCHEM BIOPH RES CO, V18, P221, DOI 10.1016/0006-291X(65)90743-6; DESNICK RJ, 1982, GAUCHER DISEASE CENT, P1; ERICKSON AH, 1985, J BIOL CHEM, V260, P4319; FABBRO D, 1987, AM J HUM GENET, V40, P15; Frederickson DS, 1972, METABOLIC BASIS INHE, P730; GALLIONE CJ, 1981, J VIROL, V39, P529, DOI 10.1128/JVI.39.2.529-535.1981; GINNS EI, 1982, P NATL ACAD SCI-BIOL, V79, P5607, DOI 10.1073/pnas.79.18.5607; GRABOWSKI GA, 1985, AM J HUM GENET, V37, P499; GRABOWSKI GA, 1985, AM J MED GENET, V21, P529, DOI 10.1002/ajmg.1320210316; GRABOWSKI GA, 1986, J BIOL CHEM, V261, P8263; GRAVEL RA, 1983, HUM GENET, V65, P112, DOI 10.1007/BF00286645; GRAVES PN, 1986, AM J HUM GENET, V39, P763; GRAVES PN, 1988, DNA-J MOLEC CELL BIO, V7, P521, DOI 10.1089/dna.1.1988.7.521; HASILIK A, 1980, J BIOL CHEM, V255, P4937; HASILIK A, 1980, TRENDS BIOCHEM SCI, V5, P237, DOI 10.1016/S0968-0004(80)80810-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MALEY F, 1981, J BIOL CHEM, V256, P1088; MUDD JA, 1970, VIROLOGY, V42, P328, DOI 10.1016/0042-6822(70)90277-1; MUELLER OT, 1977, J BIOL CHEM, V252, P825; OBIJESKI JF, 1974, J GEN VIROL, V22, P21, DOI 10.1099/0022-1317-22-1-21; Parkin J, 1982, GAUCHER DISEASE CENT, P151; PENTCHEV PG, 1983, AM J HUM GENET, V35, P621; ROGALSKI AA, 1984, J CELL BIOL, V99, P1101, DOI 10.1083/jcb.99.3.1101; ROSE JK, 1981, J VIROL, V39, P519, DOI 10.1128/JVI.39.2.519-528.1981; SCHUBERT M, 1984, J VIROL, V51, P505, DOI 10.1128/JVI.51.2.505-514.1984; SORGE J, 1985, P NATL ACAD SCI USA, V82, P7289, DOI 10.1073/pnas.82.21.7289; STECKEL F, 1983, J BIOL CHEM, V258, P4322; TAGER JM, 1986, ENZYMES LIPID METABO, V2, P735; TSUJI S, 1988, P NATL ACAD SCI USA, V85, P2349, DOI 10.1073/pnas.85.7.2349; TSUJI S, 1986, J BIOL CHEM, V261, P50; TSUJI S, 1987, NEW ENGL J MED, V316, P570, DOI 10.1056/NEJM198703053161002; WENGER DA, 1983, PEDIATR RES, V17, P344, DOI 10.1203/00006450-198305000-00007; WUNNER WH, 1972, J GEN VIROL, V16, P1, DOI 10.1099/0022-1317-16-1-1	35	52	54	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1989	44	5					741	750						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	U3338	2495719				2022-12-18	WOS:A1989U333800016
J	LEDUC, F; BRAUCH, H; HAJJ, C; DOBROVIC, A; KAYE, F; GAZDAR, A; HARBOUR, JW; PETTENGILL, OS; SORENSON, GD; VANDENBERG, A; KOK, K; CAMPLING, B; PAQUIN, F; BRADLEY, WEC; ZBAR, B; MINNA, J; BUYS, C; AYOUB, J				LEDUC, F; BRAUCH, H; HAJJ, C; DOBROVIC, A; KAYE, F; GAZDAR, A; HARBOUR, JW; PETTENGILL, OS; SORENSON, GD; VANDENBERG, A; KOK, K; CAMPLING, B; PAQUIN, F; BRADLEY, WEC; ZBAR, B; MINNA, J; BUYS, C; AYOUB, J			LOSS OF HETEROZYGOSITY IN A GENE CODING FOR A THYROID-HORMONE RECEPTOR IN LUNG CANCERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HOP NOTRE DAME, INST CANC MONTREAL, 1560 SHERBROOKE EST, MONTREAL H2L 4M1, QUEBEC, CANADA; HOP NOTRE DAME, DEPT PATHOL, MONTREAL H2L 4M1, QUEBEC, CANADA; NCI, FREDERICK CANC RES FACIL, FREDERICK, MD 21701 USA; FLINDERS UNIV S AUSTRALIA, DEPT HEMATOL, BEDFORD PK, SA 5042, AUSTRALIA; NCI, BETHESDA, MD 20205 USA; DARTMOUTH COLL, HITCHCOCK MED CTR, DARTMOUTH MED SCH, HANOVER, NH 03756 USA; STATE UNIV GRONINGEN, DEPT HUMAN GENET, 9700 AB GRONINGEN, NETHERLANDS; KINGSTON REG CANC CTR, KINGSTON, ONTARIO, CANADA	Universite de Montreal; Universite de Montreal; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Flinders University South Australia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Dartmouth College; University of Groningen			kaye, frederic/E-2437-2011; Harbour, J. William/B-1448-2015; van den Berg, Anke/H-1718-2011	Harbour, J. William/0000-0002-1104-9809; van den Berg, Anke/0000-0002-8894-2638; Brauch, Hiltrud/0000-0001-7531-2736; Dobrovic, Alexander/0000-0003-3414-112X				BRAUCH H, 1987, NEW ENGL J MED, V317, P1109, DOI 10.1056/NEJM198710293171803; CARRITT B, 1986, AM J HUM GENET, V38, P428; DILIEGRO I, 1987, DIFFERENTIATION, V35, P165; DOBROVIC A, 1988, CANCER RES, V48, P682; GAREAU JLP, 1988, NUCLEIC ACIDS RES, V16, P1223, DOI 10.1093/nar/16.3.1223; KOK K, 1987, NATURE, V330, P578, DOI 10.1038/330578a0; Maniatis T., 1982, MOL CLONING; NAYLOR SL, 1987, NATURE, V329, P451, DOI 10.1038/329451a0; REY JA, 1987, CANCER GENET CYTOGEN, V25, P355, DOI 10.1016/0165-4608(87)90197-X; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; WHANGPENG J, 1982, SCIENCE, V215, P181, DOI 10.1126/science.6274023; WHANGPENG J, 1982, CANCER GENET CYTOGEN, V3, P233; YOKOTA J, 1987, P NATL ACAD SCI USA, V84, P9252, DOI 10.1073/pnas.84.24.9252; ZECH L, 1985, CANCER GENET CYTOGEN, V15, P335, DOI 10.1016/0165-4608(85)90178-5	14	52	54	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1989	44	2					282	287						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R9705	2536219				2022-12-18	WOS:A1989R970500014
J	JARMAN, AP; HIGGS, DR				JARMAN, AP; HIGGS, DR			A NEW HYPERVARIABLE MARKER FOR THE HUMAN ALPHA-GLOBIN GENE-CLUSTER	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											JARMAN, AP (corresponding author), UNIV OXFORD,JOHN RADCLIFFE HOSP,NUFFIELD DEPT CLIN MED,MRC,MOLEC HAEMATOL UNIT,OXFORD OX3 9DU,ENGLAND.			Jarman, Andrew/0000-0003-4036-5701				BELL GI, 1982, NATURE, V295, P31, DOI 10.1038/295031a0; CAPON DJ, 1983, NATURE, V302, P33, DOI 10.1038/302033a0; DAS HK, 1987, J BIOL CHEM, V262, P4787; FISCHELGHODSIAN N, 1987, NUCLEIC ACIDS RES, V15, P9215, DOI 10.1093/nar/15.22.9215; Goodbourn S E, 1984, Mol Biol Med, V2, P223; GOODBOURN SEY, 1983, P NATL ACAD SCI-BIOL, V80, P5022, DOI 10.1073/pnas.80.16.5022; HIGGS DR, 1986, P NATL ACAD SCI USA, V83, P5165, DOI 10.1073/pnas.83.14.5165; JARMAN AP, 1986, EMBO J, V5, P1857, DOI 10.1002/j.1460-2075.1986.tb04437.x; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; KNOTT TJ, 1986, NUCLEIC ACIDS RES, V14, P9215, DOI 10.1093/nar/14.22.9215; KOBORI JA, 1986, SCIENCE, V234, P173, DOI 10.1126/science.3018929; LUPTON S, 1985, MOL CELL BIOL, V5, P2533, DOI 10.1128/MCB.5.10.2533; MANIATIS T, 1982, MOL CLONING LABORATO; Maxam A M, 1980, Methods Enzymol, V65, P499; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MERMER B, 1987, P NATL ACAD SCI USA, V84, P3320, DOI 10.1073/pnas.84.10.3320; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NICHOLLS RD, 1985, NUCLEIC ACIDS RES, V13, P7569, DOI 10.1093/nar/13.21.7569; NICHOLLS RD, 1987, CELL, V49, P369, DOI 10.1016/0092-8674(87)90289-3; OBERLE I, 1985, P NATL ACAD SCI USA, V82, P2824, DOI 10.1073/pnas.82.9.2824; OLD JM, 1982, METHODS HAEMATOLOGY, P74; PROUDFOOT NJ, 1982, CELL, V31, P553, DOI 10.1016/0092-8674(82)90311-7; REEDERS ST, 1985, NATURE, V317, P542, DOI 10.1038/317542a0; SIMMLER MC, 1987, EMBO J, V6, P963, DOI 10.1002/j.1460-2075.1987.tb04846.x; SMITH GP, 1976, SCIENCE, V191, P528, DOI 10.1126/science.1251186; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; ULLRICH A, 1982, NUCLEIC ACIDS RES, V10, P2225, DOI 10.1093/nar/10.7.2225; WONG Z, 1986, NUCLEIC ACIDS RES, V14, P4605, DOI 10.1093/nar/14.11.4605; ZERIAL M, 1986, EUR J BIOCHEM, V160, P479, DOI 10.1111/j.1432-1033.1986.tb10064.x	29	52	54	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1988	43	3					249	256						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	P8841	2901223				2022-12-18	WOS:A1988P884100004
J	PAIRITZ, G; DAVIGNON, J; MAILLOUX, H; SING, CF				PAIRITZ, G; DAVIGNON, J; MAILLOUX, H; SING, CF			SOURCES OF INTERINDIVIDUAL VARIATION IN THE QUANTITATIVE LEVELS OF APOLIPOPROTEIN-B IN PEDIGREES ASCERTAINED THROUGH A LIPID CLINIC	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MICHIGAN, SCH MED, DEPT HUMAN GENET, 4708 MED SCI II, ANN ARBOR, MI 48109 USA; HOSP UNIV PENN, DEPT MED, PHILADELPHIA, PA 19104 USA; CLIN RES INST MONTREAL, DEPT LIPID METAB & ATHEROSCLEROSIS RES, MONTREAL H2W 1R7, QUEBEC, CANADA	University of Michigan System; University of Michigan; University of Pennsylvania; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal			Jarvik, Gail P/N-6476-2014	Jarvik, Gail P/0000-0002-6710-8708; Sing, Charles/0000-0001-5872-7956	NHLBI NIH HHS [HL 39107, HL 24489] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL024489, R01HL039107] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALLAIN CC, 1974, CLIN CHEM, V20, P470; AMOS CI, 1987, GENET EPIDEMIOL, V4, P115, DOI 10.1002/gepi.1370040206; AVOGARO P, 1978, ARTERY, V4, P385; AVOGARO P, 1979, LANCET, V1, P901; BEATY TH, 1986, AM J HUM GENET, V38, P492; BEUMONT JL, 1970, B WORLD HEALTH ORGAN, V43, P891; BOUTHILLIER D, 1983, J LIPID RES, V24, P1060; CANNINGS C, 1978, ADV APPL PROBAB, V10, P26, DOI 10.2307/1426718; DAGOSTIN.R, 1973, BIOMETRIKA, V60, P613, DOI 10.1093/biomet/60.3.613; DEMENAIS F, 1986, AM J HUM GENET, V38, P228; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; ELSTON RC, 1986, MODERN STATISTICAL M, P213; HASSTEDT SJ, 1982, COMPUT BIOMED RES, V15, P295, DOI 10.1016/0010-4809(82)90064-7; HASSTEDT SJ, 1987, GENET EPIDEMIOL, V4, P67, DOI 10.1002/gepi.1370040202; HASSTEDT SJ, 1979, 13 U UT DEP MED BIOP; HEISS G, 1980, CIRCULATION, V61, P302, DOI 10.1161/01.CIR.61.2.302; LALOUEL JM, 1979, 14 U UT DEP MED BIOP; MACLEAN CJ, 1975, AM J HUM GENET, V27, P365; MACLEAN CJ, 1976, BIOMETRICS, V32, P695, DOI 10.2307/2529760; ODENHEIMER D, 1985, THESIS U MICHIGAN AN; REARDON MF, 1981, CLIN CHEM, V27, P892; RIESEN WF, 1980, ATHEROSCLEROSIS, V37, P157, DOI 10.1016/0021-9150(80)90104-5; ROSSENEU M, 1981, ANAL BIOCHEM, V116, P204, DOI 10.1016/0003-2697(81)90345-6; SAMPSON EJ, 1975, CLIN CHEM, V21, P1983; SCHMIDT SB, 1985, AM J CARDIOL, V55, P1459, DOI 10.1016/0002-9149(85)90953-1; SING CF, 1985, AM J HUM GENET, V37, P268; SNIDERMAN A, 1980, P NATL ACAD SCI-BIOL, V77, P604, DOI 10.1073/pnas.77.1.604; SNIDERMAN A, 1985, AM J CARDIOL, V55, P291, DOI 10.1016/0002-9149(85)90363-7; SNIDERMAN AD, 1982, ANN INTERN MED, V97, P833, DOI 10.7326/0003-4819-97-6-833; Sokal R.R., 1981, BIOMETRY, V2nd ed.; TENG B, 1983, P NATL ACAD SCI-BIOL, V80, P6662, DOI 10.1073/pnas.80.21.6662; UTERMANN G, 1985, DIABETES OBESITY HYP, V3, P1; WHAYNE TF, 1981, ATHEROSCLEROSIS, V39, P411, DOI 10.1016/0021-9150(81)90026-5; 1984, ARTERIOSCLEROSIS, V4, pA445; 1974, NIH75628 US DHEW LIP	35	52	52	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1988	43	3					311	321						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	P8841	3414686				2022-12-18	WOS:A1988P884100012
J	OVERHAUSER, J; GOLBUS, MS; SCHONBERG, SA; WASMUTH, JJ				OVERHAUSER, J; GOLBUS, MS; SCHONBERG, SA; WASMUTH, JJ			MOLECULAR ANALYSIS OF AN UNBALANCED DELETION OF THE SHORT ARM OF CHROMOSOME-5 THAT PRODUCES NO PHENOTYPE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF SAN FRANCISCO,MED CTR,DEPT OBSTET & GYNECOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,MED CTR,DEPT PEDIAT,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco	OVERHAUSER, J (corresponding author), UNIV CALIF IRVINE,CALIF COLL MED,DEPT BIOL CHEM,IRVINE,CA 92717, USA.				NICHD NIH HHS [HD-18642] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018642] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		CANNON G, 1985, ANAL BIOCHEM, V149, P229, DOI 10.1016/0003-2697(85)90500-7; CARLOCK LR, 1985, SOMAT CELL MOLEC GEN, V11, P267, DOI 10.1007/BF01534683; COMINGS DE, 1974, BIRTH DEFECTS, P44; COUTURIER J, 1985, HUM GENET, V70, P87, DOI 10.1007/BF00389468; DANA S, 1982, SOMAT CELL GENET, V8, P245, DOI 10.1007/BF01538680; DANA S, 1982, MOL CELL BIOL, V2, P1220, DOI 10.1128/MCB.2.10.1220; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GOLDMAN MA, 1984, SCIENCE, V224, P686, DOI 10.1126/science.6719109; HELMS C, 1985, DNA-J MOLEC CELL BIO, V4, P39, DOI 10.1089/dna.1985.4.39; HOLMQUIST G, 1982, CELL, V31, P121, DOI 10.1016/0092-8674(82)90411-1; KORENBERG JR, 1978, HUM GENET, V43, P13, DOI 10.1007/BF00396473; MEINKOTH J, 1984, ANAL BIOCHEM, V138, P267, DOI 10.1016/0003-2697(84)90808-X; NIEBUHR E, 1978, HUM GENET, V44, P227, DOI 10.1007/BF00394291; NIEBUHR E, 1978, HUM GENET, V42, P142; OVERHAUSER J, 1985, CYTOGENET CELL GENET, V40, P718; PATEL PI, 1984, SOMAT CELL MOLEC GEN, V10, P483, DOI 10.1007/BF01534853; SEALEY PG, 1985, NUCLEIC ACIDS RES, V13, P1905, DOI 10.1093/nar/13.6.1905; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WILKINS LE, 1983, J PEDIATR-US, V102, P528, DOI 10.1016/S0022-3476(83)80179-6; Woo S L, 1979, Methods Enzymol, V68, P389; Worton R G, 1979, Methods Enzymol, V58, P322; YUNIS JJ, 1977, CHROMOSOMA, V61, P335, DOI 10.1007/BF00288617	23	52	54	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1986	39	1					1	10						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D9615	3752077				2022-12-18	WOS:A1986D961500001
J	NUSSBAUM, RL; BOGGS, BA; BEAUDET, AL; DOYLE, S; POTTER, JL; OBRIEN, WE				NUSSBAUM, RL; BOGGS, BA; BEAUDET, AL; DOYLE, S; POTTER, JL; OBRIEN, WE			NEW MUTATION AND PRENATAL-DIAGNOSIS IN ORNITHINE TRANSCARBAMYLASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BAYLOR COLL MED,DEPT MED,HOUSTON,TX 77030; BAYLOR COLL MED,HOWARD HUGHES MED INST,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; CHILDRENS MED CTR,DEPT PATHOL & LAB MED,AKRON,OH	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine					NIADDK NIH HHS [AM32861] Funding Source: Medline	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BOGGS BA, 1984, SOMAT CELL MOLEC GEN, V10, P607, DOI 10.1007/BF01535226; HOKANSON JT, 1978, J PEDIATR-US, V93, P75, DOI 10.1016/S0022-3476(78)80606-4; HOLZGREVE W, 1984, AM J HUM GENET, V36, P320; HORWICH AL, 1984, SCIENCE, V224, P1068, DOI 10.1126/science.6372096; HORWICH AL, 1983, P NATL ACAD SCI-BIOL, V80, P4258, DOI 10.1073/pnas.80.14.4258; LINGREN V, 1984, SCIENCE, V226, P698; MICHELSON AM, 1983, P NATL ACAD SCI-BIOL, V80, P472, DOI 10.1073/pnas.80.2.472; NUSSBAUM RL, 1983, P NATL ACAD SCI-BIOL, V80, P4035, DOI 10.1073/pnas.80.13.4035; OLD JM, 1985, LANCET, V1, P73; RICCIUTI FC, 1976, AM J HUM GENET, V28, P332; RODECK CH, 1982, LANCET, V2, P297; ROSENBERG LE, 1980, METABOLIC CONTROL DI, P682; ROZEN R, 1985, NATURE, V313, P815, DOI 10.1038/313815a0; WALZER M, 1983, METABOLIC BASIS INHE, P402; WILSON JM, 1983, J CLIN INVEST, V72, P767, DOI 10.1172/JCI111047	16	52	52	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1986	38	2					149	158						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	A3111	3004207				2022-12-18	WOS:A1986A311100004
J	GORG, A; POSTEL, W; WESER, J; PATUTSCHNICK, W; CLEVE, H				GORG, A; POSTEL, W; WESER, J; PATUTSCHNICK, W; CLEVE, H			IMPROVED RESOLUTION OF PI (ALPHA-1-ANTITRYPSIN) PHENOTYPES BY A LARGE-SCALE IMMOBILIZED PH GRADIENT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MUNICH,INST ANTHROPOL & HUMANGENET,D-8000 MUNICH 2,FED REP GER	University of Munich	GORG, A (corresponding author), TECH UNIV MUNICH,LEHRSTUHL ALLGEMEINE LEBENSMITTELTECHNOL,D-8050 FREISING,FED REP GER.							ALLEN RC, 1974, AM J CLIN PATHOL, V62, P732; ARNAUD P, 1974, CR SOC BIOL, V168, P58; BJELLQVIST B, 1982, J BIOCHEM BIOPH METH, V6, P317, DOI 10.1016/0165-022X(82)90013-6; BJELLQVIST B, 1983, LKB324 APPL NOT; CONSTANS J, 1980, HUM GENET, V55, P119, DOI 10.1007/BF00329137; CONSTANS J, 1975, CR ACAD SCI D NAT, V281, P1361; COX DW, 1980, HUM GENET, V53, P429, DOI 10.1007/BF00287070; DAVRINCHE C, 1984, HUM HERED, V34, P297, DOI 10.1159/000153483; Fagerhol M K, 1981, Adv Hum Genet, V11, P1; FRANTS RR, 1976, HUM HERED, V26, P435, DOI 10.1159/000152838; FRANTS RR, 1978, HUM HERED, V28, P201, DOI 10.1159/000152959; GENZ T, 1977, HUM GENET, V38, P325, DOI 10.1007/BF00402159; GORG A, 1983, ELECTROPHORESIS, V4, P153, DOI 10.1002/elps.1150040210; GORG A, 1980, J BIOCHEM BIOPH METH, V3, P273, DOI 10.1016/0165-022X(80)90008-1; GORG A, 1982, LKB320 APPL NOT; GORG A, 1979, ELECTROPHORESIS 79, P67; KLASEN EC, 1977, HUM GENET, V37, P303, DOI 10.1007/BF00393613; KUEPPERS F, 1976, AM J HUM GENET, V28, P370; KUHNEL P, 1978, ARCH GENETIK, V51, P15; LAURELL CB, 1963, SCAND J CLIN LAB INV, V15, P132, DOI 10.3109/00365516309051324; LEBAS J, 1974, CR HEBD ACAD SCI, V258, P2359; Lieberman J., 1983, PRINCIPLES PRACTICE, V2, P911; WEIDINGER S, 1982, Z RECHTSMED, V88, P203; WEIDINGER S, 1984, ELECTROPHORESIS, V5, P223, DOI 10.1002/elps.1150050407	24	52	53	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	5					922	930						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ASD55	3876767				2022-12-18	WOS:A1985ASD5500009
J	SCRIVER, CR; BARDANIS, M; CARTIER, L; CLOW, CL; LANCASTER, GA; OSTROWSKY, JT				SCRIVER, CR; BARDANIS, M; CARTIER, L; CLOW, CL; LANCASTER, GA; OSTROWSKY, JT			BETA-THALASSEMIA DISEASE PREVENTION - GENETIC MEDICINE APPLIED	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MCGILL UNIV,MONTREAL CHILDRENS HOSP,RES INST,MONTREAL H3H 1P3,QUEBEC,CANADA	McGill University	SCRIVER, CR (corresponding author), QUEBEC NETWORK GENET MED,MONTREAL,QUEBEC,CANADA.			Ostrowsky, Julia/0000-0001-7473-2464				ANGASTINIOTIS MA, 1981, LANCET, V1, P369; [Anonymous], 1980, INT CLASSIFICATION I; BARRAI I, 1980, AM J MED GENET, V6, P195, DOI 10.1002/ajmg.1320060304; BARRAI I, 1980, LANCET, V2, P1257; BECK E, 1974, NEW ENGL J MED, V291, P1166, DOI 10.1056/NEJM197411282912206; BOEHM CD, 1983, NEW ENGL J MED, V308, P1054, DOI 10.1056/NEJM198305053081803; CAO A, 1980, LANCET, V2, P1189; CLOW CL, 1977, PEDIATRICS, V59, P86; CONGOTE LF, 1981, BLOOD, V57, P353; DESJARDINS L, 1978, CAN MED ASSOC J, V119, P709; Drummond M.F., 1980, PRINCIPLES EC APPRAI; HOLTZMAN NA, 1977, PEDIATRICS, V59, P131; LOUKOPOULOS D, 1980, LANCET, V2, P1188; MODELL B, 1980, BMJ-BRIT MED J, V1, P1347; MOTULSKY AG, 1973, ISRAEL J MED SCI, V9, P1341; MOUZOURAS M, 1980, LANCET, V2, P574; OSTROWSKY JT, 1983, THESIS MCGILL U MONT; ROWLEY PT, 1979, AM J HUM GENET, V31, P718; ROWLEY PT, 1982, BIRTH DEFECTS-ORIG, V18, P231; SCRIVER CR, 1978, SCIENCE, V200, P946, DOI 10.1126/science.644337; SILVESTRONI E, 1980, J MED GENET, V17, P161, DOI 10.1136/jmg.17.3.161; SPRITZ RA, 1983, AM J HUM GENET, V35, P333; Weatherall DJ, 1981, THALASSEMIA SYNDROME; WILLIAMS A, 1974, BRIT MED BULL, V30, P252, DOI 10.1093/oxfordjournals.bmb.a071211; ZANNISHADJOPOUL.M, 1977, HUM GENET, V38, P315; ZEESMAN S, 1984, AM J MED GENET; 1975, GENETIC SCREENING PR; 1983, B WHO, V61, P63; 1980, 1 OFF TECHN ASS BACK; 1982, B WHO, V60, P643	30	52	53	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	5					1024	1038						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TS302	6496471				2022-12-18	WOS:A1984TS30200009
J	CHAGANTI, RSK; JHANWAR, SC; EHRENBARD, LT; KOURIDES, IA; WILLIAMS, JJ				CHAGANTI, RSK; JHANWAR, SC; EHRENBARD, LT; KOURIDES, IA; WILLIAMS, JJ			GENETICALLY-DETERMINED ASYNAPSIS, SPERMATOGENIC DEGENERATION, AND INFERTILITY IN MEN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MEM SLOAN KETTERING CANC CTR,MOLEC ENDOCRINOL LAB,NEW YORK,NY 10021; CORNELL UNIV,MED CTR,NEW YORK HOSP,DEPT UROL,NEW YORK,NY 10021	Memorial Sloan Kettering Cancer Center; Cornell University; NewYork-Presbyterian Hospital	CHAGANTI, RSK (corresponding author), MEM SLOAN KETTERING CANC CTR,CANC GENET & CYTOGENET LAB,NEW YORK,NY 10021, USA.							BAKER BS, 1976, ANNU REV GENET, V10, P53, DOI 10.1146/annurev.ge.10.120176.000413; BEADLE G. W., 1933, CYTOLOGIA, V4, P269, DOI 10.1508/cytologia.4.269; Beadle GW, 1928, SCIENCE, V68, P433, DOI 10.1126/science.68.1766.433; Beadle GW, 1930, CORNELL U AES, V129, P1; BIGOS ST, 1978, J CLIN ENDOCR METAB, V46, P317, DOI 10.1210/jcem-46-2-317; CARPENTER ATC, 1979, CHROMOSOMA, V75, P259, DOI 10.1007/BF00293472; CARR DH, 1961, STAIN TECHNOL, V36, P233, DOI 10.3109/10520296109113278; CHAGANTI RSK, 1979, AM J HUM GENET, V31, P634; CHAGANTI RSK, 1965, CYTOGENETIC STUDIES; CHANDLEY AC, 1976, ANN HUM GENET, V40, P165, DOI 10.1111/j.1469-1809.1976.tb00176.x; DUTRILLAUX B, 1971, ANN GENET-PARIS, V14, P49; EVANS EP, 1964, CYTOGENETICS, V3, P289, DOI 10.1159/000129818; Ferguson-Smith MA, 1976, CHROMOSOMES TODAY, V5, P33; FOREJT J, 1979, CHROMOSOMA, V73, P255, DOI 10.1007/BF00331576; GATTI M, 1979, P NATL ACAD SCI USA, V76, P1377, DOI 10.1073/pnas.76.3.1377; GILLIES CB, 1973, COLD SPRING HARB SYM, V38, P117, DOI 10.1101/SQB.1974.038.01.015; Gowen JW, 1933, J EXP ZOOL, V65, P83, DOI 10.1002/jez.1400650106; Gowen MS, 1922, AM NAT, V56, P286, DOI 10.1086/279868; GOWEN SW, 1928, SCIENCE, V68, P211; HODGKIN J, 1979, GENETICS, V91, P67; HOTTA Y, 1977, CHROMOSOMA, V62, P255, DOI 10.1007/BF00286047; HULTEN M, 1978, CYTOGENET CELL GENET, V22, P37, DOI 10.1159/000130917; HULTEN M, 1974, HEREDITAS, V78, P105; HULTEN M, 1970, HEREDITAS-GENETISK A, V65, P285; JHANWAR SC, 1979, AM J HUM GENET, V31, pA98; KOULISCHER L, 1974, CLIN GENET, V5, P116; KOURIDES IA, 1976, J CLIN ENDOCR METAB, V43, P97, DOI 10.1210/jcem-43-1-97; LACOUR LF, 1970, CHROMOSOMA, V29, P419, DOI 10.1007/BF00281924; LEHMANN AR, 1977, CANCER RES, V37, P904; McKusick V.A., 1978, MENDELIAN INHERITANC; MILLER OL, 1963, GENETICS, V48, P1445; MOENS PB, 1969, CAN J GENET CYTOL, V11, P857, DOI 10.1139/g69-101; PALMER RG, 1971, CHROMOSOMA, V35, P233, DOI 10.1007/BF00326276; PATHAK S, 1979, CHROMOSOMA, V70, P195, DOI 10.1007/BF00288406; PEARSON PL, 1970, CYTOGENETICS, V9, P460, DOI 10.1159/000130115; PURNELL DJ, 1973, CYTOGENET CELL GENET, V12, P327, DOI 10.1159/000130471; REAME NE, 1975, NEW ENGL J MED, V292, P675, DOI 10.1056/NEJM197503272921306; RUSSEL JK, 1954, P STUDY FERTIL, V6, P115; RUSSELL ES, 1975, BIOL LABORATORY MOUS, P571; SASAKI MS, 1977, JPN J GENET, V52, P472; SKAKKEBAEK NE, 1973, J REPROD FERTIL, V35, P23; SMITH PA, 1968, GENETICS, V60, P335; STERN H, 1973, ANNU REV GENET, V7, P37, DOI 10.1146/annurev.ge.07.120173.000345; TEMPLADO C, 1976, ANDROLOGIA, V8, P285; THOMSON E, 1979, J MED GENET, V16, P270, DOI 10.1136/jmg.16.4.270; Van Zyl JA, 1976, HUMAN SEMEN FERTILIT, P363	46	52	53	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	6					833	848						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KT964	7446525				2022-12-18	WOS:A1980KT96400006
J	GREENACRE, MJ; DEGOS, L				GREENACRE, MJ; DEGOS, L			CORRESPONDENCE ANALYSIS OF HLA GENE FREQUENCY DATA FROM 124 POPULATION SAMPLES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HOP ST LOUIS, CTR HAYEM, INSERM, IMMUNOHEMATOL LAB, PARIS 10E, FRANCE; UNIV PARIS 06, STAT MATH LAB, PARIS 5E, FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite			Greenacre, Michael J/D-7401-2013	Greenacre, Michael J/0000-0002-0054-3131				Anderson T.W, 1958, INTRO MULTIVARIATE S; BALAKRISHNAN V, 1968, BIOMETRICS, V24, P859, DOI 10.2307/2528876; Benzecri J.-P., 1973, ANALYSE DONNEES, V2; BODMER JG, 1973, HISTOCOMPATIBILITY T, P619; BODMER JG, 1976, HISTOCOMPATIBILITY T, P21; DEGOS L, 1973, HISTOCOMPATIBILITY T, P739; EDWARDS AWF, 1971, BIOMETRICS, V27, P873, DOI 10.2307/2528824; GABRIEL KR, 1971, BIOMETRIKA, V58, P453, DOI 10.2307/2334381; Hill M. O., 1974, Applied Statistics, V23, P340, DOI 10.2307/2347127; LALOUEL JM, 1975, THESIS U PARIS; PIAZZA A, 1975, TISSUE ANTIGENS, V5, P445, DOI 10.1111/j.1399-0039.1975.tb01489.x; PIAZZA A, 1973, HISTOCOMPATIBILITY T, P731; TEIL H, 1975, MATH GEOL, V7, P3; THORSBY E, 1976, HISTOCOMPATIBILITY T, P414; [No title captured]; 1976, HISTOCOMPATIBILITY T, P5	16	52	54	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1977	29	1					60	75						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CU441	835576				2022-12-18	WOS:A1977CU44100007
J	PIAZZA, A; VANLOGHEM, E; DELANGE, G; CURTONI, ES; ULIZZI, L; TERRENATO, L				PIAZZA, A; VANLOGHEM, E; DELANGE, G; CURTONI, ES; ULIZZI, L; TERRENATO, L			IMMUNOGLOBULIN ALLOTYPES IN SARDINIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									IST GENET MED,TURIN,ITALY; NETHERLANDS RED CROSS BLOOD TRANSF SERV,CENT LAB,AMSTERDAM,NETHERLANDS; UNIV ROME,FAC SCI,IST GENET,ROME,ITALY	Sapienza University Rome				Piazza, Alberto/0000-0002-2355-4183				Bodmer J.G., 1973, HISTOCOMPATIBILITY T, P621; CARCASSI U, 1957, 1 B SIER MIL, V36, P206; CEPPELLINI R, 1955, COLD SPRING HARBOR S, V26, P252; FERMI E, 1938, MALARIA SARDEGNA; FISHER R, 1959, MATHEMATICAL THEORY; GEDDEDAHL T, 1972, ANN HUM GENET, V35, P393; GRUBB R, 1961, AM J HUM GENET, V13, P171; Grubb R., 1970, GENETIC MARKERS HUMA; KUNKEL HG, 1970, J EXP MED, V132, P508, DOI 10.1084/jem.132.3.508; Logan J. A., 1953, SARDINIAN PROJECT; Natvig J B, 1973, Adv Immunol, V16, P1, DOI 10.1016/S0065-2776(08)60295-3; NATVIG JB, 1971, CLIN EXP IMMUNOL, V8, P685; Piazza A, 1973, HISTOCOMPATIBILITY T, P73; PIAZZA A, TO BE PUBLISHED; SANTACHIARABENE.AS, 1972, HUMAN HERED, V21, P290; SINISCALCO M, 1966, B WORLD HEALTH ORGAN, V34, P378; STEINBERG AG, 1974, AM J HUM GENET, V26, P223; STEINBERG AG, 1969, ANNU REV GENET, V3, P25, DOI 10.1146/annurev.ge.03.120169.000325; TERRACINI A, 1964, SAGGIO ATLANTE LINGU; Terrenato L, 1971, REND ACAD NAZ LINC 8, V51, P249; VANLOGHEM E, 1970, ANN HUM GENET, V33, P351; VANLOGHEM E, 1972, TRANSPL P, V4, P129; VANLOGHEM E, 1971, HUMAN ANTIHUMAN GAMM, P29; YOUNT WJ, 1968, J EXP MED, V127, P633, DOI 10.1084/jem.127.3.633	24	52	52	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	1					77	86						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	BC888	1247022				2022-12-18	WOS:A1976BC88800010
J	LITTLEFIELD, LG; MAILHES, JB				LITTLEFIELD, LG; MAILHES, JB			OBSERVATIONS OF DE NOVO CLONES OF CYTOGENETICALLY ABERRANT CELLS IN PRIMARY FIBROBLAST CELL STRAINS FROM PHENOTYPICALLY NORMAL WOMEN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									OAK RIDGE ASSOC UNIV,MED DIV,POB 117,OAK RIDGE,TN 37830	Oak Ridge Associated Universities								HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; MAILHES JB, 1973, ORAU122 US AT EN COM, P177; SCHNEIDER EL, 1974, SCIENCE, V184, P477, DOI 10.1126/science.184.4135.477	3	52	52	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1975	27	2					190	197						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V9467	1124763				2022-12-18	WOS:A1975V946700005
J	NEEL, JV; ROTHHAMMER, F; LINGOES, JC				NEEL, JV; ROTHHAMMER, F; LINGOES, JC			GENETIC STRUCTURE OF A TRIBAL POPULATION, YANOMAMA INDIANS .10. AGREEMENT BETWEEN REPRESENTATIONS OF VILLAGE DISTANCES BASED ON DIFFERENT SETS OF CHARACTERISTICS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MICHIGAN, DEPT HUMAN GENET, ANN ARBOR, MI 48104 USA; UNIV MICHIGAN, DEPT PSYCHOL, ANN ARBOR, MI 48104 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan								Cavalli-Sforza LL, 1965, GENETICS TODAY, V3, P923; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; EDWARDS AWF, 1964, 6 SYST ASS PUBL, P67; ELLIS FR, 1963, HUM BIOL, V35, P26; FITCH WM, 1969, AM J HUM GENET, V21, P384; FRIEDLAENDER JS, 1971, AM J HUM GENET, V23, P253; GERSHOWITZ H, 1972, ANN HUM GENET, V35, P261, DOI 10.1111/j.1469-1809.1957.tb01400.x; GOWER JC, 1971, AM J PHYS ANTHROPOL, V35, P280; GUTTMAN L, 1968, PSYCHOMETRIKA, V33, P469, DOI 10.1007/BF02290164; GUTTMAN R, 1967, AM J PHYS ANTHROPOL, V27, P259, DOI 10.1002/ajpa.1330270302; Herskovits Melville, 1930, ANTHROPOMETRY AM NEG; HIERNAUX J, 1956, ANN MUSEE ROYAL CONG, V3; Kendall M. G., 1962, RANK CORRELATION MET; KIDD KK, 1971, AM J HUM GENET, V23, P235; LEWONTIN RC, 1973, GENETICS, V74, P175; Lingoes J., 1973, GUTTMAN LINGOES NONM; LINGOES JC, 1971, PSYCHOMETRIKA, V36, P195, DOI 10.1007/BF02291398; LINGOES JC, 1965, BEHAV SCI, V10, P183; LINGOES JC, 1973, MICHIGAN MATHEMATICA; LINGOES JC, IN PRESS; MAHALANOBIS P. C., 1949, Sankhya. The Indian Journal of Statistics, V9, P89; MIGLIAZZA E, 1972, THESIS U INDIANA; NEEL J, 1972, HUM GENET, V7, P96; NEEL J V, 1970, Proceedings of the National Academy of Sciences of the United States of America, V65, P323, DOI 10.1073/pnas.65.2.323; NEEL JV, 1972, ANN HUM GENET, V35, P255, DOI 10.1111/j.1469-1809.1957.tb01399.x; NEEL JV, 1964, AM J HUM GENET, V16, P52; OSBORNE RH, 1958, AM J PHYS ANTHROPOL, V16, P187, DOI 10.1002/ajpa.1330160204; POLLITZER WS, 1958, AM J PHYS ANTHROPOL, V16, P241, DOI 10.1002/ajpa.1330160208; PRIM RC, 1957, AT&T TECH J, V36, P1389, DOI 10.1002/j.1538-7305.1957.tb01515.x; ROSKAM EECI, 1970, BEHAV SCI, V15, P204; ROTHHAMMER F, 1973, AM J HUM GENET, V25, P152; Sanghvi LD, 1953, AM J PHYS ANTHROP-NE, V11, P385, DOI 10.1002/ajpa.1330110313; SCHONEMANN PH, 1970, PSYCHOMETRIKA, V35, P245, DOI 10.1007/BF02291266; SPIELMAN RS, 1972, AM J PHYS ANTHROPOL, V37, P345, DOI 10.1002/ajpa.1330370304; SPIELMAN RS, 1973, AM J PHYS ANTHROPOL, V39, P461, DOI 10.1002/ajpa.1330390312; STEGGERDA M, 1942, ANTHROP BRIEFS, V2, P7; TANIS RJ, 1973, AM J HUM GENET, V25, P655; TANIS RJ, IN PRESS; WARD RH, 1970, AM J HUM GENET, V22, P538; WARD RH, 1972, ANN HUM GENET, V36, P21, DOI 10.1111/j.1469-1809.1972.tb00579.x; WEITKAMP LR, 1972, ANN HUM GENET, V35, P433, DOI 10.1111/j.1469-1809.1957.tb01868.x; WEITKAMP LR, 1972, ANN HUM GENET, V35, P271, DOI 10.1111/j.1469-1809.1957.tb01401.x; [No title captured]	43	52	52	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1974	26	3					281	303						23	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T0991	4827363				2022-12-18	WOS:A1974T099100001
J	BREWER, GJ; DERN, RJ				BREWER, GJ; DERN, RJ			NEW INHERITED ENZYMATIC DEFICIENCY OF HUMAN ERYTHROCYTES - 6-PHOSPHOGLUCONATE DEHYDROGENASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BEUTLER E, 1957, J LAB CLIN MED, V49, P84; BREWER G J, 1960, Bull World Health Organ, V22, P633; BREWER GJ, 1962, JAMA-J AM MED ASSOC, V180, P386, DOI 10.1001/jama.1962.03050180032008; BREWER GJ, 1964, CLIN RES, V12, P215; CARSON PE, 1956, SCIENCE, V124, P484, DOI 10.1126/science.124.3220.484-a; CHILDS B, 1959, S BIOCHEMISTRY HUMAN, P76; DERN RJ, 1963, J LAB CLIN MED, V62, P319; FILDES RA, 1963, NATURE, V200, P890, DOI 10.1038/200890a0; GLOCK GE, 1953, BIOCHEM J, V55, P400, DOI 10.1042/bj0550400; MENDEL G, 1963, 2 P INT C HUM GEN RO, V1, P618; MOTULSKY AG, 1959, CLIN RES, V7, P89; PORTER IH, 1963, 2 P INT C HUM GEN RO, V1, P618; WOLSTENHOLME GEW, 1959, S BIOCHEMISTRY HUMAN, P76; ZINKHAM WH, 1959, J PEDIATR-US, V55, P319, DOI 10.1016/S0022-3476(59)80228-6	14	52	52	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1964	16	4					472	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2974A	14250427				2022-12-18	WOS:A19642974A00002
J	BENNETT, JH; RHODES, FA; ROBSON, HN				BENNETT, JH; RHODES, FA; ROBSON, HN			A POSSIBLE GENETIC BASIS FOR KURU	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BENNETT J. H., 1958, AUSTRALASIAN, V7, P269; Berndt RM, 1954, OCEANIA, V25, P23, DOI 10.1002/j.1834-4461.1954.tb00622.x; Berndt Ronald M.A, 1958, SOCIOLOGUS, V8, P4; FOWLER MALCOLM, 1959, AUSTRALASIAN ANN MED, V8, P16; GAJDUSEK DC, 1957, NEW ENGL J MED, V257, P974, DOI 10.1056/NEJM195711142572005; GAJDUSEK DC, 1958, KLIN WOCHENSCHR, V36, P445, DOI 10.1007/BF01484635; Greenfield JG., 1954, SPINO CEREBELLAR DEG; SIMPSON D. A., 1959, AUSTRALASIAN ANN MED, V8, P8; ZIGAS V, 1957, Med J Aust, V44, P745; ZIGAS V, 1958, COMMUNICATION	10	52	52	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1959	11	2					169	187						19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF073	13661152				2022-12-18	WOS:A1959WF07300005
J	PENROSE, LS				PENROSE, LS			PARENTAL AGE IN ACHONDROPLASIA AND MONGOLISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		GREBE H, 1955, CHONDRODYSPLASIE; Jenkins RL, 1933, AM J DIS CHILD, V45, P506; KROOTH RS, 1952, THESIS U LONDON; Morch ET, 1941, CHONDRODYSTROPHIC DW; Oster J., 1953, MONGOLISM; Penrose LS, 1933, J GENET, V27, P219, DOI 10.1007/BF02984413; Penrose LS, 1934, P R SOC LOND B-CONTA, V115, P431, DOI 10.1098/rspb.1934.0051; PENROSE LS, 1955, LANCET, V2, P312; Schulz B, 1931, Z GESAMTE NEUROL PSY, V134, P268, DOI 10.1007/BF02896998; STEVENSON AC, 1957, AM J HUM GENET, V9, P81; VANDERSCHEER WM, 1927, ABH NEUR PSYCHIAT, V41, P1; Weinberg W., 1912, ARCH RASSEN U GESEL, V9, P710; Wright S, 1926, AM NAT, V60, P552, DOI 10.1086/280125	13	52	53	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1957	9	3					167	169						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA216	13507646				2022-12-18	WOS:A1957WA21600002
J	KOMAI, T; KISHIMOTO, K; OZAKI, Y				KOMAI, T; KISHIMOTO, K; OZAKI, Y			GENETIC STUDY OF MICROCEPHALY BASED ON JAPANESE MATERIAL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Allan W, 1944, AM J MENT DEF, V48, P325; BAILEY TJ, 1951, ANN EUGENICS, V16, P223; Benda CE, 1941, AM J PSYCHIAT, V97, P1135, DOI 10.1176/ajp.97.5.1135; Bernstein C, 1922, J HERED, V13, P30, DOI 10.1093/oxfordjournals.jhered.a102152; BESWICK RC, 1949, AM J DIS CHILD, V78, P334; BIEMOND A, 1938, ANN ANAT PATHOL ANAT, V15, P883; Book JA, 1953, AM J MENT DEF, V57, P637; BOOK JA, 1949, AM J HUMAN GENET, V1, P61; BRENNER W, 1951, Z MENSCHL VERERB KON, V30, P375; BRUGGER C, 1939, HDB ERBBIOLOGIE MENS, V2, P750; DAHLBERG G, 1947, MATH METHODS POPULAT; DAHLBERG G, 1948, ADV GENET, V2, P69; DUBITSCHER F, 1937, HDB ERBKRANKHEITEN, V1, P106; DUNN LC, 1947, P NATL ACAD SCI USA, V33, P359, DOI 10.1073/pnas.33.12.359; ERNST F, 1907, MORPHOLOGIE MISSBILD, P190; Glass SJ, 1944, J CLIN ENDOCRINOL, V4, P47, DOI 10.1210/jcem-4-2-47; Goldstein L, 1929, AM J ROENTGENOL RADI, V22, P322; GOLDSTEIN L, 1929, ARCH NEUROL PSYCHIAT, V27, P102; GREBE H, 1939, Z MENSCHL VERERBUNGS, V24, P506; GREENFIELD JG, 1935, ARCH NEUROL PSYCHIAT, V34, P1296; Haldane JBS, 1938, ANN EUGENIC, V8, P255, DOI 10.1111/j.1469-1809.1938.tb02179.x; HALLERVORDEN J, 1950, ARCH PSYCHIAT NERVEN, V184, P579; Halperin SL, 1944, J HERED, V35, P211; HARA A, 1940, KEIO IGAKU, V20, P150; Hogben L, 1931, J GENET, V25, P97, DOI 10.1007/BF02983936; Jelgersma HC, 1928, Z GESAMTE NEUROL PSY, V112, P88, DOI 10.1007/BF02863887; KOMAI T., 1953, PROC JAPANESE ACAD, V29, P220; KURBITZ W, 1931, ARCH PSYCHIAT NERVEN, V90, P172; LANDE L, 1950, J PEDIATR-US, V36, P625, DOI 10.1016/S0022-3476(50)80131-2; Li C.C., 1948, INTRO POPULATION GEN; MAYER C, 1930, ARCH PSYCHIAT, V89, P662; MITSUKAWA M, 1937, 15TH ANN DEP NEUR KE, P122; MIYAO G, 1949, MAN HEREDITY, V2, P65; MURPHY DP, 1947, CONGENITAL MALFORMAT; NEEL JV, 1951, SCIENCE, V114, P419, DOI 10.1126/science.114.2964.419; NEEL JV, 1949, AM J HUM GENET, V1, P156; NEEL JV, 1952, AM NAT, V86, P129, DOI 10.1086/281718; OZAKI Y, 1940, MINZOKU EISEI, V8, P159; PATERSON DONALD, 1926, PROC ROY SOC MED [SEC DIS CHILD], V19, P60; PENROSE LS, 1946, ANN EUGENIC, V13, P73, DOI 10.1111/j.1469-1809.1946.tb02344.x; PENROSE LS, 1939, J MENTAL SCI, V85, P1; PENROSE LS, 1938, J MENTAL SCI, V84, P1; PENROSE LS, 1938, 229 MED RES COUNC SP; PLUMMER G, 1952, PEDIATRICS, V10, P687; POLMAN A., 1950, GENETICA, V25, P29; SAKO M, 1948, IDENGAKU ZASSHI, V2, P150; Spencer W G, 1920, Proc R Soc Med, V13, P76; STRINGARIS MG, 1929, FRANKFURT Z PATHOL, V37, P396; SWAN C, 1943, CONGENITAL DEFECTS I; THELANDER HE, 1949, AM J DIS CHILD, V77, P642; TREDGOLD AF, 1949, TXB MENTAL DEFICIENC; VERSCHUER O, 1945, ERBPATHOLOGIE; WATANABE T, 1922, MITT MED FAK K U TOK, V28, P77; YOSIDA T, 1943, OSAKA IGAKU, V42, P1460; ZAPPERT J, 1927, ARCH KINDERHEILKD, V80, P34	55	52	52	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1955	7	1					51	65						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA210	14361394				2022-12-18	WOS:A1955WA21000007
J	TRANKELL, A				TRANKELL, A			ASPECTS OF GENETICS IN PSYCHOLOGY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Chamberlain HD, 1928, J HERED, V19, P557, DOI 10.1093/oxfordjournals.jhered.a102943; DAHLBERG G, 1947, MATH METHODS POPULAT; Dahlberg G., 1926, TWIN BIRTHS TWINS HE; HALLGREN B, 1950, SPECIFIC DYSLEXIA; Ramaley F, 1913, AM NAT, V47, P730, DOI 10.1086/279383; Rife DC, 1940, GENETICS, V25, P0178; SNYDER LH, 1951, AM J HUM GENET, V3, P1; Stern C., 1950, PRINCIPLES HUMAN GEN; Stromgren, 1938, BEITRAGE PSYCHIATRIS; TRANKELL A, 1955, NORD PSYKOLOGI, V7, P65; TRANKELL A, 1954, NORD PSYKOLOGI, V6, P1	11	52	53	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1955	7	3					264	276						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA212	13258559				2022-12-18	WOS:A1955WA21200003
J	Kerminen, S; Martin, AR; Koskela, J; Ruotsalainen, SE; Havulinna, AS; Surakka, I; Palotie, A; Perola, M; Salomaa, V; Daly, MJ; Ripatti, S; Pirinen, M				Kerminen, Sini; Martin, Alicia R.; Koskela, Jukka; Ruotsalainen, Sanni E.; Havulinna, Aki S.; Surakka, Ida; Palotie, Aarno; Perola, Markus; Salomaa, Veikko; Daly, Mark J.; Ripatti, Samuli; Pirinen, Matti			Geographic Variation and Bias in the Polygenic Scores of Complex Diseases and Traits in Finland	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENETIC ARCHITECTURE; SCHIZOPHRENIA; RISK; LOCI; METAANALYSIS; PREDICTION; DISORDERS; INSIGHTS; BIOLOGY	Polygenic scores (PSs) are becoming a useful tool to identify individuals with high genetic risk for complex diseases, and several projects are currently testing their utility for translational applications. It is also tempting to use PSs to assess whether genetic variation can explain a part of the geographic distribution of a phenotype. However, it is not well known how the population genetic properties of the training and target samples affect the geographic distribution of PSs. Here, we evaluate geographic differences, and related biases, of PSs in Finland in a geographically well-defined sample of 2,376 individuals from the National FINRISK study. First, we detect geographic differences in PSs for coronary artery disease (CAD), rheumatoid arthritis, schizophrenia, waist-hip ratio (WHR), body-mass index (BMI), and height, but not for Crohn disease or ulcerative colitis. Second, we use height as a model trait to thoroughly assess the possible population genetic biases in PSs and apply similar approaches to the other phenotypes. Most importantly, we detect suspiciously large accumulations of geographic differences for CAD, WHR, BMI, and height, suggesting bias arising from the population's genetic structure rather than from a direct genotype-phenotype association. This work demonstrates how sensitive the geographic patterns of current PSs are for small biases even within relatively homogeneous populations and provides simple tools to identify such biases. A thorough understanding of the effects of population genetic structure on PSs is essential for translational applications of PSs.	[Kerminen, Sini; Koskela, Jukka; Ruotsalainen, Sanni E.; Havulinna, Aki S.; Surakka, Ida; Palotie, Aarno; Perola, Markus; Daly, Mark J.; Ripatti, Samuli; Pirinen, Matti] Univ Helsinki, Inst Mol Med Finland, Helsinki Inst Life Sci, FIN-00014 Helsinki, Finland; [Martin, Alicia R.; Palotie, Aarno; Daly, Mark J.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Martin, Alicia R.; Palotie, Aarno; Daly, Mark J.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Martin, Alicia R.; Daly, Mark J.] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Havulinna, Aki S.; Perola, Markus; Salomaa, Veikko] Natl Inst Hlth & Welf, Helsinki 00271, Finland; [Surakka, Ida] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Palotie, Aarno] Massachusetts Gen Hosp, Dept Psychiat, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Palotie, Aarno] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Ripatti, Samuli; Pirinen, Matti] Univ Helsinki, Dept Publ Hlth, Helsinki 00014, Finland; [Pirinen, Matti] Univ Helsinki, Helsinki Inst Informat Technol, FIN-00014 Helsinki, Finland; [Pirinen, Matti] Univ Helsinki, Dept Math & Stat, FIN-00014 Helsinki, Finland	University of Helsinki; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Finland National Institute for Health & Welfare; University of Michigan System; University of Michigan; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Helsinki; University of Helsinki; University of Helsinki	Pirinen, M (corresponding author), Univ Helsinki, Inst Mol Med Finland, Helsinki Inst Life Sci, FIN-00014 Helsinki, Finland.; Pirinen, M (corresponding author), Univ Helsinki, Dept Publ Hlth, Helsinki 00014, Finland.; Pirinen, M (corresponding author), Univ Helsinki, Helsinki Inst Informat Technol, FIN-00014 Helsinki, Finland.; Pirinen, M (corresponding author), Univ Helsinki, Dept Math & Stat, FIN-00014 Helsinki, Finland.	matti.pirinen@helsinki.fi	Daly, Mark J/B-2453-2017; Havulinna, Aki/AAM-4769-2021	Daly, Mark J/0000-0002-0949-8752; Kerminen, Sini/0000-0001-6361-6759; Surakka, Ida/0000-0002-6669-5541; Koskela, Jukka/0000-0002-0154-7222; Pirinen, Matti/0000-0002-1664-1350; Palotie, Aarno/0000-0002-2527-5874	National Institute for Health and Welfare; Academy of Finland [139635]; Finnish Foundation for Cardiovascular Research; University of Helsinki Doctoral Programme in Population Health; Academy of Finland, its Center of Excellence in Complex Disease Genetics [288509, 294050, 251217, 285380, 312076, 213506, 129680]; Research Funds of the University of Helsinki; EU FP7 project ENGAGE [201413]; EU FP7 project BioSHaRE [261433]; Biocentrum Helsinki; Sigrid Juselius Foundation; National Institutes of Health [K99MH117229]; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH117229] Funding Source: NIH RePORTER	National Institute for Health and Welfare; Academy of Finland(Academy of Finland); Finnish Foundation for Cardiovascular Research; University of Helsinki Doctoral Programme in Population Health; Academy of Finland, its Center of Excellence in Complex Disease Genetics(Academy of Finland); Research Funds of the University of Helsinki; EU FP7 project ENGAGE; EU FP7 project BioSHaRE; Biocentrum Helsinki; Sigrid Juselius Foundation(Sigrid Juselius Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the participants of the FINRISK cohort and its funders: the National Institute for Health and Welfare, the Academy of Finland (139635 to V.S.), and the Finnish Foundation for Cardiovascular Research. This research was conducted with the UK Biobank Resource under application no. 22627. Data on coronary artery disease have been contributed by CARDIoGRAMplusC4D investigators and have been downloaded from www.cardiogramplusc4d.org.We thank the Psychiatric Genomics Consortium (PGC) Schizophrenia working group and GIANT/height for access to summary statistics at the cohort level. We thank the International Inflammatory Bowel Disease Genetics Consortium (IIBDGC), the GIANT and RA consortia, and the Neale lab for publicly available summary statistics. This work was financially supported by the University of Helsinki Doctoral Programme in Population Health (S.K.), the Academy of Finland (288509 and 294050 to M. Pirinen; 251217 and 285380 to S.R.), its Center of Excellence in Complex Disease Genetics (312076 to M. Pirinen; 213506 and 129680 to S.R.), and by the Research Funds of the University of Helsinki to M. Pirinen. S.R. was further supported by EU FP7 projects ENGAGE (201413) and BioSHaRE (261433), the Finnish Foundation for Cardiovascular Research, Biocentrum Helsinki, and the Sigrid Juselius Foundation. A.R.M. was supported by funding from the National Institutes of Health (K99MH117229).	Abraham G, 2016, EUR HEART J, V37, P3267, DOI 10.1093/eurheartj/ehw450; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Borodulin K, 2017, INT J EPIDEMIOL, V47; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; CHURCHHOUSE C, 2017, RAPID GWAS 1000 PHEN; Curtis D, 2018, PSYCHIAT GENET, V28, P85, DOI 10.1097/YPG.0000000000000206; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642; Fullman N, 2018, LANCET, V391, P2236, DOI [10.1016/S0140-6736(18)30994-2, 10.1016/s0140-6736(18)30994-2]; Goudarzi M, 2019, ELIFE, V8, DOI [10.7554/eLife.40815, 10.7554/eLife.39725]; Hartiala J, 2017, CURR ATHEROSCLER REP, V19, DOI 10.1007/s11883-017-0641-6; Haukka J, 2001, PSYCHOL MED, V31, P1045, DOI 10.1017/S0033291701004299; Hovatta I, 1997, AM J MED GENET, V74, P353, DOI 10.1002/(SICI)1096-8628(19970725)74:4<353::AID-AJMG3>3.3.CO;2-I; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; Jussila Airi, 2013, J Crohns Colitis, V7, pe256, DOI 10.1016/j.crohns.2012.10.007; Kaipiainen-Seppanen O, 2001, ANN RHEUM DIS, V60, P128, DOI 10.1136/ard.60.2.128; Kerminen S, 2017, G3-GENES GENOM GENET, V7, P3459, DOI 10.1534/g3.117.300217; Khera AV, 2018, NAT GENET, V50, P1219, DOI 10.1038/s41588-018-0183-z; Kurki MI, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08262-y; Lappalainen T, 2006, GENE, V376, P207, DOI 10.1016/j.gene.2006.03.004; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Lehtinen P, 2016, J PEDIATR GASTR NUTR, V63, P65, DOI 10.1097/MPG.0000000000001050; LEHTINEN V, 1990, ACTA PSYCHIAT SCAND, V81, P418, DOI 10.1111/j.1600-0447.1990.tb05474.x; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Martin AR, 2019, NAT GENET, V51, P584, DOI 10.1038/s41588-019-0379-x; Martin AR, 2018, AM J HUM GENET, V102, P760, DOI 10.1016/j.ajhg.2018.03.003; Martin AR, 2017, AM J HUM GENET, V100, P635, DOI 10.1016/j.ajhg.2017.03.004; Mavaddat N, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv036; McEvoy BP, 2009, ECON HUM BIOL, V7, P294, DOI 10.1016/j.ehb.2009.09.005; Neuvonen AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130331; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; O'Connell KS, 2018, MOL CELL NEUROSCI, V88, P300, DOI 10.1016/j.mcn.2018.02.010; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Perala J, 2008, SCHIZOPHR RES, V106, P337, DOI 10.1016/j.schres.2008.08.017; Pietilainen O., 2014, THESIS; Price AL, 2008, AM J HUM GENET, V83, P132, DOI 10.1016/j.ajhg.2008.06.005; Puska P, 2009, NORTHER KARELIA PROJ; R Core Development Team, 2018, LANG ENV STAT COMP; Reisberg S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179238; Ripatti P, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006078; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Salmela E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003519; Schumacher FR, 2018, NAT GENET, V50, P928, DOI 10.1038/s41588-018-0142-8; Scutari M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006288; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/136905203770326402; Sohail M, 2019, ELIFE, V8, DOI 10.7554/eLife.39702; Stocker H, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0221-8; Visscher P. M., 2018, BIORXIV, DOI [10.1101/310565, DOI 10.1101/310565]; Visscher PM, 2017, AM J HUM GENET, V101, P5, DOI 10.1016/j.ajhg.2017.06.005; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Yang Jian, 2011, Am J Hum Genet, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	58	51	51	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 6	2019	104	6					1169	1181		10.1016/j.ajhg.2019.05.001	http://dx.doi.org/10.1016/j.ajhg.2019.05.001			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IB4KJ	31155286	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000470240000012
J	Backenroth, D; He, ZH; Kiryluk, K; Boeva, V; Pethukova, L; Khurana, E; Christiano, A; Buxbaum, JD; Ionita-Laza, I				Backenroth, Daniel; He, Zihuai; Kiryluk, Krzysztof; Boeva, Valentina; Pethukova, Lynn; Khurana, Ekta; Christiano, Angela; Buxbaum, Joseph D.; Ionita-Laza, Iuliana			FUN-LDA: A Latent Dirichlet Allocation Model for Predicting Tissue-Specific Functional Effects of Noncoding Variation: Methods and Applications	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; TRANSCRIPTION FACTOR-BINDING; PARALLEL REPORTER ASSAY; GENETIC-VARIANTS; SYSTEMATIC DISSECTION; REGULATORY VARIANTS; HISTONE MODIFICATIONS; SUSCEPTIBILITY LOCI; ALZHEIMERS-DISEASE	We describe a method based on a latent Dirichlet allocation model for predicting functional effects of noncoding genetic variants in a cell-type- and/or tissue-specific way (FUN-LDA). Using this unsupervised approach, we predict tissue-specific functional effects for every position in the human genome in 127 different tissues and cell types. We demonstrate the usefulness of our predictions by using several validation experiments. Using eQTL data from several sources, including the GTEx project, Geuvadis project, and TwinsUK cohort, we show that eQTLs in specific tissues tend to be most enriched among the predicted functional variants in relevant tissues in Roadmap. We further show how these integrated functional scores can be used for (1) deriving the most likely cell or tissue type causally implicated for a complex trait by using summary statistics from genome-wide association studies and (2) estimating a tissue-based correlation matrix of various complex traits. We found large enrichment of heritability in functional components of relevant tissues for various complex traits, and FUN-LDA yielded higher enrichment estimates than existing methods. Finally, using experimentally validated functional variants from the literature and variants possibly implicated in disease by previous studies, we rigorously compare FUN-LDA with state-ofthe-art functional annotation methods and show that FUN-LDA has better prediction accuracy and higher resolution than these methods. In particular, our results suggest that tissue- and cell-type-specific functional prediction methods tend to have substantially better prediction accuracy than organism-level prediction methods. Scores for each position in the human genome and for each ENCODE and Roadmap tissue are available online (see feb Resources).	[Backenroth, Daniel; He, Zihuai; Ionita-Laza, Iuliana] Columbia Univ, Dept Biostat, New York, NY 10032 USA; [Kiryluk, Krzysztof] Columbia Univ, Dept Med, New York, NY 10032 USA; [Boeva, Valentina] INSERM, U900, F-75005 Paris, France; [Boeva, Valentina] PSL Res Univ, Inst Curie, Mines ParisTech, F-75005 Paris, France; [Pethukova, Lynn] Columbia Univ, Dept Epidemiol, New York, NY 10032 USA; [Pethukova, Lynn; Christiano, Angela] Columbia Univ, Dept Dermatol, New York, NY 10032 USA; [Khurana, Ekta] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Christiano, Angela] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Genet, New York, NY 10029 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Genom Sci, New York, NY 10029 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA	Columbia University; Columbia University; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; UNICANCER; Institut Curie; Columbia University; Columbia University; Cornell University; Columbia University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Ionita-Laza, I (corresponding author), Columbia Univ, Dept Biostat, New York, NY 10032 USA.	ii2135@columbia.edu	Boeva, Valentina/C-2855-2017; Buxbaum, Joseph D/G-6001-2010	Boeva, Valentina/0000-0002-4382-7185; Buxbaum, Joseph/0000-0001-8898-8313; He, Zihuai/0000-0002-8220-4183	National Institutes of Health [MH106910, MH095797, AR065963, DK105124, MH100233]; Herbert Irving Scholars Award; Seaver Foundation; ATIP-Avenir program; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095797, U01MH100233, R01MH106910, R21MH106888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Herbert Irving Scholars Award; Seaver Foundation; ATIP-Avenir program; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We gratefully acknowledge support by National Institutes of Health grants MH106910 and MH095797 (D.B., Z.H., and I. I.-L.), AR065963 (L.P. and A.C.), DK105124 (K.K.), and MH100233 ( J.D.B.), the Herbert Irving Scholars Award (K.K.), the Seaver Foundation (J.D.B.), and the ATIP-Avenir program (V.B.). We thank Bin Xu and Badri Vardarajan for helpful discussions. We thank Andrew Brown for making the data on lead eQTLs in the Geuvadis and TwinsUK cohort available to us.	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Anney RJL, 2014, LANCET NEUROL, V13, P893, DOI 10.1016/S1474-4422(14)70171-1; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Attias H, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P21; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Betz RC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6966; Biesinger J, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S5-S4; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Brown AA, 2017, NAT GENET, V49, P1747, DOI 10.1038/ng.3979; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Choi JY, 2017, NAT GENET, V49, P1326, DOI 10.1038/ng.3927; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2015, NAT BIOTECHNOL, V33, P364, DOI 10.1038/nbt.3157; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Friedman N, 2015, GENOME RES, V25, P1482, DOI 10.1101/gr.190165.115; Fu Y, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0480-5; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gilks WP, 2012, WORLD J BIOL PSYCHIA, V13, P550, DOI 10.3109/15622975.2012.666359; Gjoneska E, 2015, NATURE, V518, P365, DOI 10.1038/nature14252; Grossman SR, 2017, P NATL ACAD SCI USA, V114, pE1291, DOI 10.1073/pnas.1621150114; Guenther CA, 2014, NAT GENET, V46, P748, DOI 10.1038/ng.2991; He ZH, 2017, AM J HUM GENET, V101, P340, DOI 10.1016/j.ajhg.2017.07.011; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hoffman MM, 2012, NAT METHODS, V9, P473, DOI [10.1038/NMETH.1937, 10.1038/nmeth.1937]; Huang YF, 2017, NAT GENET, V49, P618, DOI 10.1038/ng.3810; Ionita-Laza I, 2016, NAT GENET, V48, P214, DOI 10.1038/ng.3477; Ionita-Laza I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004729; Jefferson AL, 2015, CIRCULATION, V131, P1333, DOI 10.1161/CIRCULATIONAHA.114.012438; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kellis M, 2014, P NATL ACAD SCI USA, V111, P6131, DOI 10.1073/pnas.1318948111; Kheradpour P, 2013, GENOME RES, V23, P800, DOI 10.1101/gr.144899.112; Khurana E, 2016, NAT REV GENET, V17, P93, DOI 10.1038/nrg.2015.17; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kiryluk K, 2014, NAT GENET, V46, P1187, DOI 10.1038/ng.3118; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lee D, 2015, NAT GENET, V47, P955, DOI 10.1038/ng.3331; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Leslie EJ, 2015, AM J HUM GENET, V96, P397, DOI 10.1016/j.ajhg.2015.01.004; Li MLJ, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1177-3; Li MJ, 2016, BIOINFORMATICS, V32, P2729, DOI 10.1093/bioinformatics/btw288; Libbrecht M. W, 2016, BIORXIV, DOI [10.1101/086025, DOI 10.1101/086025]; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Lu QS, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005947; Mammana A, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0708-z; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Maurano MT, 2015, NAT GENET, V47, P1393, DOI 10.1038/ng.3432; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Perry JRB, 2014, NATURE, V514, P92, DOI 10.1038/nature13545; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Petukhova L, 2016, J INVEST DERMATOL, V136, P314, DOI 10.1038/JID.2015.402; Quang D, 2015, BIOINFORMATICS, V31, P761, DOI 10.1093/bioinformatics/btu703; Ramsey SA, 2010, BIOINFORMATICS, V26, P2071, DOI 10.1093/bioinformatics/btq405; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Silverman B.W., 1986, DENSITY ESTIMATION S; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Soldner F, 2016, NATURE, V533, P95, DOI 10.1038/nature17939; Song JM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0598-0; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tewhey R, 2016, CELL, V165, P1519, DOI 10.1016/j.cell.2016.04.027; van den Boogaard M, 2014, J CLIN INVEST, V124, P1844, DOI 10.1172/JCI73140; Visser M, 2014, HUM MOL GENET, V23, P5750, DOI 10.1093/hmg/ddu289; Xing LZ, 2014, NAT MED, V20, P1043, DOI 10.1038/nm.3645; Yokoyama JS, 2016, JAMA NEUROL, V73, P691, DOI 10.1001/jamaneurol.2016.0150; Zacher B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169249; Zhang Y., 2017, BIORXIV, DOI [10.1101/118752, DOI 10.1101/118752]; Zhang Y, 2016, NUCLEIC ACIDS RES, V44, P6721, DOI 10.1093/nar/gkw278; Zhou J, 2015, NAT METHODS, V12, P931, DOI [10.1038/NMETH.3547, 10.1038/nmeth.3547]	86	51	52	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 3	2018	102	5					920	942		10.1016/j.ajhg.2018.03.026	http://dx.doi.org/10.1016/j.ajhg.2018.03.026			23	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG1IH	29727691	Green Published, Bronze			2022-12-18	WOS:000432440100015
J	Hook, PW; McClymont, SA; Cannon, GH; Law, WD; Morton, AJ; Goff, LA; McCallion, AS				Hook, Paul W.; McClymont, Sarah A.; Cannon, Gabrielle H.; Law, William D.; Morton, A. Jennifer; Goff, Loyal A.; McCallion, Andrew S.			Single-Cell RNA-Seq of Mouse Dopaminergic Neurons Informs Candidate Gene Selection for Sporadic Parkinson Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUBSTANTIA-NIGRA; NERVOUS-SYSTEM; NETWORK ANALYSIS; OLFACTORY-BULB; KNOCKOUT MICE; STEM-CELLS; RISK LOCI; R PACKAGE; EXPRESSION	Genetic variation modulating risk of sporadic Parkinson disease (PD) has been primarily explored through genome-wide association studies (GWASs). However, like many other common genetic diseases, the impacted genes remain largely unknown. Here, we used single-cell RNA-seq to characterize dopaminergic (DA) neuron populations in the mouse brain at embryonic and early postnatal time points. These data facilitated unbiased identification of DA neuron subpopulations through their unique transcriptional profiles, including a postnatal neuroblast population and substantia nigra (SN) DA neurons. We use these population-specific data to develop a scoring system to prioritize candidate genes in all 49 GWAS intervals implicated in PD risk, including genes with known PD associations and many with extensive supporting literature. As proof of principle, we confirm that the nigrostriatal pathway is compromised in Cplx1-null mice. Ultimately, this systematic approach establishes biologically pertinent candidates and testable hypotheses for sporadic PD, informing a new era of PD genetic research.	[Hook, Paul W.; McClymont, Sarah A.; Cannon, Gabrielle H.; Law, William D.; Goff, Loyal A.; McCallion, Andrew S.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Morton, A. Jennifer] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England; [Goff, Loyal A.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [McCallion, Andrew S.] Johns Hopkins Univ, Sch Med, Dept Comparat & Mol Pathobiol, Baltimore, MD 21205 USA; [McCallion, Andrew S.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; University of Cambridge; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Goff, LA; McCallion, AS (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.; Goff, LA (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.; McCallion, AS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Comparat & Mol Pathobiol, Baltimore, MD 21205 USA.; McCallion, AS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	loyalgoff@jhmi.edu; andy@jhmi.edu	Morton, Jenny/AAT-8642-2020	Morton, Jenny/0000-0003-0181-6346; Hook, Paul/0000-0002-3912-1999; Goff, Loyal/0000-0003-2875-451X; Brown, Stephen/0000-0002-1347-5908	US NIH [R01 NS62972, MH106522]; CHDI Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH106522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062972] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHDI Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors wish to thank Stephen M. Brown for implementation and optimization of smFISH, Dr. Zhiguang Zheng and Mrs. Wendy Leavens for excellent technical support with the Cplx1 knockout mice and immunohistochemistry, and Drs. Kerstin Reim and Niels Brose for the gift of the founder mice for the Cambridge Cplx1 knockout mice colony. This research was supported in part by US NIH grants R01 NS62972 and MH106522 to A.S.M. and a grant from CHDI Inc. to A.J.M.	Abuirmeileh A, 2009, EUR J PHARMACOL, V604, P45, DOI 10.1016/j.ejphar.2008.11.009; Agoston Z, 2014, DEVELOPMENT, V141, P28, DOI 10.1242/dev.097295; Arenas E, 2015, DEVELOPMENT, V142, P1918, DOI 10.1242/dev.097394; Asmus SE, 2011, BRAIN RES, V1383, P108, DOI 10.1016/j.brainres.2011.01.101; Barallobre MJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.253; Basso M, 2004, PROTEOMICS, V4, P3943, DOI 10.1002/pmic.200400848; Benko S, 2009, NAT GENET, V41, P359, DOI 10.1038/ng.329; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Booth HDE, 2017, TRENDS NEUROSCI, V40, P358, DOI 10.1016/j.tins.2017.04.001; Boyle EA, 2017, CELL, V169, P1177, DOI 10.1016/j.cell.2017.05.038; Brichta L, 2015, NAT NEUROSCI, V18, P1325, DOI 10.1038/nn.4070; Burns JC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9557; Cai HB, 2014, TRANSL NEURODEGENER, V3, DOI 10.1186/2047-9158-3-27; Chang D, 2017, NAT GENET, V49, P1511, DOI 10.1038/ng.3955; Close J, 2012, J NEUROSCI, V32, P17690, DOI 10.1523/JNEUROSCI.3583-12.2012; Curran JE, 2010, HUM GENET, V127, P183, DOI 10.1007/s00439-009-0756-0; Darland T, 1998, TRENDS NEUROSCI, V21, P215, DOI 10.1016/S0166-2236(97)01204-6; Deas E, 2011, HUM MOL GENET, V20, P867, DOI 10.1093/hmg/ddq526; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; deRijk MC, 1997, J NEUROL NEUROSUR PS, V62, P10, DOI 10.1136/jnnp.62.1.10; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Doan RN, 2016, CELL, V167, P341, DOI 10.1016/j.cell.2016.08.071; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Ellis Blake C., 2012, Frontiers in Genetics, V3, P270, DOI 10.3389/fgene.2012.00270; EVERITT BJ, 1984, NEUROENDOCRINOLOGY, V39, P189, DOI 10.1159/000123977; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Fenselau H, 2017, NAT NEUROSCI, V20, P42, DOI 10.1038/nn.4442; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Galter D, 2006, ANN NEUROL, V59, P714, DOI 10.1002/ana.20808; Gispert S, 2015, MOL NEUROBIOL, V52, P57, DOI 10.1007/s12035-014-8844-0; Glynn D, 2005, HUM MOL GENET, V14, P2369, DOI 10.1093/hmg/ddi239; Glynn D, 2007, NEUROBIOL DIS, V25, P483, DOI 10.1016/j.nbd.2006.10.011; Gokce O, 2016, CELL REP, V16, P1126, DOI 10.1016/j.celrep.2016.06.059; Gupta RM, 2017, CELL, V170, P522, DOI 10.1016/j.cell.2017.06.049; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Higashi S, 2007, J NEUROCHEM, V100, P368, DOI 10.1111/j.1471-4159.2006.04246.x; Hildick-Smith GJ, 2013, AM J HUM GENET, V93, P906, DOI 10.1016/j.ajhg.2013.09.011; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Islam MM, 1997, BIOCHEM MOL BIOL INT, V41, P1109; Itoh N, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00015; Jackson-Lewis V, 2000, J COMP NEUROL, V424, P476, DOI 10.1002/1096-9861(20000828)424:3<476::AID-CNE6>3.0.CO;2-0; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kielar C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032636; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Klein C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a008888; Kozicz T, 1998, BRAIN RES, V810, P211, DOI 10.1016/S0006-8993(98)00692-1; La Manno G, 2016, CELL, V167, P566, DOI 10.1016/j.cell.2016.09.027; Lahut S, 2017, DIS MODEL MECH, V10, P619, DOI 10.1242/dmm.028035; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2012, J STAT SOFTW, V46, P1; Lee D, 2015, NAT GENET, V47, P955, DOI 10.1038/ng.3331; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Li H, 1996, EMBO J, V15, P714, DOI 10.1002/j.1460-2075.1996.tb00407.x; Li Z, 2008, BBA-GENE REGUL MECH, V1779, P479, DOI 10.1016/j.bbagrm.2008.03.008; Lieb K, 1996, DEV BRAIN RES, V94, P37, DOI 10.1016/0165-3806(96)00063-6; Lin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018068; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Molyneaux BJ, 2015, NEURON, V85, P275, DOI 10.1016/j.neuron.2014.12.024; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morales M, 2017, NAT REV NEUROSCI, V18, P73, DOI 10.1038/nrn.2016.165; Mudge JM, 2015, MAMM GENOME, V26, P366, DOI 10.1007/s00335-015-9583-x; Nakadate K, 2006, ACTA NEUROPATHOL, V112, P64, DOI 10.1007/s00401-006-0058-8; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Ng SY, 2013, MOL CELL, V51, P349, DOI 10.1016/j.molcel.2013.07.017; Panman L, 2014, CELL REP, V8, P1018, DOI 10.1016/j.celrep.2014.07.016; Parent M, 2010, CAN J NEUROL SCI, V37, P313, DOI 10.1017/S0317167100010209; Pascoli V, 2015, NEURON, V88, DOI 10.1016/j.neuron.2015.10.017; Perry VH, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009373; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Plovanich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055785; Poulin JF, 2014, CELL REP, V9, P930, DOI 10.1016/j.celrep.2014.10.008; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Puschmann A, 2013, PARKINSONISM RELAT D, V19, P407, DOI 10.1016/j.parkreldis.2013.01.020; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Qiu XJ, 2017, NAT METHODS, V14, P309, DOI [10.1038/NMETH.4150, 10.1038/nmeth.4150]; Russo I, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-52; Saxena A, 2012, BIOTECHNIQUES, V52, P381, DOI 10.2144/0000113878; Shi G, 2011, HUM MOL GENET, V20, P1966, DOI 10.1093/hmg/ddr077; Simunovic F, 2009, BRAIN, V132, P1795, DOI 10.1093/brain/awn323; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Soden ME, 2013, NEURON, V80, P997, DOI 10.1016/j.neuron.2013.07.044; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Ueda S, 2000, NEUROSCIENCE, V95, P389; Uhde CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008641; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vergano-Vera E, 2015, DEV NEUROBIOL, V75, P823, DOI 10.1002/dneu.22251; Viereckel T, 2016, SCI REP-UK, V6, DOI 10.1038/srep35203; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wang XF, 2017, STAT METHODS MED RES, V26, P2800, DOI 10.1177/0962280215609948; Winklhofer KF, 2010, BBA-MOL BASIS DIS, V1802, P29, DOI 10.1016/j.bbadis.2009.08.013; Wonsey DR, 2002, P NATL ACAD SCI USA, V99, P6649, DOI 10.1073/pnas.102523299; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	100	51	52	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 1	2018	102	3					427	446		10.1016/j.ajhg.2018.02.001	http://dx.doi.org/10.1016/j.ajhg.2018.02.001			20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FX9ZL	29499164	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000426469600014
J	Cuvertino, S; Stuart, HM; Chandler, KE; Roberts, NA; Armstrong, R; Bernardini, L; Bhaskar, S; Callewaert, B; Clayton-Smith, J; Davalillo, CH; Deshpande, C; Devriendt, K; Digilio, MC; Dixit, A; Edwards, M; Friedman, JM; Gonzalez-Meneses, A; Joss, S; Kerr, B; Lampe, AK; Langlois, S; Lennon, R; Loget, P; Ma, DYT; McGowan, R; Des Medt, M; O'Sullivan, J; Odent, S; Parker, MJ; Pebrel-Richard, C; Petit, F; Stark, Z; Stockler-Ipsiroglu, S; Tinschert, S; Vasudevan, P; Villa, O; White, SM; Zahir, FR; Woolf, AS; Banka, S				Cuvertino, Sara; Stuart, Helen M.; Chandler, Kate E.; Roberts, Neil A.; Armstrong, Ruth; Bernardini, Laura; Bhaskar, Sanjeev; Callewaert, Bert; Clayton-Smith, Jill; Hernando Davalillo, Cristina; Deshpande, Charu; Devriendt, Koenraad; Digilio, Maria C.; Dixit, Abhijit; Edwards, Matthew; Friedman, Jan M.; Gonzalez-Meneses, Antonio; Joss, Shelagh; Kerr, Bronwyn; Lampe, Anne Katrin; Langlois, Sylvie; Lennon, Rachel; Loget, Philippe; Ma, David Y. T.; McGowan, Ruth; Des Medt, Maryse; O'Sullivan, James; Odent, Sylvie; Parker, Michael J.; Pebrel-Richard, Celine; Petit, Florence; Stark, Zornitza; Stockler-Ipsiroglu, Sylvia; Tinschert, Sigrid; Vasudevan, Pradeep; Villa, Olaya; White, Susan M.; Zahir, Farah R.; Woolf, Adrian S.; Banka, Siddharth		DDD Study	ACTB Loss-of-Function Mutations Result in a Pleiotropic Developmental Disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WINTER CEREBROFRONTOFACIAL SYNDROME; DE-NOVO MUTATIONS; NUCLEAR ACTIN; BETA-ACTIN; DELAY; DYNAMICS; MALFORMATIONS; CYTOSKELETON; ARCHITECTURE; MECHANICS	ACTB encodes beta-actin, an abundant cytoskeletal housekeeping protein. In humans, postulated gain-of-function missense mutations cause Baraitser-Winter syndrome (BRWS), characterized by intellectual disability, cortical malformations, coloboma, sensorineural deafness, and typical facial features. To date, the consequences of loss-of-function ACTB mutations have not been proven conclusively. We describe heterozygous ACTB deletions and nonsense and frameshift mutations in 33 individuals with developmental delay, apparent intellectual disability, increased frequency of internal organ malformations (including those of the heart and the renal tract), growth retardation, and a recognizable facial gestalt (interrupted wavy eyebrows, dense eyelashes, wide nose, wide mouth, and a prominent chin) that is distinct from characteristics of individuals with BRWS. Strikingly, this spectrum overlaps with that of several chromatin-remodeling developmental disorders. In wild-type mouse embryos, beta-actin expression was prominent in the kidney, heart, and brain. ACTB mRNA expression levels in lymphoblastic lines and fibroblasts derived from affected individuals were decreased in comparison to those in control cells. Fibroblasts derived from an affected individual and ACTB siRNA knockdown in wild-type fibroblasts showed altered cell shape and migration, consistent with known roles of cytoplasmic beta-actin. We also demonstrate that ACTB haploinsufficiency leads to reduced cell proliferation, altered expression of cell-cycle genes, and decreased amounts of nuclear, but not cytoplasmic, beta-actin. In conclusion, we show that heterozygous loss-of-function ACTB mutations cause a distinct pleiotropic malformation syndrome with intellectual disability. Our biological studies suggest that a critically reduced amount of this protein alters cell shape, migration, proliferation, and gene expression to the detriment of brain, heart, and kidney development.	[Cuvertino, Sara; Stuart, Helen M.; Clayton-Smith, Jill; O'Sullivan, James; Banka, Siddharth] Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Div Evolut & Genom Sci, Manchester M13 9PL, Lancs, England; [Stuart, Helen M.; Chandler, Kate E.; Bhaskar, Sanjeev; Clayton-Smith, Jill; Kerr, Bronwyn; O'Sullivan, James; Banka, Siddharth] Manchester Univ Fdn NHS Trust, Hlth Innovat Manchester, St Marys Hosp, Manchester Ctr Genom Med, Manchester M13 9WL, Lancs, England; [Deshpande, Charu] Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Div Cell Matrix Biol & Regenerat Med, Manchester M13 9PL, Lancs, England; [Armstrong, Ruth] Addenbrookes Hosp, Dept Clin Genet, East Anglian Med Genet Serv, Cambridge CB2 0QQ, England; [Bernardini, Laura] Casa Sollievo Sofferenza Hosp, Cytogenet Unit, I-71013 San Giovanni Rotondo, Italy; [Callewaert, Bert] Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium; [Hernando Davalillo, Cristina; Villa, Olaya] Quantitat Genom Med Labs qGen, Barcelona 08950, Spain; [Deshpande, Charu] Guys Hosp, Clin Genet Dept, London SE1 9RT, England; [Devriendt, Koenraad; Des Medt, Maryse] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Leuven, Belgium; [Devriendt, Koenraad; Des Medt, Maryse] Univ Hosp Leuven, B-3000 Leuven, Belgium; [Digilio, Maria C.] Bambino Gesu Pediat Hosp, IRCCS, Med Genet, I-00165 Rome, Italy; [Dixit, Abhijit] Nottingham City Hosp, Dept Clin Genet, Nottingham NG5 1PB, England; [Edwards, Matthew] Univ Western Sydney, Sch Med, Dept Paediat, Penrith, NSW 2751, Australia; [Friedman, Jan M.; Langlois, Sylvie; Ma, David Y. T.; Stockler-Ipsiroglu, Sylvia; Zahir, Farah R.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z4, Canada; [Gonzalez-Meneses, Antonio] Hosp Viamed Santa Angela Cruz, Serv Pediat, Seville 41014, Spain; [Joss, Shelagh; McGowan, Ruth] Queen Elizabeth Univ Hosp, West Scotland Genet Serv, Glasgow G51 4TF, Lanark, Scotland; [Lampe, Anne Katrin] Western Gen Hosp, South East Scotland Clin Genet Dept, Edinburgh EH4 2XU, Midlothian, Scotland; [Loget, Philippe] Univ Rennes 1, Hop Pontchaillou, Serv Anat Pathol, F-35000 Rennes, France; [Odent, Sylvie] Univ Rennes 1, UMR 6290, Hop SUD, Serv Genet Clin,Ctr Reference Malad Rares CLAD Ou, F-35000 Rennes, France; [Parker, Michael J.] Sheffield Childrens NHS Fdn Trust, Sheffield Clin Genet Serv, Western Bank, Sheffield S20 1NZ, S Yorkshire, England; [Pebrel-Richard, Celine] Ctr Hosp Reg Clermont Ferrand, Serv Cytogenet Med, F-63000 Clermont Ferrand, France; [Petit, Florence] Ctr Hosp Reg Lille, Serv Genet Clin, F-59000 Lille, France; [Stark, Zornitza; White, Susan M.] Murdoch Childrens Res Inst, Victorian Clin Genet Serv, Parkville, Vic 3052, Australia; [Tinschert, Sigrid] Med Univ Innsbruck, Zentrum Med Genet, A-6020 Innsbruck, Austria; [Vasudevan, Pradeep] Univ Hosp Leicester NHS Trust, Leicester Royal Infirm, Dept Clin Genet, Leicester LE1 5WW, Leics, England; [White, Susan M.] Univ Melbourne, Dept Paediat, Melbourne, Vic 3010, Australia; [Zahir, Farah R.] Hamad Bin Khalifa Univ, Qatar Biomed Res Inst, Doha 34110, Qatar; [Lennon, Rachel] Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Wellcome Ctr Cell Matrix Res,Div Cell Matrix Biol, Manchester M13 9PL, Lancs, England; [DDD Study] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Woolf, Adrian S.] Royal Manchester Childrens Hosp, Manchester Acad Hlth Sci Ctr, Dept Nephrol, Manchester M13 9WL, Lancs, England	University of Manchester; University of Manchester; University of Manchester; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; IRCCS Casa Sollievo Della Sofferenza; Ghent University; Guy's & St Thomas' NHS Foundation Trust; KU Leuven; KU Leuven; University Hospital Leuven; IRCCS Bambino Gesu; Nottingham University Hospital NHS Trust; Nottingham City Hospital; Western Sydney University; University of British Columbia; Queen Elizabeth University Hospital (QEUH); University of Edinburgh; CHU Rennes; Universite de Rennes 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Rennes; Universite de Rennes 1; Sheffield Children's NHS Foundation Trust; CHU Clermont Ferrand; Universite de Lille - ISITE; CHU Lille; Murdoch Children's Research Institute; Medical University of Innsbruck; University Hospitals of Leicester NHS Trust; University of Leicester; University of Melbourne; Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Qatar Biomedical Research Institute (QBRI); University of Manchester; Wellcome Trust Sanger Institute; Royal Manchester Children's Hospital; University of Manchester	Banka, S (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Div Evolut & Genom Sci, Manchester M13 9PL, Lancs, England.; Banka, S (corresponding author), Manchester Univ Fdn NHS Trust, Hlth Innovat Manchester, St Marys Hosp, Manchester Ctr Genom Med, Manchester M13 9WL, Lancs, England.	siddharth.banka@manchester.ac.uk	Lennon, Rachel/AAJ-2134-2020; Langlois, Sylvie/AAR-7978-2021; Edwards, Matthew/L-8698-2019; Digilio, Maria Cristina/AAI-2434-2019; Woolf, Adrian S./AAZ-1075-2020; Hernando, Cristina/AAA-6837-2019; Bernardini, Laura/H-5360-2016; Roberts, Neil A/H-6773-2014; Hernando, Cristina/GNM-8667-2022; Zahir, Farah R/AAF-8618-2021; Callewaert, Bert/J-6357-2014	Lennon, Rachel/0000-0001-6400-0227; Edwards, Matthew/0000-0001-8437-8120; Woolf, Adrian S./0000-0001-5541-1358; Hernando, Cristina/0000-0002-5811-134X; Bernardini, Laura/0000-0002-3554-2817; Zahir, Farah R/0000-0002-1810-3505; Friedman, Jan/0000-0002-7482-9570; Callewaert, Bert/0000-0002-9743-4205; Roberts, Neil/0000-0002-6955-5536; Banka, Siddharth/0000-0002-8527-2210	Newlife Foundation [SG/L4-L5l01, 16-17/10, 15-16/03]; Medical Research Council UK [L002744/1]; Central Manchester University Hospitals NHS Foundation Trust, Kabuki Research Fund [629396]; Kidney Research UK fellowship; NIHR; Academy of Medical Sciences; Wellcome Trust Senior Clinical Fellowship; Health Innovation Challenge Fund [HICF-1009-003]; Wellcome Trust Sanger Institute [WT098051]; Cambridge South REC [10/H0305/83]; Republic of Ireland REC [GEN/284/12]; National Institute for Health Research through Comprehensive Clinical Research Network; MRC [MR/L002744/1] Funding Source: UKRI; Academy of Medical Sciences (AMS) [AMS-SGCL13-Stuart] Funding Source: researchfish; Medical Research Council [MR/L002744/1] Funding Source: researchfish	Newlife Foundation; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Central Manchester University Hospitals NHS Foundation Trust, Kabuki Research Fund; Kidney Research UK fellowship(Kidney Research UK (KRUK)); NIHR(National Institute for Health Research (NIHR)); Academy of Medical Sciences(Academy of Medical Sciences (AMS)); Wellcome Trust Senior Clinical Fellowship(Wellcome Trust); Health Innovation Challenge Fund; Wellcome Trust Sanger Institute(Wellcome Trust); Cambridge South REC; Republic of Ireland REC; National Institute for Health Research through Comprehensive Clinical Research Network; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are thankful to all individual and their families for participating in the study. We acknowledge the support of the Newlife Foundation (S.B., SG/L4-L5l01 and 16-17/10; and A.S.W., 15-16/03) and Medical Research Council UK (L002744/1). We are grateful to the Scales family and friends for supporting S.C. through the Central Manchester University Hospitals NHS Foundation Trust, Kabuki Research Fund number 629396. N.A.R. is supported by a Kidney Research UK fellowship. H.M.S. is supported by NIHR Lecturer award and the Academy of Medical Sciences. R.L. is supported by a Wellcome Trust Senior Clinical Fellowship. B.C. is a senior clinical investigator of the Fund for Scientific Research-Flanders. We thank Prof. Susan Kimber for providing laboratory space to conduct some of the experiments. The Deciphering Developmental Disorders study presents independent research commissioned by the Health Innovation Challenge Fund (grant number HICF-1009-003), a funding partnership between the Wellcome Trust and the Department of Health, and the Wellcome Trust Sanger Institute (grant number WT098051). The views expressed in this publication are those of the author(s) and not necessarily those of the Wellcome Trust or the Department of Health. The study has UK Research Ethics Committee approval (10/H0305/83, granted by the Cambridge South REC, and GEN/284/12 granted by the Republic of Ireland REC). The research team acknowledges the support of the National Institute for Health Research, through the Comprehensive Clinical Research Network. None of the authors have any conflicts of interests to declare.	Banka S, 2015, CLIN GENET, V87, P252, DOI 10.1111/cge.12363; Banka S, 2015, ANN RHEUM DIS, V74, P1249, DOI 10.1136/annrheumdis-2013-204309; Banka S, 2012, EUR J HUM GENET, V20, P381, DOI 10.1038/ejhg.2011.220; Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Bunnell TM, 2011, MOL BIOL CELL, V22, P4047, DOI 10.1091/mbc.E11-06-0582; Coe BP, 2014, NAT GENET, V46, P1063, DOI 10.1038/ng.3092; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; de Goede C, 2016, EUR J PAEDIATR NEURO, V20, P286, DOI 10.1016/j.ejpn.2015.11.012; De La Cruz EM, 2015, J BIOL CHEM, V290, P17137, DOI 10.1074/jbc.R115.636472; Hendzel MJ, 2014, CURR OPIN CELL BIOL, V28, P84, DOI 10.1016/j.ceb.2014.04.003; Hood RL, 2012, AM J HUM GENET, V90, P308, DOI 10.1016/j.ajhg.2011.12.001; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Kapoor P, 2014, TRENDS CELL BIOL, V24, P238, DOI 10.1016/j.tcb.2013.10.007; Kasher PR, 2016, AM J HUM GENET, V98, P363, DOI 10.1016/j.ajhg.2015.12.014; Khokha MK, 2017, PEDIATR RES, V81, P282, DOI 10.1038/pr.2016.229; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lohez OD, 2003, J CELL BIOL, V161, P67, DOI 10.1083/jcb.200208140; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Procaccio V, 2006, AM J HUM GENET, V78, P947, DOI 10.1086/504271; Reijnders MRF, 2017, AM J HUM GENET, V101, P466, DOI 10.1016/j.ajhg.2017.08.007; Riviere JB, 2012, NAT GENET, V44, P440, DOI 10.1038/ng.1091; Santen GWE, 2012, NAT GENET, V44, P379, DOI 10.1038/ng.2217; Serebryannyy LA, 2016, J CELL SCI, V129, P3412, DOI 10.1242/jcs.195867; Shimojima K, 2016, EUR J MED GENET, V59, P502, DOI 10.1016/j.ejmg.2016.09.008; Sifrim A, 2016, NAT GENET, V48, P1060, DOI 10.1038/ng.3627; Spence EF, 2015, J BIOL CHEM, V290, P28613, DOI 10.1074/jbc.R115.655118; Tarailo-Graovac M, 2016, NEW ENGL J MED, V374, P2246, DOI 10.1056/NEJMoa1515792; Triedman JK, 2016, CIRCULATION, V133, P2716, DOI 10.1161/CIRCULATIONAHA.116.023544; van der Kooij MA, 2016, NEUROSCI BIOBEHAV R, V62, P69, DOI 10.1016/j.neubiorev.2015.12.001; Verloes A, 2015, EUR J HUM GENET, V23, P292, DOI 10.1038/ejhg.2014.95; Visa N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000620; Weizer AZ, 2003, J UROLOGY, V170, P1722, DOI 10.1097/01.ju.0000092537.96414.4a; Wesolowska N, 2015, CHROMOSOMA, V124, P481, DOI 10.1007/s00412-015-0519-8; Wiesel A, 2005, EUR J MED GENET, V48, P131, DOI 10.1016/j.ejmg.2005.02.003; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6; Yang K, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-32; Yates TM, 2017, CLIN GENET, V92, P3, DOI 10.1111/cge.12864	38	51	55	2	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 7	2017	101	6					1021	1033		10.1016/j.ajhg.2017.11.006	http://dx.doi.org/10.1016/j.ajhg.2017.11.006			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FP5FD	29220674	Green Published, hybrid			2022-12-18	WOS:000417644500013
J	Miyatake, S; Mitsuhashi, S; Hayashi, YK; Purevjav, E; Nishikawa, A; Koshimizu, E; Suzuki, M; Yatabe, K; Tanaka, Y; Ogata, K; Kuru, S; Shiina, M; Tsurusaki, Y; Nakashima, M; Mizuguchi, T; Miyake, N; Saitsu, H; Ogata, K; Kawai, M; Towbin, J; Nonaka, I; Nishino, I; Matsumoto, N				Miyatake, Satoko; Mitsuhashi, Satomi; Hayashi, Yukiko K.; Purevjav, Enkhsaikhan; Nishikawa, Atsuko; Koshimizu, Eriko; Suzuki, Mikiya; Yatabe, Kana; Tanaka, Yuzo; Ogata, Katsuhisa; Kuru, Satoshi; Shiina, Masaaki; Tsurusaki, Yoshinori; Nakashima, Mitsuko; Mizuguchi, Takeshi; Miyake, Noriko; Saitsu, Hirotomo; Ogata, Kazuhiro; Kawai, Mitsuru; Towbin, Jeffrey; Nonaka, Ikuya; Nishino, Ichizo; Matsumoto, Naomichi			Biallelic Mutations in MYPN, Encoding Myopalladin, Are Associated with Childhood-Onset, Slowly Progressive Nemaline Myopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALPHA-ACTIN GENE; DILATED CARDIOMYOPATHY; PROTEIN MYOPALLADIN; SARCOMERIC PROTEIN; PATHWAY; DYSFUNCTION; GENERATION; DATABASE; BINDING	Nemaline myopathy (NM) is a common form of congenital nondystrophic skeletal muscle disease characterized by muscular weakness of proximal dominance, hypotonia, and respiratory insufficiency but typically not cardiac dysfunction. Wide variation in severity has been reported. Intranuclear rod myopathy is a subtype of NM in which rod-like bodies are seen in the nucleus, and it often manifests as a severe phenotype. Although ten mutant genes are currently known to be associated with NM, only ACTA1 is associated with intranuclear rod myopathy. In addition, the genetic cause remains unclear in approximately 25%-30% of individuals with NM. We performed whole-exome sequencing on individuals with histologically confirmed but genetically unsolved NM. Our study included individuals with milder, later-onset NM and identified biallelic loss-of-function mutations in myopalladin (MYPN) in four families. Encoded MYPN is a sarcomeric protein exclusively localized in striated muscle in humans. Individuals with identified MYPN mutations in all four of these families have relatively mild, childhood- to adult-onset NM with slowly progressive muscle weakness. Walking difficulties were recognized around their forties. Decreased respiratory function, cardiac involvement, and intranuclear rods in biopsied muscle were observed in two individuals. MYPN was localized at the Z-line in control skeletal muscles but was absent from affected individuals. Homozygous knockin mice with a nonsense mutation in Mypn showed Z-streaming and nemaline-like bodies adjacent to a disorganized Z-line on electron microscopy, recapitulating the disease. Our results suggest that MYPN screening should be considered in individuals with mild NM, especially when cardiac problems or intranuclear rods are present.	[Miyatake, Satoko; Koshimizu, Eriko; Tsurusaki, Yoshinori; Nakashima, Mitsuko; Mizuguchi, Takeshi; Miyake, Noriko; Saitsu, Hirotomo; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 2360004, Japan; [Miyatake, Satoko] Yokohama City Univ Med, Dept Clin Genet, Yokohama, Kanagawa 2360004, Japan; [Mitsuhashi, Satomi; Hayashi, Yukiko K.; Nishikawa, Atsuko; Nonaka, Ikuya; Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Kodaira, Tokyo 1878551, Japan; [Mitsuhashi, Satomi] Natl Ctr Neurol & Psychiat, Med Genome Ctr, Dept Genome Med Dev, Kodaira, Tokyo 1878551, Japan; [Mitsuhashi, Satomi] Tokai Univ, Sch Med, Dept Mol Life Sci, Biomed Informat Lab, Isehara, Kanagawa 2591193, Japan; [Hayashi, Yukiko K.] Tokyo Med Univ, Dept Pathophysiol, Shinjuku Ku, Tokyo 1608402, Japan; [Purevjav, Enkhsaikhan; Towbin, Jeffrey] Univ Tennessee, Hlth Sci Ctr, Inst Heart, Dept Pediat, Memphis, TN 38103 USA; [Nishikawa, Atsuko] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Educ, Chuo, Yamanashi 4093898, Japan; [Suzuki, Mikiya; Yatabe, Kana; Tanaka, Yuzo; Ogata, Katsuhisa; Kawai, Mitsuru] Natl Hosp Org, Higashisaitama Hosp, Dept Neurol, Hasuda, Saitama 3490196, Japan; [Kuru, Satoshi] Natl Hosp Org, Suzuka Natl Hosp, Dept Neurol, Suzuka, Mie 5138501, Japan; [Shiina, Masaaki; Ogata, Kazuhiro] Yokohama City Univ, Grad Sch Med, Dept Biochem, Yokohama, Kanagawa 2360004, Japan; [Saitsu, Hirotomo] Hamamatsu Univ Sch Med, Dept Biochem, Hamamatsu, Shizuoka 4313192, Japan	Yokohama City University; Yokohama City University; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; Tokai University; Tokyo Medical University; University of Tennessee System; University of Tennessee Health Science Center; University of Yamanashi; Yokohama City University; Hamamatsu University School of Medicine	Matsumoto, N (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 2360004, Japan.	naomat@yokohama-cu.ac.jp	Towbin, Jeffrey A./J-5595-2019; Nishino, Ichizo/G-2676-2010; Saitsu, Hirotomo/AAM-7131-2021	Towbin, Jeffrey A./0000-0002-6585-714X; Nishino, Ichizo/0000-0001-9452-112X; Saitsu, Hirotomo/0000-0003-0723-0960; Tsurusaki, Yoshinori/0000-0002-7240-6355	Grants-in-Aid for Scientific Research [17K15630, 16H05357] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Agrawal PB, 2007, AM J HUM GENET, V80, P162, DOI 10.1086/510402; Bang ML, 2001, J CELL BIOL, V153, P413, DOI 10.1083/jcb.153.2.413; Chami N, 2014, CAN J CARDIOL, V30, P1655, DOI 10.1016/j.cjca.2014.09.030; de Winter JM, 2016, ANN NEUROL, V79, P959, DOI 10.1002/ana.24654; Donner K, 2002, NEUROMUSCULAR DISORD, V12, P151, DOI 10.1016/S0960-8966(01)00252-8; Duboscq-Bidot L, 2008, CARDIOVASC RES, V77, P118, DOI 10.1093/cvr/cvm015; Fukuda H, 2006, MICROBIOL IMMUNOL, V50, P643, DOI 10.1111/j.1348-0421.2006.tb03829.x; Gupta VA, 2013, AM J HUM GENET, V93, P1108, DOI 10.1016/j.ajhg.2013.10.020; Hertz CL, 2016, EUR J HUM GENET, V24, P817, DOI 10.1038/ejhg.2015.198; Higasa K, 2016, J HUM GENET, V61, P547, DOI 10.1038/jhg.2016.12; Huby AC, 2014, J AM COLL CARDIOL, V64, P2765, DOI 10.1016/j.jacc.2014.09.071; Johnston JJ, 2000, AM J HUM GENET, V67, P814, DOI 10.1086/303089; LAING N, 1995, NAT GENET, V10, P249, DOI 10.1038/ng0695-249a; Laing NG, 2009, HUM MUTAT, V30, P1267, DOI 10.1002/humu.21059; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marttila M, 2012, BIOCHEM J, V442, P231, DOI 10.1042/BJ20111030; Meyer T, 2013, EUR J HUM GENET, V21, P294, DOI 10.1038/ejhg.2012.173; Mitsuhashi S, 2011, HUM MOL GENET, V20, P3841, DOI 10.1093/hmg/ddr305; Nance JR, 2012, CURR NEUROL NEUROSCI, V12, P165, DOI 10.1007/s11910-012-0255-x; Nguyen NUN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124762; Nowak KJ, 1999, NAT GENET, V23, P208, DOI 10.1038/13837; Nozawa RS, 2013, NAT STRUCT MOL BIOL, V20, P566, DOI 10.1038/nsmb.2532; Nunn LM, 2016, EUROPACE, V18, P888, DOI 10.1093/europace/euv285; Parast MM, 2000, J CELL BIOL, V150, P643, DOI 10.1083/jcb.150.3.643; Pelin K, 1999, P NATL ACAD SCI USA, V96, P2305, DOI 10.1073/pnas.96.5.2305; Purevjav E, 2012, HUM MOL GENET, V21, P2039, DOI 10.1093/hmg/dds022; Ravenscroft G, 2013, AM J HUM GENET, V93, P6, DOI 10.1016/j.ajhg.2013.05.004; Romero NB, 2013, CURR OPIN NEUROL, V26, P519, DOI 10.1097/WCO.0b013e328364d681; Ryan MM, 2001, ANN NEUROL, V50, P312, DOI 10.1002/ana.1080; Saitsu H, 2013, NAT GENET, V45, P445, DOI 10.1038/ng.2562; Sambuughin N, 2010, AM J HUM GENET, V87, P842, DOI 10.1016/j.ajhg.2010.10.020; Ugai H, 2005, J GENE MED, V7, P1148, DOI 10.1002/jgm.786; Wallgren-Pettersson C, 2000, Neuromuscul Disord, V10, P299, DOI 10.1016/S0960-8966(99)00129-7; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yuen M, 2014, J CLIN INVEST, V124, P4693, DOI 10.1172/JCI75199; Zhao Y, 2015, INT J MOL MED, V36, P1479, DOI 10.3892/ijmm.2015.2361; Zou YM, 1997, DEVELOPMENT, V124, P793	37	51	52	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 5	2017	100	1					169	178		10.1016/j.ajhg.2016.11.017	http://dx.doi.org/10.1016/j.ajhg.2016.11.017			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EH6UX	28017374	Green Published, Bronze			2022-12-18	WOS:000391910500015
J	Sobota, RS; Stein, CM; Kodaman, N; Scheinfeldt, LB; Maro, I; Wieland-Alter, W; Igo, RP; Magohe, A; Malone, LL; Chervenak, K; Hall, NB; Modongo, C; Zetola, N; Matee, M; Joloba, M; Froment, A; Nyambo, TB; Moore, JH; Scott, WK; Lahey, T; Boom, WH; von Reyn, CF; Tishkoff, SA; Sirugo, G; Williams, SM				Sobota, Rafal S.; Stein, Catherine M.; Kodaman, Nun; Scheinfeldt, Laura B.; Maro, Isaac; Wieland-Alter, Wendy; Igo, Robert P., Jr.; Magohe, Albert; Malone, LaShaunda L.; Chervenak, Keith; Hall, Noemi B.; Modongo, Chawangwa; Zetola, Nicola; Matee, Mecky; Joloba, Moses; Froment, Alain; Nyambo, Thomas B.; Moore, Jason H.; Scott, William K.; Lahey, Timothy; Boom, W. Henry; von Reyn, C. Fordham; Tishkoff, Sarah A.; Sirugo, Giorgio; Williams, Scott M.			A Locus at 5q33.3 Confers Resistance to Tuberculosis in Highly Susceptible Individuals	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; MYCOBACTERIUM-TUBERCULOSIS; GENETIC-STRUCTURE; LINKAGE ANALYSES; COMMON VARIANTS; INTERLEUKIN-12; INFECTION; IMMUNITY; PSORIASIS; GENOTYPE	Immunosuppression resulting from HIV infection increases the risk of progression to active tuberculosis (TB) both in individuals newly exposed to Mycobacterium tuberculosis (MTB) and in those with latent infections. We hypothesized that HIV-positive individuals who do not develop TB, despite living in areas where it is hyperendemic, provide a model of natural resistance. We performed a genome-wide association study of TB resistance by using 581 HIV-positive Ugandans and Tanzanians enrolled in prospective cohort studies of TB; 267 of these individuals developed active TB, and 314 did not. A common variant, rs4921437 at 5q33.3, was significantly associated with TB (odds ratio = 0.37, p = 2.11 x 10(-8)). This variant lies within a genomic region that includes IL12B and is embedded in an H3K27Ac histone mark. The locus also displays consistent patterns of linkage disequilibrium across African populations and has signals of strong selection in populations from equatorial Africa. Along with prior studies demonstrating that therapy with IL-12 (the cytokine encoded in part by IL12B, associated with longer survival following MTB infection in mice deficient in CD4 T cells), our results suggest that this pathway might be an excellent target for the development of new modalities for treating TB, especially for HIV-positive individuals. Our results also indicate that studying extreme disease resistance in the face of extensive exposure can increase the power to detect associations in complex infectious disease.	[Sobota, Rafal S.; Kodaman, Nun] Vanderbilt Univ, Vanderbilt Genet Inst, Nashville, TN 37232 USA; [Sobota, Rafal S.; Kodaman, Nun; Wieland-Alter, Wendy; Moore, Jason H.; Lahey, Timothy; von Reyn, C. Fordham; Williams, Scott M.] Dartmouth Coll, Geisel Sch Med, Hanover, NH 03755 USA; [Stein, Catherine M.; Kodaman, Nun; Igo, Robert P., Jr.; Hall, Noemi B.; Williams, Scott M.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Stein, Catherine M.; Malone, LaShaunda L.; Chervenak, Keith; Boom, W. Henry] Case Western Reserve Univ, TB Res Unit, Cleveland, OH 44106 USA; [Scheinfeldt, Laura B.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Scheinfeldt, Laura B.] Coriell Inst Med Res, Camden, NJ 08103 USA; [Maro, Isaac] Tokyo Med & Dent Univ, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan; [Magohe, Albert; Matee, Mecky] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania; [Modongo, Chawangwa; Zetola, Nicola] Univ Penn, Div Infect Dis, Philadelphia, PA 19104 USA; [Modongo, Chawangwa; Zetola, Nicola] Botswana UPenn Partnership, 214 Independence Ave, Gaborone, Botswana; [Modongo, Chawangwa; Zetola, Nicola] Univ Botswana, Dept Med, Gaborone, Botswana; [Joloba, Moses; Boom, W. Henry] Uganda CWRU Res Collaborat, Kampala, Uganda; [Joloba, Moses] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Joloba, Moses] Mulago Hosp, Kampala, Uganda; [Froment, Alain] Museum Natl Hist Nat, Inst Rech Dev, UMR 208, F-75116 Paris, France; [Froment, Alain] Museum Natl Hist Nat, Musee Homme, F-75116 Paris, France; [Nyambo, Thomas B.] Muhimbili Univ Hlth & Allied Sci, Dept Biochem, Dar Es Salaam, Tanzania; [Moore, Jason H.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Scott, William K.] Univ Miami, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Tishkoff, Sarah A.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Sirugo, Giorgio] Osped San Pietro Fatebenefratelli, Ctr Ric, I-00189 Rome, Italy	Vanderbilt University; Dartmouth College; Case Western Reserve University; Case Western Reserve University; University of Pennsylvania; Coriell Institute for Medical Research; Tokyo Medical & Dental University (TMDU); Muhimbili University of Health & Allied Sciences; University of Pennsylvania; University of Botswana; Case Western Reserve University; Makerere University; Mulago National Referral Hospital; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Museum National d'Histoire Naturelle (MNHN); Muhimbili University of Health & Allied Sciences; University of Pennsylvania; Pennsylvania Medicine; University of Miami; University of Pennsylvania	Williams, SM (corresponding author), Dartmouth Coll, Geisel Sch Med, Hanover, NH 03755 USA.; Williams, SM (corresponding author), Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA.	smw154@case.edu	Moore, Jason H./AAV-9645-2021; Stein, Catherine/P-9498-2019; Williams, Scott/Q-4812-2019; Igo, Rob/P-3438-2019; Sirugo, Giorgio/N-9056-2019; Sirugo, Giorgio/L-1628-2016	Moore, Jason H./0000-0002-5015-1099; Stein, Catherine/0000-0002-9763-5023; Williams, Scott/0000-0002-4835-9544; Igo, Rob/0000-0002-0024-1993; Sobota, Rafal/0000-0002-5945-5830; Scott, William/0000-0001-9336-6404; Scheinfeldt, Laura/0000-0001-6529-6701; Joloba, Moses/0000-0002-0334-9983	Public Health Service award from the National Institute of General Medical Studies [T32 GM07347]; NIH [P20 GM103534, LM010098, AI59694, AI116794, LM009012, 1R01GM113657-01, 8DP1ES022577-04]; Tuberculosis Research Unit from the National Institute of Allergy and Infectious Diseases [N01-AI95383, HHSN266200700022C/N01-AI70022]; National Heart, Lung, and Blood Institute (NHLBI) [R01HL096811]; NHLBI [R01HL10566113, T32HL007567]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096811, T32HL007567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI095383, P30AI045008, R01AI116794, P30AI036219, R01AI059694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [DP1ES022577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347, R01GM113657, P20GM103534] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010098, R01LM009012] Funding Source: NIH RePORTER	Public Health Service award from the National Institute of General Medical Studies; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tuberculosis Research Unit from the National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	R.S.S. was supported by Public Health Service award T32 GM07347 from the National Institute of General Medical Studies for the Vanderbilt Medical-Scientist Training Program. R.S.S., N.K., and S.M.W. were partially supported by NIH grant P20 GM103534. C.M.S., L.L.M., K.C., and W.H.B. were partially supported by the Tuberculosis Research Unit (grants N01-AI95383 and HHSN266200700022C/N01-AI70022 from the National Institute of Allergy and Infectious Diseases). C.M.S., W.H.B., and R.P.I. were supported by National Heart, Lung, and Blood Institute (NHLBI) grant R01HL096811. C.M.S. and W.H.B. were partially supported by NHLBI grant R01HL10566113, and N.B.H. was supported by NHLBI grant T32HL007567. J.H.M. and S.M.W. were supported by NIH grant LM010098. J.H.M. was supported by NIH grants AI59694, AI116794, and LM009012. S.A.T. was partially supported by NIH grants 1R01GM113657-01 and 8DP1ES022577-04.	Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; [Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Bustamante J, 2014, SEMIN IMMUNOL, V26, P454, DOI 10.1016/j.smim.2014.09.008; Capon F, 2007, HUM GENET, V122, P201, DOI 10.1007/s00439-007-0397-0; CHAN SH, 1991, J EXP MED, V173, P869, DOI 10.1084/jem.173.4.869; COOPER AM, 1995, IMMUNOLOGY, V84, P423; Cooper AM, 1997, J EXP MED, V186, P39, DOI 10.1084/jem.186.1.39; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Curtis J, 2015, NAT GENET, V47, P523, DOI 10.1038/ng.3248; DIPERRI G, 1989, LANCET, V2, P1502; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edwards DRV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032275; FLYNN JL, 1995, J IMMUNOL, V155, P2515; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; GATELY MK, 1991, J IMMUNOL, V147, P874; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gopal R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004099; Guo X, 2011, P NATL ACAD SCI USA, V108, P18649, DOI 10.1073/pnas.1113170108; Guwatudde D, 2003, B WORLD HEALTH ORGAN, V81, P799; Hall NB, 2015, GENES IMMUN, V16, P127, DOI 10.1038/gene.2014.77; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Holscher C, 2001, J IMMUNOL, V167, P6957, DOI 10.4049/jimmunol.167.12.6957; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huffmeier U, 2010, NAT GENET, V42, P996, DOI 10.1038/ng.688; Jarvis JP, 2012, PLOS GENET, V8, P299, DOI 10.1371/journal.pgen.1002641; Kim E, 2014, J ACQ IMMUN DEF SYND, V67, P569; Lahey T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022074; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Morahan G, 2007, TISSUE ANTIGENS, V69, P234, DOI 10.1111/j.1399-0039.2006.773_3.x; Morris GAJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016656; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nolt D, 2004, INFECT IMMUN, V72, P2976, DOI 10.1128/IAI.72.5.2976-2988.2004; O'Donnell CJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S4; Olesen R, 2007, GENES IMMUN, V8, P456, DOI 10.1038/sj.gene.6364410; Picard C, 2002, AM J HUM GENET, V70, P336, DOI 10.1086/338625; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team, 2007, R LANG ENV STAT COMP; Rasmussen S, 2015, CELL, V163, P571, DOI 10.1016/j.cell.2015.10.009; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Scheinfeldt LB, 2013, NAT REV GENET, V14, P692, DOI 10.1038/nrg3604; SELWYN PA, 1989, JAMA-J AM MED ASSOC, V261, P1289, DOI 10.1001/jama.261.9.1289; SIEBURTH D, 1992, GENOMICS, V14, P59, DOI 10.1016/S0888-7543(05)80283-6; Sobota RS, 2015, ANN HUM GENET, V79, P136, DOI 10.1111/ahg.12095; StataCorp, 2019, STAT STAT SOFTW; Stein Catherine M., 2013, Frontiers in Genetics, V4, P61, DOI 10.3389/fgene.2013.00061; Swaminathan B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115176; Thye T, 2012, NAT GENET, V44, P257, DOI 10.1038/ng.1080; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; von Reyn CF, 2010, AIDS, V24, P675, DOI 10.1097/QAD.0b013e3283350f1b; World Health Organization, 2015, GLOB TUB REP 2015; World Health Organization, 2015, GLOB TUB REP 2015, P143; Yang Q, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S12; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606	67	51	51	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 3	2016	98	3					514	524		10.1016/j.ajhg.2016.01.015	http://dx.doi.org/10.1016/j.ajhg.2016.01.015			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DG9DN	26942285	Bronze, Green Published			2022-12-18	WOS:000372383100014
J	Jansen, JC; Timal, S; van Scherpenzeel, M; Michelakakis, H; Vicogne, D; Ashikov, A; Moraitou, M; Hoischen, A; Huijben, K; Steenbergen, G; van den Boogert, MAW; Porta, F; Calvo, PL; Mavrikou, M; Cenacchi, G; van den Bogaart, G; Salomon, J; Holleboom, AG; Rodenburg, RJ; Drenth, JPH; Huynen, MA; Wevers, RA; Morava, E; Foulquier, F; Veltman, JA; Lefeber, DJ				Jansen, Jos C.; Timal, Sharita; van Scherpenzeel, Monique; Michelakakis, Helen; Vicogne, Dorothee; Ashikov, Angel; Moraitou, Marina; Hoischen, Alexander; Huijben, Karin; Steenbergen, Gerry; van den Boogert, Marjolein A. W.; Porta, Francesco; Calvo, Pier Luigi; Mavrikou, Mersyni; Cenacchi, Giovanna; van den Bogaart, Geert; Salomon, Jody; Holleboom, Adriaan G.; Rodenburg, Richard J.; Drenth, Joost P. H.; Huynen, Martijn A.; Wevers, Ron A.; Morava, Eva; Foulquier, Francois; Veltman, Joris A.; Lefeber, Dirk J.			TMEM199 Deficiency Is a Disorder of Golgi Homeostasis Characterized by Elevated Aminotransferases, Alkaline Phosphatase, and Cholesterol and Abnormal Glycosylation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RENAL TUBULAR-ACIDOSIS; VACUOLAR PROTON PUMP; CONGENITAL DISORDERS; MENDELIAN DISORDERS; MUTATIONS; ATPASE; SUBUNIT; DISEASE; OSTEOPETROSIS; CDG	Congenital disorders of glycosylation (CDGs) form a genetically and clinically heterogeneous group of diseases with aberrant protein glycosylation as a hallmark. A subgroup of CDGs can be attributed to disturbed Golgi homeostasis. However, identification of pathogenic variants is seriously complicated by the large number of proteins involved. As part of a strategy to identify human homologs of yeast proteins that are known to be involved in Golgi homeostasis, we identified uncharacterized transmembrane protein 199 (TMEM199, previously called C17orf32) as a human homolog of yeast V-ATPase assembly factor Vph2p (also known as Vma12p). Subsequently, we analyzed raw exome-sequencing data from families affected by genetically unsolved CDGs and identified four individuals with different mutations in TMEM199. The adolescent individuals presented with a mild phenotype of hepatic steatosis, elevated aminotransferases and alkaline phosphatase, and hypercholesterolemia, as well as low serum ceruloplasmin. Affected individuals showed abnormal N- and mucin-type O-glycosylation, and mass spectrometry indicated reduced incorporation of galactose and sialic acid, as seen in other Golgi homeostasis defects. Metabolic labeling of sialic acids in fibroblasts confirmed deficient Golgi glycosylation, which was restored by lentiviral transduction with wild-type TMEM199. V5-tagged TMEM199 localized with ERGIC and COPI markers in HeLa cells, and electron microscopy of a liver biopsy showed dilated organelles suggestive of the endoplasmic reticulum and Golgi apparatus. In conclusion, we have identified TMEM199 as a protein involved in Golgi homeostasis and show that TMEM199 deficiency results in a hepatic phenotype with abnormal glycosylation.	[Jansen, Jos C.; Salomon, Jody; Drenth, Joost P. H.] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, NL-6525 GA Nijmegen, Netherlands; [Jansen, Jos C.; Timal, Sharita; van Scherpenzeel, Monique; Ashikov, Angel; Huijben, Karin; Steenbergen, Gerry; Rodenburg, Richard J.; Wevers, Ron A.; Lefeber, Dirk J.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Translat Metab Lab, NL-6525 GA Nijmegen, Netherlands; [Timal, Sharita; van Scherpenzeel, Monique; Ashikov, Angel; Lefeber, Dirk J.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Donders Inst Brain Cognit & Behav, NL-6525 GA Nijmegen, Netherlands; [Michelakakis, Helen; Moraitou, Marina] Inst Child Hlth, Dept Enzymol & Cellular Funct, Athens 11526, Greece; [Vicogne, Dorothee; Foulquier, Francois] Univ Lille, CNRS UMR 8576, Struct & Funct Glycobiol Unit, Federat Res Struct & Funct Biochem Biomol Assembl, F-59655 Villeneuve Dascq, France; [Hoischen, Alexander; Veltman, Joris A.] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, NL-6525 GA Nijmegen, Netherlands; [van den Boogert, Marjolein A. W.; Holleboom, Adriaan G.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Porta, Francesco; Calvo, Pier Luigi] Univ Turin, Dept Pediat, Azienda Osped Citta Salute & Sci, I-10126 Turin, Italy; [Mavrikou, Mersyni] PA Kyriakou Childrens Hosp, Dept Pediat 1, Athens 11527, Greece; [Cenacchi, Giovanna] Alma Mater Studiorum Univ Bologna, Dept Biomed & Neuromotor Sci, I-40138 Bologna, Italy; [van den Bogaart, Geert] Radboud Univ Nijmegen, Med Ctr, Dept Tumor Immunol, NL-6525 GA Nijmegen, Netherlands; [Rodenburg, Richard J.] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, Nijmegen Ctr Mitochondrial Disorders, NL-6525 GA Nijmegen, Netherlands; [Huynen, Martijn A.] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6525 GA Nijmegen, Netherlands; [Morava, Eva] Univ Leuven, Dept Human Genet, B-3000 Louvain, Belgium; [Morava, Eva] Tulane Univ, Sch Med, Dept Pediat, Hayward Genet Ctr, New Orleans, LA 70112 USA; [Veltman, Joris A.] Maastricht Univ, Med Ctr, Dept Clin Genet, NL-6229 HX Maastricht, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Radboud University Nijmegen; University of Amsterdam; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; University of Bologna; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; KU Leuven; Tulane University; Maastricht University	Lefeber, DJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Translat Metab Lab, NL-6525 GA Nijmegen, Netherlands.; Lefeber, DJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Donders Inst Brain Cognit & Behav, NL-6525 GA Nijmegen, Netherlands.	dirk.lefeber@radboudumc.nl	van den Bogaart, Geert/GLV-3283-2022; Huynen, Martijn A/A-1530-2014; Rodenburg, Richard/N-3579-2014; Veltman, Joris A/F-5128-2010; van Scherpenzeel, Monique/N-7008-2015; Lefeber, Dirk DJ/A-2146-2014; Drenth, J.P.H./H-8025-2014; Ashikov, Angel/N-7714-2015; Hoischen, Alexander/D-1282-2013; foulquier, francois/ABE-5886-2020; Hoischen, Alexander/AGF-7293-2022; Jansen, Jos/P-6362-2015; Drenth, Joost/V-7436-2019; van den Bogaart, Geert/A-1089-2014; Wevers, Ron A./H-8116-2014; FOULQUIER, FRANCOIS/AAI-1182-2021	van den Bogaart, Geert/0000-0003-2180-6735; Huynen, Martijn A/0000-0001-6189-5491; Rodenburg, Richard/0000-0001-5227-3527; Veltman, Joris A/0000-0002-3218-8250; van Scherpenzeel, Monique/0000-0002-9696-4562; Ashikov, Angel/0000-0001-9679-7955; Hoischen, Alexander/0000-0002-8072-4476; foulquier, francois/0000-0002-6551-3240; Hoischen, Alexander/0000-0002-8072-4476; van den Bogaart, Geert/0000-0003-2180-6735; Wevers, Ron A./0000-0003-2278-9746; CENACCHI, GIOVANNA/0000-0001-5824-3118; Holleboom, A.G. (Onno)/0000-0002-2911-2917; Calvo, Pier Luigi/0000-0001-9264-3465	Institute of Genetic and Metabolic Disease; Dutch Organization for Scientific Research (ZONMW Medium Investment Grant) [40-00506-98-9001]; VIDI Grant [91713359]; VENI grant; Metakids foundation; AMC graduate school Ph.D scholarship; Dr. Karel-Lodewijk Verleysen Award; French National Agency (ANR SOLV-CDG); ERA-Net for Research Programs on Rare Diseases Joint Transnational Call (EURO-CDG) [ERARE11-135]	Institute of Genetic and Metabolic Disease; Dutch Organization for Scientific Research (ZONMW Medium Investment Grant); VIDI Grant; VENI grant; Metakids foundation; AMC graduate school Ph.D scholarship; Dr. Karel-Lodewijk Verleysen Award; French National Agency (ANR SOLV-CDG)(French National Research Agency (ANR)); ERA-Net for Research Programs on Rare Diseases Joint Transnational Call (EURO-CDG)	We would like to thank the CDG-affected families for their participation in this study. We would also like to thank the group of Dr. Y. Guerardel and Prof. C. Biot for their generous donation of ManNAl. This work was financially supported by grants from the Institute of Genetic and Metabolic Disease (to D.J.L., R.J.R., and J.A.V.), the Dutch Organization for Scientific Research (ZONMW Medium Investment Grant 40-00506-98-9001 and VIDI Grant 91713359 to D.J.L. and VENI grant to A.G.H.), the Metakids foundation (J.C.J., M.v.S., J.P.H.D., and D.J.L.), the AMC graduate school Ph.D scholarship (M.A.W.v.d.B.), the Dr. Karel-Lodewijk Verleysen Award (J.C.J. and J.P.H.D.), the French National Agency (ANR SOLV-CDG to F.F.), and by grant ERARE11-135 of the ERA-Net for Research Programs on Rare Diseases Joint Transnational Call 2011 (EURO-CDG).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Borthwick KJ, 2003, J MED GENET, V40, P115, DOI 10.1136/jmg.40.2.115; Calvo PL, 2008, J INHERIT METAB DIS, V31, pS437, DOI 10.1007/s10545-008-1004-9; De Matteis MA, 2011, NEW ENGL J MED, V365, P927, DOI 10.1056/NEJMra0910494; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Foulquier F, 2012, AM J HUM GENET, V91, P15, DOI 10.1016/j.ajhg.2012.05.002; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Freeze HH, 2014, AM J HUM GENET, V94, P161, DOI 10.1016/j.ajhg.2013.10.024; Graham LA, 1998, J CELL BIOL, V142, P39, DOI 10.1083/jcb.142.1.39; Guillard M, 2009, BBA-MOL BASIS DIS, V1792, P903, DOI 10.1016/j.bbadis.2008.12.009; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; Hucthagowder V, 2009, HUM MOL GENET, V18, P2149, DOI 10.1093/hmg/ddp148; Jansen J.C., 2016, AM J HUM GENET, V98, P309; Javed A, 2014, NAT METHODS, V11, P935, DOI [10.1038/NMETH.3046, 10.1038/nmeth.3046]; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kornak U, 2008, NAT GENET, V40, P32, DOI 10.1038/ng.2007.45; Kortum F, 2015, NAT GENET, V47, P661, DOI 10.1038/ng.3282; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Marshansky V, 2014, BBA-BIOENERGETICS, V1837, P857, DOI 10.1016/j.bbabio.2014.01.018; Miller VJ, 2012, TRAFFIC, V13, P891, DOI 10.1111/j.1600-0854.2012.01338.x; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Ramachandran N, 2013, ACTA NEUROPATHOL, V125, P439, DOI 10.1007/s00401-012-1073-6; Rosnoblet C, 2013, HUM MOL GENET, V22, P2914, DOI 10.1093/hmg/ddt146; Smith AN, 2000, NAT GENET, V26, P71, DOI 10.1038/79208; Stranecky V, 2013, AM J HUM GENET, V92, P792, DOI 10.1016/j.ajhg.2013.03.023; Szklarczyk R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r12; Timal S, 2012, HUM MOL GENET, V21, P4151, DOI 10.1093/hmg/dds123; Vanbeselaere J, 2013, CHEM COMMUN, V49, P11293, DOI 10.1039/c3cc45914d; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555	31	51	53	1	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 4	2016	98	2					322	330		10.1016/j.ajhg.2015.12.011	http://dx.doi.org/10.1016/j.ajhg.2015.12.011			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DE3BR	26833330	Green Published, Bronze			2022-12-18	WOS:000370502300008
J	Fischer-Zirnsak, B; Escande-Beillard, N; Ganesh, J; Tan, YX; Al Bughaili, M; Lin, AE; Sahai, I; Bahena, P; Reichert, SL; Loh, A; Wright, GD; Liu, J; Rahikkala, E; Pivnick, EK; Choudhri, AF; Kruger, U; Zemojtel, T; van Ravenswaaij-Arts, C; Mostafavi, R; Stolte-Dijkstra, I; Symoens, S; Pajunen, L; Al-Gazali, L; Meierhofer, D; Robinson, PN; Mundlos, S; Villarroel, CE; Byers, P; Masri, A; Robertson, SP; Schwarze, U; Callewaert, B; Reversade, B; Kornak, U				Fischer-Zirnsak, Bjoern; Escande-Beillard, Nathalie; Ganesh, Jaya; Tan, Yu Xuan; Al Bughaili, Mohammed; Lin, Angela E.; Sahai, Inderneel; Bahena, Paulina; Reichert, Sara L.; Loh, Abigail; Wright, Graham D.; Liu, Jaron; Rahikkala, Elisa; Pivnick, Eniko K.; Choudhri, Asim F.; Krueger, Ulrike; Zemojtel, Tomasz; van Ravenswaaij-Arts, Conny; Mostafavi, Roya; Stolte-Dijkstra, Irene; Symoens, Sofie; Pajunen, Leila; Al-Gazali, Lihadh; Meierhofer, David; Robinson, Peter N.; Mundlos, Stefan; Villarroel, Camilo E.; Byers, Peter; Masri, Amira; Robertson, Stephen P.; Schwarze, Ulrike; Callewaert, Bert; Reversade, Bruno; Kornak, Uwe			Recurrent De Novo Mutations Affecting Residue Arg1 38 of Pyrroline-5-Carboxylate Synthase Cause a Progeroid Form of Autosomal-Dominant Cutis Laxa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BARSY-SYNDROME; PHENOTYPE; ALDH18A1; OSTEODYSPLASTICA; ORNITHINE; SPECTRUM; COLLAGEN; PROLINE; DISEASE; GENE	Progeroid disorders overlapping with De Barsy syndrome (DBS) are collectively denoted as autosomal-recessive cutis laxa type 3 (ARCL3). They are caused by biallelic mutations in PYCR1 or ALDH18A1, encoding pyrroline-5-carboxylate reductase 1 and pyrroline-5-carboxylate synthase (P5CS), respectively, which both operate in the mitochondrial proline cycle. We report here on eight unrelated individuals born to non-consanguineous families clinically diagnosed with DBS or wrinkly skin syndrome. We found three heterozygous mutations in ALDH18A1 leading to amino acid substitutions of the same highly conserved residue, Arg138 in P5CS. A de novo origin was confirmed in all six probands for whom parental DNA was available Using fibroblasts from affected individuals and heterologous overexpression, we found that the P5CS-p.Arg138Trp protein was stable and able to interact with wild-type P5CS but showed an altered sub-mitochondrial distribution. A reduced size upon native gel electrophoresis indicated an alteration of the structure or composition of P5CS mutant complex. Furthermore, we found that the mutant cells had a reduced P5CS enzymatic activity leading to a delayed proline accumulation. In summary, recurrent de novo mutations, affecting the highly conserved residue Arg138 of P5 CS, cause an autosomal-dominant form of cutis laxa with progeroid features. Our data provide insights into the etiology of cutis laxa diseases and will have immediate impact on diagnostics and genetic counseling.	[Fischer-Zirnsak, Bjoern; Al Bughaili, Mohammed; Krueger, Ulrike; Zemojtel, Tomasz; Robinson, Peter N.; Mundlos, Stefan; Kornak, Uwe] Charite, Inst Med Genet & Humangenet, D-13353 Berlin, Germany; [Fischer-Zirnsak, Bjoern; Robinson, Peter N.; Mundlos, Stefan; Kornak, Uwe] Max Planck Inst Mol Genet, FG Dev & Dis, D-14195 Berlin, Germany; [Escande-Beillard, Nathalie; Tan, Yu Xuan; Wright, Graham D.; Liu, Jaron; Reversade, Bruno] ASTAR, Med Biol Inst, Singapore 138648, Singapore; [Ganesh, Jaya; Reichert, Sara L.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Lin, Angela E.; Sahai, Inderneel] Mass Gen Hosp Children, Med Genet & Metab, Boston, MA 02114 USA; [Bahena, Paulina; Villarroel, Camilo E.] Inst Nacl Pediat, Dept Genet Humana, Mexico City 19050, DF, Mexico; [Loh, Abigail] ASTAR, Inst Mol & Cellular Biol, Singapore 138648, Singapore; [Rahikkala, Elisa; Pajunen, Leila] Univ Oulu, PEDEGO Res Grp, Oulu 90029, Finland; [Rahikkala, Elisa; Pajunen, Leila] Univ Oulu, Med Res Ctr Oulu, Oulu 90029, Finland; [Rahikkala, Elisa; Pajunen, Leila] Oulu Univ Hosp, Dept Clin Genet, Oulu 90029, Finland; [Pivnick, Eniko K.; Mostafavi, Roya] Univ Tennessee, Hlth Sci Ctr, Dept Pediat, Div Med Genet, Memphis, TN 38163 USA; [Pivnick, Eniko K.; Mostafavi, Roya] Univ Tennessee, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN 38163 USA; [Choudhri, Asim F.] Univ Tennessee, Hlth Sci Ctr, Dept Radiol, Memphis, TN 38163 USA; [Choudhri, Asim F.] Univ Tennessee, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN 38163 USA; [Choudhri, Asim F.] Univ Tennessee, Ctr Hlth Sci, Dept Neurosurg, Memphis, TN 38163 USA; [Choudhri, Asim F.] Le Bonheur Childrens Hosp, Memphis, TN 38163 USA; [Zemojtel, Tomasz] Labor Berlin, D-13353 Berlin, Germany; [van Ravenswaaij-Arts, Conny; Stolte-Dijkstra, Irene] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9712 Groningen, Netherlands; [Symoens, Sofie] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Al-Gazali, Lihadh] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Pediat, Al Ain, U Arab Emirates; [Al-Gazali, Lihadh] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Pathol, Al Ain, U Arab Emirates; [Al-Gazali, Lihadh] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Radiol, Al Ain, U Arab Emirates; [Meierhofer, David] Max Planck Inst Mol Genet, Mass Spectrometry Facil, D-14195 Berlin, Germany; [Robinson, Peter N.; Mundlos, Stefan; Kornak, Uwe] Charite, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany; [Byers, Peter] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Masri, Amira] Univ Jordan, Fac Med, Dept Pediat, Amman 11942, Jordan; [Robertson, Stephen P.] Univ Otago, Dept Womens & Childrens Hlth, Dunedin 9016, New Zealand; [Schwarze, Ulrike] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Reversade, Bruno] Natl Univ Singapore, Dept Pediat, Singapore 119077, Singapore	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of Oulu; University of Oulu; University of Oulu; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Groningen; Ghent University; Ghent University Hospital; United Arab Emirates University; United Arab Emirates University; United Arab Emirates University; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Washington; University of Washington Seattle; University of Jordan; University of Otago; University of Washington; University of Washington Seattle; National University of Singapore	Reversade, B (corresponding author), ASTAR, Med Biol Inst, Singapore 138648, Singapore.	bruno@reversade.com; uwe.kornak@charite.de	Fischer-Zirnsak, Björn/D-7487-2013; Meierhofer, David/V-4711-2019; Callewaert, Bert/J-6357-2014; Mundlos, Stefan/ABH-9585-2020; Rahikkala, Elisa/AAN-3450-2020; masri, amira/C-4570-2015	Fischer-Zirnsak, Björn/0000-0002-1075-7571; Meierhofer, David/0000-0002-0170-868X; Callewaert, Bert/0000-0002-9743-4205; Rahikkala, Elisa/0000-0003-2760-7059; masri, amira/0000-0001-6103-8713; REVERSADE, Bruno/0000-0002-4070-7997; Mundlos, Stefan/0000-0002-9788-3166; Escande-Beillard, Nathalie/0000-0002-7706-1608; Villarroel, Camilo/0000-0001-5717-9863; Wright, Graham/0000-0003-2362-1312; Robertson, Stephen/0000-0002-5181-7809; Tan, Yu Xuan/0000-0001-7515-8118	Deutsche Forschungsgemeinschaft [KO 2891/1-1]; Skin Research Institute of Singapore; Strategic Positioning Fund on Genetic Orphan Diseases from A*STAR, Singapore; Methusalem grant from the Ghent University [BOF 08/01M01108]; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Skin Research Institute of Singapore(Agency for Science Technology & Research (A*STAR)); Strategic Positioning Fund on Genetic Orphan Diseases from A*STAR, Singapore; Methusalem grant from the Ghent University; Max Planck Society(Max Planck SocietyFoundation CELLEX)	We are grateful to the affected individuals and their families whose cooperation made this study possible. We thank Beata Lukaszewska-McGreal for excellent technical assistance and metabolite sample preparation. The study was funded by the Deutsche Forschungsgemeinschaft (KO 2891/1-1) to U. Kornak. B.R. is a fellow of the Branco Weiss Foundation, an A*STAR Investigator, and Young EMBO Investigator. This work was partly funded by the Skin Research Institute of Singapore and a Strategic Positioning Fund on Genetic Orphan Diseases from A*STAR, Singapore. B.C. is a senior clinical investigator of the Fund for Scientific Research - Flanders. This study was funded in part by a Methusalem grant from the Ghent University (BOF 08/01M01108). This study was funded in part by the Max Planck Society.	Albrecht B, 2010, AM J MED GENET A, V152A, P2916, DOI 10.1002/ajmg.a.33712; Basel-Vanagaite L, 2009, AM J HUM GENET, V85, P254, DOI 10.1016/j.ajhg.2009.07.001; Baumgartner MR, 2000, HUM MOL GENET, V9, P2853, DOI 10.1093/hmg/9.19.2853; Bicknell LS, 2008, EUR J HUM GENET, V16, P1176, DOI 10.1038/ejhg.2008.91; Callewaert BL, 2008, HUM MUTAT, V29, P150, DOI 10.1002/humu.20623; Callewaert B, 2013, HUM MUTAT, V34, P111, DOI 10.1002/humu.22165; Callewaert B, 2011, HUM MUTAT, V32, P445, DOI 10.1002/humu.21462; Coucke PJ, 2006, NAT GENET, V38, P452, DOI 10.1038/ng1764; Coutelier M, 2015, BRAIN, V138, P2191, DOI 10.1093/brain/awv143; DEBARSY AM, 1968, HELV PAEDIATR ACTA, V23, P305; Dimopoulou A, 2013, MOL GENET METAB, V110, P352, DOI 10.1016/j.ymgme.2013.08.009; Egerer J., 2015, J INVEST DERMATOL; Fischer B, 2012, HUM GENET, V131, P1761, DOI 10.1007/s00439-012-1197-8; Fischer B, 2014, MOL GENET METAB, V112, P310, DOI 10.1016/j.ymgme.2014.05.003; Gardeitchik T, 2014, EUR J HUM GENET, V22, P888, DOI 10.1038/ejhg.2013.154; Gielisch I, 2015, J PROTEOME RES, V14, P224, DOI 10.1021/pr500894v; Handley MT, 2014, MOL GENET GENOM MED, V2, P319, DOI 10.1002/mgg3.70; Hennies HC, 2008, NAT GENET, V40, P1410, DOI 10.1038/ng.252; Hucthagowder V, 2006, AM J HUM GENET, V78, P1075, DOI 10.1086/504304; Hucthagowder V, 2009, HUM MOL GENET, V18, P2149, DOI 10.1093/hmg/ddp148; Jukkola A, 1998, J MED GENET, V35, P513, DOI 10.1136/jmg.35.6.513; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Kornak U, 2008, NAT GENET, V40, P32, DOI 10.1038/ng.2007.45; Kouwenberg D, 2011, AM J MED GENET A, V155A, P2331, DOI 10.1002/ajmg.a.34154; KUNZE J, 1985, EUR J PEDIATR, V144, P348, DOI 10.1007/BF00441776; Lin DS, 2011, AM J MED GENET A, V155A, P1285, DOI 10.1002/ajmg.a.33963; Loeys B, 2002, HUM MOL GENET, V11, P2113, DOI 10.1093/hmg/11.18.2113; Marco-Marin C, 2007, J MOL BIOL, V367, P1431, DOI 10.1016/j.jmb.2007.01.073; Markova D, 2003, AM J HUM GENET, V72, P998, DOI 10.1086/373940; Martinelli D, 2012, J INHERIT METAB DIS, V35, P761, DOI 10.1007/s10545-011-9411-8; Megarbane H, 2009, J INVEST DERMATOL, V129, P1650, DOI 10.1038/jid.2008.450; Mohamed M, 2011, J INHERIT METAB DIS, V34, P907, DOI 10.1007/s10545-011-9305-9; Morava E, 2009, EUR J HUM GENET, V17, P1099, DOI 10.1038/ejhg.2009.22; Mossmann D, 2012, BBA-GENE REGUL MECH, V1819, P1098, DOI 10.1016/j.bbagrm.2011.11.007; Nakayama T, 2015, AM J HUM GENET, V96, P709, DOI 10.1016/j.ajhg.2015.03.003; Perez-Arellano I, 2010, PROTEIN SCI, V19, P372, DOI 10.1002/pro.340; Phang JM, 2008, J NUTR, V138, p2008S, DOI 10.1093/jn/138.10.2008S; Rajab A, 2008, AM J MED GENET A, V146A, P965, DOI 10.1002/ajmg.a.32143; Reversade B, 2009, NAT GENET, V41, P1016, DOI 10.1038/ng.413; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Skidmore DL, 2011, AM J MED GENET A, V155A, P1848, DOI 10.1002/ajmg.a.34057; Urban Z, 2005, J INVEST DERMATOL, V124, P1193, DOI 10.1111/j.0022-202X.2005.23758.x; Urban Z, 2009, AM J HUM GENET, V85, P593, DOI 10.1016/j.ajhg.2009.09.013; Wolthuis DFGJ, 2014, EUR J PAEDIATR NEURO, V18, P511, DOI 10.1016/j.ejpn.2014.01.003; Yildirim Y, 2011, AM J MED GENET A, V155A, P134, DOI 10.1002/ajmg.a.33747; Zampatti S, 2012, AM J MED GENET A, V158A, P927, DOI 10.1002/ajmg.a.35231; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI 10.1038/NCHEMBIO.495	47	51	53	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 3	2015	97	3					483	492		10.1016/j.ajhg.2015.08.001	http://dx.doi.org/10.1016/j.ajhg.2015.08.001			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CR1KW	26320891	Green Published, Bronze			2022-12-18	WOS:000361084700011
J	Vulto-van Silfhout, AT; Rajamanickam, S; Jensik, PJ; Vergult, S; de Rocker, N; Newhall, KJ; Raghavan, R; Reardon, SN; Jarrett, K; McIntyre, T; Bulinski, J; Ownby, SL; Huggenvik, JI; McKnight, GS; Rose, GM; Cai, X; Willaert, A; Zweier, C; Endele, S; De Ligt, J; Van Bon, BWM; Lugtenberg, D; de Vries, PF; Veltman, JA; van Bokhoven, H; Brunner, HG; Rauch, A; De Brouwer, APM; Carvill, GL; Hoischen, A; Mefford, HC; Eichler, EE; Vissers, LELM; Menten, B; Collard, MW; de Vries, BBA				Vulto-van Silfhout, Anneke T.; Rajamanickam, Shivakumar; Jensik, Philip J.; Vergult, Sarah; de Rocker, Nina; Newhall, Kathryn J.; Raghavan, Ramya; Reardon, Sara N.; Jarrett, Kelsey; McIntyre, Tara; Bulinski, Joseph; Ownby, Stacy L.; Huggenvik, Jodi I.; McKnight, G. Stanley; Rose, Gregory M.; Cai, Xiang; Willaert, Andy; Zweier, Christiane; Endele, Sabine; de Ligt, Joep; van Bon, Bregje W. M.; Lugtenberg, Dorien; de Vries, Petra F.; Veltman, Joris A.; van Bokhoven, Hans; Brunner, Han G.; Rauch, Anita; de Brouwer, Arjan P. M.; Carvill, Gemma L.; Hoischen, Alexander; Mefford, Heather C.; Eichler, Evan E.; Vissers, Lisenka E. L. M.; Menten, Bjorn; Collard, Michael W.; de Vries, Bert B. A.			Mutations Affecting the SAND Domain of DEAF1 Cause Intellectual Disability with Severe Speech Impairment and Behavioral Problems	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DE-NOVO MUTATIONS; CELL-CYCLE ENTRY; FACTOR-I DEAF-1; RECEPTOR GENE; PROTEIN; EXPRESSION; DISEASE; AUTISM; NUDR; TRANSCRIPTION	Recently, we identified in two individuals with intellectual disability (ID) different de novo mutations in DEAF1, which encodes a transcription factor with an important role in embryonic development. To ascertain whether these mutations in DEAF1 are causative for the ID phenotype, we performed targeted resequencing of DEAF1 in an additional cohort of over 2,300 individuals with unexplained ID and identified two additional individuals with de novo mutations in this gene. All four individuals had severe ID with severely affected speech development, and three showed severe behavioral problems. DEAF1 is highly expressed in the CNS, especially during early embryonic development. All four mutations were missense mutations affecting the SAND domain of DEAF1. Altered DEAF1 harboring any of the four amino acid changes showed impaired transcriptional regulation of the DEAF1 promoter. Moreover, behavioral studies in mice with a conditional knockout of Deaf1 in the brain showed memory deficits and increased anxiety-like behavior. Our results demonstrate that mutations in DEAF1 cause ID and behavioral problems, most likely as a result of impaired transcriptional regulation by DEAF1.	[Vulto-van Silfhout, Anneke T.; de Ligt, Joep; van Bon, Bregje W. M.; Lugtenberg, Dorien; de Vries, Petra F.; Veltman, Joris A.; van Bokhoven, Hans; Brunner, Han G.; de Brouwer, Arjan P. M.; Hoischen, Alexander; Vissers, Lisenka E. L. M.; de Vries, Bert B. A.] Radford Univ, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Rajamanickam, Shivakumar; Jensik, Philip J.; Raghavan, Ramya; Reardon, Sara N.; Jarrett, Kelsey; McIntyre, Tara; Bulinski, Joseph; Ownby, Stacy L.; Huggenvik, Jodi I.; Rose, Gregory M.; Cai, Xiang; Collard, Michael W.] So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA; [Rajamanickam, Shivakumar; Jensik, Philip J.; Raghavan, Ramya; Reardon, Sara N.; Jarrett, Kelsey; McIntyre, Tara; Bulinski, Joseph; Ownby, Stacy L.; Huggenvik, Jodi I.; Rose, Gregory M.; Cai, Xiang; Collard, Michael W.] So Illinois Univ, Sch Med, Ctr Integrated Res Cognit & Neural Sci, Carbondale, IL 62901 USA; [Vergult, Sarah; de Rocker, Nina; Willaert, Andy; Menten, Bjorn] Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium; [Newhall, Kathryn J.; McKnight, G. Stanley] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Rose, Gregory M.] So Illinois Univ, Sch Med, Dept Anat, Carbondale, IL 62901 USA; [Zweier, Christiane; Endele, Sabine] Univ Erlangen Nurnberg, D-91054 Erlangen, Germany; [van Bokhoven, Hans; de Brouwer, Arjan P. M.] Radboud Univ Nijmegen, Med Ctr, Dept Cognit Neurosci, NL-6500 HB Nijmegen, Netherlands; [Rauch, Anita] Univ Zurich, Inst Med Genet, CH-8603 Schwerzenbach, Switzerland; [Rauch, Anita] Univ Zurich, Neurosci Ctr Zurich, CH-8603 Schwerzenbach, Switzerland; [Rauch, Anita] Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8603 Schwerzenbach, Switzerland; [Carvill, Gemma L.; Mefford, Heather C.] Univ Washington, Div Med Genet, Dept Pediat, Seattle, WA 98195 USA; [Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA 98195 USA	Radboud University Nijmegen; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Ghent University; University of Washington; University of Washington Seattle; Southern Illinois University System; Southern Illinois University; University of Erlangen Nuremberg; Radboud University Nijmegen; University of Zurich; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute	de Vries, BBA (corresponding author), Radford Univ, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands.	bert.devries@radboudumc.nl	Cai, Xiang/AAD-8012-2021; de Brouwer, Arjan PM/P-5949-2015; Rauch, Anita/C-5568-2014; Lugtenberg, Dorien/B-6338-2018; Hoischen, Alexander/AGF-7293-2022; Willaert, Andy/AAZ-9111-2020; AT, Vulto-van Silfhout/H-4199-2015; Zweier, Christiane/F-2202-2015; van Bon, Bregje/Q-2445-2015; Menten, Björn/B-3072-2013; Bokhoven, J.H.L.M. van van/H-8015-2014; Veltman, Joris A/F-5128-2010; Hoischen, Alexander/D-1282-2013; Vissers, Lisenka ELM/A-2598-2015; Brunner, Han/C-9928-2013	Rauch, Anita/0000-0003-2930-3163; Hoischen, Alexander/0000-0002-8072-4476; Zweier, Christiane/0000-0001-8002-2020; van Bon, Bregje/0000-0003-2234-0105; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Veltman, Joris A/0000-0002-3218-8250; Hoischen, Alexander/0000-0002-8072-4476; Vissers, Lisenka ELM/0000-0001-6470-5497; Willaert, Andy/0000-0002-9543-1932; Jarrett, Kelsey/0000-0001-5358-8280; de Ligt, Joep/0000-0002-0348-419X; Vergult, Sarah/0000-0002-0816-6262	European Commission GENCODYS [241995]; Netherlands Organisation for Health Research and Development [917-86-319, 912-12-109, 916-12-095]; NIH [CA89438, CA137556, HD060122]; Southern Illinois University School of Medicine; Fraternal Order of Eagles in Carbondale; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R15HD060122] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA089438, R15CA137556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032875] Funding Source: NIH RePORTER	European Commission GENCODYS; Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Southern Illinois University School of Medicine; Fraternal Order of Eagles in Carbondale; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the individuals involved and their parents for their participation. We would like to thank Hanka Venselaar for the in silico modeling of the DEAF1 mutations. This work was supported by European Commission GENCODYS grant 241995 under the Seventh Framework Programme (to A.T.V.v.S. and B.B.A.d.V.), Netherlands Organisation for Health Research and Development grants 917-86-319 (to B.B.A.d.V.), 912-12-109 (to B.B.A.d.V. and J.A.V.), and 916-12-095 (to A.H.), NIH grants CA89438, CA137556, and HD060122 (to J.I.H. and M.W.C.), funds from the Southern Illinois University School of Medicine (to J.I.H. and M.W.C.), and funds from the Fraternal Order of Eagles in Carbondale (to J.I.H. and M.W.C.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Barker HE, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-94; Bottomley MJ, 2001, NAT STRUCT BIOL, V8, P626, DOI 10.1038/89675; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Cubeddu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039218; Czesak M, 2012, J BIOL CHEM, V287, P6615, DOI 10.1074/jbc.M111.293027; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Gibson TJ, 1998, TRENDS BIOCHEM SCI, V23, P242, DOI 10.1016/S0968-0004(98)01231-6; Gross CT, 1996, EMBO J, V15, P1961, DOI 10.1002/j.1460-2075.1996.tb00547.x; Hahm KM, 2004, MOL CELL BIOL, V24, P2074, DOI 10.1128/MCB.24.5.2074-2082.2004; Huggenvik JI, 1998, MOL ENDOCRINOL, V12, P1619, DOI 10.1210/me.12.10.1619; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jensik PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033404; Jensik PJ, 2004, J BIOL CHEM, V279, P32692, DOI 10.1074/jbc.M400946200; Kateb F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054715; LeBoeuf RD, 1998, J BIOL CHEM, V273, P361, DOI 10.1074/jbc.273.1.361; Lemonde S, 2003, J NEUROSCI, V23, P8788; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Manne U, 2001, CLIN CANCER RES, V7, P3495; Michelson RJ, 1999, J BIOL CHEM, V274, P30510, DOI 10.1074/jbc.274.43.30510; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Ordureau A, 2013, J BIOL CHEM, V288, P24569, DOI 10.1074/jbc.M113.479550; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Szewczyk B, 2009, INT J NEUROPSYCHOPH, V12, P155, DOI 10.1017/S1461145708009012; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548; Veraksa A, 2002, GENESIS, V33, P67, DOI 10.1002/gene.10090; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Yip L, 2013, J MOL CELL BIOL, V5, P99, DOI 10.1093/jmcb/mjs052; Yip LD, 2009, NAT IMMUNOL, V10, P1026, DOI 10.1038/ni.1773; Zhang JH, 2004, PHYSIOL GENOMICS, V18, P167, DOI 10.1152/physiolgenomics.00220.2003	36	51	52	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 1	2014	94	5					649	661		10.1016/j.ajhg.2014.03.013	http://dx.doi.org/10.1016/j.ajhg.2014.03.013			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG5VB	24726472	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000335485700001
J	Basel-Vanagaite, L; Hershkovitz, T; Heyman, E; Raspall-Chaure, M; Kakar, N; Smirin-Yosef, P; Vila-Pueyo, M; Kornreich, L; Thiele, H; Bode, H; Lagovsky, I; Dahary, D; Haviv, A; Hubshman, MW; Pasmanik-Chor, M; Nurnberg, P; Gothelf, D; Kubisch, C; Shohat, M; Macaya, A; Borck, G				Basel-Vanagaite, Lina; Hershkovitz, Tova; Heyman, Eli; Raspall-Chaure, Miguel; Kakar, Naseebullah; Smirin-Yosef, Pola; Vila-Pueyo, Marta; Kornreich, Liora; Thiele, Holger; Bode, Harald; Lagovsky, Irina; Dahary, Dvir; Haviv, Ami; Hubshman, Monika Weisz; Pasmanik-Chor, Metsada; Nuernberg, Peter; Gothelf, Doron; Kubisch, Christian; Shohat, Mordechai; Macaya, Alfons; Borck, Guntram			Biallelic SZT2 Mutations Cause Infantile Encephalopathy with Epilepsy and Dysmorphic Corpus Callosum	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE	Epileptic encephalopathies are genetically heterogeneous severe disorders in which epileptic activity contributes to neurological deterioration. We studied two unrelated children presenting with a distinctive early-onset epileptic encephalopathy characterized by refractory epilepsy and absent developmental milestones, as well as thick and short corpus callosum and persistent cavum septum pellucidum on brain MET. Using whole-exome sequencing, we identified biallelic mutations in seizure threshold 2 (SZT2) in both affected children. The causative mutations include a homozygous nonsense mutation and a nonsense mutation together with an exonic splice-site mutation in a compound-heterozygous state. The latter mutation leads to exon skipping and premature termination of translation, as shown by RT-PCR in blood RNA of the affected boy. Thus, all three mutations are predicted to result in nonsense-mediated mRNA decay and/or premature protein truncation and thereby loss of SZT2 function. Although the molecular role of the peroxisomal protein SZT2 in neuronal excitability and brain development remains to be defined, Szt2 has been shown to influence seizure threshold and epileptogenesis in mice, consistent with our findings in humans. We conclude that mutations in SZT2 cause a severe type of autosomal-recessive infantile encephalopathy with intractable seizures and distinct neuroradiological anomalies.	[Basel-Vanagaite, Lina; Shohat, Mordechai] Rabin Med Ctr, Raphael Recanati Genet Inst, IL-49100 Petah Tiqwa, Israel; [Basel-Vanagaite, Lina; Smirin-Yosef, Pola; Gothelf, Doron; Shohat, Mordechai] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Basel-Vanagaite, Lina; Shohat, Mordechai] Rabin Med Ctr, Felsenstein Med Res Ctr, IL-49100 Petah Tiqwa, Israel; [Basel-Vanagaite, Lina; Hubshman, Monika Weisz; Shohat, Mordechai] Schneider Childrens Med Ctr Israel, Pediatr Genet Unit, IL-49202 Petah Tiqwa, Israel; [Hershkovitz, Tova] Dept Pediat B, IL-31096 Haifa, Israel; [Heyman, Eli] Assaf Harofeh Med Ctr, Dept Pediat Neurol, IL-70300 Zerifin, Israel; [Raspall-Chaure, Miguel; Vila-Pueyo, Marta; Macaya, Alfons] Univ Autonoma Barcelona, Vall Hebron Res Inst, Grup Recerca Neurol Pediatr, Barcelona 08035, Spain; [Kakar, Naseebullah; Kubisch, Christian; Borck, Guntram] Univ Ulm, Inst Human Genet, D-89081 Ulm, Germany; [Kornreich, Liora] Schneider Childrens Med Ctr Israel, Dept Imaging, IL-49202 Petah Tiqwa, Israel; [Thiele, Holger; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Bode, Harald] Univ Ulm, Childrens Hosp, Div Pediat Neurol, D-89075 Ulm, Germany; [Dahary, Dvir; Haviv, Ami] Toldot Genet Ltd, IL-45217 Hod Hasharon, Israel; [Pasmanik-Chor, Metsada] Tel Aviv Univ, George S Wise Fac Life Sci, Bioinformat Unit, IL-69978 Tel Aviv, Israel; [Nuernberg, Peter] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Gothelf, Doron] Edmond & Lily Safra Childrens Hosp, Sheba Med Ctr, Child Psychiat Unit, IL-52620 Tel Hashomer, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Tel Aviv University; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Ulm University; University of Cologne; Ulm University; Tel Aviv University; University of Cologne; University of Cologne; Chaim Sheba Medical Center	Basel-Vanagaite, L (corresponding author), Rabin Med Ctr, Raphael Recanati Genet Inst, Beilinson Campus, IL-49100 Petah Tiqwa, Israel.	basel@post.tau.ac.il; guntram.borck@uni-ulm.de	Kubisch, Christian/F-1893-2011; Borck, Guntram/F-1868-2015; Thiele, Holger/ABE-6792-2020; Dahary, Dvir/AAR-4534-2020; Vila-Pueyo, Marta/M-2530-2019; Vila-Pueyo, Marta/C-8415-2018	Kubisch, Christian/0000-0003-4220-0978; Thiele, Holger/0000-0002-0169-998X; Vila-Pueyo, Marta/0000-0003-0652-2988; Basel-Vanagaite, Vanagaite, Lina/0000-0002-9076-8157; Macaya Ruiz, Alfons/0000-0001-7998-4185; Raspall-Chaure, Miquel/0000-0002-3132-3342; /0000-0002-6826-8535	Adler Chair in Pediatric Cardiology at Tel Aviv University; Israeli Ministry of Health Chief Scientist Foundation [3-4963]; Israeli Science Foundation [558/09]; German Federal Ministry of Education and Research (NGENplus-EMINet); EuroEPINOMICS program (Deutsche Forschungsgemeinschaft [DFG] [NU50/8-1]; Ministerio de Ciencia y Competitividad at Instituto de Salud Carlos III [PI12/01005]; Agencia de Gestio d'Ajuts Universitaris i de Recerca [SGR 2009/0078]; DFG	Adler Chair in Pediatric Cardiology at Tel Aviv University; Israeli Ministry of Health Chief Scientist Foundation; Israeli Science Foundation(Israel Science Foundation); German Federal Ministry of Education and Research (NGENplus-EMINet); EuroEPINOMICS program (Deutsche Forschungsgemeinschaft [DFG](German Research Foundation (DFG)); Ministerio de Ciencia y Competitividad at Instituto de Salud Carlos III; Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); DFG(German Research Foundation (DFG))	We thank the families for participating in this study and M. van der Knaap for reviewing MRI images. We thank G.J. Halpern for her help with editing the manuscript. The study was supported by the Adler Chair in Pediatric Cardiology at Tel Aviv University, the Israeli Ministry of Health Chief Scientist Foundation (grant 3-4963 to L.B.-V.), the Israeli Science Foundation (grant 558/09 to L.B.-V.), the German Federal Ministry of Education and Research (NGENplus-EMINet to P.N. and C.K.), the EuroEPINOMICS program (Deutsche Forschungsgemeinschaft [DFG] grant NU50/8-1 to P.N.), the Ministerio de Ciencia y Competitividad at Instituto de Salud Carlos III (grant PI12/01005 to A.M.), the Agencia de Gestio d'Ajuts Universitaris i de Recerca (grant SGR 2009/0078 to A.M.), and the DFG (to G.B.). D.D. and A.H. are the owners of Toldot Genetics Ltd.	Asher YJT, 2012, EUR J MED GENET, V55, P299, DOI 10.1016/j.ejmg.2012.04.002; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Ben-Ari Y, 2006, LANCET NEUROL, V5, P1055, DOI 10.1016/S1474-4422(06)70626-3; Dagli AI, 2008, AM J MED GENET A, V146A, P204, DOI 10.1002/ajmg.a.32079; Frankel WN, 2009, GENES BRAIN BEHAV, V8, P568, DOI 10.1111/j.1601-183X.2009.00509.x; Gohlich-Ratmann G, 1998, AM J MED GENET, V79, P161, DOI 10.1002/(SICI)1096-8628(19980923)79:3<161::AID-AJMG2>3.0.CO;2-Q; Holmes GL, 2001, PEDIATR RES, V49, P320, DOI 10.1203/00006450-200103000-00004; Iannetti P, 2011, CHILD NERV SYST, V27, P765, DOI 10.1007/s00381-010-1322-8; Kivitie-Kallio S, 1998, NEUROPEDIATRICS, V29, P298, DOI 10.1055/s-2007-973581; Lerman-Sagie T, 2009, ULTRASOUND OBST GYN, V34, P55, DOI 10.1002/uog.6356; Mefford HC, 2011, ANN NEUROL, V70, P974, DOI 10.1002/ana.22645; Noh GJ, 2012, EUR J MED GENET, V55, P281, DOI 10.1016/j.ejmg.2011.12.010; Paul LK, 2007, NAT REV NEUROSCI, V8, P287, DOI 10.1038/nrn2107; Pavone P, 2012, BRAIN DEV-JPN, V34, P459, DOI 10.1016/j.braindev.2011.09.004; Rho JA, 2004, EPILEPSIA, V45, P5, DOI 10.1111/j.0013-9580.2004.05001.x; Rosenfeld JA, 2012, NEUROGENETICS, V13, P31, DOI 10.1007/s10048-011-0306-5; Saitsu H, 2008, NAT GENET, V40, P782, DOI 10.1038/ng.150; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Toutzaris D, 2010, FREE RADICAL BIO MED, V48, P811, DOI 10.1016/j.freeradbiomed.2009.12.023; Zupanc ML, 2009, J CHILD NEUROL, V24, p6S, DOI 10.1177/0883073809338151	20	51	56	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 5	2013	93	3					524	529		10.1016/j.ajhg.2013.07.005	http://dx.doi.org/10.1016/j.ajhg.2013.07.005			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	297QB	23932106	Green Published, Bronze			2022-12-18	WOS:000330268900011
J	Hua, X; Xu, HM; Yang, YN; Zhu, J; Liu, PY; Lu, Y				Hua, Xing; Xu, Haiming; Yang, Yaning; Zhu, Jun; Liu, Pengyuan; Lu, Yan			DrGaP: A Powerful Tool for Identifying Driver Genes and Pathways in Cancer Sequencing Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CELL LUNG-CANCER; SOMATIC MUTATIONS; FREQUENT MUTATION; INACTIVATING MUTATIONS; HUMAN BREAST; GENOME; RET; SUSCEPTIBILITY; FUSIONS; LANDSCAPE	Cancers are caused by the accumulation of genomic alterations. Driver mutations are required for the cancer phenotype, whereas passenger mutations are irrelevant to tumor development and accumulate through DNA replication. A major challenge facing the field of cancer genome sequencing is to identify cancer-associated genes with mutations that drive the cancer phenotype. Here, we describe a powerful and flexible statistical framework for identifying driver genes and driver signaling pathways in cancer genome-sequencing studies. Biological knowledge of the mutational process in tumors is fully integrated into our statistical models and includes such variables as the length of protein-coding regions, transcript isoforms, variation in mutation types, differences in background mutation rates, the redundancy of genetic code, and multiple mutations in one gene. This framework provides several significant features that are not addressed or naively obtained by previous methods. In particular, on the observation of low prevalence of somatic mutations in individual tumors, we propose a heuristic strategy to estimate the mixture proportion of chi-square distribution of likelihood ratio test (LRT) statistics. This provides significantly increased statistical power compared to regular LRT. Through a combination of simulation and analysis of TCGA cancer sequencing study data, we demonstrate high accuracy and sensitivity in our methods. Our statistical methods and several auxiliary bioinformatics tools have been incorporated into a computational tool, DrGaP. The newly developed tool is immediately applicable to cancer genome-sequencing studies and will lead to a more complete identification of altered driver genes and driver signaling pathways in cancer.	[Hua, Xing; Xu, Haiming; Liu, Pengyuan; Lu, Yan] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Hua, Xing; Xu, Haiming; Liu, Pengyuan; Lu, Yan] Med Coll Wisconsin, Ctr Canc, Milwaukee, WI 53226 USA; [Hua, Xing; Yang, Yaning] Univ Sci & Technol China, Dept Stat & Finance, Hefei 230026, Anhui, Peoples R China; [Xu, Haiming; Zhu, Jun] Zhejiang Univ, Inst Bioinformat, Hangzhou 310029, Zhejiang, Peoples R China	Medical College of Wisconsin; Medical College of Wisconsin; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Zhejiang University	Liu, PY (corresponding author), Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	pliu@mcw.edu; ylu@mcw.edu	Xu, Haiming/AAF-8067-2019		National Institutes of Health [1R21AG040777, 5R01CA134433, 5R01CA134682]; Advancing a Healthier Wisconsin Fund [FP00001701, FP00001703]; National Natural Science Foundation of China [11271346]; NATIONAL CANCER INSTITUTE [R01CA134682, R01CA134433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG040777] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Advancing a Healthier Wisconsin Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank TCGA for providing access to lung cancer exome-sequencing data. We thank Hans Vikis for reading and commenting the manuscript, Liping Li for creating webpage for the software DrGaP and pairdoc, and two anonymous reviewers for useful comments. This work has been support in part by National Institutes of Health grants (1R21AG040777, 5R01CA134433, and 5R01CA134682), start-up from Advancing a Healthier Wisconsin Fund (FP00001701 and FP00001703), and National Natural Science Foundation of China (No 11271346).	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bott M, 2011, NAT GENET, V43, P668, DOI 10.1038/ng.855; CASELLA G, 1985, AM STAT, V39, P83, DOI 10.2307/2682801; Chano T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011404; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Cho YG, 2011, INT J ONCOL, V39, P337, DOI 10.3892/ijo.2011.1050; Colomiere M, 2009, BRIT J CANCER, V100, P134, DOI 10.1038/sj.bjc.6604794; Costa-Pereira AP, 2011, AM J CANCER RES, V1, P806; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Getz G, 2007, SCIENCE, V317, DOI 10.1126/science.1138764; Greenman C, 2006, GENETICS, V173, P2187, DOI 10.1534/genetics.105.044677; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Iorns E, 2012, BREAST CANCER RES TR, V135, P79, DOI 10.1007/s10549-012-2068-7; Jeon HS, 2010, J THORAC ONCOL, V5, P417, DOI 10.1097/JTO.0b013e3181ce3afd; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Ju YS, 2012, GENOME RES, V22, P436, DOI 10.1101/gr.133645.111; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Lin J, 2007, GENOME RES, V17, P1304, DOI 10.1101/gr.6431107; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Looyenga BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030820; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Marty M, 2005, J CLIN ONCOL, V23, P4265, DOI 10.1200/JCO.2005.04.173; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Miki D, 2010, NAT GENET, V42, P893, DOI 10.1038/ng.667; MILLER DG, 1980, CANCER, V46, P1307, DOI 10.1002/1097-0142(19800915)46:6<1307::AID-CNCR2820460602>3.0.CO;2-6; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Parmigiani G, 2008, STAT APPL GENET MOL, V7; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Prickett TD, 2011, NAT GENET, V43, P1119, DOI 10.1038/ng.950; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Wendl MC, 2011, BIOINFORMATICS, V27, P1595, DOI 10.1093/bioinformatics/btr193; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788; Youn A, 2011, BIOINFORMATICS, V27, P175, DOI 10.1093/bioinformatics/btq630; Zbuk KM, 2007, NAT REV CANCER, V7, P35, DOI 10.1038/nrc2037; Zhang L, 2012, LANCET ONCOL, V13, P466, DOI 10.1016/S1470-2045(12)70117-1	57	51	52	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 5	2013	93	3					439	451		10.1016/j.ajhg.2013.07.003	http://dx.doi.org/10.1016/j.ajhg.2013.07.003			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	297QB	23954162	Green Published, Bronze			2022-12-18	WOS:000330268900003
J	Hu, YJ; Berndt, SI; Gustafsson, S; Ganna, A; Hirschhorn, J; North, KE; Ingelsson, E; Lin, DY				Hu, Yi-Juan; Berndt, Sonja I.; Gustafsson, Stefan; Ganna, Andrea; Hirschhorn, Joel; North, Kari E.; Ingelsson, Erik; Lin, Dan-Yu		Genetic Invest ANthropometric Trai	Meta-analysis of Gene-Level Associations for Rare Variants Based on Single-Variant Statistics	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; EFFICIENCY; LOCI; MAP	Meta-analysis of genome-wide association studies (GWASs) has led to the discoveries of many common variants associated with complex human diseases. There is a growing recognition that identifying "causal" rare variants also requires large-scale meta-analysis. The fact that association tests with rare variants are performed at the gene level rather than at the variant level poses unprecedented challenges in the meta-analysis. First, different studies may adopt different gene-level tests, so the results are not compatible. Second, gene-level tests require multivariate statistics (i.e., components of the test statistic and their covariance matrix), which are difficult to obtain. To overcome these challenges, we propose to perform gene-level tests for rare variants by combining the results of single-variant analysis (i.e., p values of association tests and effect estimates) from participating studies. This simple strategy is possible because of an insight that multivariate statistics can be recoVered from single-variant statistics, together with the correlation matrix of the single-variant test statistics, which can be estimated from one of the participating studies or from a publicly available database. We show both theoretically and numerically that the proposed meta-analysis approach provides accurate control of the type I error and is as powerful as joint analysis of individual participant data. This approach accommodates any disease phenotype and any study design and produces all commonly used gene-level tests. An application to the GWAS summary results of the Genetic Investigation of ANthropometric Traits (GIANT) consortium reveals rare and low-frequency variants associated with human height. The relevant software is freely available.	[Hu, Yi-Juan] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Berndt, Sonja I.] Natl Canc Inst, Natl Inst Hlth, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Gustafsson, Stefan; Ganna, Andrea; Ingelsson, Erik] Univ Uppsala Hosp, Dept Med Sci, Mol Epidemiol & Sci Life Lab, S-75185 Uppsala, Sweden; [Ganna, Andrea] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Hirschhorn, Joel] Childrens Hosp, Div Genet & Endocrinol, Boston, MA 02115 USA; [Hirschhorn, Joel] Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA 02115 USA; [Hirschhorn, Joel] Broad Inst, Metab Initiat & Program Med & Populat Genet, Cambridge, MA 02142 USA; [Hirschhorn, Joel] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [North, Kari E.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [North, Kari E.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Ingelsson, Erik] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Lin, Dan-Yu] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA	Emory University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Uppsala University; Uppsala University Hospital; Karolinska Institutet; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Oxford; Wellcome Centre for Human Genetics; University of North Carolina; University of North Carolina Chapel Hill	Lin, DY (corresponding author), Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA.	lin@bios.unc.edu	Kanoni, Stavroula/AAN-7161-2021; Langenberg, Claudia/ABG-9067-2021; Wang, Zhaoming/R-5527-2018; Scherag, Andre/B-3805-2014; Meyre, David/D-7315-2011; Visscher, Peter/ABB-6151-2020; Peters, Annette/A-6117-2011; Fall, Tove/O-7226-2014; Colaus, PsyColaus/K-6607-2013; Tregouet, David-Alexandre/E-3961-2016; Erdmann, Jeanette/P-7513-2014; Polasek, Ozren/B-6002-2011; Liu, Jianjun/AAK-4989-2020; Berndt, Sonja I/J-8423-2016; Deloukas, Panos/B-2922-2013; Gudnason, Vilmundur/K-6885-2015; Feitosa, Mary F/K-8044-2012; Milani, Lili/N-1097-2019; Hypponen, Elina/B-2596-2014; Boehm, Bernhard Otto/F-8750-2015; Trégouët, David-Alexandre/P-9210-2019; Palmer, Lyle John/K-3196-2014; Palmer, Lyle John/N-1948-2019; Dei, Mariano/AAY-3870-2020; FROGUEL, Philippe/O-6799-2017; Medland, Sarah E/C-7630-2013; Manunta, Paolo/ABH-5476-2020; Asselbergs, Folkert W./ABD-6752-2021; Ripatti, Samuli/H-9446-2014; Milani, Lili/C-8759-2011; Kiemeney, Lambertus A./D-3357-2009; Erdmann, Jeanette/A-4417-2009; den Heijer, Martin/J-8036-2015; Müller-Nurasyid, Martina/I-8735-2018; Rudan, Igor/I-1467-2012; Strawbridge, Rona/H-5422-2012; Evans, David/H-6325-2013; Paternoster, Lavinia/C-1292-2015; Smith, Albert Vernon/K-5150-2015; Franke, Lude/P-7036-2016; McCarthy, Mark/M-3763-2015; Loos, Ruth/Q-2862-2016	Kanoni, Stavroula/0000-0002-1691-9615; Langenberg, Claudia/0000-0002-5017-7344; Wang, Zhaoming/0000-0001-7556-3869; Meyre, David/0000-0003-4850-7444; Visscher, Peter/0000-0002-2143-8760; Peters, Annette/0000-0001-6645-0985; Erdmann, Jeanette/0000-0002-4486-6231; Polasek, Ozren/0000-0002-5765-1862; Liu, Jianjun/0000-0002-3255-3019; Deloukas, Panos/0000-0001-9251-070X; Gudnason, Vilmundur/0000-0001-5696-0084; Feitosa, Mary F/0000-0002-0933-2410; Milani, Lili/0000-0002-5323-3102; Hypponen, Elina/0000-0003-3670-9399; Trégouët, David-Alexandre/0000-0001-9084-7800; Palmer, Lyle John/0000-0002-1628-3055; Palmer, Lyle John/0000-0002-1628-3055; FROGUEL, Philippe/0000-0003-2972-0784; Medland, Sarah E/0000-0003-1382-380X; Manunta, Paolo/0000-0003-3976-9696; Asselbergs, Folkert W./0000-0002-1692-8669; Ripatti, Samuli/0000-0002-0504-1202; Milani, Lili/0000-0002-5323-3102; Kiemeney, Lambertus A./0000-0002-2368-1326; den Heijer, Martin/0000-0003-3620-5617; Müller-Nurasyid, Martina/0000-0003-3793-5910; Rudan, Igor/0000-0001-6993-6884; Strawbridge, Rona/0000-0001-8506-3585; Esko, Tonu/0000-0003-1982-6569; Kumari, Meena/0000-0001-9716-1035; Wolffenbuttel, Bruce H.R./0000-0001-9262-6921; Nicholson, George/0000-0001-9588-6075; Beilby, John/0000-0002-4915-2254; Koenig, Wolfgang/0000-0002-2064-9603; Kahonen, Mika/0000-0002-4510-7341; Stumvoll, Michael/0000-0001-6225-8240; Hunt, Sarah/0000-0002-8350-1235; Lakka, Timo/0000-0002-9199-2871; Munroe, Patricia/0000-0002-4176-2947; van Meurs, Joyce/0000-0001-6245-2123; Amouyel, Philippe/0000-0001-9088-234X; Vandenput, Liesbeth/0000-0002-1712-6131; Soranzo, Nicole/0000-0003-1095-3852; Waeber, Gerard/0000-0003-4193-788X; Evans, David/0000-0003-0663-4621; Dei, Mariano/0000-0002-7404-508X; Kivimaki, Mika/0000-0002-4699-5627; Magi, Reedik/0000-0002-2964-6011; Van Duijn, Cornelia/0000-0002-2374-9204; Kuulasmaa, Kari/0000-0003-2165-1411; Medina-Gomez, Carolina/0000-0001-7999-5538; Lindgren, Cecilia/0000-0002-4903-9374; Paternoster, Lavinia/0000-0003-2514-0889; Smith, Albert Vernon/0000-0003-1942-5845; Yaluri, Alena/0000-0002-1375-0252; Lindstrom, Jaana/0000-0001-9255-020X; Gentilini, Davide/0000-0002-8391-0725; Franke, Lude/0000-0002-5159-8802; Shungin, Dmitry/0000-0001-7900-5856; Pramstaller, Peter P/0000-0002-9831-8302; Preuss, Michael/0000-0001-5266-8465; Ohlsson, Claes/0000-0002-9633-2805; Kristiansson, Kati/0000-0003-4688-107X; Wheeler, Eleanor/0000-0002-8616-6444; McCarthy, Mark/0000-0002-4393-0510; Franks, Paul/0000-0002-0520-7604; Ganna, Andrea/0000-0002-8147-240X; van Vliet-Ostaptchouk, Jana/0000-0002-7943-3153; Stolk, Ronald/0000-0002-0518-1205; Ouwehand, Willem/0000-0002-7744-1790; Scherag, Andre/0000-0002-9406-4704; Loos, Ruth/0000-0002-8532-5087; Willemsen, Gonneke/0000-0003-3755-0236; Ferrario, Marco M/0000-0003-2741-7124; Rendon, Augusto/0000-0001-8994-0039; Kleber, Marcus/0000-0003-0663-7275	National Institutes of Health [R01CA082659, P01CA142538, U01HG004803, HHSN268200625226C, UL1RR025005]; Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Heart, Lung, and Blood Institute [HHSN26820110005C, HHSN26820110006C, HHSN26820110007C, HHSN26820110008C, HHSN26820 110009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, HHSN26800625226C, R01HL087641, R01HL59367, R01HL086694]; National Human Genome Research Institute [U01HG004402]; ESRC [ES/J023299/1] Funding Source: UKRI; MRC [MC_PC_U127561128, MR/K013351/1] Funding Source: UKRI; Cancer Research UK [14136] Funding Source: researchfish; Economic and Social Research Council [ES/J023299/1] Funding Source: researchfish; Medical Research Council [G1000143, MC_PC_U127561128, G0401527, MR/K013351/1] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA082659, P01CA142538] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086694, R01HL059367, R01HL087641] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402, U01HG004803, ZIAHG000024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K05AA017688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Cancer Epidemiology and Genetics, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by the National Institutes of Health awards R01CA082659 (D.-Y.L.), P01CA142538 (D.-Y.L.), and U01HG004803 (D.-Y.L., K.E.N.) and by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute (S.I.B.). ARIC is a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN26820110005C, HHSN26820110006C, HHSN26820110007C, HHSN26820110008C, HHSN26820 110009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, and HHSN26800625226C) and grants R01HL087641, R01HL59367, and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. The authors thank the staff and participants of the ARIC study for their important contribution. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and the National Institutes of Health Roadmap for Medical Research.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Cox D.R., 1979, THEORETICAL STAT; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li C, 2008, BIOINFORMATICS, V24, P140, DOI 10.1093/bioinformatics/btm549; Lin DY, 2010, BIOMETRIKA, V97, P321, DOI 10.1093/biomet/asq006; Lin DY, 2010, GENET EPIDEMIOL, V34, P60, DOI 10.1002/gepi.20435; Lin DY, 2013, P NATL ACAD SCI USA, V110, P12247, DOI 10.1073/pnas.1221713110; Lin DY, 2011, AM J HUM GENET, V89, P354, DOI [10.1016/j.ajhg.2011.07.015, 10.1016/j.ajhg.2011.07.015.]; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Tzeng JY, 2007, AM J HUM GENET, V81, P927, DOI 10.1086/521558; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zeggini E, 2009, PHARMACOGENOMICS, V10, P191, DOI 10.2217/14622416.10.2.191	24	51	52	0	47	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG 8	2013	93	2					236	248		10.1016/j.ajhg.2013.06.011	http://dx.doi.org/10.1016/j.ajhg.2013.06.011			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202AP	23891470	Green Published, Bronze			2022-12-18	WOS:000323186200004
J	Lappalainen, T; Montgomery, SB; Nica, AC; Dermitzakis, ET				Lappalainen, Tuuli; Montgomery, Stephen B.; Nica, Alexandra C.; Dermitzakis, Emmanouil T.			Epistatic Selection between Coding and Regulatory Variation in Human Evolution and Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MISSING HERITABILITY; GENE INTERACTIONS; COMPLEX DISEASES; EXPRESSION; COMMON; POPULATION; STRATEGIES	Interaction (nonadditive effects) between genetic variants has been highlighted as an important mechanism underlying phenotypic variation, but the discovery of genetic interactions in humans has proved difficult. In this study, we show that the spectrum of variation in the human genome has been shaped by modifier effects of cis-regulatory variation on the functional impact of putatively deleterious protein-coding variants. We analyzed 1000 Genomes population-scale resequencing data from Europe (CEU [Utah residents with Northern and Western European ancestry from the CEPH collection]) and Africa (YRI [Yoruba in Madan, Nigeria]) together with gene expression data from arrays and RNA sequencing for the same samples. We observed an underrepresentation of derived putatively functional coding variation on the more highly expressed regulatory haplotype, which suggests stronger purifying selection against deleterious coding variants that have increased penetrance because of their regulatory background. Furthermore, the frequency spectrum and impact size distribution of common regulatory polymorphisms (eQTLs) appear to be shaped in order to minimize the selective disadvantage of having deleterious coding mutations on the more highly expressed haplotype. Interestingly, eQTEs explaining common disease GWAS signals showed an enrichment of putative epistatic effects, suggesting that some disease associations might arise from interactions increasing the penetrance of rare coding variants. In conclusion, our results indicate that regulatory and coding variants often modify the functional impact of each other. This specific type of genetic interaction is detectable from sequencing data in a genome-wide manner, and characterizing these joint effects might help us understand functional mechanisms behind genetic associations to human phenotypes including both Mendelian and common disease.	[Lappalainen, Tuuli; Montgomery, Stephen B.; Nica, Alexandra C.; Dermitzakis, Emmanouil T.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva 4, Switzerland	University of Geneva	Lappalainen, T (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva 4, Switzerland.	tuuli.lappalainen@unige.ch; emmanouil.dermitzakis@unige.ch	Dermitzakis, Emmanouil/B-7687-2013; Lappalainen, Tuuli/AAE-6532-2020	Lappalainen, Tuuli/0000-0002-7746-8109; Montgomery, Stephen/0000-0002-5200-3903	Louis Jeantet Foundation; Swiss National Science Foundation; National Centers of Competence in Research Frontiers in Genetics (Swiss National Science Foundation); Academy of Finland; Emil Aaltonen foundation	Louis Jeantet Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Centers of Competence in Research Frontiers in Genetics (Swiss National Science Foundation)(Swiss National Science Foundation (SNSF)); Academy of Finland(Academy of Finland); Emil Aaltonen foundation	The funding for this study was provided by Louis Jeantet Foundation, Swiss National Science Foundation and National Centers of Competence in Research Frontiers in Genetics (Swiss National Science Foundation) to E.T.D. T. L. is funded by the Academy of Finland and the Emil Aaltonen foundation. We would like to thank Vital-IT.ch for managing computer resources, and Alfonso Buil and Eugenia Migliavacca for assistance with the analyses.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bickel RD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001275; Carlborg O, 2006, NAT GENET, V38, P418, DOI 10.1038/ng1761; Cheung VG, 2009, NAT REV GENET, V10, P595, DOI 10.1038/nrg2630; Clayton DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000540; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dimas AS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000244; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Emison ES, 2010, AM J HUM GENET, V87, P60, DOI 10.1016/j.ajhg.2010.06.007; Gregersen JW, 2006, NATURE, V443, P574, DOI 10.1038/nature05133; Haig D, 2011, EUR J HUM GENET, V19, P123, DOI 10.1038/ejhg.2010.161; Hindorff L. A., 2010, CATALOG PUBLISHED GE; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Majewski J, 2011, TRENDS GENET, V27, P72, DOI 10.1016/j.tig.2010.10.006; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Montgomery SB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002144; Montgomery SB, 2011, NAT REV GENET, V12, P277, DOI 10.1038/nrg2969; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Moore JH, 2009, AM J HUM GENET, V85, P309, DOI 10.1016/j.ajhg.2009.08.006; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Stam LF, 1996, GENETICS, V144, P1559; van Heyningen V, 2004, HUM MOL GENET, V13, pR225, DOI 10.1093/hmg/ddh254; Weinreich DM, 2005, EVOLUTION, V59, P1165; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167	27	51	54	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP 9	2011	89	3					459	463		10.1016/j.ajhg.2011.08.004	http://dx.doi.org/10.1016/j.ajhg.2011.08.004			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	820XQ	21907014	Green Published, Bronze			2022-12-18	WOS:000294939800012
J	Kullo, IJ; Ding, KY; Shameer, K; McCarty, CA; Jarvik, GR; Denny, JC; Ritchie, MD; Ye, Z; Crosslin, DR; Chisholm, RL; Manolio, TA; Chute, CG				Kullo, Iftikhar J.; Ding, Keyue; Shameer, Khader; McCarty, Catherine A.; Jarvik, Gail R.; Denny, Joshua C.; Ritchie, Marylyn D.; Ye, Zi; Crosslin, David R.; Chisholm, Rex L.; Manolio, Teri A.; Chute, Christopher G.			Complement Receptor 1 Gene Variants Are Associated with Erythrocyte Sedimentation Rate	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; MALARIA; DISEASE; PROTEIN; INFLAMMATION; POLYMORPHISM; EXPRESSION; PROTECTION; REGULATOR	The erythrocyte sedimentation rate (ESR), a commonly performed test of the acute phase response, is the rate at which erythrocytes sediment in vitro in 1 hr. The molecular basis of erythrocyte sedimentation is unknown. To identify genetic variants associated with ESR, we carried out a genome-wide association study of 7607 patients in the Electronic Medical Records and Genomics (eMERGE) network. The discovery cohort consisted of 1979 individuals from the Mayo Clinic, and the replication cohort consisted of 5628 individuals from the remaining four eMERGE sites. A nonsynonymous SNP, rs6691117 (Val -> IIe), in the complement receptor 1 gene (CR1) was associated with ESR (discovery cohort p = 7 x 10(-12), replication cohort p = 3 x 10(-14), combined cohort p = 9 x 10(-24)). We imputed 61 SNPs in CR1, and a "possibly damaging" SNP (rs2274567, His -> Arg) in linkage disequilibrium (r(2) = 0.74) with rs6691117 was also associated with ESR (discovery p = 5 x 10(-11), replication p = 7 x 10(-17), and combined cohort p = 2 x 10(-25)). The two nonsynonymous SNPs in CR1 are near the C3b/C4b binding site, suggesting a possible mechanism by which the variants may influence ESR. In conclusion, genetic variation in CR1, which encodes a protein that clears complement-tagged inflammatory particles from the circulation, influences interindividual variation in ESR, highlighting an association between the innate immunity pathway and erythrocyte interactions.	[Kullo, Iftikhar J.; Ding, Keyue; Shameer, Khader; Ye, Zi] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA; [McCarty, Catherine A.] Marshfield Clin Res Fdn, Ctr Human Genet, Marshfield, WI 54449 USA; [Jarvik, Gail R.] Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA; [Jarvik, Gail R.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Denny, Joshua C.] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; [Denny, Joshua C.] Vanderbilt Univ, Dept Biomed Informat, Nashville, TN 37232 USA; [Ritchie, Marylyn D.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Ctr Human Genet, Nashville, TN 37231 USA; [Crosslin, David R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Chisholm, Rex L.] Northwestern Univ, Ctr Genet Med, Chicago, IL 60611 USA; [Manolio, Teri A.] NHGRI, Off Populat Genom, Bethesda, MD 20892 USA; [Chute, Christopher G.] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Washington; University of Washington Seattle; Northwestern University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Mayo Clinic	Kullo, IJ (corresponding author), Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA.	kullo.iftikhar@mayo.edu	Ding, Keyue/AAH-7228-2019; Denny, Josh/AAL-3359-2021; Jarvik, Gail P/N-6476-2014; Ritchie, Marylyn/C-1114-2012; Zi, Ye/GWM-3932-2022; Khader, Shameer/J-2564-2016; Chute, Christopher/AAT-8540-2021; Chisholm, Rex/B-3418-2009	Ding, Keyue/0000-0002-3496-6415; Denny, Josh/0000-0002-3049-7332; Jarvik, Gail P/0000-0002-6710-8708; McCarty, Catherine/0000-0003-1089-0142; Chisholm, Rex/0000-0002-5638-3990	National Human Genome Research Institute (NHGRI); National Institute of General Medical Sciences (NIGMS) [U01-HG-04599, U01-HG-004610, U01-HG-004608, U01HG004609, U01-HG-04603]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004610, U01HG004599, U01HG006375, U01HG004609, U01HG004608, U01HG004603] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors acknowledge Elizabeth Pugh for helpful discussions. The eMERGE Network was initiated and funded by the National Human Genome Research Institute (NHGRI), with additional funding from National Institute of General Medical Sciences (NIGMS) through the following grants: U01-HG-04599 (Mayo Clinic), U01-HG-004610 (Group Health Cooperative), U01-HG-004608 (Marshfield Clinic), U01HG004609 (Northwestern University), and U01-HG-04603 (Vanderbilt University, also serving as the Administrative Coordinating Center).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; BAIN BJ, 1983, CLIN LAB HAEMATOL, V5, P45; Brigden ML, 1999, AM FAM PHYSICIAN, V60, P1443; Cockburn IA, 2004, P NATL ACAD SCI USA, V101, P272, DOI 10.1073/pnas.0305306101; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; FABRY TL, 1987, BLOOD, V70, P1572; Furtado PB, 2008, J MOL BIOL, V375, P102, DOI 10.1016/j.jmb.2007.09.085; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Ghiran I, 2008, BLOOD, V112, P3465, DOI 10.1182/blood-2008-04-151845; Glodek AM, 2010, BLOOD, V116, P6063, DOI 10.1182/blood-2010-04-273904; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Khera R, 2009, MOL IMMUNOL, V46, P761, DOI 10.1016/j.molimm.2008.09.026; Krushkal J, 2000, MOL BIOL EVOL, V17, P1718, DOI 10.1093/oxfordjournals.molbev.a026270; Krych-Goldberg M, 2001, IMMUNOL REV, V180, P112, DOI 10.1034/j.1600-065X.2001.1800110.x; Kullo IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013011; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Li J, 2010, INFECT IMMUN, V78, P3129, DOI 10.1128/IAI.01263-09; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Liu D, 2009, IMMUNOPHARM IMMUNOT, V31, P524, DOI 10.3109/08923970902845768; Logar CM, 2004, MOL IMMUNOL, V40, P831, DOI 10.1016/j.molimm.2003.09.010; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; Miwa T, 2009, BLOOD, V113, P2684, DOI 10.1182/blood-2008-05-157966; Molina H, 1996, P NATL ACAD SCI USA, V93, P3357, DOI 10.1073/pnas.93.8.3357; Nath SK, 2005, HUM GENET, V118, P225, DOI 10.1007/s00439-005-0044-6; NORMAN DG, 1991, J MOL BIOL, V219, P717, DOI 10.1016/0022-2836(91)90666-T; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reumers J, 2006, BIOINFORMATICS, V22, P2183, DOI 10.1093/bioinformatics/btl348; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; SOX HC, 1986, ANN INTERN MED, V104, P515, DOI 10.7326/0003-4819-104-4-515; Teeranaipong P, 2008, J INFECT DIS, V198, P1880, DOI 10.1086/593338; Tham WH, 2010, P NATL ACAD SCI USA, V107, P17327, DOI 10.1073/pnas.1008151107; Thomas BN, 2005, GENES IMMUN, V6, P31, DOI 10.1038/sj.gene.6364150; TURNER S, 2011, CURRENT PROTOCOLS HU, V68; Wagner C, 2006, MOL IMMUNOL, V43, P643, DOI 10.1016/j.molimm.2005.04.006; WEISMAN HF, 1990, SCIENCE, V249, P146, DOI 10.1126/science.2371562; ARRAY EXPRESS	37	51	52	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL 15	2011	89	1					131	138		10.1016/j.ajhg.2011.05.019	http://dx.doi.org/10.1016/j.ajhg.2011.05.019			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	796HF	21700265	Bronze, Green Published			2022-12-18	WOS:000293041700011
J	Gusev, A; Kenny, EE; Lowe, JK; Salit, J; Saxena, R; Kathiresan, S; Altshuler, DM; Friedman, JM; Breslow, JL; Pe'er, I				Gusev, Alexander; Kenny, Eimear E.; Lowe, Jennifer K.; Salit, Jaqueline; Saxena, Richa; Kathiresan, Sekar; Altshuler, David M.; Friedman, Jeffrey M.; Breslow, Jan L.; Pe'er, Itsik			DASH: A Method for Identical-by-Descent Haplotype Mapping Uncovers Association with Recent Variation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GENOTYPE-IMPUTATION; TRAITS; VARIANTS; POWERFUL; ACCURACY; LOCUS	Rare variants affecting phenotype pose a unique challenge for human genetics. Although genome-wide association studies have successfully detected many common causal variants, they are underpowered in identifying disease variants that are too rare or population-specific to be imputed from a general reference panel and thus are poorly represented on commercial SNP arrays. We set out to overcome these challenges and detect association between disease and rare alleles using SNP arrays by relying on long stretches of genomic sharing that are identical by descent. We have developed an algorithm, DASH, which builds upon pairwise identical-by-descent shared segments to infer clusters of individuals likely to be sharing a single haplotype. DASH constructs a graph with nodes representing individuals and links on the basis of such segments spanning a locus and uses an iterative minimum cut algorithm to identify densely connected components. We have applied DASH to simulated data and diverse GWAS data sets by constructing haplotype clusters and testing them for association. In simulations we show this approach to be significantly more powerful than single-marker testing in an isolated population that is from Kosrae, Federated States of Micronesia and has abundant IBD, and we provide orthogonal information for rare, recent variants in the outbred Wellcome Trust Case-Control Consortium (WTCCC) data. In both cohorts, we identified a number of haplotype associations, five such loci in the WTCCC data and ten in the isolated, that were conditionally significant beyond any individual nearby markers. We have replicated one of these loci in an independent European cohort and identified putative structural changes in low-pass whole-genome sequence of the cluster carriers.	[Gusev, Alexander; Kenny, Eimear E.; Pe'er, Itsik] Columbia Univ, Dept Comp Sci, New York, NY 10027 USA; [Kenny, Eimear E.; Salit, Jaqueline; Friedman, Jeffrey M.; Breslow, Jan L.] Rockefeller Univ, New York, NY 10065 USA; [Lowe, Jennifer K.; Altshuler, David M.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Lowe, Jennifer K.; Saxena, Richa; Kathiresan, Sekar; Altshuler, David M.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Kathiresan, Sekar] Harvard Univ, Massachusetts Gen Hosp, Cardiovasc Dis Prevent Ctr, Cardiol Div,Dept Med,Med Sch, Boston, MA 02114 USA; [Altshuler, David M.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Altshuler, David M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Columbia University; Rockefeller University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Pe'er, I (corresponding author), Columbia Univ, Dept Comp Sci, New York, NY 10027 USA.	itsik@cs.columbia.edu	Altshuler, David M/A-4476-2009; Saxena, Richa/AAG-7279-2020; Breslow, Jan L/B-7544-2008	Altshuler, David M/0000-0002-7250-4107; Saxena, Richa/0000-0003-2233-1065; Kenny, Eimear/0000-0001-9198-759X	National Science Foundation [0845677, 0829882]; National Institutes of Health [U54-CA121852]; National Science Foundation; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the reviewers for comments and suggestions that have greatly improved this manuscript. This study makes use of genotype data from the WTCCC as well as genotype and sequence data from the island of Kosrae, Federated States of Micronesia. This work has been supported by National Science Foundation grants 0845677 and 0829882, National Institutes of Health award U54-CA121852 and the National Science Foundation Graduate Research Fellowship Program.	Albrechtsen A, 2009, GENET EPIDEMIOL, V33, P266, DOI 10.1002/gepi.20378; Allen AS, 2009, GENET EPIDEMIOL, V33, P657, DOI 10.1002/gepi.20417; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Browning BL, 2008, HUM GENET, V123, P273, DOI 10.1007/s00439-008-0472-1; Browning BL, 2007, GENET EPIDEMIOL, V31, P365, DOI 10.1002/gepi.20216; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Browning BL, 2009, AM J HUM GENET, V85, P847, DOI 10.1016/j.ajhg.2009.11.004; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Browning SR, 2010, AM J HUM GENET, V86, P526, DOI 10.1016/j.ajhg.2010.02.021; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Feng T, 2010, HUM GENET, V128, P269, DOI 10.1007/s00439-010-0849-9; GUSEV A, 2011, LOW PASS GENOMEWIDE; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Hartuv E, 2000, GENOMICS, V66, P249, DOI 10.1006/geno.2000.6187; Huang L, 2009, AM J HUM GENET, V84, P235, DOI 10.1016/j.ajhg.2009.01.013; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kenny EE, 2011, HUM MOL GENET, V20, P827, DOI 10.1093/hmg/ddq510; Kenny EE, 2009, P NATL ACAD SCI USA, V106, P13886, DOI 10.1073/pnas.0907336106; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kwee LC, 2008, AM J HUM GENET, V82, P386, DOI 10.1016/j.ajhg.2007.10.010; Lowe JK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000365; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Patterson NJ, 2005, GENETICS, V169, P1093, DOI 10.1534/genetics.103.015768; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell S, 2007, BIOINFORMATICS, V23, P255, DOI 10.1093/bioinformatics/btl580; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Smith JG, 2009, HEART RHYTHM, V6, P634, DOI 10.1016/j.hrthm.2009.02.022; Stoer M, 1997, J ACM, V44, P585, DOI 10.1145/263867.263872; Toutenburg H., 1973, BIOMETRISCHE Z 1975, V17, P526, DOI 10.1002/ bimj.19750170808; Tregouet DA, 2009, NAT GENET, V41, P283, DOI 10.1038/ng.314; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Zhu XF, 2010, GENET EPIDEMIOL, V34, P171, DOI 10.1002/gepi.20449	37	51	51	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 10	2011	88	6					706	717		10.1016/j.ajhg.2011.04.023	http://dx.doi.org/10.1016/j.ajhg.2011.04.023			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	779HK	21620352	Green Published, Bronze			2022-12-18	WOS:000291768500003
J	Alvarado, DM; Aferol, H; McCall, K; Huang, JB; Techy, M; Buchan, J; Cady, J; Gonzales, PR; Dobbs, MB; Gurnett, CA				Alvarado, David M.; Aferol, Hyuliya; McCall, Kevin; Huang, Jason B.; Techy, Matthew; Buchan, Jillian; Cady, Janet; Gonzales, Patrick R.; Dobbs, Matthew B.; Gurnett, Christina A.			Familial Isolated Clubfoot Is Associated with Recurrent Chromosome 17q23.1q23.2 Microduplications Containing TBX4	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TALIPES EQUINOVARUS; NATIONAL-INSTITUTE; BIPOLAR DISORDER; PONSETI METHOD; GENE; FOOT; MICRODELETION; HEALTH; CLASSIFICATION; IDENTIFY	Clubfoot is a common musculoskeletal birth defect for which few causative genes have been identified. To identify the genes responsible for isolated clubfoot, we screened for genomic copy-number variants with the Affymetrix Genome-wide Human SNP Array 6.0. A recurrent chromosome 17q23.1q23.2 microduplication was identified in 3 of 66 probands with familial isolated clubfoot. The chromosome 17q23.1q23.2 microduplication segregated with autosomal-dominant clubfoot in all three families but with reduced penetrance. Mild short stature was common and one female had developmental hip dysplasia. Subtle skeletal abnormalities consisted of broad and shortened metatarsals and calcanei, small distal tibial epiphyses, and thickened ischia. Several skeletal features were opposite to those described in the reciprocal chromosome 17q23.1q23.2 microdeletion syndrome associated with developmental delay and cardiac and limb abnormalities. Of note, during our study, we also identified a microdeletion at the locus in a sibling pair with isolated clubfoot. The chromosome 17q23.1q23.2 region contains the T-box transcription factor TBX4, a likely target of the bicoid-related transcription factor PITX1 previously implicated in clubfoot etiology. Our result suggests that this chromosome 17q23.1q23.2 microduplication is a relatively common cause of familial isolated clubfoot and provides strong evidence linking clubfoot etiology to abnormal early limb development.	[Alvarado, David M.; Aferol, Hyuliya; McCall, Kevin; Dobbs, Matthew B.; Gurnett, Christina A.] Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO 63110 USA; [Gurnett, Christina A.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Techy, Matthew; Gurnett, Christina A.] Dept Neurol, St Louis, MO 63110 USA; [Buchan, Jillian; Cady, Janet; Gonzales, Patrick R.] Washington Univ, Sch Med, Div Biol & Biomed Sci, St Louis, MO 63110 USA; [Dobbs, Matthew B.] SSt Louis Shriners Hosp Children, St Louis, MO 63131 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Dobbs, MB (corresponding author), Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO 63110 USA.	dobbsm@wudosis.wustl.edu; gurnettc@neuro.wustl.edu	Gonzales, Patrick Rolland/ABC-3669-2021	Gonzales, Patrick/0000-0003-1594-0233; Gurnett, Christina/0000-0001-9129-315X	Shriners Hospital for Children; Children's Discovery Institute; St. Louis Children's Hospital Foundation; National Institute of Health [K12 HD001459]; March of Dimes; Orthopaedic Research and Education Foundation; Pediatric Orthopaedic Society of North America; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057235] Funding Source: NIH RePORTER	Shriners Hospital for Children; Children's Discovery Institute; St. Louis Children's Hospital Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Orthopaedic Research and Education Foundation; Pediatric Orthopaedic Society of North America; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the Shriners Hospital for Children, the Children's Discovery Institute, the St. Louis Children's Hospital Foundation, the National Institute of Health (K12 HD001459), the March of Dimes Basil O'Connor Starter Scholar Research Award, the Orthopaedic Research and Education Foundation, and the Pediatric Orthopaedic Society of North America. We kindly thank Seth Crosby and Mike Heinz at the Washington University Genome Center for processing the Affymetrix microarrays. Genotyping of control samples was provided through the Genetic Association Information Network (GAIN). The control data set used for the analysis described in this manuscript was obtained from the Database of Genotype and Phenotype (dbGaP) through dbGaP accession number phs000017.v3.p1. Data for control samples were provided by John R. Kelsoe and John Numberger as part of the National Institute of Mental Health Bipolar Genetics Collaborative.	Ballif BC, 2010, AM J HUM GENET, V86, P454, DOI 10.1016/j.ajhg.2010.01.038; BEALS RK, 1978, NEW ZEAL MED J, V88, P144; Bongers EMHF, 2004, AM J HUM GENET, V74, P1239, DOI 10.1086/421331; Bongers EMHF, 2001, J MED GENET, V38, P209, DOI 10.1136/jmg.38.3.209; Brewer C, 1998, AM J HUM GENET, V63, P1153, DOI 10.1086/302041; Carney Brian T, 2006, J Surg Orthop Adv, V15, P71; CHUNG CS, 1969, HUM HERED, V19, P321, DOI 10.1159/000152236; Dick DM, 2003, AM J HUM GENET, V73, P107, DOI 10.1086/376562; DIMEGLIO A, 1995, J PEDIATR ORTHOP B, V4, P129, DOI 10.1097/01202412-199504020-00002; Dobbs MB, 2004, J BONE JOINT SURG AM, V86A, P22, DOI 10.2106/00004623-200401000-00005; Dyer PJ, 2006, J BONE JOINT SURG BR, V88B, P1082, DOI 10.1302/0301-620X.88B8.17482; Ester AR, 2007, CLIN ORTHOP RELAT R, P32, DOI 10.1097/BLO.0b013e318073c2d9; Ester AR, 2009, AM J MED GENET A, V149A, P2745, DOI 10.1002/ajmg.a.33130; Flynn JM, 1998, J PEDIATR ORTHOPED, V18, P323, DOI 10.1097/00004694-199805000-00010; Greenway SC, 2009, NAT GENET, V41, P931, DOI 10.1038/ng.415; Gurnett CA, 2008, AM J HUM GENET, V83, P616, DOI 10.1016/j.ajhg.2008.10.004; Gurnett CA, 2008, DEV MED CHILD NEUROL, V50, P498, DOI 10.1111/j.1469-8749.2008.03016.x; Hasson P, 2010, DEV CELL, V18, P148, DOI 10.1016/j.devcel.2009.11.013; Lewis K, 1999, J PEDIATR ORTHOPED, V19, P760, DOI 10.1097/00004694-199911000-00013; Lochmiller C, 1998, AM J MED GENET, V79, P90, DOI 10.1002/(SICI)1096-8628(19980901)79:2<90::AID-AJMG3>3.3.CO;2-M; Logan M, 1999, SCIENCE, V283, P1736, DOI 10.1126/science.283.5408.1736; McInnis MG, 2003, BIOL PSYCHIAT, V54, P1265, DOI 10.1016/j.biopsych.2003.08.001; Mefford HC, 2007, AM J HUM GENET, V81, P1057, DOI 10.1086/522591; Menke DB, 2008, DEVELOPMENT, V135, P2543, DOI 10.1242/dev.017384; Naiche LA, 2007, DEVELOPMENT, V134, P93, DOI 10.1242/dev.02712; PONSETI IV, 1963, J BONE JOINT SURG AM, V45, P261, DOI 10.2106/00004623-196345020-00004; Rodriguez-Esteban C, 1999, NATURE, V398, P814, DOI 10.1038/19769; Scher DM, 2004, J PEDIATR ORTHOPED, V24, P349, DOI 10.1097/01241398-200407000-00001; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Takeuchi JK, 1999, NATURE, V398, P810, DOI 10.1038/19762; van Bon BWM, 2009, J MED GENET, V46, P511, DOI 10.1136/jmg.2008.063412; Veitia RA, 2010, J PATHOL, V220, P174, DOI 10.1002/path.2623; Westberry DE, 2003, J PEDIATR ORTHOPED, V23, P503; WYNNEDAVIES R, 1964, J BONE JOINT SURG BR, V46, P445, DOI 10.1302/0301-620X.46B3.445; WYNNEDAVIES R, 1972, CLIN ORTHOP RELAT R, P9, DOI 10.1097/00003086-197205000-00003	37	51	53	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 9	2010	87	1					154	160		10.1016/j.ajhg.2010.06.010	http://dx.doi.org/10.1016/j.ajhg.2010.06.010			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	627HD	20598276	Green Published, Bronze			2022-12-18	WOS:000280029200017
J	Basel-Vanagaite, L; Sarig, O; Hershkovitz, D; Fuchs-Telem, D; Rapaport, D; Gat, A; Isman, G; Shirazi, I; Shohat, M; Enk, CD; Birk, E; Kohlhase, J; Matysiak-Scholze, U; Maya, I; Knopf, C; Peffekoven, A; Hennies, HC; Bergman, R; Horowitz, M; Ishida-Yamamoto, A; Sprecher, E				Basel-Vanagaite, Lina; Sarig, Ofer; Hershkovitz, Dov; Fuchs-Telem, Dana; Rapaport, Debora; Gat, Andrea; Isman, Gila; Shirazi, Idit; Shohat, Mordechai; Enk, Claes D.; Birk, Efrat; Kohlhase, Juergen; Matysiak-Scholze, Uta; Maya, Idit; Knopf, Carlos; Peffekoven, Anette; Hennies, Hans-Christian; Bergman, Reuven; Horowitz, Mia; Ishida-Yamamoto, Akemi; Sprecher, Eli			RIN2 Deficiency Results in Macrocephaly, Alopecia, Cutis Laxa, and Scoliosis: MACS Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NUCLEOTIDE EXCHANGE FACTOR; EHLERS-DANLOS-SYNDROME; OF-THE-LITERATURE; SMALL GTPASE RAB5; GAPO SYNDROME; 2 SIBLINGS; GENE; MUTATIONS; ALSIN; ENDOCYTOSIS	Inherited disorders of elastic tissue represent a complex and heterogeneous group of diseases, characterized often by sagging skin and occasionally by life-threatening visceral complications. In the present study, we report on an autosomal-recessive disorder that we have termed MACS syndrome (macrocephaly, alopecia, cutis laxa, and scoliosis). The disorder was mapped to chromosome 20p11.21-p11.23, and a homozygous frameshift mutation in RIN2 was found to segregate with the disease phenotype in a large consanguineous kindred. The mutation identified results in decreased expression of RIN2, a ubiquitously expressed protein that interacts with Rab5 and is involved in the regulation of endocytic trafficking. RIN2 deficiency was found to be associated with paucity of dermal microfibrils and deficiency of fibulin-5, which may underlie the abnormal skin phenotype displayed by the patients.	[Basel-Vanagaite, Lina; Fuchs-Telem, Dana; Shohat, Mordechai; Birk, Efrat; Sprecher, Eli] Tel Aviv Univ, Sackler Fac Med, IL-69978 Ramat Aviv, Israel; [Basel-Vanagaite, Lina; Shohat, Mordechai; Maya, Idit] Schneider Childrens Med Ctr Israel, IL-49100 Petah Tiqwa, Israel; [Basel-Vanagaite, Lina; Shohat, Mordechai; Maya, Idit] Rabin Med Ctr, Raphael Recanati Genet Inst, IL-49100 Petah Tiqwa, Israel; [Rapaport, Debora; Horowitz, Mia] Tel Aviv Univ, Dept Cell Res & Immunol, IL-69978 Ramat Aviv, Israel; [Sarig, Ofer; Fuchs-Telem, Dana; Isman, Gila; Shirazi, Idit; Sprecher, Eli] Tel Aviv Sourasky Med Ctr, Dept Dermatol, IL-64289 Tel Aviv, Israel; [Gat, Andrea] Tel Aviv Sourasky Med Ctr, Dept Pathol, IL-64289 Tel Aviv, Israel; [Hershkovitz, Dov; Sprecher, Eli] Technion Israel Inst Technol, Rappaport Inst, Ctr Translat Genet, IL-31096 Haifa, Israel; [Hershkovitz, Dov] Meyer Childrens Hosp, Dept Pathol, IL-31096 Haifa, Israel; [Bergman, Reuven] Meyer Childrens Hosp, Dept Dermatol, IL-31096 Haifa, Israel; [Knopf, Carlos] Meyer Childrens Hosp, Metab Dis Unit, IL-31096 Haifa, Israel; [Enk, Claes D.] Hadassah Hebrew Univ, Sch Med, Dept Dermatol, IL-91120 Jerusalem, Israel; [Kohlhase, Juergen; Matysiak-Scholze, Uta] Ctr Human Genet, D-79100 Freiburg, Germany; [Shohat, Mordechai; Peffekoven, Anette; Hennies, Hans-Christian] Univ Cologne, Cologne Ctr Genom, Div Dermatogenet, D-50674 Cologne, Germany; [Ishida-Yamamoto, Akemi] Asahikawa Med Coll, Dept Dermatol, Asahikawa, Hokkaido 0788510, Japan	Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Rambam Health Care Campus; Rambam Health Care Campus; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Cologne; Asahikawa Medical College	Sprecher, E (corresponding author), Tel Aviv Univ, Sackler Fac Med, IL-69978 Ramat Aviv, Israel.	elisp@tasmc.health.gov.il	Hennies, Hans C/G-9424-2014; maya, idit/AAU-4449-2021	Hennies, Hans C/0000-0001-7210-2389; Basel-Vanagaite, Vanagaite, Lina/0000-0002-9076-8157; Hershkovitz, Dov/0000-0002-7954-4486				Barbieri MA, 1996, BIOCELL, V20, P331; Bateman JF, 2009, NAT REV GENET, V10, P173, DOI 10.1038/nrg2520; BUCCI C, 1995, FEBS LETT, V366, P65, DOI 10.1016/0014-5793(95)00477-Q; Boente MDC, 2006, PEDIATR DERMATOL, V23, P467, DOI 10.1111/j.1525-1470.2006.00285.x; Carney DS, 2006, TRENDS CELL BIOL, V16, P27, DOI 10.1016/j.tcb.2005.11.001; CHOI J, 2009, MATRIX BIOL IN PRESS; Colige A, 2004, J INVEST DERMATOL, V123, P656, DOI 10.1111/j.0022-202X.2004.23406.x; De Coster PJ, 2003, J ORAL PATHOL MED, V32, P568, DOI 10.1034/j.1600-0714.2003.00170.x; Demirgunes EF, 2009, AM J MED GENET A, V149A, P802, DOI 10.1002/ajmg.a.32686; Eymard-Pierre E, 2002, AM J HUM GENET, V71, P518, DOI 10.1086/342359; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukuda M, 2006, BIOCHEM SOC T, V34, P691, DOI 10.1042/BST0340691; Goloni-Bertollo EM, 2008, AM J MED GENET A, V146A, P1523, DOI 10.1002/ajmg.a.32157; Gros-Louis F, 2006, BBA-MOL BASIS DIS, V1762, P956, DOI 10.1016/j.bbadis.2006.01.004; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Hennies HC, 2008, NAT GENET, V40, P1410, DOI 10.1038/ng.252; Hu QR, 2006, HUM MOL GENET, V15, P3379, DOI 10.1093/hmg/ddl414; Hucthagowder V, 2006, AM J HUM GENET, V78, P1075, DOI 10.1086/504304; Hucthagowder V, 2009, HUM MOL GENET, V18, P2149, DOI 10.1093/hmg/ddp148; HYLAND J, 1992, NAT GENET, V2, P228, DOI 10.1038/ng1192-228; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Kielty Cay M., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S146239940600007X; Kimura T, 2006, J BIOL CHEM, V281, P10598, DOI 10.1074/jbc.M510531200; Kivuva EC, 2008, CLIN DYSMORPHOL, V17, P99, DOI 10.1097/MCD.0b013e3282f4a964; Kocabay G, 2009, AM J MED GENET A, V149A, P415, DOI 10.1002/ajmg.a.32638; Kornak U, 2008, NAT GENET, V40, P32, DOI 10.1038/ng.2007.45; Li GP, 1996, BIOCELL, V20, P325; Loeys B, 2002, HUM MOL GENET, V11, P2113, DOI 10.1093/hmg/11.18.2113; Loubery S, 2008, TRAFFIC, V9, P492, DOI 10.1111/j.1600-0854.2008.00704.x; MANOUVRIERHANU S, 1987, AM J MED GENET, V26, P683, DOI 10.1002/ajmg.1320260323; Markova D, 2003, AM J HUM GENET, V72, P998, DOI 10.1086/373940; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Otomo A, 2003, HUM MOL GENET, V12, P1671, DOI 10.1093/hmg/ddg184; Ringpfeil F, 2005, CLIN DERMATOL, V23, P41, DOI 10.1016/j.clindermatol.2004.09.006; Saito K, 2002, J BIOL CHEM, V277, P3412, DOI 10.1074/jbc.M106276200; Simpson JC, 2005, BIOCHEM SOC SYMP, V72, P99, DOI 10.1042/bss0720099; STEINMANN B, 1975, HELV PAEDIATR ACTA, V30, P255; TIPTON RE, 1984, AM J MED GENET, V19, P209, DOI 10.1002/ajmg.1320190202; Topp JD, 2004, J BIOL CHEM, V279, P24612, DOI 10.1074/jbc.M313504200; Topp JD, 2005, METHOD ENZYMOL, V403, P261, DOI 10.1016/S0076-6879(05)03022-3; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang MC, 1999, J BIOL CHEM, V274, P981, DOI 10.1074/jbc.274.2.981	44	51	52	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 14	2009	85	2					254	263		10.1016/j.ajhg.2009.07.001	http://dx.doi.org/10.1016/j.ajhg.2009.07.001			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488EV	19631308	Green Published, Bronze			2022-12-18	WOS:000269332900014
J	Gobin-Limballe, S; Djouadi, F; Aubey, F; Olpin, S; Andresen, BS; Yamaguchi, S; Mandel, H; Fukao, T; Ruiter, JPN; Wanders, RJA; McAndrew, R; Kim, JJ; Bastin, J				Gobin-Limballe, S.; Djouadi, F.; Aubey, F.; Olpin, S.; Andresen, B. S.; Yamaguchi, S.; Mandel, H.; Fukao, T.; Ruiter, J. P. N.; Wanders, R. J. A.; McAndrew, R.; Kim, J. J.; Bastin, J.			Genetic basis for correction of very-long-chain acyl-coenzyme A dehydrogenase deficiency by bezafibrate in patient fibroblasts: Toward a genotype-based therapy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FATTY-ACID OXIDATION; SENSITIVE MILD MUTATIONS; COA DEHYDROGENASE; BETA-OXIDATION; MOLECULAR HETEROGENEITY; VLCAD DEFICIENCY; MITOCHONDRIAL; DEFECTS; IDENTIFICATION; DISORDERS	Very-long-chain acyl-coenzyme A dehydrogenase (VLCAD) deficiency is an inborn mitochondrial fatty-acid beta-oxidation (FAO) defect associated with a broad mutational spectrum, with phenotypes ranging from fatal cardiopathy in infancy to adolescent-onset myopathy, and for which there is no established treatment. Recent data suggest that bezafibrate could improve the FAO capacities in beta-oxidation-deficient cells, by enhancing the residual level of mutant enzyme activity via gene-expression stimulation. Since VLCAD-deficient patients frequently harbor missense mutations with unpredictable effects on enzyme activity, we investigated the response to bezafibrate as a function of genotype in 33 VLCAD-deficient fibroblasts representing 45 different mutations. Treatment with bezafibrate (400 mu M for 48 h) resulted in a marked increase in FAO capacities, often leading to restoration of normal values, for 21 genotypes that mainly corresponded to patients with the myopathic phenotype. In contrast, bezafibrate induced no changes in FAO for 11 genotypes corresponding to severe neonatal or infantile phenotypes. This pattern of response was not due to differential inductions of VLCAD messenger RNA, as shown by quantitative real-time polymerase chain reaction, but reflected variable increases in measured VLCAD residual enzyme activity in response to bezafibrate. Genotype cross-analysis allowed the identification of alleles carrying missense mutations, which could account for these different pharmacological profiles and, on this basis, led to the characterization of 9 mild and 11 severe missense mutations. Altogether, the responses to bezafibrate reflected the severity of the metabolic blockage in various genotypes, which appeared to be correlated with the phenotype, thus providing a new approach for analysis of genetic heterogeneity. Finally, this study emphasizes the potential of bezafibrate, a widely prescribed hypolipidemic drug, for the correction of VLCAD deficiency and exemplifies the integration of molecular information in a therapeutic strategy.	Ctr Natl Rech Sci, Unit Propre Rech, Fac Necker Enfants Malad, F-75015 Paris, France; Univ Paris 05, Ctr Natl Rech Sci Biotram, Unit Propre Rech, Fac Med Necker Enfants Malad, Paris, France; Sheffield Childrens Hosp, Dept Clin Chem, Sheffield, S Yorkshire, England; Aarhus Univ Hosp, Inst Human Genet, Res Unit Mol Med, DK-8000 Aarhus, Denmark; Shimane Univ, Sch Med, Matsue, Shimane, Japan; Ramban Med Ctr, Paediat Metab Unit, Haifa, Israel; Gifu Univ, Grad Sch Med, Dept Pediat,Med Informat Sci Div, United Grad Sch Drug Discovery & Med Informat Sci, Gifu, Japan; Univ Amsterdam, Acad Med Ctr, Amsterdam, Netherlands; Med Coll Wisconsin, Milwaukee, WI 53226 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; Aarhus University; Shimane University; Rambam Health Care Campus; Gifu University; University of Amsterdam; Academic Medical Center Amsterdam; Medical College of Wisconsin	Bastin, J (corresponding author), Ctr Natl Rech Sci, Unit Propre Rech, Fac Necker Enfants Malad, 9078,156 rue de Vaugirard, F-75015 Paris, France.	bastin@necker.fr	Bastin, Jean/E-3083-2016; DJOUADI, Fatima/C-6187-2019; Andresen, Brage/D-2515-2012	Andresen, Brage/0000-0001-7488-3035; Djouadi, Fatima/0000-0003-0350-0935; Bastin, Jean/0000-0001-8350-8667	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029076] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM29076, R01 GM029076] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andresen BS, 1996, HUM MOL GENET, V5, P461, DOI 10.1093/hmg/5.4.461; Andresen BS, 1999, AM J HUM GENET, V64, P479, DOI 10.1086/302261; AOYAMA T, 1995, J CLIN INVEST, V95, P2465, DOI 10.1172/JCI117947; AOYAMA T, 1993, BIOCHEM BIOPH RES CO, V191, P1369, DOI 10.1006/bbrc.1993.1368; Battaile KP, 2002, J BIOL CHEM, V277, P12200, DOI 10.1074/jbc.M111296200; Boneh A, 2006, MOL GENET METAB, V88, P166, DOI 10.1016/j.ymgme.2005.12.012; Cai ZW, 2006, J BIOL CHEM, V281, P1970, DOI 10.1074/jbc.M510576200; Chaudhuri TK, 2006, FEBS J, V273, P1331, DOI 10.1111/j.1742-4658.2006.05181.x; Djouadi F, 2005, HUM MOL GENET, V14, P2695, DOI 10.1093/hmg/ddi303; Djouadi F, 2005, J CLIN ENDOCR METAB, V90, P1791, DOI 10.1210/jc.2004-1936; Djouadi F, 2003, PEDIATR RES, V54, P446, DOI 10.1203/01.PDR.0000083001.91588.BB; Engbers HM, 2005, J INHERIT METAB DIS, V28, P1151, DOI 10.1007/s10545-005-0190-y; Ensenauer R, 2005, J BIOL CHEM, V280, P32309, DOI 10.1074/jbc.M504460200; Fukao T, 2001, PEDIATR RES, V49, P227, DOI 10.1203/00006450-200102000-00016; Goetzman ES, 2007, MOL GENET METAB, V91, P138, DOI 10.1016/j.ymgme.2007.01.013; Gregersen N, 2004, EUR J BIOCHEM, V271, P470, DOI 10.1046/j.1432-1033.2003.03949.x; Gregersen N, 2001, HUM MUTAT, V18, P169, DOI 10.1002/humu.1174; KIM JJP, 1993, P NATL ACAD SCI USA, V90, P7523, DOI 10.1073/pnas.90.16.7523; Kluge S, 2003, CRIT CARE MED, V31, P1273, DOI 10.1097/01.CCM.0000045201.10682.F6; Liebig M, 2006, PEDIATRICS, V118, P1065, DOI 10.1542/peds.2006-0666; MANNING NJ, 1990, J INHERIT METAB DIS, V13, P58, DOI 10.1007/BF01799333; Mathur A, 1999, CIRCULATION, V99, P1337, DOI 10.1161/01.CIR.99.10.1337; Nasser I, 2004, BBA-MOL BASIS DIS, V1690, P22, DOI 10.1016/j.bbadis.2004.04.008; Parenti G, 2007, MOL THER, V15, P508, DOI 10.1038/sj.mt.6300074; Pearson ER, 2006, NEW ENGL J MED, V355, P467, DOI 10.1056/NEJMoa061759; Pedersen CB, 2003, J BIOL CHEM, V278, P47449, DOI 10.1074/jbc.M309514200; Pons R, 2000, PEDIATR NEUROL, V22, P98, DOI 10.1016/S0887-8994(99)00132-0; Roe CR, 2002, J CLIN INVEST, V110, P259, DOI [10.1172/JCI200215311, 10.1172/JCI0215311]; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Smelt AHM, 1998, ANN NEUROL, V43, P540, DOI 10.1002/ana.410430422; Souri M, 1996, AM J HUM GENET, V58, P97; Souri M, 1998, J BIOL CHEM, V273, P4227, DOI 10.1074/jbc.273.7.4227; Spiekerkoetter U, 2003, J PEDIATR-US, V143, P335, DOI 10.1067/S0022-3476(03)00292-0; Takusa Y, 2002, MOL GENET METAB, V75, P227, DOI 10.1006/mgme.2002.3297; Tenenbaum A, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-14; Tong MKH, 2006, EUR RESPIR J, V28, P447, DOI 10.1183/09031936.06.00139205; Wanders RJA, 1999, J INHERIT METAB DIS, V22, P442, DOI 10.1023/A:1005504223140; Watanabe H, 2000, HUM MUTAT, V15, P430, DOI 10.1002/(SICI)1098-1004(200005)15:5<430::AID-HUMU4>3.3.CO;2-T	38	51	56	1	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2007	81	6					1133	1143		10.1086/522375	http://dx.doi.org/10.1086/522375			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233NY	17999356	Green Published, Bronze			2022-12-18	WOS:000251098800002
J	Rincon, A; Aguado, C; Desviat, LR; Sanchez-Alcudia, R; Ugarte, M; Perez, B				Rincon, A.; Aguado, C.; Desviat, L. R.; Sanchez-Alcudia, R.; Ugarte, M.; Perez, B.			Propionic and methylmalonic acidemia: Antisense therapeutics for intronic variations causing aberrantly spliced messenger RNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ERYTHROID-CELLS; HUMAN GENES; MUTATIONS; EXON; IDENTIFICATION; OLIGONUCLEOTIDES; NONSENSE; DEFINITION; DIAGNOSIS; VARIANTS	We describe the use of antisense morpholino oligonucleotides (AMOs) to restore normal splicing caused by intronic molecular defects identified in methylmalonic acidemia (MMA) and propionic acidemia (PA). The three new point mutations described in deep intronic regions increase the splicing scores of pseudoexons or generate consensus binding motifs for splicing factors, such as SRp40, which favor the intronic inclusions in MUT(r.1957ins76), PCCA (r.1284ins84), or PCCB (r.654ins72) messenger RNAs (mRNAs). Experimental confirmation that these changes are pathogenic and cause the activation of the pseudoexons was obtained by use of minigenes. AMOs were targeted to the 5' or 3' cryptic splice sites to block access of the splicing machinery to the pseudoexonic regions in the pre-mRNA. Using this antisense therapeutics, we have obtained correctly spliced mRNA that was effectively translated, and propionyl coenzyme A (CoA) carboxylase (PCC) or methylmalonylCoA mutase (MCM) activities were rescued in patients' fibroblasts. The effect of AMOs was sequence and dose dependent. In the affected patient with MUT mutation, close to 100% of MCM activity, measured by incorporation of C-14-propionate, was obtained after 48 h, and correctly spliced MUT mRNA was still detected 15 d after treatment. In the PCCA-mutated and PCCB-mutated cell lines, 100% of PCC activity was measured after 72 h of AMO delivery, and the presence of biotinylated PCCA protein was detected by western blot in treated PCCA-deficient cells. Our results demonstrate that the aberrant inclusions of the intronic sequences are disease-causing mutations in these patients. These findings provide a new therapeutic strategy in these genetic disorders, potentially applicable to a large number of cases with deep intronic changes that, at the moment, remain undetected by standard mutation-detection techniques.	Univ Autonoma Madrid, Fac Ciencias, CSIC UAM, Ctr Biol Mol, Madrid 28049, Spain; Ctr Invest Biomed & Res Enfermedades Raras, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Ugarte, M (corresponding author), Univ Autonoma Madrid, Fac Ciencias, CSIC UAM, Ctr Biol Mol, Madrid 28049, Spain.	mugarte@cbm.uam.es	DESVIAT, LOURDES R/L-3055-2013	DESVIAT, LOURDES R/0000-0003-0492-3323				Aartsma-Rus A, 2003, HUM MOL GENET, V12, P907, DOI 10.1093/hmg/ddg100; Baralle M, 2006, FEBS LETT, V580, P4449, DOI 10.1016/j.febslet.2006.07.018; Buratti E, 2006, NUCLEIC ACIDS RES, V34, P3494, DOI 10.1093/nar/gkl498; Campeau E, 1999, HUM MOL GENET, V8, P107, DOI 10.1093/hmg/8.1.107; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Clavero S, 2002, BBA-MOL BASIS DIS, V1588, P119, DOI 10.1016/S0925-4439(02)00155-2; Desviat LR, 2004, MOL GENET METAB, V83, P28, DOI 10.1016/j.ymgme.2004.08.001; Du LT, 2007, P NATL ACAD SCI USA, V104, P6007, DOI 10.1073/pnas.0608616104; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Fenton WA, 2001, METABOLIC MOL BASES, P2165; Friedman KJ, 1999, J BIOL CHEM, V274, P36193, DOI 10.1074/jbc.274.51.36193; Grellscheid SN, 2006, MOL CELL BIOL, V26, P2237, DOI 10.1128/MCB.26.6.2237-2246.2006; KRAWCZAK M, 1992, HUM GENET, V90, P41; Krawczak M, 2000, HUM MUTAT, V15, P45, DOI 10.1002/(SICI)1098-1004(200001)15:1<45::AID-HUMU10>3.0.CO;2-T; Lacerra G, 2000, P NATL ACAD SCI USA, V97, P9591, DOI 10.1073/pnas.97.17.9591; LEONARD JV, 1995, J INHERIT METAB DIS, V18, P430, DOI 10.1007/BF00710054; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Martinez MA, 2005, MOL GENET METAB, V84, P317, DOI 10.1016/j.ymgme.2004.11.011; Morcos PA, 2007, BIOCHEM BIOPH RES CO, V358, P521, DOI 10.1016/j.bbrc.2007.04.172; Pagani F, 2004, NAT REV GENET, V5, P389, DOI 10.1038/nrg1327; Perez B, 2003, MOL GENET METAB, V78, P59, DOI 10.1016/S1096-7192(02)00197-X; PEREZCERDA C, 1989, J INHERIT METAB DIS, V12, P274, DOI 10.1007/BF03335396; Sun HZ, 2000, MOL CELL BIOL, V20, P6414, DOI 10.1128/MCB.20.17.6414-6425.2000; SUORMALA T, 1985, CLIN CHIM ACTA, V145, P151, DOI 10.1016/0009-8981(85)90282-7; Suwanmanee T, 2002, MOL THER, V6, P718, DOI 10.1006/mthe.2002.0805; Takeshima Y, 2006, PEDIATR RES, V59, P690, DOI 10.1203/01.pdr.0000215047.51278.7c; Tazi J, 2005, TRENDS BIOCHEM SCI, V30, P469, DOI 10.1016/j.tibs.2005.06.002; Vetrini F, 2006, HUM MUTAT, V27, P420, DOI 10.1002/humu.20303; Vockley J, 2000, AM J HUM GENET, V66, P356, DOI 10.1086/302751; Worgan LC, 2006, HUM MUTAT, V27, P31, DOI 10.1002/humu.20258; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304	31	51	52	0	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2007	81	6					1262	1270		10.1086/522376	http://dx.doi.org/10.1086/522376			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233NY	17966092	Green Published, Bronze			2022-12-18	WOS:000251098800011
J	Chen, CTL; Wang, JC; Cohen, BA				Chen, Christina T. L.; Wang, Jen C.; Cohen, Barak A.			The strength of selection on ultraconserved elements in the human genome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POPULATION-GENETICS; SEQUENCES; GENES; POLYMORPHISM; MUTATIONS	Ultraconserved elements are stretches of consecutive nucleotides that are perfectly conserved in multiple mammalian genomes. Although these sequences are identical in the reference human, mouse, and rat genomes, we identified numerous polymorphisms within these regions in the human population. To determine whether polymorphisms in ultraconserved elements affect fitness, we genotyped unrelated human DNA samples at loci within these sequences. For all single-nucleotide polymorphisms tested in ultraconserved regions, individuals homozygous for derived alleles (alleles that differ from the rodent reference genomes) were present, viable, and healthy. The distribution of allele frequencies in these samples argues against strong, ongoing selection as the force maintaining the conservation of these sequences. We then used two methods to determine the minimum level of selection required to generate these sequences. Despite the lack of fixed differences in these sequences between humans and rodents, the average level of selection on ultraconserved elements is less than that on essential genes. The strength of selection associated with ultraconserved elements suggests that mutations in these regions may have subtle phenotypic consequences that are not easily detected in the laboratory.	Washington Univ, Sch Med, Ctr Genome Sci, Dept Genet, St Louis, MO 63108 USA; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63108 USA	Washington University (WUSTL); Washington University (WUSTL)	Cohen, BA (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci, Dept Genet, Campus 8510,4444 Forest Pk Pkwy, St Louis, MO 63108 USA.	cohen@genetics.wustl.edu			NATIONAL INSTITUTE ON AGING [P50AG005681] Funding Source: NIH RePORTER; NIAAA NIH HHS [U10AA0840] Funding Source: Medline; NIA NIH HHS [P50AG05681, P50 AG005681] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 2009, BIOINFORMATICS, V26, P139, DOI [10.1093/bioinformatics/btp616, DOI 10.1093/BIOINFORMATICS/BTP616, DOI 10.1093/BIOINFORMATICS/17.SUPPL_1.S140]; [Anonymous], 1984, AM NAT; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bejerano G, 2004, BIOINFORMATICS, V20, P40, DOI 10.1093/bioinformatics/bth946; Chiaromonte F, 2003, COLD SPRING HARB SYM, V68, P245, DOI 10.1101/sqb.2003.68.245; Dermitzakis ET, 2002, NATURE, V420, P578, DOI 10.1038/nature01251; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; Eddy SR, 2005, PLOS BIOL, V3, P95, DOI 10.1371/journal.pbio.0030010; Goldberg TL, 1997, MOL BIOL EVOL, V14, P976, DOI 10.1093/oxfordjournals.molbev.a025841; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hardison RC, 2003, PLOS BIOL, V1, P156, DOI 10.1371/journal.pbio.0000058; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; Jurinke Christian, 2002, Adv Biochem Eng Biotechnol, V77, P57; Keightley PD, 2005, GENOME RES, V15, P1373, DOI 10.1101/gr.3942005; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim Y, 2004, MOL BIOL EVOL, V21, P286, DOI 10.1093/molbev/msh020; KIMURA M, 1962, GENETICS, V47, P713; Kryukov GV, 2005, HUM MOL GENET, V14, P2221, DOI 10.1093/hmg/ddi226; Lu J, 2005, P NATL ACAD SCI USA, V102, P4063, DOI 10.1073/pnas.0500436102; Margulies EH, 2003, GENOME RES, V13, P2507, DOI 10.1101/gr.1602203; Nachman MW, 2000, GENETICS, V156, P297; Rivas E, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-8; Roff D, 2000, HEREDITY, V84, P135, DOI 10.1046/j.1365-2540.2000.00695.x; SAWYER SA, 1992, GENETICS, V132, P1161; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; TAKAHATA N, 1986, GENET RES, V48, P187, DOI 10.1017/S001667230002499X; Wang T, 2003, BIOINFORMATICS, V19, P2369, DOI 10.1093/bioinformatics/btg329; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WEIR BS, 1996, GENET DATA ANAL 2 ME; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Williamson S, 2004, GENETICS, V168, P463, DOI 10.1534/genetics.103.024745	33	51	53	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2007	80	4					692	704		10.1086/513149	http://dx.doi.org/10.1086/513149			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	153VV	17357075	Green Published, Bronze			2022-12-18	WOS:000245465200010
J	Zaitlen, N; Kang, HM; Eskin, E; Halperin, E				Zaitlen, Noah; Kang, Hyun Min; Eskin, Eleazar; Halperin, Eran			Leveraging the HapMap correlation structure in association studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE-DISEQUILIBRIUM; HAPLOTYPE FREQUENCIES; GENOME; POWER; POPULATION; SELECTION; MODELS; SNPS	Recent high-throughput genotyping technologies, such as the Affymetrix 500k array and the Illumina HumanHap 550 beadchip, have driven down the costs of association studies and have enabled the measurement of single-nucleotide polymorphism (SNP) allele frequency differences between case and control populations on a genomewide scale. A key aspect in the efficiency of association studies is the notion of "indirect association," where only a subset of SNPs are collected to serve as proxies for the uncollected SNPs, taking advantage of the correlation structure between SNPs. Recently, a new class of methods for indirect association, multimarker methods, has been proposed. Although the multimarker methods are a considerable advancement, current methods do not fully take advantage of the correlation structure between SNPs and their multimarker proxies. In this article, we propose a novel multimarker indirect-association method, WHAP, that is based on a weighted sum of the haplotype frequency differences. In contrast to traditional indirect-association methods, we show analytically that there is a considerable gain in power achieved by our method compared with both single-marker and multimarker tests, as well as traditional haplotype-based tests. Our results are supported by empirical evaluation across the HapMap reference panel data sets, and a software implementation for the Affymetrix 500k and Illumina HumanHap 550 chips is available for download.	Int Comp Sci Inst, Berkeley, CA 94704 USA; Univ Calif San Diego, Bioinformat Program, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA; Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90024 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Halperin, E (corresponding author), Int Comp Sci Inst, 1947 Ctr St,Suite 600, Berkeley, CA 94704 USA.	heran@icsi.berkeley.edu	Eskin, Eleazar/J-9187-2012	Eskin, Eleazar/0000-0003-1149-4758	NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017588, P41RR008605] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL080079] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR008605, C06 RR017588, P41 RR08605] Funding Source: Medline; NHLBI NIH HHS [1K25HL080079, K25 HL080079] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Halperin E, 2006, J COMPUT BIOL, V13, P481, DOI 10.1089/cmb.2006.13.481; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Matsuzaki H, 2004, NAT METHODS, V1, P109, DOI 10.1038/nmeth718; Nicolae DL, 2006, GENET EPIDEMIOL, V30, P718, DOI 10.1002/gepi.20182; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; RISCH N, 1996, SCIENCE, V273, P1517; Sham PC, 2000, AM J HUM GENET, V66, P1616, DOI 10.1086/302891; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202; Stram DO, 2004, GENET EPIDEMIOL, V27, P365, DOI 10.1002/gepi.20028; Wang HS, 2006, GENET EPIDEMIOL, V30, P356, DOI 10.1002/gepi.20150; Weale ME, 2003, AM J HUM GENET, V73, P551, DOI 10.1086/378098; Zaitlen NA, 2005, GENOME RES, V15, P1594, DOI 10.1101/gr.4297805	22	51	52	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2007	80	4					683	691		10.1086/513109	http://dx.doi.org/10.1086/513109			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	153VV	17357074	Bronze, Green Published			2022-12-18	WOS:000245465200009
J	Jaffe, EK; Stith, L				Jaffe, Eileen K.; Stith, Linda			ALAD porphyria is a conformational disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DELTA-AMINOLEVULINATE DEHYDRATASE; HUMAN PORPHOBILINOGEN SYNTHASE; QUATERNARY STRUCTURE ISOFORMS; BLOOD LEAD LEVELS; ACID DEHYDRATASE; 5-AMINOLEVULINIC ACID; MOLECULAR ANALYSIS; POLYMORPHISM; GENE; PATIENT	ALAD porphyria is a rare porphyric disorder, with five documented compound heterozygous patients, and it is caused by a profound lack of porphobilinogen synthase (PBGS) activity. PBGS, also called "delta-aminolevulinate dehydratase," is encoded by the ALAD gene and catalyzes the second step in the biosynthesis of heme. ALAD porphyria is a recessive disorder; there are two common variant ALAD alleles, which encode K59 and N59, and eight known porphyria-associated ALAD mutations, which encode F12L, E89K, C132R, G133R, V153M, R240W, A274T, and V275M. Human PBGS exists as an equilibrium of functionally distinct quaternary structure assemblies, known as "morpheeins," in which one functional homo-oligomer can dissociate, change conformation, and reassociate into a different oligomer. In the case of human PBGS, the two assemblies are a high-activity octamer and a low-activity hexamer. The current study quantifies the morpheein forms of human PBGS for the common and porphyria-associated variants. Heterologous expression in Escherichia coli, followed by separation of the octameric and hexameric assemblies on an ion-exchange column, showed that the percentage of hexamer for F12L (100%), R240W (80%), G133R (48%), C132R (36%), E89K (31%), and A274T (14%)was appreciably larger than for the wild-type proteins K59 and N59 (0% and 3%, respectively). All eight porphyria-associated variants, including V153M and V275M, showed an increased propensity to form the hexamer, according to a kinetic analysis. Thus, all porphyria-associated human PBGS variants are found to shift the morpheein equilibrium for PBGS toward the less active hexamer. We propose that the disequilibrium of morpheein assemblies broadens the definition of conformational diseases beyond the prion disorders and that ALAD porphyria is the first example of a morpheein-based conformational disease.	Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Jaffe, EK (corresponding author), Fox Chase Canc Ctr, 333 Cottman Ave, Philadelphia, PA 19111 USA.	Eileen.Jaffe@fccc.edu			NCI NIH HHS [CA006727] Funding Source: Medline; NIEHS NIH HHS [R01 ES003654, ES03654] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003654] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Akagi R, 2000, HEPATOLOGY, V31, P704, DOI 10.1002/hep.510310321; Akagi R, 1999, BRIT J HAEMATOL, V106, P931, DOI 10.1046/j.1365-2141.1999.01647.x; Akagi R, 2000, BLOOD, V96, P3618, DOI 10.1182/blood.V96.10.3618.h8003618_3618_3623; Akagi R, 2006, MOL GENET METAB, V87, P329, DOI 10.1016/j.ymgme.2005.10.011; Akagi R, 2006, BRIT J HAEMATOL, V132, P237, DOI 10.1111/j.1365-2141.2005.05852.x; BATTISTUZZI G, 1981, ANN HUM GENET, V45, P223, DOI 10.1111/j.1469-1809.1981.tb00333.x; Breinig S, 2003, NAT STRUCT BIOL, V10, P757, DOI 10.1038/nsb963; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; DOSS M, 1972, Z KLIN CHEM KLIN BIO, V10, P230; Doss MO, 2004, J INHERIT METAB DIS, V27, P529, DOI 10.1023/B:BOLI.0000037341.21975.9d; Fishbein L, 1998, SCI TOTAL ENVIRON, V217, P71, DOI 10.1016/S0048-9697(98)00164-8; Fujita H, 1995, Nihon Rinsho, V53, P1408; Gross M, 1999, J BIOL CHEM, V274, P3125, DOI 10.1074/jbc.274.5.3125; Gross U, 1998, CLIN CHEM, V44, P1892; GUO GG, 1994, J BIOL CHEM, V269, P12399; Hamosh A, 2000, HUM MUTAT, V15, P57, DOI 10.1002/(SICI)1098-1004(200001)15:1<57::AID-HUMU12>3.0.CO;2-G; ISHIDA N, 1992, J CLIN INVEST, V89, P1431, DOI 10.1172/JCI115732; Jaffe EK, 2004, BIOORG CHEM, V32, P316, DOI 10.1016/j.bioorg.2004.05.010; Jaffe EK, 2000, ACTA CRYSTALLOGR D, V56, P115, DOI 10.1107/S0907444999014894; Jaffe EK, 2000, J BIOL CHEM, V275, P2619, DOI 10.1074/jbc.275.4.2619; Jaffe EK, 2001, J BIOL CHEM, V276, P1531, DOI 10.1074/jbc.M007663200; Jaffe EK, 2005, TRENDS BIOCHEM SCI, V30, P490, DOI 10.1016/j.tibs.2005.07.003; LIEDGENS W, 1980, Z NATURFORSCH C, V35, P958; Maruno M, 2001, BLOOD, V97, P2972, DOI 10.1182/blood.V97.10.2972; Montenegro MF, 2006, CLIN CHIM ACTA, V367, P192, DOI 10.1016/j.cca.2005.12.009; Muraoka Akihiro, 1995, Kobe Journal of Medical Sciences, V41, P23; PARRA EJ, 1995, AM J PHYS ANTHROPOL, V97, P381, DOI 10.1002/ajpa.1330970405; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; Sakamoto D, 2004, MECH DEVELOP, V121, P747, DOI 10.1016/j.mod.2004.03.030; Sassa S, 1998, SEMIN LIVER DIS, V18, P95, DOI 10.1055/s-2007-1007145; SASSA S, 1992, T ASSOC AM PHYSICIAN, V105, P250; Sassa S, 2002, PHOTODERMATOL PHOTO, V18, P56, DOI 10.1034/j.1600-0781.2002.180202.x; SHEMIN D, 1955, J BIOL CHEM, V215, P613; SHEMIN D, 1953, J AM CHEM SOC, V75, P4873, DOI 10.1021/ja01115a546; SHEMIN D, 1972, ENZYMES, P323; Shen XM, 2001, ENVIRON RES, V85, P185, DOI 10.1006/enrs.2000.4230; Sithisarankul P, 1997, AM J IND MED, V32, P15, DOI 10.1002/(SICI)1097-0274(199707)32:1<15::AID-AJIM2>3.0.CO;2-Q; Suzen HS, 2004, BIOCHEM GENET, V42, P461, DOI 10.1023/B:BIGI.0000043988.79625.89; Tang L, 2006, J BIOL CHEM, V281, P6682, DOI 10.1074/jbc.M511134200; Tang L, 2005, J BIOL CHEM, V280, P15786, DOI 10.1074/jbc.M500218200; THUNELL S, 1987, J CLIN CHEM CLIN BIO, V25, P5; VANHEYNINGEN S, 1971, BIOCHEMISTRY-US, V10, P4676, DOI 10.1021/bi00801a013; WETMUR JG, 1991, ENVIRON RES, V56, P109, DOI 10.1016/S0013-9351(05)80001-5; WETMUR JG, 1991, AM J HUM GENET, V49, P757; Weuve J, 2006, OCCUP ENVIRON MED, V63, P746, DOI 10.1136/oem.2006.027417; YANO Y, 1998, RYOIKIBETSU SHOKOGUN, V19, P139; Zheng Yuxin, 2001, Zhonghua Yufang Yixue Zazhi, V35, P16	47	51	53	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2007	80	2					329	337		10.1086/511444	http://dx.doi.org/10.1086/511444			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	129KX	17236137	Bronze, Green Published			2022-12-18	WOS:000243729500012
J	Roach, JC; Deutsch, K; Li, S; Siegel, AF; Bekris, LM; Einhaus, DC; Sheridan, CM; Glusman, G; Hood, L; Lernmark, A; Janer, M				Roach, Jared C.; Deutsch, Kerry; Li, Sarah; Siegel, Andrew F.; Bekris, Lynn M.; Einhaus, Derek C.; Sheridan, Colleen M.; Glusman, Gustavo; Hood, Leroy; Lernmark, Ake; Janer, Marta		Swedish Childhood Diabet Study Grp; Diabet Incidence Sweden Study Grp	Genetic mapping at 3-kilobase resolution reveals inositol 1,4,5-triphosphate receptor 3 as a risk factor for type 1 diabetes in Sweden	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; SINGLE-NUCLEOTIDE POLYMORPHISMS; ISLET-CELL; LINKAGE-DISEQUILIBRIUM; ASSOCIATION; LOCI; PREDICTION; SELECTION; PATTERN; VARIANT	We mapped the genetic influences for type 1 diabetes (T1D), using 2,360 single-nucleotide polymorphism ( SNP) markers in the 4.4-Mb human major histocompatibility complex (MHC) locus and the adjacent 493 kb centromeric to the MHC, initially in a survey of 363 Swedish T1D cases and controls. We confirmed prior studies showing association with T1D in the MHC, most significantly near HLA-DR/DQ. In the region centromeric to the MHC, we identified a peak of association within the inositol 1,4,5-triphosphate receptor 3 gene (ITPR3; formerly IP3R3). The most significant single SNP in this region was at the center of the ITPR3 peak of association (P = 1.7 x 10(-4) the survey study). For validation, we typed an additional 761 Swedish individuals. The P value for association computed from all 1,124 individuals was (recessive odds ratio 2.5; 95% confidence interval [CI] 1.7 - 3.9). The estimated population-attributable risk 1.30 x 10(-6) of 21.6% (95% CI 10.0% - 31.0%) suggests that variation within ITPR3 reflects an important contribution to T1D in Sweden. Two-locus regression analysis supports an influence of ITPR3 variation on T1D that is distinct from that of any MHC class II gene.	Univ Washington, Inst Syst Biol, Seattle, WA 98103 USA; Univ Washington, Dept Stat, Seattle, WA 98103 USA; Univ Washington, Dept Management Sci & Finance & Business Econ, Seattle, WA 98103 USA; Univ Washington, Dept Med, Seattle, WA 98103 USA	Institute for Systems Biology (ISB); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Roach, JC (corresponding author), Univ Washington, Inst Syst Biol, 1441 N 34th St, Seattle, WA 98103 USA.	jroach@systemsbiology.org	Lernmark, Åke/F-8140-2015	Lernmark, Åke/0000-0003-1735-0499; Glusman, Gustavo/0000-0001-8060-5955	NIAID NIH HHS [U54 AI054523, K08 AI056092, 5K08AI056092, 5U54AI054523] Funding Source: Medline; NIDDK NIH HHS [DK26190, DK532004, R01 DK026190] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI054523, K08AI056092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026190] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andolfatto P, 2001, CURR OPIN GENET DEV, V11, P635, DOI 10.1016/S0959-437X(00)00246-X; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bezprozvanny I, 2005, CELL CALCIUM, V38, P261, DOI 10.1016/j.ceca.2005.06.030; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; CHRISTIANSEN FB, 1977, AM J HUM GENET, V29, P195; Clerget-Darpoux F, 2000, AM J HUM GENET, V66, P1468, DOI 10.1086/302854; Concannon P, 2005, DIABETES, V54, P2995, DOI 10.2337/diabetes.54.10.2995; Cullen M, 2002, AM J HUM GENET, V71, P759, DOI 10.1086/342973; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Deruytter N, 2004, DIABETES, V53, P3323, DOI 10.2337/diabetes.53.12.3323; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Glusman G, 2006, PLOS COMPUT BIOL, V2, P160, DOI 10.1371/journal.pcbi.0020018; Graham J, 1999, EUR J IMMUNOGENET, V26, P117, DOI 10.1046/j.1365-2370.1999.00127.x; Graham J, 2002, DIABETES, V51, P1346, DOI 10.2337/diabetes.51.5.1346; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Green A, 2001, DIABETOLOGIA, V44, pB3, DOI 10.1007/PL00002950; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Herr M, 2000, HUM MOL GENET, V9, P1291, DOI 10.1093/hmg/9.9.1291; Holm P, 2001, AM J HUM GENET, V69, P1301; HUBLEY R, 2002, PPSN 7 WORKSH, V7, P32; Hubley RM, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-30; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Jurinke Christian, 2002, Methods Mol Biol, V187, P179; LANDINOLSSON M, 1992, DIABETES, V41, P1022, DOI 10.2337/diabetes.41.8.1022; LANDINOLSSON M, 1992, DIABETOLOGIA, V35, P1068, DOI 10.1007/BF02221683; Lee B, 2001, ENDOCRINOLOGY, V142, P1744, DOI 10.1210/en.142.5.1744; Lincoln MR, 2005, NAT GENET, V37, P1108, DOI 10.1038/ng1647; Livingston RJ, 2004, GENOME RES, V14, P1821, DOI 10.1101/gr.2730004; Maier SA, 2005, CURR NANOSCI, V1, P17, DOI 10.2174/1573413052953165; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672300014634, 10.1017/S0016672308009579]; Miretti MM, 2005, AM J HUM GENET, V76, P634, DOI 10.1086/429393; NEW MI, 1986, ENDOCR RES, V12, P505, DOI 10.3109/07435808609035453; North BV, 2005, HUM HERED, V59, P79, DOI 10.1159/000085222; OETH P, 2005, 8876006 R01; Onengut-Gumuscu S, 2005, J AUTOIMMUN, V25, P34, DOI 10.1016/j.jaut.2005.09.007; Park Y, 2004, DIABETES RES CLIN PR, V66, pS19, DOI 10.1016/j.diabres.2003.10.026; Pociot F, 2004, AM J HUM GENET, V74, P647, DOI 10.1086/383095; Roberts SB, 1999, AM J HUM GENET, V65, P876, DOI 10.1086/302528; Smink LJ, 2005, NUCLEIC ACIDS RES, V33, pD544; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Srivastava M, 2002, MOL MED, V8, P781, DOI 10.1007/BF03402083; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stewart CA, 2004, GENOME RES, V14, P1176, DOI 10.1101/gr.2188104	45	51	52	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2006	79	4					614	627		10.1086/507876	http://dx.doi.org/10.1086/507876			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	089BV	16960798	Bronze, Green Published			2022-12-18	WOS:000240855900003
J	Paulsen, M; Lund, C; Akram, Z; Winther, JR; Horn, N; Moller, LB				Paulsen, Marianne; Lund, Connie; Akram, Zarqa; Winther, Jakob R.; Horn, Nina; Moller, Lisbeth Birk			Evidence that translation reinitiation leads to a partially functional Menkes protein containing two copper-binding sites	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MESSENGER-RNA DECAY; WILSONS-DISEASE PROTEIN; BIOCHEMICAL-CHARACTERIZATION; INTRACELLULAR TRAFFICKING; SACCHAROMYCES-CEREVISIAE; IRON UPTAKE; ATPASE; GENE; NONSENSE; YEAST	Menkes disease (MD) is an X-linked recessive disorder of copper metabolism. It is caused by mutations in the ATP7A gene encoding a copper-translocating P-type ATPase, which contains six N-terminal copper-binding sites (CBS1-CBS6). Most patients die in early childhood. We investigated the functional effect of a large frameshift deletion in ATP7A (including exons 3 and 4) identified in a patient with MD with unexpectedly mild symptoms and long survival. The mutated transcript, ATP7(Delta ex3+ex4), contains a premature termination codon after 46 codons. Although such transcripts are generally degraded by nonsense-mediated mRNA decay (NMD), it was established by real-time PCR quantification that the ATP7A(Delta ex3+ex4) transcript was protected from degradation. A combination of in vitro translation, recombinant expression, and immunocytochemical analysis provided evidence that the ATP7A(Delta ex3+ex4) transcript was protected from degradation because of reinitiation of protein translation. Our findings suggest that reinitiation takes place at two downstream internal codons. The putative N-terminally truncated proteins contain only CBS5 and CBS6. Cellular localization and copper-dependent trafficking of the major part of endogenous and recombinant ATP7A(Delta ex3+ex4) proteins were similar to the wildtype ATP7A protein. Furthermore, the ATP7A(Delta ex3+ex4) cDNA was able to rescue a yeast strain lacking the homologous gene, CCC2. In summary, we propose that reinitiation of the NMD-resistant ATP7A(Delta ex3+ex4) transcript leads to the synthesis of N-terminally truncated and at-least-partially functional Menkes proteins missing CBS1-CBS4. This finding-that a mutation that would have been assumed to be null is not-highlights the need to examine the biochemical phenotype of patients to deduce the efficacy of copper therapy.	Kennedy Inst, Natl Eye Clin, Glostrup, Denmark; Univ Copenhagen, Inst Mol Biol & Physiol, Copenhagen, Denmark	University of Copenhagen	Moller, LB (corresponding author), John F Kennedy Inst, Gl Landevej 7, DK-2600 Glostrup, Denmark.	lbm@kisoe.org	Winther, Jakob R./K-4451-2014	Winther, Jakob R./0000-0001-6995-9154; Moller, Lisbeth/0000-0002-9524-4301				Ambrosini L, 1999, HUM MOL GENET, V8, P1547, DOI 10.1093/hmg/8.8.1547; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; Cater MA, 2004, BIOCHEM J, V380, P805, DOI 10.1042/BJ20031804; Chang CC, 1998, AM J HUM GENET, V63, P1294, DOI 10.1086/302103; Cox D W, 1996, Prog Liver Dis, V14, P245; Cuthbert JA, 1998, GASTROENTEROL CLIN N, V27, P655, DOI 10.1016/S0889-8553(05)70025-X; DANKS DM, 1972, LANCET, V1, P1100; Forbes JR, 1999, J BIOL CHEM, V274, P12408, DOI 10.1074/jbc.274.18.12408; Forbes JR, 1998, AM J HUM GENET, V63, P1663, DOI 10.1086/302163; Francis MJ, 1998, HUM MOL GENET, V7, P1245, DOI 10.1093/hmg/7.8.1245; FU DD, 1995, YEAST, V11, P283, DOI 10.1002/yea.320110310; HAAS RH, 1981, NEUROLOGY, V31, P852, DOI 10.1212/WNL.31.7.852; Hamza I, 2003, P NATL ACAD SCI USA, V100, P1215, DOI 10.1073/pnas.0336230100; Hamza I, 1999, P NATL ACAD SCI USA, V96, P13363, DOI 10.1073/pnas.96.23.13363; Horn N., 2002, CONNECTIVE TISSUE IT, V14, P651; Hung IH, 1997, J BIOL CHEM, V272, P21461, DOI 10.1074/jbc.272.34.21461; Inacio A, 2004, J BIOL CHEM, V279, P32170, DOI 10.1074/jbc.M405024200; Kaler SG, 1996, NAT GENET, V13, P21, DOI 10.1038/ng0596-21; Kaler SG, 1996, BIOCHEM MOL MED, V57, P37, DOI 10.1006/bmme.1996.0007; Kim BE, 2003, J MED GENET, V40, P290, DOI 10.1136/jmg.40.4.290; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Kozak M, 2001, NUCLEIC ACIDS RES, V29, P5226, DOI 10.1093/nar/29.24.5226; KOZAK M, 1987, MOL CELL BIOL, V7, P3438, DOI 10.1128/MCB.7.10.3438; Larin D, 1999, J BIOL CHEM, V274, P28497, DOI 10.1074/jbc.274.40.28497; LEDLEY FD, 1990, BIOESSAYS, V12, P335, DOI 10.1002/bies.950120706; LUUKKONEN BGM, 1995, J VIROL, V69, P4086, DOI 10.1128/JVI.69.7.4086-4094.1995; MAQUAT LE, 1995, RNA, V1, P453; Mercer JFB, 2003, BIOMETALS, V16, P175, DOI 10.1023/A:1020719016675; Moller LB, 2005, HUM MUTAT, V26, P84, DOI 10.1002/humu.20190; Moller LB, 2000, AM J HUM GENET, V66, P1211, DOI 10.1086/302857; MOLLER M, 1986, ADV PINEAL RES, V1, P51; Perrin-Vidoz L, 2002, HUM MOL GENET, V11, P2805, DOI 10.1093/hmg/11.23.2805; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; Poulsen L, 2002, CLIN GENET, V62, P440, DOI 10.1034/j.1399-0004.2002.620604.x; Poulsen L, 2002, CLIN GENET, V62, P449, DOI 10.1034/j.1399-0004.2002.620605.x; Schaefer M, 1999, GASTROENTEROLOGY, V117, P1380, DOI 10.1016/S0016-5085(99)70288-X; SCHENA M, 1991, METHOD ENZYMOL, V194, P389; SIKORSKI RS, 1989, GENETICS, V122, P19; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; Strausak D, 1999, J BIOL CHEM, V274, P11170, DOI 10.1074/jbc.274.16.11170; Strausak D, 2003, J BIOL CHEM, V278, P20821, DOI 10.1074/jbc.M212437200; Subramaniam VN, 1996, SCIENCE, V272, P1161, DOI 10.1126/science.272.5265.1161; TONNESEN T, 1991, J MED GENET, V28, P615, DOI 10.1136/jmg.28.9.615; Tumer Z, 2003, HUM MUTAT, V22, P457, DOI 10.1002/humu.10287; TUMER Z, 1994, J INHERIT METAB DIS, V17, P267, DOI 10.1007/BF00711804; van Dongen EMWM, 2004, BIOCHEM BIOPH RES CO, V323, P789, DOI 10.1016/j.bbrc.2004.08.160; Vega Laso Maria R., 1993, Journal of Biological Chemistry, V268, P6453; Voskoboinik N, 1999, J BIOL CHEM, V274, P22008, DOI 10.1074/jbc.274.31.22008; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; Walker JM, 2004, J BIOL CHEM, V279, P15376, DOI 10.1074/jbc.M400053200; Wormington M, 2003, MOL CELL, V12, P536, DOI 10.1016/S1097-2765(03)00362-9; Yamaguchi Y, 1996, P NATL ACAD SCI USA, V93, P14030, DOI 10.1073/pnas.93.24.14030; YUAN DS, 1995, P NATL ACAD SCI USA, V92, P2632, DOI 10.1073/pnas.92.7.2632; Zhang J, 1997, EMBO J, V16, P826, DOI 10.1093/emboj/16.4.826; ZOPPI S, 1993, J CLIN INVEST, V91, P1105, DOI 10.1172/JCI116269	55	51	52	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2006	79	2					214	229		10.1086/505407	http://dx.doi.org/10.1086/505407			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	063SR	16826513	Green Published, Bronze			2022-12-18	WOS:000239040400004
J	Kuokkanen, M; Kokkonen, J; Enattah, NS; Ylisaukko-Oja, T; Komu, H; Varilo, T; Peltonen, L; Savilahti, E; Jarvela, I				Kuokkanen, M; Kokkonen, J; Enattah, NS; Ylisaukko-Oja, T; Komu, H; Varilo, T; Peltonen, L; Savilahti, E; Jarvela, I			Mutations in the translated region of the lactase gene (LCT) underlie congenital lactase deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ADULT-TYPE HYPOLACTASIA; FINNISH-DISEASE HERITAGE; PHLORHIZIN HYDROLASE GENE; MESSENGER-RNA DECAY; LACTOSE-MALABSORPTION; PHLORIZIN HYDROLASE; CLEAVAGE SITES; PERSISTENCE; ENZYME; IDENTIFICATION	Congenital lactase deficiency ( CLD) is a severe gastrointestinal disorder characterized by watery diarrhea in infants fed with breast milk or other lactose-containing formulas. We initially assigned the CLD locus by linkage and linkage disequilibrium on 2q21 in 19 Finnish families. Here we report the molecular background of CLD via characterization of five distinct mutations in the coding region of the lactase ( LCT) gene. Twenty-seven patients out of 32 ( 84%) were homozygous for a nonsense mutation, c.4170TrA ( Y1390X), designated "Fin(major)." Four rare mutations-two that result in a predicted frameshift and early truncation at S1666fsX1722 and S218fsX224 and two point mutations that result in substitutions Q268H and G1363S of the 1,927-aa polypeptide-confirmed the lactase mutations as causative for CLD. These findings facilitate genetic testing in clinical practice and enable genetic counseling for this severe disease. Further, our data demonstrate that, in contrast to common adult-type hypolactasia ( lactose intolerance) caused by a variant of the regulatory element, the severe infancy form represents the outcome of mutations affecting the structure of the protein inactivating the enzyme.	Univ Helsinki, Cent Hosp, Mol Genet Lab, Lab Serv HUSLAB, FIN-00290 Helsinki, Finland; Univ Helsinki, Dept Mol Med, Natl Publ Hlth Inst, Helsinki, Finland; Univ Helsinki, Dept Med Genet, Helsinki, Finland; Univ Helsinki, Hosp Childrens & Adolescents, Helsinki, Finland; Oulu Univ Hosp, Dept Paediat, Oulu, Finland; MIT, Broad Inst, Boston, MA USA; Harvard Univ, Boston, MA 02115 USA	University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; University of Helsinki; University of Oulu; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Jarvela, I (corresponding author), Univ Helsinki, Cent Hosp, Mol Genet Lab, Lab Serv HUSLAB, Haartmaninkatu 2,POB 140, FIN-00290 Helsinki, Finland.	irma.jarvela@hus.fi	Jarvela, Irma E/L-5836-2013; Kuokkanen, Mikko/M-8247-2016; Alshali, Rasha A/K-8051-2012	Jarvela, Irma E/0000-0002-1770-6187; Kuokkanen, Mikko/0000-0003-4375-9327; Varilo, Teppo/0000-0002-5839-8854				Arribas JCD, 2000, EUR J BIOCHEM, V267, P6996, DOI 10.1046/j.1432-1327.2000.01784.x; BASERGA SJ, 1988, P NATL ACAD SCI USA, V85, P2056, DOI 10.1073/pnas.85.7.2056; BOLL W, 1991, AM J HUM GENET, V48, P889; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; FREIBURGHAUS AU, 1976, NEW ENGL J MED, V294, P1030, DOI 10.1056/NEJM197605062941903; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; HOLZEL A, 1967, ARCH DIS CHILD, V42, P341, DOI 10.1136/adc.42.224.341; Inoue K, 2004, NAT GENET, V36, P361, DOI 10.1038/ng1322; Jacob R, 1996, EUR J BIOCHEM, V236, P789, DOI 10.1111/j.1432-1033.1996.t01-1-00789.x; Jacob R, 2002, J BIOL CHEM, V277, P8217, DOI 10.1074/jbc.M111500200; Jarvela I, 1998, AM J HUM GENET, V63, P1078, DOI 10.1086/302064; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kuokkanen M, 2003, GUT, V52, P647, DOI 10.1136/gut.52.5.647; LAUNIALA K, 1966, ACTA PAEDIATR SCAND, V55, P257, DOI 10.1111/j.1651-2227.1966.tb17652.x; MANTEI N, 1988, EMBO J, V7, P2705, DOI 10.1002/j.1460-2075.1988.tb03124.x; Maquat LE, 2005, J CELL SCI, V118, P1773, DOI 10.1242/jcs.01701; NAIM HY, 1994, J BIOL CHEM, V269, P26933; Naim HY, 2001, HISTOL HISTOPATHOL, V16, P553, DOI 10.14670/HH-16.553; Norio R, 2003, HUM GENET, V112, P441, DOI 10.1007/s00439-002-0875-3; Norio R, 2003, HUM GENET, V112, P457, DOI 10.1007/s00439-002-0876-2; Olds LC, 2003, HUM MOL GENET, V12, P2333, DOI 10.1093/hmg/ddg244; Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913; POGGI V, 1991, AM J HUM GENET, V49, P105; Rasinpera H, 2005, GUT, V54, P1660, DOI 10.1136/gut.2005.077404; Rasinpera H, 2004, GUT, V53, P1571, DOI 10.1136/gut.2004.040048; SAHI T, 1994, SCAND J GASTROENTE S, V202, P1; SAVILAHTI E, 1983, ARCH DIS CHILD, V58, P246, DOI 10.1136/adc.58.4.246; Smith RF, 1996, GENOME RES, V6, P454, DOI 10.1101/gr.6.5.454; Troelsen JT, 2003, GASTROENTEROLOGY, V125, P1686, DOI 10.1053/j.gastro.2003.09.031; VANDENPLAS S, 1984, J MED GENET, V21, P164, DOI 10.1136/jmg.21.3.164; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; Wuthrich M, 1996, ARCH BIOCHEM BIOPHYS, V336, P27, DOI 10.1006/abbi.1996.0528; Ylisaukko-oja T, 2004, MOL PSYCHIATR, V9, P161, DOI 10.1038/sj.mp.4001385; Zecca L, 1998, FEBS LETT, V435, P225, DOI 10.1016/S0014-5793(98)01076-X	34	51	56	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2006	78	2					339	344		10.1086/500053	http://dx.doi.org/10.1086/500053			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	031ZY	16400612	Green Published, Bronze			2022-12-18	WOS:000236744900014
J	Kok, C; Kennerson, ML; Spring, PJ; Ing, AJ; Pollard, JD; Nicholson, GA				Kok, C; Kennerson, ML; Spring, PJ; Ing, AJ; Pollard, JD; Nicholson, GA			A locus for hereditary sensory neuropathy with cough and gastroesophageal reflux on chromosome 3p22-p24	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MARIE-TOOTH-DISEASE; CHRONIC PERSISTENT COUGH; AXONAL NEUROPATHY; TOPOISOMERASE-II; GENE; DNA; LINKAGE; TYPE-2; HETEROGENEITY; LOCALIZATION	Hereditary sensory neuropathy type I (HSN I) is a group of dominantly inherited degenerative disorders of peripheral nerve in which sensory features are more prominent than motor involvement. We have described a new form of HSN I that is associated with cough and gastroesophageal reflux. To map the chromosomal location of the gene causing the disorder, a 10-cM genome screen was undertaken in a large Australian family. Two-point analysis showed linkage to chromosome 3p22-p24 (Z(max) = 3.51 at recombination fraction (theta) 0.0 for marker D3S2338). A second family with a similar phenotype shares a different disease haplotype but segregates at the same locus. Extended haplotype analysis has refined the region to a 3.42-cM interval, flanked by markers D3S2336 and D3S1266.	Univ Sydney, Neurobiol Lab, ANZAC Res Inst, Sydney, NSW 2139, Australia; Concord Hosp, Dept Mol Med, Sydney, NSW, Australia; Concord Hosp, Dept Resp Med, Sydney, NSW, Australia; Royal Prince Alfred Hosp, Inst Clin Neurosci, Sydney, NSW, Australia; Univ Sydney, Sydney, NSW 2006, Australia	University of Sydney; ANZAC Research Institute; Concord Repatriation General Hospital; Concord Repatriation General Hospital; University of Sydney; University of Sydney	Kok, C (corresponding author), Univ Sydney, Neurobiol Lab, ANZAC Res Inst, Hosp Rd, Sydney, NSW 2139, Australia.		Kennerson, Marina L/B-5058-2014; Research Institute, ANZAC/CAE-9030-2022; Ekanayake, Kanchana/P-8817-2016	Nicholson, Garth/0000-0001-9694-066X; Ing, Alvin/0000-0002-6391-020X; Kennerson, Marina/0000-0003-3332-5074				Bejaoui K, 2001, NAT GENET, V27, P261, DOI 10.1038/85817; BENOTHMANE K, 1993, GENOMICS, V17, P370; BIRD TD, 1983, ANN NEUROL, V14, P679, DOI 10.1002/ana.410140612; CRABB DW, 1985, ANN INTERN MED, V103, P52, DOI 10.7326/0003-4819-103-1-52; DAVIES SM, 1989, NUCLEIC ACIDS RES, V17, P1337, DOI 10.1093/nar/17.4.1337; Dawkins JL, 2001, NAT GENET, V27, P309, DOI 10.1038/85879; Hicks EP, 1922, LANCET, V1, P319; Hu FZ, 2000, JAMA-J AM MED ASSOC, V284, P325, DOI 10.1001/jama.284.3.325; ING AJ, 1994, AM J RESP CRIT CARE, V149, P160, DOI 10.1164/ajrccm.149.1.8111576; Ionasescu V, 1996, HUM MOL GENET, V5, P1373, DOI 10.1093/hmg/5.9.1373; IRWIN RS, 1993, CHEST, V104, P1511, DOI 10.1378/chest.104.5.1511; IRWIN RS, 1990, AM REV RESPIR DIS, V141, P640, DOI 10.1164/ajrccm/141.3.640; IRWIN RS, 1989, AM REV RESPIR DIS, V140, P1294, DOI 10.1164/ajrccm/140.5.1294; Ismailov SM, 2001, EUR J HUM GENET, V9, P646, DOI 10.1038/sj.ejhg.5200686; JENKINS JR, 1992, NUCLEIC ACIDS RES, V20, P5587, DOI 10.1093/nar/20.21.5587; JONES R, 1989, BRIT MED J, V298, P30, DOI 10.1136/bmj.298.6665.30; KWON JM, 1995, AM J HUM GENET, V57, P853; Lang AJ, 1998, GENE, V221, P255, DOI 10.1016/S0378-1119(98)00468-5; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Mersiyanova IV, 2000, AM J HUM GENET, V67, P37, DOI 10.1086/302962; NEBEL OT, 1976, AM J DIG DIS, V21, P953, DOI 10.1007/BF01071906; Nicholson GA, 1996, NAT GENET, V13, P101, DOI 10.1038/ng0596-101; POE RH, 1989, CHEST, V95, P723, DOI 10.1378/chest.95.4.723; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; Pushkin A, 1999, GENOMICS, V57, P321, DOI 10.1006/geno.1999.5781; Seri M, 1999, AM J HUM GENET, V64, P586, DOI 10.1086/302241; Spring PJ, 2002, J NEUROL SCI, V199, pS64; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; THOMAS PK, 1993, J NEUROL NEUROSUR PS, V56, P107, DOI 10.1136/jnnp.56.1.107; VALENTIJN LJ, 1992, NAT GENET, V1, P166, DOI 10.1038/ng0692-166; Vance JM, 1996, AM J HUM GENET, V59, P258; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Yang SW, 1996, P NATL ACAD SCI USA, V93, P11534, DOI 10.1073/pnas.93.21.11534	33	51	53	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2003	73	3					632	637		10.1086/377591	http://dx.doi.org/10.1086/377591			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	718FG	12870133	Green Published, Bronze			2022-12-18	WOS:000185134000015
J	Wang, LL; Worley, K; Gannavarapu, A; Chintagumpala, MM; Levy, ML; Plon, SE				Wang, LL; Worley, K; Gannavarapu, A; Chintagumpala, MM; Levy, ML; Plon, SE			Intron-size constraint as a mutational mechanism in Rothmund-Thomson syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MESSENGER-RNA; GENE; SEQUENCE; DELETION; RECQL4	Rothmund-Thomson syndrome (RTS) is an autosomal recessive disorder caused by deleterious mutations in the RECQL4 gene on chromosome 8. The RECQL4 gene structure is unusual because it contains many small introns <100 bp. We describe a proband with RTS who has a novel 11-bp intronic deletion, and we show that this mutation results in a 66-bp intron too small for proper splicing. Constraint on intron size may represent a general mutational mechanism, since human-genome analysis reveals that similar to 15% of genes have introns <100 bp and are therefore susceptible to size constraint. Thus, monitoring of intron size may allow detection of mutations missed by exon-by-exon approaches.	Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Dermatol, Houston, TX 77030 USA; Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Plon, SE (corresponding author), 6621 Fannin St,MC 3-3320, Houston, TX 77030 USA.	splon@bcm.tmc.edu		Worley, Kim/0000-0002-0282-1000	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Kitao S, 1999, GENOMICS, V61, P268, DOI 10.1006/geno.1999.5959; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li M, 2000, J BIOL CHEM, V275, P18079, DOI 10.1074/jbc.M910197199; Lindor NM, 2000, AM J MED GENET, V90, P223, DOI 10.1002/(SICI)1096-8628(20000131)90:3<223::AID-AJMG7>3.0.CO;2-Z; McCarthy EMS, 1998, HUM MOL GENET, V7, P1491, DOI 10.1093/hmg/7.9.1491; PERAL B, 1995, HUM MOL GENET, V4, P569, DOI 10.1093/hmg/4.4.569; VANSANTEN VL, 1985, P NATL ACAD SCI USA, V82, P2885; VENNOS EM, 1992, J AM ACAD DERMATOL, V27, P750, DOI 10.1016/0190-9622(92)70249-F; Wang LL, 2001, AM J MED GENET, V102, P11, DOI 10.1002/1096-8628(20010722)102:1<11::AID-AJMG1413>3.0.CO;2-A; Wang WD, 2000, MAR BIOTECHNOL, V2, P376; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844	13	51	51	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2002	71	1					165	167		10.1086/341234	http://dx.doi.org/10.1086/341234			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	564GY	12016592	Bronze, Green Published			2022-12-18	WOS:000176307700017
J	Sullivan, AK; Crawford, DC; Scott, EH; Leslie, ML; Sherman, SL				Sullivan, AK; Crawford, DC; Scott, EH; Leslie, ML; Sherman, SL			Paternally transmitted FMR1 alleles are less stable than maternally transmitted alleles in the common and intermediate size range	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGILE-X-SYNDROME; EDUCATION-NEEDS POPULATION; CGG REPEAT; HUNTINGTONS-DISEASE; TRINUCLEOTIDE REPEAT; FRAXE ALLELES; CAG REPEAT; INSTABILITY; MUTATION; HAPLOTYPE	Fragile X syndrome, a form of X-linked mental retardation, results from the hyperexpansion of a CGG trinucleotide repeat located in the 5' untranslated region of the fragile X mental retardation (FMR1) gene. Relatively little is known about the initial mutation that causes a stable allele to become unstable and, eventually, to expand to the full mutation. In the present study, we have examined 1,452 parent-child transmissions of alleles of common (less than or equal to39 repeats) or intermediate (40-59 repeats) sizes to study the initial mutation events. Of these, 201 have been sequenced and haplotyped. Using logistic regression analysis, we found that parental origin of transmission, repeat size (for unsequenced alleles), and number of the 3' CGGs (for sequenced alleles) were significant risk factors for repeat instability. Interestingly, transmission of the repeat through males was less stable than that through females, at the common- and intermediate-size level. This pattern differs from that seen for premutation-size alleles: paternally transmitted alleles are far more stable than maternally transmitted alleles. This difference that depends on repeat size suggests either a different mutational mechanism of instability or an increase in selection against sperm as their repeat size increases.	Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA	Emory University	Sherman, SL (corresponding author), Emory Univ, Sch Med, Dept Human Genet, 615 Michael St, Atlanta, GA 30322 USA.		Crawford, Dana/O-5578-2019; Crawford, Dana/C-1054-2012	Crawford, Dana/0000-0002-6437-6248; 	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029909, P01HD035576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008490] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD029909, HD 29909, P01 HD035576, HD 35576] Funding Source: Medline; NIGMS NIH HHS [T32 GM008490] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ashley CT, 1995, ANNU REV GENET, V29, P703, DOI 10.1146/annurev.ge.29.120195.003415; Ashley-Koch AE, 1998, AM J HUM GENET, V63, P776, DOI 10.1086/302018; BROWN WT, 1993, JAMA-J AM MED ASSOC, V270, P1569, DOI 10.1001/jama.270.13.1569; Burman RW, 2000, GENET MED, V2, P242, DOI 10.1097/00125817-200007000-00007; CHAKRAVARTI A, 1992, NAT GENET, V1, P237, DOI 10.1038/ng0792-237; Crawford DC, 1999, AM J HUM GENET, V64, P495, DOI 10.1086/302260; Crawford DC, 2000, HUM MOL GENET, V9, P1759, DOI 10.1093/hmg/9.12.1759; Crawford DC, 2000, HUM MOL GENET, V9, P2909, DOI 10.1093/hmg/9.19.2909; DEROOIJ KE, 1993, J MED GENET, V30, P996, DOI 10.1136/jmg.30.12.996; Dombrowski C, 2002, HUM MOL GENET, V11, P371, DOI 10.1093/hmg/11.4.371; Eichler EE, 1996, HUM MOL GENET, V5, P319, DOI 10.1093/hmg/5.3.319; EICHLER EE, 1994, NAT GENET, V8, P88, DOI 10.1038/ng0994-88; FalikZaccai TC, 1997, AM J HUM GENET, V60, P103; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Gunter C, 1998, HUM MOL GENET, V7, P1935, DOI 10.1093/hmg/7.12.1935; Gusella JF, 1996, ANNU REV MED, V47, P201; HIRST MC, 1994, HUM MOL GENET, V3, P1553, DOI 10.1093/hmg/3.9.1553; KREMER B, 1995, AM J HUM GENET, V57, P343; Kunst CB, 1997, J MED GENET, V34, P627, DOI 10.1136/jmg.34.8.627; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; Leeflang EP, 1999, HUM MOL GENET, V8, P173, DOI 10.1093/hmg/8.2.173; MACPHERSON JN, 1994, HUM MOL GENET, V3, P399, DOI 10.1093/hmg/3.3.399; Meadows KL, 1996, AM J MED GENET, V64, P428, DOI 10.1002/(SICI)1096-8628(19960809)64:2<428::AID-AJMG39>3.3.CO;2-7; Mornet E, 1996, HUM MOL GENET, V5, P821, DOI 10.1093/hmg/5.6.821; MORTON NE, 1992, P NATL ACAD SCI USA, V89, P4215, DOI 10.1073/pnas.89.9.4215; Murray A, 1997, HUM MOL GENET, V6, P173, DOI 10.1093/hmg/6.2.173; Murray A, 1996, HUM MOL GENET, V5, P727, DOI 10.1093/hmg/5.6.727; Nolin SL, 1999, AM J HUM GENET, V65, P680, DOI 10.1086/302543; Nolin SL, 1996, AM J HUM GENET, V59, P1252; NORREMOLLE A, 1995, CLIN GENET, V47, P113; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; SNOW K, 1994, HUM MOL GENET, V3, P1543, DOI 10.1093/hmg/3.9.1543; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; SUTHERLAND GR, 1995, P NATL ACAD SCI USA, V92, P3636, DOI 10.1073/pnas.92.9.3636; TROTTIER Y, 1994, J MED GENET, V31, P377, DOI 10.1136/jmg.31.5.377; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Wells R.D., 1998, GENETIC INSTABILITIE; Youings SA, 2000, J MED GENET, V37, P415, DOI 10.1136/jmg.37.6.415; ZHONG N, 1995, AM J HUM GENET, V57, P351	42	51	52	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2002	70	6					1532	1544		10.1086/340846	http://dx.doi.org/10.1086/340846			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549LP	11992259	Green Published, Bronze			2022-12-18	WOS:000175445700014
J	Niimi, T; Munakata, M; Keck-Waggoner, CL; Popescu, NC; Levitt, RC; Hisada, M; Kimura, S				Niimi, T; Munakata, M; Keck-Waggoner, CL; Popescu, NC; Levitt, RC; Hisada, M; Kimura, S			A polymorphism in the human UGRP1 gene promoter that regulates transcription is associated with an increased risk of asthma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUSCEPTIBILITY GENES; LUNG INFLAMMATION; PROTEIN CC16; SERUM IGE; CELL	Several traits associated with asthma phenotypes, such as high total serum immunoglobulin E and bronchial hyperresponsiveness, have been linked by numerous genome-screen studies and linkage analyses to markers on human chromosome 5q31-q34. In the present article, we describe UGRP1 (encoding uteroglobin-related protein 1) as one of asthma-susceptibility genes that is located on chromosome 5q31-q32. UGRP1 is a homodimeric secretory protein of 17 kDa and is expressed only in lung and trachea. The G-->A polymorphism was identified at -112 bp in the human UGRP1 gene promoter. The -112A allele is responsible for a 24% reduction in the promoter activity in relation to the -112G allele, as examined by transfection analysis. Electrophoretic mobility-shift analysis revealed that an unknown nuclear factor binds to the region around 5 112 bp. The binding affinity with the -112A oligonucleotide was reduced by approximately one half, as compared with the -112G oligonucleotide. In a case-control study using 169 Japanese individuals (84 patients with asthma and 85 healthy control individuals), those with a -112A allele (G/A or A/A) were 4.1 times more likely to have asthma than were those with the wild-type allele (G/G).	NCI, Met Lab, NIH, Bethesda, MD 20892 USA; NCI, Expt Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA; Fukushima Med Univ, Dept Pulm Med, Fukushima, Japan; Genaera Corp, Plymouth Meeting, PA USA; NCI, Div Canc Epidemiol & Genet, NIH, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fukushima Medical University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kimura, S (corresponding author), NCI, Met Lab, NIH, Bldg 37,Room 3E-24, Bethesda, MD 20892 USA.	shioko@helix.nih.gov						Arsalane K, 2000, AM J RESP CRIT CARE, V161, P1624, DOI 10.1164/ajrccm.161.5.9812157; Bleecker ER, 1998, CLIN EXP ALLERGY, V28, P6; Breslow N.E., 1980, STAT METHODS CANC RE, P192; Broeckaert F, 2000, CLIN EXP ALLERGY, V30, P469; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; Cookson WOC, 2000, HUM MOL GENET, V9, P2359, DOI 10.1093/hmg/9.16.2359; DeBry RW, 1996, GENOMICS, V33, P337, DOI 10.1006/geno.1996.0209; Harrod KS, 1998, AM J PHYSIOL-LUNG C, V275, pL924, DOI 10.1152/ajplung.1998.275.5.L924; Hayashida S, 2000, AM J PHYSIOL-LUNG C, V279, pL452, DOI 10.1152/ajplung.2000.279.3.L452; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Laing IA, 1998, J MED GENET, V35, P463, DOI 10.1136/jmg.35.6.463; Laing IA, 2000, AM J RESP CRIT CARE, V161, P124, DOI 10.1164/ajrccm.161.1.9904073; Lensmar C, 2000, CELL MOL LIFE SCI, V57, P976, DOI 10.1007/PL00000738; Marsh DG, 1997, NAT GENET, V15, P389; MCFADDEN ER, 1992, NEW ENGL J MED, V327, P1928, DOI 10.1056/NEJM199212313272708; Mukerjhee A., 2000, ANN NY ACAD SCI, V932, P1; Niimi T, 2001, MOL ENDOCRINOL, V15, P2021, DOI 10.1210/me.15.11.2021; Ober C, 2000, CLIN CHEST MED, V21, P245, DOI 10.1016/S0272-5231(05)70264-1; POSTMA DS, 1995, NEW ENGL J MED, V333, P894, DOI 10.1056/NEJM199510053331402; Ruffilli A, 1997, ALLERGY, V52, P256, DOI 10.1111/j.1398-9995.1997.tb00990.x; RYDEN TA, 1989, MOL CELL BIOL, V9, P1155, DOI 10.1128/MCB.9.3.1155; SEARLE AG, 1989, ANN HUM GENET, V53, P89, DOI 10.1111/j.1469-1809.1989.tb01777.x; SEARS MR, 1991, NEW ENGL J MED, V325, P1067, DOI 10.1056/NEJM199110103251504; Shijubo N, 1999, AM J RESP CRIT CARE, V160, P930, DOI 10.1164/ajrccm.160.3.9803113; ZIMONJIC DB, 1995, CANCER GENET CYTOGEN, V80, P100, DOI 10.1016/0165-4608(94)00161-4	25	51	61	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2002	70	3					718	725		10.1086/339272	http://dx.doi.org/10.1086/339272			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	522DG	11813133	Green Published, Bronze			2022-12-18	WOS:000173880000014
J	Edelmann, L; Wasserstein, MP; Kornreich, R; Sansaricq, C; Snyderman, SE; Diaz, GA				Edelmann, L; Wasserstein, MP; Kornreich, R; Sansaricq, C; Snyderman, SE; Diaz, GA			Maple syrup urine disease: Identification and carrier-frequency determination of a novel founder mutation in the Ashkenazi Jewish population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACID DEHYDROGENASE COMPLEX; FANCONI-ANEMIA; CEREBRAL EDEMA; BOVINE KIDNEY; PURIFICATION; CHILDREN; DBT	Maple syrup urine disease (MSUD) is a rare, autosomal recessive disorder of branched-chain amino acid metabolism. We noted that a large proportion (10 of 34) of families with MSUD that were followed in our clinic were of Ashkenazi Jewish (AJ) descent, leading us to search for a common mutation within this group. On the basis of genotyping data suggestive of a conserved haplotype at tightly linked markers on chromosome 6q14, the BCKDHB gene encoding the E1 beta subunit was sequenced. Three novel mutations were identified in seven unrelated AJ patients with MSUD. The locations of the affected residues in the crystal structure of the E1 beta subunit suggested possible mechanisms for the deleterious effects of these mutations. Large-scale population screening of AJ individuals for R183P, the mutation present in six of seven patients, revealed that the carrier frequency of the mutant allele was similar to1/113; the patient not carrying R183P had a previously described homozygous mutation in the gene encoding the E2 subunit. These findings suggested that a limited number of mutations might underlie MSUD in the AJ population, potentially facilitating prenatal diagnosis and carrier detection of MSUD in this group.	Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Diaz, GA (corresponding author), Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA.		Diaz, George/AAF-6199-2021		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD028822] Funding Source: NIH RePORTER; NICHD NIH HHS [5 P30 HD 28822] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AEvarsson A, 2000, STRUCTURE, V8, P277, DOI 10.1016/S0969-2126(00)00105-2; Auerbach AD, 1997, GENET TEST, V1, P27, DOI 10.1089/gte.1997.1.27; Bargal R, 2001, HUM MUTAT, V17, P397, DOI 10.1002/humu.1115; CHUANG DT, 2000, METABOLIC MOL BASES, P1971; DAMUNI Z, 1984, P NATL ACAD SCI-BIOL, V81, P4335, DOI 10.1073/pnas.81.14.4335; Danner Dean J., 1998, Frontiers in Bioscience, V3, pD517; FISHER CW, 1993, AM J HUM GENET, V52, P414; Fodor FH, 1998, AM J HUM GENET, V63, P45, DOI 10.1086/301903; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; KAPLAN P, 1991, J PEDIATR-US, V119, P46, DOI 10.1016/S0022-3476(05)81037-6; LEVIN ML, 1993, J PEDIATR-US, V122, P167, DOI 10.1016/S0022-3476(05)83521-8; Li L, 1998, MOL GENET METAB, V64, P286, DOI 10.1006/mgme.1998.2733; MARSHALL L, 1981, AM J HUM GENET, V33, pA139; MENKES JH, 1954, PEDIATRICS, V14, P462; NAYLOR EW, 1980, NEONATAL SCREENING I, P19, DOI 10.1007/978-3-642-67488-4_3; Nellis MM, 2001, AM J HUM GENET, V68, P232, DOI 10.1086/316950; PEINEMANN F, 1993, BIOCHEM MED METAB B, V50, P338, DOI 10.1006/bmmb.1993.1074; PETTIT FH, 1978, P NATL ACAD SCI USA, V75, P4881, DOI 10.1073/pnas.75.10.4881; REED LJ, 1985, CURR TOP CELL REGUL, V27, P41; RIVIELLO JJ, 1991, J PEDIATR-US, V119, P42, DOI 10.1016/S0022-3476(05)81036-4; Schuchman EH, 1997, GENET TEST, V1, P13, DOI 10.1089/gte.1997.1.13; SNYDERMAN SE, 1964, PEDIATRICS, V34, P454; VERLANDER PC, 1995, BLOOD, V86, P4034, DOI 10.1182/blood.V86.11.4034.bloodjournal86114034; WYNN RM, 2001, IN PRESS J BIOL CHEM; ZNEIMER SM, 1991, GENOMICS, V10, P740, DOI 10.1016/0888-7543(91)90458-Q	25	51	52	0	18	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2001	69	4					863	868		10.1086/323677	http://dx.doi.org/10.1086/323677			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	472WP	11509994	Green Published, Bronze			2022-12-18	WOS:000171008200018
J	Falush, D; Almqvist, EW; Brinkmann, RR; Iwasa, Y; Hayden, MR				Falush, D; Almqvist, EW; Brinkmann, RR; Iwasa, Y; Hayden, MR			Measurement of mutational flow implies both a high new-mutation rate for Huntington disease and substantial underascertainment of late-onset cases	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTERMEDIATE ALLELES; CAG REPEATS; SIZE; EPIDEMIOLOGY; INSTABILITY; ORIGIN; GENE; SEX	We describe a new approach for analysis of the epidemiology of progressive genetic disorders that quantifies the rate of progression of the disease in the population by measuring the mutational flow. The framework is applied to Huntington disease (HD), a dominant neurological disorder caused by the expansion of a CAG-trinucleotide sequence to >35 repeats. The disease is 100% penetrant in individuals with greater than or equal to 42 repeats. Measurement of the flow from disease alleles provides a minimum estimate of the flow in the whole population and implies that the new mutation rate for HD in each generation is greater than or equal to 10% of currently known cases (95% confidence limits 6%-14%). Analysis of the pattern of flow demonstrates systematic underascertainment for repeat lengths <44. Ascertainment falls to <50% for individuals with 40 repeats and to <5% for individuals with 36-38 repeats. Clinicians should not assume that HD is rare outside known pedigrees or that most cases have onset at age <50 years.	Kyushu Univ, Fac Sci, Dept Biol, Kyushu, Japan; Univ British Columbia, Womens & Childrens Hosp, Dept Med Genet, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 1M9, Canada	Kyushu University; University of British Columbia	Falush, D (corresponding author), Max Planck Inst Infekt Biol, Schumannstr 21-22, D-10117 Berlin, Germany.	daniel@bio-math10.biology.kyushu-u.ac.jp	Hayden, Michael R/D-8581-2011; Iwasa, Yoh/G-5368-2010	Hayden, Michael R/0000-0001-5159-1419; Iwasa, Yoh/0000-0003-0691-1852				Andrew SE, 1997, HUM MOL GENET, V6, P2005, DOI 10.1093/hmg/6.12.2005; Brinkman RR, 1997, AM J HUM GENET, V60, P1202; Chong SS, 1997, HUM MOL GENET, V6, P301, DOI 10.1093/hmg/6.2.301; CONNEALLY PM, 1984, AM J HUM GENET, V36, P506; DEROOIJ KE, 1993, J MED GENET, V30, P996, DOI 10.1136/jmg.30.12.996; Falush D, 1999, MOL BIOL EVOL, V16, P960, DOI 10.1093/oxfordjournals.molbev.a026185; GOLDBERG YP, 1993, NAT GENET, V5, P174, DOI 10.1038/ng1093-174; GOLDBERG YP, 1995, HUM MOL GENET, V4, P1911, DOI 10.1093/hmg/4.10.1911; GRIMM T, 1994, J MED GENET, V31, P183, DOI 10.1136/jmg.31.3.183; HARPER PS, 1979, LANCET, V2, P346; HARPER PS, 1992, HUM GENET, V89, P365; Huttley GA, 2000, MOL BIOL EVOL, V17, P929, DOI 10.1093/oxfordjournals.molbev.a026373; JAMES CM, 1994, AGE AGEING, V23, P445, DOI 10.1093/ageing/23.6.445; Jones AG, 1999, GENETICS, V152, P1057; KIMURA M, 1978, P NATL ACAD SCI USA, V75, P2868, DOI 10.1073/pnas.75.6.2868; KREMER B, 1995, AM J HUM GENET, V57, P343; KREMER B, 1994, NEW ENGL J MED, V330, P1401, DOI 10.1056/NEJM199405193302001; Lawrence AD, 1998, BRAIN, V121, P1329, DOI 10.1093/brain/121.7.1329; Leeflang EP, 1999, HUM MOL GENET, V8, P173, DOI 10.1093/hmg/8.2.173; LEEFLANG EP, 1995, HUM MOL GENET, V4, P1519; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; McNeil SM, 1997, HUM MOL GENET, V6, P775, DOI 10.1093/hmg/6.5.775; RUBINSZTEIN DC, 1994, NAT GENET, V7, P525, DOI 10.1038/ng0894-525; Rubinsztein DC, 1996, AM J HUM GENET, V59, P16; SHAW M, 1982, J MED GENET, V19, P161, DOI 10.1136/jmg.19.3.161; Smith MA, 2000, NATURE, V403, P544, DOI 10.1038/35000576; Vogel F., 1986, HUMAN GENETICS PROBL; VOGEL F, 1975, ADV HUM GENET, V5, P233	28	51	51	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2001	68	2					373	385		10.1086/318193	http://dx.doi.org/10.1086/318193			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	394LD	11225602	Green Published, Bronze			2022-12-18	WOS:000166524800008
J	Gallardo, ME; Desviat, LR; Rodriguez, JM; Esparza-Gordillo, J; Perez-Cerda, C; Perez, B; Rodriguez-Pombo, P; Criado, O; Sanz, R; Morton, DH; Gibson, KM; Le, TP; Ribes, A; de Cordoba, SR; Ugarte, M; Penalva, MA				Gallardo, ME; Desviat, LR; Rodriguez, JM; Esparza-Gordillo, J; Perez-Cerda, C; Perez, B; Rodriguez-Pombo, P; Criado, O; Sanz, R; Morton, DH; Gibson, KM; Le, TP; Ribes, A; de Cordoba, SR; Ugarte, M; Penalva, MA			The molecular basis of 3-methylcrotonylglycinuria, a disorder of leucine catabolism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROPIONYL-COA CARBOXYLASE; RADIATION HYBRID MAP; BIOTIN CARBOXYLASE; HUMAN GENOME; PCCB GENES; IDENTIFICATION; DEFICIENCY; ALKAPTONURIA; METABOLISM; SUBUNIT	3-Methylcrotonylglycinuria is an inborn error of leucine catabolism and has a recessive pattern of inheritance that results from the deficiency of 3-methylcrotonyl-CoA carboxylase (MCC). The introduction of tandem mass spectrometry in newborn screening has revealed an unexpectedly high incidence of this disorder, which, in certain areas, appears to be the most frequent organic aciduria. MCC, an heteromeric enzyme consisting of alpha (biotin-containing) and beta subunits, is the only one of the four biotin-dependent carboxylases known in humans that has genes that have not yet been characterized, precluding molecular studies of this disease. Here we report the characterization, at the genomic level and at the cDNA level, of both the MCCA gene and the MCCB gene, encoding the MCC alpha and MCC beta subunits, respectively. The 19-exon MCCA gene maps to 3q25-27 and encodes a 725-residue protein with a biotin attachment site; the 17-exon MCCB gene maps to 5q12-q13 and encodes a 563-residue polypeptide. We show that disease-causing mutations can be classified into two complementation groups, denoted "CGA" and "CGB." We detected two MCCA missense mutations in CGA patients, one of which leads to absence of biotinylated MCC alpha. Two MCCB missense mutations and one splicing defect mutation leading to early MCC beta truncation were found in CGB patients. A fourth MCCB mutation also leading to early MCC beta truncation was found in two nonclassified patients. A fungal model carrying an mccA null allele has been constructed and was used to demonstrate, in vivo, the involvement of MCC in leucine catabolism. These results establish that 3-methylcrotonylglycinuria results from loss-of-function mutations in the genes encoding the alpha and beta subunits of MCC and complete the genetic characterization of the four human biotin-dependent carboxylases.	Univ Autonoma Madrid, CSIC, Ctr Biol Mol, E-28049 Madrid, Spain; Univ Autonoma Madrid, CSIC, Ctr Invest Biol, E-28049 Madrid, Spain; Univ Autonoma Madrid, CSIC, Fdn Jimenez Diaz, E-28049 Madrid, Spain; Clin Special Children, Strasburg, PA USA; Oregon Hlth Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; Corp Sanitaria Clin, Inst Biouim Clin, Barcelona, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Oregon Health & Science University; University of California System; University of California San Diego	Ugarte, M (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol, E-28049 Madrid, Spain.	mugarte@cbm.uam.es	Penalva, Miguel A/G-2295-2015; Gallardo, M. Esther/AFK-7298-2022; Rodriguez Pombo, M Pilar/G-5231-2016; de Cordoba, Santiago Rodriguez/K-6727-2014; DESVIAT, LOURDES R/L-3055-2013	Penalva, Miguel A/0000-0002-3102-2806; Gallardo, M. Esther/0000-0002-8699-8734; Rodriguez Pombo, M Pilar/0000-0001-9315-5906; de Cordoba, Santiago Rodriguez/0000-0001-6401-1874; DESVIAT, LOURDES R/0000-0003-0492-3323; Ribes Rubio, Antonia/0000-0002-2249-246X; Criado, Olga/0000-0003-1200-6365				BAUMGARTNER MR, IN PRESS J CLIN INVE; CHUANG DT, 1995, METABOLIC MOL BASES, P1239; Cotton RGH, 2000, HUM MUTAT, V15, P16, DOI 10.1002/(SICI)1098-1004(200001)15:1<16::AID-HUMU6>3.0.CO;2-S; de Bernabe DBV, 1998, AM J HUM GENET, V62, P776, DOI 10.1086/301805; DELRIO AL, 1994, J BIOL CHEM, V269, P22964; Fernandez-Canon JM, 1998, J BIOL CHEM, V273, P329, DOI 10.1074/jbc.273.1.329; FERNANDEZCANON JM, 1995, J BIOL CHEM, V270, P21199, DOI 10.1074/jbc.270.36.21199; FERNANDEZCANON JM, 1995, P NATL ACAD SCI USA, V92, P9132, DOI 10.1073/pnas.92.20.9132; FernandezCanon JM, 1996, NAT GENET, V14, P19, DOI 10.1038/ng0996-19; Gibson KM, 2000, METHOD ENZYMOL, V324, P432; Gibson KM, 1998, J PEDIATR-US, V132, P519, DOI 10.1016/S0022-3476(98)70032-0; GOLDBERG AL, 1978, FED PROC, V37, P2301; GRAVEL RA, 1977, AM J HUM GENET, V29, P378; Gyapay G, 1996, HUM MOL GENET, V5, P339, DOI 10.1093/hmg/5.3.339; Lam Hon Wah A M, 1983, Am J Hum Genet, V35, P889; LAMHONWAH AM, 1986, P NATL ACAD SCI USA, V83, P4864, DOI 10.1073/pnas.83.13.4864; LAU EP, 1980, ARCH BIOCHEM BIOPHYS, V205, P352, DOI 10.1016/0003-9861(80)90117-4; McKean AL, 2000, J BIOL CHEM, V275, P5582, DOI 10.1074/jbc.275.8.5582; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; Naylor EW, 1999, J CHILD NEUROL, V14, pS4, DOI 10.1177/0883073899014001021; RANIERI E, 2000, J INHERIT METAB D S1, V23, P6; RANIERI E, 2000, J INHERIT METAB D S1, V23, P177; ROSCHER A, 2000, J INHERIT METAB D S1, V23, P8; Scriver CR, 1999, TRENDS GENET, V15, P267, DOI 10.1016/S0168-9525(99)01761-8; Smith WE, 2000, AM J HUM GENET, V67, P292; SONG JP, 1994, P NATL ACAD SCI USA, V91, P5779, DOI 10.1073/pnas.91.13.5779; Stewart EA, 1997, GENOME RES, V7, P422, DOI 10.1101/gr.7.5.422; Sweetman L., 1995, METABOLIC MOL BASES, V7th, P1387; Thoden JB, 2000, J BIOL CHEM, V275, P16183, DOI 10.1074/jbc.275.21.16183; Ugarte M, 1999, HUM MUTAT, V14, P275, DOI 10.1002/(SICI)1098-1004(199910)14:4<275::AID-HUMU1>3.0.CO;2-N; VANHOVE JLK, 1995, J INHERIT METAB DIS, V18, P592, DOI 10.1007/BF02436004; WAHREN J, 1976, J CLIN INVEST, V57, P987, DOI 10.1172/JCI108375; WALDROP GL, 1994, BIOCHEMISTRY-US, V33, P10249, DOI 10.1021/bi00200a004; WILCKEN B, 2000, J INHERIT METAB D S1, V23, P7; Wolf B, 1995, METABOLIC MOL BASES, P3151	35	51	55	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2001	68	2					334	346		10.1086/318202	http://dx.doi.org/10.1086/318202			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	394LD	11170888	Green Published, Bronze			2022-12-18	WOS:000166524800004
J	Howell, N; Smejkal, CB				Howell, N; Smejkal, CB			Persistent heteroplasmy of a mutation in the human mtDNA control region: Hypermutation as an apparent consequence of simple-repeat expansion/contraction	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; SUBSTITUTION RATE VARIATION; OPTIC NEUROPATHY; SEQUENCE; GENOME; TISSUE; ORIGIN; SITES; TRACT	In the genealogical and phylogenetic analyses that are reported here, we obtained evidence for an unusual pattern of mutation/reversion in the human mitochondrial genome. The cumulative results indicate that, when there is a T-->C polymorphism at nt 16189 and a C-->T substitution at nt 16192, there is an extremely high rate of reversion (hypermutation) at the latter site. The apparent reversion rate is sufficiently high that there is persistent heteroplasmy at nt 16192 in maternal lineages and at the phylogenetic level, a situation that is similar to that observed for the rapid expansion/contraction of simple repeats within the control region. This is the first specific instance in which the mutation frequency at one site in the D-loop is markedly influenced by the local sequence "context." The 16189 T-->C polymorphism lengthens a (C:G)(n) simple repeat, which then undergoes expansion and contraction, probably through replication slippage. This proclivity toward expansion/contraction is more pronounced when there is a C residue, rather than a T, at nt 16192. The high T-->C reversion frequency at nt 16192 apparently is the result of polymerase misincorporation or slippage during replication, the same mechanism that also causes the expansion/contraction of this simple-repeat sequence. In addition to the first analysis of this mitochondrial hypermutation process, these results also yield mechanistic insights into the expansion/contraction of simple-repeat sequences in mtDNA.	Univ Texas, Med Branch, Dept Radiat Oncol, Biol Div 0656, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Howell, N (corresponding author), Univ Texas, Med Branch, Dept Radiat Oncol, Biol Div 0656, Galveston, TX 77555 USA.							ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; BENDALL KE, 1995, AM J HUM GENET, V57, P248; Bendall KE, 1996, AM J HUM GENET, V59, P1276; Bidichandani SI, 1999, HUM MOL GENET, V8, P2425, DOI 10.1093/hmg/8.13.2425; Domingo E., 1988, RNA GENETICS, VIII, P3; Eigen M., 1988, RNA GENETICS, V3, P211; Excoffier L, 1999, MOL BIOL EVOL, V16, P1357, DOI 10.1093/oxfordjournals.molbev.a026046; HASEGAWA M, 1993, J MOL EVOL, V37, P347, DOI 10.1007/BF00178865; HAUSWIRTH WW, 1984, CELL, V37, P1001, DOI 10.1016/0092-8674(84)90434-3; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; Howell N, 1997, AM J HUM GENET, V61, P986; Howell N, 1998, AM J HUM GENET, V62, P196, DOI 10.1086/301675; Howell N, 1996, AM J HUM GENET, V59, P501; Howell N, 1999, INT REV CYTOL, V186, P49; HOWELL N, 1995, GENETICS, V140, P285; HOWELL N, 1994, AM J HUM GENET, V55, P203; KOCHER TD, 1991, EVOLUTION OF LIFE, P391; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; Levy DD, 1996, J MOL BIOL, V258, P251, DOI 10.1006/jmbi.1996.0247; Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3; Macaulay VA, 1997, AM J HUM GENET, V61, P983; Marchington DR, 1997, AM J HUM GENET, V60, P408; Meyer S, 1999, GENETICS, V152, P1103; Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363; TINDALL KR, 1988, BIOCHEMISTRY-US, V27, P6008, DOI 10.1021/bi00416a027; TORRONI A, 1994, AM J HUM GENET, V55, P760; WAKELEY J, 1993, J MOL EVOL, V37, P613	28	51	90	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2000	66	5					1589	1598		10.1086/302910	http://dx.doi.org/10.1086/302910			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QT	10762545	Bronze, Green Published			2022-12-18	WOS:000088373700013
J	Brockington, M; Sewry, CA; Herrmann, R; Naom, I; Dearlove, A; Rhodes, M; Topaloglu, H; Dubowitz, V; Voit, T; Muntoni, F				Brockington, M; Sewry, CA; Herrmann, R; Naom, I; Dearlove, A; Rhodes, M; Topaloglu, H; Dubowitz, V; Voit, T; Muntoni, F			Assignment of a form of congenital muscular dystrophy with secondary merosin deficiency to chromosome 1q42	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LAMININ ALPHA-2 CHAIN; BETHLEM MYOPATHY; GENE; MUTATIONS; LOCALIZATION; CONTRACTURES; EXPRESSION; SUBUNITS; LOCUS; 6Q2	We have previously reported an autosomal recessive form of congenital muscular dystrophy, characterized by proximal girdle weakness, generalized muscle hypertrophy, rigidity of the spine, and contractures of the tendo Achilles, in a consanguineous family from the United Arab Emirates. Early respiratory failure resulting from severe diaphragmatic involvement was present. Intellect and the results of brain imaging were normal. Serum creatine kinase levels were grossly elevated, and muscle-biopsy samples showed dystrophic changes. The expression of the laminin-alpha 2 chain of merosin was reduced on several fibers, but linkage analysis excluded the LAMA2 locus on chromosome 6q22-23. Here, we report the results of genomewide linkage analysis of this family, by use of homozygosity mapping. In all four affected children, an identical homozygous region was identified on chromosome 1q42, spanning 6-15 cM between flanking markers D1S2860 and D1S2800. We have identified a second German family with two affected children having similar clinical and histopathological features; they are consistent with linkage to the same locus. The cumulative LOD score was 3.57 (theta = .00) at marker D1S213. This represents a novel locus for congenital muscular dystrophy. We suggest calling this disorder "CMD1B.'' The expression of three functional candidate genes in the CMD1B critical region was investigated, and no detectable changes in their level of expression were observed. The secondary reduction in laminin-alpha 2 chain in these families suggests that the primary genetic defect resides in a gene coding for a protein involved in basal lamina assembly.	Hammersmith Hosp, Imperial Coll Sch Med, Div Paediat Obstet & Gynaecol, Neuromuscular Unit, London W12 0NN, England; Robert Jones & Agnes Hunt Orthopaed Hosp, Dept Histopathol, Oswestry SY10 7AG, Shrops, England; Univ Essen Gesamthsch, Dept Paediat, Essen, Germany; MRC, Resource Ctr, Human Genome Mapping Project, Cambridge, England; Hacettepe Childrens Hosp, Dept Paediat Neurol, Ankara, Turkey	Imperial College London; Keele University; University of Duisburg Essen; Hacettepe University	Muntoni, F (corresponding author), Hammersmith Hosp, Imperial Coll Sch Med, Div Paediat Obstet & Gynaecol, Neuromuscular Unit, Du Cane Rd, London W12 0NN, England.		TOPALOGLU, HALUK AYDIN/I-9318-2013					Allamand V, 1997, HUM MOL GENET, V6, P747, DOI 10.1093/hmg/6.5.747; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; Cohn RD, 1998, NEUROLOGY, V51, P94, DOI 10.1212/WNL.51.1.94; Corman B, 1999, AM J HUM GENET, V64, P126, DOI 10.1086/302206; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dubowitz V., 1985, MUSCLE BIOPSY PRACTI; Dubowitz V., 1995, MUSCLE DISORDERS CHI; Goebel HH, 1997, NEUROMUSCULAR DISORD, V7, P160, DOI 10.1016/S0960-8966(97)00441-0; Haltia M, 1997, ANN NEUROL, V41, P173, DOI 10.1002/ana.410410208; HAYASHI YK, 1993, J NEUROL SCI, V119, P53, DOI 10.1016/0022-510X(93)90191-Z; Hayashi YK, 1998, NAT GENET, V19, P94, DOI 10.1038/ng0598-94; HelblingLeclerc A, 1995, CR ACAD SCI III-VIE, V318, P1245; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; HERMANN R, 1996, EUR J PEDIATR, V155, P968; HILLAIRE D, 1994, HUM MOL GENET, V3, P1657, DOI 10.1093/hmg/3.9.1657; Jobsis GJ, 1996, NAT GENET, V14, P113, DOI 10.1038/ng0996-113; Jobsis GJ, 1999, BRAIN, V122, P649, DOI 10.1093/brain/122.4.649; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Manilal S, 1999, HUM MOL GENET, V8, P353, DOI 10.1093/hmg/8.2.353; Moghadaszadeh B, 1998, AM J HUM GENET, V62, P1439, DOI 10.1086/301882; Mora M, 1996, NEUROMUSCULAR DISORD, V6, P377, DOI 10.1016/0960-8966(96)00359-8; Muntoni F, 1998, Eur J Paediatr Neurol, V2, P19; Muntoni F, 1998, NEUROLOGY, V51, P14, DOI 10.1212/WNL.51.1.14; Naom I, 1998, NEUROMUSCULAR DISORD, V8, P495, DOI 10.1016/S0960-8966(98)00065-0; Naom I, 2000, BRAIN, V123, P31, DOI 10.1093/brain/123.1.31; Naom IS, 1997, J MED GENET, V34, P99, DOI 10.1136/jmg.34.2.99; Nowak KJ, 1999, NAT GENET, V23, P208, DOI 10.1038/13837; Pan TC, 1998, HUM MOL GENET, V7, P807, DOI 10.1093/hmg/7.5.807; Sewry CA, 1997, NEUROMUSCULAR DISORD, V7, P169, DOI 10.1016/S0960-8966(97)00425-2; SEWRY CA, 1995, NEUROMUSCULAR DISORD, V5, P307, DOI 10.1016/0960-8966(94)00072-H; TODA T, 1993, NAT GENET, V5, P283, DOI 10.1038/ng1193-283; TOME FMS, 1994, C R ACAD SCI 3, V317, P315	33	51	51	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					428	435		10.1086/302775	http://dx.doi.org/10.1086/302775			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677302	Green Published, Bronze			2022-12-18	WOS:000088373100009
J	Hubert, A; Peretz, T; Manor, O; Kaduri, L; Wienberg, N; Lerer, I; Sagi, M; Abeliovich, D				Hubert, A; Peretz, T; Manor, O; Kaduri, L; Wienberg, N; Lerer, I; Sagi, M; Abeliovich, D			The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							HEREDITARY BREAST-CANCER; OVARIAN-CANCER; DOMINANT INHERITANCE; SUSCEPTIBILITY LOCUS; CARRIER FREQUENCY; FAMILY HISTORY; BRCA1; RISK; MEN; INDIVIDUALS		Hadassah Univ Hosp, Dept Human Genet, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Abeliovich, D (corresponding author), Hadassah Univ Hosp, Dept Human Genet, POB 12000, IL-91120 Jerusalem, Israel.							Abeliovich D, 1997, AM J HUM GENET, V60, P505; ARASON A, 1993, AM J HUM GENET, V52, P711; Berthon P, 1998, AM J HUM GENET, V62, P1416, DOI 10.1086/301879; Blackwood MA, 1998, J CLIN ONCOL, V16, P1969, DOI 10.1200/JCO.1998.16.5.1969; Claus EB, 1996, CANCER, V77, P2318, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z; Eisinger F, 1996, CANCER RES, V56, P471; Fodor FH, 1998, AM J HUM GENET, V63, P45, DOI 10.1086/301903; FORD D, 1995, AM J HUM GENET, V57, P1457; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Gronberg H, 1997, AM J EPIDEMIOL, V146, P552, DOI 10.1093/oxfordjournals.aje.a009313; Gronberg H, 1997, JAMA-J AM MED ASSOC, V278, P1251, DOI 10.1001/jama.278.15.1251; ISAACS SD, 1995, J NATL CANCER I, V87, P991, DOI 10.1093/jnci/87.13.991; Johannesdottir G, 1996, CANCER RES, V56, P3663; Langston AA, 1996, AM J HUM GENET, V58, P881; Marcus JN, 1996, CANCER-AM CANCER SOC, V77, P697, DOI 10.1002/(SICI)1097-0142(19960215)77:4<697::AID-CNCR16>3.0.CO;2-W; McCahy PJ, 1996, BRIT J UROL, V78, P552, DOI 10.1046/j.1464-410X.1996.17111.x; Oddoux C, 1996, NAT GENET, V14, P188, DOI 10.1038/ng1096-188; Roa BB, 1996, NAT GENET, V14, P185, DOI 10.1038/ng1096-185; Robson M, 1998, J CLIN ONCOL, V16, P1642, DOI 10.1200/JCO.1998.16.5.1642; Schaid DJ, 1998, AM J HUM GENET, V62, P1425, DOI 10.1086/301862; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; SPITZ MR, 1991, J UROLOGY, V146, P1305, DOI 10.1016/S0022-5347(17)38074-6; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Thorlacius S, 1996, NAT GENET, V13, P117, DOI 10.1038/ng0596-117; WHITTEMORE AS, 1995, AM J EPIDEMIOL, V141, P732, DOI 10.1093/oxfordjournals.aje.a117495; Wilkens EP, 1999, PROSTATE, V39, P280; Xu JF, 1998, NAT GENET, V20, P175, DOI 10.1038/2477; 1994, CANC ISRAEL, P19	30	51	51	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					921	924		10.1086/302525	http://dx.doi.org/10.1086/302525			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441598	Bronze, Green Published			2022-12-18	WOS:000082426400037
J	Yoon, SJK; Kim, HS; Moon, JI; Lim, JM; Joo, CK				Yoon, SJK; Kim, HS; Moon, JI; Lim, JM; Joo, CK			Mutations of the TIGR/MYOC gene in primary open-angle glaucoma in Korea	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							TIGR GENE; OLFACTOMEDIN; LINKAGE		Catholic Univ, Coll Med, Dept Ophthalmol, Seoul 137701, South Korea; Catholic Univ, Coll Med, Res Inst, Seoul, South Korea; St Marys Hosp, Dept Ophthalmol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University Korea Hospital; Seoul St. Mary's Hospital	Yoon, SJK (corresponding author), Catholic Univ, Coll Med, Dept Ophthalmol, 505 Banpo-dong,Seochoku, Seoul 137701, South Korea.							ADAM MF, 1997, HUM MOL GENET, V6, P2061; Alward WLM, 1998, NEW ENGL J MED, V338, P1022, DOI 10.1056/NEJM199804093381503; Brezin AP, 1997, J MED GENET, V34, P546, DOI 10.1136/jmg.34.7.546; Kee C, 1997, Korean J Ophthalmol, V11, P75; Mansergh FC, 1998, HUM MUTAT, V11, P244, DOI 10.1002/(SICI)1098-1004(1998)11:3<244::AID-HUMU10>3.3.CO;2-X; Michels-Rautenstrauss KG, 1998, HUM GENET, V102, P103, DOI 10.1007/s004390050661; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; Raymond V, 1997, AM J HUM GENET, V60, P272; SHEFFIELD VC, 1993, NAT GENET, V4, P47, DOI 10.1038/ng0593-47; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Suzuki Y, 1997, AM J HUM GENET, V61, P1202, DOI 10.1086/301612; YOKOE H, 1993, P NATL ACAD SCI USA, V90, P4655, DOI 10.1073/pnas.90.10.4655	12	51	55	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1999	64	6					1775	1778		10.1086/302407	http://dx.doi.org/10.1086/302407			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	203FA	10330365	Green Published, Bronze			2022-12-18	WOS:000080696200030
J	Durner, M; Zhou, CL; Fu, DY; Abreu, P; Shinnar, S; Resor, SR; Moshe, SL; Rosenbaum, D; Cohen, J; Harden, C; Kang, H; Wallace, S; Luciano, D; Ballaban-Gil, K; Klotz, I; Dicker, E; Greenberg, DA				Durner, M; Zhou, CL; Fu, DY; Abreu, P; Shinnar, S; Resor, SR; Moshe, SL; Rosenbaum, D; Cohen, J; Harden, C; Kang, H; Wallace, S; Luciano, D; Ballaban-Gil, K; Klotz, I; Dicker, E; Greenberg, DA			Evidence for linkage of adolescent-onset idiopathic generalized epilepsies to chromosome 8 - and genetic heterogeneity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							JUVENILE MYOCLONIC EPILEPSY; FAMILIAL NEONATAL CONVULSIONS; SINGLE-LOCUS APPROXIMATIONS; CHILDHOOD ABSENCE EPILEPSY; POTASSIUM CHANNEL GENE; SUSCEPTIBILITY LOCUS; OLIGOGENIC TRAITS; NO EVIDENCE; HLA REGION; LOCALIZATION	Several loci and candidate genes for epilepsies or epileptic syndromes map or have been suggested to map to chromosome 8. We investigated families with adolescent-onset idiopathic generalized epilepsy (IGE), for linkage to markers spanning chromosome 8. The IGEs that we studied included juvenile myoclonic epilepsy (JME), epilepsy with only generalized tonic-clonic seizures occurring either randomly-during the day (random grand mal) or on awakening (awakening grand mal), and juvenile absence epilepsy (JAE). We looked for a gene common to all these IGEs, but we also investigated linkage to specific subforms of IGE. We found evidence for linkage to chromosome 8 in adolescent-onset IGE families in which JME was not present. The maximum multipoint LOD score was 3.24 when family members with IGE or generalized spike-and-waves (SW) were considered affected. The LOD score remained very similar (3.18) when clinically normal family members with SW were not considered to be affected. Families with either pure grand mal epilepsy or absence epilepsy contributed equally to the positive LOD score. The area where the LOD score reaches the maximum encompasses the location of the gene for the beta 3-subunit of the nicotinic acetylcholine receptor (CHRNB3), thus making this gene a possible candidate for these specific forms of adolescent-onset IGE. The data excluded linkage of JME to this region. These results indicate genetic heterogeneity within IGE and provide no evidence, on chromosome 8, for a gene common to all IGEs.	Mt Sinai Med Ctr, Dept Psychiat, New York, NY 10029 USA; Mt Sinai Med Ctr, Dept Biostat, New York, NY 10029 USA; Mt Sinai Med Ctr, Dept Neurol, New York, NY 10029 USA; Mt Sinai Med Ctr, Div Neuropediat, New York, NY 10029 USA; Columbia Presbyterian Med Ctr, New York, NY 10032 USA; Beth Israel Deaconess Med Ctr, New York, NY 10003 USA; Cornell Univ, New York Hosp, New York, NY 10021 USA; NYU, Hosp Joint Dis, New York, NY 10003 USA; Columbia Univ, Div Biostat, New York, NY 10032 USA; Albert Einstein Coll Med, Bronx, NY 10467 USA; Montefiore Med Ctr, Bronx, NY 10467 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Columbia University; NewYork-Presbyterian Hospital; Harvard University; Beth Israel Deaconess Medical Center; Cornell University; NewYork-Presbyterian Hospital; New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC; Columbia University; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Greenberg, DA (corresponding author), Mt Sinai Med Ctr, Dept Psychiat, Box 1229,1 Gustave Levy Pl, New York, NY 10029 USA.	dag@shallot.salad.mssm.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027941] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 27941] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		[Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; BECK MG, 1991, EPILEPSY RES S, V4, P105; Berkovic S.F, 1994, EPILEPTIC SEIZURES S, P157; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Durner M, 1999, AM J HUM GENET, V64, P281, DOI 10.1086/302181; DURNER M, 1991, NEUROLOGY, V41, P1651, DOI 10.1212/WNL.41.10.1651; Elmslie FV, 1996, AM J HUM GENET, V59, P653; Elmslie FV, 1997, HUM MOL GENET, V6, P1329, DOI 10.1093/hmg/6.8.1329; Fong GCY, 1998, AM J HUM GENET, V63, P1117, DOI 10.1086/302066; GEDDA L, 1971, ACTA GENET MED GEMEL, V20, P380, DOI 10.1017/S1120962300011343; GLICK JL, 1980, FUNDAMENTALS HUMAN L; GOLDIN LR, 1993, AM J HUM GENET, V53, P908; GREENBERG DA, 1989, GENET EPIDEMIOL, V6, P259, DOI 10.1002/gepi.1370060145; GREENBERG DA, 1989, AM J MED GENET, V34, P480, DOI 10.1002/ajmg.1320340406; GREENBERG DA, 1988, GENET EPIDEMIOL, V5, P81, DOI 10.1002/gepi.1370050204; GREENBERG DA, 1992, NEUROLOGY, V42, P56; GREENBERG DA, 1995, NEUROLOGY, V45, P942, DOI 10.1212/WNL.45.5.942; GREENBERG DA, 1988, AM J MED GENET, V31, P185, DOI 10.1002/ajmg.1320310125; Greenberg DA, 1998, AM J HUM GENET, V63, P870, DOI 10.1086/301997; GREENBERG DA, 1989, HUM GEN MAPP 10 YAL; Hodge SE, 1997, AM J HUM GENET, V60, P217; JANZ D, 1989, CLEV CLIN J MED, V56, pS23; JANZ D, 1992, NEUROLOGY, V42, P48; KOYAMA K, 1994, GENOMICS, V21, P460, DOI 10.1006/geno.1994.1300; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LEPPERT M, 1989, NATURE, V337, P647, DOI 10.1038/337647a0; Levitt P, 1997, TRENDS NEUROSCI, V20, P269, DOI 10.1016/S0166-2236(96)01028-4; Lewis TB, 1996, GENOMICS, V32, P131, DOI 10.1006/geno.1996.0088; LEWIS TB, 1993, AM J HUM GENET, V53, P670; Liu AW, 1996, AM J MED GENET, V63, P438; MEENCKE HJ, 1984, EPILEPSIA, V25, P8, DOI 10.1111/j.1528-1157.1984.tb04149.x; Morita R, 1998, BIOCHEM BIOPH RES CO, V248, P307, DOI 10.1006/bbrc.1998.8947; Morita R, 1998, BIOCHEM BIOPH RES CO, V250, P536, DOI 10.1006/bbrc.1998.9289; NELSON KB, 1981, FEBRILE SEIZURES, P19; NOEBELS JL, 1990, EPILEPSY RES, V7, P129, DOI 10.1016/0920-1211(90)90098-G; Rathouz MM, 1996, MOL NEUROBIOL, V12, P117, DOI 10.1007/BF02740649; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; SANDER T, 1995, ANN NEUROL, V38, P210, DOI 10.1002/ana.410380213; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; STEINLEIN O, 1992, GENOMICS, V12, P69, DOI 10.1016/0888-7543(92)90408-K; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; TAHVANAINEN E, 1994, P NATL ACAD SCI USA, V91, P7267, DOI 10.1073/pnas.91.15.7267; Terwilliger JD, 1997, AM J HUM GENET, V61, P430, DOI 10.1086/514855; VIELAND VJ, 1992, GENET EPIDEMIOL, V9, P45, DOI 10.1002/gepi.1370090106; VIELAND VJ, 1993, HUM HERED, V43, P329, DOI 10.1159/000154155; Wallace RH, 1996, J MED GENET, V33, P308, DOI 10.1136/jmg.33.4.308; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEISSBECKER KA, 1991, AM J MED GENET, V38, P32, DOI 10.1002/ajmg.1320380109; WHITEHOUSE WP, 1993, AM J HUM GENET, V53, P652; ZARA F, 1995, HUM MOL GENET, V4, P1201, DOI 10.1093/hmg/4.7.1201	51	51	52	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1999	64	5					1411	1419		10.1086/302371	http://dx.doi.org/10.1086/302371			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192RP	10205274	Green Published, Bronze			2022-12-18	WOS:000080093000021
J	Blumenfeld, A; Slaugenhaupt, SA; Liebert, CB; Temper, V; Maayan, C; Gill, S; Lucente, DE; Idelson, M; MacCormack, K; Monahan, MA; Mull, J; Leyne, M; Mendillo, M; Schiripo, T; Mishori, E; Breakefield, X; Axelrod, FB; Gusella, JF				Blumenfeld, A; Slaugenhaupt, SA; Liebert, CB; Temper, V; Maayan, C; Gill, S; Lucente, DE; Idelson, M; MacCormack, K; Monahan, MA; Mull, J; Leyne, M; Mendillo, M; Schiripo, T; Mishori, E; Breakefield, X; Axelrod, FB; Gusella, JF			Precise genetic mapping and haplotype analysis of the familial dysautonomia gene on human chromosome 9q31	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NERVE GROWTH-FACTOR; TORSION DYSTONIA; ASHKENAZI JEWS; HUMAN GENOME; LINKAGE MAP; DNA; POPULATION; POLYMORPHISMS; LOCALIZATION; DIAGNOSIS	Familial dysautonomia (FD) is an autosomal recessive disorder characterized by developmental arrest in the sensory and autonomic nervous systems and by Ashkenazi Jewish ancestry. We previously had mapped the defective gene (DYS) to an 11-cM segment of chromosome 9q31-33, flanked by D9S53 and D9S105. By using 11 new polymorphic loci, we now have narrowed the location of DYS to <0.5 cM between the markers 43B1GAGT and 157A3. Two markers in this interval, 164D1 and D9S1677, show no recombination with the disease. Haplotype analysis confirmed this candidate region and revealed a major haplotype shared by 435 of 441 FD chromosomes, indicating a striking founder effect. Three other haplotypes, found on the remaining 6 FD chromosomes, might represent independent mutations. The frequency of the major FD haplotype in the Ashkenazim (5 in 324 control chromosomes) was consistent with the estimated DYS carrier frequency of 1 in 32, and none of the four haplotypes associated with FD was observed on 492 non-FD chromosomes from obligatory carriers. It is now possible to provide accurate genetic testing both for families with FD and for carriers, on the basis of close flanking markers and the capacity to identify >98% of FD chromosomes by their haplotype.	Massachusetts Gen Hosp, Mol Neurogenet Unit, Charlestown, MA 02129 USA; Hadassah Univ Hosp, Dept Pediat, IL-91120 Jerusalem, Israel; Hadassah Univ Hosp, Unit Mol Biol & Genet Engn, IL-91120 Jerusalem, Israel; Harvard Univ, Sch Med, Inst Human Genet, Boston, MA USA; NYU, Med Ctr, Dept Pediat, Dysautonomia Diagnost & Treatment Ctr, New York, NY 10016 USA	Harvard University; Massachusetts General Hospital; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Harvard University; Harvard Medical School; New York University	Gusella, JF (corresponding author), Massachusetts Gen Hosp, Mol Neurogenet Unit, Bldg 149,13th St, Charlestown, MA 02129 USA.			Mendillo, Marc/0000-0001-8128-0128				ABELIOVICH D, 1992, AM J HUM GENET, V51, P951; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; Axelrod F B, 1974, Adv Pediatr, V21, P75; AXELROD FB, 1984, AM J DIS CHILD, V138, P947, DOI 10.1001/archpedi.1984.02140480049016; AXELROD FB, 1982, J PEDIATR-US, V101, P234, DOI 10.1016/S0022-3476(82)80130-3; Axelrod FB, 1984, CELL MOL BIOL NEURON, P331; Axelrod FB, 1996, PRIMER AUTONOMIC NER, P242; AXELROD FB, 1995, AUT NER SYS, V5, P217; BEUTLER E, 1993, AM J HUM GENET, V52, P85; BLUMENFELD A, 1993, J MED GENET, V30, P47, DOI 10.1136/jmg.30.1.47; Blumenfeld A, 1995, Harefuah, V128, P97; BLUMENFELD A, 1993, NAT GENET, V4, P160, DOI 10.1038/ng0693-160; BREAKEFIELD XO, 1984, P NATL ACAD SCI-BIOL, V81, P4213, DOI 10.1073/pnas.81.13.4213; BREAKEFIELD XO, 1986, MOL BIOL MED, V3, P483; BRUNT PW, 1970, MEDICINE, V49, P343, DOI 10.1097/00005792-197009000-00001; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; ENG CM, 1995, AM J MED GENET, V59, P349, DOI 10.1002/ajmg.1320590314; Gusella J F, 1993, Mol Genet Med, V3, P139; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARRIS DJ, 1980, PEDIATRICS, V65, P107; KLEBANOFF MA, 1980, J PEDIATR-US, V96, P75, DOI 10.1016/S0022-3476(80)80334-9; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; LEVINE SL, 1977, J PEDIATR-US, V90, P79, DOI 10.1016/S0022-3476(77)80769-5; MAAYAN C, 1987, CLIN GENET, V32, P106; MEHTA K, 1978, AM J DIS CHILD, V132, P719, DOI 10.1001/archpedi.1978.02120320079018; ODDOUX C, 1995, PRENATAL DIAG, V15, P817, DOI 10.1002/pd.1970150905; ORBECK H, 1977, ACTA PAEDIATR SCAND, V66, P777, DOI 10.1111/j.1651-2227.1977.tb07988.x; Ozelius LJ, 1997, GENOME RES, V7, P483, DOI 10.1101/gr.7.5.483; PEARSON J, 1978, J NEUROL SCI, V39, P123, DOI 10.1016/0022-510X(78)90193-4; PEARSON J, 1978, J NEUROL SCI, V39, P47, DOI 10.1016/0022-510X(78)90187-9; PEARSON J, 1978, J NEUROL SCI, V35, P77, DOI 10.1016/0022-510X(78)90103-X; Povey S, 1997, ANN HUM GENET, V61, P183, DOI 10.1017/S0003480097006106; RILEY CM, 1949, PEDIATRICS, V3, P468; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; SCHWARTZ JP, 1980, P NATL ACAD SCI-BIOL, V77, P1154, DOI 10.1073/pnas.77.2.1154; SLAUGENHAUPT SA, 1995, GENOMICS, V25, P730, DOI 10.1016/0888-7543(95)80019-I; SLAUGENHAUPT SA, 1995, ANN HUM GENET, V59, P347; SUZUKI T, 1976, EUR NEUROL, V14, P146, DOI 10.1159/000114737; TRIGGSRAINE BL, 1990, NEW ENGL J MED, V323, P6, DOI 10.1056/NEJM199007053230102; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WRATHALL JR, 1986, BRAIN RES, V364, P23, DOI 10.1016/0006-8993(86)90983-2	42	51	55	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					1110	1118		10.1086/302339	http://dx.doi.org/10.1086/302339			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	10090896	Green Published, Bronze			2022-12-18	WOS:000079632900022
J	Kuslich, CD; Kobori, JA; Mohapatra, G; Gregorio-King, C; Donlon, TA				Kuslich, CD; Kobori, JA; Mohapatra, G; Gregorio-King, C; Donlon, TA			Prader-Willi syndrome is caused by disruption of the SNRPN gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOME REGION; DNA METHYLATION; EXPRESSED GENE; HUMAN-CHROMOSOME-15; 15Q11-Q13; DELETIONS; ANGELMAN; IMPRINT; DEFINE; LOCUS	A Prader-Willi syndrome patient is described who has a de novo balanced translocation, (4;15)(q27;q11.2)pat, with breakpoints lying between SNRPN exons 2 and 3. Parental-origin studies indicate that there is no uniparental disomy and no apparent deletion. This patient expresses ZNF127, SNRPN exons 1 and 2, IPW, and D15S227E (PAR1) but does not express either SNRPN exons 3 and 4 or D15S226E (PARS), as assayed by reverse transcription-PCR, of peripheral blood cells. Methylation studies showed normal biparental patterns of inheritance of loci DN34/ZNF127, D15S63, and SNRPN exon 1. Results for this patient and that reported by Sun et al. support the contention that an intact genomic region and/or transcription of SNRPN exons 2 and 3 play a pivotal role in the manifestations of the major clinical phenotype in Prader-Willi syndrome.	Kapiolani Hlth Res Inst, Mol & Cytogenet Lab, Honolulu, HI USA; So Calif Permanente Med Grp, Dept Pediat, San Jose, CA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Univ Hawaii Manoa, Dept Genet & Mol Biol, Honolulu, HI 96822 USA	Kaiser Permanente; Southern California Permanente Medical Group (SCPMG); Permanente Medical Groups; University of California System; University of California San Francisco; University of Hawaii System; University of Hawaii Manoa	Donlon, TA (corresponding author), Ohana Genet, POB 161052, Honolulu, HI 96816 USA.	donlon@hawaii.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028015] Funding Source: NIH RePORTER; NICHD NIH HHS [HD28015] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; BUTLER MG, 1983, LANCET, V1, P1285; Cassidy S. B., 1996, American Journal of Human Genetics, V59, pA21; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; Conroy JM, 1997, AM J HUM GENET, V61, P388, DOI 10.1086/514852; CRACOPOLI NC, 1997, CURRENT PROTOCOLS HU; DITTRICH B, 1993, HUM MOL GENET, V2, P1995, DOI 10.1093/hmg/2.12.1995; Dittrich B, 1996, NAT GENET, V14, P163, DOI 10.1038/ng1096-163; DONLON TA, 1986, P NATL ACAD SCI USA, V83, P4408, DOI 10.1073/pnas.83.12.4408; GLENN CC, 1993, HUM MOL GENET, V2, P2001, DOI 10.1093/hmg/2.12.2001; GLENN CC, 1993, HUM MOL GENET, V2, P1377, DOI 10.1093/hmg/2.9.1377; Glenn CC, 1996, AM J HUM GENET, V58, P335; HOLM VA, 1993, PEDIATRICS, V91, P398; Kuwano Akira, 1992, Human Molecular Genetics, V1, P417, DOI 10.1093/hmg/1.6.417; LEDBETTER DH, 1981, NEW ENGL J MED, V304, P325, DOI 10.1056/NEJM198102053040604; MUTIRANGURA A, 1993, GENOMICS, V18, P546, DOI 10.1016/S0888-7543(11)80011-X; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; OZCELIK T, 1992, NAT GENET, V2, P265, DOI 10.1038/ng1292-265; Prader A., 1956, SCHWEIZ MED WSCHR, V86, P1260, DOI DOI 10.1007/978-3-642-47669-3_24; RICH DC, 1988, NUCLEIC ACIDS RES, V16, P8740, DOI 10.1093/nar/16.17.8740; Schulze A, 1996, NAT GENET, V12, P452, DOI 10.1038/ng0496-452; SEABRIGH.M, 1971, LANCET, V2, P971; Sun YM, 1996, HUM MOL GENET, V5, P517, DOI 10.1093/hmg/5.4.517; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; WEVRICK R, 1994, HUM MOL GENET, V3, P1877, DOI 10.1093/hmg/3.10.1877; YUNIS JJ, 1977, PROGR CLIN PATHOL, V7, P267	26	51	51	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					70	76		10.1086/302177	http://dx.doi.org/10.1086/302177			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164RM	9915945	Green Published, Bronze			2022-12-18	WOS:000078477400011
J	Shimozawa, N; Suzuki, Y; Zhang, Z; Imamura, A; Kondo, N; Kinoshita, N; Fujiki, Y; Tsukamoto, T; Osumi, T; Imanaka, T; Orii, T; Beemer, F; Mooijer, P; Dekker, C; Wanders, RJA				Shimozawa, N; Suzuki, Y; Zhang, Z; Imamura, A; Kondo, N; Kinoshita, N; Fujiki, Y; Tsukamoto, T; Osumi, T; Imanaka, T; Orii, T; Beemer, F; Mooijer, P; Dekker, C; Wanders, RJA			Genetic basis of peroxisome-assembly mutants of humans, Chinese hamster ovary cells, and yeast: Identification of a new complementation group of peroxisome-biogenesis disorders apparently lacking peroxisomal-membrane ghosts	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							RHIZOMELIC CHONDRODYSPLASIA PUNCTATA; ZELLWEGER SYNDROME; PTS1 RECEPTOR; DEFICIENT DISORDERS; PROTEIN IMPORT; REPRESENT 2; HUMAN PEX7; ENCODES; HETEROGENEITY; MUTATIONS		Gifu Univ, Sch Med, Dept Pediat, Gifu 5008076, Japan; Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan; Himeji Inst Technol, Dept Life Sci, Himeji, Hyogo 67122, Japan; Teikyo Univ, Fac Pharmaceut Sci, Dept Microbiol & Mol Pathol, Kanagawa, Japan; Chubu Gakuin Univ, Fac Human Welfare, Seki, Japan; Wilhelmina Childrens Hosp, Dept Clin Genet, Clin Genet Ctr, Utrecht, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Clin Biochem & Pediat, NL-1105 AZ Amsterdam, Netherlands	Gifu University; Kyushu University; University of Hyogo; Teikyo University; Wilhelmina Kinderziekenhuis; University of Amsterdam; Academic Medical Center Amsterdam	Shimozawa, N (corresponding author), Gifu Univ, Sch Med, Dept Pediat, 40 Tsukasa Machi, Gifu 5008076, Japan.			Shimozawa, Nobuyuki/0000-0003-3040-5458; Imanaka, Tsuneo/0000-0003-4677-1356				Baerends RJS, 1996, J BIOL CHEM, V271, P8887, DOI 10.1074/jbc.271.15.8887; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; BRUL S, 1988, J CLIN INVEST, V81, P1710, DOI 10.1172/JCI113510; Chang CC, 1997, NAT GENET, V15, P385, DOI 10.1038/ng0497-385; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Fukuda S, 1996, AM J HUM GENET, V59, P1210; Gould SJ, 1996, J CELL BIOL, V135, P85, DOI 10.1083/jcb.135.1.85; Imanaka T, 1996, J BIOL CHEM, V271, P3706; KAMIJO K, 1992, BIOCHIM BIOPHYS ACTA, V1129, P323, DOI 10.1016/0167-4781(92)90510-7; Kinoshita N, 1998, J BIOL CHEM, V273, P24122, DOI 10.1074/jbc.273.37.24122; MOSER AB, 1995, J PEDIATR-US, V127, P13, DOI 10.1016/S0022-3476(95)70250-4; MOSSER J, 1994, HUM MOL GENET, V3, P265, DOI 10.1093/hmg/3.2.265; Motley AM, 1997, NAT GENET, V15, P377, DOI 10.1038/ng0497-377; Okumoto K, 1997, NAT GENET, V17, P265, DOI 10.1038/ng1197-265; Portsteffen H, 1997, NAT GENET, V17, P449, DOI 10.1038/ng1297-449; POULOS A, 1995, J PEDIATR-US, V127, P596, DOI 10.1016/S0022-3476(95)70121-4; Purdue PE, 1997, NAT GENET, V15, P381, DOI 10.1038/ng0497-381; Reuber BE, 1997, NAT GENET, V17, P445, DOI 10.1038/ng1297-445; ROSCHER AA, 1989, PEDIATR RES, V26, P67, DOI 10.1203/00006450-198907000-00019; SANTOS MJ, 1992, J CELL PHYSIOL, V151, P103, DOI 10.1002/jcp.1041510115; SANTOS MJ, 1988, SCIENCE, V239, P1536, DOI 10.1126/science.3281254; Shimozawa N, 1998, BIOCHEM BIOPH RES CO, V243, P368, DOI 10.1006/bbrc.1997.8067; SHIMOZAWA N, 1992, J CLIN INVEST, V90, P1864, DOI 10.1172/JCI116063; SHIMOZAWA N, 1993, AM J HUM GENET, V52, P843; SHIMOZAWA N, 1988, PEDIATR RES, V24, P723, DOI 10.1203/00006450-198812000-00015; SHIMOZAWA N, 1992, SCIENCE, V255, P1132, DOI 10.1126/science.1546315; Shimozawa N, 1996, PEDIATR RES, V39, P812, DOI 10.1203/00006450-199605000-00011; SUZUKI Y, 1991, BIOCHEM PHARMACOL, V41, P453, DOI 10.1016/0006-2952(91)90544-F; Tateishi K, 1997, EUR J CELL BIOL, V73, P352; WENDLAND M, 1993, J CLIN INVEST, V92, P2462, DOI 10.1172/JCI116854; Wiemer EAC, 1996, J BIOL CHEM, V271, P18973, DOI 10.1074/jbc.271.31.18973; Yahraus T, 1996, EMBO J, V15, P2914, DOI 10.1002/j.1460-2075.1996.tb00654.x; YAJIMA S, 1992, HUM GENET, V88, P491, DOI 10.1007/BF00219334	34	51	52	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1898	1903		10.1086/302142	http://dx.doi.org/10.1086/302142			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EL	9837841	Green Published, Bronze			2022-12-18	WOS:000077707700034
J	Drigalenko, E				Drigalenko, E			How Sib pairs reveal linkage	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							QUANTITATIVE TRAIT		Case Western Reserve Univ, Dept Biostat & Epidemiol, Rammelkamp Ctr Educ & Res, Cleveland, OH 44109 USA	Case Western Reserve University; MetroHealth System	Drigalenko, E (corresponding author), Case Western Reserve Univ, Dept Biostat & Epidemiol, Rammelkamp Ctr Educ & Res, MetroHlth Campus,2500 MetroHlth Dr,Room R258, Cleveland, OH 44109 USA.				FOGARTY INTERNATIONAL CENTER [F05TW005285] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; FIC NIH HHS [F05 TW05285] Funding Source: Medline; NCRR NIH HHS [P41 RR03655] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AMOS CI, 1994, AM J HUM GENET, V54, P535; BLACKWELDER WC, 1982, COMMUN STAT A-THEOR, V11, P449, DOI 10.1080/03610928208828250; DRIGALENKO E, IN PRESS THEOR POPUL; FULKER DW, 1995, AM J HUM GENET, V56, P1224; Fulker DW, 1996, BEHAV GENET, V26, P527, DOI 10.1007/BF02359758; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; MALECOT G, 1966, PROBABILITES HEREDIT; Wright FA, 1997, AM J HUM GENET, V60, P740	8	51	52	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					1242	1245						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9758613				2022-12-18	WOS:000076577800043
J	Kruglyak, L				Kruglyak, L			What is significant in whole-genome linkage disequilibrium studies?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							GENE; LIKELIHOOD; POPULATIONS; TRAITS; MAPS				Kruglyak, L (corresponding author), WHITEHEAD INST BIOMED RES,1 KENDALL SQ,BLDG 300,CAMBRIDGE,MA 02139, USA.							Bodmer W. F., 1976, GENETICS EVOLUTION M; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Devlin B, 1996, GENOMICS, V36, P1, DOI 10.1006/geno.1996.0419; FEINGOLD E, 1993, AM J HUM GENET, V53, P234; FEINGOLD E, 1993, J APPL PROBAB, V30, P766, DOI 10.2307/3214511; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; JORDE LB, 1995, AM J HUM GENET, V56, P11; KAPLAN NL, 1995, AM J HUM GENET, V56, P18; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KRUGLYAK I, 1997, NAT GENET, V17, P21; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1989, GENETICS, V121, P185; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; Wang D., 1996, American Journal of Human Genetics, V59, pA3	16	51	58	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1997	61	4					810	812		10.1086/514893	http://dx.doi.org/10.1086/514893			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YA591	9382090	Bronze, Green Published			2022-12-18	WOS:A1997YA59100006
J	Payami, H; Grimslid, H; Oken, B; Camicioli, R; Sexton, G; Dame, A; Howieson, D; Kaye, J				Payami, H; Grimslid, H; Oken, B; Camicioli, R; Sexton, G; Dame, A; Howieson, D; Kaye, J			A prospective study of cognitive health in the elderly (Oregon brain aging study): Effects of family history and apolipoprotein E genotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ONSET ALZHEIMERS-DISEASE; CORONARY-HEART-DISEASE; E ALLELE EPSILON-4; OLDEST-OLD; E POLYMORPHISM; TYPE-4 ALLELE; E PHENOTYPES; ASSOCIATION; GENE; RISK	The oldest old are the fastest-growing segment of our population and have the highest prevalence of dementia. Little is known about the genetics of cognitive health in the very old. The aim of this study was to determine whether the genetic risk factors for Alzheimer disease (AD)-namely, apolipoprotein E (APOE) epsilon 4 allele and a family history of dementia-continue to be important factors in the cognitive health of the very old. Case-control studies suggest that the effect of genetic factors diminishes at age >75 years. The present prospective study provided evidence to the contrary. We studied 114 Caucasian subjects who were physically healthy and cognitively intact at age 75 years and who were followed, for an average of 4 years, with neurological, psychometric, and neuroimaging examinations. Excellent health at entry did not protect against cognitive decline. Incidence of cognitive decline rose sharply with age. epsilon 4 and a family history of dementia (independent of epsilon 4) were associated with an earlier age at onset of dementia. Subjects who had epsilon 4 or a family history of dementia had a ninefold-higher age-specific risk for dementia than did those who had neither epsilon 4 nor a family history of dementia. These observations suggest that the rate of cognitive decline increases with age and that APOE and other familial/genetic factors influence the onset age throughout life.	OREGON HLTH SCI UNIV,DEPT NEUROL,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT SURG,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT MED,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT PREVENT MED,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,VET AFFAIRS MED CTR,PORTLAND,OR 97201	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Payami, H (corresponding author), OREGON HLTH SCI UNIV,DEPT MED & MOL GENET,CDW2,745 SW GAINES RD,PORTLAND,OR 97201, USA.			Camicioli, Richard/0000-0003-2977-8660; Kaye, Jeffrey/0000-0002-9971-3478	NIA NIH HHS [AG0817] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BENNETT C, 1995, AM J MED GENET, V60, P1, DOI 10.1002/ajmg.1320600102; CORDER EH, 1995, NEUROLOGY, V45, P1323, DOI 10.1212/WNL.45.7.1323; Corder EH, 1996, ARCH NEUROL-CHICAGO, V53, P418, DOI 10.1001/archneur.1996.00550050048022; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; COUDERC R, 1993, STROKE, V24, P661, DOI 10.1161/01.STR.24.5.661; Cox D.R., 1984, ANAL SURVIVAL DATA; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; DAVIGNON J, 1988, T AM CLIN CLIMAT ASS, V99, P100; Duara R, 1996, NEUROLOGY, V46, P1575, DOI 10.1212/WNL.46.6.1575; FARRER LA, 1995, ANN NEUROL, V38, P797, DOI 10.1002/ana.410380515; HIXSON JE, 1990, J LIPID RES, V31, P545; HOULDEN H, 1994, NEUROSCI LETT, V174, P222, DOI 10.1016/0304-3940(94)90026-4; HOWIESON DB, 1993, NEUROLOGY, V43, P1882, DOI 10.1212/WNL.43.10.1882; Jarvik GP, 1996, AM J HUM GENET, V58, P191; KAMINO K, 1992, AM J HUM GENET, V51, P998; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Katzman Robert, 1994, P105; KAYE JA, 1994, ARCH NEUROL-CHICAGO, V51, P1205, DOI 10.1001/archneur.1994.00540240049015; KERVINEN K, 1994, ATHEROSCLEROSIS, V105, P89, DOI 10.1016/0021-9150(94)90011-6; KUUSISTO J, 1994, BRIT MED J, V309, P636, DOI 10.1136/bmj.309.6955.636; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li G, 1996, GENET EPIDEMIOL, V13, P285, DOI 10.1002/(SICI)1098-2272(1996)13:3<285::AID-GEPI5>3.0.CO;2-5; LOCKE PA, 1995, GENET EPIDEMIOL, V12, P83, DOI 10.1002/gepi.1370120108; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Myers RH, 1996, NEUROLOGY, V46, P673, DOI 10.1212/WNL.46.3.673; PAYAMI H, 1994, AM J HUM GENET, V54, P650; PAYAMI H, 1994, JAMA-J AM MED ASSOC, V271, P1316, DOI 10.1001/jama.271.17.1316; Payami H, 1996, AM J HUM GENET, V58, P803; PAYAMI H, 1995, NEUROLOGY, V45, pA217; PAYAMI H, 1993, LANCET, V342, P737; PAYNE MN, 1992, LANCET, V340, P1350, DOI 10.1016/0140-6736(92)92532-K; PEDROBOTET J, 1992, STROKE, V23, P1556, DOI 10.1161/01.STR.23.11.1556; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; Rao VS, 1996, AM J HUM GENET, V59, P664; REBECK GW, 1994, NEUROLOGY, V44, P1513, DOI 10.1212/WNL.44.8.1513; RITCHIE K, 1995, LANCET, V346, P931, DOI 10.1016/S0140-6736(95)91556-7; ROSENWAIKE I, 1985, MILBANK FUND Q, V63, P187, DOI 10.2307/3349880; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; SCHELLENBERG GD, 1993, AM J HUM GENET, V53, P619; SILVERMAN JM, 1994, ARCH GEN PSYCHIAT, V51, P577; SOBEL E, 1995, NEUROLOGY, V45, P903, DOI 10.1212/WNL.45.5.903; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; TALBOT C, 1994, LANCET, V343, P1432, DOI 10.1016/S0140-6736(94)92557-7; Tang MX, 1996, AM J HUM GENET, V58, P574; TSAI MS, 1994, AM J HUM GENET, V54, P643; VANBOCKXMEER FM, 1992, LANCET, V340, P879, DOI 10.1016/0140-6736(92)93288-X; VANDUIJN CM, 1995, ANN NEUROL, V37, P605, DOI 10.1002/ana.410370510; WEST HL, 1994, NEUROSCI LETT, V175, P46, DOI 10.1016/0304-3940(94)91074-X; WILSON PWF, 1994, JAMA-J AM MED ASSOC, V272, P1666, DOI 10.1001/jama.272.21.1666; YASUDA M, 1995, ALZHEIMER RES, V1, P77; YU CE, 1994, AM J HUM GENET, V54, P631; ZUBENKO GS, 1994, AM J MED GENET, V54, P199, DOI 10.1002/ajmg.1320540306	54	51	51	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1997	60	4					948	956						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WT614	9106542				2022-12-18	WOS:A1997WT61400025
J	Surralles, J; Jeppesen, P; Morrison, H; Natarajan, AT				Surralles, J; Jeppesen, P; Morrison, H; Natarajan, AT			Analysis of loss of inactive X chromosomes in interphase cells	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HISTONE H-4; ANEUPLOIDY; GENE; LYMPHOCYTES; ACETYLATION; CHROMATIN; AGE	We have developed a method that allows, for the first time, a specific analysis of the inactive X chromosome (Xi) in interphase cells. By combining immunolabeling of acetylated histone H4 with specific antisera and FISH with an X-chromosome centromere-specific DNA probe, micronucleated whole Xis in human female cells may be identified by their lack of histone H4 acetylation. As one example of the potential applications of this methodology in genetic studies in humans, an artifact-free X-chromosome aneuploidy detection in lymphocytes of women of different ages has been performed. Our results indicate that not only the Xi but also the active X chromosome is preferentially lost during aging, indicating that the high frequency of sex-chromosome aneuploidy in human females cannot be explained solely by a lack of negative selection of Xi aneuploid cells. Further applications of the proposed methodology in genetic studies are discussed.	WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND	University of Edinburgh	Surralles, J (corresponding author), LEIDEN UNIV,MGC,DEPT RADIAT GENET & CHEM MUTAGENESIS,WASSENAARSEWEG 72,NL-2333 AL LEIDEN,NETHERLANDS.		Surrallés, Jordi/AAE-7667-2020	Surralles, Jordi/0000-0002-4041-7519				ABRUZZO MA, 1985, CYTOGENET CELL GENET, V39, P275, DOI 10.1159/000132157; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; CATALAN J, 1995, CYTOGENET CELL GENET, V68, P11, DOI 10.1159/000133879; CHAHAL SS, 1980, NATURE, V287, P76, DOI 10.1038/287076a0; DAVIE JR, 1978, P NATL ACAD SCI USA, V75, P3574, DOI 10.1073/pnas.75.8.3574; FORD JH, 1988, AM J HUM GENET, V43, P733; GALLOWAY SM, 1978, CYTOGENET CELL GENET, V20, P78, DOI 10.1159/000130842; HAAF T, 1993, CYTOGENET CELL GENET, V63, P160, DOI 10.1159/000133526; JACOBS PA, 1963, NATURE, V197, P1080, DOI 10.1038/1971080a0; JACOBS PA, 1961, NATURE, V191, P1178, DOI 10.1038/1911178a0; JEPPESEN P, 1993, CELL, V74, P281, DOI 10.1016/0092-8674(93)90419-Q; Lyon MF, 1996, NATURE, V379, P116, DOI 10.1038/379116a0; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MANDEL JL, 1992, SCIENCE, V258, P103, DOI 10.1126/science.1439756; MOHANDAS T, 1981, SCIENCE, V211, P393, DOI 10.1126/science.6164095; NOWINSKI GP, 1990, AM J HUM GENET, V46, P1101; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; SEALY L, 1978, CELL, V14, P115, DOI 10.1016/0092-8674(78)90306-9; Tucker JD, 1996, HUM GENET, V97, P471; TURNER BM, 1993, CELL, V75, P5, DOI 10.1016/S0092-8674(05)80078-9; WILLARD HF, 1976, AM J HUM GENET, V28, P213	23	51	51	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1996	59	5					1091	1096						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN900	8900238				2022-12-18	WOS:A1996VN90000017
J	Dallapiccola, B; Pizzuti, A; Novelli, G				Dallapiccola, B; Pizzuti, A; Novelli, G			How many breaks do we need to CATCH on 22q11?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							CARDIO-FACIAL SYNDROME; SYNDROME CRITICAL REGION; BALANCED TRANSLOCATION BREAKPOINT; DIGEORGE-SYNDROME; CHROMOSOME 22Q11; DELETIONS; GENE; MICRODELETIONS; IDENTIFICATION; PHENOTYPE		UNIV MILAN, INST NEUROL, I-20122 MILAN, ITALY; CSS IRCCS HOSP, SAN GIOVANNI ROTONDO, ITALY	University of Milan	Dallapiccola, B (corresponding author), UNIV ROMA TOR VERGATA, DIPARTIMENTO SANITA PUBBL & BIOL CELLULARE, VIA TOR VERGATA 135, I-00133 ROME, ITALY.		Novelli, Giuseppe/GQB-3329-2022; Novelli, Giuseppe/T-8822-2019; Novelli, Giuseppe/A-5195-2013; Dallapiccola, Bruno/K-8692-2016	Novelli, Giuseppe/0000-0002-7781-602X; Novelli, Giuseppe/0000-0002-7781-602X; Dallapiccola, Bruno/0000-0002-5031-1013; PIZZUTI, Antonio/0000-0003-3245-1925	Telethon [E.0399] Funding Source: Medline	Telethon(Fondazione Telethon)		AMATI F, 1995, HUM GENET, V95, P479; AUGUSSEAU S, 1986, HUM GENET, V74, P206, DOI 10.1007/BF00282098; Bedell MA, 1996, NAT GENET, V12, P229, DOI 10.1038/ng0396-229; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; BUDARF ML, 1995, NAT GENET, V10, P269, DOI 10.1038/ng0795-269; BURN J, 1993, J MED GENET, V30, P822, DOI 10.1136/jmg.30.10.822; CONLEY ME, 1979, J PEDIATR-US, V94, P883, DOI 10.1016/S0022-3476(79)80207-3; Debrus S, 1996, HUM GENET, V97, P138, DOI 10.1007/BF02265254; DELACHAPELLE A, 1981, HUM GENET, V57, P253, DOI 10.1007/BF00278938; DEMCZUK S, 1995, HUM MOL GENET, V4, P551, DOI 10.1093/hmg/4.4.551; Demczuk S, 1996, HUM MOL GENET, V5, P633, DOI 10.1093/hmg/5.5.633; Devriendt K, 1996, J MED GENET, V33, P349, DOI 10.1136/jmg.33.4.349; DRISCOLL DA, 1992, AM J MED GENET, V44, P261, DOI 10.1002/ajmg.1320440237; DRISCOLL DA, 1993, J MED GENET, V30, P813, DOI 10.1136/jmg.30.10.813; Fryer A, 1996, J MED GENET, V33, P173, DOI 10.1136/jmg.33.2.173; GIANNOTTI A, 1994, AM J MED GENET, V53, P303, DOI 10.1002/ajmg.1320530320; GOLDBERG R, 1993, AM J MED GENET, V45, P313, DOI 10.1002/ajmg.1320450307; GOLDMUNTZ E, 1993, J MED GENET, V30, P807, DOI 10.1136/jmg.30.10.807; GOODSHIP J, 1995, J MED GENET, V32, P746, DOI 10.1136/jmg.32.9.746; GREENBERG F, 1993, J MED GENET, V30, P803, DOI 10.1136/jmg.30.10.803; GREENBERG F, 1988, AM J HUM GENET, V43, P605; HALFORD S, 1993, HUM MOL GENET, V2, P2099, DOI 10.1093/hmg/2.12.2099; Hatchwell E, 1996, J MED GENET, V33, P261, DOI 10.1136/jmg.33.3.261; HEISTERKAMP N, 1995, GENOMICS, V29, P451, DOI 10.1006/geno.1995.9982; JOHNSON MC, 1995, AM J CARDIOL, V76, P66, DOI 10.1016/S0002-9149(99)80803-0; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; KELLEY RI, 1982, J PEDIATR-US, V101, P197, DOI 10.1016/S0022-3476(82)80116-9; Lammer E J, 1986, Am J Med Genet Suppl, V2, P113, DOI 10.1002/ajmg.1320250615; LAMOUR V, 1995, HUM MOL GENET, V4, P791, DOI 10.1093/hmg/4.5.791; LEVY A, 1995, HUM MOL GENET, V4, P2417, DOI 10.1093/hmg/4.12.2417; Lindsay EA, 1996, GENOMICS, V32, P104, DOI 10.1006/geno.1996.0082; LINDSAY EA, 1995, AM J MED GENET, V56, P191, DOI 10.1002/ajmg.1320560216; LINDSAY EA, 1993, GENOMICS, V17, P403, DOI 10.1006/geno.1993.1339; Lorain S, 1996, GENOME RES, V6, P43, DOI 10.1101/gr.6.1.43; MCDONALDMCGINN DM, 1995, AM J MED GENET, V59, P103, DOI 10.1002/ajmg.1320590122; Milot E, 1996, TRENDS GENET, V12, P123, DOI 10.1016/0168-9525(96)30019-X; MINGARELLI R, IN PRESS J CRANIOFAC; MITNICK RJ, 1994, AM J MED GENET, V54, P100, DOI 10.1002/ajmg.1320540204; NICKEL RE, 1994, AM J MED GENET, V52, P445, DOI 10.1002/ajmg.1320520410; PANSHIN IB, 1995, RUSSIAN J GENET, V31, P1246; Pizzuti A, 1996, AM J HUM GENET, V58, P722; PIZZUTI A, 1995, BIOCHEM BIOPH RES CO, V206, P294, DOI 10.1006/bbrc.1995.1041; ROBIN NH, 1995, NAT GENET, V11, P459, DOI 10.1038/ng1295-459; SCAMBLER PJ, 1993, CURR OPIN GENET DEV, V3, P432, DOI 10.1016/0959-437X(93)90117-8; SCAMBLER PJ, 1991, GENOMICS, V10, P201, DOI 10.1016/0888-7543(91)90501-5; SCAMBLER PJ, 1992, LANCET, V339, P1138, DOI 10.1016/0140-6736(92)90734-K; Schulze A, 1996, NAT GENET, V12, P452, DOI 10.1038/ng0496-452; SHPRINTZEN RJ, 1978, CLEFT PALATE J, V15, P56; Sun YM, 1996, HUM MOL GENET, V5, P517, DOI 10.1093/hmg/5.4.517; Sutherland HF, 1996, AM J HUM GENET, V59, P23; WADEY R, 1995, HUM MOL GENET, V4, P1027, DOI 10.1093/hmg/4.6.1027; WILSON DI, 1993, J MED GENET, V30, P852, DOI 10.1136/jmg.30.10.852	53	51	52	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1996	59	1					7	11						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL455	8659546				2022-12-18	WOS:A1996VL45500002
J	Lopes, J; LeGuern, E; Gouider, R; Tardieu, S; Abbas, N; Birouk, N; Gugenheim, M; Bouche, P; Agid, Y; Brice, A; ArneBes, MC; Brichet, B; Chapon, F; Chazot, G; Clavelou, P; Desnuelle, C; Diraison, P; Dubas, F; Gonnaud, PM; Hurtevent, JF; Kuntzer, T; Lagueny, A; Mabin, D; Mayer, M; Ochsner, F; OllagnonRoman, E; Pouget, J; Tabaraud, F; Vallat, JM; Vandenberghe, A				Lopes, J; LeGuern, E; Gouider, R; Tardieu, S; Abbas, N; Birouk, N; Gugenheim, M; Bouche, P; Agid, Y; Brice, A; ArneBes, MC; Brichet, B; Chapon, F; Chazot, G; Clavelou, P; Desnuelle, C; Diraison, P; Dubas, F; Gonnaud, PM; Hurtevent, JF; Kuntzer, T; Lagueny, A; Mabin, D; Mayer, M; Ochsner, F; OllagnonRoman, E; Pouget, J; Tabaraud, F; Vallat, JM; Vandenberghe, A			Recombination hot spot in a 3.2-kb region of the Charcot-Marie-Tooth type 1A repeat sequences: New tools for molecular diagnosis of hereditary neuropathy with liability to pressure palsies and of Charcot-Marie-Tooth type 1A	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISEASE TYPE-1A; GENE; DUPLICATION; MUTATION; PMP-22	Charcot-Marie-Tooth type 1A (CMT1A) disease and hereditary neuropathy with liability to pressure palsies (HNPP) are autosomal dominant neuropathies, associated, respectively, with duplications and deletions of the same 1.5-Mb region on 17p11.2-p12. These two rearrangements are the reciprocal products of an unequal meiotic crossover between the two chromosome 17 homologues, caused by the misalignment of the CMT1A repeat sequences (CMT1A-REPs), the homologous sequences flanking the 1.5-Mb CMT1A/HNPP monomer unit. In order to map recombination breakpoints within the CMT1A-REPs, a 12.9-kb restriction map was constructed from cloned EcoRI fragments of the proximal and distal CMT1A-REPs. Only 3 of the 17 tested restriction sites were present in the proximal CMT1A-REP but absent in the distal CMT1A-REP, indicating a high degree of homology between these sequences. The rearrangements were mapped in four regions of the CMT1A-REPs by analysis of 76 CMT1A index cases and 38 HNPP patients, who where unrelated. A hot spot of crossover breakpoints, located in a 3.2-kb region, accounted for three-quarters of the rearrangements, detected after EcoRI/SacI digestion, by the presence of 3.2-kb and 7.8-kb junction fragments in CMT1A and HNPP patients, respectively. These junction fragments, which can be detected on classical Southern blots, permit molecular diagnosis. Other rearrangements can also be detected by gene dosage on the same Southern blots.	HOP LA PITIE SALPETRIERE,INSERM,U289,F-75651 PARIS 13,FRANCE; HOP LA PITIE SALPETRIERE,FEDERAT NEUROL,F-75651 PARIS 13,FRANCE; HOP LA PITIE SALPETRIERE,SERV EXPLORAT FONCTIONNELLES NEUROL,F-75651 PARIS 13,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite			Brice, Alexis/A-2170-2009; Gouider, Riadh/AAX-2634-2020; Lopes, Judith/K-3788-2017; Kuntzer, Thierry/O-8589-2016; brice, alexis/AAE-8275-2019	Gouider, Riadh/0000-0001-9615-3797; Lopes, Judith/0000-0003-4907-6797; Kuntzer, Thierry/0000-0002-7788-1673; brice, alexis/0000-0002-0941-3990; Clavelou, Pierre/0000-0003-2363-9352				BRICE A, 1992, J MED GENET, V29, P807, DOI 10.1136/jmg.29.11.807; CHANCE PF, 1994, HUM MOL GENET, V3, P223, DOI 10.1093/hmg/3.2.223; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; CUDREY C, 1995, J MED GENET, V32, P231, DOI 10.1136/jmg.32.3.231; Dyck P.J, 1993, PNP, P1094; HAYASAKA K, 1993, HUM MOL GENET, V2, P1369, DOI 10.1093/hmg/2.9.1369; KIYOSAWA H, 1995, HUM MOL GENET, V4, P2327, DOI 10.1093/hmg/4.12.2327; LEGUERN E, 1994, CYTOGENET CELL GENET, V65, P261, DOI 10.1159/000133643; LEGUERN E, 1995, HUM MOL GENET, V4, P1673, DOI 10.1093/hmg/4.9.1673; LeGuern E, 1996, HUM MOL GENET, V5, P103, DOI 10.1093/hmg/5.1.103; LORENZETTI D, 1995, AM J HUM GENET, V56, P91; LUPSKI JR, 1992, NAT GENET, V1, P29, DOI 10.1038/ng0492-29; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; NICHOLSON GA, 1994, NAT GENET, V6, P263, DOI 10.1038/ng0394-263; PALAU F, 1993, HUM MOL GENET, V2, P2031, DOI 10.1093/hmg/2.12.2031; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; PHAMDINH D, 1993, HUM MOL GENET, V2, P2051, DOI 10.1093/hmg/2.12.2051; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; TIMMERMAN V, 1992, NAT GENET, V1, P171, DOI 10.1038/ng0692-171; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; VALENTIJN LJ, 1992, NAT GENET, V1, P166, DOI 10.1038/ng0692-166; VANCE JM, 1991, GENOMICS, V9, P623, DOI 10.1016/0888-7543(91)90355-I; Windebank A, 1993, PERIPHERAL NEUROPATH, V2, P1137	25	51	52	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1996	58	6					1223	1230						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UM271	8651299				2022-12-18	WOS:A1996UM27100015
J	Souri, M; Aoyama, T; Orii, K; Yamaguchi, S; Hashimoto, T				Souri, M; Aoyama, T; Orii, K; Yamaguchi, S; Hashimoto, T			Mutation analysis of very-long-chain acyl-coenzyme A dehydrogenase (VLCAD) deficiency: Identification and characterization of mutant VLCAD cDNAs from four patients	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MESSENGER-RNA DEGRADATION; BETA-OXIDATION ENZYMES; RAT-LIVER MITOCHONDRIA; COA DEHYDROGENASE; IMMUNOCHEMICAL CHARACTERIZATION; A DEHYDROGENASE; AMPLIFIED CDNA; MCAD GENE; FIBROBLASTS; EXPRESSION	Very-long-chain acyl-coenzyme A dehydrogenase (VLCAD) deficiency is a newly identified disease. A 105-bp deletion in the VLCAD cDNA in two patients has been reported, and detailed molecular characterization of this disease has remained to be done. We report here five mutations identified in four patients: a 135-bp deletion encompassing bases 343-477, a C-1837-to-T transition (R613W), 3-bp deletions at the nucleotide positions 388-390 (E130del) and 895-897 (K299del), and an A-1144-to-C transversion (K382Q). Sequencing of genomic DNA amplified by PCR revealed a 135-bp deletion caused by exon skipping due to a l-bp deletion in a 3' splice site of an intron. Zn cDNA expression experiments using Chinese hamster ovary (CHO) cells, we found that each of the mRNAs derived from E130del and K299del clones were unstable and that translation products from R613W E130del, K299del, and K382Q clones were labile. Each of R613W, E130del, K299del, and K382Q proteins expressed in CHO cells appeared abnormal in dimer assembly, as shown in gel-filtration analysis. VLCAD activity was not detected in mutants' transfectants. Thus, we verified that all five mutations identified in these four patients were disease-causing alterations.	GIFU UNIV, SCH MED, DEPT PEDIAT, GIFU 500, JAPAN; SHIMANE MED UNIV, DEPT PEDIAT, IZUMO, SHIMANE 693, JAPAN	Gifu University; Shimane University	Souri, M (corresponding author), SHINSHU UNIV, SCH MED, DEPT BIOCHEM, MATSUMOTO, NAGANO 390, JAPAN.							AKLI S, 1991, GENOMICS, V11, P124, DOI 10.1016/0888-7543(91)90109-R; AOYAMA T, 1994, J BIOL CHEM, V269, P19088; AOYAMA T, 1995, J CLIN INVEST, V95, P2465, DOI 10.1172/JCI117947; AOYAMA T, 1995, AM J HUM GENET, V57, P273; AOYAMA T, 1993, BIOCHEM BIOPH RES CO, V191, P1369, DOI 10.1006/bbrc.1993.1368; BERTRAND C, 1993, BIOCHIM BIOPHYS ACTA, V1180, P327, DOI 10.1016/0925-4439(93)90058-9; CHELLY J, 1990, CELL, V63, P1239, DOI 10.1016/0092-8674(90)90419-F; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COATES PM, 1992, PEDIATR RES, V31, P34, DOI 10.1203/00006450-199201000-00006; DAAR IO, 1988, MOL CELL BIOL, V8, P802, DOI 10.1128/MCB.8.2.802; GIBBS RA, 1989, P NATL ACAD SCI USA, V86, P1919, DOI 10.1073/pnas.86.6.1919; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HALE DE, 1990, PROG CLIN BIOL RES, V321, P303; INDO Y, 1991, PEDIATR RES, V30, P211, DOI 10.1203/00006450-199109000-00001; INGLEHEARN CF, 1991, AM J HUM GENET, V48, P26; IZAI K, 1992, J BIOL CHEM, V267, P1027; KAMIJO T, 1994, J CLIN INVEST, V93, P1740, DOI 10.1172/JCI117158; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMHONWAH AM, 1990, GENOMICS, V8, P249, DOI 10.1016/0888-7543(90)90279-4; LIM SK, 1992, MOL CELL BIOL, V12, P1149, DOI 10.1128/MCB.12.3.1149; MATSUBARA Y, 1989, J BIOL CHEM, V264, P16321; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; OGILVIE I, 1994, NEUROLOGY, V44, P467, DOI 10.1212/WNL.44.3_Part_1.467; SAIJO T, 1994, J BIOL CHEM, V269, P4401; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Tanaka K., 1992, Human Mutation, V1, P271, DOI 10.1002/humu.1380010402; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UCHIDA Y, 1992, J BIOL CHEM, V267, P1034; VERITY MA, 1993, BIOCHEM MED METAB B, V49, P351, DOI 10.1006/bmmb.1993.1036; YAMAGUCHI S, 1993, PEDIATR RES, V34, P111, DOI 10.1203/00006450-199307000-00025; YOKOTA I, 1992, J BIOL CHEM, V267, P26004; YOKOTA I, 1991, AM J HUM GENET, V49, P1280; ZIEGLER A, 1990, J BIOL CHEM, V265, P21194	34	51	52	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1996	58	1					97	106						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TL697	8554073				2022-12-18	WOS:A1996TL69700013
J	BRAUN, A; AMBACH, H; KAMMERER, S; ROLINSKI, B; STOCKLER, S; RABL, W; GARTNER, J; ZIERZ, S; ROSCHER, AA				BRAUN, A; AMBACH, H; KAMMERER, S; ROLINSKI, B; STOCKLER, S; RABL, W; GARTNER, J; ZIERZ, S; ROSCHER, AA			MUTATIONS IN THE GENE FOR X-LINKED ADRENOLEUKODYSTROPHY IN PATIENTS WITH DIFFERENT CLINICAL PHENOTYPES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								Recently, the gene for the most common peroxisomal disorder, X-linked adrenoleukodystrophy (X-ALD), has been described encoding a peroxisomal membrane transporter protein. We analyzed the entire protein-coding sequence of this gene by reverse-transcription PCR, SSCP, and DNA sequencing in five patients with different clinical expressions of X-ALD and in their female relatives; these clinical expressions were cerebral childhood ALD, adrenomyeloneuropathy (AMN), and ''Addison disease only'' (ADO) phenotype. In the three patients exhibiting the classical picture of severe childhood ALD we identified in the 5' portion of the X-ALD gene a 38-bp deletion that causes a frameshift mutation, a 3-bp deletion leading to a deletion of an amino acid in the ATP-binding domain of the ALD protein, and a missense mutation. In the patient with the clinical phenotype of AMN, a nonsense mutation in codon 212, along with a second site mutation at codon 178, was observed. Analysis of the patient with the ADO phenotype revealed a further missense mutation at a highly conserved position in the ALDP/PMP70 comparison. The disruptive nature of two mutations (i.e., the frameshift and the nonsense mutation) in patients with biochemically proved childhood ALD and AMN further strongly supports the hypothesis that alterations in this gene play a crucial role in the pathogenesis of X-ALD. Since the current biochemical techniques for X-ALD carrier detection in affected families lack sufficient reliability, our procedure described for systematic mutation scanning is also capable of improving genetic counseling and prenatal diagnosis.	UNIV MUNICH,INST ANTHROPOL & HUMAN GENET,W-8000 MUNICH,GERMANY; TECH UNIV MUNICH,DEPT PEDIAT,W-8000 MUNICH,GERMANY; GRAZ UNIV,DEPT PEDIAT,GRAZ,AUSTRIA; UNIV DUSSELDORF,DEPT PEDIAT,W-4000 DUSSELDORF,GERMANY; UNIV BONN,DEPT NEUROL,W-5300 BONN,GERMANY	University of Munich; Technical University of Munich; University of Graz; Heinrich Heine University Dusseldorf; University of Bonn	BRAUN, A (corresponding author), UNIV MUNICH,DEPT PEDIAT,CLIN BIOCHEM & METAB UNIT,LINDWURMSTR 4,D-80337 MUNICH,GERMANY.							BRAUN A, 1992, HUM GENET, V89, P401; CARTIER N, 1993, HUM MOL GENET, V2, P1949, DOI 10.1093/hmg/2.11.1949; CONTRERAS M, 1994, FEBS LETT, V344, P211, DOI 10.1016/0014-5793(94)00400-5; FANEN P, 1994, J CLIN INVEST, V94, P516, DOI 10.1172/JCI117363; GARTNER J, 1992, NAT GENET, V1, P16, DOI 10.1038/ng0492-16; GREGORY RJ, 1991, MOL CELL BIOL, V11, P3886, DOI 10.1128/MCB.11.8.3886; KEMP S, 1994, BIOCHEM BIOPH RES CO, V202, P647, DOI 10.1006/bbrc.1994.1979; LAZO O, 1988, P NATL ACAD SCI USA, V85, P7647, DOI 10.1073/pnas.85.20.7647; MAESTRI NE, 1992, AM J MED GENET, V44, P576, DOI 10.1002/ajmg.1320440509; MOSER HW, 1991, DEV NEUROSCI-BASEL, V13, P254, DOI 10.1159/000112170; MOSER HW, 1989, METABOLIC BASIS INHE, P1511; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; MOSSER J, 1994, HUM MOL GENET, V3, P265, DOI 10.1093/hmg/3.2.265; ROMEO G, 1994, NAT GENET, V7, P451, DOI 10.1038/ng0894-451; SARDE CO, 1994, GENOMICS, V22, P13, DOI 10.1006/geno.1994.1339; SMITH KD, 1991, AM J HUM GENET, V49, P165; UCHIYAMA A, 1994, BIOCHEM BIOPH RES CO, V198, P632, DOI 10.1006/bbrc.1994.1092; VALLE D, 1993, NATURE, V361, P682, DOI 10.1038/361682a0; WANDERS RJ, 1988, J INHERIT METAB D S2, V2, P173	19	51	53	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1995	56	4					854	861						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QP663	7717396				2022-12-18	WOS:A1995QP66300006
J	BYTH, BC; BILLINGSLEY, GD; COX, DW				BYTH, BC; BILLINGSLEY, GD; COX, DW			PHYSICAL AND GENETIC-MAPPING OF THE SERPIN GENE-CLUSTER AT 14Q32.1 - ALLELIC ASSOCIATION AND A UNIQUE HAPLOTYPE ASSOCIATED WITH ALPHA(1)-ANTITRYPSIN DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; ALPHA-1-ANTITRYPSIN; PI	The alpha(1)-antitrypsin (PI) gene is part of a cluster of structurally related serine protease inhibitor genes localized at chromosome 14q32.1, a cluster that includes the alpha(1)-antichymotrypsin (AACT), protein C inhibitor (PCI), and corticosteroid-binding globulin (CBG) genes and the alpha(1)-antitrypsin-like pseudogene (PIL). The order of the genes is refined here by genetic mapping using simple tandem repeat polymorphisms (STRPs) and by physical mapping in YACs. The order of the genes is (centromere)-CBG-PIL-PI-PCI-AACT-(telomere). Analysis of DNA haplotypes comprising STRP and RFLP markers in the serpin genes reveals considerable allelic association throughout the cluster. Furthermore, the common alpha(1)-antitrypsin deficiency allele, PI*Z, has a unique DNA haplotype at the CBG, PIL, and PI loci, which extends over 60 kb in 97% of cases and in 44% of cases includes the PCI and AACT loci. This unique haplotype will be of use in examining a number of other diseases, particularly those with an inflammatory component, thought to be associated with alpha(1)-antitrypsin deficiency or partial deficiency.	HOSP SICK CHILDREN,DEPT GENET,RES INST,TORONTO M5G 1X8,ON,CANADA; UNIV TORONTO,DEPT PAEDIAT,TORONTO M5S 1A1,ON,CANADA; UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO,ON,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto								ALBERTSEN HM, 1990, P NTL ACAD SCI US, V87, P5019; BILLINGSLEY GD, 1993, AM J HUM GENET, V52, P343; BILLINGSLEY GD, UNPUB CONTIGUOUS LIN; BRZUSTOWICZ LM, 1993, AM J HUM GENET, V53, P982; BYTH BC, 1993, HUM MOL GENET, V2, P1085, DOI 10.1093/hmg/2.7.1085-a; BYTH BC, 1993, HUM MOL GENET, V2, P1752, DOI 10.1093/hmg/2.10.1752-a; BYTH BC, UNPUB ALPHA 1 ANTITR; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; COX DW, 1985, NATURE, V316, P79, DOI 10.1038/316079a0; COX DW, 1987, PROTIDES BIOL FLUIDS, V35, P123; COX DW, IN PRESS METABOLIC B; HEDRICK PW, 1988, HEREDITY, V60, P435, DOI 10.1038/hdy.1988.61; KELSEY GD, 1988, J MED GENET, V25, P361, DOI 10.1136/jmg.25.6.361; KURNIT DM, 1979, LANCET, V1, P104; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LERNER TJ, 1994, AM J HUM GENET, V54, P88; LEWONTIN RC, 1964, GENETICS, V49, P49; OUDET C, 1993, AM J HUM GENET, V52, P297; SEFTON L, 1990, GENOMICS, V7, P382, DOI 10.1016/0888-7543(90)90172-Q; SHERRINGTON R, 1991, AM J HUM GENET, V49, P966; SIITERI PK, 1982, RECENT PROG HORM RES, V38, P457; THOMPSON EA, 1988, AM J HUM GENET, V42, P113	22	51	52	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1994	55	1					126	133						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NW461	7912884				2022-12-18	WOS:A1994NW46100018
J	GOLDSTEIN, AM; STEWART, C; BALE, AE; BALE, SJ; DEAN, M				GOLDSTEIN, AM; STEWART, C; BALE, AE; BALE, SJ; DEAN, M			LOCALIZATION OF THE GENE FOR THE NEVOID BASAL-CELL CARCINOMA SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GORLIN SYNDROME; LINKAGE; DNA	The nevoid basal cell carcinoma syndrome (NBCC) is an autosomal dominant multisystem disorder characterized by multiple basal cell carcinomas, jaw cysts, pits of the palms and/or soles, ectopic calcification, and skeletal malformations. The NBCC gene has recently been mapped to chromosome 9q22.3-9q31. In order to further define the region containing the NBCC gene, we have analyzed 137 individuals from eight families for linkage, using 11 markers from the region. Eight markers showed statistically significant evidence for linkage to NBCC. Three markers (D9S180, ALDOB, and D9S173) showed no definite recombination with the disease locus. All families showed some evidence for linkage to markers in this region. On the basis of the inspection of individual recombinants and previously published information about map location, we suggest the following order for the markers: D9S119-D9S12-D9S197-D9S196-(NBCC,D9S180-D9S173,ALDOB)-D9S109-D9S127-(D9S53,D9S29). We are currently developing YAC contigs for the most closely linked markers, to further refine the location of the NBCC gene.	NCI,CLIN EPIDEMIOL BRANCH,BETHESDA,MD 20892; NCI,VIRAL CARCINOGENESIS LAB,BETHESDA,MD 20892; FREDERICK CANC RES & DEV CTR,DYNCORP,PROGRAM RESOURCES INC,BCDP,FREDERICK,MD 21701	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	GOLDSTEIN, AM (corresponding author), NCI,GENET EPIDEMIOL BRANCH,EXECUT PLAZA N,ROOM 439,BETHESDA,MD 20892, USA.		Dean, Michael C/G-8172-2012; Dean, Michael/R-7501-2019	Dean, Michael C/0000-0003-2234-0631; 				ANDERSON DE, 1967, AM J HUM GENET, V19, P12; BINKLEY GW, 1951, AMA ARCH DERM SYPH, V63, P73, DOI 10.1001/archderm.1951.01570010076006; CHENEVIXTRENCH G, 1993, AM J HUM GENET, V53, P760; COMPTON JC, UNPUB FINE MAPPING N; DEAN M, 1993, AM J HUM GENET, V53, P285; EVANS DGR, 1991, BRIT J CANCER, V64, P959, DOI 10.1038/bjc.1991.435; FARNDON PA, 1992, LANCET, V339, P581, DOI 10.1016/0140-6736(92)90868-4; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GAILANI MR, 1992, CELL, V69, P111, DOI 10.1016/0092-8674(92)90122-S; GOLDSTEIN AM, IN PRESS AM J MED GE; GORLIN RJ, 1960, NEW ENGL J MED, V262, P908, DOI 10.1056/NEJM196005052621803; GORLIN RJ, 1987, MEDICINE, V66, P98, DOI 10.1097/00005792-198703000-00002; GOUDIE DR, 1993, NAT GENET, V3, P165, DOI 10.1038/ng0293-165; HOWELL JB, 1959, ARCH DERMATOL, V79, P67, DOI 10.1001/archderm.1959.01560130069008; HOWELL JB, 1982, ARCH DERMATOL, V118, P824, DOI 10.1001/archderm.1982.01650220128018; JARISCH W, 1894, ARCH DERMATOL SYPHIL, V28, P162; LATHROP GM, 1985, AM J HUM GENET, V37, P482; REIS A, 1992, LANCET, V339, P617, DOI 10.1016/0140-6736(92)90903-G; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; White J. C., 1894, J CUTAN GENITOURIN D, V12, P477; WILLIAMSON R, 1991, CYTOGENET CELL GENET, V58, P1190, DOI 10.1159/000133727	22	51	52	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1994	54	5					765	773						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NH394	7909984				2022-12-18	WOS:A1994NH39400005
J	LOPESCENDES, I; ANDERMANN, E; ATTIG, E; CENDES, F; BOSCH, S; WAGNER, M; GERSTENBRAND, F; ANDERMANN, F; ROULEAU, GA				LOPESCENDES, I; ANDERMANN, E; ATTIG, E; CENDES, F; BOSCH, S; WAGNER, M; GERSTENBRAND, F; ANDERMANN, F; ROULEAU, GA			CONFIRMATION OF THE SCA-2 LOCUS AS AN ALTERNATIVE LOCUS FOR DOMINANTLY INHERITED SPINOCEREBELLAR ATAXIAS AND REFINEMENT OF THE CANDIDATE REGION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY ATAXIA; GENETIC-LINKAGE; OLIVOPONTOCEREBELLAR ATROPHY; REPEAT POLYMORPHISM; CEREBELLAR-ATAXIA; DISEASE LOCUS; HLA; CHROMOSOME-6; KINDREDS; HETEROGENEITY	The autosomal dominant spinocerebellar ataxias (SCAs) are a clinically heterogeneous group of neurodegenerative diseases. To date, two SCA loci have been identified-one locus (SCA-I) on the shore arm of chromosome 6 and the second locus (SCA-2) on the long arm of chromosome 12. We have studied two large kindreds from different ethnic backgrounds, segregating an autosomal dominant form of SCA. A total of 207 living individuals, including 50 affected, were examined, and blood was collected. We performed linkage analysis using anonymous DNA markers which flank the two previously described loci. Our results demonstrate that the two kindreds, one Austrian-Canadian and one French-Canadian, are linked to SCA-2 (chromosome 12q). Multipoint linkage analysis places the SCA-2 locus within a region of approximately 16 cM between the microsatellites D12S58 and D12S84/D12S105 (odds ratio 2,371:1 in favor of this position). We show that the SCA-2 locus is not a private gene and represents an alternative SCA locus.	MCGILL UNIV, MONTREAL CHILDRENS HOSP, RES INST, CTR RES NEUROSCI, MONTREAL H3G 1A4, PQ, CANADA; MCGILL UNIV, NEUROGENET UNIT, MONTREAL, PQ, CANADA; MCGILL UNIV, MONTREAL NEUROL INST, DEPT NEUROL, MONTREAL, PQ, CANADA; MCGILL UNIV HOSP, MONTREAL, PQ, CANADA; MCGILL UNIV, DEPT NEUROSURG, MONTREAL H3A 2T5, PQ, CANADA; MCGILL UNIV, DEPT HUMAN GENET, MONTREAL, PQ, CANADA; HOP HOTEL DIEU, DEPT NEUROL, MONTREAL, PQ, CANADA; UNIV INNSBRUCK HOSP, DEPT NEUROL, A-6020 INNSBRUCK, AUSTRIA	McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; Universite de Montreal; Medical University of Innsbruck			Wagner, Michael/E-2325-2011; Lopes-Cendes, Iscia/B-9416-2013; Cendes, Fernando/C-1301-2012	Wagner, Michael/0000-0003-2589-6440; Lopes-Cendes, Iscia/0000-0002-6221-6822; Cendes, Fernando/0000-0001-9336-9568				ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; AUBURGER G, 1990, AM J HUM GENET, V46, P1163; BARBEAU A, 1978, SPINOCEREBELLAR DEGE, P121; BLASS JP, 1988, REV NEUROL, V144, P543; CARSON WJ, 1992, GENOMICS, V13, P852, DOI 10.1016/0888-7543(92)90168-R; DIAZ GO, 1990, NEUROLOGY, V40, P1369, DOI 10.1212/WNL.40.9.1369; DUVOISIN RC, 1983, NEUROLOGY, V33, P1322; FRONTALI M, 1991, ANN HUM GENET, V55, P7, DOI 10.1111/j.1469-1809.1991.tb00393.x; GERSTENBRAND F, 1962, WIEN KLIN WOCHENSCHR, V41, P702; GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; Greenfield JG, 1954, SPINOCEREBELLAR DEGE; GUDMUNDSSON KR, 1969, ACTA NEUROL SCAND, V45, P114; HAINES JL, 1984, NEUROLOGY, V34, P1542, DOI 10.1212/WNL.34.12.1542; HARDING AE, 1984, HEREDITARY ATAXIAS R, P129; HODGE SE, 1979, AM J HUM GENET, V31, pA135; Jackson J F, 1978, Adv Neurol, V21, P315; JACKSON JF, 1977, NEW ENGL J MED, V296, P1138, DOI 10.1056/NEJM197705192962003; KEATS BJB, 1991, AM J HUM GENET, V49, P972; KHATI C, 1993, NEUROLOGY, V43, P1131, DOI 10.1212/WNL.43.6.1131; KISH SJ, 1987, ANN NEUROL, V22, P272, DOI 10.1002/ana.410220214; KOEPPEN AH, 1980, LANCET, V1, P92; KUMAR D, 1986, HUM GENET, V72, P327, DOI 10.1007/BF00290959; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LAZZARINI A, 1992, NEUROLOGY, V42, P2118, DOI 10.1212/WNL.42.11.2118; LITT M, 1990, NUCLEIC ACIDS RES, V18, P4301, DOI 10.1093/nar/18.14.4301; MANYAM BV, 1990, ARCH NEUROL-CHICAGO, V47, P1194, DOI 10.1001/archneur.1990.00530110048016; MOLLER E, 1978, TISSUE ANTIGENS, V12, P357, DOI 10.1111/j.1399-0039.1978.tb01345.x; NANCARROW DJ, 1992, GENOMICS, V14, P939, DOI 10.1016/S0888-7543(05)80115-6; NINO HE, 1980, NEUROLOGY, V30, P12, DOI 10.1212/WNL.30.1.12; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; OTT J, 1974, AM J HUM GENET, V26, P588; OTT J, 1991, ANAL HUMAN GENETIC L, P65; PEDERSEN L, 1980, HUM GENET, V54, P371, DOI 10.1007/BF00291585; PEDRAZA OL, 1992, J NEUROL NEUROSUR PS, V55, P136, DOI 10.1136/jnnp.55.2.136; POLYMEROPOULOS MH, 1990, NUCLEIC ACIDS RES, V18, P7468, DOI 10.1093/nar/18.24.7468-a; PULST SM, 1993, NAT GENET, V5, P8, DOI 10.1038/ng0993-8c; RANUM LPW, 1991, AM J HUM GENET, V49, P31; RANUM LPW, 1992, NEUROLOGY, V42, P344, DOI 10.1212/WNL.42.2.344; RICH SS, 1987, AM J HUM GENET, V41, P524; ROSENBERG RN, 1990, NEUROLOGY, V40, P1329, DOI 10.1212/WNL.40.9.1329; Sambrook J., 1989, MOL CLONING LAB MANU; SKRE H, 1978, SPINOCEREBELLAR DEGE, P103; TAKIYAMA Y, 1993, NAT GENET, V4, P300, DOI 10.1038/ng0793-300; WADIA NH, 1971, BRAIN, V94, P359, DOI 10.1093/brain/94.2.359; WASTIAUX JP, 1978, CAN J NEUROL SCI, V5, P75, DOI 10.1017/S0317167100024811; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WERDELIN L, 1990, NEUROEPIDEMIOLOGY, V9, P321, DOI 10.1159/000110795; WILKIE PJ, 1991, HUM GENET, V87, P405; YAKURA H, 1974, NEW ENGL J MED, V291, P154; ZOGHBI HY, 1991, AM J HUM GENET, V49, P23; 1992, GENETHON MICROSATELL	51	51	52	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1994	54	5					774	781						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NH394	8178818				2022-12-18	WOS:A1994NH39400006
J	SZATHMARY, EJE				SZATHMARY, EJE			MTDNA AND THE PEOPLING OF THE AMERICA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							NORTH AMERINDIAN POPULATIONS; GENETIC-VARIATION; MITOCHONDRIAL DNAS; MOLECULAR-DATA; SOUTH-AMERICA; SETTLEMENT; DIVERSITY; INDIANS; MICROEVOLUTION; FREQUENCIES				SZATHMARY, EJE (corresponding author), UNIV WESTERN ONTARIO,FAC SOCIAL SCI,OFF DEAN,LONDON N6A 5C2,ONTARIO,CANADA.							ADOVASIO JM, 1992, AM ANTIQUITY, V57, P327, DOI 10.2307/280737; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; BARRANTES R, 1990, AM J HUM GENET, V46, P63; BLACK FL, 1983, AM J PHYS ANTHROPOL, V60, P327, DOI 10.1002/ajpa.1330600305; Brues A.M., 1977, PEOPLE RACES; CALLEGARIJACQUES SM, 1993, AM J PHYS ANTHROPOL, V90, P427, DOI 10.1002/ajpa.1330900404; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; CAVALLISFORZA LL, 1965, GENETICS TODAY, P923; CHAKRABORTY R, 1988, AM J HUM GENET, V43, P709; CHAKRABORTY R, 1991, AM J PHYS ANTHROPOL, V86, P497, DOI 10.1002/ajpa.1330860405; DILLEHAY TD, 1991, AM ANTIQUITY, V56, P333, DOI 10.2307/281422; Fagan Brian M, 1987, GREAT JOURNEY PEOPLI; FITCH WM, 1969, AM J HUM GENET, V21, P384; Greenberg J. H, 1987, LANGUAGE AM; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; GRUHN R, 1991, AM ANTIQUITY, V56, P342, DOI 10.2307/281423; HOFFECKER JF, 1993, SCIENCE, V259, P46, DOI 10.1126/science.259.5091.46; JACKSON LE, IN PRESS PREHISTORIC; LUNDSTROM R, 1992, P NATL ACAD SCI USA, V89, P5961, DOI 10.1073/pnas.89.13.5961; LYNCH TF, 1990, AM ANTIQUITY, V55, P12, DOI 10.2307/281490; MADDISON DR, 1991, SYST ZOOL, V40, P355, DOI 10.2307/2992327; MCGHEE R, 1978, CURR ANTHROPOL, V19, P690; Meltzer David J., 1993, EVOL ANTHROPOL, V1, P157; MERRIWETHER DA, 1991, J MOL EVOL, V33, P543, DOI 10.1007/BF02102807; MORELL V, 1990, SCIENCE, V248, P439, DOI 10.1126/science.248.4954.439; NEI M, 1982, EVOL BIOL, V14, P1; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; NEI M, 1993, MOL BIOL EVOL, V10, P927; Nei M., 1987, MOL EVOLUTIONARY GEN; Neumann G., 1952, ARCHAEOLOGY E US, P13; NICHOLS J, 1990, LANGUAGE, V66, P475, DOI 10.2307/414609; OROURKE DH, 1985, AM J PHYS ANTHROPOL, V67, P241, DOI 10.1002/ajpa.1330670309; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; POWERS WR, 1989, AM ANTIQUITY, V54, P263, DOI 10.2307/281707; ROGERS RA, 1991, J BIOGEOGR, V18, P623, DOI 10.2307/2845543; ROYCHOUDHURY AK, 1975, AM J PHYS ANTHROPOL, V42, P449, DOI 10.1002/ajpa.1330420312; RUHLEN M, IN PRESS ORIGN LANGU; SCHURR TG, 1990, AM J HUM GENET, V46, P613; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; SHIELDS GF, 1992, AM J HUM GENET, V50, P758; Spuhler J. N., 1979, 1ST AM ORIGINS AFFIN, P135; SPUHLER JN, 1972, ASSESSMENT POPULATIO, P72; Stewart TD, 1951, AM ANTHROPOL, V53, P19, DOI 10.1525/aa.1951.53.1.02a00040; STEWART TD, 1974, PEOPLE AM; SUAREZ BK, 1985, AM J PHYS ANTHROPOL, V67, P233, DOI 10.1002/ajpa.1330670308; SUAREZ BK, 1985, AM J PHYS ANTHROPOL, V67, P217, DOI 10.1002/ajpa.1330670307; SZATHMARY E J E, 1984, Acta Anthropogenetica, V8, P79; Szathmary E.J.E., 1981, YEARB PHYS ANTHROPOL, V24, P37; SZATHMARY EJE, 1978, CURR ANTHROPOL, V19, P673, DOI 10.1086/202192; Szathmary Emoke J. E., 1993, EVOL ANTHROPOL, V1, P202; TEMPLETON AR, 1993, AM ANTHROPOL, V95, P51, DOI 10.1525/aa.1993.95.1.02a00030; THOMPSON EA, 1992, AM J HUM GENET, V51, P609; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; TURNER CG, 1988, SCI AM, V260, P88; Turner II C. G., 1983, EARLY MAN NEW WORLD, P147; WALLACE DC, 1985, AM J PHYS ANTHROPOL, V68, P149, DOI 10.1002/ajpa.1330680202; WARD RH, 1976, GENETICS, V82, P103; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; WARD RH, IN PRESS P NATL ACAD; WEISS KM, 1988, BIOL ASPECTS HUMAN M; WILLIAMS RC, 1985, AM J PHYS ANTHROPOL, V66, P1, DOI 10.1002/ajpa.1330660102; [No title captured]; [No title captured]	66	51	51	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1993	53	4					793	799						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	LY627	7692724				2022-12-18	WOS:A1993LY62700001
J	RAY, AK; FIELD, LL; MARAZITA, ML				RAY, AK; FIELD, LL; MARAZITA, ML			NONSYNDROMIC CLEFT-LIP WITH OR WITHOUT CLEFT-PALATE IN WEST-BENGAL, INDIA - EVIDENCE FOR AN AUTOSOMAL MAJOR LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX SEGREGATION ANALYSIS	Ninety extended families having one or more individuals affected with nonsyndromic cleft lip (CL) with or without cleft palate (CL/P) were ascertained in rural West Bengal, India. These families included 138 affected people, 64% of whom had CL alone and 66% of whom were male. Multiple-affected-member (''multiplex'') pedigrees were less common than single-affected-member (''simplex'') pedigrees, composing 34% of all extended pedigrees. There was no difference between multiplex and simplex pedigrees in the frequency of affected persons with CL alone, but multiplex pedigrees had a lower frequency of affected males (58%) than did simplex pedigrees (76%; P = .02). Complex segregation analysis using the POINTER computer program rejected both the hypothesis of no familial transmission (P < .0001) and the hypothesis that familiality could be explained solely by a multifactorial/threshold model (P < .05). The hypothesis of major-locus inheritance alone could not be rejected. Among major-locus models examined, strictly recessive inheritance was rejected (P < .0001), but codominant and dominant models were not. Neither the addition of a multifactorial component nor the addition of a proportion of sporadic cases to the major-locus model improved the fit of the data. In conclusion, the results of complex segregation analysis were consistent with a dominant or codominant major-locus mode of inheritance of CL/P in these families.	UNIV CALGARY,HLTH SCI CTR,DEPT PEDIAT,3330 HOSP DR NW,CALGARY T2N 4N1,AB,CANADA; ALBERTA CHILDRENS PROV GEN HOSP,CALGARY T2T 5C7,ALBERTA,CANADA; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,RICHMOND,VA 23298; UNIV TORONTO,TORONTO M5S 1A1,ONTARIO,CANADA	University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba; Alberta Childrens Hospital; University of Calgary; Virginia Commonwealth University; University of Toronto					NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE007360] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE-07360] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; DRONAMRAJU KR, 1984, CLIN GENET, V26, P322; FARRALL M, 1992, AM J HUM GENET, V50, P270; Fogh-Andersen, 1942, INHERITANCE HARELIP; ISELIUS L, 1991, AM J HUM GENET, V49, P459; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; MARAZITA ML, 1992, AM J HUM GENET, V51, P648; MELNICK M, 1980, AM J MED GENET, V6, P83, DOI 10.1002/ajmg.1320060108; MITCHELL LE, 1992, AM J HUM GENET, V51, P323; Morton N.E., 1983, METHODS GENETIC EPID; MORTON NE, 1974, AM J HUM GENET, V26, P489; NEMANA LJ, 1992, AM J MED GENET, V42, P5, DOI 10.1002/ajmg.1320420103; NISWANDER JD, 1972, LANCET, V2, P858	14	51	51	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1993	52	5					1006	1011						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LB889	8488830				2022-12-18	WOS:A1993LB88900019
J	KONTUSAARI, S; TROMP, G; KUIVANIEMI, H; STOLLE, C; POPE, FM; PROCKOP, DJ				KONTUSAARI, S; TROMP, G; KUIVANIEMI, H; STOLLE, C; POPE, FM; PROCKOP, DJ			SUBSTITUTION OF ASPARTATE FOR GLYCINE-1018 IN THE TYPE-III PROCOLLAGEN (COL3A1) GENE CAUSES TYPE-IV EHLERS-DANLOS SYNDROME - THE MUTATED ALLELE IS PRESENT IN MOST BLOOD LEUKOCYTES OF THE ASYMPTOMATIC AND MOSAIC MOTHER	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISMS; LETHAL OSTEOGENESIS IMPERFECTA; MUSCULAR-DYSTROPHY MUTATIONS; SINGLE BASE MUTATION; ALPHA-1(III) COLLAGEN; SOMATIC MOSAICISM; AORTIC-ANEURYSMS; 3' END; PATIENT; CDNA	A proband with arterial ruptures and skin changes characteristic of the type IV variant of Ehlers-Danlos syndrome was found to have a single-base mutation in the type III procollagen gene, which converted the codon for glycine at amino acid position 1018 to a codon for aspartate. (Amino acid positions are numbered by the standard convention in which the first glycine of the triple-helical domain of an alpha-chain is number 1. The numbers of positions in the alpha-1(III) chains can be converted to positions in the human pro-alpha(III) chain by adding 167.) Nucleotide sequencing of overlapping PCR products in which the two alleles were distinguished demonstrated that the mutation of glycine 1018 was the only mutation that changed the primary structure of type III procollagen. The glycine substitution markedly decreased the amount of type III procollagen secreted into the medium by cultured skin fibroblasts from the proband. It is surprising that the same mutation was found in about 94% of the peripheral blood leukocytes from the proband's asymptomatic 72-year-old mother. Other tissues from the mother contained the mutated allele; it was present in 0%-100% of different samples of hair cells and in about 40% of cells from the oral epithelium. Therefore, the mother was a mosaic for the mutation. Since the mutated allele was present in cells derived from all three germ layers, the results indicated that the mutation arose by the late blastocyst stage of development. The results also indicate that assays of blood leukocytes do not always reveal mosaicism or predict phenotypic involvement of tissues, such as blood vessels, that are derived from the same embryonic cells as are leukocytes.	THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,JEFFERSON INST MOLEC MED,DEPT BIOCHEM & MOLEC BIOL,PHILADELPHIA,PA 19107; UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,DEPT MED,PISCATAWAY,NJ 08854; CLIN RES CTR,DERMATOL RES GRP,HARROW HA1 3UJ,MIDDX,ENGLAND; UNIV OULU,DEPT BIOCHEM,SF-90100 OULU 10,FINLAND; UNIV OULU,BIOCTR,SF-90100 OULU 10,FINLAND	Jefferson University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu			Kuivaniemi, Helena/Q-8178-2019; Tromp, Gerard/B-2677-2017	Kuivaniemi, Helena/0000-0001-5753-8766; Tromp, Gerard/0000-0002-7761-0806	NIAMS NIH HHS [AR-38188] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR038188] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALAKOKKO L, 1989, BIOCHEM J, V260, P509, DOI 10.1042/bj2600509; BAKKER E, 1987, NATURE, V329, P554, DOI 10.1038/329554a0; BAKKER E, 1989, J MED GENET, V26, P553, DOI 10.1136/jmg.26.9.553; Beighton PH, 1970, EHLERS DANLOS SYNDRO; BRUCKNER P, 1981, ANAL BIOCHEM, V110, P365; BYERS PH, 1988, AM J HUM GENET, V42, P237; BYERS PH, 1981, LAB INVEST, V44, P336; BYERS PH, 1982, CLIN MED, P1; CARLSON BM, 1988, PATTENS F EMBRYOLOGY; CHU ML, 1985, J BIOL CHEM, V260, P4357; COHN DH, 1990, AM J HUM GENET, V46, P591; COLE WG, 1990, J BIOL CHEM, V265, P17070; CONSTANTINOU CD, 1990, AM J HUM GENET, V47, P670; DARRAS BT, 1987, NATURE, V329, P556, DOI 10.1038/329556a0; DEAK SB, 1990, MATRIX, V10, pA237; DEPAEPE A, 1988, CLIN NEUROL NEUROSUR, V90, P53, DOI 10.1016/S0303-8467(88)80010-6; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HALL JG, 1988, AM J HUM GENET, V43, P355; Higuchi R, 1989, PCR TECHNOLOGY PRINC, P31; KONTUSAARI S, 1990, J CLIN INVEST, V86, P1465, DOI 10.1172/JCI114863; KONTUSAARI S, 1990, AM J HUM GENET, V47, P112; KUIVANIEMI H, 1991, FASEB J, V5, P2052, DOI 10.1096/fasebj.5.7.2010058; KUIVANIEMI H, 1990, J BIOL CHEM, V265, P12067; LEE B, 1991, J BIOL CHEM, V266, P5256; LEE B, 1991, AM J HUM GENET, V48, P511; LOIDL HR, 1984, NUCLEIC ACIDS RES, V12, P9383, DOI 10.1093/nar/12.24.9383; Maniatis T., 1982, MOL CLONING; MANKOO BS, 1988, NUCLEIC ACIDS RES, V16, P2337, DOI 10.1093/nar/16.5.2337; MCGOOKEY D J, 1989, American Journal of Human Genetics, V45, pA206; MCKUSICK VA, 1972, HERITABLE DISORDERS, P292; MISKULIN M, 1986, BIOCHEMISTRY-US, V25, P1408, DOI 10.1021/bi00354a033; MORRIS D, 1957, J R SOC MED, V50, P330; NEILDWYER G, 1983, J NEUROSURG, V59, P16, DOI 10.3171/jns.1983.59.1.0016; OSTERGAARD JR, 1987, J NEUROSURG, V67, P690, DOI 10.3171/jns.1987.67.5.0690; PELTONEN L, 1980, P NATL ACAD SCI-BIOL, V77, P162, DOI 10.1073/pnas.77.1.162; POPE FM, 1983, J ROY SOC MED, V76, P518, DOI 10.1177/014107688307600614; POPE FM, 1975, P NATL ACAD SCI USA, V72, P1314, DOI 10.1073/pnas.72.4.1314; RICHARDS AJ, 1991, J MED GENET, V28, P458, DOI 10.1136/jmg.28.7.458; Sadler T.W, 1990, LANGMANS MED EMBRYOL, Vsixth; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARKAR G, 1990, NATURE, V343, P27, DOI 10.1038/343027a0; SHAMBAN A, 1989, TXB PEDIATRIC DERMAT, P117; STOLLE CA, 1985, J BIOL CHEM, V260, P1937; STUDENCKI AB, 1984, DNA-J MOLEC CELL BIO, V3, P7, DOI 10.1089/dna.1.1984.3.7; SUPERTIFURGA A, 1989, HUM GENET, V82, P104, DOI 10.1007/BF00284038; SYKES B, 1976, BIOCHEM BIOPH RES CO, V72, P1472, DOI 10.1016/S0006-291X(76)80180-5; THAKKER-VARIA S, 1990, Matrix, V10, P249; TOMAN PD, 1988, NUCLEIC ACIDS RES, V16, P7201, DOI 10.1093/nar/16.14.7201; TROMP G, 1989, J BIOL CHEM, V264, P1349; TROMP G, 1989, J BIOL CHEM, V264, P19313; VISSING H, 1991, J BIOL CHEM, V266, P5244; WALLIS GA, 1990, AM J HUM GENET, V46, P1034; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4636, DOI 10.1093/nar/18.15.4636-a; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4039, DOI 10.1093/nar/18.13.4039; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4640, DOI 10.1093/nar/18.15.4640-a; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P2201; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P2199; ZAFARULLAH K, 1990, NUCLEIC ACIDS RES, V18, P6180, DOI 10.1093/nar/18.20.6180	59	51	52	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1992	51	3					497	507						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JJ828	1496983				2022-12-18	WOS:A1992JJ82800006
J	BASLER, E; GROMPE, M; PARENTI, G; YATES, J; BALLABIO, A				BASLER, E; GROMPE, M; PARENTI, G; YATES, J; BALLABIO, A			IDENTIFICATION OF POINT MUTATIONS IN THE STEROID SULFATASE GENE OF 3 PATIENTS WITH X-LINKED ICHTHYOSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FREQUENT OCCURRENCE; DEFICIENCY; CDNA; DNA; DELETIONS; CHROMOSOME; CLONING; HETEROGENEITY; REACTIVITY; CYTOSINE	X-linked ichthyosis (XLI) is an inborn error of metabolism caused by steroid sulfatase (STS) deficiency. In more than 80% of XLI patients the enzyme deficiency is due to large deletions involving the entire STS gene and flanking sequences. However, some patients with the classical XLI phenotype and complete STS deficiency do not show any detectable deletions by Southern blot analysis using full-length STS cDNA as a probe. We have studied five unrelated patients who are such "nondeletion" mutants. Western blot analysis using anti-STS antibodies was performed on patients' fibroblast extracts and revealed absence of cross-reacting material. First-strand cDNA synthesis by reverse transcription from patients' RNA isolated from cultured fibroblasts and PCR amplification of overlapping segments of the entire STS polypeptide coding region were performed. Three point mutations were identified by chemical mismatch cleavage, sequenced by dideoxynucleotide chain-termination sequencing and confirmed by allele-specific oligonucleotide hybridization of the patients' genomic DNA. The mutations resulted in the substitution of a tryptophan for an arginine at codon 1319, changing a hydrophobic to a basic hydrophilic amino acid, the substitution of a cysteine for a tyrosine at codon 1542, potentially losing a disulfide bond, and the substitution of a serine for a leucine at codon 1237. These are the first point mutations to be documented in the STS gene and may allow insight into functionally important domains of the protein.	BAYLOR COLL MED,INST MOLEC GENET,1 BAYLOR PLAZA,HOUSTON,TX 77030; UNIV REGGIO CALABRIA,DEPT PEDIAT,CATANZARO,ITALY; UNIV CAMBRIDGE,DEPT PATHOL,CAMBRIDGE,ENGLAND	Baylor College of Medicine; Universita Mediterranea di Reggio Calabria; University of Cambridge				Grompe, Markus/0000-0002-6616-4345; parenti, giancarlo/0000-0002-6287-5748; BALLABIO, Andrea/0000-0003-1381-4604	NICHD NIH HHS [HD00850, HD24064] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BALLABIO A, 1987, P NATL ACAD SCI USA, V84, P4519, DOI 10.1073/pnas.84.13.4519; BALLABIO A, 1985, HUM GENET, V70, P315, DOI 10.1007/BF00295367; BALLABIO A, 1989, GENOMICS, V4, P36, DOI 10.1016/0888-7543(89)90311-X; BONIFAS JM, 1987, P NATL ACAD SCI USA, V84, P9248, DOI 10.1073/pnas.84.24.9248; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CONARY JT, 1987, BIOCHEM BIOPH RES CO, V144, P1010, DOI 10.1016/S0006-291X(87)80064-5; COTTON RGH, 1989, NUCLEIC ACIDS RES, V17, P4223, DOI 10.1093/nar/17.11.4223; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; COTTON RGH, 1990, AM J HUNT GENET S, V47, pA212; DIANZANI I, 1991, AM J HUM GENET, V48, P631; GIBBS RA, 1989, P NATL ACAD SCI USA, V86, P1919, DOI 10.1073/pnas.86.6.1919; GROMPE M, 1989, P NATL ACAD SCI USA, V86, P5888, DOI 10.1073/pnas.86.15.5888; GROMPE M, 1991, J BACTERIOL, V173, P1268, DOI 10.1128/jb.173.3.1268-1278.1991; LAMANDE SR, 1989, J BIOL CHEM, V264, P15809; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; PARENTI G, 1987, J INHERIT METAB DIS, V10, P224, DOI 10.1007/BF01800065; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHUCHMAN EH, 1990, GENOMICS, V6, P149, DOI 10.1016/0888-7543(90)90460-C; SHAPIRO LJ, 1989, P NATL ACAD SCI USA, V86, P8477, DOI 10.1073/pnas.86.21.8477; SHAPIRO LJ, 1989, METABOLIC BASIS INHE, P1945; TIEPOLO L, 1980, HUM GENET, V54, P205, DOI 10.1007/BF00278973; VANDERLOOS CM, 1984, J INHERIT METAB DIS, V7, P97, DOI 10.1007/BF01801762; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; WIRTH B, 1988, HUM GENET, V80, P191, DOI 10.1007/BF00702868; YEN PH, 1988, CELL, V55, P1123, DOI 10.1016/0092-8674(88)90257-7; YEN PH, 1987, CELL, V49, P443, DOI 10.1016/0092-8674(87)90447-8	27	51	54	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1992	50	3					483	491						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HH974	1539590				2022-12-18	WOS:A1992HH97400005
J	SHEN, FM; LEE, MK; GONG, HM; CAI, XQ; KING, MC				SHEN, FM; LEE, MK; GONG, HM; CAI, XQ; KING, MC			COMPLEX SEGREGATION ANALYSIS OF PRIMARY HEPATOCELLULAR-CARCINOMA IN CHINESE FAMILIES - INTERACTION OF INHERITED SUSCEPTIBILITY AND HEPATITIS-B VIRAL-INFECTION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRIMARY LIVER-CANCER; VIRUS; EPIDEMIOLOGY; ANTIGEN; TAIWAN; TUMOR	Primary hepatocellular carcinoma (PHC) is extremely common in eastern China, where it is both associated with chronic infection with hepatitis B virus (HBV) and often familial. Complex segregation analysis of 490 extended families was undertaken with liability classes defined by age, sex, and HBV infection status. The maximum-likelihood model suggests that a recessive allele with population frequency approximately .25 yields lifetime risk of PHC, in the presence of both HBV infection and genetic susceptibility, of .84 for males and .46 for females. The model further predicts that, in the absence of genetic susceptibility, lifetime risk of PHC is .09 for HBV-infected males and .01 for HBV-infected females and that, regardless of genotype, it is virtually zero for uninfected persons. Complex segregation analysis therefore provides evidence for the interaction of genotype, environmental exposure, sex and age in determining the occurrence of PHC in this population.	UNIV CALIF BERKELEY,SCH PUBL HLTH,BERKELEY,CA 94720; SHANGHAI MED UNIV,DEPT EPIDEMIOL,SHANGHAI,PEOPLES R CHINA; INST LIVER CANC RES,JIANGSU,PEOPLES R CHINA	University of California System; University of California Berkeley; Fudan University				King, Mary-Claire/0000-0001-9426-1743				BEASLEY RP, 1981, LANCET, V2, P1129; BLUMBERG BS, 1981, NEW ENGL J MED, V304, P782, DOI 10.1056/NEJM198103263041312; BUETOW KH, 1989, P NATL ACAD SCI USA, V86, P8852, DOI 10.1073/pnas.86.22.8852; CAMPBELL TC, 1990, CANCER RES, V50, P6882; FALK H, 1982, CANCER EPIDEMIOL, P668; FERET E, 1987, AM J EPIDEMIOL, V125, P140, DOI 10.1093/oxfordjournals.aje.a114497; GONG HM, 1986, CHIN MED J, V66, P93; HSU HC, 1989, HEPATOLOGY, V9, P747, DOI 10.1002/hep.1840090515; HSU HC, 1991, NATURE, V305, P427; ILJIMA J, 1984, GANN, V75, P571; KEW MC, 1986, CANCER SURV, V5, P719; LALOUEL JM, 1980, POINTER COMPUTER PRO; LAM KC, 1982, CANCER RES, V42, P5246; LOK ASF, 1988, CANCER, V61, P1287, DOI 10.1002/1097-0142(19880401)61:7<1287::AID-CNCR2820610702>3.0.CO;2-D; LONDON WT, 1988, CANCER INVEST, V6, P317, DOI 10.3109/07357908809080654; Morton N.E., 1983, METHODS GENETIC EPID; OHBAYASHI A, 1972, GASTROENTEROLOGY, V62, P618; SUNG JL, 1980, SCAND J GASTROENTERO, V15, P321, DOI 10.3109/00365528009181477; YANG P, 1990, AM J HUM GENET S, V47, pA25; YEH FS, 1989, CANCER RES, V49, P2506; YEH FS, 1986, ADV CANCER RES, V47, P297; 1979, ATLAS CANCER MORTALI	22	51	57	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1991	49	1					88	93						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FW511	1648308				2022-12-18	WOS:A1991FW51100011
J	DEKA, R; CHAKRAVARTI, A; SURTI, U; HAUSELMAN, E; REEFER, J; MAJUMDER, PP; FERRELL, RE				DEKA, R; CHAKRAVARTI, A; SURTI, U; HAUSELMAN, E; REEFER, J; MAJUMDER, PP; FERRELL, RE			GENETICS AND BIOLOGY OF HUMAN OVARIAN TERATOMAS .2. MOLECULAR ANALYSIS OF ORIGIN OF NONDISJUNCTION AND GENE-CENTROMERE MAPPING OF CHROMOSOME-1 MARKERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV PITTSBURGH,GRAD SCH PUBL HLTH,DEPT HUMAN GENET,130 DESOTO ST,PITTSBURGH,PA 15261; UNIV PITTSBURGH,DEPT PATHOL,PITTSBURGH,PA 15261	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh					NCI NIH HHS [CA 43882] Funding Source: Medline; NICHD NIH HHS [HD 00774] Funding Source: Medline; NIGMS NIH HHS [GM 33771] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K04HD000774] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA043882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033771] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; CARRITT B, 1982, P NATL ACAD SCI-BIOL, V79, P7400, DOI 10.1073/pnas.79.23.7400; CHAKRAVARTI A, 1987, Genomics, V1, P35, DOI 10.1016/0888-7543(87)90102-9; CHAKRAVARTI A, 1989, MOL CYTOGENETIC STUD, P45; CLIMIE ARW, 1968, CANCER, V22, P824, DOI 10.1002/1097-0142(196810)22:4<824::AID-CNCR2820220421>3.0.CO;2-J; DRACOPOLI NC, 1988, AM J HUM GENET, V43, P462; EPPIG JT, 1983, GENETICS, V103, P797; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HASSOLD TJ, 1989, MOL CYTOGENETIC STUD, P113; KEATS B, 1989, CYTOGENET CELL GENET, V51, P459, DOI 10.1159/000132805; KRIEG P, 1983, ANAL BIOCHEM, V134, P288, DOI 10.1016/0003-2697(83)90299-3; LINDER D, 1975, NEW ENGL J MED, V292, P63, DOI 10.1056/NEJM197501092920202; LINDER D, 1969, P NATL ACAD SCI USA, V63, P699, DOI 10.1073/pnas.63.3.699; LINDER D, 1970, ANN HUM GENET, V34, P21, DOI 10.1111/j.1469-1809.1970.tb00216.x; MCCAW BK, 1976, CYTOGENET CELL GENET, V16, P391; MERRIAM JR, 1964, GENETICS, V49, P109; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MORTON NE, 1985, GENET RES, V45, P279, DOI 10.1017/S0016672300022266; OCONNELL P, 1989, GENOMICS, V4, P12, DOI 10.1016/0888-7543(89)90308-X; OTT J, 1976, ANN HUM GENET, V40, P191, DOI 10.1111/j.1469-1809.1976.tb00179.x; PARRINGTON JM, 1984, J MED GENET, V21, P4, DOI 10.1136/jmg.21.1.4; PERKINS DD, 1962, GENETICS, V47, P1253; PETERSON WF, 1955, AM J OBSTET GYNECOL, V70, P368, DOI 10.1016/S0002-9378(16)37681-5; SAHAR S, 1986, HUM GENET, V74, P215; SHERMAN SL, 1984, ANN HUM GENET, V48, P243, DOI 10.1111/j.1469-1809.1984.tb01021.x; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SURTI U, 1990, AM J HUM GENET, V47, P635; VASSART G, 1987, SCIENCE, V235, P683, DOI 10.1126/science.2880398; WARREN AC, 1987, SCIENCE, V237, P652, DOI 10.1126/science.2955519	29	51	51	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1990	47	4					644	655						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EB319	1977308				2022-12-18	WOS:A1990EB31900009
J	HATA, A; EMI, M; LUC, G; BASDEVANT, A; GAMBERT, P; IVERIUS, PH; LALOUEL, JM				HATA, A; EMI, M; LUC, G; BASDEVANT, A; GAMBERT, P; IVERIUS, PH; LALOUEL, JM			COMPOUND HETEROZYGOTE FOR LIPOPROTEIN-LIPASE DEFICIENCY - SER-]THR244 AND TRANSITION IN 3' SPLICE SITE OF INTRON-2 (AG-]AA) IN THE LIPOPROTEIN-LIPASE GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV UTAH, HLTH SCI CTR,HOWARD HUGHES MED INST,WINTROBE BLDG, 6TH FLOOR, SALT LAKE CITY, UT 84132 USA; UNIV UTAH, HLTH SCI CTR, DEPT HUMAN GENET, SALT LAKE CITY, UT 84132 USA; UNIV UTAH, VET ADM HOSP, HLTH SCI CTR, SALT LAKE CITY, UT 84132 USA; UNIV UTAH, HLTH SCI CTR, DEPT INTERNAL MED, SALT LAKE CITY, UT 84132 USA; INST PASTEUR, SERLIA, LILLE, FRANCE; INST PASTEUR, INSERM, U325, LILLE, FRANCE; HOP HEROLD, SERV NUTR, F-75935 PARIS 19, FRANCE; CTR HOSP DIJON, BIOCHIM MED LAB, DIJON, FRANCE	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Dijon Bourgogne					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL039595] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL39595] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKESON AL, 1987, P NATL ACAD SCI USA, V84, P5947, DOI 10.1073/pnas.84.16.5947; BAGINSKY ML, 1979, J LIPID RES, V20, P548; BLACHE D, 1983, CLIN CHEM, V29, P154; BRUNZELL JD, 1989, METABOLIC BASIS INHE, P1128; Bunn HF, 1986, HEMOGLOBIN MOL GENET; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; DATTA S, 1988, J BIOL CHEM, V263, P1107; DEEB SS, 1989, BIOCHEMISTRY-US, V28, P4132, DOI 10.1021/bi00436a001; DEVLIN RH, 1990, AM J HUM GENET, V46, P112; EMI M, 1990, J BIOL CHEM, V265, P5910; EMI M, 1988, GENOMICS, V3, P373, DOI 10.1016/0888-7543(88)90130-9; EMI M, 1990, AM J HUM GENET, V47, P107; FIEVETDESREUMAUX C, 1979, CLIN CHIM ACTA, V95, P405, DOI 10.1016/0009-8981(79)90384-X; FRUCHART JC, 1985, METHOD ENZYMAT AN, V3, P126; FRUCHART JC, 1980, PHARMACIEN BIOL, V24, P227; GARFINKEL AS, 1987, PLASMA LIPOPROTEINS, P335; GILMAN M, 1988, CURRENT PROTOCOLS MO; Iverius P H, 1986, Methods Enzymol, V129, P691; IVERIUS PH, 1985, AM J PHYSIOL, V249, pE107, DOI 10.1152/ajpendo.1985.249.1.E107; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LANGLOIS S, 1989, P NATL ACAD SCI USA, V86, P948, DOI 10.1073/pnas.86.3.948; MACGREGOR GR, 1987, SOMAT CELL MOLEC GEN, V13, P253, DOI 10.1007/BF01535207; MACGREGOR GR, 1989, NUCLEIC ACIDS RES, V17, P2365, DOI 10.1093/nar/17.6.2365; MICKEL FS, 1989, J BIOL CHEM, V264, P12895; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NIKKILA EA, 1983, METABOLIC BASIS INHE, P622; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.biochem.55.1.1119; Saiki R. K., 1988, Genome analysis: a practical approach., P141; SELDEN RF, 1986, MOL CELL BIOL, V6, P3173, DOI 10.1128/MCB.6.9.3173; SPITZER SG, 1988, J BIOL CHEM, V263, P10545; TENENBAUM D, 1988, BIOL NEONATE, V54, P241; WHITNEY JB, 1985, P NATL ACAD SCI USA, V82, P7646, DOI 10.1073/pnas.82.22.7646; WION KL, 1987, SCIENCE, V235, P1638, DOI 10.1126/science.3823907; YANG CY, 1989, J BIOL CHEM, V264, P16822; ZTEGENHORN J, 1980, CLIN CHEM, V260, P973	36	51	53	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1990	47	4					721	726						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EB319	2121025				2022-12-18	WOS:A1990EB31900018
J	LEVINSON, B; LEHESJOKI, AE; DELACHAPELLE, A; GITSCHIER, J				LEVINSON, B; LEHESJOKI, AE; DELACHAPELLE, A; GITSCHIER, J			MOLECULAR ANALYSIS OF HEMOPHILIA-A MUTATIONS IN THE FINNISH POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,ROOM U-426,BOX 0724,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; UNIV HELSINKI,DEPT MED GENET,SF-00100 HELSINKI 10,FINLAND	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Helsinki								ANETTE HJT, 1988, CIRCULATION S2, V78, pA254; ANTONARAKIS SE, 1985, NEW ENGL J MED, V313, P842, DOI 10.1056/NEJM198510033131402; BAKKER E, 1987, NATURE, V329, P554, DOI 10.1038/329554a0; DARRAS BT, 1987, NATURE, V329, P556, DOI 10.1038/329556a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GITSCHIER J, 1985, NATURE, V315, P427, DOI 10.1038/315427a0; GITSCHIER J, 1988, AM J HUM GENET, V43, P274; GITSCHIER J, 1984, NATURE, V312, P326, DOI 10.1038/312326a0; GITSCHIER J, 1988, BLOOD, V72, P1022; GITSCHIER J, 1989, LANCET, V1, P273; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; HALL JG, 1988, AM J HUM GENET, V43, P355; HARDISTY RM, 1962, THROMB DIATH HAEMOST, V7, P215; HIGUCHI M, 1988, MOL BIOL MED, V5, P23; KASPER CK, 1975, THROMB DIATH HAEMOST, V34, P869; KOGAN SC, 1987, NEW ENGL J MED, V317, P985, DOI 10.1056/NEJM198710153171603; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LANMAN JT, 1987, AM J HUM GENET, V41, P138; LEVINSON B, 1987, NUCLEIC ACIDS RES, V15, P9797, DOI 10.1093/nar/15.23.9797; MADDALENA A, 1988, NEW ENGL J MED, V319, P999, DOI 10.1056/NEJM198810133191507; NEVANLINNA HR, 1972, HEREDITAS-GENETISK A, V71, P195; Norio R., 1981, BIOCULTURAL ASPECTS, P359; PAGE DC, 1984, AM J HUM GENET, V36, P565; ROSSOUW CMS, 1987, J BIOL CHEM, V262, P15151; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; WONG C, 1987, NATURE, V330, P384, DOI 10.1038/330384a0; WOOD WI, 1985, P NATL ACAD SCI USA, V82, P1585, DOI 10.1073/pnas.82.6.1585; YOUSSOUFIAN H, 1988, AM J HUM GENET, V42, P718; YOUSSOUFIAN H, 1988, HUM GENET, V80, P143, DOI 10.1007/BF00702857; YOUSSOUFIAN H, 1987, P NATL ACAD SCI USA, V84, P3772, DOI 10.1073/pnas.84.11.3772; Youssoufian H, 1988, GENOMICS, V2, P32, DOI 10.1016/0888-7543(88)90106-1	32	51	52	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1990	46	1					53	62						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ043	2104741				2022-12-18	WOS:A1990CJ04300008
J	TRIGGSRAINE, BL; GRAVEL, RA				TRIGGSRAINE, BL; GRAVEL, RA			DIAGNOSTIC HETERODUPLEXES - SIMPLE DETECTION OF CARRIERS OF A 4-BP INSERTION MUTATION IN TAY-SACHS DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter											TRIGGSRAINE, BL (corresponding author), HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ONTARIO,CANADA.		Triggs-Raine, Barbara/AAF-6209-2021	Triggs-Raine, Barbara/0000-0003-4719-6779				MYEROWITZ R, 1988, J BIOL CHEM, V263, P18587; NAGAMINE CM, 1989, AM J HUM GENET, V45, P337	2	51	52	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1990	46	1					183	184						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ043	2294750				2022-12-18	WOS:A1990CJ04300024
J	ESTIVILL, X; MCLEAN, C; NUNES, V; CASALS, T; GALLANO, P; SCAMBLER, P; WILLIAMSON, R				ESTIVILL, X; MCLEAN, C; NUNES, V; CASALS, T; GALLANO, P; SCAMBLER, P; WILLIAMSON, R			ISOLATION OF A NEW DNA MARKER IN LINKAGE DISEQUILIBRIUM WITH CYSTIC-FIBROSIS, SITUATED BETWEEN J3.11 (D7S8) AND IRP	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									FDN INVEST SANTA CREU & SANT PAU,MOLEC GENET UNIT,BARCELONA,SPAIN; ST MARYS HOSP,SCH MED,DEPT BIOCHEM & MOLEC GENET,LONDON,ENGLAND	Imperial College London			Estivill, Xavier/A-3125-2013; Scambler, Peter J/C-4998-2008; Scambler, Peter/AAZ-6026-2020; Nunes, Virginia/AAD-1014-2019	Estivill, Xavier/0000-0002-0723-2256; Scambler, Peter J/0000-0002-1487-4628; Scambler, Peter/0000-0002-1487-4628; Nunes, Virginia/0000-0002-5747-9310				BEAUDET A, 1986, AM J HUM GENET, V39, P681; BEAUDET AL, 1988, NEW ENGL J MED, V318, P50; CARLE GF, 1984, NUCLEIC ACIDS RES, V12, P5647, DOI 10.1093/nar/12.14.5647; CROCE CM, 1974, J EXP MED, V139, P1350, DOI 10.1084/jem.139.5.1350; Drumm ML, 1988, GENOMICS, V2, P346, DOI 10.1016/0888-7543(88)90024-9; EIBERG H, 1985, CLIN GENET, V28, P265; ESTIVILL X, 1986, HUM GENET, V74, P320; ESTIVILL X, 1987, NUCLEIC ACIDS RES, V15, P1415, DOI 10.1093/nar/15.4.1415; ESTIVILL X, 1987, Genomics, V1, P257, DOI 10.1016/0888-7543(87)90052-8; ESTIVILL X, 1988, AM J HUM GENET, V43, P23; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; FARRALL M, 1987, LANCET, V2, P156; FARRALL M, 1988, AM J HUM GENET, V43, P471; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; MANIATIS T, 1982, MOL CLONING LABORATO; Poustka A, 1988, GENOMICS, V2, P337, DOI 10.1016/0888-7543(88)90023-7; SCAMBLER PJ, 1987, NUCLEIC ACIDS RES, V15, P3639, DOI 10.1093/nar/15.9.3639; SCAMBLER PJ, 1986, NUCLEIC ACIDS RES, V14, P7159, DOI 10.1093/nar/14.18.7159; TSUI LC, 1985, SCIENCE, V230, P1054, DOI 10.1126/science.2997931; WAINWRIGHT BJ, 1985, NATURE, V318, P384, DOI 10.1038/318384a0; WAINWRIGHT BJ, 1988, EMBO J, V7, P1743, DOI 10.1002/j.1460-2075.1988.tb03003.x; WHITE R, 1985, NATURE, V318, P382, DOI 10.1038/318382a0	22	51	55	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1989	44	5					704	710						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	U3338	2565082				2022-12-18	WOS:A1989U333800011
J	BAIRD, PA; SADOVNICK, AD				BAIRD, PA; SADOVNICK, AD			CAUSES OF DEATH TO AGE 30 IN DOWN SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MINIST HLTH,DIV VITAL STAT,HLTH SURVEILLANCE REGISTRY,VANCOUVER,BC,CANADA		BAIRD, PA (corresponding author), UNIV BRITISH COLUMBIA,DEPT MED GENET,6174 UNIV BLVD,VANCOUVER V6T 1W5,BC,CANADA.							AARSKOG D, 1969, ARCH DIS CHILD, V44, P454, DOI 10.1136/adc.44.236.454; ARMITAGE P, 1971, STATISTICAL METHODS; BAIRD PA, 1987, CAN MED ASSOC J, V136, P109; BAIRD PA, 1987, J PEDIATR-US, V110, P849, DOI 10.1016/S0022-3476(87)80395-5; BAIRD PA, 1984, J MED GENET, V21, P72, DOI 10.1136/jmg.21.1.72; BALARAJAN R, 1982, J EPIDEMIOL COMMUN H, V36, P127, DOI 10.1136/jech.36.2.127; Brewster H., 1930, NEW ORLEANS MED SURG, V82, P872; BROTHERS CRD, 1954, J MENT SCI, V100, P580, DOI 10.1192/bjp.100.419.580; Cabot RC, 1912, J AMER MED ASSOC, V59, P2295; CANT AJ, 1987, ARCH DIS CHILD, V62, P962, DOI 10.1136/adc.62.9.962; CARTER CO, 1958, J MENT DEFIC RES, V2, P64, DOI 10.1111/j.1365-2788.1958.tb00388.x; CARTER G, 1984, PSYCHOL MED, V14, P691, DOI 10.1017/S0033291700015300; COLLS MH, 1980, MED INFORM, V5, P121, DOI 10.3109/14639238009014006; COMSTOCK GW, 1986, AM J EPIDEMIOL, V124, P180, DOI 10.1093/oxfordjournals.aje.a114376; DEATON JG, 1973, J MENT DEFIC RES, V17, P117; DORN HF, 1964, AM J PUBLIC HEALTH N, V54, P400, DOI 10.2105/AJPH.54.3.400; FABIA J, 1970, J MENT DEFIC RES, V19, P157; FERENCZ C, 1987, TERATOLOGY, V35, P367, DOI 10.1002/tera.1420350311; FONG C, 1987, CANCER GENET CYTOGEN, V28, P55, DOI 10.1016/0165-4608(87)90354-2; FRIEDMAN WF, 1980, HARRISONS PRINCIPLES, P1075; HOOK EB, 1983, AM J HUM GENET, V35, P110; ISRAEL RA, 1986, AM J EPIDEMIOL, V124, P161, DOI 10.1093/oxfordjournals.aje.a114375; KARDOS G, 1983, ONCOLOGY, V40, P280, DOI 10.1159/000225743; KIRCHER T, 1987, JAMA-J AM MED ASSOC, V258, P349, DOI 10.1001/jama.258.3.349; KRUEGER DEAN E., 1966, NAT CANCER INST MONOGR, V19, P431; LOBO EDH, 1980, BRIT MED J, V280, P1253, DOI 10.1136/bmj.280.6226.1253; MILUNSKY A, 1968, ARCH ENVIRON HEALTH, V17, P372, DOI 10.1080/00039896.1968.10665244; MULCAHY MT, 1979, CLIN GENET, V16, P103; OSTER J, 1975, ACTA PAEDIATR SCAND, V64, P322, DOI 10.1111/j.1651-2227.1975.tb03842.x; RADETTI G, 1986, HELV PAEDIATR ACTA, V41, P377; ROBISON LL, 1984, J PEDIATR-US, V105, P235, DOI 10.1016/S0022-3476(84)80119-5; ROY A, 1987, J MENT DEFIC RES, V31, P193; SCHOLL T, 1982, DEV MED CHILD NEUROL, V24, P817; SEELY S, 1987, LANCET, V1, P220; TRIMBLE BK, 1978, AM J MED GENET, V2, P1, DOI 10.1002/ajmg.1320020102; WONG O, 1978, J CHRON DIS, V31, P183, DOI 10.1016/0021-9681(78)90033-4; 1977, MANUAL INT STATISTIC, V2; 1977, MANUAL INT STATISTIC, V1	38	51	51	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1988	43	3					239	248						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	P8841	2970794				2022-12-18	WOS:A1988P884100003
J	RAMSAY, M; JENKINS, T				RAMSAY, M; JENKINS, T			GLOBIN GENE - ASSOCIATED RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISMS IN SOUTHERN AFRICAN PEOPLES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									S AFRICAN INST MED RES, SCH PATHOL,DEPT HUMAN GENET,MRC, HUMAN ECOGENET RES UNIT,POB 1038, JOHANNESBURG 2000, SOUTH AFRICA; UNIV WITWATERSRAND, JOHANNESBURG 2001, SOUTH AFRICA	University of Witwatersrand				Ramsay, Michele/0000-0002-4156-4801				ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P137, DOI 10.1073/pnas.79.1.137; ANTONARAKIS SE, 1984, P NATL ACAD SCI-BIOL, V81, P853, DOI 10.1073/pnas.81.3.853; BAIRD M, 1981, P NATL ACAD SCI-BIOL, V78, P4218, DOI 10.1073/pnas.78.7.4218; BLEEK W, 1962, COMP GRAMMAR S AFRIC; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; FLINT J, 1986, NATURE, V321, P744, DOI 10.1038/321744a0; FRITSCH EF, 1980, CELL, V19, P959, DOI 10.1016/0092-8674(80)90087-2; GEEVER RF, 1981, P NATL ACAD SCI-BIOL, V78, P5081, DOI 10.1073/pnas.78.8.5081; GILES E, 1986, NATURE, V322, P21, DOI 10.1038/322021b0; HIGGS DR, 1986, P NATL ACAD SCI USA, V83, P5165, DOI 10.1073/pnas.83.14.5165; JOHNSTON HH, 1907, J AFR SOC, V6, P329; JONES JS, 1986, NATURE, V319, P449, DOI 10.1038/319449b0; LUZZATTO L, 1979, BLOOD, V54, P961; MAGGIO A, 1986, HUM GENET, V72, P229, DOI 10.1007/BF00291883; NEI M, 1982, EVOL BIOL, V14, P1; Nurse GT., 1985, PEOPLES SO AFRICA TH; OLD JM, 1984, BRIT J HAEMATOL, V57, P255, DOI 10.1111/j.1365-2141.1984.tb08528.x; OPPENHEIMER SJ, 1984, LANCET, V1, P424; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; PAGNIER J, 1984, P NATL ACAD SCI-BIOL, V81, P1771, DOI 10.1073/pnas.81.6.1771; RAMSAY M, 1984, LANCET, V2, P410, DOI 10.1016/S0140-6736(84)90581-6; RAMSAY M, 1985, HEMOGLOBIN, V9, P385, DOI 10.3109/03630268508997013; RAMSAY M, 1985, S AFR J SCI, V81, P98; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SELIGMAN CG, 1961, RACES AFRICA; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SYKES BC, 1983, LANCET, V2, P787; TOBIAS P V, 1971, South African Journal of Science, V67, P517; WAINSCOAT JS, 1986, NATURE, V319, P491, DOI 10.1038/319491a0; WAINSCOAT JS, 1986, HUM GENET, V74, P90; WILSON JT, 1978, NUCLEIC ACIDS RES, V5, P563, DOI 10.1093/nar/5.2.563	31	51	51	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1987	41	6					1132	1144						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L2984	2891298				2022-12-18	WOS:A1987L298400015
J	JABS, EW; PERSICO, MG				JABS, EW; PERSICO, MG			CHARACTERIZATION OF HUMAN CENTROMERIC REGIONS OF SPECIFIC CHROMOSOMES BY MEANS OF ALPHOID DNA-SEQUENCES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									INST INT GENET & BIOFIS,NAPLES,ITALY	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR)	JABS, EW (corresponding author), JOHNS HOPKINS UNIV,CMSC 1004,600 N WOLFE ST,BALTIMORE,MD 21205, USA.			Jabs, Ethylin/0000-0001-8983-5466	NICHD NIH HHS [HD19074, HD22819, HD05465] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R23HD019074] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BRUTLAG DL, 1980, ANNU REV GENET, V14, P121, DOI 10.1146/annurev.ge.14.120180.001005; CAMARGO M, 1982, AM J HUM GENET, V34, P757; CARBON J, 1984, CELL, V37, P351, DOI 10.1016/0092-8674(84)90363-5; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; CLARKE L, 1986, P NATL ACAD SCI USA, V83, P8253, DOI 10.1073/pnas.83.21.8253; COMINGS DE, 1978, ANNU REV GENET, V12, P25, DOI 10.1146/annurev.ge.12.120178.000325; DEVILEE P, 1986, NUCLEIC ACIDS RES, V14, P2059, DOI 10.1093/nar/14.5.2059; DUTRILLAUX B, 1976, CHROMOSOMA, V58, P51, DOI 10.1007/BF00293440; Favaloro J, 1980, Methods Enzymol, V65, P718; FEDEROFF NV, 1978, CELL, V13, P701; GOLDMAN MA, 1984, SCIENCE, V224, P686, DOI 10.1126/science.6719109; HEITER P, 1985, CELL, V42, P913; HOLMQUIST G, 1982, CELL, V31, P121, DOI 10.1016/0092-8674(82)90411-1; JABS EW, 1986, AM J HUM GENET, V38, P297; JABS EW, 1984, P NATL ACAD SCI-BIOL, V81, P4884, DOI 10.1073/pnas.81.15.4884; JABS EW, 1984, SOMAT CELL MOLEC GEN, V10, P93, DOI 10.1007/BF01534476; JORGENSEN AL, 1986, J MOL BIOL, V187, P185, DOI 10.1016/0022-2836(86)90227-5; MANIATIS T, 1982, MOL CLONING LABORATO; MANUELIDIS L, 1978, CHROMOSOMA, V66, P1, DOI 10.1007/BF00285812; MANUELIDIS L, 1980, J MOL BIOL, V142, P363; MCDERMID HE, 1986, CHROMOSOMA, V94, P228, DOI 10.1007/BF00288497; MENVERI R, 1984, BIOCH BIOPHYS ACTA, V783, P53; MITCHELL AR, 1985, CHROMOSOMA, V92, P369, DOI 10.1007/BF00327469; NAKASEKO Y, 1986, EMBO J, V5, P1011, DOI 10.1002/j.1460-2075.1986.tb04316.x; QUEEN C, 1984, NUCLEIC ACIDS RES, V12, P581, DOI 10.1093/nar/12.1Part2.581; RAO PN, 1968, SCIENCE, V160, P774, DOI 10.1126/science.160.3829.774; REIS RJS, 1985, J MOL BIOL, V186, P31, DOI 10.1016/0022-2836(85)90254-2; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHMECKPEPER BJ, 1984, J BIOL CHEM, V259, P1218; SINGER MF, 1982, INT REV CYTOL, V76, P67, DOI 10.1016/S0074-7696(08)61789-1; SOLOMON MJ, 1986, P NATL ACAD SCI USA, V83, P1276, DOI 10.1073/pnas.83.5.1276; STRAUSS F, 1984, CELL, V37, P889, DOI 10.1016/0092-8674(84)90424-0; WAYE JS, 1985, NUCLEIC ACIDS RES, V13, P2731, DOI 10.1093/nar/13.8.2731; WAYE JS, 1986, MOL CELL BIOL, V6, P3156, DOI 10.1128/MCB.6.9.3156; WILLARD HF, 1985, AM J HUM GENET, V37, P524; WILLARD HF, 1983, NUCLEIC ACIDS RES, V11, P2017, DOI 10.1093/nar/11.7.2017; WOLFE J, 1985, J MOL BIOL, V182, P477, DOI 10.1016/0022-2836(85)90234-7; YANG TP, 1982, P NATL ACAD SCI-BIOL, V79, P6593, DOI 10.1073/pnas.79.21.6593	38	51	52	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1987	41	3					374	390						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	K0191	3631075				2022-12-18	WOS:A1987K019100004
J	KAMBOH, MI; FERRELL, RE				KAMBOH, MI; FERRELL, RE			GENETIC-STUDIES OF HUMAN APOLIPOPROTEINS .1. POLYMORPHISM OF APOLIPOPROTEIN A-IV	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											KAMBOH, MI (corresponding author), UNIV PITTSBURGH,GRAD SCH PUBL HLTH,DEPT BIOSTAT,HUMAN GENET PROGRAM,PITTSBURGH,PA 15261, USA.			Kamboh, M. Ilyas/0000-0002-3453-1438	NATIONAL CANCER INSTITUTE [P01CA034936] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR003577] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL024799] Funding Source: NIH RePORTER; NCI NIH HHS [CA 34936] Funding Source: Medline; NCRR NIH HHS [RR 03577] Funding Source: Medline; NHLBI NIH HHS [HL 24799] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BEISIEGEL U, 1979, EUR J BIOCHEM, V93, P601, DOI 10.1111/j.1432-1033.1979.tb12860.x; BISGAIER CL, 1985, J LIPID RES, V26, P11; GORDON JI, 1984, J BIOL CHEM, V259, P468; GREEN PHR, 1979, J CLIN INVEST, V64, P233, DOI 10.1172/JCI109444; GREEN PHR, 1980, J CLIN INVEST, V65, P911, DOI 10.1172/JCI109745; GREEN PHR, 1982, GASTROENTEROLOGY, V83, P1223; KAMBOH MI, 1986, BIOCHEM GENET, V24, P273, DOI 10.1007/BF00502794; KAMBOH MI, 1985, ELECTROPHORESIS, V6, P185, DOI 10.1002/elps.1150060408; MENZEL HJ, 1982, HUM GENET, V62, P349, DOI 10.1007/BF00304554; MENZEL HJ, 1982, J LIPID RES, V23, P915; ROHEIM PS, 1976, P NATL ACAD SCI USA, V73, P1757, DOI 10.1073/pnas.73.5.1757; SCANU AM, 1984, J LIPID RES, V25, P1593; SCHAMAUN O, 1985, PROTIDES BIOL FLUIDS, V33, P471; STEIN O, 1986, BIOCHIM BIOPHYS ACTA, V878, P7, DOI 10.1016/0005-2760(86)90337-1; STEINMETZ A, 1985, J BIOL CHEM, V260, P2258; UTERMANN G, 1979, EUR J BIOCHEM, V99, P333, DOI 10.1111/j.1432-1033.1979.tb13261.x; UTERMANN G, 1982, J BIOL CHEM, V257, P501; WEINBERG RB, 1983, J LIPID RES, V24, P52; WEISGRABER KH, 1978, BIOCHEM BIOPH RES CO, V85, P287, DOI 10.1016/S0006-291X(78)80041-2; ZANNIS VI, 1985, ADV HUM GENET, V14, P125	20	51	51	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1987	41	2					119	127						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	J7575	3618592				2022-12-18	WOS:A1987J757500003
J	WIESNER, GL; BENDEL, CM; OLDS, DP; WHITE, JG; ARTHUR, DC; BALL, DW; KING, RA				WIESNER, GL; BENDEL, CM; OLDS, DP; WHITE, JG; ARTHUR, DC; BALL, DW; KING, RA			HYPOPIGMENTATION IN THE PRADER-WILLI SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MINNESOTA,DEPT MED,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,DEPT PEDIAT,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,DEPT LAB MED & PATHOL,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,INST HUMAN GENET,MINNEAPOLIS,MN 55455	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities				Bendel, Catherine/0000-0001-6093-5930	NIADDK NIH HHS [AM 32407] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM032407] Funding Source: NIH RePORTER	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BUTLER MG, 1986, AM J MED GENET, V23, P793, DOI 10.1002/ajmg.1320230307; CASSIDY SB, 1984, CURR PROBL PEDIATR, V14, P5; CREEL D, 1978, SCIENCE, V201, P931, DOI 10.1126/science.684419; CREEL D, 1974, INVEST OPHTH VISUAL, V13, P430; CREEL DJ, 1986, NEW ENGL J MED, V314, P1606, DOI 10.1056/NEJM198606193142503; HANSSON C, 1979, J CHROMATOGR, V162, P7, DOI 10.1016/S0378-4347(00)82058-7; HARNDEN DG, 1985, CYTOGENET CELL GENET; HITTNER HM, 1982, AM J OPHTHALMOL, V94, P328, DOI 10.1016/0002-9394(82)90358-0; Holm V. A., 1981, PRADERWILLI SYNDROME, P27; JIMBOW K, 1983, J INVEST DERMATOL, V81, P506, DOI 10.1111/1523-1747.ep12522838; JIMBOW K, 1979, J INVEST DERMATOL, V73, P278, DOI 10.1111/1523-1747.ep12531650; KINEBUCHI S, 1971, ABNORMAL MELANOCYTES, P195; KING RA, 1985, AM J MED GENET, V20, P49, DOI 10.1002/ajmg.1320200108; KING RA, 1978, J INVEST DERMATOL, V71, P136, DOI 10.1111/1523-1747.ep12546765; KING RA, 1985, OPHTHALMOLOGY, V92, P1496; KING RA, IN PRESS NEUROCUTANE; LEDBETTER DH, 1982, AM J HUM GENET, V34, P278; MINTZ B, 1967, P NATL ACAD SCI USA, V58, P344, DOI 10.1073/pnas.58.1.344; MOORE KL, 1973, DEV HUMAN CLIN ORIEN, P306; PATHAK MA, 1987, DERMATOLOGY GENERAL, P1507; PROTA G, 1980, J INVEST DERMATOL, V75, P122, DOI 10.1111/1523-1747.ep12521344; RAWLES ME, 1947, PHYSIOL ZOOL, V20, P248, DOI 10.1086/physzool.20.3.30151958; STRONGIN AC, 1981, J NEUROSCI, V1, P1193; SZABO G, 1967, ADVANCES BIOLOGY SKI, V8, P379; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; YUNIS JJ, 1978, CHROMOSOMA, V67, P293, DOI 10.1007/BF00285963; ZELICKSON AS, 1967, ULTRASTRUCTURE NORMA, P163	27	51	51	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1987	40	5					431	442						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	H5759	3578281				2022-12-18	WOS:A1987H575900005
J	NAKAGOME, Y; ABE, T; MISAWA, S; TAKESHITA, T; IINUMA, K				NAKAGOME, Y; ABE, T; MISAWA, S; TAKESHITA, T; IINUMA, K			THE LOSS OF CENTROMERES FROM CHROMOSOMES OF AGED WOMEN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									KYOTO PREFECTURAL UNIV MED,DEPT MED,KAMIGYO KU,KYOTO,JAPAN; MED UNIV YAMANASHI,DEPT HLTH SCI,KOKU,YAMANASHI,JAPAN; EBINA KOSEI HOSP,DEPT PEDIAT,EBINA,KANAGAWA,JAPAN	Kyoto Prefectural University of Medicine; University of Yamanashi	NAKAGOME, Y (corresponding author), NATL INST GENET,DEPT HUMAN GENET,MISHIMA,SHIZUOKA 411,JAPAN.							BROWN WMC, 1969, ANN HUM GENET, V33, P1, DOI 10.1111/j.1469-1809.1969.tb01623.x; BROWN WMC, 1966, EUGENIC LAB MEMOIRS, V42; DANIEL A, 1979, HUM GENET, V48, P85, DOI 10.1007/BF00273279; EIBERG H, 1974, NATURE, V248, P55, DOI 10.1038/248055a0; EVANS HJ, 1967, NATURE, V214, P361, DOI 10.1038/214361a0; EVANS HJ, 1974, NATURE, V249, P861, DOI 10.1038/249861a0; FITZGERALD PH, 1975, ANN HUM GENET, V38, P417, DOI 10.1111/j.1469-1809.1975.tb00631.x; GRELL RF, 1967, J CELL PHYSIOL, V70, P119, DOI 10.1002/jcp.1040700410; HENDERSON SA, 1968, NATURE, V218, P22, DOI 10.1038/218022a0; JACOBS PA, 1964, ANN HUM GENET, V27, P353; MARASCHIO P, 1981, HUM GENET, V57, P345, DOI 10.1007/BF00281681; MARASCHIO P, 1980, HUM GENET, V54, P265, DOI 10.1007/BF00278982; MATSUNAGA E, 1978, HUM GENET, V40, P259, DOI 10.1007/BF00272186; MIKAMO K, 1968, CYTOGENETICS, V7, P212, DOI 10.1159/000129985; NAKAGOME Y, 1976, CLIN GENET, V9, P621; NAKAGOME Y, 1983, AM J HUM GENET, V35, P288; NAKAGOME Y, 1980, ANNU REP NAT I GENET, V30, P97; ROMAIN DR, 1982, J MED GENET, V19, P306, DOI 10.1136/jmg.19.4.306; ROOS UP, 1975, NATURE, V254, P463, DOI 10.1038/254463a0; SCHWEIZER D, 1978, EXP CELL RES, V111, P327, DOI 10.1016/0014-4827(78)90177-5; STENE J, 1977, ANN HUM GENET, V40, P299, DOI 10.1111/j.1469-1809.1977.tb00194.x; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; TRIMBLE BK, 1978, AM J MED GENET, V2, P1, DOI 10.1002/ajmg.1320020102	23	51	53	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	2					398	404						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SM324	6711561				2022-12-18	WOS:A1984SM32400014
J	BOEHNKE, M; CONNEALLY, PM; LANGE, K				BOEHNKE, M; CONNEALLY, PM; LANGE, K			2 MODELS FOR A MATERNAL FACTOR IN THE INHERITANCE OF HUNTINGTON DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									INDIANA UNIV,SCH MED,DEPT MED GENET,INDIANAPOLIS,IN 46223	Indiana University System; Indiana University-Purdue University Indianapolis	BOEHNKE, M (corresponding author), UNIV CALIF LOS ANGELES,DEPT BIOMATH,LOS ANGELES,CA 90024, USA.				NICHD NIH HHS [K04-HD00307] Funding Source: Medline; NIGMS NIH HHS [GM-07191, GM-07104] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 1960, CONTRIBUTIONS PROBAB; AYALA FJ, 1980, MODERN GENETICS, P160; BARBEAU A, 1970, LANCET, V2, P937; BIRD ED, 1974, ANN HUM GENET, V37, P255, DOI 10.1111/j.1469-1809.1974.tb01833.x; BRACKENRIDGE C J, 1971, Clinical Genetics, V2, P267; BRACKENRIDGE CJ, 1972, J MED GENET, V9, P23, DOI 10.1136/jmg.9.1.23; BRACKENRIDGE CJ, 1972, J MED GENET, V9, P17, DOI 10.1136/jmg.9.1.17; BROWNLEE KA, 1965, STATISTICAL THEORY M, P299; Davenport CB, 1916, AM J INSANITY, V73, P195, DOI 10.1176/ajp.73.2.195; Haldane JBS, 1941, J GENET, V41, P149, DOI 10.1007/BF02983018; HAYDEN MR, 1982, AM J MED GENET, V11, P135, DOI 10.1002/ajmg.1320110203; Hayden MR., 1981, HUNTINGTONS CHOREA, P45; HERBST AL, 1971, NEW ENGL J MED, V284, P878, DOI 10.1056/NEJM197104222841604; Huntington G., 1872, MED SURG REP, V26, P320; Imai Y, 1936, J GENET, V33, P163, DOI 10.1007/BF02982530; JONES M B, 1970, Journal of Medical Genetics, V7, P20, DOI 10.1136/jmg.7.1.20; JONES MB, 1973, ADV NEUROL, V1, P171; LANGE K, 1980, THEOR POPUL BIOL, V18, P31, DOI 10.1016/0040-5809(80)90038-6; MERRITT AD, 1969, PROGR NEUROGENETICS, V1, P645; MURPHY EA, 1975, PRINCIPLES GENETIC C, P277; MYERS RH, 1982, AM J HUM GENET, V34, P481; MYRIANTHOPOULOS NC, 1973, ADV NEUROL, V1, P149; NEISWANGER K, 1982, HEREDITARY DISEASE F; NEWCOMBE RG, 1981, ANN HUM GENET, V45, P387, DOI 10.1111/j.1469-1809.1981.tb00352.x; PENROSE LS, 1948, ANN EUGENIC, V14, P125; RAO CR, 1973, LINEAR STAT INFERENC, P97; REED TE, 1959, AM J HUM GENET, V11, P107; SENETA E, 1973, NONNEGATIVE MATRICES, P6; SLONIMSKI P, 1982, COLD SPRING HARBOR M, V12; SNEDECOR GW, 1980, STATISTICAL METHODS, P191; STERN C, 1957, AM J HUM GENET, V9, P249; STEVENS DL, 1976, THESIS U LONDON; THOMPSON JS, 1980, GENETICS MED, P214; VOGEL F, 1979, HUMAN GENETICS PROBL, P95; WALLACE DC, 1972, J NEUROL NEUROSUR PS, V35, P789, DOI 10.1136/jnnp.35.6.789; WALLACE DC, 1976, ANN HUM GENET, V39, P375, DOI 10.1111/j.1469-1809.1976.tb00142.x; WALLACE DC, 1979, ADV NEUROL, V23, P73; WENDT GG, 1961, ANTHROPOL ANZ, V24, P299	38	51	51	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	5					845	860						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RK604	6225335				2022-12-18	WOS:A1983RK60400005
J	COX, DW				COX, DW			NEW VARIANTS OF ALPHA-1-ANTITRYPSIN - COMPARISON OF PI TYPING TECHNIQUES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TORONTO,DEPT PAEDIAT,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV TORONTO,DEPT MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA	University of Toronto; University of Toronto	COX, DW (corresponding author), HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ONTARIO,CANADA.							ALLEN RC, 1974, AM J CLIN PATHOL, V62, P732; ARNAUD P, 1977, J IMMUNOL METHODS, V16, P221, DOI 10.1016/0022-1759(77)90200-9; ARNAUD P, 1978, AM J HUM GENET, V30, P653; ARNAUD P, 1975, PROTIDES BIOL FLUIDS, V22, P515; AXELSSON U, 1965, AM J HUM GENET, V17, P466; CONSTANS J, 1975, CR ACAD SCI D NAT, V281, P1361; COOK PJL, 1975, ANN HUM GENET, V38, P275, DOI 10.1111/j.1469-1809.1975.tb00611.x; COX DW, 1978, AM J HUM GENET, V30, P660; COX DW, 1980, HUM GENET, V53, P429, DOI 10.1007/BF00287070; COX DW, 1980, CLIN GENET, V17, P153; COX DW, 1977, AM J HUM GENET, V29, pA34; COX DW, 1974, CAN J GENET CYTOL, V16, P297, DOI 10.1139/g74-033; COX DW, 1976, PROTIDES BIOL FLUIDS, V23, P375; ERIKSSON S, 1965, ACTA MED SCAND, V432, P5; FAGERHOL MAGNE K., 1968, SER HAEMATOL, V1, P153; FAGERHOL MK, 1968, VOX SANG, V15, P396, DOI 10.1111/j.1423-0410.1968.tb04081.x; FAGERHOL MK, 1967, CLIN CHIM ACTA, V16, P199, DOI 10.1016/0009-8981(67)90181-7; FAGERHOL MK, 1967, ACTA PATHOL MIC SC, V70, P421; FAGERHOL MK, 1969, SCAND J CLIN LAB INV, V23, P97, DOI 10.3109/00365516909078092; FAGERHOL MK, 1981, ADV HUMAN GENETICS; FAGERHOL MK, 1972, PULMONARY EMPHYSEMA, P123; FRANTS RR, 1976, HUM HERED, V26, P435, DOI 10.1159/000152838; FRANTS RR, 1978, HUM HERED, V28, P201, DOI 10.1159/000152959; GENZ T, 1977, HUM GENET, V38, P325, DOI 10.1007/BF00402159; HUG G, 1979, PEDIATR RES, V13, P420; JEPPSSON JO, 1979, CLIN CHEM, V25, P629; JOHANSSON BG, 1972, SCAND J CLIN LAB INV, V29, P7, DOI 10.3109/00365517209102747; JOHNSON AM, 1976, J LAB CLIN MED, V87, P152; KLASEN EC, 1977, HUM GENET, V37, P303, DOI 10.1007/BF00393613; KUEPPERS F, 1976, AM J HUM GENET, V28, P370; KUHNL P, 1979, HUM GENET, V50, P221, DOI 10.1007/BF00390245; LAURELL CB, 1972, SCAND J CLIN LAB INV, V29, P21, DOI 10.3109/00365517209102748; LAURELL CB, 1963, SCAND J CLIN LAB INV, V15, P132, DOI 10.3109/00365516309051324; LEBAS J, 1974, CR ACAD SCI D NAT, V278, P2359; LIEBERMAN J, 1976, AM REV RESPIR DIS, V113, P31; LIEINJO LE, 1976, CLIN CHIM ACTA, V72, P83, DOI 10.1016/0009-8981(76)90038-3; MARTIN JP, 1973, BIOMED EXPRESS, V19, P395; MOROZ SP, 1976, J PEDIATR-US, V88, P19, DOI 10.1016/S0022-3476(76)80720-2; PIERCE JA, 1976, ANAL BIOCHEM, V74, P227, DOI 10.1016/0003-2697(76)90327-4; ROBINETLEVY M, 1972, REV FR TRANSFUS IMMU, V15, P61, DOI 10.1016/S0035-2977(72)80029-4; TALAMO RC, 1973, SCIENCE, V181, P70, DOI 10.1126/science.181.4094.70; VANDENBROEK WGM, 1976, HUM GENET, V34, P17, DOI 10.1007/BF00284429; VANDEVILLE D, 1974, HUMANGENETIK, V21, P33, DOI 10.1007/BF00278562; YOSHIDA A, 1979, AM J HUM GENET, V31, P555	44	51	51	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	3					354	365						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LT725	6972696				2022-12-18	WOS:A1981LT72500003
J	FIALKOW, PJ; THULINE, HC; HECHT, F; BRYANT, J				FIALKOW, PJ; THULINE, HC; HECHT, F; BRYANT, J			FAMILIAL PREDISPOSITION TO THYROID DISEASE IN DOWNS SYNDROME - CONTROLLED IMMUNOCLINICAL STUDIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		AARSKOG D, 1969, ARCH DIS CHILD, V44, P454, DOI 10.1136/adc.44.236.454; BENDA CE, 1949, JAMA-J AM MED ASSOC, V139, P979, DOI 10.1001/jama.1949.02900320009004; BURGIO GR, 1966, LANCET, V1, P497; BURROW GN, 1965, J CLIN ENDOCR METAB, V25, P403, DOI 10.1210/jcem-25-3-403; DALLAIRE L, 1967, CAN MED ASSOC J, V97, P209; Doniach D, 1966, Clin Exp Immunol, V1, P237; EK J I, 1959, Acta Paediatr, V48, P33, DOI 10.1111/j.1651-2227.1959.tb16015.x; ENGELBERTH O, 1967, SB LEK, V69, P232; FIALKOW PJ, 1966, AM J HUM GENET, V18, P93; FIALKOW PJ, 1967, NATURE, V214, P1253, DOI 10.1038/2141253a0; FIALKOW PJ, 1965, LANCET, V2, P868; FIALKOW PJ, 1970, ANN NY ACAD SCI, V171, P500, DOI 10.1111/j.1749-6632.1970.tb39359.x; FIALKOW PJ, 1969, PROG MED GENET, V6, P117; FIALKOW PJ, 1968, ANN NY ACAD SCI, V155, P759, DOI 10.1111/j.1749-6632.1968.tb55062.x; FORBES AP, 1963, METABOLISM, V12, P428; HODGES RE, 1952, ARCH INTERN MED, V90, P863, DOI 10.1001/archinte.1952.00240120138011; KAPLAN AR, 1970, AM J MENT DEF, V74, P745; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P1721; MAN EB, 1958, AM J OBSTET GYNECOL, V75, P728, DOI 10.1016/0002-9378(58)90651-3; MELLON JP, 1963, J MENT DEFIC RES, V7, P31; MILUNSKY A, 1968, ARCH ENVIRON HEALTH, V17, P372, DOI 10.1080/00039896.1968.10665244; MYERS CR, 1938, P AMER ASSOC MENT DE, V62, P142; NIELSEN J, 1969, J CLIN ENDOCR METAB, V29, P1062, DOI 10.1210/jcem-29-8-1062; PENROSE L. S., 1966, ADVANCE TERATOLOGY, V1, P9; SCHULER D, 1970, HUM HERED, V20, P13, DOI 10.1159/000152289; Vaccaro R, 1969, Minerva Pediatr, V21, P1175; VANHAELST L, 1969, ANN ENDOCRINOL-PARIS, V30, P659; VANHAELST L, 1970, J CLIN ENDOCR METAB, V30, P792, DOI 10.1210/jcem-30-6-792	28	51	51	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1971	23	1					67	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	I6190	4253284				2022-12-18	WOS:A1971I619000009
J	ARENDS, T; WEITKAMP, LR; GALLANGO, ML; NEEL, JV; SCHULTZ, J				ARENDS, T; WEITKAMP, LR; GALLANGO, ML; NEEL, JV; SCHULTZ, J			GENE FREQUENCIES AND MICRODIFFERENTIATION AMONG MAKIRITARE INDIANS .2. 7 SERUM PROTEIN SYSTEMS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ARENDS T, 1970, BLOOD, V33, P414; ARENDS T, 1964, 10 P C INT SOC BLOOD, P405; ARENDS T, 1960, 8 P C INT SOC BLOOD, P379; ARENDS T, 1962, 9 P C INT SOC BLOOD, P463; ASHTON GC, 1965, AUST J BIOL SCI, V18, P665, DOI 10.1071/BI9650665; ASHTON GC, 1966, AM J HUM GENET, V18, P438; BAUR EW, 1963, J LAB CLIN MED, V61, P166; BOWMAN BH, 1965, P NATL ACAD SCI USA, V53, P722, DOI 10.1073/pnas.53.4.722; GAHNE B, 1963, HEREDITAS, V50, P126; GALLANGO ML, 1969, HUMANGENETIK, V7, P104, DOI 10.1007/BF00287074; GALLANGO ML, 1966, 11 P C INT SOC BLOOD, P299; GERSHOWITZ H, 1967, AM J HUM GENET, V19, P502; GERSHOWITZ H, 1970, AM J HUM GENET, V22, P515; GIBLETT ER, 1959, NATURE, V183, P1589, DOI 10.1038/1831589a0; HARRIS H, 1963, LANCET, V2, P218; HIGASHI G. I., 1966, J MED GENET, V3, P281, DOI 10.1136/jmg.3.4.281; OWEN JA, 1958, NATURE, V182, P1373, DOI 10.1038/1821373a0; OWEN JA, 1961, CLIN CHIM ACTA, V6, P441, DOI 10.1016/0009-8981(61)90074-2; SCHEIDEGGER JJ, 1955, INT ARCH ALLER A IMM, V7, P103, DOI 10.1159/000228215; SCHULTZ JS, 1968, P NATL ACAD SCI USA, V61, P963, DOI 10.1073/pnas.61.3.963; Shreffler D C, 1967, Biochem Genet, V1, P101, DOI 10.1007/BF00486512; SMITHIES O, 1959, BIOCHEM J, V71, P585, DOI 10.1042/bj0710585; SMITHIES O, 1955, BIOCHEM J, V61, P629, DOI 10.1042/bj0610629; WEITKAMP LR, 1970, HUM HERED, V20, P1, DOI 10.1159/000152287; WEITKAMP LR, 1966, AM J HUM GENET, V18, P559; WEITKAMP LR, 1969, HUMANGENETIK, V7, P180, DOI 10.1007/BF00287083; WEITKAMP LR, 1969, HUM HERED, V19, P159, DOI 10.1159/000152212	27	51	51	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1970	22	5					526	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	H6097	5534560				2022-12-18	WOS:A1970H609700004
J	ALTER, M				ALTER, M			IS HYPERPLOIDY OF SEX CHROMOSOMES ASSOCIATED WITH REDUCED TOTAL FINGER RIDGE COUNT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ATKINS L., 1963, CYTOGENETLCS [BASEL], V2, P208, DOI 10.1159/000129780; FARQUHAR HG, 1964, ANN HUM GENET, V28, P11, DOI 10.1111/j.1469-1809.1964.tb00455.x; FORBES AP, 1964, NEW ENGL J MED, V270, P1268, DOI 10.1056/NEJM196406112702402; FRACCARO M., 1962, CYTO GENETICS, V1, P52, DOI 10.1159/000129713; HOLT SB, 1964, ANN HUM GENET, V28, P87, DOI 10.1111/j.1469-1809.1964.tb00463.x; HOLT SB, 1961, BRIT MED BULL, V17, P247, DOI 10.1093/oxfordjournals.bmb.a069917; PENROSE LS, 1963, NATURE, V197, P933, DOI 10.1038/197933a0; SCHADE H., 1963, MED WELT, V16, P869; Uchida I.A., 1963, PEDIATR CLIN N AM, V10, P409; UCHIDA IA, 1964, AM J HUM GENET, V16, P284	10	51	51	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1965	17	6					473	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	69652	5844122				2022-12-18	WOS:A19656965200003
J	TIPS, RL				TIPS, RL			A STUDY OF THE INHERITANCE OF ATOPIC HYPERSENSITIVITY IN MAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Adkinson J, 1920, GENETICS, V5, P363; Balyeat RM, 1928, AM J MED SCI, V176, P332, DOI 10.1097/00000441-192809000-00003; BALYEAT RM, 1933, GENETICS, V18, P129; BOYD WC, 1947, FUNDAMENTALS IMMUNOL; BRAY GEORGE W., 1931, JOUR ALLERGY, V2, P205, DOI 10.1016/S0021-8707(31)90069-5; BRAY GW, 1930, BRIT MED J, V1, P384; BUCHER CS, 1934, J ALLERGY, V5, P611; CAMPBELL DH, 1950, J ALLERGY, V21, P519, DOI 10.1016/0021-8707(50)90102-X; Coca AF, 1927, J LAB CLIN MED, V12, P1135; Coca AF, 1925, J IMMUNOL, V10, P445; COCA AF, 1925, J IMMUN, V10, P471; Coca AF, 1945, FAMILIAL NONREAGINIC; Cooke RA, 1916, J IMMUNOL, V1, P201; Cooke RA, 1935, J EXP MED, V62, P733, DOI 10.1084/jem.62.6.733; HOGBEN L, 1932, J GENET, V25, P97; Levine P, 1926, J IMMUNOL, V11, P411; Loveless MH, 1940, J IMMUNOL, V38, P25; SCULLY MARGARET A., 1941, JOUR ALLERGY, V12, P549, DOI 10.1016/S0021-8707(41)90202-2; SHERMAN B, 1940, J ALLERGY, V12, P605; Smith AE, 1928, ARCH INTERN MED, V41, P472, DOI 10.1001/archinte.1928.00130160022002; SNYDER LH, 1947, YALE J BIOL MED, V19, P817; Snyder LH, 1946, PRINCIPLES HEREDITY, V3; Spain WC, 1924, J IMMUNOL, V9, P521; Stern C., 1949, PRINCIPLES HUMAN GEN; VAUGHN WT, 1931, ALLERGY APPLIED IMMU; WALZER M, 1948, ANN N Y ACAD SCI, V50, P743; WIENER AS, 1935, ANN EUGEN, V7, P141; ZINSSER H, 1939, IMMUNITY PRINCIPLES, P340	28	51	51	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1954	6	3					328	343						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YB734	13197361				2022-12-18	WOS:A1954YB73400003
J	Dimmock, D; Caylor, S; Waldman, B; Benson, W; Ashburner, C; Carmichael, JL; Carroll, J; Cham, E; Chowdhury, S; Cleary, J; D'Harlingue, A; Doshi, A; Ellsworth, K; Galarreta, CI; Hobbs, C; Houtchens, K; Hunt, J; Joe, P; Joseph, M; Kaplan, RH; Kingsmore, SF; Knight, J; Kochhar, A; Kronick, RG; Limon, J; Martin, M; Rauen, KA; Schwarz, A; Shankar, SP; Spicer, R; Rojas, MA; Vargas-Shiraishi, O; Wigby, K; Zadeh, N; Farnaes, L				Dimmock, David; Caylor, Sara; Waldman, Bryce; Benson, Wendy; Ashburner, Christina; Carmichael, Jason L.; Carroll, Jeanne; Cham, Elaine; Chowdhury, Shimul; Cleary, John; D'Harlingue, Arthur; Doshi, A.; Ellsworth, Katarzyna; Galarreta, Carolina, I; Hobbs, Charlotte; Houtchens, Kathleen; Hunt, Juliette; Joe, Priscilla; Joseph, Maries; Kaplan, Robert H.; Kingsmore, Stephen F.; Knight, Jason; Kochhar, Aaina; Kronick, Richard G.; Limon, Jolie; Martin, Madelena; Rauen, Katherine A.; Schwarz, Adam; Shankar, Suma P.; Spicer, Rosanna; Rojas, Mario Augusto; Vargas-Shiraishi, Ofelia; Wigby, Kristen; Zadeh, Neda; Farnaes, Lauge			Project Baby Bear: Rapid precision care incorporating rWGS in 5 California children's hospitals demonstrates improved clinical outcomes and reduced costs of care	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEONATAL INTENSIVE-CARE; WHOLE-GENOME; MEDICAL GENETICS; ILL INFANTS; GUIDELINES; DISORDERS	Genetic disorders are a leading contributor to mortality in neonatal and pediatric intensive care units (ICUs). Rapid whole-genome sequencing (rWGS)-based rapid precision medicine (RPM) is an intervention that has demonstrated improved clinical outcomes and reduced costs of care. However, the feasibility of broad clinical deployment has not been established. The objective of this study was to implement RPM based on rWGS and evaluate the clinical and economic impact of this implementation as a first line diagnostic test in the California Medicaid (Medi-Cal) program. Project Baby Bear was a payor funded, prospective, real-world quality improvement project in the regional ICUs of five tertiary care children's hospitals. Participation was limited to acutely ill Medi-Cal beneficiaries who were admitted November 2018 to May 2020, were <1 year old and within one week of hospitalization, or had just developed an abnormal response to therapy. The whole cohort received RPM. There were two prespecified primary outcomes-changes in medical care reported by physicians and changes in the cost of care. The majority of infants were from underserved populations. Of 184 infants enrolled, 74 (40%) received a diagnosis by rWGS that explained their admission in a median time of 3 days. In 58 (32%) affected individuals, rWGS led to changes in medical care. Testing and precision medicine cost $1.7 million and led to $2.2-2.9 million cost savings. rWGS-based RPM had clinical utility and reduced net health care expenditures for infants in regional ICUs. rWGS should be considered early in ICU admission when the underlying etiology is unclear.	[Dimmock, David; Caylor, Sara; Waldman, Bryce; Benson, Wendy; Carroll, Jeanne; Chowdhury, Shimul; Doshi, A.; Ellsworth, Katarzyna; Hobbs, Charlotte; Kingsmore, Stephen F.; Wigby, Kristen; Farnaes, Lauge] Rady Childrens Inst Genom Med, San Diego, CA 92130 USA; [Ashburner, Christina; Carmichael, Jason L.; Galarreta, Carolina, I; Joseph, Maries; Kochhar, Aaina; Limon, Jolie; Spicer, Rosanna; Rojas, Mario Augusto] Valley Childrens Hosp, Madera, CA 93636 USA; [Cham, Elaine; D'Harlingue, Arthur; Houtchens, Kathleen; Joe, Priscilla] Univ Calif San Francisco, Benioff Childrens Hosp Oakland, Oakland, CA 94609 USA; [Cleary, John; Hunt, Juliette; Knight, Jason; Schwarz, Adam; Vargas-Shiraishi, Ofelia; Zadeh, Neda] Childrens Hosp Orange Cty, Orange, CA 92868 USA; [Carroll, Jeanne; Doshi, A.; Wigby, Kristen] Univ Calif San Diego, San Diego, CA 92093 USA; [Kaplan, Robert H.; Kronick, Richard G.] Torrey Pines Hlth Grp Inc, San Diego, CA 92037 USA; [Kronick, Richard G.] Univ Calif San Diego, Dept Family Med & Publ Hlth, San Diego, CA 92093 USA; [Martin, Madelena; Rauen, Katherine A.; Shankar, Suma P.] Univ Calif Davis, Sacramento, CA 95817 USA; [Martin, Madelena; Rauen, Katherine A.; Shankar, Suma P.] Davis Childrens Hosp, Sacramento, CA 95817 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Childrens Hospital of Orange County; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Davis	Dimmock, D (corresponding author), Rady Childrens Inst Genom Med, San Diego, CA 92130 USA.	ddimmock@rchsd.org			California Department of Health Care Services (DHCS) - California State Senate appropriation [4260-001-0001]; Brown Family; Lantzman Family Fund	California Department of Health Care Services (DHCS) - California State Senate appropriation; Brown Family; Lantzman Family Fund	This project was funded by a grant to Rady Children's Hospital-San Diego from the California Department of Health Care Services (DHCS) for ``Project Baby Bear,'' funded by California State Senate appropriation (4260-001-0001, provision 8). Further support came from Meredith and Craig Garner, the Brown Family, Rowena and Marc Treitler, the Lantzman Family Fund, Joni LeSage, Shelley Siegan, and ananonymous donor. The funders playedno role in the conduct of the project. Additional contributions: Lynne Bird, Nicole Coufal, Miguel Del Campo Casanelles, Annette Feigenbaum, Marva Evans, Jeff Gold, Helen Harvey, Jose Honold, Marilyn Jones, Amy Kimball, Brian Lane, Crystal Le, Jennie Le, Sandra Leibel, Rebecca Mardach, Laurel Moyer, Mark Speziale, Denise Suttner, Charles Sauer, Richard Song, and AudraWise; Christina Clarke, Michele Feddock, Mary Gaughran, Jerica Lenberg, Kathryn Nguyen, Seema Rego, Iris Reyes, Kelly Watkins, Cheyenne Camp, Karin Fuentes-Fajardo, Russell Nofsinger, Lisa Salz, Wes Segal, Tye Barber, Regina Griffing, Olivia Simonides, Donna Slade, Karen Garman, and Grace Sevilla; Brent Dethlefs, Phuong Dao, Erum Naeem, and Cathy Flores; Zaira Bezares-Orin, Bianca Covarrubias, Yan Ding, Kasia Ellsworth, Lucia Guidulgi, Monia Hammer, Christian Hansen, Stacey Huynh, Kiely James, Alma Johnson, Jennie Le, Jerica Lenberg, Shareef Nahas, Maria Ortiz-Arechiga, Sujal Phadke, Abigail Pham, Laura Puckett, Leila Schwanemann, Mari J. Tokita, Luca Van Der Kraan, Terence Wong, Meredith Wright, Catherine Yamada, Sergey Batalov, Eric Blincow, Josh Braun, Kevin Chau, Carlos Diaz, Christian Hansen, Dana Mashburn, Daeheon Oh, Daniken Orendain, Daniel Perry, Ray Veeraraghavan, and KellyWatkins.	Bick D, 2017, J PEDIATR GENET, V6, P61, DOI 10.1055/s-0036-1593968; Blue Shield of California, 2020, WHOL EX WHOL GEN SEQ; Cakici JA, 2020, AM J HUM GENET, V107, P953, DOI 10.1016/j.ajhg.2020.10.004; Carey AS, 2020, PEDIATR RES, V88, P761, DOI 10.1038/s41390-020-0858-x; Clark MM, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat6177; Clark MM, 2018, NPJ GENOM MED, V3, DOI 10.1038/s41525-018-0053-8; Dewey B., 2018, CLAIMS BASED APPROAC; Dimmock DP, 2020, AM J HUM GENET, V107, P942, DOI 10.1016/j.ajhg.2020.10.003; Farnaes L, 2018, NPJ GENOM MED, V3, DOI 10.1038/s41525-018-0049-4; Freed A.S., 2020, J PEDIAT; French CE, 2019, INTENS CARE MED, V45, P627, DOI 10.1007/s00134-019-05552-x; Genetti CA, 2019, GENET MED, V21, P622, DOI 10.1038/s41436-018-0105-6; Goodman DC, 2019, J PEDIATR-US, V209, P44, DOI 10.1016/j.jpeds.2019.02.014; Gubbels CS, 2020, GENET MED, V22, P736, DOI 10.1038/s41436-019-0708-6; Harrison W, 2015, JAMA PEDIATR, V169, P855, DOI 10.1001/jamapediatrics.2015.1305; Harrison WN, 2018, J PEDIATR-US, V192, P73, DOI 10.1016/j.jpeds.2017.08.028; Hayeems RZ, 2017, EUR J HUM GENET, V25, P1303, DOI 10.1038/s41431-017-0020-3; Iglesias CP, 2016, PHARMACOECONOMICS, V34, P1161, DOI 10.1007/s40273-016-0425-9; Kingsmore SF, 2019, AM J HUM GENET, V105, P719, DOI 10.1016/j.ajhg.2019.08.009; Lunke S, 2020, JAMA-J AM MED ASSOC, V323, P2503, DOI 10.1001/jama.2020.7671; Meng LY, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2017.3438; Mestek-Boukhibar L, 2018, J MED GENET, V55, P721, DOI 10.1136/jmedgenet-2018-105396; Petrikin JE, 2018, NPJ GENOM MED, V3, DOI 10.1038/s41525-018-0045-8; Petrikin JE, 2015, SEMIN PERINATOL, V39, P623, DOI 10.1053/j.semperi.2015.09.009; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Sanford EF, 2019, PEDIATR CRIT CARE ME, V20, P1007, DOI 10.1097/PCC.0000000000002056; Schulman J, 2018, JAMA PEDIATR, V172, P17, DOI 10.1001/jamapediatrics.2017.3913; Smigiel R, 2020, J CLIN MED, V9, DOI 10.3390/jcm9072220; Smith HS, 2020, GENET MED, V22, P1303, DOI 10.1038/s41436-020-0798-1; Stark Z, 2019, GENET MED, V21, P173, DOI 10.1038/s41436-018-0006-8; Stark Z, 2016, GENET MED, V18, P1090, DOI 10.1038/gim.2016.1; Stevenson DA, 2004, AM J MED GENET A, V126A, P393, DOI 10.1002/ajmg.a.20409; Wang HJ, 2020, NPJ GENOM MED, V5, DOI 10.1038/s41525-020-0129-0; Willig LK, 2015, LANCET RESP MED, V3, P377, DOI 10.1016/S2213-2600(15)00139-3	34	50	50	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 1	2021	108	7					1231	1238		10.1016/j.ajhg.2021.05.008	http://dx.doi.org/10.1016/j.ajhg.2021.05.008		JUL 2021	8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TC9NQ	34089648	Bronze, Green Published			2022-12-18	WOS:000668964500005
J	Glazer, AM; Wada, Y; Li, B; Muhammad, A; Kalash, OR; O'Neill, MJ; Shields, T; Hall, L; Short, L; Blair, MA; Kroncke, BM; Capra, JA; Roden, DM				Glazer, Andrew M.; Wada, Yuko; Li, Bian; Muhammad, Ayesha; Kalash, Olivia R.; O'Neill, Matthew J.; Shields, Tiffany; Hall, Lynn; Short, Laura; Blair, Marcia A.; Kroncke, Brett M.; Capra, John A.; Roden, Dan M.			High-Throughput Reclassification of SCN5A Variants	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ST SEGMENT ELEVATION; BRUGADA-SYNDROME; MEDICAL GENETICS; AMERICAN-COLLEGE; HIGH-RISK; MUTATIONS; DISEASE; COMMON; EXPRESSION; STABILITY	Partial or complete loss-of-function variants in SCN5A are the most common genetic cause of the arrhythmia disorder Brugada syndrome (BrS1). However, the pathogenicity of SCN5A variants is often unknown or disputed; 80% of the 1,390 SCN5A missense variants observed in at least one individual to date are variants of uncertain significance (VUSs). The designation of VUS is a barrier to the use of sequence data in clinical care. We selected 83 variants: 10 previously studied control variants, 10 suspected benign variants, and 63 suspected Brugada syndrome-associated variants, selected on the basis of their frequency in the general population and in individuals with Brugada syndrome. We used high-throughput automated patch clamping to study the function of the 83 variants, with the goal of reclassifying variants with functional data. The ten previously studied controls had functional properties concordant with published manual patch clamp data. All 10 suspected benign variants had wild-type-like function. 22 suspected BrS variants had loss of channel function (<10% normalized peak current) and 22 variants had partial loss of function (10%-50% normalized peak current). The previously unstudied variants were initially classified as likely benign (n = 2), likely pathogenic (n = 10), or VUSs (n = 61). After the patch clamp studies, 16 variants were benign/likely benign, 45 were pathogenic/likely pathogenic, and only 12 were still VUSs. Structural modeling identified likely mechanisms for loss of function including altered thermostability and disruptions to alpha helices, disulfide bonds, or the permeation pore. High-throughput patch clamping enabled reclassification of the majority of tested VUSs in SCN5A.	[Glazer, Andrew M.; Wada, Yuko; Muhammad, Ayesha; Kalash, Olivia R.; O'Neill, Matthew J.; Shields, Tiffany; Hall, Lynn; Short, Laura; Blair, Marcia A.; Kroncke, Brett M.; Roden, Dan M.] Vanderbilt Univ, Vanderbilt Ctr Arrhythmia Res & Therapeut, Dept Med, Div Clin Pharmacol,Med Ctr, Nashville, TN 37232 USA; [Li, Bian; Capra, John A.] Vanderbilt Univ, Dept Biol Sci, Ctr Struct Biol, Nashville, TN 37235 USA; [Li, Bian; Capra, John A.] Vanderbilt Univ, Vanderbilt Genet Inst, Nashville, TN 37235 USA; [Kroncke, Brett M.; Roden, Dan M.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Roden, Dan M.] Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Roden, DM (corresponding author), Vanderbilt Univ, Vanderbilt Ctr Arrhythmia Res & Therapeut, Dept Med, Div Clin Pharmacol,Med Ctr, Nashville, TN 37232 USA.; Roden, DM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA.; Roden, DM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN 37232 USA.	dan.roden@vumc.org	Li, Bian/AAM-4001-2020; Roden, Dan/ABD-5412-2021; Li, Bian/AAV-3933-2021	Li, Bian/0000-0002-8280-5018; Li, Bian/0000-0002-8280-5018; O'Neill, Matthew/0000-0003-2014-7950; Muhammad, Ayesha/0000-0003-0870-2923; Glazer, Andrew/0000-0002-3938-4713	NIH Shared Instrumentation Grant [1S10OD025281]; NIH [K99 HG010904, K99 HL135442, R01 HL149826, P50 GM115305]; American Heart Association fellowships [20POST35220002, 20PRE35180088]	NIH Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association fellowships(American Heart Association)	We thank Kenneth Matreyek and Douglas Fowler for sharing HEK293 cell lines and Tim Strassmaier and Carlos Vanoye for helpful advice. The Nanion SyncroPatch 384PE is housed and managed within the Vanderbilt High-Throughput Screening center, an institutionally supported core, and was funded by NIH Shared Instrumentation Grant 1S10OD025281. This research was funded by NIH grants K99 HG010904 (A.M.G.), K99 HL135442 (B.M.K.), R01 HL149826 (D.M.R.), and P50 GM115305 (D.M.R.) and American Heart Association fellowships 20POST35220002 (B.L.) and 20PRE35180088 (A.M.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aiba T, 2014, CIRC-CARDIOVASC GENE, V7, P249, DOI 10.1161/CIRCGENETICS.113.000480; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Benson DW, 2003, J CLIN INVEST, V112, P1019, DOI 10.1172/JCI200318062; Bezzina CR, 2013, NAT GENET, V45, P1044, DOI 10.1038/ng.2712; Bezzina CR, 2003, CIRC RES, V92, P159, DOI 10.1161/01.RES.0000052672.97759.36; Brnich SE, 2019, GENOME MED, V12, DOI 10.1186/s13073-019-0690-2; Brugada J, 2018, J AM COLL CARDIOL, V72, P1046, DOI 10.1016/j.jacc.2018.06.037; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J; Casadio R, 2011, HUM MUTAT, V32, P1161, DOI 10.1002/humu.21555; Casini S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205033; Chavali NV, 2019, HEART RHYTHM, V16, P1686, DOI 10.1016/j.hrthm.2019.04.031; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Clatot J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02262-0; Clatot J, 2012, CARDIOVASC RES, V96, P53, DOI 10.1093/cvr/cvs211; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Deschenes I, 2000, CARDIOVASC RES, V46, P55, DOI 10.1016/S0008-6363(00)00006-7; Fatima A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083005; Findlay GM, 2018, NATURE, V562, P217, DOI 10.1038/s41586-018-0461-z; Frigo G, 2007, EUROPACE, V9, P391, DOI 10.1093/europace/eum053; Glazer AM, 2020, CIRC-GENOM PRECIS ME, V13, DOI 10.1161/CIRCGEN.119.002786; Gui JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010985; Hermann M, 2014, NUCLEIC ACIDS RES, V42, P3894, DOI 10.1093/nar/gkt1361; Heyne H.O., 2019, BIORXIV, DOI [10.1101/671453, DOI 10.1101/671453]; Hosseini SM, 2018, CIRCULATION, V138, P1195, DOI 10.1161/CIRCULATIONAHA.118.035070; Itoh H, 2016, EUR J HUM GENET, V24, P1160, DOI 10.1038/ejhg.2015.257; Jiang DK, 2017, COMPUT IND ENG, V107, P100, DOI 10.1016/j.cie.2017.02.021; Kalia SS, 2017, GENET MED, V19, P249, DOI 10.1038/gim.2016.190; Kang SK, 2019, ANN NEUROL, V86, P899, DOI 10.1002/ana.25607; Kapplinger JD, 2015, CIRC-CARDIOVASC GENE, V8, P582, DOI 10.1161/CIRCGENETICS.114.000831; Kapplinger JD, 2010, HEART RHYTHM, V7, P33, DOI 10.1016/j.hrthm.2009.09.069; Kapplinger JD, 2009, HEART RHYTHM, V6, P1297, DOI 10.1016/j.hrthm.2009.05.021; Kim MK, 1999, PROTEIN SCI, V8, P1492, DOI 10.1110/ps.8.7.1492; Kroncke B.M., 2019, BIO RXIV, DOI [10.1101/571158., DOI 10.1101/571158]; Kroncke BM, 2019, COMPUT STRUCT BIOTEC, V17, P206, DOI 10.1016/j.csbj.2019.01.008; Kroncke BM, 2018, CIRC-GENOM PRECIS ME, V11, DOI 10.1161/CIRCGEN.118.002095; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Makielski JC, 2003, CIRC RES, V93, P821, DOI 10.1161/01.RES.0000096652.14509.96; Makiyama T, 2005, J AM COLL CARDIOL, V46, P2100, DOI 10.1016/j.jacc.2005.08.043; Matreyek KA, 2020, NUCLEIC ACIDS RES, V48, DOI 10.1093/nar/gkz910; Matreyek KA, 2018, NAT GENET, V50, P874, DOI 10.1038/s41588-018-0122-z; Matreyek KA, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx183; Milman A, 2019, HEART RHYTHM, V16, P1468, DOI 10.1016/j.hrthm.2019.07.003; Milman A, 2018, HEART RHYTHM, V15, P1457, DOI 10.1016/j.hrthm.2018.06.019; Moreau A, 2015, J GEN PHYSIOL, V145, P93, DOI 10.1085/jgp.201411304; Ng CA, 2020, HEART RHYTHM, V17, P492, DOI 10.1016/j.hrthm.2019.09.020; Park H, 2016, J CHEM THEORY COMPUT, V12, P6201, DOI 10.1021/acs.jctc.6b00819; Pfahnl AE, 2007, HEART RHYTHM, V4, P46, DOI 10.1016/j.hrthm.2006.09.031; Potet F, 2003, J CARDIOVASC ELECTR, V14, P200, DOI 10.1046/j.1540-8167.2003.02382.x; Priori SG, 2002, CIRCULATION, V105, P1342, DOI 10.1161/hc1102.105288; Probst V, 2006, J CARDIOVASC ELECTR, V17, P270, DOI 10.1111/j.1540-8167.2006.00349.x; Remme CA, 2008, TRENDS CARDIOVAS MED, V18, P78, DOI 10.1016/j.tcm.2008.01.002; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Selga E, 2018, J MOL CELL CARDIOL, V114, P10, DOI 10.1016/j.yjmcc.2017.10.002; Shen H., 2018, SCIENCE, V362, P362; Shen HZ, 2019, SCIENCE, V363, P1303, DOI 10.1126/science.aaw2493; Stein A, 2019, TRENDS BIOCHEM SCI, V44, P575, DOI 10.1016/j.tibs.2019.01.003; Takehara N, 2004, J INTERN MED, V255, P137, DOI 10.1046/j.0954-6820.2003.01247.x; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Valdivia CR, 2004, CARDIOVASC RES, V62, P53, DOI 10.1016/j.cardiores.2004.01.022; Valdivia CR, 2002, CARDIOVASC RES, V55, P279, DOI 10.1016/S0008-6363(02)00445-5; Vanoye CG, 2018, CIRC-GENOM PRECIS ME, V11, DOI 10.1161/CIRCGEN.118.002345; Wang DW, 1996, P NATL ACAD SCI USA, V93, P13200, DOI 10.1073/pnas.93.23.13200; Whiffin N, 2017, GENET MED, V19, P1151, DOI 10.1038/gim.2017.26; Wilde AAM, 2018, JACC-CLIN ELECTROPHY, V4, P569, DOI 10.1016/j.jacep.2018.03.006; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020; Zhou YF, 2000, J BIOL CHEM, V275, P6975, DOI 10.1074/jbc.275.10.6975	70	50	50	2	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 2	2020	107	1					111	123		10.1016/j.ajhg.2020.05.015	http://dx.doi.org/10.1016/j.ajhg.2020.05.015			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MH4EU	32533946	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000546685300010
J	Karolak, JA; Vincent, M; Deutsch, G; Gambin, T; Cogne, B; Pichon, O; Vetrini, F; Mefford, HC; Dines, JN; Golden-Grant, K; Dipple, K; Freed, AS; Leppig, KA; Dishop, M; Mowat, D; Bennetts, B; Gifford, AJ; Weber, MA; Lee, AF; Boerkoel, CF; Bartell, TM; Ward-Melver, C; Besnard, T; Petit, F; Bache, I; Tumer, Z; Denis-Musquer, M; Joubert, M; Martinovic, J; Beneteau, C; Molin, A; Carles, D; Andre, G; Bieth, E; Chassaing, N; Devisme, L; Chalabreysse, L; Pasquier, L; Secq, V; Don, M; Orsaria, M; Missirian, C; Mortreux, J; Sanlaville, D; Pons, L; Kury, S; Bezieau, S; Liet, JM; Joram, N; Bihouee, T; Scott, DA; Brown, CW; Scaglia, F; Tsai, ACH; Grange, DK; Phillips, JA; Pfotenhauer, JP; Jhangiani, SN; Gonzaga-Jauregui, CG; Chung, WK; Schauer, GM; Lipson, MH; Mercer, CL; van Haeringen, A; Liu, Q; Popek, E; Akdemir, ZHC; Lupski, JR; Szafranski, P; Isidor, B; Le Caignec, C; Stankiewicz, P				Karolak, Justyna A.; Vincent, Marie; Deutsch, Gail; Gambin, Tomasz; Cogne, Benjamin; Pichon, Olivier; Vetrini, Francesco; Mefford, Heather C.; Dines, Jennifer N.; Golden-Grant, Katie; Dipple, Katrina; Freed, Amanda S.; Leppig, Kathleen A.; Dishop, Megan; Mowat, David; Bennetts, Bruce; Gifford, Andrew J.; Weber, Martin A.; Lee, Anna F.; Boerkoel, Cornelius F.; Bartell, Tina M.; Ward-Melver, Catherine; Besnard, Thomas; Petit, Florence; Bache, Iben; Tumer, Zeynep; Denis-Musquer, Marie; Joubert, Madeleine; Martinovic, Jelena; Beneteau, Claire; Molin, Arnaud; Carles, Dominique; Andre, Gwenaelle; Bieth, Eric; Chassaing, Nicolas; Devisme, Louise; Chalabreysse, Lara; Pasquier, Laurent; Secq, Veronique; Don, Massimiliano; Orsaria, Maria; Missirian, Chantal; Mortreux, Jeremie; Sanlaville, Damien; Pons, Linda; Kury, Sebastien; Bezieau, Stephane; Liet, Jean-Michel; Joram, Nicolas; Bihouee, Tiphaine; Scott, Daryl A.; Brown, Chester W.; Scaglia, Fernando; Tsai, Anne Chun-Hui; Grange, Dorothy K.; Phillips, John A., III; Pfotenhauer, Jean P.; Jhangiani, Shalini N.; Gonzaga-Jauregui, Claudia G.; Chung, Wendy K.; Schauer, Galen M.; Lipson, Mark H.; Mercer, Catherine L.; van Haeringen, Arie; Liu, Qian; Popek, Edwina; Akdemir, Zeynep H. Coban; Lupski, James R.; Szafranski, Przemyslaw; Isidor, Bertrand; Le Caignec, Cedric; Stankiewicz, Pawe			Complex Compound Inheritance of Lethal Lung Developmental Disorders Due to Disruption of the TBX-FGF Pathway	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL ACINAR DYSPLASIA; ALVEOLAR-CAPILLARY DYSPLASIA; BRANCHING MORPHOGENESIS; RARE CAUSE; HEART-DEFECTS; MUTATIONS; GENE; VARIANTS; APLASIA; DELETION	Primary defects in lung branching morphogenesis, resulting in neonatal lethal pulmonary hypoplasias, are incompletely understood. To elucidate the pathogenetics of human lung development, we studied a unique collection of samples obtained from deceased individuals with clinically and histopathologically diagnosed interstitial neonatal lung disorders: acinar dysplasia (n = 14), congenital alveolar dysplasia (n = 2), and other lethal lung hypoplasias (n = 10). We identified rare heterozygous copy-number variant deletions or single-nucleotide variants (SNVs) involving TBX4 (n = 8 and n = 2, respectively) or FGF10 (n = 2 and n = 2, respectively) in 16/26 (61%) individuals. In addition to TBX4, the overlapping similar to 2 Mb recurrent and nonrecurrent deletions at 17q23.1q23.2 identified in seven individuals with lung hypoplasia also remove a lung-specific enhancer region. Individuals with coding variants involving either TBX4 or FGF10 also harbored at least one non-coding SNV in the predicted lung-specific enhancer region, which was absent in 13 control individuals with the overlapping deletions but without any structural lung anomalies. The occurrence of rare coding variants involving TBX4 or FGF10 with the putative hypomorphic non-coding SNVs implies a complex compound inheritance of these pulmonary hypoplasias. Moreover, they support the importance of TBX4-FGF10-FGFR2 epithelial-mesenchymal signaling in human lung organogenesis and help to explain the histopathological continuum observed in these rare lethal developmental disorders of the lung.	[Karolak, Justyna A.; Scott, Daryl A.; Scaglia, Fernando; Liu, Qian; Akdemir, Zeynep H. Coban; Lupski, James R.; Szafranski, Przemyslaw; Stankiewicz, Pawe] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Karolak, Justyna A.] Poznan Univ Med Sci, Dept Genet & Pharmaceut Microbiol, PL-60781 Poznan, Poland; [Vincent, Marie; Cogne, Benjamin; Pichon, Olivier; Besnard, Thomas; Beneteau, Claire; Kury, Sebastien; Bezieau, Stephane; Isidor, Bertrand; Le Caignec, Cedric] CHU Nantes, Serv Genet Med, F-44000 Nantes, France; [Vincent, Marie; Cogne, Benjamin; Besnard, Thomas; Beneteau, Claire; Kury, Sebastien; Bezieau, Stephane; Isidor, Bertrand] Univ Nantes, INSERM, CNRS, Inst Thorax, F-44000 Nantes, France; [Deutsch, Gail] Seattle Childrens Hosp, Dept Pathol, Seattle, WA 98105 USA; [Gambin, Tomasz] Inst Mother & Child Hlth, Dept Med Genet, PL-01211 Warsaw, Poland; [Gambin, Tomasz] Warsaw Univ Technol, Inst Comp Sci, PL-00665 Warsaw, Poland; [Vetrini, Francesco; Stankiewicz, Pawe] Baylor Genet, Houston, TX 77021 USA; [Mefford, Heather C.; Dines, Jennifer N.; Dipple, Katrina; Freed, Amanda S.] Univ Washington, Dept Pediat, Div Med Genet, Seattle, WA 98195 USA; [Dines, Jennifer N.; Freed, Amanda S.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Golden-Grant, Katie; Dipple, Katrina] Seattle Childrens Hosp, Div Med Genet, Seattle, WA 98105 USA; [Leppig, Kathleen A.] Genet Serv Kaiser Permanente Washington, Seattle, WA 98112 USA; [Dishop, Megan] Phoenix Childrens Hosp, Pathol & Lab Med, Phoenix, AZ 85016 USA; [Mowat, David] Sydney Childrens Hosp, Clin Genet Ctr, Randwick Sydney, NSW 2031, Australia; [Mowat, David; Gifford, Andrew J.] Univ New South Wales, Sch Womens & Childrens Hlth, Sydney, NSW 2052, Australia; [Bennetts, Bruce] Univ Sydney, Sydney Med Sch, Discipline Child & Adolescent Hlth, Sydney, NSW 2006, Australia; [Bennetts, Bruce] Childrens Hosp Westmead, Dept Mol Genet, Western Sydney Genet Program, Sydney, NSW 2145, Australia; [Bennetts, Bruce] Univ Sydney, Discipline Genet Med, Sydney Med Sch, Sydney, NSW 2006, Australia; [Gifford, Andrew J.; Weber, Martin A.] Prince Wales Hosp, Dept Anat Pathol, Randwick, NSW 2031, Australia; [Weber, Martin A.] Univ New South Wales, Sch Med Sci, Sydney, NSW 2052, Australia; [Lee, Anna F.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada; [Boerkoel, Cornelius F.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; [Bartell, Tina M.; Lipson, Mark H.] Kaiser Permanente Sacramento Med Ctr, Dept Genet, Sacramento, CA 95815 USA; [Ward-Melver, Catherine] Akron Childrens Hosp, Div Med Genet, Akron, OH 44302 USA; [Petit, Florence] CHU Lille, Serv Genet Clin, F-59000 Lille, France; [Bache, Iben] Univ Copenhagen, Dept Cellular & Mol Med, DK-2200 Copenhagen N, Denmark; [Bache, Iben] Rigshosp, Dept Clin Genet, Copenhagen Univ Hosp, DK-2100 Copenhagen O, Denmark; [Tumer, Zeynep] Rigshosp, Kennedy Ctr, Dept Clin Genet, Copenhagen Univ Hosp, DK-2600 Copenhagen, Denmark; [Tumer, Zeynep] Univ Copenhagen, Deparment Clin Med, Fac Hlth & Med Sci, DK-2200 Copenhagen N, Denmark; [Denis-Musquer, Marie; Joubert, Madeleine] CHU Nantes, Serv Anatomopathol, F-44093 Nantes, France; [Martinovic, Jelena] Antoine Beclere Hosp, AP HP, Unit Fetal Pathol, F-75000 Paris, France; [Molin, Arnaud] CHU Caen, Serv Genet Med, F-14000 Caen, France; [Carles, Dominique; Andre, Gwenaelle] CHU Bordeaux, Serv Anatomopathol, F-33000 Bordeaux, France; [Bieth, Eric; Chassaing, Nicolas] CHU Toulouse, Serv Genet Med, Toulouse, France; [Bieth, Eric; Chassaing, Nicolas] Univ Toulouse, UDEAR, UMR 1056, INSERM, F-31000 Toulouse, France; [Devisme, Louise] CHU Lille, Inst Pathol, F-59000 Lille, France; [Chalabreysse, Lara] CHU Lyon, Serv Anatomopathol, F-69000 Lyon, France; [Pasquier, Laurent] CHU Rennes, Serv Genet Med, F-35000 Rennes, France; [Secq, Veronique] Aix Marseille Univ, Hop Nord, APHM, Serv Anatomopathol, F-13000 Marseille, France; [Don, Massimiliano] St Antonio Gen Hosp, Pediat Care Unit, I-33100 Udine, Italy; [Orsaria, Maria] Univ Udine, Dept Med & Biol Sci, Pathol Unit, Udine, Italy; [Missirian, Chantal; Mortreux, Jeremie] Aix Marseille Univ, Timone Hosp, APHM, INSERM,MMG, F-13000 Marseille, France; [Sanlaville, Damien; Pons, Linda] Hosp Civils Lyon, GHE, Dept Genet, F-69000 Lyon, France; [Sanlaville, Damien; Pons, Linda] Lyon Univ, F-69000 Lyon, France; [Liet, Jean-Michel; Joram, Nicolas] CHU Nantes, Serv Reanimat Pediat, F-44000 Nantes, France; [Bihouee, Tiphaine] CHU Nantes, Serv Pediat, F-44000 Nantes, France; [Scott, Daryl A.; Scaglia, Fernando; Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA; [Scott, Daryl A.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Brown, Chester W.] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Div Genet, Memphis, TN 38163 USA; [Scaglia, Fernando] Prince Wales Hosp, Joint BCM CUHK Ctr Med Genet, ShaTin, Hong Kong, Peoples R China; [Tsai, Anne Chun-Hui] Univ Colorado, Dept Pediat, Childrens Hosp, Sch Med, Aurora, CO 80045 USA; [Grange, Dorothy K.] Washington Univ, Dept Pediat, Div Genet & Genom Med, Sch Med,St Louis Childrens Hosp, St Louis, MO 63110 USA; [Phillips, John A., III; Pfotenhauer, Jean P.] Vanderbilt Univ, Med Ctr, Dept Pediat, Div Med Genet & Genom Med, Nashville, TN 37232 USA; [Jhangiani, Shalini N.; Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Gonzaga-Jauregui, Claudia G.] Regeneron Pharmaceut Inc, Regeneron Genet Ctr, Tarrytown, NY 10599 USA; [Chung, Wendy K.] Columbia Univ, Dept Pediat, New York, NY 10032 USA; [Chung, Wendy K.] Columbia Univ, Dept Med, New York, NY 10032 USA; [Schauer, Galen M.] Kaiser Permanente Oakland Med Ctr, Dept Pathol, Oakland, CA 94611 USA; [Mercer, Catherine L.] Univ Hosp Southampton NHS Fdn Trust, Wessex Clin Genet Serv, Princess Anne Hosp, Southampton SO16 5YA, Hants, England; [van Haeringen, Arie] Leiden Univ, Dept Clin Genet, Med Ctr, NL-2333 ZA Leiden, Netherlands; [Popek, Edwina] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Stankiewicz, Pawe] Inst Mother & Child Hlth, PL-01211 Warsaw, Poland	Baylor College of Medicine; Poznan University of Medical Sciences; Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Seattle Children's Hospital; Warsaw University of Technology; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Phoenix Children's Hospital; University of New South Wales Sydney; University of Sydney; University of Sydney; University of Sydney; University of New South Wales Sydney; University of British Columbia; University of British Columbia; Kaiser Permanente; Akron Children's Hospital; Universite de Lille - ISITE; CHU Lille; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU Bordeaux; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; CHU Lyon; CHU Rennes; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of Udine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Lyon; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Baylor College of Medicine; Baylor College of Medicine; University of Tennessee System; University of Tennessee Health Science Center; Chinese University of Hong Kong; Prince of Wales Hospital; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; St. Louis Children's Hospital; Washington University (WUSTL); Vanderbilt University; Baylor College of Medicine; Regeneron; Columbia University; Columbia University; Kaiser Permanente; University of Southampton; University Hospital Southampton NHS Foundation Trust; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Baylor College of Medicine; Baylor College of Medicine	Stankiewicz, P (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Le Caignec, C (corresponding author), CHU Nantes, Serv Genet Med, F-44000 Nantes, France.; Stankiewicz, P (corresponding author), Baylor Genet, Houston, TX 77021 USA.; Stankiewicz, P (corresponding author), Inst Mother & Child Hlth, PL-01211 Warsaw, Poland.	cedric.lecaignec@chu-nantes.fr; pawels@bcm.edu	Gambin, Tomasz/HDN-5840-2022; Stankiewicz, Paweł/AAP-7906-2021; Besnard, Thomas/L-2303-2019; Weber, Martin/GPW-6095-2022; KÜRY, Sébastien/G-5971-2015; Sanlaville, Damien/M-4716-2014; Boerkoel, Cornelius Franciscus/AFW-4948-2022; Isidor, Bertrand/AAJ-3456-2021; Orsaria, Maria/AAH-6310-2021; Tumer, Zeynep/AAF-8501-2019; Gonzaga-Jauregui, Claudia/H-4752-2019; Pasquier, Laurent/AAN-4081-2020; Vincent, Marie/K-7342-2018	Gambin, Tomasz/0000-0002-0941-4571; Stankiewicz, Paweł/0000-0002-6456-7490; Besnard, Thomas/0000-0003-4804-5147; KÜRY, Sébastien/0000-0001-5497-0465; Sanlaville, Damien/0000-0001-9939-2849; Boerkoel, Cornelius Franciscus/0000-0003-3097-241X; Isidor, Bertrand/0000-0001-6480-126X; Tumer, Zeynep/0000-0002-4777-5802; Gonzaga-Jauregui, Claudia/0000-0002-4667-3679; Pasquier, Laurent/0000-0003-3985-1286; Lee, Anna/0000-0002-6703-0656; Bache, Iben/0000-0001-7562-8546; MISSIRIAN, Chantal/0000-0002-4748-348X; Deutsch, Gail/0000-0002-0571-0285; beneteau, Claire/0000-0002-1682-523X; Karolak, Justyna/0000-0002-2340-4513; Gifford, Andrew/0000-0002-4092-2347; Vincent, Marie/0000-0003-1010-5618	US National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) [R01HL137203]; US National Human Genome Research Institute (NHGRI)/NHLBI [UM1HG006542]; National Institute of Neurological Disorders and Stroke (NINDS) [R35 NS105078]; National Institute of General Medical Sciences of NIH Postdoctoral Training Program in Medical Genetics [5T32GM007454]; JPB Foundation; Polish budget funds for science in years 2016-2019, Iuventus Plus grant [IP2015 019874]; Wellcome Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL137203] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R35NS105078] Funding Source: NIH RePORTER	US National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US National Human Genome Research Institute (NHGRI)/NHLBI; National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of General Medical Sciences of NIH Postdoctoral Training Program in Medical Genetics; JPB Foundation; Polish budget funds for science in years 2016-2019, Iuventus Plus grant; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants awarded by the US National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) R01HL137203 to P. Stankiewicz, the US National Human Genome Research Institute (NHGRI)/NHLBI grant number UM1HG006542 to the Baylor-Hopkins Center for Mendelian Genomics (BHCMG), the National Institute of Neurological Disorders and Stroke (NINDS) R35 NS105078 to J.R.L., National Institute of General Medical Sciences of NIH Postdoctoral Training Program in Medical Genetics 5T32GM007454 to J.N.D. and A.S.F., a grant from the JPB Foundation to W.K.C., and from Polish budget funds for science in years 2016-2019, Iuventus Plus grant IP2015 019874 to T.G. This study makes use of data generated by the DECIPHER community. A full list of centers who contributed to the generation of the data is available from https://decipher.sanger.ac.uk and via email from decipher@sanger.ac.uk. Funding for the project was provided by the Wellcome Trust.	Abler LL, 2009, DEV DYNAM, V238, P1999, DOI 10.1002/dvdy.22032; Abou Hassan OK, 2018, BMC MED GENET, V19, DOI 10.1186/s12881-018-0608-7; Agulnik SI, 1996, GENETICS, V144, P249; Al-Senan KA, 2003, SAUDI MED J, V24, P88; Albers CA, 2012, NAT GENET, V44, P435, DOI 10.1038/ng.1083; Alvares K, 2006, DEV DYNAM, V235, P2980, DOI 10.1002/dvdy.20935; Archie JG, 2006, AM J CLIN PATHOL, V126, P256, DOI 10.1309/FK9D5WBA1UEPT5BB; Ardini-Poleske ME, 2017, AM J PHYSIOL-LUNG C, V313, pL733, DOI 10.1152/ajplung.00139.2017; Arora R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002866; Ballif BC, 2010, AM J HUM GENET, V86, P454, DOI 10.1016/j.ajhg.2010.01.038; Barnett CP, 2016, HUM MUTAT, V37, P955, DOI 10.1002/humu.23032; Bellusci S, 1997, DEVELOPMENT, V124, P4867; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bongers EMHF, 2004, AM J HUM GENET, V74, P1239, DOI 10.1086/421331; Brandler WM, 2018, SCIENCE, V360, P327, DOI 10.1126/science.aan2261; Cebra-Thomas JA, 2003, DEV DYNAM, V226, P82, DOI 10.1002/dvdy.10208; CHAMBERS HM, 1991, PATHOLOGY, V23, P69, DOI 10.3109/00313029109061444; Chow CW, 2013, PATHOLOGY, V45, P38, DOI 10.1097/PAT.0b013e32835b3a9d; Coban-Akdemir Z, 2018, AM J HUM GENET, V103, P171, DOI 10.1016/j.ajhg.2018.06.009; Daley WP, 2017, DEVELOPMENT, V144, P2200, DOI 10.1242/dev.146894; Davidson LA, 1998, HISTOPATHOLOGY, V32, P57; DeBoer EM, 2012, FETAL PEDIATR PATHOL, V31, P217, DOI 10.3109/15513815.2011.650284; Don M, 2014, FETAL PEDIATR PATHOL, V33, P109, DOI 10.3109/15513815.2013.878009; Entesarian M, 2005, NAT GENET, V37, P125, DOI 10.1038/ng1507; Entesarian M, 2007, EUR J HUM GENET, V15, P379, DOI 10.1038/sj.ejhg.5201762; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Ghoussaini M, 2016, AM J HUM GENET, V99, P903, DOI 10.1016/j.ajhg.2016.07.017; Gillespie LM, 2004, ACTA PAEDIATR, V93, P712, DOI 10.1111/j.1651-2227.2004.tb03003.x; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Hegde S, 2007, ACTA PAEDIATR, V96, P1248, DOI 10.1111/j.1651-2227.2007.00394.x; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Horie M, 2018, AM J PHYSIOL-LUNG C, V314, pL177, DOI 10.1152/ajplung.00193.2017; Kerstjens-Frederikse WS, 2013, J MED GENET, V50, P500, DOI 10.1136/jmedgenet-2012-101152; Kimura J, 2007, PEDIATR DEVEL PATHOL, V10, P335, DOI 10.2350/07-06-0290.1; Klar J, 2011, J MED GENET, V48, P705, DOI 10.1136/jmedgenet-2011-100166; Klopocki E, 2007, AM J HUM GENET, V80, P232, DOI 10.1086/510919; Langenstroer M, 2013, AJP REP, V3, P9, DOI 10.1055/s-0032-1329126; Langston C, 2009, PEDIATR DEVEL PATHOL, V12, P421, DOI 10.2350/08-11-0559.1; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lertsburapa T, 2014, PEDIATR DEVEL PATHOL, V17, P374, DOI 10.2350/14-05-1485-CR.1; Li CG, 2005, DEV BIOL, V287, P86, DOI 10.1016/j.ydbio.2005.08.035; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu N, 2018, HUM MOL GENET, V27, P2454, DOI 10.1093/hmg/ddy146; Ludtke TH, 2016, DEV CELL, V39, P239, DOI 10.1016/j.devcel.2016.08.007; Ludtke THW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003189; Lupski JR, 2013, GENOME MED, V5, DOI 10.1186/gm461; MACMAHON HE, 1948, PEDIATRICS, V2, P43; McDonald-McGinn DM, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.71; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McPherson JP, 2009, CELL DEATH DIFFER, V16, P331, DOI 10.1038/cdd.2008.167; Menke DB, 2008, DEVELOPMENT, V135, P2543, DOI 10.1242/dev.017384; Milunsky JM, 2006, CLIN GENET, V69, P349, DOI 10.1111/j.1399-0004.2006.00597.x; Moerman P, 1998, J MED GENET, V35, P964, DOI 10.1136/jmg.35.11.964; Morrisey EE, 2013, ANN AM THORAC SOC, V10, pS12, DOI 10.1513/AnnalsATS.201207-036OT; Nimmakayalu M, 2011, AM J MED GENET A, V155A, P418, DOI 10.1002/ajmg.a.33827; Nogee LM, 2017, SEMIN FETAL NEONAT M, V22, P227, DOI 10.1016/j.siny.2017.03.003; Oda Tomoyuki, 2018, J Orthop Case Rep, V8, P85, DOI 10.13107/jocr.2250-0685.1012; Ou ZS, 2006, HUM GENET, V120, P227, DOI 10.1007/s00439-006-0200-7; Potocki L, 2003, GENET MED, V5, P430, DOI 10.1097/01.GIM.0000095625.14160.AB; Prince LS, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00517; Quaggin SE, 1999, DEVELOPMENT, V126, P5771; Rohmann E, 2006, NAT GENET, V38, P414, DOI 10.1038/ng1757; RUTLEDGE JC, 1986, HUM PATHOL, V17, P1290, DOI 10.1016/S0046-8177(86)80576-7; Sakiyama J, 2003, DEVELOPMENT, V130, P1225, DOI 10.1242/dev.00345; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; Schmitt AD, 2016, CELL REP, V17, P2042, DOI 10.1016/j.celrep.2016.10.061; Schonewolf-Greulich B, 2011, AM J MED GENET A, V155A, P2964, DOI 10.1002/ajmg.a.34302; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Seymen F, 2017, CLIN ORAL INVEST, V21, P167, DOI 10.1007/s00784-016-1771-x; Short PJ, 2018, NATURE, V555, P611, DOI 10.1038/nature25983; Sifrim A, 2016, NAT GENET, V48, P1060, DOI 10.1038/ng.3627; Stuhrmann S, 2007, PEDIATR CRIT CARE ME, V8, P580, DOI 10.1097/01.PCC.0000288803.19741.59; Suhrie K, 2019, J PEDIATR-US, V206, P286, DOI 10.1016/j.jpeds.2018.10.018; Szafranski P, 2016, AM J MED GENET A, V170, P2440, DOI 10.1002/ajmg.a.37822; Szafranski P, 2016, HUM GENET, V135, P569, DOI 10.1007/s00439-016-1655-9; Szafranski P, 2014, AM J MED GENET A, V164, P2013, DOI 10.1002/ajmg.a.36606; Szafranski P, 2013, GENOME RES, V23, P23, DOI 10.1101/gr.141887.112; Takahashi T, 2017, PEDIATR SURG INT, V33, P139, DOI 10.1007/s00383-016-4005-z; Vanlerberghe C, 2018, CLIN GENET, V94, P43, DOI 10.1111/cge.13209; Vergaelen E, 2015, EUR J MED GENET, V58, P244, DOI 10.1016/j.ejmg.2015.01.008; Wu N, 2015, NEW ENGL J MED, V372, P341, DOI 10.1056/NEJMoa1406829; Yang N, 2019, HUM MOL GENET, V28, P539, DOI 10.1093/hmg/ddy358; Zhang F, 2015, HUM MOL GENET, V24, pR102, DOI 10.1093/hmg/ddv259; Zhu N, 2018, CIRC-GENOM PRECIS ME, V11, DOI 10.1161/CIRCGEN.117.001887	84	50	52	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 7	2019	104	2					213	228		10.1016/j.ajhg.2018.12.010	http://dx.doi.org/10.1016/j.ajhg.2018.12.010			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HL2SW	30639323	Green Published, Bronze			2022-12-18	WOS:000458557800004
J	Auguste, Y; Delague, V; Desvignes, JP; Longepied, G; Gnisci, A; Besnier, P; Levy, N; Beroud, C; Megarbane, A; Metzler-Guillemain, C; Mitchell, MJ				Auguste, Yasmina; Delague, Valerie; Desvignes, Jean-Pierre; Longepied, Guy; Gnisci, Audrey; Besnier, Pierre; Levy, Nicolas; Beroud, Christophe; Megarbane, Andre; Metzler-Guillemain, Catherine; Mitchell, Michael J.			Loss of Calmodulin- and Radial-Spoke-Associated Complex Protein CFAP251 Leads to Immotile Spermatozoa Lacking Mitochondria and Infertility in Men	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPLE MORPHOLOGICAL ABNORMALITIES; KNOCKOUT MICE LACKING; HEAVY-CHAIN MDHC7; SPERM FLAGELLA; FIBROUS SHEATH; DYNEIN; MUTATIONS; ASTHENOZOOSPERMIA; DNAH1; CSC	Flagella and motile cilia share a 9 thorn 2 microtubule-doublet axoneme structure, and asthenozoospermia (reduced spermatozoamotility) is found in 76% of men with primary ciliary dyskinesia (PCD). Nevertheless, causal genetic variants in a conserved axonemal component have been found in cases of isolated asthenozoospermia: 30% of men with multiple morphological anomalies of sperm flagella (MMAF) carry bi-allelic mutations in DNAH1, encoding one of the seven inner-arm dynein heavy chains of the 9 thorn 2 axoneme. To further understand the basis for isolated asthenozoospermia, we used whole-exome and Sanger sequencing to study two brothers and two independent men with MMAF. In three men, we found bi-allelic loss-of-function mutations in WDR66, encoding cilia- and flagella-associated protein 251 (CFAP251): the two brothers were homozygous for the frameshift chr12: g.122359334delA (p.Asp42Metfs*4), and the third individual was compound heterozygous for chr12: g.122359542G>T (p.Glu111*) and chr12: g.122395032_122395033delCT (p.Leu530Valfs*4). We show that CFAP251 is normally located along the flagellum but is absent in men carrying WDR66 mutations and reveal a spermatozoa-specific isoform probably generated during spermatozoon maturation. CFAP251 is a component of the calmodulin- and radial-spoke-associated complex, located adjacent to DNAH1, on the inner surface of the peripheral microtubule doublets of the axoneme. In Tetrahymena, the CFAP251 ortholog is necessary for efficient coordinated ciliary beating. Using immunofluorescent and transmission electron microscopy, we provide evidence that loss of CFAP251 affects the formation of the mitochondrial sheath. We propose that CFAP251 plays a structural role during biogenesis of the spermatozoon flagellum in vertebrates.	[Auguste, Yasmina; Delague, Valerie; Desvignes, Jean-Pierre; Longepied, Guy; Levy, Nicolas; Beroud, Christophe; Metzler-Guillemain, Catherine; Mitchell, Michael J.] Aix Marseille Univ, INSERM, Marseille Med Genet, U1251, Marseille, France; [Besnier, Pierre] Ctr Hosp Univ Nice, Hop Archet 2, Lab Biol Reprod, UF7740, F-06202 Nice, France; [Megarbane, Andre] Inst Jerome Lejeune, F-75015 Paris, France; [Gnisci, Audrey; Metzler-Guillemain, Catherine] Hop La Concept, AP HM, Ctr Clinicobiol Assistance Med Procreat, Ctr Conservat OEufs & Sperme Humain,Pole Femmes P, F-13385 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; CHU Nice; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Mitchell, MJ (corresponding author), Aix Marseille Univ, INSERM, Marseille Med Genet, U1251, Marseille, France.	michael.mitchell@univ-amu.fr	Mitchell, Michael/I-3987-2016; BEROUD, Christophe/A-8381-2008; LEVY, Nicolas/J-1632-2014; Megarbane, Andre/ABD-5574-2021; delague, valerie/K-5837-2013	Mitchell, Michael/0000-0003-2052-7347; BEROUD, Christophe/0000-0003-2986-8738; LEVY, Nicolas/0000-0001-5171-6365; delague, valerie/0000-0003-2652-362X	INSERM; French Guiana region (Le Conseil Regional de la Guyane)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French Guiana region (Le Conseil Regional de la Guyane)	We are extremely grateful to the affected individuals and the members of their families who gave their informed consent for the use of their samples in this research study. We thank Alexandre Altie from the Electronic Microscopy core facility in the La Timone Medical Faculty at Aix-Marseille University for ultrastructural analyses of sperm samples. We also thank gnomAD and the groups that provided exome and genome variant data to this resource. A full list of contributing groups can be found at http://gnomad.broadinstitute.org/about. This work was supported by core funding from INSERM to M.J.M. Y.A. was supported by a PhD fellowship from the French Guiana region (Le Conseil Regional de la Guyane).	Amiri-Yekta A, 2016, HUM REPROD, V31, P2872, DOI 10.1093/humrep/dew262; Bastin P, 1998, NATURE, V391, P548, DOI 10.1038/35300; Ben Khelifa M, 2014, AM J HUM GENET, V94, P95, DOI 10.1016/j.ajhg.2013.11.017; Bui KH, 2012, J CELL BIOL, V198, P913, DOI 10.1083/jcb.201201120; Chemes HE, 1998, HUM REPROD, V13, P2521, DOI 10.1093/humrep/13.9.2521; CHEMES HE, 1987, FERTIL STERIL, V48, P664; Coutton C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02792-7; Dacheux JL, 2014, REPRODUCTION, V147, pR27, DOI 10.1530/REP-13-0420; Desvignes JP, 2018, NUCLEIC ACIDS RES, V46, pW545, DOI 10.1093/nar/gky471; Dymek EE, 2007, J CELL BIOL, V179, P515, DOI 10.1083/jcb.200703107; Dymek EE, 2011, MOL BIOL CELL, V22, P2520, DOI 10.1091/mbc.E11-03-0271; Heuser T, 2012, MOL BIOL CELL, V23, P3143, DOI 10.1091/mbc.E12-05-0357; Inaba K, 2011, MOL HUM REPROD, V17, P524, DOI 10.1093/molehr/gar034; Kissel H, 2005, DEV CELL, V8, P353, DOI 10.1016/j.devcel.2005.01.021; Knowles MR, 2016, CLIN CHEST MED, V37, P449, DOI 10.1016/j.ccm.2016.04.008; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lhuillier P, 2009, HUM REPROD, V24, P1296, DOI 10.1093/humrep/dep020; Luo HR, 2009, GENE, V435, P96, DOI 10.1016/j.gene.2008.12.021; Neesen J, 2001, HUM MOL GENET, V10, P1117, DOI 10.1093/hmg/10.11.1117; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Salgado D, 2016, HUM MUTAT, V37, P439, DOI 10.1002/humu.22965; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Sha YW, 2019, REPROD SCI, V26, P26, DOI 10.1177/1933719117749756; Sha YW, 2017, FERTIL STERIL, V107, P1312, DOI 10.1016/j.fertnstert.2017.04.007; Tang SY, 2017, AM J HUM GENET, V100, P854, DOI 10.1016/j.ajhg.2017.04.012; THONNEAU P, 1991, HUM REPROD, V6, P811, DOI 10.1093/oxfordjournals.humrep.a137433; Urbanska P, 2015, MOL BIOL CELL, V26, P1463, DOI 10.1091/mbc.E14-11-1545; Vanaken GJ, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00314-2017; Vernon GG, 2005, CELL MOTIL CYTOSKEL, V61, P65, DOI 10.1002/cm.20066; Wang X, 2017, CLIN GENET, V91, P313, DOI 10.1111/cge.12857; Woolley DM, 2005, CELL MOTIL CYTOSKEL, V61, P74, DOI 10.1002/cm.20067	31	50	54	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 6	2018	103	3					413	420		10.1016/j.ajhg.2018.07.013	http://dx.doi.org/10.1016/j.ajhg.2018.07.013			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GS6PJ	30122541	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000443819500010
J	Ganna, A; Satterstrom, FK; Zekavat, SM; Das, I; Kurki, MI; Churchhouse, C; Alfoldi, J; Martin, AR; Havulinna, AS; Byrnes, A; Thompson, WK; Nielsen, PR; Karczewski, KJ; Saarentaus, E; Rivas, MA; Gupta, N; Pietilainen, O; Emdin, CA; Lescai, F; Bybjerg-Grauholm, J; Flannick, J; Mercader, JM; Udler, M; Laakso, M; Salomaa, V; Hultman, C; Ripatti, S; Hamalainen, E; Moilanen, JS; Korkko, J; Kuismin, O; Nordentoft, M; Hougaard, DM; Mors, O; Werge, T; Mortensen, PB; MacArthur, D; Daly, MJ; Sullivan, PF; Locke, AE; Palotie, A; Borglum, AD; Kathiresan, S; Neale, BM				Ganna, Andrea; Satterstrom, F. Kyle; Zekavat, Seyedeh M.; Das, Indraniel; Kurki, Mitja, I; Churchhouse, Claire; Alfoldi, Jessica; Martin, Alicia R.; Havulinna, Aki S.; Byrnes, Andrea; Thompson, Wesley K.; Nielsen, Philip R.; Karczewski, Konrad J.; Saarentaus, Elmo; Rivas, Manuel A.; Gupta, Namrata; Pietilainen, Olli; Emdin, Connor A.; Lescai, Francesco; Bybjerg-Grauholm, Jonas; Flannick, Jason; Mercader, Josep M.; Udler, Miriam; Laakso, Markku; Salomaa, Veikko; Hultman, Christina; Ripatti, Samuli; Hamalainen, Eija; Moilanen, Jukka S.; Korkko, Jarmo; Kuismin, Outi; Nordentoft, Merete; Hougaard, David M.; Mors, Ole; Werge, Thomas; Mortensen, Preben Bo; MacArthur, Daniel; Daly, Mark J.; Sullivan, Patrick F.; Locke, Adam E.; Palotie, Aarno; Borglum, Anders D.; Kathiresan, Sekar; Neale, Benjamin M.		GoT2D T2D-GENES Consortium; SIGMA Consortium Helmsley IBD Exom; FinMetSeq Consortium; iPSYCH-Broad Consortium	Quantifying the Impact of Rare and Ultra-rare Coding Variation across the Phenotypic Spectrum	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASSOCIATION; VARIANTS; DISORDERS; MUTATIONS; GENES; RISK	There is a limited understanding about the impact of rare protein-truncating variants across multiple phenotypes. We explore the impact of this class of variants on 13 quantitative traits and 10 diseases using whole-exome sequencing data from 100,296 individuals. Protein-truncating variants in genes intolerant to this class of mutations increased risk of autism, schizophrenia, bipolar disorder, intellectual disability, and ADHD. In individuals without these disorders, there was an association with shorter height, lower education, increased hospitalization, and reduced age at enrollment. Gene sets implicated from GWASs did not show a significant protein-truncating variants burden beyond what was captured by established Mendelian genes. In conclusion, we provide a thorough investigation of the impact of rare deleterious coding variants on complex traits, suggesting widespread pleiotropic risk.	[Ganna, Andrea; Satterstrom, F. Kyle; Kurki, Mitja, I; Churchhouse, Claire; Alfoldi, Jessica; Martin, Alicia R.; Byrnes, Andrea; Karczewski, Konrad J.; MacArthur, Daniel; Daly, Mark J.; Palotie, Aarno; Neale, Benjamin M.] Massachusetts Gen Hosp, Ctr Gen Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Ganna, Andrea; Satterstrom, F. Kyle; Zekavat, Seyedeh M.; Kurki, Mitja, I; Churchhouse, Claire; Alfoldi, Jessica; Martin, Alicia R.; Byrnes, Andrea; Karczewski, Konrad J.; Gupta, Namrata; Emdin, Connor A.; Flannick, Jason; MacArthur, Daniel; Daly, Mark J.; Palotie, Aarno; Kathiresan, Sekar; Neale, Benjamin M.] Brd Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Ganna, Andrea; Satterstrom, F. Kyle; Churchhouse, Claire; Martin, Alicia R.; Byrnes, Andrea; Pietilainen, Olli; Daly, Mark J.; Palotie, Aarno; Neale, Benjamin M.] Brd Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Ganna, Andrea; Hultman, Christina; Sullivan, Patrick F.] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17176 Stockholm, Sweden; [Zekavat, Seyedeh M.; Flannick, Jason; Kathiresan, Sekar] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Gen Med, Boston, MA 02114 USA; [Zekavat, Seyedeh M.; Flannick, Jason; Kathiresan, Sekar] Harvard Med Sch, Dept Med, Boston, MA 02114 USA; [Das, Indraniel; Locke, Adam E.] Washington Univ, McDonnell Genome Inst, Sch Med, St Louis, MO 63108 USA; [Das, Indraniel; Locke, Adam E.] Univ Michigan, Dept Biostat, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Das, Indraniel; Locke, Adam E.] Univ Michigan, Ctr Stat Genet, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Kurki, Mitja, I; Havulinna, Aki S.; Saarentaus, Elmo; Ripatti, Samuli; Hamalainen, Eija; Palotie, Aarno] Univ Helsinki, Inst Mol Med Finland, FIMM, FIN-00290 Helsinki, Finland; [Thompson, Wesley K.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 94143 USA; [Thompson, Wesley K.; Werge, Thomas] Inst Biol Psychiat, Mental Hlth Serv Copenhagen, MHC Sct Hans, DK-4000 Roskilde, Denmark; [Thompson, Wesley K.; Nielsen, Philip R.; Lescai, Francesco; Bybjerg-Grauholm, Jonas; Nordentoft, Merete; Hougaard, David M.; Mors, Ole; Werge, Thomas; Mortensen, Preben Bo; Borglum, Anders D.] Lundbeck Fdn Initiat Integrat Psychiat Res, iPSYCH, Copenhagen, Denmark; [Thompson, Wesley K.] Oslo Univ Hosp, KG Jebsen Ctr Psychosis Res, Norway Div Mental Hlth & Addict, N-0318 Oslo, Norway; [Nielsen, Philip R.; Mortensen, Preben Bo] Aarhus Univ, Natl Ctr Register Based Res, Sch Business & Social Sci, DK-8210 Aarhus, Denmark; [Nielsen, Philip R.; Mortensen, Preben Bo] Aarhus Univ, Ctr Integrated Register Based Res, DK-8210 Aarhus, Denmark; [Rivas, Manuel A.] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Pietilainen, Olli] Univ Harvard, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Lescai, Francesco; Mortensen, Preben Bo; Borglum, Anders D.] Aarhus Univ, iSEQ, Ctr Integrat Sequencing, DK-8210 Aarhus, Denmark; [Lescai, Francesco; Borglum, Anders D.] Aarhus Univ, Dept Biomed Human Genet, DK-8210 Aarhus, Denmark; [Bybjerg-Grauholm, Jonas; Hougaard, David M.] Statens Serum Inst, Ctr Neonatal Screening, Dept Congenital Disorders, DK-2300 Copenhagen, Denmark; [Mercader, Josep M.; Udler, Miriam] Brd Inst Harvard & MIT, Program Metab, Cambridge, MA USA; [Mercader, Josep M.; Udler, Miriam] Brd Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Havulinna, Aki S.; Mercader, Josep M.; Udler, Miriam] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; [Havulinna, Aki S.; Mercader, Josep M.; Udler, Miriam] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Laakso, Markku] Univ Eastern Finland, Internal Med, Inst Clin Med, Kuopio 70211, Finland; [Salomaa, Veikko] THL Natl Inst Hlth & Welf, Dept Hlth, Helsinki 00271, Finland; [Ripatti, Samuli] Univ Helsinki, Dept Publ Hlth, Helsinki 00014, Finland; [Ripatti, Samuli] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Moilanen, Jukka S.; Korkko, Jarmo; Kuismin, Outi] Univ Oulu, Oulu Univ Hosp, Dept Clin Genet, Oulu 90029, Finland; [Moilanen, Jukka S.; Korkko, Jarmo; Kuismin, Outi] Univ Oulu, Med Res Ctr Oulu, Oulu 90029, Finland; [Moilanen, Jukka S.; Korkko, Jarmo; Kuismin, Outi] Univ Oulu, PEDEGO Res Unit, Oulu 90029, Finland; [Nordentoft, Merete] Univ Copenhagen, Mental Hlth Ctr Copenhagen, Mental Hlth Serv Capital Reg Denmark, DK-2100 Copenhagen, Denmark; [Mors, Ole] Aarhus Univ Hosp, Psychosis Res Unit, DK-8240 Risskov, Denmark; [Werge, Thomas] Univ Copenhagen, Dept Clin Med, DK-2200 Copenhagen, Denmark; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA	Harvard University; Massachusetts General Hospital; Karolinska Institutet; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Washington University (WUSTL); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Helsinki; University of California System; University of California San Diego; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); University of Oslo; Aarhus University; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Stanford University; Harvard University; Aarhus University; Aarhus University; Statens Serum Institut; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Eastern Finland; Finland National Institute for Health & Welfare; University of Helsinki; Wellcome Trust Sanger Institute; University of Oulu; University of Oulu; University of Oulu; University of Copenhagen; Aarhus University; University of Copenhagen; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Ganna, A; Neale, BM (corresponding author), Massachusetts Gen Hosp, Ctr Gen Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA.; Ganna, A; Neale, BM (corresponding author), Brd Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA.; Ganna, A; Neale, BM (corresponding author), Brd Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA.; Ganna, A (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, S-17176 Stockholm, Sweden.	aganna@broadinstitute.org; bneale@broadinstitute.org	Daly, Mark J/B-2453-2017; Hougaard, David/AAD-6368-2019; Locke, Adam/K-2000-2019; Nordentoft, Merete/AAH-3253-2019; Kurki, Mitja/GWM-5671-2022; Mortensen, Preben B/D-2358-2015; Moilanen, Jukka S/G-2604-2012; Zekavat, Seyedeh M/N-7570-2018; Bybjerg-Grauholm, Jonas/AAO-5447-2020; Saarentaus, Elmo C/AAW-4979-2021; Rivas, Manuel/ABE-8173-2020; Havulinna, Aki/AAM-4769-2021	Daly, Mark J/0000-0002-0949-8752; Locke, Adam/0000-0001-6227-198X; Mortensen, Preben B/0000-0002-5230-9865; Moilanen, Jukka S/0000-0002-8041-3205; Zekavat, Seyedeh M/0000-0003-4026-8944; Bybjerg-Grauholm, Jonas/0000-0003-1705-4008; Rivas, Manuel/0000-0003-1457-9925; Nordentoft, Merete/0000-0003-4895-7023; Palotie, Aarno/0000-0002-2527-5874; Kuismin, Outi/0000-0002-0157-8985; Satterstrom, Frederick/0000-0001-6187-7680; Ganna, Andrea/0000-0002-8147-240X; Saarentaus, Elmo/0000-0002-8475-7187; Borglum, Anders/0000-0001-8627-7219; Lescai, Francesco/0000-0002-6399-9101; MacArthur, Daniel/0000-0002-5771-2290	Knut and Alice Wallenberg Foundation [2015.0327]; Swedish Research Council [2016-00250]; National Human Genome Research Institute [U54 HG003067, R01 HG006855]; National Institute of Mental Health [1U01MH105666-01, 1R01MH101244-02, R01 MH077139, RC2 MH089905]; National Institute of Diabetes and Digestive and Kidney Disease [1U54DK105566-02]; Stanley Center for Psychiatric Research; Alexander and Margaret Stewart Trust; Sylvan C. Herman Foundation; Finnish Foundation for Cardiovascular Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, R01HG006855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK114551, U54DK105566, P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101244, RC2MH089905, U01MH109528, R01MH077139, U01MH105666] Funding Source: NIH RePORTER; Lundbeck Foundation [R155-2014-1724, R248-2017-2003] Funding Source: researchfish	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Diabetes and Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Stanley Center for Psychiatric Research; Alexander and Margaret Stewart Trust; Sylvan C. Herman Foundation; Finnish Foundation for Cardiovascular Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Lundbeck Foundation(Lundbeckfonden)	A.G. is supported by the Knut and Alice Wallenberg Foundation (2015.0327) and the Swedish Research Council (2016-00250). This study was supported by grants from the National Human Genome Research Institute (U54 HG003067, R01 HG006855), the National Institute of Mental Health (1U01MH105666-01, 1R01MH101244-02, R01 MH077139, and RC2 MH089905), the National Institute of Diabetes and Digestive and Kidney Disease (1U54DK105566-02), the Stanley Center for Psychiatric Research, the Alexander and Margaret Stewart Trust, and the Sylvan C. Herman Foundation. V.S. was supported by the Finnish Foundation for Cardiovascular Research.	Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; CAVALLIS.LL, 1966, PROC R SOC SER B-BIO, V164, P362, DOI 10.1098/rspb.1966.0038; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Ganna A, 2016, NAT NEUROSCI, V19, P1563, DOI 10.1038/nn.4404; Genovese G, 2016, NAT NEUROSCI, V19, P1433, DOI 10.1038/nn.4402; Henn BM, 2016, P NATL ACAD SCI USA, V113, pE440, DOI 10.1073/pnas.1510805112; Kosmicki JA, 2017, NAT GENET, V49, P504, DOI 10.1038/ng.3789; Krumm N, 2015, NAT GENET, V47, P582, DOI 10.1038/ng.3303; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lim ET, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004494; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Luo Y, 2017, NAT GENET, V49, P186, DOI 10.1038/ng.3761; Marouli E, 2017, NATURE, V542, P186, DOI 10.1038/nature21039; Mathieson I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004528; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; Ostrer H, 2013, HUM GENET, V132, P119, DOI 10.1007/s00439-012-1235-6; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; PRICE GR, 1970, NATURE, V227, P520, DOI 10.1038/227520a0; Robinson EB, 2016, NAT GENET, V48, P552, DOI 10.1038/ng.3529; Stitziel NO, 2016, NEW ENGL J MED, V374, P1134, DOI 10.1056/NEJMoa1507652; Sund R, 2012, SCAND J PUBLIC HEALT, V40, P505, DOI 10.1177/1403494812456637; Taylor MJ, 2016, J AM ACAD CHILD PSY, V55, P504, DOI 10.1016/j.jaac.2016.04.004; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	28	50	50	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 7	2018	102	6					1204	1211		10.1016/j.ajhg.2018.05.002	http://dx.doi.org/10.1016/j.ajhg.2018.05.002			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GJ0LP	29861106	Bronze, Green Submitted, Green Published			2022-12-18	WOS:000434946200016
J	Quinodoz, M; Royer-Bertrand, B; Cisarova, K; Di Gioia, SA; Superti-Furga, A; Rivolta, C				Quinodoz, Mathieu; Royer-Bertrand, Beryl; Cisarova, Katarina; Di Gioia, Silvio Alessandro; Superti-Furga, Andrea; Rivolta, Carlo			DOMINO: Using Machine Learning to Predict Genes Associated with Dominant Disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-DISEASE; MUTATIONS; EVOLUTION; SELECTION; VARIANTS; LIFE	In contrast to recessive conditions with biallelic inheritance, identification of dominant (monoallelic) mutations for Mendelian disorders is more difficult, because of the abundance of benign heterozygous variants that act as massive background noise (typically, in a 400:1 excess ratio). To reduce this overflow of false positives in next-generation sequencing (NGS) screens, we developed DOMINO, a tool assessing the likelihood for a gene to harbor dominant changes. Unlike commonly-used predictors of pathogenicity, DOMINO takes into consideration features that are the properties of genes, rather than of variants. It uses a machine-learning approach to extract discriminant information from a broad array of features (N=432), including: genomic data, intra-, and interspecies conservation, gene expression, protein-protein interactions, protein structure, etc. DOMINO's iterative architecture includes a training process on 985 genes with well-established inheritance patterns for Mendelian conditions, and repeated cross-validation that optimizes its discriminant power. When validated on 99 newly-discovered genes with pathogenic mutations, the algorithm displays an excellent final performance, with an area under the curve (AUC) of 0.92. Furthermore, unsupervised analysis by DOMINO of real sets of NGS data from individuals with intellectual disability or epilepsy correctly recognizes known genes and predicts 9 new candidates, with very high confidence. In summary, DOMINO is a robust and reliable tool that can infer dominance of candidate genes with high sensitivity and specificity, making it a useful complement to any NGS pipeline dealing with the analysis of the morbid human genome.	[Quinodoz, Mathieu; Royer-Bertrand, Beryl; Cisarova, Katarina; Di Gioia, Silvio Alessandro; Rivolta, Carlo] Univ Lausanne, Unit Med Genet, Dept Computat Biol, CH-1011 Lausanne, Switzerland; [Royer-Bertrand, Beryl; Superti-Furga, Andrea] Lausanne Univ Hosp CHUV, Div Med Genet, CH-1011 Lausanne, Switzerland; [Rivolta, Carlo] Univ Leicester, Dept Genet & Genome Biol, Leicester LE1 9HN, Leics, England	University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Leicester	Rivolta, C (corresponding author), Univ Lausanne, Unit Med Genet, Dept Computat Biol, CH-1011 Lausanne, Switzerland.; Rivolta, C (corresponding author), Univ Leicester, Dept Genet & Genome Biol, Leicester LE1 9HN, Leics, England.	carlo.rivolta@unil.ch	superti-furga, andrea/E-9162-2015	superti-furga, andrea/0000-0002-3543-7531; Rivolta, Carlo/0000-0002-0733-9950; Di Gioia, Silvio Alessandro/0000-0002-7235-5682; Cisarova, Katarina/0000-0003-2711-0480	Swiss National Science Foundation [156260]; University of Lausanne	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Lausanne	This work was supported by the Swiss National Science Foundation (grant # 156260, to C.R.) and by the PhD Fellowships in Life Science of the University of Lausanne (to M.Q.).	Blekhman R, 2008, CURR BIOL, V18, P883, DOI 10.1016/j.cub.2008.04.074; Bonafe L, 2015, AM J MED GENET A, V167, P2869, DOI 10.1002/ajmg.a.37365; Chen DH, 2016, AM J HUM GENET, V98, P1146, DOI 10.1016/j.ajhg.2016.04.009; Chong JX, 2015, AM J HUM GENET, V97, P199, DOI 10.1016/j.ajhg.2015.06.009; Davidson AE, 2016, AM J HUM GENET, V98, P75, DOI 10.1016/j.ajhg.2015.11.018; Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733; Gilissen C, 2012, EUR J HUM GENET, V20, P490, DOI 10.1038/ejhg.2011.258; Hastie T., 2009, SPRINGER, V2nd, DOI DOI 10.1007/978-0-387-21606-5; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Kamphans T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070151; KIMURA M, 1977, NATURE, V267, P275, DOI 10.1038/267275a0; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lelieveld SH, 2016, NAT NEUROSCI, V19, P1194, DOI 10.1038/nn.4352; Lin ZM, 2016, NAT GENET, V48, P1508, DOI 10.1038/ng.3701; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Norris M, 2013, G3-GENES GENOM GENET, V3, P1965, DOI 10.1534/g3.113.008144; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Shyr C, 2014, BMC MED GENOMICS, V7, DOI 10.1186/s12920-014-0064-y; Steinberg J, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv474; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Turner TN, 2017, NUCLEIC ACIDS RES, V45, pD804, DOI 10.1093/nar/gkw865; Warr A, 2015, G3-GENES GENOM GENET, V5, P1543, DOI 10.1534/g3.115.018564; WILKIE AOM, 1994, J MED GENET, V31, P89, DOI 10.1136/jmg.31.2.89; Wright AE, 2013, J EVOLUTION BIOL, V26, P1841, DOI 10.1111/jeb.12201	27	50	50	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 5	2017	101	4					623	629		10.1016/j.ajhg.2017.09.001	http://dx.doi.org/10.1016/j.ajhg.2017.09.001			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FI8UJ	28985496	Green Submitted, Green Published, Bronze, Green Accepted			2022-12-18	WOS:000412277300013
J	Vermeulen, C; Geeven, G; de Wit, E; Verstegen, MJAM; Jansen, RPM; van Kranenburg, M; de Bruijn, E; Pulit, SL; Kruisselbrink, E; Shahsavari, Z; Omrani, D; Zeinali, F; Najmabadi, H; Katsila, T; Vrettou, C; Patrinos, GP; Traeger-Synodinos, J; Splinter, E; Beekman, JM; Kia, SK; te Meerman, GJ; van Amstel, HKP; de Laat, W				Vermeulen, Carlo; Geeven, Geert; de Wit, Elzo; Verstegen, Marjon J. A. M.; Jansen, Rumo P. M.; van Kranenburg, Melissa; de Bruijn, Ewart; Pulit, Sara L.; Kruisselbrink, Evelien; Shahsavari, Zahra; Omrani, Davood; Zeinali, Fatemeh; Najmabadi, Hossein; Katsila, Theodora; Vrettou, Christina; Patrinos, George P.; Traeger-Synodinos, Joanne; Splinter, Erik; Beekman, Jeffrey M.; Kia, Sima Kheradmand; te Meerman, Gerard J.; van Amstel, Hans Kristian Ploos; de Laat, Wouter			Sensitive Monogenic Noninvasive Prenatal Diagnosis by Targeted Haplotyping	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; FREE FETAL DNA; MATERNAL PLASMA; DISORDERS; DISEASES; AMNIOCENTESIS; ANEUPLOIDY; SERVICE; DOSAGE; BLOOD	During pregnancy, cell-free DNA (cfDNA) in maternal blood encompasses a small percentage of cell-free fetal DNA (cffDNA), an easily accessible source for determination of fetal disease status in risk families through non-invasive procedures. In case of monogenic heritable disease, background maternal cfDNA prohibits direct observation of the maternally inherited allele. Non-invasive prenatal diagnostics (NIPD) of monogenic diseases therefore relies on parental haplotyping and statistical assessment of inherited alleles from cffDNA, techniques currently unavailable for routine clinical practice. Here, we present monogenic NIPD (MG-NIPD), which requires a blood sample from both parents, for targeted locus amplification (TLA)-based phasing of heterozygous variants selectively at a gene of interest. Capture probes-based targeted sequencing of cfDNA from the pregnant mother and a tailored statistical analysis enables predicting fetal gene inheritance. MG-NIPD was validated for 18 pregnancies, focusing on CFTR, CYP21A2, and HBB. In all cases we could predict the inherited alleles with >98% confidence, even at relatively early stages (8 weeks) of pregnancy. This prediction and the accuracy of parental haplotyping was confirmed by sequencing of fetal material obtained by parallel invasive procedures. MG-NIPD is a robust method that requires standard instrumentation and can be implemented in any clinic to provide families carrying a severe monogenic disease with a prenatal diagnostic test based on a simple blood draw.	[Vermeulen, Carlo; Geeven, Geert; de Wit, Elzo; Verstegen, Marjon J. A. M.; van Kranenburg, Melissa; de Laat, Wouter] KNAW, Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands; [Vermeulen, Carlo; Geeven, Geert; de Wit, Elzo; Verstegen, Marjon J. A. M.; van Kranenburg, Melissa; de Laat, Wouter] Univ Med Ctr Utrecht, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands; [Jansen, Rumo P. M.; de Bruijn, Ewart; Pulit, Sara L.; van Amstel, Hans Kristian Ploos] Univ Med Ctr Utrecht, Dept Med Genet, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands; [Kruisselbrink, Evelien; Beekman, Jeffrey M.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Pulmonol, NL-3584 EA Utrecht, Netherlands; [Shahsavari, Zahra] Shahid Beheshti Univ Med Sci, Fac Paramed Sci, Dept Lab Med, Arabi Ave, Tehran 1983963113, Iran; [Omrani, Davood] Shahid Beheshti Univ Med Sci, Sch Med, Dept Med Genet, Arabi Ave, Tehran 1985717443, Iran; [Zeinali, Fatemeh; Najmabadi, Hossein] Kariminejad Najmabadi Pathol & Genet Ctr, 2 Med Bldg,Sanat Sq, Tehran 1466713713, Iran; [Katsila, Theodora; Patrinos, George P.] Univ Patras, Dept Pharm, Univ Campus, Patras 26504, Greece; [Vrettou, Christina; Traeger-Synodinos, Joanne] Univ Athens, Choremio Res Lab, Dept Med Genet, Aghia Sophia Childrens Hosp, Athens 11527, Greece; [Splinter, Erik] Cergentis BV, Yalelaan 62, NL-3584 CM Utrecht, Netherlands; [Kia, Sima Kheradmand] Sara Med Genet Lab, Shariati St,Niam St 53,1948854151, Tehran, Iran; [te Meerman, Gerard J.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Hanzepl 1, NL-9713 GZ Groningen, Netherlands; [de Wit, Elzo] Netherlands Canc Inst, Div Gene Regulat, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; University of Patras; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital; University of Groningen; Netherlands Cancer Institute	de Laat, W (corresponding author), KNAW, Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.; de Laat, W (corresponding author), Univ Med Ctr Utrecht, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	w.delaat@hubrecht.eu	Shahsavari, Zahra/N-2386-2017; Najmabadi, Hossein/P-8182-2017; Traeger-Synodinos, J/E-4283-2010; Katsila, Theodora/O-3228-2015; Beekman, Jeffrey M/I-7781-2014	Shahsavari, Zahra/0000-0002-4451-7525; Traeger-Synodinos, J/0000-0002-1860-5628; Katsila, Theodora/0000-0002-6263-4231; Beekman, Jeffrey M/0000-0003-4886-3756; de Wit, Elzo/0000-0003-2883-1415; Geeven, Geert/0000-0002-5603-0095; de Laat, Wouter/0000-0002-6393-595X; Pulit, Sara/0000-0002-2502-3669	U-fonds; K.F. Hein Fonds; NWO/CW TOP [714.012.002]; NWO VICI [724.012.003]; EU [2010-259743]	U-fonds; K.F. Hein Fonds; NWO/CW TOP; NWO VICI(Netherlands Organization for Scientific Research (NWO)); EU(European Commission)	We thank Utrecht Sequencing Facility (USF) for providing sequencing data and service, Carien Hilvering for providing a custom primer design tool, P.I. de Bakker for helpful discussion and critical reading of the manuscript, Michael van Gerven for designing part of the primers, and Ewart Kuijk for providing cell lines used in optimization experiments. This work was supported by a grant from the U-fonds and the K.F. Hein Fonds, an NWO/CW TOP grant (714.012.002), an NWO VICI grant (724.012.003), and an EU grant 2010-259743 (MODHEP) to W.d.L.	Akolekar R, 2015, ULTRASOUND OBST GYN, V45, P16, DOI 10.1002/uog.14636; Caughey AB, 2006, OBSTET GYNECOL, V108, P612, DOI 10.1097/01.AOG.0000232512.46869.fc; Chan KCA, 2016, P NATL ACAD SCI USA, V113, pE8159, DOI 10.1073/pnas.1615800113; Chen SP, 2013, GENOME MED, V5, DOI 10.1186/gm422; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; de Vree PJP, 2014, NAT BIOTECHNOL, V32, P1019, DOI 10.1038/nbt.2959; Dekkers JF, 2013, NAT MED, V19, P939, DOI 10.1038/nm.3201; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Drury S, 2016, ADV EXP MED BIOL, V924, P71, DOI 10.1007/978-3-319-42044-8_14; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Ferrari M, 2015, CLIN CHIM ACTA, V451, P9, DOI 10.1016/j.cca.2014.12.026; Finning K, 2004, ANN NY ACAD SCI, V1022, P119, DOI 10.1196/annals.1318.019; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Han J, 2014, J OBSTET GYNAECOL, V34, P669, DOI 10.3109/01443615.2014.920793; Hui WWI, 2017, CLIN CHEM, V63, P513, DOI 10.1373/clinchem.2016.268375; Kitzman JO, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004323; Lam KWG, 2012, CLIN CHEM, V58, P1467, DOI 10.1373/clinchem.2012.189589; Lench N, 2013, PRENATAL DIAG, V33, P555, DOI 10.1002/pd.4124; Liao GJW, 2011, CLIN CHEM, V57, P92, DOI 10.1373/clinchem.2010.154336; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lo YMD, 1998, NEW ENGL J MED, V339, P1734, DOI 10.1056/NEJM199812103392402; Lun FMF, 2008, P NATL ACAD SCI USA, V105, P19920, DOI 10.1073/pnas.0810373105; Ma DY, 2014, GENE, V544, P252, DOI 10.1016/j.gene.2014.04.055; Milani R, 2015, EUR J PHARM SCI, V78, P225, DOI 10.1016/j.ejps.2015.07.013; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; New MI, 2014, J CLIN ENDOCR METAB, V99, pE1022, DOI 10.1210/jc.2014-1118; Parks M, 2017, EUR J HUM GENET, V25, P416, DOI 10.1038/ejhg.2016.195; Regan JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118270; Shi XL, 2015, CLIN CHIM ACTA, V439, P24, DOI 10.1016/j.cca.2014.09.032; Speiser PW, 2003, NEW ENGL J MED, V349, P776, DOI 10.1056/NEJMra021561; Traeger-Synodinos J, 2017, BEST PRACT RES CL OB, V39, P74, DOI 10.1016/j.bpobgyn.2016.10.010; Verhoef TI, 2016, PRENATAL DIAG, V36, P636, DOI 10.1002/pd.4832; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Wilton L, 2009, HUM REPROD, V24, P1221, DOI 10.1093/humrep/den488	38	50	52	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 7	2017	101	3					326	339		10.1016/j.ajhg.2017.07.012	http://dx.doi.org/10.1016/j.ajhg.2017.07.012			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FG1CS	28844486	Green Published, hybrid			2022-12-18	WOS:000409530900002
J	Carmona, FD; Vaglio, A; Mackie, SL; Hernandez-Rodriguez, J; Monach, PA; Castaneda, S; Solans, R; Morado, IC; Narvaez, J; Ramentol-Sintas, M; Pease, CT; Dasgupta, B; Watts, R; Khalidi, N; Langford, CA; Ytterberg, S; Boiardi, L; Beretta, L; Govoni, M; Emmi, G; Bonatti, F; Cimmino, MA; Witte, T; Neumann, T; Holle, J; Schoenau, V; Sailler, L; Papo, T; Haroche, J; Mahr, A; Mouthon, L; Molberg, O; Diamantopoulos, AP; Voskuyl, A; Brouwer, E; Daikeler, T; Berger, CT; Molloy, ES; O'Neill, L; Blockmans, D; Lie, BA; Mclaren, P; Vyse, TJ; Wijmenga, C; Allanore, Y; Koeleman, BPC; Barrett, JH; Cid, MC; Salvarani, C; Merkel, PA; Morgan, AW; Gonzalez-Gay, MA; Martin, J				David Carmona, F.; Vaglio, Augusto; Mackie, Sarah L.; Hernandez-Rodriguez, Jose; Monach, Paul A.; Castaneda, Santos; Solans, Roser; Morado, Inmaculada C.; Narvaez, Javier; Ramentol-Sintas, Marc; Pease, Colin T.; Dasgupta, Bhaskar; Watts, Richard; Khalidi, Nader; Langford, Carol A.; Ytterberg, Steven; Boiardi, Luigi; Beretta, Lorenzo; Govoni, Marcello; Emmi, Giacomo; Bonatti, Francesco; Cimmino, Marco A.; Witte, Torsten; Neumann, Thomas; Holle, Julia; Schoenau, Verena; Sailler, Laurent; Papo, Thomas; Haroche, Julien; Mahr, Alfred; Mouthon, Luc; Molberg, Oyvind; Diamantopoulos, Andreas P.; Voskuyl, Alexandre; Brouwer, Elisabeth; Daikeler, Thomas; Berger, Christoph T.; Molloy, Eamonn S.; O'Neill, Lorraine; Blockmans, Daniel; Lie, Benedicte A.; Mclaren, Paul; Vyse, Timothy J.; Wijmenga, Cisca; Allanore, Yannick; Koeleman, Bobby P. C.; Barrett, Jennifer H.; Cid, Maria C.; Salvarani, Carlo; Merkel, Peter A.; Morgan, Ann W.; Gonzalez-Gay, Miguel A.; Martin, Javier		Spanish CGA Grp; UKGCA Consortium; Vasculitis Clinical Res Consortium	A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ANCA-ASSOCIATED VASCULITIS; FUNCTIONAL VARIATION; GENETIC-VARIANTS; DISEASE; SUSCEPTIBILITY; EXPRESSION; PATHOGENESIS; INSIGHTS; HYPOXIA; LOCUS	Giant cell arteritis (GCA) is the most common form of vasculitis in individuals older than SO years in Western countries. To shed light onto the genetic background influencing susceptibility for GCA, we performed a genome-wide association screening in a well-powered study cohort. After imputation, 1,844,133 genetic variants were analyzed in 2,134 case subjects and 9,125 unaffected individuals from ten independent populations of European ancestry. Our data confirmed HLA class II as the strongest associated region (independent signals: rs9268905, p = 1.94 x 10(-54), per-allele OR = 1.79; and rs9275592, p = 1.14 x 10(-4), OR = 2.08). Additionally, PLG and P4HA2 were identified as GCA risk genes at the genome-wide level of significance (rs4252134, p = 1.23 x 10(-10), OR = 1.28; and rs128738, p = 4.60 x 10(-9), OR = 1.32, respectively). Interestingly, we observed that the association peaks overlapped with different regulatory elements related to cell types and tissues involved in the pathophysiology of GCA. PLG and P4HA2 are involved in vascular remodelling and angiogenesis, suggesting a high relevance of these processes for the pathogenic mechanisms underlying this type of vasculitis.	[David Carmona, F.; Martin, Javier] PTS Granada, CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada 18016, Spain; [David Carmona, F.] Univ Granada, Dept Genet, Granada 18016, Spain; [David Carmona, F.] Univ Granada, Inst Biotecnol, Granada 18016, Spain; [Vaglio, Augusto] Univ Hosp Parma, Unit Nephrol, I-43126 Parma, Italy; [Mackie, Sarah L.; Pease, Colin T.; Barrett, Jennifer H.; Morgan, Ann W.] Univ Leeds, Sch Med, Leeds LS7 4SA, W Yorkshire, England; [Mackie, Sarah L.; Pease, Colin T.; Barrett, Jennifer H.; Morgan, Ann W.] Leeds Teaching Hosp NHS Trust, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds LS7 4SA, W Yorkshire, England; [Hernandez-Rodriguez, Jose; Cid, Maria C.] Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Vasculitis Res Unit,Dept Autoimmune Dis, E-08036 Barcelona, Spain; [Monach, Paul A.] Boston Univ, Sect Rheumatol, Boston, MA 02118 USA; [Castaneda, Santos] Hosp Princesa, IIS IP, Dept Rheumatol, Madrid 28006, Spain; [Solans, Roser; Ramentol-Sintas, Marc] Autonomous Univ Barcelona, Hosp Vall dHebron, Dept Internal Med, Autoimmune Syst Dis Unit, E-08035 Barcelona, Spain; [Morado, Inmaculada C.] Hosp Clin San Carlos, Dept Rheumatol, Madrid 28040, Spain; [Narvaez, Javier] Hosp Univ Bellvitge IDIBELL, Dept Rheumatol, Barcelona 08907, Spain; [Dasgupta, Bhaskar] Southend Univ Hosp NHS Fdn Trust, Dept Rheumatol, Westcliff On Sea SS0 0RY, England; [Watts, Richard] Ipswich Hosp NHS Trust, Dept Rheumatol, Ipswich IP4 5PD, Suffolk, England; [Khalidi, Nader] McMaster Univ, Div Rheumatol, Hamilton, ON L8N 1Y2, Canada; [Langford, Carol A.] Cleveland Clin, Div Rheumatol, Cleveland, OH 44195 USA; [Ytterberg, Steven] Mayo Clin, Div Rheumatol, Rochester, MN 55905 USA; [Boiardi, Luigi; Salvarani, Carlo] Azienda Osped Arcispedale Santa Maria Nuova, Ist Ricovero & Cura Carattere Sci, Dept Internal Med, Rheumatol Unit, I-42123 Reggio Emilia, Italy; [Beretta, Lorenzo] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Referral Ctr System Autoimmune Dis, I-20122 Milan, Italy; [Govoni, Marcello] Univ Ferrara, Azienda Osped Univ S Anna, Dept Rheumatol, I-44121 Ferrara, Italy; [Emmi, Giacomo] Univ Florence, Dept Expt & Clin Med, I-50134 Florence, Italy; [Bonatti, Francesco] Univ Parma, Med Genet Unit, Dept Clin & Expt Med, I-43124 Parma, Italy; [Cimmino, Marco A.] Univ Genoa, Dept Internal Med, Res Lab, I-16132 Genoa, Italy; [Cimmino, Marco A.] Univ Genoa, Dept Internal Med, Acad Div Clin Rheumatol, I-16132 Genoa, Italy; [Witte, Torsten] Hannover Med Sch, D-30625 Hannover, Germany; [Neumann, Thomas] Univ Hosp Jena, Innere Med Klin 3, D-07743 Jena, Germany; [Holle, Julia] Klinikum Bad Bramstedt, Vasculitis Clin, D-24576 Bad Bramstedt, Germany; [Holle, Julia] Univ Hosp Schleswig Holstein, D-24576 Bad Bramstedt, Germany; [Schoenau, Verena] Univ Klinikum Erlangen, Dept Rheumatol & Immunol, D-91054 Erlangen, Germany; [Sailler, Laurent] Univ Toulouse, CHU Toulouse, INSERM, Serv Med Interne,Hop Purpan,UMR 1027, F-31059 Toulouse, France; [Papo, Thomas] Univ Paris Diderot, Hop Bichat, Serv Med Interne, F-75018 Paris, France; [Haroche, Julien] Hop La Pitie Salpetriere, AP HP, Dept Internal Med, F-75013 Paris, France; [Haroche, Julien] Hop La Pitie Salpetriere, AP HP, French Reference Ctr Rare Autoimmune & Syst Dis, F-75013 Paris, France; [Mahr, Alfred] Univ Paris Diderot, Host St Louis, ECSTRA Team,UMR 1153, Sorbonne Paris Cite,Res Ctr,Dept Internal Med,Epi, F-75010 Paris, France; [Mouthon, Luc] Univ Paris 05, Cochin Hosp, AP HP, Natl Referral Ctr Rare Autoimmune & Syst Dis,Dept, F-75014 Paris, France; [Molberg, Oyvind] Oslo Univ Hosp, Dept Rheumatol, N-0424 Oslo, Norway; [Diamantopoulos, Andreas P.] Hosp Southern Norway Trust, Dept Rheumatol, N-4604 Kristiansand, Norway; [Voskuyl, Alexandre] Vrije Univ Amsterdam, Med Ctr, Amsterdam Rheumatol & Immunol Ctr, NL-1007 MB Amsterdam, Netherlands; [Brouwer, Elisabeth] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, NL-9713 GZ Groningen, Netherlands; [Daikeler, Thomas] Univ Hosp, Rheumatol Dept Internal Med, CH-4056 Basel, Switzerland; [Berger, Christoph T.] Univ Hosp, Translat Immunol & Med Outpatient Clin, Dept Biomed, CH-4056 Basel, Switzerland; [Berger, Christoph T.] Univ Hosp, Translat Immunol & Med Outpatient Clin, Dept Internal Med, CH-4056 Basel, Switzerland; [Molloy, Eamonn S.; O'Neill, Lorraine] St Vincents Univ Hosp, Dublin Acad Med Ctr, Ctr Arthrit & Rheumat Dis, Dept Rheumatol, Dublin 4, Ireland; [Blockmans, Daniel] Univ Hosp Gasthuisberg, Dept Gen Internal Med, B-3000 Leuven, Belgium; [Lie, Benedicte A.] Univ Oslo, Dept Med Genet, N-0450 Oslo, Norway; [Lie, Benedicte A.] Oslo Univ Hosp, N-0450 Oslo, Norway; [Mclaren, Paul] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Vyse, Timothy J.] Kings Coll London, Div Genet, London SE1 9RT, England; [Vyse, Timothy J.] Kings Coll London, Div Mol Med, London SE1 9RT, England; [Vyse, Timothy J.] Kings Coll London, Div Immunol Infect & Inflammatory Dis, London SE1 9RT, England; [Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9713 AV Groningen, Netherlands; [Allanore, Yannick] Paris Descartes Univ, Cochin Hosp, Sorbonne Paris Cite, Rheumatol Dept A, F-75014 Paris, France; [Koeleman, Bobby P. C.] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Med Genet, NL-3584 CX Utrecht, Netherlands; [Merkel, Peter A.] Univ Penn, Div Rheumatol, Vasculitis Ctr, Philadelphia, PA 19104 USA; [Gonzalez-Gay, Miguel A.] Univ Cantabria, IDIVAL, Hosp Univ Marques de Valdecilla, Dept Rheumatol, Santander 39008, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Granada; University of Granada; University of Parma; University Hospital of Parma; University of Leeds; Leeds Biomedical Research Centre; University of Leeds; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Boston University; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Hospital Clinico San Carlos; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Ipswich Hospital NHS Trust; Ipswich Hospital; McMaster University; Cleveland Clinic Foundation; Mayo Clinic; IRCCS Arcispedale S. Maria Nuova; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Ferrara; Arcispedale Sant'Anna; University of Florence; University of Parma; University Hospital of Parma; University of Genoa; University of Genoa; Hannover Medical School; Friedrich Schiller University of Jena; University of Kiel; Schleswig Holstein University Hospital; University of Erlangen Nuremberg; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Oslo; Vrije Universiteit Amsterdam; University of Groningen; University College Dublin; Saint Vincent's University Hospital; KU Leuven; University Hospital Leuven; University of Oslo; University of Oslo; Swiss Institute of Bioinformatics; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of Groningen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Utrecht University; Utrecht University Medical Center; University of Pennsylvania; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria	Carmona, FD (corresponding author), PTS Granada, CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada 18016, Spain.; Carmona, FD (corresponding author), Univ Granada, Dept Genet, Granada 18016, Spain.; Carmona, FD (corresponding author), Univ Granada, Inst Biotecnol, Granada 18016, Spain.	dcarmona@ipb.csic.es	Carmona, F. David/F-9953-2016; Berger, Christoph T/I-6126-2019; Narvaez, Javier/AAD-7434-2020; Narvaez, Javier/AAD-7456-2020; Beretta, Lorenzo/AAB-8605-2019; Emmi, Giacomo/J-6913-2016; Brouwer, Elisabeth/A-3198-2015; Salvarani, Carlo/K-2431-2018; Witte, Torsten/B-5783-2016; Pagnoux, Christian/C-4612-2015; Vaglio, Augusto/AHE-8117-2022; Centeno, Norberto Ortego/C-4793-2019; Bonatti, Francesco/K-6362-2016; Martín, Javier/AAV-5209-2021; Martín, María/HDL-9512-2022; Wijmenga, Cisca/AAE-7719-2019; Brouwer, Elisabeth/AAL-9029-2020; Martin, Javier/B-8141-2008; Hernandez-Rodriguez, Jose/L-2073-2017; Robinson, James/D-9096-2016	Carmona, F. David/0000-0002-1427-7639; Berger, Christoph T/0000-0002-1730-8824; Narvaez, Javier/0000-0002-1614-8064; Beretta, Lorenzo/0000-0002-6529-6258; Brouwer, Elisabeth/0000-0002-5652-4423; Vaglio, Augusto/0000-0002-3814-9172; Centeno, Norberto Ortego/0000-0003-2325-0937; Bonatti, Francesco/0000-0002-5067-5423; Wijmenga, Cisca/0000-0002-5635-1614; Brouwer, Elisabeth/0000-0002-5652-4423; Martin, Javier/0000-0002-2202-0622; Morgan, Ann/0000-0003-1109-624X; Isaacs, John/0000-0002-6103-7056; Mahr, Alfred/0000-0002-1564-9115; Moreland, Larry/0000-0003-4483-0359; Hernandez-Rodriguez, Jose/0000-0002-2357-2015; Tio Barrera, Laura/0000-0003-1408-7381; Rios-Fernandez, Raquel/0000-0001-6630-8292; MARTINEZ ZAPICO, ALEIDA/0000-0001-9443-8043; Mollan, Susan/0000-0002-6314-4437; Voskuyl, Alexandre/0000-0002-9699-1827; Seo, Philip/0000-0003-3435-6737; Robinson, James/0000-0001-5425-7520; callejas, jose luis/0000-0002-1653-0087; Warrington, Kenneth/0000-0001-7708-2487; McLaren, Paul/0000-0001-6019-7018; Emmi, Giacomo/0000-0001-9575-8321	Institute de Salud Carlos III (ISCIII), Spain, through the RETICS Program [RD12/0009/0004]; Ramon y Cajal program of the Spanish Ministry of Economy and Competitiveness [RYC-2014-16458]; United States National Institute of Arthritis and Musculoskeletal and Skin Diseases [U54AR057319]; National Center for Research Resources [U54 RR019497]; Office of Rare Diseases Research; National Center for Advancing Translational Science; Research into Ageing; Wellcome Trust; National Institute for Health Research; Medical Research Council; Ann Wilks Memorial Fund; National Institute for Health Research (NIHR); Medical Research Council [MR/L01629X/1, G1001518] Funding Source: researchfish; National Institute for Health Research [NIHR-CS-012-016] Funding Source: researchfish; Fight for Sight [24PMR13] Funding Source: researchfish; MRC [G1001518, MR/L01629X/1, MR/N011775/1] Funding Source: UKRI	Institute de Salud Carlos III (ISCIII), Spain, through the RETICS Program; Ramon y Cajal program of the Spanish Ministry of Economy and Competitiveness(Spanish Government); United States National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Rare Diseases Research; National Center for Advancing Translational Science; Research into Ageing; Wellcome Trust(Wellcome Trust); National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ann Wilks Memorial Fund; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Fight for Sight; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	F.D.C. was supported by Institute de Salud Carlos III (ISCIII), Spain, through the RETICS Program RD12/0009/0004 (RIER), and by the Ramon y Cajal program of the Spanish Ministry of Economy and Competitiveness through the grant RYC-2014-16458. J.M. was founded by Junta de Andalucia through PAI group CTS180. The Vasculitis Clinical Research Consortium (VCRC) received support from the United States National Institute of Arthritis and Musculoskeletal and Skin Diseases (U54AR057319), the National Center for Research Resources (U54 RR019497), the Office of Rare Diseases Research, and the National Center for Advancing Translational Science. The VCRC is part of the Rare Diseases Clinical Research Network (RDCRN).r The UKGCA Consortium has been funded by Research into Ageing and The Wellcome Trust and is currently supported by the National Institute for Health Research (Clinician Scientist Fellowship for S.L.M., Leeds Musculoskeletal Biomedical Research Unit [A.W.M. and J.H.B.], and Diagnostic Evidence Co-operative [A.W.M.]), the Medical Research Council, and the Ann Wilks Memorial Fund. This article presents independent research funded in part by the National Institute for Health Research (NIHR). The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR, or the Department of Health.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett JH, 2011, NAT GENET, V43, P1108, DOI 10.1038/ng.959; Bentham J, 2015, NAT GENET, V47, P1457, DOI 10.1038/ng.3434; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carmona FD, 2016, EXPERT REV CLIN IMMU, V12, P57, DOI 10.1586/1744666X.2016.1089173; Carmona FD, 2015, AM J HUM GENET, V96, P565, DOI 10.1016/j.ajhg.2015.02.009; Carmona FD, 2014, RHEUMATOLOGY, V53, P6, DOI 10.1093/rheumatology/ket231; Carmona FD, 2015, CURR OPIN RHEUMATOL, V27, P10, DOI 10.1097/BOR.0000000000000124; Deng W, 2016, CELL IMMUNOL, V303, P7, DOI 10.1016/j.cellimm.2016.04.001; Dimova EY, 2004, ANTIOXID REDOX SIGN, V6, P777, DOI 10.1089/1523086041361596; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Gilkes DM, 2013, J BIOL CHEM, V288, P10819, DOI 10.1074/jbc.M112.442939; Gonzalez-Gay MA, 2005, MEDICINE, V84, P269, DOI 10.1097/01.md.0000180042.42156.d1; Gonzalez-Gay MA, 2009, ARTHRIT CARE RES, V61, P1454, DOI 10.1002/art.24459; Gregersen PK, 2012, ANN NEUROL, V72, P927, DOI 10.1002/ana.23691; Hao J, 2014, RHEUMATOLOGY, V53, P300, DOI 10.1093/rheumatology/ket345; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1122; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Kaiser M, 1999, AM J PATHOL, V155, P765, DOI 10.1016/S0002-9440(10)65175-9; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Law RHP, 2013, CURR OPIN STRUC BIOL, V23, P836, DOI 10.1016/j.sbi.2013.10.006; Li MX, 2012, HUM GENET, V131, P747, DOI 10.1007/s00439-011-1118-2; Ly KH, 2010, AUTOIMMUN REV, V9, P635, DOI 10.1016/j.autrev.2010.05.002; Lyons PA, 2012, NEW ENGL J MED, V367, P214, DOI 10.1056/NEJMoa1108735; Manolio TA, 2013, NAT REV GENET, V14, P549, DOI 10.1038/nrg3523; Marquez A, 2014, ANN RHEUM DIS, V73, P1742, DOI 10.1136/annrheumdis-2014-205261; Miles LA, 2013, SEMIN THROMB HEMOST, V39, P329, DOI 10.1055/s-0033-1334483; Moser TL, 1999, P NATL ACAD SCI USA, V96, P2811, DOI 10.1073/pnas.96.6.2811; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Radstake TRDJ, 2010, NAT GENET, V42, P426, DOI 10.1038/ng.565; Rotger M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000781; Sadovnick AD, 2016, G3-GENES GENOM GENET, V6, P2073, DOI 10.1534/g3.116.030841; Schaefer AS, 2015, CIRC-CARDIOVASC GENE, V8, P159, DOI 10.1161/CIRCGENETICS.114.000554; Serrano A, 2013, ANN RHEUM DIS, V72, P1882, DOI 10.1136/annrheumdis-2013-203641; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Ward LD, 2016, NUCLEIC ACIDS RES, V44, pD877, DOI 10.1093/nar/gkv1340; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756	50	50	50	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 5	2017	100	1					64	74		10.1016/j.ajhg.2016.11.013	http://dx.doi.org/10.1016/j.ajhg.2016.11.013			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EH6UX	28041642	Green Submitted, Green Published, Green Accepted, Bronze			2022-12-18	WOS:000391910500006
J	George, A; Zand, DJ; Hufnagel, RB; Sharma, R; Sergeev, YV; Legare, JM; Rice, GM; Schwoerer, JAS; Rius, M; Tetri, L; Gamm, DM; Bharti, K; Brooks, BP				George, Aman; Zand, Dina J.; Hufnagel, Robert B.; Sharma, Ruchi; Sergeev, Yuri V.; Legare, Janet M.; Rice, Gregory M.; Schwoerer, Jessica A. Scott; Rius, Mariana; Tetri, Laura; Gamm, David M.; Bharti, Kapil; Brooks, Brian P.			Biallelic Mutations in MITF Cause Coloboma, Osteopetrosis, Microphthalmia, Macrocephaly, Albinism, and Deafness	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WAARDENBURG SYNDROME; TFE FAMILY; MOUSE; GENE; MELANOCYTES; HOMOLOG; NETWORK; PROTEIN	Human MITF is, by convention, called the "microphthalmia-associated transcription factor'' because of previously published seminal mouse genetic studies; however, mutations in MITF have never been associated with microphthalmia in humans. Here, we describe a syndrome that we term COMMAD, characterized by coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness. COMMAD is associated with biallelic MITF mutant alleles and hence suggests a role for MITF in regulating processes such as optic-fissure closure and bone development or homeostasis, which go beyond what is usually seen in individuals carrying monoallelic MITF mutations.	[George, Aman; Hufnagel, Robert B.; Sergeev, Yuri V.; Rius, Mariana; Brooks, Brian P.] NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA; [Zand, Dina J.; Brooks, Brian P.] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Sharma, Ruchi; Bharti, Kapil] NEI, Unit Ocular & Stem Cell Translat Res, NIH, Bethesda, MD 20892 USA; [Legare, Janet M.; Rice, Gregory M.; Tetri, Laura; Gamm, David M.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53726 USA; [Schwoerer, Jessica A. Scott; Gamm, David M.] Univ Wisconsin, Sch Med & Publ Hlth, McPherson Eye Res Inst, Madison, WI 53726 USA; [Schwoerer, Jessica A. Scott; Gamm, David M.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI 53726 USA; [Zand, Dina J.] US FDA, Off New Drugs, Off Drug Evaluat 3, Div Gastroenterol & Inborn Errors Prod, Silver Spring, MD 20993 USA; [Rius, Mariana] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11790 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Children's National Health System; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; US Food & Drug Administration (FDA); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Brooks, BP (corresponding author), NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA.; Brooks, BP (corresponding author), Childrens Natl Med Ctr, Washington, DC 20010 USA.	brian.brooks1@nih.gov	George, Aman/I-1718-2019; Legare, Janet/AAK-7899-2020		NEI; NATIONAL EYE INSTITUTE [ZIAEY000469, ZIAEY000476, ZIAEY000532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the probands and their families. We thank Dr. Heinz Arnheiter for critical comments on the manuscript, Dr. James Lister (Virginia Commonwealth University, Richmond, VA) for the zebrafish mitfa construct, Drs. Noriko Esumi (Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD) and Sridhar Mani (Albert Einstein College of Medicine, Bronx, NY) for luciferase promoter constructs, Drs. Chun Gao and Robert Farris (Biological Imaging Core, National Eye Institute [NEI]) for expert assistance with confocal laser-scanning microscopy experiments, Ramakrishna Alur for technical assistance, Delphine Blain for genetic counseling, the NEI Clinical Photography Section for outstanding technical assistance, and Anna Larson and Tyler Fayard for zebrafish breeding and maintenance. This work was supported by the intramural program of the NEI.	Bharti K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002757; Esumi N, 2007, J BIOL CHEM, V282, P1838, DOI 10.1074/jbc.M609517200; Grill C, 2013, HUM MOL GENET, V22, P4357, DOI 10.1093/hmg/ddt285; HERO I, 1989, EXP EYE RES, V49, P229, DOI 10.1016/0014-4835(89)90093-6; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; HUGHES AE, 1994, NAT GENET, V7, P509, DOI 10.1038/ng0894-509; Izumi K, 2008, CLIN GENET, V74, P93, DOI 10.1111/j.1399-0004.2008.01010.x; King R, 2002, AM J DERMATOPATH, V24, P282, DOI 10.1097/00000372-200206000-00017; Leger S, 2012, EUR J HUM GENET, V20, P584, DOI 10.1038/ejhg.2011.234; Nakayama A, 1998, MECH DEVELOP, V70, P155, DOI 10.1016/S0925-4773(97)00188-3; Nguyen MTT, 2000, DEVELOPMENT, V127, P3581; Niceta M, 2015, AM J HUM GENET, V96, P816, DOI 10.1016/j.ajhg.2015.03.001; Price ER, 2001, NEURON, V30, P15, DOI 10.1016/S0896-6273(01)00259-8; Raviv S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004360; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Steingrimsson E, 2002, P NATL ACAD SCI USA, V99, P4477, DOI 10.1073/pnas.072071099; STEINGRIMSSON E, 1994, NAT GENET, V8, P256, DOI 10.1038/ng1194-256; Takebayashi K, 1996, MOL CELL BIOL, V16, P1203; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; TASSABEHJI M, 1995, HUM MOL GENET, V4, P2131, DOI 10.1093/hmg/4.11.2131; TIETZ W, 1963, AM J HUM GENET, V15, P259; WAARDENBURG PJ, 1951, AM J HUM GENET, V3, P195; Weilbaecher KN, 1998, J EXP MED, V187, P775, DOI 10.1084/jem.187.5.775	23	50	52	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 1	2016	99	6					1388	1394		10.1016/j.ajhg.2016.11.004	http://dx.doi.org/10.1016/j.ajhg.2016.11.004			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED8VI	27889061	Green Published, Bronze			2022-12-18	WOS:000389148600014
J	Kim, JH; Shinde, DN; Reijnders, MRF; Hauser, NS; Belmonte, RL; Wilson, GR; Bosch, DGM; Bubulya, PA; Shashi, V; Petrovski, S; Stone, JK; Park, EY; Veltman, JA; Sinnema, M; Stumpel, CTRM; Draaisma, JM; Nicolai, J; Yntema, HG; Lindstrom, K; de Vries, BBA; Jewett, T; Santoro, SL; Vogt, J; Bachman, KK; Seeley, AH; Krokosky, A; Turner, C; Rohena, L; Hempel, M; Kortum, F; Lessel, D; Neu, A; Strom, TM; Wieczorek, D; Bramswig, N; Laccone, FA; Behunova, J; Rehder, H; Gordon, CT; Rio, M; Romana, S; Tang, S; El-Khechen, D; Cho, MT; McWalter, K; Douglas, G; Baskin, B; Begtrup, A; Funari, T; Schoch, K; Stegmann, APA; Stevens, SJC; Zhang, DE; Traver, D; Yao, X; MacArthur, DG; Brunner, HG; Mancini, GM; Myers, RM; Owen, LB; Lim, ST; Stachura, DL; Vissers, LELM; Ahn, EYE				Kim, Jung-Hyun; Shinde, Deepali N.; Reijnders, Margot R. F.; Hauser, Natalie S.; Belmonte, Rebecca L.; Wilson, Gregory R.; Bosch, Danielle G. M.; Bubulya, Paula A.; Shashi, Vandana; Petrovski, Slave; Stone, Joshua K.; Park, Eun Young; Veltman, Joris A.; Sinnema, Margje; Stumpel, Connie T. R. M.; Draaisma, Jos M.; Nicolai, Joost; Yntema, Helger G.; Lindstrom, Kristin; de Vries, Bert B. A.; Jewett, Tamison; Santoro, Stephanie L.; Vogt, Julie; Bachman, Kristine K.; Seeley, Andrea H.; Krokosky, Alyson; Turner, Clesson; Rohena, Luis; Hempel, Maja; Kortuem, Fanny; Lessel, Davor; Neu, Axel; Strom, Tim M.; Wieczorek, Dagmar; Bramswig, Nuria; Laccone, Franco A.; Behunova, Jana; Rehder, Helga; Gordon, Christopher T.; Rio, Marlene; Romana, Serge; Tang, Sha; El-Khechen, Dima; Cho, Megan T.; McWalter, Kirsty; Douglas, Ganka; Baskin, Berivan; Begtrup, Amber; Funari, Tara; Schoch, Kelly; Stegmann, Alexander P. A.; Stevens, Servi J. C.; Zhang, Dong-Er; Traver, David; Yao, Xu; MacArthur, Daniel G.; Brunner, Han G.; Mancini, Grazia M.; Myers, Richard M.; Owen, Laurie B.; Lim, Ssang-Taek; Stachura, David L.; Vissers, Lisenka E. L. M.; Ahn, Eun-Young Erin		Univ Washington; Deciphering Dev Disorders Study	De Novo Mutations in SON Disrupt RNA Splicing of Genes Essential for Brain Development and Metabolism, Causing an Intellectual-Disability Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CELL-CYCLE PROGRESSION; MENTAL-RETARDATION; STEM-CELLS; WDR62; MALFORMATIONS; SCHIZOPHRENIA; NETWORK; DISEASE; PROTEIN; AUTISM	The overall understanding of the molecular etiologies of intellectual disability (ID) and developmental delay (DD) is increasing as next generation sequencing technologies identify genetic variants in individuals with such disorders. However, detailed analyses conclusively confirming these variants, as well as the underlying molecular mechanisms explaining the diseases, are often lacking. Here, we report on an ID syndrome caused by de novo heterozygous loss-of-function (LoF) mutations in SON. The syndrome is characterized by ID and/or DD, malformations of the cerebral cortex, epilepsy, vision problems, musculoskeletal abnormalities, and congenital malformations. Knockdown of son in zebrafish resulted in severe malformation of the spine, brain, and eyes. Importantly, analyses of RNA from affected individuals revealed that genes critical for neuronal migration and cortex organization (TUBG1, FLNA, PNKP, WDR62, PSMD3, and HDAC6) and metabolism (PCK2, PFKL, IDH2, ACY1, and ADA) are significantly downregulated because of the accumulation of mis-spliced transcripts resulting from erroneous SON-mediated RNA splicing. Our data highlight SON as a master regulator governing neurodevelopment and demonstrate the importance of SON-mediated RNA splicing in human development.	[Kim, Jung-Hyun; Stone, Joshua K.; Park, Eun Young; Owen, Laurie B.; Ahn, Eun-Young Erin] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36604 USA; [Shinde, Deepali N.; Tang, Sha; El-Khechen, Dima] Ambry Genet, Aliso Viejo, CA 92656 USA; [Reijnders, Margot R. F.; Bosch, Danielle G. M.; Veltman, Joris A.; Yntema, Helger G.; de Vries, Bert B. A.; Brunner, Han G.; Vissers, Lisenka E. L. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands; [Hauser, Natalie S.] Valley Childrens Hosp, Med Genet & Metab, Madera, CA 93636 USA; [Belmonte, Rebecca L.; Wilson, Gregory R.; Stachura, David L.] Calif State Univ Chico, Dept Biol Sci, Chico, CA 95929 USA; [Bubulya, Paula A.] Wright State Univ, Dept Biol Sci, Dayton, OH 45435 USA; [Shashi, Vandana; Schoch, Kelly] Duke Univ, Sch Med, Div Med Genet, Dept Pediat, Durham, NC 27710 USA; [Petrovski, Slave] Univ Melbourne, Dept Med, Austin Hosp, Parkville, Vic 3010, Australia; [Petrovski, Slave] Royal Melbourne Hosp, Parkville, Vic 3010, Australia; [Petrovski, Slave] Columbia Univ, Inst Genom Med, New York, NY 10027 USA; [Veltman, Joris A.; Sinnema, Margje; Stumpel, Connie T. R. M.; Stegmann, Alexander P. A.; Stevens, Servi J. C.; Brunner, Han G.] Maastricht Univ, Med Ctr, Dept Clin Genet, NL-6202 AZ Maastricht, Netherlands; [Veltman, Joris A.; Sinnema, Margje; Stumpel, Connie T. R. M.; Stegmann, Alexander P. A.; Stevens, Servi J. C.; Brunner, Han G.] Maastricht Univ, Med Ctr, Sch Oncol & Dev Biol GROW, NL-6202 AZ Maastricht, Netherlands; [Draaisma, Jos M.] Radboudumc Amalia Childrens Hosp, Dept Pediat, NL-6500 HB Nijmegen, Netherlands; [Nicolai, Joost] Maastricht Univ, Med Ctr, Dept Neurol, NL-6299 HX Maastricht, Netherlands; [Lindstrom, Kristin] Phoenix Childrens Hosp, Div Genet & Metab, Phoenix, AZ 85016 USA; [Jewett, Tamison] Wake Forest Sch Med, Sect Med Genet, Dept Pediat, Winston Salem, NC 27157 USA; [Santoro, Stephanie L.] Nationwide Childrens Hosp, Columbus, OH 43205 USA; [Santoro, Stephanie L.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Vogt, Julie] Birmingham Womens NHS Fdn Trust, West Midlands Reg Genet Serv, Birmingham B15 2TG, W Midlands, England; [Deciphering Dev Disorders Study] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Bachman, Kristine K.; Seeley, Andrea H.] Geisinger Med Ctr, Danville, PA 17822 USA; [Krokosky, Alyson; Turner, Clesson] Walter Reed Natl Mil Med Ctr, Div Genet, Dept Pediat, Bethesda, MD 20889 USA; [Rohena, Luis] San Antonio Mil Med Ctr, Div Genet, Dept Pediat, Ft Sam Houston, TX 78234 USA; [Rohena, Luis] Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat, San Antonio, TX 78229 USA; [Hempel, Maja; Kortuem, Fanny; Lessel, Davor] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, D-20246 Hamburg, Germany; [Neu, Axel] Univ Med Ctr Hamburg Eppendorf, Dept Pediat, D-20246 Hamburg, Germany; [Strom, Tim M.] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Strom, Tim M.] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Wieczorek, Dagmar] Univ Dusseldorf, Inst Human Genet, Univ Clin Dusseldorf, D-40225 Dusseldorf, Germany; [Wieczorek, Dagmar; Bramswig, Nuria] Univ Duisburg Essen, Univ Clin Essen, Inst Human Genet, D-45147 Essen, Germany; [Laccone, Franco A.; Behunova, Jana; Rehder, Helga] Med Univ Vienna, Inst Med Genet, Waehringer Str 10, A-1090 Vienna, Austria; [Gordon, Christopher T.] INSERM, UMR 1163, Inst Imagine, Lab Embryol & Genet Congenital Malformat, F-75015 Paris, France; [Gordon, Christopher T.] Univ Paris 05, Sorbonne Paris Cite, Inst Imagine, F-75015 Paris, France; [Rio, Marlene] Hop Necker Enfants Malad, Dept Genet, F-75015 Paris, France; [Romana, Serge] Hop Necker Enfants Malad, Serv Cytogenet, F-75015 Paris, France; [Romana, Serge] Paris Descartes Sorbonne Paris Cite Univ, Inst Imagine, F-75015 Paris, France; [Cho, Megan T.; McWalter, Kirsty; Douglas, Ganka; Baskin, Berivan; Begtrup, Amber; Funari, Tara] GeneDx Inc, 205 Perry Pkwy, Gaithersburg, MD 20877 USA; [Zhang, Dong-Er; Yao, Xu] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Zhang, Dong-Er] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Zhang, Dong-Er; Traver, David] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [MacArthur, Daniel G.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [MacArthur, Daniel G.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [MacArthur, Daniel G.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Mancini, Grazia M.] Erasmus Univ, Med Ctr, Dept Clin Genet, NL-3015 CN Rotterdam, Netherlands; [Myers, Richard M.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Lim, Ssang-Taek; Ahn, Eun-Young Erin] Univ S Alabama, Dept Biochem & Mol Biol, Coll Med, Mobile, AL 36688 USA	University of South Alabama; Radboud University Nijmegen; California State University System; California State University Chico; University System of Ohio; Wright State University Dayton; Duke University; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Royal Melbourne Hospital; Columbia University; Maastricht University; Maastricht University; Maastricht University; Phoenix Children's Hospital; Wake Forest University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Wellcome Trust Sanger Institute; Geisinger Medical Center; Walter Reed National Military Medical Center; San Antonio Military Medical Center; University of Texas System; University of Texas Health San Antonio; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Duisburg Essen; Medical University of Vienna; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Erasmus University Rotterdam; Erasmus MC; HudsonAlpha Institute for Biotechnology; University of South Alabama	Ahn, EYE (corresponding author), Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36604 USA.; Vissers, LELM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands.; Ahn, EYE (corresponding author), Univ S Alabama, Dept Biochem & Mol Biol, Coll Med, Mobile, AL 36688 USA.	lisenka.vissers@radboudumc.nl; eahn@health.southalabama.edu	Wieczorek, Dagmar/AAU-6008-2021; Laccone, Franco A/B-3655-2018; Vissers, Lisenka ELM/A-2598-2015; Kim, Jung-Hyun/AAK-8795-2021; Lessel, Davor/ABD-6088-2021; Yntema, H.G./L-4771-2015; Stevens, Servi/P-8450-2015; Veltman, Joris A/F-5128-2010; Santoro, Stephanie L./AAM-4696-2021; Gordon, Chris/F-1267-2017; Draaisma, J.M.T./L-4283-2015	Wieczorek, Dagmar/0000-0003-2812-6492; Vissers, Lisenka ELM/0000-0001-6470-5497; Kim, Jung-Hyun/0000-0001-7176-409X; Stevens, Servi/0000-0001-8769-3150; Veltman, Joris A/0000-0002-3218-8250; Santoro, Stephanie L./0000-0002-4172-0288; Gordon, Chris/0000-0002-9300-8399; Belmonte, Rebecca/0000-0003-0464-0577; Blue, Elizabeth/0000-0002-0633-0305; Lim, Steve/0000-0003-0323-8607; Lessel, Davor/0000-0003-4496-244X; MacArthur, Daniel/0000-0002-5771-2290; Neu, Axel/0000-0001-7045-7194; Romana, Serge Pierrick/0000-0003-3435-239X; Ahn, Eun-Young Erin/0000-0001-8795-7734; Stegmann, Alexander/0000-0002-9736-7137; Rio, Marlene/0000-0003-2049-5058	National Human Genome Research Institute; National Heart, Lung, and Blood Institute [1U54HG006493]; Radboudumc Genomics Technology Center for family-based sequencing; NIH [CA190688, CA185818, GM084407]; University of South Alabama Mitchell Cancer Institute; Ohio Board of Regents; California State University Chico Internal Research Grant; Stichting ODAS [5781251]; Dutch Organization for Health Research and Development [912-12-109]; Wellcome Trust; Vereniging Bartimeus-Sonneheerdt; NATIONAL CANCER INSTITUTE [R21CA185818, R01CA190688] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006493, UM1HG006493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM084407] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Radboudumc Genomics Technology Center for family-based sequencing; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of South Alabama Mitchell Cancer Institute; Ohio Board of Regents; California State University Chico Internal Research Grant; Stichting ODAS; Dutch Organization for Health Research and Development; Wellcome Trust(Wellcome TrustEuropean Commission); Vereniging Bartimeus-Sonneheerdt; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are deeply grateful to all individuals and their families for participating in this study. We thank Dr. Michael Markey (Wright State University) for transcript splicing analysis, Dr. David Goldstein, Jennifer Sullivan, and Nicole Walley (Duke University) for their help in collecting clinical information, Petra de Vries (Radboudumc) and Hermann-Josef Ludecke (University Duisburg-Essen) for technical support, and Dr. Christian Gilissen (Radboudumc) for bioinformatic support. We thank the University of Washington Center for Mendelian Genomics (funded by the National Human Genome Research Institute and National Heart, Lung, and Blood Institute grant 1U54HG006493 to Drs. Debbie Nickerson, Jay Shendure, and Michael Bamshad) and the Radboudumc Genomics Technology Center for family-based sequencing. This work was supported by NIH grants (CA190688 and CA185818 to E.-Y.E.A. and GM084407 to P.A.B.), a start-up fund from the University of South Alabama Mitchell Cancer Institute (to E.-Y.E.A.), the Ohio Board of Regents (to P.A.B.), a California State University Chico Internal Research Grant (to D.L.S.), grants from Stichting ODAS and Vereniging Bartimeus-Sonneheerdt (5781251 to B.B.A.d.V. and D.G.M.B.), and a grant from the Dutch Organization for Health Research and Development (912-12-109 to B.B.A.d.V. and J.A.V.). This study used data generated by the DECIPHER Consortium. A full list of centers who contributed to the generation of the data is available at http://decipher.sanger.ac.uk and via email at decipher@sanger.ac.uk. Funding for the DECIPHER project was provided by the Wellcome Trust.	Ahn EEY, 2013, J BIOL CHEM, V288, P5381, DOI 10.1074/jbc.M112.447227; Ahn EY, 2011, MOL CELL, V42, P185, DOI 10.1016/j.molcel.2011.03.014; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Chen JF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4885; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Exome Aggregation Consorsium, 2016, BIORXIV; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Hickey CJ, 2014, J CELL BIOCHEM, V115, P224, DOI 10.1002/jcb.24672; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Jamuar SS, 2014, NEW ENGL J MED, V371, P733, DOI 10.1056/NEJMoa1314432; Jensen LR, 2007, EUR J HUM GENET, V15, P68, DOI 10.1038/sj.ejhg.5201714; Kim JH, 2016, MOL CELL, V61, P859, DOI 10.1016/j.molcel.2016.02.024; Lelieveld S. H., 2016, NAT NEUROSCI; Lu XY, 2013, NAT CELL BIOL, V15, P1141, DOI 10.1038/ncb2839; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Mefford HC, 2012, NEW ENGL J MED, V366, P733, DOI 10.1056/NEJMra1114194; Nicholas AK, 2010, NAT GENET, V42, P1010, DOI 10.1038/ng.682; Nofech-Mozes Y, 2007, PEDIATR NEUROL, V37, P218, DOI 10.1016/j.pediatrneurol.2007.03.011; Petrovski S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005492; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Poirier K, 2013, NAT GENET, V45, P639, DOI 10.1038/ng.2613; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Sharma A, 2011, J CELL SCI, V124, P4286, DOI 10.1242/jcs.092239; Sharma A, 2010, MOL BIOL CELL, V21, P650, DOI 10.1091/mbc.E09-02-0126; Shen J, 2010, NAT GENET, V42, P245, DOI 10.1038/ng.526; Vissers LELM, 2016, NAT REV GENET, V17, P9, DOI 10.1038/nrg3999; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Yu TW, 2010, NAT GENET, V42, P1015, DOI 10.1038/ng.683; Zhu XL, 2015, GENET MED, V17, P774, DOI 10.1038/gim.2014.191	35	50	53	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 1	2016	99	3					711	719		10.1016/j.ajhg.2016.06.029	http://dx.doi.org/10.1016/j.ajhg.2016.06.029			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DV7KM	27545680	Green Published, Bronze			2022-12-18	WOS:000383114800016
J	Strong, E; Butcher, DT; Singhania, R; Mervis, CB; Morris, CA; De Carvalho, D; Weksberg, R; Osborne, LR				Strong, Emma; Butcher, Darci T.; Singhania, Rajat; Mervis, Carolyn B.; Morris, Colleen A.; De Carvalho, Daniel; Weksberg, Rosanna; Osborne, Lucy R.			Symmetrical Dose-Dependent DNA-Methylation Profiles in Children with Deletion or Duplication of 7q11.23	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTISM-SPECTRUM; TRANSCRIPTION FACTOR; WILLIAMS-SYNDROME; YOUNG-CHILDREN; TFII-I; EPIGENETIC REGULATION; GENE; ALPHA; FAMILY; CTCF	Epigenetic dysfunction has been implicated in a growing list of disorders that include cancer, neurodevelopmental disorders, and neurodegeneration. Williams syndrome (WS) and 7q11.23 duplication syndrome (Dup7) are rare neurodevelopmental disorders with broad phenotypic spectra caused by deletion and duplication, respectively, of a 1.5-Mb region that includes several genes with a role in epigenetic regulation. We have identified striking differences in DNA methylation across the genome between blood cells from children with WS or Dup7 and blood cells from typically developing (TD) children. Notably, regions that were differentially methylated in both WS and Dup7 displayed a significant and symmetrical gene-dose-dependent effect, such that WS typically showed increased and Dup7 showed decreased DNA methylation. Differentially methylated genes were significantly enriched with genes in pathways involved in neurodevelopment, autism spectrum disorder (ASD) candidate genes, and imprinted genes. Using alignment with ENCODE data, we also found the differentially methylated regions to be enriched with CCCTC-binding factor (CTCF) binding sites. These findings suggest that gene(s) within 7q11.23 alter DNA methylation at specific sites across the genome and result in dose-dependent DNA-methylation profiles in WS and Dup7. Given the extent of DNA-methylation changes and the potential impact on CTCF binding and chromatin regulation, epigenetic mechanisms most likely contribute to the complex neurological phenotypes of WS and Dup7. Our findings highlight the importance of DNA methylation in the pathogenesis of WS and Dup7 and provide molecular mechanisms that are potentially shared by WS, Dup7, and ASD.	[Strong, Emma; Osborne, Lucy R.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Butcher, Darci T.; Weksberg, Rosanna] Hosp Sick Children, Genet & Genome Biol, Toronto, ON M5G 0A4, Canada; [Singhania, Rajat; De Carvalho, Daniel] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [Mervis, Carolyn B.] Univ Louisville, Dept Psychol & Brain Sci, Louisville, KY 40292 USA; [Morris, Colleen A.] Univ Nevada, Sch Med, Dept Pediat, Las Vegas, NV 89102 USA; [De Carvalho, Daniel] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Weksberg, Rosanna] Hosp Sick Children, Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Weksberg, Rosanna] Univ Toronto, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Osborne, Lucy R.] Univ Toronto, Dept Med, Toronto, ON M5G 2C4, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Louisville; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Osborne, LR (corresponding author), Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	lucy.osborne@utoronto.ca	De Carvalho, Daniel D/J-5503-2014; De Carvalho, Daniel/J-5503-2014	De Carvalho, Daniel D/0000-0002-8572-5259; De Carvalho, Daniel/0000-0003-0771-2265	Autism Speaks Weatherstone Predoctoral Fellowship [9093]; Canadian Institutes for Health Research [MOP77720]; Simons Foundation Autism Research Initiative [238896]; National Institute of Neurological Disorders and Stroke [R01 NS35102]; National Institute of Child Health and Development [R37 HD29957]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD029957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035102] Funding Source: NIH RePORTER	Autism Speaks Weatherstone Predoctoral Fellowship; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Simons Foundation Autism Research Initiative; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Elaine Tam for technical assistance with collecting blood samples, Youliang Lou for performing the pyrosequencing assays, and The Centre for Applied Genomics for providing DNA samples from typically developing children. E.S. was supported by an Autism Speaks Weatherstone Predoctoral Fellowship (9093). This work was funded by grants from the Canadian Institutes for Health Research (MOP77720) to L.R.O., from the Simons Foundation Autism Research Initiative (238896) to C.B.M and L.R.O., and from the National Institute of Neurological Disorders and Stroke (R01 NS35102) and the National Institute of Child Health and Development (R37 HD29957) to C.B.M.	Abreu AP, 2013, NEW ENGL J MED, V368, P2467, DOI 10.1056/NEJMoa1302160; Adalsteinsson BT, 2014, GENES-BASEL, V5, P635, DOI 10.3390/genes5030635; Adamo A, 2015, NAT GENET, V47, P132, DOI 10.1038/ng.3169; Anitha A, 2013, J PSYCHIATR NEUROSCI, V38, P192, DOI 10.1503/jpn.120058; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Asada K, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00247; Bacon C, 2012, HUM GENET, V131, P1687, DOI 10.1007/s00439-012-1193-z; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berg JS, 2007, GENET MED, V9, P427, DOI 10.1097/GIM.0b013e3180986192; Bonnefont J, 2008, AM J HUM GENET, V83, P208, DOI 10.1016/j.ajhg.2008.07.007; Buckley M., 2014, DNRCATE ILLUMINA 450; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Campbell DB, 2008, SCHIZOPHR RES, V101, P67, DOI 10.1016/j.schres.2008.01.006; Cook EH, 1997, AM J HUM GENET, V60, P928; Coskun V, 2012, CURR OPIN NEUROBIOL, V22, P762, DOI 10.1016/j.conb.2012.07.001; Crusselle-Davis VJ, 2007, FEBS J, V274, P6065, DOI 10.1111/j.1742-4658.2007.06128.x; Culver-Cochran AE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-740; Dallosso AR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000745; Devlin B, 2012, CURR OPIN GENET DEV, V22, P229, DOI 10.1016/j.gde.2012.03.002; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; Gapp K, 2014, NEUROSCIENCE, V264, P99, DOI 10.1016/j.neuroscience.2012.11.040; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; Golan-Mashiach M, 2012, NUCLEIC ACIDS RES, V40, P3378, DOI 10.1093/nar/gkr1260; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Guenat D, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0082-4; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; Hannula-Jouppi K, 2014, EPIGENETICS-US, V9, P351, DOI 10.4161/epi.27160; Hogart A, 2007, HUM MOL GENET, V16, P691, DOI 10.1093/hmg/ddm014; Jager D, 2001, CANCER RES, V61, P2055; Jangani M, 2014, J BIOL CHEM, V289, P8931, DOI 10.1074/jbc.M113.540906; Kaneko R, 2006, J BIOL CHEM, V281, P30551, DOI 10.1074/jbc.M605677200; Klein-Tasman BP, 2007, CHILD NEUROPSYCHOL, V13, P444, DOI 10.1080/09297040601033680; Klein-Tasman BP, 2009, J DEV BEHAV PEDIATR, V30, P289, DOI 10.1097/DBP.0b013e3181ad1f9a; Krefft M, 2014, EPIGENOMICS-UK, V6, P677, DOI [10.2217/EPI.14.52, 10.2217/epi.14.52]; Ladd-Acosta C, 2014, MOL PSYCHIATR, V19, P862, DOI 10.1038/mp.2013.114; Lazebnik MB, 2008, J BIOL CHEM, V283, P11078, DOI 10.1074/jbc.C800049200; Leyfer O, 2009, J NEURODEV DISORD, V1, P4, DOI 10.1007/s11689-009-9003-1; Lincoln AJ, 2007, J AM ACAD CHILD PSY, V46, P323, DOI 10.1097/chi.0b013e31802b9522; Makeyev AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044443; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; McLeay RC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-165; Mervis CB, 2015, AM J MED GENET A, V167, P1436, DOI 10.1002/ajmg.a.37071; Mervis Carolyn B, 2011, Perspect Lang Learn Educ, V18, P98; Middeljans E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033834; Monahan K, 2012, P NATL ACAD SCI USA, V109, P9125, DOI 10.1073/pnas.1205074109; Morris C. A., 2013, GENEREVIEWS R; Mulle JG, 2014, BIOL PSYCHIAT, V75, P371, DOI 10.1016/j.biopsych.2013.05.040; Numata S, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00280; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Otowa T, 2011, AM J MED GENET B, V156B, P430, DOI 10.1002/ajmg.b.31178; Pacaud R, 2014, BIOCHIMIE, V104, P36, DOI 10.1016/j.biochi.2014.05.005; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Pedrosa E, 2008, SCHIZOPHR RES, V102, P210, DOI 10.1016/j.schres.2008.04.013; Pena-Hernandez R, 2015, P NATL ACAD SCI USA, V112, pE677, DOI 10.1073/pnas.1416674112; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pidsley R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-293; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Rabinovitz S, 2012, P NATL ACAD SCI USA, V109, P7403, DOI 10.1073/pnas.1116661109; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Schosserer M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7158; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwarting GA, 2004, EUR J NEUROSCI, V19, P11, DOI 10.1111/j.1460-9568.2004.03094.x; Schwartz JJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5370; Segura-Puimedon M, 2014, HUM MOL GENET, V23, P6481, DOI 10.1093/hmg/ddu368; Sheikh MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055826; Shimojima K, 2011, AM J MED GENET A, V155A, P732, DOI 10.1002/ajmg.a.33891; Smoller JW, 2008, ARCH GEN PSYCHIAT, V65, P298, DOI 10.1001/archgenpsychiatry.2007.48; Smyth G. K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027/MACHINEREADABLECITATION/RIS]; Somerville MJ, 2005, NEW ENGL J MED, V353, P1694, DOI 10.1056/NEJMoa051962; Strathdee G, 2006, LEUKEMIA, V20, P1326, DOI 10.1038/sj.leu.2404254; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Thu CA, 2014, CELL, V158, P1045, DOI 10.1016/j.cell.2014.07.012; Tordjman S, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-29; Tordjman S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030778; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Toyoda S, 2014, NEURON, V82, P94, DOI 10.1016/j.neuron.2014.02.005; Tsang Sharon, 2010, Front Biosci (Schol Ed), V2, P547; Tussie-Luna MI, 2002, P NATL ACAD SCI USA, V99, P12807, DOI 10.1073/pnas.192464499; Van der Aa N, 2009, EUR J MED GENET, V52, P94, DOI 10.1016/j.ejmg.2009.02.006; Veyrac A, 2014, PROG MOL BIOL TRANSL, V122, P89, DOI 10.1016/B978-0-12-420170-5.00004-0; Wang D, 2012, BIOINFORMATICS, V28, P729, DOI 10.1093/bioinformatics/bts013	82	50	51	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 6	2015	97	2					216	227		10.1016/j.ajhg.2015.05.019	http://dx.doi.org/10.1016/j.ajhg.2015.05.019			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CO7GY	26166478	Green Published, Bronze			2022-12-18	WOS:000359328800002
J	Mlynarski, EE; Sheridan, MB; Xie, M; Guo, TW; Racedo, SE; McDonald-McGinn, DM; Gai, XW; Chow, EWC; Vorstman, J; Swillen, A; Devriendt, K; Breckpot, J; Digilio, MC; Marino, B; Dallapiccola, B; Philip, N; Simon, TJ; Roberts, AE; Piotrowicz, M; Bearden, CE; Eliez, S; Gothelf, D; Coleman, K; Kates, WR; Devoto, M; Zackai, E; Heine-Suner, D; Shaikh, TH; Bassett, AS; Goldmuntz, E; Morrow, BE; Emanuel, BS				Mlynarski, Elisabeth E.; Sheridan, Molly B.; Xie, Michael; Guo, Tingwei; Racedo, Silvia E.; McDonald-McGinn, Donna M.; Gai, Xiaowu; Chow, Eva W. C.; Vorstman, Jacob; Swillen, Ann; Devriendt, Koen; Breckpot, Jeroen; Digilio, Maria Cristina; Marino, Bruno; Dallapiccola, Bruno; Philip, Nicole; Simon, Tony J.; Roberts, Amy E.; Piotrowicz, Malgorzata; Bearden, Carrie E.; Eliez, Stephan; Gothelf, Doron; Coleman, Karlene; Kates, Wendy R.; Devoto, Marcella; Zackai, Elaine; Heine-Suner, Damian; Shaikh, Tamim H.; Bassett, Anne S.; Goldmuntz, Elizabeth; Morrow, Bernice E.; Emanuel, Beverly S.		Int Chromosome 22q11 2 Consortium	Copy-Number Variation of the Glucose Transporter Gene SLC2A3 and Congenital Heart Defects in the 22q11.2 Deletion Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTRAUTERINE GROWTH RESTRICTION; CARDIOVASCULAR-DISEASE; SCIENTIFIC STATEMENT; STRUCTURAL VARIATION; DEVELOPMENTAL DELAY; CHROMOSOME 22Q11.2; CURRENT KNOWLEDGE; CARDIAC DEFECTS; 3 GLUT3; GENOME	The 22q11.2 deletion syndrome (22q11DS; velocardiofacial/DiGeorge syndrome; VCFS/DGS) is the most common microdeletion syndrome and the phenotypic presentation is highly variable. Approximately 65% of individuals with 22q11DS have a congenital heart defect (CHD), mostly of the conotruncal type, and/or an aortic arch defect. The etiology of this phenotypic variability is not currently known. We hypothesized that copy-number variants (CNVs) outside the 22q11.2 deleted region might increase the risk of being born with a CHD in this sensitized population. Genotyping with Affymetrix SNP Array 6.0 was performed on two groups of subjects with 22q11DS separated by time of ascertainment and processing. CNV analysis was completed on a total of 949 subjects (cohort 1, n = 562; cohort 2, n = 387), 603 with CHDs (cohort 1, n = 363; cohort 2, n = 240) and 346 with normal cardiac anatomy (cohort 1, n = 199; cohort 2, n = 147). Our analysis revealed that a duplication of SLC2A3 was the most frequent CNV identified in the first cohort. It was present in 18 subjects with CHDs and 1 subject without (p = 3.12 x 10(-3), two-tailed Fisher's exact test). In the second cohort, the SLC2A3 duplication was also significantly enriched in subjects with CHDs (p = 3.30 x 10(-2), two-tailed Fisher's exact test). The SLC2A3 duplication was the most frequent CNV detected and the only significant finding in our combined analysis (p = 2.68 x 10(-4), two-tailed Fisher's exact test), indicating that the SLC2A3 duplication might serve as a genetic modifier of CHDs and/or aortic arch anomalies in individuals with 22q11DS.	[Mlynarski, Elisabeth E.; Sheridan, Molly B.; McDonald-McGinn, Donna M.; Devoto, Marcella; Zackai, Elaine; Emanuel, Beverly S.] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Xie, Michael] Childrens Hosp Philadelphia, Ctr Biomed Informat, Philadelphia, PA 19104 USA; [Guo, Tingwei; Racedo, Silvia E.; Morrow, Bernice E.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [McDonald-McGinn, Donna M.; Devoto, Marcella; Zackai, Elaine; Goldmuntz, Elizabeth; Emanuel, Beverly S.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Gai, Xiaowu] Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Ocular Genom Inst, Boston, MA 02114 USA; [Gai, Xiaowu] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Chow, Eva W. C.; Bassett, Anne S.] Univ Toronto, Clin Genet Res Program, Ctr Addict & Mental Hlth, Toronto, ON M5T 1R8, Canada; [Chow, Eva W. C.; Bassett, Anne S.] Univ Toronto, Dept Psychiat, Toronto, ON M5T 1R8, Canada; [Vorstman, Jacob] Univ Med Ctr Utrecht, Dept Psychiat, Brain Ctr Rudolf Magnus, NL-3584 Utrecht, Netherlands; [Swillen, Ann; Devriendt, Koen; Breckpot, Jeroen] Univ Leuven, Ctr Human Genet, B-3000 Leuven, Belgium; [Digilio, Maria Cristina; Dallapiccola, Bruno] Bambino Gesu Pediat Hosp, Med Genet, I-00165 Rome, Italy; [Marino, Bruno] Univ Roma La Sapienza, Lorillard Spencer Cenci Fdn, I-00165 Rome, Italy; [Marino, Bruno] Univ Roma La Sapienza, Dept Pediat, I-00165 Rome, Italy; [Philip, Nicole] AP HM, Dept Med Genet, F-13005 Marseille, France; [Philip, Nicole] Univ Aix Marseille 2, Timone Childrens Hosp, F-13005 Marseille, France; [Simon, Tony J.] Univ Calif Davis, MIND Inst, Sacramento, CA 95817 USA; [Simon, Tony J.] Univ Calif Davis, Dept Psychiat & Behav Sci, Sacramento, CA 95817 USA; [Roberts, Amy E.] Boston Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Roberts, Amy E.] Boston Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Piotrowicz, Malgorzata] Polish Mothers Mem Hosp, Res Inst, Dept Genet, PL-93338 Lodz, Poland; [Bearden, Carrie E.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Eliez, Stephan] Univ Geneva, Sch Med, Dept Psychiat, Off Medicopedag Res Unit, CH-1211 Geneva 8, Switzerland; [Gothelf, Doron] Edmond & Lily Safra Childrens Hosp, Sheba Med Ctr, Tel Hashomer, Israel; [Gothelf, Doron] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Coleman, Karlene] Childrens Healthcare Atlanta, Atlanta, GA 30322 USA; [Coleman, Karlene] Emory Univ, Sch Nursing, Atlanta, GA 30322 USA; [Kates, Wendy R.] SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY 13210 USA; [Kates, Wendy R.] SUNY Upstate Med Univ, Program Neurosci, Syracuse, NY 13210 USA; [Devoto, Marcella] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Devoto, Marcella] Univ Roma La Sapienza, Dept Mol Med, I-00185 Rome, Italy; [Heine-Suner, Damian] Hosp Univ Son Espases, Dept Genet, Palma De Mallorca 07020, Spain; [Shaikh, Tamim H.] Univ Colorado, Dept Pediat, Denver, CO 80202 USA; [Goldmuntz, Elizabeth] Childrens Hosp Philadelphia, Div Cardiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Yeshiva University; Albert Einstein College of Medicine; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; Utrecht University; Utrecht University Medical Center; KU Leuven; IRCCS Bambino Gesu; Sapienza University Rome; Sapienza University Rome; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of California System; University of California Davis; University of California System; University of California Davis; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Polish Mother's Memorial Hospital - Research Institute; University of California System; University of California Los Angeles; University of Geneva; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Children's Healthcare of Atlanta (CHOA); Emory University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Pennsylvania; Pennsylvania Medicine; Sapienza University Rome; Hospital Universitari Son Espases; University of Colorado System; University of Colorado Denver; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Emanuel, BS (corresponding author), Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA.	beverly@mail.med.upenn.edu	Devoto, Marcella/AAP-7595-2021; Suñer, Damian Heine/AAW-9664-2020; Philip, Nicole/I-2881-2016; Heine-Suñer, Damian/J-8045-2012; McDonald-McGinn, Donna/L-8643-2019; Digilio, Maria Cristina/AAI-2434-2019; Dallapiccola, Bruno/K-8692-2016	Suñer, Damian Heine/0000-0001-9374-1219; Heine-Suñer, Damian/0000-0001-9374-1219; Swillen, Ann/0000-0003-4258-4537; gai, Xiaowu/0000-0001-8679-9703; Bearden, Carrie/0000-0002-8516-923X; McDonald-McGinn, Donna/0000-0003-4077-250X; Morrow, Bernice/0000-0002-8076-4726; DEVOTO, MARCELLA/0000-0002-4431-5114; Dallapiccola, Bruno/0000-0002-5031-1013	NIH [MH87636, HL84410, HD070454, HD026979]; NIH/NCATS (National Center for Advancing Translational Sciences) [UL1TR000003]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042974, P30HD026979, P01HD070454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000003, UL1TR001073] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH087636, U01MH101723] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCATS (National Center for Advancing Translational Sciences); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Thanks to Colleen Franconi, Meghan McNamara, April Hacker, Tracy Busse, Mark Bowser, Anne Marie Higgins, Chad Haldeman-Englert, Petra Warner, Jenna Walck, and Danica Kuncio for technical assistance. Special thanks go to the subjects and their families for their willing participation. We also thank the Molecular Cytogenetics and Genomics Cores at Einstein for preparing DNA and genotyping with Affymetrix 6.0 arrays. This work was funded by NIH (MH87636, HL84410, HD070454, and HD026979) and in part by NIH/NCATS (National Center for Advancing Translational Sciences), Grant UL1TR000003.	Abel ED, 2004, FRONT BIOSCI-LANDMRK, V9, P201, DOI 10.2741/1216; Agopian AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096057; Burn J, 1996, CURR OPIN GENET DEV, V6, P322, DOI 10.1016/S0959-437X(96)80009-8; Carayannopoulos MO, 2014, MOL GENET METAB, V111, P477, DOI 10.1016/j.ymgme.2014.01.013; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; Emanuel BS, 2008, DEV DISABIL RES REV, V14, P11, DOI 10.1002/ddrr.3; Erdogan F, 2008, J MED GENET, V45, P704, DOI 10.1136/jmg.2008.058776; Fowden AL, 2008, J NEUROENDOCRINOL, V20, P439, DOI 10.1111/j.1365-2826.2008.01663.x; Gai X, 2012, MOL PSYCHIATR, V17, P402, DOI 10.1038/mp.2011.10; Gai XW, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-74; Ganguly A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1241, DOI 10.1152/ajpendo.00344.2006; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Goldmuntz E, 1998, J AM COLL CARDIOL, V32, P492, DOI 10.1016/S0735-1097(98)00259-9; Goldmuntz E, 2009, BIRTH DEFECTS RES A, V85, P125, DOI 10.1002/bdra.20501; Greenway SC, 2009, NAT GENET, V41, P931, DOI 10.1038/ng.415; Grover-McKay M, 1999, BBA-BIOMEMBRANES, V1416, P145, DOI 10.1016/S0005-2736(98)00216-8; Guo TW, 2011, HUM MUTAT, V32, P1278, DOI 10.1002/humu.21568; Janzen C, 2013, PLACENTA, V34, P1072, DOI 10.1016/j.placenta.2013.08.010; Jenkins KJ, 2007, CIRCULATION, V115, P2995, DOI 10.1161/CIRCULATIONAHA.106.183216; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Kong B, 2008, CHINESE MED J-PEKING, V121, P1257, DOI 10.1097/00029330-200807020-00002; Lalani SR, 2013, EUR J HUM GENET, V21, P173, DOI 10.1038/ejhg.2012.155; Lammer EJ, 2009, BIRTH DEFECTS RES A, V85, P30, DOI 10.1002/bdra.20541; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lesage J, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740037; Lindsay EA, 2001, NATURE, V410, P97, DOI 10.1038/35065105; McDonald-McGinn DM, 2001, GENET MED, V3, P23, DOI 10.1097/00125817-200101000-00006; McDonald-McGinn DM, 1997, GENET TEST, V1, P99, DOI 10.1089/gte.1997.1.99; Merscher S, 2001, CELL, V104, P619, DOI 10.1016/S0092-8674(01)00247-1; Nowotschin S, 2006, DEVELOPMENT, V133, P1565, DOI 10.1242/dev.02309; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robin NH, 2005, J PEDIATR-US, V147, P90, DOI 10.1016/j.jpeds.2005.03.007; Rosano A, 2000, J EPIDEMIOL COMMUN H, V54, P660, DOI 10.1136/jech.54.9.660; Ryan AK, 1997, J MED GENET, V34, P798, DOI 10.1136/jmg.34.10.798; Sandrin-Garcia P, 2007, MOL CELL BIOCHEM, V303, P9, DOI 10.1007/s11010-007-9450-5; Schmidt S, 2009, J ENDOCRINOL, V200, P23, DOI 10.1677/JOE-08-0262; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; SHEPHERD PR, 1992, BIOCHEM BIOPH RES CO, V188, P149, DOI 10.1016/0006-291X(92)92362-2; Silversides CK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002843; Simpson IA, 2008, AM J PHYSIOL-ENDOC M, V295, pE242, DOI 10.1152/ajpendo.90388.2008; Soemedi R, 2012, AM J HUM GENET, V91, P489, DOI 10.1016/j.ajhg.2012.08.003; Swaby JAM, 2011, AM J CARDIOL, V107, P466, DOI 10.1016/j.amjcard.2010.09.045; Tomita-Mitchell A, 2012, PHYSIOL GENOMICS, V44, P518, DOI 10.1152/physiolgenomics.00013.2012; van der Bom T, 2011, NAT REV CARDIOL, V8, P50, DOI 10.1038/nrcardio.2010.166; Veal CD, 2014, HUM MUTAT, V35, P248, DOI 10.1002/humu.22471; Vittori A, 2014, HUM MOL GENET, V23, P3129, DOI 10.1093/hmg/ddu022; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; White PS, 2014, BIRTH DEFECTS RES A, V100, P951, DOI 10.1002/bdra.23279; Wu XH, 2002, GENOMICS, V80, P553, DOI 10.1006/geno.2002.7010; Zhu H, 2009, CLIN GENET, V75, P409, DOI 10.1111/j.1399-0004.2009.01174.x	53	50	52	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 7	2015	96	5					753	764		10.1016/j.ajhg.2015.03.007	http://dx.doi.org/10.1016/j.ajhg.2015.03.007			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CH7AZ	25892112	Green Published, Bronze			2022-12-18	WOS:000354189300006
J	Gordon, CT; Petit, F; Kroisel, PM; Jakobsen, L; Zechi-Ceide, RM; Oufadem, M; Bole-Feysot, C; Pruvost, S; Masson, C; Tores, F; Hieu, T; Nitschke, P; Lindholm, P; Pellerin, P; Guion-Almeida, ML; Kokitsu-Nakata, NM; Vendramini-Pittoli, S; Munnich, A; Lyonnet, S; Holder-Espinasse, M; Amiel, J				Gordon, Christopher T.; Petit, Florence; Kroisel, Peter M.; Jakobsen, Linda; Zechi-Ceide, Roseli Maria; Oufadem, Myriam; Bole-Feysot, Christine; Pruvost, Solenn; Masson, Cecile; Tores, Frederic; Hieu, Thierry; Nitschke, Patrick; Lindholm, Pernille; Pellerin, Philippe; Guion-Almeida, Maria Leine; Kokitsu-Nakata, Nancy Mizue; Vendramini-Pittoli, Siulan; Munnich, Arnold; Lyonnet, Stanislas; Holder-Espinasse, Muriel; Amiel, Jeanne			Mutations in Endothelin 1 Cause Recessive Auriculocondylar Syndrome and Dominant Isolated Question-Mark Ears	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HYPOHIDROTIC ECTODERMAL DYSPLASIA; PHARYNGEAL ARCH DEVELOPMENT; SYNDROME TYPE-IV; WAARDENBURG SYNDROME; PROCESSING ENDOPROTEASE; ECTODYSPLASIN-A; MICE DEFICIENT; FURIN; RECEPTOR; GENE	Auriculocondylar syndrome (ACS) is a rare craniofacial disorder with mandibular hypoplasia and question-mark ears (QMEs) as major features. QMEs, consisting of a specific defect at the lobe-helix junction, can also occur as an isolated anomaly. Studies in animal models have indicated the essential role of endothelin 1 (EDN1) signaling through the endothelin receptor type A (EDNRA) in patterning the mandibular portion of the first pharyngeal arch. Mutations in the genes coding for phospholipase C, beta 4 (PLCB4) and guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3 (GNAI3), predicted to function as signal transducers downstream of EDNRA, have recently been reported in ACS. By whole-exome sequencing (WES), we identified a homozygous substitution in a furin cleavage site of the EDN1 proprotein in ACS-affected siblings born to consanguineous parents. WES of two cases with vertical transmission of isolated QMEs revealed a stop mutation in EDN1 in one family and a missense substitution of a highly conserved residue in the mature EDN1 peptide in the other. Targeted sequencing of EDN1 in an ACS individual with related parents identified a fourth, homozygous mutation falling close to the site of cleavage by endothelin-converting enzyme. The different modes of inheritance suggest that the degree of residual EDN1 activity differs depending on the mutation. These findings provide further support for the hypothesis that ACS and QMEs are uniquely caused by disruption of the EDN1-EDNRA signaling pathway.	[Gordon, Christopher T.; Oufadem, Myriam; Munnich, Arnold; Lyonnet, Stanislas; Amiel, Jeanne] Hop Necker Enfants Malad, Inst Natl Sante & Rech Med U781, F-75015 Paris, France; [Gordon, Christopher T.; Oufadem, Myriam; Masson, Cecile; Nitschke, Patrick; Munnich, Arnold; Lyonnet, Stanislas; Amiel, Jeanne] Univ Paris Descartes Sorbonne Paris Cite, Inst Imagine, F-75015 Paris, France; [Petit, Florence] Univ Lille, Serv Genet Clin, Hop Jeanne Flandre, Ctr Hosp Reg, F-59037 Lille, France; [Kroisel, Peter M.] Med Univ Graz, Inst Human Genet, A-8010 Graz, Austria; [Jakobsen, Linda] Copenhagen Univ Hosp, Dept Plast Surg, DK-2730 Herlev, Denmark; [Zechi-Ceide, Roseli Maria; Guion-Almeida, Maria Leine; Kokitsu-Nakata, Nancy Mizue; Vendramini-Pittoli, Siulan] Univ Sao Paulo, Dept Clin Genet, Hosp Rehabil Craniofacial Anomalies, BR-17012900 Bauru, Brazil; [Bole-Feysot, Christine; Pruvost, Solenn] Inst Imagine, Plateforme Genom, F-75015 Paris, France; [Masson, Cecile; Tores, Frederic; Hieu, Thierry; Nitschke, Patrick] Inst Imagine, Plateforme Bioinformat, F-75015 Paris, France; [Lindholm, Pernille] Copenhagen Univ Hosp, Dept Plast & Reconstruct Surg, Copenhagen 2100, Denmark; [Pellerin, Philippe] Univ Lille, Ctr Reference Malformat Cranio Maxilio Faciales R, Ctr Hosp Reg, F-59037 Lille, France; [Munnich, Arnold; Lyonnet, Stanislas; Amiel, Jeanne] Hop Necker Enfants Malad, Serv Genet, F-75015 Paris, France; [Holder-Espinasse, Muriel] Guys Hosp, Dept Clin Genet, London SE1 9RT, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre Hospitalier Annecy Genevois; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Medical University of Graz; University of Copenhagen; Universidade de Sao Paulo; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Copenhagen; Centre Hospitalier Annecy Genevois; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Guy's & St Thomas' NHS Foundation Trust	Gordon, CT (corresponding author), Hop Necker Enfants Malad, Inst Natl Sante & Rech Med U781, F-75015 Paris, France.	chris.gordon@inserm.fr; jeanne.amiel@inserm.fr	Lyonnet, Stanislas/H-5483-2017; Kokitsu-Nakata, Nancy Mizue/G-3746-2013; amiel, jeanne/H-3501-2017; Gordon, Chris/F-1267-2017; amiel, jeanne/AGX-1124-2022; Zechi-Ceide, Roseli Maria/I-8178-2013	Lyonnet, Stanislas/0000-0001-5426-9417; Kokitsu-Nakata, Nancy Mizue/0000-0003-0252-5452; amiel, jeanne/0000-0001-5973-4728; Gordon, Chris/0000-0002-9300-8399; Zechi-Ceide, Roseli Maria/0000-0002-4526-3336; petit, florence/0000-0002-1368-1023	Universite Paris Descartes - Sorbonne Paris Cite Pole de Recherche et d'Enseignement Superieur grant [SPC/JFG/2013-031]; Agence Nationale de la Recherche; E-Rare CRANIRARE	Universite Paris Descartes - Sorbonne Paris Cite Pole de Recherche et d'Enseignement Superieur grant; Agence Nationale de la Recherche(French National Research Agency (ANR)); E-Rare CRANIRARE	J.A. was supported by a Universite Paris Descartes - Sorbonne Paris Cite Pole de Recherche et d'Enseignement Superieur grant (project number SPC/JFG/2013-031). S.L. was supported by funding from the Agence Nationale de la Recherche (project EvoDevoMut 2010). J.A. and S.L. were supported by funding from E-Rare CRANIRARE. We thank Mohammed Zarhrate, Melanie Parisot, and Olivier Alibeu from the Plateforme Genomique at the Institut Imagine for technical assistance.	BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; Brooks C, 1998, J MOL ENDOCRINOL, V21, P307, DOI 10.1677/jme.0.0210307; Chen YW, 2001, P NATL ACAD SCI USA, V98, P7218, DOI 10.1073/pnas.131076098; Clouthier DE, 1998, DEVELOPMENT, V125, P813; Cordero DR, 2011, AM J MED GENET A, V155A, P270, DOI 10.1002/ajmg.a.33702; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Gordon CT, 2013, J MED GENET, V50, P174, DOI 10.1136/jmedgenet-2012-101331; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Guion-Almeida ML, 2002, AM J MED GENET, V112, P209, DOI 10.1002/ajmg.10631; HATSUZAWA K, 1992, J BIOL CHEM, V267, P16094; Kapoor S, 2012, MOL VIS, V18, P2022; Kido Y, 2013, AM J MED GENET A, V161, P2339, DOI 10.1002/ajmg.a.36066; Krysan DJ, 1999, J BIOL CHEM, V274, P23229, DOI 10.1074/jbc.274.33.23229; KURIHARA Y, 1994, NATURE, V368, P703, DOI 10.1038/368703a0; KURIHARA Y, 1995, J CLIN INVEST, V96, P293, DOI 10.1172/JCI118033; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Matera I, 2007, PIGM CELL RES, V20, P210, DOI 10.1111/j.1600-0749.2007.00371.x; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miller CT, 2000, DEVELOPMENT, V127, P3815; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Ozeki H, 2004, MECH DEVELOP, V121, P387, DOI 10.1016/j.mod.2004.02.002; Passos-Bueno MR, 2009, AM J MED GENET A, V149A, P1853, DOI 10.1002/ajmg.a.32950; Pingault V, 2002, HUM GENET, V111, P198, DOI 10.1007/s00439-002-0765-8; Pingault V, 2001, J MED GENET, V38, P205, DOI 10.1136/jmg.38.3.205; Pingault V, 2010, HUM MUTAT, V31, P391, DOI 10.1002/humu.21211; Rieder MJ, 2012, AM J HUM GENET, V90, P907, DOI 10.1016/j.ajhg.2012.04.002; Ruest LB, 2004, DEVELOPMENT, V131, P4413, DOI 10.1242/dev.01291; Sato T, 2008, DEVELOPMENT, V135, P755, DOI 10.1242/dev.012708; Sato T, 2008, P NATL ACAD SCI USA, V105, P18806, DOI 10.1073/pnas.0807345105; Schneider P, 2001, J BIOL CHEM, V276, P18819, DOI 10.1074/jbc.M101280200; Shamseldin HE, 2010, AM J MED GENET A, V152A, P1841, DOI 10.1002/ajmg.a.33123; Svensson PJ, 1999, PEDIATR RES, V45, P714, DOI 10.1203/00006450-199905010-00018; TAM JP, 1994, PEPTIDES, V15, P703, DOI 10.1016/0196-9781(94)90099-X; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Vieux-Rochas M, 2010, GENESIS, V48, P362, DOI 10.1002/dvg.20625; Vinuela A, 2009, AM J MED GENET A, V149A, P2296, DOI 10.1002/ajmg.a.33026; WALKER JA, 1994, J VIROL, V68, P1213, DOI 10.1128/JVI.68.2.1213-1218.1994; Walker MB, 2007, DEV BIOL, V304, P194, DOI 10.1016/j.ydbio.2006.12.027; Yanagisawa H, 1998, DEVELOPMENT, V125, P825; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	42	50	53	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 5	2013	93	6					1118	1125		10.1016/j.ajhg.2013.10.023	http://dx.doi.org/10.1016/j.ajhg.2013.10.023			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	273FS	24268655	Green Published, Bronze			2022-12-18	WOS:000328521300011
J	Mercier, S; Kury, S; Shaboodien, G; Houniet, DT; Khumalo, NP; Bou-Hanna, C; Bodak, N; Cormier-Daire, V; David, A; Faivre, L; Figarella-Branger, D; Gherardi, RK; Glen, E; Hamel, A; Laboisse, C; Le Caignec, C; Lindenbaum, P; Magot, A; Munnich, A; Mussini, JM; Pillay, K; Rahman, T; Redon, R; Salort-Campana, E; Santibanez-Koref, M; Thauvin, C; Barbarot, S; Keavney, B; Bezieau, S; Mayosi, BM				Mercier, Sandra; Kuery, Sebastien; Shaboodien, Gasnat; Houniet, Darren T.; Khumalo, Nonhlanhla P.; Bou-Hanna, Chantal; Bodak, Nathalie; Cormier-Daire, Valerie; David, Albert; Faivre, Laurence; Figarella-Branger, Dominique; Gherardi, Romain K.; Glen, Elise; Hamel, Antoine; Laboisse, Christian; Le Caignec, Cedric; Lindenbaum, Pierre; Magot, Armelle; Munnich, Arnold; Mussini, Jean-Marie; Pillay, Komala; Rahman, Thahira; Redon, Richard; Salort-Campana, Emmanuelle; Santibanez-Koref, Mauro; Thauvin, Christel; Barbarot, Sebastien; Keavney, Bernard; Bezieau, Stephane; Mayosi, Bongani M.			Mutations in FAM111B Cause Hereditary Fibrosing Poikiloderma with Tendon Contracture, Myopathy, and Pulmonary Fibrosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SCLEROSING POIKILODERMA; IDENTIFICATION; NEUTROPENIA; DISORDER	Congenital poikiloderma is characterized by a combination of mottled pigmentation, telangiectasia, and epidermal atrophy in the first few months of life. We have previously described a South African European-descent family affected by a rare autosomal-dominant form of hereditary fibrosing poikiloderma accompanied by tendon contracture, myopathy, and pulmonary fibrosis. Here, we report the identification of causative mutations in FAM111B by whole-exome sequencing. In total, three FAM111B missense mutations were identified in five kindreds of different ethnic backgrounds. The mutation segregated with the disease in one large pedigree, and mutations were de novo in two other pedigrees. All three mutations were absent from public databases and were not observed on Sanger sequencing of 388 ethnically matched control subjects. The three single-nucleotide mutations code for amino acid changes that are clustered within a putative trypsin-like cysteine/serine peptidase domain of FAM111B. These findings provide evidence of the involvement of FAM111B in congenital poikiloderma and multisystem fibrosis.	[Mercier, Sandra; David, Albert] Univ Nantes, Unite Genet Clin, Serv Genet Med, Ctr Reference Anomalies Dev Syndromes Malformatif, F-44093 Nantes, France; [Mercier, Sandra] Univ Nantes, Inst Natl Sante Res Med, UMR 1089, Atlantic Gene Therapy Inst, F-44007 Nantes, France; [Kuery, Sebastien; Le Caignec, Cedric; Bezieau, Stephane] Ctr Hosp Univ Nantes, SErv Genet Med, 9 Quai Moncousu, F-44093 Nantes, France; [Shaboodien, Gasnat; Mayosi, Bongani M.] Groote Schuur Hosp, Cardiovascular Genet Lab, Hatter Inst Cardiovascular Res Africa, Dept Med, ZA-7925 Cape Town, South Africa; [Shaboodien, Gasnat; Mayosi, Bongani M.] Univ Cape Town, Dept Med, Cardiovascular Genet Lab, Hatter Inst Cardiovascular Res Africa, ZA-7925 Cape Town, South Africa; [Houniet, Darren T.; Glen, Elise; Rahman, Thahira; Santibanez-Koref, Mauro; Keavney, Bernard] Newcastle Univ, Inst Med Genet, Fac Med Sci, Newcastle Upon Tyne NE3 4DS, Tyne & Wear, England; [Khumalo, Nonhlanhla P.] Groote Schuur Hosp, Div Dermatol, Dept Med, ZA-7925 Cape Town, South Africa; [Khumalo, Nonhlanhla P.] Univ Cape Town, Dept Med, Div Dermatol, ZA-7925 Cape Town, South Africa; [Bou-Hanna, Chantal; Laboisse, Christian; Bezieau, Stephane] Univ Nantes, Equipe Accuel Biometadys 4273, Fac Med, F-44035 Nantes, France; [Bodak, Nathalie] Hop Necker Enfants Malad, Serv Dermatol, Assistance Publ Hopitaux Paris, F-75015 Paris, France; [Cormier-Daire, Valerie; Munnich, Arnold] Univ Paris 04, Inst Nat Sante Rech Med U781,Assistance Publ Hop, Serv Genet, Fdn Imagine,Hop Necker Enfants Malades, F-75015 Paris, France; [Faivre, Laurence; Thauvin, Christel] Univ Bourgogne, Equipe Accueil Genet Anomalies Dev 4271, Inst Federatif Rech Sante Sci Techn Informat Comm, F-21078 Dijon, France; [Faivre, Laurence] Ctr Hosp Univ, Ctr Reference Anomalies Dev & Syndromes Malformat, F-21079 Dijon, France; [Faivre, Laurence] Ctr Hosp Univ, Ctr Reference Anomalies Dev & Syndromes Malformat, Ctr Genet Hop Enfants, F-21079 Dijon, France; [Figarella-Branger, Dominique] Hop Enfants La Timone, Serv Anatomorpatholog & Neuropathol, F-13000 Marseille, France; [Gherardi, Romain K.] Hop Henri Mondor, Serv Anatomopathol, F-94010 Creteil, France; [Hamel, Antoine] Ctr Hosp Univ Nantes, Serv Chirurg Infantile, F-44093 Nantes 1, France; [Laboisse, Christian] Ctr Hosp Univ Nantes, Lab Anatomopathol A, F-44093 Nantes, France; [Lindenbaum, Pierre; Redon, Richard] Univ Nantes, Inst Natl Sante Rech Med UMR 1087, Ctr Natl Rech Sci UMR 6291, F-44007 Nantes, France; [Lindenbaum, Pierre; Redon, Richard] Ctr Hosp Univ Nantes, Inst Thorax, F-44007 Nantes, France; [Magot, Armelle] Univ Nantes, Serv Explorat Fonctionneles, Ctr Reference Maladies Neuromusculaires, Ctr Hosp, F-44093 Nantes, France; [Pillay, Komala] Natl Hlth Lab Serv, Div Anat Pathol, Dept Clin Lab Sci, ZA-7925 Cape Town, South Africa; [Pillay, Komala] Univ Cape Town, Div Anat Pathol, Dept Clin Lab Sci, ZA-7925 Cape Town, South Africa; [Salort-Campana, Emmanuelle] Hop Enfants La Timone, Serv neurol, Ctr Reference maladies neuromuscularies Sclerose, F-13000 Marseille, France; [Barbarot, Sebastien] Univ Nantes, Dermatol Clin, Hotel Dieu, Ctr Hosp, F-44000 Nantes, France; [Keavney, Bernard] Univ Manchester, Inst Cardiovascular Sci, Core Technol Fac, Manchester M13 9NT, England	Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; University of Cape Town; University of Cape Town; Newcastle University - UK; University of Cape Town; University of Cape Town; Nantes Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut Agro; AgroSup Dijon; Universite de Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; University of Cape Town; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Nantes Universite; CHU de Nantes; University of Manchester	Bezieau, S (corresponding author), Ctr Hosp Univ Nantes, SErv Genet Med, 9 Quai Moncousu, F-44093 Nantes, France.	stephane.bezieau@chu-nantes.fr; bongani.mayosi@uct.ac.za	Mercier, Sandra/E-8922-2018; Lindenbaum, Pierre/A-7154-2008; Le Caignec, Cedric/K-8467-2015; KÜRY, Sébastien/G-5971-2015; pillay, komala/AAB-1964-2019; Bézieau, stéphane/G-5621-2015; Hamel, Antoine/ABA-6745-2021; Redon, Richard/F-3303-2014; Hamel, Antoine/AAH-7437-2020; Khumalo, Nonhlanhla/AAA-8068-2020; cormier-daire, valerie/H-6520-2017	Lindenbaum, Pierre/0000-0003-0148-9787; Le Caignec, Cedric/0000-0002-0598-653X; KÜRY, Sébastien/0000-0001-5497-0465; pillay, komala/0000-0003-1971-900X; Bézieau, stéphane/0000-0003-0095-1319; Hamel, Antoine/0000-0003-3348-9060; Redon, Richard/0000-0001-7751-2280; Khumalo, Nonhlanhla/0000-0002-1686-1900; Barbarot, Sebastien/0000-0002-6629-9100; cormier-daire, valerie/0000-0002-2839-9856; Mayosi, Bongani/0000-0001-6641-8950; Faivre, Laurence/0000-0001-9770-444X; Keavney, Bernard/0000-0001-9573-0812	South African Medical Research Council; National Research Foundation of South Africa; Lily and Ernst Hausmann Research Trust; British Heart Foundation Personal Chair; British Heart Foundation [RG/08/012/25941] Funding Source: researchfish	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation of South Africa(National Research Foundation - South Africa); Lily and Ernst Hausmann Research Trust; British Heart Foundation Personal Chair; British Heart Foundation(British Heart Foundation)	We thank the families who participated in this study. B.M.M. is funded in part through grants from the South African Medical Research Council, the National Research Foundation of South Africa, and the Lily and Ernst Hausmann Research Trust. B.K. is funded by a British Heart Foundation Personal Chair. We are very grateful to all the French collaborators who also contributed to this work: Claire Beneteau, Marc Tardieu, Isabelle Desguerre, Julie Perrier, Jean-Yves Mahe, Emmanuelle Fleurence, Jean-Benoit Courcet, Jerome Franques, France Leturcq, Sylvie Fraitag, Olivier Pichon, Jocelyne Havard, Laetitia de Peufeilhoux, Catherine Bodemer, and Solange Duriez, as well as Flora Breheret, Mane Troudet, and Celine Chewier. We thank Nasr-eddine Benchick, who provided us with control DNAs from Algeria. We acknowledge the bioinformatics core facility of Nantes (BiRD, Biogenouest) and Oxford Gene Technology for their expert service.	Arnold AW, 2010, BRIT J DERMATOL, V163, P866, DOI 10.1111/j.1365-2133.2010.09929.x; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001; Hilcenko C, 2013, BLOOD, V121, P1028, DOI 10.1182/blood-2012-10-461491; Khumalo NP, 2006, BRIT J DERMATOL, V155, P1057, DOI 10.1111/j.1365-2133.2006.07473.x; KINDLER T, 1954, BRIT J DERMATOL, V66, P104, DOI 10.1111/j.1365-2133.1954.tb12598.x; Larizza L, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-2; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meier M, 2012, RHEUMATOLOGY, V51, P2109, DOI 10.1093/rheumatology/kes143; Piard J, 2012, EUR J MED GENET, V55, P8, DOI 10.1016/j.ejmg.2011.07.004; Povlsen LK, 2012, NAT CELL BIOL, V14, P1089, DOI 10.1038/ncb2579; Salvat CG, 1999, BRIT J DERMATOL, V140, P366; Simpson MA, 2011, NAT GENET, V43, P303, DOI 10.1038/ng.779; Unger S., 2013, AM J HUM GENET; Usenovic M, 2012, HUM MOL GENET, V21, P3785, DOI 10.1093/hmg/dds206; Wang LL, 2001, AM J MED GENET, V102, P11, DOI 10.1002/1096-8628(20010722)102:1<11::AID-AJMG1413>3.0.CO;2-A; WEARY PE, 1969, ARCH DERMATOL, V100, P413, DOI 10.1001/archderm.100.4.413	18	50	52	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 5	2013	93	6					1100	1107		10.1016/j.ajhg.2013.10.013	http://dx.doi.org/10.1016/j.ajhg.2013.10.013			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	273FS	24268661	Green Published, Bronze			2022-12-18	WOS:000328521300009
J	Davidson, AE; Schwarz, N; Zelinger, L; Stern-Schneider, G; Shoemark, A; Spitzbarth, B; Gross, M; Laxer, U; Sosna, J; Sergouniotis, PI; Waseem, NH; Wilson, R; Kahn, RA; Plagnol, V; Wolfrum, U; Banin, E; Hardcastle, AJ; Cheetham, ME; Sharon, D; Webster, AR				Davidson, Alice E.; Schwarz, Nele; Zelinger, Lina; Stern-Schneider, Gabriele; Shoemark, Amelia; Spitzbarth, Benjamin; Gross, Menachem; Laxer, Uri; Sosna, Jacob; Sergouniotis, Panagiotis I.; Waseem, Naushin H.; Wilson, Robert; Kahn, Richard A.; Plagnol, Vincent; Wolfrum, Uwe; Banin, Eyal; Hardcastle, Alison J.; Cheetham, Michael E.; Sharon, Dror; Webster, Andrew R.			Mutations in ARL2BP, Encoding ADP-Ribosylation-Factor-Like 2 Binding Protein, Cause Autosomal-Recessive Retinitis Pigmentosa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CILIARY; TRANSPORT; GENE; RP2; COMPLEX; GTPASE; ARL3; INTERACTS; MEMBRANE; ARL2-GTP	Retinitis pigmentosa (RP) is a genetically heterogeneous retinal degeneration characterized by photoreceptor death, which results in visual failure. Here, we used a combination of homozygosity mapping and exome sequencing to identify mutations in ARL2BP, which encodes an effector protein of the small GTPases ARL2 and ARL3, as causative for autosomal-recessive RP (RP66). In a family affected by RP and situs inversus, a homozygous, splice-acceptor mutation, c.101-1G>C, which alters pre-mRNA splicing of ARLBP2 in blood RNA, was identified. In another family, a homozygous c.134T>G (p.Met45Arg) mutation was identified. In the mouse retina, ARL2BP localized to the basal body and cilium-associated centriole of photoreceptors and the periciliary extension of the inner segment. Depletion of ARL2BP caused cilia shortening. Moreover, depletion of ARL2, but not ARL3, caused displacement of ARL2BP from the basal body, suggesting that ARL2 is vital for recruiting or anchoring ARL2BP at the base of the cilium. This hypothesis is supported by the finding that the p.Met45Arg amino acid substitution reduced binding to ARL2 and caused the loss of ARL2BP localization at the basal body in ciliated nasal epithelial cells. These data demonstrate a role for ARL2BP and ARL2 in primary cilia function and that this role is essential for normal photoreceptor maintenance and function.	[Davidson, Alice E.; Schwarz, Nele; Sergouniotis, Panagiotis I.; Hardcastle, Alison J.; Cheetham, Michael E.; Webster, Andrew R.] UCL Inst Ophthalmol, London EC1V 9EL, England; [Zelinger, Lina; Banin, Eyal; Sharon, Dror] Hadassah Hebrew Univ, Med Ctr, Dept Ophthalmol, IL-91120 Jerusalem, Israel; [Stern-Schneider, Gabriele; Spitzbarth, Benjamin; Wolfrum, Uwe] Johannes Gutenberg Univ Mainz, Inst Zool, D-55099 Mainz, Germany; [Shoemark, Amelia] Royal Brompton & Harefield NHS Fdn Trust, Dept Pediat Resp Med, London SW3 6NP, England; [Gross, Menachem] Hadassah Hebrew Univ, Med Ctr, Dept Otolaryngol Head & Neck Surg, IL-91120 Jerusalem, Israel; [Laxer, Uri] Hadassah Hebrew Univ, Med Ctr, Dept Pulmonol, IL-91120 Jerusalem, Israel; [Sosna, Jacob] Hadassah Hebrew Univ, Med Ctr, Dept Radiol, IL-91120 Jerusalem, Israel; [Sergouniotis, Panagiotis I.; Webster, Andrew R.] Moorfields Eye Hosp, London EC1V 2PD, England; [Wilson, Robert] Royal Brompton & Harefield NHS Fdn Trust, Dept Resp Med, London SW3 6NP, England; [Kahn, Richard A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Plagnol, Vincent] UCL Genet Inst, London WC1E 6BT, England	University of London; University College London; Hebrew University of Jerusalem; Hadassah University Medical Center; Johannes Gutenberg University of Mainz; Royal Brompton & Harefield NHS Foundation Trust; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; Royal Brompton & Harefield NHS Foundation Trust; Emory University; University of London; University College London	Cheetham, ME (corresponding author), UCL Inst Ophthalmol, London EC1V 9EL, England.	michael.cheetham@ucl.ac.uk; dror.sharon1@gmail.com	Sharon, Dror/P-4539-2015; Kahn, Richard/ABD-2666-2020; Shoemark, Amelia/I-4068-2019; Zelinger, Lina/L-3272-2019	Sharon, Dror/0000-0002-1789-5811; Kahn, Richard/0000-0002-0259-0601; Shoemark, Amelia/0000-0001-7360-6060; Hardcastle, Alison/0000-0002-0038-6770; Cheetham, Michael/0000-0001-6429-654X; Plagnol, Vincent/0000-0002-5597-9215; Zelinger, Lina/0000-0003-3028-7172	RP Fighting Blindness; Fight for Sight; Moorfields Eye Hospital Special Trustees; Moorfields Eye Charity; National Institute for Health Research (NIHR) (Moorfields Eye Hospital and Institute of Ophthalmology [London, UK]); Foundation Fighting Blindness [BR-GE-0510-0490-HUJ]; Yedidut 1 research grant; European Community [FP7/2009/241955]; FAUN Foundation (Nuremburg, Germany); UK Medical Research Council [G1001158]; NIHR Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust; Institute of Ophthalmology at University College London; National Institutes of Health [GM090158]; MRC [G1001158] Funding Source: UKRI; Medical Research Council [G1001158] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090158] Funding Source: NIH RePORTER	RP Fighting Blindness; Fight for Sight; Moorfields Eye Hospital Special Trustees; Moorfields Eye Charity; National Institute for Health Research (NIHR) (Moorfields Eye Hospital and Institute of Ophthalmology [London, UK]); Foundation Fighting Blindness(European Commission); Yedidut 1 research grant; European Community(European Commission); FAUN Foundation (Nuremburg, Germany); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust; Institute of Ophthalmology at University College London; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the cooperation and help provided by the family members in this study. We are grateful to colleagues who referred affected individuals to us at Moorfields Eye Hospital and those who contributed to the assembly of large panels of probands, particularly Bev Scott, Genevieve Wright, Sophie Devery, Michel Michaelides, Tony Moore, Eva Lenassi, Graham Holder, and Tony Robson. We acknowledge the nationally commissioned Royal Brompton Hospital Primary Ciliary Dyskinesia diagnostic service led by Claire Hogg and Steve Rothery at the Imperial College Imaging Facility (London, UK). We acknowledge Alexy Obolensky for retinal-imaging assistance. We are grateful to Nick Cowan, Karl Matter, and Jane Evans for providing antibodies or plasmids. We acknowledge the following sources of funding: RP Fighting Blindness, Fight for Sight, Moorfields Eye Hospital Special Trustees, the Moorfields Eye Charity, the National Institute for Health Research (NIHR) (Moorfields Eye Hospital and Institute of Ophthalmology [London, UK]), the Foundation Fighting Blindness (BR-GE-0510-0490-HUJ to D.S.), a Yedidut 1 research grant (to E.B.), European Community's Seventh Framework Programme FP7/2009/241955 (SYSCILIA), and the FAUN Foundation (Nuremburg, Germany) (to U.W.). V.P. is partly funded by the UK Medical Research Council (G1001158) and by the NIHR Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust and Institute of Ophthalmology at University College London. R.A.K. is supported in part by a grant from the National Institutes of Health (GM090158).	Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; Estrada-Cuzcano A, 2012, HUM MOL GENET, V21, pR111, DOI 10.1093/hmg/dds298; Evans RJ, 2010, HUM MOL GENET, V19, P1358, DOI 10.1093/hmg/ddq012; Fan YL, 2004, NAT GENET, V36, P989, DOI 10.1038/ng1414; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Hardcastle AJ, 1999, AM J HUM GENET, V64, P1210, DOI 10.1086/302325; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Ismail SA, 2012, EMBO J, V31, P4085, DOI 10.1038/emboj.2012.257; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/NCHEMBIO.686, 10.1038/nchembio.686]; Kobayashi A, 2003, FEBS LETT, V534, P26, DOI 10.1016/S0014-5793(02)03766-3; Linari M, 1999, FEBS LETT, V458, P55, DOI 10.1016/S0014-5793(99)01117-5; Maerker T, 2008, HUM MOL GENET, V17, P71, DOI 10.1093/hmg/ddm285; Marshall WF, 2008, CURR TOP DEV BIOL, V85, P1, DOI 10.1016/S0070-2153(08)00801-6; Mitchison HM, 2012, NAT GENET, V44, P381, DOI 10.1038/ng.1106; Mockel A, 2011, PROG RETIN EYE RES, V30, P258, DOI 10.1016/j.preteyeres.2011.03.001; Olbrich H, 2012, AM J HUM GENET, V91, P672, DOI 10.1016/j.ajhg.2012.08.016; Omran H, 2009, METHOD CELL BIOL, V91, P123, DOI 10.1016/S0091-679X(08)91007-4; Plagnol V, 2012, BIOINFORMATICS, V28, P2747, DOI 10.1093/bioinformatics/bts526; Reiter JF, 2012, EMBO REP, V13, P608, DOI 10.1038/embor.2012.73; Renault L, 2001, ACTA CRYSTALLOGR D, V57, P1167, DOI 10.1107/S0907444901009556; Robson AG, 2012, INVEST OPHTH VIS SCI, V53, P6187, DOI 10.1167/iovs.12-10195; RUTLAND J, 1982, J CLIN PATHOL, V35, P357, DOI 10.1136/jcp.35.3.357; Schrick JJ, 2006, AM J PATHOL, V168, P1288, DOI 10.2353/ajpath.2006.050941; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; Schwarz N, 2012, VISION RES, V75, P2, DOI 10.1016/j.visres.2012.07.016; Schwarz N, 2012, HUM MOL GENET, V21, P863, DOI 10.1093/hmg/ddr520; Schwarz N, 2012, ADV EXP MED BIOL, V723, P527, DOI 10.1007/978-1-4614-0631-0_66; Sedmak T, 2010, J CELL BIOL, V189, P171, DOI 10.1083/jcb.200911095; Sharer JD, 1999, J BIOL CHEM, V274, P27553, DOI 10.1074/jbc.274.39.27553; Veltel S, 2008, NAT STRUCT MOL BIOL, V15, P373, DOI 10.1038/nsmb.1396; Wolfrum U, 2000, CELL MOTIL CYTOSKEL, V46, P95, DOI 10.1002/1097-0169(200006)46:2<95::AID-CM2>3.0.CO;2-Q; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717; Wright KJ, 2011, GENE DEV, V25, P2347, DOI 10.1101/gad.173443.111; Zhang HB, 2011, NAT NEUROSCI, V14, P874, DOI 10.1038/nn.2835; Zhang TL, 2009, STRUCTURE, V17, P602, DOI 10.1016/j.str.2009.01.014; Zhou CJ, 2006, MOL BIOL CELL, V17, P2476, DOI 10.1091/mbc.E05-10-0929; Zito I, 2003, J MED GENET, V40, P609, DOI 10.1136/jmg.40.8.609	37	50	53	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 8	2013	93	2					321	329		10.1016/j.ajhg.2013.06.003	http://dx.doi.org/10.1016/j.ajhg.2013.06.003			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202AP	23849777	Green Published, Bronze			2022-12-18	WOS:000323186200012
J	Liu, XY; Ong, RTH; Pillai, EN; Elzein, AM; Small, KS; Clark, TG; Kwiatkowski, DP; Teo, YY				Liu, Xuanyao; Ong, Rick Twee-Hee; Pillai, Esakimuthu Nisha; Elzein, Abier M.; Small, Kerrin S.; Clark, Taane G.; Kwiatkowski, Dominic P.; Teo, Yik-Ying			Detecting and Characterizing Genomic Signatures of Positive Selection in Global Populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NATURAL-SELECTION; COALESCENT SIMULATION; HAPLOTYPE MAP; WIDE; RECOMBINATION; ASSOCIATION; VARIANTS; PROGRAM; SIGNALS; RARE	Natural selection is a significant force that shapes the architecture of the human genome and introduces diversity across global populations. The question of whether advantageous mutations have arisen in the human genome as a result of single or multiple mutation events remains unanswered except for the fact that there exist a handful of genes such as those that confer lactase persistence, affect skin pigmentation, or cause sickle cell anemia. We have developed a long-range-haplotype method for identifying genomic signatures of positive selection to complement existing methods, such as the integrated haplotype score (iHS) or cross-population extended haplotype homozygosity (XP-EHH), for locating signals across the entire allele frequency spectrum. Our method also locates the founder haplotypes that carry the advantageous variants and infers their corresponding population frequencies. This presents an opportunity to systematically interrogate the whole human genome whether a selection signal shared across different populations is the consequence of a single mutation process followed subsequently by gene flow between populations or of convergent evolution due to the occurrence of multiple independent mutation events either at the same variant or within the same gene. The application of our method to data from 14 populations across the world revealed that positive-selection events tend to cluster in populations of the same ancestry. Comparing the founder haplotypes for events that are present across different populations revealed that convergent evolution is a rare occurrence and that the majority of shared signals stem from the same evolutionary event.	[Liu, Xuanyao; Teo, Yik-Ying] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore; [Liu, Xuanyao; Ong, Rick Twee-Hee; Teo, Yik-Ying] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117597, Singapore; [Pillai, Esakimuthu Nisha; Teo, Yik-Ying] Natl Univ Singapore, Inst Life Sci, Singapore 117456, Singapore; [Elzein, Abier M.] Univ Khartoum, Inst Endem Dis, Dept Mol Biol, Khartoum 11111, Sudan; [Small, Kerrin S.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Clark, Taane G.] London Sch Hyg & Trop Med, London WC1E 7HT, England; [Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Kwiatkowski, Dominic P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Kwiatkowski, Dominic P.] Univ Oxford, MRC Ctr Genom & Global Hlth, Oxford OX3 7BN, England; [Teo, Yik-Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117546, Singapore; [Teo, Yik-Ying] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore 138672, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; University of Khartoum; University of London; King's College London; University of London; London School of Hygiene & Tropical Medicine; Wellcome Trust Sanger Institute; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Teo, YY (corresponding author), Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore.	statyy@nus.edu.sg	Liu, Xuanyao/J-8387-2014; Clark, Taane G./AAM-2570-2020	Clark, Taane G./0000-0001-8985-9265; Kwiatkowski, Dominic/0000-0002-5023-0176; Small, Kerrin/0000-0003-4566-0005	Saw Swee Hock School of Public Health from the National University of Singapore; National Research Foundation Singapore [NRF-RF-2010-05]; Life Sciences Institute, National University of Singapore; MalariaGEN Consortium; Wellcome Trust [WT00383/Z/05/Z, 090532/Z/09/Z, 098051, 090770/Z/09/Z]; Bill and Melinda Gates Foundation through the Foundation for the National Institutes of Health as part of the Grand Challenges in Global Health Initiative [566]; Medical Research Council UK [G0600718]; Medical Research Council [G19/9, G0600718] Funding Source: researchfish; MRC [G0600718, G19/9] Funding Source: UKRI	Saw Swee Hock School of Public Health from the National University of Singapore(National University of Singapore); National Research Foundation Singapore(National Research Foundation, Singapore); Life Sciences Institute, National University of Singapore(National University of Singapore); MalariaGEN Consortium; Wellcome Trust(Wellcome TrustEuropean Commission); Bill and Melinda Gates Foundation through the Foundation for the National Institutes of Health as part of the Grand Challenges in Global Health Initiative; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	X.L., R.T.H.O., and Y.Y.T. acknowledge support from the Saw Swee Hock School of Public Health from the National University of Singapore and the National Research Foundation Singapore (NRF-RF-2010-05). E.N.P. and Y.Y.T. also acknowledge the support from the Life Sciences Institute, National University of Singapore. A.M.E., K.S.S., T.G.C., D.P.K., and Y.Y.T. acknowledge support from the MalariaGEN Consortium. The MalariaGEN Consortium is supported by grants from the Wellcome Trust (WT00383/Z/05/Z) and the Bill and Melinda Gates Foundation through the Foundation for the National Institutes of Health (566) as part of the Grand Challenges in Global Health Initiative. The Wellcome Trust also provided core awards to the Wellcome Trust Centre for Human Genetics (090532/Z/09/Z) and the Wellcome Trust Sanger Institute (098051). D.P.K. also acknowledges support from the Medical Research Council UK (G0600718) and the Wellcome Trust (090770/Z/09/Z).	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Chen W, 2013, GENOME RES, V23, P142, DOI 10.1101/gr.142455.112; Coop G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000500; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Denny JC, 2011, AM J HUM GENET, V89, P529, DOI 10.1016/j.ajhg.2011.09.008; Ewing G, 2010, BIOINFORMATICS, V26, P2064, DOI 10.1093/bioinformatics/btq322; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Hanchard N, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-52; Hernandez RD, 2011, SCIENCE, V331, P920, DOI 10.1126/science.1198878; Menelaou A, 2013, BIOINFORMATICS, V29, P84, DOI 10.1093/bioinformatics/bts632; Ong RTH, 2011, BIOINFORMATICS, V27, P822, DOI 10.1093/bioinformatics/btr007; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Spencer CCA, 2004, BIOINFORMATICS, V20, P3673, DOI 10.1093/bioinformatics/bth417; Suo C, 2012, EUR J HUM GENET, V20, P102, DOI 10.1038/ejhg.2011.139; Teo YY, 2009, GENOME RES, V19, P2154, DOI 10.1101/gr.095000.109; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Zhao ZZ, 2009, ANN HUM BIOL, V36, P46, DOI 10.1080/03014460802558522	23	50	50	1	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN 6	2013	92	6					866	881		10.1016/j.ajhg.2013.04.021	http://dx.doi.org/10.1016/j.ajhg.2013.04.021			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164MX	23731540	Green Published, hybrid			2022-12-18	WOS:000320415300004
J	Stranecky, V; Hoischen, A; Hartmannova, H; Zaki, MS; Chaudhary, A; Zudaire, E; Noskova, L; Baresova, V; Pristoupilova, A; Hodanova, K; Sovova, J; Hulkova, H; Piherova, L; Hehir-Kwa, JY; de Silva, D; Senanayake, MP; Farrag, S; Zeman, J; Martasek, P; Baxova, A; Afifi, HH; St Croix, B; Brunner, HG; Temtamy, S; Kmoch, S				Stranecky, Viktor; Hoischen, Alexander; Hartmannova, Hana; Zaki, Maha S.; Chaudhary, Amit; Zudaire, Enrique; Noskova, Lenka; Baresova, Veronika; Pristoupilova, Anna; Hodanova, Katerina; Sovova, Jana; Hulkova, Helena; Piherova, Lenka; Hehir-Kwa, Jayne Y.; de Silva, Deepthi; Senanayake, Manouri P.; Farrag, Sameh; Zeman, Jiri; Martasek, Pavel; Baxova, Alice; Afifi, Hanan H.; St Croix, Brad; Brunner, Han G.; Temtamy, Samia; Kmoch, Stanislav			Mutations in ANTXR1 Cause GAPO Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CAPILLARY MORPHOGENESIS PROTEIN-2; EXONIC SPLICING ENHANCERS; OF-THE-LITERATURE; ANTHRAX TOXIN; ACTIN CYTOSKELETON; TUMOR ENDOTHELIUM; RECEPTOR; TEM8; EXPRESSION; MARKER-8	The genetic cause of GAPO syndrome, a condition characterized by growth retardation, alopecia, pseudoanodontia, and progressive visual impairment, has not previously been identified. We studied four ethnically unrelated affected individuals and identified homozygous nonsense mutations (c.262C>T [p.Arg88*] and c.505C>T [p.Arg169*]) or splicing mutations (c.1435-12A>G [p.Gly479Phefs*119]) in ANTXR1, which encodes anthrax toxin receptor 1. The nonsense mutations predictably trigger nonsense-mediated mRNA decay, resulting in the loss of ANTXR1. The transcript with the splicing mutation theoretically encodes a truncated ANTXR1 containing a neopeptide composed of 118 unique amino acids in its C terminus. GAPO syndrome's major phenotypic features, which include dental abnormalities and the accumulation of extracellular matrix, recapitulate those found in Antxr1-mutant mice and point toward an underlying defect in extracellular-matrix regulation. Thus, we propose that mutations affecting ANTXR1 function are responsible for this disease's characteristic generalized defect in extracellular-matrix homeostasis.	[Stranecky, Viktor; Hartmannova, Hana; Noskova, Lenka; Baresova, Veronika; Pristoupilova, Anna; Hodanova, Katerina; Sovova, Jana; Hulkova, Helena; Piherova, Lenka; Kmoch, Stanislav] Charles Univ Prague, Fac Med 1, Inst Inherited Metab Disorders, Prague 12000 2, Czech Republic; [Hoischen, Alexander; Hehir-Kwa, Jayne Y.; Brunner, Han G.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen Ctr Mol Life Sci,Inst Genet & Metab Dis, NL-6500 HC Nijmegen, Netherlands; [Zaki, Maha S.; Afifi, Hanan H.; Temtamy, Samia] Natl Res Ctr, Dept Clin Genet, Cairo 12311, Egypt; [Chaudhary, Amit; Zudaire, Enrique; St Croix, Brad] Frederick Natl Lab Canc Res, Tumor Angiogenesis Sect, Frederick, MD 21702 USA; [de Silva, Deepthi] Univ Kelaniya, Fac Med, Ragama 11010, Sri Lanka; [Senanayake, Manouri P.] Univ Colombo, Fac Med, Dept Paediat, Colombo 08, Sri Lanka; [Farrag, Sameh; Zeman, Jiri; Martasek, Pavel] Charles Univ Prague, Fac Med 1, Dept Pediat, Prague 12000 2, Czech Republic; [Baxova, Alice] Charles Univ Prague, Fac Med 1, Dept Med Genet, Prague 12000 2, Czech Republic	Charles University Prague; Radboud University Nijmegen; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University Kelaniya; University of Colombo; Charles University Prague; Charles University Prague	Kmoch, S (corresponding author), Charles Univ Prague, Fac Med 1, Inst Inherited Metab Disorders, Prague 12000 2, Czech Republic.	skmoch@lfl.cuni.cz	Pristoupilova, Anna/F-4990-2017; Stranecky, Viktor/I-8524-2017; Hůlková, Helena/O-2268-2017; Martásek, Pavel/G-6622-2017; Baresova, Veronika/H-4931-2017; Hoischen, Alexander/AGF-7293-2022; Baxova, Alice/L-7197-2017; Zaki, Maha S/B-9361-2013; Noskova, Lenka/F-6564-2017; Brunner, Han/C-9928-2013; Piherová, Lenka/F-6777-2017; Kmoch, Stanislav/C-1575-2010; Hoischen, Alexander/D-1282-2013; Hehir, g. J.Y./L-4358-2015; Hodaňová, Kateřina/I-4727-2017; Hartmannova, Hana/H-4735-2017; Zeman, Jiri/K-2691-2017	Pristoupilova, Anna/0000-0003-0047-9405; Stranecky, Viktor/0000-0002-2599-6479; Hůlková, Helena/0000-0002-7441-6610; Martásek, Pavel/0000-0001-6165-4444; Baresova, Veronika/0000-0001-8989-6090; Hoischen, Alexander/0000-0002-8072-4476; Baxova, Alice/0000-0002-0651-0410; Noskova, Lenka/0000-0001-7011-4327; Piherová, Lenka/0000-0001-7917-6364; Kmoch, Stanislav/0000-0002-6239-707X; Hoischen, Alexander/0000-0002-8072-4476; Hodaňová, Kateřina/0000-0001-9172-9945; Hartmannova, Hana/0000-0001-7787-832X; Hehir-Kwa, Jayne/0000-0003-0837-304X; Zeman, Jiri/0000-0002-2678-7919; Afifi, Hanan Hosny/0000-0002-2502-4776; temtamy, samia/0000-0002-6452-823X; Zaki, Maha/0000-0001-7840-0002	Charles University [PRVOUK-P24/LF1/3, UNCE 204011, SVV2012/2645, CZ.1.05/1.1.00/02.0109]; Biotechnology and Biomedicine Centre of the Academy of Sciences; European Regional Development Fund; Ministry of Education [NT13116-4/2012]; Ministry of Health of the Czech Republic; National Cancer Institute, National Institutes of Health, US Department of Health and Social Services; Netherlands Organization for Health Research and Development [ZonMW 916-12-095]; NATIONAL CANCER INSTITUTE [ZIABC010578] Funding Source: NIH RePORTER	Charles University; Biotechnology and Biomedicine Centre of the Academy of Sciences; European Regional Development Fund(European Commission); Ministry of Education; Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); National Cancer Institute, National Institutes of Health, US Department of Health and Social Services; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Charles University institutional programs PRVOUK-P24/LF1/3, UNCE 204011, and SVV2012/2645; by the Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University (CZ.1.05/1.1.00/02.0109); by the European Regional Development Fund; by grant NT13116-4/2012 from the Ministry of Education and Ministry of Health of the Czech Republic; and by the intramural research program of the National Cancer Institute, National Institutes of Health, US Department of Health and Social Services. A.H. was supported by the Netherlands Organization for Health Research and Development (ZonMW 916-12-095). We thank clinical colleagues and families who contributed samples used in this study, as well as members of the Genomic Disorders Group Nijmegen for their technical support. A.C. and B.S.C. are coinventors of filed patents related to the development of ANTXR1 antibodies for cancer therapy.	Baxova A, 1997, Radiol Med, V93, P289; Becker J, 2011, AM J HUM GENET, V88, P362, DOI 10.1016/j.ajhg.2011.01.015; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Carson-Walter EB, 2001, CANCER RES, V61, P6649; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Castrillon-Oberndorfer G, 2010, AM J MED GENET A, V152A, P225, DOI 10.1002/ajmg.a.33192; Chaudhary A, 2012, CELL CYCLE, V11, P2253, DOI 10.4161/cc.20374; Cullen M, 2009, CANCER RES, V69, P6021, DOI 10.1158/0008-5472.CAN-09-1086; Davies G, 2006, INT J ONCOL, V29, P1311; Demirgunes EF, 2009, AM J MED GENET A, V149A, P802, DOI 10.1002/ajmg.a.32686; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Goloni-Bertollo EM, 2008, AM J MED GENET A, V146A, P1523, DOI 10.1002/ajmg.a.32157; Goucha S, 2000, ANN DERMATOL VENER, V127, P501; Gu JS, 2010, EXP CELL RES, V316, P1946, DOI 10.1016/j.yexcr.2010.03.026; Hanks S, 2003, AM J HUM GENET, V73, P791, DOI 10.1086/378418; Hoischen A, 2011, NAT GENET, V43, P729, DOI 10.1038/ng.868; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Hotchkiss KA, 2005, EXP CELL RES, V305, P133, DOI 10.1016/j.yexcr.2004.12.025; Jinnin M, 2008, NAT MED, V14, P1236, DOI 10.1038/nm.1877; Kocabay G, 2009, AM J MED GENET A, V149A, P415, DOI 10.1002/ajmg.a.32638; Lei SB, 2010, CLIN DYSMORPHOL, V19, P79, DOI 10.1097/MCD.0b013e32833593d1; Liu SH, 2003, J BIOL CHEM, V278, P5227, DOI 10.1074/jbc.M210321200; Liu SL, 2009, P NATL ACAD SCI USA, V106, P12424, DOI 10.1073/pnas.0905409106; Meguid NA, 1997, CLIN GENET, V52, P110; Nanda A, 2004, CANCER RES, V64, P817, DOI 10.1158/0008-5472.CAN-03-2408; Nanda A, 2010, PEDIATR DERMATOL, V27, P156, DOI 10.1111/j.1525-1470.2010.01100.x; Nicolae C, 2010, CELL TISSUE RES, V339, P155, DOI 10.1007/s00441-009-0874-y; Noskova L, 2011, AM J HUM GENET, V89, P241, DOI 10.1016/j.ajhg.2011.07.003; Sinha R, 2011, PEDIATR ANESTH, V21, P910, DOI 10.1111/j.1460-9592.2011.03550.x; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; St Croix B, 2000, SCIENCE, V289, P1197; TIPTON RE, 1984, AM J MED GENET, V19, P209, DOI 10.1002/ajmg.1320190202; van de Steeg E, 2012, J CLIN INVEST, V122, P519, DOI 10.1172/JCI59526; Vargas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043174; Verma K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022334; WAJNTAL A, 1990, AM J MED GENET, V37, P213, DOI 10.1002/ajmg.1320370210; Werner E, 2006, J BIOL CHEM, V281, P23227, DOI 10.1074/jbc.M603676200; Yang MY, 2011, BBA-MOL CELL RES, V1813, P39, DOI 10.1016/j.bbamcr.2010.11.013	38	50	53	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY 2	2013	92	5					792	799		10.1016/j.ajhg.2013.03.023	http://dx.doi.org/10.1016/j.ajhg.2013.03.023			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139KY	23602711	Green Published, Bronze			2022-12-18	WOS:000318582800014
J	Saadi, I; Alkuraya, FS; Gisselbrecht, SS; Goessling, W; Cavallesco, R; Turbe-Doan, A; Petrin, AL; Harris, J; Siddiqui, U; Grix, AW; Hove, HD; Leboulch, P; Glover, TW; Morton, CC; Richieri-Costa, A; Murray, JC; Erickson, RP; Maas, RL				Saadi, Irfan; Alkuraya, Fowzan S.; Gisselbrecht, Stephen S.; Goessling, Wolfram; Cavallesco, Resy; Turbe-Doan, Annick; Petrin, Aline L.; Harris, James; Siddiqui, Ursela; Grix, Arthur W., Jr.; Hove, Hanne D.; Leboulch, Philippe; Glover, Thomas W.; Morton, Cynthia C.; Richieri-Costa, Antonio; Murray, Jeffrey C.; Erickson, Robert P.; Maas, Richard L.			Deficiency of the Cytoskeletal Protein SPECC1L Leads to Oblique Facial Clefting	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MICROTUBULE; INTEGRINS; MOVEMENT; ENCODES; PATHWAY; CELLS	Genetic mutations responsible for oblique facial clefts (ObFC), a unique class of facial malformations, are largely unknown. We show that loss-of-function mutations in SPECC1L. are pathogenic for this human developmental disorder and that SPECC1L is a critical organizer of vertebrate facial morphogenesis. During murine embryogenesis, Speed 1 1 is expressed in cell populations of the developing facial primordial, which proliferate and fuse to form the face. In zebrafish, knockdown of a SPECC1L homolog produces a faceless phenotype with loss of jaw and facial structures, and knockdown in Drosophila phenocopies mutants in the integrin signaling pathway that exhibit cell-migration and -adhesion defects. Furthermore, in mammalian cells, SPECC1L colocalizes with both tubulin and actin, and its deficiency results in defective actin-cytoskeleton reorganization, as well as abnormal cell adhesion and migration. Collectively, these data demonstrate that SPECC1L functions in actin-cytoskeleton reorganization and is required for proper facial morphogenesis.	[Saadi, Irfan; Alkuraya, Fowzan S.; Gisselbrecht, Stephen S.; Goessling, Wolfram; Cavallesco, Resy; Turbe-Doan, Annick; Siddiqui, Ursela; Leboulch, Philippe; Morton, Cynthia C.; Maas, Richard L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Petrin, Aline L.; Murray, Jeffrey C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Harris, James] Beth Israel Deaconess Med Ctr, Dept Expt Pathol, Boston, MA 02115 USA; [Grix, Arthur W., Jr.] Kaiser Permanente, Sacramento Med Ctr, Dept Genet, Sacramento, CA 95815 USA; [Hove, Hanne D.] Rigshosp, Copenhagen Univ Hosp, Dept Clin Genet, DK-2100 Copenhagen, Denmark; [Leboulch, Philippe] Univ Paris XI, F-92265 Paris, France; [Leboulch, Philippe] INSERM, U962, Inst Malad Emergentes & Therapies Innovantes, Commissariate Energie Atom, F-92265 Paris, France; [Glover, Thomas W.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Morton, Cynthia C.] Brigham & Womens Hosp, Dept Obstet & Gynecol & Reprod Biol, Boston, MA 02115 USA; [Morton, Cynthia C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Richieri-Costa, Antonio] Univ Sao Paulo, Hosp Anomalias Craniofaciais, Dept Serv Genet Clin, BR-17012 Bauru, Brazil; [Erickson, Robert P.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85724 USA; [Erickson, Robert P.] Univ Arizona, Sect Med & Mol Genet, Dept Pediat, Tucson, AZ 85724 USA; [Saadi, Irfan; Alkuraya, Fowzan S.; Gisselbrecht, Stephen S.; Goessling, Wolfram; Cavallesco, Resy; Turbe-Doan, Annick; Siddiqui, Ursela; Leboulch, Philippe; Maas, Richard L.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; University of Iowa; Harvard University; Beth Israel Deaconess Medical Center; Kaiser Permanente; Rigshospitalet; University of Copenhagen; UDICE-French Research Universities; Universite Paris Saclay; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Universidade de Sao Paulo; University of Arizona; University of Arizona; Harvard University; Brigham & Women's Hospital	Maas, RL (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.	maas@genetics.med.harvard.edu	Alkuraya, Fowzan S./A-1542-2009; Richieri-Costa, Antonio/B-2514-2013; Saadi, Irfan/I-5989-2019; Petrin, Aline/I-1880-2019	Alkuraya, Fowzan S./0000-0003-4158-341X; Saadi, Irfan/0000-0002-6250-6651; Petrin, Aline/0000-0003-2239-8120; Harris, James/0000-0002-8995-8324; Gisselbrecht, Stephen/0000-0001-8723-902X; Goessling, Wolfram/0000-0001-9972-1569	Canadian Institutes of Health; Holsclaw Family Chair in Human Genetics and Inherited Disease; National Institutes of Health [HD060050, GM061354, DE08559, HL090921]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060050] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Holsclaw Family Chair in Human Genetics and Inherited Disease; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Lund for assistance with cell lines, B. Gerami-Naini for help with Matrigel experiment, S. Daack-Hirsch for help with patient samples, and J. Shah for helpful suggestions. I.S. was supported by a Canadian Institutes of Health Research postdoctoral fellowship. R.P.E. is recipient of the Holsclaw Family Chair in Human Genetics and Inherited Disease. This work was supported by National Institutes of Health grants HD060050 (R.L.M.), GM061354 (C.C.M. and R.L.M.), DE08559 (J.C.M.), and HL090921 (P.L.).	[Anonymous], COMBINED DNA INDEX S; [Anonymous], CONSTRAINT BASED MUL; Barth AIM, 2008, SEMIN CELL DEV BIOL, V19, P245, DOI 10.1016/j.semcdb.2008.02.003; Beaty TH, 2010, NAT GENET, V42, P525, DOI 10.1038/ng.580; Bokel C, 2002, DEV CELL, V3, P311, DOI 10.1016/S1534-5807(02)00265-4; Brown NH, 2000, DEV BIOL, V223, P1, DOI 10.1006/dbio.2000.9711; Cerrato A, 2006, DEV BIOL, V298, P59, DOI 10.1016/j.ydbio.2006.06.013; Clouthier David E, 2004, Birth Defects Res C Embryo Today, V72, P190, DOI 10.1002/bdrc.20007; Crump JG, 2004, PLOS BIOL, V2, P1432, DOI 10.1371/journal.pbio.0020244; DASOUKI M, 1988, J MED GENET, V25, P427, DOI 10.1136/jmg.25.6.427; Delon I, 2007, CURR OPIN CELL BIOL, V19, P43, DOI 10.1016/j.ceb.2006.12.013; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Eppley BL, 2005, PLAST RECONSTR SURG, V115, p101E, DOI 10.1097/01.PRS.0000164494.45986.91; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; Hall Brian K., 2009, P3; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Higgins AW, 2008, AM J HUM GENET, V82, P712, DOI 10.1016/j.ajhg.2008.01.011; Jalali GR, 2008, HUM MUTAT, V29, P433, DOI 10.1002/humu.20640; Jugessur A, 2009, ORAL DIS, V15, P437, DOI 10.1111/j.1601-0825.2009.01577.x; Kislauskis EH, 1997, J CELL BIOL, V136, P1263, DOI 10.1083/jcb.136.6.1263; Kodama A, 2004, J CELL BIOL, V167, P203, DOI 10.1083/jcb.200408047; Kunda P, 2009, TRENDS CELL BIOL, V19, P174, DOI 10.1016/j.tcb.2009.01.006; Le Douarin N.M., 1982, NEURAL CREST; Lee SB, 2003, DEVELOPMENT, V130, P4001, DOI 10.1242/dev.00595; Leung CL, 2002, TRENDS CELL BIOL, V12, P37, DOI 10.1016/S0962-8924(01)02180-8; Maschhoff KL, 2000, AM J MED GENET, V97, P280, DOI 10.1002/1096-8628(200024)97:4<280::AID-AJMG1278>3.0.CO;2-N; McCartney BM, 2001, NAT CELL BIOL, V3, P933, DOI 10.1038/ncb1001-933; Miller CT, 2000, DEVELOPMENT, V127, P3815; Nelms B.L., 2010, TRANSCRIPTIONAL CONT; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Rinon A, 2007, DEVELOPMENT, V134, P3065, DOI 10.1242/dev.002501; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; ROTHLEIN R, 1986, J EXP MED, V163, P1132, DOI 10.1084/jem.163.5.1132; Salmon WC, 2002, J CELL BIOL, V158, P31, DOI 10.1083/jcb.200203022; SCHILLING TF, 1994, DEVELOPMENT, V120, P483; Schilling TF, 1996, DEVELOPMENT, V122, P1417; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Slusarski DC, 2007, DEV BIOL, V307, P1, DOI 10.1016/j.ydbio.2007.04.043; TESSIER P, 1976, Journal of Maxillofacial Surgery, V4, P69, DOI 10.1016/S0301-0503(76)80013-6; Thusberg J, 2009, HUM MUTAT, V30, P703, DOI 10.1002/humu.20938; Tsvetkov AS, 2007, CELL MOTIL CYTOSKEL, V64, P519, DOI 10.1002/cm.20201; Waterman-Storer C, 2000, J CELL BIOL, V150, P361, DOI 10.1083/jcb.150.2.361; Webb DJ, 2003, CURR OPIN CELL BIOL, V15, P614, DOI 10.1016/S0955-0674(03)00105-4; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; Witze ES, 2008, SCIENCE, V320, P365, DOI 10.1126/science.1151250; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; DATABASE GENOMIC VAR; REFSEQ DATABASE	50	50	52	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 15	2011	89	1					44	55		10.1016/j.ajhg.2011.05.023	http://dx.doi.org/10.1016/j.ajhg.2011.05.023			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	796HF	21703590	Green Published, Bronze			2022-12-18	WOS:000293041700004
J	Giorda, R; Bonaglia, MC; Beri, S; Fichera, M; Novara, F; Magini, P; Urquhart, J; Sharkey, FH; Zucca, C; Grasso, R; Marelli, S; Castiglia, L; Di Benedetto, D; Musumeci, SA; Vitello, GA; Failla, P; Reitano, S; Avola, E; Bisulli, F; Tinuper, P; Mastrangelo, M; Fiocchi, I; Spaccini, L; Torniero, C; Fontana, E; Lynch, SA; Clayton-Smith, J; Black, G; Jonveaux, P; Leheup, B; Seri, M; Romano, C; dalla Bernardina, B; Zuffardi, O				Giorda, Roberto; Bonaglia, M. Clara; Beri, Silvana; Fichera, Marco; Novara, Francesca; Magini, Pamela; Urquhart, Jill; Sharkey, Freddie H.; Zucca, Claudio; Grasso, Rita; Marelli, Susan; Castiglia, Lucia; Di Benedetto, Daniela; Musumeci, Sebastiano A.; Vitello, Girolamo A.; Failla, Pinella; Reitano, Santina; Avola, Emanuela; Bisulli, Francesca; Tinuper, Paolo; Mastrangelo, Massimo; Fiocchi, Isabella; Spaccini, Luigina; Torniero, Claudia; Fontana, Elena; Lynch, Sally Ann; Clayton-Smith, Jill; Black, Graeme; Jonveaux, Philippe; Leheup, Bruno; Seri, Marco; Romano, Corrado; dalla Bernardina, Bernardo; Zuffardi, Orsetta			Complex Segmental Duplications Mediate a Recurrent dup(X)(p11.22-p11.23) Associated with Mental Retardation, Speech Delay, and EEG Anomalies in Males and Females	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STRUCTURAL VARIATION; MISSENSE MUTATION; GENE; PROTEIN; MICRODELETION; FAMILY; XLMR; IDENTIFICATION; EXPRESSION; DOSAGE	Submicroscopic copy-number variations make a considerable contribution to the genetic etiology of human disease. We have analyzed subjects with idiopathic mental retardation (MR) by using whole-genome oligonucleotide-based array comparative genomic hybridization (aCGH) and identified familial and de novo recurrent Xp11.22-p11.23 duplications in males and females with MR, speech delay, and a peculiar electroencephalographic (EEG) pattern in childhood. The size of the duplications ranges from 0.8-9.2 Mb. Most affected females show preferential activation of the duplicated X chromosome. Carriers of the smallest duplication show X-linked recessive inheritance. All other affected individuals present dominant expression and comparable clinical phenotypes irrespective of sex, duplication size, and X-inactivation pattern. The majority of the rearrangements are mediated by recombination between flanking complex segmental duplications. The identification of common clinical features, including the typical EEG pattern, predisposing genomic structure, and peculiar X-inactivation pattern, suggests that duplication of Xp11.22-p11.23 constitutes a previously undescribed syndrome.	[Giorda, Roberto; Zucca, Claudio] Eugenio Medea Sci Inst, Neurofisiol Clin, I-23842 Bosisio Parini, LC, Italy; [Fichera, Marco; Castiglia, Lucia; Di Benedetto, Daniela] Inst Ricovero & Cura Caratterre Sci Res & Care Me, Oasi Inst, Lab Genet Diag, I-94018 Troina, EN, Italy; [Musumeci, Sebastiano A.; Vitello, Girolamo A.; Romano, Corrado] Inst Ricovero & Cura Caratterre Sci Res & Care Me, Oasi Inst, Neurol Unit, I-94018 Troina, EN, Italy; [Failla, Pinella; Reitano, Santina; Avola, Emanuela] Inst Ricovero & Cura Caratterre Sci Res & Care Me, Oasi Inst, Unit Pediat & Med Genet, I-94018 Troina, EN, Italy; [Novara, Francesca; Zuffardi, Orsetta] Univ Pavia, I-27100 Pavia, PV, Italy; [Magini, Pamela; Seri, Marco] Univ Bologna, Unita Operat Genet Med, Dipartimento Sci Ginecol Ostetr & Pediat, Policlin St Orsola Malpighi, I-40126 Bologna, BO, Italy; [Urquhart, Jill] Cent Manchester Fdn Trust, Biomed Res Ctr, Manchester M13 9WL, Lancs, England; [Sharkey, Freddie H.] Western Gen Hosp, Dept Cytogenet, Edinburgh EH4 2XU, Midlothian, Scotland; [Bisulli, Francesca; Tinuper, Paolo] Univ Bologna, Dipartimento Sci Neurol, I-40126 Bologna, BO, Italy; [Mastrangelo, Massimo; Fiocchi, Isabella; Spaccini, Luigina] Osped Bambini V Buzzi, I-20136 Milan, MI, Italy; [Torniero, Claudia; Fontana, Elena] Univ Verona, Policlin GB Rossi, I-37129 Verona, VR, Italy; [Lynch, Sally Ann] Our Ladys Childrens Hosp, Natl Ctr Med Genet, BT-29 Crumlin, Ireland; [Clayton-Smith, Jill; Black, Graeme] Cent Manchester Fdn Trust, Dept Clin Genet, Manchester M13 9WL, Lancs, England; [Jonveaux, Philippe] Nancy Univ, CHU Nancy, Med Genet Lab, F-54500 Vandoeuvre Les Nancy, France; [Leheup, Bruno] Nancy Univ, CHU Nancy, Serv Med Infantile & Genet Clin 3, F-54500 Vandoeuvre Les Nancy, France; [Zuffardi, Orsetta] Inst Ricovero & Cura Caratterre Sci C Mondino, I-27100 Pavia, PV, Italy	IRCCS Eugenio Medea; IRCCS Oasi Maria SS; IRCCS Oasi Maria SS; IRCCS Oasi Maria SS; University of Pavia; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Edinburgh; University of Bologna; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; National Children's Research Centre (NCRC); CHU de Nancy; Universite de Lorraine; CHU de Nancy; Universite de Lorraine; IRCCS Fondazione Casimiro Mondino	Giorda, R (corresponding author), Eugenio Medea Sci Inst, Neurofisiol Clin, I-23842 Bosisio Parini, LC, Italy.	roberto.giorda@bp.lnf.it	Bonaglia, Maria Clara/K-2775-2016; Giorda, Roberto/Q-6010-2019; Magini, Pamela/K-4508-2016; Tinuper, Paolo/AAB-7760-2020; Bisulli, Francesca/AAJ-4811-2020; Avola, Emanuela/E-5435-2017; Fichera, Marco/K-9220-2016; Musumeci, Sebastiano Antonino/E-3879-2017; Zucca, Claudio/AAV-2162-2020; Romano, Corrado/B-9695-2008; Urquhart, Jill/G-2282-2015; Castiglia, Lucia/D-8563-2017; Bisulli, Francesca/AAB-3307-2019; marelli, susan/AAC-2827-2021; Marelli, Susan/AAB-5906-2021; Giorda, Roberto/J-1052-2014; Vitello, Aurelio Girolamo/E-3208-2017; Failla, Pinella/AAE-9963-2019; Seri, Marco/A-4339-2014	Bonaglia, Maria Clara/0000-0002-7121-7712; Giorda, Roberto/0000-0001-8175-9606; Magini, Pamela/0000-0002-1752-9977; Avola, Emanuela/0000-0002-6740-665X; Fichera, Marco/0000-0002-8225-6880; Musumeci, Sebastiano Antonino/0000-0002-6865-5367; Zucca, Claudio/0000-0001-7621-2542; Romano, Corrado/0000-0003-1049-0683; Urquhart, Jill/0000-0002-5788-5511; Castiglia, Lucia/0000-0002-3261-8847; Bisulli, Francesca/0000-0002-1109-7296; marelli, susan/0000-0001-5217-7391; Giorda, Roberto/0000-0001-8175-9606; Vitello, Aurelio Girolamo/0000-0002-6285-9692; Failla, Pinella/0000-0003-3969-7266; tinuper, paolo/0000-0002-0588-3063; Seri, Marco/0000-0003-2425-2176; Lynch, Sally Ann/0000-0003-3540-1333; zuffardi, orsetta/0000-0002-1466-4559; Novara, Francesca/0000-0003-1216-0231; Fontana, Elena/0000-0002-4553-2452	Telethon Grant [GGP06208A/B]; Cassa di Risparmio delle Provincie Lombarde (CARIPLO) Foundation [2007.5197]; Ministry of Health [RF2007-AOM-2007-636538]; CHERISH [223692]; European Commission's FP7	Telethon Grant(Fondazione Telethon); Cassa di Risparmio delle Provincie Lombarde (CARIPLO) Foundation(Fondazione Cariplo); Ministry of Health; CHERISH; European Commission's FP7	The authors wish to thank the patients and their families for contributing to this research study. This work was supported by Telethon Grant GGP06208A/B to R.G. and M.C.B.; funding from the Cassa di Risparmio delle Provincie Lombarde (CARIPLO) Foundation (2007.5197) to O.Z.; Ministry of Health Grant RF2007-AOM-2007-636538 to S.R; and project CHERISH grant agreement no. 223692 to M.S. from the European Commission's FP7 funding.	ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Bonaglia MC, 2009, EUR J HUM GENET, V17, P179, DOI 10.1038/ejhg.2008.160; Bonnet C, 2006, J HUM GENET, V51, P815, DOI 10.1007/s10038-006-0023-3; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Di Pasquale E, 2004, AM J HUM GENET, V75, P106, DOI 10.1086/422103; Dube JL, 1998, MOL ENDOCRINOL, V12, P1809, DOI 10.1210/me.12.12.1809; Freude K, 2004, AM J HUM GENET, V75, P305, DOI 10.1086/422507; Froyen G, 2008, AM J HUM GENET, V82, P432, DOI 10.1016/j.ajhg.2007.11.002; Froyen G, 2007, HUM MUTAT, V28, P1034, DOI 10.1002/humu.20564; Froyen G, 2007, HUM GENET, V121, P539, DOI 10.1007/s00439-007-0343-1; Galloway SM, 2000, NAT GENET, V25, P279, DOI 10.1038/77033; Garcia CC, 2004, J MED GENET, V41, P183, DOI 10.1136/jmg.2003.013680; Hagens O, 2006, HUM GENET, V118, P578, DOI 10.1007/s00439-005-0072-2; Hamel BCJ, 1999, J MED GENET, V36, P140; Hurles ME, 2006, GENOMIC DISORDERS: THE GENOMIC BASIS OF DISEASE, P341, DOI 10.1007/978-1-59745-039-3_24; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Kalscheuer VM, 2003, NAT GENET, V35, P313, DOI 10.1038/ng1264; Koivisto AM, 2007, CLIN GENET, V72, P145, DOI 10.1111/j.1399-0004.2007.00836.x; Koolen DA, 2008, J MED GENET, V45, P710, DOI 10.1136/jmg.2008.058701; Laumonnier F, 2005, J MED GENET, V42, P780, DOI 10.1136/jmg.2004.029439; Lebel RR, 2002, CLIN GENET, V61, P139, DOI 10.1034/j.1399-0004.2002.610209.x; LEHRKE R, 1972, AM J MENT DEF, V76, P611; Lenski C, 2004, AM J HUM GENET, V74, P777, DOI 10.1086/383205; Lenski C, 2007, AM J HUM GENET, V80, P372, DOI 10.1086/511527; Leonard H, 2002, MENT RETARD DEV D R, V8, P117, DOI 10.1002/mrdd.10031; Lubs H, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.037556; Lugtenberg D, 2009, EUR J HUM GENET, V17, P444, DOI 10.1038/ejhg.2008.208; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Ofman R, 2003, AM J HUM GENET, V72, P1300, DOI 10.1086/375116; Okuda T, 2003, HUM MOL GENET, V12, P711, DOI 10.1093/hmg/ddg084; PASTERIS NG, 1994, CELL, V79, P669; Qiao Y, 2008, CLIN GENET, V74, P134, DOI 10.1111/j.1399-0004.2008.01028.x; Ropers HH, 2003, TRENDS GENET, V19, P316, DOI 10.1016/S0168-9525(03)00113-6; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; TASSINARI CA, 1992, SYNDROMES EPILEPTIQU, P245	38	50	51	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 11	2009	85	3					394	400		10.1016/j.ajhg.2009.08.001	http://dx.doi.org/10.1016/j.ajhg.2009.08.001			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	497ZN	19716111	Green Published, Bronze			2022-12-18	WOS:000270104500008
J	Murphy, A; Tantisira, KG; Soto-Quiros, ME; Avila, L; Klanderman, BJ; Lake, S; Weiss, ST; Celedon, JC				Murphy, Amy; Tantisira, Kelan G.; Soto-Quiros, Manuel E.; Avila, Lydiana; Klanderman, Barbara J.; Lake, Stephen; Weiss, Scott T.; Celedon, Juan C.			PRKCA: A Positional Candidate Gene for Body Mass Index and Asthma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN-KINASE-C; FAMILY-BASED ASSOCIATION; VASCULAR SMOOTH-MUSCLE; GENOME-WIDE SEARCH; LINKAGE ANALYSIS; CHILDHOOD ASTHMA; UNIFIED APPROACH; SKELETAL-MUSCLE; SEVERE OBESITY; ABDOMINAL FAT	Asthma incidence and prevalence are higher in obese individuals. A potential mechanistic basis for this relationship is pleiotropy. We hypothesized that significant linkage and candidate-gene association would be found for body mass index (BMI) in a population ascertained on asthma affection status. Linkage analysis for BMI was performed on 657 subjects in eight Costa Rican families enrolled in a study of asthma. Family-based association studies were conducted for BMI with SNPs within a positional candidate gene, PRKCA. SNPs within PRKCA were also tested for association with asthma. Association studies were conducted in 415 Costa Rican parent-child trios and 493 trios participating in the Childhood Asthma Management Program (CAMP). Although only modest evidence of linkage for BMI was obtained for the whole cohort, significant linkage was noted for BMI in females on chromosome 17q (peak LOD = 3.39). Four SNPs in a candidate gene in this region (PRKCA) had unadjusted association p values <0.05 for BMI in both cohorts, with the joint p value for two SNPs remaining significant after adjustment for multiple comparisons (rs228883 and rs1005651, joint p values = 9.5 x 10(-5) and 5.6 x 10(-5)). Similarly, eight SNPs had unadjusted association p values <0.05 for asthma in both populations, with one SNP remaining significant after adjustment for multiple comparisons (rs11079657, joint p value = 2.6 x 10(-5)). PRKCA is a pleiotropic locus that is associated with both BMI and asthma and that has been identified via linkage analysis of BMI in a population ascertained on asthma.	[Murphy, Amy; Tantisira, Kelan G.; Klanderman, Barbara J.; Lake, Stephen; Weiss, Scott T.; Celedon, Juan C.] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Tantisira, Kelan G.; Weiss, Scott T.; Celedon, Juan C.] Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Murphy, Amy; Tantisira, Kelan G.; Klanderman, Barbara J.; Weiss, Scott T.; Celedon, Juan C.] Brigham & Womens Hosp, Ctr Genom Med, Boston, MA 02115 USA; [Murphy, Amy; Tantisira, Kelan G.; Klanderman, Barbara J.; Weiss, Scott T.; Celedon, Juan C.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Soto-Quiros, Manuel E.; Avila, Lydiana] Hosp Nacl Ninos Dr Carlos Saenz Herrera, Div Pediat Pulmonol, San Jose, Costa Rica	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Celedon, JC (corresponding author), Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA.	juan.celedon@channing.harvard.edu	Avila, Lydiana/D-5638-2015	Avila, Lydiana/0000-0002-9579-1591	NHLBI of the National Institutes of Health (NIH) [U01 HL075419, U01 HL65899, P01 HI083069, R01 HL 086601, T32 HL07427, K01 HL04370, R37 HL66289]; NHGRI of the NIH [K23 HG3983]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007427, K01HL004370, U01HL065899, U01HL075419, P01HL083069, R37HL066289, R01HL086601] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K23HG003983] Funding Source: NIH RePORTER	NHLBI of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHGRI of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank all subjects for their ongoing participation in this study. We acknowledge the CAMP investigators and research team, supported by NHLBI, for collection of CAMP Genetic Ancillary Study data. All work on data collected from the Genetics of Asthma in Costa Rica and the CAMP Genetic Ancillary Study was conducted at the Channing Laboratory of Brigham and Women's Hospital under appropriate CAMP policies and human subject's protections. The CAMP Genetics Ancillary Study is Supported by grants U01 HL075419, U01 HL65899, 1101 HI,083069, R01 HL 086601, and T32 HL07427 from the NHLBI of the National Institutes of Health (NIH). The Genetics of Asthma in Costa Rica study is supported by grants K01 HL04370 and R37 HL66289 from the NIH. K.G.T. is supported by K23 HG3983 from the NHGRI of the NIH. S.W. is a consultant for Genentech, Inc. and the Chair of the Genentech TENOR advisory board.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; [Anonymous], 1932, STAT METHODS RES WOR; Artemenko Y, 2005, J CELL PHYSIOL, V204, P646, DOI 10.1002/jcp.20314; Bell CG, 2004, DIABETES, V53, P1857, DOI 10.2337/diabetes.53.7.1857; Blangero J, 2000, HUM BIOL, V72, P35; Blumenthal MN, 2004, HUM GENET, V114, P157, DOI 10.1007/s00439-003-1030-5; BORECKI IB, 1993, AM J HUM GENET, V53, P676; Bouzigon E, 2004, HUM MOL GENET, V13, P3103, DOI 10.1093/hmg/ddh340; Camargo CA, 1999, ARCH INTERN MED, V159, P2582, DOI 10.1001/archinte.159.21.2582; Capiati DA, 1999, J CELL BIOCHEM, V74, P292, DOI 10.1002/(SICI)1097-4644(19990801)74:2<292::AID-JCB13>3.0.CO;2-M; Celedon JC, 2000, AM J RESP CRIT CARE, V162, P1679, DOI 10.1164/ajrccm.162.5.2003007; Celedon JC, 2001, AM J RESP CRIT CARE, V164, P1835, DOI 10.1164/ajrccm.164.10.2105033; Celedon JC, 2007, HUM GENET, V120, P691, DOI 10.1007/s00439-006-0255-5; Chen Y, 2002, AM J EPIDEMIOL, V155, P191, DOI 10.1093/aje/155.3.191; Cherniack R, 1999, CONTROL CLIN TRIALS, V20, P91; Cipok M, 2006, BIOCHEM BIOPH RES CO, V345, P817, DOI 10.1016/j.bbrc.2006.05.008; COMUZZIE AG, 1995, GENET EPIDEMIOL, V12, P475, DOI 10.1002/gepi.1370120505; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; DEKKER LV, 1994, TRENDS BIOCHEM SCI, V19, P73, DOI 10.1016/0968-0004(94)90038-8; Dizier MH, 2000, AM J RESP CRIT CARE, V162, P1812, DOI 10.1164/ajrccm.162.5.2002113; Figueroa-Munoz JI, 2001, THORAX, V56, P133, DOI 10.1136/thorax.56.2.133; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gokina NI, 1999, AM J PHYSIOL-HEART C, V277, pH1178, DOI 10.1152/ajpheart.1999.277.3.H1178; Gold DR, 2003, PEDIATR PULM, V36, P514, DOI 10.1002/ppul.10376; Hallstrand TS, 2005, J ALLERGY CLIN IMMUN, V116, P1235, DOI 10.1016/j.jaci.2005.09.016; Hancox RJ, 2005, AM J RESP CRIT CARE, V171, P440, DOI 10.1164/rccm.200405-623OC; Heath SC, 1997, AM J HUM GENET, V61, P748, DOI 10.1086/515506; Hoshino M, 1998, J BIOL CHEM, V273, P4878, DOI 10.1074/jbc.273.9.4878; Hunninghake GM, 2008, AM J RESP CRIT CARE, V177, P830, DOI 10.1164/rccm.200711-1697OC; Iyer D, 2006, P NATL ACAD SCI USA, V103, P4516, DOI 10.1073/pnas.0505338103; Jarvis D, 2002, CLIN EXP ALLERGY, V32, P831, DOI 10.1046/j.1365-2222.2002.01380.x; Koppelman GH, 2002, J ALLERGY CLIN IMMUN, V109, P498, DOI 10.1067/mai.2002.122235; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lange C, 2003, BIOSTATISTICS, V4, P195, DOI 10.1093/biostatistics/4.2.195; Lange C, 2004, AM J HUM GENET, V74, P367, DOI 10.1086/381563; Lange C., 2004, STAT APPL GENET MOL, V3, P17, DOI [DOI 10.2202/1544-6115.1067, 10.2202/1544-6115.1067]; LEE MW, 1994, AM J PHYSIOL, V267, pC659, DOI 10.1152/ajpcell.1994.267.3.C659; Letiges M, 2002, MOL ENDOCRINOL, V16, P847, DOI 10.1210/me.16.4.847; Little DP, 1997, NAT MED, V3, P1413, DOI 10.1038/nm1297-1413; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; McGowan K, 1996, J CELL PHYSIOL, V167, P113, DOI 10.1002/(SICI)1097-4652(199604)167:1<113::AID-JCP13>3.0.CO;2-C; McGraw DW, 2007, J CLIN INVEST, V117, P1391, DOI 10.1172/JCI30489; Michie AM, 2005, IMMUNOL LETT, V96, P155, DOI 10.1016/j.imlet.2004.08.013; Miele C, 2003, J BIOL CHEM, V278, P47376, DOI 10.1074/jbc.M301088200; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; Norris JM, 2005, INT J OBESITY, V29, P67, DOI 10.1038/sj.ijo.0802793; OLIPHANT A, 2002, BIOTECHNIQUES S, V56, P60; Oriente F, 2005, J BIOL CHEM, V280, P40642, DOI 10.1074/jbc.M508570200; Perusse L, 2001, DIABETES, V50, P614, DOI 10.2337/diabetes.50.3.614; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Ranganathan G, 2002, J BIOL CHEM, V277, P38669, DOI 10.1074/jbc.M206917200; Roeder K, 2006, AM J HUM GENET, V78, P243, DOI 10.1086/500026; Romieu I, 2004, PEDIATR PULM, V38, P31, DOI 10.1002/ppul.20042; Romieu I, 2003, AM J EPIDEMIOL, V158, P165, DOI 10.1093/aje/kwg131; Salamanca DA, 2005, BIOCHEM PHARMACOL, V70, P1537, DOI 10.1016/j.bcp.2005.07.017; Shaheen SO, 1999, THORAX, V54, P396, DOI 10.1136/thx.54.5.396; Song JS, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-28; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Steemers Frank J., 2007, Biotechnology Journal, V2, P41, DOI 10.1002/biot.200600213; Stone S, 2002, AM J HUM GENET, V70, P1459, DOI 10.1086/340670; Sutton BS, 2006, INT J OBESITY, V30, P1433, DOI 10.1038/sj.ijo.0803298; Szefler S, 2000, NEW ENGL J MED, V343, P1054; Tantisira KG, 2001, THORAX, V56, P64; Thomsen SF, 2007, ALLERGY, V62, P1199, DOI 10.1111/j.1398-9995.2007.01480.x; Whittemore AS, 2005, GENET EPIDEMIOL, V28, P244, DOI 10.1002/gepi.20055; NAT GENET, V15, P389	69	50	53	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 10	2009	85	1					87	96		10.1016/j.ajhg.2009.06.011	http://dx.doi.org/10.1016/j.ajhg.2009.06.011			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	470RO	19576566	Green Published, Bronze			2022-12-18	WOS:000267997600010
J	Li, MD; Payne, TJ; Ma, JZ; Lou, XY; Zhang, D; Dupont, RT; Crews, KM; Somes, G; Williams, NJ; Elston, RC				Li, Ming D.; Payne, Thomas J.; Ma, Jennie Z.; Lou, Xiang-Yang; Zhang, Dong; Dupont, Randolph T.; Crews, Karen M.; Somes, Grant; Williams, Nancy J.; Elston, Robert C.			A genomewide search finds major susceptibility loci for nicotine dependence on chromosome 10 in African Americans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DUTCH SIBLING PAIRS; SMOKING-BEHAVIOR; LINKAGE ANALYSIS; GENETIC-ANALYSIS; IDENTIFY LOCI; SCAN; CIGARETTE; ALCOHOL; TOBACCO; TWINS	Epidemiological studies have demonstrated that genetic factors account for at least 50% of the liability for nicotine dependence (ND). Although several linkage studies have been conducted, all samples to date were primarily of European origin. In this study, we conducted a genomewide scan of 1,261 individuals, representing 402 nuclear families, of African American ( AA) origin. We examined 385 autosomal microsatellite markers for ND, which was assessed by smoking quantity (SQ), the Heaviness of Smoking Index (HSI), and the Fagerstrom Test for ND (FTND). After performing linkage analyses using various methods implemented in the GENEHUNTER and S. A. G. E. programs, we found a region near marker D10S1432 on chromosome 10q22 that showed a significant linkage to indexed SQ, with a maximum LOD score of 4.17 at 92 cM and suggestive linkage to HSI, SQ, and log-transformed SQ. Additionally, we identified three regions that met the criteria for suggestive linkage to at least one ND measure: on chromosomes 9q31 at marker D9S1825, 11p11 between markers D11S1993 and D11S1344, and 13q13 between markers D13S325 and D13S788. Other locations on chromosomes 15p11, 17q25, and 18q12 exhibited some evidence of linkage for ND (LOD > 11.44). The four regions with significant or suggestive linkage were positive for multiple ND measures by multiple statistical methods. Some of these regions have been linked to smoking behavior at nominally significant levels in other studies, which provides independent replication of the regions for ND in different cohorts. In summary, we found significant linkage on chromosome 10q22 and suggestive linkage on chromosomes 9, 11, and 13 for major genetic determinants of ND in an AA sample. Further analysis of these positive regions by fine mapping and/or association analysis is thus warranted. To our knowledge, this study represents the first genomewide linkage scan of ND in an AA sample.	Univ Virginia, Dept Psychiat Med, Charlottesville, VA 22911 USA; Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA 22911 USA; Univ Mississippi, Med Ctr, Ctr Tobacco Treatment Educ & Res, Jackson, MS 39216 USA; Univ Memphis, Dept Criminol & Criminal Justice, Memphis, TN 38152 USA; Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Dept Dent Hyg, Memphis, TN 38163 USA; Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA	University of Virginia; University of Virginia; University of Mississippi; University of Mississippi Medical Center; University of Memphis; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Case Western Reserve University	Li, MD (corresponding author), Univ Virginia, Dept Psychiat Med, 1670 Discovery Dr,Suite 110, Charlottesville, VA 22911 USA.	ml2km@virginia.edu	Payne, Thomas/R-4290-2019; Lou, Xiang-Yang/B-6291-2013	Payne, Thomas/0000-0002-9839-6255; 	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028356, R37GM028356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012844] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR003655, RR03655] Funding Source: Medline; NIDA NIH HHS [R01 DA012844, DA-12844] Funding Source: Medline; NIGMS NIH HHS [R37 GM028356, R01 GM028356, GM-28356] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bergen AW, 1999, GENET EPIDEMIOL, V17, pS55; Beuten J, 2005, AM J HUM GENET, V76, P859, DOI 10.1086/429839; Beuten J, 2005, AM J MED GENET B, V139B, P73, DOI 10.1002/ajmg.b.30231; BEUTEN J, 2006, ASS SPECIFIC HAPLOTY; Bierut LJ, 2004, AM J MED GENET A, V124A, P19, DOI 10.1002/ajmg.a.20329; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; Centers for Disease Control and Prevention, 2002, MMWR-MORBID MORTAL W, V51, P642; Daza P, 2006, SUBST USE MISUSE, V41, P317, DOI 10.1080/10826080500410884; Duggirala R, 1999, GENET EPIDEMIOL, V17, pS139; Ehlers CL, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-9; Fallin MD, 2005, AM J HUM GENET, V77, P918, DOI 10.1086/497703; Gelernter J, 2004, AM J MED GENET B, V128B, P94, DOI 10.1002/ajmg.b.30019; Goode EL, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S102; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hwang YY, 2006, PROTEOMICS, V6, P3138, DOI 10.1002/pmic.200500745; Kabbani N, 2004, CELL SIGNAL, V16, P497, DOI 10.1016/j.cellsig.2003.09.011; Kendler KS, 1999, PSYCHOL MED, V29, P299, DOI 10.1017/S0033291798008022; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Li MD, 2003, ADDICTION, V98, P23, DOI 10.1046/j.1360-0443.2003.00295.x; Li MD, 2004, CLIN GENET, V66, P382, DOI 10.1111/j.1399-0004.2004.00302.x; Li MD, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S103; Maes HH, 1999, J STUD ALCOHOL, V60, P293, DOI 10.15288/jsa.1999.60.293; Morley KI, 2006, BEHAV GENET, V36, P87, DOI 10.1007/s10519-005-9004-0; Nyholt DR, 2000, AM J HUM GENET, V67, P282, DOI 10.1086/303029; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Perez-Stable EJ, 1998, JAMA-J AM MED ASSOC, V280, P152, DOI 10.1001/jama.280.2.152; Saccone NL, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S105; Shete S, 2003, HUM HERED, V55, P79, DOI 10.1159/000072312; Straub RE, 1999, MOL PSYCHIATR, V4, P129, DOI 10.1038/sj.mp.4000518; Sullivan P F, 1999, Nicotine Tob Res, V1 Suppl 2, pS51; Swan G E, 1990, J Subst Abuse, V2, P39; Swan GE, 1996, J SUBST ABUSE, V8, P19, DOI 10.1016/S0899-3289(96)90055-3; True WR, 1999, ARCH GEN PSYCHIAT, V56, P655, DOI 10.1001/archpsyc.56.7.655; US Department of Health and Human Services, 1998, TOB US US RAC ETHN M; Vink JM, 2006, BEHAV GENET, V36, P100, DOI 10.1007/s10519-005-9012-0; Vink JM, 2004, PHARMACOGENOMICS J, V4, P274, DOI 10.1038/sj.tpj.6500255; Wang D, 2005, PHARMACOGENOMICS J, V5, P166, DOI 10.1038/sj.tpj.6500304; World Health Organisation, 2002, WORLD HLTH REPORT 20	38	50	50	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2006	79	4					745	751		10.1086/508208	http://dx.doi.org/10.1086/508208			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	089BV	16960812	Green Published, Bronze			2022-12-18	WOS:000240855900017
J	Webb, EL; Rudd, MF; Houlston, RS				Webb, Emily L.; Rudd, Mathew F.; Houlston, Richard S.			Colorectal cancer risk in monoallelic carriers of MYH variants	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							MUTATIONS; GENE; SUSCEPTIBILITY; ASSOCIATION; POLYPOSIS		Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England	University of London; Institute of Cancer Research - UK	Houlston, RS (corresponding author), Inst Canc Res, Sect Canc Genet, Brookes Lawley Bldg, Sutton SM2 5NG, Surrey, England.	Richard.houlston@icr.ac.uk		Houlston, Richard/0000-0002-5268-0242; Webb, Emily/0000-0002-4019-7456				Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Chatterjee N, 2001, BIOMETRICS, V57, P245, DOI 10.1111/j.0006-341X.2001.00245.x; Croitoru ME, 2004, JNCI-J NATL CANCER I, V96, P1631, DOI 10.1093/jnci/djh288; Enholm S, 2003, AM J PATHOL, V163, P827, DOI 10.1016/S0002-9440(10)63443-8; Farrington SM, 2005, AM J HUM GENET, V77, P112, DOI 10.1086/431213; Fleischmann C, 2004, INT J CANCER, V109, P554, DOI 10.1002/ijc.20020; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kambara T, 2004, GENE CHROMOSOME CANC, V40, P1, DOI 10.1002/gcc.20011; Martin DO, 2000, EPIDEMIOLOGY, V11, P255, DOI 10.1097/00001648-200005000-00005; Peterlongo P, 2005, INT J CANCER, V114, P505, DOI 10.1002/ijc.20767; Sieber OM, 2003, NEW ENGL J MED, V348, P791, DOI 10.1056/NEJMoa025283; Wang L, 2004, GASTROENTEROLOGY, V127, P9, DOI 10.1053/j.gastro.2004.03.070; Zhou XL, 2005, GENET TEST, V9, P147, DOI 10.1089/gte.2005.9.147	13	50	53	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2006	79	4					768	771		10.1086/507912	http://dx.doi.org/10.1086/507912			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	089BV	16960817	Green Published, Bronze			2022-12-18	WOS:000240855900022
J	Modi, WS; Lautenberger, J; An, P; Scott, K; Goedert, JJ; Kirk, GD; Buchbinder, S; Phair, J; Donfield, S; O'Brien, SJ; Winkler, C				Modi, William S.; Lautenberger, James; An, Ping; Scott, Kevin; Goedert, James J.; Kirk, Gregory D.; Buchbinder, Susan; Phair, John; Donfield, Sharyne; O'Brien, Stephen J.; Winkler, Cheryl			Genetic variation in the CCL18-CCL3-CCL4 chemokine gene cluster influences HIV type 1 transmission and AIDS disease progression	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ANTIRETROVIRAL THERAPY; CHEMOTACTIC CYTOKINES; VIRUS-REPLICATION; T-CELLS; INFECTION; RANTES; COHORT; MIP-1-ALPHA; HEMOPHILIA; CCR5	CCL3 ( MIP-1 alpha), CCL4 ( MIP-1 beta), and CCL18 ( DC-CK1/PARC/AMAC-1) are potent chemoattractants produced by macrophages, natural killer cells, fibroblasts, mast cells, CD4(+) T cells, and CD8(+) T cells. CCL3 and CCL4 are natural ligands for the primary human immunodeficiency virus type 1 ( HIV-1) coreceptor CCR5 and are also known to activate and enhance the cytotoxicity of natural killer cells. Genomic DNAs from 13,000 participants enrolled in five United States based natural-history cohorts with acquired immunodeficiency syndrome ( AIDS) were genotyped for 21 single-nucleotide polymorphisms ( SNPs) in a 47-kb interval on chromosome 17q12 containing the genes CCL3, CCL4, and CCL18. All 21 SNPs were polymorphic in African Americans ( AAs), whereas 7 of the 21 had minor-allele frequencies < 0.01 in European Americans ( EAs). Substantial linkage disequilibrium was observed in a 37-kb interval containing 17 SNPs where many pairwise D' values exceeded 0.70 in both racial groups, but particularly in EAs. Four and three haplotype blocks were observed in AAs and EAs, respectively. Blocks were strongly correlated with each other, and common haplotype diversity within blocks was limited. Two significant associations are reported that replicate an earlier study. First, among AA members of the AIDS Link to the Intravenous Experience cohort of injection drug users, frequencies of three correlated SNPs covering 2,231 bp in CCL3 were significantly elevated among highly exposed, persistently HIV-1-uninfected individuals compared with HIV-1-infected seroconvertors (). Second, seven highly correlated SNPs spanning P = .02 -. 03 36 kb and containing all three genes were significantly associated with more-rapid disease progression among EAs enrolled in the Multicenter AIDS Cohort Study cohort (). These results reiterate the importance of chemokine gene P = .01 -. 02 variation in HIV-1/AIDS pathogenesis and emphasize that localized linkage disequilibrium makes the identification of causal mutations difficult.	NCI, SAIC Frederick, Basic Res Program, Frederick, MD 21702 USA; NCI, Lab Genom Divers, Frederick, MD 21702 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; NCI, Viral Epidemiol Branch, Rockville, MD USA; San Francisco Dept Publ Hlth, San Francisco, CA USA; Northwestern Univ, Sch Med, Dept Med, Evanston, IL USA; Rho Inc, Chapel Hill, NC USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); San Francisco Department of Public Health; Northwestern University; Rho	Winkler, C (corresponding author), NCI, SAIC Frederick, Basic Res Program, Frederick, MD 21702 USA.	winkler@ncifcrf.gov	OBRIEN, STEPHEN/ABD-1346-2020; Kirk, Gregory/A-8484-2009	OBRIEN, STEPHEN/0000-0001-7857-0757; An, Ping/0000-0002-5322-3510	Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [N01-CO-12400, N01CO12400] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC010297, Z01BC010317] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139; An P, 2002, P NATL ACAD SCI USA, V99, P10002, DOI 10.1073/pnas.142313799; [Anonymous], 1987, MMWR-MORBID MORTAL W, V36, p1S; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; *CDCP, 1992, MMWR-MORBID MORTAL W, V41, P1; Celentano DD, 2001, AIDS, V15, P1707, DOI 10.1097/00002030-200109070-00015; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; DETELS R, 1994, J ACQ IMMUN DEF SYND, V7, P1263; Detels R, 1998, JAMA-J AM MED ASSOC, V280, P1497, DOI 10.1001/jama.280.17.1497; DeVico AL, 2004, NAT REV MICROBIOL, V2, P401, DOI 10.1038/nrmicro878; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; GOEDERT JJ, 1989, NEW ENGL J MED, V321, P1141, DOI 10.1056/NEJM198910263211701; Gonzalez E, 2001, P NATL ACAD SCI USA, V98, P5199, DOI 10.1073/pnas.091056898; Gross E, 2003, J LEUKOCYTE BIOL, V74, P781, DOI 10.1189/jlb.0403187; Gunther C, 2005, J IMMUNOL, V174, P1723, DOI 10.4049/jimmunol.174.3.1723; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; HILGARTNER MW, 1993, AM J PEDIAT HEMATOL, V15, P208; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; KRONER BL, 1994, J ACQ IMMUN DEF SYND, V7, P279; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; MACKEWICZ C, 1992, AIDS RES HUM RETROV, V8, P1039, DOI 10.1089/aid.1992.8.1039; McDermott DH, 2000, AIDS, V14, P2671, DOI 10.1097/00002030-200012010-00006; Modi WS, 2005, GENES IMMUN, V6, P691, DOI 10.1038/sj.gene.6364258; Modi WS, 2004, GENOMICS, V83, P735, DOI 10.1016/j.ygeno.2003.09.019; Modi WS, 2003, AIDS, V17, P2357, DOI 10.1097/00002030-200311070-00011; NAKAO M, 1990, MOL CELL BIOL, V10, P3646, DOI 10.1128/MCB.10.7.3646; Ober C, 2005, J ALLERGY CLIN IMMUN, V116, P274, DOI 10.1016/j.jaci.2005.04.039; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; RUTHERFORD GW, 1990, BRIT MED J, V301, P1183, DOI 10.1136/bmj.301.6762.1183; Signoret N, 1998, J CELL SCI, V111, P2819; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Vila-Coro AJ, 2000, P NATL ACAD SCI USA, V97, P3388, DOI 10.1073/pnas.050457797; Vlahov D, 1998, JAMA-J AM MED ASSOC, V279, P35, DOI 10.1001/jama.279.1.35; WALKER CM, 1986, SCIENCE, V234, P1563, DOI 10.1126/science.2431484; Weiss RA, 2004, NAT MED, V10, pS70, DOI 10.1038/nm1150; Winkler C, 2004, HUM MOL GENET, V13, pR9, DOI 10.1093/hmg/ddh075; Xin X, 2001, GENES IMMUN, V2, P156, DOI 10.1038/sj.gene.6363759	39	50	51	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2006	79	1					120	128		10.1086/505331	http://dx.doi.org/10.1086/505331			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	053YD	16773571	Bronze, Green Published			2022-12-18	WOS:000238341200012
J	Farrer, MJ; Haugarvoll, K; Ross, OA; Stone, JT; Whittle, AJ; Lincoln, SJ; Hulihan, MM; Heckman, MG; White, LR; Aasly, JO; Gibson, JM; Gosal, D; Lynch, T; Wszolek, ZK; Uitti, RJ; Toft, M				Farrer, Matthew J.; Haugarvoll, Kristoffer; Ross, Owen A.; Stone, Jeremy T.; Whittle, Andrew J.; Lincoln, Sarah J.; Hulihan, Mary M.; Heckman, Michael G.; White, Linda R.; Aasly, Jan O.; Gibson, J. Mark; Gosal, David; Lynch, Timothy; Wszolek, Zbigniew K.; Uitti, Ryan J.; Toft, Mathias			Genomewide association, Parkinson disease, and PARK10	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							FACTOR-H POLYMORPHISM; MACULAR DEGENERATION; LINKAGE DISEQUILIBRIUM; WIDE ASSOCIATION; AGE; SUSCEPTIBILITY; ONSET; GENE		Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA; Mayo Clin, Coll Med, Dept Neurol, Jacksonville, FL 32224 USA; Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; St Olavs Hosp, Dept Neurol, Trondheim, Norway; Royal Victoria Hosp, Dept Neurol, Belfast BT12 6BA, Antrim, North Ireland; Mater Misericordiae Hosp, Dept Neurol, Dublin 7, Ireland; Univ Coll Dublin, Conway Inst, Dublin 2, Ireland	Mayo Clinic; Mayo Clinic; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Mater Misericordiae University Hospital; University College Dublin; University College Dublin	Ross, OA (corresponding author), Mayo Clin, Coll Med, Dept Neurosci, Birdsall Bldg,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	ross.owen@mayo.edu	Haugarvoll, Kristoffer/AAB-5860-2019; Ross, Owen/D-7573-2013; Lynch, Timothy/M-1316-2019; Sander-Effron, Samuel/AAX-2231-2020; Resource Center, NINDS Human Genetics/AGF-2474-2022; Wszolek, Zbigniew K./AAB-1431-2019; Toft, Mathias/AAY-5212-2021; Haugarvoll, Kristoffer/L-1486-2015	Haugarvoll, Kristoffer/0000-0001-9381-1109; Haugarvoll, Kristoffer/0000-0001-9381-1109; Toft, Mathias/0000-0002-6723-6865; Whittle, Andrew/0000-0002-3181-8855; Ross, Owen/0000-0003-4813-756X; Farrer, Matthew/0000-0003-1159-5321	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS040256, R01NS036960] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS40256, R01 NS36960, R01 NS036960, P01 NS040256] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hattersley AT, 2005, LANCET, V366, P1315, DOI 10.1016/S0140-6736(05)67531-9; Helgason A, 2000, AM J HUM GENET, V67, P697, DOI 10.1086/303046; Hicks AA, 2002, ANN NEUROL, V52, P549, DOI 10.1002/ana.10324; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Kachergus J, 2005, AM J HUM GENET, V76, P672, DOI 10.1086/429256; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Li YJ, 2002, AM J HUM GENET, V70, P985, DOI 10.1086/339815; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Pals P, 2004, ANN NEUROL, V56, P591, DOI 10.1002/ana.20268; Ross OA, 2005, BIOCHEM SOC T, V33, P586, DOI 10.1042/BST0330586; Skipper L, 2004, AM J HUM GENET, V75, P669, DOI 10.1086/424492; Tapper WJ, 2003, ANN HUM GENET, V67, P487, DOI 10.1046/j.1469-1809.2003.00050.x; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522	19	50	50	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2006	78	6					1084	1088		10.1086/504728	http://dx.doi.org/10.1086/504728			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	042TZ	16685661	Green Published, Bronze			2022-12-18	WOS:000237553800020
J	Brown, PW; Judis, L; Chan, ER; Schwartz, S; Seftel, A; Thomas, A; Hassold, TJ				Brown, PW; Judis, L; Chan, ER; Schwartz, S; Seftel, A; Thomas, A; Hassold, TJ			Meiotic synapsis proceeds from a limited number of subtelomeric sites in the human male	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOUBLE-STRAND BREAKS; SYNAPTONEMAL COMPLEX; MEIOSIS-I; RECOMBINATION NODULES; CHROMOSOME SYNAPSIS; CENTRAL ELEMENT; PHOSPHORYLATION; MECHANISM; PROPHASE; ENCODES	The formation of the synaptonemal complex (SC) is a crucial early step in the meiotic process, but relatively little is known about the establishment of the human SC. Accordingly, we recently initiated a study of synapsis in the human male, combining immunofluorescence and fluorescence in situ hybridization methodologies to analyze prophase spermatocytes from a series of control individuals. Our results indicate that synapsis is a tightly regulated process, with relatively little variation among individuals. On nonacrocentric chromosomes, there are two synaptic initiation sites, one on the distal short arm and one on the distal long arm, whereas acrocentric chromosomes exhibit a single site on the distal long arm. For both types of chromosomes, synapsis then proceeds toward the centromere, with little evidence that specific p- or q-arm sequences affect the process. However, the centromere appears to have an inhibitory effect on synapsis-that is, when one arm of a nonacrocentric chromosome is "zippered up" before the other, the centromere acts as a barrier to further movement from that arm.	Case Western Reserve Univ, Sch Med, Ctr Human Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Urol, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; Cleveland Clin Fdn, Glickman Urol Inst, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; Cleveland Clinic Foundation	Hassold, TJ (corresponding author), Washington State Univ, Sch Mol Biosci, 542 Fulmer Hall, Pullman, WA 99164 USA.	terryhassold@wsu.edu		Chan, Ernest/0000-0001-9277-5329	NICHD NIH HHS [HD42720, R01 HD042720, R37 HD021341, HD21341, R01 HD021341] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD021341] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042720, R01HD021341] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Anderson LK, 2005, P NATL ACAD SCI USA, V102, P4482, DOI 10.1073/pnas.0500172102; Barlow AL, 1998, ZYGOTE, V6, P27, DOI 10.1017/S0967199400005050; Barlow AL, 1996, CHROMOSOME RES, V4, P562, DOI 10.1007/BF02261719; Broman KW, 2000, AM J HUM GENET, V66, P1911, DOI 10.1086/302923; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; HOLM PB, 1977, CARLSBERG RES COMMUN, V42, P283, DOI 10.1007/BF02910454; Hunt PA, 2002, SCIENCE, V296, P2181, DOI 10.1126/science.1071907; Judis LA, 2004, FERTIL STERIL, V81, P205, DOI 10.1016/j.fertnstert.2003.05.021; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; LAMMERS JHM, 1995, CHROMOSOMA, V104, P154, DOI 10.1007/s004120050103; Lenzi ML, 2005, AM J HUM GENET, V76, P112, DOI 10.1086/427268; Liu JG, 1996, EXP CELL RES, V226, P11, DOI 10.1006/excr.1996.0197; Lynn A, 2002, SCIENCE, V296, P2222, DOI 10.1126/science.1071220; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; McIlwraith MJ, 2000, J MOL BIOL, V304, P151, DOI 10.1006/jmbi.2000.4180; McKim KS, 1998, GENE DEV, V12, P2932, DOI 10.1101/gad.12.18.2932; McKim KS, 1998, SCIENCE, V279, P876, DOI 10.1126/science.279.5352.876; Page SL, 2001, GENE DEV, V15, P3130, DOI 10.1101/gad.935001; RASMUSSEN SW, 1978, CARLSBERG RES COMMUN, V43, P275, DOI 10.1007/BF02906106; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Scherthan H, 1996, J CELL BIOL, V134, P1109, DOI 10.1083/jcb.134.5.1109; Schmekel K, 1998, CHROMOSOME RES, V6, P155, DOI 10.1023/A:1009295115033; SPEED RM, 1990, HUM GENET, V84, P547; SPEED RM, 1984, HUM GENET, V66, P176, DOI 10.1007/BF00286596; Sun F, 2005, HUM GENET, V116, P172, DOI 10.1007/s00439-004-1215-6; SYM M, 1994, CELL, V79, P283, DOI 10.1016/0092-8674(94)90197-X; Tease C, 2004, CYTOGENET GENOME RES, V107, P208, DOI 10.1159/000080599; WALLACE BMN, 1983, ANN HUM GENET, V47, P271, DOI 10.1111/j.1469-1809.1983.tb00996.x; WALLACE BMN, 1985, ANN HUM GENET, V49, P215, DOI 10.1111/j.1469-1809.1985.tb01695.x; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	35	50	53	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2005	77	4					556	566		10.1086/468188	http://dx.doi.org/10.1086/468188			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967QS	16175502	Green Published, Bronze			2022-12-18	WOS:000232106900004
J	Purcell, S; Sham, P; Daly, MJ				Purcell, S; Sham, P; Daly, MJ			Parental phenotypes in family-based association analysis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE TRAITS; LINKAGE; DISEQUILIBRIUM; TESTS; POWER	Family-based association designs are popular, because they offer inherent control of population stratification based on age, sex, ethnicity, and environmental exposure. However, the efficiency of these designs is hampered by current analytic strategies that consider only offspring phenotypes. Here, we describe the incorporation of parental phenotypes and, specifically, the inclusion of parental genotype-phenotype correlation terms in association tests, providing a series of tests that effectively span an efficiency-robustness spectrum. The model is based on the between-within-sibship association model presented in 1999 by Fulker and colleagues for quantitative traits and extended here to nuclear families. By use of a liability-threshold-model approach, standard dichotomous and/or qualitative disease phenotypes can be analyzed (and can include appropriate corrections for phenotypically ascertained samples), which allows for the application of this model to analysis of the commonly used affected-proband trio design. We show that the incorporation of parental phenotypes can considerably increase power, as compared with the standard transmission/disequilibrium test and equivalent quantitative tests, while providing both significant protection against stratification and a means of evaluating the contribution of stratification to positive results. This methodology enables the extraction of more information from existing family-based collections that are currently being genotyped and analyzed by use of standard approaches.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Res Ctr, London WC2R 2LS, England; Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Genome Res Ctr, Hong Kong, Hong Kong, Peoples R China	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of London; King's College London; University of Hong Kong; University of Hong Kong	Purcell, S (corresponding author), 9 Cambridge Ctr, Cambridge, MA 02142 USA.	purcell@wi.mit.edu	Daly, Mark J/B-2453-2017	Daly, Mark J/0000-0002-0949-8752	NATIONAL EYE INSTITUTE [R01EY012562] Funding Source: NIH RePORTER; NEI NIH HHS [EY-12562, R01 EY012562] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abecasis GR, 2000, EUR J HUM GENET, V8, P545, DOI 10.1038/sj.ejhg.5200494; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; PURCELL S, IN PRESS HUM HERED; Sham PC, 2000, AM J HUM GENET, V66, P1616, DOI 10.1086/302891; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Whittaker JC, 1998, AM J HUM GENET, V63, P889, DOI 10.1086/302008	9	50	52	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2005	76	2					249	259		10.1086/427886	http://dx.doi.org/10.1086/427886			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	886GO	15614722	Green Published, Bronze			2022-12-18	WOS:000226215100010
J	Venken, T; Claes, S; Sluijs, S; Paterson, AD; van Duijn, C; Adolfsson, R; Del-Favero, J; Van Broeckhoven, C				Venken, T; Claes, S; Sluijs, S; Paterson, AD; van Duijn, C; Adolfsson, R; Del-Favero, J; Van Broeckhoven, C			Genomewide scan for affective disorder susceptibility loci in families of a northern Swedish isolated population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BIPOLAR DISORDER; LINKAGE ANALYSIS; WIDE SCAN; SCHIZOPHRENIA; PEDIGREES; GENETICS; SCREEN; RECOMBINATION; CHROMOSOME-9; METAANALYSIS	We analyzed nine multigenerational families with ascertained affective spectrum disorders in northern Sweden's geographically isolated population of Vasterbotten. This northern Swedish population, which originated from a limited number of early settlers similar to8,000 years ago, is genetically more homogeneous than outbred populations. In a genomewide linkage analysis, we identified three chromosomal loci with multipoint LOD scores (MPLOD) greater than or equal to2 at 9q31.1-q34.1 (MPLOD 3.24), 6q22.2-q24.2 (MPLOD 2.48), and 2q33-q36 (MPLOD 2.26) under a recessive affected-only model. Follow-up genotyping with application of a 2-cM density simple-tandem-repeat (STR) map confirmed linkage at 9q31.1-q34.1 (MPLOD 3.22), 6q23-q24 (MPLOD 3.25), and 2q33-q36 (MPLOD 2.2). In an initial analysis aimed at identification of the underlying susceptibility genes, we focused our attention on the 9q locus. We fine mapped this region at a 200-kb STR density, with the result of an MPLOD of 3.70. Genealogical studies showed that three families linked to chromosome 9q descended from common founder couples similar to10 generations ago. In this similar to10-generation pedigree, a common ancestral haplotype was inherited by the patients, which reduced the 9q candidate region to 1.6 Mb. Further, the shared haplotype was observed in 4.2% of patients with bipolar disorder with alternating episodes of depression and mania, but it was not observed in control individuals in a patient-control sample from the Vasterbotten isolate. These results suggest a susceptibility locus on 9q31-q33 for affective disorder in this common ancestral region.	Univ Antwerp VIB, Dept Mol Genet, B-2020 Antwerp, Belgium; Univ Antwerp Hosp, Dept Psychiat, Antwerp, Belgium; Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Publ Hlth Serv, Toronto, ON, Canada; Erasmus MC, Dept Epidemiol & Biostat, Rotterdam, Netherlands; Umea Univ, Div Psychiat, Dept Clin Sci, Umea, Sweden	Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Erasmus University Rotterdam; Erasmus MC; Umea University	Van Broeckhoven, C (corresponding author), Univ Antwerp, Dept Mol Genet VIB8, Campus Drie Eiken,Univ Pl 1, B-2610 Antwerp, Belgium.	christine.vanbroeckhoven@ua.ac.be	Paterson, Andrew D/A-4088-2011; Paterson, Andrew/AAQ-7511-2020; Van Broeckhoven, Christine/M-7853-2019; Van Broeckhoven, Christine/G-8362-2017	Paterson, Andrew D/0000-0002-9169-118X; Paterson, Andrew/0000-0002-9169-118X; Van Broeckhoven, Christine/0000-0003-0183-7665; Van Broeckhoven, Christine/0000-0003-0183-7665; Van Duijn, Cornelia/0000-0002-2374-9204; Adolfsson, Rolf/0000-0001-9785-8473; Claes, Stephan/0000-0002-1175-492X; Del Favero, jurgen/0000-0002-7427-7489				Badenhop RF, 2002, MOL PSYCHIATR, V7, P594, DOI 10.1038/sj.mp.4001025; Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; Bailer U, 2002, BIOL PSYCHIAT, V52, P40, DOI 10.1016/S0006-3223(02)01320-3; Balciuniene J, 1998, MOL PSYCHIATR, V3, P162, DOI 10.1038/sj.mp.4000372; Baron M, 2002, MOL PSYCHIATR, V7, P342, DOI 10.1038/sj.mp.4000998; Bennett P, 2002, MOL PSYCHIATR, V7, P189, DOI 10.1038/sj.mp.4000957; Chumakov I, 2002, P NATL ACAD SCI USA, V99, P13675, DOI 10.1073/pnas.182412499; Cichon S, 2001, HUM MOL GENET, V10, P2933, DOI 10.1093/hmg/10.25.2933; Craddock N, 1999, J MED GENET, V36, P585, DOI 10.1136/jmg.36.8.585; DeteraWadleigh SD, 1997, AM J MED GENET, V74, P254, DOI 10.1002/(SICI)1096-8628(19970531)74:3<254::AID-AJMG4>3.0.CO;2-Q; Dick DM, 2003, AM J HUM GENET, V73, P107, DOI 10.1086/376562; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Ewald H, 2002, MOL PSYCHIATR, V7, P734, DOI 10.1038/sj.mp.4001074; Ewald H, 2003, AM J MED GENET B, V120B, P63, DOI 10.1002/ajmg.b.20039; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kruglyak L, 1998, J COMPUT BIOL, V5, P1, DOI 10.1089/cmb.1998.5.1; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Lerer B, 2003, MOL PSYCHIATR, V8, P488, DOI 10.1038/sj.mp.4001322; Lindblad WJ, 2004, WOUND REPAIR REGEN, V12, P1, DOI 10.1111/j.1067-1927.2004.012103.x; Lindholm E, 2001, AM J HUM GENET, V69, P96, DOI 10.1086/321288; Liu J, 2003, MOL PSYCHIATR, V8, P333, DOI 10.1038/sj.mp.4001254; Majewski J, 2000, GENOME RES, V10, P1108, DOI 10.1101/gr.10.8.1108; Middleton FA, 2004, AM J HUM GENET, V74, P886, DOI 10.1086/420775; Muller-Oerlinghausen B, 2002, LANCET, V359, P241, DOI 10.1016/S0140-6736(02)07450-0; Nilsson LG, 1997, AGING NEUROPSYCHOL C, V4, P1, DOI 10.1080/13825589708256633; NYLANDER PO, 1991, HUM HERED, V41, P157, DOI 10.1159/000153995; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Paunio T, 2001, HUM MOL GENET, V10, P3037, DOI 10.1093/hmg/10.26.3037; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Segurado R, 2003, AM J HUM GENET, V73, P49, DOI 10.1086/376547; SHINK E, 2004, MOL PSYCHIAT    1019; Smoller JW, 2003, AM J MED GENET C, V123C, P48, DOI 10.1002/ajmg.c.20013; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; Thorgeirsson TE, 2003, AM J HUM GENET, V72, P1221, DOI 10.1086/375141; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; Wijsman EM, 2003, MOL PSYCHIATR, V8, P695, DOI 10.1038/sj.mp.4001356; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589; Zhao JH, 2000, HUM HERED, V50, P133, DOI 10.1159/000022901	42	50	50	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2005	76	2					237	248		10.1086/427836	http://dx.doi.org/10.1086/427836			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	886GO	15614721	Green Published, Bronze			2022-12-18	WOS:000226215100009
J	Tukel, T; Shalata, A; Present, D; Rachmilewitz, D; Mayer, L; Grant, D; Risch, N; Desnick, RJ				Tukel, T; Shalata, A; Present, D; Rachmilewitz, D; Mayer, L; Grant, D; Risch, N; Desnick, RJ			Crohn disease: Frequency and nature of CARD15 mutations in Ashkenazi and Sephardi/Oriental Jewish families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; SUSCEPTIBILITY LOCI; HAPLOTYPE STRUCTURE; JAPANESE PATIENTS; GENETIC-VARIATION; NOD2 VARIANTS; KAPPA-B; ASSOCIATION; RISK; POPULATION	Crohn disease ( CD), an inflammatory bowel disease, is a multifactorial trait with the highest frequency in Ashkenazi Jewish (AJ) individuals of Central European origin. Recently, three common predisposing CARD15 mutations (R702W, G908R, and 1007fs) and a polymorphism (P268S) were identified. To determine whether CARD15 mutations account for the higher prevalence of CD in AJ individuals, the haplotypes and allele frequencies of the common mutations and variants were assessed in 219 members of 50 AJ and 53 members of 10 Sephardi/ Oriental Jewish (SOJ) multiplex families with CD, in 36 AJ patients with sporadic CD, and in 246 AJ and 82 SOJ controls. A higher frequency of CARD15 mutations was found in AJ patients from multiplex families with CD from Central (44.0%) versus Eastern (24.0%) Europe, especially for G908R and 1007fs, and in SOJ patients (34.5%) compared with AJ (10.1%) or SOJ (5.4%) controls. Contrary to expectation, the frequency of the common mutations was slightly lower in AJ patients with CD ( 30.1%) than in SOJ patients with CD ( 34.5%). The 702W allele was associated with both the P268 and 268S alleles. CARD15 mutation frequencies were greater in affected sib pairs than in sporadic CD cases but actually decreased in families with three or more affected sibs, raising the possibility of genetic heterogeneity. Similarly, our linkage evidence on chromosome 16 was diminished in the families with three or more affected sibs compared with sib pairs. Screening the CARD15 gene for rare variants revealed five novel changes (D113N, D357A, I363F, L550V, and N852S) of which N852S occurred only in AJ individuals and may be disease predisposing. Also, there was no evidence for increased risk associated with the recently described IVS+158 single-nucleotide polymorphism. Although the AJ controls appear to have a higher frequency of CARD15 mutations than the SOJ controls, it is unlikely that this difference fully explains the excess frequency of CD in the AJ population.	NYU, Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; NYU, Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; NYU, Mt Sinai Sch Med, Dept Immunobiol, New York, NY 10029 USA; NYU, Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; Shaare Zedek Med Ctr, Dept Med, IL-91000 Jerusalem, Israel; Istanbul Univ, Inst Expt Med DETAE, Dept Genet, Istanbul, Turkey; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Icahn School of Medicine at Mount Sinai; New York University; Icahn School of Medicine at Mount Sinai; New York University; Icahn School of Medicine at Mount Sinai; New York University; Icahn School of Medicine at Mount Sinai; New York University; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Istanbul University; Stanford University	Desnick, RJ (corresponding author), NYU, Mt Sinai Sch Med, Dept Human Genet, 1425 Madison Ave,Box 1498, New York, NY 10029 USA.	rjdesnick@mssm.edu						Ahmad T, 2001, ALIMENT PHARM THER, V15, P731, DOI 10.1046/j.1365-2036.2001.00981.x; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; Binder V, 1998, DIGEST DIS, V16, P351, DOI 10.1159/000016891; Bonen DK, 2003, GASTROENTEROLOGY, V124, P140, DOI 10.1053/gast.2003.50019; Bonen DK, 2002, GASTROENTEROLOGY, V122, pA29; Cavanaugh J, 2001, AM J HUM GENET, V68, P1165, DOI 10.1086/320119; Cavanaugh JA, 2003, ANN HUM GENET, V67, P35, DOI 10.1046/j.1469-1809.2003.00006.x; Chamaillard M, 2002, AM J HUM GENET, V71, P191; Cho JH, 1998, P NATL ACAD SCI USA, V95, P7502, DOI 10.1073/pnas.95.13.7502; Croucher PJP, 2003, EUR J HUM GENET, V11, P6, DOI 10.1038/sj.ejhg.5200897; Cuthbert AP, 2002, GASTROENTEROLOGY, V122, P867, DOI 10.1053/gast.2002.32415; Duerr RH, 1998, AM J HUM GENET, V63, P95, DOI 10.1086/301929; Edelmann L, 2002, AM J HUM GENET, V70, P1023, DOI 10.1086/339519; Hampe J, 2002, LANCET, V359, P1661, DOI 10.1016/S0140-6736(02)08590-2; Hampe J, 1999, AM J HUM GENET, V64, P808, DOI 10.1086/302294; Hampe J, 1999, AM J HUM GENET, V65, P1647, DOI 10.1086/302677; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Inoue N, 2002, GASTROENTEROLOGY, V123, P86, DOI 10.1053/gast.2002.34155; KING RA, 1992, GENETIC BASIS COMMON; Kleinbaum D.G., 1982, EPIDEMIOLOGIC RES PR; KURATA JH, 1992, GASTROENTEROLOGY, V102, P1940, DOI 10.1016/0016-5085(92)90317-R; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Ma YH, 1999, INFLAMM BOWEL DIS, V5, P271, DOI 10.1097/00054725-199911000-00005; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; PROBERT CSJ, 1993, GUT, V34, P1547, DOI 10.1136/gut.34.11.1547; Rioux JD, 2000, AM J HUM GENET, V66, P1863, DOI 10.1086/302913; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; ROTH MP, 1989, GASTROENTEROLOGY, V96, P1016, DOI 10.1016/0016-5085(89)91618-1; ROTH MP, 1989, GASTROENTEROLOGY, V97, P900, DOI 10.1016/0016-5085(89)91495-9; SONNENBERG A, 1991, GASTROENTEROLOGY, V100, P143, DOI 10.1016/0016-5085(91)90594-B; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Sugimura K, 2003, AM J HUM GENET, V72, P509, DOI 10.1086/367848; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Vermeire S, 2002, AM J HUM GENET, V71, P74, DOI 10.1086/341124; Yamazaki K, 2002, J HUM GENET, V47, P469, DOI 10.1007/s100380200067; YANG H, 1993, GUT, V34, P517, DOI 10.1136/gut.34.4.517; Yang HY, 2001, MOL GENET METAB, V74, P1, DOI 10.1006/mgme.2001.3199; Zhou ZF, 2002, AM J GASTROENTEROL, V97, P3095, DOI 10.1111/j.1572-0241.2002.07105.x; ZLOTOGORA J, 1990, GASTROENTEROLOGY, V99, P286, DOI 10.1016/0016-5085(90)91273-9	45	50	51	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2004	74	4					623	636		10.1086/382226	http://dx.doi.org/10.1086/382226			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	804EA	15024686	Green Published, Bronze			2022-12-18	WOS:000220280800003
J	Shete, S; Amos, CI				Shete, S; Amos, CI			Testing for genetic linkage in families by a variance-components approach in the presence of genomic imprinting	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE TRAIT; MODELS; POWER	Some genes that affect development and behavior in mammals are known to be imprinted; and greater than or equal to1% of all mammalian genes are imprinted. Hence, incorporating an imprinting parameter into linkage analysis may increase the power to detect linkage for these traits. Here we propose theoretical justifications for a recently developed model for testing of linkage, in the presence of genetic imprinting, between a quantitative-trait locus and a polymorphic marker; this is achieved in the variance-components framework. We also incorporate sex-specific recombination fractions into this model. We discuss the effects that imprinting and nonimprinting have on the power of the usual variance-components method and on the variance-components method that incorporates an imprinting parameter. We provide noncentrality parameters that can be used to determine the sample size necessary to attain a specified power for a given significance level, which is useful in the planning of a linkage study. Optimal strategies for a genome scan of potentially imprinted traits are discussed.	Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Shete, S (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, 1515 Holcombe Blvd, Houston, TX 77030 USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009912] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG002275, HG 02275] Funding Source: Medline; NIEHS NIH HHS [R01 ES009912, ES 09912] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AMOS CI, 1994, AM J HUM GENET, V54, P535; [Anonymous], 1997, GENETICS ANAL QUANTI; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; FANN CSJ, 1995, GENOMICS, V29, P571, DOI 10.1006/geno.1995.9964; Hanson RL, 2001, AM J HUM GENET, V68, P951, DOI 10.1086/319508; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Lalande M, 1996, ANNU REV GENET, V30, P173, DOI 10.1146/annurev.genet.30.1.173; Morison IM, 2001, NUCLEIC ACIDS RES, V29, P275, DOI 10.1093/nar/29.1.275; Pfeifer K, 2000, AM J HUM GENET, V67, P777, DOI 10.1086/303101; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Sage MR, 1997, INT J NEURORADIOL, V3, P1; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Sham PC, 2000, AM J HUM GENET, V66, P1616, DOI 10.1086/302891; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; Williams JT, 1999, ANN HUM GENET, V63, P545, DOI 10.1017/S0003480099007848	15	50	51	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2002	70	3					751	757		10.1086/338931	http://dx.doi.org/10.1086/338931			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	522DG	11836650	Green Published, Bronze			2022-12-18	WOS:000173880000017
J	Sieberts, SK; Wijsman, EM; Thompson, EA				Sieberts, SK; Wijsman, EM; Thompson, EA			Relationship inference from trios of individuals, in the presence of typing error	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOTYPING ERRORS; PAIR LINKAGE	Misspecification of relationships and of genotype data can cause problems in linkage analyses based on genome-scan data. Previous reports have focused on pairwise relationships and a simple error model. This article considers the increased information available from the joint analysis of trios of individuals, integrating this analysis with an error model that allows for the most common genotyping errors. Given observed marker phenotypes in a genome scan, computational methods are outlined both for likelihoods of relationships and for the posterior probabilities of underlying genotypes. The methods are applied to examples from two real data sets: one has been previously well analyzed, and, hence, Mendelian inconsistencies have been removed; the other typifies the pedigree and genotype errors encountered in the initial analyses of a study. It is demonstrated that the coupling of relationship inference and error detection is quite effective, that the error model is computationally practical, and that data on a third relative can often clarify relationships.	Univ Washington, Dept Stat, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Thompson, EA (corresponding author), Univ Washington, Dept Stat, Box 354322, Seattle, WA 98195 USA.			Wijsman, Ellen/0000-0002-2725-6669	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM046255, R01GM046255] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM046255, R37 GM046255, GM-46255] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAUM LE, 1970, ANN MATH STAT, V41, P164, DOI 10.1214/aoms/1177697196; Baum LE, 1972, INEQUALITIES, V3, P1; Begleiter H, 1995, ALCOHOL HEALTH RES W, V19, P228; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; Broman KW, 1998, AM J HUM GENET, V63, P1563, DOI 10.1086/302112; Broman KW, 1999, GENET EPIDEMIOL, V17, pS79; Browning S, 1999, AM J HUM GENET, V65, pA244; CARDON LR, 1995, SCIENCE, V268, P1553, DOI 10.1126/science.7777847; CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; Douglas JA, 2000, AM J HUM GENET, V66, P1287, DOI 10.1086/302861; Epstein MP, 2000, AM J HUM GENET, V67, P1219, DOI 10.1016/S0002-9297(07)62952-8; Ewen KR, 2000, AM J HUM GENET, V67, P727, DOI 10.1086/303048; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; Goring HHH, 1997, EUR J HUM GENET, V5, P69, DOI 10.1159/000484736; Kumm J, 1999, AM J HUM GENET, V65, pA208; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; THOMPSON EA, 1974, BIOMETRICS, V30, P667, DOI 10.2307/2529231	17	50	50	0	10	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2002	70	1					170	180		10.1086/338444	http://dx.doi.org/10.1086/338444			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	499LD	11727198	Green Published, Bronze			2022-12-18	WOS:000172571900015
J	Parvari, R; Brodyansky, I; Elpeleg, O; Moses, S; Landau, D; Hershkovitz, E				Parvari, R; Brodyansky, I; Elpeleg, O; Moses, S; Landau, D; Hershkovitz, E			A recessive contiguous gene deletion of chromosome 2p16 associated with cystinuria and a mitochondrial disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOCALIZATION	Deletions ranging from 100 Kb to 1 Mb-too small to be detected under the microscope-may still involve dozens of genes, thus causing microdeletion syndromes. The vast majority of these syndromes are caused by haploinsufficiency of one or several genes and are transmitted as dominant traits. We identified seven patients originating from an extended family and presenting with a unique syndrome, inherited in a recessive mode, consisting of cystinuria, neonatal seizures, hypotonia, severe somatic and developmental delay, facial dysmorphism, and lactic acidemia. Reduced activity of all the respiratory chain enzymatic complexes that are encoded in the mitochondria was found in muscle biopsy specimens of the patients examined. The molecular basis of this disorder is a homozygous deletion of 179,311 bp on chromosome 2p16, which includes the type I cystinuria gene (SLC3A1), the protein phosphatase 2C beta gene (PP2C beta), an unidentified gene (KIAA0436), and several expressed sequence tags. The extent of the deletion suggests that this unique syndrome is related to the complete absence of these genes' products, one of which may be essential for the synthesis of mitochondrial encoded proteins.	Ben Gurion Univ Negev, Soroka Med Ctr, Dept Pediat, IL-84105 Beer Sheva, Israel; Shaare Zedek Med Ctr, Metabol Dis Unit, Jerusalem, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, Dept Dev Mol Genet, IL-84105 Beer Sheva, Israel	Ben Gurion University; Soroka Medical Center; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Ben Gurion University	Parvari, R (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Immunol, Beer Sheva, IL-84105 Beer Sheva, Israel.		Herskowitz, eli/F-1922-2012	Herskowitz, eli/0000-0003-1624-1960				Bisceglia L, 1997, AM J HUM GENET, V60, P611; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; CALONGE MT, 1994, NAT GENET, V6, P420, DOI 10.1038/ng0494-420; Cheng AY, 2000, J BIOL CHEM, V275, P34744, DOI 10.1074/jbc.M006210200; Feliubadalo L, 1999, NAT GENET, V23, P52, DOI 10.1038/12652; GOLD RJM, 1977, CLIN GENET, V12, P329; Ishikawa K, 1997, DNA Res, V4, P307, DOI 10.1093/dnares/4.5.307; Marley AE, 1998, FEBS LETT, V431, P121, DOI 10.1016/S0014-5793(98)00708-X; Parvari R, 1998, AM J HUM GENET, V63, P163, DOI 10.1086/301915; PRAS E, 1994, NAT GENET, V6, P415, DOI 10.1038/ng0494-415; Prasad KR, 1996, INDIAN J ENG MATER S, V3, P167; SEGAL S, 1995, METABOLIC MOL BASES, P3581; STEPHENS AD, 1989, J INHERIT METAB DIS, V12, P197, DOI 10.1007/BF01800726; Vu TH, 1998, NEUROLOGY, V50, P1783, DOI 10.1212/WNL.50.6.1783	14	50	51	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2001	69	4					869	875		10.1086/323624	http://dx.doi.org/10.1086/323624			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	472WP	11524703	Green Published, Bronze			2022-12-18	WOS:000171008200019
J	Cormier-Daire, V; Dagoneau, N; Nabbout, R; Burglen, L; Penet, C; Soufflet, C; Desguerre, I; Munnich, A; Dulac, O				Cormier-Daire, V; Dagoneau, N; Nabbout, R; Burglen, L; Penet, C; Soufflet, C; Desguerre, I; Munnich, A; Dulac, O			A gene for pyridoxine-dependent epilepsy maps to chromosome 5q31	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								Pyridoxine-dependent epilepsy (PDE) is a rare autosomal recessive disorder characterized by generalized seizures in the first hours of life and responding only to pyridoxine hydrochloride. The pathogenesis of PDE is unknown, but an alteration in the binding of pyridoxal 5-phosphate to glutamic acid decarboxylase (GAD) has been postulated in patients with PDE. Results are reported for genetic linkage analyses in four families with consanguineous parents and in one family with nonconsanguineous parents. The GAD1 (2q31) and GAD2 genes (10p23) were tested and excluded. A genomewide search was subsequently performed, using microsatellite markers at an average distance of 10 cM, and the search revealed linkage of the disease-causing gene to markers on chromosome 5q31.2-q31.3 (maximum LOD score [Z(max)] 8.43 at recombination fraction [theta] 0 and Z(max) = 7.58 at theta = 0 at loci D5S2017 and D5S1972, respectively). A recombination event, between loci D5S638 and D5S463, in one family defined the distal boundary, and a second recombination event between loci D5S2011 and D5S2017 in another family defined the proximal boundary of the genetic interval encompassing the PDE gene (5.1 cM). Ongoing studies may lead to the identification of the disease-causing gene.	Hop Necker Enfants Malad, Dept Med Genet, Paris, France; Hop Necker Enfants Malad, INSERM, U 393, Paris, France; Hop St Vincent de Paul, Serv Neurol Pediat, F-75674 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Munnich, A (corresponding author), Necker Hosp, Dept Med Genet, 149 Rue Savres, F-75015 Paris, France.		cormier-daire, valerie/H-6520-2017	cormier-daire, valerie/0000-0002-2839-9856				BAUMEISTER FAM, 1994, PEDIATRICS, V94, P318; Belin V, 1998, NAT GENET, V19, P67, DOI 10.1038/ng0198-67; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; HUNT AD, 1954, PEDIATRICS, V13, P140; Kostrzewa M, 1998, EUR J HUM GENET, V6, P266, DOI 10.1038/sj.ejhg.5200188; LATHROP GM, 1984, P NATL ACAD SCI USA, V81, P3433; LOTT IT, 1978, NEUROLOGY, V28, P47, DOI 10.1212/WNL.28.1.47; Nabbout R, 1999, ARCH DIS CHILD-FETAL, V81, pF125, DOI 10.1136/fn.81.2.F125; Scriver C. R., 1995, METABOLIC MOL BASES, V1, P1349; SCRIVER CR, 1969, ANN NY ACAD SCI, V166, P83; WALDINGER C, 1963, PEDIATRICS, V32, P161; YOSHIDA T, 1971, TOHOKU J EXP MED, V104, P195, DOI 10.1620/tjem.104.195	12	50	52	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4					991	993		10.1086/303087	http://dx.doi.org/10.1086/303087			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	360DL	10978228	Bronze, Green Published			2022-12-18	WOS:000089651100022
J	Vazza, G; Zortea, M; Boaretto, F; Micaglio, GF; Sartori, V; Mostacciuolo, ML				Vazza, G; Zortea, M; Boaretto, F; Micaglio, GF; Sartori, V; Mostacciuolo, ML			A new locus for autosomal recessive spastic paraplegia associated with mental retardation and distal motor neuropathy, SPG14, maps to chromosome 3q27-q28	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC-HETEROGENEITY; LINKAGE ANALYSIS; HUMAN GENOME; FAMILIES; DNA; PARAPARESIS	Hereditary spastic paraplegias (HSPs), a group of neurodegenerative disorders that cause progressive spasticity of the lower limbs, are characterized by clinical and genetic heterogeneity. To date, three loci for autosomal recessive HSP have been mapped on chromosomes 8p, 16q, and 15q. After exclusion of linkage at these loci, we performed a genomewide search in a consanguineous Italian family with autosomal recessive HSP complicated by mild mental retardation and distal motor neuropathy. Using homozygosity mapping, we obtained positive LOD scores for markers on chromosome region 3q27-q28, with a maximum multipoint LOD score of 3.9 for marker D3S1601. Haplotype analysis allowed us to identify a homozygous region (4.5 cM), flanked by markers D3S1580 and D3S3669, that cosegregates with the disease. These data strongly support the presence, on chromosome 3q27-28, of a new locus for complicated recessive spastic paraplegia, which we have named "SPG14".	Univ Padua, Dept Biol, I-35121 Padua, Italy; Hosp Montebelluna, Dept Neurol, Treviso, Italy	University of Padua; ULSS 2 Marca TV; Ospedale Montebelluna	Mostacciuolo, ML (corresponding author), Univ Padua, Dept Biol, Via G Colombo 3, I-35121 Padua, Italy.		Mostacciuolo, Maria Luisa/A-2397-2014; boaretto, francesca/K-9811-2016	boaretto, francesca/0000-0003-2015-929X				BEHAN WMH, 1974, J NEUROL NEUROSUR PS, V37, P8, DOI 10.1136/jnnp.37.1.8; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Coutinho P, 1999, ARCH NEUROL-CHICAGO, V56, P943, DOI 10.1001/archneur.56.8.943; De Michele G, 1998, AM J HUM GENET, V63, P135, DOI 10.1086/301930; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Figlewicz DA, 1999, NEUROLOGY, V53, P5, DOI 10.1212/WNL.53.1.5; Fink JK, 1997, CURR OPIN NEUROL, V10, P313, DOI 10.1097/00019052-199708000-00006; FINK JK, 1995, AM J HUM GENET, V56, P188; Fontaine B, 2000, AM J HUM GENET, V66, P702, DOI 10.1086/302776; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARDING AE, 1981, J NEUROL NEUROSUR PS, V44, P871, DOI 10.1136/jnnp.44.10.871; HAZAN J, 1993, NAT GENET, V5, P163, DOI 10.1038/ng1093-163; HAZAN J, 1994, HUM MOL GENET, V3, P1569, DOI 10.1093/hmg/3.9.1569; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Hedera P, 1999, NEUROLOGY, V53, P44, DOI 10.1212/WNL.53.1.44; HENTATI A, 1994, HUM MOL GENET, V3, P1263, DOI 10.1093/hmg/3.8.1263; KENWRICK S, 1986, HUM GENET, V73, P264, DOI 10.1007/BF00401241; KEPPEN LD, 1987, AM J HUM GENET, V41, P933; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Murillo FM, 1999, NEUROLOGY, V53, P50, DOI 10.1212/WNL.53.1.50; POLO JM, 1993, J NEUROL NEUROSUR PS, V56, P175, DOI 10.1136/jnnp.56.2.175; POLO JM, 1991, BRAIN, V114, P855, DOI 10.1093/brain/114.2.855; Reid E, 1999, BRAIN, V122, P1741, DOI 10.1093/brain/122.9.1741; Reid E, 1999, J NEUROL, V246, P995, DOI 10.1007/s004150050503; Reid E, 2000, AM J HUM GENET, V66, P728, DOI 10.1086/302783; Reid E, 1999, NEUROLOGY, V53, P1844, DOI 10.1212/WNL.53.8.1844; Reid E, 1999, AM J HUM GENET, V65, P757, DOI 10.1086/302555; SANTOS FR, 1993, HUM GENET, V90, P655; Seri M, 1999, AM J HUM GENET, V64, P586, DOI 10.1086/302241; Smallwood PM, 1996, P NATL ACAD SCI USA, V93, P9850, DOI 10.1073/pnas.93.18.9850; Weeks DE., 1990, AM J HUM GENET, V47, pA203; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	34	50	50	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2000	67	2					504	509		10.1086/303017	http://dx.doi.org/10.1086/303017			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354YA	10877981	Green Published, Bronze			2022-12-18	WOS:000089357800026
J	Ghadami, M; Makita, Y; Yoshida, K; Nishimura, G; Fukushima, Y; Wakui, K; Ikegawa, S; Yamada, K; Kondo, S; Niikawa, N; Tomita, H				Ghadami, M; Makita, Y; Yoshida, K; Nishimura, G; Fukushima, Y; Wakui, K; Ikegawa, S; Yamada, K; Kondo, S; Niikawa, N; Tomita, H			Genetic mapping of the Camurati-Engelmann disease locus to chromosome 19q13.1-q13.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROGRESSIVE DIAPHYSEAL DYSPLASIA; LINKAGE ANALYSIS; LOCALIZATION; BONE; EXPRESSION; MOUSE; BETA	Camurati-Engelmann disease (CED [MIM 131300]), or progressive diaphyseal dysplasia, is an autosomal dominant sclerosing bone dysplasia characterized by progressive bone formation along the periosteal and endosteal surfaces at the diaphyseal and metaphyseal regions of long bones and cranial hyperostosis, particularly at the skull base. The gene for CED, or its chromosomal localization, has not yet been identified. We performed a genomewide linkage analysis of two unrelated Japanese families with CED, in which a total of 27 members were available for this study; 16 of them were affected with the disease. Two-point linkage analysis revealed a maximum LOD score of 7.41 (recombination fraction .00; penetrance 1.00) for the D19S918 microsatellite marker locus. Haplotype analysis revealed that all the affected individuals shared a common haplotype observed, in each family, between D19S881 and D19S606, at chromosome 19q13.1-q13.3. These findings, together with a genetic distance among the marker loci, indicate that the CED locus can be assigned to a 15.1-cM segment between D19S881 and D19S606.	Nagasaki Univ, Sch Med, Dept Human Genet, Nagasaki 8528523, Japan; Nagasaki Univ, Sch Med, Dept Ophthalmol, Nagasaki 8528523, Japan; Nagasaki Univ, Sch Med, Dept Plast Surg, Nagasaki 8528523, Japan; Asahikawa Med Coll, Dept Pediat & Publ Hlth, Asahikawa, Hokkaido 078, Japan; Shinshu Univ, Sch Med, Dept Hyg & Med Genet, Matsumoto, Nagano 390, Japan; Univ Tokyo, Ctr Human Genome, Tokyo, Japan; Univ Tokyo, Nishi Tama Hosp, Dept Radiol, Tokyo, Japan	Nagasaki University; Nagasaki University; Nagasaki University; Asahikawa Medical College; Shinshu University; University of Tokyo; University of Tokyo	Ghadami, M (corresponding author), Nagasaki Univ, Sch Med, Dept Human Genet, Sakamoto 1-12-4, Nagasaki 8528523, Japan.		Ikegawa, Shiro/N-6895-2015	Ikegawa, Shiro/0000-0003-0316-2147; Tomita, Hiroaki/0000-0003-2628-880X				ALLEN DT, 1970, PEDIATRICS, V46, P523; BERCHTOLD MW, 1993, GENOMICS, V16, P461, DOI 10.1006/geno.1993.1211; Clybouw C., 1994, Genetic Counseling, V5, P195; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CRISP AJ, 1982, ANN RHEUM DIS, V41, P183, DOI 10.1136/ard.41.2.183; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FUJII D, 1986, SOMAT CELL MOLEC GEN, V12, P281, DOI 10.1007/BF01570787; Geiser AG, 1998, BONE, V23, P87, DOI 10.1016/S8756-3282(98)00078-7; HUNDLEY JD, 1973, J BONE JOINT SURG AM, VA 55, P461, DOI 10.2106/00004623-197355030-00002; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MAKITA Y, IN PRESS AM J MED GE; MINFORD AMB, 1981, J BONE JOINT SURG BR, V63, P597, DOI 10.1302/0301-620X.63B4.7298693; NAVEH Y, 1985, PEDIATRICS, V76, P944; POLLACK S, 1989, J RHEUMATOL, V16, P1259; RUBIN P, 1964, DYNAMIC CLASSIFICATI, P325; SANDBERG M, 1988, DEVELOPMENT, V102, P461; SANDBERG M, 1988, DEV BIOL, V130, P324, DOI 10.1016/0012-1606(88)90438-1; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SMITH R, 1977, Q J MED, V46, P273; SPARKES RS, 1972, J MED GENET, V9, P73, DOI 10.1136/jmg.9.1.73; TAYLOR GA, 1991, NUCLEIC ACIDS RES, V19, P3454, DOI 10.1093/nar/19.12.3454; Wynne-Davies R, 1985, ATLAS SKELETAL DYSPL, P488; YOSHIOKA H, 1980, ARCH DIS CHILD, V55, P716, DOI 10.1136/adc.55.9.716	23	50	57	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2000	66	1					143	147		10.1086/302728	http://dx.doi.org/10.1086/302728			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279FK	10631145	Green Published, Bronze			2022-12-18	WOS:000085033600016
J	Holden, P; Canty, EG; Mortier, GR; Zabel, B; Spranger, J; Carr, A; Grant, ME; Loughlin, JA; Briggs, MD				Holden, P; Canty, EG; Mortier, GR; Zabel, B; Spranger, J; Carr, A; Grant, ME; Loughlin, JA; Briggs, MD			Identification of novel pro-alpha 2(IX) collagen gene mutations in two families with distinctive olgo-epiphyseal forms of multiple epiphyseal dysplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OLIGOMERIC MATRIX PROTEIN; SYNDROME TYPE-IV; OSTEOGENESIS IMPERFECTA; IX COLLAGEN; RNA; PSEUDOACHONDROPLASIA; COL9A2; CHAIN; TRANSCRIPTS; POSITION	Multiple epiphyseal dysplasia (MED) is a genetically heterogeneous disorder with marked clinical and radiographic variability. Traditionally, the mild "Ribbing" and severe "Fairbank" types have been used to define a broad phenotypic spectrum. Mutations in the gene encoding cartilage oligomeric-matrix protein have been shown to result in several types of MED, whereas mutations in the gene encoding the alpha 2 chain of type IX collagen (COL9A2) have so far been found only in two families with the Fairbank type of MED. Type IX collagen is a heterotrimer of pro-alpha chains derived from three distinct genes-COL9A1, COL9A2, and COL9A3. In this article, we describe two families with distinctive oligo-epiphyseal forms of MED, which are heterozygous for different mutations in the COL9A2 exon 3/intron 3 splice-donor site. Both of these mutations result in the skipping of exon 3 from COL9A2 mRNA, but the position of the mutation in the splice-donor site determines the stability of the mRNA produced from the mutant COL9A2 allele.	Univ Manchester, Sch Biol Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; Ghent Univ Hosp, Dept Med Genet, B-9000 Ghent, Belgium; Johannes Gutenberg Univ Mainz, Childrens Hosp, D-6500 Mainz, Germany; John Radcliffe Hosp, Inst Mol Med, Nuffield Orthopaed Ctr, Oxford OX3 9DU, England; John Radcliffe Hosp, Inst Mol Med, Cellular Genet Grp, Oxford OX3 9DU, England	University of Manchester; Ghent University; Ghent University Hospital; Johannes Gutenberg University of Mainz; Nuffield Orthopaedic Centre; University of Oxford; University of Oxford	Briggs, MD (corresponding author), Univ Manchester, Sch Biol Sci, Wellcome Trust Ctr Cell Matrix Res, 2-205 Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	mike.briggs@man.ac.uk	Mortier, Geert/D-2542-2012; Laird, Elizabeth/AAX-7280-2020	Mortier, Geert/0000-0001-9871-4578; Laird, Elizabeth/0000-0001-5041-1316; Loughlin, John/0000-0003-2018-3361	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ballo R, 1997, AM J MED GENET, V68, P396, DOI 10.1002/(SICI)1096-8628(19970211)68:4<396::AID-AJMG4>3.3.CO;2-R; BARRIE H, 1958, BRIT MED J, V2, P133, DOI 10.1136/bmj.2.5089.133; BATEMAN JF, 1994, BIOCHEM J, V302, P729, DOI 10.1042/bj3020729; BONADIO J, 1990, J BIOL CHEM, V265, P2262; BREWTON RG, 1995, GENOMICS, V30, P329, DOI 10.1006/geno.1995.9870; BRIGGS MD, 1994, AM J HUM GENET, V55, P678; Briggs MD, 1998, AM J HUM GENET, V62, P311, DOI 10.1086/301713; BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330; Byers PH, 1997, AM J MED GENET, V72, P94, DOI 10.1002/(SICI)1096-8628(19971003)72:1<94::AID-AJMG20>3.0.CO;2-O; DEERE M, 1995, AM J HUM GENET, V56, P698; Fairbank H A, 1935, Proc R Soc Med, V28, P1611; Fairbank HAT, 1927, BRIT J SURG, V15, P120, DOI 10.1002/bjs.1800155711; FAIRBANK T, 1947, BRIT J SURG, V34, P225, DOI 10.1002/bjs.18003413502; FAIRBANK T, 1909, TRANS MED SOC LOND, V32, P352; FAIRBANK T, 1946, P R SOC MED ORTHO SE, V39, P315; FAIRBANK T, 1925, BRIT MED J, V1, P260; GANGULY A, 1991, J BIOL CHEM, V266, P12035; International Working Group on Constitutional Diseases of Bone, 1998, AM J MED GENET, V79, P376; KUIVANIEMI H, 1995, J INVEST DERMATOL, V105, P352, DOI 10.1111/1523-1747.ep12320704; LEE B, 1991, J BIOL CHEM, V266, P5256; Loughlin J, 1998, HUM MUTAT, pS10; MAUDSLEY RH, 1955, J BONE JOINT SURG BR, V37, P228, DOI 10.1302/0301-620X.37B2.228; MCCORMICK D, 1987, P NATL ACAD SCI USA, V84, P4044, DOI 10.1073/pnas.84.12.4044; Muragaki Y, 1996, NAT GENET, V12, P103, DOI 10.1038/ng0196-103; MURAGAKI Y, 1990, P NATL ACAD SCI USA, V87, P2400, DOI 10.1073/pnas.87.7.2400; Nicholls AC, 1996, HUM MUTAT, V7, P219, DOI 10.1002/(SICI)1098-1004(1996)7:3<219::AID-HUMU6>3.0.CO;2-5; OEHLMANN R, 1994, AM J HUM GENET, V54, P3; Olsen BR, 1997, INT J BIOCHEM CELL B, V29, P555, DOI 10.1016/S1357-2725(96)00100-8; Pihlajamaa T, 1998, MATRIX BIOL, V17, P237, DOI 10.1016/S0945-053X(98)90063-4; Ribbing S, 1937, ACTA RADIOL S, V34, P1; RIMOIN DL, 1993, MCKUSICKS HERITABLE, P557; SHEPHARD E, 1956, J BONE JOINT SURG BR, V38, P458, DOI 10.1302/0301-620X.38B2.458; Susic S, 1997, CLIN GENET, V51, P219; TILLER GE, 1995, AM J HUM GENET, V56, P388; van Mourik JBA, 1998, ULTRASTRUCT PATHOL, V22, P249, DOI 10.3109/01913129809033476; van Mourik JBA, 1998, AM J MED GENET, V77, P234, DOI 10.1002/(SICI)1096-8628(19980518)77:3<234::AID-AJMG9>3.0.CO;2-P; WAUGH W, 1952, J BONE JOINT SURG BR, V34, P82, DOI 10.1302/0301-620X.34B1.82	37	50	54	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1999	65	1					31	38		10.1086/302440	http://dx.doi.org/10.1086/302440			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	212NZ	10364514	Bronze, Green Published			2022-12-18	WOS:000081224300006
J	Kovach, MJ; Lin, JP; Boyadjiev, S; Campbell, K; Mazzeo, L; Herman, K; Rimer, LA; Frank, W; Llewellyn, B; Jabs, EW; Gelber, D; Kimonis, VE				Kovach, MJ; Lin, JP; Boyadjiev, S; Campbell, K; Mazzeo, L; Herman, K; Rimer, LA; Frank, W; Llewellyn, B; Jabs, EW; Gelber, D; Kimonis, VE			A unique point mutation in the PMP22 gene is associated with Charcot-Marie-Tooth disease and deafness	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PERIPHERAL MYELIN PROTEIN-22; DEJERINE-SOTTAS NEUROPATHY; SENSORINEURAL HEARING-LOSS; MOTOR-SENSORY NEUROPATHY; TREMBLER-J MOUSE; HEREDITARY NEUROPATHY; AUTOSOMAL-DOMINANT; PRESSURE PALSIES; DEMYELINATING NEUROPATHY; TRINUCLEOTIDE REPEATS	Charcot-Marie-Tooth disease (CMT) with deafness is clinically distinct among:the genetically heterogeneous group of CMT disorders. Molecular studies in a large family with-autosomal dominant CMT and deafness have not been reported. The present molecular study involves a family with progressive features of CMT and deafness, originally reported by Kousseff et al. Genetic analysis of 70 individuals (31 affected, 28 unaffected, and 11 spouses):revealed linkage to markers on chromosome 17p11.2-p12, with a maximum LOD score of 9.01 for marker D17S1357 at a recombination fraction of .03. Haplotype-analysis placed:the CMT-deafness locus between markers D17S839 and D17S122, a similar to 0.6-Mb interval. This critical region lies: within the CMT type 1A duplication region and excludes MYO15, a gene coding an unconventional myosin that causes a form of autosomal recessive deafness called DFNB3. Affected individuals from this family do not have the common 1.5- Mb duplication of CMT type 1A. Direct sequencing of the candidate peripheral myelin protein 22 (PMP22) gene detected a unique G-->C transversion in the heterozygous state in all affected individuals, at position 248 in coding exon, predicted to result in an Ala67Pro substitution in the second transmembrane domain of PMP22.	So Illinois Univ, Sch Med, Dept Pediat, Div Genet & Metab, Springfield, IL 62794 USA; So Illinois Univ, Sch Med, Dept Surg, Springfield, IL 62794 USA; So Illinois Univ, Sch Med, Dept Neurol, Springfield, IL 62794 USA; Illinois State Police Lab, Springfield, IL USA; NIAMSD, Genet Study Sect, Skin Biol Lab, NIH, Bethesda, MD 20892 USA; Johns Hopkins Univ, Sch Med, Inst Med Genet, Dept Pediat Med & Surg, Baltimore, MD USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Johns Hopkins University	Kimonis, VE (corresponding author), So Illinois Univ, Sch Med, Dept Pediat, Div Genet & Metab, POB 19230, Springfield, IL 62794 USA.	vkimonis@pav-nt1.siumed.edu		Jabs, Ethylin/0000-0001-8983-5466	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041090] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00722] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Ashley CT, 1995, ANNU REV GENET, V29, P703, DOI 10.1146/annurev.ge.29.120195.003415; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; BLAIR IP, 1995, CLIN CHEM, V41, P1105; BOLTSHAUSER E, 1989, J MED GENET, V26, P105, DOI 10.1136/jmg.26.2.105; Bort S, 1997, HUM GENET, V99, P746, DOI 10.1007/s004390050442; Bort S, 1998, HUM MUTAT, pS95; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Charcot JM, 1886, REV MED-PARIS, V6, P97; CORNELL J, 1984, CLIN GENET, V25, P163; COWCHOCK FS, 1985, AM J MED GENET, V20, P307, DOI 10.1002/ajmg.1320200214; DEWEERDT CJ, 1974, EUR NEUROL, V12, P253, DOI 10.1159/000114624; DYCK PJ, 1992, PERIPHERAL NEUROPATH, P1094; Fagerheim T, 1996, HUM MOL GENET, V5, P1187, DOI 10.1093/hmg/5.8.1187; Fraser FC, 1997, LANCET, V350, P459, DOI 10.1016/S0140-6736(05)63077-2; FRIEDMAN TB, 1995, NAT GENET, V9, P86, DOI 10.1038/ng0195-86; GADOTH N, 1991, BRAIN DEV-JPN, V13, P91, DOI 10.1016/S0387-7604(12)80113-6; HAMIEL OP, 1993, J PEDIATR-US, V123, P431, DOI 10.1016/S0022-3476(05)81752-4; Ikegami T, 1998, HUM GENET, V102, P294, DOI 10.1007/s004390050694; Ionasescu VV, 1997, MUSCLE NERVE, V20, P97, DOI 10.1002/(SICI)1097-4598(199701)20:1<97::AID-MUS13>3.0.CO;2-Z; IONASESCU VV, 1995, NEUROLOGY, V45, P1766, DOI 10.1212/WNL.45.9.1766; Ionasescu VV, 1996, J MED GENET, V33, P1048, DOI 10.1136/jmg.33.12.1048; Kalaydjieva L, 1996, NAT GENET, V14, P214, DOI 10.1038/ng1096-214; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Kirschhofer K, 1998, CYTOGENET CELL GENET, V82, P126, DOI 10.1159/000015086; KOUSSEFF BG, 1982, BIRTH DEFECTS-ORIG, V18, P223; LORENZETTI D, 1995, AM J HUM GENET, V56, P91; LUPSKI JR, 1992, CLIN RES, V40, P645; LUPSKI JR, 1991, CURRENT NEUROLOGY, P1; Marques W, 1998, ANN NEUROL, V43, P680, DOI 10.1002/ana.410430521; Marrosu MG, 1997, NEUROLOGY, V48, P489, DOI 10.1212/WNL.48.2.489; MCKUSICK VA, 1992, MENDELIAN INHERITANC, P211; Navon R, 1996, HUM GENET, V97, P685, DOI 10.1007/s004390050116; Nelis E, 1996, EUR J HUM GENET, V4, P25; Nicholson G, 1996, J NEUROL NEUROSUR PS, V61, P43, DOI 10.1136/jnnp.61.1.43; NICHOLSON GA, 1994, NAT GENET, V6, P263, DOI 10.1038/ng0394-263; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; OHNISHI A, 1995, CLIN NEUROL, V35, P788; PARMANTIER E, 1995, EUR J NEUROSCI, V7, P1080, DOI 10.1111/j.1460-9568.1995.tb01095.x; Peral B, 1996, HUM MOL GENET, V5, P539, DOI 10.1093/hmg/5.4.539; PRIEST JM, 1995, GENOMICS, V29, P409, DOI 10.1006/geno.1995.9987; ROA BB, 1993, NAT GENET, V5, P189, DOI 10.1038/ng1093-189; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; ROA BB, 1993, NAT GENET, V5, P269, DOI 10.1038/ng1193-269; ROBERTSON NG, 1994, GENOMICS, V23, P42, DOI 10.1006/geno.1994.1457; Sahenk Z, 1998, NEUROLOGY, V51, P702, DOI 10.1212/WNL.51.3.702; SCHALLING M, 1993, NAT GENET, V4, P135, DOI 10.1038/ng0693-135; Shaffer LG, 1997, AM J MED GENET, V69, P325, DOI 10.1002/(SICI)1096-8628(19970331)69:3<325::AID-AJMG20>3.0.CO;2-S; SKRE H, 1974, CLIN GENET, V6, P98; SNIPES GJ, 1993, J NEUROCHEM, V61, P1961, DOI 10.1111/j.1471-4159.1993.tb09840.x; SNIPES GJ, 1992, J CELL BIOL, V117, P225, DOI 10.1083/jcb.117.1.225; SUTER U, 1992, P NATL ACAD SCI USA, V89, P4382, DOI 10.1073/pnas.89.10.4382; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; SUTER U, 1994, J BIOL CHEM, V269, P25795; Tamagawa Y, 1996, HUM MOL GENET, V5, P849, DOI 10.1093/hmg/5.6.849; Taroni F., 1995, American Journal of Human Genetics, V57, pA229; Tooth HH, 1886, PERONEAL TYPE PROGRE; Tyson J, 1997, BRAIN, V120, P47, DOI 10.1093/brain/120.1.47; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; VALENTIJN LJ, 1995, HUM MUTAT, V5, P76, DOI 10.1002/humu.1380050110; Verhoeven K, 1997, AM J HUM GENET, V60, P1168; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; WELCHER AA, 1991, P NATL ACAD SCI USA, V88, P7195, DOI 10.1073/pnas.88.16.7195; WHITE TW, 1995, MOL BIOL CELL, V6, P459, DOI 10.1091/mbc.6.4.459; Xia JH, 1998, NAT GENET, V20, P370, DOI 10.1038/3845; Young P, 1997, NEUROLOGY, V48, P450, DOI 10.1212/WNL.48.2.450	66	50	56	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1999	64	6					1580	1593		10.1086/302420	http://dx.doi.org/10.1086/302420			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	203FA	10330345	Green Published, Bronze			2022-12-18	WOS:000080696200010
J	Mears, AJ; Gieser, L; Yan, D; Chen, C; Fahrner, S; Hiriyanna, S; Fujita, R; Jacobson, SG; Sieving, PA; Swaroop, A				Mears, AJ; Gieser, L; Yan, D; Chen, C; Fahrner, S; Hiriyanna, S; Fujita, R; Jacobson, SG; Sieving, PA; Swaroop, A			Protein-truncation mutations in the RP2 gene in a North American cohort of families with X-linked retinitis pigmentosa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							NUCLEOTIDE-EXCHANGE FACTOR; LOCUS; HOMOLOGY; REGION; RPGR; RCC1		Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol, Ann Arbor, MI 48105 USA; Univ Michigan, Kellogg Eye Ctr, Dept Human Genet, Ann Arbor, MI 48105 USA; Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Philadelphia, PA 19104 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Pennsylvania; Pennsylvania Medicine	Swaroop, A (corresponding author), Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol, 1000 Wall St, Ann Arbor, MI 48105 USA.			Fujita, Ricardo/0000-0002-9617-5109; Jacobson, Samuel/0000-0003-2122-169X; Swaroop, Anand/0000-0002-1975-1141	NATIONAL EYE INSTITUTE [R29EY007961, R01EY005627, R01EY007961] Funding Source: NIH RePORTER; NEI NIH HHS [EY05627, EY06094, EY07961] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aldred MA, 1994, MOL GENETICS INHERIT, P259; BIRD AC, 1975, BRIT J OPHTHALMOL, V59, P177, DOI 10.1136/bjo.59.4.177; Buraczynska M, 1997, AM J HUM GENET, V61, P1287, DOI 10.1086/301646; Fujita R, 1997, AM J HUM GENET, V61, P571, DOI 10.1086/515523; Fujita R, 1996, Mol Vis, V2, P4; Fujita R, 1996, AM J HUM GENET, V59, P152; Gieser L, 1998, AM J HUM GENET, V63, P1439, DOI 10.1086/302121; MacDonald IM, 1998, OPHTHALMOLOGY, V105, P1637, DOI 10.1016/S0161-6420(98)99031-5; MCGUIRE RE, 1995, AM J HUM GENET, V57, P87; Meindl A, 1996, NAT GENET, V13, P35, DOI 10.1038/ng0596-35; MUSARELLA MA, 1990, GENOMICS, V8, P286, DOI 10.1016/0888-7543(90)90284-2; OTT J, 1990, P NATL ACAD SCI USA, V87, P701, DOI 10.1073/pnas.87.2.701; Roepman R, 1996, HUM MOL GENET, V5, P1035, DOI 10.1093/hmg/5.7.1035; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; TEAGUE PW, 1994, AM J HUM GENET, V55, P105; Thiselton DL, 1996, GENOME RES, V6, P1093, DOI 10.1101/gr.6.11.1093; Tian GL, 1996, CELL, V86, P287, DOI 10.1016/S0092-8674(00)80100-2; Yan D, 1998, J BIOL CHEM, V273, P19656, DOI 10.1074/jbc.273.31.19656	18	50	50	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1999	64	3					897	900		10.1086/302298	http://dx.doi.org/10.1086/302298			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	177HN	10053026	Bronze, Green Published			2022-12-18	WOS:000079204700029
J	Potocki, L; Chen, KS; Koeuth, T; Killian, J; Iannaccone, ST; Shapira, SK; Kashork, CD; Spikes, AS; Shaffer, LG; Lupski, JR				Potocki, L; Chen, KS; Koeuth, T; Killian, J; Iannaccone, ST; Shapira, SK; Kashork, CD; Spikes, AS; Shaffer, LG; Lupski, JR			DNA rearrangements on both homologues of chromosome 17 in a mildly delayed individual with a family history of autosomal dominant carpal tunnel syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SMITH-MAGENIS SYNDROME; MARIE-TOOTH-DISEASE; GENE DELETION SYNDROME; PERIPHERAL NEUROPATHY; DUPLICATION; RECOMBINATION; 17P11.2; TYPE-1A	Disorders known to be caused by molecular and cytogenetic abnormalities of the proximal short arm of chromosome 17 include Charcot-Marie-Tooth disease type 1A (CMT1A), hereditary neuropathy with liability to pressure palsies (HNPP), Smith-Magenis syndrome (SMS), and mental retardation and congenital anomalies associated with partial duplication of 17p. We identified a patient with multifocal mononeuropathies and mild distal neuropathy, growth hormone deficiency, and mild mental retardation who was found to have a duplication of the SMS region of 17p11.2 and a deletion of the peripheral myelin protein 22 (PMP22) gene within 17p12 on the homologous chromosome. Further molecular analyses reveal that the dup(17)(p11.2p11.2) is a de novo event but that the PMP22 deletion is familial. The family members with deletions of PMP22 have abnormalities indicative of carpal tunnel syndrome, documented by electrophysiological studies prior to molecular analysis. The chromosomal duplication was shown by interphase FISH analysis to be a tandem duplication. These data indicate that familial entrapment neuropathies, such as carpal tunnel syndrome and focal ulnar neuropathy syndrome, can occur because of deletions of the PMP22 gene. The co-occurrence of the 17p11.2 duplication and the PMP22 deletion in this patient likely reflects the relatively high frequency at which these abnormalities arise and the underlying molecular characteristics of the genome in this region.	Baylor Coll Med, Texas Childrens Hosp, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Texas Childrens Hosp, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Texas Childrens Hosp, Dept Neurol, Houston, TX 77030 USA; Univ Texas, SW Med Ctr, Dept Neurol, Dallas, TX 75235 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Lupski, JR (corresponding author), Baylor Coll Med, 1 Baylor Plaza,Room 609E, Houston, TX 77030 USA.		Chen, Ken-Shiung/A-2204-2011		NICHD NIH HHS [HD2406402, K08HD01149] Funding Source: Medline; NINDS NIH HHS [R01NS2742] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD001149] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BARTSCHSANDHOFF M, 1979, HUM GENET, V49, P123; Brown A, 1996, AM J MED GENET, V63, P373, DOI 10.1002/(SICI)1096-8628(19960517)63:2<373::AID-AJMG9>3.0.CO;2-U; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; CHANG FY, 1994, IEEE T COMPON PACK B, V17, P3, DOI 10.1109/96.296425; Chen K-S, 1996, MENTAL RETARD DEV DI, V2, P122; CHEN KS, 1995, AM J HUM GENET, V56, P175; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Chen RM, 1996, OPHTHALMOLOGY, V103, P1084, DOI 10.1016/S0161-6420(96)30563-0; DANTA G, 1975, J NEUROL NEUROSUR PS, V38, P350, DOI 10.1136/jnnp.38.4.350; Dykens EM, 1997, J AUTISM DEV DISORD, V27, P203, DOI 10.1023/A:1025800126086; FELDMAN GM, 1982, AM J MED GENET, V11, P299, DOI 10.1002/ajmg.1320110306; FINUCANE BM, 1993, AM J MED GENET, V45, P443, DOI 10.1002/ajmg.1320450409; FINUCANE BM, 1994, DEV MED CHILD NEUROL, V36, P78; GRAY RG, 1979, ANN INTERN MED, V91, P37, DOI 10.7326/0003-4819-91-1-37; GREENBERG F, 1991, AM J HUM GENET, V49, P1207; Greenberg F, 1996, AM J MED GENET, V62, P247, DOI 10.1002/(SICI)1096-8628(19960329)62:3<247::AID-AJMG9>3.3.CO;2-9; LEIFER D, 1992, ARCH PHYS MED REHAB, V73, P393, DOI 10.1016/0003-9993(92)90017-Q; Lupski J., 1998, SCI AM MOL NEUROLOGY, P239; Lupski JR, 1997, HOSP PRACT, V32, P83, DOI 10.1080/21548331.1997.11443485; LUPSKI JR, 1992, CLIN RES, V40, P645; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; MAGENIS RE, 1986, AM J MED GENET, V24, P415, DOI 10.1002/ajmg.1320240304; MASCARELLO JT, 1983, AM J MED GENET, V14, P67, DOI 10.1002/ajmg.1320140111; MCDONNELL JM, 1987, J BONE JOINT SURG AM, V69A, P928, DOI 10.2106/00004623-198769060-00021; MOCHIZUKI Y, 1981, J NEUROL NEUROSUR PS, V44, P367, DOI 10.1136/jnnp.44.4.367; Murakami T, 1996, MEDICINE, V75, P233, DOI 10.1097/00005792-199609000-00001; Pellegrino JE, 1996, AM J MED GENET, V61, P377, DOI 10.1002/(SICI)1096-8628(19960202)61:4<377::AID-AJMG13>3.0.CO;2-P; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; Reitemeier A, 1997, Z HIST FORSCH, V24, P1; Reiter LT, 1996, NAT GENET, V12, P288, DOI 10.1038/ng0396-288; Reiter LT, 1998, AM J HUM GENET, V62, P1023, DOI 10.1086/301827; Roa BB, 1996, HUM GENET, V97, P642; SCHRANDERSTUMPEL C, 1990, CLIN GENET, V37, P148; SHAFFER LG, 1993, AM J MED GENET, V47, P383, DOI 10.1002/ajmg.1320470317; Shaffer LG, 1997, AM J MED GENET, V69, P325, DOI 10.1002/(SICI)1096-8628(19970331)69:3<325::AID-AJMG20>3.0.CO;2-S; SMITH ACM, 1986, AM J MED GENET, V24, P393, DOI 10.1002/ajmg.1320240303; Tyson J, 1996, ANN NEUROL, V39, P180, DOI 10.1002/ana.410390207; UPADHYAYA M, 1993, HUM GENET, V91, P392; Vadasz AG, 1997, MUSCLE NERVE, V20, P376, DOI 10.1002/(SICI)1097-4598(199703)20:3<376::AID-MUS20>3.3.CO;2-5; ZHAO ZY, 1995, HUM MOL GENET, V4, P589, DOI 10.1093/hmg/4.4.589	40	50	50	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					471	478		10.1086/302240	http://dx.doi.org/10.1086/302240			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973284	Green Published, Bronze			2022-12-18	WOS:000078740600016
J	Xiong, MM; Jin, L				Xiong, MM; Jin, L			Comparison of the power and accuracy of biallelic and microsatellite markers in population-based gene-mapping methods	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETICALLY COMPLEX TRAITS; AFFECTED RELATIVE PAIRS; LINKAGE DISEQUILIBRIUM; POSITIONAL CLONING; DIASTROPHIC DYSPLASIA; HUMAN GENOME; STRATEGIES; MAP; POLYMORPHISMS; INFORMATION	Because of their great abundance and amenability to fully automated genotyping, single-nucleotide polymorphisms (SNPs) and simple insertion/deletion are emerging as a new generation of markers for positional cloning. Although the efficiency and cost associated with the markers are important in the mapping of human disease genes, the power to detect the linkage between the marker and the disease locus, as well as the accuracy of the estimation of the map location of the disease gene, dictate the selection of the markers. Both the power and the accuracy depend not only on the type of the markers but also on other factors, such as the age of the disease mutation, the magnitude of the genetic effect, the marker-allele distribution in the population, mutation rates of marker loci, the frequency of the disease allele, the recombination fraction, and the methods for mapping the human disease genes. In this article, we develop a mathematical framework and the analytical formulas for calculation of the power and the accuracy and investigate the impact that the aforementioned factors have on the power and the accuracy, by using two population-based gene-mapping methods-likelihood-based linkage-disequilibrium mapping and the transmission/disequilibrium test, for both biallelic SNPs and microsatellites. These studies provide not only guidance in selection of the markers and in the design of the sample scheme for positional cloning but also insight into the biological bases of the mapping of human disease genes.	Univ Texas, Hlth Sci Ctr, Ctr Human Genet, Houston, TX 77225 USA	University of Texas System; University of Texas Health Science Center Houston	Xiong, MM (corresponding author), Univ Texas, Hlth Sci Ctr, Ctr Human Genet, Houston, TX 77225 USA.		Jin, Li/C-1468-2009; Jin, Li/M-5063-2019	Jin, Li/0000-0002-4546-2415; 				BODMER WF, 1986, COLD SPRING HARB SYM, V51, P1; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; COLLINS FS, 1992, NAT GENET, V1, P3, DOI 10.1038/ng0492-3; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; Curtis D, 1997, ANN HUM GENET, V61, P319, DOI 10.1017/S000348009700626X; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; Jin L., 1995, American Journal of Human Genetics, V57, pA26; JORDE LB, 1995, AM J HUM GENET, V56, P11; KAPLAN NL, 1995, AM J HUM GENET, V56, P18; Kwok PY, 1996, GENOMICS, V31, P123, DOI 10.1006/geno.1996.0019; Li W.H., 1997, MOL EVOLUTION; LITT M, 1989, AM J HUM GENET, V44, P397; MORTON NE, 1955, AM J HUM GENET, V7, P277; Oefner P. J., 1995, American Journal of Human Genetics, V57, pA266; Ott J., 1991, ANAL HUMAN GENETIC L; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P242; RISCH N, 1990, AM J HUM GENET, V46, P222; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Serfling RJ, 1980, APPROXIMATION THEORE; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; Xiong MM, 1997, AM J HUM GENET, V60, P1513, DOI 10.1086/515475	32	50	55	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					629	640		10.1086/302231	http://dx.doi.org/10.1086/302231			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973302	Green Published, Bronze			2022-12-18	WOS:000078740600034
J	Jones, AC; Yamamura, Y; Almasy, L; Bohlega, S; Elibol, B; Hubble, J; Kuzuhara, S; Uchida, M; Yanagi, T; Weeks, DE; Nygaard, TG				Jones, AC; Yamamura, Y; Almasy, L; Bohlega, S; Elibol, B; Hubble, J; Kuzuhara, S; Uchida, M; Yanagi, T; Weeks, DE; Nygaard, TG			Autosomal recessive juvenile parkinsonism maps to 6q25.2-q27 in four ethnic groups: Detailed genetic mapping of the linked region	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; HUMAN GENOME; DISEASE; DYSTONIA; DESCENT; RISK	Parkinson disease (PD) is a common neurodegenerative condition associated with degeneration of dopaminergic neurons in the zona compacta of the substantia nigra. There is increasing evidence that genetic factors play a role in the etiology of PD, although genetic heterogeneity is likely. An autosomal dominant syndrome with many similarities to sporadic PD has been mapped to 4q21-22 in a large Italian pedigree and has been found to be due to mutation of the alpha-synuclein gene. However, this gene appears to account for only a minority of PD, and a susceptibility locus for autosomal dominant parkinsonism has recently been mapped, on 2p13. Autosomal recessive juvenile parkinsonism (JP), which shows marked clinical similarity to PD, maps to 6q25.2-q27. We found linkage to this region in a group of 15 families from four distinct ethnic backgrounds. A full genomic screen excluded other candidate regions. We have constructed a detailed genetic map of the linked region and have mapped the position of the manganese superoxide dismutase gene (SOD2). Recombination events restricted the JP locus to a 6.9-cM region and excluded SOD2. The apparent homozygosity for null alleles at D6S955 in one family suggested a deletion and finer localization of the JP locus.	Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Hiroshima Univ, Sch Med, Inst Hlth Sci, Hiroshima, Japan; SW Fdn Biomed Res, Dept Genet, San Antonio, TX USA; King Faisal Specialist Hosp & Res Ctr, Dept Neurol, Riyadh 11211, Saudi Arabia; Hacettepe Univ Hosp, Dept Neurol, Ankara, Turkey; Ohio State Univ Hosp, Dept Neurol, Columbus, OH 43210 USA; Mie Univ, Sch Med, Dept Neurol, Tsu, Mie 514, Japan; Tosei Gen Hosp, Seto City, Japan; Second Nagoya Red Cross Hosp, Nagoya, Aichi, Japan; Univ Pittsburgh, Dept Genet, Pittsburgh, PA USA; Wellcome Trust Ctr Human Genet, Oxford, England	Columbia University; Hiroshima University; Texas Biomedical Research Institute; King Faisal Specialist Hospital & Research Center; Hacettepe University; University System of Ohio; Ohio State University; Mie University; Tosei General Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Oxford; Wellcome Centre for Human Genetics	Nygaard, TG (corresponding author), Columbia Univ Coll Phys & Surg, Dept Neurol, BB303,650 W 168th St, New York, NY 10032 USA.		Almasy, Laura/V-3156-2019; Weeks, Daniel E/B-2995-2012	Weeks, Daniel E/0000-0001-9410-7228	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS032035] Funding Source: NIH RePORTER; NINDS NIH HHS [NS32035] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Becker A, 1998, HUM HERED, V48, P49, DOI 10.1159/000022781; CHURCH SL, 1992, GENOMICS, V14, P823, DOI 10.1016/S0888-7543(05)80202-2; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; DeMichele G, 1996, MOVEMENT DISORD, V11, P17, DOI 10.1002/mds.870110105; deRijk MC, 1997, J NEUROL NEUROSUR PS, V62, P10, DOI 10.1136/jnnp.62.1.10; Gasser T, 1998, NAT GENET, V18, P262, DOI 10.1038/ng0398-262; GASSER T, 1994, ANN NEUROL, V36, P387, DOI 10.1002/ana.410360310; Ishikawa A, 1996, NEUROLOGY, V47, P160, DOI 10.1212/WNL.47.1.160; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LAZZARINI AM, 1994, NEUROLOGY, V44, P499, DOI 10.1212/WNL.44.3_Part_1.499; MARAGANORE DM, 1991, MOVEMENT DISORD, V6, P205, DOI 10.1002/mds.870060303; Marder K, 1996, NEUROLOGY, V47, P155, DOI 10.1212/WNL.47.1.155; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; Matsumine H, 1997, AM J HUM GENET, V60, P588; Matsumine H, 1998, NEUROLOGY, V50, P1340, DOI 10.1212/WNL.50.5.1340; MIZUTANI Y, 1991, CLIN NEUROPATHOL, V10, P91; NYGAARD TG, 1993, NAT GENET, V5, P386, DOI 10.1038/ng1293-386; NYGAARD TG, 1993, PARKINSONIAN SYNDROM, P451; Ott J., 1991, ANAL HUMAN GENETIC L; Polymeropoulos MH, 1996, SCIENCE, V274, P1197, DOI 10.1126/science.274.5290.1197; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; SNOW BJ, 1993, HEREDITARY PROGR DYS, P181; Sobel E, 1996, AM J HUM GENET, V58, P1323; TAKAHASHI H, 1994, NEUROLOGY, V44, P437, DOI 10.1212/WNL.44.3_Part_1.437; TANAKA H, 1991, NEUROLOGY, V41, P719, DOI 10.1212/WNL.41.5.719; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Yamamura Y, 1996, ADV BEHAV BIOL, V47, P485; YAMAMURA Y, 1973, NEUROLOGY, V23, P239, DOI 10.1212/WNL.23.3.239; Yamamura Y, 1993, Rinsho Shinkeigaku, V33, P491	33	50	50	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					80	87		10.1086/301937	http://dx.doi.org/10.1086/301937			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	9634534	Green Published, hybrid			2022-12-18	WOS:000074761000013
J	Quimby, BB; Alano, A; Almashanu, S; DeSandro, AM; Cowan, TM; FridovichKeil, JL				Quimby, BB; Alano, A; Almashanu, S; DeSandro, AM; Cowan, TM; FridovichKeil, JL			Characterization of two mutations associated with epimerase-deficiency galactosemia, by use of a yeast expression system for human UDP-galactose-4-epimerase	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ENZYME GALACTOSE-1-PHOSPHATE URIDYLYLTRANSFERASE; ESCHERICHIA-COLI; 4-EPIMERASE; PURIFICATION; DISRUPTION; PROTEIN; ALLELE; CELLS; CDNA	UDP-galactose-4-epimerase (GALE) is a highly conserved enzyme that catalyzes the interconversion of UDP-galactose and UDP-glucose. Impairment of this enzyme in humans results in one of two clinically distinct forms of epimerase-deficiency galactosemia-one benign, the other severe. The molecular and biochemical distinction between these disorders remains unknown. To enable structural and functional studies of both wild-type and patient-derived alleles of human GALE (hGALE), we have developed and applied a null-background yeast expression system for the human enzyme, We have demonstrated that wild-type hGALE sequences phenotypically complement a yeast gal10 deletion, and we have biochemically characterized the wild-type human enzyme isolated from these cells. Furthermore, we have expressed and characterized two mutant alleles, L183P-hGALE and N34S-hGALE, both derived from a patient: with no detectable GALE activity in red blood cells but with similar to 14% activity in cultured lymphoblasts, Analyses of crude extracts of Beast expressing L183P-hGALE demonstrated 4% wild-type activity and 6% wild-type abundance. Extracts of yeast expressing N34S-hGALE demonstrated similar to 70% wild-type activity and normal abundance. However, yeast-coexpressing both L183P-hGALE and N34S-hGALE exhibited only similar to 7% wild-type levels of activity, thereby confirming the functional impact of both substitutions and raising the intriguing possibility that same form of dominant-negative interaction may exist between the mutant alleles found in this patient. The results reported here establish the utility of the yeast-based hGALE-expression system and set the stage for more-detailed studies of this important enzyme and its role in epimerase-deficiency galactosemia.	EMORY UNIV, SCH MED, DEPT GENET, ATLANTA, GA 30322 USA; UNIV MARYLAND, SCH MED, GRAD PROGRAM GENET & MOL BIOL, BALTIMORE, MD 21201 USA; UNIV MARYLAND, SCH MED, DIV HUMAN GENET, BALTIMORE, MD 21201 USA	Emory University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046403, R29DK046403] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK46403] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test; ALANO A, 1997, J INVEST MED, V45, P191; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; BERGREN WR, 1973, BIOCHIM BIOPHYS ACTA, V315, P464, DOI 10.1016/0005-2744(73)90277-5; Beutler E, 1982, GLUTATHIONE RED CELL, V3 rd; CHACKO CM, 1972, BIOCHIM BIOPHYS ACTA, V284, P552, DOI 10.1016/0005-2744(72)90153-2; DARROW RA, 1968, BIOCHEMISTRY-US, V7, P1645, DOI 10.1021/bi00845a005; DAUDE N, 1995, BIOCHEM MOL MED, V56, P1, DOI 10.1006/bmme.1995.1048; Elsevier JP, 1996, P NATL ACAD SCI USA, V93, P7166, DOI 10.1073/pnas.93.14.7166; Frey PA, 1996, FASEB J, V10, P461, DOI 10.1096/fasebj.10.4.8647345; FRIDOVICHKEIL JL, 1995, AM J HUM GENET, V56, P640; FRIDOVICHKEIL JL, 1993, P NATL ACAD SCI USA, V90, P398, DOI 10.1073/pnas.90.2.398; FridovichKeil JL, 1995, BIOCHEM MOL MED, V56, P121, DOI 10.1006/bmme.1995.1067; GENTZ R, 1989, P NATL ACAD SCI USA, V86, P821, DOI 10.1073/pnas.86.3.821; GITZELMANN R, 1972, HELV PAEDIATR ACTA, V27, P125; GITZELMANN R, 1973, HELV PAEDIATR ACTA, V28, P497; HOLTON JB, 1981, ARCH DIS CHILD, V56, P885, DOI 10.1136/adc.56.11.885; JOHNSTON M, 1987, MICROBIOL REV, V51, P458, DOI 10.1128/MMBR.51.4.458-476.1987; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; LANGER R, 1974, J BIOL CHEM, V249, P1126; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALEY F, 1959, BIOCHIM BIOPHYS ACTA, V31, P577, DOI 10.1016/0006-3002(59)90047-2; MAXWELL ES, 1957, J BIOL CHEM, V229, P139; MERRIL CR, 1976, ANAL BIOCHEM, V72, P606, DOI 10.1016/0003-2697(76)90573-X; MITCHELL B, 1975, P NATL ACAD SCI USA, V72, P5026, DOI 10.1073/pnas.72.12.5026; PILLER F, 1983, J BIOL CHEM, V258, P774; Quimby BB, 1996, J BIOL CHEM, V271, P26835, DOI 10.1074/jbc.271.43.26835; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; SALO WL, 1968, BIOCHIM BIOPHYS ACTA, V151, P484, DOI 10.1016/0005-2744(68)90116-2; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; SARDHARWALLA IB, 1988, J INHERIT METAB DIS, V11, P249, DOI 10.1007/BF01804249; Thoden JB, 1996, BIOCHEMISTRY-US, V35, P2557, DOI 10.1021/bi952715y; TSAI CM, 1970, ARCH BIOCHEM BIOPHYS, V136, P233, DOI 10.1016/0003-9861(70)90347-4; White, 1990, BIOCH TECHNIQUES THE; WILSON DB, 1969, J BIOL CHEM, V244, P2132; WILSON DB, 1964, J BIOL CHEM, V239, P2469; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4; ZESCHNIGK M, 1990, NUCLEIC ACIDS RES, V18, P5289, DOI 10.1093/nar/18.17.5289; ZYDOWSKY LD, 1992, PROTEIN SCI, V1, P961, DOI 10.1002/pro.5560010801	39	50	55	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1997	61	3					590	598		10.1086/515517	http://dx.doi.org/10.1086/515517			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY523	9326324	Green Published, Bronze			2022-12-18	WOS:A1997XY52300016
J	Verhoeven, K; VanCamp, G; Govaerts, PJ; Balemans, W; Schatteman, I; Verstreken, M; VanLaer, L; Smith, RJH; Brown, MR; VandeHeyning, PH; Somers, T; Offeciers, FE; Willems, PJ				Verhoeven, K; VanCamp, G; Govaerts, PJ; Balemans, W; Schatteman, I; Verstreken, M; VanLaer, L; Smith, RJH; Brown, MR; VandeHeyning, PH; Somers, T; Offeciers, FE; Willems, PJ			A gene for autosomal dominant nonsyndromic hearing loss (DFNA12) maps to chromosome 11q22-24	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECESSIVE DEAFNESS; LOCALIZATION; ASSOCIATION; COACTIVATOR	We performed linkage analysis in a Belgian family with autosomal dominant midfrequency hearing loss, which has a prelingual onset and a nonprogressive course in most patients. We found LOD scores >6 with markers on chromosome 11q. Analysis of key recombinants maps this deafness gene (DFNA12) to a 36-cM interval on chromosome 11q22-24, between markers D11S4120 and D11S912. The critical regions for the recessive deafness locus DFNB2 and the dominant locus DFNA11, which were previously localized to the long arm of chromosome 11, do not overlap with the candidate interval of DFNA12.	UNIV ANTWERP, DEPT MED GENET, B-2610 ANTWERP, BELGIUM; UNIV ANTWERP, DEPT OTOLARYNGOL, B-2610 ANTWERP, BELGIUM; UNIV ANTWERP, ST AUGUSTINUS HOSP, DEPT OTOLARYNGOL, B-2610 ANTWERP, BELGIUM; UNIV IOWA HOSP & CLIN, DEPT OTOLARYNGOL, IOWA CITY, IA 52242 USA	University of Antwerp; University of Antwerp; University of Antwerp; University of Iowa			Van Camp, Guy/F-3386-2013; Heyning, Paul H Vande/I-8278-2017	Van Camp, Guy/0000-0001-5105-9000; Heyning, Paul H Vande/0000-0002-8424-3717; Smith, Richard/0000-0003-1201-6731				BAILEY DW, 1988, MOUSE NEWS LETT, V8, P69; CHAIB H, 1994, HUM MOL GENET, V3, P2219, DOI 10.1093/hmg/3.12.2219; Cohen M. M., 1995, HEREDITARY HEARING L, P9; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DeBry RW, 1996, GENOMICS, V33, P337, DOI 10.1006/geno.1996.0209; DEKOK YJM, 1995, SCIENCE, V267, P685, DOI 10.1126/science.7839145; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; GOLDSBOROUGH AS, 1993, NUCLEIC ACIDS RES, V21, P127, DOI 10.1093/nar/21.1.127; GSTAIGER M, 1995, NATURE, V373, P360, DOI 10.1038/373360a0; GUILFORD P, 1994, HUM MOL GENET, V3, P989, DOI 10.1093/hmg/3.6.989; HUGHES AE, 1993, GENOMICS, V15, P433, DOI 10.1006/geno.1993.1083; *INT ORG STAND, 1984, 7029 ISO; *J HOPK U CTR MED, 1996, ONL MEND INH MAN; Junker S, 1996, GENOMICS, V33, P143, DOI 10.1006/geno.1996.0173; KIRSCHHOFER K, 1995, MOL BIOL HEAR DEAFN; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; *MOUS GEN DAT, 1996, MOUS GEN INF; SMITH RJH, 1992, GENOMICS, V14, P995, DOI 10.1016/S0888-7543(05)80122-3; STRUBIN M, 1995, CELL, V80, P497, DOI 10.1016/0092-8674(95)90500-6; Tamagawa Y, 1996, HUM MOL GENET, V5, P849, DOI 10.1093/hmg/5.6.849; VANCAMP G, 1996, HEREDITARY HEARING L; VANHEYNINGEN V, 1995, CYTOGENET CELL GENET, V69, P128, DOI 10.1159/000133953; Veske A, 1996, HUM MOL GENET, V5, P165, DOI 10.1093/hmg/5.1.165; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0	25	50	50	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1997	60	5					1168	1173						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX760	9150164				2022-12-18	WOS:A1997WX76000017
J	Stuppia, L; Calabrese, G; Franchi, PG; Mingarelli, R; Gatta, V; Palka, G; Dallapiccola, B				Stuppia, L; Calabrese, G; Franchi, PG; Mingarelli, R; Gatta, V; Palka, G; Dallapiccola, B			Widening of a Y-chromosome interval-6 deletion transmitted from a father to his infertile son accounts for an oligozoospermia critical region distal to the RBM1 and DAZ genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							HUMAN SPERMATOGENESIS; AZOOSPERMIA; AZF		UNIV G DANNUNZIO,CNR,IST CITOMORFOL UMANS NORMALE & PATOL,CHIETI,ITALY; UNIV G DANNUNZIO,IST BIOL & GENET,CHIETI,ITALY; UNIV ROMA TOR VERGATA,IST GENET,SAN GIOVANNI ROTO,ITALY; OSPED CCS,SAN GIOVANNI ROTO,ITALY	Consiglio Nazionale delle Ricerche (CNR); G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of Rome Tor Vergata			Gatta, Valentina/G-5765-2014; Dallapiccola, Bruno/K-8692-2016	GATTA, Valentina/0000-0002-9999-5823; Stuppia, Liborio/0000-0002-6232-0996; Dallapiccola, Bruno/0000-0002-5031-1013				KOBAYASHI K, 1994, HUM MOL GENET, V3, P1965, DOI 10.1093/hmg/3.11.1965; MA K, 1993, CELL, V75, P1287, DOI 10.1016/0092-8674(93)90616-X; MEZZANOTTE R, 1983, J HISTOCHEM CYTOCHEM, V31, P553, DOI 10.1177/31.4.6298309; NAGAFUCHI S, 1993, J UROLOGY, V150, P1155, DOI 10.1016/S0022-5347(17)35712-9; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Reijo R, 1996, LANCET, V347, P1290, DOI 10.1016/S0140-6736(96)90938-1; SEABRIGH.M, 1971, LANCET, V2, P971; Stuppia L, 1996, CYTOGENET CELL GENET, V72, P155, DOI 10.1159/000134174; VOGT P, 1992, HUM GENET, V89, P491; VOLLRATH D, 1992, SCIENCE, V258, P52, DOI 10.1126/science.1439769	10	50	55	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1996	59	6					1393	1395						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV315	8940286				2022-12-18	WOS:A1996VV31500027
J	Elmslie, FV; Williamson, MP; Rees, M; Kerr, M; Kjeldsen, MJ; Pang, KA; Sundqvist, A; Friis, ML; Richens, A; Chadwick, D; Whitehouse, WP; Gardiner, RM				Elmslie, FV; Williamson, MP; Rees, M; Kerr, M; Kjeldsen, MJ; Pang, KA; Sundqvist, A; Friis, ML; Richens, A; Chadwick, D; Whitehouse, WP; Gardiner, RM			Linkage analysis of juvenile myoclonic epilepsy and microsatellite loci spanning 61 cM of human chromosome 6p in 19 nuclear pedigrees provides no evidence for a susceptibility locus in this region	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IDIOPATHIC GENERALIZED EPILEPSY; COMPLEX TRAITS; HLA REGION; FAMILIES; DISEASE; GENES	Linkage analysis in separately ascertained families of probands with juvenile myoclonic epilepsy (JME) has previously provided evidence both for and against the existence of a locus (designated ''EJM1''), on chromosome 6p, predisposing to a trait defined as either clinical JME, its associated electroencephalographic abnormality, or idiopathic generalized epilepsy. Linkage analysis was performed in 19 families in which a proband and at least one first- or two second-degree relatives have clinical JME. Family members were typed for seven highly polymorphic microsatellite markers on chromosome 6p: D6S260, D6S276, D6S291, D6S271, D6S465, D6S257, and D6S254. Pairwise and multipoint linkage analysis was carried out under the assumptions of autosomal dominant inheritance at 70% and 50% penetrance and autosomal recessive inheritance at 70% and 50% penetrance. No significant evidence in favor of linkage to the clinical trait of JME was obtained for any locus. The region formally excluded (LOD score <-2) by using multipoint analysis varies depending on the assumptions made concerning inheritance parameters and the proportion of linked families, alpha - that is, the degree of locus heterogeneity. Further analysis either classifying all unaffected individuals as unknown or excluding a subset of four families in which pyknoleptic absence seizures were present in one or more individuals did not alter these conclusions.	UNIV WALES COLL MED,DEPT MED PHYSIOL,CARDIFF CF4 4XN,S GLAM,WALES; UNIV WALES COLL MED,DEPT THERAPEUT & PHARMACOL,CARDIFF CF4 4XN,S GLAM,WALES; ODENSE UNIV HOSP,DEPT NEUROL,DK-5000 ODENSE,DENMARK; WALTON CTR NEUROL & NEUROSURG,LIVERPOOL,MERSEYSIDE,ENGLAND; SODER HOSP,DEPT NEUROL,STOCKHOLM,SWEDEN	Cardiff University; Cardiff University; University of Southern Denmark; Odense University Hospital; Walton Centre	Elmslie, FV (corresponding author), UNIV LONDON UNIV COLL,SCH MED,DEPT PAEDIAT,RAYNE INST,UNIV ST,LONDON WC1E 6JJ,ENGLAND.		Whitehouse, William P/F-9065-2017	Whitehouse, William P/0000-0001-5207-5731; Williamson, Magali/0000-0002-7183-7495				CURTIS D, 1993, HUM HERED, V43, P173, DOI 10.1159/000154174; DELGADOESCUETA AV, 1990, EPILEPSIA, V31, pS19, DOI 10.1111/j.1528-1157.1990.tb05855.x; DURNER M, 1991, NEUROLOGY, V41, P1651, DOI 10.1212/WNL.41.10.1651; *GDB, 1990, HUM GEN DAT BAS; GREENBERG DA, 1988, AM J MED GENET, V31, P185, DOI 10.1002/ajmg.1320310125; GREENBERG DA, 1993, EPILEPSIA, V34, pS12; GREENBERG DA, 1989, GENETICS EPILEPSIES, P53; Janz D., 1957, DTSCH Z NERVENHEILKD, V176, P346, DOI [DOI 10.1007/BF00242439, 10.1007/BF00242439]; Janz D, 1989, GENETICS EPILEPSIES, P43; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LIU AW, 1995, AM J HUM GENET, V57, P368; LIU AWH, 1992, 1 INT WORKSH CHROM A, V6; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; OTT J, 1991, ANAL HUMAN GENETIC L, P194; PANAYIOTOPOULOS CP, 1989, ANN NEUROL, V25, P440, DOI 10.1002/ana.410250504; RISCH N, 1990, AM J HUM GENET, V46, P229; SANDER T, 1995, ANN NEUROL, V38, P210, DOI 10.1002/ana.410380213; THOMSON G, 1994, NAT GENET, V8, P108, DOI 10.1038/ng1094-108; TSUBOI T, 1973, HUMANGENETIK, V19, P155; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; WEISSBECKER KA, 1991, AM J MED GENET, V38, P32, DOI 10.1002/ajmg.1320380109; WHITEHOUSE WP, 1993, AM J HUM GENET, V53, P652; ZARA F, 1995, HUM MOL GENET, V4, P1201, DOI 10.1093/hmg/4.7.1201	24	50	51	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1996	59	3					653	663						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN625	8751867				2022-12-18	WOS:A1996VN62500020
J	Fukai, K; Oh, J; Karim, MA; Moore, KJ; Kandil, HH; Ito, H; Burger, J; Spritz, RA				Fukai, K; Oh, J; Karim, MA; Moore, KJ; Kandil, HH; Ito, H; Burger, J; Spritz, RA			Homozygosity mapping of the gene for Chediak-Higashi syndrome to chromosome 1q42-q44 in a segment of conserved synteny that includes the mouse beige locus (bg)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BONE-MARROW TRANSPLANTATION; LINKAGE; ORGANELLES; EXPRESSION; NIDOGEN; MAP	Chediak-Higashi syndrome (CHS) is an autosomal recessive disorder characterized by hypopigmentation or oculocutaneous albinism and severe immunologic deficiency with neutropenia and lack of natural killer (NK) cell function. Most patients die in childhood from pyogenic infections or an unusual lymphoma-like condition. A hallmark of the disorder is giant inclusion bodies seen in all granule-containing cells, including granulocytes, lymphocytes, melanocytes, mast cells, and neurons. Similar ultrastructural abnormalities occur in the beige mouse, which thus has been suggested to be homologous to human CHS. High-resolution genetic mapping has indicated that the bg gene region of mouse chromosome 13 is likely homologous to the distal portion of human chromosome Iq. Accordingly, we carried out homozygosity mapping using markers derived from distal human chromosome Iq in four inbred families or probands with CHS. Our results indicate that the human CHS gene maps to an 18.8-cM interval in chromosome segment 1q42-q44 and that human CHS therefore is very likely homologous to mouse bg.	UNIV WISCONSIN, SCH MED, DEPT MED GENET, MADISON, WI USA; UNIV WISCONSIN, SCH MED, DEPT PEDIAT, MADISON, WI USA; MILLENNIUM PHARMACEUT INC, CAMBRIDGE, MA USA; AL JAHRA HOSP, DEPT PEDIAT, AL JAHRA, KUWAIT; KOBE UNIV, SCH MED, DEPT PATHOL 1, KOBE 650, JAPAN; HUMBOLDT UNIV BERLIN, VIRCHOW KLINIKUM, INST HUMANGENET, BERLIN, GERMANY	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Jahra Hosptial; Kobe University; Humboldt University of Berlin			Fukai, Kazuyoshi/AAI-7365-2020		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039892] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR39892] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ARGYLE JC, 1982, BLOOD, V60, P672; BEGGS AH, 1992, GENOMICS, V13, P1314, DOI 10.1016/0888-7543(92)90054-V; Beguez-Cesar AB, 1943, B SOC CUBANA PEDIAT, V15, P900; BENNETT DC, 1991, J CELL SCI, V98, P135; BrayWard P, 1996, GENOMICS, V32, P1, DOI 10.1006/geno.1996.0070; BURKHARDT JK, 1993, J EXP MED, V178, P1845, DOI 10.1084/jem.178.6.1845; CHEDIAK M M, 1952, Rev Hematol, V7, P362; DONOHUE WL, 1957, PEDIATRICS, V20, P416; DRACOPOLI NC, 1994, CURRENT PROTOCOLS HU, V1; FILIPOVICH AH, 1992, BLOOD, V80, P270; FUKAI K, 1995, HUM MOL GENET, V4, P1665, DOI 10.1093/hmg/4.9.1665; Fukai Kazuyoshi, 1993, Journal of Dermatology (Tokyo), V20, P231; HIGASHI O, 1954, Tohoku J Exp Med, V59, P315; HOLCOMBE R F, 1987, Genomics, V1, P287, DOI 10.1016/0888-7543(87)90058-9; HOLCOMBE RF, 1991, GENET RES, V58, P41, DOI 10.1017/S0016672300029591; JENKINS NA, 1991, GENOMICS, V9, P401, DOI 10.1016/0888-7543(91)90275-J; KANDIL HH, 1993, AM J HUM GENET, V53, P460; KAZMIEROWSKI JA, 1976, BLOOD, V47, P555; KRAMER JW, 1977, LAB INVEST, V36, P554; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LEADER RW, 1963, BLOOD, V22, P477, DOI 10.1182/blood.V22.4.477.477; LOCKMAN LA, 1967, J PEDIATR-US, V70, P942, DOI 10.1016/S0022-3476(67)80267-1; LUTZNER MA, 1967, J HERED, V58, P299, DOI 10.1093/oxfordjournals.jhered.a107620; Lyon M., 1989, GENETIC VARIANTS STR; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; MURRE C, 1985, NATURE, V316, P549, DOI 10.1038/316549a0; NES N, 1985, NORSK PELSDYRBLAD, V59, P25; Nes N, 1983, FINSK VETERINAERTIDS, V89, P313; NISHIMURA M, 1989, BLOOD, V74, P270; OLSEN DR, 1989, AM J HUM GENET, V44, P876; ORLOW SJ, 1995, J INVEST DERMATOL, V105, P3, DOI 10.1111/1523-1747.ep12312291; PADGETT GA, 1964, GENETICS, V49, P505; PEROU CM, 1993, SOMAT CELL MOLEC GEN, V19, P459, DOI 10.1007/BF01233251; Perou CM, 1996, NAT GENET, V13, P303, DOI 10.1038/ng0796-303; RUBIN CM, 1985, CANCER, V56, P524, DOI 10.1002/1097-0142(19850801)56:3<524::AID-CNCR2820560320>3.0.CO;2-Z; SATO A, 1955, Tohoku J Exp Med, V61, P201; Silvers WK., 1979, COAT COLORS MICE, DOI [10.1007/978-1-4612-6164-3, DOI 10.1007/978-1-4612-6164-3]; STEINBRINCK W, 1948, DEUT ARCH KLIN MED, V193, P577; TAYLOR RF, 1973, FED PROC, V32, P822; WHITE JG, 1966, BLOOD-J HEMATOL, V28, P143, DOI 10.1182/blood.V28.2.143.143; WINDHORST DB, 1966, SCIENCE, V151, P81, DOI 10.1126/science.151.3706.81; WINDHORST DB, 1973, J INVEST DERMATOL, V60, P529, DOI 10.1111/1523-1747.ep12703609; ZELICKSON AS, 1967, J INVEST DERMATOL, V49, P575, DOI 10.1038/jid.1967.183	43	50	51	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1996	59	3					620	624						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN625	8751863				2022-12-18	WOS:A1996VN62500016
J	KassovskaBratinova, S; Fukao, T; Song, XQ; Duncan, AMV; Chen, HS; Robert, MF; PerezCerda, C; Ugarte, M; Chartrand, C; Vobecky, S; Kondo, N; Mitchell, GA				KassovskaBratinova, S; Fukao, T; Song, XQ; Duncan, AMV; Chen, HS; Robert, MF; PerezCerda, C; Ugarte, M; Chartrand, C; Vobecky, S; Kondo, N; Mitchell, GA			Succinyl CoA: 3-oxoacid CoA transferase (SCOT): Human cDNA cloning, human chromosomal mapping to 5p13, and mutation detection in a SCOT-deficient patient	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COENZYME-A-TRANSFERASE; NONSENSE MUTATIONS; MESSENGER-RNA; ACTIVE-SITE; LYASE HL; GENE; SEQUENCE; IDENTIFICATION; METABOLISM; CATALYSIS	Succinyl CoA: 3-oxoacid CoA transferase (SCOT; E.C.2.8.3.5) mediates the rate-determining step of ketolysis in extrahepatic tissues, the esterification of acetoacetate to CoA for use in energy production. Hereditary SCOT deficiency in humans causes episodes of severe ketoacidosis. We obtained human-heart SCOT cDNA clones spanning the entire 1,560-nt coding sequence. Sequence alignment of the human SCOT peptides with other known CoA transferases revealed several conserved regions of potential functional importance. A single similar to 3.2-kb SCOT mRNA is present in human tissues (heart > leukocytes much greater than fibroblasts), but no signal is detectable in the human hepatoma cell line HepG2. We mapped the human SCOT locus (OXCT) to the cytogenetic band 5p13 by in situ hybridization. From fibroblasts of a patient with hereditary SCOT deficiency, we amplified and cloned cDNA fragments containing the entire SCOT coding sequence. We found a homozygous C-to-G transversion at nt 848, which changes the Ser 283 codon to a stop codon. This mutation (S283X) is incompatible with normal enzyme function and represents the first documentation of a pathogenic mutation in SCOT deficiency.	HOP ST JUSTINE,SERV GENET MED,MONTREAL,PQ H3T 1C5,CANADA; HOP ST JUSTINE,DEPT CHIRURG,MONTREAL,PQ H3T 1C5,CANADA; GIFU UNIV,SCH MED,DEPT PEDIAT,GIFU 500,JAPAN; HOSP SICK CHILDREN,DEPT MED GENET,TORONTO,ON M5G 1X8,CANADA; KINGSTON GEN HOSP,DEPT PATHOL,KINGSTON,ON K7L 2V7,CANADA; QUEENS UNIV,KINGSTON,ON,CANADA; UNIV AUTONOMA MADRID,CTR DIAGNOST ENFERMEDADES MOL,MADRID,SPAIN	Universite de Montreal; Universite de Montreal; Gifu University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Queens University - Canada; Queens University - Canada; Autonomous University of Madrid								[Anonymous], 1992, FETAL NEONATAL PHYSL; BASERGA SJ, 1988, P NATL ACAD SCI USA, V85, P2056, DOI 10.1073/pnas.85.7.2056; BOUKAFTANE Y, 1994, GENOMICS, V23, P552, DOI 10.1006/geno.1994.1542; BRODY LC, 1992, J BIOL CHEM, V267, P3302; CHENG J, 1990, Molecular and Cellular Biology, V10, P5215; Doolittle RF, 1996, SCIENCE, V271, P470, DOI 10.1126/science.271.5248.470; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FIERKE CA, 1986, J BIOL CHEM, V261, P7603; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; FUKAO T, 1992, J CLIN INVEST, V89, P474, DOI 10.1172/JCI115608; FUKAO T, 1994, J CLIN INVEST, V93, P1034; GANAPATHI MK, 1987, BIOCHEM J, V248, P853, DOI 10.1042/bj2480853; HERSH LB, 1967, J BIOL CHEM, V242, P3468; HERSH LB, 1967, J BIOL CHEM, V242, P3481; KALOUSEK F, 1992, EMBO J, V11, P2803, DOI 10.1002/j.1460-2075.1992.tb05347.x; Kassovska-Bratinova S., 1995, American Journal of Human Genetics, V57, pA180; Kassovska-Bratinova S., 1994, American Journal of Human Genetics, V55, pA134; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LIN TW, 1992, J BIOL CHEM, V267, P975; MIDDLETON B, 1987, J INHERIT METAB DIS, V10, P273, DOI 10.1007/BF01811424; MITCHELL GA, 1993, J BIOL CHEM, V268, P4376; MITCHELL GA, 1995, CLIN INVEST MED, V18, P193; MOORE SA, 1982, J BIOL CHEM, V257, P893; PARALES RE, 1992, J BACTERIOL, V174, P4657, DOI 10.1128/JB.174.14.4657-4666.1992; PEREZCERDA C, 1992, J INHERIT METAB DIS, V15, P371, DOI 10.1007/BF02435979; PICKART CM, 1979, J BIOL CHEM, V254, P9120; ROCHET JC, 1994, PROTEIN SCI, V3, P975; SAKAZAKI H, 1995, J INHERIT METAB DIS, V18, P323, DOI 10.1007/BF00710423; Sambrook J, 1989, MOL CLONING LAB MANU; SAUDUBRAY JM, 1987, ENZYME, V38, P80, DOI 10.1159/000469194; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHARP JA, 1978, BIOCHEM J, V173, P759, DOI 10.1042/bj1730759; SPENCE MW, 1973, PEDIATR RES, V7, P394; TILDON JT, 1972, J CLIN INVEST, V51, P493, DOI 10.1172/JCI106837; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; WAHLE E, 1992, ANNU REV BIOCHEM, V61, P419; WANG SP, 1993, MAMM GENOME, V4, P382, DOI 10.1007/BF00360589; WHITE H, 1976, J BIOL CHEM, V251, P1688; WHITE H, 1976, J BIOL CHEM, V251, P1708; WHITE H, 1976, J BIOL CHEM, V251, P1700; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; WILLIAMS.DH, 1971, BIOCHEM J, V121, P41, DOI 10.1042/bj1210041; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0	44	50	52	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1996	59	3					519	528						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN625	8751852				2022-12-18	WOS:A1996VN62500005
J	Chalmers, RM; Davis, MB; Sweeney, MG; Wood, NW; Harding, AE				Chalmers, RM; Davis, MB; Sweeney, MG; Wood, NW; Harding, AE			Evidence against an X-linked visual loss susceptibility locus in Leber hereditary optic neuropathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA MUTATION; CHROMOSOME INACTIVATION; Y-CHROMOSOME; LINKAGE; FAMILIES; GENE; NEURORETINOPATHY; SPECIFICITY; FEMALES; ANTIGEN	Pedigree analysis of British families with Leber hereditary optic neuropathy (LHON) closely fits a model in which a pathogenic mtDNA mutation interacts with an X-linked visual loss susceptibility locus (VLSL). This model predicts that 60% of affected females will show marked skewing of X inactivation. Linkage analysis in British and Italian families with genetically proven LHON has excluded the presence of such a VLSL over 169 cM of the X chromosome both when all families were analyzed together and when only families with the bp 11778 mutation were studied. Further, there was no excess skewing of X inactivation in affected females. There was no evidence for close linkage to three markers in the pseudoautosomal region of the sex chromosomes. The mechanism of incomplete penetrance and male predominance in LHON remains unclear.			Chalmers, RM (corresponding author), UNIV LONDON,INST NEUROL,DEPT CLIN NEUROL,NEUROGENET SECT,QUEEN SQ,LONDON WC1N 3BG,ENGLAND.		Wood, Nicholas W/C-2505-2009	Wood, Nicholas W/0000-0002-9500-3348				BU XD, 1992, CLIN GENET, V42, P143; BU XD, 1991, P NATL ACAD SCI USA, V88, P8198, DOI 10.1073/pnas.88.18.8198; CARVALHO MRS, 1992, HUM HERED, V42, P316, DOI 10.1159/000154089; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DAVIES JD, 1991, J EXP MED, V173, P823, DOI 10.1084/jem.173.4.823; DECORTE R, 1994, AM J HUM GENET, V54, P506; DIB C, IN PRESS NATURE; ELLIS N, 1990, AM J HUM GENET, V46, P950; GALE RE, 1994, BLOOD, V83, P2899, DOI 10.1182/blood.V83.10.2899.2899; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARDING AE, 1992, BRAIN, V115, P979, DOI 10.1093/brain/115.4.979; HARDING AE, 1995, AM J HUM GENET, V57, P77; HO MF, IN PRESS ANN NEUROL; HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739; JUVONEN V, 1993, AM J HUM GENET, V53, P289; LEROUX MG, 1994, HUM MOL GENET, V3, P389; LOVELAND B, 1990, CELL, V60, P971, DOI 10.1016/0092-8674(90)90345-F; NAKAMURA M, 1993, HUM GENET, V91, P339; Ott J., 1991, ANAL HUMAN GENETIC L; PEGORARO E, 1994, AM J HUM GENET, V54, P989; RAPPOLD GA, 1993, HUM GENET, V92, P315, DOI 10.1007/BF01247327; RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SCHMITT K, 1993, HUM MOL GENET, V2, P1978, DOI 10.1093/hmg/2.11.1978; SMITH PR, 1995, J NEUROL SCI, V130, P134, DOI 10.1016/0022-510X(95)00021-S; SWEENEY MG, 1992, AM J HUM GENET, V51, P741; VILKKI J, 1991, American Journal of Human Genetics, V48, P486	27	50	52	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1996	59	1					103	108						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL455	8659512				2022-12-18	WOS:A1996VL45500015
J	Litjens, T; Brooks, DA; Peters, C; Gibson, GJ; Hopwood, JJ				Litjens, T; Brooks, DA; Peters, C; Gibson, GJ; Hopwood, JJ			Identification, expression, and biochemical characterization of N-acetylgalactosamine-4-sulfatase mutations and relationship with clinical phenotype in MPS-VI patients	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUCOPOLYSACCHARIDOSIS TYPE-VI; MAROTEAUX-LAMY SYNDROME; HUMAN ARYLSULFATASE-B; FULL-LENGTH CDNA; ENDOPLASMIC-RETICULUM; PROTEIN MATURATION; SULFATASE; DIAGNOSIS; CLEAVAGE; CLONING	Maroteaux-Lamy syndrome, or mucopolysaccharidosis type VI (MPS-VI), is a lysosomal storage disorder characterized by the defective degradation of dermatan sulfate due to the deficiency of N-acetylgalactosamine-4-sulfatase (4S). The clinical severity of MPS-VI ranges in a continuum from mildly affected to severely affected patients. Mutations in MPS-VI patient samples were identified by chemical cleavage and direct DNA sequencing of PCR products derived from patient cDNA. Five amino acid substitutions were identified (T92M, R95Q, Y210C, H393P, and L498P), individually introduced into the wild-type 4S cDNA by site-directed in vitro mutagenesis, and transfected into Chinese hamster ovary cells. Three of the five mutations (R95Q, Y210C, and H333P) were observed in >1 of 25 unrelated MPS-VI patients; however, the mutations were not found in 20 control individuals. The residual 4S activity and protein (biochemical phenotype) were determined for each mutant in order to confirm their identity as mutations and to dissect the contribution of each mutant allele to the overall clinical phenotype of the patient. For each patient, the combined biochemical phenotypes of the two 4S mutant alleles demonstrated a good correspondence with the observed clinical phenotype (with the possible exception of a patient who was a compound heterozygote for T92M and L498P). This preliminary correspondence between genotype and the phenotype in MPS-VI may, with further refinement, contribute to the assessment of therapeutic approaches for MPS-VI patients.	WOMENS & CHILDRENS HOSP, DEPT CHEM PATHOL, LYSOSOMAL DIS RES UNIT, ADELAIDE, SA 5006, AUSTRALIA; UNIV GOTTINGEN, W-3400 GOTTINGEN, GERMANY; HENRY FORD HOSP, CTR BONE & JOINT, BREECH RES LAB, DETROIT, MI 48202 USA	Womens & Childrens Hospital Australia; University of Gottingen; Henry Ford Health System; Henry Ford Hospital			Brooks, Doug A/K-6714-2012	Brooks, Doug/0000-0001-9098-3626				ANSON DS, 1992, BIOCHEM J, V284, P789, DOI 10.1042/bj2840789; ARLT G, 1994, J BIOL CHEM, V269, P9638; BROOKS DA, 1995, BIOCHEM J, V307, P457, DOI 10.1042/bj3070457; BROOKS DA, 1991, AM J HUM GENET, V48, P710; BROOKS DA, 1993, J INHERIT METAB DIS, V16, P3, DOI 10.1007/BF00711309; CONNER BJ, 1983, P NATL ACAD SCI-BIOL, V80, P278, DOI 10.1073/pnas.80.1.278; CONZELMANN E, 1984, DEV NEUROSCI-BASEL, V6, P58, DOI 10.1159/000112332; FORREST SM, 1991, AM J HUM GENET, V49, P175; GIBSON GJ, 1987, BIOCHEM J, V248, P755, DOI 10.1042/bj2480755; HOPWOOD JJ, 1986, BIOCHEM J, V234, P507, DOI 10.1042/bj2340507; HOPWOOD JJ, 1990, MOL BIOL MED, V7, P381; HOPWOOD JJ, 1985, BIOCHEM J, V229, P579, DOI 10.1042/bj2290579; ISBRANDT D, 1994, AM J HUM GENET, V54, P454; JIN WD, 1992, AM J HUM GENET, V50, P795; LIPPINCOTTSCHWARTZ J, 1988, CELL, V54, P209, DOI 10.1016/0092-8674(88)90553-3; LITJENS T, 1991, BIOCHEM INT, V24, P209; Litjens Tom, 1992, Human Mutation, V1, P397, DOI 10.1002/humu.1380010509; LODISH HF, 1988, J BIOL CHEM, V263, P2107; MAROTEAUX P, 1963, PRESSE MED, V71, P1849; NAKAMAYE KL, 1986, NUCLEIC ACIDS RES, V14, P9679, DOI 10.1093/nar/14.24.9679; NELSON PV, 1989, MED J AUSTRALIA, V151, P126, DOI 10.5694/j.1326-5377.1989.tb139595.x; Neufeld EF, 1995, METABOLIC MOL BASES, P2465; PETERS C, 1990, J BIOL CHEM, V265, P3374; SCHMIDT B, 1995, CELL, V82, P271, DOI 10.1016/0092-8674(95)90314-3; SCHUCHMAN EH, 1990, GENOMICS, V6, P149, DOI 10.1016/0888-7543(90)90460-C; STUMPF DA, 1973, AM J DIS CHILD, V126, P747, DOI 10.1001/archpedi.1973.02110190597003; TOMATSU S, 1991, BIOCHEM BIOPH RES CO, V181, P677, DOI 10.1016/0006-291X(91)91244-7; VOSKOBOEVA E, 1994, HUM GENET, V93, P259, DOI 10.1007/BF00212019; WICKER G, 1991, J BIOL CHEM, V266, P21386; WILSON PJ, 1990, P NATL ACAD SCI USA, V87, P8531, DOI 10.1073/pnas.87.21.8531	30	50	54	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1996	58	6					1127	1134						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UM271	8651289				2022-12-18	WOS:A1996UM27100005
J	RobertsThomson, JM; Martinson, JJ; Norwich, JT; Harding, RM; Clegg, JB; Boettcher, B				RobertsThomson, JM; Martinson, JJ; Norwich, JT; Harding, RM; Clegg, JB; Boettcher, B			An ancient common origin of Aboriginal Australians and New Guinea highlanders is supported by alpha-globin haplotype analysis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PAPUA-NEW-GUINEA; HUMAN OCCUPATION SITE; HUMAN-POPULATIONS; THALASSEMIA; AFFINITIES; NEUTRALITY	The origins of aboriginal Australians and their relationship with New Guineans and neighboring Southeast Asians remain controversial. We have studied the alpha-globin haplotype composition of an aboriginal tribe from central Australia, to address some of the ambiguities of previous studies. Australians have a haplotype repertoire that is shared with New Guinea highlanders, a fact that strongly supports a common origin of these two populations. Further, Australians and New Guinea highlanders have a different set of a haplotypes from Southeast Asians and a lower genetic diversity. This, coupled with the presence of many locally specific central Australian haplotypes, suggests that much of the original diversity was lost in a population bottleneck prior to or during the early colonization of Sahul and that subsequent recovery of diversity has been accompanied by the generation of new haplotypes. These conclusions contrast with some previous genetic studies suggesting links between Australians, coastal New Guineans, and present-day Southeast Asians. Much of this discrepancy appears to be due to more recent Southeast Asian admixture on the north coast of Australia.	JOHN RADCLIFFE HOSP,INST MOLEC MED,MRC,MOLEC HAEMATOL UNIT,OXFORD OX3 9DU,ENGLAND; UNIV NEWCASTLE,DEPT BIOL SCI,NEWCASTLE,NSW 2308,AUSTRALIA	University of Oxford; University of Newcastle				Martinson, Jeremy/0000-0003-4673-7238	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		[Anonymous], 1993, MEGA MOL EVOLUTIONAR; Bellwood P., 1978, MANS CONQUEST PACIFI; Bellwood P.S., 1989, COLONIZATION PACIFIC, P1; Belwood P, 1985, PREHISTORY INDOMALAY; Berndt Ronald M., 1985, WORLD 1 AUSTR; BOWDLER S, 1993, SAHUL REV, P60; CAVALLISFORZA LL, 1967, EVOLUTION, V21, P550, DOI 10.1111/j.1558-5646.1967.tb03411.x; CHEN LZ, 1990, HUM GENET, V85, P89; CHEN LZ, 1990, MOL BIOL EVOL, V7, P423; CHEN LZ, 1992, HUM BIOL, V64, P1; CLARK AG, 1987, AM J HUM GENET, V41, P948; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; FLINT J, 1986, NATURE, V321, P744, DOI 10.1038/321744a0; Flood J., 1989, ARCHAEOLOGY DREAMTIM; GAO X, 1991, HUM IMMUNOL, V32, P269, DOI 10.1016/0198-8859(91)90090-V; GOSDEN C, 1993, SAHUL REV PLEISTOCEN, P131; GROUBE L, 1986, NATURE, V324, P453, DOI 10.1038/324453a0; GROUBE L, 1993, COMMUNITY CULTURE PE, P64; HERTZBERG MS, 1988, AM J HUM GENET, V43, P971; HIGGS DR, 1986, P NATL ACAD SCI USA, V83, P5165, DOI 10.1073/pnas.83.14.5165; HILL AVS, 1989, COLONISATION PACIFIC; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; KIRK RL, 1989, COLONIZATION PACIFIC, P60; LIN AA, 1994, GENE GEOGR, V8, P191; MARTINSON JJ, 1995, AM J HUM GENET, V57, P1186; MARTINSON JJ, 1994, AM J HUM GENET, V55, P513; NEI M, 1993, MOL BIOL EVOL, V10, P927; OSHAUGHNESSY DF, 1990, AM J HUM GENET, V46, P144; ROBERTS RG, 1990, NATURE, V345, P153, DOI 10.1038/345153a0; Rohlf FJ, 1990, NTSYS PC NUMERICAL T; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SERJEANTSON SW, 1985, J PAC HIST, P133; STONEKING M, 1990, GENETICS, V124, P717; STONEKING M, 1989, COLONIZATION PACIFIC, P215; TERRELL JE, 1986, PREHISTORY PACIFIC I, P14; THORNE AG, 1992, SCI AM, V266, P28; TSINTSOF AS, 1990, AM J HUM GENET, V46, P138; WATTERSON GA, 1978, GENETICS, V88, P405; White P. J., 1982, PREHISTORY AUSTR NEW; YENCHITSOMANUS P, 1986, HUM GENET, V74, P432, DOI 10.1007/BF00280500; YENCHITSOMANUS PT, 1986, AUST J EXP BIOL MED, V64, P297, DOI 10.1038/icb.1986.31; ZAGO MA, 1995, HUM BIOL, V67, P535	42	50	50	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1996	58	5					1017	1024						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH192	8651262				2022-12-18	WOS:A1996UH19200014
J	PADMA, T; AYYAGARI, R; MURTY, JS; BASTI, S; FLETCHER, T; RAO, GN; KAISERKUPFER, M; HEJTMANCIK, JF				PADMA, T; AYYAGARI, R; MURTY, JS; BASTI, S; FLETCHER, T; RAO, GN; KAISERKUPFER, M; HEJTMANCIK, JF			AUTOSOMAL-DOMINANT ZONULAR CATARACT WITH SUTURAL OPACITIES LOCALIZED TO CHROMOSOME 17Q11-12	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CRYSTALLIN GENE; BETA-CRYSTALLIN; LENS; LINKAGE; MUTATION	Congenital cataracts constitute a morphologically and genetically heterogeneous group of diseases that are a major cause of childhood blindness. Different loci for hereditary congenital cataracts have been mapped to chromosomes 1, 2, 16, and 17q24. We report linkage of a gene causing a unique form of autosomal dominant zonular cataracts with Y-sutural opacities to chromosome 17q11-12 in a three-generation family exhibiting a maximum lod score of 3.9 at D17S805. Multipoint analysis gave a l-lod confidence interval of 17 cM. This interval is bounded by the markers D17S799 and D17S798, a region that would encompass a number of candidate genes including that coding for beta A3/A1-crystallin.	NEI,LMOD,BETHESDA,MD 20892; LV PRASAD EYE INST,HYDERABAD,ANDHRA PRADESH,INDIA; OSMANIA UNIV,DEPT GENET,HYDERABAD 500007,ANDHRA PRADESH,INDIA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); L. V. Prasad Eye Institute; Osmania University								AARTS HJM, 1989, EUR J BIOCHEM, V183, P31, DOI 10.1111/j.1432-1033.1989.tb14892.x; ARMITAGE MM, 1995, NAT GENET, V9, P37, DOI 10.1038/ng0195-37; BAMSHAD M, 1995, AM J PHYS ANTHR S, V18, P53; BASTI S, IN PRESS AM J OPHTHA; BASTI S, 1993, NOV INT COOP CAT RES, V42; BRAKENHOFF RH, 1994, HUM MOL GENET, V3, P279, DOI 10.1093/hmg/3.2.279; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; CARTIER M, 1992, NAT GENET, V2, P42, DOI 10.1038/ng0992-42; CHAMBERS C, 1991, J BIOL CHEM, V266, P6742; CONNEALLY PM, 1978, CYTOGENET CELL GENET, V22, P295, DOI 10.1159/000130957; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; EIBERG H, 1988, CLIN GENET, V34, P272; FRACCARO M, 1967, ANN HUM GENET, V31, P45, DOI 10.1111/j.1469-1809.1967.tb02019.x; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; Hejtmancik J. F., 1995, METABOLIC MOL BASES, P4325; HEJTMANCIK JF, 1985, DEV BIOL, V109, P72, DOI 10.1016/0012-1606(85)90347-1; HOPE JN, 1994, PROTEIN ENG, V7, P445, DOI 10.1093/protein/7.3.445; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LUBSEN NH, 1987, P NATL ACAD SCI USA, V84, P489, DOI 10.1073/pnas.84.2.489; MARNER E, 1989, ACTA OPHTHALMOL, V67, P151; MOUNTAIN JL, 1995, AM J HUM GENET, V56, P979; OTT J, 1978, ANN HUM GENET, V42, P255, DOI 10.1111/j.1469-1809.1978.tb00657.x; RENWICK JH, 1963, ANN HUM GENET, V27, P67, DOI 10.1111/j.1469-1809.1963.tb00782.x; ROBB RM, 1994, PRINCIPLES PRACTICE, P2761; SCOTT MH, 1994, OPHTHALMOLOGY, V101, P866; SMITH RJH, 1992, GENOMICS, V14, P995, DOI 10.1016/S0888-7543(05)80122-3; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI	30	50	51	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1995	57	4					840	845						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RV793	7573044				2022-12-18	WOS:A1995RV79300014
J	EARLEY, CL; STRONG, LC				EARLEY, CL; STRONG, LC			CERTIFICATES OF CONFIDENTIALITY - A VALUABLE TOOL FOR PROTECTING GENETIC DATA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LEGAL-ASPECTS	Protecting the confidentiality of genetic research data is an important aspect of genetic research that has been discussed in various forums. Research data must be protected to prevent discrimination and its use in litigation. The certificate of confidentiality was created to protect the subjects of alcohol- and drug-abuse studies, who may be engaging in illegal activities. As revised in 1988, the certificate protects investigators engaging in other kinds of studies from being compelled to reveal information about subjects. Because the certificate protects information that could damage a subject's financial or social standing or employability, it is an appropriate tool to use to maintain the confidentiality of genetic data. The Department of Health and Human Services issues the certificates; the procedure for applying for a certificate of confidentiality is presented.			EARLEY, CL (corresponding author), UNIV TEXAS,MD ANDERSON CANC CTR,DEPT EXPTL PEDIAT,BOX 209,1515 HOLCOMBE BLVD,HOUSTON,TX 77030, USA.				NCI NIH HHS [CA38929, CA34936] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA034936, R01CA038929] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDREWS LB, 1991, YALE J BIOL MED, V64, P29; Angastiniotis M, 1992, Birth Defects Orig Artic Ser, V28, P38; BILLINGS PR, 1992, AM J HUM GENET, V50, P476; Brownlee Shannon, 1994, US News World Rep, V117, P58; BRUCE JAC, 1984, PRIVACY CONFIDENTIAL; Capron Alexander Morgan, 1990, Emory Law J, V39, P665; COOKDEEGAN RM, 1990, SOUTHERN MED J, V83, P879, DOI 10.1097/00007611-199008000-00007; GILLON R, 1988, J MED ETHICS, V14, P171, DOI 10.1136/jme.14.4.171; HARPER PS, 1993, LANCET, V341, P224, DOI 10.1016/0140-6736(93)90080-Z; Kass Nancy E, 1993, IRB, V15, P7, DOI 10.2307/3563730; MODELL B, 1992, ANN MED, V24, P549, DOI 10.3109/07853899209167009; REILLY P, 1991, YALE J BIOL MED, V64, P43; SASSE G, 1994, HUM HERED, V44, P337, DOI 10.1159/000154241; SCHMIDTKE J, 1992, J PHARM PHARMACOL, V44, P205; TOUCHETTE N, 1990, J NATL I HLTH RES, V2, P17; WERTZ DC, 1992, SOC SCI MED, V35, P495, DOI 10.1016/0277-9536(92)90342-N; WULFSBERG EA, 1994, JAMA-J AM MED ASSOC, V271, P217, DOI 10.1001/jama.271.3.217; 1989, RES CONFIDENTIALITY; 1986, WEBSTERS MED DESK DI	19	50	50	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1995	57	3					727	731						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR605	7668302				2022-12-18	WOS:A1995RR60500023
J	MCEWEN, JE; REILLY, PR				MCEWEN, JE; REILLY, PR			STORED GUTHRIE CARDS AS DNA BANKS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								Recently there has been much discussion about the possibility of using dried blood spots on Guthrie cards as a source of DNA for research or testing purposes. The collections of Guthrie cards stored by state newborn-screening laboratories can thus be viewed as inchoate ''DNA banks.'' This has generated concern among some persons who are interested in preserving the privacy of medical records. This study examines the policies of state newborn-screening laboratories in the United States, regarding their retention of Guthrie cards and the degree to which they permit the sharing of those cards with various third parties. We found that although most laboratories retain their cards, if at all, for only a short time, a growing number plan to keep them for an extended period-and, in several cases, indefinitely. We also found that although most laboratories would decline to release individually identifiable blood spots from the cards to third parties without a written release or other explicit authorization, a large number would at least consider sharing anonymous cards for research purposes.	BOSTON COLL,SCH LAW,NEWTON,MA	Boston College	MCEWEN, JE (corresponding author), EUNICE KENNEDY SHRIVER CTR MENTAL RETARDAT INC,DIV SOCIAL SCI ETH & LAW,200 TRAPELO RD,WALTHAM,MA 02254, USA.				PHS HHS [MCH MCJ-259151-02-0] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ANDREWS LB, 1985, STATE LAWS REGULATIO; ANNAS GJ, 1993, JAMA-J AM MED ASSOC, V270, P2346, DOI 10.1001/jama.270.19.2346; McCabe E R, 1991, PCR Methods Appl, V1, P99; MCEWEN JE, 1994, AM J HUM GENET, V54, P941; REILLY PR, 1992, AM J HUM GENET, V51, P1169; 1994, ASSESSING GENETIC RI; 1992, 1990 COUNC REG GEN N; 1988, AM J HUM GENET, V42, P781; 1993, PROTECTING HUMAN RES	9	50	53	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1994	55	1					196	200						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NW461	8023846				2022-12-18	WOS:A1994NW46100026
J	HENNEKAM, RCM; TILANUS, M; HAMEL, BCJ; VOSHARTVANHEEREN, H; MARIMAN, ECM; VANBEERSUM, SEC; VANDENBOOGAARD, MJH; BREUNING, MH				HENNEKAM, RCM; TILANUS, M; HAMEL, BCJ; VOSHARTVANHEEREN, H; MARIMAN, ECM; VANBEERSUM, SEC; VANDENBOOGAARD, MJH; BREUNING, MH			DELETION AT CHROMOSOME 16P13.3 AS A CAUSE OF RUBINSTEIN-TAYBI SYNDROME - CLINICAL ASPECTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA	In the accompanying paper, a chromosomal localization of the Rubinstein-Taybi syndrome by cytogenetic investigations with fluorescence in situ hybridization techniques at chromosome 16p13.3 is described. We investigated 19 of these patients and their parents (a) to ascertain the parental origin of the chromosome with the deletion in families where such a deletion was detected, (b) to disclose whether uniparental disomy plays a role in etiology, and (c) to compare clinical features in patients with a deletion to those in individuals in whom deletions were not detectable. Molecular studies showed a copy of chromosome 16 from each parent in all 19 patients. Uniparental disomy was also excluded for five other chromosome arms known to be imprinted in mice. None of the probes used for determining the origin of the deleted chromosome proved to be informative. The clinical features were essentially the same in patients with and without visible deletion, with a possible exception for the incidence of microcephaly, angulation of thumbs and halluces, and partial duplication of the halluces. A small deletion at 16p13.3 may be found in some patients with Rubinstein-Taybi syndrome. Cytogenetically undetectable deletions, point mutations, mosaicism, heterogeneity, or phenocopy by a nongenetic cause are the most probable explanations for the absence of cytogenetic or molecular abnormalities in other patients with Rubinstein-Taybi syndrome.	CLIN GENET CTR,UTRECHT,NETHERLANDS; UNIV UTRECHT,MOLEC LAB,UTRECHT,NETHERLANDS; UNIV HOSP NIJMEGEN,DEPT HUMAN GENET,NIJMEGEN,NETHERLANDS; CLIN GENET CTR ROTTERDAM,ROTTERDAM,NETHERLANDS	Utrecht University; Radboud University Nijmegen			Breuning, Martijn H/E-3429-2010					Ballabio A, 1991, CURR OPIN GENET DEV, V1, P25, DOI 10.1016/0959-437X(91)80036-L; Bazacliu E, 1973, Ftiziologia, V22, P645; BENIRSCHKE K, 1979, AM J MED GENET, V3, P297, DOI 10.1002/ajmg.1320030309; BILIR BM, 1990, AM J MED GENET S, V6, P69; BREUNING MH, 1993, AM J HUM GENET, V52, P249; DAVISON BCC, 1967, DEV MED CHILD NEUROL, V9, P588; GRAFFRADFORD SB, 1981, S AFR MED J, V60, P71; HALL JG, 1990, AM J HUM GENET, V46, P857; HENNEKAM RCM, 1991, J CRAN GENET DEV BIO, V11, P33; HENNEKAM RCM, 1992, AM J MENT RETARD, V96, P645; HENNEKAM RCM, 1989, EUR J PEDIATR, V148, P439, DOI 10.1007/BF00595907; HENNEKAM RCM, 1990, AM J MED GENET S, V6, P17; HENNEKAM RCM, 1990, AM J MED GENET S, V6, P56; HENNEKAM RCM, 1990, AM J MED GENET S, V6, P42; HENNEKAN RCM, 1990, AM J MED GENET S, V6, P48; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; REEDERS ST, 1985, NATURE, V317, P542, DOI 10.1038/317542a0; RUBINSTEIN JH, 1963, AM J DIS CHILD, V105, P588, DOI 10.1001/archpedi.1963.02080040590010; RUBINSTEIN JH, 1990, AM J MED GENET S, V6, P3; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; SEARLE AG, 1989, ANN HUM GENET, V53, P89, DOI 10.1111/j.1469-1809.1989.tb01777.x; SPRANGER J, 1982, J PEDIATR-US, V100, P160, DOI 10.1016/S0022-3476(82)80261-8; STEVENS CA, 1990, AM J MED GENET S, V6, P51; WAGSTAFF J, 1992, NAT GENET, V1, P291, DOI 10.1038/ng0792-291; WEBER JL, 1989, AM J HUM GENET, V44, P388; WILLIAMSON R, 1991, CYTOGENET CELL GENET, V58, P1663	26	50	52	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1993	52	2					255	262						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KN275	8430692				2022-12-18	WOS:A1993KN27500002
J	PATTERSON, DF; PEXIEDER, T; SCHNARR, WR; NAVRATIL, T; ALAILI, R				PATTERSON, DF; PEXIEDER, T; SCHNARR, WR; NAVRATIL, T; ALAILI, R			A SINGLE MAJOR-GENE DEFECT UNDERLYING CARDIAC CONOTRUNCAL MALFORMATIONS INTERFERES WITH MYOCARDIAL GROWTH DURING EMBRYONIC-DEVELOPMENT - STUDIES IN THE CTD LINE OF KEESHOND DOGS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL HEART-DISEASE; SEPTAL-DEFECTS	The common forms of isolated congenital heart disease are usually not inherited in a Mendelian pattern, and most are considered multifactorial threshold traits. A large subset consisting of a group of malformations of the ventricular outflow region, termed ''conotruncal defects'' (CTDs), include subarterial ventricular septal defects, tetralogy of Fallot, and persistent truncus arteriosus. Similar aggregations of CTDs have been reported in human families and in the keeshond breed of dog. The results of our early breeding experiments utilizing noninbred keeshonds were not consistent with any hypothesis of a fully penetrant monogenic inheritance. Here we report a recent series of genetic and embryologic studies conducted after more than 10 generations of selective inbred matings between affected-CTD-line dogs. The results are now consistent with a defect at a single autosomal locus, the Mendelian pattern of transmission having been obscured prior to selective inbreeding by genetic background. On the basis of morphometric embryologic studies, the mutant CTD allele causes conotruncal malformations in homozygous animals by interfering with myocardial growth in the conotruncus during the critical window when the conotruncal cushions fuse to form the conotruncal septum.	UNIV LAUSANNE, INST HISTOL & EMBRYOL, CH-1000 LAUSANNE 17, SWITZERLAND	University of Lausanne	PATTERSON, DF (corresponding author), UNIV PENN, SCH VET MED, MED GENET SECT, 3850 SPRUCE ST, PHILADELPHIA, PA 19104 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL018848, R37HL018848] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-18848] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALAILI R, 1985, European Heart Journal, V6, P38; Campbell M, 1965, Br Med J, V2, P895; CARTER CO, 1961, BRIT MED BULL, V17, P251, DOI 10.1093/oxfordjournals.bmb.a069918; CARTER CO, 1969, BRIT MED BULL, V25, P52, DOI 10.1093/oxfordjournals.bmb.a070671; CLARK EB, 1987, GENETICS CARDIOVASCU, P3; CORONE P, 1983, AM J CARDIOL, V51, P942, DOI 10.1016/S0002-9149(83)80170-2; DAVISON B C C, 1967, Journal of Medical Genetics, V4, P245, DOI 10.1136/jmg.4.4.245; Detweiler D. K., 1979, Canine medicine. Volume II, P813; EDWARDS J. H., 1960, ACTA GENET ET STATIST MED, V10, P63; EDWARDS JH, 1969, BRIT MED BULL, V25, P58, DOI 10.1093/oxfordjournals.bmb.a070672; EHLERS KH, 1966, CIRCULATION, V34, P503, DOI 10.1161/01.CIR.34.3.503; EMANUEL R, 1970, BRIT HEART J, V32, P281; ETTINGER SJ, 1970, CANINE CARDIOLOGY; Falconer D.S., 1960, INTRO QUANTITATIVE G; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; FERENCZ C, 1985, AM J EPIDEMIOL, V121, P31, DOI 10.1093/oxfordjournals.aje.a113979; FERENCZ C, 1991, Teratology, V43, P450; FRASER FC, 1975, AM J CARDIOL, V36, P793, DOI 10.1016/0002-9149(75)90461-0; FRASER FC, 1976, TERATOLOGY, V14, P267, DOI 10.1002/tera.1420140302; FUHRMANN W, 1968, HUMANGENETIK, V6, P1, DOI 10.1007/BF00287149; GRUNEBERG H, 1952, J GENET, V51, P95, DOI 10.1007/BF02986708; KIRBY ML, 1983, SCIENCE, V220, P1059, DOI 10.1126/science.6844926; KURNIT DM, 1987, AM J HUM GENET, V41, P979; KURNIT DM, 1985, AM J MED GENET, V20, P385, DOI 10.1002/ajmg.1320200222; LAMY M, 1957, AM J HUM GENET, V9, P17; MARKWALD RR, 1990, ANN NY ACAD SCI, V588, P13, DOI 10.1111/j.1749-6632.1990.tb13193.x; MCKEOWN T, 1953, BRIT HEART J, V15, P273; MILLER ME, 1979, PEDIATRICS, V63, P890; MJAATVEDT CH, 1991, DEV BIOL, V145, P219, DOI 10.1016/0012-1606(91)90121-I; MULVIHILL JJ, 1973, TERATOLOGY, V7, P73, DOI 10.1002/tera.1420070111; NORA JJ, 1968, CIRCULATION, V38, P604, DOI 10.1161/01.CIR.38.3.604; NORA JJ, 1978, CIRCULATION, V57, P205, DOI 10.1161/01.CIR.57.2.205; NORA JJ, 1978, GENETICS COUNSELING; NORA JJ, 1980, CONGENITAL HEART DIS, P3; PATTERSO.DF, 1968, CIRC RES, V23, P171, DOI 10.1161/01.RES.23.2.171; Patterson D F, 1978, Birth Defects Orig Artic Ser, V14, P315; PATTERSON D. F., 1965, ANN N Y ACAD SCI, V127, P541, DOI 10.1111/j.1749-6632.1965.tb49423.x; PATTERSON DF, 1974, AM J CARDIOL, V34, P187, DOI 10.1016/0002-9149(74)90198-2; PEXIEDER T, 1989, EUR J EPIDEMIOL, V5, P254; PEXIEDER T, 1981, PAEDIATRIC CARDIOLOG, V4, P24; PEXIEDER T, 1984, CONGENITAL HEART DIS, P439; PEXIEDER T, 1989, CORRELATIONS EXPT CA, P37; PITT DB, 1962, AUSTRALAS ANN MED, V11, P179, DOI 10.1111/imj.1962.11.3.179; REAL F, 1968, P ASS EUROPEAN PAEDI, V4, P46; SANCHEZCASCOS A, 1978, EUR J CARDIOL, V7, P197; Siegel S, 1956, NONPARAMETRIC STATIS; SINNING AR, 1992, ANAT REC, V232, P285, DOI 10.1002/ar.1092320213; SOTO B, 1980, BRIT HEART J, V43, P332; STREETER GL, 1948, CONTRIB EMBRYOL, V32, P113; TAKAO A, 1980, ETIOLOGY MORPHOGENES, P253; Van Mierop L H, 1978, Birth Defects Orig Artic Ser, V14, P361; VANMIEROP LHS, 1978, AM J CARDIOL, V41, P755, DOI 10.1016/0002-9149(78)90828-7; VANMIEROP LHS, 1977, AM J CARDIOL, V40, P936, DOI 10.1016/0002-9149(77)90045-5; Wright S, 1934, GENETICS, V19, P0537; 1985, PHA NIH8523 PUBL	55	50	50	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1993	52	2					388	397						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KN275	8430699				2022-12-18	WOS:A1993KN27500017
J	ROTHSCHILD, CB; AKOTS, G; HAYWORTH, R; PETTENATI, MJ; RAO, PN; WOOD, P; STOLZ, FM; HANSMANN, I; SERINO, K; KEITH, TP; FAJANS, SS; BOWDEN, DW				ROTHSCHILD, CB; AKOTS, G; HAYWORTH, R; PETTENATI, MJ; RAO, PN; WOOD, P; STOLZ, FM; HANSMANN, I; SERINO, K; KEITH, TP; FAJANS, SS; BOWDEN, DW			A GENETIC-MAP OF CHROMOSOME 20Q12-Q13.1 - MULTIPLE HIGHLY POLYMORPHIC MICROSATELLITE AND RFLP MARKERS LINKED TO THE MATURITY-ONSET DIABETES OF THE YOUNG (MODY) LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOMIC CLONES; LINKAGE MAP; IDENTIFICATION; LOCALIZATION; SEQUENCE; LIBRARY; CDNA	Multiple highly polymorphic markers have been used to construct a genetic map of the q12-q13.1 region of chromosome 20 and to map the location of the maturity-onset diabetes of the young (MODY) locus. The genetic map encompasses 23 cM and includes 11 loci with PIC values >.50, seven of which have PICs >.70. New dinucleotide repeat polymorphisms associated with the D20S17, PPGB, and ADA loci have been identified and mapped. The dinucleotide repeat polymorphisms have increased the PIC of the ADA locus to .89 and, with an additional RFLP at the D20S17 locus, the PIC of the D20S17 locus to .88. The order of the D20S17 and ADA loci determined genetically (cen-ADA-D20S17-qter) was confirmed by multicolor fluorescence in situ hybridization. The previously unmapped PPGB marker is closely linked to D20S17, with a two-point lod score of 50.53 at theta = .005. These markers and dinucleotide repeat markers associated with the D20S43, D20S46, D20S55, D20S75, and PLC1 loci and RFLPs at the D20S16, D20S17, D20S22, and D20S33 have been used to map the MODY locus on chromosome 20 to a 13-cM (sex averaged) interval encompassing ADA, D20S17, PPGB, D20S16, and D20S75 on the long arm of chromosome 20 and to create a genetic framework for additional genetic and physical mapping studies of the region. With these multiple highly polymorphic loci, any MODY family of appropriate size can be tested for the chromosome 20 linkage.	WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT BIOCHEM,MED CTR BLVD,WINSTON SALEM,NC 27157; UNIV MICHIGAN,MED CTR,DEPT INTERNAL MED,ANN ARBOR,MI 48109; WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT PEDIAT,WINSTON SALEM,NC 27157; UNIV GOTTINGEN,INST HUMAN GENET,W-3400 GOTTINGEN,GERMANY; COLLABORAT RES INC,WALTHAM,MA	Wake Forest University; Wake Forest Baptist Medical Center; University of Michigan System; University of Michigan; Wake Forest University; Wake Forest Baptist Medical Center; University of Gottingen					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, R01DK041269] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-20572, R01 DK41269] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDRIA G, 1981, SIALIDASES SIALIDOSE, P379; BARR CL, 1991, CYTOGENET CELL GENET, V58, P2028; BELL GI, 1991, P NATL ACAD SCI USA, V88, P1484, DOI 10.1073/pnas.88.4.1484; BOWDEN DW, 1989, AM J HUM GENET, V44, P671; BOWDEN DW, 1992, AM J HUM GENET, V50, P607; BOWDEN DW, 1989, GENOMICS, V5, P718, DOI 10.1016/0888-7543(89)90113-4; BOWDEN DW, 1992, DIABETES, V41, P88, DOI 10.2337/diabetes.41.1.88; BOWDEN DW, 1988, GENE, V71, P391, DOI 10.1016/0378-1119(88)90056-X; BRISTOL A, 1988, COLD SPRING HARB SYM, V53, P915, DOI 10.1101/SQB.1988.053.01.105; DADDONA PE, 1984, J BIOL CHEM, V259, P2101; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; ECONOMOU EP, 1990, P NATL ACAD SCI USA, V87, P2951, DOI 10.1073/pnas.87.8.2951; FAJANS SS, 1990, DIABETES CARE, V13, P49, DOI 10.2337/diacare.13.1.49; FAJANS SS, 1992, J LAB CLIN MED, V119, P206; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; GALJART NJ, 1988, CELL, V54, P755, DOI 10.1016/S0092-8674(88)90999-3; GOODFELLOW PJ, 1987, CYTOGENET CELL GENET, V44, P112, DOI 10.1159/000132354; HATTERSLEY AT, 1992, LANCET, V339, P1307, DOI 10.1016/0140-6736(92)91958-B; HAZAN J, 1992, GENOMICS, V12, P183, DOI 10.1016/0888-7543(92)90364-X; HAZAN J, 1991, CYTOGENET CELL GENET, V58, P2029; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; IKEUCHI T, 1984, CYTOGENET CELL GENET, V38, P56, DOI 10.1159/000132030; JHANWAR SC, 1987, CYTOGENET CELL GENET, V46, P634; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; OTT J, 1985, ANAL HUMAN GENETIC L; RAO PN, 1992, GENOMICS, V14, P532, DOI 10.1016/S0888-7543(05)80262-9; ROTHSCHILD CB, 1992, GENOMICS, V13, P560, DOI 10.1016/0888-7543(92)90125-C; SCHNITTGER S, 1991, CYTOGENET CELL GENET, V58, P2032; SCHUMM JW, 1988, AM J HUM GENET, V42, P143; STOLZ FM, 1991, GENOMICS, V11, P948, DOI 10.1016/0888-7543(91)90019-B; VERGNAUD G, 1991, GENOMICS, V11, P135, DOI 10.1016/0888-7543(91)90110-Z; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0; WIEGANT J, 1991, GENOMICS, V10, P345, DOI 10.1016/0888-7543(91)90318-9	33	50	50	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1993	52	1					110	123						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KK908	8094595				2022-12-18	WOS:A1993KK90800014
J	PRIOR, L; BORDET, S; TRIFIRO, MA; MHATRE, A; KAUFMAN, M; PINSKY, L; WROGEMAN, K; BELSHAM, DD; PEREIRA, F; GREENBERG, C; TRAPMAN, J; BRINKMAN, AO; CHANG, C; LIAO, SS				PRIOR, L; BORDET, S; TRIFIRO, MA; MHATRE, A; KAUFMAN, M; PINSKY, L; WROGEMAN, K; BELSHAM, DD; PEREIRA, F; GREENBERG, C; TRAPMAN, J; BRINKMAN, AO; CHANG, C; LIAO, SS			REPLACEMENT OF ARGININE-773 BY CYSTEINE OR HISTIDINE IN THE HUMAN ANDROGEN RECEPTOR CAUSES COMPLETE ANDROGEN INSENSITIVITY WITH DIFFERENT RECEPTOR PHENOTYPES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; MALE PSEUDOHERMAPHRODITISM; PREMATURE TERMINATION; SKIN FIBROBLASTS; BINDING DOMAIN; POINT MUTATION; GENE; FAMILY; DNA; RESISTANCE	We have discovered two different point mutations in a single codon of the X-linked androgen-receptor (AR) gene in two pairs of unrelated families who have complete androgen insensitivity (resistance) associated with different AR phenotypes in their genital skin fibroblasts. One mutation is a C-to-T transition at a CpG sequence near the 5' terminus of exon 6; it changes the sense of codon 773 from arginine to cysteine, ablates specific androgen-binding activity at 37-degrees-C, and eliminates a unique KpnI site at the intron-exon boundary. The other mutation is a G-to-A transition that changes amino acid 773 to histidine and eliminates an SphI site. This mutant AR has a normal androgen-binding capacity at 37-degrees-C but has a reduced affinity for androgens and is thermolabile in their presence. Transient transfection of COS cells with cDNA expression vectors yielded little androgen-binding activity at 37-degrees-C from Arg773Cys and abundant activity with abnormal properties from Arg773His, thereby proving the pathogenicity of both sequence alterations. This conclusion coincides with the following facts about evolutionary preservation of the position homologous to Arg773 in the AR: it is occupied by Arg or lysine in the progesterone, glucocorticoid, and mineralocorticoid receptors, and it is within a 14-amino-acid region of their steroid-binding domains that share approximately 85% amino acid identity.	MCGILL UNIV,DEPT BIOL,MONTREAL H3A 2T5,QUEBEC,CANADA; MCGILL UNIV,DEPT MED,MONTREAL H3A 2T5,QUEBEC,CANADA; MCGILL UNIV,DEPT PEDIAT,MONTREAL H3A 2T5,QUEBEC,CANADA; UNIV MANITOBA,DEPT BIOCHEM & MOLEC BIOL,WINNIPEG R3T 2N2,MANITOBA,CANADA; UNIV MANITOBA,DEPT HUMAN GENET,WINNIPEG R3T 2N2,MANITOBA,CANADA; ERASMUS UNIV,DEPT PATHOL,3000 DR ROTTERDAM,NETHERLANDS; ERASMUS UNIV,DEPT ENDOCRINOL & REPROD,3000 DR ROTTERDAM,NETHERLANDS; UNIV CHICAGO,BEN MAY INST,CHICAGO,IL 60637; UNIV CHICAGO,DEPT BIOCHEM & MOLEC BIOL,CHICAGO,IL 60637	McGill University; McGill University; McGill University; University of Manitoba; University of Manitoba; Erasmus University Rotterdam; Erasmus University Rotterdam; University of Chicago; University of Chicago	PRIOR, L (corresponding author), SIR MORTIMER B DAVIS JEWISH HOSP,LADY DAVIS INST MED RES,3755 COTE ST CATHERINE RD,MONTREAL H3T 1E2,QUEBEC,CANADA.			Pereira, Fred/0000-0003-2100-0280				Alwine J C, 1979, Methods Enzymol, V68, P220; BAKKER E, 1989, J MED GENET, V26, P553, DOI 10.1136/jmg.26.9.553; BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BRINKMANN AO, 1989, J STEROID BIOCHEM, V34, P1; BROWN CJ, 1989, AM J HUM GENET, V44, P264; BROWN TR, 1990, MOL ENDOCRINOL, V4, P1759, DOI 10.1210/mend-4-12-1759; BROWN TR, 1988, P NATL ACAD SCI USA, V85, P8151, DOI 10.1073/pnas.85.21.8151; CHANG CS, 1988, P NATL ACAD SCI USA, V85, P7211, DOI 10.1073/pnas.85.19.7211; CLEVELAND DW, 1980, CELL, V20, P95, DOI 10.1016/0092-8674(80)90238-X; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GITSCHIER J, 1989, LANCET, V1, P273; GOTTLIEB B, 1987, J STEROID BIOCHEM, V28, P279, DOI 10.1016/0022-4731(87)91019-3; GOVINDAN MV, 1990, MOL ENDOCRINOL, V4, P417, DOI 10.1210/mend-4-3-417; GREENBERG CR, 1987, AM J HUM GENET, V41, P128; INNIS MA, 1990, PCR PROTOCOLS, P54; KAUFMAN M, 1983, J STEROID BIOCHEM, V18, P383, DOI 10.1016/0022-4731(83)90055-9; KAUFMAN M, 1976, J CLIN INVEST, V58, P345, DOI 10.1172/JCI108478; KRONGRAD A, 1991, MOL CELL ENDOCRINOL, V76, P79, DOI 10.1016/0303-7207(91)90262-Q; KUIPER GGJM, 1989, J MOL ENDOCRINOL, V2, pR1, DOI 10.1677/jme.0.002R001; LUBAHN DB, 1989, P NATL ACAD SCI USA, V86, P9534, DOI 10.1073/pnas.86.23.9534; LUBAHN DB, 1988, MOL ENDOCRINOL, V2, P1265, DOI 10.1210/mend-2-12-1265; MADDALENA A, 1988, NEW ENGL J MED, V319, P999, DOI 10.1056/NEJM198810133191507; MARCELLI M, 1990, J CLIN INVEST, V85, P1522, DOI 10.1172/JCI114599; MARCELLI M, 1991, J CLIN ENDOCR METAB, V73, P318, DOI 10.1210/jcem-73-2-318; MARCELLI M, 1990, MOL ENDOCRINOL, V4, P1105, DOI 10.1210/mend-4-8-1105; MARCELLI M, 1991, J CLIN INVEST, V87, P1123, DOI 10.1172/JCI115076; MCPHAUL MJ, 1991, J CLIN INVEST, V87, P1413, DOI 10.1172/JCI115147; MEBARKI E, 1990, 72D ANN M END SOC AT; MIESFELD R, 1986, CELL, V46, P389, DOI 10.1016/0092-8674(86)90659-8; MURPHY LC, 1989, MOL ENDOCRINOL, V3, P611, DOI 10.1210/mend-3-4-611; OMALLEY B, 1990, MOL ENDOCRINOL, V4, P363, DOI 10.1210/mend-4-3-363; PINSKY L, 1977, CAN MED ASSOC J, V116, P1274; RISSTALPERS C, 1991, MOL ENDOCRINOL, V5, P1562, DOI 10.1210/mend-5-10-1562; RISSTALPERS C, 1990, P NATL ACAD SCI USA, V87, P7866, DOI 10.1073/pnas.87.20.7866; SAI T, 1990, AM J HUM GENET, V46, P1095; Sambrook J., 1989, MOL CLONING LAB MANU; TILLEY WD, 1989, P NATL ACAD SCI USA, V86, P327, DOI 10.1073/pnas.86.1.327; TILLEY WD, 1990, 72D END SOC ANN M AT; TRIFIRO M, 1989, American Journal of Human Genetics, V45, pA225; TRIFIRO M, 1991, MOL CELL ENDOCRINOL, V75, P37, DOI 10.1016/0303-7207(91)90243-L; TRIFIRO M, 1991, AM J MED GENET, V40, P493, DOI 10.1002/ajmg.1320400425; WILSON EM, 1986, J BIOL CHEM, V261, P6501; WILSON JD, 1978, ANNU REV PHYSIOL, V40, P279, DOI 10.1146/annurev.ph.40.030178.001431; ZEGERS ND, 1991, BIOCHIM BIOPHYS ACTA, V1073, P23, DOI 10.1016/0304-4165(91)90178-J	44	50	53	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1992	51	1					143	155						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JA467	1609793				2022-12-18	WOS:A1992JA46700015
J	MARGARITTE, P; BONAITIPELLIE, C; KING, MC; CLERGETDARPOUX, F				MARGARITTE, P; BONAITIPELLIE, C; KING, MC; CLERGETDARPOUX, F			LINKAGE OF FAMILIAL BREAST-CANCER TO CHROMOSOME-17Q21 MAY NOT BE RESTRICTED TO EARLY-ONSET DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INHERITANCE	Lod scores for linkage between familial breast and ovarian cancer and markers on chromosome 17q21 are more frequently positive among families with disease diagnosed at younger ages than they are among older-onset families, suggesting that linkage is restricted to early-onset disease. However, for late-onset cases, the relative probability of sporadic rather than inherited disease is higher than previously suggested. If this correction is made, then later-onset families are much less informative; linkage heterogeneity based on age at onset is no longer significant; and for the sample of families as a whole, linkage is significant at a recombination fraction since demonstrated to be close to the correct locale. There is probably more than one gene for inherited breast cancer, but heterogeneity may not be due to age at disease onset.	UNIV CALIF BERKELEY,SCH PUBL HLTH,BERKELEY,CA 94720; UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720	University of California System; University of California Berkeley; University of California System; University of California Berkeley	CLERGETDARPOUX, F (corresponding author), INSERM,U155,UNITE RECH EPIDEMIOL GENET,CHATEAU LONGCHAMP,F-75016 PARIS,FRANCE.		; Clerget-Darpoux, Francoise/I-4825-2017	King, Mary-Claire/0000-0001-9426-1743; Clerget-Darpoux, Francoise/0000-0003-4816-6619				BISHOP DT, 1988, GENET EPIDEMIOL, V5, P151, DOI 10.1002/gepi.1370050303; CLAUS EB, 1991, AM J HUM GENET, V48, P232; HALL JM, 1992, AM J HUM GENET, V50, P1235; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; ISELIUS L, 1991, ANN HUM GENET, V55, P151, DOI 10.1111/j.1469-1809.1991.tb00408.x; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MORTON NE, 1956, AM J HUM GENET, V8, P80; NAROD SA, 1990, AM J HUM GENET, V46, P266; NAROD SA, 1991, LANCET, V338, P82; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P3044, DOI 10.1073/pnas.85.9.3044; Ott J., 1991, ANAL HUMAN GENETIC L; RISCH N, 1988, AM J HUM GENET, V42, P353; SKOLNICK MH, 1990, SCIENCE, V250, P1715, DOI 10.1126/science.2270486; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; WILLIAMS W R, 1984, Genetic Epidemiology, V1, P7, DOI 10.1002/gepi.1370010104	15	50	51	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1992	50	6					1231	1234						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HY654	1598903				2022-12-18	WOS:A1992HY65400010
J	BOTTEMA, CDK; BOTTEMA, MJ; KETTERLING, RP; YOON, HS; JANCO, RL; PHILLIPS, JA; SOMMER, SS				BOTTEMA, CDK; BOTTEMA, MJ; KETTERLING, RP; YOON, HS; JANCO, RL; PHILLIPS, JA; SOMMER, SS			WHY DOES THE HUMAN FACTOR-IX GENE HAVE A G+C CONTENT OF 40-PERCENT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COAGULATION FACTOR-IX; HEMOPHILIA-B PATIENTS; ARGININE RESIDUES; NUCLEAR EXTRACTS; POINT MUTATIONS; G.T MISPAIRS; HUMAN-CELLS; DINUCLEOTIDE; SUBSTITUTION; GLUTAMINE	The factor IX gene has a G + C content of approximately 40% in all mammalian species examined. In human factor IX, C --> T and G --> A transitions at the dinucleotide CpG are elevated at least 24-fold relative to other transitions. Can the G + C content be explained solely by this hot spot of mutation? Using our mathematical model, we show that the elevation of mutation at CpG cannot alone lower the G + C content below 45%. To search for other hot spots of mutation that might contribute to the reduction of G + C content, we assessed the relative rates of base substitution in our sample of 160 families with hemophilia B. Seventeen independent single-base substitutions are reported herein for a total of 96 independent point mutations in our sample. The following conclusions emerge from the analysis of our data and, where appropriate, the data of others: (1) Transversions at CpG are elevated an estimated 7.7-fold relative to other transversions. (2) The mutation rates at non-CpG dinucleotides are remarkably uniform; none of the observed rates are either more than twofold above the median for transitions or more than threefold above the median for transversions. (3) The pattern of recent mutation is compatible with the pattern during mammalian evolution that has maintained the G + C content of the factor IX gene at approximately 40%.	MAYO CLIN & MAYO FDN, DEPT BIOCHEM & MOLEC BIOL, ROCHESTER, MN 55905 USA; VANDERBILT UNIV, MED CTR, SCH MED, DEPT PEDIAT, DIV GENET, NASHVILLE, TN 37232 USA; WINONA STATE UNIV, DEPT MATH & STAT, WINONA, MN 55987 USA	Mayo Clinic; Vanderbilt University; Winona State University				Ketterling, Rhett/0000-0001-6479-7897; Bottema, Cynthia/0000-0001-6245-0099	NHLBI NIH HHS [HL39762] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039762] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AMES BN, 1990, P NATL ACAD SCI USA, V87, P7772, DOI 10.1073/pnas.87.19.7772; AMES BN, 1989, MUTAT RES, V214, P41, DOI 10.1016/0027-5107(89)90196-6; BENTLEY AK, 1986, CELL, V45, P343, DOI 10.1016/0092-8674(86)90319-3; BERNARDI G, 1985, SCIENCE, V228, P953, DOI 10.1126/science.4001930; BOTTEMA CDK, 1990, BRIT J HAEMATOL, V75, P212, DOI 10.1111/j.1365-2141.1990.tb02651.x; BOTTEMA CDK, 1990, AM J HUM GENET, V47, P835; BOTTEMA CDK, 1990, NUCLEIC ACIDS RES, V18, P1924, DOI 10.1093/nar/18.7.1924; BOTTEMA CDK, 1991, AM J HUM GENET, V49, P820; CAMERINO G, 1984, P NATL ACAD SCI-BIOL, V81, P498, DOI 10.1073/pnas.81.2.498; CHAKRABORTY R, 1989, P NATL ACAD SCI USA, V86, P9407, DOI 10.1073/pnas.86.23.9407; Dantzig G. B., 1963, LINEAR PROGRAMMING, DOI 10.7249/R366; DENTON PH, 1988, BLOOD, V72, P407; DISPERT S, 1989, AM J HUM GENET S, V45, pA189; DIUGUID DL, 1989, BLOOD, V74, P193; EVANS JP, 1989, BLOOD, V74, P207; EYSTER ME, 1980, AM J HEMATOL, V9, P277, DOI 10.1002/ajh.2830090306; GIANNELLI F, 1986, NATURE, V320, P196, DOI 10.1038/320196a0; GIANNELLI F, 1990, NUCLEIC ACIDS RES, V18, P4053, DOI 10.1093/nar/18.14.4053; GREEN PM, 1990, NUCLEIC ACIDS RES, V18, P3227, DOI 10.1093/nar/18.11.3227; GREEN PM, 1989, EMBO J, V8, P1067, DOI 10.1002/j.1460-2075.1989.tb03474.x; GUSTAFSON S, 1987, ANAL BIOCHEM, V165, P294, DOI 10.1016/0003-2697(87)90272-7; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; IKKALA E, 1960, THESIS U HELSINSKI; KETTERLING RP, 1991, GENOMICS, V10, P1093, DOI 10.1016/0888-7543(91)90207-U; KETTERLING RP, IN PRESS HUM GENET; KOEBERL DD, 1990, HUM GENET, V84, P387; KOEBERL DD, 1990, AM J HUM GENET, V47, P202; KOEBERL DD, 1989, AM J HUM GENET, V45, P448; LIDDELL MB, 1989, BRIT J HAEMATOL, V72, P208, DOI 10.1111/j.1365-2141.1989.tb07684.x; LOEB LA, 1989, CANCER RES, V49, P5489; MANDEL JL, 1989, NATURE, V339, P584, DOI 10.1038/339584a0; MONTANDON AJ, 1990, HUM GENET, V85, P200; MORLEY AA, 1990, PROG CLIN BIOL RES, V340, P1; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NOYES CM, 1983, P NATL ACAD SCI-BIOL, V80, P4200, DOI 10.1073/pnas.80.14.4200; NUSSINOV R, 1981, J MOL BIOL, V149, P125, DOI 10.1016/0022-2836(81)90264-3; SMITH CWJ, 1989, NATURE, V342, P243, DOI 10.1038/342243a0; SOMMER SS, 1990, NATURE, V346, P22, DOI 10.1038/346022b0; SOMMER SS, 1990, PCR PROTOCOLS GUIDE, P197; STOFLET ES, 1988, SCIENCE, V239, P414; SUGIMOTO M, 1989, BRIT J HAEMATOL, V72, P216, DOI 10.1111/j.1365-2141.1989.tb07685.x; SUZUKI DT, 1986, INTRO GENETIC ANAL, P333; SVED J, 1990, P NATL ACAD SCI USA, V87, P4692, DOI 10.1073/pnas.87.12.4692; SWARTZ MN, 1962, J BIOL CHEM, V237, P1961; THOMPSON AR, 1990, LANCET, V335, P418, DOI 10.1016/0140-6736(90)90259-8; WANG NS, 1990, THROMB HAEMOSTASIS, V64, P302; WARE J, 1989, J BIOL CHEM, V264, P11401; WIEBAUER K, 1990, P NATL ACAD SCI USA, V87, P5842, DOI 10.1073/pnas.87.15.5842; WIEBAUER K, 1989, NATURE, V339, P234, DOI 10.1038/339234a0; WINSHIP PR, 1984, NUCLEIC ACIDS RES, V12, P8861, DOI 10.1093/nar/12.23.8861; WINSHIP PR, 1989, LANCET, V1, P631; WU SM, 1990, GENE, V86, P275, DOI 10.1016/0378-1119(90)90290-8; YOSHITAKE S, 1985, BIOCHEMISTRY-US, V24, P3736, DOI 10.1021/bi00335a049	53	50	52	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1991	49	4					839	850						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG665	1897528				2022-12-18	WOS:A1991GG66500015
J	LEE, B; DALESSIO, M; VISSING, H; RAMIREZ, F; STEINMANN, B; SUPERTIFURGA, A				LEE, B; DALESSIO, M; VISSING, H; RAMIREZ, F; STEINMANN, B; SUPERTIFURGA, A			CHARACTERIZATION OF A LARGE DELETION ASSOCIATED WITH A POLYMORPHIC BLOCK OF REPEATED DINUCLEOTIDES IN THE TYPE-III PROCOLLAGEN GENE (COL3AL) OF A PATIENT WITH EHLERS-DANLOS SYNDROME TYPE-IV	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE BASE MUTATION; ALPHA-1(III) CHAIN; HUMAN DNA; COLLAGEN; EXON; IDENTIFICATION; AMPLIFICATION; SUBSTITUTION; FIBROBLASTS; CHROMOSOME	Ehlers-Danlos syndrome type IV (EDS IV) is an autosomal dominant condition characterized by extreme fragility of skin, blood vessels, intestine, gravid uterus, and lungs. The phenotype is accounted for by mutations affecting the integrity and/or synthesis of the precursor procollagen molecules of type III collagen. In this article, we report the elucidation of the molecular defect in an EDS IV patient whose type III collagen was previously found to be structurally abnormal. We utilized PCR in a two-step process involving first the localization of the mutation in the mRNA and then the characterization of the defect in the gene. The results established the patient's heterozygosity for a genomic deletion of about 7.5 kb which eliminates 1,026 nucleotides of coding sequences in the message. The mutation arose as a result of an exon-to-intron recombination. The deleted segment extends from the 13th nucleotide of exon 9 to within a DNA sequence of intron 24, which is composed of a series of dinucleotide repeats. Using PCR, we tested the polymorphic nature of this DNA element on several unrelated individuals. Analysis of amplified genomic products of 45 chromosomes recognized at least four distinct allelic forms that display frequencies ranging from 5% to 61%. Mendelian segregation of three of the four alleles was established by the same method in a 3-generation family.	CUNY MT SINAI SCH MED,BROOKDALE CTR MOLEC BIOL,BOX 1128A,1 GUSTAVE LEVY PL,NEW YORK,NY 10029; UNIV ZURICH,DEPT PEDIAT,DIV METAB,CH-8006 ZURICH,SWITZERLAND	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; University of Zurich			superti-furga, andrea/E-9162-2015	superti-furga, andrea/0000-0002-3543-7531	NIAMS NIH HHS [AR-38648] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR038648, R01AR038648] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALAKOKKO L, 1989, BIOCHEM J, V260, P509, DOI 10.1042/bj2600509; BENSONCHANDA V, 1989, GENE, V78, P255, DOI 10.1016/0378-1119(89)90228-X; BYERS PH, 1990, TRENDS GENET, V6, P293, DOI 10.1016/0168-9525(90)90235-X; BYERS PH, 1981, LAB INVEST, V44, P336; BYERS PH, 1983, PRINCIPLES PRACTICE, P836; CHU ML, 1985, J BIOL CHEM, V260, P4357; COLE WG, 1990, J BIOL CHEM, V265, P17070; EMANUEL BS, 1985, P NATL ACAD SCI USA, V82, P3385, DOI 10.1073/pnas.82.10.3385; HUERREJEANPIERRE C, 1986, AM J HUM GENET, V38, P26; JANECZKO R, 1989, NUCLEIC ACIDS RES, V17, P742; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; KONTUSAARI S, 1990, AM J HUM GENET, V47, P112; KUIVANIEMI H, 1990, J BIOL CHEM, V265, P12067; LEE B, 1989, SCIENCE, V244, P978, DOI 10.1126/science.2543071; LEE B, IN PRESS J BIOL CHEM; LITT M, 1989, AM J HUM GENET, V44, P397; LUTY JA, 1990, AM J HUM GENET, V46, P776; Maniatis T., 1982, MOL CLONING; POPE FM, 1975, P NATL ACAD SCI USA, V72, P1314, DOI 10.1073/pnas.72.4.1314; RAMIREZ F, 1989, COLLAGEN, V4, P22; ROYLE NJ, 1988, GENOMICS, V3, P352, DOI 10.1016/0888-7543(88)90127-9; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; STOLLE CA, 1985, J BIOL CHEM, V260, P1937; SUPERTIFURGA A, 1989, HUM GENET, V82, P104, DOI 10.1007/BF00284038; SUPERTIFURGA A, 1988, BIOCHEM BIOPH RES CO, V150, P140, DOI 10.1016/0006-291X(88)90497-4; SUPERTIFURGA A, 1988, J BIOL CHEM, V263, P6226; TROMP G, 1989, J BIOL CHEM, V264, P1349; TROMP G, 1989, J BIOL CHEM, V264, P19313; TSIPOURAS P, 1984, AM J HUM GENET, V36, P1172; VISSING H, IN PRESS J BIOL CHEM; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEIL D, 1989, EMBO J, V8, P1705, DOI 10.1002/j.1460-2075.1989.tb03562.x; WEIL D, 1988, J BIOL CHEM, V263, P8561; WILLARD HF, 1986, P NATL ACAD SCI USA, V83, P5611, DOI 10.1073/pnas.83.15.5611; ZAGURSKY RJ, 1986, GENE ANAL TECH, V2, P232	35	50	50	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1991	48	3					511	517						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK470	1998337				2022-12-18	WOS:A1991FK47000011
J	GIACCIA, AJ; DENKO, N; MACLAREN, R; MIRMAN, D; WALDREN, C; HART, I; STAMATO, TD				GIACCIA, AJ; DENKO, N; MACLAREN, R; MIRMAN, D; WALDREN, C; HART, I; STAMATO, TD			HUMAN CHROMOSOME-5 COMPLEMENTS THE DNA DOUBLE-STRAND BREAK-REPAIR DEFICIENCY AND GAMMA-RAY SENSITIVITY OF THE XR-1 HAMSTER VARIANT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WISTAR INST,PHILADELPHIA,PA 19104; COLORADO STATE UNIV,DEPT RADIOL & RADIAT BIOL,FT COLLINS,CO 80523; ELEANOR ROOSEVELT INST CANC RES,DENVER,CO	The Wistar Institute; Colorado State University			denko, nicholas/F-8444-2010		NATIONAL CANCER INSTITUTE [R01CA045277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES002470, R01ES002274] Funding Source: NIH RePORTER; NCI NIH HHS [CA-45277] Funding Source: Medline; NIEHS NIH HHS [ES-02470, ES-02274] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; BOOTSMA D, 1988, CANCER SURV, V7, P303; BRUNBORG G, 1980, RADIAT RES, V82, P547, DOI 10.2307/3575321; CARLOCK LR, 1986, SOMAT CELL MOLEC GEN, V12, P163, DOI 10.1007/BF01560663; CHEN MJ, 1984, J BIOL CHEM, V259, P3933; DENKO N, 1989, ANAL BIOCHEM, V178, P172, DOI 10.1016/0003-2697(89)90375-8; FAN JB, 1989, NUCLEIC ACIDS RES, V7, P2801; FRIEDBERG EC, 1988, MICROBIOL REV, V52, P70, DOI 10.1128/MMBR.52.1.70-102.1988; FRIEND KK, 1976, SOMAT CELL GENET, V2, P183, DOI 10.1007/BF01542631; GIACCIA A, 1985, SOMAT CELL MOLEC GEN, V11, P485, DOI 10.1007/BF01534842; GIACCIA AJ, 1989, SOMAT CELL MOLEC GEN, V15, P71, DOI 10.1007/BF01534671; GIACCIA AJ, 1989, THESIS U PENNSYLVANI; HICKSON ID, 1988, TRENDS GENET, V4, P101, DOI 10.1016/0168-9525(88)90097-2; JEGGO PA, 1985, MUTAT RES, V146, P265, DOI 10.1016/0167-8817(85)90067-7; JEGGO PA, 1983, MUTAT RES, V112, P313, DOI 10.1016/0167-8817(83)90026-3; JEGGO PA, 1986, MOL CELL BIOL, V6, P2944, DOI 10.1128/MCB.6.8.2944; JONES NJ, 1988, MUTAT RES, V193, P139, DOI 10.1016/0167-8817(88)90044-2; KEMP LM, 1984, MUTAT RES, V132, P189, DOI 10.1016/0167-8817(84)90037-3; Maniatis T., 1982, MOL CLONING; NAGASAWA H, 1980, PROC R SOC SER B-BIO, V211, P25, DOI 10.1098/rspb.1980.0156; SEABRIGH.M, 1971, LANCET, V2, P971; SICILIANO MJ, 1986, MUTAT RES, V174, P303, DOI 10.1016/0165-7992(86)90051-5; SMITH KC, 1980, INT J RADIAT ONCOL, V6, P1573, DOI 10.1016/0360-3016(80)90017-6; SOLOMON E, 1990, NATURE, V343, P412, DOI 10.1038/343412a0; STAMATO TD, 1990, RADIAT RES, V121, P196, DOI 10.2307/3577504; STAMATO TD, 1983, SOMAT CELL GENET, V9, P165, DOI 10.1007/BF01543175; STAMATO TD, 1987, CANCER RES, V4715, P1588; THOMPSON LH, 1989, ENVIRON MOL MUTAGEN, V14, P264, DOI 10.1002/em.2850140409; THOMPSON LH, 1982, MUTAT RES, V95, P427, DOI 10.1016/0027-5107(82)90276-7; THOMPSON LH, 1988, SOMAT CELL MOLEC GEN, V14, P605, DOI 10.1007/BF01535314; THOMPSON LH, 1987, J CELL SCI S, V6, P97; VANDUIN M, 1986, CELL, V44, P913, DOI 10.1016/0092-8674(86)90014-0; WEBER CA, 1988, MOL CELL BIOL, V8, P1137, DOI 10.1128/MCB.8.3.1137	33	50	50	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1990	47	3					459	469						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX223	1697445				2022-12-18	WOS:A1990DX22300011
J	HUFF, V; MEADOWS, A; RICCARDI, VM; STRONG, LC; SAUNDERS, GF				HUFF, V; MEADOWS, A; RICCARDI, VM; STRONG, LC; SAUNDERS, GF			PARENTAL ORIGIN OF DENOVO CONSTITUTIONAL DELETIONS OF CHROMOSOMAL BAND-11P13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT BIOCHEM & MOLEC BIOL,1515 HOLCOMBE BLVD,HOUSTON,TX 77030; UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT EXPTL PEDIAT GENET,HOUSTON,TX 77030; BAYLOR UNIV,RES CYTOGENET LAB,HOUSTON,TX 77030; CHILDRENS HOSP,DIV ONCOL,PHILADELPHIA,PA 19104	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor University; University of Pennsylvania; Childrens Hospital of Philadelphia					NATIONAL CANCER INSTITUTE [T32CA009299, P01CA034936, R01CA046720] Funding Source: NIH RePORTER; NCI NIH HHS [CA46720, CA34936, CA09299] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BRESLOW N, 1988, CANCER RES, V48, P1653; BRESLOW NE, 1982, JNCI-J NATL CANCER I, V68, P429; BUNIN GR, 1989, CANCER RES, V49, P725; BUTLER MG, 1986, AM J MED GENET, V23, P793, DOI 10.1002/ajmg.1320230307; CHAMBERLIN J, 1980, HUM GENET, V53, P343, DOI 10.1007/BF00287054; COMPTON DA, 1988, CELL, V55, P826; DAO DD, 1987, AM J HUM GENET, V41, P202; DRYJA TP, 1989, NATURE, V339, P556, DOI 10.1038/339556a0; EJIMA Y, 1988, HUM GENET, V79, P118, DOI 10.1007/BF00280548; EMANUEL BS, 1988, AM J HUM GENET, V43, P575; FEARON ER, 1984, NATURE, V309, P176, DOI 10.1038/309176a0; FEDER J, 1985, AM J HUM GENET, V37, P635; FRANCKE U, 1979, CYTOGENET CELL GENET, V24, P185, DOI 10.1159/000131375; GLASER T, 1989, GENOMICS, V5, P880, DOI 10.1016/0888-7543(89)90130-4; GRUNDY P, 1988, NATURE, V336, P374, DOI 10.1038/336374a0; HICKS N, 1984, CANCER, V53, P1637, DOI 10.1002/1097-0142(19840415)53:8<1637::AID-CNCR2820530802>3.0.CO;2-Y; HITTNER HM, 1979, OPHTHALMOLOGY, V86, P1173; HUFF V, 1987, NUCLEIC ACIDS RES, V15, P7651, DOI 10.1093/nar/15.18.7651; HUFF V, 1990, HUM GENET, V84, P253; HUFF V, UNPUB CHROMOSOME 11P; JADAYEL D, 1990, NATURE, V343, P558, DOI 10.1038/343558a0; KANEKO Y, 1981, CANCER RES, V41, P4577; KANTOR AF, 1979, J EPIDEMIOL COMMUN H, V33, P253, DOI 10.1136/jech.33.4.253; KIDD JR, 1987, CYTOGENET CELL GENET, V45, P63, DOI 10.1159/000132428; KNUDSON AG, 1972, J NATL CANCER I, V48, P313; KONDO I, 1985, HUM GENET, V71, P263, DOI 10.1007/BF00284588; KOUFOS A, 1984, NATURE, V309, P170, DOI 10.1038/309170a0; KOUSSEFF BG, 1981, J PEDIATR-US, V98, P676, DOI 10.1016/S0022-3476(81)80817-7; KWA SL, 1980, J OCCUP ENVIRON MED, V22, P792, DOI 10.1097/00043764-198012000-00012; LAVEDAN C, 1989, CYTOGENET CELL GENET, V50, P70, DOI 10.1159/000132726; MANNENS M, 1988, HUM GENET, V81, P41, DOI 10.1007/BF00283727; MATSUNAGA E, 1981, HUM GENET, V57, P231; NAKAGOME Y, 1985, HUM GENET, V70, P289; NARAHARA K, 1984, HUM GENET, V66, P181, DOI 10.1007/BF00286597; NIIKAWA N, 1985, HUM GENET, V69, P22, DOI 10.1007/BF00295524; OLSON SB, 1988, CYTOGENETICS MAMMALI, P583; ORKIN SH, 1984, NATURE, V309, P172, DOI 10.1038/309172a0; QUAN F, 1985, NUCLEIC ACIDS RES, V13, P8288, DOI 10.1093/nar/13.22.8288; QUAN F, 1986, NUCLEIC ACIDS RES, V14, P5321, DOI 10.1093/nar/14.13.5321; REEVE AE, 1984, NATURE, V309, P174, DOI 10.1038/309174a0; RICCARDI VM, 1982, J PEDIATR-US, V100, P574, DOI 10.1016/S0022-3476(82)80755-5; RICCARDI VM, 1980, CANCER GENET CYTOGEN, V2, P131, DOI 10.1016/0165-4608(80)90056-4; RICCARDI VM, 1978, PEDIATRICS, V61, P604; SCHROEDER WT, 1987, AM J HUM GENET, V40, P413; Sokal R.R., 1981, BIOMETRY, V2nd ed.; STROBEL RJ, 1980, AM J MED GENET, V7, P15, DOI 10.1002/ajmg.1320070105; TON CCT, 1990, NUCLEIC ACIDS RES, V18, P1084, DOI 10.1093/nar/18.4.1084; VOGEL F, 1975, ADV HUM GENET, V5, P223; WILLIAMS JC, 1989, LANCET, V1, P285; YUNIS JJ, 1980, J PEDIATR-US, V96, P1027, DOI 10.1016/S0022-3476(80)80630-5; ZHU XP, 1989, NATURE, V340, P312, DOI 10.1038/340312a0	51	50	50	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1990	47	1					155	160						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK482	1971994				2022-12-18	WOS:A1990DK48200021
J	ZLOTOGORA, J; CHAKRABORTY, S; KNOWLTON, RG; WENGER, DA				ZLOTOGORA, J; CHAKRABORTY, S; KNOWLTON, RG; WENGER, DA			KRABBE DISEASE LOCUS MAPPED TO CHROMOSOME-14 BY GENETIC-LINKAGE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT MED,DIV MED GENET,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT BIOCHEM & MOLEC BIOL,PHILADELPHIA,PA 19107; HADASSAH UNIV HOSP,DEPT HUMAN GENET,IL-91120 JERUSALEM,ISRAEL	Jefferson University; Jefferson University; Hebrew University of Jerusalem					NIDDK NIH HHS [DK38795] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038795, R55DK038795] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARKER DF, 1989, CYTOGENET CELL GENET, V51, P957; COX DW, 1989, CYTOGENET CELL GENET, V51, P280, DOI 10.1159/000132795; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; FEDER J, 1985, AM J HUM GENET, V37, P635; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GOLDGAR DE, 1989, AM J HUM GENET, V44, P6; HARRISON GS, 1987, SOMAT CELL MOLEC GEN, V13, P119, DOI 10.1007/BF01534692; KOBAYASHI T, 1980, BRAIN RES, V202, P479, DOI 10.1016/0006-8993(80)90159-6; LALLEY PA, 1989, CYTOGENET CELL GENET, V51, P503, DOI 10.1159/000132806; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LYERLA TA, 1989, AM J HUM GENET, V44, P198; Maniatis T., 1982, MOL CLONING; MITCHELL AL, 1989, CYTOGENET CELL GENET, V51, P1045; NAKAMURA Y, 1989, GENOMICS, V4, P76, DOI 10.1016/0888-7543(89)90317-0; NAKAMURA Y, 1988, GENOMICS, V2, P301; NEWGARD CB, 1987, AM J HUM GENET, V40, P351; OTT J, 1974, AM J HUM GENET, V26, P588; PRCHAL JT, 1987, P NATL ACAD SCI USA, V84, P7468, DOI 10.1073/pnas.84.21.7468; SKOOG WA, 1956, BLOOD, V11, P436, DOI 10.1182/blood.V11.5.436.436; SOLOMON E, 1989, CYTOGENET CELL GENET, V51, P319, DOI 10.1159/000132797; STANISLOVITIS P, 1989, CYTOGENET CELL GENET, V51, P1085; SUZUKI K, 1970, P NATL ACAD SCI USA, V66, P302, DOI 10.1073/pnas.66.2.302; SUZUKI K, 1989, METABOLIC BASIS INHE, P1699; SWEET H, 1986, MOUSE NEWSLETTER, V75, P30; WENGER DA, 1974, CLIN CHIM ACTA, V56, P199, DOI 10.1016/0009-8981(74)90228-9; ZLOTOGORA J, 1985, AM J MED GENET, V21, P765, DOI 10.1002/ajmg.1320210420	26	50	50	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1990	47	1					37	44						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK482	1971996				2022-12-18	WOS:A1990DK48200006
J	HALL, JM; ZUPPAN, PJ; ANDERSON, LA; HUEY, B; CARTER, C; KING, MC				HALL, JM; ZUPPAN, PJ; ANDERSON, LA; HUEY, B; CARTER, C; KING, MC			ONCOGENES AND HUMAN-BREAST CANCER	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF BERKELEY,SCH PUBL HLTH,BERKELEY,CA 94720; NCI,DIV CANC PREVENT & CONTROL,BETHESDA,MD 20205	University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)				King, Mary-Claire/0000-0001-9426-1743	DIVISION OF CANCER PREVENTION AND CONTROL [N01CN065010] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA027632] Funding Source: NIH RePORTER; NCI NIH HHS [CN65010, CA27632] Funding Source: Medline	DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALI IU, 1987, SCIENCE, V238, P185, DOI 10.1126/science.3659909; ALI IU, 1988, SCIENCE, V240, P1795, DOI 10.1126/science.3289120; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; Barker D, 1983, Mol Biol Med, V1, P199; BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; BURKE RE, 1978, CANCER RES, V38, P3769; CARTER CL, 1988, AM J EPIDEMIOL, V128, P467, DOI 10.1093/oxfordjournals.aje.a114995; CASEY G, 1986, MOL CELL BIOL, V6, P502, DOI 10.1128/MCB.6.2.502; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; DICKSON C, 1984, CELL, V37, P529, DOI 10.1016/0092-8674(84)90383-0; ESCOT C, 1986, P NATL ACAD SCI USA, V83, P4834, DOI 10.1073/pnas.83.13.4834; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GOSDEN JR, 1986, CYTOGENET CELL GENET, V43, P150, DOI 10.1159/000132313; HALL JM, UNPUB RARE HRAS ALLE; HEIGHWAY J, 1986, NUCLEIC ACIDS RES, V14, P8700, DOI 10.1093/nar/14.21.8700; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KOZBOR D, 1984, CANCER RES, V44, P438; KRONTIRIS TG, 1985, NATURE, V313, P369, DOI 10.1038/313369a0; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LIDEREAU R, 1988, ONCOGENE RES, V2, P285; LIDEREAU R, 1985, P NATL ACAD SCI USA, V82, P7068, DOI 10.1073/pnas.82.20.7068; LIDEREAU R, 1987, ONCOGENE, V1, P235; LOUIE L, 1987, American Journal of Human Genetics, V41, pA174; MORSE B, 1988, NATURE, V333, P87, DOI 10.1038/333087a0; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P3044, DOI 10.1073/pnas.85.9.3044; OTT J, 1985, ANAL HUMAN GENETIC L; PEARSON PL, 1987, CYTOGENET CELL GENET, V46, P390, DOI 10.1159/000132487; PROSPERI MT, 1987, ONCOGENE RES, V1, P121; RIDER SH, 1987, ANN HUM GENET, V51, P153, DOI 10.1111/j.1469-1809.1987.tb01057.x; SEIZINGER BR, 1988, NATURE, V332, P268, DOI 10.1038/332268a0; SLAMON DJ, 1988, SCIENCE, V240, P1796, DOI 10.1126/science.240.4860.1796; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SOLOMON E, 1987, NATURE, V328, P616, DOI 10.1038/328616a0; VANDEVIJVER M, 1987, MOL CELL BIOL, V7, P2019, DOI 10.1128/MCB.7.5.2019; VANDEVIJVER MJ, 1988, EUR J SURG ONCOL, V14, P111; VARLEY JM, 1987, ONCOGENE, V1, P423; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; WINTER E, 1985, P NATL ACAD SCI USA, V82, P7575, DOI 10.1073/pnas.82.22.7575; YOKOTA J, 1986, SCIENCE, V231, P261, DOI 10.1126/science.3941898; ZHOU DJ, 1987, CANCER RES, V47, P6123	42	50	50	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1989	44	4					577	584						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T8109	2564734				2022-12-18	WOS:A1989T810900019
J	BURNS, JP; KODURU, PRK; ALONSO, ML; CHAGANTI, RSK				BURNS, JP; KODURU, PRK; ALONSO, ML; CHAGANTI, RSK			ANALYSIS OF MEIOTIC SEGREGATION IN A MAN HETEROZYGOUS FOR 2 RECIPROCAL TRANSLOCATIONS USING THE HAMSTER INVITRO PENETRATION SYSTEM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MEM SLOAN KETTERING CANC CTR,DEPT PATHOL,NEW YORK,NY 10021; CORNELL UNIV,MED CTR,NEW YORK HOSP,DEPT PATHOL,CYTOGENET LAB,NEW YORK,NY 10021	Memorial Sloan Kettering Cancer Center; Cornell University; NewYork-Presbyterian Hospital	BURNS, JP (corresponding author), MEM SLOAN KETTERING CANC CTR,CANC GENET & CYTOGENET LAB,1275 YORK AVE,NEW YORK,NY 10021, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018866] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-18866] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANGER B, 1982, CANCER, V50, P1518, DOI 10.1002/1097-0142(19821015)50:8<1518::AID-CNCR2820500812>3.0.CO;2-R; BALKAN W, 1983, HUM GENET, V63, P345, DOI 10.1007/BF00274760; BALKAN W, 1983, AM J MED GENET, V16, P169, DOI 10.1002/ajmg.1320160206; BELL EF, 1977, J MED GENET, V16, P141; BIJLSMA JB, 1978, HUM GENET, V40, P135, DOI 10.1007/BF00272294; BRANDRIFF B, 1984, HUM GENET, V66, P193, DOI 10.1007/BF00286600; CHANDLEY AC, 1979, BRIT MED BULL, V35, P181, DOI 10.1093/oxfordjournals.bmb.a071567; FORD CE, 1969, BRIT MED BULL, V25, P110, DOI 10.1093/oxfordjournals.bmb.a070659; FREUND M, 1976, P344; HULTEN M, 1974, HEREDITAS, V76, P55; JACKSON L, 1975, CYTOGENET CELL GENET, V15, P400, DOI 10.1159/000130539; JACOBS PA, 1981, AM J HUM GENET, V33, P44; JACOBS PA, 1977, POPULATION CYTOGENET, P81; KODURU PRK, 1984, GENETICS, V108, P707; LAURIE DA, 1984, HUM GENET, V68, P235, DOI 10.1007/BF00418394; MARTIN RH, 1984, CLIN GENET, V25, P357; MARTIN RH, 1983, HUM GENET, V63, P305, DOI 10.1007/BF00274750; MARTIN RH, 1983, AM J HUM GENET, V35, pA143; REES H, 1961, BOT REV, V27, P288, DOI 10.1007/BF02860084; REES HUBERT, 1955, HEREDITY, V9, P93, DOI 10.1038/hdy.1955.5; RICKARDS GK, 1983, ANNU REV GENET, V17, P443, DOI 10.1146/annurev.ge.17.120183.002303; ROGERS BJ, 1979, FERTIL STERIL, V32, P664; RUDAK E, 1978, NATURE, V274, P911, DOI 10.1038/274911a0; RUDAK E, 1981, BIOREGULATORS REPROD, P167; SIMONI G, 1979, HUM GENET, V46, P159, DOI 10.1007/BF00291917; STENE J, 1984, PRENATAL DIAG, V4, P81, DOI 10.1002/pd.1970040707; STENE J, 1982, ANN HUM GENET, V46, P41, DOI 10.1111/j.1469-1809.1982.tb00694.x; SYBENGA J, 1975, MONOGRAPHS THEORETIC, V1, P83; YANAGIMACHI R, 1976, BIOL REPROD, V15, P471, DOI 10.1095/biolreprod15.4.471	29	50	51	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1986	38	6					954	964						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D3922	3728467				2022-12-18	WOS:A1986D392200017
J	KAZAZIAN, HH; ORKIN, SH; BOEHM, CD; GOFF, SC; WONG, C; DOWLING, CE; NEWBURGER, PE; KNOWLTON, RG; BROWN, V; DONISKELLER, H				KAZAZIAN, HH; ORKIN, SH; BOEHM, CD; GOFF, SC; WONG, C; DOWLING, CE; NEWBURGER, PE; KNOWLTON, RG; BROWN, V; DONISKELLER, H			CHARACTERIZATION OF A SPONTANEOUS MUTATION TO A BETA-THALASSEMIA ALLELE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HARVARD UNIV, CHILDRENS HOSP, SCH MED, DIV HEMATOL, BOSTON, MA 02115 USA; UNIV MASSACHUSETTS, SCH MED, DEPT PEDIAT, DIV HEMATOL, WORCESTER, MA 01605 USA; COLLABORAT RES INC, LEXINGTON, MA USA	Harvard University; Boston Children's Hospital; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester	KAZAZIAN, HH (corresponding author), JOHNS HOPKINS UNIV, SCH MED, DEPT PEDIAT, GENET UNIT, BALTIMORE, MD 21205 USA.			Newburger, Peter/0000-0002-8615-673X				BAGLIONI C, 1962, BIOCHIM BIOPHYS ACTA, V59, P437, DOI 10.1016/0006-3002(62)90194-4; BAGLIONI C, 1962, NATURE, V196, P229, DOI 10.1038/196229a0; BARKER D, 1984, AM J HUM GENET, V36, P1159; BLATTNER FR, 1978, SCIENCE, V202, P1279, DOI 10.1126/science.725603; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BRAMAN J, 1985, CYTOGENET CELL GENET, V40, P589; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; DAVIE AM, 1978, J MED GENET, V15, P339, DOI 10.1136/jmg.15.5.339; FRANCKE U, 1976, AM J HUM GENET, V28, P123; GITSCHIER J, 1985, NATURE, V315, P427, DOI 10.1038/315427a0; KAZAZIAN HH, 1984, NATURE, V310, P152, DOI 10.1038/310152a0; KAZAZIAN HH, 1984, EMBO J, V3, P593, DOI 10.1002/j.1460-2075.1984.tb01853.x; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LAWN RM, 1978, CELL, V15, P1157, DOI 10.1016/0092-8674(78)90043-0; Maxam A M, 1980, Methods Enzymol, V65, P499; NORONHA PA, 1978, AM J HEMATOL, V4, P187, DOI 10.1002/ajh.2830040211; ORKIN SH, 1984, ANNU REV GENET, V18, P131; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; PENROSE LS, 1957, AM J HUM GENET, V9, P167; TONZ O, 1973, HUMANGENETIK, V20, P321; VOGEL F, 1975, ADV HUM GENET, V5, P223; VOGEL F, 1983, PRINCIPLES PRACTICE, P26; WEATHERALL CJ, 1981, THALASSEMIA SYNDROME; YANG TP, 1984, NATURE, V310, P412, DOI 10.1038/310412a0	24	50	50	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1986	38	6					860	867						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D3922	3014870				2022-12-18	WOS:A1986D392200009
J	FUJIBAYASHI, S; KAO, FT; JONES, C; MORSE, H; LAW, M; WENGER, DA				FUJIBAYASHI, S; KAO, FT; JONES, C; MORSE, H; LAW, M; WENGER, DA			ASSIGNMENT OF THE GENE FOR HUMAN SPHINGOLIPID ACTIVATOR PROTEIN-2 (SAP-2) TO CHROMOSOME-10	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV COLORADO,SCH MED,DEPT PEDIAT,BOX C233,DENVER,CO 80262; UNIV COLORADO,SCH MED,DEPT BIOCHEM BIOPHYS & GENET,DENVER,CO 80262; ELEANOR ROOSEVELT INST CANC RES,DENVER,CO 80262	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver					NIADDK NIH HHS [AM-33170] Funding Source: Medline; NICHD NIH HHS [HD-02080, HD-08315] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD002080] Funding Source: NIH RePORTER; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM033170] Funding Source: NIH RePORTER	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CHRISTOMANOU H, 1980, H-S Z PHYSIOL CHEM, V361, P1489, DOI 10.1515/bchm2.1980.361.2.1489; CONZELMANN E, 1978, P NATL ACAD SCI USA, V75, P3979, DOI 10.1073/pnas.75.8.3979; FUJIBAYASHI S, 1984, J PEDIATR-US, V104, P739, DOI 10.1016/S0022-3476(84)80957-9; FUJIBAYASHI S, 1985, CLIN CHIM ACTA, V146, P147, DOI 10.1016/0009-8981(85)90053-1; HO MW, 1971, P NATL ACAD SCI USA, V68, P2810, DOI 10.1073/pnas.68.11.2810; INUI K, 1985, HUM GENET, V69, P197, DOI 10.1007/BF00293023; INUI K, 1984, ARCH BIOCHEM BIOPHYS, V233, P556, DOI 10.1016/0003-9861(84)90479-X; JONES C, 1980, CYTOGENET CELL GENET, V28, P181, DOI 10.1159/000131529; KAO FT, 1982, P NATL ACAD SCI-BIOL, V79, P865, DOI 10.1073/pnas.79.3.865; KAO FT, 1970, NATURE, V228, P329, DOI 10.1038/228329a0; KAO FT, 1982, HUM GENET, V62, P337, DOI 10.1007/BF00304551; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI EC, 1983, AM J HUM GENET, V35, P385; LI SC, 1976, J BIOL CHEM, V251, P1159; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mehl E, 1964, Hoppe Seylers Z Physiol Chem, V339, P260, DOI 10.1515/bchm2.1964.339.1.260; MILLER YE, 1983, AM J HUM GENET, V35, P573; MOORE EE, 1977, AM J HUM GENET, V29, P389; MORSE HG, 1982, MAMM CHROMOSOME NEWS, V23, P127; PETERS SP, 1977, J BIOL CHEM, V252, P563; POULOS A, 1984, BIOCHIM BIOPHYS ACTA, V793, P141, DOI 10.1016/0005-2760(84)90315-1; SANDHOFF K, 1979, TRENDS BIOCHEM SCI, V4, P231, DOI 10.1016/0968-0004(79)90125-7; SHAFITZAGARDO B, 1981, AM J HUM GENET, V33, P564; WENGER DA, 1982, BIOCHIM BIOPHYS ACTA, V712, P639, DOI 10.1016/0005-2760(82)90293-4; WENGER DA, 1984, MOL BASIS LYSOSOMAL, P61	25	50	52	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	4					741	748						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	APR18	9556662				2022-12-18	WOS:A1985APR1800011
J	PAGE, DC; DELACHAPELLE, A				PAGE, DC; DELACHAPELLE, A			THE PARENTAL ORIGIN OF X-CHROMOSOMES IN XX MALES DETERMINED USING RESTRICTION FRAGMENT LENGTH POLYMORPHISMS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV HELSINKI, DEPT MED GENET, SF-00290 HELSINKI 29, FINLAND	University of Helsinki	PAGE, DC (corresponding author), MIT, DEPT BIOL, CAMBRIDGE, MA 02139 USA.				NIGMS NIH HHS [GM30467] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030467] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; CHAPELLE ADL, 1979, HUM GENET, V52, P157, DOI 10.1007/BF00271568; CHAPELLE ADL, 1978, CELL, V15, P837, DOI 10.1016/0092-8674(78)90268-4; DAVIES KE, 1983, NUCLEIC ACIDS RES, V11, P2303, DOI 10.1093/nar/11.8.2303; DAVIS RM, 1981, J MED GENET, V18, P161, DOI 10.1136/jmg.18.3.161; DELACHAPELLE A, 1984, NATURE, V307, P170, DOI 10.1038/307170a0; DELACHAPELLE A, 1964, ACTA MED SCAND, V175, P25; DELACHAPELLE A, 1977, CLIN GENET, V11, P91; DELACHAPELLE A, 1981, HUM GENET, V58, P105, DOI 10.1007/BF00284157; DELACHAPELLE A, 1984, ASPECTS HUMAN GENETI, P125; DRAYNA D, 1984, P NATL ACAD SCI US; EVANS HJ, 1979, HUM GENET, V49, P11; FERGUSONSMITH MA, 1966, LANCET, V2, P475; GOODFELLOW PN, 1981, NATURE, V289, P404, DOI 10.1038/289404a0; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; MAGENIS RE, 1982, HUM GENET, V62, P271, DOI 10.1007/BF00333535; MURRAY JM, 1982, NATURE, V300, P69, DOI 10.1038/300069a0; PAGE D, 1982, P NATL ACAD SCI-BIOL, V79, P5352, DOI 10.1073/pnas.79.17.5352; PAGE D, 1983, RECOMBINANT DNA APPL; PALUTKE WA, 1973, J MED GENET, V10, P170, DOI 10.1136/jmg.10.2.170; Race RR., 1975, BLOOD GROUPS MAN; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SKOLNICK MH, 1984, CYTOGENET CELL GENET, V37, P210, DOI 10.1159/000132011; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TIPPETT P, 1984, CYTOGENET CELL GENET, V37, P595	25	50	50	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1984	36	3					565	575						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SY119	6328977				2022-12-18	WOS:A1984SY11900006
J	RICE, J; MCGUFFIN, P; GOLDIN, LR; SHASKAN, EG; GERSHON, ES				RICE, J; MCGUFFIN, P; GOLDIN, LR; SHASKAN, EG; GERSHON, ES			PLATELET MONOAMINE-OXIDASE (MAO) ACTIVITY - EVIDENCE FOR A SINGLE MAJOR LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WASHINGTON UNIV,DIV BIOSTAT PREVENT MED,ST LOUIS,MO 63130; JEWISH HOSP ST LOUIS,ST LOUIS,MO 63110; INST PSYCHIAT,LONDON SE5 8AF,ENGLAND; NIMH,BIOL PSYCHIAT BRANCH,PSYCHOGENET SECT,BETHESDA,MD 20205; UNIV CONNECTICUT,CTR HLTH,DEPT PSYCHIAT,FARMINGTON,CT 06032	Washington University (WUSTL); Barnes-Jewish Hospital; University of London; King's College London; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Connecticut	RICE, J (corresponding author), WASHINGTON UNIV,DEPT PSYCHIAT,ST LOUIS,MO 63130, USA.		McGuffin, Peter/A-1565-2012	McGuffin, Peter/0000-0002-9888-2907	NIAAA NIH HHS [AA-03539] Funding Source: Medline; NIMH NIH HHS [MH37685, MH31302] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH031302, R01MH037685, P50MH031302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA003539] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		BREAKEFIELD XO, 1981, GENETIC RES STRATEGI, P129; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; GARRICK NA, 1979, MONOAMINE OXIDASE ST, P351; GERSHON ES, 1980, ENZYMES NEUROTRANSMI, P281; GOLDIN LR, 1982, AM J HUM GENET, V34, P250; HUSSEIN L, 1980, HUM HERED, V30, P65, DOI 10.1159/000153104; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; MACLEAN CJ, 1976, BIOMETRICS, V32, P695, DOI 10.2307/2529760; MORTON NE, 1974, AM J HUM GENET, V26, P489; MORTON NF, 1984, METHODS GENETIC EPID; NIES A, 1973, ARCH GEN PSYCHIAT, V28, P834; PANDEY GN, 1979, LIFE SCI, V25, P1173, DOI 10.1016/0024-3205(79)90140-1; PINTAR JE, 1981, J NEUROSCI, V1, P166; RICE J, 1982, PSYCHIAT RES, V7, P325, DOI 10.1016/0165-1781(82)90069-5; WINTER H, 1978, PSYCHOPHARMACOLOGY, V57, P63, DOI 10.1007/BF00426959; WYATT RJ, 1973, SCIENCE, V179, P916, DOI 10.1126/science.179.4076.916	16	50	50	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	1					36	43						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SC430	6695924				2022-12-18	WOS:A1984SC43000004
J	GREENBERG, DA; HODGE, SE; ROTTER, JI				GREENBERG, DA; HODGE, SE; ROTTER, JI			EVIDENCE FOR RECESSIVE AND AGAINST DOMINANT INHERITANCE AT THE HLA-LINKED LOCUS IN CELIAC-DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF LOS ANGELES, MENTAL RETARDAT RES CTR, SCH MED, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, HARBOR GEN HOSP,MED CTR,SCH MED,DEPT PEDIAT, DIV MED GENET, TORRANCE, CA 90509 USA; UNIV CALIF LOS ANGELES, HARBOR GEN HOSP, MED CTR, SCH MED, DEPT MED, TORRANCE, CA 90509 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	GREENBERG, DA (corresponding author), VET ADM WADSWORTH HOSP CTR, LOS ANGELES, CA 90073 USA.				NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [P01AM017328] Funding Source: NIH RePORTER; NIADDK NIH HHS [AM-17328, AM-25834] Funding Source: Medline; NIMH NIH HHS [MH-33617] Funding Source: Medline	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BETUEL H, 1980, TISSUE ANTIGENS, V15, P231; BODMER WF, 1978, BRIT MED BULL, V34, P309, DOI 10.1093/oxfordjournals.bmb.a071518; DEMARCHI M, 1979, TISSUE ANTIGENS, V14, P309; ELLIS A, 1980, GENETICS HETEROGENEI, P243; FALCHUK ZM, 1978, SCAND J GASTROENTERO, V13, P839, DOI 10.3109/00365527809182200; FALCHUK ZM, 1972, J CLIN INVEST, V51, P1602, DOI 10.1172/JCI106958; GAZIT E, 1977, ISRAEL J MED SCI, V13, P400; GREENBERG DA, 1981, AM J HUM GENET, V33, P519; GREENBERG DA, 1981, AM J MED GENET, V8, P205, DOI 10.1002/ajmg.1320080211; HODGE SE, 1981, AM J HUM GENET, V33, P396; MACKINTOSH P, 1978, BRIT MED BULL, V34, P291, DOI 10.1093/oxfordjournals.bmb.a071514; MANN DL, 1976, LANCET, V1, P110; MCCONNELL RB, 1981, GENETICS COELIAC DIS, P251; MCKENNA R, 1981, GENETICS COELIAC DIS, P153; MYLOTTE M, 1973, BMJ-BRIT MED J, V1, P703, DOI 10.1136/bmj.1.5855.703; PENA AS, 1978, GASTROENTEROLOGY, V75, P230; PENA AS, 1981, GENETICS COELIAC DIS, P161; POLANCO I, 1981, GENETICS COELIAC DIS, P211; ROBINSON BN, 1980, J IMMUNOGENET, V7, P381; SCHOLZ S, 1981, GENETICS COELIAC DIS, P143; STOKES PL, 1972, LANCET, V2, P162; STROBER W, 1976, CLIN GASTROENTEROL, V5, P429; STROBER W, 1975, ANN INTERN MED, V83, P242, DOI 10.7326/0003-4819-83-2-242; STROBER W, 1980, GENETICS HETEROGENEI, P243; STROBER W, 1977, HLA DISEASE, P168; Thomson G, 1977, HLA DISEASE, P84	26	50	51	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1982	34	2					263	277						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NH732	6951410				2022-12-18	WOS:A1982NH73200010
J	GOSDEN, JR; LAWRIE, SS; GOSDEN, CM				GOSDEN, JR; LAWRIE, SS; GOSDEN, CM			SATELLITE DNA-SEQUENCES IN THE HUMAN ACROCENTRIC CHROMOSOMES - INFORMATION FROM TRANSLOCATIONS AND HETEROMORPHISMS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											GOSDEN, JR (corresponding author), WESTERN GEN HOSP,MRC,CLIN & POPULAT CYTOGENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND.							BOSTOCK CJ, 1978, NATURE, V272, P324, DOI 10.1038/272324a0; BRASCH JM, 1979, CYTOGENET CELL GENET, V24, P122, DOI 10.1159/000131365; COOKE H, 1976, NATURE, V262, P182, DOI 10.1038/262182a0; COOKE HJ, 1979, NUCLEIC ACIDS RES, V6, P3177, DOI 10.1093/nar/6.10.3177; DENTON TE, 1977, STAIN TECHNOL, V52, P311, DOI 10.3109/10520297709116804; EVANS HJ, 1971, CHROMOSOMA, V35, P310, DOI 10.1007/BF00326281; EVANS HJ, 1974, CHROMOSOMA, V48, P405, DOI 10.1007/BF00290996; GOSDEN J, 1978, CYTOGENET CELL GENET, V21, P1, DOI 10.1159/000130873; GOSDEN JR, 1977, CHROMOSOMA, V63, P253, DOI 10.1007/BF00327453; GOSDEN JR, 1975, EXP CELL RES, V92, P138, DOI 10.1016/0014-4827(75)90647-3; GOSDEN JR, 1978, HUM GENET, V41, P131; GOSDEN JR, 1979, CLIN GENET, V15, P518; GOSDEN JR, 1975, EXP CELL RES, V92, P148, DOI 10.1016/0014-4827(75)90648-5; GOSDEN JR, 1977, ICN UCLA S MOL HUMAN; GOSDEN JR, CYTOGENET CELL GENET; HENDERSON AS, 1972, P NATL ACAD SCI USA, V69, P3394, DOI 10.1073/pnas.69.11.3394; LAWRIE SS, 1980, HUM GENET, V53, P371, DOI 10.1007/BF00287058; MATTEI MG, 1979, HUM GENET, V50, P33, DOI 10.1007/BF00295586; MIKKELSEN M, 1980, CYTOGENET CELL GENET, V26, P14, DOI 10.1159/000131416; MIKLOS GLG, 1979, AM J HUM GENET, V31, P264; MILLER DA, 1974, CYTOGENET CELL GENET, V13, P536, DOI 10.1159/000130305; MITCHELL AR, 1977, CHROMOSOMA, V61, P345, DOI 10.1007/BF00288618; SCHRECK RR, 1977, HUM GENET, V36, P1, DOI 10.1007/BF00390430; SZABO P, 1977, J MOL BIOL, V115, P539, DOI 10.1016/0022-2836(77)90170-X	24	50	60	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	2					243	251						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LH910	6163355				2022-12-18	WOS:A1981LH91000011
J	WARD, BE; HENRY, GP; ROBINSON, A				WARD, BE; HENRY, GP; ROBINSON, A			CYTOGENETIC STUDIES IN 100 COUPLES WITH RECURRENT SPONTANEOUS-ABORTIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV COLORADO,HLTH SCI CTR,DEPT BIOPHYS & GENET,DENVER,CO 80202; UNIV COLORADO,HLTH SCI CTR,DEPT OBSTET & GYNECOL,DENVER,CO 80202; ELEANOR ROOSEVELT INST CANC RES INC,DENVER,CO	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	WARD, BE (corresponding author), NATL JEWISH HOSP & RES CTR,NATL ASTHMA CTR,DENVER,CO 80206, USA.							ARAKAKI D. T., 1963, CYTOGENETICS [BASEL], V2, P57, DOI 10.1159/000129767; BOUE J, 1975, HUMANGENETIK, V30, P217, DOI 10.1007/BF00279187; BYRD JR, 1977, FERTIL STERIL, V28, P246; DELACHAPELLE A, 1974, AM J HUM GENET, V26, P746; GLASS RH, 1978, FERTIL STERIL, V29, P257; HECHT F, 1975, NATURE, V255, P243, DOI 10.1038/255243a0; HSU LYF, 1972, OBSTET GYNECOL, V40, P98; HUNGERFORD DA, 1965, STAIN TECHNOL, V40, P333, DOI 10.3109/10520296509116440; JACOBS PA, 1972, ANN HUM GENET, V35, P301, DOI 10.1111/j.1469-1809.1957.tb01403.x; JACOBS PA, 1977, POPULATION CYTOGENET, P81; KAJII T, 1978, AM J OBSTET GYNECOL, V131, P33, DOI 10.1016/0002-9378(78)90470-2; KIM HJ, 1975, NEW ENGL J MED, V293, P844, DOI 10.1056/NEJM197510232931703; LEONARD C, 1975, HUMANGENETIK, V28, P121, DOI 10.1007/BF00735744; LUCAS M, 1972, J OBSTET GYN BR COMM, V79, P1119; MENNUTI MT, 1978, OBSTET GYNECOL, V52, P308; NEU RL, 1979, OBSTET GYNECOL, V53, P373; PREDESCU V, 1969, LANCET, V2, P217; SCHMIDT R, 1976, JAMA-J AM MED ASSOC, V236, P369, DOI 10.1001/jama.236.4.369; SEABRIGH.M, 1971, LANCET, V2, P971; STENCHEVER MA, 1977, AM J OBSTET GYNECOL, V127, P143, DOI 10.1016/S0002-9378(16)33240-9; TSENGHI C, 1976, OBSTET GYNECOL, V47, P463	21	50	52	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	4					549	554						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	KB522	7395867				2022-12-18	WOS:A1980KB52200008
J	BIRD, TD; HAMERNYIK, P; NUTTER, JY; LABBE, RF				BIRD, TD; HAMERNYIK, P; NUTTER, JY; LABBE, RF			INHERITED DEFICIENCY OF DELTA-AMINOLEVULINIC-ACID DEHYDRATASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WASHINGTON,SCH MED,DEPT LAB MED,SEATTLE,WA 98195; VET ADM MED CTR,SEATTLE,WA	University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA)	BIRD, TD (corresponding author), UNIV WASHINGTON,SCH MED,DEPT MED NEUROL & MED GENET,SEATTLE,WA 98195, USA.							BONKOWSKY HL, 1975, J CLIN INVEST, V56, P1139, DOI 10.1172/JCI108189; BRODIE MJ, 1977, Q J MED, V46, P229; BURCH HB, 1971, CLIN CHEM, V17, P1038; CHALEVELAKIS G, 1977, ACTA HAEMATOL-BASEL, V57, P305, DOI 10.1159/000207895; DOYLE D, 1969, J BIOL CHEM, V244, P5449; ELDER GH, 1978, NEW ENGL J MED, V299, P274, DOI 10.1056/NEJM197808102990603; FINELLI VN, 1974, BIOCHEM BIOPH RES CO, V60, P1418, DOI 10.1016/0006-291X(74)90356-8; HAEGERAR.B, 1971, ARCH ENVIRON HEALTH, V23, P440, DOI 10.1080/00039896.1971.10666033; HUTTON JJ, 1969, BIOCHEM GENET, V3, P517, DOI 10.1007/BF00485612; KUSHNER JP, 1976, J CLIN INVEST, V58, P1089, DOI 10.1172/JCI108560; LABBE RF, 1977, BIOCHEM MED METAB B, V18, P323, DOI 10.1016/0006-2944(77)90067-9; LINDBLAD B, 1977, P NATL ACAD SCI USA, V74, P4641, DOI 10.1073/pnas.74.10.4641; MARGOLIS FL, 1965, SCIENCE, V150, P496, DOI 10.1126/science.150.3695.496; MEYER UA, 1978, METABOLIC BASIS INHE, P1166; PETERSON LR, 1976, CLIN CHEM, V22, P1835; PIMSTONE NR, 1973, ENZYME, V16, P354, DOI 10.1159/000459400; ROMEO G, 1977, HUM GENET, V39, P261, DOI 10.1007/BF00295419; SASSA S, 1973, ENZYME, V16, P326, DOI 10.1159/000459397; SASSA S, 1977, P NATL ACAD SCI USA, V74, P1181, DOI 10.1073/pnas.74.3.1181; SASSA S, 1975, ANN NY ACAD SCI, V244, P419, DOI 10.1111/j.1749-6632.1975.tb41546.x; STRAND LJ, 1972, J CLIN INVEST, V51, P2530, DOI 10.1172/JCI107068	21	50	51	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	6					662	668						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HZ742	517518				2022-12-18	WOS:A1979HZ74200002
J	MORTON, NE; GULBRANDSEN, CL; RHOADS, GG; KAGAN, A; LEW, R				MORTON, NE; GULBRANDSEN, CL; RHOADS, GG; KAGAN, A; LEW, R			MAJOR LOCI FOR LIPOPROTEIN CONCENTRATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV HAWAII,SCH PUBL HLTH,HONOLULU,HI 96822	University of Hawaii System	MORTON, NE (corresponding author), UNIV HAWAII,POPULAT GENET LAB,HONOLULU,HI 96822, USA.							GULBRANDSEN CL, 1977, SOC BIOL, V24, P289, DOI 10.1080/19485565.1977.9988299; MACLEAN CJ, 1975, AM J HUM GENET, V27, P365; MACLEAN CJ, 1976, BIOMETRICS, V32, P695, DOI 10.2307/2529760; MORTON NE, 1977, AM J HUM GENET, V29, P52; MORTON NE, 1974, AM J HUM GENET, V26, P489; MORTON NE, CLIN GENET; RAO DC, UNPUBLISHED; RHOADS GG, AM J EPIDEMIOL; UTERMANN G, 1976, EXCERPTA MEDICA  397, P54	9	50	50	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	6					583	589						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	GK656	747186				2022-12-18	WOS:A1978GK65600002
J	BADEN, HP; JACKSON, CE; WEISS, L; JIMBOW, K; LEE, L; KUBILUS, J; GOLD, RJM				BADEN, HP; JACKSON, CE; WEISS, L; JIMBOW, K; LEE, L; KUBILUS, J; GOLD, RJM			PHYSICOCHEMICAL PROPERTIES OF HAIR IN BIDS SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,DEPT DERMATOL,BOSTON,MA 02114; HENRY FORD HOSP,DETROIT,MI 48202; MONTREAL CHILDRENS HOSP,RES INST,MRC,GENET GRP,MONTREAL H3H 1P3,QUEBEC,CANADA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Henry Ford Health System; Henry Ford Hospital; McGill University								BADEN HP, 1973, BIOCHIM BIOPHYS ACTA, V322, P269, DOI 10.1016/0005-2795(73)90303-6; BRILPETERSEN E, 1963, BIOCHIM BIOPHYS ACTA, V76, P152; BROWN AC, 1970, J INVEST DERMATOL, V54, P496, DOI 10.1111/1523-1747.ep12259317; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; HENDRICKS DM, 1969, EXP CELL RES, V40, P402; HIRS CHW, 1967, METHOD ENZYMOL, P199; JACKSON CE, 1974, PEDIATRICS, V54, P201; NORWOOD WF, 1964, J PEDIATR-US, V65, P431, DOI 10.1016/S0022-3476(64)80408-X; POLLITT RJ, 1968, ARCH DIS CHILD, V43, P211, DOI 10.1136/adc.43.228.211; PORTER PS, 1971, CLINICAL DELINEATION, P69	10	50	50	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	5					514	521						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CH661	984047				2022-12-18	WOS:A1976CH66100010
J	WARD, JC; MERRITT, AD; BIXLER, D				WARD, JC; MERRITT, AD; BIXLER, D			HUMAN SALIVARY AMYLASE - GENETICS OF ELECTROPHORETIC VARIANTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BAHN E, 1967, HEREDITAS-GENETISK A, V58, P1; BOETTCHER B, 1969, AUST J EXP BIOL MED, V47, P97, DOI 10.1038/icb.1969.9; BOETTCHER B, 1969, ANAL BIOCHEM, V28, P510, DOI 10.1016/0003-2697(69)90206-1; KAMARYT J, 1965, HUMANGENETIK, V1, P579; KAMARYT J, 1966, HUMANGENETIK, V3, P41, DOI 10.1007/BF00273017; KAUFFMAN DL, 1970, ARCH BIOCHEM BIOPHYS, V137, P325, DOI 10.1016/0003-9861(70)90446-7; Ogita S, 1966, Med J Osaka Univ, V16, P271; OGITA Z, 1968, 12 P INT C GEN, V2, P77; RITCHIE RF, 1966, J LAB CLIN MED, V68, P842; SICK K, 1964, HEREDITAS, V51, P291; WOLF RO, 1967, NATURE, V213, P1128, DOI 10.1038/2131128a0	11	50	50	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1971	23	4					403	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	J8113	5097906				2022-12-18	WOS:A1971J811300008
J	COOPER, HL; HERNITS, R				COOPER, HL; HERNITS, R			A FAMILIAL CHROMOSOME VARIANT IN A SUBJECT WITH ANOMALOUS SEX DIFFERENTIATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; PATAU K, 1961, CHROMOSOMA, V12, P573, DOI 10.1007/BF00328943; YUNIS JJ, 1963, CHROMOSOMA, V14, P146, DOI 10.1007/BF00336756	3	50	50	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1963	15	4					465	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2968A	14097240				2022-12-18	WOS:A19632968A00004
J	JEANNERET, O; MACMAHON, B				JEANNERET, O; MACMAHON, B			SECULAR CHANGES IN RATES OF MULTIPLE BIRTHS IN UNITED STATES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALLEN G, 1960, AM J HUM GENET, V12, P210; BULMER MG, 1960, ANN HUM GENET, V24, P121; GUTTMACHER AF, 1953, OBSTET GYNECOL, V2, P22; LILIENFELD AM, 1955, AM J HUM GENET, V7, P204; MACMAHON B, 1954, AM J HUM GENET, V6, P284; McARTHUR N, 1954, Acta Genet Med Gemellol (Roma), V3, P16; MCKEOWN T, 1952, J ENDOCRINOL, V8, P386, DOI 10.1677/joe.0.0080386; Record RG, 1952, BR J SOC MED, V6, P192; Waterhouse JAH, 1950, BR J SOC MED, V4, P197; Weinberg W, 1901, ARCH GESAMTE PHYSIOL, V88, P346, DOI 10.1007/BF01657695	10	50	50	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1962	14	4					410	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2965A	14028923				2022-12-18	WOS:A19622965A00003
J	JARVIK, LF; FALEK, A; KALLMANN, FJ; LORGE, I				JARVIK, LF; FALEK, A; KALLMANN, FJ; LORGE, I			SURVIVAL TRENDS IN A SENESCENT TWIN POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALLEN G, 1955, Acta Genet Med Gemellol (Roma), V4, P143; FEINGOLD L, 1950, THESIS COLUMBIA U; JALAVISTO E, 1951, ANN MED INTERN FENN, V40, P263; KALLMANN FJ, 1949, AM J PSYCHIAT, V106, P29, DOI 10.1176/ajp.106.1.29; KALLMANN FJ, 1948, J HERED, V39, P349, DOI 10.1093/oxfordjournals.jhered.a105785; KALLMANN FJ, 1959, AGING INDIVIDUAL; KALLMANN FJ, 1956, NOVANTANNI LEGGI MEN; Pearl R., 1934, ANCESTRY LONG LIVED; Spector WS, 1956, HDB BIOL DATA; Weinberg W, 1901, ARCH GESAMTE PHYSL M, V88, P346; YERUSHALMY J., 1940, HUMAN BIOL, V12, P95; YERUSHALMY J., 1940, HUMAN BIOL, V12, P247; 1954, VIT STATIST SPEC REP, V41	13	50	51	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1960	12	2					170	179						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF078	14406852				2022-12-18	WOS:A1960WF07800004
J	GRAHAM, JB				GRAHAM, JB			FAMILIAL HYPOPHOSPHATEMIA WITH VITAMIN-D-RESISTANT RICKETS .2. 3 ADDITIONAL KINDREDS OF THE SEX-LINKED DOMINANT TYPE WITH A GENETIC ANALYSIS OF 4 SUCH FAMILIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Alport AC, 1927, BMJ-BRIT MED J, V1927, P504, DOI 10.1136/bmj.1.3454.504; Eason J, 1924, LANCET, V2, P639; GOLDBLOOM RB, 1957, PEDIATRICS, V20, P241; Haldane JBS, 1936, ANN EUGENIC, V7, P28, DOI 10.1111/j.1469-1809.1936.tb02127.x; HAMBURGER J, 1956, J Urol Medicale Chir, V62, P113; MORTON NE, 1957, AM J HUM GENET, V9, P55; PERKOFF GT, 1951, ARCH INTERN MED, V88, P191, DOI 10.1001/archinte.1951.03810080059006; PERKOFF GT, 1958, ARCH INTERN MED, V102, P733, DOI 10.1001/archinte.1958.00260220049005; REYERSBACH GC, 1954, NEW ENGL J MED, V251, P377, DOI 10.1056/NEJM195409022511003; ROBIN ED, 1957, T ASSOC AM PHYSICIAN, V70, P140; STEPHENS FE, 1951, AM J HUM GENET, V3, P303; STURTZ GS, 1956, NEW ENGL J MED, V254, P1123, DOI 10.1056/NEJM195606142542404	12	50	50	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1959	11	4					333	338						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF076	13828799				2022-12-18	WOS:A1959WF07600004
J	Thomas, M; Sakoda, LC; Hoffmeister, M; Rosenthal, EA; Lee, JK; van Duijnhoven, FJB; Platz, EA; Wu, AH; Dampier, CH; de la Chapelle, A; Wolk, A; Joshi, AD; Burnett-Hartman, A; Gsur, A; Lindblom, A; Castells, A; Win, AK; Namjou, B; Van Guelpen, B; Tangen, CM; He, QC; Li, CI; Schafmayer, C; Joshu, CE; Ulrich, CM; Bishop, DT; Buchanan, DD; Schaid, D; Drew, DA; Muller, DC; Duggan, D; Crosslin, DR; Albanes, D; Giovannucci, EL; Larson, E; Qu, F; Mentch, F; Giles, GG; Hakonarson, H; Hampel, H; Stanaway, IB; Figueiredo, JC; Huyghe, JR; Minnier, J; Chang-Claude, J; Hampe, J; Harley, JB; Visvanathan, K; Curtis, KR; Offit, K; Li, L; Le Marchand, L; Vodickova, L; Gunter, MJ; Jenkins, MA; Slattery, ML; Lemire, M; Woods, MO; Song, MY; Murphy, N; Lindor, NM; Dikilitas, O; Pharoah, PDP; Campbell, PT; Newcomb, PA; Milne, RL; MacInnis, RJ; Castellvi-Bel, S; Ogino, S; Berndt, SI; Bezieau, S; Thibodeau, SN; Gallinger, SJ; Zaidi, SH; Harrison, TA; Keku, TO; Hudson, TJ; Vymetalkova, V; Moreno, V; Martin, V; Arndt, V; Wei, WQ; Chung, W; Su, YR; Hayes, RB; White, E; Vodicka, P; Casey, G; Gruber, SB; Schoen, RE; Chan, AT; Potter, JD; Brenner, H; Jarvik, GP; Corley, DA; Peters, U; Hsu, L				Thomas, Minta; Sakoda, Lori C.; Hoffmeister, Michael; Rosenthal, Elisabeth A.; Lee, Jeffrey K.; van Duijnhoven, Franzel J. B.; Platz, Elizabeth A.; Wu, Anna H.; Dampier, Christopher H.; de la Chapelle, Albert; Wolk, Alicja; Joshi, Amit D.; Burnett-Hartman, Andrea; Gsur, Andrea; Lindblom, Annika; Castells, Antoni; Win, Aung Ko; Namjou, Bahram; Van Guelpen, Bethany; Tangen, Catherine M.; He, Qianchuan; Li, Christopher, I; Schafmayer, Clemens; Joshu, Corinne E.; Ulrich, Cornelia M.; Bishop, D. Timothy; Buchanan, Daniel D.; Schaid, Daniel; Drew, David A.; Muller, David C.; Duggan, David; Crosslin, David R.; Albanes, Demetrius; Giovannucci, Edward L.; Larson, Eric; Qu, Flora; Mentch, Frank; Giles, Graham G.; Hakonarson, Hakon; Hampel, Heather; Stanaway, Ian B.; Figueiredo, Jane C.; Huyghe, Jeroen R.; Minnier, Jessica; Chang-Claude, Jenny; Hampe, Jochen; Harley, John B.; Visvanathan, Kala; Curtis, Keith R.; Offit, Kenneth; Li, Li; Le Marchand, Loic; Vodickova, Ludmila; Gunter, Marc J.; Jenkins, Mark A.; Slattery, Martha L.; Lemire, Mathieu; Woods, Michael O.; Song, Mingyang; Murphy, Neil; Lindor, Noralane M.; Dikilitas, Ozan; Pharoah, Paul D. P.; Campbell, Peter T.; Newcomb, Polly A.; Milne, Roger L.; MacInnis, Robert J.; Castellvi-Bel, Sergi; Ogino, Shuji; Berndt, Sonja, I; Bezieau, Stephane; Thibodeau, Stephen N.; Gallinger, Steven J.; Zaidi, Syed H.; Harrison, Tabitha A.; Keku, Temitope O.; Hudson, Thomas J.; Vymetalkova, Veronika; Moreno, Victor; Martin, Vicente; Arndt, Volker; Wei, Wei-Qi; Chung, Wendy; Su, Yu-Ru; Hayes, Richard B.; White, Emily; Vodicka, Pavel; Casey, Graham; Gruber, Stephen B.; Schoen, Robert E.; Chan, Andrew T.; Potter, John D.; Brenner, Hermann; Jarvik, Gail P.; Corley, Douglas A.; Peters, Ulrike; Hsu, Li			Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; PREDICTION; ASSOCIATION; PERFORMANCE; POPULATION; HEALTH	Accurate colorectal cancer (CRC) risk prediction models are critical for identifying individuals at low and high risk of developing CRC, as they can then be offered targeted screening and interventions to address their risks of developing disease (if they are in a high-risk group) and avoid unnecessary screening and interventions (if they are in a low-risk group). As it is likely that thousands of genetic variants contribute to CRC risk, it is clinically important to investigate whether these genetic variants can be used jointly for CRC risk prediction. In this paper, we derived and compared different approaches to generating predictive polygenic risk scores (PRS) from genome-wide association studies (GWASs) including 55,105 CRC-affected case subjects and 65,079 control subjects of European ancestry. We built the PRS in three ways, using (1) 140 previously identified and validated CRC loci; (2) SNP selection based on linkage disequilibrium (LD) clumping followed by machine-learning approaches; and (3) LDpred, a Bayesian approach for genome-wide risk prediction. We tested the PRS in an independent cohort of 101,987 individuals with 1,699 CRC-affected case subjects. The discriminatory accuracy, calculated by the age- and sex-adjusted area under the receiver operating characteristics curve (AUC), was highest for the LDpred-derived PRS (AUC = 0.654) including nearly 1.2 M genetic variants (the proportion of causal genetic variants for CRC assumed to be 0.003), whereas the PRS of the 140 known variants identified from GWASs had the lowest AUC (AUC = 0.629). Based on the LDpred-derived PRS, we are able to identify 30% of individuals without a family history as having risk for CRC similar to those with a family history of CRC, whereas the PRS based on known GWAS variants identified only top 10% as having a similar relative risk. About 90% of these individuals have no family history and would have been considered average risk under current screening guidelines, but might benefit from earlier screening. The developed PRS offers a way for risk-stratified CRC screening and other targeted interventions.	[Thomas, Minta; Sakoda, Lori C.; He, Qianchuan; Li, Christopher, I; Qu, Flora; Huyghe, Jeroen R.; Curtis, Keith R.; Newcomb, Polly A.; Harrison, Tabitha A.; Su, Yu-Ru; White, Emily; Potter, John D.; Peters, Ulrike; Hsu, Li] Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div, Seattle, WA 98109 USA; [Sakoda, Lori C.; Lee, Jeffrey K.; Corley, Douglas A.] Kaiser Permanente Northern Calif, Div Res, Oakland, CA 94612 USA; [Hoffmeister, Michael; Arndt, Volker; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-69120 Heidelberg, Germany; [Rosenthal, Elisabeth A.; Stanaway, Ian B.; Jarvik, Gail P.] Univ Washington, Dept Med Med Genet, Med Ctr, Seattle, WA 98195 USA; [van Duijnhoven, Franzel J. B.] Wageningen Univ & Res, Div Human Nutr & Hlth, NL-176700 Wageningen, Netherlands; [Platz, Elizabeth A.; Joshu, Corinne E.; Visvanathan, Kala] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21287 USA; [Platz, Elizabeth A.; Joshu, Corinne E.; Visvanathan, Kala] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21287 USA; [Wu, Anna H.] Univ Southern Calif, Preventat Med, Los Angeles, CA 90089 USA; [Dampier, Christopher H.] Univ Virginia Hlth Syst, Dept Surg, Charlottesville, VA 22903 USA; [de la Chapelle, Albert] Ohio State Univ, Dept Canc Biol & Genet, Columbus, OH 43210 USA; [de la Chapelle, Albert] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA; [Wolk, Alicja] Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden; [Joshi, Amit D.; Drew, David A.; Song, Mingyang; Chan, Andrew T.] Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, Boston, MA 02114 USA; [Joshi, Amit D.; Drew, David A.; Song, Mingyang; Chan, Andrew T.] Harvard Med Sch, Boston, MA 02114 USA; [Joshi, Amit D.; Giovannucci, Edward L.; Ogino, Shuji; Chan, Andrew T.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Burnett-Hartman, Andrea] Kaiser Permanente Colorado, Inst Hlth Res, Denver, CO 80014 USA; [Gsur, Andrea] Med Univ Vienna, Inst Canc Res, Dept Med 1, A-1090 Vienna, Austria; [Lindblom, Annika] Karolinska Univ Hosp, Dept Clin Genet, S-17177 Stockholm, Sweden; [Lindblom, Annika] Karolinska Inst, Dept Mol Med & Surg, S-17177 Stockholm, Sweden; [Castells, Antoni; Castellvi-Bel, Sergi] Univ Barcelona, Hosp Clin, Gastroenterol Dept,Ctr Invest Biomed Red Enfermed, Inst Invest Biomed August Pi i Sunyer IDIBAP, Barcelona 08007, Spain; [Win, Aung Ko; Giles, Graham G.; Jenkins, Mark A.; Milne, Roger L.; MacInnis, Robert J.] Univ Melbourne, Ctr Epidemiol & Biostat, Melbourne Sch Populat & Global Hlth, Melbourne, Vic 3000, Australia; [Namjou, Bahram; Harley, John B.] Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol CAGE, Cincinnati, OH 45229 USA; [Namjou, Bahram; Harley, John B.] Univ Cincinnati, Coll Med, Cincinnati, OH 45229 USA; [Namjou, Bahram; Harley, John B.] Cincinnati VA Med Ctr, Cincinnati, OH 45229 USA; [Van Guelpen, Bethany] Umea Univ, Dept Radiat Sci, Oncol Unit, S-90187 Umea, Sweden; [Van Guelpen, Bethany] Umea Univ, Wallenberg Ctr Mol Med, S-90187 Umea, Sweden; [Tangen, Catherine M.] Fred Hutchinson Canc Res Ctr, SWOG Stat Ctr, Seattle, WA 98109 USA; [Schafmayer, Clemens] Univ Hosp Rostock, Dept Gen Surg, D-18051 Rostock, Germany; [Ulrich, Cornelia M.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Ulrich, Cornelia M.] Univ Utah, Dept Populat Hlth Sci, Salt Lake City, UT 84112 USA; [Bishop, D. Timothy] Univ Leeds, Leeds Inst Canc & Pathol, Leeds LS2 9JT, W Yorkshire, England; [Buchanan, Daniel D.] Univ Melbourne, Victorian Comprehens Canc Ctr, Ctr Canc Res, Parkville, Vic 3010, Australia; [Buchanan, Daniel D.] Univ Melbourne, Dept Clin Pathol, Colorectal Oncogen Grp, Parkville, Vic 3010, Australia; [Buchanan, Daniel D.] Royal Melbourne Hosp, Genom Med & Family Canc Clin, Parkville, Vic 3010, Australia; [Schaid, Daniel] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Muller, David C.] Imperial Coll London, Sch Publ Hlth, London SW7 2AZ, England; [Duggan, David] City Hope Natl Med Ctr, Translat Genom Res Inst, Phoenix, AZ 85003 USA; [Crosslin, David R.] Univ Washington, Dept Bioinformat & Med Educ, Med Ctr, Seattle, WA 98195 USA; [Albanes, Demetrius; Berndt, Sonja, I] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Giovannucci, Edward L.; Chan, Andrew T.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Giovannucci, Edward L.; Chan, Andrew T.] Harvard Med Sch, Boston, MA 02115 USA; [Giovannucci, Edward L.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02108 USA; [Larson, Eric] Kaiser Permanente Washington Res Inst, Seattle, WA 98101 USA; [Mentch, Frank; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Giles, Graham G.; Milne, Roger L.; MacInnis, Robert J.] Canc Council Victoria, Canc Epidemiol Div, 615 St Kilda Rd, Melbourne, Vic 3004, Australia; [Giles, Graham G.; Milne, Roger L.] Monash Univ, Sch Clin Sci, Precis Med, Monash Hlth, Clayton, Vic 3168, Australia; [Hampel, Heather] Ohio State Univ, Dept Internal Med, Div Human Genet, Comprehens Canc Ctr, Columbus, OH 43210 USA; [Figueiredo, Jane C.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Dept Med, Los Angeles, CA 90048 USA; [Figueiredo, Jane C.] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Minnier, Jessica] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97239 USA; [Chang-Claude, Jenny] German Canc Res Ctr, Div Canc Epidemiol, D-69120 Heidelberg, Germany; [Chang-Claude, Jenny] Univ Canc Ctr Hamburg UCCH, Univ Med Ctr Hamburg Eppendorf, D-20246 Hamburg, Germany; [Hampe, Jochen] Tech Univ Dresden TU Dresden, Univ Hosp Dresden, Dept Med 1, D-01062 Dresden, Germany; [Offit, Kenneth] Mem Sloan Kettering Canc Ctr, Dept Med, Clin Genet Serv, New York, NY 10021 USA; [Offit, Kenneth] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Li, Li] Univ Virginia, Dept Family Med, Charlottesville, VA 22903 USA; [Le Marchand, Loic] Univ Hawaii, Canc Ctr, Honolulu, HI 96813 USA; [Vodickova, Ludmila; Vymetalkova, Veronika; Vodicka, Pavel] Czech Acad Sci, Dept Mol Biol Canc, Inst Expt Med, Prague 142204, Czech Republic; [Vodickova, Ludmila; Vymetalkova, Veronika; Vodicka, Pavel] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague 12800, Czech Republic; [Vodickova, Ludmila; Vymetalkova, Veronika; Vodicka, Pavel] Charles Univ Prague, Fac Med, Plzen 32300, Czech Republic; [Vodickova, Ludmila; Vymetalkova, Veronika; Vodicka, Pavel] Charles Univ Prague, Biomed Ctr Pilsen, Plzen 32300, Czech Republic; [Gunter, Marc J.; Murphy, Neil] WHO, Nutr & Metab Sect, Int Agcy Res Canc, F-69372 Lyon, France; [Slattery, Martha L.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84132 USA; [Lemire, Mathieu] Inst Canc Res, PanCuRx Translat Res Initiat, Toronto, ON M5G0A3, Canada; [Woods, Michael O.] Mem Univ Newfoundland, Discipline Genet, St John, NF A1B 3R7, Canada; [Song, Mingyang; Chan, Andrew T.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Song, Mingyang; Ogino, Shuji; Chan, Andrew T.] Broad Inst Harvard & Mit, Cambridge, MA 02141 USA; [Song, Mingyang] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Moreno, Victor] Catalan Inst Oncol, Oncol Data Analyt Program, Barcelona 08908, Spain; [Lindor, Noralane M.] Mayo Clin, Dept Hlth Sci Res, Scottsdale, AZ 85260 USA; [Dikilitas, Ozan] Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55905 USA; [Pharoah, Paul D. P.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB2 OSR, England; [Campbell, Peter T.] Amer Canc Soc, Behav & Epidemiol Res Grp, Atlanta, GA 30303 USA; [Newcomb, Polly A.] Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA; [Ogino, Shuji] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Program MPE Mol Pathol Epidemiol, Boston, MA 02115 USA; [Ogino, Shuji] Dana Farber Canc Inst, Dept Oncol Pathol, Boston, MA 02215 USA; [Bezieau, Stephane] Ctr Hosp Univ CHU Nantes, Serv Genet Med, F-44093 Nantes, France; [Thibodeau, Stephen N.] Mayo Clin, Div Lab Genet, Dept Lab Med & Pathol, Rochester, MN 85054 USA; [Gallinger, Steven J.] Univ Toronto, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Zaidi, Syed H.; Hudson, Thomas J.] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada; [Keku, Temitope O.] Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC 27599 USA; [Moreno, Victor; Martin, Vicente] CIBER Epidemiol & Salud Publ CIBERESP, Madrid 28029, Spain; [Moreno, Victor] Univ Barcelona, Fac Med, Dept Clin Sci, Barcelona 08907, Spain; [Moreno, Victor] Bellvitge Biomed Res Inst IDIBELL, ONCOBEL Program, Barcelona 08908, Spain; [Martin, Vicente] Univ Leon, Biomed Inst IBIOMED, Leon 24071, Spain; [Wei, Wei-Qi] Vanderbilt Univ, Dept Biomed Informat, Med Ctr, Nashville, TN 37232 USA; [Chung, Wendy] Dept Vet Affairs, Off Res & Dev, Washington, DC 20420 USA; [Chung, Wendy] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10032 USA; [Chung, Wendy] Columbia Univ, Dept Med, Med Ctr, New York, NY 10032 USA; [Hayes, Richard B.] NYU, Dept Populat Hlth, Div Epidemiol, Sch Med, New York, NY 10016 USA; [White, Emily; Peters, Ulrike] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Casey, Graham] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22903 USA; [Gruber, Stephen B.] Univ Southern Calif, USC Norris Comprehens Canc Ctr, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA; [Schoen, Robert E.] Univ Pittsburgh, Dept Med & Epidemiol, Med Ctr, Pittsburgh, PA 15219 USA; [Chan, Andrew T.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Potter, John D.] Massey Univ, Ctr Publ Hlth Res, Wellington 6140, New Zealand; [Brenner, Hermann] German Canc Res Ctr, Div Prevent Oncol, D-69120 Heidelberg, Germany; [Brenner, Hermann] Natl Ctr Tumor Dis NCT, D-69120 Heidelberg, Germany; [Brenner, Hermann] German Canc Res Ctr, German Canc Consortium DKTK, D-69120 Heidelberg, Germany; [Jarvik, Gail P.] Univ Washington, Genome Sci, Med Ctr, Seattle, WA 98195 USA; [Hsu, Li] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Kaiser Permanente; Helmholtz Association; German Cancer Research Center (DKFZ); University of Washington; University of Washington Seattle; Wageningen University & Research; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; University of Southern California; University of Virginia; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Karolinska Institutet; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Kaiser Permanente; Medical University of Vienna; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Melbourne; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; Umea University; Umea University; Fred Hutchinson Cancer Center; Southwest Oncology Group; University of Rostock; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Leeds; University of Melbourne; University of Melbourne; Royal Melbourne Hospital; Mayo Clinic; Imperial College London; City of Hope; Translational Genomics Research Institute; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Kaiser Permanente; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Cancer Council Victoria; Monash University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Cedars Sinai Medical Center; University of Southern California; Oregon Health & Science University; Helmholtz Association; German Cancer Research Center (DKFZ); University of Hamburg; University Medical Center Hamburg-Eppendorf; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Memorial Sloan Kettering Cancer Center; Cornell University; University of Virginia; Cancer Research Center of Hawaii; University of Hawaii System; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Charles University Prague; Charles University Prague; Charles University Prague; World Health Organization; International Agency for Research on Cancer (IARC); Utah System of Higher Education; University of Utah; University of Toronto; University Toronto Affiliates; Memorial University Newfoundland; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health; Catalan Institute of Oncology; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; University of Cambridge; American Cancer Society; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Nantes Universite; CHU de Nantes; Mayo Clinic; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of North Carolina; University of North Carolina Chapel Hill; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Universidad de Leon; Vanderbilt University; Columbia University; Columbia University; New York University; University of Washington; University of Washington Seattle; University of Virginia; University of Southern California; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard T.H. Chan School of Public Health; Massey University; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Peters, U; Hsu, L (corresponding author), Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div, Seattle, WA 98109 USA.; Hsu, L (corresponding author), Univ Washington, Dept Biostat, Seattle, WA 98195 USA.	upeters@fredhutch.org; lih@fredhutch.org	Van Guelpen, Bethany/J-8159-2015; Hoffmeister, Michael/T-7187-2019; Visvanathan, Kala/AAE-4396-2021; Sakoda, Lori/ABD-6828-2020; Martin, Vicente/GRE-8306-2022; Brenner, Hermann/B-4627-2017; Brenner, Hermann/ABE-6383-2020; Win, Aung K./J-6204-2015; Castells, Antoni/ABC-1002-2021; Minnier, Jessica/I-8788-2019; Martin, Vicente/A-1597-2008; van Duijnhoven, Fränzel/GWC-0059-2022; Hoffmeister, Michael/AAB-2321-2022; Muller, David/V-8207-2017; Moreno, Victor/A-1697-2010; Murphy, Neil/E-1189-2017	Van Guelpen, Bethany/0000-0002-9692-101X; Hoffmeister, Michael/0000-0002-8307-3197; Sakoda, Lori/0000-0002-0900-5735; Martin, Vicente/0000-0003-0552-2804; Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572; Win, Aung K./0000-0002-2794-5261; Castells, Antoni/0000-0001-8431-2033; Minnier, Jessica/0000-0002-3527-2757; Martin, Vicente/0000-0003-0552-2804; Hoffmeister, Michael/0000-0002-8307-3197; Muller, David/0000-0002-2350-0417; Bishop, Tim/0000-0002-8752-8785; Gunter, Marc/0000-0001-5472-6761; Moreno, Victor/0000-0002-2818-5487; Dampier, Christopher/0000-0003-3099-6462; Murphy, Neil/0000-0003-3347-8249; Hayes, Richard/0000-0002-0918-661X; Vodicka, Pavel/0000-0003-2376-1243				Abraham G, 2013, GENET EPIDEMIOL, V37, P184, DOI 10.1002/gepi.21698; Arora N, 2009, QUAL LIFE RES, V18, P1, DOI 10.1007/s11136-008-9415-5; Bien SA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186518; Bureau A, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S64; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chatterjee N, 2013, NAT GENET, V45, P400, DOI 10.1038/ng.2579; Dafnis G, 2001, GASTROINTEST ENDOSC, V54, P302, DOI 10.1067/mge.2001.117545; De La Vega FM, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0610-x; de Vlaming R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/143712; Dunlop MG, 2013, GUT, V62, P871, DOI 10.1136/gutjnl-2011-300537; Evans DM, 2009, HUM MOL GENET, V18, P3525, DOI 10.1093/hmg/ddp295; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Gatto NM, 2003, J NATL CANCER I, V95, P230, DOI 10.1093/jnci/95.3.230; Goldstein BA, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-49; Gordon N.P., 2006, DOES ADULT KAISER PE; Gottesman O, 2013, GENET MED, V15, P761, DOI 10.1038/gim.2013.72; Hang D, 2020, INT J EPIDEMIOL, V49, P259, DOI 10.1093/ije/dyz096; Hastie T., 2009, ELEMENTS STAT LEARNI, DOI DOI 10.1007/978-0-387-84858-7; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Hoffman JM, 2014, AM J MED GENET C, V166, P45, DOI 10.1002/ajmg.c.31391; Howlader N, 2019, SEER CANC STAT REV 1; Hsu L, 2015, GASTROENTEROLOGY, V148, P1330, DOI 10.1053/j.gastro.2015.02.010; Hu YM, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005589; Huyghe JR, 2019, NAT GENET, V51, P76, DOI 10.1038/s41588-018-0286-6; Ibanez-Sanz G, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43263; Jeon J, 2018, GASTROENTEROLOGY, V154, P2152, DOI 10.1053/j.gastro.2018.02.021; Khera AV, 2018, NAT GENET, V50, P1219, DOI 10.1038/s41588-018-0183-z; Kooperberg C, 2010, GENET EPIDEMIOL, V34, P643, DOI 10.1002/gepi.20509; Kvale MN, 2015, GENETICS, V200, P1051, DOI 10.1534/genetics.115.178905; Law PJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09775-w; Lee JK, 2019, J CLIN GASTROENTEROL, V53, pE25, DOI 10.1097/MCG.0000000000000929; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lu Y, 2019, GASTROENTEROLOGY, V156, P1455, DOI 10.1053/j.gastro.2018.11.066; Malo N, 2008, AM J HUM GENET, V82, P375, DOI 10.1016/j.ajhg.2007.10.012; Martin AR, 2019, BIOL PSYCHIAT, V86, P97, DOI 10.1016/j.biopsych.2018.12.015; Masys DR, 2012, J BIOMED INFORM, V45, P419, DOI 10.1016/j.jbi.2011.12.005; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Sandouk F, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/457901; Schork AJ, 2018, NAT GENET, V50, P1210, DOI 10.1038/s41588-018-0213-x; Smith RA, 2000, CA-CANCER J CLIN, V50, P34, DOI 10.3322/canjclin.50.1.34; Smith T, 2018, BRIT J CANCER, V119, P1036, DOI 10.1038/s41416-018-0282-8; Su YR, 2018, AM J HUM GENET, V102, P904, DOI 10.1016/j.ajhg.2018.03.019; Vilhjalmsson BJ, 2015, AM J HUM GENET, V97, P576, DOI 10.1016/j.ajhg.2015.09.001; Vogelaar I, 2006, CANCER-AM CANCER SOC, V107, P1624, DOI 10.1002/cncr.22115; Wei Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000678; Weigl K, 2018, GASTROENTEROLOGY, V155, P88, DOI 10.1053/j.gastro.2018.03.030; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhang YD, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16483-3; Zhong H, 2008, BIOSTATISTICS, V9, P621, DOI 10.1093/biostatistics/kxn001	49	49	49	6	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 3	2020	107	3					432	444		10.1016/j.ajhg.2020.07.006	http://dx.doi.org/10.1016/j.ajhg.2020.07.006			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NJ2TF	32758450	Green Published, Bronze			2022-12-18	WOS:000565899700005
J	Vasileiou, G; Vergarajauregui, S; Endele, S; Popp, B; Buttner, C; Ekici, AB; Gerard, M; Bramswig, NC; Albrecht, B; Clayton-Smith, J; Morton, J; Tomkins, S; Low, K; Weber, A; Wenzel, M; Altmuller, J; Li, Y; Wollnik, B; Hoganson, G; Plona, MR; Cho, MT; Thiel, CT; Ludecke, HJ; Strom, TM; Calpena, E; Wilkie, AOM; Wieczorek, D; Engel, FB; Reis, A				Vasileiou, Georgia; Vergarajauregui, Silvia; Endele, Sabine; Popp, Bernt; Buettner, Christian; Ekici, Arif B.; Gerard, Marion; Bramswig, Nuria C.; Albrecht, Beate; Clayton-Smith, Jill; Morton, Jenny; Tomkins, Susan; Low, Karen; Weber, Astrid; Wenzel, Maren; Altmueller, Janine; Li, Yun; Wollnik, Bernd; Hoganson, George; Plona, Maria-Renee; Cho, Megan T.; Thiel, Christian T.; Luedecke, Hermann-Josef; Strom, Tim M.; Calpena, Eduardo; Wilkie, Andrew O. M.; Wieczorek, Dagmar; Engel, Felix B.; Reis, Andre		Deciphering Developmental	Mutations in the BAF-Complex Subunit DPF2 Are Associated with Coffin-Siris Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMATIN-REMODELING COMPLEX; DE-NOVO MUTATIONS; PHD FINGER; SWI/SNF COMPLEX; GENOTYPE-PHENOTYPE; HISTONE-BINDING; GENE; COMPONENTS; ARID1B; INDIVIDUALS	Variants affecting the function of different subunits of the BAF chromatin-remodelling complex lead to various neurodevelopmental syndromes, including Coffin-Siris syndrome. Furthermore, variants in proteins containing PHD fingers, motifs recognizing specific histone tail modifications, have been associated with several neurological and developmental-delay disorders. Here, we report eight heterozygous de novo variants (one frameshift, two splice site, and five missense) in the gene encoding the BAF complex subunit double plant homeodomain finger 2 (DPF2). Affected individuals share common clinical features described in individuals with Coffin-Siris syndrome, including coarse facial features, global developmental delay, intellectual disability, speech impairment, and hypoplasia of fingernails and toenails. All variants occur within the highly conserved PHD1 and PHD2 motifs. Moreover, missense variants are situated close to zinc binding sites and are predicted to disrupt these sites. Pull-down assays of recombinant proteins and histone peptides revealed that a subset of the identified missense variants abolish or impaire DPF2 binding to unmodified and modified H3 histone tails. These results suggest an impairment of PHD finger structural integrity and cohesion and most likely an aberrant recognition of histone modifications. Furthermore, the overexpression of these variants in HEK293 and COS7 cell lines was associated with the formation of nuclear aggregates and the recruitment of both wild-type DPF2 and BRG1 to these aggregates. Expression analysis of truncating variants found in the affected individuals indicated that the aberrant transcripts escape nonsense-mediated decay. Altogether, we provide compelling evidence that de novo variants in DPF2 cause Coffin-Siris syndrome and propose a dominant-negative mechanism of pathogenicity.	[Vasileiou, Georgia; Endele, Sabine; Popp, Bernt; Buettner, Christian; Ekici, Arif B.; Thiel, Christian T.; Reis, Andre] Friedrich Alexander Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; [Vergarajauregui, Silvia; Engel, Felix B.] Friedrich Alexander Univ Erlangen Nurnberg, Dept Nephropathol, Inst Pathol, Expt Renal & Cardiovasc Res, D-91054 Erlangen, Germany; [Gerard, Marion] CHU Caen, Genet Clin, F-14000 Caen, France; [Bramswig, Nuria C.; Albrecht, Beate; Luedecke, Hermann-Josef; Wieczorek, Dagmar] Univ Duisburg Essen, Univ Klinikum Essen, Inst Humangenet, D-45122 Essen, Germany; [Clayton-Smith, Jill] Manchester Acad Hlth Sci Ctr, Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Ctr Genom Med, Manchester M13 9WL, Lancs, England; [Morton, Jenny] Birmingham Womens Hosp NHS Fdn Trust, West Midlands Reg Clin Genet Serv, Birmingham B15 2TG, W Midlands, England; [Morton, Jenny] Birmingham Womens Hosp NHS Fdn Trust, Birmingham Hlth Partners, Birmingham B15 2TG, W Midlands, England; [Tomkins, Susan; Low, Karen] Univ Hosp Bristol NHS Fdn Trust, Clin Genet Serv, Bristol BS2 8HW, Avon, England; [Weber, Astrid] Liverpool Womens NHS Fdn Hosp Trust, Merseyside & Cheshire Clin Genet Serv, Liverpool L8 7SS, Merseyside, England; [Wenzel, Maren] Genetikum Neu Ulm, D-89231 Neu Ulm, Germany; [Altmueller, Janine] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Li, Yun; Wollnik, Bernd] Univ Med Ctr Gottingen, Inst Human Genet, D-37073 Gottingen, Germany; [Hoganson, George; Plona, Maria-Renee] Univ Illinois Hosp, Pediat Genet, Chicago, IL 60612 USA; [Cho, Megan T.] GeneDx, Gaithersburg, MD 20877 USA; [Deciphering Developmental] Wellcome Trust Genome Campus, Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Luedecke, Hermann-Josef; Wieczorek, Dagmar] Heinrich Heine Univ, Univ Klinikum Dusseldorf, Inst Humangenet, D-40225 Dusseldorf, Germany; [Strom, Tim M.] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Calpena, Eduardo; Wilkie, Andrew O. M.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Clin Genet Grp,MRC, Oxford OX3 9DS, England	University of Erlangen Nuremberg; University of Erlangen Nuremberg; CHU de Caen NORMANDIE; Universite de Caen Normandie; University of Duisburg Essen; University of Manchester; Birmingham Women's Hospital; Birmingham Women's Hospital; University of Bristol; University of Cologne; University of Gottingen; University of Illinois System; University of Illinois Chicago; Wellcome Trust Sanger Institute; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Oxford	Reis, A (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany.	andre.reis@uk-erlangen.de	Ekici, Arif B/C-3971-2013; Vergarajauregui, Silvia/ABG-8402-2020; Popp, Bernt/M-2157-2019; Wieczorek, Dagmar/AAU-6008-2021; , WaNgtJ/AAR-7045-2020; Reis, André/D-2309-2009; Wollnik, Bernd/GRY-6062-2022; Wilkie, Andrew/AAC-3820-2020; Thiel, Christian T/H-8964-2012; Engel, Felix/A-1767-2008; Calpena, Eduardo/HCI-9261-2022	Ekici, Arif B/0000-0001-6099-7066; Vergarajauregui, Silvia/0000-0002-9247-6123; Popp, Bernt/0000-0002-3679-1081; Wieczorek, Dagmar/0000-0003-2812-6492; Reis, André/0000-0002-6301-6363; Wollnik, Bernd/0000-0003-2589-0364; Wilkie, Andrew/0000-0002-2972-5481; Thiel, Christian T/0000-0003-3817-7277; Engel, Felix/0000-0003-2605-3429; Calpena, Eduardo/0000-0001-6399-6528; Reis, AlessanRSS/0000-0001-8486-7469; Vasileiou, Georgia/0000-0002-1993-1134; Altmuller, Janine/0000-0003-4372-1521	German Federal Ministry of Research and Education as part of the Chromatin-Net Consortium [01GM1520A, 01GM1520B, 01GM1520D, 01GM1520E]; Interdisciplinary Centre for Clinical Research Erlangen; German Research Foundation [INST 410/91-1 FUGG]; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme (AOMW); Wellcome Trust [102731]; Wellcome Trust Sanger Institute [WT098051]; HealthInnovation Challenge Fund [HICF-1009-003]; Wellcome Trust; Department of Health; NIHR through the Comprehensive Clinical Research Network	German Federal Ministry of Research and Education as part of the Chromatin-Net Consortium; Interdisciplinary Centre for Clinical Research Erlangen; German Research Foundation(German Research Foundation (DFG)); National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme (AOMW)(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); Wellcome Trust Sanger Institute(Wellcome Trust); HealthInnovation Challenge Fund; Wellcome Trust(Wellcome Trust); Department of Health; NIHR through the Comprehensive Clinical Research Network	We thank the individuals and their families for participating in this study. We also thank Juliane Hoyer and Michel Hadjihannas for useful advice. We are indebted to Daniela Schweitzer, Olga Zwenger, Angelika Diem, and Heike Friebel for excellent technical assistance. This work was supported by the German Federal Ministry of Research and Education (01GM1520A to A.R., 01GM1520B to N.B., 01GM1520D to T.S., and 01GM1520E to D.W.) as part of the Chromatin-Net Consortium, by Interdisciplinary Centre for Clinical Research Erlangen project E16 (A.R.), by the German Research Foundation (INST 410/91-1 FUGG to F.B.E), and by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme (AOMW) and Wellcome Trust (Senior Investigator Award 102731 to the AOMW). The Deciphering Developmental Disorders Study presents independent research commissioned by the Wellcome Trust Sanger Institute (grant WT098051) and the HealthInnovation Challenge Fund (grant HICF-1009-003), a parallel funding partnership between the Wellcome Trust and the Department of Health. The views expressed in this publication are those of the authors and not necessarily those of the Wellcome Trust or the Department of Health. The research team acknowledges the support of the NIHR through the Comprehensive Clinical Research Network.	Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Bodenhofer U, 2015, BIOINFORMATICS, V31, P3997, DOI 10.1093/bioinformatics/btv494; Bramswig NC, 2017, HUM GENET, V136, P297, DOI 10.1007/s00439-017-1757-z; Bramswig NC, 2015, HUM GENET, V134, P553, DOI 10.1007/s00439-015-1535-8; Chestkov AV, 1996, GENOMICS, V36, P174, DOI 10.1006/geno.1996.0440; COFFIN GS, 1970, AM J DIS CHILD, V119, P433, DOI 10.1001/archpedi.1970.02100050435009; GABIG TG, 1994, J BIOL CHEM, V269, P29515; Gibbons RJ, 1997, NAT GENET, V17, P146, DOI 10.1038/ng1097-146; Gordon CT, 2017, NAT GENET, V49, P249, DOI 10.1038/ng.3765; Hempel A, 2016, J MED GENET, V53, P152, DOI 10.1136/jmedgenet-2015-103393; Hoyer J, 2012, AM J HUM GENET, V90, P565, DOI 10.1016/j.ajhg.2012.02.007; Huber FM, 2017, P NATL ACAD SCI USA, V114, P6016, DOI 10.1073/pnas.1700328114; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Kalkhoven E, 2003, HUM MOL GENET, V12, P441, DOI 10.1093/hmg/ddg039; Kosho T, 2014, AM J MED GENET C, V166, P241, DOI 10.1002/ajmg.c.31415; Kosho T, 2014, AM J MED GENET C, V166, P262, DOI 10.1002/ajmg.c.31407; Kosho T, 2013, AM J MED GENET A, V161A, P1221, DOI 10.1002/ajmg.a.35933; Lange M, 2008, GENE DEV, V22, P2370, DOI 10.1101/gad.471408; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Lindeboom RGH, 2016, NAT GENET, V48, P1112, DOI 10.1038/ng.3664; Liu C, 2015, BBA-MOL CELL RES, V1853, P3279, DOI 10.1016/j.bbamcr.2015.09.029; Lower KM, 2002, NAT GENET, V32, P661, DOI 10.1038/ng1040; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; Mignot C, 2016, BRAIN, V139, DOI 10.1093/brain/aww181; Millan F, 2016, AM J MED GENET A, V170, P1791, DOI 10.1002/ajmg.a.37670; Miyake N, 2014, AM J MED GENET C, V166, P257, DOI 10.1002/ajmg.c.31406; Nacinovich Renata, 2014, BMC Res Notes, V7, P248, DOI 10.1186/1756-0500-7-248; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sanchez R, 2011, TRENDS BIOCHEM SCI, V36, P364, DOI 10.1016/j.tibs.2011.03.005; Santen GWE, 2014, AM J MED GENET C, V166, P276, DOI 10.1002/ajmg.c.31414; Santen GWE, 2013, HUM MUTAT, V34, P1519, DOI 10.1002/humu.22394; Santen GWE, 2012, NAT GENET, V44, P379, DOI 10.1038/ng.2217; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Tando T, 2010, J BIOL CHEM, V285, P21951, DOI 10.1074/jbc.M109.087783; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toma KG, 2015, RNA, V21, P887, DOI 10.1261/rna.048637.114; Tsurusaki Y, 2014, CLIN GENET, V85, P548, DOI 10.1111/cge.12225; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; Turkmen S, 2003, EUR J HUM GENET, V11, P858, DOI 10.1038/sj.ejhg.5201050; Vasileiou G, 2015, AM J HUM GENET, V97, P445, DOI 10.1016/j.ajhg.2015.08.002; Wieczorek D, 2013, HUM MOL GENET, V22, P5121, DOI 10.1093/hmg/ddt366; Wu JI, 2012, ACTA BIOCH BIOPH SIN, V44, P54, DOI 10.1093/abbs/gmr099; Xiong XZ, 2016, NAT CHEM BIOL, V12, P1111, DOI [10.1038/NCHEMBIO.2218, 10.1038/nchembio.2218]; Yan KZ, 2017, AM J HUM GENET, V100, P91, DOI 10.1016/j.ajhg.2016.11.011; Zeng L, 2010, NATURE, V466, P258, DOI 10.1038/nature09139; Zhang W, 2011, BIOCHEM BIOPH RES CO, V413, P58, DOI 10.1016/j.bbrc.2011.08.043	49	49	52	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 1	2018	102	3					468	479		10.1016/j.ajhg.2018.01.014	http://dx.doi.org/10.1016/j.ajhg.2018.01.014			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FX9ZL	29429572	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000426469600017
J	Kury, S; Besnard, T; Ebstein, F; Khan, TN; Gambin, T; Douglas, J; Bacino, CA; Sanders, SJ; Lehmann, A; Latypova, X; Khan, K; Pacault, M; Sacharow, S; Glaser, K; Bieth, E; Perrin-Sabourin, L; Jacquemont, ML; Cho, MT; Roeder, E; Denomme-Pichon, AS; Monaghan, KG; Yuan, B; Xia, F; Simon, S; Bonneau, D; Parent, P; Gilbert-Dussardier, B; Odent, S; Toutain, A; Pasquier, L; Barbouth, D; Shaw, CA; Pate, A; Smith, JL; Bi, WM; Schmitt, S; Deb, W; Nizon, M; Mercier, S; Vincent, M; Rooryck, C; Malan, V; Briceno, I; Gomez, A; Nugent, KM; Gibson, JB; Cogne, B; Lupski, JR; Stessman, HAF; Eichler, EE; Retterer, K; Yang, YP; Redon, R; Katsanis, N; Rosenfeld, JA; Kloetze, PM; Golzio, C; Bezieau, S; Stankiewicz, P; Isidor, B				Kury, Sebastien; Besnard, Thomas; Ebstein, Frederic; Khan, Tahir N.; Gambin, Tomasz; Douglas, Jessica; Bacino, Carlos A.; Sanders, Stephan J.; Lehmann, Andrea; Latypova, Xenia; Khan, Kamal; Pacault, Mathilde; Sacharow, Stephanie; Glaser, Kimberly; Bieth, Eric; Perrin-Sabourin, Laurence; Jacquemont, Marie-Line; Cho, Megan T.; Roeder, Elizabeth; Denomme-Pichon, Anne-Sophie; Monaghan, Kristin G.; Yuan, Bo; Xia, Fan; Simon, Sylvain; Bonneau, Dominique; Parent, Philippe; Gilbert-Dussardier, Brigitte; Odent, Sylvie; Toutain, Annick; Pasquier, Laurent; Barbouth, Deborah; Shaw, Chad A.; Pate, Ankita; Smith, Janice L.; Bi, Weimin; Schmitt, Sebastien; Deb, Wallid; Nizon, Mathilde; Mercier, Sandra; Vincent, Marie; Rooryck, Caroline; Malan, Valerie; Briceno, Ignacio; Gomez, Alberto; Nugent, Kimberly M.; Gibson, James B.; Cogne, Benjamin; Lupski, James R.; Stessman, Holly A. F.; Eichler, Evan E.; Retterer, Kyle; Yang, Yaping; Redon, Richard; Katsanis, Nicholas; Rosenfeld, Jill A.; Kloetze, Peter -Michael; Golzio, Christelle; Bezieau, Stephane; Stankiewicz, Pawel; Isidor, Bertrand			De Novo Disruption of the Proteasome Regulatory Subunit PSMD12 Causes a Syndromic Neurodevelopmental Disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							26S PROTEASOME; INTELLECTUAL-DISABILITY; PROTEIN HOMEOSTASIS; UBIQUITIN; MUTATIONS; DEGRADATION; COMPLEXES; RPN5; DEUBIQUITINATION; DATABASE	Degradation of proteins by the ubiquitin-proteasome system (UPS) is an essential biological process in the development of eukaryotic organisms. Dysregulation of this mechanism leads to numerous human neurodegenerative or neurodevelopmental disorders. Through a multi-center collaboration, we identified six de novo genomic deletions and four de novo point mutations involving PSMD12, encoding the non-ATPase subunit PSMD12 (aka RPN5) of the 19S regulator of 26S proteasome complex, in unrelated individuals with intellectual disability, congenital malformations, ophthalmologic anomalies, feeding difficulties, deafness, and subtle dysmorphic facial features. We observed reduced PSMD12 levels and an accumulation of ubiquitinated proteins without any impairment of proteasome catalytic activity. Our PSMD12 loss-of-function zebrafish CRISPR/Cas9 model exhibited microcephaly, decreased convolution of the renal tubules, and abnormal craniofacial morphology. Our data support the biological importance of PSMD12 as a scaffolding subunit in proteasome function during development and neurogenesis in particular; they enable the definition of a neurodevelopmental disorder due to PSMD12 variants, expanding the phenotypic spectrum of UPS-dependent disorders.	[Kury, Sebastien; Besnard, Thomas; Latypova, Xenia; Pacault, Mathilde; Schmitt, Sebastien; Deb, Wallid; Nizon, Mathilde; Mercier, Sandra; Vincent, Marie; Cogne, Benjamin; Bezieau, Stephane; Isidor, Bertrand] CHU Nantes, Serv Genet Med, 9 Quai Moncousu, F-44093 Nantes 1, France; [Ebstein, Frederic; Lehmann, Andrea; Kloetze, Peter -Michael] Charite, Inst Biochem, Charite Pl 1,Virchowweg 6, D-10117 Berlin, Germany; [Khan, Tahir N.; Khan, Kamal; Katsanis, Nicholas; Golzio, Christelle] Duke Univ, Med Ctr, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Gambin, Tomasz; Bacino, Carlos A.; Roeder, Elizabeth; Yuan, Bo; Xia, Fan; Shaw, Chad A.; Pate, Ankita; Smith, Janice L.; Bi, Weimin; Lupski, James R.; Yang, Yaping; Rosenfeld, Jill A.; Stankiewicz, Pawel] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Gambin, Tomasz] Warsaw Univ Technol, Inst Comp Sci, PL-00661 Warsaw, Poland; [Gambin, Tomasz] Inst Mother & Child Hlth, Dept Med Genet, PL-01211 Warsaw, Poland; [Douglas, Jessica; Sacharow, Stephanie] Boston Childrens Hosp, Div Genet & Genom, Boston, MA 02115 USA; [Douglas, Jessica; Sacharow, Stephanie] Harvard Med Sch, Boston, MA 02115 USA; [Bacino, Carlos A.; Yuan, Bo; Xia, Fan; Shaw, Chad A.; Pate, Ankita; Smith, Janice L.; Bi, Weimin; Yang, Yaping; Stankiewicz, Pawel] Baylor Genet, Houston, TX 77030 USA; [Sanders, Stephan J.] Univ Calif San Francisco, Dept Psychiat, Weill Inst Neurosci, San Francisco, CA 94158 USA; [Glaser, Kimberly; Barbouth, Deborah] Univ Miami, Miller Sch Med, Dr John T Macdonald Fdn, Dept Human Genet, Miami, FL 33136 USA; [Bieth, Eric] CHU Toulouse, Hop Purpan, Serv Genet Med, F-31059 Toulouse, France; [Perrin-Sabourin, Laurence] Hop Robert Debre, AP HP, Federat Genet, F-75935 Paris 19, France; [Jacquemont, Marie-Line] CHU La Reunion, Genet Med, St Pierre 97448, Reunion, France; [Cho, Megan T.; Monaghan, Kristin G.; Retterer, Kyle] GeneDx, Gaithersburg, MD 20877 USA; [Roeder, Elizabeth; Nugent, Kimberly M.] Baylor Coll Med, Dept Pediat, San Antonio, TX 78207 USA; [Denomme-Pichon, Anne-Sophie; Bonneau, Dominique] CHU Angers, Dept Biochim & Genet, F-49933 Angers 9, France; [Simon, Sylvain; Bezieau, Stephane] Univ Angers, Ctr Rech Cancerol & Immunol Nantes Angers, INSERM, F-44007 Nantes, France; [Simon, Sylvain; Bezieau, Stephane] Univ Nantes, F-44007 Nantes, France; [Simon, Sylvain] LabEx Immunotherapy Graft Oncol, F-44093 Nantes, France; [Simon, Sylvain] CHU Nantes, Dept Dermatocancerol, F-44093 Nantes, France; [Bonneau, Dominique] CNRS, UMR 6214, INSERM, UMR 1083, F-49933 Angers 9, France; [Parent, Philippe] CHRU Brest, Genet Med, F-29609 Brest, France; [Gilbert-Dussardier, Brigitte] CHU Poitiers, Serv Genet, BP 577, F-86021 Poitiers, France; [Gilbert-Dussardier, Brigitte] Univ Poitiers, Equipe Accueil 3808, F-86022 Poitiers, France; [Odent, Sylvie; Pasquier, Laurent] Ctr Hosp Univ Rennes, Serv Genet Clin, F-35203 Rennes, France; [Odent, Sylvie; Pasquier, Laurent] Univ Rennes 1, CNRS, UMR 6290, 2 Ave Prof Leon Bernard, F-35043 Rennes, France; [Toutain, Annick] CHU Tours, Serv Genet, 2 Blvd Tonnelle, F-37044 Tours, France; [Toutain, Annick] Univ Tours, Fac Med, INSERM, UMR U930, F-37044 Tours, France; [Rooryck, Caroline] CHU Bordeaux, Serv Genet Med, F-33076 Bordeaux, France; [Malan, Valerie] Hop Necker Enfants Malad, AP HP, Serv Histol Ernbryol Cytogenet, F-75015 Paris, France; [Briceno, Ignacio; Gomez, Alberto] Pontificia Univ Javeriana, Inst Genet Humana, Fac Med, Bogota 110231, Colombia; [Gibson, James B.] Specially Children, Clin & Metab Genet, Austin, TX 78723 USA; [Lupski, James R.] Texas Childrens Hosp, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Stessman, Holly A. F.; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA 98195 USA; [Redon, Richard] Univ Nantes, INSERM, CNRS, Inst Thorax, F-44007 Nantes, France; [Redon, Richard] CHU Nantes, Inst Thorax, F-44093 Nantes, France; [Katsanis, Nicholas] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Stankiewicz, Pawel] Inst Mother & Child Hlth, PL-01211 Warsaw, Poland	Nantes Universite; CHU de Nantes; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Duke University; Baylor College of Medicine; Warsaw University of Technology; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; University of Miami; CHU de Toulouse; Assistance Publique Hopitaux Paris (APHP); CHU Reunion; Baylor College of Medicine; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Nantes Universite; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Brest; Universite de Bretagne Occidentale; CHU Poitiers; Universite de Poitiers; Universite de Poitiers; CHU Rennes; Universite de Rennes 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes 1; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Pontificia Universidad Javeriana; Baylor College of Medicine; Baylor College of Medicine; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Duke University	Isidor, B (corresponding author), CHU Nantes, Serv Genet Med, 9 Quai Moncousu, F-44093 Nantes 1, France.; Stankiewicz, P (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Stankiewicz, P (corresponding author), Baylor Genet, Houston, TX 77030 USA.; Stankiewicz, P (corresponding author), Inst Mother & Child Hlth, PL-01211 Warsaw, Poland.	pawels@bcm.edu; bertrand.isidor@chu-nantes.fr	Malan, Valerie/H-7423-2017; BESNARD, Thomas/D-1329-2018; Mercier, Sandra/E-8922-2018; Pasquier, Laurent/AAN-4081-2020; Sanders, Stephan/S-8645-2019; KÜRY, Sébastien/G-5971-2015; Gambin, Tomasz/HDN-5840-2022; Besnard, Thomas/L-2303-2019; Isidor, Bertrand/AAJ-3456-2021; Redon, Richard/F-3303-2014; Stankiewicz, Paweł/AAP-7906-2021; Briceno Balcazar, Ignacio/N-3337-2017; Vincent, Marie/K-7342-2018	Malan, Valerie/0000-0002-3450-4958; BESNARD, Thomas/0000-0003-4804-5147; Pasquier, Laurent/0000-0003-3985-1286; KÜRY, Sébastien/0000-0001-5497-0465; Gambin, Tomasz/0000-0002-0941-4571; Besnard, Thomas/0000-0003-4804-5147; Isidor, Bertrand/0000-0001-6480-126X; Redon, Richard/0000-0001-7751-2280; Stankiewicz, Paweł/0000-0002-6456-7490; Sanders, Stephan/0000-0001-9112-5148; Golzio, Christelle/0000-0002-4420-3921; Khan, Tahir/0000-0003-3096-8795; Gomez, Alberto/0000-0002-5592-3844; Toutain, Annick/0000-0002-5999-5300; Briceno Balcazar, Ignacio/0000-0001-7300-6401; GILBERT-DUSSARDIER, Brigitte/0000-0001-7182-9914; Bonneau, Dominique/0000-0002-6886-0969; Rooryck, Caroline/0000-0002-9789-3591; Stessman, Holly/0000-0002-0764-3493; Vincent, Marie/0000-0003-1010-5618	French Ministry of Health; Health Regional Agency from Poitou-Charentes (HUGODIMS) [RC14_0107]; US National Human Genome Research Institute [U54HG006542]; National Heart, Lung, and Blood Institute; Wellcome Trust; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK096493] Funding Source: NIH RePORTER	French Ministry of Health; Health Regional Agency from Poitou-Charentes (HUGODIMS)(Region Nouvelle-Aquitaine); US National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank all families for participating in this study. We acknowledge HUGODIMS (a Western France exome-based trio-approach project to identify genes involved in intellectual disability); funding for HUGODIMS (subject 1) is supported by a grant from the French Ministry of Health and from the Health Regional Agency from Poitou-Charentes (HUGODIMS, 2013, RC14_0107). We thank Dr. Frederique Allaire from the Health Regional Agency of Poitou-Charentes for supporting this project. We thank Lea Ferrand and Emilie Le Blanc for grant and data management. We acknowledge GEM HUGO (Western France Network of Medical Genetics and Genomics). We are most grateful to the Nantes Genomics core facility (Biogenouest Genomics) for its technical support and for performing exome sequencing for subject 1 and his parents. This work was supported in part by grant U54HG006542 from the US National Human Genome Research Institute and National Heart, Lung, and Blood Institute to the Baylor Hopkins Center for Mendelian Genomics. This study made use of data generated by the DECIPHER community. A full list of centers who contributed to data generation is available at http://decipher.sanger.ac.uk and via email at decipher@sanger.ac.uk. Funding for the project was provided by the Wellcome Trust. M.T.C, K.G.M, and K.R. are employees of GeneDx.	Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; Bainbridge MN, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r68; Bartnik M, 2014, J APPL GENET, V55, P125, DOI 10.1007/s13353-013-0181-x; Basel-Vanagaite L, 2012, AM J HUM GENET, V91, P998, DOI 10.1016/j.ajhg.2012.10.011; Bhattacharyya S, 2014, NAT REV MOL CELL BIO, V15, P122, DOI 10.1038/nrm3741; Blake J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090894; Bochmann I, 2014, J CELL MOL MED, V18, P59, DOI 10.1111/jcmm.12160; Boehringer J, 2012, BIOCHEM J, V448, P55, DOI 10.1042/BJ20120542; Bolar NA, 2016, AM J HUM GENET, V99, P174, DOI 10.1016/j.ajhg.2016.05.028; Book AJ, 2009, PLANT CELL, V21, P460, DOI 10.1105/tpc.108.064444; Boone PM, 2010, HUM MUTAT, V31, P1326, DOI 10.1002/humu.21360; Borck G, 2015, GENOME RES, V25, P155, DOI 10.1101/gr.176925.114; Burrage LC, 2013, AM J MED GENET A, V161A, P841, DOI 10.1002/ajmg.a.35751; Cajigas IJ, 2010, EMBO J, V29, P2746, DOI 10.1038/emboj.2010.173; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Dambacher CM, 2016, ELIFE, V5, DOI 10.7554/eLife.13027; Dantuma NP, 2014, FRONT MOL NEUROSCI, V7, DOI [10.3389/fnmo1.2014.00070, 10.3389/fnmol.2014.00070]; Dauber A, 2013, AM J HUM GENET, V93, P798, DOI 10.1016/j.ajhg.2013.09.010; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Ebstein F, 2012, CELL MOL LIFE SCI, V69, P2443, DOI 10.1007/s00018-012-0933-5; Fecto F, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt243; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Froyen G, 2008, AM J HUM GENET, V82, P432, DOI 10.1016/j.ajhg.2007.11.002; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gomes AV, 2013, SCI CAIRO, V2013, DOI DOI 10.1155/2013/637629; Gordon CT, 2015, AM J HUM GENET, V96, P519, DOI 10.1016/j.ajhg.2015.01.015; Hamilton AM, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/196848; Hao H, 2015, MOL CELL, V59, P956, DOI 10.1016/j.molcel.2015.07.033; Hegde AN, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00096; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Homan CC, 2014, AM J HUM GENET, V94, P470, DOI 10.1016/j.ajhg.2014.02.004; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Isidor B, 2016, HUM MUTAT, V37, P354, DOI 10.1002/humu.22952; Isrie M, 2015, AM J HUM GENET, V97, P790, DOI 10.1016/j.ajhg.2015.10.014; Kague E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047394; Kim HM, 2011, BBA-GENE REGUL MECH, V1809, P67, DOI 10.1016/j.bbagrm.2010.08.008; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Maytal-Kivity V, 2003, INT J BIOCHEM CELL B, V35, P706, DOI 10.1016/S1357-2725(02)00378-3; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Notwell JH, 2016, GENOME RES, V26, P1013, DOI 10.1101/gr.203612.115; Pardo-Martin C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2475; Peters LZ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005178; Retterer K, 2016, GENET MED, V18, P696, DOI 10.1038/gim.2015.148; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Schwarz LA, 2012, MOL CELL NEUROSCI, V49, P387, DOI 10.1016/j.mcn.2011.08.006; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Sharon M, 2006, PLOS BIOL, V4, P1314, DOI 10.1371/journal.pbio.0040267; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Sullivan JA, 2003, NAT REV GENET, V4, P948, DOI 10.1038/nrg1228; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Vergult S, 2012, EUR J HUM GENET, V20, P534, DOI 10.1038/ejhg.2011.239; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wiszniewska J, 2014, EUR J HUM GENET, V22, P79, DOI 10.1038/ejhg.2013.77; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Yen HCS, 2003, J BIOL CHEM, V278, P30669, DOI 10.1074/jbc.M302093200; Yu ZL, 2011, MOL BIOL CELL, V22, P911, DOI 10.1091/mbc.E10-08-0655	63	49	58	3	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 2	2017	100	2					352	363		10.1016/j.ajhg.2017.01.003	http://dx.doi.org/10.1016/j.ajhg.2017.01.003			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ6TP	28132691	Green Published, Bronze			2022-12-18	WOS:000393352000015
J	Diggle, CP; Rizzo, SJS; Popiolek, M; Hinttala, R; Schulke, JP; Kurian, MA; Carr, IM; Markham, AF; Bonthron, DT; Watson, C; Sharif, SM; Reinhart, V; James, LC; Vanase-Frawley, MA; Charych, E; Allen, M; Harms, J; Schmidt, CJ; Ng, J; Pysden, K; Strick, C; Vieira, P; Mankinen, K; Kokkonen, H; Kallioinen, M; Sormunen, R; Rinne, JO; Johansson, J; Alakurtti, K; Huilaja, L; Hurskainen, T; Tasanen, K; Anttila, E; Marques, TR; Howes, O; Politis, M; Fahiminiya, S; Nguyen, KQ; Majewski, J; Uusimaa, J; Sheridan, E; Brandon, NJ				Diggle, Christine P.; Rizzo, Stacey J. Sukoff; Popiolek, Michael; Hinttala, Reetta; Schuelke, Jan-Philip; Kurian, Manju A.; Carr, Ian M.; Markham, Alexander F.; Bonthron, David T.; Watson, Christopher; Sharif, Saghira Malik; Reinhart, Veronica; James, Larry C.; Vanase-Frawley, Michelle A.; Charych, Erik; Allen, Melanie; Harms, John; Schmidt, Christopher J.; Ng, Joanne; Pysden, Karen; Strick, Christine; Vieira, Paeivi; Mankinen, Katariina; Kokkonen, Hannaleena; Kallioinen, Matti; Sormunen, Raija; Rinne, Juha O.; Johansson, Jarkko; Alakurtti, Kati; Huilaja, Laura; Hurskainen, Tiina; Tasanen, Kaisa; Anttila, Eija; Marques, Tiago Reis; Howes, Oliver; Politis, Marius; Fahiminiya, Somayyeh; Nguyen, Khanh Q.; Majewski, Jacek; Uusimaa, Johanna; Sheridan, Eamonn; Brandon, Nicholas J.			Biallelic Mutations in PDE1 0A Lead to Loss of Striatal PDE10A and a Hyperkinetic Movement Disorder with Onset in Infancy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA-SEQUENCING DATA; HUNTINGTONS-DISEASE; PHOSPHODIESTERASE 10A; IMMUNOHISTOCHEMICAL LOCALIZATION; PARKINSONS-DISEASE; MICE; SCHIZOPHRENIA; DYSKINESIA; FRAMEWORK; MODEL	Deficits in the basal ganglia pathways modulating cortical motor activity underlie both Parkinson disease (PD) and Huntington disease (HD). Phosphodiesterase 10A (PDE10A) is enriched in the striatum, and animal data suggest that it is a key regulator of this circuitry. Here, we report on germline PDE10A mutations in eight individuals from two families affected by a hyperkinetic movement disorder due to homozygous mutations c.320A>G (p.Tyr107Cys) and c.346G>C (p.Ala116Pro). Both mutations lead to a reduction in PDE10A levels in recombinant cellular systems, and critically, positron-emission-tomography (PET) studies with a specific PDE10A ligand confirmed that the p.Tyr107Cys variant also reduced striatal PDE10A levels in one of the affected individuals. A knock-in mouse model carrying the homologous p.Tyr97Cys variant had decreased striatal PDE10A and also displayed motor abnormalities. Striatal preparations from this animal had an impaired capacity to degrade cyclic adenosine monophosphate (cAMP) and a blunted pharmacological response to PDE10A inhibitors. These observations highlight the critical role of PDE10A in motor control across species.	[Diggle, Christine P.; Carr, Ian M.; Markham, Alexander F.; Bonthron, David T.; Watson, Christopher; Sharif, Saghira Malik; Sheridan, Eamonn] Univ Leeds, Sch Med, Leeds LS9 7TF, W Yorkshire, England; [Rizzo, Stacey J. Sukoff; Popiolek, Michael; Schuelke, Jan-Philip; Reinhart, Veronica; James, Larry C.; Charych, Erik; Harms, John; Schmidt, Christopher J.; Strick, Christine; Brandon, Nicholas J.] Pfizer Res & Dev, Neurosci Res Unit, Cambridge, MA 02139 USA; [Hinttala, Reetta; Vieira, Paeivi; Huilaja, Laura; Hurskainen, Tiina; Tasanen, Kaisa; Anttila, Eija; Uusimaa, Johanna] Univ Oulu, PEDEGO Res Unit, Oulu 90014, Finland; [Hinttala, Reetta; Vieira, Paeivi; Huilaja, Laura; Hurskainen, Tiina; Tasanen, Kaisa; Anttila, Eija; Uusimaa, Johanna] Univ Oulu, Med Res Ctr Oulu, Oulu 90014, Finland; [Hinttala, Reetta; Vieira, Paeivi; Huilaja, Laura; Hurskainen, Tiina; Tasanen, Kaisa; Anttila, Eija; Uusimaa, Johanna] Oulu Univ Hosp, POB 5000, Oulu 90014, Finland; [Hinttala, Reetta; Vieira, Paeivi; Anttila, Eija; Uusimaa, Johanna] Oulu Univ Hosp, Dept Children & Adolescents, POB 23, Oulu 90029, Finland; [Hinttala, Reetta; Fahiminiya, Somayyeh; Majewski, Jacek] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Hinttala, Reetta; Nguyen, Khanh Q.] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Hinttala, Reetta; Sormunen, Raija; Uusimaa, Johanna; Sheridan, Eamonn] Univ Oulu, Bioctr Oulu, POB 5000, Oulu 90014, Finland; [Kurian, Manju A.; Ng, Joanne] UCL Inst Child Hlth, Dev Neurosci Programme, London WC1N 1EH, England; [Kurian, Manju A.] Great Ormond St Hosp Sick Children, Dept Neurol, London WC1N 1EH, England; [Vanase-Frawley, Michelle A.; Allen, Melanie] Pfizer Res & Dev, Groton, CT 06340 USA; [Ng, Joanne] UCL, Inst Womens Hlth, London WC1N 1EH, England; [Pysden, Karen] Leeds Gen Infirm, Dept Pediat Neurol, Great George St, Leeds LS1 3EX, W Yorkshire, England; [Mankinen, Katariina] Lansi Pohja Cent Hosp, Kemi 94100, Finland; [Kokkonen, Hannaleena] Univ Oulu, Dept Clin Chem, POB 5000, Oulu 90014, Finland; [Kokkonen, Hannaleena] Oulu Univ Hosp, Northern Finland Lab Ctr, POB 500, Oulu 90029, Finland; [Kallioinen, Matti; Sormunen, Raija] Oulu Univ Hosp, Dept Pathol, Oulu 90014, Finland; [Kallioinen, Matti; Sormunen, Raija; Huilaja, Laura; Hurskainen, Tiina; Tasanen, Kaisa] Univ Oulu, POB 5000, Oulu 90014, Finland; [Rinne, Juha O.] Turku Univ Hosp, Div Clin Neurosci, Turku 20521, Finland; [Rinne, Juha O.; Johansson, Jarkko; Alakurtti, Kati] Univ Turku, POB 52, Turku 20521, Finland; [Rinne, Juha O.; Johansson, Jarkko; Alakurtti, Kati] Turku Univ Hosp, Turku PET Ctr, Turku 20521, Finland; [Alakurtti, Kati] Univ Turku, Dept Diagnost Radiol, Turku 20521, Finland; [Alakurtti, Kati] Turku Univ Hosp, POB 52, Turku 20521, Finland; [Huilaja, Laura; Hurskainen, Tiina; Tasanen, Kaisa] Oulu Univ Hosp, Dept Dermatol, Oulu 90014, Finland; [Huilaja, Laura; Hurskainen, Tiina; Tasanen, Kaisa] Oulu Univ Hosp, Oulu Ctr Cell Matrix Res, Oulu 90014, Finland; [Marques, Tiago Reis; Howes, Oliver] Kings Coll London, Dept Psychosis Studies, Inst Psychiat Psychol & Neurosci, London SE5 8AF, England; [Howes, Oliver] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Hammersmith Hosp Campus, London W12 0NN, England; [Politis, Marius] Kings Coll London, Neurodegenerat Imaging Grp, Inst Psychiat Psychol & Neurosci, London SE5 8AF, England; [Fahiminiya, Somayyeh; Majewski, Jacek] McGill Univ, Montreal, PQ H3A 0G1, Canada; [Fahiminiya, Somayyeh; Majewski, Jacek] Genome Quebec Innovat Ctr, Montreal, PQ H3A 0G1, Canada; [Brandon, Nicholas J.] AstraZeneca Neurosci, Innovat Medicines & Early Dev Biotech Unit, 141 Portland St, Cambridge, MA 02139 USA	University of Leeds; Pfizer; University of Oulu; University of Oulu; University of Oulu; University of Oulu; McGill University; McGill University; University of Oulu; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Pfizer; University of London; University College London; Leeds General Infirmary; University of Leeds; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Turku; University of Turku; University of Turku; University of Turku; University of Turku; University of Oulu; University of Oulu; University of London; King's College London; Imperial College London; University of London; King's College London; McGill University; AstraZeneca	Sheridan, E (corresponding author), Univ Leeds, Sch Med, Leeds LS9 7TF, W Yorkshire, England.; Brandon, NJ (corresponding author), Pfizer Res & Dev, Neurosci Res Unit, Cambridge, MA 02139 USA.; Uusimaa, J (corresponding author), Univ Oulu, PEDEGO Res Unit, Oulu 90014, Finland.; Uusimaa, J (corresponding author), Univ Oulu, Med Res Ctr Oulu, Oulu 90014, Finland.; Uusimaa, J (corresponding author), Oulu Univ Hosp, POB 5000, Oulu 90014, Finland.; Uusimaa, J (corresponding author), Oulu Univ Hosp, Dept Children & Adolescents, POB 23, Oulu 90029, Finland.; Uusimaa, J (corresponding author), Univ Oulu, Bioctr Oulu, POB 5000, Oulu 90014, Finland.; Brandon, NJ (corresponding author), AstraZeneca Neurosci, Innovat Medicines & Early Dev Biotech Unit, 141 Portland St, Cambridge, MA 02139 USA.	johanna.uusimaa@oulu.fi; e.sheridan@leeds.ac.uk; nick.brandon@azneuro.com	Marques, Tiago Reis/F-2489-2010; Nguyen, Khanh q/K-8869-2013; Rizzo, Stacey/AAU-1145-2021; Johansson, Jarkko/M-1443-2019; Howes, Oliver/E-7156-2010	Marques, Tiago Reis/0000-0003-0602-7661; Nguyen, Khanh q/0000-0002-5378-6671; Johansson, Jarkko/0000-0002-4501-4735; Howes, Oliver/0000-0002-2928-1972; Brandon, Nicholas/0000-0002-3917-0096; Hinttala, Reetta/0000-0002-7642-4008; Tasanen, Kaisa/0000-0001-8056-5949; Sukoff Rizzo, Stacey J./0000-0002-1460-8127; Ng, Joanne/0000-0002-7946-9965; Watson, Christopher Mark/0000-0003-2371-1844	Wellbeing of Women [RG992]; University of Leeds Biomedical Health Research Centre [PSF42]; Academy of Finland Research Council for Health [138566, 266498, 273790]; Sigrid Juselius Foundation; Finland Foundation for Pediatric Research; Alma and K.A. Snellman Foundation; Emil Aaltonen Foundation; European Union [273669]; Department of Pediatrics and Adolescence at Oulu University Hospital (Special State Grants for Health Research); Medical Research Council [G0700995, MR/K02342X/1, MC_U120097115, MR/L01629X/1, 1116129] Funding Source: researchfish; Rosetrees Trust [M576] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [ICH1031, V1284] Funding Source: researchfish; Action Medical Research [1722] Funding Source: researchfish; MRC [MR/L01629X/1, G0700995, MR/K02342X/1] Funding Source: UKRI	Wellbeing of Women(Wellbeing of Women (WoW)); University of Leeds Biomedical Health Research Centre; Academy of Finland Research Council for Health(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finland Foundation for Pediatric Research; Alma and K.A. Snellman Foundation; Emil Aaltonen Foundation; European Union(European Commission); Department of Pediatrics and Adolescence at Oulu University Hospital (Special State Grants for Health Research); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust); Great Ormond Street Hospital Childrens Charity; Action Medical Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors are grateful to Ted Simon and Michael Roos for assistance with the generation of the transgenic knock-in mice and Edwin Berryman, Bonnie Deschenes, Tabitha Jones, Mona Sisodia, Ms. Pirjo Keranen, Ms. Anja Mattila, and Ms. Riitta Vuento for their expert assistance. This work was supported by the following: Wellbeing of Women (grant RG992), the University of Leeds Biomedical Health Research Centre (grant PSF42 to E.S.), the Academy of Finland Research Council for Health (decision numbers 138566 to J.U. and 266498 and 273790 to R.H.), the Sigrid Juselius Foundation (J.U. and R.H.), the Finland Foundation for Pediatric Research (J.U.), the Alma and K.A. Snellman Foundation (J.U.), the Emil Aaltonen Foundation (R.H.), the European Union's Seventh Framework Programme (Marie Curie International Outgoing Fellowship under grant 273669 [BioMit] to R.H.), and the Department of Pediatrics and Adolescence at Oulu University Hospital (Special State Grants for Health Research).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Berardelli A, 1999, MOVEMENT DISORD, V14, P398, DOI 10.1002/1531-8257(199905)14:3<398::AID-MDS1003>3.0.CO;2-F; Carr IM, 2006, HUM MUTAT, V27, P1041, DOI 10.1002/humu.20383; Carr IM, 2009, HUM MUTAT, V30, P960, DOI 10.1002/humu.20974; Charych EI, 2010, J NEUROSCI, V30, P9027, DOI 10.1523/JNEUROSCI.1635-10.2010; Chen DH, 2015, NEUROLOGY, V85, P2026, DOI 10.1212/WNL.0000000000002058; Chen YZ, 2014, ANN NEUROL, V75, P542, DOI 10.1002/ana.24119; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Coskran TM, 2006, J HISTOCHEM CYTOCHEM, V54, P1205, DOI 10.1369/JHC.6A6930.2006; DeLong MR, 2007, ARCH NEUROL-CHICAGO, V64, P20, DOI 10.1001/archneur.64.1.20; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Giampa C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013417; Gratwicke J, 2015, BRAIN, V138, P1454, DOI 10.1093/brain/awv104; Hebb ALO, 2004, NEUROSCIENCE, V123, P967, DOI 10.1016/j.neuroscience.2003.11.009; Jellinger KA, 2001, ADV NEUROL, V86, P55; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Longenecker G., 2009, CURR PROTOC CELL BIO, V14, P1; Marques TR, 2016, AM J PSYCHIAT; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Muyrers Joep P P, 2004, Methods Mol Biol, V256, P107; Niccolini F, 2015, BRAIN, V138, P3016, DOI 10.1093/brain/awv214; Pouladi MA, 2013, NAT REV NEUROSCI, V14, P708, DOI 10.1038/nrn3570; ROACH ML, 1995, EXP CELL RES, V221, P520, DOI 10.1006/excr.1995.1403; Rogers DC, 2001, NEUROSCI LETT, V306, P89, DOI 10.1016/S0304-3940(01)01885-7; Russell DS, 2014, JAMA NEUROL, V71, P1520, DOI 10.1001/jamaneurol.2014.1954; Schmidt CJ, 2008, J PHARMACOL EXP THER, V325, P681, DOI 10.1124/jpet.107.132910; Seeger TF, 2003, BRAIN RES, V985, P113, DOI 10.1016/S0006-8993(03)02754-9; Threlfell S, 2009, J PHARMACOL EXP THER, V328, P785, DOI 10.1124/jpet.108.146332; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wilson LS, 2015, CURR PHARM DESIGN, V21, P378	33	49	51	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 7	2016	98	4					735	743		10.1016/j.ajhg.2016.03.015	http://dx.doi.org/10.1016/j.ajhg.2016.03.015			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DJ4UO	27058446	Green Published, Bronze			2022-12-18	WOS:000374203800011
J	Zhao, J; Akinsanmi, I; Arafat, D; Cradick, TJ; Lee, CM; Banskota, S; Marigorta, UM; Bao, G; Gibson, G				Zhao, Jing; Akinsanmi, Idowu; Arafat, Dalia; Cradick, T. J.; Lee, Ciaran M.; Banskota, Samridhi; Marigorta, Urko M.; Bao, Gang; Gibson, Greg			A Burden of Rare Variants Associated with Extremes of Gene Expression in Human Peripheral Blood	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME SEQUENCE; COMMON DISEASES; NEANDERTHAL; MUTATIONS; NORMALIZATION; FRAMEWORK; SELECTION; ANCESTRY; HEALTH	In order to evaluate whether rare regulatory variants in the vicinity of promoters are likely to impact gene expression, we conducted a novel burden test for enrichment of rare variants at the extremes of expression. After sequencing 2-kb promoter regions of 472 genes in 410 healthy adults, we performed a quadratic regression of rare variant count on bins of peripheral blood transcript abundance from microarrays, summing over ranks of all genes. After adjusting for common eQTLs and the major axes of gene expression covariance, a highly significant excess of variants with minor allele frequency less than 0.05 at both high and low extremes across individuals was observed. Further enrichment was seen in sites annotated as potentially regulatory by RegulomeDB, but a deficit of effects was associated with known metabolic disease genes. The main result replicates in an independent sample of 75 individuals with RNA-seq and whole-genome sequence information. Three of four predicted large-effect sites were validated by CRISPR/Cas9 knockdown in K562 cells, but simulations indicate that effect sizes need not be unusually large to produce the observed burden. Unusually divergent low-frequency promoter haplotypes were observed at 31 loci, at least 9 of which appear to be derived from Neandertal admixture, but these were not associated with divergent gene expression in blood. The overall burden test results are consistent with rare and private regulatory variants driving high or low transcription at specific loci, potentially contributing to disease.	[Zhao, Jing; Akinsanmi, Idowu; Arafat, Dalia; Banskota, Samridhi; Marigorta, Urko M.; Gibson, Greg] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Zhao, Jing; Akinsanmi, Idowu; Arafat, Dalia; Banskota, Samridhi; Marigorta, Urko M.; Gibson, Greg] Georgia Inst Technol, Ctr Integrat Genom, Atlanta, GA 30332 USA; [Cradick, T. J.; Lee, Ciaran M.; Bao, Gang] Georgia Inst Technol, Lab Biomol Engn & Nanomed, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Lee, Ciaran M.; Bao, Gang] Rice Univ, Texas Med Ctr, Dept Bioengn, Houston, TX 77030 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Baylor College of Medicine; Rice University; University of Texas System; University of Texas Health Science Center Houston	Gibson, G (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.; Gibson, G (corresponding author), Georgia Inst Technol, Ctr Integrat Genom, Atlanta, GA 30332 USA.	greg.gibson@biology.gatech.edu	Lee, Ciaran Michael/AAV-4690-2020; Cradick, Thomas/ABC-3775-2021; Marigorta, Urko M/L-9512-2014	Lee, Ciaran Michael/0000-0002-0789-9149; Cradick, Thomas/0000-0002-8489-8318; Marigorta, Urko M/0000-0002-9087-6609; Banskota, Samridhi/0000-0002-3934-2273	NIH Program [1-P01-GM0996568]; NIH [RC2MH089915]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC2MH089915] Funding Source: NIH RePORTER	NIH Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH Program Project 1-P01-GM0996568 (Project 3, G.G. Principal Investigator), directed by Bruce Weir (University of Washington). We are grateful to Cathy Laurie and Sarah Nelson for assistance with imputation, Shweta Biliya for sequencing, Sahar Gelfman and David Goldstein for provision of the replication dataset (which was generated with the support of NIH grant RC2MH089915), Mary-Jane Chandler for assistance with the ancestral genome analysis, and Cathy Laurie, Joe Lachance, Patrick McGrath, and Fred Vannberg for comments on the manuscript. We thank all of the staff and participants at the CHDWB for their willing assistance, especially Ken Brigham for his vision for the Center.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Brigham KL, 2010, J AM GERIATR SOC, V58, pS298, DOI 10.1111/j.1532-5415.2010.03107.x; Chandrasekharappa SC, 2013, BLOOD, V121, pE138, DOI 10.1182/blood-2012-12-474585; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Hodgins-Davis A, 2015, MOL BIOL EVOL, V32, P2130, DOI 10.1093/molbev/msv094; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Huerta-Sanchez E, 2014, NATURE, V512, P194, DOI 10.1038/nature13408; Hunt KA, 2013, NATURE, V498, P232, DOI 10.1038/nature12170; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kiss MM, 2008, ANAL CHEM, V80, P8975, DOI 10.1021/ac801276c; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Lemos B, 2005, EVOLUTION, V59, P126; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lozzio B B, 1977, Int J Cancer, V19, P136, DOI 10.1002/ijc.2910190119; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; MASHAL RD, 1995, NAT GENET, V9, P177, DOI 10.1038/ng0295-177; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mecham BH, 2010, BIOINFORMATICS, V26, P1308, DOI 10.1093/bioinformatics/btq118; Metzger BPH, 2015, NATURE, V521, P344, DOI 10.1038/nature14244; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Montgomery SB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002144; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Preininger M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003362; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Qin PF, 2015, MOL BIOL EVOL, V32, P2665, DOI 10.1093/molbev/msv141; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Stegle O, 2012, NAT PROTOC, V7, P500, DOI 10.1038/nprot.2011.457; Tabassum R, 2014, J PERS MED, V4, DOI 10.3390/jpm4040489; Vernot B, 2014, SCIENCE, V343, P1017, DOI 10.1126/science.1245938; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zeng Y, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004942	46	49	49	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 4	2016	98	2					299	309		10.1016/j.ajhg.2015.12.023	http://dx.doi.org/10.1016/j.ajhg.2015.12.023			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DE3BR	26849112	Green Published, Bronze			2022-12-18	WOS:000370502300006
J	Vivante, A; Kleppa, MJ; Schulz, J; Kohl, S; Sharma, A; Chen, J; Shril, S; Hwang, DY; Weiss, AC; Kaminski, MM; Shukrun, R; Kemper, MJ; Lehnhardt, A; Beetz, R; Sanna-Cherchi, S; Verbitsky, M; Gharavi, AG; Stuart, HM; Feather, SA; Goodship, JA; Goodship, THJ; Woolf, AS; Westra, SJ; Doody, DP; Bauer, SB; Lee, RS; Adam, RM; Lu, W; Reutter, HM; Kehinde, EO; Mancini, EJ; Lifton, RP; Tasic, V; Lienkamp, SS; Juppner, H; Kispert, A; Hildebrandt, F				Vivante, Asaf; Kleppa, Marc-Jens; Schulz, Julian; Kohl, Stefan; Sharma, Amita; Chen, Jing; Shril, Shirlee; Hwang, Daw-Yang; Weiss, Anna-Carina; Kaminski, Michael M.; Shukrun, Rachel; Kemper, Markus J.; Lehnhardt, Anja; Beetz, Rolf; Sanna-Cherchi, Simone; Verbitsky, Miguel; Gharavi, All G.; Stuart, Helen M.; Feather, Sally A.; Goodship, Judith A.; Goodship, Timothy H. J.; Woolf, Adrian S.; Westra, Sjirk J.; Doody, Daniel P.; Bauer, Stuart B.; Lee, Richard S.; Adam, Rosalyn M.; Lu, Weining; Reutter, Heiko M.; Kehinde, Elijah O.; Mancini, Erika J.; Lifton, Richard P.; Tasic, Velibor; Lienkamp, Soeren S.; Jueppner, Harald; Kispert, Andreas; Hildebrandt, Friedhelm			Mutations in TBX18 Cause Dominant Urinary Tract Malformations via Transcriptional Dysregulation of Ureter Development	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL-ANOMALIES; KIDNEY; EXPRESSION; GENES; DISRUPTION; DISORDERS; DOMAIN	Congenital anomalies of the kidneys and urinary tract (CAKUT) are the most common cause of chronic kidney disease in the first three decades of life. Identification of single-gene mutations that cause CAKUT permits the first insights into related disease mechanisms. However, for most cases the underlying defect remains elusive. We identified a kindred with an autosomal-dominant form of CAKUT with predominant ureteropelvic junction obstruction. By whole exome sequencing, we identified a heterozygous truncating mutation (c.1010delG) of T-Box transcription factor 18 (TBX18) in seven affected members of the large kindred. A screen of additional families with CAKUT identified three families harboring two heterozygous TBX18 mutations (c.1570C>T and c.487A>G). TBX18 is essential for developmental specification of the ureteric mesenchyme and ureteric smooth muscle cells. We found that all three TBX18 altered proteins still dimerized with the wild-type protein but had prolonged protein half life and exhibited reduced transcriptional repression activity compared to wild-type TBX18. The p.Lys163Glu substitution altered an amino acid residue critical for TBX18-DNA interaction, resulting in impaired TBX18-DNA binding. These data indicate that dominant-negative TBX18 mutations cause human CAKUT by interference with TBX18 transcriptional repression, thus implicating ureter smooth muscle cell development in the pathogenesis of human CAKUT.	[Vivante, Asaf; Schulz, Julian; Kohl, Stefan; Chen, Jing; Shril, Shirlee; Hwang, Daw-Yang; Shukrun, Rachel; Hildebrandt, Friedhelm] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Vivante, Asaf] Sheba Med Ctr, Talpiot Med Leadership Program, IL-52621 Tel Hashomer, Israel; [Kleppa, Marc-Jens; Weiss, Anna-Carina; Kispert, Andreas] Hannover Med Sch, Inst Molbiol, D-30625 Hannover, Germany; [Sharma, Amita] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Pediatr Nephrol Unit, Boston, MA 02114 USA; [Sharma, Amita] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Sharma, Amita; Doody, Daniel P.; Jueppner, Harald] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Hwang, Daw-Yang] Kaohsiung Med Univ, Div Nephrol, Dept Med, Kaohsiung Med Univ Hosp, Kaohsiung 807, Taiwan; [Kaminski, Michael M.; Lienkamp, Soeren S.] Univ Freiburg, Med Ctr, Dept Med, Div Renal, D-79106 Freiburg, Germany; [Kemper, Markus J.; Lehnhardt, Anja] Univ Med Ctr Hamburg Eppendorf, Dept Pediat, D-20246 Hamburg, Germany; [Beetz, Rolf] Univ Med Clin, Ctr Pediat & Adolescent Med, D-55131 Mainz, Germany; [Sanna-Cherchi, Simone; Verbitsky, Miguel; Gharavi, All G.] Columbia Univ, Dept Med, New York, NY 10023 USA; [Stuart, Helen M.; Woolf, Adrian S.] Univ Manchester, Inst Human Dev, Fac Med & Human Sci, Manchester Acad Hlth Sci Ctr, Manchester M13 9WL, Lancs, England; [Stuart, Helen M.; Woolf, Adrian S.] Royal Manchester Childrens & St Marys Hosp, Manchester M13 9WL, Lancs, England; [Feather, Sally A.] Leeds Teaching Hosp NHS Trust, Leeds LS1 3EX, W Yorkshire, England; [Goodship, Judith A.; Goodship, Timothy H. J.] Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Westra, Sjirk J.] Harvard Univ, Sch Med, Pediat Radiol Unit, Massachusetts Gen Hosp, Boston, MA 02114 USA; [Doody, Daniel P.] Harvard Univ, Sch Med, Dept Pediat Surg, Massachusetts Gen Hosp, Boston, MA 02114 USA; [Bauer, Stuart B.; Lee, Richard S.; Adam, Rosalyn M.] Harvard Univ, Sch Med, Dept Urol, Boston Childrens Hosp, Boston, MA 02114 USA; [Lu, Weining] Boston Univ, Med Ctr, Renal Sect, Dept Med, Boston, MA 02118 USA; [Reutter, Heiko M.] Univ Bonn, Dept Neonatol, Childrens Hosp, D-53127 Bonn, Germany; [Kehinde, Elijah O.] Kuwait Univ, Div Urol, Dept Surg, Safat 13110, Kuwait; [Mancini, Erika J.] Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford 0X3 7BN, England; [Mancini, Erika J.] Univ Sussex, Sch Life Sci, Brighton BN1 9QD, E Sussex, England; [Lifton, Richard P.] Yale Univ, Sch Med, Dept Human Genet, New Haven, CT 06510 USA; [Lifton, Richard P.; Hildebrandt, Friedhelm] Howard Hughes Med Inst, Skopje 1000, Macedonia; [Tasic, Velibor] Univ Childrens Hosp, Med Sch Skopje, Skopje 1000, Macedonia; [Lienkamp, Soeren S.] Ctr Biol Signaling Studies BIOSS, D-79104 Freiburg, Germany	Harvard University; Boston Children's Hospital; Harvard Medical School; Chaim Sheba Medical Center; Hannover Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Kaohsiung Medical University; Kaohsiung Medical University Hospital; University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Columbia University; University of Manchester; University of Leeds; Newcastle University - UK; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; Boston University; University of Bonn; Kuwait University; University of Oxford; Wellcome Centre for Human Genetics; University of Sussex; Yale University	Hildebrandt, F (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Med, Boston, MA 02115 USA.	friedhelm.hildebrandt@childrens.harvard.edu	Tasic, Velibor/H-8714-2019; Shril, Shirlee/Q-5825-2016; Lienkamp, Soeren/AAH-6296-2020; Wang, Guilin/G-8794-2018; Mancini, Erika J/J-9880-2013; Woolf, Adrian S./AAZ-1075-2020; Stuart, Helen/G-3535-2015	Tasic, Velibor/0000-0002-3377-1245; Lienkamp, Soeren/0000-0003-2963-6865; Mancini, Erika J/0000-0001-9591-7898; Woolf, Adrian S./0000-0001-5541-1358; Stuart, Helen/0000-0003-2569-235X; Lu, Weining/0000-0002-6570-3044	NIH [DK096238, 5U54HG006504, DK 46718, DK078226, DK088767]; March of Dimes; German Research Foundation (DFG) [SFB1140]; Emmy Noether programme; Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy) at Hannover Medical School; Kidney Research UK; Medical Research Council [G0600040, MR/L002744/1]; Wellcome Trust [066647]; NIHR UK; Fulbright postdoctoral scholar award; Boston Children's Hospital;  [Ki72817-1]; MRC [G0600040, MR/L002744/1] Funding Source: UKRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078226, P30DK079310, R01DK088767, R01DK046718, R01DK096238, R37DK046718, R56DK046718] Funding Source: NIH RePORTER; Academy of Medical Sciences (AMS) [AMS-SGCL13-Stuart] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); German Research Foundation (DFG)(German Research Foundation (DFG)); Emmy Noether programme(German Research Foundation (DFG)); Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy) at Hannover Medical School; Kidney Research UK(Kidney Research UK (KRUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); NIHR UK(National Institute for Health Research (NIHR)); Fulbright postdoctoral scholar award; Boston Children's Hospital; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS))	We are grateful the families who contributed to this study. We thank Seymour Rosen, Heather J. Cordell, William G. Newman, Stanley Swierzewski III, Frank Croke, John Blanchete, Dicken Ko, Ghaleb Daouk, John Herrin, and the UK VUR Study Group for contributing renal pathology, radiology, and clinical materials. This research was supported by grants from the NIH to R.S.L. (DK096238), to R.P.L. (5U54HG006504), to H.J. (DK 46718), to W.L. (DK078226), and to F.H. (DK088767) and from the March of Dimes to W.L. and F.H. This work was supported by grants from the German Research Foundation (DFG) to S.S.L. within SFB1140 and the Emmy Noether programme and to A.K. by an individual grant (Ki72817-1) and within the Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy) at Hannover Medical School. A.S.W. received project grants from Kidney Research UK, the Medical Research Council (G0600040 and MR/L002744/1), and the Wellcome Trust (066647). H.M.S. was funded by fellowships from NIHR UK and the Wellcome Trust. A.S.W.'s and H.M.S.'s research was facilitated by the Manchester Academic Health Sciences Centre. A.V. is a recipient of a Fulbright postdoctoral scholar award and of a Manton Center fellowship award from Boston Children's Hospital. F.H. and R.P.L. are Investigators of the Howard Hughes Medical Institute. F.H. is the Warren E. Grupe Professor of Pediatrics at Harvard Medical School.	Airik R, 2006, J CLIN INVEST, V116, P663, DOI 10.1172/JCI26027; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bohnenpoll T, 2013, DEV BIOL, V380, P25, DOI 10.1016/j.ydbio.2013.04.036; Bussen M, 2004, GENE DEV, V18, P1209, DOI 10.1101/gad.300104; Chen F, 2009, PEDIATR NEPHROL, V24, P1621, DOI 10.1007/s00467-008-1072-y; El Omari K, 2012, PROTEINS, V80, P655, DOI 10.1002/prot.23208; Farin HF, 2008, J BIOL CHEM, V283, P25372, DOI 10.1074/jbc.M802723200; Farin HF, 2007, J BIOL CHEM, V282, P25748, DOI 10.1074/jbc.M703724200; Halbritter J, 2013, HUM GENET, V132, P865, DOI 10.1007/s00439-013-1297-0; Halbritter J, 2012, J MED GENET, V49, P756, DOI 10.1136/jmedgenet-2012-100973; Hu YF, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008681; Hwang DY, 2014, KIDNEY INT, V85, P1429, DOI 10.1038/ki.2013.508; Ichikawa I, 2002, KIDNEY INT, V61, P889, DOI 10.1046/j.1523-1755.2002.00188.x; Kapoor N, 2013, NAT BIOTECHNOL, V31, P54, DOI 10.1038/nbt.2465; Kohl S, 2014, J AM SOC NEPHROL, V25, P1917, DOI 10.1681/ASN.2013101103; Kraus F, 2001, MECH DEVELOP, V100, P83, DOI 10.1016/S0925-4773(00)00494-9; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; Lu WN, 2007, AM J HUM GENET, V80, P616, DOI 10.1086/512735; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Muller CW, 1997, NATURE, V389, P884, DOI 10.1038/39929; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Nie XG, 2010, DEVELOPMENT, V137, P755, DOI 10.1242/dev.045757; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; Pohl M, 2002, KIDNEY INT, V61, P10, DOI 10.1046/j.1523-1755.2002.00086.x; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Ruf RG, 2004, P NATL ACAD SCI USA, V101, P8090, DOI 10.1073/pnas.0308475101; Saisawat P, 2014, KIDNEY INT, V85, P1310, DOI 10.1038/ki.2013.417; Sanna-Cherchi S, 2013, NEW ENGL J MED, V369, P621, DOI 10.1056/NEJMoa1214479; Sanna-Cherchi S, 2012, AM J HUM GENET, V91, P987, DOI 10.1016/j.ajhg.2012.10.007; Smith JM, 2007, PEDIATR TRANSPLANT, V11, P366, DOI 10.1111/j.1399-3046.2007.00704.x; Vivante A, 2014, PEDIATR NEPHROL, V29, P695, DOI 10.1007/s00467-013-2684-4; Wiese C, 2009, CIRC RES, V104, P388, DOI 10.1161/CIRCRESAHA.108.187062; Woolf AS, 2000, KIDNEY INT, V58, P500, DOI 10.1046/j.1523-1755.2000.00196.x; Xu JS, 2014, DEV BIOL, V391, P17, DOI 10.1016/j.ydbio.2014.04.006	34	49	53	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 6	2015	97	2					291	301		10.1016/j.ajhg.2015.07.001	http://dx.doi.org/10.1016/j.ajhg.2015.07.001			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CO7GY	26235987	Green Published, Bronze			2022-12-18	WOS:000359328800009
J	Johnston, JJ; Lewis, KL; Ng, D; Singh, LN; Wynter, J; Brewer, C; Brooks, BP; Brownell, I; Candotti, F; Gonsalves, SG; Hart, SP; Kong, HH; Rother, KI; Sokolic, R; Solomon, BD; Zein, WM; Cooper, DN; Stenson, PD; Mullikin, JC; Biesecker, LG				Johnston, Jennifer J.; Lewis, Katie L.; Ng, David; Singh, Larry N.; Wynter, Jamila; Brewer, Carmen; Brooks, Brian P.; Brownell, Isaac; Candotti, Fabio; Gonsalves, Steven G.; Hart, Suzanne P.; Kong, Heidi H.; Rother, Kristina I.; Sokolic, Robert; Solomon, Benjamin D.; Zein, Wadih M.; Cooper, David N.; Stenson, Peter D.; Mullikin, James C.; Biesecker, Leslie G.			Individualized Iterative Phenotyping for Genome-wide Analysis of Loss-of-Function Mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISEASE; PROTEIN; VARIANTS	Next-generation sequencing provides the opportunity to practice predictive medicine based on identified variants. Putative loss-of-function (pLOF) variants are common in genomes and understanding their contribution to disease is critical for predictive medicine. To this end, we characterized the consequences of pLOF variants in an exome cohort by iterative phenotyping. Exome data were generated on 951 participants from the ClinSeq cohort and filtered for pLOF variants in genes likely to cause a phenotype in heterozygotes. 103 of 951 exomes had such a pLOF variant and 79 participants were evaluated. Of those 79, 34 had findings or family histories that could be attributed to the variant (28 variants in 18 genes), 2 had indeterminate findings (2 variants in 2 genes), and 43 had no findings or a negative family history for the trait (34 variants in 28 genes). The presence of a phenotype was correlated with two mutation attributes: prior report of pathogenicity for the variant (p = 0.0001) and prior report of other mutations in the same exon (p = 0.0001). We conclude that 1/30 unselected individuals harbor a pLOF mutation associated with a phenotype either in themselves or their family. This is more common than has been assumed and has implications for the setting of prior probabilities of affection status for predictive medicine.	[Johnston, Jennifer J.; Lewis, Katie L.; Ng, David; Singh, Larry N.; Wynter, Jamila; Candotti, Fabio; Gonsalves, Steven G.; Hart, Suzanne P.; Sokolic, Robert; Solomon, Benjamin D.; Mullikin, James C.; Biesecker, Leslie G.] NHGRI, NIH, Bethesda, MD 20892 USA; [Brewer, Carmen] Natl Inst Deafness & Other Commun Disorders, NIH, Bethesda, MD 20892 USA; [Brooks, Brian P.; Zein, Wadih M.] NEI, NIH, Bethesda, MD 20892 USA; [Brownell, Isaac; Kong, Heidi H.] NCI, NIH, Bethesda, MD 20892 USA; [Rother, Kristina I.] NIDDK, NIH, Bethesda, MD 20892 USA; [Cooper, David N.; Stenson, Peter D.] Cardiff Univ, Inst Med Genet, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Mullikin, James C.; Biesecker, Leslie G.] NIH, Intramural Sequencing Ctr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Cardiff University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Biesecker, LG (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.	lesb@mail.nih.gov	Brownell, Isaac/Q-1937-2018; Sokolic, Robert/E-6224-2017; Gonsalves, Stephen/AAH-5601-2020; Cooper, David N/H-4384-2011; Singh, Larry N./AAG-6880-2021; Kong, Heidi H/L-4856-2018	Sokolic, Robert/0000-0002-3399-7893; Cooper, David N/0000-0002-8943-8484; Singh, Larry N./0000-0002-2478-5864; Kong, Heidi H/0000-0003-4424-064X; Candotti, Fabio/0000-0001-6399-6042	National Human Genome Research Institute; National Cancer Institute; National Eye Institute; National Institute of Deafness and Other Communication Disorders; National Institute of Diabetes and Digestive and Kidney Diseases of the NIH; BIOBASE/Qiagen; Cardiff University; NATIONAL EYE INSTITUTE [ZIEEY000477] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG000196, ZIAHG200330, ZIAHG200359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000064] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of Diabetes and Digestive and Kidney Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); BIOBASE/Qiagen; Cardiff University; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The study described here was supported by the Intramural Research Programs of the National Human Genome Research Institute, the National Cancer Institute, the National Eye Institute, the National Institute of Deafness and Other Communication Disorders, and the National Institute of Diabetes and Digestive and Kidney Diseases of the NIH. L.G.B. is an uncompensated advisor to the Illumina Corp. and receives royalties from Genentech Corp. D.N.C. and P.D.S. acknowledge receipt of funding from BIOBASE/Qiagen through a License Agreement with Cardiff University. The authors thank Michael Collins, Julia Fekecs, Travis Hyams, Irini Manoli, and Frances Wright for support and advice.	Ahituv N, 2007, AM J HUM GENET, V80, P779, DOI 10.1086/513471; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Biesecker LG, 2013, GENOME RES, V23, P1051, DOI 10.1101/gr.157826.113; Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109; Facio FM, 2010, GENET MED, V12, P370, DOI 10.1097/GIM.0b013e3181e15bd5; Gerrits MCF, 2009, EUR J PAEDIATR NEURO, V13, P178, DOI 10.1016/j.ejpn.2008.03.007; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Jamsheer A, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-4; Johnston JJ, 2012, AM J HUM GENET, V91, P97, DOI 10.1016/j.ajhg.2012.05.021; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Singh KK, 2013, J THORAC CARDIOV SUR, V146, P949, DOI 10.1016/j.jtcvs.2012.12.064; Suleiman L, 2013, CRIT REV ONCOL HEMAT, V88, P637, DOI 10.1016/j.critrevonc.2013.07.004; Teer JK, 2012, BIOINFORMATICS, V28, P599, DOI 10.1093/bioinformatics/btr711; Teer JK, 2010, GENOME RES, V20, P1420, DOI 10.1101/gr.106716.110; Thomas AQ, 2002, AM J RESP CRIT CARE, V165, P1322, DOI 10.1164/rccm.200112-123OC; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015	19	49	52	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 4	2015	96	6					913	925		10.1016/j.ajhg.2015.04.013	http://dx.doi.org/10.1016/j.ajhg.2015.04.013			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CK0YH	26046366	Bronze, Green Published			2022-12-18	WOS:000355931200005
J	Sergouniotis, PI; Chakarova, C; Murphy, C; Becker, M; Lenassi, E; Arno, G; Lek, M; MacArthur, DG; Bhattacharya, SS; Moore, AT; Holder, GE; Robson, AG; Wolfrum, U; Webster, AR; Plagnol, V				Sergouniotis, Panagiotis I.; Chakarova, Christina; Murphy, Cian; Becker, Mirjana; Lenassi, Eva; Arno, Gavin; Lek, Monkol; MacArthur, Daniel G.; Bhattacharya, Shomi S.; Moore, Anthony T.; Holder, Graham E.; Robson, Anthony G.; Wolfrum, Uwe; Webster, Andrew R.; Plagnol, Vincent		UCL-Exomes Consortium	Biallelic Variants in TTLL5, Encoding a Tubulin Glutamylase, Cause Retinal Dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA-SEQUENCING DATA; GLUCOCORTICOID-RECEPTOR; PROTEIN; CILIA; POLYGLUTAMYLATION; GENE; DEGENERATION; CILIOPATHIES; ASSOCIATION; MECHANISMS	In a subset of inherited retinal degenerations (including cone, cone-rod, and macular dystrophies), cone photoreceptors are more severely affected than rods; ABCA4 mutations are the most common cause of this heterogeneous class of disorders. To identify retinal-disease-associated genes, we performed exome sequencing in 28 individuals with "cone-first" retinal disease and clinical features atypical for ABCA4 retinopathy. We then conducted a gene-based case-control association study with an internal exome data set as the control group. TILLS, encoding a tubulin glutamylase, was highlighted as the most likely disease-associated gene; 2 of 28 affected subjects harbored presumed loss-of-function variants: c.[1586_1589delAGAG];[1586_1589delAGAG], p.[Glu529Valfs(star)2];[Glu529Valfs(star)2], and c.[401delT(;) 3354G>A], p.[Leu134Argfs(star)45(;)Trp1118(star)]. We then inspected previously collected exome sequence data from individuals with related phenotypes and found two siblings with homozygous nonsense variant c.1627G>T (p.Glu543(star)) in TILLS. Subsequently, we tested a panel of 55 probands with retinal dystrophy for TILLS mutations; one proband had a homozygous missense change (c.1627G>A [p.Glu543Lys]). The retinal phenotype was highly similar in three of four families; the sibling pair had a more severe, early-onset disease. In human and murine retinae, TTLL5 localized to the centrioles at the base of the connecting cilium. TILLS has been previously reported to be essential for the correct function of sperm flagella-in mice and play a role in polyglutamylation of primary cilia in vitro. Notably, genes involved in the polyglutamylation and deglutamylation of tubulin have been associated with photoreceptor degeneration in mice. The electrophysiological and fundus autofluorescence imaging presented here should facilitate the molecular diagnosis in further families.	[Sergouniotis, Panagiotis I.; Chakarova, Christina; Lenassi, Eva; Arno, Gavin; Bhattacharya, Shomi S.; Moore, Anthony T.; Holder, Graham E.; Robson, Anthony G.; Webster, Andrew R.] UCL Inst Ophthalmol, London EC1V 9EL, England; [Sergouniotis, Panagiotis I.; Lenassi, Eva; Moore, Anthony T.; Holder, Graham E.; Robson, Anthony G.; Webster, Andrew R.] Moorfields Eye Hosp, London EC1V 2PD, England; [Murphy, Cian; Plagnol, Vincent] UCL Genet Inst, London WC1E 6BT, England; [Becker, Mirjana; Wolfrum, Uwe] Johannes Gutenberg Univ Mainz, Inst Zool, Focus Program Translat Neurosci, D-55099 Mainz, Germany; [Lek, Monkol; MacArthur, Daniel G.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Lek, Monkol; MacArthur, Daniel G.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA	University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Johannes Gutenberg University of Mainz; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Webster, AR (corresponding author), UCL Inst Ophthalmol, London EC1V 9EL, England.	andrew.webster@ucl.ac.uk	Bhattacharya, Shom/N-2926-2016; Murphy, Cian/N-4343-2019	Bhattacharya, Shom/0000-0002-1601-6344; Murphy, Cian/0000-0003-1356-959X; Robson, Anthony/0000-0002-8391-6123; Sergouniotis, Panos/0000-0003-0986-4123; MacArthur, Daniel/0000-0002-5771-2290; Plagnol, Vincent/0000-0002-5597-9215	Macular Society UK; UK National Institute for Health Research (Biomedical Research Centre); RP Fighting Blindness; Fight for Sight (including the Mercer Fund); US Foundation Fighting Blindness; UK Medical Research Council; Wellcome Trust; German Ministry of Education and Research ("HOPE2"); FAUN-Stiftung; European Commission [EC FP7/2009/241955]; NIH National Institute of General Medical Sciences [1R01GM104371]; UK National Institute for Health Research (Moorfields Eye Hospital); UK National Institute for Health Research (Institute of Ophthalmology); National Institute for Health Research [NF-SI-0507-10204, ACF-2013-06-009] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104371] Funding Source: NIH RePORTER	Macular Society UK; UK National Institute for Health Research (Biomedical Research Centre)(National Institute for Health Research (NIHR)); RP Fighting Blindness; Fight for Sight (including the Mercer Fund); US Foundation Fighting Blindness; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); German Ministry of Education and Research ("HOPE2"); FAUN-Stiftung; European Commission(European CommissionEuropean Commission Joint Research Centre); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); UK National Institute for Health Research (Moorfields Eye Hospital); UK National Institute for Health Research (Institute of Ophthalmology); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the cooperation and help provided by the family members in this study. We are grateful to colleagues who referred affected individuals to us at Moorfields Eye Hospital and to those who contributed to the assembly of the cone-rod and macular dystrophy panel, particularly Kaoru Fujinami, Alice Davidson, Alan Bird, Michel Michaelides, Genevieve Wright, Sophie Devery, Ravinder Chana, Beverley Scott, and Naushin Waseem. We thank our colleagues from the cornea bank of the Department of Ophthalmology at Johannes Gutenberg University Mainz for providing the human donor eye and our colleagues at University College London for kindly contributing to the UCL-exomes Control panel. We acknowledge the following sources of funding: Macular Society UK (www.maculardisease.org), the UK National Institute for Health Research (Biomedical Research Centre, Moorfields Eye Hospital, and Institute of Ophthalmology), RP Fighting Blindness, Fight for Sight (including the Mercer Fund), the US Foundation Fighting Blindness; the UK Medical Research Council, the Wellcome Trust, the German Ministry of Education and Research ("HOPE2"), FAUN-Stiftung, and the European Commission Seventh Framework Program (EC FP7/2009/241955, SYSCILIA). D.G.M. and M.L. were funded by the NIH National Institute of General Medical Sciences under award 1R01GM104371.	Awasthi S, 2012, MOL CELL ENDOCRINOL, V355, P121, DOI 10.1016/j.mce.2012.02.001; Bach M, 2013, DOC OPHTHALMOL, V126, P1, DOI 10.1007/s10633-012-9353-y; Backer CB, 2012, MOL BIOL CELL, V23, P2122, DOI 10.1091/mbc.E11-11-0931; Bobinnec Y, 1998, J CELL BIOL, V143, P1575, DOI 10.1083/jcb.143.6.1575; Chakarova CF, 2011, HUM MOL GENET, V20, P975, DOI 10.1093/hmg/ddq543; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Drexler W, 2008, PROG RETIN EYE RES, V27, P45, DOI 10.1016/j.preteyeres.2007.07.005; EDDE B, 1990, SCIENCE, V247, P83, DOI 10.1126/science.1967194; Estrada-Cuzcano A, 2012, HUM MOL GENET, V21, pR111, DOI 10.1093/hmg/dds298; Evans RJ, 2010, HUM MOL GENET, V19, P1358, DOI 10.1093/hmg/ddq012; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Grau MB, 2013, J CELL BIOL, V202, P441, DOI 10.1083/jcb.201305041; He YZ, 2007, MOL CELL BIOL, V27, P1467, DOI 10.1128/MCB.01360-06; Ikegami K, 2010, P NATL ACAD SCI USA, V107, P10490, DOI 10.1073/pnas.1002128107; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Janke C, 2008, EMBO REP, V9, P636, DOI 10.1038/embor.2008.114; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Lee GS, 2013, J BIOL CHEM, V288, P15167, DOI 10.1074/jbc.M113.453936; Maerker T, 2008, HUM MOL GENET, V17, P71, DOI 10.1093/hmg/ddm285; Marchena M, 2011, EXP EYE RES, V93, P607, DOI 10.1016/j.exer.2011.07.010; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Maugeri A, 2000, AM J HUM GENET, V67, P960, DOI 10.1086/303079; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Overlack N, 2011, BBA-MOL CELL RES, V1813, P1883, DOI 10.1016/j.bbamcr.2011.05.015; Pathak N, 2007, MOL BIOL CELL, V18, P4353, DOI 10.1091/mbc.E07-06-0537; Pathak N, 2011, J BIOL CHEM, V286, P11685, DOI 10.1074/jbc.M110.209817; Pearson RD, 2011, NAT GENET, V43, P392, DOI 10.1038/ng.816; Roepman Ronald, 2007, V43, P209, DOI 10.1007/978-1-4020-5943-8_10; Rogowski K, 2010, CELL, V143, P564, DOI 10.1016/j.cell.2010.10.014; Schmitz-Valckenberg S, 2008, RETINA-J RET VIT DIS, V28, P385, DOI 10.1097/IAE.0b013e318164a907; Sheffield VC, 2011, NEW ENGL J MED, V364, P1932, DOI 10.1056/NEJMra1012354; Van Dijk J, 2008, J BIOL CHEM, V283, P3915, DOI 10.1074/jbc.M705813200; van Dijk J, 2007, MOL CELL, V26, P437, DOI 10.1016/j.molcel.2007.04.012; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zach F, 2012, HUM MOL GENET, V21, P4573, DOI 10.1093/hmg/dds268	38	49	51	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 1	2014	94	5					760	769		10.1016/j.ajhg.2014.04.003	http://dx.doi.org/10.1016/j.ajhg.2014.04.003			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG5VB	24791901	Green Published, hybrid			2022-12-18	WOS:000335485700010
J	Gamsiz, ED; Viscidi, EW; Frederick, AM; Nagpal, S; Sanders, SJ; Murtha, MT; Schmidt, M; Triche, EW; Geschwind, DH; State, MW; Istrail, S; Cook, EH; Devlin, B; Morrow, EM				Gamsiz, Ece D.; Viscidi, Emma W.; Frederick, Abbie M.; Nagpal, Shailender; Sanders, Stephan J.; Murtha, Michael T.; Schmidt, Michael; Triche, Elizabeth W.; Geschwind, Daniel H.; State, Matthew W.; Istrail, Sorin; Cook, Edwin H., Jr.; Devlin, Bernie; Morrow, Eric M.		Simons Simplex Collection Genetics	Intellectual Disability Is Associated with Increased Runs of Homozygosity in Simplex Autism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUTATIONS; IDENTIFICATION; DISORDERS; GENETICS; TRAPPC9; PROTEIN	Intellectual disability (ID), often attributed to autosomal-recessive mutations, occurs in 40% of autism spectrum disorders (ASDs). For this reason, we conducted a genome-wide analysis of runs of homozygosity (ROH) in simplex ASD-affected families consisting of a proband diagnosed with ASD and at least one unaffected sibling. In these families, probands with an IQ <= 70 show more ROH than their unaffected siblings, whereas probands with an IQ > 70 do not show this excess. Although ASD is far more common in males than in females, the proportion of females increases with decreasing IQ. Our data do support an association between ROH burden and autism diagnosis in girls; however, we are not able to show that this effect is independent of low IQ. We have also discovered several autism candidate genes on the basis of finding (1) a single gene that is within an ROH interval and that is recurrent in autism or (2) a gene that is within an autism ROH block and that harbors a homozygous, rare deleterious variant upon analysis of exome-sequencing data. In summary, our data suggest a distinct genetic architecture for participants with autism and co-occurring intellectual disability and that this architecture could involve a role for recessively inherited loci for this autism subgroup.	[Gamsiz, Ece D.; Viscidi, Emma W.; Frederick, Abbie M.; Nagpal, Shailender; Schmidt, Michael; Morrow, Eric M.] Brown Univ, Mol Med Lab, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Gamsiz, Ece D.; Viscidi, Emma W.; Frederick, Abbie M.; Nagpal, Shailender; Schmidt, Michael; Morrow, Eric M.] Brown Univ, Inst Brain Sci, Providence, RI 02912 USA; [Gamsiz, Ece D.; Schmidt, Michael; Morrow, Eric M.] Emma Pendleton Bradley Hosp, Dev Disorders Genet Res Program, East Providence, RI 02915 USA; [Gamsiz, Ece D.; Schmidt, Michael; Morrow, Eric M.] Brown Univ, East Providence, RI 02915 USA; [Gamsiz, Ece D.; Schmidt, Michael; Morrow, Eric M.] Brown Univ, Sch Med, Dept Psychiat & Human Behav, East Providence, RI 02915 USA; [Gamsiz, Ece D.] Rhode Isl Hosp, Norman Prince Neurosci Inst, Providence, RI 02903 USA; [Viscidi, Emma W.; Triche, Elizabeth W.] Brown Univ, Dept Epidemiol, Providence, RI 02912 USA; [Sanders, Stephan J.; Murtha, Michael T.; State, Matthew W.] Yale Univ, Sch Med, Program Neurogenet, New Haven, CT 06520 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Program Neurogenet, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Istrail, Sorin] Brown Univ, Dept Comp Sci, Ctr Computat Mol Biol, Providence, RI 02912 USA; [Cook, Edwin H., Jr.] Univ Illinois, Dept Psychiat, Inst Juvenile Res, Chicago, IL 60608 USA; [Devlin, Bernie] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA	Brown University; Brown University; Brown University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Yale University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Brown University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Morrow, EM (corresponding author), Brown Univ, Mol Med Lab, Dept Mol Biol Cell Biol & Biochem, 70 Ship St, Providence, RI 02912 USA.	eric_morrow@brown.edu	Morrow, Eric/J-2767-2013; Grice, Dorothy E/X-3372-2019; Sanders, Stephan/S-8645-2019; Triche, Elizabeth/I-4986-2014; Fombonne, Eric/M-4893-2018; Sutcliffe, James S/C-1348-2012; State, Matthew/W-2256-2019	Morrow, Eric/0000-0003-3430-3520; Grice, Dorothy E/0000-0002-8833-2549; Fombonne, Eric/0000-0002-8605-3538; Sutcliffe, James S/0000-0001-5200-6007; Gamsiz Uzun, Ece Dilber/0000-0003-4068-7153; State, Matthew/0000-0003-1624-8302; Sanders, Stephan/0000-0001-9112-5148	Simons Foundation Autism Research Initiative (SFARI) grant [124827EM]; Burroughs Wellcome Fund; National Institutes of Health grant [5K23MH080954-05]; Brown Institute for Brain Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD055782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103410, T32GM007601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH080954] Funding Source: NIH RePORTER	Simons Foundation Autism Research Initiative (SFARI) grant; Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brown Institute for Brain Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by Simons Foundation Autism Research Initiative (SFARI) grant 124827EM to E.M.M. We are grateful to all of the families at the participating Simons Simplex Collection (SSC) sites, as well as the principal investigators (A.L. Beaudet, R. Bernier, J. Constantino, E.H.C., Jr., E. Fombonne, D.H.G., E. . Hanson, D.E. Grice, A. Klin, R. Kochel, D. Ledbetter, C. Lord, C. Martin, D.M. Martin, R. Maxim, J. Miles, O. Ousley, K. Pelphrey, B. Peterson, J. Piggot, C. Saulnier, M.W.S., W. Stone, J.S. Sutcliffe, C.A. Walsh, Z. Warren, and E. Wijsman). We appreciate obtaining . access to phenotypic data in SFARI Base. Approved researchers can obtain the SSC population data set described in this study by applying at https://base.sfari.org. E.M.M. was also supported by the Career Award in Medical Science from the Burroughs Wellcome Fund and National Institutes of Health grant 5K23MH080954-05. E.D.G. is the first Brown University Alpert Medical School Translational Neuroscience Postdoctoral Fellow . jointly sponsored by the Lifespan Research Institute, the Lifespan Division of Psychiatry, the Brown Institute for Brain Science, and the Norman Prince Neurosciences Institute. E.W.V. receives partial support from the Brown Institute for Brain Science. We would like to acknowledge the strong collaborations of the SSC Genetics Consortium, led by M.W.S. and also including B.D., J.S. Sutcliffe, . C.A. Walsh, D.H.G., E.H.C., Jr, R.M. Cantor, D.E. Grice, A.L. Beaudet, D.M. Martin, and E.M.M.	Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Amiet C, 2008, BIOL PSYCHIAT, V64, P577, DOI 10.1016/j.biopsych.2008.04.030; Baio Jon, 2012, Morbidity and Mortality Weekly Report, V61, P1; Basel-Vanagaite L, 2007, CLIN GENET, V72, P167, DOI 10.1111/j.1399-0004.2007.00881.x; Casey JP, 2012, HUM GENET, V131, P565, DOI 10.1007/s00439-011-1094-6; Chahrour MH, 2012, PLOS GENET, V8, P236, DOI 10.1371/journal.pgen.1002635; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Mir A, 2009, AM J HUM GENET, V85, P909, DOI 10.1016/j.ajhg.2009.11.009; Mochida GH, 2009, AM J HUM GENET, V85, P897, DOI 10.1016/j.ajhg.2009.10.027; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Morrow EM, 2010, J AM ACAD CHILD PSY, V49, P1091, DOI 10.1016/j.jaac.2010.08.009; Novarino G, 2012, SCIENCE, V338, P394, DOI 10.1126/science.1224631; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Philippe O, 2009, AM J HUM GENET, V85, P903, DOI 10.1016/j.ajhg.2009.11.007; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ropers HH, 2008, CURR OPIN GENET DEV, V18, P241, DOI 10.1016/j.gde.2008.07.008; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Wang LS, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-134	22	49	51	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 11	2013	93	1					103	109		10.1016/j.ajhg.2013.06.004	http://dx.doi.org/10.1016/j.ajhg.2013.06.004			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	183HG	23830515	Bronze, Green Published			2022-12-18	WOS:000321804500009
J	Stuart, HM; Roberts, NA; Burgu, B; Daly, SB; Urquhart, JE; Bhaskar, S; Dickerson, JE; Mermerkaya, M; Silay, MS; Lewis, MA; Olondriz, MBO; Gener, B; Beetz, C; Varga, RE; Gulpinar, O; Suer, E; Soygur, T; Ozcakar, ZB; Yalcinkaya, F; Kavaz, A; Bulum, B; Gucuk, A; Yue, WW; Erdogan, F; Berry, A; Hanley, NA; McKenzie, EA; Hilton, EN; Woolf, AS; Newman, WG				Stuart, Helen M.; Roberts, Neil A.; Burgu, Berk; Daly, Sarah B.; Urquhart, Jill E.; Bhaskar, Sanjeev; Dickerson, Jonathan E.; Mermerkaya, Murat; Silay, Mesrur Selcuk; Lewis, Malcolm A.; Orive Olondriz, M. Beatriz; Gener, Blanca; Beetz, Christian; Varga, Rita E.; Gulpinar, Omer; Suer, Evren; Soygur, Tarkan; Ozcakar, Zeynep B.; Yalcinkaya, Fatos; Kavaz, Asli; Bulum, Burcu; Gucuk, Adnan; Yue, Wyatt W.; Erdogan, Firat; Berry, Andrew; Hanley, Neil A.; McKenzie, Edward A.; Hilton, Emma N.; Woolf, Adrian S.; Newman, William G.			LRIG2 Mutations Cause Urofacial Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OCHOA-SYNDROME; IMMUNOHISTOCHEMICAL ANALYSIS; HEPARANASE EXPRESSION; URINARY-BLADDER; ADULT RATS; GROWTH; DISEASE; PATIENT; FAMILY; GENE	Urofacial syndrome (UFS) (or Ochoa syndrome) is an autosomal-recessive disease characterized by congenital urinary bladder dysfunction, associated with a significant risk of kidney failure, and an abnormal facial expression upon smiling, laughing, and crying. We report that a subset of UFS-affected individuals have biallelic mutations in LRIG2, encoding leucine-rich repeats and immunoglobulin-like domains 2, a protein implicated in neural cell signaling and tumorigenesis. Importantly, we have demonstrated that rare variants in LRIG2 might be relevant to nonsyndromic bladder disease. We have previously shown that UFS is also caused by mutations in HPSE2, encoding heparanase-2. LRIG2 and heparanase-2 were immunodetected in nerve fascicles growing between muscle bundles within the human fetal bladder, directly implicating both molecules in neural development in the lower urinary tract.	[Stuart, Helen M.; Roberts, Neil A.; Daly, Sarah B.; Urquhart, Jill E.; Bhaskar, Sanjeev; Dickerson, Jonathan E.; Hilton, Emma N.; Newman, William G.] Univ Manchester, Fac Med & Human Sci, Ctr Genet Med, Inst Human Dev, Manchester M13 9WL, Lancs, England; [Stuart, Helen M.; Roberts, Neil A.; Daly, Sarah B.; Urquhart, Jill E.; Bhaskar, Sanjeev; Dickerson, Jonathan E.; Hilton, Emma N.; Newman, William G.] St Marys Hosp, Manchester Acad Hlth Sci Ctr, Manchester M13 9WL, Lancs, England; [Roberts, Neil A.; Lewis, Malcolm A.; Woolf, Adrian S.] Univ Manchester, Fac Med & Human Sci, Ctr Paediat & Child Hlth, Inst Human Dev, Manchester M13 9WL, Lancs, England; [Roberts, Neil A.; Lewis, Malcolm A.; Woolf, Adrian S.] Royal Manchester Childrens Hosp, Manchester Acad Hlth Sci Ctr, Manchester M13 9WL, Lancs, England; [Berry, Andrew; Hanley, Neil A.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Med & Human Sci, Ctr Endocrinol & Diabet,Inst Human Dev, Manchester M13 9WL, Lancs, England; [Burgu, Berk; Mermerkaya, Murat; Gulpinar, Omer; Suer, Evren; Soygur, Tarkan; Ozcakar, Zeynep B.] Ankara Univ, Sch Med, Dept Urol, TR-06100 Ankara, Turkey; [Yalcinkaya, Fatos; Kavaz, Asli; Bulum, Burcu] Ankara Univ, Sch Med, Dept Pediat Nephrol, TR-06100 Ankara, Turkey; [Silay, Mesrur Selcuk] Bezmialem Vakif Univ, Fac Med, Dept Urol, TR-34093 Istanbul, Turkey; [Orive Olondriz, M. Beatriz] Hosp Univ Araba, Serv Pediat, Unidad Nefrol Infantil, Vitoria 01009, Spain; [Gener, Blanca] Hosp Univ Cruces, Serv Genet, Baracaldo 48903, Vizcaya, Spain; [Beetz, Christian; Varga, Rita E.] Jena Univ Hosp, Dept Clin Chem & Lab Med, D-07747 Jena, Germany; [Gucuk, Adnan] Abant Izzet Baysal Univ, Fac Med, Dept Urol, TR-14280 Bolu, Turkey; [Yue, Wyatt W.] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Erdogan, Firat] Medipol Univ, Fac Med, Dept Pediat, TR-34718 Istanbul, Turkey; [McKenzie, Edward A.] Univ Manchester, Fac Life Sci, Prot Express Facil, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England	University of Manchester; University of Manchester; University of Manchester; Royal Manchester Children's Hospital; University of Manchester; University of Manchester; Ankara University; Ankara University; Bezmialem Vakif University; University Hospital of Araba; Hospital Universitario Cruces; Friedrich Schiller University of Jena; Abant Izzet Baysal University; University of Oxford; Istanbul Medipol University; University of Manchester	Newman, WG (corresponding author), Univ Manchester, Fac Med & Human Sci, Ctr Genet Med, Inst Human Dev, Manchester M13 9WL, Lancs, England.	william.newman@manchester.ac.uk	Yalcinkaya, Fatma Fatos/AAI-7277-2020; tufan, aslı kavaz/ABI-3407-2020; Bulum, Burcu/X-4541-2018; Roberts, Neil A/H-6773-2014; Urquhart, Jill/G-2282-2015; Stuart, Helen/G-3535-2015; soygur, tarkan/V-7209-2019; Woolf, Adrian S./AAZ-1075-2020; Ozcakar, Zeynep/AAG-1760-2020; Süer, Evren/AAP-9953-2020	tufan, aslı kavaz/0000-0003-1311-9468; Urquhart, Jill/0000-0002-5788-5511; Stuart, Helen/0000-0003-2569-235X; soygur, tarkan/0000-0001-7014-1798; Woolf, Adrian S./0000-0001-5541-1358; Ozcakar, Zeynep/0000-0002-6376-9189; Roberts, Neil/0000-0002-6955-5536; Burgu, Berk/0000-0003-1546-1179; Beetz, Christian/0000-0001-7061-2895; Hanley, Neil/0000-0003-3234-4038; Newman, William/0000-0002-6382-4678; Hilton, Emma/0000-0002-3750-577X	Wellcome Trust; Kidney Research UK; Kidneys for Life; Manchester Biomedical Research Centre; Kidney Research UK [RP33/2010] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Kidney Research UK(Kidney Research UK (KRUK)); Kidneys for Life; Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Kidney Research UK(Kidney Research UK (KRUK))	H.M.S. is funded through a Wellcome Trust Clinical Training Fellowship. N.A.H. is a Wellcome Trust Senior Fellow in Clinical Science. The study was also funded by project grants from Kidney Research UK and Kidneys for Life and was also supported from the Manchester Biomedical Research Centre.	Adalat S, 2010, PEDIATR NEPHROL, V25, P2247, DOI 10.1007/s00467-010-1578-y; Aydogdu O, 2010, EUR J PEDIATR, V169, P431, DOI 10.1007/s00431-009-1042-9; Benarroch EE, 2010, NEUROLOGY, V75, P1839, DOI 10.1212/WNL.0b013e3181fdabba; Carr IM, 2006, HUM MUTAT, V27, P1041, DOI 10.1002/humu.20383; Claverie-Martin F, 2005, J HUM GENET, V50, P370, DOI 10.1007/s10038-005-0265-5; Cui HX, 2011, BIOCHEM J, V440, P273, DOI 10.1042/BJ20110167; Daly SB, 2010, AM J HUM GENET, V86, P963, DOI 10.1016/j.ajhg.2010.05.006; Emir S, 2011, PEDIATR HEMAT ONCOL, V28, P616, DOI 10.3109/08880018.2011.600803; Ghasimi S, 2012, J NEURO-ONCOL, V108, P435, DOI 10.1007/s11060-012-0856-x; GILPIN SA, 1983, J ANAT, V137, P503; Guo DS, 2004, GENOMICS, V84, P157, DOI 10.1016/j.ygeno.2004.01.013; Hedman H, 2007, EUR J CANCER, V43, P676, DOI 10.1016/j.ejca.2006.10.021; Holmlund C, 2009, NEUROPATHOLOGY, V29, P242, DOI 10.1111/j.1440-1789.2008.00970.x; Homma S, 2009, GENE EXPR PATTERNS, V9, P1, DOI 10.1016/j.gep.2008.09.004; Jenkins D, 2007, J ANAT, V211, P620, DOI 10.1111/j.1469-7580.2007.00808.x; Kerecuk L, 2008, NAT CLIN PRACT NEPHR, V4, P312, DOI 10.1038/ncpneph0807; Lambert HJ, 2011, CLIN J AM SOC NEPHRO, V6, P760, DOI 10.2215/CJN.04580510; Leclair MD, 2010, J PEDIATR UROL, V6, P338, DOI 10.1016/j.jpurol.2010.01.006; Levy-Adam F, 2010, J BIOL CHEM, V285, P28010, DOI 10.1074/jbc.M110.116384; McKenzie E, 2000, BIOCHEM BIOPH RES CO, V276, P1170, DOI 10.1006/bbrc.2000.3586; Natrajan R, 2007, GENE CHROMOSOME CANC, V46, P607, DOI 10.1002/gcc.20446; Navarro FP, 2008, J NEUROCHEM, V105, P34, DOI 10.1111/j.1471-4159.2007.05116.x; OCHOA B, 1987, AM J MED GENET, V27, P661, DOI 10.1002/ajmg.1320270320; Ochoa B, 2004, PEDIATR NEPHROL, V19, P6, DOI 10.1007/s00467-003-1291-1; Pang JF, 2010, AM J HUM GENET, V86, P957, DOI 10.1016/j.ajhg.2010.04.016; Silay MS, 2011, UROLOGY, V78, P1397, DOI 10.1016/j.urology.2011.08.018; Vidal I, 2009, J PEDIATR UROL, V5, P3, DOI 10.1016/j.jpurol.2008.11.004; Wang BF, 2009, CANCER BIOL THER, V8, P1018, DOI 10.4161/cbt.8.11.8375; Weber S, 2011, AM J HUM GENET, V89, P668, DOI 10.1016/j.ajhg.2011.10.007; Zhang Y, 2006, J COMP NEUROL, V494, P345, DOI 10.1002/cne.20811	30	49	51	0	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB 7	2013	92	2					259	264		10.1016/j.ajhg.2012.12.002	http://dx.doi.org/10.1016/j.ajhg.2012.12.002			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	093GL	23313374	Green Published, hybrid, Green Accepted			2022-12-18	WOS:000315179600010
J	Talkowski, ME; Maussion, G; Crapper, L; Rosenfeld, JA; Blumenthal, I; Hanscom, C; Chiang, C; Lindgren, A; Pereira, S; Ruderfer, D; Diallo, AB; Lopez, JP; Turecki, G; Chen, ES; Gigek, C; Harris, DJ; Lip, V; An, Y; Biagioli, M; MacDonald, ME; Lin, M; Haggarty, SJ; Sklar, P; Purcell, S; Kellis, M; Schwartz, S; Shaffer, LG; Natowicz, MR; Shen, YP; Morton, CC; Gusella, JF; Ernst, C				Talkowski, Michael E.; Maussion, Gilles; Crapper, Liam; Rosenfeld, Jill A.; Blumenthal, Ian; Hanscom, Carrie; Chiang, Colby; Lindgren, Amelia; Pereira, Shahrin; Ruderfer, Douglas; Diallo, Alpha B.; Lopez, Juan Pablo; Turecki, Gustavo; Chen, Elizabeth S.; Gigek, Carolina; Harris, David J.; Lip, Va; An, Yu; Biagioli, Marta; MacDonald, Marcy E.; Lin, Michael; Haggarty, Stephen J.; Sklar, Pamela; Purcell, Shaun; Kellis, Manolis; Schwartz, Stuart; Shaffer, Lisa G.; Natowicz, Marvin R.; Shen, Yiping; Morton, Cynthia C.; Gusella, James F.; Ernst, Carl			Disruption of a Large Intergenic Noncoding RNA in Subjects with Neurodevelopmental Disabilities	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE-EXPRESSION; CHROMATIN; REARRANGEMENTS; REVEALS; GENOME	Large intergenic noncoding (linc) RNAs represent a newly described class of ribonucleic acid whose importance in human disease remains undefined. We identified a severely developmentally delayed 16-year-old female with karyotype 46,XX,t(2;11)(p25.1;p15.1)dn in the absence of clinically significant copy number variants (CNVs). DNA capture followed by next-generation sequencing of the translocation breakpoints revealed disruption of a single noncoding gene on chromosome 2, LINC00299, whose RNA product is expressed in all tissues measured, but most abundantly in brain. Among a series of additional, unrelated subjects referred for clinical diagnostic testing who showed CNV affecting this locus, we identified four with exon-crossing deletions in association with neurodevelopmental abnormalities. No disruption of the LINC00299 coding sequence was seen in almost 14,000 control subjects. Together, these subjects with disruption of LINC00299 implicate this particular noncoding RNA in brain development and raise the possibility that, as a class, abnormalities of lincRNAs may play a significant role in human developmental disorders.	[Maussion, Gilles; Crapper, Liam; Diallo, Alpha B.; Lopez, Juan Pablo; Turecki, Gustavo; Chen, Elizabeth S.; Gigek, Carolina; Ernst, Carl] McGill Univ, Douglas Hosp, Res Inst, Dept Psychiat, Quebec City, ON H4H 1R3, Canada; [Talkowski, Michael E.; Blumenthal, Ian; Hanscom, Carrie; Chiang, Colby; Biagioli, Marta; MacDonald, Marcy E.; Haggarty, Stephen J.; Purcell, Shaun; Shen, Yiping; Ernst, Carl] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Talkowski, Michael E.; Biagioli, Marta; MacDonald, Marcy E.; Haggarty, Stephen J.; Gusella, James F.] Harvard Univ, Dept Neurol & Genet, Boston, MA 02114 USA; [Talkowski, Michael E.; MacDonald, Marcy E.; Lin, Michael; Purcell, Shaun; Kellis, Manolis; Morton, Cynthia C.; Gusella, James F.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02114 USA; [Rosenfeld, Jill A.; Shaffer, Lisa G.] Signature Genom Inc, PerkinElmer, Spokane, WA 99207 USA; [Lindgren, Amelia; Pereira, Shahrin; Morton, Cynthia C.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; [Lindgren, Amelia; Pereira, Shahrin; Morton, Cynthia C.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Ruderfer, Douglas; Sklar, Pamela; Purcell, Shaun] Mt Sinai Sch Med, Dept Psychiat & Genet, New York, NY 10029 USA; [Ruderfer, Douglas; Sklar, Pamela; Purcell, Shaun] Mt Sinai Sch Med, Dept Genom Sci, New York, NY 10029 USA; [Harris, David J.; Lip, Va; An, Yu; Shen, Yiping] Harvard Univ, Sch Med, Dept Lab Med, Boston Childrens Hosp, Boston, MA 02115 USA; [Harris, David J.; Lip, Va; Shen, Yiping] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [An, Yu] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [An, Yu] Fudan Univ, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Lin, Michael; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02114 USA; [Schwartz, Stuart] Genzyme Genet Inc, Labcorp, Res Triangle Pk, NC 27709 USA; [Natowicz, Marvin R.] Cleveland Clin, Inst Pathol & Lab Med, Cleveland, OH 44195 USA; [Natowicz, Marvin R.] Cleveland Clin, Inst Genom Med, Cleveland, OH 44195 USA; [Shen, Yiping] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Shanghai 200127, Peoples R China; [Natowicz, Marvin R.] Cleveland Clin, Inst Neurol & Pediat, Cleveland, OH 44195 USA	McGill University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Fudan University; Fudan University; Massachusetts Institute of Technology (MIT); Sanofi-Aventis; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Shanghai Jiao Tong University; Cleveland Clinic Foundation	Ernst, C (corresponding author), McGill Univ, Douglas Hosp, Res Inst, Dept Psychiat, Quebec City, ON H4H 1R3, Canada.	carl.ernst@mcgill.ca	Kellis, Manolis/ABE-7385-2020; Lopez, Juan Pablo/AAM-5727-2021; Chen, Elizabeth Suchi/CAF-4285-2022; Maussion, Gilles/AAA-2027-2021; Haggarty, Stephen J/M-9495-2016; Turecki, Gustavo/K-5100-2015; Chen, Elizabeth/G-1598-2012; Lopez, Juan Pablo/ABF-2377-2020; Ruderfer, Douglas M/M-5795-2016	Kellis, Manolis/0000-0001-7113-9630; Chen, Elizabeth Suchi/0000-0002-3573-0164; Maussion, Gilles/0000-0001-5785-6238; Haggarty, Stephen J/0000-0002-7872-168X; Chen, Elizabeth/0000-0002-3573-0164; Lopez, Juan Pablo/0000-0002-5812-4220; Ruderfer, Douglas M/0000-0002-2365-386X; Biagioli, Marta/0000-0001-8295-8025; Chiang, Colby/0000-0002-4113-6065; Talkowski, Michael/0000-0003-2889-0992; Gigek, Carolina/0000-0003-4857-687X; Turecki, Gustavo/0000-0003-4075-2736	NIH [GM061354, HD065286, K99MH095867, R33MH087896]; Simons Foundation for Autism Research; Nancy Lurie Marks Family Foundation; Canada Institute of Health Research Canada Research Chair in Psychiatric Genetics; Div Of Biological Infrastructure [0644282] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD065286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH095867, R33MH087896] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation for Autism Research; Nancy Lurie Marks Family Foundation; Canada Institute of Health Research Canada Research Chair in Psychiatric Genetics; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the subjects and their families for participating in this study. This work was funded by NIH GM061354 (J.F.G. and C.C.M.), HD065286 (J.F.G.), K99MH095867 (M.E.T.), and R33MH087896 (S.J.H.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. M.E.T. and J.F.G. are supported by the Simons Foundation for Autism Research and the Nancy Lurie Marks Family Foundation. C.E. is funded by a Canada Institute of Health Research Canada Research Chair in Psychiatric Genetics.	Burd CE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001233; Chiang C, 2012, NAT GENET, V44, P390, DOI 10.1038/ng.2202; Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Higgins AW, 2008, AM J HUM GENET, V82, P712, DOI 10.1016/j.ajhg.2008.01.011; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Sheridan SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026203; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Talkowski ME, 2011, AM J HUM GENET, V88, P469, DOI 10.1016/j.ajhg.2011.03.013; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819	15	49	50	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC 7	2012	91	6					1128	1134		10.1016/j.ajhg.2012.10.016	http://dx.doi.org/10.1016/j.ajhg.2012.10.016			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	055LI	23217328	Green Published, Bronze			2022-12-18	WOS:000312417400018
J	Dauber, A; Yu, YG; Turchin, MC; Chiang, CW; Meng, YA; Demerath, EW; Patel, SR; Rich, SS; Rotter, JI; Schreiner, PJ; Wilson, JG; Shen, YP; Wu, BL; Hirschhorn, JN				Dauber, Andrew; Yu, Yongguo; Turchin, Michael C.; Chiang, Charleston W.; Meng, Yan A.; Demerath, Ellen W.; Patel, Sanjay R.; Rich, Stephen S.; Rotter, Jerome I.; Schreiner, Pamela J.; Wilson, James G.; Shen, Yiping; Wu, Bai-Lin; Hirschhorn, Joel N.			Genome-wide Association of Copy-Number Variation Reveals an Association between Short Stature and the Presence of Low-Frequency Genomic Deletions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMMON	Height is a model polygenic trait that is highly heritable. Genome-wide association studies have identified hundreds of single-nucleotide polymorphisms associated with stature, but the role of structural variation in determining height is largely unknown. We performed a genome-wide association study of copy-number variation and stature in a clinical cohort of children who had undergone comparative genomic hybridization (CGH) microarray analysis for clinical indications. We found that subjects with short stature had a greater global burden of copy-number variants (CNVs) and a greater average CNV length than did controls (p<0.002). These associations were present for lower-frequency (<5%) and rare (<1%) deletions, but there were no significant associations seen for duplications. Known gene-deletion syndromes did not account for our findings, and we saw no significant associations with tall stature. We then extended our findings into a population-based cohort and found that, in agreement with the clinical cohort study, an increased burden of lower-frequency deletions was associated with shorter stature (p = 0.015). Our results suggest that in individuals undergoing copy-number analysis for clinical indications, short stature increases the odds that a low-frequency deletion will be found. Additionally, copy-number variation might contribute to genetic variation in stature in the general population.	[Yu, Yongguo; Shen, Yiping] Jiao Tong Univ, Shanghai Childrens Med Ctr, Shanghai 200127, Peoples R China; [Dauber, Andrew; Hirschhorn, Joel N.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Dauber, Andrew; Turchin, Michael C.; Chiang, Charleston W.; Meng, Yan A.; Hirschhorn, Joel N.] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02141 USA; [Turchin, Michael C.; Chiang, Charleston W.; Meng, Yan A.; Hirschhorn, Joel N.] Broad Inst, Metab Program, Cambridge, MA 02141 USA; [Dauber, Andrew] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Clin Investigator Training Program, Boston, MA 02115 USA; [Yu, Yongguo; Shen, Yiping; Wu, Bai-Lin] Childrens Hosp Boston, Dept Lab Med, Boston, MA 02115 USA; [Shen, Yiping; Wu, Bai-Lin] Childrens Hosp Boston, Dept Pathol, Boston, MA 02115 USA; [Turchin, Michael C.; Chiang, Charleston W.; Hirschhorn, Joel N.] Childrens Hosp Boston, Div Genet, Boston, MA 02115 USA; [Turchin, Michael C.; Chiang, Charleston W.; Hirschhorn, Joel N.] Childrens Hosp Boston, Ctr Basic & Translat Obes Res, Boston, MA 02115 USA; [Chiang, Charleston W.; Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Demerath, Ellen W.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Patel, Sanjay R.] Brigham & Womens Hosp, Div Sleep Med, Boston, MA 02115 USA; [Rich, Stephen S.] Univ Virginia, Charlottesville, VA 22908 USA; [Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Schreiner, Pamela J.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Wilson, James G.] Univ Mississippi, Dept Physiol & Biophys, Med Ctr, Jackson, MS 39216 USA; [Wu, Bai-Lin] Fudan Univ, Childrens Hosp, Shanghai 200032, Peoples R China; [Wu, Bai-Lin] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China	Shanghai Jiao Tong University; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Brigham & Women's Hospital; University of Virginia; Cedars Sinai Medical Center; University of Minnesota System; University of Minnesota Twin Cities; University of Mississippi; University of Mississippi Medical Center; Fudan University; Fudan University	Shen, YP (corresponding author), Jiao Tong Univ, Shanghai Childrens Med Ctr, Shanghai 200127, Peoples R China.	yiping.shen@childrens.harvard.edu; joelh@broadinstitute.org	Rotter, Jerome/AAY-6598-2021; Chiang, Charleston W. K./H-3169-2019	Chiang, Charleston W. K./0000-0002-0668-7865; yu, yongguo/0000-0002-4472-0910; Rich, Stephen/0000-0003-3872-7793; Turchin, Michael/0000-0003-3569-1529; Patel, Sanjay/0000-0002-9142-5172; Demerath, Ellen/0000-0002-4585-4064; Schreiner, Pamela/0000-0002-9920-6257	March of Dimes [6-FY09-507]; National Basic Research Program of China (973 Program) [2010CB529601]; Science and Technology Council of Shanghai [09JC1402400, 09ZR1404500]; National Heart, Lung, and Blood Institute;  [N01-HC-55015];  [N01-HC-55016];  [N01-HC-55018];  [N01-HC-55019];  [N01-HC-55020];  [N01-HC-55021];  [N01-HC-55022];  [R01HL087641];  [R01HL59367];  [R01HL086694];  [RC2 HL102419];  [U01HG004402];  [HHSN268200625226C];  [UL1RR025005];  [N01-HC-95095];  [N01-HC-48047];  [N01-HC-48048];  [N01-HC-48049];  [N01-HC-48050];  [N01-HC-45134];  [N01-HC-05187];  [N01-HC-45205];  [N01-HC-45204];  [HL46380-01-16];  [N01-HC-95170];  [N01-HC-95171];  [N01-HC-95172];  [N01 HC-95159];  [N01-HC-95160];  [N01-HC-95161];  [N01-HC-95162];  [N01-FIC-95163];  [N01-HC-95164];  [N01-HC-95165];  [N01-HC-95166];  [N01-HC-95167];  [N01-HC-95168];  [N01-HC-95169];  [RR-024156];  [5RC1HL099911];  [1DP3DK085695]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095171, N01HC095166, N01HC055016, N01HC048049, N01HC095161, N01HC095162, N01HC095159, N01HC095168, N01HC095165, N01HC055015, N01HC095167, N01HC045134, N01HC055021, N01HC055018, N01HC048047, N01HC095170, N01HC048050, N01HC005187, N01HC055022, N01HC095095, N01HC095164, N01HC055020, N01HC095160, N01HC095172, N01HC095169, N01HC048048, N01HC095163] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005, UL1RR024156] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095163, R43HL095169, R01HL048050, R43HL095161, RC2HL102419, R01HL086694, R21HL095165, R13HL095166, R01HL046380, RC1HL099911, R44HL095169, R29HL048048, R01HL048048, R01HL048049, R41HL095172, R43HL095167, R01HL065226, R41HL055018, R01HL059367, R43HL095160, R42HL055018, R41HL055019, R01HL087641] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK085695] Funding Source: NIH RePORTER	March of Dimes(March of Dimes); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Science and Technology Council of Shanghai; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank Guillaume Lettre and the CARe anthropometric working group for generating the height Z scores for the CARe cohort. We would like to thank Steve McCaroll, Joshua Korn, and James Nemesh for their assistance in calling the CNVs in the CARe cohorts. Funding for the work with the clinical cohort was supported by the March of Dimes 6-FY09-507 (J.N.H.), by the National Basic Research Program of China (973 Program) (2010CB529601) (B.L.W.), and by the Science and Technology Council of Shanghai (09JC1402400 and 09ZR1404500) (B.L.W.).; For the CARe cohort, the authors wish to acknowledge the support of the National Heart, Lung, and Blood Institute and the contributions of the research institutions, study investigators, field staff, and study participants in creating this resource for biomedical research. The ARIC, CARDIA, CFS, JHS, and MESA studies contributed parent study data, ancillary study data, and DNA samples through the Broad Institute (N01-HC-65226) to create this genotype/phenotype database for wide dissemination to the biomedical research community. Further acknowledgments of the individual CARe cohort funding can be found in the supplemental materials and include the following grants: N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, R01HL087641, R01HL59367, R01HL086694, RC2 HL102419, U01HG004402, HHSN268200625226C, UL1RR025005, N01-HC-95095, N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050, N01-HC-45134, N01-HC-05187, N01-HC-45205, N01-HC-45204, HL46380-01-16, N01-HC-95170, N01-HC-95171, N01-HC-95172, N01 HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-FIC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169, RR-024156, 5RC1HL099911, and 1DP3DK085695.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Chen MH, 2010, BIOINFORMATICS, V26, P580, DOI 10.1093/bioinformatics/btp710; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Hirschhorn JN, 2009, HORM RES, V71, P5, DOI 10.1159/000192430; Jarick I, 2011, HUM MOL GENET, V20, P840, DOI 10.1093/hmg/ddq518; Kang SJ, 2010, HUM MOL GENET, V19, P2725, DOI 10.1093/hmg/ddq154; Kollars J, 2005, PEDIATRICS, V115, P974, DOI 10.1542/peds.2004-0804; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Kuczmarski R. J, 2002, VITAL HLTH STAT, DOI DOI 10.1016/J.BBRC.2015.06.114; Lettre G, 2011, HUM GENET, V129, P465, DOI 10.1007/s00439-011-0969-x; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Li X, 2010, J GENET GENOMICS, V37, P779, DOI 10.1016/S1673-8527(09)60095-3; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; Musunuru K, 2010, CIRC-CARDIOVASC GENE, V3, P267, DOI 10.1161/CIRCGENETICS.109.882696; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340	22	49	51	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 9	2011	89	6					751	759		10.1016/j.ajhg.2011.10.014	http://dx.doi.org/10.1016/j.ajhg.2011.10.014			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	864AF	22118881	Green Published, Bronze			2022-12-18	WOS:000298208700006
J	Tompson, SW; Bacino, CA; Safina, NP; Bober, MB; Proud, VK; Funari, T; Wangler, MF; Nevarez, L; Ala-Kokko, L; Wilcox, WR; Eyre, DR; Krakow, D; Cohn, DH				Tompson, Stuart W.; Bacino, Carlos A.; Safina, Nicole P.; Bober, Michael B.; Proud, Virginia K.; Funari, Tara; Wangler, Michael F.; Nevarez, Lisette; Ala-Kokko, Leena; Wilcox, William R.; Eyre, David R.; Krakow, Deborah; Cohn, Daniel H.			Fibrochondrogenesis Results from Mutations in the COL11A1 Type XI Collagen Gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNDROMIC HEARING-LOSS; STICKLER-SYNDROME; CHONDRODYSPLASIA; CARTILAGE; LETHAL; FAMILY; LOCUS	Fibrochondrogenesis is a severe, autosomal recessive, short limbed skeletal dysplasia In a single case of fibrochondrogenesis, whole genome SNP genotyping identified unknown ancestral consanguinity by detecting three autozygous regions Because of the predominantly skeletal nature of the phenotype the 389 genes localized to the autozygous intervals were prioritized for mutation analysis by correlation of their expression with known cartilage selective genes via the UCLA Gene Expression Tool, UGET The gene encoding the alpha 1 chain of type XI collagen (COL11A1) was the only cartilage selective gene among the three candidate intervals Sequence analysis of COL11A1 in two genetically independent fibrochondrogenesis cases demonstrated that each was a compound heterozygote for a loss of function mutation on one allele and a mutation predicting substitution for a conserved triple helical glycine residue on the other The parents who were carriers of missense mutations had myopia Early onset hearing loss was noted in both parents who carried a loss of function allele, suggesting COL11A1 as a locus for mild, dominantly inherited hearing loss These findings identify COL11A1 as a locus for fibrochondrogenesis and indicate that there might be phenotypic manifestations among carriers	[Tompson, Stuart W.; Funari, Tara; Nevarez, Lisette; Wilcox, William R.; Krakow, Deborah; Cohn, Daniel H.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Bacino, Carlos A.; Wangler, Michael F.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77013 USA; [Safina, Nicole P.; Proud, Virginia K.] Childrens Hosp Kings Daughters, Norfolk, VA 23507 USA; [Bober, Michael B.] Nemours Alfred I duPont Hosp Children, Wilmington, DE 19803 USA; [Ala-Kokko, Leena] Connect Tissue Gene Tests, Allentown, PA 18106 USA; [Eyre, David R.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA; [Krakow, Deborah; Cohn, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Krakow, Deborah] Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthoped Surg, Los Angeles, CA 90095 USA; [Wilcox, William R.; Cohn, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA	Cedars Sinai Medical Center; Baylor College of Medicine; Nemours Alfred I. duPont Hospital for Children; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cohn, DH (corresponding author), Cedars Sinai Med Ctr, Inst Med Genet, Steven Spielberg Bldg,8723 Alden Dr, Los Angeles, CA 90048 USA.		Wangler, Michael/H-6368-2019; Krakow, Deborah/B-5778-2009; Bober, Michael/AAH-4553-2021	Wangler, Michael/0000-0001-5245-5910; Krakow, Deborah/0000-0001-9906-4968; Bober, Michael/0000-0002-6178-1264; Tompson, Stuart/0000-0001-9788-6730	National Institutes of Health [DE019567, HD22657, M01 RR00425]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR037318, R37AR036794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank the families who participated in this work This work was supported in part by grants from the National Institutes of Health (DE019567, HD22657, and M01 RR00425)	Al-Gazali LI, 1999, CLIN DYSMORPHOL, V8, P59; Annunen S, 1999, AM J HUM GENET, V65, P974, DOI 10.1086/302585; BANKIER A, 1991, AM J MED GENET, V38, P95, DOI 10.1002/ajmg.1320380121; Chen W, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.032615; Day A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r112; Day A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008491; ETESON DJ, 1984, AM J MED GENET, V19, P277, DOI 10.1002/ajmg.1320190210; EYRE DR, 1991, SEMIN ARTHRITIS RHEU, V21, P2, DOI 10.1016/0049-0172(91)90035-X; Eyre DR, 2002, BIOCHEM SOC T, V30, P894, DOI 10.1042/bst0300894; FARAG TI, 1987, J MED GENET, V24, P597, DOI 10.1136/jmg.24.10.597; Fernandes RJ, 2007, MATRIX BIOL, V26, P597, DOI 10.1016/j.matbio.2007.06.007; FOSSATI FL, 1978, ARCH FR PEDIATR, V35, P1096; FRIAS MLM, 1996, J MED GENET, V33, P429; Funari VA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-165; Leeners B, 2004, AM J MED GENET A, V127A, P318, DOI 10.1002/ajmg.a.20620; LI Y, 1995, CELL, V80, P423, DOI 10.1016/0092-8674(95)90492-1; Majava M, 2007, AM J MED GENET A, V143A, P258, DOI 10.1002/ajmg.a.31586; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Martin S, 1999, EUR J HUM GENET, V7, P807, DOI 10.1038/sj.ejhg.5200377; McGuirt WT, 1999, NAT GENET, V23, P413, DOI 10.1038/70516; Randrianaivo H, 2002, PRENATAL DIAG, V22, P806, DOI 10.1002/pd.423; Richards AJ, 1996, HUM MOL GENET, V5, P1339, DOI 10.1093/hmg/5.9.1339; Richards AJ, 2010, HUM MUTAT, V31, pE1461, DOI 10.1002/humu.21257; SEEGMILLER R, 1971, J CELL BIOL, V48, P580, DOI 10.1083/jcb.48.3.580; WHITLEY CB, 1984, AM J MED GENET, V19, P265, DOI 10.1002/ajmg.1320190209; Wu JJ, 2009, J BIOL CHEM, V284, P5539, DOI 10.1074/jbc.M806369200	26	49	52	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 12	2010	87	5					708	712		10.1016/j.ajhg.2010.10.009	http://dx.doi.org/10.1016/j.ajhg.2010.10.009			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	686AE	21035103	Bronze, Green Published			2022-12-18	WOS:000284668400018
J	Sun, M; Li, N; Dong, W; Chen, ZG; Liu, Q; Xu, YM; He, G; Shi, YY; Li, X; Hao, JJ; Luo, Y; Shang, DD; Lv, D; Ma, F; Zhang, D; Hua, R; Lu, CX; Wen, YR; Cao, LH; Irvine, AD; McLean, WHI; Dong, Q; Wang, MR; Yu, J; He, L; Lo, WHY; Zhang, X				Sun, Miao; Li, Ning; Dong, Wu; Chen, Zugen; Liu, Qing; Xu, Yiming; He, Guang; Shi, Yongyong; Li, Xin; Hao, Jiajie; Luo, Yang; Shang, Dandan; Lv, Dan; Ma, Fen; Zhang, Dai; Hua, Rui; Lu, Chaoxia; Wen, Yaran; Cao, Lihua; Irvine, Alan D.; McLean, W. H. Irwin; Dong, Qi; Wang, Ming-Rong; Yu, Jun; He, Lin; Lo, Wilson H. Y.; Zhang, Xue			Copy-Number Mutations on Chromosome 17q24.2-q24.3 in Congenital Generalized Hypertrichosis Terminalis with or without Gingival Hyperplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ZIMMERMANN-LABAND-SYNDROME; HUMAN-DISEASE; FIBROMATOSIS; MKK6; REARRANGEMENTS; INVOLVEMENT; DISORDERS; 3P14.3; LOCI; MICE	Congenital generalized hypertrichosis terminalis (CGHT) is a rare condition characterized by universal excessive growth of pigmented terminal hairs and often accompanied with gingival hyperplasia. In the present study, we describe three Han Chinese families with autosomal-dominant CGHT and a sporadic case with extreme CGHT and gingival hyperplasia. We first did a genome-wide linkage scan in a large four-generation family. Our parametric multipoint linkage analysis revealed a genetic locus for CGHT on chromosome 17q24.2-c24.3. Further two-point linkage and haplotyping with microsatellite markers from the same chromosome region confirmed the genetic mapping and showed in all the families a microdeletion within the critical region that was present in all affected individuals but not in unaffected family members. We then carried out copy-number analysis with the Affymetrix Genome-Wide Human SNP Array 6.0 and detected genomic microdeletions of different sizes and with different breakpoints in the three families. We validated these microdeletions by real-time quantitative PCR and confirmed their perfect cosegregation with the disease phenotype in the three families. In the sporadic case, however, we found a de novo microduplication. Two-color interphase FISH analysis demonstrated that the duplication was inverted. These copy-number variations (CNVs) shared a common genomic region in which CNV is not reported in the public database and was not detected in Our 434 unrelated Han Chinese normal controls. Thus, pathogenic copy-number mutations on 17q24.2-q24.3 are responsible for CGHT with or without gingival hyperplasia. Our work identifies CGHT as a genomic disorder.	[Sun, Miao; Liu, Qing; Xu, Yiming; Shang, Dandan; Lv, Dan; Ma, Fen; Zhang, Dai; Hua, Rui; Lu, Chaoxia; Wen, Yaran; Lo, Wilson H. Y.; Zhang, Xue] Chinese Acad Med Sci, McKusick Zhang Ctr Genet Med, Beijing 100005, Peoples R China; [Sun, Miao; Liu, Qing; Xu, Yiming; Shang, Dandan; Lv, Dan; Ma, Fen; Zhang, Dai; Hua, Rui; Lu, Chaoxia; Wen, Yaran; Lo, Wilson H. Y.; Zhang, Xue] Chinese Acad Med Sci, State Key Lab Med Mol Biol, Inst Basic Med Sci, Beijing 100005, Peoples R China; [Sun, Miao; Liu, Qing; Xu, Yiming; Shang, Dandan; Lv, Dan; Ma, Fen; Zhang, Dai; Hua, Rui; Lu, Chaoxia; Wen, Yaran; Lo, Wilson H. Y.; Zhang, Xue] Peking Union Med Coll, Beijing 100005, Peoples R China; [Li, Ning; Luo, Yang; Cao, Lihua; Zhang, Xue] China Med Univ, Res Ctr Med Genom, Shenyang 110001, Peoples R China; [Dong, Wu; Dong, Qi] Peoples Hosp Liaoning Prov, Shenyang 110016, Peoples R China; [Chen, Zugen] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [He, Guang; Shi, Yongyong; He, Lin] Shanghai Jiao Tong Univ, Bio X Ctr, Shanghai 200030, Peoples R China; [Li, Xin; Yu, Jun] Chinese Acad Sci, Beijing Inst Genom, Beijing 100029, Peoples R China; [Hao, Jiajie; Wang, Ming-Rong] Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst Hosp, Beijing 100021, Peoples R China; [Hao, Jiajie; Wang, Ming-Rong] Peking Union Med Coll, Beijing 100021, Peoples R China; [Irvine, Alan D.] Our Ladys Childrens Hosp, Dept Pediat Dermatol, Dublin 12, Ireland; [McLean, W. H. Irwin] Univ Dundee, Epithelial Genet Grp, Div Mol Med, Coll Life Sci, Dundee DD1 5EH, Scotland; [McLean, W. H. Irwin] Univ Dundee, Epithelial Genet Grp, Div Mol Med, Coll Med Dent & Nursing, Dundee DD1 5EH, Scotland; [He, Lin] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; China Medical University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Shanghai Jiao Tong University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; University of Dundee; University of Dundee; Fudan University	Zhang, X (corresponding author), Chinese Acad Med Sci, McKusick Zhang Ctr Genet Med, Beijing 100005, Peoples R China.	xuezhang@pumc.edu.cn	Shi, Yongyong/GSO-1627-2022; He, Guang/ABF-7381-2021; McLean, William HI/C-6352-2009; Wen, Yaran/D-4453-2012; miao, sun/E-2834-2018; Irvine, Alan D/A-3982-2008	Shi, Yongyong/0000-0003-1710-1505; He, Guang/0000-0002-4911-088X; Wen, Yaran/0000-0001-6346-8653; Irvine, Alan D/0000-0002-9048-2044; McLean, William Henry Irwin/0000-0001-5539-5757	National Natural Science Foundation of China [30730097, 30721063]; Ministry of Science and Technology of China [2005DKA21302]; Ministry of Education of China; 863 Program of China [2006AA02A407]; Dystrophic Epidermolysis Bullosa Research Association; Pachyonychia Congenita Project; British Skin Foundation; National Eczema Society; Medical Research Council [G0700314]; MRC [G0700314] Funding Source: UKRI	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Education of China(Ministry of Education, China); 863 Program of China(National High Technology Research and Development Program of China); Dystrophic Epidermolysis Bullosa Research Association; Pachyonychia Congenita Project; British Skin Foundation; National Eczema Society; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank all the family members for their participation in the study. This work was mainly supported by the National Natural Science Foundation of China (30730097 and 30721063) and the Ministry of Science and Technology of China (2005DKA21302) (to X.Z.). X.Z. is a Chang Jiang Scholar of Genetic Medicine supported by the Ministry of Education of China. X.Z., M.S., and G.H. are very grateful to K.-L. Sun for his encouragement as a mentor. This paper is also dedicated to Victor A. McKusick. The He Laboratory is supported by the National 863 Program of China (2006AA02A407). The W.H.I.M. group is supported by grants from The Dystrophic Epidermolysis Bullosa Research Association, Pachyonychia Congenita Project, The British Skin Foundation, The National Eczema Society, and The Medical Research Council (reference number G0700314).	Abo-Dalo B, 2007, AM J MED GENET A, V143A, P2668, DOI 10.1002/ajmg.a.32034; BERGMAN J, 2002, TECHNICAL J, V16, P116; Blyth M, 2008, EUR J MED GENET, V51, P672, DOI 10.1016/j.ejmg.2008.09.002; BONDESON J, 1993, AM J MED GENET, V47, P198; Canun S, 2003, AM J MED GENET A, V116A, P278, DOI 10.1002/ajmg.a.10883; Denayer E, 2008, J MED GENET, V45, P695, DOI 10.1136/jmg.2007.055772; Digilio MC, 2008, EUR J PEDIATR, V167, P621, DOI 10.1007/s00431-007-0558-0; Fantauzzo KA, 2008, HUM MOL GENET, V17, P3539, DOI 10.1093/hmg/ddn247; FIGUERA LE, 1995, NAT GENET, V10, P202, DOI 10.1038/ng0695-202; Garcia-Cruz D, 2002, CLIN GENET, V61, P321, DOI 10.1034/j.1399-0004.2002.610501.x; HALL BK, 1995, NAT GENET, V10, P126, DOI 10.1038/ng0695-126; Hart TC, 2002, AM J HUM GENET, V70, P943, DOI 10.1086/339689; Irvine AD, 1996, J MED GENET, V33, P972, DOI 10.1136/jmg.33.11.972; Jang SI, 2007, J BIOL CHEM, V282, P20245, DOI 10.1074/jbc.M701609200; Kaminski WE, 2006, BBA-MOL BASIS DIS, V1762, P510, DOI 10.1016/j.bbadis.2006.01.011; Kim HG, 2007, AM J MED GENET A, V143A, P107, DOI 10.1002/ajmg.a.31544; LAURENCE JZ, 1857, LANCET, V2, P48; Lin CH, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-92; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Mangino M, 2003, AM J MED GENET A, V116A, P312, DOI 10.1002/ajmg.a.10850; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Roberts A, 2006, J MED GENET, V43, P833, DOI 10.1136/jmg.2006.042796; Sarri C, 1997, AM J MED GENET, V70, P87, DOI 10.1002/(SICI)1096-8628(19970502)70:1<87::AID-AJMG16>3.0.CO;2-T; Sharp AJ, 2009, HUM MUTAT, V30, P135, DOI 10.1002/humu.20843; SOKOLOV J, 1862, LANCET, V1, P467; Sun M, 2008, J MED GENET, V45, P589, DOI 10.1136/jmg.2008.057646; Suzuki H, 2003, FASEB J, V17, P1538, DOI 10.1096/fj.02-0869fje; Tanaka N, 2002, EMBO REP, V3, P785, DOI 10.1093/embo-reports/kvf153; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Zhang R, 2006, P NATL ACAD SCI USA, V103, P365, DOI 10.1073/pnas.0507979103	32	49	53	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 12	2009	84	6					807	813		10.1016/j.ajhg.2009.04.018	http://dx.doi.org/10.1016/j.ajhg.2009.04.018			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458SC	19463983	Bronze, Green Published			2022-12-18	WOS:000267042800011
J	Ghosh, A; Zou, F; Wright, FA				Ghosh, Arpita; Zou, Fei; Wright, Fred A.			Estimating odds ratios in genome scans: An approximate conditional likelihood approach	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC ASSOCIATION; WIDE ASSOCIATION; BIAS; SUSCEPTIBILITY; PARAMETERS; VARIANTS	In modern whole-genome scans, the use of stringent thresholds to control the genome-wide testing error distorts the estimation process, producing estimated effect sizes that may be on average far greater in magnitude than the true effect sizes. We introduce a method, based on the estimate of genetic effect and its standard error as reported by standard statistical software, to correct for this bias in case-control association studies. Our approach is widely applicable, is far easier to implement than competing approaches, and may often be applied to published studies without access to the original data. We evaluate the performance of our approach via extensive simulations for a range of genetic models, minor allele frequencies, and genetic effect sizes. Compared to the naive estimation procedure, our approach reduces the bias and the mean squared error, especially for modest effect sizes. We also develop a principled method to construct confidence intervals for the genetic effect that acknowledges the conditioning on statistical significance. Our approach is described in the specific context of odds ratios and logistic modeling but is more widely applicable. Application to recently published data sets demonstrates the relevance of our approach to modern genome scans.	[Ghosh, Arpita; Zou, Fei; Wright, Fred A.] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA; [Zou, Fei; Wright, Fred A.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Zou, Fei; Wright, Fred A.] Univ N Carolina, Ctr Environm Bioinformat, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Wright, FA (corresponding author), Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA.	fwright@bios.unc.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074175] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL068890] Funding Source: Medline; NIGMS NIH HHS [R01 GM074175] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agresti A., 2003, CATEGORICAL DATA ANA; Allison DB, 2002, AM J HUM GENET, V70, P575, DOI 10.1086/339273; Aschengrau A., 2020, ESSENTIALS EPIDEMIOL; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Cox DH, 1989, ANAL BINARY DATA; Garner C, 2007, GENET EPIDEMIOL, V31, P288, DOI 10.1002/gepi.20209; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Leonard T., 2001, BAYESIAN METHODS ANA; Liu AY, 2004, BIOMETRICAL J, V46, P760, DOI 10.1002/bimj.200410076; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; MCCULLAGH P, 1989, GEN LINEAR MOELS; Rao CR, 2002, LINEAR STAT INFERENC; RISCH N, 1996, SCIENCE, V273, P1517; Rothman N, 2006, LANCET ONCOL, V7, P27, DOI 10.1016/S1470-2045(05)70434-4; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Siegmund D, 2002, AM J HUM GENET, V71, P1183, DOI 10.1086/343819; Sun L, 2005, GENET EPIDEMIOL, V28, P352, DOI 10.1002/gepi.20068; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Wald A, 1943, T AM MATH SOC, V54, P426, DOI 10.2307/1990256; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Yu K, 2007, AM J HUM GENET, V81, P540, DOI 10.1086/520678; Zollner S, 2007, AM J HUM GENET, V80, P605, DOI 10.1086/512821; Zondervan KT, 2007, NAT PROTOC, V2, P2492, DOI 10.1038/nprot.2007.366; [No title captured]	28	49	50	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2008	82	5					1064	1074		10.1016/j.ajhg.2008.03.002	http://dx.doi.org/10.1016/j.ajhg.2008.03.002			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	301VJ	18423522	Green Published, Bronze			2022-12-18	WOS:000255923600006
J	Miyazawa, H; Kato, M; Awata, T; Kohda, M; Iwasa, H; Koyama, N; Tanaka, T; Huqun; Kyo, S; Okazaki, Y; Hagiwara, K				Miyazawa, Hitoshi; Kato, Masaaki; Awata, Takuya; Kohda, Masakazu; Iwasa, Hiroyasu; Koyama, Nobuyuki; Tanaka, Tomoaki; Huqun; Kyo, Shunei; Okazaki, Yasushi; Hagiwara, Koichi			Homozygosity haplotype allows a genomewide search for the autosomal segments shared among patients	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE; PEDIGREES; TRAITS; QUEBEC; PAIRS; LOCI	A promising strategy for identifying disease susceptibility genes for both single- and multiple-gene diseases is to search patients' autosomes for shared chromosomal segments derived from a common ancestor. Such segments are characterized by the distinct identity of their haplotype. The methods and algorithms currently available have only a limited capability for determining a high-resolution haplotype genomewide. We herein introduce the homozygosity haplotype (HH), a haplotype described by the homozygous SNPs that are easily obtained from high-density SNP genotyping data. The HH represents haplotypes of both copies of homologous autosomes, allowing for direct comparisons of the autosomes among multiple patients and enabling the identification of the shared segments. The HH successfully detected the shared segments from members of a large family with Marfan syndrome, which is an autosomal dominant, single- gene disease. It also detected the shared segments from patients with model multigene diseases originating with common ancestors who lived 10-25 generations ago. The HH is therefore considered to be useful for the identification of disease susceptibility genes in both single- and multiple-gene diseases.	Saitama Med Univ, Dept Resp Med, Moroyama, Saitama 3500495, Japan; Saitama Med Univ, Dept Cardiovasc Surg, Moroyama, Saitama 3500495, Japan; Saitama Med Univ, Div Endocrinol & Diabet, Dept Med, Moroyama, Saitama 3500495, Japan; Saitama Med Univ, Div Radioisotope Lab, Biomed Res Ctr, Moroyama, Saitama 3500495, Japan; Saitama Med Univ, Div Funct Genom & Syst Med, Res Ctr Genom Med, Moroyama, Saitama 3500495, Japan; Saitama Med Univ, Div Translat Res, Res Ctr Genom Med, Moroyama, Saitama 3500495, Japan	Saitama Medical University; Saitama Medical University; Saitama Medical University; Saitama Medical University; Saitama Medical University; Saitama Medical University	Hagiwara, K (corresponding author), Saitama Med Univ, Dept Resp Med, 38 Morohongo, Moroyama, Saitama 3500495, Japan.	hagiwark@saitama-med.ac.jp		Okazaki, Yasushi/0000-0003-3241-5502; Awata, Takuya/0000-0003-2622-8129; KOHDA, Masakazu/0000-0001-5970-2224				AMOS CI, 1990, AM J HUM GENET, V47, P842; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Di Rienzo A, 2005, TRENDS GENET, V21, P596, DOI 10.1016/j.tig.2005.08.007; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gillanders EM, 2006, AM J HUM GENET, V79, P458, DOI 10.1086/506626; Haldane JBS, 1919, J GENET, V8, P299; Hayward C, 1997, HUM MUTAT, V10, P415, DOI 10.1002/(SICI)1098-1004(1997)10:6<415::AID-HUMU1>3.3.CO;2-2; HEYER E, 1995, AM J HUM GENET, V56, P970; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Laberge AM, 2005, CLIN GENET, V68, P287, DOI 10.1111/j.1399-0004.2005.00497.x; LONG JC, 1995, AM J HUM GENET, V56, P799; MORTON NE, 1955, AM J HUM GENET, V7, P277; PRITCHARD DJ, 2003, MED GENETICS GLANCE; RISCH N, 1990, AM J HUM GENET, V46, P229; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; STRACHAN T, 2003, HUMAN MOL GENETICS; Sturtevant A. H., 1915, Zs indukt Abstamm Berlin, V13, DOI 10.1007/BF01792906; Zhang K, 2006, GENET EPIDEMIOL, V30, P423, DOI 10.1002/gepi.20154	19	49	52	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2007	80	6					1090	1102		10.1086/518176	http://dx.doi.org/10.1086/518176			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	168WD	17503327	Bronze, Green Published			2022-12-18	WOS:000246553800008
J	Dagoneau, N; Bellais, S; Blanchet, P; Sarda, P; Al-Gazali, LI; Di Rocco, M; Huber, C; Djouadi, F; Le Goff, C; Munnich, A; Cormier-Daire, V				Dagoneau, N.; Bellais, S.; Blanchet, P.; Sarda, P.; Al-Gazali, L. I.; Di Rocco, M.; Huber, C.; Djouadi, F.; Le Goff, C.; Munnich, A.; Cormier-Daire, V.			Mutations in cytokine receptor-like factor 1 (CRLF1) account for both Crisponi and cold-induced sweating syndromes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEUROTROPHIC FACTOR-RECEPTOR; CARDIOTROPHIN-LIKE CYTOKINE; CNTF RECEPTOR; MICE LACKING; PATIENT; TYPE-2; GENE	Crisponi syndrome is a rare autosomal recessive disorder characterized by congenital muscular contractions of facial muscles, with trismus in response to stimuli, dysmorphic features, bilateral camptodactyly, major feeding and respiratory difficulties, and access of hyperthermia leading to death in the first months of life. The overlap with Stuve-Wiedemann syndrome (SWS) is striking, but the two conditions differ in that congenital lower limb bowing is absent in Crisponi syndrome, whereas it is a cardinal feature of SWS. We report here the exclusion of the leukemia inhibitory factor receptor gene in Crisponi syndrome and the identification of homozygote or compound heterozygote cytokine receptor-like factor 1 (CRLF1) mutations in four children from three unrelated families. The four mutations were located in the immunoglobulin-like and type III fibronectin domains, and three of them predicted premature termination of translation. Using real-time quantitative polymerase chain reaction, we found a significant decrease in CRLF1 mRNA expression in patient fibroblasts, which is suggestive of a mutation-mediated decay of the abnormal transcript. CRLF1 forms a heterodimer complex with cardiotrophin-like cytokine factor 1, and this heterodimer competes with ciliary neurotrophic factor for binding to the ciliary neurotrophic factor receptor (CNTFR) complex. The identification of CRLF1 mutations in Crisponi syndrome supports the key role of the CNTFR pathway in the function of the autonomic nervous system.	Univ Paris 05, Dept Genet, Hop Necker Enfants Malad, Assistance Publ Hop Paris,Fac Med, F-75015 Paris, France; Univ Paris 05, Fac Med, Hop Necker Enfants Malad, Assistance Publ Hop Paris,INSERM,U781, F-75015 Paris, France; CNRS, UPR9078, Fac Necker Enfants Malad, Paris, France; Hop Arnaud de Villeneuve, Dept Genet, Montpellier, France; United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Paediat, Al Ain, U Arab Emirates; Ist Giannina Gaslini, Unit Pediat 2, I-16148 Genoa, Italy	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier; CHU de Montpellier; United Arab Emirates University; University of Genoa; IRCCS Istituto Giannina Gaslini	Cormier-Daire, V (corresponding author), Univ Paris 05, Dept Genet, Hop Necker Enfants Malad, Assistance Publ Hop Paris,Fac Med, 149 Rue Sevres, F-75015 Paris, France.	cormier@necker.fr	Le Goff, Carine/N-9940-2017; LE GOFF, Carine/AAG-2390-2020; DJOUADI, Fatima/C-6187-2019; cormier-daire, valerie/H-6520-2017	LE GOFF, Carine/0000-0002-7788-708X; Djouadi, Fatima/0000-0003-0350-0935; cormier-daire, valerie/0000-0002-2839-9856; huber, celine/0000-0002-8601-9655				Accorsi P, 2003, AM J MED GENET A, V123A, P183, DOI 10.1002/ajmg.a.20292; Alexander WS, 1999, CURR BIOL, V9, P605, DOI 10.1016/S0960-9822(99)80266-8; Cormier-Daire V, 1998, AM J MED GENET, V78, P146, DOI 10.1002/(SICI)1096-8628(19980630)78:2<146::AID-AJMG9>3.0.CO;2-M; Crisponi G, 1996, AM J MED GENET, V62, P365, DOI 10.1002/(SICI)1096-8628(19960424)62:4<365::AID-AJMG8>3.0.CO;2-Q; Dagoneau N, 2004, AM J HUM GENET, V74, P298, DOI 10.1086/381715; DECHIARA TM, 1995, CELL, V83, P313, DOI 10.1016/0092-8674(95)90172-8; Elson GCA, 2000, NAT NEUROSCI, V3, P867, DOI 10.1038/78765; Hahn AF, 2006, J NEUROL SCI, V250, P62, DOI 10.1016/j.jns.2006.07.001; Knappskog PM, 2003, AM J HUM GENET, V72, P375, DOI 10.1086/346120; Nannenberg EA, 2005, AM J MED GENET A, V133A, P90, DOI 10.1002/ajmg.a.30536; Plun-Favreau H, 2001, EMBO J, V20, P1692, DOI 10.1093/emboj/20.7.1692; Rousseau F, 2006, P NATL ACAD SCI USA, V103, P10068, DOI 10.1073/pnas.0509598103; TAKAHASHI R, 1994, NAT GENET, V7, P79, DOI 10.1038/ng0594-79	13	49	51	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2007	80	5					966	970		10.1086/513608	http://dx.doi.org/10.1086/513608			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160WM	17436251	Bronze, Green Published			2022-12-18	WOS:000245973200015
J	Mahr, S; Burmester, GR; Hilke, D; Gobel, U; Grutzkau, A; Haupl, T; Hauschild, M; Koczan, D; Krenn, V; Neidel, J; Perka, C; Radbruch, A; Thiesen, HJ; Muller, B				Mahr, S; Burmester, GR; Hilke, D; Gobel, U; Grutzkau, A; Haupl, T; Hauschild, M; Koczan, D; Krenn, V; Neidel, J; Perka, C; Radbruch, A; Thiesen, HJ; Muller, B			Cis- and trans-acting gene regulation is associated with osteoarthritis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HAND OSTEOARTHRITIS; ALZHEIMERS-DISEASE; GENOME SCAN; EXPRESSION; PROTEIN; SUSCEPTIBILITY; TRANSCRIPTION; EPIDEMIOLOGY; POLYMORPHISM; THIOREDOXIN	Osteoarthritis (OA) is a complex disease of the skeleton and is associated with aging. Both environmental and genetic factors contribute to its pathogenesis. We set out to identify novel genes associated with OA, concentrating on regulatory polymorphisms allowing for differential expression. Our strategy to identify differentially expressed genes included an initial transcriptome analysis of the peripheral blood mononuclear cells of six patients with OA and six age-matched healthy controls. These were screened for allelic expression imbalances and potentially regulatory single-nucleotide polymorphisms (SNPs) in the 5' regions of the genes. To establish disease association, disparate promoter SNP distributions correlating with the differential expression were tested on larger cohorts. Our approach yielded 26 candidate genes differentially expressed between patients and controls. Whereas BLP2 and CIAS1 seem to be trans-regulated, as the absence of allelic expression imbalances suggests, the presence of allelic imbalances confirms cis-regulatory mechanisms for RHOB and TXNDC3. Interestingly, on/off-switching suggests additional trans-regulation for TXNDC3. Moreover, we demonstrate for RHOB and TXNDC3 statistically significant associations between 5' SNPs and the disease that hint at regulatory functions. Investigating the respective genes functionally will not only shed light on the disease association but will also add to the understanding of the pathogenic processes involved in OA and may point out novel therapeutic approaches.	Univ Rostock, Inst Immunol, Fac Med, D-18055 Rostock, Germany; Univ Rostock, Inst Orthoped Surg, Fac Med, D-18055 Rostock, Germany; Humboldt Univ, Fac Med, Charite Univ Hosp, Berlin, Germany; THALES IS, Berlin, Germany; German Rheumatism Res Ctr, Berlin, Germany; Contact Software GmbH, Bremen, Germany; Orthopad Zentrum Altona, Hamburg, Germany	University of Rostock; University of Rostock; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Thales Group; Deutsches Rheuma-Forschungszentrum (DRFZ)	Mahr, S (corresponding author), Univ Rostock, Inst Immunol, Fac Med, Schillingallee 70, D-18055 Rostock, Germany.	sandra.mahr@med.uni-rostock.de	Perka, Carsten/ABG-6505-2021; Burmester, Gerd R./AAY-7514-2020; mueller-hilke, brigitte/G-5583-2013	Perka, Carsten/0000-0002-0993-581X; Radbruch, Andreas/0000-0001-5753-0000				AFFYMETRIX, 2003, AFFYMETRIX TECHNICAL; Aigner T, 2004, REJUV RES, V7, P134, DOI 10.1089/1549168041552964; Anderson LVB, 1999, HUM MOL GENET, V8, P855, DOI 10.1093/hmg/8.5.855; AurrandLions M, 1996, IMMUNITY, V5, P391, DOI 10.1016/S1074-7613(00)80496-3; Baumgart M, 1998, P NATL ACAD SCI USA, V95, P6936, DOI 10.1073/pnas.95.12.6936; Bernard P, 2003, HUM MOL GENET, V12, P1755, DOI 10.1093/hmg/ddg182; Buckwalter JA, 2004, CLIN ORTHOP RELAT R, pS6, DOI 10.1097/01.blo.0000143938.30681.9d; Chan CC, 2004, RNA, V10, P200, DOI 10.1261/rna.5230104; de Crombrugghe B, 2000, MATRIX BIOL, V19, P389, DOI 10.1016/S0945-053X(00)00094-9; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Felson DT, 2004, RADIOL CLIN N AM, V42, P1, DOI 10.1016/S0033-8389(03)00161-1; Forster T, 2004, ARTHRITIS RHEUM-US, V50, P98, DOI 10.1002/art.11427; Horton WE, 1998, OSTEOARTHR CARTILAGE, V6, P245, DOI 10.1053/joca.1998.0117; Hunter DJ, 2004, ARTHRITIS RHEUM, V50, P2489, DOI 10.1002/art.20445; Ikura M, 2002, BIOESSAYS, V24, P625, DOI 10.1002/bies.10105; Kajkowski EM, 2001, J BIOL CHEM, V276, P18748, DOI 10.1074/jbc.M011161200; KNOWLTON RG, 1990, NEW ENGL J MED, V322, P526, DOI 10.1056/NEJM199002223220807; Krenn V, 2002, PATHOL RES PRACT, V198, P317, DOI 10.1078/0344-0338-5710261; Leppavuori J, 1999, AM J HUM GENET, V65, P1060, DOI 10.1086/302569; Lorenzo P, 2004, MATRIX BIOL, V23, P381, DOI 10.1016/j.matbio.2004.07.007; Matsuo Y, 2001, J BIOL CHEM, V276, P10032, DOI 10.1074/jbc.M011037200; Meulenbelt I, 2004, ARTHRITIS RHEUM, V50, P1179, DOI 10.1002/art.20121; Millar DS, 2003, HUM MUTAT, V21, P424, DOI 10.1002/humu.10168; Mitchison NA, 2000, HUM IMMUNOL, V61, P177, DOI 10.1016/S0198-8859(99)00141-X; MOHR W, 1985, RHEUMATOL INT, V5, P273, DOI 10.1007/BF00541355; Moos V, 2000, ARTHRITIS RHEUM, V43, P2417, DOI 10.1002/1529-0131(200011)43:11<2417::AID-ANR7>3.0.CO;2-R; Muller B, 2002, CYTOKINE, V18, P334, DOI 10.1006/cyto.2002.0882; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Peach CA, 2005, TRENDS MOL MED, V11, P186, DOI 10.1016/j.molmed.2005.02.005; Rosengren S, 2005, ANN RHEUM DIS, V64, P708, DOI 10.1136/ard.2004.025577; Sadek CM, 2001, GENES CELLS, V6, P1077, DOI 10.1046/j.1365-2443.2001.00484.x; Sharif M, 2004, ARTHRITIS RHEUM-US, V50, P507, DOI 10.1002/art.20020; Sheikh MS, 1999, J BIOL CHEM, V274, P16487, DOI 10.1074/jbc.274.23.16487; Spector T. D., 2004, Osteoarthritis and Cartilage, V12, P39, DOI 10.1016/j.joca.2003.09.005; Stefansson SE, 2003, AM J HUM GENET, V72, P1448, DOI 10.1086/375556; Tanzi RE, 1999, J CLIN INVEST, V104, P1175, DOI 10.1172/JCI8593; Unoki M, 2001, ONCOGENE, V20, P4457, DOI 10.1038/sj.onc.1204608; von Rotz RC, 2005, EUR J NEUROSCI, V21, P1289, DOI 10.1111/j.1460-9568.2005.03977.x; Wilson MJ, 2005, J BIOL CHEM, V280, P5917, DOI 10.1074/jbc.M412806200	39	49	54	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2006	78	5					793	803		10.1086/503849	http://dx.doi.org/10.1086/503849			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032EH	16642435	Green Published, Bronze			2022-12-18	WOS:000236756200006
J	Lin, DY				Lin, DY			Evaluating statistical significance in two-stage genomewide association studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DESIGNS	Genomewide association studies are being conducted to unravel the genetic etiology of complex human diseases. Because of cost constraints, these studies typically employ a two-stage design, under which a large panel of markers is examined in a subsample of subjects, and the most-promising markers are then examined in all subjects. This report describes a simple and efficient method to evaluate statistical significance for such genome studies. The proposed method, which properly accounts for the correlated nature of polymorphism data, provides accurate control of the overall false-positive rate and is substantially more powerful than the standard Bonferroni correction, especially when the markers are in strong linkage disequilibrium.	Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Lin, DY (corresponding author), Univ N Carolina, Dept Biostat, McGavran Greenberg Hall,CB 7420, Chapel Hill, NC 27599 USA.	lin@bios.unc.edu			NATIONAL CANCER INSTITUTE [R01CA082659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047845] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA082659, 2 R01 CA082659-08] Funding Source: Medline; NIGMS NIH HHS [2 R37 GM047845-15, R37 GM047845] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Cox DR., 1974, THEORETICAL STAT; Dudbridge F, 2004, AM J HUM GENET, V75, P424, DOI 10.1086/423738; Epstein MP, 2003, AM J HUM GENET, V73, P1316, DOI 10.1086/380204; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Lehmann EL, 2005, ANN STAT, V33, P1138, DOI 10.1214/009053605000000084; Lin DY, 2005, BIOINFORMATICS, V21, P781, DOI 10.1093/bioinformatics/bti053; Lin DY, 2005, AM J HUM GENET, V77, P513, DOI 10.1086/432817; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Satagopan JM, 2003, GENET EPIDEMIOL, V25, P149, DOI 10.1002/gepi.10260; Satagopan JM, 2002, BIOMETRICS, V58, P163, DOI 10.1111/j.0006-341X.2002.00163.x; Satagopan JM, 2004, BIOMETRICS, V60, P589, DOI 10.1111/j.0006-341X.2004.00207.x; SKOL AD, IN PRESS NAT GENET; Thomas DC, 2005, AM J HUM GENET, V77, P337, DOI 10.1086/432962; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042	17	49	50	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2006	78	3					505	509		10.1086/500812	http://dx.doi.org/10.1086/500812			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032AY	16408254	Green Published, Bronze			2022-12-18	WOS:000236747500017
J	Schumacher, J; Kaneva, R; Abou Jamra, R; Diaz, GO; Ohlraun, S; Milanova, V; Lee, YA; Rivas, F; Mayoral, F; Fuerst, R; Flaquer, A; Windemuth, C; Gay, E; Sanz, S; Gonzalez, MJ; Gil, S; Cabaleiro, F; del Rio, F; Perez, F; Haro, J; Kostov, C; Chorbov, V; Nikolova-Hill, A; Stoyanova, V; Onchev, G; Kremensky, I; Strauch, K; Schulze, TG; Nurnberg, P; Gaebel, W; Klimke, A; Auburger, G; Wienker, TF; Kalaydjieva, L; Propping, P; Cichon, S; Jablensky, A; Rietschel, M; Nothen, MM				Schumacher, J; Kaneva, R; Abou Jamra, R; Diaz, GO; Ohlraun, S; Milanova, V; Lee, YA; Rivas, F; Mayoral, F; Fuerst, R; Flaquer, A; Windemuth, C; Gay, E; Sanz, S; Gonzalez, MJ; Gil, S; Cabaleiro, F; del Rio, F; Perez, F; Haro, J; Kostov, C; Chorbov, V; Nikolova-Hill, A; Stoyanova, V; Onchev, G; Kremensky, I; Strauch, K; Schulze, TG; Nurnberg, P; Gaebel, W; Klimke, A; Auburger, G; Wienker, TF; Kalaydjieva, L; Propping, P; Cichon, S; Jablensky, A; Rietschel, M; Nothen, MM			Genomewide scan and fine-mapping linkage studies in four European samples with bipolar affective disorder suggest a new susceptibility locus on chromosome 1p35-p36 and provides further evidence of loci on chromosome 4q31 and 6q24	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NATIONAL-INSTITUTE; WIDE SCAN; LOD SCORE; GENETICS; FAMILIES; PEDIGREES; METAANALYSIS; SUPPORT; MODELS	We present the findings of a large linkage study of bipolar affective disorder (BPAD) that involved genomewide analysis of 52 families (448 genotyped individuals) of Spanish, Romany, and Bulgarian descent and further fine mapping of the 1p34-p36, 4q28-q31, and 6q15-q24 regions. An additional sample of 56 German families (280 individuals) was included for this fine-mapping step. The highest nonparametric linkage scores obtained in the fine mapping were 5.49 for 4q31 and 4.87 for 6q24 in the Romany families and 3.97 for 1p35-p36 in the Spanish sample. MOD-score (LOD scores maximized over genetic model parameters) analysis provided significant evidence of linkage to 4q31 and at least borderline significance for the 1p and 6q regions. On the basis of these results and previous positive research findings, 4q31 and 6q24 should now be considered confirmed BPAD susceptibility loci, and 1p35-p36 is proposed as a new putative locus that requires confirmation in replication studies.	Univ Bonn, Dept Genom, Life & Brain Ctr, D-53105 Bonn, Germany; Univ Bonn, Inst Human Genet, D-53105 Bonn, Germany; Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-53105 Bonn, Germany; Med Univ Sofia, Lab Mol Pathol, Sofia, Bulgaria; Med Univ Sofia, Dept Psychiat, Sofia, Bulgaria; Civil Hosp Carlos Haya, Malaga, Spain; Cent Inst Mental Hlth, Div Genet Epidemiol Psychiat, D-6800 Mannheim, Germany; Max Delbruck Ctr Mol Med, Berlin, Germany; Univ Hosp Reina Sofia, Cordoba, Spain; Mental Hlth Care Ctr Lucena, Cordoba, Spain; Mental Hlth Care Ctr Montoro, Cordoba, Spain; Prov Hosp, Jaen, Spain; Mental Hlth Care Ctr San Dionisio Jerez de la Fro, Cadiz, Spain; URA Puerto Santamaria, Cadiz, Spain; Mental Hlth Care Ctr Algeciras Cadiz, Cadiz, Spain; Newcastle Reg Mental Hlth Serv, Newcastle, NSW, Australia; Univ Marburg, Inst Med Biometry & Epidemiol, Marburg, Germany; Univ Dusseldorf, Dept Psychiat, D-4000 Dusseldorf, Germany; Goethe Univ Frankfurt, Neurol Clin, D-6000 Frankfurt, Germany; Univ Western Australia, Western Australia Inst Med Res, Perth, WA 6009, Australia; Univ Western Australia, Med Res Ctr, Perth, WA 6009, Australia; Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia	University of Bonn; University of Bonn; University of Bonn; Medical University Sofia; Medical University Sofia; Central Institute of Mental Health; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Hospital Universitario Reina Sofia - Cordoba; Philipps University Marburg; Heinrich Heine University Dusseldorf; Goethe University Frankfurt; University of Western Australia; University of Western Australia; University of Western Australia	Nothen, MM (corresponding author), Univ Bonn, Dept Genom, Life & Brain Ctr, Sigmund Freud Str 25, D-53105 Bonn, Germany.	markus.noethen@uni-bonn.de	Kaneva, Radka P/AGS-5076-2022; Cichon, Sven/B-9618-2014; Abou Jamra, Rami/AAC-8192-2019; Kaneva, Radka P/V-6535-2017; Jablensky, Assen/H-5116-2014; Jamra, Rami Abou/I-2350-2012; Schulze, Thomas G/H-2157-2013; Jamra, Rami Abou/I-4805-2015; Cichon, Sven/H-8803-2013; mayoral, fermin/C-2652-2013; Nöthen, Markus/B-2027-2009; Kaneva, Radka/AAT-5322-2021; Schumacher, Johannes/F-4970-2015	Kaneva, Radka P/0000-0002-1437-1393; Cichon, Sven/0000-0002-9475-086X; Abou Jamra, Rami/0000-0002-1542-1399; Kaneva, Radka P/0000-0002-1437-1393; Jablensky, Assen/0000-0003-0602-6810; Jamra, Rami Abou/0000-0002-1542-1399; Jamra, Rami Abou/0000-0002-1542-1399; Cichon, Sven/0000-0002-9475-086X; Nöthen, Markus/0000-0002-8770-2464; Schumacher, Johannes/0000-0001-9217-6457; Mayoral-Cleries, Fermin/0000-0002-9710-9672; Onchev, Georgi/0000-0002-5139-5917; Klimke, Ansgar/0000-0002-1160-5270				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; American Psychiatric Association DSM-IV, 1994, DSM 4 DIAGN STAT MAN; Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; Bjornsson A, 2003, AM J HUM GENET, V73, P986, DOI 10.1086/378417; BJORNSSON A, 2003, AM J HUM GENET, V76, P715; Cichon S, 2001, HUM MOL GENET, V10, P2933, DOI 10.1093/hmg/10.25.2933; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; Craddock N, 1999, J MED GENET, V36, P585, DOI 10.1136/jmg.36.8.585; Curtis D, 2003, PSYCHIAT GENET, V13, P77, DOI 10.1097/01.ypg.0000056684.89558.d2; Dick DM, 2003, AM J HUM GENET, V73, P107, DOI 10.1086/376562; Ekholm JM, 2003, HUM MOL GENET, V12, P1907, DOI 10.1093/hmg/ddg199; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; Ewald H, 2002, MOL PSYCHIATR, V7, P734, DOI 10.1038/sj.mp.4001074; Fallin MD, 2004, AM J HUM GENET, V75, P204, DOI 10.1086/422474; Fangerau H, 2004, HUM HERED, V58, P122, DOI 10.1159/000083538; Hodge SE, 1997, AM J HUM GENET, V60, P217; Kruglyak L, 1998, J COMPUT BIOL, V5, P1, DOI 10.1089/cmb.1998.5.1; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lee YA, 2000, AM J HUM GENET, V67, P1020, DOI 10.1086/303075; Liu J, 2003, MOL PSYCHIATR, V8, P333, DOI 10.1038/sj.mp.4001254; Markianos K, 2001, AM J HUM GENET, V68, P963, DOI 10.1086/319507; McInnis MG, 2003, BIOL PSYCHIAT, V54, P1265, DOI 10.1016/j.biopsych.2003.08.001; Middleton FA, 2004, AM J HUM GENET, V74, P886, DOI 10.1086/420775; Pato CN, 2004, AM J MED GENET B, V127B, P30, DOI 10.1002/ajmg.b.30001; Rice JP, 1997, AM J MED GENET, V74, P247, DOI 10.1002/(SICI)1096-8628(19970531)74:3<247::AID-AJMG3>3.0.CO;2-N; Schulze TG, 2004, BIOL PSYCHIAT, V56, P18, DOI 10.1016/j.biopsych.2004.04.004; Schulze TG, 2003, AM J MED GENET C, V123C, P36, DOI 10.1002/ajmg.c.20012; Segurado R, 2003, AM J HUM GENET, V73, P49, DOI 10.1086/376547; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; Strauch K, 2003, AM J HUM GENET, V73, P615; Suarez Brian K., 1994, P23; Terwilliger JD, 1997, AM J HUM GENET, V61, P430, DOI 10.1086/514855; Venken T, 2005, AM J HUM GENET, V76, P237, DOI 10.1086/427836; WEEKS DE, 1990, GENET EPIDEMIOL, V7, P237, DOI 10.1002/gepi.1370070402; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589; World Health Organisation, 2002, WORLD HLTH REPORT 20; Zubenko GS, 2003, AM J MED GENET B, V123B, P1, DOI 10.1002/ajmg.b.20073	37	49	49	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2005	77	6					1102	1111		10.1086/498619	http://dx.doi.org/10.1086/498619			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	983OE	16380920	Green Published, Bronze			2022-12-18	WOS:000233241200018
J	Wang, K; Sheffield, VC				Wang, K; Sheffield, VC			A constrained-likelihood approach to marker-trait association studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC-MARKERS; TREND TESTS; SAMPLE-SIZE; POWER; LOCI	Marker-trait association analysis is an important statistical tool for detecting DNA variants responsible for genetic traits. In such analyses, an analysis model of the mean genetic effects of the genotypes is often specified. For instance, the effect of the disease allele on the trait is often specified to be dominant, recessive, additive, or multiplicative. Although this model-based approach is powerful when the analysis model is correctly specified, it has been found to have low power sometimes when the specified model is incorrect. We introduce an approach that does not require the specification of a particular genetic model. This approach is built upon a constrained maximum likelihood in which the mean genetic effect of the heterozygous genotype is required to not exceed those of the two homozygous genotypes. The asymptotic distribution of the likelihood-ratio statistic is derived for two special cases. A simulation study suggests that this new approach has power comparable to that of the model-based method when the analysis model is correctly specified. This approach uses one marker at a time (i.e., it is a single-marker analysis). However, given the latest findings that powerful inferential procedures for haplotype analyses can be constructed from single-marker analyses, we expect this approach to be useful for haplotype analyses.	Univ Iowa, Coll Publ Hlth, Program Publ Hlth Genet, Iowa City, IA 52242 USA; Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa	Wang, K (corresponding author), Univ Iowa, Coll Publ Hlth, Program Publ Hlth Genet, 2188 WL, Iowa City, IA 52242 USA.	kai-wang@uiowa.edu		Sheffield, Val/0000-0002-6282-0835	NATIONAL EYE INSTITUTE [R01EY011298] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Freidlin B, 2003, HUM HERED, V55, P117, DOI 10.1159/000072316; Freidlin B, 2002, HUM HERED, V53, P146, DOI 10.1159/000064976; HOLMANS P, 1993, AM J HUM GENET, V52, P362; Knapp M, 1998, ANN HUM GENET, V62, P75, DOI 10.1017/S0003480098006617; PRENTICE RL, 1979, BIOMETRIKA, V66, P403, DOI 10.1093/biomet/66.3.403; Roeder K, 2005, GENET EPIDEMIOL, V28, P207, DOI 10.1002/gepi.20050; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schaid DJ, 2005, AM J HUM GENET, V76, P780, DOI 10.1086/429838; Slager SL, 2001, HUM HERED, V52, P149, DOI 10.1159/000053370; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222; Zheng G, 2003, ANN HUM GENET, V67, P589, DOI 10.1046/j.1529-8817.2003.00065.x; Zheng G, 2003, STAT MED, V22, P2657, DOI 10.1002/sim.1474; [No title captured]	16	49	50	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2005	77	5					768	780		10.1086/497434	http://dx.doi.org/10.1086/497434			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	974CT	16252237	Bronze, Green Published			2022-12-18	WOS:000232569600007
J	Lynn, A; Schrump, S; Cherry, J; Hassold, T; Hunt, P				Lynn, A; Schrump, S; Cherry, J; Hassold, T; Hunt, P			Sex, not genotype, determines recombination levels in mice	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC-LINKAGE MAP; SYNAPTONEMAL COMPLEX; TELOMERE REDISTRIBUTION; MEIOTIC RECOMBINATION; SYNAPSIS INITIATION; HUMAN MEIOSIS; Y-CHROMOSOME; HUMAN GENOME; EXCHANGE; FEMALE	Recombination, the precise physical breakage and rejoining of DNA between homologous chromosomes, plays a central role in mediating the orderly segregation of meiotic chromosomes in most eukaryotes. Despite its importance, the factors that control the number and placement of recombination events within a cell remain poorly defined. The rate of recombination exhibits remarkable species specificity, and, within a species, recombination is affected by the physical size of the chromosome, chromosomal location, proximity to other recombination events (i.e., chiasma interference), and, intriguingly, the sex of the transmitting parent. To distinguish between simple genetic and nongenetic explanations of sex-specific recombination differences in mammals, we compared recombination in meiocytes from XY sex-reversed and XO females with that in meiocytes from XX female and XY male mice. The rate and pattern of recombination in XY and XO oocytes were virtually identical to those in normal XX females, indicating that sex, not genotype, is the primary determinant of meiotic recombination patterns in mammals.	Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA	Case Western Reserve University	Hassold, T (corresponding author), Washington State Univ, Sch Mol Biosci, 542 Fulmer Hall, Pullman, WA 99164 USA.	terryhassold@wsu.edu			NICHD NIH HHS [R01 HD037502, R01 HD042720, R37 HD021341, HD21341, HD37502, R01 HD021341, HD42720] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD021341] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042720, R01HD021341, R01HD037502] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Albrecht KH, 2000, DEV BIOL, V225, P26, DOI 10.1006/dbio.2000.9819; Anderson LK, 1999, GENETICS, V151, P1569; Bean CJ, 2001, HUM MOL GENET, V10, P963, DOI 10.1093/hmg/10.9.963; BOJKO M, 1983, CARLSBERG RES COMMUN, V48, P457, DOI 10.1007/BF02911920; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Brown PW, 2005, AM J HUM GENET, V77, P556, DOI 10.1086/468188; CRAWFORD AM, 1995, GENETICS, V140, P703; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; Dunn LC, 1920, GENETICS, V5, P325; EICHER EM, 1982, SCIENCE, V217, P535, DOI 10.1126/science.7089579; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; HUNT PA, 1991, DEVELOPMENT, V111, P1137; Hunt PA, 2002, SCIENCE, V296, P2181, DOI 10.1126/science.1071907; Jiang YH, 2004, ANNU REV GENOM HUM G, V5, P479, DOI 10.1146/annurev.genom.5.061903.180014; Koehler KE, 2002, GENETICS, V162, P297; Kondo M, 2001, GENET RES, V78, P23, DOI 10.1017/S0016672301005109; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2004, NAT GENET, V36, P1203, DOI 10.1038/ng1445; Lynn A, 2002, SCIENCE, V296, P2222, DOI 10.1126/science.1071220; Matin SA, 2003, WIREL COMMUN MOB COM, V3, P73, DOI 10.1002/wcm.65; MERRIAM JR, 1967, GENETICS, V57, P409; Mikawa S, 1999, ANIM GENET, V30, P407, DOI 10.1046/j.1365-2052.1999.00493.x; Morgan T. H., 1912, Science New York N S, V36; Neff MW, 1999, GENETICS, V151, P803; Pfeifer C, 2003, DEV BIOL, V255, P206, DOI 10.1016/S0012-1606(02)00093-3; Pfeifer C, 2001, CYTOGENET CELL GENET, V93, P304, DOI 10.1159/000057002; RASMUSSEN SW, 1978, CARLSBERG RES COMMUN, V43, P275, DOI 10.1007/BF02906106; ROBINSON WP, 1995, HUM MOL GENET, V4, P801, DOI 10.1093/hmg/4.5.801; Singer A, 2002, GENETICS, V160, P649; Tease C, 2004, CYTOGENET GENOME RES, V107, P208, DOI 10.1159/000080599; YAMAMOTO T, 1961, J EXP ZOOL, V146, P163, DOI 10.1002/jez.1401460206; Zenger KR, 2002, GENETICS, V162, P321	33	49	53	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2005	77	4					670	675		10.1086/491718	http://dx.doi.org/10.1086/491718			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967QS	16175513	Bronze, Green Published			2022-12-18	WOS:000232106900015
J	Nakabayashi, K; Amann, D; Ren, Y; Saarialho-Kere, U; Avidan, N; Gentles, S; MacDonald, JR; Puffenberger, EG; Christiano, AM; Martinez-Mir, A; Salas-Alanis, JC; Rizzo, R; Vamos, E; Raams, A; Les, C; Seboun, E; Jaspers, NGJ; Beckmann, JS; Jackson, CE; Scherer, SW				Nakabayashi, K; Amann, D; Ren, Y; Saarialho-Kere, U; Avidan, N; Gentles, S; MacDonald, JR; Puffenberger, EG; Christiano, AM; Martinez-Mir, A; Salas-Alanis, JC; Rizzo, R; Vamos, E; Raams, A; Les, C; Seboun, E; Jaspers, NGJ; Beckmann, JS; Jackson, CE; Scherer, SW			Identification of C7orf11 (TTDN1) gene mutations and genetic heterogeneity in nonphotosensitive trichothiodystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SHORT STATURE; BRITTLE HAIR; DECREASED FERTILITY; ITALIAN PATIENTS; RETARDATION; IMPAIRMENT; SEQUENCE; TFIIH	We have identified C7orf11, which localizes to the nucleus and is expressed in fetal hair follicles, as the first disease gene for nonphotosensitive trichothiodystrophy (TTD). C7orf11 maps to chromosome 7p14, and the disease locus has been designated "TTDN1" ( TTD nonphotosensitive 1). Mutations were found in patients with Amish brittle-hair syndrome and in other nonphotosensititive TTD cases with mental retardation and decreased fertility but not in patients with Sabinas syndrome or Pollitt syndrome. Therefore, genetic heterogeneity in nonphotosensitive TTD is a feature similar to that observed in photosensitive TTD, which is caused by mutations in transcription factor II H (TFIIH) subunit genes. Comparative immunofluorescence analysis, however, suggests that C7orf11 does not influence TFIIH directly. Given the absence of cutaneous photosensitivity in the patients with C7orf11 mutations, together with the protein's nuclear localization, C7orf11 may be involved in transcription but not DNA repair.	Scott & White Mem Hosp & Clin, Dept Med, Temple, TX 76508 USA; Univ Lausanne, CHU Vaudois, Serv Med Genet, Lausanne, Switzerland; Univ Paris 06, Div Genet & Microbiol, Paris, France; Henry Ford Hosp, Detroit, MI 48202 USA; Erasmus Univ, Dept Genet, Med Genet Cluster, Rotterdam, Netherlands; Hop Univ Erasme, Dept Med Genet, Brussels, Belgium; Univ Catania, Dept Pediat, Catania, Italy; Columbia Univ, Dept Dermatol, New York, NY 10027 USA; Clin Special Children, Strasburg, PA USA; Stockholm Soder Hosp, Karolinska Inst, Stockholm, Sweden; Univ Helsinki, Dept Dermatol, Helsinki, Finland; Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; Univ Toronto, Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5G 1X8, Canada	Scott & White Medical Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); UDICE-French Research Universities; Sorbonne Universite; Henry Ford Health System; Henry Ford Hospital; Erasmus University Rotterdam; Universite Libre de Bruxelles; University of Catania; Columbia University; Karolinska Institutet; University of Helsinki; Weizmann Institute of Science; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Scherer, SW (corresponding author), 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	steve@genet.sickkids.on.ca	IBIS, NEUROGENETICA/P-2947-2015; Beckmann, Jacques S/A-9772-2008; Rizzo, Renata/AAB-8772-2019; MacDonald, Jeffrey Robert/GLU-2255-2022; Scherer, Stephen W./B-3785-2013; Martinez-Mir, Amalia/K-7715-2018	Beckmann, Jacques S/0000-0002-9741-1900; Scherer, Stephen W./0000-0002-8326-1999; Martinez-Mir, Amalia/0000-0002-1628-8972; Rizzo, Renata/0000-0002-3997-1328; Puffenberger, Erik/0000-0002-6388-9148; MacDonald, Jeffrey/0000-0001-5058-2393				ALFANDARI S, 1993, DERMATOLOGY, V186, P197, DOI 10.1159/000247345; BADEN HP, 1976, AM J HUM GENET, V28, P514; Bergmann E, 2001, TRENDS GENET, V17, P279, DOI 10.1016/S0168-9525(01)02280-6; Botta E, 2002, HUM MOL GENET, V11, P2919, DOI 10.1093/hmg/11.23.2919; Botta E, 1998, AM J HUM GENET, V63, P1036, DOI 10.1086/302063; Giglia-Mari G, 2004, NAT GENET, V36, P714, DOI 10.1038/ng1387; HOWELL RR, 1981, AM J HUM GENET, V33, P957; JACKSON CE, 1974, PEDIATRICS, V54, P201; JORIZZO JL, 1982, BRIT J DERMATOL, V106, P705, DOI 10.1111/j.1365-2133.1982.tb11687.x; Nakabayashi K, 2002, GENOMICS, V79, P186, DOI 10.1006/geno.2002.6695; POLLITT RJ, 1968, ARCH DIS CHILD, V43, P211, DOI 10.1136/adc.43.228.211; PRICE VH, 1980, ARCH DERMATOL, V116, P1375, DOI 10.1001/archderm.116.12.1375; PRZEDBORSKI S, 1990, AM J MED GENET, V35, P566, DOI 10.1002/ajmg.1320350424; RIZZO R, 1992, J CHILD NEUROL, V7, P300, DOI 10.1177/088307389200700311; SAARIALHOKERE UK, 1992, J CLIN INVEST, V90, P1952, DOI 10.1172/JCI116073; Scherer SW, 2003, SCIENCE, V300, P767, DOI 10.1126/science.1083423; SEBOUN E, IN PRESS AM J MED GE; STEFANINI M, 1992, MUTAT RES, V273, P119, DOI 10.1016/0921-8777(92)90073-C; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Weeda G, 1997, AM J HUM GENET, V60, P320	20	49	51	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2005	76	3					510	516		10.1086/428141	http://dx.doi.org/10.1086/428141			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	895HO	15645389	Green Published, Bronze			2022-12-18	WOS:000226851900013
J	Correa, CR; Cheung, VG				Correa, CR; Cheung, VG			Genetic variation in radiation-induced expression phenotypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NORMAL TISSUE-REACTIONS; LYMPHOBLASTOID-CELLS; RESPONSES	Studies have demonstrated that natural variation in the expression level of genes at baseline is extensive, and the determinants of this variation can be mapped by a genetic-linkage approach. In this study, we used lymphoblastoid cells to explore the variation in radiation-induced transcriptional changes. We found that, among normal individuals, there is extensive variation in transcriptional response to radiation exposure. By studying monozygotic twins, we demonstrated that there is evidence of a heritable component to this variation. The postradiation variation in the expression level of several genes, including the ferredoxin reductase gene (FDXR) and the cyclin-dependent kinase inhibitor 1A gene (CDKN1A), is significantly greater (P < .001) among twin pairs than within twin pairs. The induction of FDXR by radiation showed a bimodal distribution. Our findings have important implications for understanding the genetic basis of radiation response, which has remained largely unknown due to the lack of family material needed for genetic studies. Our approach, which uses expression phenotypes in cell lines, allows us to expose cells from family members to radiation. Similar study design can be applied to dissect the genetic basis of other complex human traits.	Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Cheung, VG (corresponding author), Univ Penn, Dept Pediat, 1316 Civic Ctr Blvd,ARC 516, Philadelphia, PA 19104 USA.	vcheung@mail.med.upenn.edu	Cheung, Vivian G./AAT-3115-2020		NHGRI NIH HHS [HG02386, R01 HG002386] Funding Source: Medline; NIEHS NIH HHS [R01 ES015733, R01 ES015733-01] Funding Source: Medline; NIGMS NIH HHS [GM070540, R01 GM070540] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070540] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amundson SA, 2003, MOL CANCER RES, V1, P445; Amundson SA, 2001, RADIAT RES, V156, P657, DOI 10.1667/0033-7587(2001)156[0657:IOGEAA]2.0.CO;2; Andreassen CN, 2003, RADIOTHER ONCOL, V69, P127, DOI 10.1016/j.radonc.2003.09.010; Andreassen CN, 2002, RADIOTHER ONCOL, V64, P131, DOI 10.1016/S0167-8140(02)00154-8; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Cheung VG, 2002, NAT GENET, V32, P522, DOI 10.1038/ng1036; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Ford BN, 2001, RADIAT RES, V156, P668, DOI 10.1667/0033-7587(2001)156[0668:GERILC]2.0.CO;2; Gatti RA, 2001, ACTA ONCOL, V40, P702, DOI 10.1080/02841860152619115; Geara FB, 1996, INT J RADIAT ONCOL, V35, P455, DOI 10.1016/0360-3016(96)00021-1; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Jen KY, 2003, GENOME RES, V13, P2092, DOI 10.1101/gr.1240103; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; OTT J, 1992, NOCOM COMPMIX PROGRA; Safwat A, 2002, INT J RADIAT ONCOL, V52, P198, DOI 10.1016/S0360-3016(01)02690-6; SOKAL RR, 1994, BIOMETRY, P213; Watts JA, 2002, AM J HUM GENET, V71, P791, DOI 10.1086/342974	18	49	54	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2004	75	5					885	890		10.1086/425221	http://dx.doi.org/10.1086/425221			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	859YE	15359380	Green Published, Bronze			2022-12-18	WOS:000224303500014
J	Cheng, LSC; Chiang, SL; Tu, HP; Chang, SJ; Wang, TN; Ko, AMJ; Chakraborty, R; Ko, YC				Cheng, LSC; Chiang, SL; Tu, HP; Chang, SJ; Wang, TN; Ko, AMJ; Chakraborty, R; Ko, YC			Genomewide scan for gout in Taiwanese aborigines reveals linkage to chromosome 4q25	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSFER PROTEIN; HIGH PREVALENCE; HYPERURICEMIA; POPULATION; IDENTIFICATION; LONGEVITY; CANCER; MODEL; TESTS; TREES	Gout is a disorder of uric-acid metabolism. The Pacific Austronesian population, including Taiwanese aborigines, has a remarkably high prevalence of hyperuricemia and gout, which suggests a founder effect across the Pacific region. We report here a genomewide linkage study of 21 multiplex pedigrees with gout from an aboriginal tribe in Taiwan. From observations of familial clustering, early onset of gout, and clinically severe manifestations, we hypothesized that a major gene plays a role in this trait. Using 382 random polymorphic markers spread across 22 autosomes, we demonstrated a highly significant linkage for gout at marker D4S2623 on chromosome 4q25 (P=.0002 by nonparametric linkage [the NPLall statistic]; empirical;, by P=.0006; LOD=4.3, P=4.4x10(-6) by logistic regression). When alcohol consumption was included as a covariate in the model, the LOD score increased to 5.66 (P=1.3x10(-6)). Quantitative traits, including serum uric acid and creatinine, also showed a moderate linkage to this region. To our knowledge, this is the first genome-scan report to identify a genetic locus harboring a gout-susceptibility gene.	Kaohsiung Med Univ, Div Environm Hlth & Occupat Med, Natl Hlth Res Inst, Kaohsiung, Taiwan; City Hope Natl Med Ctr, Div Informat Sci, Duarte, CA 91010 USA; Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan; Kaohsiung Med Univ, Sch Publ Hlth, Kaohsiung, Taiwan; Univ New S Wales, Sch Med, Sydney, NSW, Australia; Univ Cincinnati, Med Ctr, Dept Environm Hlth, Ctr Genome Informat, Cincinnati, OH 45267 USA	Kaohsiung Medical University; National Health Research Institutes - Taiwan; City of Hope; Kaohsiung Medical University; Kaohsiung Medical University; University of New South Wales Sydney; University System of Ohio; University of Cincinnati	Ko, YC (corresponding author), Kaohsiung Med Univ, Div Environm Hlth & Occupat Med, Natl Hlth Res Inst, 100 Shih Chuan 1st Rd, Kaohsiung, Taiwan.	ycko@nhri.org.tw	Wang, Tsu-Nai/D-4469-2009; Ko, Ying-Chin/C-2084-2009; Chang, Shun-Jen/D-5501-2009	Tu, Hung-Pin/0000-0003-1044-2673; Wang, Tsu-Nai/0000-0002-0278-289X	NCRR NIH HHS [RR03655, P41 RR003655] Funding Source: Medline; NHLBI NIH HHS [HV48141, N01HV48141] Funding Source: Medline; DIVISION OF HEART AND VASCULAR DISEASES [N01HV048141] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; BELLWOOD P, 1991, SCI AM, V265, P88, DOI 10.1038/scientificamerican0791-88; Campion E W, 1987, Am J Med, V82, P421, DOI 10.1016/0002-9343(87)90441-4; Chang JG, 2002, J HUM GENET, V47, P60, DOI 10.1007/s100380200001; Chang SJ, 1997, J RHEUMATOL, V24, P1364; Chou CT, 1999, METABOLISM, V48, P131, DOI 10.1016/S0026-0495(99)90022-7; CUTLER RG, 1984, ARCH GERONTOL GERIAT, V3, P321, DOI 10.1016/0167-4943(84)90033-5; DARMAWAN J, 1992, J RHEUMATOL, V19, P1595; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; Diamond JM, 2000, NATURE, V403, P709, DOI 10.1038/35001685; Geesaman BJ, 2003, P NATL ACAD SCI USA, V100, P14115, DOI 10.1073/pnas.1936249100; Ghebranious N, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-6; Goddard KAB, 2001, AM J HUM GENET, V68, P1197, DOI 10.1086/320103; Gray RD, 2000, NATURE, V405, P1052, DOI 10.1038/35016575; Hussain MM, 2003, FRONT BIOSCI, V8, pS500, DOI 10.2741/1071; JACKSON L, 1981, J CHRON DIS, V34, P65, DOI 10.1016/0021-9681(81)90052-7; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Olson JM, 1999, AM J HUM GENET, V65, P1760, DOI 10.1086/302662; Prigent D, 1992, Med Trop (Mars), V52, P63; PRIOR I, 1981, SEMIN ARTHRITIS RHEU, V11, P213, DOI 10.1016/0049-0172(81)90101-3; PRIOR IAM, 1987, BRIT MED J, V295, P457, DOI 10.1136/bmj.295.6596.457; Puca AA, 2001, P NATL ACAD SCI USA, V98, P10505, DOI 10.1073/pnas.181337598; Rott KT, 2003, JAMA-J AM MED ASSOC, V289, P2857, DOI 10.1001/jama.289.21.2857; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; Wang WH, 2004, ARTHRITIS RHEUM-US, V50, P242, DOI 10.1002/art.11441; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Wright AF, 1999, NAT GENET, V23, P397, DOI 10.1038/70501; ZIMMET PZ, 1978, BRIT MED J, V1, P1237, DOI 10.1136/bmj.1.6122.1237	30	49	53	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2004	75	3					498	503						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	845VA	15252757	Green Published, Bronze			2022-12-18	WOS:000223272200014
J	van Asselt, KM; Kok, HS; Putter, H; Wijmenga, C; Peeters, PHM; van der Schouw, YT; Grobbee, DE; Velde, ERT; Mosselman, S; Pearson, PL				van Asselt, KM; Kok, HS; Putter, H; Wijmenga, C; Peeters, PHM; van der Schouw, YT; Grobbee, DE; Velde, ERT; Mosselman, S; Pearson, PL			Linkage analysis of extremely discordant and concordant sibling pairs identifies quantitative trait loci influencing variation in human menopausal age	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PREMATURE OVARIAN FAILURE; STIMULATING-HORMONE RECEPTOR; NATURAL MENOPAUSE; FOLLICLE ATRESIA; REPORTED AGE; FSH RECEPTOR; DOM-PROJECT; WOMEN; ONSET; MUTATIONS	Age at natural menopause may be used as parameter for evaluating the rate of ovarian aging. Environmental factors determine only a small part of the large variation in menopausal age. Studies have shown that genetic factors are likely to be involved in variation in menopausal age. To identify quantitative- trait loci for this trait, we performed a genomewide linkage study with age at natural menopause as a continuous quantitative phenotype in Dutch sister pairs, through use of a selective sampling scheme. A total of 165 families were ascertained using extreme selected sampling and were genotyped for 417 markers. Data were analyzed by Haseman-Elston regression and by an adjusted variance-components analysis. Subgroup analyses for early and late menopausal age were conducted by Haseman-Elston regression. In the adjusted variance-components analysis, 12 chromosomes had a LOD score of greater than or equal to 1.0. Two chromosomal regions showed suggestive linkage: 9q21.3 ( LOD score 2.6) and Xp21.3 ( LOD score 3.1). Haseman-Elston regression showed rather similar locations of the peaks but yielded lower LOD scores. A permutation test to obtain empirical P values resulted in a significant peak on the X chromosome. To our knowledge, this is the first study to attempt to identify loci responsible for variability in menopausal age and in which several chromosomal regions were identified with suggestive and significant linkage. Although the finding of the region on the X chromosome comes as no surprise, because of its widespread involvement in premature ovarian failure, the definition of which particular gene is involved is of great interest. The region on chromosome 9 deserves further consideration. Both findings require independent confirmation.	Univ Med Ctr Utrecht, Dept Biomed Genet, Complex Genet Grp, NL-3508 TA Utrecht, Netherlands; Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 TA Utrecht, Netherlands; Univ Med Ctr Utrecht, Dept Reprod Med, NL-3508 TA Utrecht, Netherlands; Leiden Univ, Med Ctr, Dept Med Stat, Utrecht, Netherlands; NV Organon, NL-5340 BH Oss, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Wijmenga, C (corresponding author), Univ Med Ctr Utrecht, Dept Biomed Genet, Complex Genet Grp, Stratenum 2-112,POB 80030, NL-3508 TA Utrecht, Netherlands.	t.n.wijmenga@med.uu.nl	Putter, Hein/C-2244-2018; Wijmenga, Cisca/AAE-7719-2019; Wijmenga, Cisca/D-2173-2009; Grobbee, Diederick/C-7651-2014; van der Schouw, Yvonne T./F-8327-2014	Putter, Hein/0000-0001-5395-1422; Wijmenga, Cisca/0000-0002-5635-1614; Grobbee, Diederick/0000-0003-4472-4468; van der Schouw, Yvonne T./0000-0002-4605-435X				Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Aittomaki K, 1996, J CLIN ENDOCR METAB, V81, P3722, DOI 10.1210/jc.81.10.3722; Allingham-Hawkins SJ, 1999, AM J MED GENET, V83, P322, DOI 10.1002/(SICI)1096-8628(19990402)83:4<322::AID-AJMG17>3.0.CO;2-B; Beau I, 1998, J CLIN INVEST, V102, P1352, DOI 10.1172/JCI3795; Billig H, 1996, HUM REPROD UPDATE, V2, P103, DOI 10.1093/humupd/2.2.103; Boker LK, 2001, EUR J EPIDEMIOL, V17, P1047, DOI 10.1023/A:1020009325797; BONGAARTS CE, 1982, 89 POP COUNC, P1; COULAM CB, 1986, OBSTET GYNECOL, V67, P604; COULAM CB, 1982, FERTIL STERIL, V38, P645; CRAMER DW, 1995, FERTIL STERIL, V64, P740, DOI 10.1016/S0015-0282(16)57849-2; CRAMER DW, 1995, AM J OBSTET GYNECOL, V172, P568, DOI 10.1016/0002-9378(95)90574-X; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Davis CJ, 2000, HUM REPROD, V15, P2418, DOI 10.1093/humrep/15.11.2418; Davison RM, 1998, HUM REPROD, V13, P3039, DOI 10.1093/humrep/13.11.3039; de Bruin JP, 2001, HUM REPROD, V16, P2014, DOI 10.1093/humrep/16.9.2014; denTonkelaar I, 1997, MATURITAS, V27, P117, DOI 10.1016/S0378-5122(97)01122-5; DEWAARD F, 1984, J CHRON DIS, V37, P1, DOI 10.1016/0021-9681(84)90123-1; Doherty E, 2002, J CLIN ENDOCR METAB, V87, P1151, DOI 10.1210/jc.87.3.1151; Gorai I, 2003, J CLIN ENDOCR METAB, V88, P799, DOI 10.1210/jc.2002-020353; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Gromoll J, 1996, MOL CELL ENDOCRINOL, V125, P177, DOI 10.1016/S0303-7207(96)03949-4; Hahn RA, 1997, AM J EPIDEMIOL, V146, P771; Hardy R, 1999, AM J EPIDEMIOL, V149, P612; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HSUEH AJW, 1994, ENDOCR REV, V15, P707, DOI 10.1210/er.15.6.707; Kaipia A, 1997, ANNU REV PHYSIOL, V59, P349, DOI 10.1146/annurev.physiol.59.1.349; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Marozzi A, 2000, HUM GENET, V107, P304, DOI 10.1007/s004390000364; Marozzi A, 2000, HUM REPROD, V15, P197, DOI 10.1093/humrep/15.1.197; MELICA F, 1995, INT J FERTIL MENOP S, V40, P79; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MORTON NE, 1959, AM J HUM GENET, V11, P1; Murray A, 1998, J MED GENET, V35, P637, DOI 10.1136/jmg.35.8.637; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; Sala C, 1997, GENOMICS, V40, P123, DOI 10.1006/geno.1996.4542; Schlessinger D, 2002, AM J MED GENET, V111, P328, DOI 10.1002/ajmg.10565; Snieder H, 1998, J CLIN ENDOCR METAB, V83, P1875, DOI 10.1210/jc.83.6.1875; te Velde ER, 1998, MATURITAS, V30, P103, DOI 10.1016/S0378-5122(98)00067-X; Tibiletti MG, 1999, HUM REPROD, V14, P2731, DOI 10.1093/humrep/14.11.2731; Torgerson DJ, 1997, EUR J OBSTET GYN R B, V74, P63, DOI 10.1016/S0301-2115(97)00085-7; Touraine P, 1999, MOL ENDOCRINOL, V13, P1844, DOI 10.1210/me.13.11.1844; Treloar SA, 1998, LANCET, V352, P1084, DOI 10.1016/S0140-6736(05)79753-1; van Asselt KM, 2003, MENOPAUSE, V10, P477, DOI 10.1097/01.GME.0000056040.51813.1A; VANASSELT KM, 2003, THESIS U MED CTR UTR; vanNoord PAH, 1997, FERTIL STERIL, V68, P95, DOI 10.1016/S0015-0282(97)81482-3; VANNOORDZAADSTRA BM, 1991, BMJ-BRIT MED J, V302, P1361, DOI 10.1136/bmj.302.6789.1361; Vegetti W, 2000, MOL CELL ENDOCRINOL, V161, P53, DOI 10.1016/S0303-7207(99)00224-5; Weel AEAM, 1999, J CLIN ENDOCR METAB, V84, P3146, DOI 10.1210/jc.84.9.3146; WOOD JW, 1989, OXFORD REV REPROD B, V11, P61; World Health Organization Scientific Group, 1996, WHO TECHN SERV DEP S, V866	52	49	49	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2004	74	3					444	453		10.1086/382136	http://dx.doi.org/10.1086/382136			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	801TP	14872408	Green Published, Bronze			2022-12-18	WOS:000220118500011
J	Nath, SK; Quintero-Del-Rio, AI; Kilpatrick, J; Feo, L; Ballesteros, M; Harley, JB				Nath, SK; Quintero-Del-Rio, AI; Kilpatrick, J; Feo, L; Ballesteros, M; Harley, JB			Linkage at 12q24 with systemic lupus erythematosus (SLE) is established and confirmed in Hispanic and European American families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SIB-PAIR FAMILIES; SUSCEPTIBILITY GENES; REVISED CRITERIA; GENOME SCAN; LOD SCORES; MODELS; GENETICS; CLASSIFICATION; POLYMORPHISM; ASSOCIATION	Systemic lupus erythematosus (SLE) is a chronic, complex, and systemic human autoimmune disease, with both an environmental component and a heritable predisposition. Clinical studies, reinforced by epidemiology and genetics, show impressive variation in disease severity, expression, prevalence, and incidence by ethnicity and sex. To identify the novel SLE susceptibility loci, we performed a genomewide scan with 318 markers on 37 multiplex Hispanic families, using a nonparametric penetrance-independent affected-only allele-sharing method. Three chromosomal regions (12q24, 16p13, and 16q12- 21) exceeded our predetermined threshold (Z(lr) > 2.32; nominal P < .01) for further evaluation. Suspected linkages at 12q24, 16p13, and 16q12- 21 were tested in an independent data set consisting of 92 European American (EA-1) and 55 African American (AA) families. The linkage at 12q24 was replicated in EA-1 (Z(lr) = 3.06; P = .001) but not in AA (Z(lr) = 0.37; P = .35). Although neither the 16p13 nor the 16q12-21 was confirmed in EA-1 or AA, the suggestive linkage (Z(lr) = 3.06; P = .001) at 16q12-21 is sufficient to confirm the significant linkage, reported elsewhere, at this location. The evidence for linkage at 12q24 in the 129 combined (Hispanic and EA-1) families exceeded the threshold for genomewide significance (Z(lr) = 4.39; P = 5.7 x 10(-6); nonparametric) LOD = 4.19). Parametric linkage analyses suggested a low-penetrance, dominant model (LOD = 3.72). To confirm the linkage effect at 12q24, we performed linkage analysis in another set of 82 independent European American families (EA-2). The evidence for linkage was confirmed (Z(lr) = 2.11; P = .017). Therefore, our results have detected, established, and confirmed the existence of a novel SLE susceptibility locus at 12q24 ( designated "SLEB4") that may cause lupus, especially in Hispanic and European American families.	Oklahoma Med Res Fdn, Arthrit & Immunol Res Program, Oklahoma City, OK 73104 USA; Oklahoma Med Res Fdn, Genet Epidemiol Unit, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; Dept Vet Affairs Med Ctr, Oklahoma City, OK USA; San Lucas Hosp, Ponce, PR USA	Oklahoma Medical Research Foundation; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Nath, SK (corresponding author), Oklahoma Med Res Fdn, Arthrit & Immunol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.				NIAID NIH HHS [R01 AI024717, AI24717, R37 AI024717, R01 AI031584, AI31584] Funding Source: Medline; NIAMS NIH HHS [AR42460, R03 AR048928, AR048928, P01 AR049084, AR048940, AR15577, R01 AR042460, P50 AR048940, AR049084, N01AR12253] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031584, R37AI024717, R01AI024717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR048940, P01AR049084, R01AR042460, N01AR012253, R03AR048928] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Barnard J, 1999, J OBJECT-ORIENT PROG, V12, P12; Bulman MP, 2002, DIABETOLOGIA, V45, P1463, DOI 10.1007/s00125-002-0919-1; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DEAPEN D, 1992, ARTHRITIS RHEUM, V35, P311; Edberg JC, 2002, ARTHRITIS RHEUM, V46, P2132, DOI 10.1002/art.10438; Ehm MG, 2000, AM J HUM GENET, V66, P1871, DOI 10.1086/302950; FARAWAY JJ, 1993, GENET EPIDEMIOL, V10, P75, DOI 10.1002/gepi.1370100108; Gaffney PM, 2000, AM J HUM GENET, V66, P547, DOI 10.1086/302767; Gaffney PM, 1998, P NATL ACAD SCI USA, V95, P14875, DOI 10.1073/pnas.95.25.14875; Graham RR, 2002, AM J HUM GENET, V71, P543, DOI 10.1086/342290; Grasemann H, 2001, Pneumologie, V55, P390, DOI 10.1055/s-2001-16199; Grayson TP, 2000, IEEE AERO EL SYS MAG, V15, P2; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; HARLEY JB, 2002, GENES IMMUN S, V1, P1; Hauser ER, 1996, GENET EPIDEMIOL, V13, P117, DOI 10.1002/(SICI)1098-2272(1996)13:2<117::AID-GEPI1>3.0.CO;2-5; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; HOCHBERG MC, 1997, DUBOIS LUPUS ERYTHEM, P49; HODGE S E, 1984, Genetic Epidemiology, V1, P109, DOI 10.1002/gepi.1370010203; HODGE SE, 1994, GENET EPIDEMIOL, V11, P329, DOI 10.1002/gepi.1370110403; Hodge SE, 1997, AM J HUM GENET, V60, P217; Immervoll T, 2001, HUM MUTAT, V18, P327, DOI 10.1002/humu.1194; Johanneson B, 2002, AM J HUM GENET, V71, P1060, DOI 10.1086/344289; KELLY JA, 2002, GENES IMMUNOL S, V1, P71; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; Mahtani MM, 1996, NAT GENET, V14, P90, DOI 10.1038/ng0996-90; McPeek MS, 1999, GENET EPIDEMIOL, V16, P225, DOI 10.1002/(SICI)1098-2272(1999)16:3<225::AID-GEPI1>3.0.CO;2-#; Moser KL, 1998, P NATL ACAD SCI USA, V95, P14869, DOI 10.1073/pnas.95.25.14869; Nath SK, 2002, HUM GENET, V111, P54, DOI 10.1007/s00439-002-0743-1; Olson JM, 1999, AM J HUM GENET, V64, P1464, DOI 10.1086/302360; OTT J, 1999, ANAL HUMAN GENETICS, P321; Petri M, 1998, J Am Med Womens Assoc (1972), V53, P9; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; Rybicki BA, 2000, AM J HUM GENET, V66, P593, DOI 10.1086/302778; Shai R, 1999, HUM MOL GENET, V8, P639, DOI 10.1093/hmg/8.4.639; Siegmund T, 1998, THYROID, V8, P1013, DOI 10.1089/thy.1998.8.1013; SUAREZ BK, 1994, GENETIC APPROACHES M, P23; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; THOMSON G, 1994, NAT GENET, V8, P108, DOI 10.1038/ng1094-108; Tsao BP, 2003, TRENDS IMMUNOL, V24, P595, DOI 10.1016/j.it.2003.09.006; Wandstrat A, 2001, NAT IMMUNOL, V2, P802, DOI 10.1038/ni0901-802; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Yokouchi Y, 2002, GENES IMMUN, V3, P9, DOI 10.1038/sj.gene.6363815	49	49	49	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2004	74	1					73	82		10.1086/380913	http://dx.doi.org/10.1086/380913			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	759DR	14658095	Green Published, Bronze			2022-12-18	WOS:000187723500007
J	Torroni, A; Campos, Y; Rengo, C; Sellitto, D; Achilli, A; Magri, C; Semino, O; Garcia, A; Jara, P; Arenas, J; Scozzari, R				Torroni, A; Campos, Y; Rengo, C; Sellitto, D; Achilli, A; Magri, C; Semino, O; Garcia, A; Jara, P; Arenas, J; Scozzari, R			Mitochondrial DNA haplogroups do not play a role in the variable phenotypic presentation of the A3243G mutation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY OPTIC NEUROPATHY; TRANSFER RNALEU(UUR) GENE; STROKE-LIKE EPISODES; LACTIC-ACIDOSIS; TRNA(LEU(UUR)) MUTATION; HUMAN-POPULATIONS; MELAS MUTATION; POINT MUTATION; HUMAN MTDNA; ENCEPHALOPATHY	Thirty-five mitochondrial (mt) DNAs from Spain that harbor the mutation A3243G in association with either MELAS ( mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes) syndrome or a wide array of disease phenotypes ( ranging from diabetes and deafness to a mixture of chronic progressive external ophthalmoplegic symptoms and strokelike episodes) were studied by use of high-resolution restriction fragment length polymorphism analysis and control-region sequencing. A total of 34 different haplotypes were found, indicating that all instances of the A3243G mutation are probably due to independent mutational events. Haplotypes were distributed into 13 haplogroups whose frequencies were close to those of the general Spanish population. Moreover, there was no statistically significant difference in haplogroup distribution between patients with MELAS and those with disease phenotypes other than MELAS. Overall, these data indicate that the A3243G mutation harbors all the evolutionary features expected from a severely deleterious mtDNA mutation under strong negative selection, and they reveal that European mtDNA backgrounds do not play a substantial role in modulating the mutation's phenotypic expression.	Univ Pavia, Dept Genet & Microbiol, I-27100 Pavia, Italy; Hosp Univ 12 Octubre, Ctr Invest, Madrid, Spain; Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, I-00185 Rome, Italy; Univ Cattolica Sacro Cuore, Ist Med Legale, I-20123 Milan, Italy; CNR, Ist Biol & Patol Mol, Rome, Italy	University of Pavia; Hospital Universitario 12 de Octubre; Sapienza University Rome; Catholic University of the Sacred Heart; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Torroni, A (corresponding author), Univ Pavia, Dept Genet & Microbiol, Via Ferrata 1, I-27100 Pavia, Italy.	torroni@ipvgen.unipv.it	REDONDO, ALBERTO GARCÍA/AAD-9453-2020; Achilli, Alessandro/I-9236-2012; Magri, Chiara/I-4691-2017; Yolanda, Campos Y/A-8711-2017; Torroni, Antonio/E-1557-2011	Achilli, Alessandro/0000-0001-6871-3451; Magri, Chiara/0000-0001-9933-8666; Torroni, Antonio/0000-0002-4163-4478; Arenas, Joaquin/0000-0002-2877-5049; SEMINO, Ornella/0000-0002-9675-9403; CAMPOS, YOLANDA/0000-0003-4785-9659	Telethon [E.0890] Funding Source: Medline	Telethon(Fondazione Telethon)		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; BANDELT HJ, 1995, GENETICS, V141, P743; Brown MD, 1997, AM J HUM GENET, V60, P381; CAMPOS Y, 1995, ACTA NEUROL SCAND, V91, P62; Campos Y, 1996, MUSCLE NERVE, V19, P187, DOI 10.1002/(SICI)1097-4598(199602)19:2<187::AID-MUS10>3.3.CO;2-5; Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X; Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199; De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532; Deschauer M, 2001, ARCH NEUROL-CHICAGO, V58, P1885, DOI 10.1001/archneur.58.11.1885; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Jacobs HT, 2000, HUM MOL GENET, V9, P463, DOI 10.1093/hmg/9.4.463; JEANFRANCOIS MJB, 1994, AUST NZ J MED, V24, P188, DOI 10.1111/j.1445-5994.1994.tb00556.x; KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5; KOBAYASHI Y, 1991, AM J HUM GENET, V49, P590; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959; MIYATA T, 1982, J MOL EVOL, V19, P28, DOI 10.1007/BF02100221; Moilanen JS, 2001, EUR J HUM GENET, V9, P59, DOI 10.1038/sj.ejhg.5200550; MONTAGNA P, 1988, NEUROLOGY, V38, P751, DOI 10.1212/WNL.38.5.751; MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q; MORTEN KJ, 1995, HUM MOL GENET, V4, P1689; PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040; Saillard J, 2000, HUM BIOL, V72, P1065; Torroni A, 1999, AM J HUM GENET, V65, P1349, DOI 10.1086/302642; Torroni A, 1996, GENETICS, V144, P1835; TORRONI A, 1994, J BIOENERG BIOMEMBR, V26, P261, DOI 10.1007/BF00763098; Torroni A, 1997, AM J HUM GENET, V60, P1107; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; van den Ouweland JMW, 1999, DIABETOLOGIA, V42, P485, DOI 10.1007/s001250051183; VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368; WALLACE DC, 1995, AM J HUM GENET, V57, P201; Wallace DC, 2001, MENT RETARD DEV D R, V7, P158, DOI 10.1002/mrdd.1023; WALLACE DC, 1987, CURR GENET, V12, P81, DOI 10.1007/BF00434661; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Zeviani M, 1998, MEDICINE, V77, P59, DOI 10.1097/00005792-199801000-00006	39	49	52	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2003	72	4					1005	1012		10.1086/373936	http://dx.doi.org/10.1086/373936			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662WT	12612863	Green Published, Bronze			2022-12-18	WOS:000181972600020
J	Izumi, Y; Maruyama, H; Oda, M; Morino, H; Okada, T; Ito, H; Sasaki, I; Tanaka, H; Komure, O; Udaka, F; Nakamura, S; Kawakami, H				Izumi, Y; Maruyama, H; Oda, M; Morino, H; Okada, T; Ito, H; Sasaki, I; Tanaka, H; Komure, O; Udaka, F; Nakamura, S; Kawakami, H			SCA8 repeat expansion: Large CTA/CTG repeat alleles are more common in ataxic patients, including those with SCA6	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPINOCEREBELLAR ATAXIA; CTG EXPANSION; LOCUS; (CTG)(N)	We analyzed the SCA8 CTA/CTG repeat in a large group of Japanese subjects. The frequency of large alleles (85-399 CTA/CTG repeats) was 1.9% in spinocerebellar ataxia (SCA), 0.4% in Parkinson disease, 0.3% in Alzheimer disease, and 0% in a healthy control group; the frequency was significantly higher in the group with SCA than in the control group. Homozygotes for large alleles were observed only in the group with SCA. In five patients with SCA from two families, a large SCA8 CTA/CTG repeat and a large SCA6 CAG repeat coexisted. Age at onset was correlated with SCA8 repeats rather than SCA6 repeats in these five patients. In one of these families, at least one patient showed only a large SCA8 CTA/CTG repeat allele, with no large SCA6 CAG repeat allele. We speculate that the presence of a large SCA8 CTA/CTG repeat allele influences the function of channels such as alpha(1A)-voltage-dependent calcium channel through changing or aberrant splicing, resulting in the development of cerebellar ataxia, especially in homozygous patients.	Hiroshima Univ, Grad Sch Biomed Sci, Dept Clin Neurosci & Therapeut, Minami Ku, Hiroshima 7348551, Japan; Kitano Hosp, Dept Neurol, Osaka, Japan; Kansai Med Univ, Dept Neurol, Osaka, Japan; Sumitomo Hosp, Dept Neurol, Osaka, Japan; Kagawa Med Univ, Dept Internal Med 3, Kagawa, Japan; Hirosaki Univ, Sch Med, Dept Internal Med 3, Aomori, Japan; Natl Utano Hosp, Dept Neurol, Kyoto, Japan	Hiroshima University; Kitano Hospital; Kansai Medical University; Sumitomo Hospital; Kagawa University; Hirosaki University	Kawakami, H (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Clin Neurosci & Therapeut, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	hkawakam@hiroshima-u.ac.jp	Kawakami, Hideshi/A-2086-2009; Morino, Hiroyuki/H-9583-2013; Maruyama, Hirofumi/B-9333-2011; Kawakami, Hideshi/ABE-4077-2021	Kawakami, Hideshi/0000-0002-1405-0901; Morino, Hiroyuki/0000-0002-5190-3547; Maruyama, Hirofumi/0000-0001-7613-8717; Kawakami, Hideshi/0000-0002-1405-0901				Cellini E, 2001, ARCH NEUROL-CHICAGO, V58, P1856, DOI 10.1001/archneur.58.11.1856; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Day JW, 2000, NEUROLOGY, V55, P649, DOI 10.1212/WNL.55.5.649; Hokezu Y, 2000, Rinsho Shinkeigaku, V40, P1116; Ikeda Y, 2000, NEUROLOGY, V54, P950, DOI 10.1212/WNL.54.4.950; Ikeda Y, 2000, J NEUROL SCI, V182, P76, DOI 10.1016/S0022-510X(00)00446-9; Juvonen V, 2000, ANN NEUROL, V48, P354, DOI 10.1002/1531-8249(200009)48:3<354::AID-ANA10>3.0.CO;2-A; Koob MD, 1999, NAT GENET, V21, P379, DOI 10.1038/7710; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Matsuyama Z, 1999, J Neurosci, V19, pRC14; Moseley ML, 2000, HUM MOL GENET, V9, P2125, DOI 10.1093/hmg/9.14.2125; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Silveira I, 2000, AM J HUM GENET, V66, P830, DOI 10.1086/302827; Sobrido MJ, 2001, NEUROLOGY, V57, P1310, DOI 10.1212/WNL.57.7.1310; Steinbach P, 1998, AM J HUM GENET, V62, P278, DOI 10.1086/301711; Stevanin G, 2000, NAT GENET, V24, P213, DOI 10.1038/73408; Tan EK, 2001, ARCH NEUROL-CHICAGO, V58, P191, DOI 10.1001/archneur.58.2.191; Vincent JB, 2000, AM J MED GENET, V97, P77, DOI 10.1002/(SICI)1096-8628(200021)97:1<77::AID-AJMG11>3.0.CO;2-3; Vincent JB, 2000, AM J HUM GENET, V66, P819, DOI 10.1086/302803; Worth PF, 2000, NAT GENET, V24, P214, DOI 10.1038/73411; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	21	49	50	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2003	72	3					704	709		10.1086/367775	http://dx.doi.org/10.1086/367775			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	648LJ	12545428	Green Published, Bronze			2022-12-18	WOS:000181152600019
J	Mukhopadhyay, D; Anant, S; Lee, RM; Kennedy, S; Viskochil, D; Davidson, NO				Mukhopadhyay, D; Anant, S; Lee, RM; Kennedy, S; Viskochil, D; Davidson, NO			C -> U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TISSUE-SPECIFIC EXPRESSION; MOLECULAR-CLONING; MOORING SEQUENCE; HEPATIC EXPRESSION; GENE; PROTEIN; RAS; NF1; BINDING; MICE	C-->U RNA editing of neurofibromatosis 1 (NF1) mRNA changes an arginine (CGA) to a UGA translational stop codon, predicted to result in translational termination of the edited mRNA. Previous studies demonstrated varying degrees of C-->U RNA editing in peripheral nerve-sheath tumor samples (PNSTs) from patients with NF1, but the basis for this heterogeneity was unexplained. In addition, the role, if any, of apobec-1, the catalytic deaminase that mediates C-->U editing of mammalian apolipoprotein B (apoB) RNA, was unresolved. We have examined these questions in PNSTs from patients with NF1 and demonstrate that a subset (8/34) manifest C-->U editing of RNA. Two distinguishing characteristics were found in the PNSTs that demonstrated editing of NF1 RNA. First, these tumors express apobec-1 mRNA, the first demonstration, in humans, of its expression beyond the luminal gastrointestinal tract. Second, PNSTs with C-->U editing of RNA manifest increased proportions of an alternatively spliced exon, 23A, downstream of the edited base. C-->U editing of RNA in these PNSTs was observed preferentially in transcripts containing exon 23A. These findings were complemented by in vitro studies using synthetic RNA templates incubated in the presence of recombinant apobec-1, which again confirmed preferential editing of transcripts containing exon 23A. Finally, adenovirus-mediated transfection of HepG2 cells revealed induction of editing of apoB RNA, along with preferential editing of NF1 transcripts containing exon 23A. Taken together, the data support the hypothesis that C-->U RNA editing of the NF1 transcript occurs both in a subset of PNSTs and in an alternatively spliced form containing a downstream exon, presumably an optimal configuration for enzymatic deamination by apobec-1.	Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pharmacol & Mol Biol, St Louis, MO 63110 USA; Univ Utah, Hlth Sci Ctr, Dept Pediat, Div Med Genet, Salt Lake City, UT USA	Washington University (WUSTL); Washington University (WUSTL); Utah System of Higher Education; University of Utah	Davidson, NO (corresponding author), Washington Univ, Sch Med, Div Gastroenterol, Box 8124,660 S Euclid Ave, St Louis, MO 63110 USA.	NOD@IM.WUSTL.EDU	Anant, Shrikant/AAF-8020-2020		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038180, R37HL038180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056260, P30DK052574] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-38180, R37 HL038180, R01 HL038180] Funding Source: Medline; NIDDK NIH HHS [DK-52574, P30 DK052574, R01 DK056260, DK-56260] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANANT S, 1995, J BIOL CHEM, V270, P14762, DOI 10.1074/jbc.270.24.14762; Anant S, 2000, MOL CELL BIOL, V20, P1982, DOI 10.1128/MCB.20.6.1982-1992.2000; Anant S, 1998, BIOL CHEM, V379, P1075, DOI 10.1515/bchm.1998.379.8-9.1075; Anderson JC., 1992, J BUS-BUS MARK, V1, P3, DOI [DOI 10.1300/J033V01N01_02, 10.1300/J033v01n01_02]; [Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; Ars E, 2000, HUM MOL GENET, V9, P237, DOI 10.1093/hmg/9.2.237; Ashkenas J, 1997, AM J HUM GENET, V60, P278; BACKUS JW, 1992, NUCLEIC ACIDS RES, V20, P6007, DOI 10.1093/nar/20.22.6007; BACKUS JW, 1994, BBA-GENE STRUCT EXPR, V1219, P1, DOI 10.1016/0167-4781(94)90240-2; BASU TN, 1992, NATURE, V356, P713, DOI 10.1038/356713a0; Bollag G, 1996, NAT GENET, V12, P144, DOI 10.1038/ng0296-144; Cappione AJ, 1997, AM J HUM GENET, V60, P305; CHEN SH, 1987, SCIENCE, V238, P363, DOI 10.1126/science.3659919; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; Costa RM, 2001, NAT GENET, V27, P399, DOI 10.1038/86898; Davidson NO, 2000, ANNU REV NUTR, V20, P169, DOI 10.1146/annurev.nutr.20.1.169; DECLUE JE, 1992, CELL, V69, P265, DOI 10.1016/0092-8674(92)90407-4; DRISCOLL DM, 1993, MOL CELL BIOL, V13, P7288, DOI 10.1128/MCB.13.12.7288; FUNAHASHI T, 1995, J LIPID RES, V36, P414; GIANNONI F, 1994, J BIOL CHEM, V269, P5932; Greeve J, 1999, ONCOGENE, V18, P6357, DOI 10.1038/sj.onc.1203039; GREEVE J, 1993, J LIPID RES, V34, P1367; Guha A, 1996, ONCOGENE, V12, P507; HADJIAGAPIOU C, 1994, NUCLEIC ACIDS RES, V22, P1874, DOI 10.1093/nar/22.10.1874; Hersberger M, 1998, J BIOL CHEM, V273, P9435, DOI 10.1074/jbc.273.16.9435; Hirano K, 1996, J BIOL CHEM, V271, P9887, DOI 10.1074/jbc.271.17.9887; Hirano K, 1997, J LIPID RES, V38, P1103; Kozarsky KF, 1996, HUM GENE THER, V7, P943, DOI 10.1089/hum.1996.7.8-943; Lau N, 2000, J NEUROPATH EXP NEUR, V59, P759, DOI 10.1093/jnen/59.9.759; LAU PP, 1994, P NATL ACAD SCI USA, V91, P8522, DOI 10.1073/pnas.91.18.8522; Lee RM, 1998, GASTROENTEROLOGY, V115, P1096, DOI 10.1016/S0016-5085(98)70080-0; Lellek H, 2000, J BIOL CHEM, V275, P19848, DOI 10.1074/jbc.M001786200; LI Y, 1995, GENOMICS, V25, P9, DOI 10.1016/0888-7543(95)80104-T; Maas S, 2000, BIOESSAYS, V22, P790, DOI 10.1002/1521-1878(200009)22:9<790::AID-BIES4>3.3.CO;2-S; MACGINNITIE AJ, 1995, J BIOL CHEM, V270, P14768, DOI 10.1074/jbc.270.24.14768; Madsen P, 1999, J INVEST DERMATOL, V113, P162, DOI 10.1046/j.1523-1747.1999.00682.x; Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000; Morrison JR, 1996, P NATL ACAD SCI USA, V93, P7154, DOI 10.1073/pnas.93.14.7154; NAKAFUKU M, 1993, P NATL ACAD SCI USA, V90, P6706, DOI 10.1073/pnas.90.14.6706; NAKAMUTA M, 1995, J BIOL CHEM, V270, P13042, DOI 10.1074/jbc.270.22.13042; Park VM, 1998, J MED GENET, V35, P813, DOI 10.1136/jmg.35.10.813; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; Qian XB, 1997, J BIOL CHEM, V272, P18060, DOI 10.1074/jbc.272.29.18060; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; SHAH RR, 1991, J BIOL CHEM, V266, P16301; Sherman LS, 2000, J BIOL CHEM, V275, P30740, DOI 10.1074/jbc.M001702200; Skuse GR, 1996, NUCLEIC ACIDS RES, V24, P478, DOI 10.1093/nar/24.3.478; Skuse GR, 1997, HUM MOL GENET, V6, P1707, DOI 10.1093/hmg/6.10.1707; SKUSE GR, 1995, LANCET, V345, P902, DOI 10.1016/S0140-6736(95)90015-2; Sowden M, 1996, J BIOL CHEM, V271, P3011, DOI 10.1074/jbc.271.6.3011; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Yamanaka S, 1996, J BIOL CHEM, V271, P11506, DOI 10.1074/jbc.271.19.11506; YAMANAKA S, 1994, J BIOL CHEM, V269, P21725; Yamanaka S, 1997, GENE DEV, V11, P321, DOI 10.1101/gad.11.3.321	54	49	57	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2002	70	1					38	50		10.1086/337952	http://dx.doi.org/10.1086/337952			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	499LD	11727199	Bronze, Green Published			2022-12-18	WOS:000172571900005
J	Griffith, AJ; Chowdhry, AA; Kurima, K; Hood, LJ; Keats, B; Berlin, CI; Morell, RJ; Friedman, TB				Griffith, AJ; Chowdhry, AA; Kurima, K; Hood, LJ; Keats, B; Berlin, CI; Morell, RJ; Friedman, TB			Autosomal recessive nonsyndromic neurosensory deafness at DFNB1 not associated with the compound-heterozygous GJB2 (connexin 26) genotype M34T/167delT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEARING-LOSS; SENSORINEURAL DEAFNESS; GENE GJB2; MUTATIONS; POPULATIONS; FAMILIES; FORM	Previous studies of the gap-junction beta-2 subunit gene GJB2 (connexin 26) have suggested that the 101T-->C (M34T) nucleotide substitution may be a mutant allele responsible for recessive deafness DFNB1. This hypothesis was consistent with observations of negligible intercellular coupling and gap-junction assembly of the M34T allele product expressed in Xenopus oocytes and HeLa cells. The results of our current study of a family cosegregating the 167delT allele of GJB2 and severe DFNB1 deafness demonstrate that this phenotype did not cosegregate with the compound-heterozygous genotype M34T/167delT. Since 167delT is a null allele of GJB2, this result indicates that the in vivo activity of a single M34T allele is not sufficiently reduced to cause the typical deafness phenotype associated with DFNB1. This observation raises the possibility that other GJB2 missense substitutions may not be recessive mutations that cause severe deafness and emphasizes the importance of observing cosegregation with deafness in large families to confirm that these missense alleles are mutant DFNB1 alleles.	Natl Inst Deafness & Other Commun Disorders, Genet Mol Lab, NIH, Rockville, MD USA; Natl Inst Deafness & Other Commun Disorders, Neuro Otol Branch, NIH, Rockville, MD USA; Louisiana State Univ, Hlth Sci Ctr, Kresge Hearing Res Lab, Dept Otohinolaryngol & Biocommun, New Orleans, LA USA; Louisiana State Univ, Hlth Sci Ctr, Dept Biometry & Genet, New Orleans, LA USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Griffith, AJ (corresponding author), NIH, NIDCD, 5 Res Court,Room 2A-02, Rockville, MD 20850 USA.		Morell, Robert James/Q-2042-2019	Morell, Robert/0000-0003-1537-7356	NIDCD NIH HHS [R01 DC003679, T32 DC000054, T32 DC000035, Z01-DC00054-01, Z01-DC00035-03, R01-DC03679] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003679, Z01DC000039, T32DC000035, Z01DC000048, Z01DC000054, Z01DC000035, T32DC000054] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		[Anonymous], 1984, 7029 ISO; Carrasquillo MM, 1997, HUM MOL GENET, V6, P2163, DOI 10.1093/hmg/6.12.2163; Cohn ES, 1999, PEDIATRICS, V103, P546, DOI 10.1542/peds.103.3.546; Denoyelle F, 1997, HUM MOL GENET, V6, P2173, DOI 10.1093/hmg/6.12.2173; Denoyelle F, 1999, LANCET, V353, P1298, DOI 10.1016/S0140-6736(98)11071-1; Estivill X, 1998, LANCET, V351, P394, DOI 10.1016/S0140-6736(97)11124-2; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Green GE, 1999, JAMA-J AM MED ASSOC, V281, P2211, DOI 10.1001/jama.281.23.2211; Grifa A, 1999, NAT GENET, V23, P16, DOI 10.1038/12612; Kelley PM, 1998, AM J HUM GENET, V62, P792, DOI 10.1086/301807; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; KIKUCHI T, 1995, ANAT EMBRYOL, V191, P101, DOI 10.1007/BF00186783; Liu XZ, 2000, HUM MOL GENET, V9, P63, DOI 10.1093/hmg/9.1.63; Martin PEM, 1999, HUM MOL GENET, V8, P2369, DOI 10.1093/hmg/8.13.2369; MEULENBELT I, 1995, AM J HUM GENET, V57, P1252; Morell RJ, 1998, NEW ENGL J MED, V339, P1500, DOI 10.1056/NEJM199811193392103; Morrell CH, 1996, J ACOUST SOC AM, V100, P1949, DOI 10.1121/1.417906; Scott DA, 1998, NATURE, V391, P32, DOI 10.1038/34079; White TW, 1998, NATURE, V394, P630, DOI 10.1038/29202; Xia JH, 1998, NAT GENET, V20, P370, DOI 10.1038/3845; Zelante L, 1997, HUM MOL GENET, V6, P1605, DOI 10.1093/hmg/6.9.1605	21	49	51	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2000	67	3					745	749		10.1086/303045	http://dx.doi.org/10.1086/303045			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	348TJ	10903123	Green Published, Bronze			2022-12-18	WOS:000089002300020
J	Turnpenny, PD; Bulman, MP; Frayling, TM; Abu-Nasra, TK; Garrett, C; Hattersley, AT; Ellard, S				Turnpenny, PD; Bulman, MP; Frayling, TM; Abu-Nasra, TK; Garrett, C; Hattersley, AT; Ellard, S			A gene for autosomal recessive spondylocostal dysostosis maps to 19q13.1-q13.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VERTEBRAL SEGMENTATION DEFECTS; DYSPLASIA; ANOMALIES; HOMOLOG; MOUSE; FORM; DNA	In spondylocostal dysostosis (SD), vertebral-segmentation defects are associated with rib anomalies. This results in short-trunk short stature, nonprogressive kyphoscoliosis, and radiological features of multiple hemivertebrae and rib fusions. SD can be familial, and both autosomal dominant and autosomal recessive (AR) inheritance have been reported, but no genes have been identified or localized for nonsyndromic SD in humans. Vile performed genomewide scanning by homozygosity mapping in a large consanguineous ARSD Arab Israeli family with six definitely affected members. Significant linkage was found to chromosome 19q13, with a LOD score of 6.9. This was confirmed in a second Pakistani family with three affected members, with a LOD score of 2.4. The combined-haplotype data identify a critical region between D19S570 and D19S908, an interval of 8.5 cM on 19q13.1-19q13.3. This is the first study to localize a gene for nonsyndromic SD. ARSD is clinically heterogeneous and is likely to result from mutations in developmental genes or from regulating transcription factors. Identification of these genes will improve the understanding of the molecular processes contributing to both normal and abnormal human vertebral development.	Royal Devon & Exeter Hosp, Dept Clin Genet, Exeter EX2 5DW, Devon, England; Sch Postgrad Med & Hlth Sci, Div Clin Sci, Dept Mol Genet, Exeter, Devon, England; Safad Hosp, Dept Psychiat, Safed, Israel; Northwick Pk & St Marks Trust, Kennedy Galton Ctr, Harrow, Middx, England	University of Exeter; University of Exeter	Turnpenny, PD (corresponding author), Royal Devon & Exeter Hosp, Dept Clin Genet, Exeter EX2 5DW, Devon, England.	turnpenn@eurobell.co.uk		Hattersley, Andrew/0000-0001-5620-473X; Ellard, Sian/0000-0002-7620-5526; Frayling, Timothy/0000-0001-8362-2603				Aurora P, 1996, CLIN DYSMORPHOL, V5, P165, DOI 10.1097/00019605-199604000-00009; AYME S, 1986, AM J MED GENET, V24, P599, DOI 10.1002/ajmg.1320240403; Balling R, 1994, Clin Dysmorphol, V3, P185; BARTSOCAS C S, 1974, Birth Defects Original Article Series, V10, P221; BEIGHTON P, 1981, CLIN GENET, V19, P23; BONAIME JL, 1978, PEDIATRIE, V33, P173; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; CANTU J M, 1971, Clinical Genetics, V2, P149; CASAMASSIMA AC, 1981, AM J MED GENET, V8, P117, DOI 10.1002/ajmg.1320080114; CASTROVIEJO IP, 1973, DEV MED CHILD NEUROL, V15, P348; Crow YJ, 1997, CLIN DYSMORPHOL, V6, P347, DOI 10.1097/00019605-199710000-00008; DAVID TJ, 1983, J MED GENET, V20, P441, DOI 10.1136/jmg.20.6.441; DEGROUCHY J, 1963, CR HEBD ACAD SCI, V256, P1614; DELGOFFE C, 1982, ANN PEDIATR-PARIS, V29, P135; Dowton SB, 1997, J MED GENET, V34, P414, DOI 10.1136/jmg.34.5.414; FLOOR E, 1989, CLIN GENET, V36, P236; FRANCESC.P, 1974, RADIOLOGY, V112, P673, DOI 10.1148/112.3.673; GELB BD, 1995, NAT GENET, V10, P235, DOI 10.1038/ng0695-235; Giampietro PF, 1999, AM J MED GENET, V83, P164, DOI 10.1002/(SICI)1096-8628(19990319)83:3<164::AID-AJMG5>3.0.CO;2-D; HORAN GSB, 1995, DEV BIOL, V169, P359, DOI 10.1006/dbio.1995.1150; Jarcho S, 1938, B JOHNS HOPKINS HOSP, V62, P216; KESSEL M, 1991, SEMIN DEV BIOL, V2, P367; KOZLOWSKI K, 1984, FORTSCHR RONTG NEUEN, V140, P204, DOI 10.1055/s-2008-1052954; Kusumi K, 1998, NAT GENET, V19, P274, DOI 10.1038/961; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LORENZ P, 1990, AM J MED GENET, V35, P219, DOI 10.1002/ajmg.1320350215; MARTINEZFRIAS ML, 1994, AM J MED GENET, V51, P203, DOI 10.1002/ajmg.1320510306; Mortier GR, 1996, AM J MED GENET, V61, P310, DOI 10.1002/(SICI)1096-8628(19960202)61:4<310::AID-AJMG3>3.0.CO;2-Y; NORUM RA, 1969, BIRTH DEFECTS, V5, P326; Riccardi V M, 1977, Birth Defects Orig Artic Ser, V13, P171; RIMOIN DL, 1968, AM J MED, V45, P948, DOI 10.1016/0002-9343(68)90193-9; ROBERTS AP, 1988, J BONE JOINT SURG BR, V70, P123, DOI 10.1302/0301-620X.70B1.3339042; SATAR M, 1992, CLIN GENET, V41, P290; SILENGO MC, 1978, CLIN GENET, V13, P289; SMITH CA, 1994, CLIN ORTHOP RELAT R, P241; TEMPLE IK, 1988, J MED GENET, V25, P831, DOI 10.1136/jmg.25.12.831; TURNPENNY PD, 1991, J MED GENET, V28, P27, DOI 10.1136/jmg.28.1.27; WADIA RS, 1978, J MED GENET, V15, P123, DOI 10.1136/jmg.15.2.123	38	49	60	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1999	65	1					175	182		10.1086/302464	http://dx.doi.org/10.1086/302464			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	212NZ	10364530	Bronze, Green Published			2022-12-18	WOS:000081224300022
J	Sybert, VP; Francis, JS; Corden, LD; Smith, LT; Weaver, M; Stephens, K; McLean, WHI				Sybert, VP; Francis, JS; Corden, LD; Smith, LT; Weaver, M; Stephens, K; McLean, WHI			Cyclic ichthyosis with epidermolytic hyperkeratosis: A phenotype conferred by mutations in the 2B domain of keratin K1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BULLOSA SIMPLEX PATIENTS; GENE; DIFFERENTIATION; ERYTHRODERMA; FAMILIES; DISORDER; SIEMENS; 2E	Bullous congenital ichthyosiform erythroderma (BCIE) is characterized by blistering and erythroderma in infancy and by erythroderma and ichthyosis thereafter. Epidermolytic hyperkeratosis is a hallmark feature of light and electron microscopy. Here we report on Tour individuals from two families with a unique clinical disorder with histological findings of epidermolytic hyperkeratosis; Manifesting erythema and superficial erosions at birth, which improved during the first few months of life, affected individuals later developed palmoplantar hyperkeratosis with patchy erythema and scale elsewhere on the body. Three affected individuals exhibit dramatic episodic flares of annular, polycyclic erythematous plaques with scale, which coalesce to involve most of the body surface. The flares last weeks to months. In the interim periods the skin may be normal, except for palmoplantar hyperkeratosis. Abnormal keratin-filament aggregates were observed in suprabasal keratinocytes from both probands, suggesting that the causative mutation might reside in keratin K1 or keratin K10. In one proband, sequencing of K1 revealed a heterozygous mutation, 1436T-->C, predicting a change of isoleucine to threonine in the highly conserved helix-termination motif. In the second family, a heterozygous mutation, 1435A-->T, was found in K1, predicting an isoleucine-to-phenylalanine substitution in the same codon. Both mutations were excluded in both a control population and all unaffected family members tested. These findings reveal that a clinical phenotype distinct from classic BCIE but with similar histology can result from K1 mutations and that mutations at this codon give rise to a clinically unique condition.	Childrens Hosp & Med Ctr, Div Dermatol, Dept Pediat, Seattle, WA 98105 USA; Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Biol Struct, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98195 USA; Univ Dundee, Dept Anat & Physiol, Dundee DD1 4HN, Scotland; Ninewells Med Sch, Dept Mol & Cellular Pathol, Dundee, Scotland	Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Dundee; University of Dundee	Sybert, VP (corresponding author), Childrens Hosp & Med Ctr, Div Dermatol, Dept Pediat, CH-25,4800 Sand Point Way NE,POB 5371, Seattle, WA 98105 USA.		McLean, William HI/C-6352-2009	McLean, William Henry Irwin/0000-0001-5539-5757	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR021557] Funding Source: NIH RePORTER; NIADDK NIH HHS [AM 62272] Funding Source: Medline; NIAMS NIH HHS [P01-AR21557] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BONIFAS JM, 1994, J INVEST DERMATOL, V103, P474, DOI 10.1111/1523-1747.ep12395570; BONIFAS JM, 1991, SCIENCE, V254, P1202, DOI 10.1126/science.1720261; CHENG J, 1992, CELL, V70, P811, DOI 10.1016/0092-8674(92)90314-3; CHIPEV CC, 1992, CELL, V70, P821, DOI 10.1016/0092-8674(92)90315-4; COLLIN C, 1992, EXP CELL RES, V202, P132, DOI 10.1016/0014-4827(92)90412-2; Corden L D, 1996, Exp Dermatol, V5, P297, DOI 10.1111/j.1600-0625.1996.tb00133.x; COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y; DIGIOVANNA JJ, 1994, ARCH DERMATOL, V130, P1026, DOI 10.1001/archderm.130.8.1026; Francis J. S., 1996, American Journal of Human Genetics, V59, pA38; HOLBROOK KA, 1987, J INVEST DERMATOL, V88, P330, DOI 10.1111/1523-1747.ep12466219; Irvine AD, 1997, NAT GENET, V16, P184, DOI 10.1038/ng0697-184; Joh GY, 1997, J INVEST DERMATOL, V108, P357, DOI 10.1111/1523-1747.ep12286491; JOHNSON LD, 1985, P NATL ACAD SCI USA, V82, P1896, DOI 10.1073/pnas.82.7.1896; KIMONIS V, 1994, J INVEST DERMATOL, V103, P764, DOI 10.1111/1523-1747.ep12412771; KOGAN SC, 1989, PCR PROTOCOLS GUIDE, P288; LANE EB, 1992, NATURE, V356, P244, DOI 10.1038/356244a0; MCLEAN WHI, 1994, J INVEST DERMATOL, V103, P277, DOI 10.1111/1523-1747.ep12394307; MCLEAN WHI, 1995, NAT GENET, V9, P273, DOI 10.1038/ng0395-273; MCLEAN WHI, 1994, J INVEST DERMATOL, V102, P24, DOI 10.1111/1523-1747.ep12371726; Michael EJ, 1997, J INVEST DERMATOL, V108, P150; QUINLAN R, 1994, PROTEIN PROFILE, V1, P779; RICHARD G, 1998, AM J HUM GENET S, V63, pA52; ROTHNAGEL JA, 1992, SCIENCE, V257, P1128, DOI 10.1126/science.257.5073.1128; ROTHNAGEL JA, 1994, NAT GENET, V7, P485, DOI 10.1038/ng0894-485; STEINERT PM, 1993, BIOCHEM BIOPH RES CO, V197, P840, DOI 10.1006/bbrc.1993.2555; Stephens K, 1997, J INVEST DERMATOL, V108, P349, DOI 10.1111/1523-1747.ep12286486; VANDERSCHROEFF JG, 1988, HUM GENET, V80, P97, DOI 10.1007/BF00451466	27	49	53	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1999	64	3					732	738		10.1086/302278	http://dx.doi.org/10.1086/302278			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	177HN	10053007	Green Published, Bronze			2022-12-18	WOS:000079204700010
J	Gieser, L; Fujita, R; Goring, HHH; Ott, J; Hoffman, DR; Cideciyan, AV; Birch, DG; Jacobson, SG; Swaroop, A				Gieser, L; Fujita, R; Goring, HHH; Ott, J; Hoffman, DR; Cideciyan, AV; Birch, DG; Jacobson, SG; Swaroop, A			A novel locus (RP24) for X-linked retinitis pigmentosa maps to Xq26-27	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; CONE-ROD DEGENERATION; LINKAGE ANALYSIS; RPGR GENE; FAMILIES; HETEROGENEITY; PHOTOTRANSDUCTION; CARRIERS; HOMOLOGY; REGION	Two genetic loci, RP2 and RP3, for X-linked retinitis pigmentosa (XLRP) have been localized to Xp11.3-11.23 and Xp21.1, respectively. RP3 appears to account for 70% of XLRP families; however, mutations in the RPGR gene (isolated from the RP3 region) are identified in only 20% of affected families. Close location of XLRP loci at Xp and a lack of unambiguous clinical criteria do not permit assignment of genetic subtype in a majority of XLRP families; nonetheless, in some pedigrees, both RP2 and RP3 could be excluded as the causative locus. We report the mapping of a novel locus, RP24, by haplotype and linkage analysis of a single XLRP pedigree. The RP24 locus was identified at Xq26-27 by genotyping 52 microsatellite markers spanning the entire X chromosome. A maximum LOD score of 4.21 was obtained with DXS8106. Haplotype analysis assigned RP24 within a 23-cM region between the DXS8094 (proximal) and DXS8043 (distal) markers. Other chromosomal regions and known XLRP loci were excluded by obligate recombination events between markers in those regions and the disease locus. Hemizygotes from the RP24 family have early onset of rod photoreceptor dysfunction; cone receptor function is normal at first, but there is progressive loss. Patients at advanced stages show little or no detectable rod or cone function and have clinical hallmarks of typical RP. Mapping of the RP24 locus expands our understanding of the genetic heterogeneity in XLRP and will assist in development of better tools for diagnosis.	Univ Michigan, WK Kellogg Eye Ctr, Dept Ophthalmol, Ann Arbor, MI 48105 USA; Univ Michigan, WK Kellogg Eye Ctr, Dept Human Genet, Ann Arbor, MI 48105 USA; Columbia Univ, Dept Genet & Dev, New York, NY 10027 USA; Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA; Retina Fdn SW, Dallas, TX USA; Univ Penn, Dept Ophthalmol, Scheie Eye Inst, Philadelphia, PA 19104 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Columbia University; Rockefeller University; Retina Foundation of the Southwest; University of Pennsylvania	Swaroop, A (corresponding author), Univ Michigan, WK Kellogg Eye Ctr, Dept Ophthalmol, 1000 Wall St, Ann Arbor, MI 48105 USA.		Cideciyan, Artur V/A-1075-2007	Cideciyan, Artur V/0000-0002-2018-0905; Swaroop, Anand/0000-0002-1975-1141; Fujita, Ricardo/0000-0002-9617-5109; Jacobson, Samuel/0000-0003-2122-169X; Birch, David/0000-0002-6594-2897	NATIONAL EYE INSTITUTE [R29EY007961, R01EY007961, R01EY005627] Funding Source: NIH RePORTER; NEI NIH HHS [EY07961, EY05235, EY05627] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALDRED MA, 1994, J MED GENET, V31, P848, DOI 10.1136/jmg.31.11.848; Aldred MA, 1994, MOL GENETICS INHERIT, P259; Becker A, 1998, HUM HERED, V48, P49, DOI 10.1159/000022781; Bergen AAB, 1997, AM J HUM GENET, V60, P1468, DOI 10.1086/515458; BERSON EL, 1979, AM J OPHTHALMOL, V87, P460, DOI 10.1016/0002-9394(79)90231-9; BHATTACHARYA SS, 1984, NATURE, V309, P253, DOI 10.1038/309253a0; BIRCH DG, 1987, INVEST OPHTH VIS SCI, V28, P140; Buraczynska M, 1997, AM J HUM GENET, V61, P1287, DOI 10.1086/301646; CHEN YT, 1990, P NATL ACAD SCI USA, V87, P3077, DOI 10.1073/pnas.87.8.3077; Cideciyan AV, 1998, P NATL ACAD SCI USA, V95, P7103, DOI 10.1073/pnas.95.12.7103; Cideciyan AV, 1996, VISION RES, V36, P2609, DOI 10.1016/0042-6989(95)00327-4; CIDECIYAN AV, 1993, INVEST OPHTH VIS SCI, V34, P3253; FISHMAN GA, 1986, ARCH OPHTHALMOL-CHIC, V104, P1329, DOI 10.1001/archopht.1986.01050210083030; Fujita R, 1997, AM J HUM GENET, V61, P571, DOI 10.1086/515523; FUJITA R, 1996, RPGR PART ONE X LINK; Heckenlively J. R., 1988, RETINITIS PIGMENTOSA; HOOD DC, 1993, VISION RES, V33, P1605, DOI 10.1016/0042-6989(93)90027-T; HOOD DC, 1995, VISION RES, V35, P2801, DOI 10.1016/0042-6989(95)00034-W; Hood Donald C., 1996, Documenta Ophthalmologica, V92, P253, DOI 10.1007/BF02584080; JACOBSON SG, 1989, EXP EYE RES, V48, P679, DOI 10.1016/0014-4835(89)90009-2; Jacobson SG, 1997, INVEST OPHTH VIS SCI, V38, P1983; JACOBSON SG, 1991, HDB CLIN VISION TEST, P475; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Li ZY, 1998, INVEST OPHTH VIS SCI, V39, P808; MCGUIRE RE, 1995, AM J HUM GENET, V57, P87; Meindl A, 1996, NAT GENET, V13, P35, DOI 10.1038/ng0596-35; MUSARELLA MA, 1990, GENOMICS, V8, P286, DOI 10.1016/0888-7543(90)90284-2; OTT J, 1990, P NATL ACAD SCI USA, V87, P701, DOI 10.1073/pnas.87.2.701; Roepman R, 1996, HUM MOL GENET, V5, P1035, DOI 10.1093/hmg/5.7.1035; ROOF DJ, 1994, INVEST OPHTH VIS SCI, V35, P4049; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; TEAGUE PW, 1994, AM J HUM GENET, V55, P105; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; Thiselton DL, 1996, GENOME RES, V6, P1093, DOI 10.1101/gr.6.11.1093	34	49	52	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1998	63	5					1439	1447		10.1086/302121	http://dx.doi.org/10.1086/302121			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	138QZ	9792872	Green Published, Bronze			2022-12-18	WOS:000076985200021
J	Mendez, M; Sorkin, L; Rossetti, MV; Astrin, KH; Batlle, AMD; Parera, VE; Aizencang, G; Desnick, RJ				Mendez, M; Sorkin, L; Rossetti, MV; Astrin, KH; Batlle, AMD; Parera, VE; Aizencang, G; Desnick, RJ			Familial porphyria cutanea tarda: Characterization of seven novel uroporphyrinogen decarboxylase mutations and frequency of common hemochromatosis alleles	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL ERYTHROPOIETIC PORPHYRIA; HEPATITIS-C VIRUS; III SYNTHASE GENE; HEPATOERYTHROPOIETIC-PORPHYRIA; HYDROXYMETHYLBILANE SYNTHASE; HEREDITARY HEMOCHROMATOSIS; NUCLEOTIDE-SEQUENCE; MOLECULAR-CLONING; EXONIC MUTATIONS; IDENTIFICATION	Familial porphyria cutanea tarda (f-PCT) results from the half-normal activity of uroporphyrinogen decarboxylase (URO-D). Heterozygotes for this autosomal dominant trait are predisposed to photosensitive cutaneous lesions by various ecogenic factors, including iron over- load and alcohol abuse. The 3.6kb URO-D gene was completely sequenced, and a long-range PCR method was developed to amplify the entire gene for mutation analysis. Four missense mutations (M165R, L195F, N304K, and R332H), a microinsertion (g10insA), a deletion (g645 Delta 1053), and a novel exonic splicing defect (E314E) were identified. Expression of the L195F, N304K, and R332H polypeptides revealed significant residual activity, whereas reverse transcription-PCR and sequencing demonstrated that the E314E lesion caused abnormal splicing and exon 9 skipping. Haplotyping indicated that three of the four families with the g10insA mutation were unrelated, indicating that these micro-insertions resulted from independent mutational events. Screening of nine f-PCT probands revealed that 44% were heterozygous or homozygous for the common hemochromatosis mutations, which suggests that iron overload may predispose to clinical expression. However, there was no clear correlation between f-PCT disease severity and the URO-D and/or hemochromatosis genotypes. These studies doubled the number of known f-PCT mutations, demonstrated that marked genetic heterogeneity underlies f-PCT, and permitted presymptomatic molecular diagnosis and counseling in these families to enable family members to avoid disease-precipitating factors.	CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Univ Buenos Aires, Ctr Invest Sobre Porfirinas & Porfirias, Buenos Aires, DF, Argentina	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; University of Buenos Aires	Desnick, RJ (corresponding author), CUNY Mt Sinai Sch Med, Dept Human Genet, Box 1498,5th Ave 100th St, New York, NY 10029 USA.	RJDesnick@vaxa.crc.mssm.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026824] Funding Source: NIH RePORTER; NCRR NIH HHS [5 M01 RR00071] Funding Source: Medline; NIDDK NIH HHS [5 R01 DK26824] Funding Source: Medline; BHP HRSA HHS [5 P30 DH28822] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); BHP HRSA HHS		AFONSO S G, 1985, Revista Argentina de Dermatologia, V66, P12; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; BATLLE A, 1997, FED BIOQUIM P BS A S, V3, P1; CHEN CH, 1994, J CLIN INVEST, V94, P1927, DOI 10.1172/JCI117543; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; de Verneuil H, 1978, Hum Genet, V44, P145; DECASTRO M, 1993, HEPATOLOGY, V17, P551, DOI 10.1002/hep.1840170405; DEVERNEUIL H, 1992, HUM GENET, V89, P548; DEVERNEUIL H, 1988, HUM GENET, V78, P101, DOI 10.1007/BF00291248; DEVERNEUIL H, 1983, J BIOL CHEM, V258, P2454; DEVERNEUIL H, 1986, J CLIN INVEST, V77, P431, DOI 10.1172/JCI112321; DEVERNEUIL H, 1986, SCIENCE, V234, P732, DOI 10.1126/science.3775362; DEVERNEUIL H, 1984, HUM GENET, V66, P202, DOI 10.1007/BF00286601; DEVERNEUIL H, 1980, BIOCHIM BIOPHYS ACTA, V611, P174, DOI 10.1016/0005-2744(80)90053-4; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DUBART A, 1986, HUM GENET, V73, P277, DOI 10.1007/BF00401245; Elder GH, 1998, SEMIN LIVER DIS, V18, P67, DOI 10.1055/s-2007-1007142; ELDER GH, 1978, NEW ENGL J MED, V299, P274, DOI 10.1056/NEJM197808102990603; Fargion S, 1996, J HEPATOL, V24, P564, DOI 10.1016/S0168-8278(96)80141-3; FARGION S, 1992, HEPATOLOGY, V16, P1322, DOI 10.1002/hep.1840160603; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; FELSHER BF, 1977, SEMIN HEMATOL, V14, P243; GAREY JR, 1993, GASTROENTEROLOGY, V105, P165, DOI 10.1016/0016-5085(93)90022-5; GAREY JR, 1989, BLOOD, V73, P892; GAREY JR, 1990, J CLIN INVEST, V86, P1416, DOI 10.1172/JCI114856; GELB BD, 1995, NAT GENET, V10, P235, DOI 10.1038/ng0695-235; GRANDCHAMP B, 1987, EUR J BIOCHEM, V162, P105, DOI 10.1111/j.1432-1033.1987.tb10548.x; GROSSMAN ME, 1979, AM J MED, V67, P277, DOI 10.1016/0002-9343(79)90403-0; JACKSON AH, 1976, PHILOS T ROY SOC B, V273, P191, DOI 10.1098/rstb.1976.0009; Kappas A, 1995, METABOLIC MOL BASES, P2103; KAYA AH, 1994, GENOMICS, V19, P242, DOI 10.1006/geno.1994.1054; KORNREICH R, 1990, J BIOL CHEM, V265, P9319; KOSZO F, 1990, BRIT J DERMATOL, V122, P365, DOI 10.1111/j.1365-2133.1990.tb08285.x; KRAWCZAK M, 1992, HUM GENET, V90, P41; KUSHNER JP, 1976, J CLIN INVEST, V58, P1089, DOI 10.1172/JCI108560; Lai K, 1998, HUM MUTAT, V11, P28; LIM CK, 1983, BIOCHEM J, V211, P435, DOI 10.1042/bj2110435; LUNDVALL O, 1970, ACTA MED SCAND, V188, P37; MCGOVERN MM, 1996, EMERY RIMOINS PRINCI, P2009; McManus JF, 1996, BLOOD, V88, P3589, DOI 10.1182/blood.V88.9.3589.bloodjournal8893589; MCMANUS JF, 1994, CLIN CHEM, V40, P1884; MEGURO K, 1994, J INVEST DERMATOL, V102, P681, DOI 10.1111/1523-1747.ep12374134; MoranJimenez MJ, 1996, AM J HUM GENET, V58, P712; ROBERTS AG, 1995, J INVEST DERMATOL, V104, P500, DOI 10.1111/1523-1747.ep12605953; Roberts AG, 1997, LANCET, V349, P321, DOI 10.1016/S0140-6736(96)09436-6; ROMANA M, 1991, EUR J CLIN INVEST, V21, P225, DOI 10.1111/j.1365-2362.1991.tb01814.x; ROMANA M, 1987, NUCLEIC ACIDS RES, V15, P7343, DOI 10.1093/nar/15.18.7343; ROMEO PH, 1986, J BIOL CHEM, V261, P9825; Sampietro M, 1998, HEPATOLOGY, V27, P181, DOI 10.1002/hep.510270128; Santos M, 1997, NEW ENGL J MED, V336, P1327, DOI 10.1056/NEJM199705013361817; SMITH SG, 1986, SEMIN DERMATOL, V5, P125; Sorkin L., 1996, American Journal of Human Genetics, V59, pA285; TSAI SF, 1988, P NATL ACAD SCI USA, V85, P7049, DOI 10.1073/pnas.85.19.7049; WARNER CA, 1992, J CLIN INVEST, V89, P693, DOI 10.1172/JCI115637; Whitby FG, 1998, EMBO J, V17, P2463, DOI 10.1093/emboj/17.9.2463; XU WM, 1995, J CLIN INVEST, V95, P905, DOI 10.1172/JCI117742; YOO HW, 1993, GENOMICS, V15, P21, DOI 10.1006/geno.1993.1005	57	49	52	0	3	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1998	63	5					1363	1375		10.1086/302119	http://dx.doi.org/10.1086/302119			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	138QZ	9792863	Green Published, Bronze			2022-12-18	WOS:000076985200012
J	Malaspina, P; Cruciani, F; Ciminelli, BM; Terrenato, L; Santolamazza, P; Alonso, A; Banyko, J; Brdicka, R; Garcia, O; Gaudiano, C; Guanti, G; Kidd, KK; Lavinha, J; Avila, M; Mandich, P; Moral, P; Qamar, R; Mehdi, SQ; Ragusa, A; Sefanescu, G; Caraghin, M; Tyler-Smith, C; Scozzari, R; Novelletto, A				Malaspina, P; Cruciani, F; Ciminelli, BM; Terrenato, L; Santolamazza, P; Alonso, A; Banyko, J; Brdicka, R; Garcia, O; Gaudiano, C; Guanti, G; Kidd, KK; Lavinha, J; Avila, M; Mandich, P; Moral, P; Qamar, R; Mehdi, SQ; Ragusa, A; Sefanescu, G; Caraghin, M; Tyler-Smith, C; Scozzari, R; Novelletto, A			Network analyses of Y-chromosomal types in Europe, Northern Africa, and Western Asia reveal specific patterns of geographic distribution	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL GENE POOL; ALPHOID SATELLITE DNA; HUMAN-POPULATIONS; MICROSATELLITE LOCI; NEOLITHIC LINEAGES; HAPLOTYPES; POLYMORPHISMS; MARKERS; TRANSITION; SEQUENCES	In a study of 908 males from Europe, northern Africa, and western Asia, the variation of four Y-linked dinucleotide microsatellites was analyzed within three "frames" that are defined by mutations that are nonrecurrent, or nearly so. The rapid generation and extinction of new dinucleotide length variants causes the haplotypes within each lineage to diverge from one another. We constructed networks of "adjacent" haplotypes within each frame, by assuming changes of a single dinucleotide unit. Two small and six large networks were obtained, the latter including 94.9% of the sampled Y chromosomes. We show that the phenetic relationships among haplotypes, represented as a network, result largely from common descent and subsequent molecular radiation. The grouping of haplotypes of the same network thus fits an evolutionarily relevant criterion. Notably, this method allows the total diversity within a sample to be partitioned. Networks can be considered optimal markers for population studies, because reliable frequency estimates can be obtained in small samples. We present synthetic maps describing the incidence of different Y-chromosomal lineages in the extant human populations of the surveyed areas. Dinucleotide diversity also was used to infer time intervals for the coalescence of each network.	Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; Univ Roma La Sapienza, Dept Genet & Mol Biol, Rome, Italy; Inst Nacl Toxicol, Madrid, Spain; Safarik Univ, Dept Anthropol, Kosice, Slovakia; Natl Inst Haematol & Blood Transfus, Prague, Czech Republic; Basque Country Police, Bilbao, Spain; Ctr Lotto Microcitemie, Matera, Italy; Univ Bari, Bari, Italy; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Inst Nacl Saude, Lisbon, Portugal; Univ Genoa, Genoa, Italy; Univ Barcelona, Dept Biol Anim, Barcelona, Spain; Oasi Inst, Troina, Italy; AQ Khan Res Labs, Islamabad, Pakistan; Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; Inst Cercetari Biol, Iasi, Romania	University of Rome Tor Vergata; Sapienza University Rome; University of Pavol Jozef Safarik Kosice; Universita degli Studi di Bari Aldo Moro; Yale University; Instituto Nacional de Saude Dr. Ricardo Jorge; University of Genoa; University of Barcelona; IRCCS Oasi Maria SS; University of Oxford	Novelletto, A (corresponding author), Univ Roma Tor Vergata, Dept Biol, Via E Carnevale, I-00173 Rome, Italy.	novelletto@bio.uniroma2.it	qamar, raheel/D-4543-2012; Moral, Pedro/K-9587-2014; Mehdi, Syed Qasim/L-2385-2015; Qamar, Raheel/G-3355-2015; Cruciani, Fulvio/G-6105-2012; Malaspina, Patrizia/G-7772-2017	Moral, Pedro/0000-0001-5072-5892; Novelletto, Andrea/0000-0002-1146-7680; Cruciani, Fulvio/0000-0002-6900-024X; Malaspina, Patrizia/0000-0002-0067-369X; Stefanescu, Gheorghe/0000-0002-6200-0992; Lavinha, Joao/0000-0002-7474-6871				BANDELT HJ, 1995, GENETICS, V141, P743; Barbujani G, 1998, AM J HUM GENET, V62, P488, DOI 10.1086/301719; BARBUJANI G, 1991, AM J HUM GENET, V48, P398; BARBUJANI G, 1990, P NATL ACAD SCI USA, V87, P1816, DOI 10.1073/pnas.87.5.1816; Bianchi NO, 1997, AM J PHYS ANTHROPOL, V102, P79; Caglia A, 1997, EUR J HUM GENET, V5, P288, DOI 10.1159/000484779; Cappello N, 1996, ANN HUM GENET, V60, P125, DOI 10.1111/j.1469-1809.1996.tb01183.x; CASANOVA M, 1985, SCIENCE, V230, P1403, DOI 10.1126/science.2999986; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CavalliSforza LL, 1997, AM J HUM GENET, V61, P247, DOI 10.1016/S0002-9297(07)64303-1; Ciminelli BM, 1995, J MOL EVOL, V41, P966; Cooper G, 1996, HUM MOL GENET, V5, P1759, DOI 10.1093/hmg/5.11.1759; DEKA R, 1995, AM J HUM GENET, V56, P461; Delfiner P, 1976, ADV GEOSTATISTICS MI, P49; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; EXCOFFIER L, 1992, GENETICS, V131, P479; Goldstein DB, 1996, MOL BIOL EVOL, V13, P1213, DOI 10.1093/oxfordjournals.molbev.a025686; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HAMMER MF, 1994, MOL BIOL EVOL, V11, P749; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Hammer MF, 1997, GENETICS, V145, P787; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; JOBLING MA, 1995, TRENDS GENET, V11, P449, DOI 10.1016/S0168-9525(00)89144-1; Kayser M, 1997, ELECTROPHORESIS, V18, P1602, DOI 10.1002/elps.1150180920; Linares AR, 1996, ANN HUM GENET, V60, P401, DOI 10.1111/j.1469-1809.1996.tb00438.x; Lucotte G, 1996, J MOL EVOL, V42, P472; Malaspina P, 1997, J MOL EVOL, V44, P652; MATHIAS N, 1994, HUM MOL GENET, V3, P115, DOI 10.1093/hmg/3.1.115; PERSICHETTI F, 1992, ANN HUM GENET, V56, P303, DOI 10.1111/j.1469-1809.1992.tb01157.x; Richards M, 1998, AM J HUM GENET, V62, P491, DOI 10.1086/301733; Richards M, 1997, AM J HUM GENET, V61, P251; Richards M, 1996, AM J HUM GENET, V59, P185; ROEWER L, 1992, HUM GENET, V89, P389; Roewer L, 1996, HUM MOL GENET, V5, P1029, DOI 10.1093/hmg/5.7.1029; SANTACHIARABENE.AS, 1994, AM J HUM GENET S, V55, pA164; Santos FR, 1996, GENOME RES, V6, P601, DOI 10.1101/gr.6.7.601; SANTOS FR, 1995, GENE, V165, P191, DOI 10.1016/0378-1119(95)00501-V; Scozzari R, 1997, AM J HUM GENET, V61, P719, DOI 10.1086/515500; SEIELSTAD MT, 1994, HUM MOL GENET, V3, P2159; Semino O, 1996, AM J HUM GENET, V59, P964; SPURDLE AB, 1994, AM J HUM GENET, V54, P319; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; TORRONI A, 1990, ANN HUM GENET, V54, P287; TYLERSMITH C, 1987, J MOL BIOL, V195, P457, DOI 10.1016/0022-2836(87)90175-6; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196; WATKINS WS, 1995, HUM MOL GENET, V4, P1485, DOI 10.1093/hmg/4.9.1485; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WHITFIELD LS, 1995, NATURE, V378, P379, DOI 10.1038/378379a0; Zerjal T, 1997, AM J HUM GENET, V60, P1174	51	49	49	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1998	63	3					847	860		10.1086/301999	http://dx.doi.org/10.1086/301999			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	119VN	9718330	hybrid, Green Published			2022-12-18	WOS:000075919000024
J	Zhao, LP; Aragaki, C; Hsu, L; Quiaoit, F				Zhao, LP; Aragaki, C; Hsu, L; Quiaoit, F			Mapping of complex traits by single-nucleotide polymorphisms	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE; ASSOCIATION; DENSITY; GENOME	Molecular geneticists are developing the third-generation human genome map with single-nucleotide polymorphisms (SNPs), which can be assayed via chip-based microarrays. One use of these SNP markers is the ability to locate loci that may be responsible for complex traits, via linkage/linkage-disequilibrium analysis. Ln this communication, we describe a semiparametric method for combined linkage/linkage-disequilibrium analysis using SNP markers. Asymptotic results are obtained for the estimated parameters, and the finite-sample properties are evaluated via a simulation study. We also applied this technique to a simulated genome-scan experiment for mapping a complex trait with two major genes. This experiment shows that separate linkage and linkage-disequilibrium analyses correctly detected the signals of both major genes; but the rates of false-positive signals seem high.When linkage and linkage-disequilibrium signals were combined, the analysis yielded much stronger and clearer signals for the presence of two major genes than did two separate analyses.	Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Quantitat Genet Epidemiol Grp, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Zhao, LP (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Quantitat Genet Epidemiol Grp, MW806,1100 Fairview Ave N, Seattle, WA 98109 USA.	lzhao@fhcrc.org			NCI NIH HHS [CA55670, CA64046, CA-33619] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA055670, R01CA064046, P01CA033619] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; EWENS WJ, 1995, AM J HUM GENET, V57, P455; Guo SW, 1997, HUM HERED, V47, P301, DOI 10.1159/000154430; Haldane JBS, 1919, J GENET, V8, P299; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; Kruglyak L, 1997, NAT GENET, V17, P21, DOI 10.1038/ng0997-21; KRUGLYAK L, 1995, AM J HUM GENET, V56, P1212; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LIPSHUTZ R, 1997, GENOME DIGEST, V4, P10; LUE PZ, 1992, AM J HUM GENET, V51, P178; Martin ER, 1997, AM J HUM GENET, V61, P439, DOI 10.1086/514860; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; OTT J, 1989, ANAL HUMAN GENETIC L; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SCHAID DJ, 1994, AM J HUM GENET, V55, P402; SELF SG, 1991, BIOMETRICS, V47, P53, DOI 10.2307/2532495; Silverman B.W., 1990, DENSITY ESTIMATION S; SPIELMAN RS, 1994, AM J HUM GENET, V54, P559; Terwilliger JD, 1997, AM J HUM GENET, V61, P430, DOI 10.1086/514855; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Whittemore AS, 1996, AM J HUM GENET, V59, P704; Xiong MM, 1997, AM J HUM GENET, V60, P1513, DOI 10.1086/515475; ZHAO LP, 1990, BIOMETRIKA, V77, P642, DOI 10.2307/2337004; Zhao LP, 1998, AM J MED GENET, V77, P366; ZHAO LP, IN PRESS AM J MED GE	27	49	60	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					225	240		10.1086/301909	http://dx.doi.org/10.1086/301909			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	9634510	Bronze, Green Published			2022-12-18	WOS:000074761000031
J	Zhao, HG; Aronovich, EL; Whitley, CB				Zhao, HG; Aronovich, EL; Whitley, CB			Genotype-phenotype correspondence in Sanfilippo syndrome type B	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALPHA-N-ACETYLGLUCOSAMINIDASE; BONE-MARROW TRANSPLANTATION; MUCOPOLYSACCHARIDOSIS-III-B; DISEASE; SIBSHIP; MILD; NOMENCLATURE; FIBROBLASTS	Sanfilippo syndrome type B, or mucopolysaccharidosis type IIIB, results from defects in the gene for alpha-N-acetylglucosaminidase (NAGLU); only a few mutations have been described. To rapidly identify most NAGLU mutations, an automated sequencing procedure was developed for analysis of the entire coding region, including exon-intron borders. By this method, eight affected families were studied, and the mutations in all 16 alleles were identified, more than doubling the number of published mutations for this gene. Eight mutations were described for the first time: five missense mutations (Y140C, Y455C, P521L, SG12G, and R674C), two nonsense mutations (W675X and Q706X), and one 24-nucleotide insertion. Currently, 36% of all point mutations (8 of 22 alleles) involve R674, a codon having a CpG dinucleotide in the critical initial position. Other mutations were found in more than one family, raising the possibility that some may be relatively common and, possibly, ancient mutations. Six new nonpathological mutations were also identified and likely represent polymorphic variants of the NAGLU gene, two of which might alter enzyme level. Establishing genotype-phenotype relationships will be vital in the evaluation of experimental treatments such as gene therapy.	Univ Minnesota, Dept Pediat, Inst Human Genet, Gene Therapy Program,UMHC, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Whitley, CB (corresponding author), Univ Minnesota, Dept Pediat, Inst Human Genet, Gene Therapy Program,UMHC, Box 446,420 Delaware St SE, Minneapolis, MN 55455 USA.	whitley@maroon.tc.umn.edu		Aronovich, Elena/0000-0002-9713-8502				ANDRIA G, 1979, CLIN GENET, V15, P500; Aronovich E. L., 1996, American Journal of Human Genetics, V59, pA246; BALLABIO A, 1984, CLIN GENET, V25, P191; BEAUDET AL, 1993, HUM MUTAT, V2, P245, DOI 10.1002/humu.1380020402; Beutler E, 1996, HUM MUTAT, V8, P203, DOI 10.1002/(SICI)1098-1004(1996)8:3<203::AID-HUMU1>3.3.CO;2-C; DINATALE P, 1982, CLIN CHIM ACTA, V122, P135, DOI 10.1016/0009-8981(82)90273-X; DINATALE P, 1991, J INHERIT METAB DIS, V14, P23, DOI 10.1007/BF01804384; FIGURA KV, 1973, J PEDIATR-US, V83, P607, DOI 10.1016/S0022-3476(73)80222-7; HARA A, 1984, J LIPID RES, V25, P175; HAUST MD, 1986, CONNECT TISSUE RES, V15, P57, DOI 10.3109/03008208609001973; Langley SD, 1997, AM J HUM GENET, V60, P366; MURATA R, 1989, AM J NEURORADIOL, V10, P1165; MUUL LM, 1997, MOL CELLULAR BIOL GE, P52; Neufeld EF, 1995, METABOLIC MOL BASES, P2465; PANDE H, 1992, CLIN GENET, V41, P243; Powell JR, 1997, P NATL ACAD SCI USA, V94, P7784, DOI 10.1073/pnas.94.15.7784; RICHARDS SM, 1993, BLOOD, V82, P1402; SANFILIPPO SJ, 1964, AM J DIS CHILD, V102, P140; Selvaggi TA, 1997, BLOOD, V89, P776, DOI 10.1182/blood.V89.3.776; VANCE JM, 1980, AM J MED GENET, V7, P131, DOI 10.1002/ajmg.1320070207; VANCE JM, 1981, CLIN GENET, V20, P135; VANDEKAMP JJP, 1981, CLIN GENET, V20, P152; VANSCHROJENSTEINDEVALK HMJ, 1987, AM J MED GENET, V28, P125; VELLODI A, 1992, J INHERIT METAB DIS, V15, P911, DOI 10.1007/BF01800232; von Figura K, 1975, Z Klin Chem Klin Biochem, V13, P285; von Figura K, 1972, Biochem Biophys Res Commun, V48, P262, DOI 10.1016/S0006-291X(72)80044-5; VONFIGURA K, 1984, AM J HUM GENET, V36, P93; Weber B, 1996, HUM MOL GENET, V5, P771, DOI 10.1093/hmg/5.6.771; WHITLEY CB, 1993, AM J MED GENET, V46, P209, DOI 10.1002/ajmg.1320460222; WHITLEY CB, 1993, AM J HUM GENET, V53, P101; Zhao H. G., 1994, American Journal of Human Genetics, V55, pA252; Zhao HG, 1996, P NATL ACAD SCI USA, V93, P6101, DOI 10.1073/pnas.93.12.6101	32	49	51	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1998	62	1					53	63		10.1086/301682	http://dx.doi.org/10.1086/301682			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YY246	9443875	Green Published, Bronze			2022-12-18	WOS:000072127900010
J	Manfredi, G; Thyagarajan, D; Papadopoulou, LC; Pallotti, F; Schon, EA				Manfredi, G; Thyagarajan, D; Papadopoulou, LC; Pallotti, F; Schon, EA			The fate of human sperm-derived mtDNA in somatic cells	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA; INHERITANCE; FERTILIZATION; EMBRYOGENESIS; SPERMATOZOA; EVOLUTION	Inheritance of animal mtDNA is almost exclusively maternal, most likely because sperm-derived mitochondria are actively eliminated from the ovum, either at or soon after fertilization. How such elimination occurs is currently unknown. We asked whether similar behavior could be detected in somatic cells, by following the fate of mitochondria and mtDNAs after entry of human sperm into transformed cells containing mitochondria but lacking endogenous mtDNAs (rho(0) cells). We found that a high proportion (10%-20%) of cells contained functioning sperm mitochondria soon after sperm entry. However, under selective conditions permitting only the survival of cells harboring functional mtDNAs, only similar to 1/10(5) cells containing sperm mitochondria survived and proliferated. These data imply that mitochondria in sperm can enter somatic cells relatively easily, but they also suggest that mechanisms exist to eliminate sperm-derived mtDNA from somatic cells, mechanisms perhaps similar to those presumed to operate in the fertilized oocyte.	COLUMBIA UNIV COLL PHYS & SURG,DEPT NEUROL,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT GENET & DEV,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,H HOUSTON MERRITT CLIN RES CTR MUSCULAR DYSTROPHY,NEW YORK,NY 10032	Columbia University; Columbia University; Columbia University			Thyagarajan, Dominic E S/H-6633-2014	Thyagarajan, Dominic E S/0000-0002-7766-4003; Papadopoulou, Lefkothea/0000-0002-5738-969X; Pallotti, Francesco/0000-0001-9946-8516	NIA NIH HHS [AG12131] Funding Source: Medline; NICHD NIH HHS [HD32062] Funding Source: Medline; NINDS NIH HHS [NS28828] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD032062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG012131] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; AnkelSimons F, 1996, P NATL ACAD SCI USA, V93, P13859, DOI 10.1073/pnas.93.24.13859; ASHIDA ER, 1987, P NATL ACAD SCI USA, V84, P3395, DOI 10.1073/pnas.84.10.3395; BAHR GF, 1970, EXP CELL RES, V60, P338, DOI 10.1016/0014-4827(70)90526-4; BENDICH A, 1974, SCIENCE, V183, P857, DOI 10.1126/science.183.4127.857; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; DESJARDINS P, 1986, SOMAT CELL MOLEC GEN, V12, P133, DOI 10.1007/BF01560660; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; GYLLENSTEN U, 1991, NATURE, V352, P255, DOI 10.1038/352255a0; HECHT NB, 1983, GAMETE RES, V7, P289, DOI 10.1002/mrd.1120070310; HIGGINS PJ, 1975, NATURE, V257, P488, DOI 10.1038/257488a0; HIRAOKA J, 1988, GAMETE RES, V19, P369, DOI 10.1002/mrd.1120190408; HUTCHINSON SA, 1974, NATURE, V251, P536; KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542; King M P, 1996, Methods Enzymol, V264, P339, DOI 10.1016/S0076-6879(96)64032-4; KING MP, 1988, CELL, V52, P811, DOI 10.1016/0092-8674(88)90423-0; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480; MORAES CT, 1991, AM J HUM GENET, V48, P492; MORAIS R, 1988, IN VITRO CELL DEV B, V24, P649, DOI 10.1007/BF02623602; ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316; SELIGMAN AM, 1969, J CELL BIOL, V38, P1; SHALGI R, 1994, MOL REPROD DEV, V37, P264, DOI 10.1002/mrd.1080370304; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Sutovsky P, 1996, BIOL REPROD, V55, P1195, DOI 10.1095/biolreprod55.6.1195; SZOLLOSI D, 1965, J EXP ZOOL, V159, P367, DOI 10.1002/jez.1401590309; TRITSCHLER HJ, 1991, NEUROLOGY, V41, P300, DOI 10.1212/WNL.41.2_Part_1.300; VELTRI KL, 1990, J CELL PHYSIOL, V143, P160, DOI 10.1002/jcp.1041430122; WEBER JL, 1989, AM J HUM GENET, V44, P388; ZEVIANI M, 1988, NEUROLOGY, V38, P1339; ZUCKERFRANKLIN D, 1964, J EXP MED, V120, P569, DOI 10.1084/jem.120.4.569	31	49	54	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1997	61	4					953	960		10.1086/514887	http://dx.doi.org/10.1086/514887			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YA591	9382109	Green Published, hybrid			2022-12-18	WOS:A1997YA59100025
J	Jarvik, GP; Goode, EL; Austin, MA; Auwerx, J; Deeb, S; Schellenberg, GD; Reed, T				Jarvik, GP; Goode, EL; Austin, MA; Auwerx, J; Deeb, S; Schellenberg, GD; Reed, T			Evidence that the apolipoprotein E genotype effects on lipid levels can change with age in males: A longitudinal analysis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DENSITY-LIPOPROTEIN-CHOLESTEROL; CORONARY-ARTERY DISEASE; BLOOD-INSTITUTE TWIN; E POLYMORPHISM; TRIGLYCERIDE LEVELS; PLASMA-CHOLESTEROL; ALZHEIMERS-DISEASE; SERUM-CHOLESTEROL; HEART-DISEASE; E PHENOTYPE	We previously reported that change, with age, in plasma levels of total cholesterol (TC) and LDL cholesterol (LDL-C) differed between apolipoprotein E (APOE) genotypes epsilon 3 epsilon 3 and epsilon 3 epsilon 4, in a sample of 77 older, unrelated males. By use of a larger sample from that cohort, followed longitudinally during 1969-87, the change in TC and in LDL-C, between the epsilon 3 epsilon 3 and epsilon 3 epsilon 4 APOE genotypes, over three exams, was reanalyzed. Additionally, the change in triglycerides (TG) and in HDL-cholesterol (HDL-C), between the epsilon 3 epsilon 3 and epsilon 3 epsilon 4 APOE genotypes-as well as the differences between the epsilon 3 epsilon 3 and epsilon 3 epsilon 2 genotypes, for TC, LDL-C, TG, and HDL-C-were contrasted over the three exams. At exam 1 TG was higher in the epsilon 3 epsilon 4 group than in the epsilon 3 epsilon 3 group (mean age 48 years), and at exams 2 and exam 3 (mean ages 58 and 63 years, respectively) it was similar (P =.009 for the exam-by-genotype-interaction effect in the repeated-measures analysis). A similar trend was seen for TC (P =.03), yet previously detected LDL-C effects were not apparent (P =.46). Those with the epsilon 3 epsilon 2 genotype had higher TG and lower LDL-C and TC at each exam than were seen in those with the epsilon 3 epsilon 3 genotype, although the differences in the values were not always statistically significant. Differences in TC, LDL-C, and TG, between the epsilon 3 epsilon 2-genotype and epsilon 3 epsilon 3-genotype groups, did not significantly change over the three exams. HDL-C levels were relatively stable over the exams; however, the exam-by-genotype interaction was significant for the epsilon 3 epsilon 2 genotype versus the epsilon 3 epsilon 3 genotype (P =.02). The epsilon 4 allele effects on TG and TC changed between longitudinal exams and may be age dependent. Changes, with age, in the effect of the epsilon 3 epsilon 4 genotype on lipids may impact the risk of developing atherosclerotic disease.	UNIV WASHINGTON,DEPT EPIDEMIOL,SCH PUBL HLTH & COMMUNITY MED,SEATTLE,WA 98195; VET AFFAIRS MED CTR,CTR GERIATR RES & CLIN,SEATTLE,WA 98108; INST PASTEUR,F-59019 LILLE,FRANCE; INDIANA UNIV,MED CTR,DEPT MED & MOL GENET,INDIANAPOLIS,IN	University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Indiana University System; Indiana University-Purdue University Indianapolis	Jarvik, GP (corresponding author), UNIV WASHINGTON,MED CTR,DIV MED GENET,SCH PUBL HLTH & COMMUNITY MED,DEP MED,BOX 357720,SEATTLE,WA 98195, USA.		Jarvik, Gail P/N-6476-2014; Auwerx, Johan/ABE-9307-2021	Jarvik, Gail P/0000-0002-6710-8708; Auwerx, Johan/0000-0002-5065-5393	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055028, N01HC055023, N01HC055027] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01 HC-55027, N01 HC-55023, N01 HC-55028] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALLAIN CC, 1974, CLIN CHEM, V20, P470; ALVAREZ C, 1984, CLIN CHEM, V30, P404; BOERWINKLE E, 1987, ANN HUM GENET, V51, P211, DOI 10.1111/j.1469-1809.1987.tb00874.x; BOERWINKLE E, 1988, AM J HUM GENET, V42, P104; CAULEY JA, 1993, GENET EPIDEMIOL, V10, P27, DOI 10.1002/gepi.1370100104; CHRISTIAN JC, 1990, ARTERIOSCLEROSIS, V10, P1020, DOI 10.1161/01.ATV.10.6.1020; CHRISTIAN JC, 1976, ACTA GENET MED GEMEL, V25, P145, DOI 10.1017/S000156600001401X; CHRISTIAN JC, 1987, GENET EPIDEMIOL, V4, P433, DOI 10.1002/gepi.1370040605; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; CUMMING AM, 1982, J MED GENET, V19, P417, DOI 10.1136/jmg.19.6.417; CUMMING AM, 1984, CLIN GENET, V25, P310; DALLONGEVILLE J, 1992, J LIPID RES, V33, P447; Davignon J, 1988, Trans Am Clin Climatol Assoc, V99, P100; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; DEMANT T, 1991, J CLIN INVEST, V88, P1490, DOI 10.1172/JCI115459; FEINLEIB M, 1977, AM J EPIDEMIOL, V106, P284, DOI 10.1093/oxfordjournals.aje.a112464; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GREGG RE, 1986, J CLIN INVEST, V78, P815, DOI 10.1172/JCI112645; GUEGUEN R, 1989, AM J HUM GENET, V45, P793; HERSHCOPF RJ, 1982, J CHRON DIS, V35, P101, DOI 10.1016/0021-9681(82)90111-4; HIXSON JE, 1990, J LIPID RES, V31, P545; JARVIK GP, 1995, NEUROLOGY, V45, P1092, DOI 10.1212/WNL.45.6.1092; JARVIK GP, 1994, GENET EPIDEMIOL, V11, P375, DOI 10.1002/gepi.1370110407; JENKINS DJA, 1993, METABOLISM, V42, P585, DOI 10.1016/0026-0495(93)90217-C; KUUSI T, 1989, ARTERIOSCLEROSIS, V9, P237, DOI 10.1161/01.ATV.9.2.237; LEHTIMAKI T, 1992, ANN MED, V24, P61, DOI 10.3109/07853899209164146; LENZEN HJ, 1986, CLIN CHEM, V32, P778; MAHLEY RW, 1983, KLIN WOCHENSCHR, V61, P225, DOI 10.1007/BF01496128; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MENZEL HJ, 1983, ARTERIOSCLEROSIS, V3, P310, DOI 10.1161/01.ATV.3.4.310; MIRANDA JL, 1994, J LIPID RES, V35, P1965; NEWSCHAFFER CJ, 1992, AM J EPIDEMIOL, V136, P23, DOI 10.1093/oxfordjournals.aje.a116417; *NIH, 1980, LIP RES CLIN POP STU, V1; REARDON MF, 1985, CIRCULATION, V71, P881, DOI 10.1161/01.CIR.71.5.881; REED T, 1991, J CLIN EPIDEMIOL, V44, P797, DOI 10.1016/0895-4356(91)90132-S; REED T, 1993, GENET EPIDEMIOL, V10, P513, DOI 10.1002/gepi.1370100630; REILLY SL, 1992, AM J HUM GENET, V51, P1311; SAMPSON EJ, 1975, CLIN CHEM, V21, P1983; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; SELBY JV, 1991, GENET EPIDEMIOL, V8, P371, DOI 10.1002/gepi.1370080603; Sheeber LB, 1996, J PSYCHIAT RES, V30, P185, DOI 10.1016/0022-3956(96)00012-X; SING CF, 1985, AM J HUM GENET, V37, P268; *SPSS, 1991, SPSS STAT ALG; TRAN LD, 1994, SIB PAIR LINKAGE PRO; UTERMANN G, 1985, DIABETES OBESITY HYP, V3, P1; UUSITUPA MIJ, 1992, J AM COLL NUTR, V11, P651; WARNICK GR, 1990, CLIN CHEM, V36, P15; WARNICK GR, 1982, CLIN CHEM, V28, P1574; WILSON PWF, 1994, JAMA-J AM MED ASSOC, V272, P1666, DOI 10.1001/jama.272.21.1666; YU CE, 1994, AM J HUM GENET, V54, P631; ZANNIS VI, 1981, AM J HUM GENET, V33, P11; Zerba KE, 1996, GENETICS, V143, P463	52	49	51	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1997	61	1					171	181		10.1086/513902	http://dx.doi.org/10.1086/513902			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM728	9245998	Green Published, Bronze			2022-12-18	WOS:A1997XM72800025
J	Engle, EC; Castro, AE; Macy, ME; Knoll, JHM; Beggs, AH				Engle, EC; Castro, AE; Macy, ME; Knoll, JHM; Beggs, AH			A gene for isolated congenital ptosis maps to a 3-cM region within 1p32-p34.1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DUANES RETRACTION SYNDROME; EXTRAOCULAR-MUSCLES; LINKAGE ANALYSIS; CHROMOSOME-12; FIBROSIS; PCR	Hereditary isolated congenital ptosis is an autosomal dominant disorder with incomplete penetrance characterized by a variable degree of unilateral or bilateral drooping of the upper eyelids. We report linkage of this disorder in a large family to markers on chromosome Ip, In our sample of 37 meioses, nine informative markers did not recombine with the disease. D1S2677 gave a maximum two-point LOD score of 8.8 on the assumption of 90% penetrance (theta = 0). D1S447/2733 and D1S1616 flank the disease locus, with two-point LOD scores of 5.6/6.6 (theta = .04) and 4.9 (theta = .05), respectively, defining a region of 2.8 cM. FISH of YACs containing flanking recombinant markers localizes the gene to chromosome 1p32-p34.1. These data establish a map location for an isolated congenital ptosis gene and demonstrate that this disorder is genetically distinct from other extraocular muscle-specific disorders such as congenital fibrosis of the extraocular muscles and blepharophimosis.	CHILDRENS HOSP,DEPT NEUROL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT PATHOL,BETH ISRAEL DEACONESS MED CTR,BOSTON,MA 02115	Harvard University; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Engle, EC (corresponding author), CHILDRENS HOSP,DIV GENET,ENDERS 512,300 LONGWOOD AVE,BOSTON,MA 02115, USA.			Knoll, Joan/0000-0001-6691-1710; Beggs, Alan/0000-0001-8818-0568	NEI NIH HHS [K11-EY00336] Funding Source: Medline; NICHD NIH HHS [HD18568] Funding Source: Medline; NATIONAL EYE INSTITUTE [K11EY000336] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AMATI P, 1995, HUM GENET, V96, P213, DOI 10.1007/BF00207381; BALDINI A, 1992, GENOMICS, V14, P181, DOI 10.1016/S0888-7543(05)80303-9; BRIGGS HH, 1919, AM J OPHTHALMOL, V2, P408; COHEN MA, 1972, ARCH OPHTHALMOL-CHIC, V87, P161; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; ENGLE EC, 1994, NAT GENET, V7, P69, DOI 10.1038/ng0594-69; ENGLE EC, 1995, AM J HUM GENET, V57, P1086; Engle EC, 1997, ANN NEUROL, V41, P314, DOI 10.1002/ana.410410306; HARRAR HS, 1995, J MED GENET, V32, P774, DOI 10.1136/jmg.32.10.774; HOTCHKISS MG, 1980, ARCH OPHTHALMOL-CHIC, V98, P870, DOI 10.1001/archopht.1980.01020030864013; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; JOHNSON CC, 1994, PRINCIPLES PRACTICE, V3, P2839; KNOLL JHM, 1994, CURRENT PROTOCOLS HU, V1; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Lemagne J M, 1992, Bull Soc Belge Ophtalmol, V243, P23; MILLER NR, 1982, ARCH OPHTHALMOL-CHIC, V100, P1468; MILLER NR, 1985, WALSH HOYTS CLIN NEU, P932; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; Porter JD, 1996, NEUROLOGY, V46, P30, DOI 10.1212/WNL.46.1.30; RANK B K, 1959, Aust N Z J Surg, V28, P274, DOI 10.1111/j.1445-2197.1959.tb06969.x; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; SMALL KW, 1995, HUM MOL GENET, V4, P443, DOI 10.1093/hmg/4.3.443; Tagle Danilo A., 1992, Human Molecular Genetics, V1, P121, DOI 10.1093/hmg/1.2.121	23	49	51	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1997	60	5					1150	1157						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX760	9150162				2022-12-18	WOS:A1997WX76000015
J	LagerstromFermer, M; Sundvall, M; Johnsen, E; Warne, GL; Forrest, SM; Zajac, JD; Rickards, A; Ravine, D; Landegren, U; Pettersson, U				LagerstromFermer, M; Sundvall, M; Johnsen, E; Warne, GL; Forrest, SM; Zajac, JD; Rickards, A; Ravine, D; Landegren, U; Pettersson, U			X-linked recessive panhypopituitarism associated with a regional duplication in Xq25-q26	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; TOOTH DISEASE TYPE-1A; MICROSATELLITE POLYMORPHISMS; HORMONE DEFICIENCY; DYSTROPHIN GENE; HUMAN GENOME; LOCUS; CHROMOSOME; DIAGNOSIS; MUTATION	We present a linkage analysis and a clinical update on a previously reported family with X-linked recessive panhypopituitarism, now in its fourth generation. Affected members exhibit variable degrees of hypopituitarism and mental retardation. The markers DXS737 and DXS1187 in the q25-q26 region of the X chromosome showed evidence for linkage with a peak LOD score (Z(max)) of 4.12 at zero recombination fraction (theta(max) = 0). An apparent extra copy of the marker DXS102, observed in the region of the disease gene in affected males and heterozygous carrier females, suggests that a segment including this marker is duplicated. The gene causing this disorder appears to code for a dosage-sensitive protein central to development of the pituitary.	ROYAL CHILDRENS HOSP,CTR HORMONE RES,MELBOURNE,AUSTRALIA; ROYAL CHILDRENS HOSP,CLIN GENET SERV,MELBOURNE,AUSTRALIA; ROYAL CHILDRENS HOSP,DEPT MED,MELBOURNE,AUSTRALIA; ROYAL CHILDRENS HOSP,DEPT PSYCHOL,MELBOURNE,AUSTRALIA	Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne	LagerstromFermer, M (corresponding author), UNIV UPPSALA,CTR BIOMED,DEPT MED GENET,BEIJER LAB,BOX 589,S-75123 UPPSALA,SWEDEN.		Ravine, David/A-6797-2008; Zajac, Jeffrey/ABC-3767-2021; Landegren, Ulf D/A-8197-2019	Zajac, Jeffrey/0000-0003-3933-5708; 				BLACK GCM, 1991, NUCLEIC ACIDS RES, V19, P689; BROWNE D, 1992, HUM MOL GENET, V1, P213, DOI 10.1093/hmg/1.3.213; BROWNE DL, 1991, NUCLEIC ACIDS RES, V19, P1721, DOI 10.1093/nar/19.7.1721-a; CLEMENS PR, 1991, AM J HUM GENET, V49, P951; COLEMAN MP, 1991, GENOMICS, V11, P991, DOI 10.1016/0888-7543(91)90024-9; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; COX TC, 1992, HUM MOL GENET, V1, P639, DOI 10.1093/hmg/1.8.639; CUTICCHIA AJ, 1993, NUCLEIC ACIDS RES, V21, P3003, DOI 10.1093/nar/21.13.3003; FEENER CA, 1991, AM J HUM GENET, V48, P621; FRASER N, 1987, CYTOGENET CELL GENET, V46, P615; GEDEON AK, 1992, AM J MED GENET, V43, P255, DOI 10.1002/ajmg.1320430140; HEARNE CM, 1991, NUCLEIC ACIDS RES, V19, P5450; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; KONRADI C, 1992, GENOMICS, V12, P176, DOI 10.1016/0888-7543(92)90426-S; LASSER DM, 1993, GENOMICS, V16, P785, DOI 10.1006/geno.1993.1269; LIN CJ, 1992, NATURE, V360, P765, DOI 10.1038/360765a0; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; LUTY JA, 1990, AM J HUM GENET, V46, P776; OUDET C, 1991, AM J HUM GENET, V49, P311; PFAFFLE RW, 1992, SCIENCE, V257, P1118, DOI 10.1126/science.257.5073.1118; PHELAN P D, 1971, Birth Defects Original Article Series, V7, P24; RADOVICK S, 1992, SCIENCE, V257, P1115, DOI 10.1126/science.257.5073.1115; RAM KT, 1992, NUCLEIC ACIDS RES, V20, P1428, DOI 10.1093/nar/20.6.1428; RICHARDS RI, 1991, AM J HUM GENET, V48, P1051; RIMOIN D L, 1971, Birth Defects Original Article Series, V7, P12; RISCHBIETH H, 1912, TREASURY HUMAN INHER; SLEDDENS HFBM, 1992, NUCLEIC ACIDS RES, V20, P1427; SMAHI A, 1994, ANN GENET-PARIS, V37, P11; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TATSUMI K, 1992, NAT GENET, V1, P56, DOI 10.1038/ng0492-56; TRYGSTAD O, 1964, ACTA PAEDIATR, V53, P527, DOI 10.1111/j.1651-2227.1964.tb07264.x; VALENTIJN LJ, 1992, NAT GENET, V1, P166, DOI 10.1038/ng0692-166; WANG LH, 1994, GENOMICS, V22, P590, DOI 10.1006/geno.1994.1432; WEBER C, 1993, HUM MOL GENET, V2, P612; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4037, DOI 10.1093/nar/18.13.4037; WILLARD HF, 1994, CYTOGENET CELL GENET, V67, P296	36	49	50	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1997	60	4					910	916						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WT614	9106538				2022-12-18	WOS:A1997WT61400021
J	Chamberlin, ME; Ubagai, T; Mudd, SH; Levy, HL; Chou, JY				Chamberlin, ME; Ubagai, T; Mudd, SH; Levy, HL; Chou, JY			Dominant inheritance of isolated hypermethioninemia is associated with a mutation in the human methionine adenosyltransferase 1A gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							S-ADENOSYLMETHIONINE SYNTHETASE; MOLECULAR-CLONING; DEFICIENCY; PURIFICATION; EXPRESSION; PATHWAY	Methionine adenosyltransferase (MAT) I/III deficiency, characterized by isolated persistent hypermethioninemia, is caused by mutations in the MAT1A gene encoding MAT alpha 1, the subunit of major hepade enzymes MAT I ([alpha 1](4)) and III ([alpha 1](2)). We have characterized 10 MAT1A mutations in MAT I/III-deficient individuals and shown that the associated hypermethioninemic phenotype was inherited as an autosomal recessive trait. However, dominant inheritance of hypermethioninemia, also hypothesized to be caused by MAT I/III deficiency, has been reported in two families. Here we show that the only mutation uncovered in one of these families, G, is a G-->A transition at nt 791 in exon VII of one MAT1A allele that converts an arginine at position 264 to a histidine (R264H). This single allelic R264H mutation was subsequently identified in two hypermethioninemic individuals in an additional family, C. Family C members were also found to inherit hypermethioninemia in a dominant fashion, and the available affected members analyzed carried the single allelic R264H mutation. Substitution of R-264 with histidine (R264H, the naturally occurring mutant), leucine (R264L), aspartic acid (R264D), or glutamic acid (R264E) greatly reduced MAT activity and severely impaired the ability of the MAT alpha 1 subunits to form homodimers essential for optimal catalytic activity. On the other hand, when lysine was substituted far R-264 (R264K), the mutant alpha 1 subunit was able to form dimers that retain significant MAT activity, suggesting that amino acid 264 is involved in intersubunit salt-bridge formation. Cotransfection studies show that R264/R264H MAT alpha 1 heterodimers are enzymatically inactive, thus providing an explanation for the R264H-mediated dominant inheritance of hypermethioninemia.	NICHHD,HERITABLE DISORDERS BRANCH,NIH,BETHESDA,MD 20892; NIMH,LAB GEN & COMPARAT BIOCHEM,NIH,BETHESDA,MD 20892; CHILDRENS HOSP,BOSTON,MA 02115; HARVARD UNIV,SCH MED,BOSTON,MA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School								BLOM HJ, 1992, J INHERIT METAB DIS, V15, P188, DOI 10.1007/BF01799629; CABRERO C, 1987, EUR J BIOCHEM, V170, P299, DOI 10.1111/j.1432-1033.1987.tb13699.x; CANTONI GL, 1953, J BIOL CHEM, V204, P403; Chamberlin ME, 1996, J CLIN INVEST, V98, P1021, DOI 10.1172/JCI118862; DELAROSA J, 1995, J BIOL CHEM, V270, P21860; FINKELSTEIN JD, 1975, BIOCHEM BIOPH RES CO, V66, P1491, DOI 10.1016/0006-291X(75)90527-6; GAHL WA, 1988, J CLIN INVEST, V81, P390, DOI 10.1172/JCI113331; GAULL GE, 1981, J PEDIATR-US, V98, P734, DOI 10.1016/S0022-3476(81)80833-5; HORIKAWA S, 1990, J BIOL CHEM, V265, P13683; HORIKAWA S, 1992, FEBS LETT, V312, P37, DOI 10.1016/0014-5793(92)81405-B; KOTB M, 1985, J BIOL CHEM, V260, P3923; KOTB M, 1993, PHARMACOL THERAPEUT, V59, P125, DOI 10.1016/0163-7258(93)90042-C; KOTB M, IN PRESS TRENDS GENE; MITSUI KI, 1988, J BIOL CHEM, V263, P11211; Mudd S.H., 1995, METABOLIC MOL BASES, V1, P1279; MUDD SH, 1995, AM J HUM GENET, V57, P882; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; SAKATA SF, 1993, J BIOL CHEM, V268, P13978; SURTEES R, 1991, LANCET, V338, P1550, DOI 10.1016/0140-6736(91)92373-A; Takusagawa F, 1996, J BIOL CHEM, V271, P136, DOI 10.1074/jbc.271.1.136; Takusagawa F, 1996, BIOCHEMISTRY-US, V35, P2586, DOI 10.1021/bi952604z; UBAGAI T, 1995, J CLIN INVEST, V96, P1943, DOI 10.1172/JCI118240; WELLS JA, 1985, GENE, V34, P315, DOI 10.1016/0378-1119(85)90140-4	23	49	53	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1997	60	3					540	546						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK403	9042912				2022-12-18	WOS:A1997WK40300009
J	Pianese, L; Cavalcanti, F; DeMichele, G; Filla, A; Campanella, G; Calabrese, O; Castaldo, I; Monticelli, A; Cocozza, S				Pianese, L; Cavalcanti, F; DeMichele, G; Filla, A; Campanella, G; Calabrese, O; Castaldo, I; Monticelli, A; Cocozza, S			The effect of parental gender on the GAA dynamic mutation in the FRDA gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							DISEASE; SPERM		UNIV NAPLES FEDERICO II,NEUROL CLIN,DEPT NEUROL,I-80131 NAPLES,ITALY; UNIV NAPLES FEDERICO II,DEPT MOL & CELLULAR BIOL,NAPLES,ITALY; UNIV NAPLES FEDERICO II,DEPT PATHOL & CEOS,NAPLES,ITALY	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II			Cocozza, Sergio/F-6488-2010; CAVALCANTI, FRANCESCA/I-3651-2014; Cavalcanti, Francesca/N-3901-2019	CAVALCANTI, FRANCESCA/0000-0001-5769-4582; Cavalcanti, Francesca/0000-0001-5769-4582; CASTALDO, IMMA/0000-0003-4785-5420	Telethon [722] Funding Source: Medline	Telethon(Fondazione Telethon)		Antinolo G, 1996, AM J HUM GENET, V58, P237; BATES G, 1994, BIOESSAYS, V16, P277, DOI 10.1002/bies.950160411; BRUNNER HG, 1993, NEW ENGL J MED, V328, P476, DOI 10.1056/NEJM199302183280705; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; FILLA A, 1992, J NEUROL, V239, P351, DOI 10.1007/BF00867594; Filla A, 1996, AM J HUM GENET, V59, P554; PIANESE L, 1994, J MED GENET, V31, P133, DOI 10.1136/jmg.31.2.133; TELENIUS H, 1995, HUM MOL GENET, V4, P189, DOI 10.1093/hmg/4.2.189; ZHANG L, 1994, NAT GENET, V7, P531, DOI 10.1038/ng0894-531	9	49	49	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1997	60	2					460	463						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WE931	9012421				2022-12-18	WOS:A1997WE93100027
J	Scozzari, R; Cruciani, F; Santolamazza, P; Sellitto, D; Cole, DEC; Rubin, LA; Labuda, D; Marini, E; Succa, V; Vona, G; Torroni, A				Scozzari, R; Cruciani, F; Santolamazza, P; Sellitto, D; Cole, DEC; Rubin, LA; Labuda, D; Marini, E; Succa, V; Vona, G; Torroni, A			mtDNA and Y chromosome-specific polymorphisms in modern Ojibwa: Implications about the origin of their gene pool	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									CNR,CTR STUDIO GENET EVOLUZIONIST,ROME,ITALY; UNIV TORONTO,DEPT CLIN BIOCHEM,TORONTO,ON,CANADA; UNIV TORONTO,DEPT MED,TORONTO,ON,CANADA; UNIV TORONTO,DEPT GENET,TORONTO,ON,CANADA; HOP ST JUSTINE,CTR RECH,CTR CANCEROL CHARLES BRUNEAU,MONTREAL,PQ H3T 1C5,CANADA; UNIV CAGLIARI,DIPARTIMENTO BIOL SPERIMENTALE,SEZ SCI ANTROPOL,CAGLIARI,ITALY	Consiglio Nazionale delle Ricerche (CNR); University of Toronto; University of Toronto; University of Toronto; Universite de Montreal; University of Cagliari	Scozzari, R (corresponding author), UNIV ROMA LA SAPIENZA,DIPARTIMENTO GENET & BIOL MOL,P ALDO MORO 5,I-00185 ROME,ITALY.		Cruciani, Fulvio/G-6105-2012; Marini, Elisabetta/H-8156-2012; Torroni, Antonio/E-1557-2011	Torroni, Antonio/0000-0002-4163-4478; Marini, Elisabetta/0000-0001-8779-8745; Cruciani, Fulvio/0000-0002-6900-024X				DUNNING RW, 1959, SOCIAL EC CHANGE NO; Forster P, 1996, AM J HUM GENET, V59, P935; HAMMER MF, 1994, MOL BIOL EVOL, V11, P749; HAMMER MF, 1995, AM J HUM GENET, V56, P951; ROEWER L, 1992, HUM GENET, V89, P389; Salzano FM, 1988, S AM INDIANS CASE ST; SEIELSTAD MT, 1994, HUM MOL GENET, V3, P2159; SPURDLE AB, 1994, AM J HUM GENET, V54, P319; SZATHMARY EJ, 1974, AM J PHYS ANTHROPOL, V40, P49, DOI 10.1002/ajpa.1330400106; SZATHMARY EJ, 1972, HUM BIOL, V44, P655; TORRONI A, 1994, AM J HUM GENET, V55, P760; TORRONI A, 1993, AM J HUM GENET, V53, P563; TORRONI A, IN PRESS GENETICS; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196	14	49	49	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1997	60	1					241	244						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA818	8981971				2022-12-18	WOS:A1997WA81800034
J	Stenico, M; Nigro, L; Bertorelle, G; Calafell, F; Capitanio, M; Corrain, C; Barbujani, G				Stenico, M; Nigro, L; Bertorelle, G; Calafell, F; Capitanio, M; Corrain, C; Barbujani, G			High mitochondrial sequence diversity in linguistic isolates of the Alps	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE FLOW; PHYLOGENETIC TREES; HUMAN-POPULATIONS; HUMAN-EVOLUTION; DNA-SEQUENCES; SINGLE HAIRS; EUROPE; BOUNDARIES; LANGUAGES; HISTORY	Segment I of the control region of mtDNA (360 bases) was sequenced in seven samples, each of 10 individuals inhabiting villages in the eastern Italian Alps (South Tyrol and Trentino). Three linguistic groups, German, Italian, and Ladin, were represented by two samples each; the seventh sample comes from an isolated group of German origin, the Mocheni, who are linguistically distinct and geographically separated from the bulk of the German speakers. Seventy-four polymorphic sites were identified, defining 63 different haplotypes. Mocheni and Ladin speakers tend to form two clusters in the evolutionary trees inferred from sequences. Analysis of molecular variance shows significant differentiation within samples, among them, and among linguistic groups. Genetic differences between the Ladins and the other groups are not much smaller than between Europeans and some Africans; variation is large within groups, as well, with the exception of only the Mocheni. In the evolutionary trees where the four alpine groups are compared with other European populations, Mocheni and especially Ladins appear as clear outliers. Romansch-speaking Swiss, who are linguistically related to Ladins, are not genetically similar to them, for this segment of DNA. Because the time elapsed since colonization of the Alps (less than or equal to 12,000 years) is short in mutational terms, the only model accounting for the observed relationships between mtDNA variation and linguistic identity seems one in which a population ancestral to Ladin speakers was already differentiated long before the Alps were settled and the current linguistic affiliations were established. For the Mocheni, the results are consistent with a simpler episode of allele loss, from an original genetic pool common to the ancestors of the current German speakers.	UNIV PADUA,DIPARTIMENTO BIOL,PADUA,ITALY; UNIV BARCELONA,FAC BIOL,UNITAT ANTROPOL,BARCELONA,SPAIN; UNIV BOLOGNA,DIPARTIMENTO SCI STAT,BOLOGNA,ITALY	University of Padua; University of Barcelona; University of Bologna			Barbujani, Guido/ABE-9998-2020; Bertorelle, Giorgio/AAE-9078-2022; Calafell, Francesc/C-8595-2014	Barbujani, Guido/0000-0001-7854-6669; Calafell, Francesc/0000-0002-1083-9438; Bertorelle, Giorgio/0000-0002-2498-2702				AMMAN H, 1958, HIST ATLAS SCHWEIZ; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BARBUJANI G, 1995, P NATL ACAD SCI USA, V92, P9171, DOI 10.1073/pnas.92.20.9171; BARBUJANI G, 1991, TRENDS ECOL EVOL, V6, P151, DOI 10.1016/0169-5347(91)90056-4; BARBUJANI G, 1991, AM J HUM GENET, V48, P398; BARBUJANI G, 1990, P NATL ACAD SCI USA, V87, P1816, DOI 10.1073/pnas.87.5.1816; Barbujani G, 1996, HUM BIOL, V68, P201; BERTRANPETIT J, 1995, ANN HUM GENET, V59, P63, DOI 10.1111/j.1469-1809.1995.tb01606.x; Broglio A., 1993, PREISTORIA ALPINA, V28, P293; Calafell F, 1996, ANN HUM GENET, V60, P35, DOI 10.1111/j.1469-1809.1996.tb01170.x; CALAFELL F, 1994, HUM BIOL, V66, P823; CAVALLISFORZA LL, 1993, SCIENCE, V259, P639, DOI 10.1126/science.8430313; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; COMAS D, IN PRESS MOL BIOL EV; CORRAIN C, 1973, STUD TRENTINI SCI NA, V50, P141; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; EXCOFFIER L, 1990, J MOL EVOL, V30, P125, DOI 10.1007/BF02099939; EXCOFFIER L, 1992, GENETICS, V131, P479; FARRIS JS, 1972, AM NAT, V106, P645, DOI 10.1086/282802; Francalacci P, 1996, AM J PHYS ANTHROPOL, V100, P443, DOI 10.1002/(SICI)1096-8644(199608)100:4<443::AID-AJPA1>3.0.CO;2-S; GRAVEN L, 1995, MOL BIOL EVOL, V12, P334; HANDT O, 1994, SCIENCE, V264, P1775, DOI 10.1126/science.8209259; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; HIGUCHI R, 1988, NATURE, V332, P543, DOI 10.1038/332543a0; HOLGATE P, 1966, J APPL PROBAB, V3, P115, DOI 10.2307/3212041; HORAI S, 1990, AM J HUM GENET, V46, P828; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; HUDSON RR, 1992, GENETICS, V132, P583; KIM J, 1993, EVOLUTION, V47, P471, DOI 10.1111/j.1558-5646.1993.tb02107.x; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; KUMAR S, 1993, MEGA MOL EVOLUTINARY; LATTER BDH, 1980, AM NAT, V116, P220, DOI 10.1086/283624; Lewontin R.C., 1972, J EVOLUTION BIOL, V14, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; MOUNTAIN JL, 1995, AM J HUM GENET, V56, P979; Nei M., 1987, MOL EVOLUTIONARY GEN; PAULI L, 1981, ALPEN FRUHZEIT MITTT; PIERCY R, 1993, INT J LEGAL MED, V106, P85, DOI 10.1007/BF01225046; PULT I, 1994, BIOL CHEM H-S, V375, P837; REA JA, 1972, CURR TRENDS LINGUIST, V2, P355; Renfrew C., 1987, ARCHAEOLOGY LANGUAGE; RICHARDS M, 1996, PALEOLITHIC NEOLITHI, V59, P185; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1995, HUM BIOL, V67, P1; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ruhlen M., 1991, GUIDE WORLDS LANGUAG, V1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SLATKIN M, 1989, GENETICS, V123, P603; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; SOKAL RR, 1988, AM J PHYS ANTHROPOL, V76, P337, DOI 10.1002/ajpa.1330760308; STONEKING M, 1993, EVOLUTIONARY ANTHR, V2, P60; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TAJIMA F, 1983, GENETICS, V105, P437; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; TORRONI A, IN PRESS CLASSIFICAT; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720	61	49	49	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1996	59	6					1363	1375						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV315	8940282				2022-12-18	WOS:A1996VV31500023
J	Wang, M; Clericuzio, CL; Godfrey, M				Wang, M; Clericuzio, CL; Godfrey, M			Familial occurrence of typical and severe lethal congenital contractural arachnodactyly caused by missplicing of exon 34 of fibrillin-2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEONATAL MARFAN-SYNDROME; ELASTIN-ASSOCIATED MICROFIBRILS; EGF-LIKE DOMAINS; OSTEOGENESIS IMPERFECTA; MISSENSE MUTATION; FBN1 MUTATIONS; ECTOPIA LENTIS; CALCIUM-BINDING; GENE COLIAI; I COLLAGEN	Genetic linkage studies have linked congenital contractural arachnodactyly (CCA), a usually mild heritable connective-tissue disorder, to FBN2, the fibrillin gene on chromosome 5. Recently, FBN2 mutations in two patients with CCA have been described. Here we report an A-->T transversion at the -2 position of the consensus acceptor splice site, resulting in the missplicing of exon 34, a calcium-binding epidermal growth factor-like repeat in fibrillin-2 in a mother and daughter with CCA. Significantly, the mother exhibited a classic CCA phenotype with arachnodactyly, joint contractures, and abnormal pinnae, whereas her daughter exhibited a markedly more severe CCA phenotype, which included cardiovascular and gastrointestinal anomalies that led to death in infancy. Analysis of cloned fibroblasts showed that the mother is a somatic mosaic for the exon 34 missplicing mutation, whereas all the daughter's cells harbored the mutation.	UNIV NEBRASKA,MED CTR,MUNROE CTR HUMAN GENET,OMAHA,NE 68198; UNIV NEBRASKA,MED CTR,DEPT PEDIAT,OMAHA,NE; UNIV NEW MEXICO,DEPT PEDIAT,ALBUQUERQUE,NM 87131	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of New Mexico					NHLBI NIH HHS [HL48126-01] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL048126] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AOYAMA T, 1993, HUM MOL GENET, V2, P2135, DOI 10.1093/hmg/2.12.2135; AUGSBURGER PB, 1994, J BIOL CHEM, V269, P28443; BASHIR MM, 1989, J BIOL CHEM, V264, P8887; BEALS RK, 1971, J BONE JOINT SURG AM, VA 53, P987, DOI 10.2106/00004623-197153050-00013; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CLEARY EG, 1983, INT REV CONNECT TISS, V10, P97; CONSTANTINOU CD, 1990, AM J HUM GENET, V47, P670; CURRARINO G, 1986, AM J MED GENET, V25, P763, DOI 10.1002/ajmg.1320250414; Dietz Harry C., 1992, Human Mutation, V1, P366, DOI 10.1002/humu.1380010504; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; DIETZ HC, 1995, HUM MOL GENET, V4, P1799, DOI 10.1093/hmg/4.suppl_1.1799; DIETZ HC, 1992, J CLIN INVEST, V89, P1674, DOI 10.1172/JCI115766; DIETZ HC, 1993, GENOMICS, V17, P468, DOI 10.1006/geno.1993.1349; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Edwards Matthew J., 1992, Human Mutation, V1, P47, DOI 10.1002/humu.1380010108; EPSTEIN CJ, 1968, J PEDIATR-US, V73, P379, DOI 10.1016/S0022-3476(68)80115-5; FRANCKE U, 1995, AM J HUM GENET, V56, P1287; GIBSON MA, 1991, J BIOL CHEM, V266, P7596; GODFREY M, 1993, AM J HUM GENET, V53, P472; GODFREY M, 1990, AM J HUM GENET, V46, P652; GODFREY M, 1995, AM J PATHOL, V146, P1414; HAYWARD C, 1994, HUM MOL GENET, V3, P373, DOI 10.1093/hmg/3.2.373; Hayward C, 1992, Hum Mutat, V1, P79, DOI 10.1002/humu.1380010115; HECHT F, 1972, PEDIATRICS, V49, P574; HEWETT D, 1994, AM J HUM GENET, V55, P447; HEWETT DR, 1994, J MED GENET, V31, P338, DOI 10.1136/jmg.31.4.338; HEWETT DR, 1993, HUM MOL GENET, V2, P475, DOI 10.1093/hmg/2.4.475; KAINULAINEN K, 1992, P NATL ACAD SCI USA, V89, P5917, DOI 10.1073/pnas.89.13.5917; KAINULAINEN K, 1994, NAT GENET, V6, P64, DOI 10.1038/ng0194-64; LEE B, 1991, NATURE, V352, P330, DOI 10.1038/352330a0; LIPSON EH, 1974, Z KINDERHEILKD, V118, P1, DOI 10.1007/BF00506049; LONNQVIST L, 1994, GENOMICS, V19, P573, DOI 10.1006/geno.1994.1110; MACNAB AJ, 1991, ARCH DIS CHILD-FETAL, V66, P1143, DOI 10.1136/adc.66.10_Spec_No.1143; MARIENCHECK MC, 1995, CONNECT TISSUE RES, V31, P87, DOI 10.3109/03008209509028396; MILEWICZ DM, 1995, J CLIN INVEST, V95, P2373, DOI 10.1172/JCI117930; MILEWICZ DM, 1994, AM J HUM GENET, V54, P447; NIJBROEK G, 1995, AM J HUM GENET, V57, P8; PEREIRA L, 1993, HUM MOL GENET, V2, P961, DOI 10.1093/hmg/2.7.961; PUTNAM EA, 1995, NAT GENET, V11, P456, DOI 10.1038/ng1295-456; Sambrook J, 1989, MOL CLONING LAB MANU; TSIPOURAS P, 1992, NEW ENGL J MED, V326, P905, DOI 10.1056/NEJM199204023261401; WALLIS GA, 1990, AM J HUM GENET, V46, P1034; WANG M, 1995, HUM MOL GENET, V4, P607, DOI 10.1093/hmg/4.4.607; WANG M, IN PRESS HUM MUTAT; WINTERPACHT A, 1993, NAT GENET, V3, P323, DOI 10.1038/ng0493-323; YIN WS, 1995, J BIOL CHEM, V270, P1798, DOI 10.1074/jbc.270.4.1798; ZHANG H, 1995, J CELL BIOL, V129, P1165, DOI 10.1083/jcb.129.4.1165; ZHANG H, 1994, J CELL BIOL, V124, P855, DOI 10.1083/jcb.124.5.855	48	49	52	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1996	59	5					1027	1034						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN900	8900230				2022-12-18	WOS:A1996VN90000009
J	Vervoort, R; Islam, MR; Sly, WS; Zabot, MT; Kleijer, WJ; Chabas, A; Fensom, A; Young, EP; Liebaers, I; Lissens, W				Vervoort, R; Islam, MR; Sly, WS; Zabot, MT; Kleijer, WJ; Chabas, A; Fensom, A; Young, EP; Liebaers, I; Lissens, W			Molecular analysis of patients with beta-glucuronidase deficiency presenting as hydrops fetalis or as early mucopolysaccharidosis VII	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NONSENSE MUTATIONS; GENE; DNA; EXPRESSION; RNA; AMPLIFICATION; SEQUENCE; PHOSPHORYLATION; IDENTIFICATION; PSEUDOGENES	Although not all mucopolysaccharidosis type VII (MPS VII) neonates present with hydrops fetalis or with related symptoms, hydrops fetalis is a common form of presentation of this mucopolysaccharidosis. We used reverse-transcription-PCR-SSCP and direct sequencing to screen for mutations in the human beta-glucuronidase cDNA of 17 MPS VII patients with severe presentation of the disease. Mutations resulting in an unstable mRNA were detected in genomic DNA with direct sequencing of the PCR-amplified beta-glucuronidase exons. We found extensive genetic heterogeneity in MPS VII alleles: in addition to 6 of 12 previously reported mutations (L176F, E216W, R357X, R382C, W507X, and W627C), we detected 14 undescribed mutations in the beta-glucuronidase coding region that produce MPS VII alleles (G136R, E150K, S312X, Y320S, Y320C, H351Y, R382H, R374C, R435P, R477W, G572D, Y508C, K606N, and 1900 Delta GA). The mutations in hydropic fetuses were widely scattered in the beta-glucuronidase gene. Analysis of three polymorphic sites of the mutant alleles (1766T/C, 1972C/T, and a new 1091+27C/G polymorphism) allowed exclusion of identity by descent for some recurrent mutations. Three of four mutations introducing a premature translation stop codon were found to affect mRNA abundance and/or structure. Expression studies provided evidence for the causal relationship between each of the mutations found in MPS VII alleles and the enzyme deficiency, in that all mutations identified exhibited markedly reduced enzyme activity expressed in COS7 cells following transfection with the mutant cDNA.	FREE UNIV BRUSSELS HOSP,DEPT MED GENET,B-1090 BRUSSELS,BELGIUM; ST LOUIS UNIV,SCH MED,EDWARD A DOISY DEPT BIOCHEM & MOLEC BIOL,ST LOUIS,MO 63104; HOP DEBROUSSE,SERV BIOCHIM,LYON,FRANCE; ERASMUS UNIV ROTTERDAM,DEPT CLIN GENET,3000 DR ROTTERDAM,NETHERLANDS; DIPUTACIO BARCELONA,INST BIOQUIM CLIN,BARCELONA,SPAIN; GUYS HOSP,SUPRAREG LAB GENET ENZYME DEFECTS,LONDON SE1 9RT,ENGLAND; UNIV LONDON,INST CHILD HLTH,LONDON WC1N 1EH,ENGLAND	Saint Louis University; CHU Lyon; Erasmus University Rotterdam; Guy's & St Thomas' NHS Foundation Trust; University of London; University College London			Lissens, Willy/B-2892-2013	Lissens, Willy/0000-0003-3875-9955				AGARWAL RK, 1993, NUCLEIC ACIDS RES, V21, P5283, DOI 10.1093/nar/21.22.5283; BEAUDET AL, 1975, J PEDIATR-US, V86, P388, DOI 10.1016/S0022-3476(75)80968-1; BONDUELLE M, 1991, Genetic Counseling, V2, P227; CHABAS A, 1991, J INHERIT METAB DIS, V14, P908, DOI 10.1007/BF01800472; CHABAS A, 1993, PRENATAL DIAG, V13, P429, DOI 10.1002/pd.1970130602; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cooper D. N., 1993, HUMAN GENE MUTATION; DAMORE MA, 1988, BIOCHEMISTRY-US, V27, P7131, DOI 10.1021/bi00418a070; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; GEHLER J, 1974, HUMANGENETIK, V23, P149; GUIBAUD P, 1979, J GENET HUM, V27, P29; HOYME HE, 1981, J MED GENET, V18, P237, DOI 10.1136/jmg.18.3.237; IRANI D, 1983, ANN NEUROL, V14, P486, DOI 10.1002/ana.410140415; ISLAM MR, 1993, J BIOL CHEM, V268, P22627; ISONIEMI A, 1995, HUM MUTAT, V5, P318, DOI 10.1002/humu.1380050408; JEFFERSON RA, 1986, P NATL ACAD SCI USA, V83, P8447, DOI 10.1073/pnas.83.22.8447; KAGIE MJ, 1992, AM J MED GENET, V42, P693, DOI 10.1002/ajmg.1320420513; KALTENBOECK B, 1992, BIOTECHNIQUES, V12, P164; KETTERLING RP, 1994, AM J HUM GENET, V54, P831; KOEBERL DD, 1990, AM J HUM GENET, V47, P202; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LEE JES, 1985, AM J DIS CHILD, V139, P57, DOI 10.1001/archpedi.1985.02140030059029; LISSENS W, 1991, PRENATAL DIAG, V11, P405, DOI 10.1002/pd.1970110612; MASHIMA Y, 1992, AM J HUM GENET, V51, P81; MCCONLOGUE L, 1988, NUCLEIC ACIDS RES, V16, P9869, DOI 10.1093/nar/16.20.9869; MILLER RD, 1990, GENOMICS, V7, P280, DOI 10.1016/0888-7543(90)90552-6; MIYOSHI Y, 1992, P NATL ACAD SCI USA, V89, P4452, DOI 10.1073/pnas.89.10.4452; NELSON A, 1982, J PEDIATR-US, V101, P574, DOI 10.1016/S0022-3476(82)80707-5; NELSON J, 1993, J CLIN PATHOL, V46, P370, DOI 10.1136/jcp.46.4.370; Neufeld EF, 1995, METABOLIC MOL BASES, P2465; NISHIMURA Y, 1986, P NATL ACAD SCI USA, V83, P7292, DOI 10.1073/pnas.83.19.7292; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; OSHIMA A, 1987, P NATL ACAD SCI USA, V84, P685, DOI 10.1073/pnas.84.3.685; PETERSON L, 1982, AM J CLIN PATHOL, V78, P544, DOI 10.1093/ajcp/78.4.544; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SEWELL AC, 1982, CLIN GENET, V21, P366; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHIPLEY JM, 1993, J BIOL CHEM, V268, P12193; SHIPLEY JM, 1993, AM J HUM GENET, V52, P517; SLY WS, 1973, J PEDIATR-US, V82, P249, DOI 10.1016/S0022-3476(73)80162-3; SPINARDI L, 1991, NUCLEIC ACIDS RES, V19, P4009, DOI 10.1093/nar/19.14.4009; STANGENBERG M, 1992, AM J MED GENET, V44, P142, DOI 10.1002/ajmg.1320440205; TEYSSIER G, 1981, ARCH FR PEDIATR, V38, P603; TOMATSU S, 1991, AM J HUM GENET, V48, P89; TOMATSU S, 1990, GENE, V89, P283, DOI 10.1016/0378-1119(90)90019-N; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868; VERVOORT R, 1993, HUM MUTAT, V2, P443, DOI 10.1002/humu.1380020604; VERVOORT R, 1995, AM J HUM GENET, V57, P798; WILSON D, 1982, J NEUROPATH EXP NEUR, V41, P344, DOI 10.1097/00005072-198205000-00019; WU BM, 1993, HUM MUTAT, V2, P446, DOI 10.1002/humu.1380020605; WU M, 1994, J BIOL CHEM, V269, P23681; YAMADA S, 1995, HUM MOL GENET, V4, P651, DOI 10.1093/hmg/4.4.651	52	49	52	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1996	58	3					457	471						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TV564	8644704				2022-12-18	WOS:A1996TV56400003
J	Mailander, V; Heine, R; Deymeer, F; LehmannHorn, F				Mailander, V; Heine, R; Deymeer, F; LehmannHorn, F			Novel muscle chloride channel mutations and their effects on heterozygous carriers	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MYOTONIA-CONGENITA; INTERCOSTAL MUSCLE; DOMINANT	Mutations within CLCN1, the gene encoding the major skeletal muscle chloride channel, cause either dominant Thomsen disease or recessive Becker-type myotonia, which are sometimes difficult to discriminate, because of reduced penetrance or lower clinical expressivity in females. We screened DNA of six unrelated Becker patients and found four novel CLCN1 mutations (Gln-74-Stop, Tyr-150-Cys, Tyr-261-Cys, and Ala-415-Val) and a previously reported 14-bp deletion. Five patients were homozygous for the changes (Gln-74-Stop, Ala-415-Val, and 14-bp deletion), four of them due to parental consanguinity. The sixth patient revealed compound heterozygosity for Tyr-150-Cys and Tyr-261-Cys. Heterozygous carriers of the Becker mutations did not display any clinical symptoms of myotonia. However, all heterozygous males, but none of the heterozygous females, exhibited myotonic discharges in the electromyogram suggesting (i) a gene dosage effect of the mutations on the chloride conductance and (ii) male predominance of subclinical myotonia. Furthermore, we report a novel Gly-200-Arg mutation resulting in a dominant phenotype in a male and a partially dominant phenotype in his mother. We discuss potential causes of the gender preference and the molecular mechanisms that may determine the mode of inheritance.	UNIV ULM,DEPT APPL PHYSIOL,D-89081 ULM,GERMANY; UNIV ISTANBUL,DEPT NEUROL,ISTANBUL,TURKEY	Ulm University; Istanbul University			Mailänder, Volker/AAD-1722-2019; Mailänder, Volker/H-3589-2012	Mailänder, Volker/0000-0001-6583-8136; Mailänder, Volker/0000-0001-6583-8136				BECKER P E, 1957, Nervenarzt, V28, P455; Becker PE, 1977, MYOTONIA CONGENITA S; BRYANT SH, 1969, J PHYSIOL-LONDON, V204, P539, DOI 10.1113/jphysiol.1969.sp008930; DISTECHE CM, 1995, TRENDS GENET, V11, P17, DOI 10.1016/S0168-9525(00)88981-7; FAHLKE C, 1995, NEURON, V15, P1; GEORGE AL, 1994, HUM MOL GENET, V3, P2071; GEORGE AL, 1993, NAT GENET, V3, P305, DOI 10.1038/ng0493-305; GRONEMEIER M, 1994, J BIOL CHEM, V269, P5963; HEINE R, 1994, HUM MOL GENET, V3, P1123, DOI 10.1093/hmg/3.7.1123; HOFFMAN EP, 1995, CELL, V80, P681, DOI 10.1016/0092-8674(95)90345-3; KAWASAKI M, 1995, NEURON, V14, P1285, DOI 10.1016/0896-6273(95)90275-9; KAWASAKI M, 1994, NEURON, V12, P597, DOI 10.1016/0896-6273(94)90215-1; KIEFERLE S, 1994, P NATL ACAD SCI USA, V91, P6943, DOI 10.1073/pnas.91.15.6943; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; KWIECINSKI H, 1988, MUSCLE NERVE, V11, P576, DOI 10.1002/mus.880110609; LEHMANNHORN F, 1995, HUM MOL GENET, V4, P1397, DOI 10.1093/hmg/4.8.1397; LIPICKY RJ, 1971, J CLIN INVEST, V50, P2091, DOI 10.1172/JCI106703; LORENZ C, 1994, HUM MOL GENET, V3, P941, DOI 10.1093/hmg/3.6.941; MEHRKE G, 1988, MUSCLE NERVE, V11, P440, DOI 10.1002/mus.880110505; MEYERKLEINE C, 1994, HUM MOL GENET, V3, P1015, DOI 10.1093/hmg/3.6.1015; MIDDLETON RE, 1994, BIOCHEMISTRY-US, V33, P13189, DOI 10.1021/bi00249a005; PALADE PT, 1977, J GEN PHYSIOL, V69, P879, DOI 10.1085/jgp.69.6.879; RUDEL R, 1988, MUSCLE NERVE, V11, P202, DOI 10.1002/mus.880110303; STEINMEYER K, 1994, EMBO J, V13, P737, DOI 10.1002/j.1460-2075.1994.tb06315.x; STEINMEYER K, 1991, NATURE, V354, P304, DOI 10.1038/354304a0; STREIB EW, 1982, MUSCLE NERVE, V5, P179; THIEMANN A, 1992, NATURE, V356, P57, DOI 10.1038/356057a0; Thomsen, 1876, ARCH PSYCHIAT NERVEN, V6, P702, DOI DOI 10.1007/BF02164912; VANSLEGTENHORST MA, 1994, HUM MOL GENET, V3, P547; YAP EPH, 1992, TRENDS GENET, V8, P49, DOI 10.1016/0168-9525(92)90339-6; ZELLWEGER H, 1980, MUSCLE NERVE, V3, P176, DOI 10.1002/mus.880030212	31	49	52	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1996	58	2					317	324						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TR791	8571958				2022-12-18	WOS:A1996TR79100008
J	PHILLIPS, JA; COHEN, M; FLEISHER, LD; SMITH, ACM; CLAYTON, EW				PHILLIPS, JA; COHEN, M; FLEISHER, LD; SMITH, ACM; CLAYTON, EW			STATEMENT ON STORAGE AND USE OF GENETIC MATERIALS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material									UNIV MARYLAND,BALTIMORE,MD 21201; SIDLEY & AUSTIN,CHICAGO,IL	University System of Maryland; University of Maryland Baltimore	PHILLIPS, JA (corresponding author), VANDERBILT UNIV,SCH MED,DD-2205 MED CTR N,NASHVILLE,TN 37232, USA.							CLAYTON EW, IN PRESS JAMA; ELIAS S, 1994, NEW ENGL J MED, V330, P1611, DOI 10.1056/NEJM199406023302213; MCEWEN JE, 1995, AM J HUM GENET, V56, P1477; MCEWEN JE, 1994, AM J HUM GENET, V55, P196; YATES JRW, 1989, J MED GENET, V26, P245, DOI 10.1136/jmg.26.4.245; 1993, PROTECTING HUMAN RES, P5	6	49	49	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1995	57	6					1499	1500						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TE655					2022-12-18	WOS:A1995TE65500028
J	STONEKING, M				STONEKING, M			ANCIENT DNA - HOW DO YOU KNOW WHEN YOU HAVE IT AND WHAT CAN YOU DO WITH IT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material											STONEKING, M (corresponding author), PENN STATE UNIV,DEPT ANTHROPOL,UNIVERSITY PK,PA 16802, USA.							BERAUDCOLOMB E, 1995, AM J HUM GENET, V57, P1267; Clifton L., 1984, NATL EXAMINER   0807, P31; HAGELBERG E, 1993, P ROY SOC B-BIOL SCI, V252, P163, DOI 10.1098/rspb.1993.0061; HAGELBERG E, 1994, NATURE, V369, P25, DOI 10.1038/369025a0; HANDT O, 1994, SCIENCE, V264, P1775, DOI 10.1126/science.8209259; HEDGES SB, 1995, SCIENCE, V268, P1191, DOI 10.1126/science.7761839; HERRMANN B, 1994, NATURE, V312, P282; PAABO S, 1989, J BIOL CHEM, V264, P9709; SALO WL, 1994, P NATL ACAD SCI USA, V91, P2091, DOI 10.1073/pnas.91.6.2091; STONE AC, 1993, AM J PHYS ANTHROPOL, V92, P463, DOI 10.1002/ajpa.1330920405; WEISHAMPEL DB, 1991, AM J PHYS ANTHROPOL, V85, P239, DOI 10.1002/ajpa.1330850214; WOODWARD SR, 1994, SCIENCE, V266, P1229; ZISCHLER H, 1995, SCIENCE, V268, P1192, DOI 10.1126/science.7605504	13	49	52	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1995	57	6					1259	1262						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TE655	8533753				2022-12-18	WOS:A1995TE65500001
J	MITCHELL, LE; HEALEY, SC; CHENEVIXTRENCH, G				MITCHELL, LE; HEALEY, SC; CHENEVIXTRENCH, G			EVIDENCE FOR AN ASSOCIATION BETWEEN NONSYNDROMIC CLEFT-LIP WITH OR WITHOUT CLEFT-PALATE AND A GENE LOCATED ON THE LONG ARM OF CHROMOSOME-4	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GROWTH-FACTOR-ALPHA; NO EVIDENCE; LINKAGE; DISEASE; INHERITANCE; EXCLUSION; DELETIONS; LOCUS	Recent studies suggest that the familial aggregation of nonsyndromic cleft lip with or without cleft palate (CL+/-P) is likely to be attributable to the effects of several susceptibility loci, acting in a multiplicative fashion. Two potential CL+/-P susceptibility loci (CSL), transforming growth factor alpha (TGFA) and retinoic acid receptor (RARA), have been identified through association studies. In addition, recent evidence of linkage bet tween CL+/-P and two markers (D4S175 and D4S192) in the region 4q25-4q31.3 raised the possibility that a CSL,with a larger effect than either TGFA or RARA, may reside within this region of the human genome. The present analyses were undertaken to determine whether D4S175 or D4S192 is significantly associated with CL+/-P in a sample of unrelated patients that have previously provided evidence of associations between CL+/-P and both TGFA and RARA. The results of these analyses provide further, tentative, evidence for the presence of a CSL locus on the long arm of chromosome 4 and help to refine the location of this locus in the region of D4S175 and D4S192.	QUEENSLAND INST MED RES,BRISBANE,QLD 4006,AUSTRALIA	QIMR Berghofer Medical Research Institute	MITCHELL, LE (corresponding author), ST LOUIS UNIV,HLTH SCI CTR,SCH PUBL HLTH,DEPT COMMUNITY HLTH,3663 LINDELL BLVD,ST LOUIS,MO 63108, USA.		Chenevix-Trench, Georgia/AAV-2014-2020	Chenevix-Trench, Georgia/0000-0002-1878-2587				ARDINGER HH, 1989, AM J HUM GENET, V45, P348; BEIRAGHI S, 1994, CLIN GENET, V46, P255; CASSARD AM, 1990, J CELL BIOCHEM, V43, P255, DOI 10.1002/jcb.240430306; CHENEVIXTRENCH G, 1991, AM J HUM GENET, V48, P1012; CHENEVIXTRENCH G, 1992, AM J HUM GENET, V51, P1377; FARRALL M, 1992, AM J HUM GENET, V50, P270; FARRALL M, 1993, AM J HUM GENET, V52, P434; FENG HS, 1994, AM J HUM GENET, V55, P932; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HECHT JT, 1991, AM J HUM GENET, V49, P682; HOLDER SE, 1992, J MED GENET, V29, P390, DOI 10.1136/jmg.29.6.390; JORDE LB, 1994, AM J HUM GENET, V54, P884; JURILOFF DM, 1995, MAMM GENOME, V6, P63, DOI 10.1007/BF00303246; JURILOFF DM, 1993, J CRAN GENET DEV BIO, V13, P223; KIDD KK, 1993, AM J MED GENET, V48, P71, DOI 10.1002/ajmg.1320480202; LIN AE, 1988, AM J MED GENET, V31, P533, DOI 10.1002/ajmg.1320310308; Melnick M, 1982, CLIN DYSMORPHOLOGY O, P360; MIETTINE.OS, 1974, AM J EPIDEMIOL, V99, P325, DOI 10.1093/oxfordjournals.aje.a121617; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MILLS KA, 1992, GENOMICS, V14, P209, DOI 10.1016/S0888-7543(05)80208-3; MITCHELL JA, 1981, AM J MED GENET, V8, P73, DOI 10.1002/ajmg.1320080110; MITCHELL LE, 1992, AM J HUM GENET, V51, P323; RISCH N, 1987, AM J HUM GENET, V40, P1; SASSANI R, 1993, AM J MED GENET, V45, P565, DOI 10.1002/ajmg.1320450508; TTHOMSON G, 1994, NAT GENET, V8, P108; VINTINER GM, 1992, J MED GENET, V29, P393, DOI 10.1136/jmg.29.6.393; VINTINER GM, 1993, J MED GENET, V30, P773, DOI 10.1136/jmg.30.9.773; 1993, LOGXACT TURBO	28	49	49	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1995	57	5					1130	1136						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TA449	7485164				2022-12-18	WOS:A1995TA44900020
J	TRACHTENBERG, EA; ERLICH, HA; RICKARDS, O; DESTEFANO, GF; KLITZ, W				TRACHTENBERG, EA; ERLICH, HA; RICKARDS, O; DESTEFANO, GF; KLITZ, W			HLA CLASS-II LINKAGE DISEQUILIBRIUM AND HAPLOTYPE EVOLUTION IN THE CAYAPA INDIANS OF ECUADOR	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OLIGONUCLEOTIDE PROBES; AMPLIFIED DNA; PATTERN-ANALYSIS; HUMAN MHC; DQ-ALPHA; ALLELES; POLYMORPHISM; POPULATIONS; AMERICANS; PRIMATES	DNA-based typing of the HLA class II loci in a sample of the Cayapa Indians of Ecuador reveals several lines of evidence that selection has operated to maintain and to diversify the existing level of polymorphism in the class II region. As has been noticed for other Native American groups, the overall level of polymorphism at the DRB1, DQA1, DQB1, and DPB1 loci is reduced relative to that found in other human populations. Nonetheless, the relative evenness in the distribution of allele frequencies at each of the four loci points to the role of balancing selection in the maintenance of the polymorphism. The DQA1 and DQB1 loci, in particular, have near-maximum departures from the neutrality model, which suggests that balancing selection has been especially strong in these cases. Several novel DQA1-DQB1 haplotypes and the discovery of a new DRB1 allele demonstrate an evolutionary tendency favoring the diversification of class LI alleles and haplotypes. The recombination interval between the centromeric DPB1 locus and the other class II loci will, in the absence of other forces such as selection, reduce disequilibrium across this region. However, nearly all common alleles were found to be part of DR-DP haplotypes in strong disequilibrium, consistent with the recent action of selection acting on these haplotypes in the Cayapa.	UNIV ROMA TOR VERGATA,DIPARTIMENTO BIOL,ROME,ITALY; UNIV CALIF BERKELEY,DEPT INTEGRAT BIOL,BERKELEY,CA	University of Rome Tor Vergata; University of California System; University of California Berkeley	TRACHTENBERG, EA (corresponding author), ROCHE MOLEC SYST,DEPT HUMAN GENET,1145 ATLANTIC AVE,ALAMEDA,CA 94501, USA.		Rickards, Olga/L-7878-2015	Rickards, Olga/0000-0003-2880-7466	NHLBI NIH HHS [HL47170-02] Funding Source: Medline; NIGMS NIH HHS [GM35326] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035326] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON R, 1979, THESIS MONASH U CLAY; Barriga Lopez F, 1987, CAYAPAS CHIACHIS, V4; Baur M.P., 1980, HISTOCOMPATIBILITY T, P955; BEGOVICH AB, 1992, J IMMUNOL, V148, P249; BODMER JG, 1994, IMMUNOBIOLOGY, V187, P51; BUGAWAN TL, 1991, IMMUNOGENETICS, V33, P163, DOI 10.1007/BF01719235; BUGAWAN TL, 1994, AM J HUM GENET, V54, P331; BUGAWAN TL, 1990, IMMUNOGENETICS, V32, P231; CAMPBELL RD, 1993, IMMUNOL TODAY, V14, P349, DOI 10.1016/0167-5699(93)90234-C; CARRINGTON M, 1994, HUM IMMUNOL, V41, P234, DOI 10.1016/0198-8859(94)90041-8; CERNA M, 1993, HUM IMMUNOL, V37, P213, DOI 10.1016/0198-8859(93)90504-T; COHEN J, 1988, STATISTICAL POWER AN; ERLICH HA, 1993, NAT GENET, V3, P358, DOI 10.1038/ng0493-358; GARBER TL, IN PRESS IMMUNOGENET; GIBBONS A, 1993, SCIENCE, V259, P312, DOI 10.1126/science.8420001; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; GYLLENSTEN UB, 1989, P NATL ACAD SCI USA, V86, P9986, DOI 10.1073/pnas.86.24.9986; GYLLENSTEN UB, 1993, HUM IMMUNOL, V36, P1, DOI 10.1016/0198-8859(93)90002-I; HAAS JP, 1994, HUM IMMUNOL, V39, P31, DOI 10.1016/0198-8859(94)90098-1; HEDRICK PW, 1987, GENETICS, V117, P331; Imanish T, 1992, HLA 1991, V1, P1065; KIDD JR, 1991, HUM BIOL, V63, P775; KLITZ W, 1986, AM J HUM GENET, V39, P340; KLITZ W, 1987, GENETICS, V116, P633; KLITZ W, 1991, MOL EVOLUTION MAJOR, P257; KWOK WW, 1989, J IMMUNOL, V143, P3598; LEWONTIN RC, 1964, GENETICS, V49, P49; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOONSAMY PV, 1994, TISSUE ANTIGENS, V43, P249, DOI 10.1111/j.1399-0039.1994.tb02333.x; MOONSAMY PV, 1992, TISSUE ANTIGENS, V40, P153, DOI 10.1111/j.1399-0039.1992.tb02039.x; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; PEPE G, 1994, HUM BIOL, V66, P979; RICKARDS O, 1994, HUM BIOL, V66, P299; RONNINGEN KS, 1990, HUM IMMUNOL, V29, P275, DOI 10.1016/0198-8859(90)90041-M; SAIKI RK, 1989, P NATL ACAD SCI USA, V86, P6230, DOI 10.1073/pnas.86.16.6230; SCACCHI R, 1994, ANN HUM BIOL, V21, P67, DOI 10.1080/03014469400003082; SCHARF SJ, 1991, HUM IMMUNOL, V32, P214; SLATKIN M, 1994, GENETICS, V137, P331; STINSON S, 1989, American Journal of Human Biology, V1, P697, DOI 10.1002/ajhb.1310010607; SZATHMARY EJE, 1993, AM J HUM GENET, V53, P793; THOMSON G, 1987, GENETICS, V116, P623; TITUSTRACHTENBE.EA, 1994, AM J HUM GENET, V55, P160; TORRONI A, 1993, AM J HUM GENET, V53, P563; TROWSDALE J, 1991, IMMUNOL TODAY, V12, P443, DOI 10.1016/0167-5699(91)90017-N; WATTERSON GA, 1978, GENETICS, V88, P405; WILLIAMS RC, 1985, AM J PHYS ANTHROPOL, V66, P1, DOI 10.1002/ajpa.1330660102; YUNIS JJ, 1994, HUM IMMUNOL, V4, P248; [No title captured]; [No title captured]	50	49	49	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1995	57	2					415	424						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RL771	7668268				2022-12-18	WOS:A1995RL77100025
J	DOERFLINGER, N; LINDER, C; OUAHCHI, K; GYAPAY, G; WEISSENBACH, J; LEPASLIER, D; RIGAULT, P; BELAL, S; BENHAMIDA, C; HENTATI, F; BENHAMIDA, M; PANDOLFO, M; DIDONATO, S; SOKOL, R; KAYDEN, H; LANDRIEU, P; DURR, A; BRICE, A; GOUTIERES, F; KOHLSCHUTTER, A; SABOURAUD, P; BENOMAR, A; YAHYAOUI, M; MANDEL, JL; KOENIG, M				DOERFLINGER, N; LINDER, C; OUAHCHI, K; GYAPAY, G; WEISSENBACH, J; LEPASLIER, D; RIGAULT, P; BELAL, S; BENHAMIDA, C; HENTATI, F; BENHAMIDA, M; PANDOLFO, M; DIDONATO, S; SOKOL, R; KAYDEN, H; LANDRIEU, P; DURR, A; BRICE, A; GOUTIERES, F; KOHLSCHUTTER, A; SABOURAUD, P; BENOMAR, A; YAHYAOUI, M; MANDEL, JL; KOENIG, M			ATAXIA WITH VITAMIN-E-DEFICIENCY - REFINEMENT OF GENETIC LOCALIZATION AND ANALYSIS OF LINKAGE DISEQUILIBRIUM BY USING NEW MARKERS IN 14 FAMILIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TOCOPHEROL TRANSFER PROTEIN; ALPHA-TOCOPHEROL; RAT-LIVER; FRIEDREICH ATAXIA; BINDING-PROTEIN; HUMAN GENOME; ABSORPTION; MAP	Ataxia with vitamin E deficiency (AVED) is an autosomal recessive disease characterized clinically by neurological symptoms with often striking resemblance to those of Friedreich ataxia. This disorder has been reported previously as familial isolated vitamin E deficiency. We have mapped recently the AVED locus to a 5-cM confidence interval on chromosome 8q by homozygosity mapping in six Mediterranean families. We have now analyzed six new and two previously described families and demonstrate genetic homogeneity despite important clinical variability and wide geographic origins. Analysis of nine new tightly linked microsatellite markers, including four characterized in this study, revealed a predominant but not unique mutation in northern African populations, where this condition is more frequent. Haplotype analysis but also classical recombinations allowed us to refine the AVED position to a 1-cM interval. A YAC contig over this interval was constructed from marker STSs and YAC fingerprint data, in order to facilitate the search of the AVED gene.	UNIV STRASBOURG 1, INSERM, INST GENET & BIOL MOLEC & CELLULAIRE, CNRS, F-67404 ILLKIRCH GRAFFENSTADEN, FRANCE; CHU STRASBOURG, F-67000 STRASBOURG, FRANCE; GENETHON, EVRY, FRANCE; HOP BICETRE, CTR ETUD POLYMORPHISME HUMAIN, PARIS, FRANCE; HOP BICETRE, DEPT PEDIAT, NEUROL SERV, PARIS, FRANCE; HOP LA PITIE SALPETRIERE, INSERM, U289, EXPTL MED LAB, PARIS, FRANCE; HOP NECKER ENFANTS MALAD, PARIS, FRANCE; INST NATL NEUROL, NEUROBIOL MOLEC & NEUROPATHOL LAB, LA RABTA, TUNISIA; IST NAZL NEUROL CARLO BESTA, MILAN, ITALY; UNIV COLORADO, SCH MED, PEDIAT GASTROENTEROL & NUTR SECT, DENVER, CO USA; NYU, MED CTR, DEPT MED, NEW YORK, NY USA; UNIV KRANKENHAUS EPPENDORF, KINDERKLIN, HAMBURG, GERMANY; AMER MEM HOSP, REIMS, FRANCE; CHU RABAT, SERV NEUROL HOP SPECIALITES, RABAT, MOROCCO	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Tunis-El-Manar; Institut National de Neurologie; IRCCS Istituto Neurologico Besta; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; New York University; University of Hamburg; University Medical Center Hamburg-Eppendorf; CHU de Reims; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat			Kohlschütter, Alfried/ABH-5710-2020; Brice, Alexis/A-2170-2009; Kohlschütter, Alfried/ABE-3495-2021; brice, alexis/AAE-8275-2019; Pandolfo, Massimo/B-2853-2010; Di Donato, Stefano/B-9717-2012	Kohlschütter, Alfried/0000-0002-2700-0401; brice, alexis/0000-0002-0941-3990; Le Paslier, Denis/0000-0003-4335-9956	NCRR NIH HHS [RR00069] Funding Source: Medline; NIADDK NIH HHS [AM34914] Funding Source: Medline; NIDDK NIH HHS [DK38446] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [P30AM034914] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038446, R29DK038446] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMIEL J, IN PRESS J INHERIT M; BEHRENS WA, 1982, NUTR RES, V2, P611, DOI 10.1016/S0271-5317(82)80073-0; BELLANNECHANTELOT C, 1992, CELL, V70, P1059, DOI 10.1016/0092-8674(92)90254-A; BENHAMIDA C, 1993, NAT GENET, V5, P195, DOI 10.1038/ng1093-195; BENHAMIDA M, 1993, NEUROLOGY, V43, P2179, DOI 10.1212/WNL.43.11.2179; BURCK U, 1981, NEUROPEDIATRICS, V12, P267, DOI 10.1055/s-2008-1059657; COHEN D, 1993, NATURE, V366, P698, DOI 10.1038/366698a0; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARDING AE, 1985, NEW ENGL J MED, V313, P32, DOI 10.1056/NEJM198507043130107; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; KAYDEN HJ, 1993, NEUROLOGY, V43, P2167, DOI 10.1212/WNL.43.11.2167; KOHLSCHUTTER A, 1988, J INHERIT METAB DIS, V11, P149, DOI 10.1007/BF01804221; KRENDEL DA, 1987, NEUROLOGY, V37, P538, DOI 10.1212/WNL.37.3.538; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LAPLANTE P, 1984, CAN J NEUROL SCI, V11, P561, DOI 10.1017/S0317167100035046; MOWRI H, 1981, EUR J BIOCHEM, V117, P537; MULLER DPR, 1983, LANCET, V1, P225; MURPHY DJ, 1981, J BIOL CHEM, V256, P464; RODIUS F, 1994, AM J HUM GENET, V54, P1050; SATO Y, 1993, J BIOL CHEM, V268, P17705; SATO Y, 1991, FEBS LETT, V288, P41, DOI 10.1016/0014-5793(91)80999-J; SIRUGO G, 1992, AM J HUM GENET, V50, P559; SOKOL RJ, 1988, J LAB CLIN MED, V111, P548; STUMPF DA, 1987, NEUROLOGY, V37, P68, DOI 10.1212/WNL.37.1.68; TRABER MG, 1990, J CLIN INVEST, V85, P397, DOI 10.1172/JCI114452; TRABER MG, 1993, J LIPID RES, V34, P201; TRABERT W, 1989, FORTSCHR NEUROL PSYC, V57, P495, DOI 10.1055/s-2007-1001146; YOKOTA T, 1987, ANN NEUROL, V22, P84, DOI 10.1002/ana.410220119	28	49	51	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1995	56	5					1116	1124						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QU586	7726167				2022-12-18	WOS:A1995QU58600014
J	KARTTUNEN, L; RAGHUNATH, M; LONNQVIST, L; PELTONEN, L				KARTTUNEN, L; RAGHUNATH, M; LONNQVIST, L; PELTONEN, L			A COMPOUND-HETEROZYGOUS MARFAN PATIENT - 2 DEFECTIVE FIBRILLIN ALLELES RESULT IN A LETHAL PHENOTYPE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EGF-LIKE DOMAIN; CALCIUM-BINDING; MUTATIONS; GENE; DISEASE; DECORIN; FORM; HOMOZYGOTES; SEQUENCE; PCR	We describe here the identification of defined mutations in both alleles of the fibrillin gene (FBN1) in a compound-heterozygote Marfan syndrome (MFS) child who had a very severe form of MFS resulting in death from cardiac failure at the age of 4 mo. The nonconsanguineous parents were both affected with MFS. The father's heterozygous point mutation has earlier been reported to result in W217G substitution, the mother was here shown to carry a heterozygous point mutation resulting in G2627R substitution, and the child had inherited both these mutations. The mutant FBN1 alleles were demonstrated to be transcribed with equal efficiency compared with the normal alleles, but metabolic labeling of fibroblast cultures from the child and both parents showed reduced biosynthesis and secretion of profibrillin. Also, the respective amounts of fibrillin in cell-culture media and extracellular-matrix extracts were markedly diminished, particularly in the cell cultures from father and child, In addition, immunofluorescence analysis of the cell cultures of all three family members revealed a drastically reduced amount of microfibrils, and virtually no visible fibrils could be seen in the case of the compound-heterozygote child. These findings demonstrate incomplete dominance of fibrillin mutations and underline the fatal consequences of the complete absence of normal fibrillin molecules in the microfibrils.	NATL PUBL HLTH INST,DEPT HUMAN MOLEC GENET,SF-00300 HELSINKI,FINLAND; UNIV ZURICH,DEPT PAEDIAT,ZURICH,SWITZERLAND	Finland National Institute for Health & Welfare; University of Zurich			Raghunath, Michael/E-6483-2010; Raghunath, Michael/M-2727-2019	Raghunath, Michael/0000-0002-2138-6614; 				BRANDI ML, 1993, AM J HUM GENET, V53, P1167; BUNTINX IM, 1991, J MED GENET, V28, P267, DOI 10.1136/jmg.28.4.267; CHEMKE J, 1984, J MED GENET, V21, P173, DOI 10.1136/jmg.21.3.173; CHENG J, 1990, Molecular and Cellular Biology, V10, P5215; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CORSON GM, 1993, GENOMICS, V17, P476, DOI 10.1006/geno.1993.1350; Dietz Harry C., 1992, Human Mutation, V1, P366, DOI 10.1002/humu.1380010504; DIETZ HC, 1993, GENOMICS, V17, P468, DOI 10.1006/geno.1993.1349; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; EIKENBOOM JCJ, 1993, LANCET, V341, P982, DOI 10.1016/0140-6736(93)91070-3; GODFREY M, 1993, AM J HUM GENET, V53, P472; HEWETT DR, 1993, HUM MOL GENET, V2, P475, DOI 10.1093/hmg/2.4.475; Ikonen E, 1992, PCR Methods Appl, V1, P234; KAINULAINEN K, 1992, P NATL ACAD SCI USA, V89, P5917, DOI 10.1073/pnas.89.13.5917; KAINULAINEN K, 1994, NAT GENET, V6, P64, DOI 10.1038/ng0194-64; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MCGOOKEYMILEWIC.D, 1992, J CLIN INVEST, V89, P79; MILEWICZ DM, 1994, AM J HUM GENET, V54, P447; PEREIRA L, 1993, HUM MOL GENET, V2, P961, DOI 10.1093/hmg/2.7.961; PULKKINEN L, 1990, J BIOL CHEM, V265, P17780; Pyeritz Reed E., 1993, P437; RAGHUNATH M, 1993, HUM GENET, V90, P511; ROA BB, 1993, NAT GENET, V5, P189, DOI 10.1038/ng1093-189; SAKAI LY, 1991, J BIOL CHEM, V266, P14763; SCHOLLIN J, 1988, ACTA PAEDIATR SCAND, V77, P452, DOI 10.1111/j.1651-2227.1988.tb10679.x; SELANDERSUNNERH.M, 1992, J BIOL CHEM, V0267; SUPERTIFURGA A, 1992, J MED GENET, V29, P875, DOI 10.1136/jmg.29.12.875; SYVANEN AC, 1993, AM J HUM GENET, V52, P46; SYVANEN AC, 1990, GENOMICS, V8, P684, DOI 10.1016/0888-7543(90)90255-S; TYNAN K, 1993, HUM MOL GENET, V2, P1813, DOI 10.1093/hmg/2.11.1813; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868; VANDENPLAS S, 1984, J MED GENET, V21, P164, DOI 10.1136/jmg.21.3.164; WEXLER NS, 1987, NATURE, V326, P194, DOI 10.1038/326194a0; 1972, Z KLIN CHEM KLIN BIO, V10, P182	34	49	51	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1994	55	6					1083	1091						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB684	7977366				2022-12-18	WOS:A1994QB68400003
J	CHAKRABORTY, R; ZHONG, YX; JIN, L; BUDOWLE, B				CHAKRABORTY, R; ZHONG, YX; JIN, L; BUDOWLE, B			NONDETECTABILITY OF RESTRICTION FRAGMENTS AND INDEPENDENCE OF DNA FRAGMENT SIZES WITHIN AND BETWEEN LOCI IN RFLP TYPING OF DNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HARDY-WEINBERG EQUILIBRIUM; VNTR LOCI; POPULATION-GENETICS; ALLELIC DATA; HOMOZYGOSITY; MARKERS; NUMBER; EXCESS; TESTS; BINS	We provide experimental evidence showing that, during the restriction-enzyme digestion of DNA samples, some of the HaeIII-digested DNA fragments are small enough to prevent their reliable sizing on a Southern gel. As a result of such nondetectability of DNA fragments, individuals who show a single-band DNA profile at a VNTR locus may not necessarily be true homozygotes. In a population database, when the presence of such nondetectable alleles is ignored, we show that a pseudodependence of alleles within as well as across loci may occur, Using a known statistical method, under the hypothesis of independence of alleles within loci, we derive an efficient estimate of null allele frequency, which may be subsequently used for testing allelic independence within and across loci. The estimates of null allele frequencies, thus derived, are shown to agree with direct experimental data on the frequencies of HaeIII-null alleles. Incorporation of null alleles into the analysis of the forensic VNTR database suggests that the assumptions of allelic independence within and between loci are appropriate. In contrast, a failure to incorporate the occurrence of null alleles would provide a wrong inference regarding the independence of alleles within and between loci.	FBI ACAD,CTR FORENS SCI RES & TRAINING,DIV LAB,QUANTICO,VA		CHAKRABORTY, R (corresponding author), UNIV TEXAS,HLTH SCI CTR,CTR DEMOG & POPULAT GENET,POB 20334,HOUSTON,TX 77225, USA.		Jin, Li/C-1468-2009; Jin, Li/M-5063-2019	Jin, Li/0000-0002-4546-2415; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045861, R01GM041399] Funding Source: NIH RePORTER; NIGMS NIH HHS [1R01-GM 45861, 1R01-GM 41399] Funding Source: Medline; CSRD VA [NIJ-92-CX-K024] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); CSRD VA		[Anonymous], 1992, DNA TECHNOLOGY FOREN; BALAZS I, 1989, AM J HUM GENET, V44, P182; BROWN AHD, 1980, GENETICS, V96, P523; BUDOWLE B, 1990, J FORENSIC SCI, V35, P530; BUDOWLE B, 1990, Applied and Theoretical Electrophoresis, V1, P181; BUDOWLE B, 1991, AM J HUM GENET, V48, P841; CALLEN DF, 1993, AM J HUM GENET, V52, P922; CHAKRABORTY R, 1994, HUM HERED, V44, P1, DOI 10.1159/000154181; CHAKRABORTY R, 1993, HUMAN POPULATION GENETICS, P189; CHAKRABORTY R, 1993, GENETICS, V133, P411; CHAKRABORTY R, 1992, ANN HUM GENET, V56, P45, DOI 10.1111/j.1469-1809.1992.tb01128.x; CHAKRABORTY R, 1992, HUM GENET, V88, P267, DOI 10.1007/BF00197257; CHAKRABORTY R, 1991, DNA FINGERPRINTING A, P127; CHAKRABORTY R, 1992, 3RD P INT S HUM ID P, P205; COHEN JE, 1990, AM J HUM GENET, V46, P358; DEVLIN B, 1990, SCIENCE, V249, P1416, DOI 10.1126/science.2205919; DEVLIN B, 1993, AM J HUM GENET, V53, P324; DEVLIN B, 1992, AM J HUM GENET, V51, P549; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; GART JJ, 1984, BIOMETRICS, V40, P887, DOI 10.2307/2531140; GART JJ, 1984, STATISTICAL METHODS, P229; GEISSER S, 1993, AM J HUM GENET, V53, P1103; GEISSER S, 1992, AM J HUM GENET, V51, P1084; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hardy GH, 1908, SCIENCE, V28, P49, DOI 10.1126/science.28.706.49; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; JEFFREYS AJ, 1991, DNA FINGERPRINTING A, P1; KOOREY DJ, 1993, HUM MOL GENET, V2, P289, DOI 10.1093/hmg/2.3.289; LANDER ES, 1991, AM J HUM GENET, V48, P819; LANDER ES, 1989, NATURE, V339, P501, DOI 10.1038/339501a0; LEWONTIN RC, 1991, SCIENCE, V254, P1745, DOI 10.1126/science.1845040; LI CC, 1976, 1ST COURSE POPULATIO; MARTIN W, 1983, INCLUSION PROBABILIT, P245; MORAN PAP, 1970, BIOMETRIKA, V57, P47, DOI 10.2307/2334934; MORTON NE, 1993, P NATL ACAD SCI USA, V90, P1892, DOI 10.1073/pnas.90.5.1892; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; Neyman J., 1959, PROBABILITY STATSITI, P213; SLIMOWITZ JR, 1993, AM J HUM GENET, V53, P314; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STEINBERGER EM, 1993, AM J HUM GENET, V52, P1275; TULLY G, 1993, HUM GENET, V92, P554, DOI 10.1007/BF00420938; Weinberg W., 1908, NATURKD WURTTEMBERG, V64, P368; Weir B.S., 1991, GENETIC DATA ANAL; WEIR BS, 1993, AM J HUM GENET, V53, P1107; WEIR BS, 1992, GENETICS, V130, P873; WEIR BS, 1992, P NATL ACAD SCI USA, V89, P11654, DOI 10.1073/pnas.89.24.11654; WYMAN AR, 1980, P NATL ACAD SCI-BIOL, V77, P6754, DOI 10.1073/pnas.77.11.6754	47	49	51	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1994	55	2					391	401						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NZ336	7913584				2022-12-18	WOS:A1994NZ33600022
J	TORCHIA, BS; CALL, LM; MIGEON, BR				TORCHIA, BS; CALL, LM; MIGEON, BR			DNA-REPLICATION ANALYSIS OF FMRI, XIST, AND FACTOR 8C LOCI BY FISH SHOWS NONTRANSCRIBED X-LINKED GENES REPLICATE LATE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FLUORESCENCE INSITU HYBRIDIZATION; DELAYED REPLICATION; INACTIVATION CENTER; SEQUENCES; REGION; CELLS; TIME; RNA; METHYLATION	The relationship between the transcriptional state of a locus and the time when it replicates during DNA synthesis is increasingly apparent. Active autosomal genes tend to replicate early, whereas inactive ones are more permissive and frequently replicate later. Although the inactive X chromosome replicates later than its active homologue, little is known about the replication of X-linked genes, We have used FISH to examine the replication of loci on the active X chromosome that are not transcribed, either because the tissue analyzed was not the expressing tissue (F8C), because the locus is silent on all active X chromosomes (XIST), or because it has been mutated by expansion and methylation of a CpG island (FMR1). In this assay, an unreplicated locus is characterized by a single hybridization signal, and a replicated locus is characterized by a doublet hybridization signal. The percentage of doublets is used as a measure of relative time of replication in S phase. The validity of this approach has been established elsewhere, since results compare favorably with those obtained using traditional methods for studying DNA replication. Our results show that the FMR1 gene replicates relatively later in fragile X (fraX) males with the full mutation than in normal males, irrespective of the probe used. The F8C locus is late replicating in both normal and fraX males and replicates at nearly the same time on active and inactive X in females. The XIST locus replicates late in all the males studied and asynchronously in female cells. From the late replication of the locus on the active X in males, we deduce that the locus on the active X is the later replicating locus in female cells. We conclude that (1) the expansion of the FMR1 locus leads to late replication, (2) silence of the XIST gene in males is associated with late replication of the locus, and (3) this assay will be useful for further studies of the relationship between transcription and replication.	JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,BALTIMORE,MD 21205	Johns Hopkins University					NICHD NIH HHS [NICHD HD05465] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ballabio A, 1992, CURR OPIN GENET DEV, V2, P439, DOI 10.1016/S0959-437X(05)80155-8; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; CALZA RE, 1984, CELL, V36, P689, DOI 10.1016/0092-8674(84)90349-0; Davis R W, 1980, Methods Enzymol, V65, P404; EICHLER EE, 1993, HUM MOL GENET, V2, P1147, DOI 10.1093/hmg/2.8.1147; FURST A, 1981, P NATL ACAD SCI-BIOL, V78, P1023, DOI 10.1073/pnas.78.2.1023; GILBERT DM, 1986, P NATL ACAD SCI USA, V83, P2924, DOI 10.1073/pnas.83.9.2924; GOLDMAN MA, 1984, SCIENCE, V224, P686, DOI 10.1126/science.6719109; GRUMBACH MM, 1963, P NATL ACAD SCI USA, V49, P581, DOI 10.1073/pnas.49.5.581; HANSEN RS, 1993, CELL, V73, P1403, DOI 10.1016/0092-8674(93)90365-W; HENDRICH BD, 1993, HUM MOL GENET, V2, P664; HOLMQUIST G, 1982, CELL, V31, P121, DOI 10.1016/0092-8674(82)90411-1; HOLMQUIST GP, 1987, AM J HUM GENET, V40, P151; JOLLY DJ, 1982, P NATL ACAD SCI-BIOL, V79, P5038, DOI 10.1073/pnas.79.16.5038; KITSBERG D, 1993, NATURE, V366, P588, DOI 10.1038/366588a0; KITSBERG D, 1993, NATURE, V364, P459, DOI 10.1038/364459a0; KNOLL JHM, 1994, NAT GENET, V6, P41, DOI 10.1038/ng0194-41; LAFRENIERE RG, 1993, HUM MOL GENET, V2, P1105, DOI 10.1093/hmg/2.8.1105; LENGAUER C, 1992, GENOMICS, V13, P826, DOI 10.1016/0888-7543(92)90160-T; LUO SY, 1993, SOMAT CELL MOLEC GEN, V19, P393, DOI 10.1007/BF01232750; MILLER DR, 1973, INT J RADIAT BIOL, V23, P591, DOI 10.1080/09553007314550691; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; RICHLER C, 1992, NAT GENET, V2, P192, DOI 10.1038/ng1192-192; ROUSSEAU F, 1992, AM J MED GENET, V43, P197, DOI 10.1002/ajmg.1320430133; SCHMIDT M, 1990, P NATL ACAD SCI USA, V87, P3685, DOI 10.1073/pnas.87.10.3685; SELIG S, 1992, EMBO J, V11, P1217, DOI 10.1002/j.1460-2075.1992.tb05162.x; TAYLOR JH, 1960, J BIOPHYS BIOCHEM CY, V7, P455, DOI 10.1083/jcb.7.3.455; TOOLE JJ, 1984, NATURE, V312, P342, DOI 10.1038/312342a0; TRASK B, 1989, GENOMICS, V5, P710, DOI 10.1016/0888-7543(89)90112-2; WEBB T, 1992, AM J MED GENET, V43, P1057, DOI 10.1002/ajmg.1320430633; WION KL, 1985, NATURE, V317, P726, DOI 10.1038/317726a0	32	49	51	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1994	55	1					96	104						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NW461	8023856				2022-12-18	WOS:A1994NW46100014
J	WATKINS, H; THIERFELDER, L; ANAN, R; JARCHO, J; MATSUMORI, A; MCKENNA, W; SEIDMAN, JG; SEIDMAN, CE				WATKINS, H; THIERFELDER, L; ANAN, R; JARCHO, J; MATSUMORI, A; MCKENNA, W; SEIDMAN, JG; SEIDMAN, CE			INDEPENDENT ORIGIN OF IDENTICAL BETA-CARDIAC MYOSIN HEAVY-CHAIN MUTATIONS IN HYPERTROPHIC CARDIOMYOPATHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLINICAL MANIFESTATIONS; PATHO-PHYSIOLOGY; MOLECULAR-BASIS; GENE; INTERRELATIONS; DINUCLEOTIDE; POLYMORPHISM; FAMILIES; DISEASE; THERAPY	The origins of the beta cardiac myosin heavy-chain (MHC) gene missense mutations that cause familial hypertrophic cardiomyopathy (FHC) in 14 families have been evaluated, Of eight different mutations, four were present in single families, while four occurred in two or more families. To investigate the origins of the four shared mutations, we defined the beta cardiac MHC haplotypes of each of the mutation-bearing chromosomes by determining the alleles present at three intragenic polymorphic loci. Two of the mutations (Arg453Cys and Val606Met) have arisen independently in each of three families, being found on different chromosomal backgrounds. A third mutation (Gly584Arg) is associated with identical haplotypes in two families with Portuguese ancestors, suggesting a founder effect. Haplotype analysis was uninformative for the fourth mutation (Arg403Gln). Thus, FHC-causing mutations have arisen independently in at least 12 of the 14 families studied, suggesting that the majority have arisen relatively recently as new mutations. This finding predicts the prevalence of disease-causing beta cardiac MHC mutations to be comparable in all population groups.	BRIGHAM & WOMENS HOSP,DIV CARDIOL,BOSTON,MA 02115; HOWARD HUGHES MED INST,BOSTON,MA; ST GEORGE HOSP,SCH MED,DEPT CARDIOL SCI,LONDON,ENGLAND; KYOTO UNIV,DEPT INTERNAL MED,KYOTO,JAPAN	Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; St Georges University London; Kyoto University	WATKINS, H (corresponding author), HARVARD UNIV,SCH MED,DEPT GENET,200 LONGWOOD AVE,BOSTON,MA 02115, USA.		McKenna, William J/C-3243-2008	McKenna, William J/0000-0001-7994-2460; Watkins, Hugh/0000-0002-5287-9016	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042467, R01HL046320, R29HL041474] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL41474, HL46320, HL42467] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BEJSOVEC A, 1990, CELL, V60, P133, DOI 10.1016/0092-8674(90)90723-R; CHOU YHW, 1992, NAT GENET, V1, P295, DOI 10.1038/ng0792-295; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; DRYJA TP, 1991, P NATL ACAD SCI USA, V88, P9370, DOI 10.1073/pnas.88.20.9370; EPSTEIN ND, 1992, CIRCULATION, V86, P345, DOI 10.1161/01.CIR.86.2.345; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; GREEN PM, 1990, NUCLEIC ACIDS RES, V18, P3227, DOI 10.1093/nar/18.11.3227; HEJTMANCIK JF, 1991, CIRCULATION, V83, P1592, DOI 10.1161/01.CIR.83.5.1592; MARON BJ, 1987, NEW ENGL J MED, V316, P844, DOI 10.1056/NEJM198704023161405; MARON BJ, 1987, NEW ENGL J MED, V316, P780, DOI 10.1056/NEJM198703263161305; MCKENNA WJ, 1989, DISEASES HEART, P933; ORKIN SH, 1984, ANNU REV GENET, V18, P131; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P4019, DOI 10.1093/nar/19.14.4019-a; ROSENZWEIG A, 1991, NEW ENGL J MED, V325, P1753, DOI 10.1056/NEJM199112193252501; SCHWARTZ K, 1992, CIRC RES, V71, P3, DOI 10.1161/01.RES.71.1.3; SOLOMON SD, 1990, J CLIN INVEST, V86, P993, DOI 10.1172/JCI114802; SOLOMON SD, 1990, AM J HUM GENET, V47, P389; TANIGAWA G, 1990, CELL, V62, P991, DOI 10.1016/0092-8674(90)90273-H; WANG J, 1993, AM J HUM GENET, V52, P1074; WATKINS H, 1992, BRIT HEART J, V67, P34; WATKINS H, 1992, NEW ENGL J MED, V326, P1108, DOI 10.1056/NEJM199204233261703; WATKINS H, 1992, J CLIN INVEST, V90, P1666, DOI 10.1172/JCI116038	22	49	50	1	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1993	53	6					1180	1185						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MJ818	8250038				2022-12-18	WOS:A1993MJ81800004
J	PENZIEN, JM; KAPPLER, J; HERSCHKOWITZ, N; SCHUKNECHT, B; LEINEKUGEL, P; PROPPING, P; TONNESEN, T; LOU, H; MOSER, H; ZIERZ, S; CONZELMANN, E; GIESELMANN, V				PENZIEN, JM; KAPPLER, J; HERSCHKOWITZ, N; SCHUKNECHT, B; LEINEKUGEL, P; PROPPING, P; TONNESEN, T; LOU, H; MOSER, H; ZIERZ, S; CONZELMANN, E; GIESELMANN, V			COMPOUND HETEROZYGOSITY FOR METACHROMATIC LEUKODYSTROPHY AND ARYLSULFATASE A PSEUDODEFICIENCY ALLELES IS NOT ASSOCIATED WITH PROGRESSIVE NEUROLOGICAL DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							A PSEUDODEFICIENCY; DEFICIENCY; MUTATIONS; DIAGNOSIS; PATIENT; FAMILY; ASSAY	Several allelic mutations at the arylsulfatase A (ASA) locus cause substantial deficiencies of this lysosomal enzyme. Depending on the genetically determined degree of the deficiency, the clinical outcome may be very different-either metachromatic leukodystrophy (MLD), a lethal lysosomal storage disorder affecting the nervous system, or, more frequently, the so-called pseudodeficiency (PD), which has no apparent clinical consequence. Because of compound heterozygosity for MLD and PD, 1/1,000 individuals in the population have low residual enzyme activities, which are intermediate between those of MLD patients and those of PD homozygous normal individuals. In order to assess whether PD/MLD compound heterozygotes bear a health risk, we examined clinically and biochemically 16 individuals with this genotype. Of these subjects, two had neurological symptoms and two showed lesions, without clinical symptoms, in magnetic resonance imaging of the brain. None of these symptoms was progressive, nor did they resemble those of MLD. Nerve conduction velocities were normal in these probands, and they secreted only low amounts of sulfatide in the urine. We conclude that the observed neurological symptoms are unrelated to the ASA genotype and that PD/MLD compound heterozygotes are not at an increased risk for developing progressive nervous system diseases.	UNIV BERN,DEPT PEDIAT,CH-3000 BERN,SWITZERLAND; UNIV BERN,DEPT RADIOL,CH-3000 BERN,SWITZERLAND; UNIV GOTTINGEN,DEPT BIOCHEM,W-3400 GOTTINGEN,GERMANY; UNIV BONN,INST ORGAN CHEM,W-5300 BONN,GERMANY; UNIV BONN,DEPT HUMAN GENET,W-5300 BONN,GERMANY; UNIV BONN,DEPT NEUROL,W-5300 BONN,GERMANY; JF KENNEDY INST,GLOSTRUP,DENMARK; JOHNS HOPKINS UNIV,KENNEDY INST,BALTIMORE,MD 21218; UNIV WURZBURG,THEODOR BOVERI INST BIOSCI,W-8700 WURZBURG,GERMANY	University of Bern; University of Bern; University of Gottingen; University of Bonn; University of Bonn; University of Bonn; Johns Hopkins University; University of Wurzburg								BOHNE W, 1991, HUM GENET, V87, P155, DOI 10.1007/BF00204172; CLARK JR, 1979, NEUROLOGY, V29, P346, DOI 10.1212/WNL.29.3.346; CONZELMANN E, 1983, DEV NEUROSCI, V6, P58; CONZELMANN E, 1987, LIPID STORAGE DISORD, P267; FLUHARTY AL, 1991, AM J HUM GENET, V49, P1340; GIESELMANN V, 1991, HUM GENET, V86, P251; GIESELMANN V, 1991, AM J HUM GENET, V49, P407; GIESELMANN V, 1989, P NATL ACAD SCI USA, V86, P9436, DOI 10.1073/pnas.86.23.9436; HERSKA M, 1987, AM J MED GENET, V26, P629, DOI 10.1002/ajmg.1320260318; HERZ B, 1984, HUM GENET, V66, P147, DOI 10.1007/BF00286589; HOHENSCHUTZ C, 1989, HUM GENET, V82, P45, DOI 10.1007/BF00288270; KAPPLER J, 1991, DEV NEUROSCI-BASEL, V13, P228, DOI 10.1159/000112165; KAPPLER J, 1991, HUM GENET, V86, P463; KIHARA H, 1980, PEDIATR RES, V14, P224, DOI 10.1203/00006450-198003000-00009; KOLODNY EH, 1989, METABOLIC BASIS INHE, P1721; LEEVAUPEL M, 1987, CLIN CHIM ACTA, V164, P171, DOI 10.1016/0009-8981(87)90068-4; LEINEKUGEL P, 1992, HUM GENET, V88, P513, DOI 10.1007/BF00219337; POLTEN A, 1991, NEW ENGL J MED, V324, P18, DOI 10.1056/NEJM199101033240104; PROPPING P, 1986, HUM GENET, V74, P244; ROSSI LN, 1975, J NEUROL, V210, P201; SCHIPPER HI, 1984, NEURORADIOLOGY, V26, P39, DOI 10.1007/BF00328202; TONNESEN T, 1983, ACTA PAEDIATR SCAND, V72, P175, DOI 10.1111/j.1651-2227.1983.tb09692.x	22	49	51	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1993	52	3					557	564						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KR720	8095368				2022-12-18	WOS:A1993KR72000013
J	PANGALOS, CG; TALBOT, CC; LEWIS, JG; ADELSBERGER, PA; PETERSEN, MB; SERRE, JL; RETHORE, MO; DEBLOIS, MC; PARENT, P; SCHINZEL, AA; BINKERT, F; BOUE, J; CORBIN, E; CROQUETTE, MF; GILGENKRANTZ, S; DEGROUCHY, J; BERTHEAS, MF; PRIEUR, M; RAOUL, O; SERVILLE, F; SIFFROI, JP; THEPOT, F; LEJEUNE, J; ANTONARAKIS, SE				PANGALOS, CG; TALBOT, CC; LEWIS, JG; ADELSBERGER, PA; PETERSEN, MB; SERRE, JL; RETHORE, MO; DEBLOIS, MC; PARENT, P; SCHINZEL, AA; BINKERT, F; BOUE, J; CORBIN, E; CROQUETTE, MF; GILGENKRANTZ, S; DEGROUCHY, J; BERTHEAS, MF; PRIEUR, M; RAOUL, O; SERVILLE, F; SIFFROI, JP; THEPOT, F; LEJEUNE, J; ANTONARAKIS, SE			DNA POLYMORPHISM ANALYSIS IN FAMILIES WITH RECURRENCE OF FREE TRISOMY-21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GT DINUCLEOTIDE REPEAT; GENETIC-LINKAGE MAP; HUMAN CHROMOSOME-21; PARENTAL ORIGIN; DOWN-SYNDROME; NONDISJUNCTION; RELATIVES; RISK; AMPLIFICATION; 2ND-DEGREE	We used DNA polymorphic markers on the long arm of human chromosome 21 in order to determine the parental and meiotic origin of the extra chromosome 21 in families with recurrent free trisomy 21. A total of 22 families were studied, 13 in which the individuals with trisomy 21 were siblings (category 1), four families in which the individuals with trisomy 21 were second-degree relatives (category 2), and five families in which the individuals with trisomy 21 were third-degree relatives, that is, their parents were siblings (category 3). In five category 1 families, parental mosaicism was detected, while in the remaining eight families, the origin of nondisjunction was maternal. In two of the four families of category 2 the nondisjunctions originated in individuals who were related. In only one of five category 3 families, the nondisjunctions originated in related individuals. These results suggest that parental mosaicism is an important etiologic factor in recurrent free trisomy 21 (5 of 22 families) and that chance alone can explain the recurrent trisomy 21 in many of the remaining families (14 of 22 families). However, in a small number of families (3 of 22), a familial predisposing factor or undetected mosaicism cannot be excluded.	JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,CMSC 1003,BALTIMORE,MD 21205; UNIV PARIS 05,HOP NECKER ENFANTS MALADES,INST PROGENESE,F-75270 PARIS 06,FRANCE; UNIV PARIS 05,HOP NECKER ENFANTS MALADES,CYTOGENET LAB,F-75270 PARIS 06,FRANCE; INSERM,UNITE 155,F-75005 PARIS,FRANCE; INSERM,UNITE 73,F-75005 PARIS,FRANCE; INSERM,UNITE 173,F-75005 PARIS,FRANCE; HOP NECKER ENFANTS MALAD,PARIS,FRANCE; HOP HOTEL DIEU,BROUSSAIS MED FAC,HISTOL EMBRYOL & CYTOGENET LAB,F-75181 PARIS 04,FRANCE; JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205; UNIV BREST,MED GENET UNIT,BREST,FRANCE; UNIV ZURICH,INST MED GENET,CH-8006 ZURICH,SWITZERLAND; HOP HOTEL DIEU,CYTOGENET LAB,NANTES,FRANCE; ST ANTOINE,CYTOGENET LAB,LILLE,FRANCE; REG TRANSFUS CTR,CYTOGENET LAB,NANCY,FRANCE; HOP NORD ST PRIEST JAREZ,CYTOGENET LAB,ST PRIEST JAREZ,FRANCE; HOP ENFANTS PELLEGRIN,MED GENET UNIT,BORDEAUX,FRANCE; UNIV AMIENS,REPROD LAB,AMIENS,FRANCE	Johns Hopkins University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Johns Hopkins University; Universite de Bretagne Occidentale; University of Zurich; Nantes Universite; CHU de Nantes; CHU Bordeaux; Picardie Universites; Universite de Picardie Jules Verne (UPJV)			Antonarakis, Stylianos E/N-8866-2014; Petersen, Michael Bjørn B/D-1483-2017	Antonarakis, Stylianos E/0000-0001-8907-5823; Petersen, Michael Bjørn B/0000-0003-0316-8207	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD024605] Funding Source: NIH RePORTER; NICHD NIH HHS [HD24605] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ABUELO D, 1986, AM J MED GENET, V25, P365, DOI 10.1002/ajmg.1320250223; ALFI OS, 1980, AM J HUM GENET, V32, P477; ANTONARAKIS SE, 1991, NEW ENGL J MED, V324, P872, DOI 10.1056/NEJM199103283241302; ANTONARAKIS SE, 1992, AM J HUM GENET, V50, P544; BURMELSTER M, 1990, NUCLEIC ACIDS RES, V18, P4969, DOI 10.1093/nar/18.16.4969; DANIEL A, 1982, AM J MED GENET, V11, P61, DOI 10.1002/ajmg.1320110109; DEVOTO M, 1985, HUM GENET, V70, P256; DUTRILLAUX B, 1971, CR ACAD SCI D NAT, V272, P2638; Epstein C. J., 1989, METABOLIC BASIS INHE, P291; EUNPU DL, 1986, AM J MED GENET, V25, P361, DOI 10.1002/ajmg.1320250222; GIRAUD F, 1975, J GENET HUM, V23, P1; HARRIS DJ, 1982, AM J HUM GENET, V34, P125; JABS EW, 1991, GENOMICS, V9, P141, DOI 10.1016/0888-7543(91)90231-3; JACKSONCOOK CK, 1985, AM J HUM GENET, V37, P1049; LEWIS JG, 1990, GENOMICS, V8, P400, DOI 10.1016/0888-7543(90)90300-J; MCINNIS MG, 1991, GENOMICS, V11, P573, DOI 10.1016/0888-7543(91)90064-L; Mikkelsen M, 1979, PRENATAL DIAGNOSIS, P22; NIELSEN KG, 1988, HUM GENET, V78, P103, DOI 10.1007/BF00291249; PANGALOS C, 1988, ANN GENET-PARIS, V31, P151; PETERSEN MB, 1990, GENOMICS, V7, P136, DOI 10.1016/0888-7543(90)90531-X; PETERSEN MB, 1991, AM J HUM GENET, V48, P65; PETERSEN MB, 1991, GENOMICS, V9, P407, DOI 10.1016/0888-7543(91)90406-5; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SCHWARTZ S, 1989, AM J HUM GENET, V44, P627; SEABRIGH.M, 1971, LANCET, V2, P971; SHERMAN SL, 1991, AM J HUM GENET, V49, P608; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TAMAREN J, 1983, AM J MED GENET, V15, P393, DOI 10.1002/ajmg.1320150305; UCHIDA IA, 1985, HUM GENET, V70, P246; VANCAMP G, 1991, HUM GENET, V87, P649, DOI 10.1007/BF00201718; WARREN AC, 1987, SCIENCE, V237, P652, DOI 10.1126/science.2955519; WARREN AC, 1989, GENOMICS, V4, P579, DOI 10.1016/0888-7543(89)90282-6; WARREN AC, 1992, GENOMICS, V13, P1365, DOI 10.1016/0888-7543(92)90072-Z; YOKOYAMA S, 1981, HUM GENET, V59, P125, DOI 10.1007/BF00293060	34	49	50	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1992	51	5					1015	1027						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JU840	1415248				2022-12-18	WOS:A1992JU84000011
J	NOGUEIRA, CP; BARTELS, CF; MCGUIRE, MC; ADKINS, S; LUBRANO, T; RUBINSTEIN, HM; LIGHTSTONE, H; VANDERSPEK, AFL; LOCKRIDGE, O; LADU, BN				NOGUEIRA, CP; BARTELS, CF; MCGUIRE, MC; ADKINS, S; LUBRANO, T; RUBINSTEIN, HM; LIGHTSTONE, H; VANDERSPEK, AFL; LOCKRIDGE, O; LADU, BN			IDENTIFICATION OF 2 DIFFERENT POINT MUTATIONS ASSOCIATED WITH THE FLUORIDE-RESISTANT PHENOTYPE FOR HUMAN BUTYRYLCHOLINESTERASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-SERUM-CHOLINESTERASE; AMINO-ACID-SEQUENCE; TORPEDO-CALIFORNICA; MOLECULAR-CLONING; BCHE GENE; ACETYLCHOLINESTERASE; VARIANTS; REGIONS; DNA	The fluoride variant of human butyrylcholinesterase owes its name to the observation that it is resistant to inhibition by 0.050 mM sodium fluoride in the in vitro assay. Individuals who are heterozygous for the fluoride and atypical alleles experience about 30 min of apnea, rather than the usual 3-5 min, after receiving succinyldicholine. Earlier we reported that the atypical variant has a nucleotide substitution which changes Asp 70 to Gly. In the present work we have identified two different point mutations associated with the fluoride-resistant phenotype. Fluoride-1 has a nucleotide substitution which changes Thr 243 to Met (ACG to ATG). Fluoride-2 has a substitution which changes Gly 390 to Val (GGT to GTT). These results were obtained by DNA sequence analysis of the butyrylcholinesterase gene after amplification by PCR. The subjects for these analyses were 4 patients and 21 family members.	UNIV MICHIGAN,SCH MED,DEPT ANESTHESIOL,KRESGE II,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH MED,DEPT PHARMACOL,ANN ARBOR,MI 48104; VET ADM MED CTR,MED & RES SERV,HINES,IL 60141; LOYOLA UNIV,STRITCH SCH MED,DEPT MED,MAYWOOD,IL 60153; ALBERT EINSTEIN MED CTR,NO DIV,DEPT ANESTHESIOL,PHILADELPHIA,PA 19141; UNIV NEBRASKA,MED CTR,EPPLEY INST,OMAHA,NE 68105	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); Loyola University Chicago; Yeshiva University; University of Nebraska System; University of Nebraska Medical Center			Adkins, Stephen W/G-2050-2014		NIGMS NIH HHS [GM044887] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044887] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADKINS S, 1991, CHOLINESTERASES, V2, P196; ALCANTARA VM, 1991, HUM HERED, V41, P103, DOI 10.1159/000153986; ALLDERDICE PW, 1991, GENOMICS, V11, P452, DOI 10.1016/0888-7543(91)90154-7; ARPAGAUS M, 1990, BIOCHEMISTRY-US, V29, P124, DOI 10.1021/bi00453a015; BARTELS CF, 1990, NUCLEIC ACIDS RES, V18, P6171, DOI 10.1093/nar/18.20.6171-a; BARTELS CF, 1992, AM J HUM GENET, V50, P1086; BARTELS CF, 1992, AM J HUM GENET, V50, P1104; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; DIETZ AA, 1972, AM J HUM GENET, V24, P58; DOCTOR BP, 1990, FEBS LETT, V266, P123, DOI 10.1016/0014-5793(90)81522-P; EVANS RT, 1984, J MED GENET, V21, P99, DOI 10.1136/jmg.21.2.99; GAUGHAN G, 1991, GENOMICS, V11, P455, DOI 10.1016/0888-7543(91)90155-8; HALL LMC, 1986, EMBO J, V5, P2949, DOI 10.1002/j.1460-2075.1986.tb04591.x; HALL LMC, 1991, CELL MOL NEUROBIOL, V11, P131, DOI 10.1007/BF00712805; HARRIS H, 1961, NATURE, V191, P496, DOI 10.1038/191496a0; JBILO O, 1990, NUCLEIC ACIDS RES, V18, P3990, DOI 10.1093/nar/18.13.3990; KALOW W, 1955, CAN J BIOCHEM PHYS, V33, P568; KALOW W, 1957, J PHARMACOL EXP THER, V120, P203; KALOW W, 1957, CAN J BIOCHEM PHYS, V35, P339, DOI 10.1139/o57-041; LADU BN, 1991, CELL MOL NEUROBIOL, V11, P79, DOI 10.1007/BF00712801; Lehmann H, 1963, Br Med J, V1, P1116; LIDDELL J, 1963, ACTA GENET STAT MED, V13, P95; LOCKRIDGE O, 1987, J BIOL CHEM, V262, P549; Maniatis T., 1982, MOL CLONING; MASSON P, IN PRESS J BIOL CHEM; MCGUIRE MC, 1989, P NATL ACAD SCI USA, V86, P953, DOI 10.1073/pnas.86.3.953; MCTIERNAN C, 1987, P NATL ACAD SCI USA, V84, P6682, DOI 10.1073/pnas.84.19.6682; MURATANI K, 1991, P NATL ACAD SCI USA, V88, P11315, DOI 10.1073/pnas.88.24.11315; NOGUEIRA CP, 1990, AM J HUM GENET, V46, P934; RACHINSKY TL, 1990, NEURON, V5, P317, DOI 10.1016/0896-6273(90)90168-F; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHUMACHER M, 1986, NATURE, V319, P407, DOI 10.1038/319407a0; SOREQ H, 1990, P NATL ACAD SCI USA, V87, P9688, DOI 10.1073/pnas.87.24.9688; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; VIBYMOGENSEN J, 1981, ANESTHESIOLOGY, V55, P231, DOI 10.1097/00000542-198109000-00008; VIBYMOGENSEN J, 1978, ACTA ANAESTH SCAND, V22, P371, DOI 10.1111/j.1399-6576.1978.tb01313.x; WHITTAKE.M, 1964, ACTA GENET STAT MED, V14, P281; WHITTAKER M, 1986, MONOGRAPHS HUMAN GEN, V11	38	49	51	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1992	51	4					821	828						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JQ667	1415224				2022-12-18	WOS:A1992JQ66700016
J	NAROD, SA; PARRY, DM; PARBOOSINGH, J; LENOIR, GM; RUTTLEDGE, M; FISCHER, G; ELDRIDGE, R; MARTUZA, RL; FRONTALI, M; HAINES, J; GUSELLA, JF; ROULEAU, GA				NAROD, SA; PARRY, DM; PARBOOSINGH, J; LENOIR, GM; RUTTLEDGE, M; FISCHER, G; ELDRIDGE, R; MARTUZA, RL; FRONTALI, M; HAINES, J; GUSELLA, JF; ROULEAU, GA			NEUROFIBROMATOSIS TYPE-2 APPEARS TO BE A GENETICALLY HOMOGENEOUS DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BILATERAL ACOUSTIC NEUROFIBROMATOSIS; POLYCYSTIC KIDNEY-DISEASE; HUMAN CHROMOSOME-22; TUBEROUS SCLEROSIS; LINKAGE ANALYSIS; POINT MUTATIONS; LENS OPACITIES; DNA MARKER; GENE; HETEROGENEITY	Neurofibromatosis type 2 (NF2) is an autosomal dominant syndrome characterized by the development of vestibular schwannomas and other tumors of the nervous system, including cranial and spinal meningiomas, schwannomas, and ependymomas. The presence of bilateral vestibular schwannomas is sufficient for the diagnosis. Skin manifestations are less common than in neurofibromatosis type 1 (NF1; von Recklinghausen disease). The apparent clinical distinction between NF1 and NF2 has been confirmed at the level of the gene locus by linkage studies; the gene for NF1 maps to chromosome 17, whereas the gene for NF2 has been assigned (in a single family) to chromosome 22. To increase the precision of the genetic mapping of NF2 and to determine whether additional susceptibility loci exist, we have performed linkage analysis on 12 families with NF2 by using four polymorphic markers from chromosome 22 and a marker at the NF1 locus on chromosome 17. Our results confirm the assignment of the gene for NF2 to chromosome 22 and do not support the hypothesis of genetic heterogeneity. We believe that chromosome 22 markers can now be used for presymptomatic diagnosis in selected families. The NF2 gene is tightly linked to the D22S32 locus (maximum lod score 4.12; recombination fraction 0). A CA-repeat polymorphism at the CRYB2 locus was the most informative marker in our families (lod score 5.99), but because the observed recombination fraction between NF2 and CRYB2 was 10 cM, predictions using this marker will need to be interpreted with caution.	LUDWIG INST CANC RES, STOCKHOLM, SWEDEN; NCI, CLIN EPIDEMIOL BRANCH, BETHESDA, MD 20892 USA; NINCDS, NEUROEPIDEMIOL BRANCH, BETHESDA, MD 20892 USA; INT AGCY RES CANC, F-69372 LYON, FRANCE; HOP NEUROL, DEPT NEUROSURG, F-69394 LYON 3, FRANCE; MCGILL CTR HUMAN GENET, MONTREAL, QUEBEC, CANADA; INST MED SPERIMENTALE, ROME, ITALY; MASSACHUSETTS GEN HOSP, DEPT SURG, BOSTON, MA 02114 USA; KAROLINSKA HOSP, DEPT CLIN GENET, S-10401 STOCKHOLM 60, SWEDEN; MASSACHUSETTS GEN HOSP, NEUROGENET LAB, BOSTON, MA 02114 USA; UNIV LYON 1, F-69365 LYON 2, FRANCE	Ludwig Institute for Cancer Research; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); World Health Organization; International Agency for Research on Cancer (IARC); CHU Lyon; McGill University; Harvard University; Massachusetts General Hospital; Karolinska Institutet; Karolinska University Hospital; Harvard University; Massachusetts General Hospital; UDICE-French Research Universities; Universite Claude Bernard Lyon 1			Narod, Steven A/AAA-6112-2022; Haines, Jonathan/C-3374-2012	Haines, Jonathan/0000-0002-4351-4728				ALLEN J C, 1974, Birth Defects Original Article Series, V10, P171; ALLIEZ J, 1975, REV NEUROL-FRANCE, V131, P545; [Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; BARKER D, 1987, SCIENCE, V236, P1100, DOI 10.1126/science.3107130; BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; DUMANSKI JP, 1991, GENOMICS, V11, P709, DOI 10.1016/0888-7543(91)90079-T; DUTCHER PO, 1987, AM J OTOL, V8, P35; ELDRIDGE R, 1992, NEUROSURGERY, V30, P962, DOI 10.1227/00006123-199206000-00030; Fischer G, 1979, Rev Laryngol Otol Rhinol (Bord), V100, P97; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HAINES JL, 1991, ANN NY ACAD SCI, V615, P256; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; KAISERKUPFER MI, 1989, ARCH OPHTHALMOL-CHIC, V107, P541, DOI 10.1001/archopht.1989.01070010555030; KANTER WR, 1980, NEUROLOGY, V30, P851, DOI 10.1212/WNL.30.8.851; KIMBERLING WJ, 1988, NEW ENGL J MED, V319, P913, DOI 10.1056/NEJM198810063191405; KOOS WT, 1972, NEUROCHIRURGIA, V15, P159; KRAPCHO K, 1988, NUCLEIC ACIDS RES, V16, P5221, DOI 10.1093/nar/16.11.5221; LANDAU K, 1990, ARCH OPHTHALMOL-CHIC, V108, P328, DOI 10.1001/archopht.1990.01070050026011; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MARINEAU C, 1992, NUCLEIC ACIDS RES, V20, P1430, DOI 10.1093/nar/20.6.1430; MARTUZA RL, 1988, NEW ENGL J MED, V318, P684, DOI 10.1056/NEJM198803173181106; MAYFRANK L, 1990, CLIN GENET, V38, P362; MCKENNAN KX, 1991, LARYNGOSCOPE, V101, P109; MELKI J, 1990, LANCET, V336, P271, DOI 10.1016/0140-6736(90)91803-I; MIYAMOTO RT, 1990, OTOLARYNG HEAD NECK, V103, P619, DOI 10.1177/019459989010300416; NAROD SA, 1991, LANCET, V338, P82; PAGE RCL, 1995, DIABETIC MED, V12, P209, DOI 10.1111/j.1464-5491.1995.tb00460.x; PARRY DM, 1991, ANN NY ACAD SCI, V630, P305, DOI 10.1111/j.1749-6632.1991.tb19615.x; PEARSONWEBB MA, 1986, NEW ENGL J MED, V315, P1553; ROMEO G, 1988, LANCET, V2, P8; ROULEAU GA, 1987, NATURE, V329, P246, DOI 10.1038/329246a0; ROULEAU GA, 1989, GENOMICS, V4, P1, DOI 10.1016/0888-7543(89)90306-6; SAMPSON JR, 1989, J MED GENET, V26, P511, DOI 10.1136/jmg.26.8.511; SEIZINGER BR, 1987, CELL, V49, P589, DOI 10.1016/0092-8674(87)90534-4; SOBOL H, 1989, NEW ENGL J MED, V321, P996, DOI 10.1056/NEJM198910123211502; TOS M, 1984, J LARYNGOL OTOL, V98, P685, DOI 10.1017/S0022215100147292; WARD K, 1990, AM J HUM GENET, V46, P943; WERTELECKI W, 1988, NEW ENGL J MED, V319, P278, DOI 10.1056/NEJM198808043190505; XU GF, 1991, NUCLEIC ACIDS RES, V19, P3764, DOI 10.1093/nar/19.13.3764; YANDELL DW, 1989, NEW ENGL J MED, V321, P1689, DOI 10.1056/NEJM198912213212501	42	49	50	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1992	51	3					486	496						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JJ828	1496982				2022-12-18	WOS:A1992JJ82800005
J	BORGLUM, AD; BYSKOV, A; RAGNO, P; ROLDAN, AL; TRIPPUTI, P; CASSANI, G; DANO, K; BLASI, F; BOLUND, L; KRUSE, TA				BORGLUM, AD; BYSKOV, A; RAGNO, P; ROLDAN, AL; TRIPPUTI, P; CASSANI, G; DANO, K; BLASI, F; BOLUND, L; KRUSE, TA			ASSIGNMENT OF THE UROKINASE-TYPE PLASMINOGEN-ACTIVATOR RECEPTOR GENE (PLAUR) TO CHROMOSOME 19Q13.1-Q13.2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CELLULAR-BINDING SITE	The urokinase-type plasminogen activator receptor (uPAR) is a key molecule in the regulation of cell-surface plasminogen activation and, as such, plays an important role in many normal as well as pathological processes. We applied a cDNA probe from the corresponding gene (PLAUR) in a location analysis using a panel of human/rodent cell hybrids and in a multipoint linkage analysis of 40 CEPH families. These two independent studies both found PLAUR to be located on chromosome 19. The cell hybrid study suggested that PLAUR is located at chromosome 19q13-qter, and the multipoint analysis indicated that PLAUR is located at chromosome 19q13.1-q13.2 and surrounded by DNA markers in the following way (with distances given in recombination fractions): D19S27-.11-CYP2A-.06-PLAUR-.03-D19S8-.04-APOC2-.24-PRKCG. Further, a ligand-binding study performed on cell hybrids verified the species specificity of the uPAR and confirmed the chromosome assignment.	UNIV COPENHAGEN,INST MICROBIOL,DK-2000 COPENHAGEN,DENMARK; UNIV COPENHAGEN,RIGSHOSP,FINSEN LABS,DK-2100 COPENHAGEN,DENMARK; CNR,CTR ENDOCRINOL & ONCOL SPERIMENTALE,NAPLES,ITALY; TECNOGEN SPA,MILAN,ITALY	University of Copenhagen; Rigshospitalet; University of Copenhagen; Consiglio Nazionale delle Ricerche (CNR)	BORGLUM, AD (corresponding author), AARHUS UNIV,INST HUMAN GENET,BARTHOLIN BLDG,DK-8000 AARHUS,DENMARK.		Tripputi, Pasquale/AAJ-3649-2021	Borglum, Anders/0000-0001-8627-7219; Tripputi, Pasquale/0000-0003-3394-8503; Blasi, Francesco/0000-0001-9406-1784				ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; APPELLA E, 1987, J BIOL CHEM, V262, P4437; BAJPAI A, 1985, BIOCHEM BIOPH RES CO, V133, P475, DOI 10.1016/0006-291X(85)90931-3; BLASI F, 1988, Fibrinolysis, V2, P73, DOI 10.1016/0268-9499(88)90370-0; BLASI F, 1987, J CELL BIOL, V104, P801, DOI 10.1083/jcb.104.4.801; BORGLUM AD, 1991, NUCLEIC ACIDS RES, V19, P6661, DOI 10.1093/nar/19.23.6661-a; BORGLUM AD, IN PRESS HUM GENET; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; ESTREICHER A, 1989, J BIOL CHEM, V264, P1180; KRUSE TA, 1988, FEBS LETT, V240, P123, DOI 10.1016/0014-5793(88)80352-1; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LEBEAU MM, 1989, CYTOGENET CELL GENET, V51, P338, DOI 10.1159/000132798; MILES L A, 1988, Fibrinolysis, V2, P61, DOI 10.1016/0268-9499(88)90369-4; PLOUG M, 1991, J BIOL CHEM, V266, P1928; REICH E, 1978, MOL BASIS BIOL DEGRA, P155; ROLDAN AL, 1990, EMBO J, V9, P467, DOI 10.1002/j.1460-2075.1990.tb08132.x; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STOPPELLI MP, 1985, P NATL ACAD SCI USA, V82, P4939, DOI 10.1073/pnas.82.15.4939; STOPPELLI MP, 1986, CELL, V45, P675, DOI 10.1016/0092-8674(86)90782-8; TRIPPUTI P, 1985, P NATL ACAD SCI USA, V82, P4448, DOI 10.1073/pnas.82.13.4448; VASSALLI JD, 1985, J CELL BIOL, V100, P86, DOI 10.1083/jcb.100.1.86	22	49	52	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1992	50	3					492	497						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HH974	1311495				2022-12-18	WOS:A1992HH97400006
J	TANIGAMI, A; TOKINO, T; TAKIGUCHI, S; MORI, M; GLASER, T; PARK, JW; JONES, C; NAKAMURA, Y				TANIGAMI, A; TOKINO, T; TAKIGUCHI, S; MORI, M; GLASER, T; PARK, JW; JONES, C; NAKAMURA, Y			MAPPING OF 262 DNA MARKERS INTO 24 INTERVALS ON HUMAN CHROMOSOME-11	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ENDOCRINE NEOPLASIA TYPE-1; CO-AMPLIFICATION; BLADDER-CANCER; GENE; CARCINOMAS; LOCALIZATION; INT-2; BREAKPOINTS; DELETION; TUMOR	We have extended our mapping effort on human chromosome 11 to encompass a total of 262 DNA markers, which have been mapped into 24 intervals on chromosome 11; 123 of the markers reveal RFLPs. These clones are scattered throughout the chromosome, although some clustering occurs in R-positive bands (p15.1, p11.2, q13, and q23.3). Fifty-two of the markers were found to contain DNA sequences conserved in Chinese hamster, and some of these 52 also cross-hybridized with DNA from other mammals and/or chicken. As the length of chromosome 11 is estimated at nearly 130 cM, the average distance between RFLP markers is roughly 1 cM. The large panel of DNA markers on our map should contribute to investigations of hereditary diseases on this chromosome, and it will also provide reagents for constructing either fine-scale linkage and physical maps or contig maps of cosmids or yeast artificial chromosomes.	JAPANESE FDN CANC RES,INST CANC,DIV BIOCHEM,1-37-1 KAMI IKEBUKURO,TOSHIMA KU,TOKYO 170,JAPAN; MIT,CTR CANC RES,CAMBRIDGE,MA 02139; ELEANOR ROOSEVELT INST,DENVER,CO	Japanese Foundation for Cancer Research; Massachusetts Institute of Technology (MIT)			Tokino, Takashi/AAI-9887-2021					ADELAIDE J, 1988, ONCOGENE, V2, P413; ALI IU, 1987, SCIENCE, V238, P185, DOI 10.1126/science.3659909; BALE AE, 1991, CANCER RES, V51, P1154; BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; CLAIR D, 1990, LANCET, V336, P13; COOKSON WOCM, 1989, CYTOGENET CELL GENET, V51, P979; DUYK GM, 1990, P NATL ACAD SCI USA, V87, P8995, DOI 10.1073/pnas.87.22.8995; FEARON ER, 1985, NATURE, V318, P377, DOI 10.1038/318377a0; FUJIMORI M, 1991, CANCER RES, V51, P89; GARDINER K, 1990, EMBO J, V9, P25, DOI 10.1002/j.1460-2075.1990.tb08076.x; GATTI RA, 1988, NATURE, V336, P577, DOI 10.1038/336577a0; GLASER T, 1989, SOMAT CELL MOLEC GEN, V15, P477, DOI 10.1007/BF01534910; GRIFFIN CA, 1986, P NATL ACAD SCI USA, V83, P6122, DOI 10.1073/pnas.83.16.6122; HATADA I, 1988, ONCOGENE, V3, P537; HOPMAN AHN, 1991, CANCER RES, V51, P644; LARSSON C, 1988, NATURE, V332, P85, DOI 10.1038/332085a0; MACKAY J, 1988, BRIT J CANCER, V58, P710, DOI 10.1038/bjc.1988.295; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NAKAMURA Y, 1989, AM J HUM GENET, V44, P751; PING AJ, 1989, AM J HUM GENET, V44, P720; Sambrook J., 1989, MOL CLONING LAB MANU; SCRABLE HJ, 1987, NATURE, V329, P645, DOI 10.1038/329645a0; SMITH M, 1990, GENOMICS, V6, P105, DOI 10.1016/0888-7543(90)90454-3; SOMERS KD, 1990, ONCOGENE, V5, P915; THEILLET C, 1986, CANCER RES, V46, P4776; TOKINO T, 1991, AM J HUM GENET, V48, P258; TSAI YC, 1990, CANCER RES, V50, P44; TSUDA T, 1989, CANCER RES, V49, P5505; TSUJIMOTO Y, 1985, NATURE, V315, P340, DOI 10.1038/315340a0; WANG HP, 1988, CYTOGENET CELL GENET, V48, P72, DOI 10.1159/000132593; YAMAKAWA K, 1991, GENOMICS, V9, P536, DOI 10.1016/0888-7543(91)90421-A; ZHOU DJ, 1988, ONCOGENE, V2, P279	32	49	52	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1992	50	1					56	64						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HA040	1346079				2022-12-18	WOS:A1992HA04000006
J	DEVOTO, M; RONCHETTO, P; FANEN, P; ORRIOLS, JJT; ROMEO, G; GOOSSENS, M; FERRARI, M; MAGNANI, C; SEIA, M; CREMONESI, L				DEVOTO, M; RONCHETTO, P; FANEN, P; ORRIOLS, JJT; ROMEO, G; GOOSSENS, M; FERRARI, M; MAGNANI, C; SEIA, M; CREMONESI, L			SCREENING FOR NON-DELTAF508 MUTATIONS IN 5 EXONS OF THE CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) GENE IN ITALY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GRADIENT GEL-ELECTROPHORESIS; SINGLE-BASE CHANGES; POINT MUTATIONS; DNA FRAGMENTS; IDENTIFICATION; MISMATCHES; CLEAVAGE	Analysis of exons 10, 11, 14a, 15, and 20 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by denaturing-gradient-gel electrophoresis (DGGE) allowed the identification of mutations causing cystic fibrosis (CF) in 25 of 109 non-deltaF508 chromosomes, as well as identification of a number of polymorphisms and sequence variations. Direct sequencing of the PCR fragments which showed an altered electrophoretic behavior not attributable to known mutations has led to the characterization of four new mutations, two in exon 11, and one each in exons 15 and 20. Screening for the different mutations thus far identified in our patients by the DGGE analysis and other independent methods should allow detection of about 70% of the molecular defects causing CF in Italy. Mutations located in exons 11 and 20 account for at least 30% of the non-deltaF508 mutations present in Italian CF patients.	CTR HOSP HENRI MONDOR,SERV BIOCHIM,GENET MOLEC LAB,CRETEIL,FRANCE; CTR HOSP HENRI MONDOR,INSERM,U91,CRETEIL,FRANCE; IST SCI H SAN RAFFAELE,CENT LAB,MILAN,ITALY; IST CLIN PERFEZIONAMENTO,RIC CLIN LAB,MILAN,ITALY	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	DEVOTO, M (corresponding author), IST GIANNINA GASLINI,GENET MOLEC LAB,I-16148 GENOA,ITALY.		Ferrari, Maurizio/D-9107-2013; Ronchetto, Patrizia/AAA-7742-2020; Devoto, Marcella/AAP-7595-2021; Telleria, Juan/AAK-8794-2020	Telleria, Juan/0000-0003-1923-8345; DEVOTO, MARCELLA/0000-0002-4431-5114; Fanen, Pascale/0000-0002-3273-5349; Ronchetto, Patrizia/0000-0002-2606-3398				ATTREE O, 1989, GENOMICS, V4, P266, DOI 10.1016/0888-7543(89)90330-3; BEAUDET AL, 1990, AM J HUM GENET, V47, P603; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; CREMONESI L, 1990, HUM GENET, V85, P400, DOI 10.1007/BF02428276; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; CUTTING GR, 1990, NEW ENGL J MED, V323, P1685, DOI 10.1056/NEJM199012133232407; DEAN M, 1990, CELL, V61, P863, DOI 10.1016/0092-8674(90)90196-L; GUILLERMIT H, 1990, HUM GENET, V85, P450, DOI 10.1007/BF02428306; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KOBAYASHI K, 1990, AM J HUM GENET, V47, P611; MYERS RM, 1985, SCIENCE, V230, P1242, DOI 10.1126/science.4071043; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWARZ MJ, IN PRESS IDENTIFICAT; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; THEOPHILUS BDM, 1989, NUCLEIC ACIDS RES, V17, P7707, DOI 10.1093/nar/17.19.7707; TRAYSTMAN MD, 1990, GENOMICS, V6, P293, DOI 10.1016/0888-7543(90)90569-G; VIDAUD M, 1990, HUM GENET, V85, P446, DOI 10.1007/BF02428305; WHITE MB, 1990, NATURE, V344, P665, DOI 10.1038/344665a0; WILFOND BS, 1990, JAMA-J AM MED ASSOC, V263, P2777, DOI 10.1001/jama.263.20.2777; 1990, HUM GENET, V85, P436	25	49	49	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1991	48	6					1127	1132						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FP092	1709778				2022-12-18	WOS:A1991FP09200014
J	SUTHERS, GK; MULLEY, JC; VOELCKEL, MA; DAHL, N; VAISANEN, ML; STEINBACH, P; GLASS, IA; SCHWARTZ, CE; VANOOST, BA; THIBODEAU, SN; HAITES, NE; OOSTRA, BA; GINE, R; CARBALLO, M; MORRIS, CP; HOPWOOD, JJ; SUTHERLAND, GR				SUTHERS, GK; MULLEY, JC; VOELCKEL, MA; DAHL, N; VAISANEN, ML; STEINBACH, P; GLASS, IA; SCHWARTZ, CE; VANOOST, BA; THIBODEAU, SN; HAITES, NE; OOSTRA, BA; GINE, R; CARBALLO, M; MORRIS, CP; HOPWOOD, JJ; SUTHERLAND, GR			GENETIC-MAPPING OF NEW DNA PROBES AT XQ27 DEFINES A STRATEGY FOR DNA STUDIES IN THE FRAGILE-X SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; COMMITTEE; LOCUS; POLYMORPHISMS; CHROMOSOME; FAMILIES; FRAXA	The fragile X syndrome is the most common cause of familial mental retardation and is characterized by a fragile site at the end of the long arm of the X chromosome. The unusual genetics and cytogenetics of this X-linked condition make genetic counseling difficult. DNA studies were of limited value in genetic counseling, because the nearest polymorphic DNA loci had recombination fractions of 12% or more with the fragile X mutation, FRAXA. Five polymorphic loci have recently been described in this region of the X chromosome. The positions of these loci in relation to FRAXA were defined in a genetic linkage study of 112 affected families. The five loci - DXS369, DXS297, DXS296, IDS, and DXS304 - had recombination fractions of 4% or less with FRAXA. The closest locus, DXS296, was distal to FRAXA and had a recombination fraction of 2%. The polymorphisms at these loci can be detected in DNA enzymatically digested with a limited number of restriction endonucleases. A strategy for DNA studies which is based on three restriction endonucleases and on five probes will detect one or more of these polymorphisms in 94% of women. This strategy greatly increases the utility of DNA studies in providing genetic advice to families with the fragile X syndrome.	ADELAIDE CHILDRENS HOSP INC,DEPT CYTOGENET & MOLEC GENET,ADELAIDE,SA 5006,AUSTRALIA; ADELAIDE CHILDRENS HOSP INC,DEPT CHEM PATHOL,LYSOSOMAL DIS RES UNIT,ADELAIDE,SA 5006,AUSTRALIA; HOP ENFANTS LA TIMONE,CTR DIAGNOST PRENATAL,F-13385 MARSEILLE 4,FRANCE; UNIV UPPSALA,DEPT MED GENET,S-75105 UPPSALA,SWEDEN; UNIV OULU,CENT HOSP,DEPT CLIN GENET,SF-90220 OULU 22,FINLAND; UNIV ULM,DEPT CLIN GENET,W-7900 ULM,GERMANY; UNIV GLASGOW,DEPT MED GENET,GLASGOW G12 8QQ,SCOTLAND; GREENWOOD GENET CTR,GREENWOOD,SC 29646; UNIV HOSP NIJMEGEN,DEPT HUMAN GENET,NIJMEGEN,NETHERLANDS; MAYO CLIN & MAYO FDN,DEPT LAB MED,ROCHESTER,MN 55905; UNIV ABERDEEN,DEPT MOLEC & CELL BIOL,ABERDEEN MED GENET GRP,ABERDEEN AB9 1FX,SCOTLAND; ERASMUS UNIV,DEPT CELL BIOL & CLIN GENET,3000 DR ROTTERDAM,NETHERLANDS; UNIV ZURICH,INST MED GENET,CH-8006 ZURICH,SWITZERLAND; CSIC,BARCELONA,SPAIN	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Uppsala University; University of Oulu; Ulm University; University of Glasgow; Greenwood Genetic Center; Radboud University Nijmegen; Mayo Clinic; University of Aberdeen; Erasmus University Rotterdam; University of Zurich; Consejo Superior de Investigaciones Cientificas (CSIC)			Sutherland, Grant Robert/D-2606-2012	Morris, Phillip/0000-0001-8976-619X				BROWN WT, 1987, LANCET, V1, P280; BROWN WT, 1988, HUM GENET, V78, P201, DOI 10.1007/BF00291662; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; DAHL N, 1989, HUM GENET, V82, P216, DOI 10.1007/BF00291157; GUSELLA JF, 1986, ANNU REV BIOCHEM, V55, P831, DOI 10.1146/annurev.biochem.55.1.831; HEILIG R, 1988, AM J MED GENET, V30, P543, DOI 10.1002/ajmg.1320300156; KEATS B, 1989, CYTOGENET CELL GENET, V51, P459, DOI 10.1159/000132805; KIDD KK, 1989, CYTOGENET CELL GENET, V51, P622, DOI 10.1159/000132810; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LATHROP GM, 1988, AM J HUM GENET, V42, P498; LEDBETTER SA, 1988, AM J HUM GENET, V42, P694; MANDEL JL, 1989, CYTOGENET CELL GENET, V51, P384, DOI 10.1159/000132801; Maniatis T., 1982, MOL CLONING; MULLEY JC, 1987, AM J MED GENET, V27, P435, DOI 10.1002/ajmg.1320270222; NUSSBAUM RL, 1986, ANNU REV GENET, V20, P109; OBERLE I, IN PRESS AM J MED GE; OOSTRA BA, 1990, GENOMICS, V6, P129, DOI 10.1016/0888-7543(90)90457-6; OTT J, 1985, ANAL HUMAN GENETIC L; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; ROUSSEAU F, 1990, HUM GENET, V84, P263; SCHNUR RE, 1989, AM J HUM GENET, V44, P248; SHERMAN SL, 1985, HUM GENET, V69, P289, DOI 10.1007/BF00291644; SHERMAN SL, 1988, AM J MED GENET, V31, P753, DOI 10.1002/ajmg.1320310405; Sutherland G, 1985, FRAGILE SITES HUMAN; SUTHERLAND GR, 1990, CLIN GENET, V37, P2; SUTHERLAND GR, 1990, CLIN GENET, V37, P167; SUTHERLAND GR, IN PRESS ADV TECHNIQ; SUTHERS G, IN PRESS GENOMICS; SUTHERS GK, 1990, AM J HUM GENET, V47, P187; SUTHERS GK, 1989, SCIENCE, V246, P1298, DOI 10.1126/science.2573953; TURNER G, 1986, NEW ENGL J MED, V315, P607, DOI 10.1056/NEJM198609043151002; VINCENT A, 1989, GENOMICS, V5, P797, DOI 10.1016/0888-7543(89)90121-3; YU S, 1990, NUCLEIC ACIDS RES, V18, P690, DOI 10.1093/nar/18.3.690-a	33	49	49	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1991	48	3					460	467						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK470	1671806				2022-12-18	WOS:A1991FK47000005
J	RASKIND, WH; WIJSMAN, E; PAGON, RA; COX, TC; BAWDEN, MJ; MAY, BK; BIRD, TD				RASKIND, WH; WIJSMAN, E; PAGON, RA; COX, TC; BAWDEN, MJ; MAY, BK; BIRD, TD			X-LINKED SIDEROBLASTIC ANEMIA AND ATAXIA - LINKAGE TO PHOSPHOGLYCERATE KINASE AT XQ13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPASTIC PARAPLEGIA; CLONAL ANALYSIS; DNA PROBES; INHERITANCE; CHROMOSOME; LEUKEMIA; BREAKPOINT; COMMITTEE; FAMILY	Molecular linkage analysis was performed on a kindred with X-linked sideroblastic anemia and ataxia. Two-point analysis with a DNA probe for phosphoglycerate kinase (PGK1), which maps to Xq13, suggested linkage to the disorder by a lod score of at least 2.60 at a recombination fraction of zero. The disease in this kindred appears to be clinically and genetically distinct from that in previously reported families with X-linked hereditary ataxia or spastic paraparesis. No mapping data are available for inherited X-linked sideroblastic anemia without neurologic abnormalities. However, structural alterations of band Xq13 may be involved in the development of idiopathic acquired sideroblastic anemia. No alterations in the restriction patterns of two X-linked genes involved in erythrocyte formation-i. e., a DNA-binding protein (GF-1) and 5-aminolevulinate synthase (ALAS)-were detected in DNA from affected males, arguing against a large deletion in either of these candidate genes.	UNIV WASHINGTON,SCH MED,DEPT MED,DIV GEN INTERNAL MED,SEATTLE,WA 98195; UNIV WASHINGTON,SCH MED,DEPT MED GENET,SEATTLE,WA 98195; UNIV WASHINGTON,SCH MED,DEPT PEDIAT,SEATTLE,WA 98195; VET ADM MED CTR,DIV NEUROL,SEATTLE,WA; UNIV ADELAIDE,DEPT BIOCHEM,ADELAIDE,SA 5001,AUSTRALIA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Adelaide					NCI NIH HHS [CA 16448] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA016448, R37CA016448] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AOKI Y, 1973, ACTA HAEMATOLOGICA J, V36, P74; BOTTOMLEY SS, 1982, CLIN HAEMATOL, V11, P389; CARTWRIGHT GE, 1975, NEW ENGL J MED, V292, P185, DOI 10.1056/NEJM197501232920405; CHAMBERLAIN S, 1988, NATURE, V334, P248, DOI 10.1038/334248a0; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; COX TC, 1990, AM J HUM GENET, V46, P107; DEWALD GW, 1989, CANCER GENET CYTOGEN, V42, P173, DOI 10.1016/0165-4608(89)90085-X; FARLOW MR, 1987, NEUROLOGY, V37, P602, DOI 10.1212/WNL.37.4.602; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GOLDBLATT J, 1989, CLIN GENET, V35, P116; GUTMANN DH, 1990, AM J MED GENET, V36, P251, DOI 10.1002/ajmg.1320360222; HARDING A, 1984, HEREDITARY ATAXIAS R; HARDING AE, 1983, LANCET, V1, P1151; KASTURI J, 1982, ACTA HAEMATOL-BASEL, V68, P321, DOI 10.1159/000207001; KENWRICK S, 1986, HUM GENET, V73, P264, DOI 10.1007/BF00401241; KEPPEN LD, 1987, AM J HUM GENET, V41, P933; KNAPP RH, 1985, MAYO CLIN PROC, V60, P507, DOI 10.1016/S0025-6196(12)60566-7; LEE GR, 1968, BLOOD, V32, P59, DOI 10.1182/blood.V32.1.59.59; LEMERRER M, 1989, CYTOGENET CELL GENET, V51, P1030; MACKINNON WB, 1988, CANCER GENET CYTOGEN, V30, P43, DOI 10.1016/0165-4608(88)90091-X; MANDEL JL, 1989, CYTOGENET CELL GENET, V51, P384, DOI 10.1159/000132801; OTT J, 1976, AM J HUM GENET, V28, P528; PAGON RA, 1985, J MED GENET, V22, P267, DOI 10.1136/jmg.22.4.267; PERUCHO M, 1981, CELL, V27, P467, DOI 10.1016/0092-8674(81)90388-3; PUI CH, 1989, J CLIN INVEST, V83, P1971, DOI 10.1172/JCI114106; RASKIND WH, 1984, BLOOD, V63, P1318; SESSAREGO M, 1983, ACTA HAEMATOL-BASEL, V70, P134, DOI 10.1159/000206707; SHOKEIR M H K, 1970, Clinical Genetics, V1, P225; SPIRA PJ, 1979, BRAIN, V102, P27, DOI 10.1093/brain/102.1.27; VOGELSTEIN B, 1987, CANCER RES, V47, P4806; YOUNG ID, 1987, J NEUROL NEUROSUR PS, V50, P1230, DOI 10.1136/jnnp.50.9.1230; ZON LI, 1990, P NATL ACAD SCI USA, V87, P668, DOI 10.1073/pnas.87.2.668	32	49	49	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1991	48	2					335	341						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV744	1671320				2022-12-18	WOS:A1991EV74400018
J	LIEINJO, LE; CAI, SP; WAHIDIJAT, I; MOESLICHAN, S; LIM, ML; EVANGELISTA, L; DOHERTY, M; KAN, YW				LIEINJO, LE; CAI, SP; WAHIDIJAT, I; MOESLICHAN, S; LIM, ML; EVANGELISTA, L; DOHERTY, M; KAN, YW			BETA-THALASSEMIA MUTATIONS IN INDONESIA AND THEIR LINKAGE TO BETA-HAPLOTYPES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT LAB MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT EPIDEMIOL & INT HLTH,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143; UNIV INDONESIA,SCH MED,DEPT CHILD HLTH,JAKARTA,INDONESIA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Indonesia					NCRR NIH HHS [S07RR05355] Funding Source: Medline; NHLBI NIH HHS [HL33853] Funding Source: Medline; NIDDK NIH HHS [DK 16666] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S07RR005355] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK016666, R01DK016666] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P6608, DOI 10.1073/pnas.79.21.6608; CAI SP, 1988, BLOOD, V71, P1357; CHAN V, 1987, AM J HUM GENET, V41, P678; CHAN V, 1988, BLOOD, V72, P1420; CHEHAB FF, 1987, NATURE, V329, P293, DOI 10.1038/329293b0; CHENG TC, 1984, P NATL ACAD SCI-BIOL, V81, P2821, DOI 10.1073/pnas.81.9.2821; CHIBANI J, 1988, HUM GENET, V78, P190, DOI 10.1007/BF00278196; Goossens M, 1981, Methods Enzymol, V76, P805; HILL AVS, 1988, BLOOD, V72, P9; KAZAZIAN HH, 1986, BLOOD, V68, P964; KAZAZIAN HH, 1988, BLOOD, V72, P1107; KAZAZIAN HH, 1984, AM J HUM GENET, V36, P212; KAZAZIAN HH, 1988, EMBO J, V3, P595; NAKATSUJI T, 1986, AM J HUM GENET, V38, P981; ORKIN SH, 1984, ANNU REV GENET, V18, P131; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; PIRASTU M, 1987, P NATL ACAD SCI USA, V84, P2882, DOI 10.1073/pnas.84.9.2882; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SAIKI RK, 1988, NEW ENGL J MED, V319, P537, DOI 10.1056/NEJM198809013190903; WONG C, 1986, P NATL ACAD SCI USA, V83, P6529, DOI 10.1073/pnas.83.17.6529; ZENG YT, 1987, J MED GENET, V24, P578, DOI 10.1136/jmg.24.10.578; ZHANG JZ, 1988, HUM GENET, V78, P37, DOI 10.1007/BF00291231	23	49	49	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1989	45	6					971	975						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CF403	2589324				2022-12-18	WOS:A1989CF40300017
J	COLLINS, FS; PONDER, BAJ; SEIZINGER, BR; EPSTEIN, CJ				COLLINS, FS; PONDER, BAJ; SEIZINGER, BR; EPSTEIN, CJ			THE VON RECKLINGHAUSEN NEUROFIBROMATOSIS REGION ON CHROMOSOME 17-GENETIC AND PHYSICAL MAPS COME INTO FOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material									INST CANC RES, HUMAN CANC GENET SECT, SUTTON SM2 5PX, SURREY, ENGLAND; MASSACHUSETTS GEN HOSP, NEUROGENET LAB, BOSTON, MA 02114 USA; MASSACHUSETTS GEN HOSP, DEPT NEUROSURG, BOSTON, MA 02114 USA; UNIV CALIF SAN FRANCISCO, DEPT PEDIAT, SAN FRANCISCO, CA 94143 USA	University of London; Institute of Cancer Research - UK; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of California System; University of California San Francisco	COLLINS, FS (corresponding author), UNIV MICHIGAN, MED CTR, DIV MED GENET, 4708 MED SCI 2, BOX 0618, ANN ARBOR, MI 48109 USA.							BARKER D, 1987, SCIENCE, V236, P1100, DOI 10.1126/science.3107130; CIEHL SR, 1989, AM J HUM GENET, V44, P33; Crowe FW, 1956, CLIN PATHOLOGICAL GE; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; FAIN PR, 1989, AM J HUM GENET, V44, P68; FIALKOW PJ, 1971, NEW ENGL J MED, V284, P298, DOI 10.1056/NEJM197102112840604; FOUNTAIN JW, 1989, AM J HUM GENET, V44, P58; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; GILLIAM TC, 1987, CELL, V50, P565, DOI 10.1016/0092-8674(87)90029-8; GOLDGAR DE, 1989, AM J HUM GENET, V44, P6; KITTUR SD, 1989, AM J HUM GENET, V44, P48; LEDBETTER DH, 1989, AM J HUM GENET, V44, P20; MATHEW CGP, 1989, AM J HUM GENET, V44, P38; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; OCONNELL P, 1989, AM J HUM GENET, V44, P51; ORKIN SH, 1986, CELL, V47, P845, DOI 10.1016/0092-8674(86)90799-3; RICCARDI VM, 1981, NEW ENGL J MED, V305, P1617, DOI 10.1056/NEJM198112313052704; RICCARDI VM, 1988, AM J HUM GENET, V42, P284; Riccardi VM., 1993, PLASTIC RECONST SURG, V91, P561, DOI [10.1097/00006534-199303000-00029, DOI 10.1097/00006534-199303000-00029]; ROMMENS JM, 1988, AM J HUM GENET, V43, P645; ROYERPOKORA B, 1986, NATURE, V322, P32, DOI 10.1038/322032a0; RUDDLE FH, 1984, AM J HUM GENET, V36, P944; SCHMIDT MA, 1987, AM J MED GENET, V28, P771, DOI 10.1002/ajmg.1320280333; SEIZINGER BR, 1987, SCIENCE, V236, P317, DOI 10.1126/science.3105060; SEIZINGER BR, 1987, CELL, V49, P589, DOI 10.1016/0092-8674(87)90534-4; SEIZINGER BR, 1989, AM J HUM GENET, V44, P30; SMITH CL, 1987, METHOD ENZYMOL, V155, P449; STEPHENS K, 1989, AM J HUM GENET, V44, P13; STUMPF DA, 1987, NEUROFIBROMATOSIS NI, V6; UPADHYAYA M, 1989, AM J HUM GENET, V44, P41; VANCE JM, 1989, AM J HUM GENET, V44, P25; WASMUTH JJ, 1988, NATURE, V332, P734, DOI 10.1038/332734a0; WILLARD HF, 1986, P NATL ACAD SCI USA, V83, P5611, DOI 10.1073/pnas.83.15.5611	33	49	50	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1989	44	1					1	5						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R5596	2491773				2022-12-18	WOS:A1989R559600001
J	KORENBERG, JR; CROYLE, ML; COX, DR				KORENBERG, JR; CROYLE, ML; COX, DR			ISOLATION AND REGIONAL MAPPING OF DNA-SEQUENCES UNIQUE TO HUMAN-CHROMOSOME 21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF SAN FRANCISCO,DEPT PEDIAT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco					NIGMS NIH HHS [GM07085] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007085] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; ANTONARAKIS SE, 1985, ANN NY ACAD SCI, V450, P95, DOI 10.1111/j.1749-6632.1985.tb21486.x; BAKKER E, 1985, LANCET, V1, P655; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BRILLIANT MH, 1984, MOL CELL BIOL, V4, P2187, DOI 10.1128/MCB.4.10.2187; BROWN WT, 1985, ANN NY ACAD SCI, V450, P69, DOI 10.1111/j.1749-6632.1985.tb21484.x; CAVENEE W, 1984, AM J HUM GENET, V36, P10; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COX DR, 1985, ANN NY ACAD SCI, V450, P169, DOI 10.1111/j.1749-6632.1985.tb21491.x; COX DR, 1984, DEV BIOL, V101, P416, DOI 10.1016/0012-1606(84)90156-8; DAVIES KE, 1984, HUM GENET, V66, P54, DOI 10.1007/BF00275186; Epstein C.J, 1986, CONSEQUENCES CHROMOS; FEDER J, 1985, AM J HUM GENET, V37, P635; GUSELLA JF, 1980, P NATL ACAD SCI-BIOL, V77, P2829, DOI 10.1073/pnas.77.5.2829; HAGEMEIJER A, 1977, HUM GENET, V38, P15, DOI 10.1007/BF00295803; HASSOLD T, 1985, ANN NY ACAD SCI, V450, P179, DOI 10.1111/j.1749-6632.1985.tb21492.x; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; HWU HR, 1986, P NATL ACAD SCI USA, V83, P3875, DOI 10.1073/pnas.83.11.3875; JANSSEN JWG, 1986, CYTOMETRY, V7, P411, DOI 10.1002/cyto.990070504; KRUMLAUF R, 1982, P NATL ACAD SCI-BIOL, V79, P2971, DOI 10.1073/pnas.79.9.2971; LITT M, 1985, P NATL ACAD SCI USA, V82, P6206, DOI 10.1073/pnas.82.18.6206; MANIATIS T, 1982, MOL CLONING LABORATO; NEIBUHR E, 1974, HUMANGENETIK, V21, P99; PATTERSON D, 1985, ANN NY ACAD SCI, V450, P109, DOI 10.1111/j.1749-6632.1985.tb21487.x; PUESCHEL SM, 1982, DOWN SYNDROME ADV BI; RUBIN CM, 1980, NATURE, V284, P372, DOI 10.1038/284372a0; SEALEY PG, 1985, NUCLEIC ACIDS RES, V13, P1905, DOI 10.1093/nar/13.6.1905; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STEWART GD, 1985, NUCLEIC ACIDS RES, V13, P4125, DOI 10.1093/nar/13.11.4125; TIPPETT P, 1985, CYTOGENET CELL GENET, V40, P268, DOI 10.1159/000132177; VANKEUREN ML, 1986, AM J HUM GENET, V38, P793; WATKINS PC, 1985, NUCLEIC ACIDS RES, V13, P6075, DOI 10.1093/nar/13.17.6075; WILLARD HF, 1985, CYTOGENET CELL GENET, V40, P360, DOI 10.1159/000132180; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	35	49	50	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1987	41	6					963	978						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L2984	2891299				2022-12-18	WOS:A1987L298400001
J	EMANUEL, BS; CANNIZZARO, L; ORNSTEINGOLDSTEIN, N; INDIK, ZK; YOON, K; MAY, M; OLIVER, L; BOYD, C; ROSENBLOOM, J				EMANUEL, BS; CANNIZZARO, L; ORNSTEINGOLDSTEIN, N; INDIK, ZK; YOON, K; MAY, M; OLIVER, L; BOYD, C; ROSENBLOOM, J			CHROMOSOMAL LOCALIZATION OF THE HUMAN ELASTIN GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV PENN,SCH DENT MED,CTR ORAL HLTH RES,PHILADELPHIA,PA 19104; UNIV STELLENBOSCH,SCH MED,MRC,MOLEC & CELLULAR CARDIOL RES UNIT,TYGERBERG 7505,SOUTH AFRICA; UNIV MED & DENT NEW JERSEY,RUTGERS MED SCH,DEPT BIOCHEM,PISCATAWAY,NJ 08854	University of Pennsylvania; Stellenbosch University; Rutgers State University New Brunswick; Rutgers State University Medical Center	EMANUEL, BS (corresponding author), UNIV PENN,SCH MED,DEPT HUMAN GENET & PEDIAT,PHILADELPHIA,PA 19104, USA.				NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [P01AM020553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL129702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE002623] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-29702] Funding Source: Medline; NIADDK NIH HHS [AM-20553] Funding Source: Medline; NIDCR NIH HHS [DE-02623] Funding Source: Medline	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BOOTSMA D, 1984, CYTOGENET CELL GENET, V37, P22, DOI 10.1159/000132003; BRESSAN GM, 1977, BIOCHEMISTRY-US, V16, P1406, DOI 10.1021/bi00626a026; BURNETT W, 1979, BIOCHEM BIOPH RES CO, V86, P478, DOI 10.1016/0006-291X(79)91739-X; BURNETT W, 1980, BIOCHEMISTRY-US, V19, P1106, DOI 10.1021/bi00547a010; BURNETT W, 1981, BIOCHEM BIOPH RES CO, V99, P364, DOI 10.1016/0006-291X(81)91754-X; BURNETT W, 1982, J BIOL CHEM, V257, P1569; CANNIZZARO LA, 1984, CYTOGENET CELL GENET, V38, P308, DOI 10.1159/000132079; DAVIDSON JM, 1982, J BIOL CHEM, V257, P747; DAVIDSON JM, 1982, ARCH BIOCHEM BIOPHYS, V218, P31, DOI 10.1016/0003-9861(82)90317-4; EICHNER R, 1979, ARCH BIOCHEM BIOPHYS, V198, P414, DOI 10.1016/0003-9861(79)90515-0; EMANUEL BS, 1979, AM J MED GENET, V4, P167, DOI 10.1002/ajmg.1320040209; ERIKSON J, 1983, P NATL ACAD SCI-BIOL, V80, P7581, DOI 10.1073/pnas.80.24.7581; FOSTER JA, 1980, BIOCHEMISTRY-US, V19, P857, DOI 10.1021/bi00546a005; FOSTER JA, 1975, BIOCHEMISTRY-US, V14, P5343, DOI 10.1021/bi00695a019; FOSTER JA, 1973, J BIOL CHEM, V248, P2876; FRANZBLAU C, 1965, BIOCHEM BIOPH RES CO, V21, P525; GERHARD DS, 1981, P NATL ACAD SCI-BIOL, V78, P3755, DOI 10.1073/pnas.78.6.3755; GRUNSTEIN M, 1975, P NATL ACAD SCI USA, V72, P3961, DOI 10.1073/pnas.72.10.3961; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; HEIDECKER G, 1980, GENE, V10, P69, DOI 10.1016/0378-1119(80)90145-6; KARR SR, 1981, J BIOL CHEM, V256, P5946; LAI EC, 1979, CELL, V16, P201; MILLER EJ, 1965, J BIOL CHEM, V240, P3623; MURPHY L, 1972, FEBS LETT, V21, P113, DOI 10.1016/0014-5793(72)80116-9; NARAYANAN AS, 1976, J BIOL CHEM, V251, P1125; PARTRIDGE SM, 1966, NATURE, V209, P399, DOI 10.1038/209399b0; PARTRIDGE SM, 1962, ADV PROTEIN CHEM, V17, P227; PINNELL SR, 1968, P NATL ACAD SCI USA, V61, P708, DOI 10.1073/pnas.61.2.708; ROSENBLOOM J, 1980, J BIOL CHEM, V255, P100; ROSENBLOOM J, 1976, BIOCHEM BIOPH RES CO, V69, P613, DOI 10.1016/0006-291X(76)90920-7; RUCKER RB, 1973, BIOCHIM BIOPHYS ACTA, V317, P193, DOI 10.1016/0005-2795(73)90212-2; SANDBERG LB, 1969, BIOCHEMISTRY-US, V8, P2940, DOI 10.1021/bi00835a037; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHIBLER U, 1978, CELL, V15, P1495, DOI 10.1016/0092-8674(78)90072-7; SHIBAHARA S, 1981, BIOCHEMISTRY-US, V20, P6577, DOI 10.1021/bi00526a009; SMITH DW, 1973, J BIOL CHEM, V248, P8157; SPRITZ RA, 1979, CYTOGENET CELL GENET, V23, P149, DOI 10.1159/000131320; UITTO J, 1976, ARCH BIOCHEM BIOPHYS, V173, P187, DOI 10.1016/0003-9861(76)90249-6; YOON K, 1984, BIOCHEM BIOPH RES CO, V118, P261, DOI 10.1016/0006-291X(84)91095-7; YUNIS JJ, 1978, CYTOGENET CELL GENET, V22, P679, DOI 10.1159/000131052	41	49	49	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	5					873	882						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ASD55	3840328				2022-12-18	WOS:A1985ASD5500004
J	KIVLIN, JD; LOVRIEN, EW; BISHOP, DT; MAUMENEE, IH				KIVLIN, JD; LOVRIEN, EW; BISHOP, DT; MAUMENEE, IH			LINKAGE ANALYSIS IN DOMINANT OPTIC ATROPHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV OREGON,HLTH SCI CTR,LINKAGE LAB,PORTLAND,OR 97201; UNIV UTAH,DEPT HUMAN GENET,SALT LAKE CITY,UT 84112; JOHNS HOPKINS UNIV HOSP,WILMER OPHTHALMOL INST,BALTIMORE,MD 21205	University of Oregon; Utah System of Higher Education; University of Utah; Johns Hopkins University; Johns Hopkins Medicine	KIVLIN, JD (corresponding author), UNIV UTAH,DEPT OPHTHALMOL,SALT LAKE CITY,UT 84112, USA.			Bishop, Tim/0000-0002-8752-8785	NATIONAL CANCER INSTITUTE [R01CA028854] Funding Source: NIH RePORTER; NCI NIH HHS [CA28854] Funding Source: Medline; NEI NIH HHS [EY01773] Funding Source: Medline; OHS HRSA HHS [ST32-EY07047] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); OHS HRSA HHS		GRUETZNER P, 1966, HUMANGENETIK, V2, P363; HASSTEDT SJ, 1979, 13 U UT DEP MED BIOP; JAEGER W, 1966, J GENET HUM, V15, P312; KEATS BJB, 1979, SOURCE BOOK LINKAGE, P44; KJER P, 1983, ACTA OPHTHALMOL, V61, P300; KJER P, 1959, ACTA OPHTHALMOL    S, V54, P1; KRILL AE, 1970, J OPT SOC AM, V60, P1132, DOI 10.1364/JOSA.60.001132; McAlpine P J, 1982, Birth Defects Orig Artic Ser, V18, P121; MCALPINE PJ, 1981, HUMAN GENE MAPPING, V6; MCKUSICK VA, 1983, MENDELIAN INHERITANC, P391; MORTON NE, 1955, AM J HUM GENET, V7, P277; THOMPSON EA, 1979, GENETIC ANAL COMMON, P363	12	49	50	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	6					1190	1195						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RU705	6580816				2022-12-18	WOS:A1983RU70500013
J	BODMER, WF				BODMER, WF			THE WILLIAM-ALLAN-MEMORIAL-AWARD-ADDRESS - GENE CLUSTERS, GENOME ORGANIZATION, AND COMPLEX PHENOTYPES - WHEN THE SEQUENCE IS KNOWN, WHAT WILL IT MEAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											BODMER, WF (corresponding author), IMPERIAL CANC RES FUND, LONDON WC2A 3PX, ENGLAND.			Bodmer, Walter/0000-0001-6244-9792				[Anonymous], 1978, HISTOCOMPATIBILITY T; [Anonymous], 1980, HISTOCOMPATIBILITY T; Barnstable C J, 1977, Cold Spring Harb Symp Quant Biol, V41 Pt 2, P443; BARNSTABLE CJ, 1978, BRIT MED BULL, V34, P241, DOI 10.1093/oxfordjournals.bmb.a071504; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; BARNSTABLE CJ, 1979, CELLULAR ASPECTS, V4, P151; Bodmer W F, 1981, Prog Clin Biol Res, V45, P213; BODMER WF, 1980, J EXP MED, V152, pS353; BODMER WF, 1978, BRIT MED BULL, V34, P213, DOI 10.1093/oxfordjournals.bmb.a071500; BODMER WF, 1973, TRANSPLANT P, V5, P1471; BODMER WF, 1980, J ROY COLL PHYS LOND, V14, P43; BODMER WF, 1978, BRIT MED BULL, V34, P309, DOI 10.1093/oxfordjournals.bmb.a071518; BODMER WF, 1972, NATURE, V237, P139, DOI 10.1038/237139a0; BODMER WF, 1981, TISSUE ANTIGENS, V17, P9; BODMER WF, 1979, HUM GENET, V66, P205; BODMER WF, 1979, CIBA F S, V66, P395; BODMER WF, 1979, LANCET          0428, P923; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BRIDGES CB, 1919, ANAT REC, V15, P357; BRODSKY FM, 1979, IMMUNOL REV, V47, P3, DOI 10.1111/j.1600-065X.1979.tb00288.x; BUCK DW, 1975, CYTOGENET CELL GENET, V14, P257, DOI 10.1159/000130357; COLIGAN JE, 1978, P NATL ACAD SCI USA, V75, P3390, DOI 10.1073/pnas.75.7.3390; CRICK F, 1979, SCIENCE, V204, P264, DOI 10.1126/science.373120; Darlington CD, 1949, ELEMENTS GENETICS; DEMANT P, 1978, P NATL ACAD SCI USA, V75, P4441, DOI 10.1073/pnas.75.9.4441; FIDDES JC, 1980, NATURE, V286, P684, DOI 10.1038/286684a0; FRANCO J, 1979, NEMATOLOGICA, V25, P32, DOI 10.1163/187529279X00343; GOSS SJ, 1975, NATURE, V255, P680, DOI 10.1038/255680a0; GUSELLA JF, 1980, P NATL ACAD SCI-BIOL, V77, P2829, DOI 10.1073/pnas.77.5.2829; GUTZ H, 1976, GENETICS, V83, P861; HOROWITZ NH, 1945, P NATL ACAD SCI USA, V31, P153, DOI 10.1073/pnas.31.6.153; IVANYI P, 1978, PROC R SOC SER B-BIO, V202, P117, DOI 10.1098/rspb.1978.0060; JEFFREYS AJ, 1979, CELL, V18, P1, DOI 10.1016/0092-8674(79)90348-9; JEFFREYS AJ, 1979, NATURE, V281, P606, DOI 10.1038/281606a0; JONES PP, 1978, J EXP MED, V148, P925, DOI 10.1084/jem.148.4.925; KRANGEL MS, 1980, SCAND J IMMUNOL, V11, P561, DOI 10.1111/j.1365-3083.1980.tb00025.x; LEE JS, 1980, J EXP MED, V152, pS3; LERNER MR, 1980, NATURE, V283, P220, DOI 10.1038/283220a0; LEWIS EB, 1951, COLD SPRING HARB SYM, V16, P159, DOI 10.1101/SQB.1951.016.01.014; MANIATIS T, 1978, CELL, V15, P687, DOI 10.1016/0092-8674(78)90036-3; MCBRIDE OW, 1973, P NATL ACAD SCI USA, V70, P1258, DOI 10.1073/pnas.70.4.1258; McKusick V.A., 1978, MENDELIAN INHERITANC; MUNYON W, 1971, J VIROL, V7, P813, DOI 10.1128/JVI.7.6.813-820.1971; NISHIOKA Y, 1980, P NATL ACAD SCI-BIOL, V77, P2806, DOI 10.1073/pnas.77.5.2806; PERUTZ M, 1980, NEW SCI         0131; POLANI PE, 1979, CIBA F SERIES, V66, P81; PONTECORVO G, 1959, TRENDS GENETIC ANAL; Porter R R, 1979, Adv Protein Chem, V33, P1, DOI 10.1016/S0065-3233(08)60458-1; ROGERS J, 1980, P NATL ACAD SCI-BIOL, V77, P1877, DOI 10.1073/pnas.77.4.1877; ROYAL A, 1979, NATURE, V279, P125, DOI 10.1038/279125a0; RUBIN CM, 1980, NATURE, V284, P372, DOI 10.1038/284372a0; SVEJGAARD A, 1980, HISTOCOMPATIBILITY T; THOMSON G, 1980, HLA DISEASE, P84; VANDENBERG J, 1978, NATURE, V276, P37, DOI 10.1038/276037a0; WAIKAN Y, 1978, P NATL ACAD SCI USA, V75, P5631, DOI 10.1073/pnas.75.11.5631; WALKER PMB, 1979, CIBA F S, V66, P41; WEATHERALL DJ, 1979, CIBA F SERIES, V66, P147; WIGLER M, 1977, CELL, V11, P223, DOI 10.1016/0092-8674(77)90333-6; WINCHESTER RJ, 1979, ADV IMMUNOL, V28, P222; WOLF SF, 1980, CELL, V21, P95, DOI 10.1016/0092-8674(80)90117-8	60	49	49	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1981	33	5					664	682						19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MJ232	6975040				2022-12-18	WOS:A1981MJ23200002
J	WARBURTON, D; YU, CY; KLINE, J; STEIN, Z				WARBURTON, D; YU, CY; KLINE, J; STEIN, Z			MOSAIC AUTOSOMAL TRISOMY IN CULTURES FROM SPONTANEOUS-ABORTIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									COLUMBIA UNIV,COLL PHYS & SURG,DEPT PEDIAT,NEW YORK,NY 10032; NEW YORK STATE PSYCHIAT INST,EPIDEMIOL BRAIN DISORDERS UNIT,NEW YORK,NY 10032; COLUMBIA UNIV,SCH PUBL HLTH,DIV EPIDEMIOL,NEW YORK,NY 10032	Columbia University; New York State Psychiatry Institute; Columbia University	WARBURTON, D (corresponding author), COLUMBIA UNIV,COLL PHYS & SURG,DEPT HUMAN GENET & DEV,NEW YORK,NY 10032, USA.							ARAKAKI D T, 1970, Journal of Medical Genetics, V7, P118, DOI 10.1136/jmg.7.2.118; BLOOM AD, 1974, J PEDIATR-US, V84, P732, DOI 10.1016/S0022-3476(74)80021-1; BOUE J, 1973, ACCIDENTS CHROMOSOMI; COX DM, 1974, PEDIATR RES, V8, P679, DOI 10.1203/00006450-197406000-00009; CREASY MR, 1976, HUM GENET, V31, P177, DOI 10.1007/BF00296145; CREASY MR, 1977, THESIS LONDON U; FORD CE, 1973, ACCIDENTS CHROMOSOMI, P271; GUSTAVSON KH, 1964, CLIN CYTOGENETICAL I; HAHNEMANN N, 1973, CLIN GENET, V4, P328; HAMERTON JL, 1965, CYTOGENETICS, V4, P171, DOI 10.1159/000129853; HASSOLD T, ANN HUM GENET; HASSOLD TJ, 1977, AM J HUM GENET, V29, pA52; HOOK EB, 1977, AM J HUM GENET, V29, P94; JACOBS PA, 1977, HUM HERED, V27, P59, DOI 10.1159/000152852; KAJII T, 1973, AM J HUM GENET, V25, P539; KAJII T, 1973, ACCIDENTS CHROMOSOMI; LAURITSEN JG, 1976, CLIN GENET, V10, P156; LAURITSEN JG, 1976, ACTA OBSTET GYNECO S, V52, P4; LOWE C, 1978, SAFETY ACCURACY MIDT; MAGENIS RE, 1977, HUM GENET, V37, P7, DOI 10.1007/BF00293766; MIKKELSEN M, 1977, HEREDITAS, V86, P45; MILUNSKY A, 1977, POPULATION CYTOGENET; NIIKAWA N, 1977, HUM GENET, V40, P73; PEAKMAN DC, 1978, PEDIATR RES, V12, P455, DOI 10.1203/00006450-197804001-00556; POLANI PE, 1976, LANCET, V2, P516; PRIEST JH, 1977, AM J HUM GENET, V29, pA88; SIMPSON NE, 1976, CAN MED ASSOC J, V115, P739; SUTHERLAND GR, 1975, CLIN GENET, V7, P400; YAMAMOTO M, 1976, HUM GENET, V34, P69; YAMAMOTO M, 1975, HUMANGENETIK, V29, P9, DOI 10.1007/BF00273345; 1976, J AM MED ASS, V236, P1471	31	49	50	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	6					609	617						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GK656	570805				2022-12-18	WOS:A1978GK65600005
J	CHEN, SH; SCOTT, CR; SWEDBERG, KR				CHEN, SH; SCOTT, CR; SWEDBERG, KR			HETEROGENEITY FOR ADENOSINE DEAMINASE DEFICIENCY - EXPRESSION OF ENZYME IN CULTURED SKIN FIBROBLASTS AND AMNIOTIC-FLUID CELLS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WASHINGTON,SCH MED,DEPT PEDIAT,SEATTLE,WA 98195	University of Washington; University of Washington Seattle								AKEDO H, 1970, BIOCHIM BIOPHYS ACTA, V212, P189, DOI 10.1016/0005-2744(70)90196-8; CHEN SH, 1974, AM J HUM GENET, V26, P103; CHEN SH, 1973, AM J HUM GENET, V25, pA21; CREAGAN RP, 1973, LANCET, V2, P1449; EDWARDS YH, 1971, ANN HUM GENET, V35, P207, DOI 10.1111/j.1469-1809.1956.tb01393.x; GIBLETT ER, 1972, LANCET, V2, P1067; HIRSCHHORN R, 1973, NATURE-NEW BIOL, V246, P200, DOI 10.1038/newbio246200a0; HIRSCHHORN R, 1974, J CLIN INVEST, V53, pA33; HIRSCHHORN R, 1973, LANCET, V2, P1217; HITZIG WH, 1973, IMMUNOLOGIC DISORDER, P218; HOPKINSON DA, 1969, ANN HUM GENET, V32, P361, DOI 10.1111/j.1469-1809.1969.tb00087.x; JENKINS T, 1973, LANCET, V2, P736; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MEUWISSEN HJ, 1973, 4 P S NEW YORK STAT; NISHIHARA H, 1973, BIOCHIM BIOPHYS ACTA, V302, P429, DOI 10.1016/0005-2744(73)90172-1; SCOTT CR, 1974, J CLIN INVEST, V53, P1194, DOI 10.1172/JCI107658; SPENCER N, 1968, ANN HUM GENET, V32, P9, DOI 10.1111/j.1469-1809.1968.tb00044.x	17	49	49	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1975	27	1					46	52						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V5202	1155449				2022-12-18	WOS:A1975V520200003
J	MCKUSICK, VA				MCKUSICK, VA			GROWTH AND DEVELOPMENT OF HUMAN GENETICS AS A CLINICAL DISCIPLINE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHNS HOPKINS UNIV, SCH MED, DEPT MED, BALTIMORE, MD 21205 USA	Johns Hopkins University								Allan W, 1939, ARCH INTERN MED, V63, P1123, DOI 10.1001/archinte.1939.00180230108008; Andersen DH, 1938, AM J DIS CHILD, V56, P344, DOI 10.1001/archpedi.1938.01980140114013; Baur Erwin, 1921, HUMAN HEREDITY; BRUTON OC, 1952, PEDIATRICS, V9, P722; CARTER CO, 1971, LANCET, V1, P281, DOI 10.1016/S0140-6736(71)91016-6; CARTER CO, 1974, BIRTH DEFECTS, P277; CHILDS B, 1968, NEW ENGL J MED, V279, P1267, DOI 10.1056/NEJM196812052792306; CHILDS B, 1974, AM J HUM GENET, V26, P120; CLOW CL, 1971, NEW ENGL J MED, V284, P1292, DOI 10.1056/NEJM197106102842304; CLOW CL, 1973, PROG MED GENET, V9, P159; Cockayne EA, 1933, INHERITED ABNORMALIT; DUNN LC, 1962, AM J HUM GENET, V14, P1; FERGUSONSMITH MA, 1960, LANCET, V2, P184; Flemming W., 1882, ZELLSUBSTANZ KERN ZE; FRASER FC, 1963, AM J HUM GENET, V15, P1; FRASER FC, 1956, EUGEN QUART, V3, P45, DOI 10.1080/19485565.1956.9987264; Garrod A, 1928, LANCET, V1, P1055; Garrod AE, 1908, LANCET, V2, P214; Garrod AE, 1908, LANCET, V2, P142; Garrod AE, 1908, LANCET, V2, P1; Garrod AE, 1908, LANCET, V2, P73; Garrod AE, 1890, TREATISE RHEUMATISM; GRUNEBERG H, 1947, ANIMAL GENETICS MEDI; Hadorn E., 1955, LETALFAKTOREN; Hadorn E., 1945, ARCH KLAUS STIFTG ER, V20, P82; HARRIS H, 1953, INTRO HUMAN BIOCHEMI; Johannsen W., 1909, ELEMENTE EXAKTEN ERB; KROOTH RS, 1964, SOMATIC CELL GENETIC; LEONARD CO, 1972, NEW ENGL J MED, V287, P433, DOI 10.1056/NEJM197208312870904; LESCH M, 1964, AM J MED, V36, P561, DOI 10.1016/0002-9343(64)90104-4; LOEWY A, 1904, Z PHYSL CHEM, V43, P338; McKusick V. A, 1975, MENDELIAN INHERITANC; McKusick V.A., 1956, HERITABLE DISORDERS; MCKUSICK VA, 1969, J CHRON DIS, V22, P1, DOI 10.1016/0021-9681(69)90081-2; MCKUSICK VA, 1973, J INVEST DERMATOL, V60, P343, DOI 10.1111/1523-1747.ep12702125; MCKUSICK VA, 1973, AM J HUM GENET, V25, P446; MUDD SH, 1970, J CLIN INVEST, V49, P1762, DOI 10.1172/JCI106394; MULLER HJ, 1950, AM J HUM GENET, V2, P111; NOWELL PC, 1960, CANCER RES, V20, P462; SCHIMKE RN, 1965, J AMER MED ASSOC, V193, P711, DOI 10.1001/jama.1965.03090090017003; SMITHIES O, 1955, BIOCHEM J, V61, P629, DOI 10.1042/bj0610629; Stern C, 1960, Am J Hum Genet, V12, P141; UHLENDORF BW, 1968, SCIENCE, V160, P1007, DOI 10.1126/science.160.3831.1007; Vogt O, 1926, Z GESAMTE NEUROL PSY, V101, P805, DOI 10.1007/BF02878364; WAARDENBERG P. J., 1932, BIBLIOGR GENETICA, V7, P1; Waldenstrom JG., 1968, MONOCLONAL POLYCLONA	46	49	50	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1975	27	3					261	273						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AD236	803163				2022-12-18	WOS:A1975AD23600001
J	TENNES, K; PUCK, M; BRYANT, K; FRANKENBURG, W; ROBINSON, A				TENNES, K; PUCK, M; BRYANT, K; FRANKENBURG, W; ROBINSON, A			DEVELOPMENTAL-STUDY OF GIRLS WITH TRISOMY-X	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV COLORADO,MED CTR,DEPT PSYCHIAT,DENVER,CO 80220; UNIV COLORADO,MED CTR,DEPT PEDIAT,DENVER,CO 80220; UNIV COLORADO,MED CTR,DEPT PHYS MED & REHABIL,DENVER,CO 80220; UNIV COLORADO,MED CTR,DEPT BIOPHYS & GENET,4200 E 9TH AVE,DENVER,CO 80220	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver								BAIKIE AG, 1966, LANCET, V1, P398; BARR ML, 1969, CAN MED ASSOC J, V101, P247; CLOSE HG, 1963, LANCET, V2, P1358; COURTBROWN WM, 1969, INT REV EXP PATHOL, V7, P31; ELLER E, 1971, PEDIATRICS, V47, P681; FRIEDRICH U, 1973, CLIN GENET, V4, P333; JACOBS PA, 1959, LANCET, V2, P423; MACLEAN N, 1968, Journal of Medical Genetics, V5, P165, DOI 10.1136/jmg.5.3.165; PUCK M, IN PRESS; ROBINSON A, 1969, AM J HUM GENET, V21, P466	10	49	50	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1975	27	1					71	80						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V5202	1155452				2022-12-18	WOS:A1975V520200006
J	FUNDERBURK, SJ; CRANDALL, BF				FUNDERBURK, SJ; CRANDALL, BF			DOMINANT PIEBALD TRAIT IN A RETARDED CHILD WITH A RECIPROCAL TRANSLOCATION AND SMALL INTERCALARY DELETION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF,MED CTR,DEPT PEDIAT,LOS ANGELES,CA 90024; UNIV CALIF,MED CTR,DEPT PSYCHIAT,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center								CARNEVALE A, 1973, J MED GENET, V10, P376, DOI 10.1136/jmg.10.4.376; CLELAND RE, 1962, ADV GENET, V11, P147; COOKE JV, 1952, J PEDIATR-US, V41, P1, DOI 10.1016/S0022-3476(52)80022-8; GERMAN J, 1973, SCIENCE, V182, P1261, DOI 10.1126/science.182.4118.1261; GOLBUS MS, 1973, J MED GENET, V10, P83, DOI 10.1136/jmg.10.1.83; King R. C., 1970, Int. Rev. Cytol., V28, P125, DOI 10.1016/S0074-7696(08)62542-5; LINDSLEY DL, 1972, GENETICS, V71, P157; MACE JW, 1972, J CLIN ENDOCR METAB, V34, P339, DOI 10.1210/jcem-34-2-339; Muller H.J, 1932, P 6 INT C GEN, V1, P213; MULLER HJ, 1930, J GENET, V22, P300; OCKEY CH, 1967, ARCH DIS CHILD, V42, P428, DOI 10.1136/adc.42.224.428; ORYE E, 1971, LANCET, V2, P1376; Race R. R, 1968, BLOOD GROUPS MAN; RYBAK M, 1971, AM J DIS CHILD, V121, P490, DOI 10.1001/archpedi.1971.02100170072008; SEABRIGH.M, 1971, LANCET, V2, P971; SEABRIGHT M, 1973, CHROMOSOMA, V40, P333, DOI 10.1007/BF00399426; Serebrovsky AS, 1929, AM NAT, V63, P374, DOI 10.1086/280271; SRB AM, 1965, GENERAL GENETICS; TELFER MA, 1971, AM J HUM GENET, V23, P383; WAARDENBURG PJ, 1951, AM J HUM GENET, V3, P195; WILSON MG, 1973, AM J HUM GENET, V25, P57; 1972, BIRTH DEFECTS OAS	22	49	49	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1974	26	6					715	722						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V0911	4140688				2022-12-18	WOS:A1974V091100006
J	CHING, GHS; CHUNG, CS; NEMECHEK, RW				CHING, GHS; CHUNG, CS; NEMECHEK, RW			GENETIC AND EPIDEMIOLOGICAL STUDIES OF CLUBFOOT IN HAWAII - ASCERTAINMENT AND INCIDENCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALBERMAN ED, 1965, ARCH DIS CHILD, V40, P548, DOI 10.1136/adc.40.213.548; BOOK JA, 1948, HEREDITAS, V34, P290; CHUNG CS, 1959, AM J HUM GENET, V11, P339; CHUNG CS, 1968, AM J HUM GENET, V20, P44; CHUNG CS, 1959, ANN HUM GENET, V23, P357, DOI 10.1111/j.1469-1809.1959.tb01479.x; CHUNG CS, IN PRESS; DUCCI L, 1954, ARCH PUTTI, V5, P515; EDWARDS J. H., 1960, ACTA GENET ET STATIST MED, V10, P63; ELLIOTT JK, 1961, J BONE JOINT SURG BR, V43, P190; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; FETSCHER R, 1921, ZENTRALBL F CHIR, V48, P334; Fisher RA, 1938, ANN EUGENIC, V8, P376, DOI 10.1111/j.1469-1809.1938.tb02189.x; GITTELSOHN AM, 1965, GENETICS EPIDEMIOLOG, P305; GRUNEBERG H, 1952, J GENET, V51, P95, DOI 10.1007/BF02986708; IDELBERGER K, 1939, VERH DTSCH ORTHOP GE, V33, P272; ISIGKEIT E, 1927, ARCH ORTHOP U UNFALL, V25, P535; Kite J, 1964, CLUBFOOT; KITE JH, 1950, J BONE JOINT SURG AM, V32-A, P500, DOI 10.2106/00004623-195032030-00003; MORTON NE, 1967, AM J HUM GENET, V19, P23; MORTON NE, 1967, GENETICS INTERRACIAL, V3; PALMER RM, 1964, J BONE JOINT SURG AM, V46, P542, DOI 10.2106/00004623-196446030-00008; SKELLAM JG, 1948, J ROY STAT SOC B, V10, P257; STEWART SF, 1951, J BONE JOINT SURG AM, V33-A, P577, DOI 10.2106/00004623-195133030-00004; WYNNEDAVIES R, 1964, J BONE JOINT SURG BR, V46, P445, DOI 10.1302/0301-620X.46B3.445	24	49	50	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1969	21	6					566	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	F0121	5365759				2022-12-18	WOS:A1969F012100005
J	MANN, JD; VALDMANI.A; CAPPS, SC; PUITE, RH				MANN, JD; VALDMANI.A; CAPPS, SC; PUITE, RH			A CASE OF PRIMARY AMENORRHEA WITH A TRANSLOCATION INVOLVING CHROMOSOMES OF GROUPS B AND C	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BOOK JA, 1961, LANCET, V1, P167; BROWN W M, 1964, J Med Genet, V1, P35, DOI 10.1136/jmg.1.1.35; CAPPS SC, 1964, LANCET, V1, P831; CLARKE G, 1964, J Med Genet, V1, P27, DOI 10.1136/jmg.1.1.27; FORD CE, 1964, CYTOGENETICS, V3, P295, DOI 10.1159/000129819; GERMAN J, 1964, CYTOGENETICS, V3, P347, DOI 10.1159/000129824; GILBERT CW, 1962, NATURE, V195, P869, DOI 10.1038/195869a0; GRUMBACH MM, 1963, P NATL ACAD SCI USA, V49, P581, DOI 10.1073/pnas.49.5.581; JACOBS PA, 1961, LANCET, V1, P1183; LYON MF, 1962, AM J HUM GENET, V14, P135; LYON MF, 1964, CYTOGENETICS, V3, P306, DOI 10.1159/000129820; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MANN JD, 1962, LANCET, V1, P8; MILLER OJ, 1964, AM J OBSTET GYNECOL, V90, P1078, DOI 10.1016/0002-9378(64)90836-1; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; MOORHEAD PS, 1961, AM J HUM GENET, V13, P32; PATAU K, 1964, ANNUAL M AMERICAN SO; ROWLEY J, 1964, P NATL ACAD SCI USA, V51, P779, DOI 10.1073/pnas.51.5.779; RUSSELL LB, 1960, GENETICS, V45, P1008; RUSSELL LB, 1961, SCIENCE, V133, P1795, DOI 10.1126/science.133.3467.1795; RUSSELL LB, 1959, GENETICS, V44, P532; WALKER S, 1962, ANN HUM GENET, V26, P151, DOI 10.1111/j.1469-1809.1962.tb01322.x; YUNIS JJ, 1964, NEW ENGL J MED, V271, P1133, DOI 10.1056/NEJM196411262712203	23	49	49	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1965	17	5					377	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	67851	14334736				2022-12-18	WOS:A19656785100001
J	MILCH, RA				MILCH, RA			STUDIES OF ALCAPTONURIA - INHERITANCE OF 47 CASES IN 8 HIGHLY INTER-RELATED DOMINICAN KINDREDS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Albrecht H., 1902, HEILKD K, V23, P366; ALLARD E, 1909, MED CHIR, V19, P24; COODLEY EL, 1950, AM J MED, V8, P816, DOI 10.1016/0002-9343(50)90132-X; COOPER JA, 1957, ARCH PATHOL, V64, P46; GALDSTON M, 1952, AM J MED, V13, P432, DOI 10.1016/0002-9343(52)90298-2; Garrod AE, 1923, INBORN ERRORS METABO; GARROD AE, 1902, LANCET, V1, P1616; HERTZBERG J, 1945, ACTA RADIOL, V26, P484, DOI 10.3109/00016924509133432; HOGBEN LANCELOT, 1932, PROC ROY SOC EDINBURGH, V52, P264; KHACHADURIAN A, 1958, J Chronic Dis, V7, P455, DOI 10.1016/0021-9681(58)90163-2; KNOX WE, 1958, AM J HUM GENET, V10, P95; LICHTENSTEIN L, 1954, AM J PATHOL, V30, P99; MARTIN WJ, 1955, ANN INTERN MED, V42, P1052, DOI 10.7326/0003-4819-42-5-1052; McKusick V.A., 1956, HERITABLE DISORDERS; MILCH H, 1951, J Int Coll Surg, V15, P669; MILCH R A, 1957, Acta Genet Stat Med, V7, P178; MILCH RA, 1955, METABOLISM, V4, P513; MILCH RA, 1959, ACTA GENET STAT MED, V10, P123; MILCH RA, 1958, B HOSP JOINT DIS, V18, P103; Oppenheimer BS, 1922, ARCH INTERN MED, V29, P732, DOI 10.1001/archinte.1922.00110060024002; Osler W, 1904, LANCET, V1, P10; PIETER H, 1925, PRESSE MED, V33, P1310; POMERANZ MM, 1941, RADIOLOGY, V37, P295; SITAJ S, 1956, Rev Czech Med, V2, P288; SITAJ S, 1956, ALKAPTONURIA OCHRONO; SKINSNES OK, 1948, ARCH PATHOL, V45, P552; Smith JW, 1942, J AMER MED ASSOC, V120, P1282, DOI 10.1001/jama.1942.02830510020005; Virchow R., 1866, VIRCHOWS ARCH PATHOL, V37, P212; Young HH, 1944, J UROLOGY, V51, P48, DOI 10.1016/S0022-5347(17)70325-4	29	49	50	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1960	12	1					76	85						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF077	17948450				2022-12-18	WOS:A1960WF07700005
J	GLASS, B				GLASS, B			THE ACTION OF SELECTION ON THE PRINCIPAL RH-ALLELES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		DIAMOND LK, 1945, NEW ENGL J MED, V232, P475, DOI 10.1056/NEJM194504262321703; DIAMOND LK, 1945, NEW ENGL J MED, V232, P447, DOI 10.1056/NEJM194504192321603; GLASS B, 1949, AM J OBSTET GYNECOL, V57, P323; Haldane JBS, 1942, ANN EUGEN, V11, P333; Lorimer Frank, 1934, DYNAMICS POPULATION; OTTENSOOSER F, 1949, AM J HUM GENET, V1, P141; Potter EL, 1947, RH ITS RELATION CONG; RACE RR, 1948, BLOOD, V3, P689; RACE RR, 1942, ANN EUGENIC, V11, P365; RACE RR, 1944, BRIT MED B, V2, P160; RIFE DAVID C., 1948, OHIO JOUR SCI, V48, P116; SACKS MS, 1947, AM J OBSTET GYNECOL, V54, P400; SACKS MS, 1949, BLOOD, V4, P1245, DOI 10.1182/blood.V4.11.1245.1245; SILVESTRONI E, 1950, NATURE, V165, P682, DOI 10.1038/165682a0; SPENCER WP, 1947, AM NAT, V81, P237, DOI 10.1086/281519; Stern C., 1949, PRINCIPLES HUMAN GEN; STRANDSKOV HH, 1945, AM BIOL TEACH, V7, P128; 1938, PROBLEMS CHANGING PO; 1944, POPULATION DIFFERENT	19	49	49	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1950	2	3					269	278						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XS390	14810691				2022-12-18	WOS:A1950XS39000004
J	Helbig, KL; Lauerer, RJ; Bahr, JC; Souza, IA; Myers, CT; Uysal, B; Schwarz, N; Gandini, MA; Huang, S; Keren, B; Mignot, C; Afenjar, A; de Villemeur, TB; Heron, D; Nava, C; Valence, S; Buratti, J; Fagerberg, CR; Soerensen, KP; Kibaek, M; Kamsteeg, EJ; Koolen, DA; Gunning, B; Schelhaas, HJ; Kruer, MC; Fox, J; Bakhtiari, S; Jarrar, R; Padilla-Lopez, S; Lindstrom, K; Jin, SC; Zeng, X; Bilguvar, K; Papavasileiou, A; Xin, QH; Zhu, CL; Boysen, K; Vairo, F; Lanpher, BC; Klee, EW; Tillema, JM; Payne, ET; Cousin, MA; Kruisselbrink, TM; Wick, MJ; Baker, J; Haan, E; Smith, N; Corbett, MA; MacLennan, AH; Gecz, J; Biskup, S; Goldmann, E; Rodan, LH; Kichula, E; Segal, E; Jackson, KE; Asamoah, A; Dimmock, D; McCarrier, J; Botto, LD; Filloux, F; Tvrdik, T; Cascino, GD; Klingerman, S; Neumann, C; Wang, R; Jacobsen, JC; Nolan, MA; Snell, RG; Lehnert, K; Sadleir, LG; Anderlid, BM; Kvarnung, M; Guerrini, R; Friez, MJ; Lyons, MJ; Leonhard, J; Kringlen, G; Casas, K; El Achkar, CM; Smith, LA; Rotenberg, A; Poduri, A; Sanchis-Juan, A; Carss, KJ; Rankin, J; Zeman, A; Raymond, FL; Blyth, M; Kerr, B; Ruiz, K; Urquhart, J; Hughes, I; Banka, S; Hedrich, UBS; Scheffer, IE; Helbig, I; Zamponi, GW; Lerche, H; Mefford, HC				Helbig, Katherine L.; Lauerer, Robert J.; Bahr, Jacqueline C.; Souza, Ivana A.; Myers, Candace T.; Uysal, Betuel; Schwarz, Niklas; Gandini, Maria A.; Huang, Sun; Keren, Boris; Mignot, Cyril; Afenjar, Alexandra; de Villemeur, Thierry Billette; Heron, Delphine; Nava, Caroline; Valence, Stephanie; Buratti, Julien; Fagerberg, Christina R.; Soerensen, Kristina P.; Kibaek, Maria; Kamsteeg, Erik-Jan; Koolen, David A.; Gunning, Boudewijn; Schelhaas, H. Jurgen; Kruer, Michael C.; Fox, Jordana; Bakhtiari, Somayeh; Jarrar, Randa; Padilla-Lopez, Sergio; Lindstrom, Kristin; Jin, Sheng Chih; Zeng, Xue; Bilguvar, Kaya; Papavasileiou, Antigone; Xin, Qinghe; Zhu, Changlian; Boysen, Katja; Vairo, Filippo; Lanpher, Brendan C.; Klee, Eric W.; Tillema, Jan-Mendelt; Payne, Eric T.; Cousin, Margot A.; Kruisselbrink, Teresa M.; Wick, Myra J.; Baker, Joshua; Haan, Eric; Smith, Nicholas; Corbett, Mark A.; MacLennan, Alastair H.; Gecz, Jozef; Biskup, Saskia; Goldmann, Eva; Rodan, Lance H.; Kichula, Elizabeth; Segal, Eric; Jackson, Kelly E.; Asamoah, Alexander; Dimmock, David; McCarrier, Julie; Botto, Lorenzo D.; Filloux, Francis; Tvrdik, Tatiana; Cascino, Gregory D.; Klingerman, Sherry; Neumann, Catherine; Wang, Raymond; Jacobsen, Jessie C.; Nolan, Melinda A.; Snell, Russell G.; Lehnert, Klaus; Sadleir, Lynette G.; Anderlid, Britt-Marie; Kvarnung, Malin; Guerrini, Renzo; Friez, Michael J.; Lyons, Michael J.; Leonhard, Jennifer; Kringlen, Gabriel; Casas, Kari; El Achkar, Christelle M.; Smith, Lacey A.; Rotenberg, Alexander; Poduri, Annapurna; Sanchis-Juan, Alba; Carss, Keren J.; Rankin, Julia; Zeman, Adam; Raymond, F. Lucy; Blyth, Moira; Kerr, Bronwyn; Ruiz, Karla; Urquhart, Jill; Hughes, Imelda; Banka, Siddharth; Hedrich, Ulrike B. S.; Scheffer, Ingrid E.; Helbig, Ingo; Zamponi, Gerald W.; Lerche, Holger; Mefford, Heather C.		Deciphering Dev Disorders Study	De Novo Pathogenic Variants in CACNA1E Cause Developmental and Epileptic Encephalopathy with Contractures, Macrocephaly, and Dyskinesias	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CALCIUM-CHANNEL DYSFUNCTION; R-TYPE; ILAE COMMISSION; POSITION PAPER; MICE LACKING; MUTATIONS; CLASSIFICATION; ARRHYTHMIA; DISORDERS; LANDSCAPE	Developmental and epileptic encephalopathies (DEEs) are severe neurodevelopmental disorders often beginning in infancy or early childhood that are characterized by intractable seizures, abundant epileptiform activity on EEG, and developmental impairment or regression. CACNA1E is highly expressed in the central nervous system and encodes the alpha(1)-subunit of the voltage-gated Ca(V)2.3 channel, which conducts high voltage-activated R-type calcium currents that initiate synaptic transmission. Using next-generation sequencing techniques, we identified de novo CACNA1E variants in 30 individuals with DEE, characterized by refractory infantile-onset seizures, severe hypotonia, and profound developmental impairment, often with congenital contractures, macrocephaly, hyperkinetic movement disorders, and early death. Most of the 14, partially recurring, variants cluster within the cytoplasmic ends of all four S6 segments, which form the presumed Ca(V)2.3 channel activation gate. Functional analysis of several S6 variants revealed consistent gain-of-function effects comprising facilitated voltage-dependent activation and slowed inactivation. Another variant located in the domain II S4-S5 linker results in facilitated activation and increased current density. Five participants achieved seizure freedom on the anti-epileptic drug topiramate, which blocks R-type calcium channels. We establish pathogenic variants in CACNA1E as a cause of DEEs and suggest facilitated R-type calcium currents as a disease mechanism for human epilepsy and developmental disorders.	[Helbig, Katherine L.; Kichula, Elizabeth; Helbig, Ingo] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA; [Lauerer, Robert J.; Bahr, Jacqueline C.; Uysal, Betuel; Schwarz, Niklas; Hedrich, Ulrike B. S.; Lerche, Holger] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurol & Epileptol, D-72076 Tubingen, Germany; [Souza, Ivana A.; Gandini, Maria A.; Huang, Sun; Zamponi, Gerald W.] Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB T2N 1N4, Canada; [Souza, Ivana A.; Gandini, Maria A.; Huang, Sun; Zamponi, Gerald W.] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB T2N 1N4, Canada; [Myers, Candace T.; Mefford, Heather C.] Univ Washington, Div Med Genet, Seattle, WA 98195 USA; [Keren, Boris; Mignot, Cyril; Heron, Delphine; Nava, Caroline; Valence, Stephanie; Buratti, Julien] Grp Hosp Pitie Salpetriere, AP HP, Ctr Reference Deficiences Intellectuelles Causes, Dept Genet, F-75013 Paris, France; [Keren, Boris; Mignot, Cyril; Heron, Delphine; Nava, Caroline; Valence, Stephanie; Buratti, Julien] Sorbonne Univ, GHUEP Hop Trousseau, GRC Deficience Intellectuelle & Autisme, F-75013 Paris, France; [Afenjar, Alexandra] Sorbonne Univ, Hop Enfants Armand Trousseau, AP HP,Dept Genet & Embryol Med,Ctr Reference Defi, GRC 19,Pathol Congenitales Cervelet LeucoDystroph, F-75012 Paris, France; [de Villemeur, Thierry Billette] Sorbonne Univ, Hop Enfants Armand Trousseau,Inserm,U1141, AP HP,Serv Neuropediat,Ctr Reference Deficits Int, GRC 19,Pathol Congenitales Cervelet LeucoDystroph, F-75012 Paris, France; [Fagerberg, Christina R.; Soerensen, Kristina P.; Kibaek, Maria] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Fagerberg, Christina R.] Odense Univ Hosp, HC Andersen Childrens Hosp, DK-5000 Odense, Denmark; [Kamsteeg, Erik-Jan; Koolen, David A.] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, NL-6525 Nijmegen, Netherlands; [Gunning, Boudewijn] Stichting Epilepsie Instellingen Nederland, NL-8025 Zwolle, Netherlands; [Schelhaas, H. Jurgen] Kempenhaeghe, Dept Neurol, Acad Ctr Epileptol, NL-5591 Heeze, Netherlands; [Schelhaas, H. Jurgen] Maastricht UMC, NL-5591 Heeze, Netherlands; [Kruer, Michael C.; Fox, Jordana; Bakhtiari, Somayeh; Jarrar, Randa; Padilla-Lopez, Sergio] Univ Arizona, Coll Med, Phoenix Childrens Hosp, Barrow Neurol Inst,Dept Child Hlth, Phoenix, AZ 85013 USA; [Kruer, Michael C.; Fox, Jordana; Bakhtiari, Somayeh; Jarrar, Randa; Padilla-Lopez, Sergio] Univ Arizona, Coll Med, Phoenix Childrens Hosp, Barrow Neurol Inst,Dept Genet, Phoenix, AZ 85013 USA; [Kruer, Michael C.; Fox, Jordana; Bakhtiari, Somayeh; Jarrar, Randa; Padilla-Lopez, Sergio] Univ Arizona, Coll Med, Phoenix Childrens Hosp, Barrow Neurol Inst,Dept Neurol, Phoenix, AZ 85013 USA; [Kruer, Michael C.; Fox, Jordana; Bakhtiari, Somayeh; Jarrar, Randa; Padilla-Lopez, Sergio] Univ Arizona, Coll Med, Phoenix Childrens Hosp, Barrow Neurol Inst,Dept Cellular & Mol Med, Phoenix, AZ 85013 USA; [Lindstrom, Kristin] Phoenix Childrens Hosp, Div Genet & Metab, Phoenix, AZ 85016 USA; [Jin, Sheng Chih; Zeng, Xue; Bilguvar, Kaya] Yale Sch Med, New Haven, CT 06510 USA; [Papavasileiou, Antigone] Penteli Childrens Hosp, Dept Pediat Neurol, Athens 15236, Greece; [Xin, Qinghe] Fudan Univ, Inst Biomed Sci, Shanghai 201102, Peoples R China; [Xin, Qinghe] Fudan Univ, Childrens Hosp, Shanghai 201102, Peoples R China; [Zhu, Changlian] Gothenburg Univ, Sahlgrenska Acad, Perinatal Ctr, S-41346 Gothenburg, Sweden; [Zhu, Changlian] Hosp Zhengzhou Univ, Zhengzhou 450001, Henan, Peoples R China; [Boysen, Katja; Scheffer, Ingrid E.] Univ Melbourne, Epilepsy Res Ctr, Dept Med, Austin Hlth, Heidelberg, Vic 3084, Australia; [Vairo, Filippo; Lanpher, Brendan C.; Klee, Eric W.; Tillema, Jan-Mendelt; Cousin, Margot A.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Payne, Eric T.; Cascino, Gregory D.; Klingerman, Sherry] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA; [Cousin, Margot A.; Kruisselbrink, Teresa M.; Wick, Myra J.] Mayo Clin, Ctr Individualized Med, Rochester, MN 55905 USA; [Kruisselbrink, Teresa M.; Wick, Myra J.] Mayo Clin, Dept Clin Genom, Rochester, MN 55905 USA; [Baker, Joshua] Univ Illinois, Coll Med Peoria, Chicago Coll Med, Peoria, IL 61605 USA; [Haan, Eric] Univ Adelaide, Royal Adelaide Hosp, Adult Genet Unit, Adelaide, SA 5000, Australia; [Haan, Eric] Univ Adelaide, Sch Med, Adelaide, SA 5000, Australia; [Smith, Nicholas] Univ Adelaide, Womens & Childrens Hosp, Dept Neurol, Adelaide, SA 5006, Australia; [Corbett, Mark A.; MacLennan, Alastair H.; Gecz, Jozef] Univ Adelaide, Adelaide Med Sch, Robinson Res Inst, Adelaide, SA 5006, Australia; [Biskup, Saskia] CeGaT, D-72076 Tubingen, Germany; [Goldmann, Eva] Univ Tubingen, Dept Human Genet, D-72076 Tubingen, Germany; [Rodan, Lance H.] Boston Childrens Hosp, Div Genet & Genom, Boston, MA 02115 USA; [Rodan, Lance H.] Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Rodan, Lance H.] Harvard Med Sch, Dept Pediat, Boston, MA 02215 USA; [Segal, Eric] Hackensack Univ Med Ctr, Northeast Reg Epilepsy Grp, Hackensack, NJ 07601 USA; [Jackson, Kelly E.; Asamoah, Alexander] Univ Louisville, Louisville, KY 40292 USA; [Dimmock, David; McCarrier, Julie] Childrens Hosp Wisconsin, Milwaukee, WI 53226 USA; [Botto, Lorenzo D.] Univ Utah, Dept Pediat, Div Med Genet, Salt Lake City, UT 84113 USA; [Filloux, Francis] Univ Utah, Div Pediat Neurol, Dept Pediat, Salt Lake City, UT 84113 USA; [Filloux, Francis] Univ Utah, Div Pediat Neurol, Dept Neurol, Salt Lake City, UT 84113 USA; [Tvrdik, Tatiana] ARUP Labs, Salt Lake City, UT 84108 USA; [Neumann, Catherine; Wang, Raymond] CHOC Childrens Hosp, Div Metab Disorders, Orange, CA 92868 USA; [Wang, Raymond] Univ Calif Irvine, Sch Med, Dept Pediat, Irvine, CA 92617 USA; [Jacobsen, Jessie C.; Snell, Russell G.; Lehnert, Klaus] Univ Auckland, Ctr Brain Res, Auckland 1142, New Zealand; [Jacobsen, Jessie C.; Snell, Russell G.; Lehnert, Klaus] Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand; [Nolan, Melinda A.] Starship Childrens Hlth, Dept Neurol, Auckland 1023, New Zealand; [Sadleir, Lynette G.] Univ Otago Wellington, Dept Paediat & Child Hlth, Wellington 6242, New Zealand; [Anderlid, Britt-Marie] Karolinska Univ Hosp, Dept Clin Genet, S-17176 Stockholm, Sweden; [Anderlid, Britt-Marie; Kvarnung, Malin] Karolinska Inst, Dept Mol Med & Surg, S-17177 Stockholm, Sweden; [Guerrini, Renzo] Univ Florence, Azienda Osped Univ Meyer, Dept Neurosci, I-50139 Florence, Italy; [Friez, Michael J.; Lyons, Michael J.] Greenwood Genet Ctr, Greenwood, SC 29646 USA; [Leonhard, Jennifer] Sanford Hlth, Med Genet, Bemidji, MN 56601 USA; [Kringlen, Gabriel; Casas, Kari] Sanford Hlth, Med Genet, Fargo, ND 58102 USA; [El Achkar, Christelle M.; Smith, Lacey A.; Poduri, Annapurna] Boston Childrens Hosp, Dept Neurol, Epilepsy Genet Program, Boston, MA 02115 USA; [El Achkar, Christelle M.; Rotenberg, Alexander; Poduri, Annapurna] Harvard Med Sch, Dept Neurol, Boston, MA 02215 USA; [Rotenberg, Alexander] Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Sanchis-Juan, Alba; Carss, Keren J.] Univ Cambridge, NHS Blood & Transplant Ctr, Dept Haematol, Cambridge CB2 0QQ, England; [Sanchis-Juan, Alba; Carss, Keren J.; Raymond, F. Lucy] Cambridge Univ Hosp NHS Fdn Trust, NIHR BioResource Rare Dis, Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Rankin, Julia] Royal Devon & Exeter NHS Fdn Trust, Clin Genet, Exeter EX2 5DW, Devon, England; [Zeman, Adam] Royal Devon & Exeter NHS Fdn Trust, Dept Neurol, Exeter EX2 5DW, Devon, England; [Raymond, F. Lucy] Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England; [Blyth, Moira] Leeds Teaching Hosp NHS Trust, Chapel Allerton Hosp, Yorkshire Reg Genet Serv, Leeds LS7 4SA, W Yorkshire, England; [Kerr, Bronwyn; Banka, Siddharth] Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Div Evolut & Genom Sci, Manchester M13 9PL, Lancs, England; [Kerr, Bronwyn; Urquhart, Jill; Banka, Siddharth] Manchester Univ Fdn NHS Trust, Hlth Innovat, St Marys Hosp, Manchester Ctr Genom Med, Manchester M13 9WL, Lancs, England; [Ruiz, Karla; Hughes, Imelda] Manchester Univ Fdn NHS Trust, Royal Manchester Childrens Hosp, Dept Paediat Neurol, Hlth Innovat, Manchester M13 9WL, Lancs, England; [Deciphering Dev Disorders Study] Wellcome Sanger Inst, Cambridge CB10 1SA, England; [Scheffer, Ingrid E.] Florey Inst, Parkville, Vic 3052, Australia; [Scheffer, Ingrid E.] Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Scheffer, Ingrid E.] Univ Melbourne, Dept Paediat, Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Scheffer, Ingrid E.] Royal Childrens Hosp, Dept Neurol, Parkville, Vic 3052, Australia; [Helbig, Ingo] Christian Albrechts Univ Kiel, Dept Neuropediat, D-24105 Kiel, Germany	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Calgary; University of Calgary; University of Washington; University of Washington Seattle; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; Radboud University Nijmegen; Maastricht University; Barrow Neurological Institute; Phoenix Children's Hospital; University of Arizona; Barrow Neurological Institute; Phoenix Children's Hospital; University of Arizona; Barrow Neurological Institute; Phoenix Children's Hospital; University of Arizona; Barrow Neurological Institute; Phoenix Children's Hospital; University of Arizona; Phoenix Children's Hospital; Yale University; Fudan University; Fudan University; University of Gothenburg; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Illinois System; University of Illinois Peoria; Royal Adelaide Hospital; University of Adelaide; University of Adelaide; University of Adelaide; Robinson Research Institute; University of Adelaide; CeGaT; Eberhard Karls University of Tubingen; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Hackensack University Medical Center; University of Louisville; Children's Hospital of Wisconsin; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; ARUP Laboratories; University of California System; University of California Irvine; University of Auckland; University of Auckland; Starship Children's Hospital; University of Otago; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; Greenwood Genetic Center; Sanford Health; Sanford Health; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; University of Cambridge; University of Cambridge; University of Exeter; University of Exeter; University of Cambridge; Chapel Allerton Hospital; University of Leeds; University of Manchester; University of Manchester; Royal Manchester Children's Hospital; Wellcome Trust Sanger Institute; Florey Institute of Neuroscience & Mental Health; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; University of Kiel	Mefford, HC (corresponding author), Univ Washington, Div Med Genet, Seattle, WA 98195 USA.	hmefford@uw.edu	Scheffer, Ingrid E/G-1668-2013; Zhu, Changlian/AAN-6205-2020; Gecz, Jozef/X-3469-2019; Helbig, Ingo/G-8467-2018; Corbett, Mark/A-8063-2010; Cousin, Margot/AAD-4591-2019; Wang, Raymond Yu Jeang/CAJ-3535-2022; Koolen, D.A./L-4448-2015; Helbig, Katherine/B-7454-2012	Scheffer, Ingrid E/0000-0002-2311-2174; Gecz, Jozef/0000-0002-7884-6861; Helbig, Ingo/0000-0001-8486-0558; Corbett, Mark/0000-0001-9298-3072; Cousin, Margot/0000-0002-6119-9346; Helbig, Katherine/0000-0001-8249-0549; Zhu, Changlian/0000-0002-5029-6730; Banka, Siddharth/0000-0002-8527-2210; Assis Souza, Ivana/0000-0001-6410-7622; Lauerer-Braun, Robert/0000-0002-8663-456X; Nava, Caroline/0000-0003-1272-0518; Leonhard, Jennifer/0000-0003-3803-2887; Buratti, Julien/0000-0002-0901-0905; Sadleir, Lynette/0000-0002-5355-7115; Gandini, Maria/0000-0003-4399-1679; /0000-0003-2885-4692; Xing, Qinghe/0000-0003-1780-4761; Zeman, Adam/0000-0003-4875-658X; Guerrini, Renzo/0000-0002-7272-7079; Vairo, Filippo/0000-0001-6030-1903	Hertie Institute of Clinical Brain Research; Lennox-Gastaut Syndrome Foundation (LGSF); Alberta Innovates; CIHR; Channel 7 Children's Research Foundation; Cerebral Palsy Alliance Research Foundation; Brian and Caris Chan Family Foundation; Rutherford Discovery Fellowship from the New Zealand Government; New Zealand eScience Infrastructure; Health Research Council of New Zealand; Cure Kids New Zealand; Canadian Institutes of Health Research (CIHR); Canada Research Chair; Cambridge BRC; National Institute for Health Research England (NIHR) for the NIHR BioResource [RG65966]; National Health and Medical Research Council of Australia; National Institutes of Health; March of Dimes; DFG Research Unit [FOR 2715, He5415/7-1, He8155/1-1, Le1030/16-1]; NIH [NINDS NS069605]; Health Innovation Challenge Fund [HICF-1009-003, REC GEN/284/12, 10/H0305/83]; Wellcome Trust; Department of Health; Wellcome Trust Sanger Institute [WT098051]; Australian Research Council; CURE; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069605] Funding Source: NIH RePORTER	Hertie Institute of Clinical Brain Research; Lennox-Gastaut Syndrome Foundation (LGSF); Alberta Innovates; CIHR(Canadian Institutes of Health Research (CIHR)); Channel 7 Children's Research Foundation; Cerebral Palsy Alliance Research Foundation; Brian and Caris Chan Family Foundation; Rutherford Discovery Fellowship from the New Zealand Government(Royal Society of New Zealand); New Zealand eScience Infrastructure; Health Research Council of New Zealand(Health Research Council of New Zealand); Cure Kids New Zealand; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Cambridge BRC(General Electric); National Institute for Health Research England (NIHR) for the NIHR BioResource(National Institute for Health Research (NIHR)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); DFG Research Unit(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Health Innovation Challenge Fund; Wellcome Trust(Wellcome Trust); Department of Health; Wellcome Trust Sanger Institute(Wellcome Trust); Australian Research Council(Australian Research Council); CURE; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the participants and families for participating in our study. R.J.L. is supported by a Siegmund-Kiener stipend for medical doctoral students at the Hertie Institute of Clinical Brain Research. C.T.M. is supported by the Lennox-Gastaut Syndrome Foundation (LGSF). M.A.G. holds fellowships from Alberta Innovates and CIHR. M.A. Corbett is supported by The Channel 7 Children's Research Foundation and the Cerebral Palsy Alliance Research Foundation. R.W. is supported by The Brian and Caris Chan Family Foundation. J.C.J. is supported by a Rutherford Discovery Fellowship from the New Zealand Government, administered by the Royal Society of New Zealand. Bioinformatic analysis was supported by the New Zealand eScience Infrastructure. L.G.S. is supported by the Health Research Council of New Zealand and Cure Kids New Zealand. G.W.Z. is supported by the Canadian Institutes of Health Research (CIHR) and is a Canada Research Chair. A.S.-J., K.J.C., and F.L.R. were supported by Cambridge BRC and the National Institute for Health Research England (NIHR) for the NIHR BioResource (grant RG65966). I.E.S. is supported by the National Health and Medical Research Council of Australia, National Institutes of Health, Australian Research Council, Health Research Council of New Zealand, CURE, and March of Dimes. I. Helbig, U.B.S.H., and H.L. are supported by the DFG Research Unit FOR 2715 (grants He5415/7-1, He8155/1-1, Le1030/16-1). H.C.M. is supported by the NIH (NINDS NS069605). We are thankful to the Deciphering Developmental Disorders (DDD) study. The DDD study (Cambridge South REC approval 10/H0305/83 and the Republic of Ireland REC GEN/284/12) presents independent research commissioned by the Health Innovation Challenge Fund (grant number HICF-1009-003), a parallel funding partnership between the Wellcome Trust and the Department of Health, and the Wellcome Trust Sanger Institute (grant number WT098051). The views expressed in this publication are those of the authors and not necessarily those of theWellcome Trust or the Department of Health.	Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Appenzeller S, 2014, AM J HUM GENET, V95, P360, DOI 10.1016/j.ajhg.2014.08.013; Carss KJ, 2017, AM J HUM GENET, V100, P75, DOI 10.1016/j.ajhg.2016.12.003; Chemin J, 2018, BRAIN, V141, P1998, DOI 10.1093/brain/awy145; Coutelier M, 2015, AM J HUM GENET, V97, P726, DOI 10.1016/j.ajhg.2015.09.007; de Goede C, 2016, EUR J PAEDIATR NEURO, V20, P286, DOI 10.1016/j.ejpn.2015.11.012; Farwell KD, 2015, GENET MED, V17, P578, DOI 10.1038/gim.2014.154; Faundes V, 2018, AM J HUM GENET, V102, P175, DOI 10.1016/j.ajhg.2017.11.013; Fisher RS, 2017, EPILEPSIA, V58, P522, DOI 10.1111/epi.13670; Gardella E, 2018, NEUROLOGY, V91, pE1112, DOI 10.1212/WNL.0000000000006199; Hainsworth AH, 2003, EUR J PHARMACOL, V467, P77, DOI 10.1016/S0014-2999(03)01625-X; Heyne HO, 2018, NAT GENET, V50, P1048, DOI 10.1038/s41588-018-0143-7; Imbrici P, 2004, BRAIN, V127, P2682, DOI 10.1093/brain/awh301; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Kuzmiski JB, 2005, EPILEPSIA, V46, P481, DOI 10.1111/j.0013-9580.2005.35304.x; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lindy AS, 2014, AM J MED GENET A, V164, P2391, DOI 10.1002/ajmg.a.36647; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; McTague A, 2016, LANCET NEUROL, V15, P304, DOI 10.1016/S1474-4422(15)00250-1; Millichap JJ, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000096; Morino H, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0180-4; Myers CT, 2018, NEW ENGL J MED, V378, P1646, DOI 10.1056/NEJMc1714579; Myers CT, 2016, AM J HUM GENET, V99, P287, DOI 10.1016/j.ajhg.2016.06.003; Parajuli LK, 2012, J NEUROSCI, V32, P13555, DOI 10.1523/JNEUROSCI.1142-12.2012; Pinggera A, 2017, HUM MOL GENET, V26, P2923, DOI 10.1093/hmg/ddx175; Rajakulendran S, 2012, NAT REV NEUROL, V8, P86, DOI 10.1038/nrneurol.2011.228; Raybaud A, 2007, J BIOL CHEM, V282, P27944, DOI 10.1074/jbc.M703895200; Raybaud A, 2006, J BIOL CHEM, V281, P39424, DOI 10.1074/jbc.M607405200; Retterer K, 2016, GENET MED, V18, P696, DOI 10.1038/gim.2015.148; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Scheffer IE, 2017, EPILEPSIA, V58, P512, DOI 10.1111/epi.13709; Scholl UI, 2013, NAT GENET, V45, P1050, DOI 10.1038/ng.2695; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Vajna R, 2001, EUR J BIOCHEM, V268, P1066, DOI 10.1046/j.1432-1327.2001.01969.x; Wall-Lacelle S, 2011, J BIOL CHEM, V286, P27197, DOI 10.1074/jbc.M111.237412; Weiergraber M, 2006, EPILEPSIA, V47, P839, DOI 10.1111/j.1528-1167.2006.00541.x; Weiergraber M, 2007, J NEUROPHYSIOL, V97, P3660, DOI 10.1152/jn.01193.2006; WILLIAMS ME, 1994, J BIOL CHEM, V269, P22347; Wolff M, 2017, BRAIN, V140, P1316, DOI 10.1093/brain/awx054; Wormuth Carola, 2016, Open Neurol J, V10, P99	42	48	49	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 1	2018	103	5					666	678		10.1016/j.ajhg.2018.09.006	http://dx.doi.org/10.1016/j.ajhg.2018.09.006			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GY9EO	30343943	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000448942100004
J	Uddin, M; Unda, BK; Kwan, V; Holzapfel, NT; White, SH; Chalil, L; Woodbury-Smith, M; Ho, KS; Harward, E; Murtaza, N; Dave, B; Pellecchia, G; D'Abate, L; Nalpathamkalam, T; Lamoureux, S; Wei, J; Speevak, M; Stavropoulos, J; Hope, KJ; Doble, BW; Nielsen, J; Wassman, ER; Scherer, SW; Singh, KK				Uddin, Mohammed; Unda, Brianna K.; Kwan, Vickie; Holzapfel, Nicholas T.; White, Sean H.; Chalil, Leon; Woodbury-Smith, Marc; Ho, Karen S.; Harward, Erin; Murtaza, Nadeem; Dave, Biren; Pellecchia, Giovanna; D'Abate, Lia; Nalpathamkalam, Thomas; Lamoureux, Sylvia; Wei, John; Speevak, Marsha; Stavropoulos, James; Hope, Kristin J.; Doble, Brad W.; Nielsen, Jacob; Wassman, E. Robert; Scherer, Stephen W.; Singh, Karun K.			OTUD7A Regulates Neurodevelopmental Phenotypes in the 15q13.3 Microdeletion Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTISM SPECTRUM DISORDER; DE-NOVO MUTATIONS; GENOME-WIDE ASSOCIATION; RECEPTOR KNOCKOUT MICE; MOUSE MODEL; COPY-NUMBER; 16P11.2 DELETION; NEUROPSYCHIATRIC DISEASES; DEVELOPMENTAL DELAY; MENTAL-RETARDATION	Copy-number variations (CNVs) are strong risk factors for neurodevelopmental and psychiatric disorders. The 15q13.3 microdeletion syndrome region contains up to ten genes and is associated with numerous conditions, including autism spectrum disorder (ASD), epilepsy, schizophrenia, and intellectual disability; however, the mechanisms underlying the pathogenesis of 15q13.3 microdeletion syndrome remain unknown. We combined whole-genome sequencing, human brain gene expression (proteome and transcriptome), and a mouse model with a syntenic heterozygous deletion (Df(h15q13)/+mice) and determined that the microdeletion results in abnormal development of cortical dendritic spines and dendrite outgrowth. Analysis of large-scale genomic, transcriptomic, and proteomic data identified OTUD7A as a critical gene for brain function. OTUD7A was found to localize to dendritic and spine compartments in cortical neurons, and its reduced levels in Df(h15q13)/+ cortical neurons contributed to the dendritic spine and dendrite outgrowth deficits. Our results reveal OTUD7A as a major regulatory gene for 15q13.3 microdeletion syndrome phenotypes that contribute to the disease mechanism through abnormal cortical neuron morphological development.	[Uddin, Mohammed; Woodbury-Smith, Marc; Pellecchia, Giovanna; D'Abate, Lia; Nalpathamkalam, Thomas; Lamoureux, Sylvia; Wei, John; Scherer, Stephen W.; Singh, Karun K.] Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 0A4, Canada; [Uddin, Mohammed; Pellecchia, Giovanna; D'Abate, Lia; Nalpathamkalam, Thomas; Lamoureux, Sylvia; Wei, John; Scherer, Stephen W.] Hosp Sick Children, Program Genet & Genome Biol GGB, Toronto, ON M5G 0A4, Canada; [Uddin, Mohammed] Mohammed Bin Rashid Univ Med & Hlth Sci, Dubai, U Arab Emirates; [Unda, Brianna K.; Kwan, Vickie; Holzapfel, Nicholas T.; White, Sean H.; Chalil, Leon; Murtaza, Nadeem; Dave, Biren; Hope, Kristin J.; Doble, Brad W.; Singh, Karun K.] McMaster Univ, Stem Cell & Canc Res Inst, Hamilton, ON, Canada; [Unda, Brianna K.; Kwan, Vickie; Holzapfel, Nicholas T.; White, Sean H.; Chalil, Leon; Murtaza, Nadeem; Dave, Biren; Hope, Kristin J.; Doble, Brad W.; Singh, Karun K.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Woodbury-Smith, Marc] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England; [Ho, Karen S.; Harward, Erin] Lineagen Inc, Salt Lake City, UT 84109 USA; [D'Abate, Lia] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Speevak, Marsha] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON L5M 2N1, Canada; [Stavropoulos, James] Hosp Sick Children, Pediat Lab Med, Genome Diagnost, Toronto, ON M5G 0A4, Canada; [Scherer, Stephen W.] Univ Toronto, McLaughlin Ctr, Toronto, ON M5G 0A4, Canada; [Nielsen, Jacob] H Lundbeck & Co AS, Neurosci Res DK, In Vitro, Synapt Transmiss, Ottiliaavej 9, DK-2500 Valby, Denmark	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University; McMaster University; Newcastle University - UK; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Lundbeck Corporation	Scherer, SW; Singh, KK (corresponding author), Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 0A4, Canada.; Scherer, SW (corresponding author), Hosp Sick Children, Program Genet & Genome Biol GGB, Toronto, ON M5G 0A4, Canada.; Singh, KK (corresponding author), McMaster Univ, Stem Cell & Canc Res Inst, Hamilton, ON, Canada.; Singh, KK (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada.; Scherer, SW (corresponding author), Univ Toronto, McLaughlin Ctr, Toronto, ON M5G 0A4, Canada.	stephen.scherer@sickkids.ca; singhk2@mcmaster.ca	Scherer, Stephen W./B-3785-2013; Doble, Bradley/V-7848-2019	Scherer, Stephen W./0000-0002-8326-1999; Doble, Bradley/0000-0002-0260-2983; Dave, Biren/0000-0002-1072-1886; Speevak, Marsha/0000-0002-1147-9067; Nielsen, Jacob/0000-0001-9842-2276; Woodbury-Smith, Marc/0000-0002-0593-8917; Hope, Kristin/0000-0003-1449-4948; Uddin, Mohammed/0000-0001-6867-5803	Canadian Institutes of Health Research [CIHR]; Natural Sciences and Engineering Research Council; Brain Canada Platform Support Grant; Ontario Brain Institute-POND study; OB; CIHR; Autism Speaks; Ontario Institute of Cancer Research	Canadian Institutes of Health Research [CIHR](Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Brain Canada Platform Support Grant; Ontario Brain Institute-POND study; OB; CIHR(Canadian Institutes of Health Research (CIHR)); Autism Speaks; Ontario Institute of Cancer Research	This work was supported by grants to K.K.S. (Canadian Institutes of Health Research [CIHR], Natural Sciences and Engineering Research Council, Brain Canada Platform Support Grant, and the Ontario Brain Institute-POND study), S.W.S. (OB, CIHR, and Autism Speaks), K.J.H. (CIHR and the Ontario Institute of Cancer Research), and B.W.D. (CIHR).	Adamo A, 2015, NAT GENET, V47, P132, DOI 10.1038/ng.3169; Adams CE, 2012, NEUROSCIENCE, V207, P274, DOI 10.1016/j.neuroscience.2012.01.033; Antonacci F, 2014, NAT GENET, V46, P1293, DOI 10.1038/ng.3120; Azzopardi E, 2013, GENES BRAIN BEHAV, V12, P414, DOI 10.1111/gbb.12038; Bierut LJ, 2010, P NATL ACAD SCI USA, V107, P5082, DOI 10.1073/pnas.0911109107; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Blizinsky KD, 2016, P NATL ACAD SCI USA, V113, P8520, DOI 10.1073/pnas.1607014113; Blumenthal I, 2014, AM J HUM GENET, V94, P870, DOI 10.1016/j.ajhg.2014.05.004; Bourgeron T, 2015, NAT REV NEUROSCI, V16, P551, DOI 10.1038/nrn3992; Chailangkarn T, 2016, NATURE, V536, P338, DOI 10.1038/nature19067; Chen JA, 2015, ANNU REV PATHOL-MECH, V10, P111, DOI 10.1146/annurev-pathol-012414-040405; Coe BP, 2014, NAT GENET, V46, P1063, DOI 10.1038/ng.3092; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Coviello AD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002805; de la Torre-Ubieta L, 2016, NAT MED, V22, P345, DOI 10.1038/nm.4071; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Ebrahimi-Fakhari D, 2015, CURR OPIN NEUROL, V28, P91, DOI 10.1097/WCO.0000000000000186; Fejgin K, 2014, BIOL PSYCHIAT, V76, P128, DOI 10.1016/j.biopsych.2013.08.014; Fenelon K, 2011, P NATL ACAD SCI USA, V108, P4447, DOI 10.1073/pnas.1101219108; Forsingdal A, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.125; Fountain MD, 2017, GENES BRAIN BEHAV, V16, P592, DOI 10.1111/gbb.12378; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Freedman R, 2014, ANNU REV MED, V65, P245, DOI 10.1146/annurev-med-092112-142937; Gass N, 2016, EUR NEUROPSYCHOPHARM, V26, P1150, DOI 10.1016/j.euroneuro.2016.03.013; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Helsmoortel C, 2014, NAT GENET, V46, P380, DOI 10.1038/ng.2899; Ionita-Laza I, 2014, P NATL ACAD SCI USA, V111, P343, DOI 10.1073/pnas.1309475110; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kogan JH, 2015, J NEUROSCI, V35, P16282, DOI 10.1523/JNEUROSCI.3967-14.2015; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Kuhnle S, 2013, P NATL ACAD SCI USA, V110, P8888, DOI 10.1073/pnas.1302792110; Kutzing MK, 2010, JOVE-J VIS EXP, DOI [10.3791/2354, DOI 10.3791/2354]; Kwan V, 2016, CELL REP, V17, P1892, DOI 10.1016/j.celrep.2016.10.047; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee E, 2017, BIOL PSYCHIAT, V81, P838, DOI 10.1016/j.biopsych.2016.05.011; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lin H, 2014, NEUROBIOL DIS, V63, P129, DOI 10.1016/j.nbd.2013.11.021; Liu H, 2002, P NATL ACAD SCI USA, V99, P16859, DOI 10.1073/pnas.232186099; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Lowther C, 2015, GENET MED, V17, P149, DOI 10.1038/gim.2014.83; Masurel-Paulet A, 2014, AM J MED GENET A, V164, P1537, DOI 10.1002/ajmg.a.36471; Merico D, 2015, G3-GENES GENOM GENET, V5, P2453, DOI 10.1534/g3.115.021345; Mevissen TET, 2016, NATURE, V538, P402, DOI 10.1038/nature19836; Mevissen TET, 2013, CELL, V154, P169, DOI 10.1016/j.cell.2013.05.046; Migliavacca E, 2015, AM J HUM GENET, V96, P784, DOI 10.1016/j.ajhg.2015.04.002; Mukai J, 2008, NAT NEUROSCI, V11, P1302, DOI 10.1038/nn.2204; Nilsson SRO, 2016, PSYCHOPHARMACOLOGY, V233, P2151, DOI 10.1007/s00213-016-4265-2; O'Roak BJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6595; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; OrrUrtreger A, 1997, J NEUROSCI, V17, P9165; Pagnamenta AT, 2009, EUR J HUM GENET, V17, P687, DOI 10.1038/ejhg.2008.228; Portmann T, 2014, CELL REP, V7, P1077, DOI 10.1016/j.celrep.2014.03.036; Pucilowska J, 2015, J NEUROSCI, V35, P3190, DOI 10.1523/JNEUROSCI.4864-13.2015; Qi C, 2014, J NEUROSCI, V34, P4494, DOI 10.1523/JNEUROSCI.3647-13.2014; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sajan SA, 2017, GENET MED, V19, P13, DOI 10.1038/gim.2016.42; Sakurai T, 2011, AUTISM RES, V4, P28, DOI 10.1002/aur.169; Santiago-Sim T, 2017, AM J HUM GENET, V100, P676, DOI 10.1016/j.ajhg.2017.03.001; Schaaf CP, 2013, NAT GENET, V45, P1405, DOI 10.1038/ng.2776; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Shinawi M, 2009, NAT GENET, V41, P1269, DOI 10.1038/ng.481; Sigurdsson T, 2010, NATURE, V464, P763, DOI 10.1038/nature08855; Spielmann M, 2011, EUR J MED GENET, V54, pE441, DOI 10.1016/j.ejmg.2011.04.004; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stewart AFR, 2009, J AM COLL CARDIOL, V53, P1471, DOI 10.1016/j.jacc.2008.12.051; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Tamura M, 2016, NEURON, V89, P1100, DOI 10.1016/j.neuron.2016.01.025; Tian D, 2015, NAT NEUROSCI, V18, P182, DOI 10.1038/nn.3911; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uddin M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28663; Uddin M, 2014, NAT GENET, V46, P742, DOI 10.1038/ng.2980; Verhoeven VJM, 2013, NAT GENET, V45, P314, DOI 10.1038/ng.2554; Xu B, 2013, CELL, V152, P262, DOI 10.1016/j.cell.2012.11.052; Yin JN, 2018, AM J HUM GENET, V102, P296, DOI 10.1016/j.ajhg.2018.01.005; Yin JN, 2017, SCI REP-UK, V7, DOI 10.1038/srep39941; Young JW, 2011, GENES BRAIN BEHAV, V10, P720, DOI 10.1111/j.1601-183X.2011.00711.x; Yuen RKC, 2015, NAT MED, V21, P185, DOI 10.1038/nm.3792; Yuen RKC, 2017, NAT NEUROSCI, V20, P602, DOI 10.1038/nn.4524; Ziats MN, 2016, GENET MED, V18, P1111, DOI 10.1038/gim.2016.9	85	48	49	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 1	2018	102	2					278	295		10.1016/j.ajhg.2018.01.006	http://dx.doi.org/10.1016/j.ajhg.2018.01.006			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FV2OL	29395074	Green Published, hybrid			2022-12-18	WOS:000424407600007
J	Van De Weghe, JC; Rusterholz, TDS; Latour, B; Grout, ME; Aldinger, KA; Shaheen, R; Dempsey, JC; Maddirevula, S; Cheng, YHH; Phelps, IG; Gesemann, M; Goel, H; Birk, OS; Alanzi, T; Rawashdeh, R; Khan, AO; Bamshad, MJ; Nickerson, DA; Neuhauss, SCF; Dobyns, WB; Alkuraya, FS; Roepman, R; Bachmann-Gagescu, R; Doherty, D				Van De Weghe, Julie C.; Rusterholz, Tamara D. S.; Latour, Brooke; Grout, Megan E.; Aldinger, Kimberly A.; Shaheen, Ranad; Dempsey, Jennifer C.; Maddirevula, Sateesh; Cheng, Yong-Han H.; Phelps, Ian G.; Gesemann, Matthias; Goel, Himanshu; Birk, Ohad S.; Alanzi, Talal; Rawashdeh, Rifaat; Khan, Arif O.; Bamshad, Michael J.; Nickerson, Deborah A.; Neuhauss, Stephan C. F.; Dobyns, William B.; Alkuraya, Fowzan S.; Roepman, Ronald; Bachmann-Gagescu, Ruxandra; Doherty, Dan		Univ Washington Ctr Mendelian Geno	Mutations in ARMC9, which Encodes a Basal Body Protein, Cause Joubert Syndrome in Humans and Ciliopathy Phenotypes in Zebrafish	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTRAFLAGELLAR TRANSPORT; PRIMARY CILIUM; FLAGELLAR REGENERATION; CENTROSOMAL PROTEIN; PROTEOMIC ANALYSIS; GENETIC-BASIS; TRANSITION; CHLAMYDOMONAS; INPP5E; MECKEL	Joubert syndrome (JS) is a recessive neurodevelopmental disorder characterized by hypotonia, ataxia, abnormal eye movements, and variable cognitive impairment. It is defined by a distinctive brain malformation known as the "molar tooth sign" on axial MRI. Subsets of affected individuals have malformations such as coloboma, polydactyly, and encephalocele, as well as progressive retinal dystrophy, fibrocystic kidney disease, and liver fibrosis. More than 35 genes have been associated with JS, but in a subset of families the genetic cause remains unknown. All of the gene products localize in and around the primary cilium, making JS a canonical ciliopathy. Ciliopathies are unified by their overlapping clinical features and underlying mechanisms involving ciliary dysfunction. In this work, we identify biallelic rare, predicted-deleterious ARMC9 variants (stop-gain, missense, splice-site, and single-exon deletion) in 11 individuals with JS from 8 families, accounting for approximately 1% of the disorder. The associated phenotypes range from isolated neurological involvement to JS with retinal dystrophy, additional brain abnormalities (e.g., heterotopia, Dandy-Walker malformation), pituitary insufficiency, and/or synpolydactyly. We show that ARMC9 localizes to the basal body of the cilium and is upregulated during ciliogenesis. Typical ciliopathy phenotypes (curved body shape, retinal dystrophy, coloboma, and decreased cilia) in a CRISPR/Cas9-engineered zebrafish mutant model provide additional support for ARMC9 as a ciliopathy-associated gene. Identifying ARMC9 mutations as a cause of JS takes us one step closer to a full genetic understanding of this important disorder and enables future functional work to define the central biological mechanisms underlying JS and other ciliopathies.	[Van De Weghe, Julie C.; Grout, Megan E.; Aldinger, Kimberly A.; Dempsey, Jennifer C.; Cheng, Yong-Han H.; Phelps, Ian G.; Bamshad, Michael J.; Dobyns, William B.; Doherty, Dan] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Rusterholz, Tamara D. S.; Gesemann, Matthias; Neuhauss, Stephan C. F.; Bachmann-Gagescu, Ruxandra] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland; [Latour, Brooke; Roepman, Ronald] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Latour, Brooke; Roepman, Ronald] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; [Aldinger, Kimberly A.; Dobyns, William B.; Doherty, Dan] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA 98101 USA; [Shaheen, Ranad; Maddirevula, Sateesh; Alanzi, Talal; Rawashdeh, Rifaat; Khan, Arif O.; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 12713, Saudi Arabia; [Goel, Himanshu] Hunter Genet, Waratah, NSW 2298, Australia; [Goel, Himanshu] Univ Newcastle, Callaghan, NSW 2308, Australia; [Birk, Ohad S.] Ben Gurion Univ Negev, Soroka Med Ctr, Genet Inst, IL-8499000 Beer Sheva, Israel; [Birk, Ohad S.] Ben Gurion Univ Negev, NIBN, IL-8499000 Beer Sheva, Israel; [Khan, Arif O.] Cleveland Clin Abu Dhabi, Eye Inst, Abu Dhabi, U Arab Emirates; [Bamshad, Michael J.; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Dobyns, William B.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Alkuraya, Fowzan S.] Alfaisal Univ, Dept Anat & Cell Biol, Coll Med, Riyadh 11533, Saudi Arabia; [Alkuraya, Fowzan S.] King Abdulaziz City Sci & Technol, Saudi Human Genome Program, Riyadh 12371, Saudi Arabia; [Bachmann-Gagescu, Ruxandra; Doherty, Dan] Univ Zurich, Inst Med Genet, CH-8952 Schlieren, Switzerland	University of Washington; University of Washington Seattle; University of Zurich; Radboud University Nijmegen; Radboud University Nijmegen; Seattle Children's Hospital; King Faisal Specialist Hospital & Research Center; University of Newcastle; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Cleveland Clinic Foundation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Alfaisal University	Doherty, D (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.; Bachmann-Gagescu, R (corresponding author), Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland.	ruxandra.bachmann@imls.uzh.ch; ddoher@uw.edu	Latour, Brooke/AAW-9199-2021; Bachmann-Gagescu, Ruxandra/A-8444-2016; Van De Weghe, Julie/AAL-7665-2020; Aldinger, Kimberly/ABB-1561-2020; Maddirevula, Sateesh/ABE-3655-2021; Roepman, Ronald/B-1339-2014; Dobyns, William/AAI-2768-2020; Dobyns, William Brian/ABC-6525-2021	Bachmann-Gagescu, Ruxandra/0000-0002-3571-5271; Van De Weghe, Julie/0000-0002-4492-6089; Aldinger, Kimberly/0000-0002-5406-8911; Maddirevula, Sateesh/0000-0003-2999-2229; Roepman, Ronald/0000-0002-5178-8163; Dobyns, William/0000-0002-7681-2844; SHAHEEN, RANAD/0000-0002-2590-1759; Blue, Elizabeth/0000-0002-0633-0305; Birk, Ohad/0000-0003-1430-1296; Grout Vandenberg, Megan/0000-0001-7704-2100; Cheng, Yong-Han/0000-0001-7686-0697	NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development [U54HD083091, 6849]; NIH National Institute of Neurological Diseases and Stroke [R01NS064077, R01NS050375]; Swiss National Science Foundation [PZ00P3_163979]; Netherlands Organization for Scientific Research [NWO Vici-865.12.005]; King Salman Center for Disability Research; Dandy-Walker Alliance; NIH National Human Genome Research Institute [U54HG006493]; Saudi Human Genome Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083091] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006493, UM1HG006493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050375, R01NS064077] Funding Source: NIH RePORTER	NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH National Institute of Neurological Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); King Salman Center for Disability Research; Dandy-Walker Alliance; NIH National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Saudi Human Genome Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We deeply thank the families who participated in this study. We also thank the Joubert syndrome and Related Disorder Foundation for referring families, Heather Mefford and her laboratory for help with arrays, the Center for Microscopy and Image Analysis, University of Zurich (ZMB), for their assistance with Scanning Electron Microscopy, in particular Gery Barmettler, the Genotyping and Sequencing Core Facilities at King Faisal Specialist Hospital & Research Centre for their technical help, and Darren Gilmour for the Cas9 protein. This work was supported by the following: NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development U54HD083091 (Genetics Core and Sub-project 6849) to D. D., NIH National Institute of Neurological Diseases and Stroke (R01NS064077 to D. D. and R01NS050375 to W.B.D.), private donations from families to D. D., the Swiss National Science Foundation (PZ00P3_163979) to R.B.-G., the Netherlands Organization for Scientific Research (NWO Vici-865.12.005) to R.R., the King Salman Center for Disability Research to F.S.A., Dandy-Walker Alliance to W.B.D., and NIH National Human Genome Research Institute (U54HG006493) to M.B. and D.N. We acknowledge the support of the Saudi Human Genome Program (F.S.A.).	Abdulwahab F, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0693-2; Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkv1290, 10.1093/nar/gkx1095]; Alkuraya F. S., 2012, CURR PROTOC HUM GENE; Alkuraya FS, 2010, GENET MED, V12, P765, DOI 10.1097/GIM.0b013e3181fbfcc4; Arts HH, 2007, NAT GENET, V39, P882, DOI 10.1038/ng2069; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; Bachmann-Gagescu R, 2015, J MED GENET, V52, P514, DOI 10.1136/jmedgenet-2015-103087; Bachmann-Gagescu R, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005575; Bachmann-Gagescu R, 2011, HUM MOL GENET, V20, P4041, DOI 10.1093/hmg/ddr332; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Bae YK, 2008, FRONT BIOSCI-LANDMRK, V13, P5959, DOI 10.2741/3129; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; Chavez M, 2015, DEV CELL, V34, P338, DOI 10.1016/j.devcel.2015.06.016; Chhin B, 2008, EUR RESPIR J, V32, P121, DOI 10.1183/09031936.00172107; Chong JX, 2015, AM J HUM GENET, V97, P199, DOI 10.1016/j.ajhg.2015.06.009; Clement DL, 2013, J CELL SCI, V126, P953, DOI 10.1242/jcs.116426; Coene KLM, 2009, AM J HUM GENET, V85, P465, DOI 10.1016/j.ajhg.2009.09.002; Craige B, 2010, J CELL BIOL, V190, P927, DOI 10.1083/jcb.201006105; Dafinger C, 2011, J CLIN INVEST, V121, P2662, DOI 10.1172/JCI43639; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Delto CF, 2015, STRUCTURE, V23, P364, DOI 10.1016/j.str.2014.11.016; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985; Doherty D, 2009, SEMIN PEDIATR NEUROL, V16, P143, DOI 10.1016/j.spen.2009.06.002; Dyson JM, 2017, J CELL BIOL, V216, P247, DOI 10.1083/jcb.201511055; Edvardson S, 2010, AM J HUM GENET, V86, P93, DOI 10.1016/j.ajhg.2009.12.007; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; FRIEDE RL, 1978, DEV MED CHILD NEUROL, V20, P758; Garcia-Gonzalo FR, 2015, DEV CELL, V34, P400, DOI 10.1016/j.devcel.2015.08.001; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Gorden NT, 2008, AM J HUM GENET, V83, P559, DOI 10.1016/j.ajhg.2008.10.002; Grimes DT, 2016, SCIENCE, V352, P1341, DOI 10.1126/science.aaf6419; Halbritter J, 2013, AM J HUM GENET, V93, P915, DOI 10.1016/j.ajhg.2013.09.012; Hartmann C, 2015, EPILEPSIA, V56, pE26, DOI 10.1111/epi.12920; He M, 2014, NAT CELL BIOL, V16, P663, DOI 10.1038/ncb2988; Hoover AN, 2008, DEVELOPMENT, V135, P4049, DOI 10.1242/dev.029835; Huang LJ, 2011, AM J HUM GENET, V89, P713, DOI 10.1016/j.ajhg.2011.11.005; Ishikawa H, 2012, CURR BIOL, V22, P414, DOI 10.1016/j.cub.2012.01.031; Juric-Sekhar G, 2012, ACTA NEUROPATHOL, V123, P695, DOI 10.1007/s00401-012-0951-2; Kane M. S., 2017, CILIA, V10; Keller LC, 2005, CURR BIOL, V15, P1090, DOI 10.1016/j.cub.2005.05.024; Kim Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064179; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Ko HW, 2010, DEV CELL, V18, P237, DOI 10.1016/j.devcel.2009.12.014; Kobayashi T, 2014, J CELL BIOL, V204, P215, DOI 10.1083/jcb.201304153; Krock BL, 2008, J CELL SCI, V121, P1907, DOI 10.1242/jcs.029397; Kunitomo H, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r17; Lancaster MA, 2011, NAT MED, V17, P726, DOI 10.1038/nm.2380; Lee JH, 2012, SCIENCE, V335, P966, DOI 10.1126/science.1213506; Lee JE, 2012, NAT GENET, V44, P193, DOI 10.1038/ng.1078; LEFEBVRE PA, 1978, J CELL BIOL, V78, P8, DOI 10.1083/jcb.78.1.8; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lessieur EM, 2017, INVEST OPHTH VIS SCI, V58, P448, DOI 10.1167/iovs.16-20326; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Lih CJ, 1996, P NATL ACAD SCI USA, V93, P4617, DOI 10.1073/pnas.93.10.4617; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mariani L. E., 2016, MOL BIOL CELL MBC; Mateja A, 2006, J MOL BIOL, V357, P621, DOI 10.1016/j.jmb.2006.01.002; Mefford HC, 2011, ANN NEUROL, V70, P974, DOI 10.1002/ana.22645; Mefford HC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000962; Mick DU, 2015, DEV CELL, V35, P497, DOI 10.1016/j.devcel.2015.10.015; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; Ocbina PJR, 2008, DEV DYNAM, V237, P2030, DOI 10.1002/dvdy.21551; Paila U, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003153; Parisi MA, 2004, AM J HUM GENET, V75, P82, DOI 10.1086/421846; Plotnikova OV, 2015, J CELL SCI, V128, P364, DOI 10.1242/jcs.161323; Poretti A, 2008, AM J NEURORADIOL, V29, P1090, DOI 10.3174/ajnr.A1038; Poretti A, 2011, AM J NEURORADIOL, V32, P1459, DOI 10.3174/ajnr.A2517; Qin JA, 2011, P NATL ACAD SCI USA, V108, P1456, DOI 10.1073/pnas.1011410108; Romani M, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-72; Romio L, 2004, J AM SOC NEPHROL, V15, P2556, DOI 10.1097/01.ASN.0000140220.46477.5C; ROSENBAU.JL, 1969, J CELL BIOL, V41, P600, DOI 10.1083/jcb.41.2.600; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Shaheen R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1099-5; Singla V, 2010, DEV CELL, V18, P410, DOI 10.1016/j.devcel.2009.12.022; Slaats GG, 2016, J MED GENET, V53, P62, DOI 10.1136/jmedgenet-2015-103250; Slaats GG, 2015, J CLIN INVEST, V125, P3657, DOI 10.1172/JCI80657; Srour M, 2012, J MED GENET, V49, P636, DOI 10.1136/jmedgenet-2012-101132; Srour M, 2012, AM J HUM GENET, V90, P693, DOI 10.1016/j.ajhg.2012.02.011; Stolc V, 2005, P NATL ACAD SCI USA, V102, P3703, DOI 10.1073/pnas.0408358102; Stratigopoulos G, 2014, CELL METAB, V19, P767, DOI 10.1016/j.cmet.2014.04.009; Sukumaran S, 2009, VISION RES, V49, P479, DOI 10.1016/j.visres.2008.12.009; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; TAMM SL, 1969, J CELL SCI, V4, P171; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Thomas S, 2012, AM J HUM GENET, V91, P372, DOI 10.1016/j.ajhg.2012.06.017; Tuz K, 2014, AM J HUM GENET, V94, P62, DOI 10.1016/j.ajhg.2013.11.019; Valente EM, 2010, NAT GENET, V42, P619, DOI 10.1038/ng.594; Vazquez-Manrique RP, 2007, GENOMICS, V89, P392, DOI 10.1016/j.ygeno.2006.10.007; Vilboux T., 2017, GENET MED; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE; Yachnis AT, 1999, J CHILD NEUROL, V14, P655, DOI 10.1177/088307389901401006; Ye X, 2014, P NATL ACAD SCI USA, V111, P2164, DOI 10.1073/pnas.1318737111; Yeh SD, 2002, J BIOL CHEM, V277, P6311, DOI 10.1074/jbc.M106941200; Yin YL, 2009, DEVELOPMENT, V136, P655, DOI 10.1242/dev.028464; Zou J, 2008, J NEUROSCI, V28, P13684, DOI 10.1523/JNEUROSCI.4333-08.2008	100	48	50	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 6	2017	101	1					23	36		10.1016/j.ajhg.2017.05.010	http://dx.doi.org/10.1016/j.ajhg.2017.05.010			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EZ7FK	28625504	Green Published, Bronze			2022-12-18	WOS:000404886800002
J	Lee, M; Roos, P; Sharma, N; Atalar, M; Evans, TA; Pellicore, MJ; Davis, E; Lam, ATN; Stanley, SE; Khalil, SE; Solomon, GM; Walker, D; Raraigh, KS; Vecchio-Pagan, B; Armanios, M; Cutting, GR				Lee, Melissa; Roos, Patrick; Sharma, Neeraj; Atalar, Melis; Evans, Taylor A.; Pellicore, Matthew J.; Davis, Emily; Lam, Anh-Thu N.; Stanley, Susan E.; Khalil, Sara E.; Solomon, George M.; Walker, Doug; Raraigh, Karen S.; Vecchio-Pagan, Briana; Armanios, Mary; Cutting, Garry R.			Systematic Computational Identification of Variants That Activate Exonic and Intronic Cryptic Splice Sites	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKED DYSKERATOSIS-CONGENITA; MUTATIONS; DISEASE; GENE; ASSOCIATION; PREDICTION; NONSENSE	We developed a variant-annotation method that combines sequence-based machine-learning classification with a context-dependent algorithm for selecting splice variants. Our approach is distinctive in that it compares the splice potential of a sequence bearing a variant with the splice potential of the reference sequence. After training, classification accurately identified 168 of 180 (93.3%) canonical splice sites of five genes. The combined method, CryptSplice, identified and correctly predicted the effect of 18 of 21 (86%) known splice-altering variants in CFTR, a well-studied gene whose loss-of-function variants cause cystic fibrosis (CF). Among 1,423 unannotated CFTR disease-associated variants, the method identified 32 potential exonic cryptic splice variants, two of which were experimentally evaluated and confirmed. After complete CFTR sequencing, the method found three cryptic intronic splice variants (one known and two experimentally verified) that completed the molecular diagnosis of CF in 6 of 14 individuals. CryptSplice interrogation of sequence data from six individuals with X-linked dyskeratosis congenita caused by an unknown disease-causing variant in DKC1 identified two splice-altering variants that were experimentally verified. To assess the extent to which disease-associated variants might activate cryptic splicing, we selected 458 pathogenic variants and 348 variants of uncertain significance (VUSs) classified as high confidence from ClinVar. Splice-site activation was predicted for 129 (28%) of the pathogenic variants and 75 (22%) of the VUSs. Our findings suggest that cryptic splice-site activation is more common than previously thought and should be routinely considered for all variants within the transcribed regions of genes.	[Lee, Melissa; Sharma, Neeraj; Atalar, Melis; Evans, Taylor A.; Pellicore, Matthew J.; Davis, Emily; Lam, Anh-Thu N.; Raraigh, Karen S.; Vecchio-Pagan, Briana; Armanios, Mary; Cutting, Garry R.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Roos, Patrick] Miner & Kasch, Severna Pk, MD 21146 USA; [Stanley, Susan E.; Khalil, Sara E.; Armanios, Mary] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Solomon, George M.] Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35233 USA; [Walker, Doug] Johns Hopkins Univ, Pediat Pulm Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; University of Alabama System; University of Alabama Birmingham; Johns Hopkins University	Cutting, GR (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	gcutting@jhmi.edu	Davis-Marcisak, Emily/X-1046-2019	Davis-Marcisak, Emily/0000-0001-8624-1013; Pellicore, Matthew/0000-0002-6792-0456	NIH [P30DK072482, R01CA160433, R01HL119476, R01DK44003]; Cystic Fibrosis Foundation [CUTTIN13A2, Sorscher15YO]; Cystic Fibrosis Foundation Therapeutics [CUTTIN15XX1]; Commonwealth Foundation Personalized Medicine Initiative at Johns Hopkins; Gilead Sciences Inc. [125828]; NATIONAL CANCER INSTITUTE [R01CA160433] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072482, R01DK044003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); Commonwealth Foundation Personalized Medicine Initiative at Johns Hopkins; Gilead Sciences Inc.(Gilead Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to acknowledge Alice Sanchez and Sean Griffith for developing and testing CryptSplice software; Zhiyong Liu and Heather Hathorne at the Gregory Fleming James Cystic Fibrosis Research Center at the University of Alabama at Birmingham for assisting with the collection of RNA from an individual with cystic fibrosis (CF); Deepika Polineni and Lyndsay Marriott at the University of Kansas Medical Center for coordinating enrollment and specimen collection; Douglas Walker and Pamela Zeitlin at the Johns Hopkins Cystic Fibrosis Center for assisting with specimen collection; Aravinda Chakravarti, Michael Beer, and Michael Parsons for their thoughtful suggestions on this work and this manuscript; and CF- and dyskeratosis-congenita-affected individuals who graciously participated in our research studies. This work was supported by the NIH (P30DK072482 to G.M.S., R01CA160433 and R01HL119476 to M.A., and R01DK44003 to G.R.C.), the Cystic Fibrosis Foundation (CUTTIN13A2 to G.R.C. and Sorscher15YO to G.M.S.), Cystic Fibrosis Foundation Therapeutics (CUTTIN15XX1 to G.R.C.), the Commonwealth Foundation Personalized Medicine Initiative at Johns Hopkins (to M.A.), and Gilead Sciences Inc. (125828 to N.S.).	Alekseyenko AV, 2007, RNA, V13, P661, DOI 10.1261/rna.325107; Amaral MD, 2001, J MED GENET, V38, P777, DOI 10.1136/jmg.38.11.777; Baralle D, 2005, J MED GENET, V42, P737, DOI 10.1136/jmg.2004.029538; Bonifert T, 2014, BRAIN, V137, P2164, DOI 10.1093/brain/awu165; Bonini J, 2015, GENET MED, V17, P796, DOI 10.1038/gim.2014.194; Burset M, 2000, NUCLEIC ACIDS RES, V28, P4364, DOI 10.1093/nar/28.21.4364; BUSSLINGER M, 1981, CELL, V27, P289, DOI 10.1016/0092-8674(81)90412-8; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; CHILLON M, 1995, AM J HUM GENET, V56, P623; Committee F.P.-A.D.A., 2014, IV TREATM CYST FIBR; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Dietz HC, 2010, NEW ENGL J MED, V363, P852, DOI 10.1056/NEJMra0907180; Dokal I, 2000, BRIT J HAEMATOL, V110, P768, DOI 10.1046/j.1365-2141.2000.02109.x; Dujardin G, 2011, J CYST FIBROS, V10, P212, DOI 10.1016/j.jcf.2010.12.008; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Finkel RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081302; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; HIGHSMITH WE, 1994, NEW ENGL J MED, V331, P974, DOI 10.1056/NEJM199410133311503; JACKSON IJ, 1991, NUCLEIC ACIDS RES, V19, P3795; Kitzman JO, 2015, NAT METHODS, V12, P203, DOI [10.1038/NMETH.3223, 10.1038/nmeth.3223]; Klikauer T, 2016, TRIPLEC-COMMUN CAPIT, V14, P260; Knight SW, 1999, AM J HUM GENET, V65, P50, DOI 10.1086/302446; Knight SW, 2001, HUM GENET, V108, P299, DOI 10.1007/s004390100494; Li JL, 2012, GENET MOL RES, V11, P3432, DOI 10.4238/2012.September.25.12; Libbrecht MW, 2015, NAT REV GENET, V16, P321, DOI 10.1038/nrg3920; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Molinski SV, 2014, GENET MED, V16, P625, DOI 10.1038/gim.2014.4; Pagani F, 2004, NAT REV GENET, V5, P389, DOI 10.1038/nrg1327; Parry EM, 2011, J MED GENET, V48, P327, DOI 10.1136/jmg.2010.085100; Pezeshkpoor B, 2013, J THROMB HAEMOST, V11, P1679, DOI 10.1111/jth.12339; Pollastro P, 2002, INT J MOD PHYS C, V13, P1105, DOI 10.1142/S0129183102003796; Poole A, 2014, J ALLERGY CLIN IMMUN, V133, P670, DOI 10.1016/j.jaci.2013.11.025; Reboul M P, 2002, J Med Genet, V39, pe73, DOI 10.1136/jmg.39.11.e73; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Reynolds SD, 2016, AM J RESP CELL MOL, V55, P323, DOI 10.1165/rcmb.2015-0274MA; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Scotti MM, 2016, NAT REV GENET, V17, P19, DOI 10.1038/nrg.2015.3; Sharma N, 2014, HUM MUTAT, V35, P1249, DOI 10.1002/humu.22624; Sheridan MB, 2011, J MED GENET, V48, P235, DOI 10.1136/jmg.2010.083287; Singh RK, 2012, TRENDS MOL MED, V18, P472, DOI 10.1016/j.molmed.2012.06.006; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Sosnay PR, 2013, NAT GENET, V45, P1160, DOI 10.1038/ng.2745; Soukarieh O, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005756; Starita LM, 2015, GENETICS, V200, P413, DOI 10.1534/genetics.115.175802; Tzetis M, 2001, HUM GENET, V109, P592, DOI 10.1007/s00439-001-0631-0; Walter JE, 2015, NEW ENGL J MED, V373, P2664, DOI 10.1056/NEJMcpc1408595; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wang JK, 2015, MOL BIOL EVOL, V32, P481, DOI 10.1093/molbev/msu317; Xing Y, 2006, NAT REV GENET, V7, P499, DOI 10.1038/nrg1896; Yu HH, 2012, J CYST FIBROS, V11, P237, DOI 10.1016/j.jcf.2011.12.005; Yu J, 2002, GENOME RES, V12, P1185, DOI 10.1101/gr.224602	52	48	49	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 4	2017	100	5					751	765		10.1016/j.ajhg.2017.04.001	http://dx.doi.org/10.1016/j.ajhg.2017.04.001			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ET8OV	28475858	Green Published, Bronze			2022-12-18	WOS:000400560000005
J	Johansen, A; Rosti, RO; Musaev, D; Sticca, E; Harripaul, R; Zaki, M; Caglayan, AO; Azam, M; Sultan, T; Froukh, T; Reis, A; Popp, B; Ahmed, I; John, P; Ayub, M; Ben-Omran, T; Vincent, JB; Gleeson, JG; Abou Jamra, R				Johansen, Anide; Rosti, Rasim O.; Musaev, Damir; Sticca, Evan; Harripaul, Ricardo; Zaki, Maha; Caglayan, Ahmet Okay; Azam, Matloob; Sultan, Tipu; Froukh, Tawfiq; Reis, Andre; Popp, Bernt; Ahmed, Iltaf; John, Peter; Ayub, Muhammad; Ben-Omran, Tawfeg; Vincent, John B.; Gleeson, Joseph G.; Abou Jamra, Rami			Mutations in MBOAT7, Encoding Lysophosphatidylinositol Acyltransferase I, Lead to Intellectual Disability Accompanied by Epilepsy and Autistic Features	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DE-NOVO MUTATIONS; LYSOPHOSPHOLIPID ACYLTRANSFERASES; GENETICS; INDIVIDUALS; RISK	The risk of epilepsy among individuals with intellectual disability (ID) is approximately ten times that of the general population. From a cohort of >5,000 families affected by neurodevelopmental disorders, we identified six consanguineous families harboring homozygous inactivating variants in MBOAT7, encoding lysophosphatidylinositol acyltransferase (LPIAT1). Subjects presented with ID frequently accompanied by epilepsy and autistic features. LPIAT1 is a membrane-bound phospholipid-remodeling enzyme that transfers arachidonic acid (AA) to lysophosphatidylinositol to produce AA-containing phosphatidylinositol. This study suggests a role for AA-containing phosphatidylinositols in the development of ID accompanied by epilepsy and autistic features.	[Johansen, Anide; Rosti, Rasim O.; Musaev, Damir; Gleeson, Joseph G.] Univ Calif San Diego, Dept Neurosci, Lab Pediat Brain Dis, Rady Childrens Inst Genom Med, La Jolla, CA 92093 USA; [Johansen, Anide] Oslo Univ Hosp, Dept Med Genet, N-0316 Oslo, Norway; [Johansen, Anide] Univ Oslo, N-0316 Oslo, Norway; [Sticca, Evan; Gleeson, Joseph G.] Rockefeller Univ, Lab Pediat Brain Dis, New York, NY 10065 USA; [Harripaul, Ricardo; Vincent, John B.] Campbell Family Mental Hlth Res Inst, Ctr Addict & Mental Hlth, Toronto, ON M5T 1R8, Canada; [Zaki, Maha] Natl Res Ctr, Human Genet & Genome Res Div, Dept Clin Genet, Cairo 12311, Egypt; [Caglayan, Ahmet Okay] Istanbul Bilim Univ, Sch Med, Dept Med Genet, TR-34394 Istanbul, Turkey; [Azam, Matloob] Wah Med Coll, Dept Pediat & Child Neurol, Wah Cantt, Pakistan; [Sultan, Tipu] Children Hosp Lahore, Inst Child Hlth, Dept Pediat Neurol, Lahore 54000, Pakistan; [Froukh, Tawfiq] Philadelphia Univ, Dept Biotechnol & Genet Engn, Amman, Jordan; [Reis, Andre; Popp, Bernt; Abou Jamra, Rami] Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; [Ahmed, Iltaf; John, Peter] Natl Univ Sci & Technol, Atta Ur Rehman Sch Appl Biosci, Islamabad, Pakistan; [Ayub, Muhammad] Queens Univ, Dept Psychiat, Kingston, ON K7L 3N6, Canada; [Ben-Omran, Tawfeg] Weill Cornell Med Coll, Clin & Metab Genet Dept, Doha, Qatar; [Ben-Omran, Tawfeg] Hamad Med Corp, Dept Pediat, Doha, Qatar; [Gleeson, Joseph G.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Abou Jamra, Rami] Univ Med Ctr Leipzig, Inst Human Genet, D-04103 Leipzig, Germany	University of California System; University of California San Diego; University of Oslo; University of Oslo; Rockefeller University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Demiroglu Bilim University; Philadelphia University Jordan; University of Erlangen Nuremberg; National University of Sciences & Technology - Pakistan; Queens University - Canada; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Hamad Medical Corporation; Howard Hughes Medical Institute; Leipzig University	Gleeson, JG (corresponding author), Univ Calif San Diego, Dept Neurosci, Lab Pediat Brain Dis, Rady Childrens Inst Genom Med, La Jolla, CA 92093 USA.; Gleeson, JG (corresponding author), Rockefeller Univ, Lab Pediat Brain Dis, New York, NY 10065 USA.; Gleeson, JG (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	jogleeson@mail.rockefeller.edu	Abou Jamra, Rami/AAC-8192-2019; Wang, Guilin/G-8794-2018; Reis, André/D-2309-2009; , Tawfiq/Y-6695-2019; Popp, Bernt/M-2157-2019; Caglayan, Ahmet O/D-1066-2012; Zaki, Maha S/B-9361-2013	Abou Jamra, Rami/0000-0002-1542-1399; Reis, André/0000-0002-6301-6363; , Tawfiq/0000-0002-2862-0733; Popp, Bernt/0000-0002-3679-1081; Caglayan, Ahmet O/0000-0002-2332-322X; Zaki, Maha/0000-0001-7840-0002; Reis, AlessanRSS/0000-0001-8486-7469; Harripaul, Ricardo/0000-0001-8948-5830	Howard Hughes Medical Institute; National Institute of Neurological Disorders and Stroke [R01NS098004, R01NS048453]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01HD070494]; Qatar National Research Fund [NPRP6-1463]; Simons Foundation Autism Research Initiative [175303, 275275]; Deutsche Forschungsgemeinschaft (DFG) [AB393/2-2, AB393/4-1]; Canadian Institutes of Health Research [MOP-102758]; Pakistani Higher Education Commission; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070494] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006504, UM1HG008900, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS098004, R01NS048453] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Qatar National Research Fund(Qatar National Research Fund (QNRF)); Simons Foundation Autism Research Initiative; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Pakistani Higher Education Commission; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the affected individuals and their families for their participation in the study. This study was supported by the Howard Hughes Medical Institute, National Institute of Neurological Disorders and Stroke (R01NS098004 and R01NS048453), Eunice Kennedy Shriver National Institute of Child Health and Human Development (P01HD070494), Qatar National Research Fund (NPRP6-1463), and Simons Foundation Autism Research Initiative (175303 and 275275). We thank the Broad Institute (U54HG003067 to E. Lander and HG00 8900 to D. MacArthur) and the Yale Center for Mendelian Disorders (U54HG006504 to R. Lifton, M. Gunel, M. Gerstein, and S. Mane) for sequencing support and analysis. This study was partially supported by grants from the Deutsche Forschungsgemeinschaft (DFG) to R.A.J. (AB393/2-2 and AB393/4-1), a grant from the Canadian Institutes of Health Research to J.B.V. (MOP-102758), and an award from the Pakistani Higher Education Commission to I.A.	Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; American Psychiatric Association, 2013, DSM 5 TASK FORCE DIA, V5th, DOI 10.1176/appi.books.9780890425596; Anderson AA, 2008, J CELL PHYSIOL, V215, P82, DOI 10.1002/jcp.21288; Berg JM, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-7-247, 10.1186/gb4034]; Chen JA, 2015, ANNU REV PATHOL-MECH, V10, P111, DOI 10.1146/annurev-pathol-012414-040405; Dauwerse JG, 2007, EUR J HUM GENET, V15, P743, DOI 10.1038/sj.ejhg.5201833; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Gaugler T, 2014, NAT GENET, V46, P881, DOI 10.1038/ng.3039; Gijon MA, 2008, J BIOL CHEM, V283, P30235, DOI 10.1074/jbc.M806194200; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Grozeva D, 2015, HUM MUTAT, V36, P1197, DOI 10.1002/humu.22901; Hamdan FF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004772; Jansen S., 2016, CLIN GENET; Kaufman L, 2010, J NEURODEV DISORD, V2, P182, DOI 10.1007/s11689-010-9055-2; LANDS WEM, 1958, J BIOL CHEM, V231, P883; Lee HC, 2008, MOL BIOL CELL, V19, P1174, DOI 10.1091/mbc.E07-09-0893; Lee HC, 2012, MOL BIOL CELL, V23, P4689, DOI 10.1091/mbc.E12-09-0673; Mancina RM, 2016, GASTROENTEROLOGY, V150, P1219, DOI 10.1053/j.gastro.2016.01.032; Maulik PK, 2011, RES DEV DISABIL, V32, P419, DOI 10.1016/j.ridd.2010.12.018; McGrother CW, 2006, SEIZURE-EUR J EPILEP, V15, P376, DOI 10.1016/j.seizure.2006.04.002; Mefford HC, 2012, NEW ENGL J MED, V366, P733, DOI 10.1056/NEJMra1114194; Musante L, 2014, TRENDS GENET, V30, P32, DOI 10.1016/j.tig.2013.09.008; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Novarino G, 2012, SCIENCE, V338, P394, DOI 10.1126/science.1224631; Perez-Chacon G, 2009, BBA-MOL CELL BIOL L, V1791, P1103, DOI 10.1016/j.bbalip.2009.08.007; Pommery J, 2005, PROSTAG LEUKOTR ESS, V73, P411, DOI 10.1016/j.plefa.2005.08.009; Ronemus M, 2014, NAT REV GENET, V15, P133, DOI 10.1038/nrg3585; Vissers LELM, 2016, NAT REV GENET, V17, P9, DOI 10.1038/nrg3999; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wright CF, 2015, LANCET, V385, P1305, DOI 10.1016/S0140-6736(14)61705-0; Young AMH, 2016, MOL AUTISM, V7, DOI 10.1186/s13229-016-0068-x; Young Adam M H, 2011, Front Psychiatry, V2, P27, DOI 10.3389/fpsyt.2011.00027; Zarini S, 2014, PROSTAG OTH LIPID M, V113, P52, DOI 10.1016/j.prostaglandins.2014.08.003	33	48	51	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 6	2016	99	4					912	916		10.1016/j.ajhg.2016.07.019	http://dx.doi.org/10.1016/j.ajhg.2016.07.019			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DY7UB	27616480	Green Published, Bronze			2022-12-18	WOS:000385333700011
J	Kopajtich, R; Murayama, K; Janecke, AR; Haack, TB; Breuer, M; Knisely, AS; Harting, I; Ohashi, T; Okazaki, Y; Watanabe, D; Tokuzawa, Y; Kotzaeridou, U; Kolker, S; Sauer, S; Carl, M; Straub, S; Entenmann, A; Gizewski, E; Feichtinger, RG; Mayr, JA; Lackner, K; Strom, TM; Meitinger, T; Muller, T; Ohtake, A; Hoffmann, GF; Prokisch, H; Staufner, C				Kopajtich, Robert; Murayama, Kei; Janecke, Andreas R.; Haack, Tobias B.; Breuer, Maximilian; Knisely, A. S.; Harting, Inga; Ohashi, Toya; Okazaki, Yasushi; Watanabe, Daisaku; Tokuzawa, Yoshimi; Kotzaeridou, Urania; Koelker, Stefan; Sauer, Sven; Carl, Matthias; Straub, Simon; Entenmann, Andreas; Gizewski, Elke; Feichtinger, Rene G.; Mayr, Johannes A.; Lackner, Karoline; Strom, Tim M.; Meitinger, Thomas; Mueller, Thomas; Ohtake, Akira; Hoffmann, Georg F.; Prokisch, Holger; Staufner, Christian			Biallelic IARS Mutations Cause Growth Retardation with Prenatal Onset, Intellectual Disability, Muscular Hypotonia, and Infantile Hepatopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSFER-RNA SYNTHETASE; EXPORT PUMP DEFICIENCY; ACUTE LIVER-FAILURE; CEREBELLAR ATROPHY; HUMAN-DISEASE; ZINC ION; ZEBRAFISH; CHILDREN; REVEALS; LARS	tRNA synthetase deficiencies are a growing group of genetic diseases associated with tissue-specific, mostly neurological, phenotypes. In cattle, cytosolic isoleucyl-tRNA synthetase (IARS) missense mutations cause hereditary weak calf syndrome. Exome sequencing in three unrelated individuals with severe prenatal-onset growth retardation, intellectual disability, and muscular hypotonia revealed biallelic mutations in IARS. Studies in yeast confirmed the pathogenicity of identified mutations. Two of the individuals had infantile hepatopathy with fibrosis and steatosis, leading in one to liver failure in the course of infections. Zinc deficiency was present in all affected individuals and supplementation with zinc showed a beneficial effect on growth in one.	[Kopajtich, Robert; Haack, Tobias B.; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Kopajtich, Robert; Haack, Tobias B.; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Murayama, Kei] Chiba Childrens Hosp, Dept Metab, Chiba 2660007, Japan; [Murayama, Kei] Chiba Canc Ctr, Res Inst, Chiba 2608717, Japan; [Janecke, Andreas R.; Straub, Simon; Entenmann, Andreas; Mueller, Thomas] Med Univ Innsbruck, Dept Pediat 1, A-6020 Innsbruck, Austria; [Janecke, Andreas R.] Med Univ Innsbruck, Div Human Genet, A-6020 Innsbruck, Austria; [Breuer, Maximilian; Kotzaeridou, Urania; Koelker, Stefan; Sauer, Sven; Hoffmann, Georg F.; Staufner, Christian] Univ Heidelberg Hosp, Dept Gen Pediat, Div Neuropediat & Metab Med, D-69120 Heidelberg, Germany; [Knisely, A. S.] Kings Coll Hosp London, Inst Liver Studies, London SE5 9RS, England; [Knisely, A. S.; Lackner, Karoline] Med Univ Graz, Inst Pathol, A-8036 Graz, Austria; [Harting, Inga] Univ Heidelberg Hosp, Dept Neuroradiol, D-69120 Heidelberg, Germany; [Ohashi, Toya] Jikei Univ, Sch Med, Dept Pediat, Tokyo 1058461, Japan; [Okazaki, Yasushi] Saitama Med Univ, Div Translat Res, Res Ctr Genom Med, Saitama 3501241, Japan; [Okazaki, Yasushi; Tokuzawa, Yoshimi] Saitama Med Univ, Div Funct Genom & Syst Med, Res Ctr Genom Med, Saitama 3501241, Japan; [Watanabe, Daisaku] Kitasato Univ, Sch Vet Med, Dept Large Anim Clin, Towada, Aomori 0348628, Japan; [Carl, Matthias] Heidelberg Univ, Med Fac Mannheim, Dept Cell & Mol Biol, D-68167 Mannheim, Germany; [Gizewski, Elke] Med Univ Innsbruck, Dept Neuroradiol, A-6020 Innsbruck, Austria; [Feichtinger, Rene G.; Mayr, Johannes A.] Paracelsus Med Univ, SALK Salzburg, Dept Paediat, A-5020 Salzburg, Austria; [Ohtake, Akira] Saitama Med Univ, Fac Med, Dept Pediat, Moroyama, Saitama 3500495, Japan	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Chiba Children's Hospital; Chiba Cancer Center; Medical University of Innsbruck; Medical University of Innsbruck; Ruprecht Karls University Heidelberg; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; Medical University of Graz; Ruprecht Karls University Heidelberg; Jikei University; Saitama Medical University; Saitama Medical University; Kitasato University; Ruprecht Karls University Heidelberg; Medical University of Innsbruck; Paracelsus Private Medical University; Saitama Medical University	Staufner, C (corresponding author), Univ Heidelberg Hosp, Dept Gen Pediat, Div Neuropediat & Metab Med, D-69120 Heidelberg, Germany.	christian.staufner@med.uni-heidelberg.de	Meitinger, Thomas/O-1318-2015; Janecke, Andreas/AAA-5227-2019	Ohashi, Toya/0000-0002-9932-0631; Gizewski, Elke Ruth/0000-0001-6859-8377; Meitinger, Thomas/0000-0002-8838-8403; Mayr, Johannes/0000-0001-6970-336X; Prokisch, Holger/0000-0003-2379-6286; Okazaki, Yasushi/0000-0003-3241-5502; Ohtake, Akira/0000-0003-1147-3113	German Bundesministerium fur Bildung und Forschung (BMBF) [01GM1207]; German Network for Mitochondrial Disorders (mitoNET) [01GM1113C]; BMBF through the Juniorverbund in der Systemmedizin "mitOmics" [FKZ 01ZX1405C]; EU [317433, 633974]; Japan Agency for Medical Research and Development (AMED); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; MEXT, Japan;  [27008B]	German Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); German Network for Mitochondrial Disorders (mitoNET); BMBF through the Juniorverbund in der Systemmedizin "mitOmics"(Federal Ministry of Education & Research (BMBF)); EU(European Commission); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	We would like to thank the families for their collaboration. The authors thank Caterina Terrile, Masakazu Kohda, and Yoshihito Kishita for excellent technical and bioinformatical assistance, Dr. Kai Hell for providing the TET-ILS1 yeast strain and pYX122 plasmid, and Dr. Takako Yoshioka for providing a liver-biopsy specimen from individual #85880 (JPN). The authors also thank Dr. Shigeru Toyoda and Dr. Takahiro Tahara for referral of subject materials and Dr. M. Meissl, who attends individual #83921 (AUT). This work was supported by the German Bundesministerium fur Bildung und Forschung (BMBF) through the E-Rare project GENOMIT (01GM1207) and the German Network for Mitochondrial Disorders (mitoNET; 01GM1113C). T.B.H. was supported by the BMBF through the Juniorverbund in der Systemmedizin "mitOmics" (FKZ 01ZX1405C) and H.P. by EU FP7 Mitochondrial European Educational Training Project (317433) and EU Horizon2020 Collaborative Research Project SOUND (633974). This work was further supported by a grant of the Practical Research Project for Rare/Intractable Diseases from Japan Agency for Medical Research and Development (AMED) to K.M., the Innovative Cell Biology by Innovative Technology (Cell Innovation Program) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan to Y.O.; the Support Project and a grant of Strategic Research Center in Private Universities from MEXT, Japan to Saitama Medical University Research Center for Genomic Medicine; and the Grant-in-Aid (27008B) for Japan Science and technology research promotion program for agriculture, forestry, fisheries, and food industry to D.W. for research on affected Japanese calves.	Abbott JA, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00158; Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Antonellis A, 2008, ANNU REV GENOM HUM G, V9, P87, DOI 10.1146/annurev.genom.9.081307.164204; Bilokapic S, 2006, EMBO J, V25, P2498, DOI 10.1038/sj.emboj.7601129; Casey JP, 2015, J INHERIT METAB DIS, V38, P1085, DOI 10.1007/s10545-015-9849-1; Casey JP, 2012, MOL GENET METAB, V106, P351, DOI 10.1016/j.ymgme.2012.04.017; Diodato Daria, 2014, Int J Cell Biol, V2014, P787956, DOI 10.1155/2014/787956; Dixon PH, 2009, GUT, V58, P537, DOI 10.1136/gut.2008.159541; Elstner M, 2009, METHOD ENZYMOL, V457, P3, DOI 10.1016/S0076-6879(09)05001-0; Guo M, 2010, FEBS LETT, V584, P434, DOI 10.1016/j.febslet.2009.11.064; Haack TB, 2015, AM J HUM GENET, V97, P163, DOI 10.1016/j.ajhg.2015.05.009; Hadchouel A, 2015, AM J HUM GENET, V96, P826, DOI 10.1016/j.ajhg.2015.03.010; Hermeziu B, 2006, J PEDIATR GASTR NUTR, V42, P114, DOI 10.1097/01.mpg.0000184429.34001.68; Hirano T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064036; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Konovalova S, 2013, MOL GENET METAB, V108, P206, DOI 10.1016/j.ymgme.2013.01.010; Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501; LANDRO JA, 1994, J BIOL CHEM, V269, P20217; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Narkewicz MR, 1999, HEPATOLOGY, V29, P830, DOI 10.1002/hep.510290322; Ogata Y, 1999, J VET MED A, V46, P327, DOI 10.1046/j.1439-0442.1999.00221.x; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Park SG, 2010, IUBMB LIFE, V62, P296, DOI 10.1002/iub.324; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Pasman Z, 2011, BIOCHEMISTRY-US, V50, P1474, DOI 10.1021/bi1013535; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; Sankaranarayanan R, 2000, NAT STRUCT BIOL, V7, P461; Schmidt WM, 2015, AM J HUM GENET, V97, P855, DOI 10.1016/j.ajhg.2015.10.011; Staufner C, 2016, J INHERIT METAB DIS, V39, P3, DOI 10.1007/s10545-015-9896-7; Strautnieks SS, 2008, GASTROENTEROLOGY, V134, P1203, DOI 10.1053/j.gastro.2008.01.038; Taft RJ, 2013, AM J HUM GENET, V92, P774, DOI 10.1016/j.ajhg.2013.04.006; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Umusig-Quitain P, 2010, J GASTROEN HEPATOL, V25, P387, DOI 10.1111/j.1440-1746.2009.06003.x; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE; Wolf NI, 2015, NEUROLOGY, V84, P226, DOI 10.1212/WNL.0000000000001157; Yao P, 2013, EMBO MOL MED, V5, P332, DOI 10.1002/emmm.201100626; Zhang XC, 2014, AM J HUM GENET, V94, P547, DOI 10.1016/j.ajhg.2014.03.003	37	48	48	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 4	2016	99	2					414	422		10.1016/j.ajhg.2016.05.027	http://dx.doi.org/10.1016/j.ajhg.2016.05.027			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TO	27426735	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000381617200012
J	Mendez, FL; Poznik, GD; Castellano, S; Bustamantel, CD				Mendez, Fernando L.; Poznik, G. David; Castellano, Sergi; Bustamantel, Carlos D.			The Divergence of Neandertal and Modern Human Y Chromosomes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME SEQUENCE; H-Y; SUPPRESSOR; CAVE; GENE	Sequencing the genomes of extinct hominids has reshaped our understanding of modern human origins. Here, we analyze similar to 120 kb of exome-captured Y-chromosome DNA from a Neandertal individual from El Sidron, Spain. We investigate its divergence from orthologous chimpanzee and modern human sequences and find strong support for a model that places the Neandertal lineage as an outgroup to modern human Y chromosomes-including A00, the highly divergent basal haplogroup. We estimate that the time to the most recent common ancestor (TMRCA) of Neandertal and modern human Y chromosomes is similar to 588 thousand years ago (kya) (95% confidence interval [CI]: 447-806 kya). This is similar to 2.1 (95% CI: 1.7-2.9) times longer than the TMRCA of A00 and other extant modern human Y-chromosome lineages. This estimate suggests that the Y-chromosome divergence mirrors the population divergence of Neandertals and modem human ancestors, and it refutes alternative scenarios of a relatively recent or super-archaic origin of Neandertal Y chromosomes. The fact that the Neandertal Y we describe has never been observed in modern humans suggests that the lineage is most likely extinct. We identify protein-coding differences between Neandertal and modem human Y chromosomes, including potentially damaging changes to PCDH11Y, TMSB4Y, USP9Y, and KDM5D. Three of these changes are missense mutations in genes that produce male-specific minor histocompatibility (H-Y) antigens. Antigens derived from KDM5D, for example, are thought to elicit a maternal immune response during gestation. It is possible that incompatibilities at one or more of these genes played a role in the reproductive isolation of the two groups.	[Mendez, Fernando L.; Poznik, G. David; Bustamantel, Carlos D.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Poznik, G. David] Stanford Univ, Program Biomed Informat, Stanford, CA 94305 USA; [Castellano, Sergi] Max Planck Inst Evolutionare Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Bustamantel, Carlos D.] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA	Stanford University; Stanford University; Max Planck Society; Stanford University	Mendez, FL; Bustamantel, CD (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.; Bustamantel, CD (corresponding author), Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA.	flmendez@stanford.edu; cdbustam@stanford.edu	; Castellano, Sergi/A-7437-2016	Bustamante, Carlos D./0000-0002-4187-7920; Mendez, Fernando/0000-0002-0879-3813; Castellano, Sergi/0000-0002-5819-4210	Stanford Center for Computational, Evolutionary, and Human Genomics (CEHG); National Science Foundation [1201234, DGE-1147470]; National Library of Medicine [LM-007033]; Max Planck Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090087] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	Stanford Center for Computational, Evolutionary, and Human Genomics (CEHG); National Science Foundation(National Science Foundation (NSF)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Max Planck Society(Max Planck SocietyFoundation CELLEX); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	F.L.M. was supported by the Stanford Center for Computational, Evolutionary, and Human Genomics (CEHG). This work was supported by the National Science Foundation grant no. 1201234. G.D.P. was supported by the National Science Foundation Graduate Research Fellowship under grant no. DGE-1147470 and by the National Library of Medicine training grant LM-007033. S.C. was supported by the Max Planck Society. We thank Bence Viola for lending expertise and Chris Gignoux for helpful comments and suggestions. G.D.P. is an employee of 23andMe. C.D.B is on the scientific advisory boards (SABs) of AncestryDNA, BigDataBio, Etalon DX, Liberty Biosecurity, and Personalis. He is also a founder and SAB chair of IdentifyGenomics. None of these entities played a role in the design, execution, interpretation, or presentation of this study.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Bogaert AF, 2011, FRONT NEUROENDOCRIN, V32, P247, DOI 10.1016/j.yfrne.2011.02.004; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Castellano S, 2014, P NATL ACAD SCI USA, V111, P6666, DOI 10.1073/pnas.1405138111; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Karmin M, 2015, GENOME RES, V25, P459, DOI 10.1101/gr.186684.114; Lee KH, 2003, REPROD FERT DEVELOP, V15, P129, DOI 10.1071/RD03002; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li N, 2016, CANCER RES, V76, P831, DOI 10.1158/0008-5472.CAN-15-0906; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Nielsen HS, 2011, HUM REPROD UPDATE, V17, P558, DOI 10.1093/humupd/dmr005; Nordborg M, 1998, AM J HUM GENET, V63, P1237, DOI 10.1086/302052; Poznik GD, 2013, SCIENCE, V341, P562, DOI 10.1126/science.1237619; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Rasmussen M, 2014, NATURE, V506, P225, DOI 10.1038/nature13025; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Sankararaman S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002947; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Seguin-Orlando A, 2014, SCIENCE, V346, P1113, DOI 10.1126/science.aaa0114; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Tyler-Smith C, 2009, NEW ENGL J MED, V360, P925, DOI 10.1056/NEJMe0900301; Vernot B, 2014, SCIENCE, V343, P1017, DOI 10.1126/science.1245938; WANG W, 1995, SCIENCE, V269, P1588, DOI 10.1126/science.7667640; Williams NA, 2006, AM J MED GENET B, V141B, P623, DOI 10.1002/ajmg.b.30357; Wong HY, 2015, ONCOTARGET, V6, P44927, DOI 10.18632/oncotarget.6743; Wood RE, 2013, ARCHAEOMETRY, V55, P148, DOI 10.1111/j.1475-4754.2012.00671.x	32	48	49	0	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 7	2016	98	4					728	734		10.1016/j.ajhg.2016.02.023	http://dx.doi.org/10.1016/j.ajhg.2016.02.023			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DJ4UO	27058445	Green Published, Green Submitted, hybrid			2022-12-18	WOS:000374203800010
J	Kotan, LD; Hutchins, BI; Ozkan, Y; Demire, F; Stoner, H; Cheng, PJ; Esen, I; Gurbuz, F; Bicakci, YK; Mengen, E; Yukse, B; Wray, S; Topaloglu, AK				Kotan, L. Damla; Hutchins, B. Ian; Ozkan, Yusuf; Demire, Fatma; Stoner, Hudson; Cheng, Paul J.; Esen, Ihsan; Gurbuz, Fatih; Bicakci, Y. Kenan; Mengen, Eda; Yukse, Bilgin; Wray, Susan; Topaloglu, A. Kemal			Mutations in FEZF1 Cause Kallmann Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; GONADOTROPIN-RELEASING-HORMONE; OF-FUNCTION MUTATIONS; FINGER GENES FEZF1; OLFACTORY SYSTEM; PROTEIN; IDENTIFICATION; DEFICIENCY; ADHESION; FGFR1	Gonadotropin-releasing hormone (GnRH) neurons originate outside the CNS in the olfactory placode and migrate into the CNS, where they become integral components of the hypothalamic-pituitary-gonadal (HPG) axis. Disruption of this migration results in Kallmann syndrome (KS), which is characterized by anosmia and pubertal failure due to hypogonadotropic hypogonadism. Using candidate-gene screening, autozygosity mapping, and whole-exome sequencing in a cohort of 30 individuals with KS, we searched for genes newly associated with KS. We identified homozygous loss-of-function mutations in FEZF1 in two independent consanguineous families each with two affected siblings. The FEZF1 product is known to enable axons of olfactory receptor neurons (ORNs) to penetrate the CNS basal lamina in mice. Because a subset of axons in these tracks is the migratory pathway for GnRH neurons, in FEZF1 deficiency, GnRH neurons also fail to enter the brain. These results indicate that FEZF1 is required for establishment of the central component of the HPG axis in humans.	[Kotan, L. Damla; Topaloglu, A. Kemal] Cukurova Univ, Inst Sci, Dept Biotechnol, TR-01330 Adana, Turkey; [Hutchins, B. Ian; Stoner, Hudson; Cheng, Paul J.; Wray, Susan] NINDS, Cellular & Dev Neurobiol Sect, NIH, Bethesda, MD 20892 USA; [Ozkan, Yusuf] Firat Univ, Dept Endocrinol, Fac Med, TR-23119 Elazig, Turkey; [Demire, Fatma; Esen, Ihsan] Ankara Pediat Hematol & Oncol Training Hosp, Div Pediat Endocrinol, TR-06200 Ankara, Turkey; [Gurbuz, Fatih; Mengen, Eda; Yukse, Bilgin; Topaloglu, A. Kemal] Cukurova Univ, Div Pediat Endocrinol, Fac Med, TR-01330 Adana, Turkey; [Bicakci, Y. Kenan] Cukurova Univ, Dept Radiol, Fac Med, TR-01330 Adana, Turkey	Cukurova University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Firat University; Cukurova University; Cukurova University	Wray, S (corresponding author), NINDS, Cellular & Dev Neurobiol Sect, NIH, Bethesda, MD 20892 USA.	wrays@ninds.nih.gov; ktopaloglu@cu.edu.tr	Hutchins, Ian/A-5713-2009; Gürbüz, Fatih/J-2700-2013; TOPALOGLU, ALI/O-1408-2015; Kotan, Leman Damla/A-2474-2015; esen, ihsan/V-8847-2018; Wray, Susan/AAT-2088-2021	Hutchins, Ian/0000-0001-7657-552X; Gürbüz, Fatih/0000-0003-2160-9838; Kotan, Leman Damla/0000-0001-6176-8986; esen, ihsan/0000-0003-1700-6778; yuksel, bilgin/0000-0003-4378-3255; Cheng-Hathaway, Paul/0000-0002-3240-9316; Mengen, Eda/0000-0003-1597-8418; wray, susan/0000-0001-7670-3915	Scientific and Technological Research Council of Turkey (TUBITAK) [109S455]; Cukurova University Scientific Research Projects (BAP); International Centre for Genetic Engineering and Biotechnology [CRP/TUR10-01]; Intramural Research Program of the NIH National Institute of Neurological Disorders and Stroke [NS002824-13]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002824, ZIANS002824] Funding Source: NIH RePORTER	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Cukurova University Scientific Research Projects (BAP)(Cukurova University); International Centre for Genetic Engineering and Biotechnology; Intramural Research Program of the NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Scientific and Technological Research Council of Turkey (TUBITAK, project no. 109S455), by the Cukurova University Scientific Research Projects (BAP), and by International Centre for Genetic Engineering and Biotechnology (CRP/TUR10-01). B.I.H., P.J.C., H.S., and S.W. received support from the Intramural Research Program of the NIH National Institute of Neurological Disorders and Stroke (NS002824-13).	Brown RS, 2005, CURR OPIN STRUC BIOL, V15, P94, DOI 10.1016/j.sbi.2005.01.006; Cariboni A, 2007, TRENDS NEUROSCI, V30, P638, DOI 10.1016/j.tins.2007.09.002; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291; Dode C, 2003, NAT GENET, V33, P463, DOI 10.1038/ng1122; Dode C, 2006, PLOS GENET, V2, P1648, DOI 10.1371/journal.pgen.0020175; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; Eckler MJ, 2011, J COMP NEUROL, V519, P1829, DOI 10.1002/cne.22596; Engle EC, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001784; Falardeau J, 2008, J CLIN INVEST, V118, P2822, DOI 10.1172/JCI34538; FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0; Fukuda T, 2010, J BIOL CHEM, V285, P40554, DOI 10.1074/jbc.M110.179481; Grumbach MM, 2005, J CLIN ENDOCR METAB, V90, P3122, DOI 10.1210/jc.2004-2465; Hanchate NK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002896; Hardelin JP, 2008, SEX DEV, V2, P181, DOI 10.1159/000152034; Hirata T, 2006, DEVELOPMENT, V133, P1433, DOI 10.1242/dev.02329; Kim HG, 2008, AM J HUM GENET, V83, P511, DOI 10.1016/j.ajhg.2008.09.005; Kim HG, 2010, AM J HUM GENET, V87, P465, DOI 10.1016/j.ajhg.2010.08.018; LEGOUIS R, 1991, CELL, V67, P423, DOI 10.1016/0092-8674(91)90193-3; Miraoui H, 2013, AM J HUM GENET, V92, P725, DOI 10.1016/j.ajhg.2013.04.008; Murata K, 2014, CURR BIOL, V24, P681, DOI 10.1016/j.cub.2014.01.073; Pingault V, 2013, AM J HUM GENET, V92, P707, DOI 10.1016/j.ajhg.2013.03.024; Pitteloud N, 2007, P NATL ACAD SCI USA, V104, P17447, DOI 10.1073/pnas.0707173104; Pitteloud N, 2007, J CLIN INVEST, V117, P457, DOI 10.1172/JCI29884; SCHWANZELFUKUDA M, 1989, NATURE, V338, P161, DOI 10.1038/338161a0; Shimizu T, 2010, DEVELOPMENT, V137, P1875, DOI 10.1242/dev.047167; Shimizu T, 2009, DEV GROWTH DIFFER, V51, P221, DOI 10.1111/j.1440-169X.2009.01088.x; Topaloglu AK, 2010, CURR OPIN OBSTET GYN, V22, P264, DOI 10.1097/GCO.0b013e32833bb425; Tornberg J, 2011, P NATL ACAD SCI USA, V108, P11524, DOI 10.1073/pnas.1102284108; Watanabe Y, 2009, J COMP NEUROL, V515, P565, DOI 10.1002/cne.22074; WRAY S, 1989, P NATL ACAD SCI USA, V86, P8132, DOI 10.1073/pnas.86.20.8132; Yoshida M, 1997, DEVELOPMENT, V124, P101; Young J, 2012, HUM REPROD, V27, P1460, DOI 10.1093/humrep/des022	33	48	55	2	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 4	2014	95	3					326	331		10.1016/j.ajhg.2014.08.006	http://dx.doi.org/10.1016/j.ajhg.2014.08.006			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AO5RX	25192046	Bronze, Green Published			2022-12-18	WOS:000341404100009
J	Roosing, S; Lamers, IJC; de Vrieze, E; van den Born, LI; Lambertus, S; Arts, HH; Peters, TA; Hoyng, CB; Kremer, H; Hetterschijt, L; Letteboer, SJF; van Wijk, E; Roepman, R; den Hollander, AI; Cremers, FPM				Roosing, Susanne; Lamers, Ideke J. C.; de Vrieze, Erik; van den Born, L. Ingeborgh; Lambertus, Stanley; Arts, Heleen H.; Peters, Theo A.; Hoyng, Carel B.; Kremer, Hannie; Hetterschijt, Lisette; Letteboer, Stef J. F.; van Wijk, Erwin; Roepman, Ronald; den Hollander, Anneke I.; Cremers, Frans P. M.		POC1B Study Grp	Disruption of the Basal Body Protein POC1B Results in Autosomal-Recessive Cone-Rod Dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LEBER CONGENITAL AMAUROSIS; RETINITIS-PIGMENTOSA; CENTROSOMAL PROTEIN; JOUBERT-SYNDROME; CENTRIOLE DUPLICATION; RETINAL DYSTROPHIES; CILIARY PROTEIN; GENE-THERAPY; MUTATIONS; ACHROMATOPSIA	Exome sequencing revealed a homozygous missense mutation (c.317C>G [p.Arg106Pro]) in POC1B, encoding POC1 centriolar protein B, in three siblings with autosomal-recessive cone dystrophy or cone-rod dystrophy and compound-heterozygous POC1B mutations (c.199_201del [p.G1n67del] and c.810+1G>T) in an unrelated person with cone-rod dystrophy. Upon overexpression of POC1B in human TERT-immortalized retinal pigment epithelium 1 cells, the encoded wild-type protein localized to the basal body of the primary cilium, whereas this localization was lost for p.Arg106Pro and p.G1n67del variant forms of POC1B. Morpholino-oligonucleotide-induced knockdown of poc1b translation in zebrafish resulted in a dose-dependent small-eye phenotype, impaired optokinetic responses, and decreased length of photoreceptor outer segments. These ocular phenotypes could partially be rescued by wild-type human POC1B mRNA, but not by c.199_201del and c.317C>G mutant human POC1B mRNAs. Yeast two-hybrid screening of a human retinal cDNA library revealed FAM161A as a binary interaction partner of POC1B. This was confirmed in coimmunoprecipitation and colocalization assays, which both showed loss of FAM161A interaction with p.Arg106Pro and p.G1n67del variant forms of POC1B. FAM161A was previously implicated in autosomal-recessive retinitis pigmentosa and shown to be located at the base of the photoreceptor connecting cilium, where it interacts with several other ciliopathy-associated proteins. Altogether, this study demonstrates that POC1B mutations result in a defect of the photoreceptor sensory cilium and thus affect cone and rod photoreceptors.	[Roosing, Susanne; Lamers, Ideke J. C.; de Vrieze, Erik; Arts, Heleen H.; Kremer, Hannie; Hetterschijt, Lisette; Letteboer, Stef J. F.; Roepman, Ronald; den Hollander, Anneke I.; Cremers, Frans P. M.] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Roosing, Susanne; Lamers, Ideke J. C.; Arts, Heleen H.; Kremer, Hannie; Letteboer, Stef J. F.; Roepman, Ronald; den Hollander, Anneke I.; Cremers, Frans P. M.] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [de Vrieze, Erik; Peters, Theo A.; Kremer, Hannie; van Wijk, Erwin] Radboud Univ Nijmegen, Dept Otorhinolaryngol, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [van den Born, L. Ingeborgh] Rotterdam Eye Hosp, NL-3000 LM Rotterdam, Netherlands; [Lambertus, Stanley; Hoyng, Carel B.; den Hollander, Anneke I.] Radboud Univ Nijmegen, Dept Ophthalmol, Med Ctr, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Rotterdam Eye Hospital; Radboud University Nijmegen	Cremers, FPM (corresponding author), Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands.	frans.cremers@radboudumc.nl	van Wijk, Erwin/J-8913-2014; Kremer, Hannie/F-5126-2010; arts, heleen/ACL-6040-2022; Cremers, Frans/A-5625-2014; Roepman, Ronald/B-1339-2014; Roosing, Susanne/ABF-9604-2021; de Vrieze, Erik/B-2541-2014; van Reeuwijk, Jeroen/P-8665-2015; Lambertus, Stanley/P-8153-2015; Koolen, D.A./L-4448-2015; Roosing, Susanne/F-1616-2018; Letteboer, Stef JF/P-8272-2015; Hoyng, C.B./H-8050-2014; Neveling, K./L-4544-2015; Hollander, Anneke den/N-4911-2014; Klaver, Caroline C.W./A-2013-2016; Lugtenberg, Dorien/B-6338-2018; Roosing, Susanne/AAK-3454-2020; Peters, T.A./L-4571-2015; Boldt, Karsten/B-7538-2014; Lamers, Ideke J.C./A-1731-2016; van Beersum, Sylvia E.C./P-8653-2015; De Baere, Elfride/E-7405-2017	van Wijk, Erwin/0000-0002-5702-3460; Kremer, Hannie/0000-0002-0841-8693; Cremers, Frans/0000-0002-4954-5592; Roepman, Ronald/0000-0002-5178-8163; Roosing, Susanne/0000-0001-9038-0067; de Vrieze, Erik/0000-0003-3448-3269; van Reeuwijk, Jeroen/0000-0002-0658-4399; Lambertus, Stanley/0000-0001-9600-9592; Roosing, Susanne/0000-0001-9038-0067; Roosing, Susanne/0000-0001-9038-0067; Peters, T.A./0000-0001-8443-5500; Lamers, Ideke J.C./0000-0003-3491-9667; van Beersum, Sylvia E.C./0000-0002-4552-2908; De Baere, Elfride/0000-0002-5609-6895; Klaver, Caroline/0000-0002-2355-5258; Arts, Heleen/0000-0002-9860-3744; Coppieters, Frauke/0000-0001-7224-0992	Foundation Fighting Blindness [BR-GE-0510-04890RAD, C-CMM-0811-0547-RAD03, C-CMM-0811-0546-RAD02, C-GE-0811-0545-RAD01]; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Gelderse Blinden Stichting; Landelijke Stichting voor Blinden en Slechtzienden; Stichting Blinden-Penning; Stichting Macula Degeneratie fonds; Rotterdamse Stichting Blindenbelangen; Netherlands Organisation for Scientific Research [Vici-016.130.664, Veni-91613008, Veni-016.136.091]; Netherlands Organisation for Health Research and Development (ZonMW) [40-42900-98-1006]; European Community [241955 SYSCILIA]; Radboudumc	Foundation Fighting Blindness(European Commission); Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Gelderse Blinden Stichting; Landelijke Stichting voor Blinden en Slechtzienden; Stichting Blinden-Penning; Stichting Macula Degeneratie fonds; Rotterdamse Stichting Blindenbelangen; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); European Community(European Commission); Radboudumc	We thank Chad Pearson and Mary Pinter for POC1B antibodies, Carsten Janke for the polyglutamylated tubulin antibody, Camiel Boon for ascertainment of affected persons, and Saskia van der Velde-Visser and Alejandro Garanto for expert technical assistance. This study was financially supported by the Foundation Fighting Blindness (grants BR-GE-0510-04890RAD to A.I.d.H., C-CMM-0811-0547-RAD03 to H.K. and E.v.W., C-CMM-0811-0546-RAD02 to R.R., and C-GE-0811-0545-RAD01 to F.P.M.C., A.I.d.H., and R.W.J. Collin); the Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; the Gelderse Blinden Stichting; the Landelijke Stichting voor Blinden en Slechtzienden; the Stichting Blinden-Penning; the Stichting Macula Degeneratie fonds; the Rotterdamse Stichting Blindenbelangen (F.P.M.C. and C.C.W.K.); the Netherlands Organisation for Scientific Research (grants Vici-016.130.664 to R.R., Veni-91613008 to H.H.A., and Veni-016.136.091 to E.v.W.); the Netherlands Organisation for Health Research and Development (ZonMW E-rare grant 40-42900-98-1006 to E.v.W.); the European Community's Seventh Framework Programme FP7/2009 (grant agreement 241955 SYSCILIA to H.K. and R.R.); and an institutional Ph.D. grant from Radboudumc to H.H.A.	Arts HH, 2007, NAT GENET, V39, P882, DOI 10.1038/ng2069; Bandah-Rozenfeld D, 2010, AM J HUM GENET, V87, P382, DOI 10.1016/j.ajhg.2010.07.022; Berger W, 2010, PROG RETIN EYE RES, V29, P335, DOI 10.1016/j.preteyeres.2010.03.004; Blachon S, 2009, GENETICS, V182, P133, DOI 10.1534/genetics.109.101709; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; den Hollander AI, 2010, J CLIN INVEST, V120, P3042, DOI 10.1172/JCI42258; Di Gioia SA, 2012, HUM MOL GENET, V21, P5174, DOI 10.1093/hmg/dds368; El Shamieh S, 2014, AM J HUM GENET, V94, P625, DOI 10.1016/j.ajhg.2014.03.005; Estrada-Cuzcano A, 2012, AM J HUM GENET, V90, P102, DOI 10.1016/j.ajhg.2011.11.015; Fourrage C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013994; Frank V, 2008, HUM MUTAT, V29, P45, DOI 10.1002/humu.20614; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Hamel CP, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-7; Harnes RS, 2008, EXP CELL RES, V314, P574, DOI 10.1016/j.yexcr.2007.10.019; Jin ZB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4517; Keller LC, 2009, MOL BIOL CELL, V20, P1150, DOI 10.1091/mbc.E08-06-0619; Kilburn CL, 2007, J CELL BIOL, V178, P905, DOI 10.1083/jcb.200703109; Kohl S, 2000, HUM MOL GENET, V9, P2107, DOI 10.1093/hmg/9.14.2107; Langmann T, 2010, AM J HUM GENET, V87, P376, DOI 10.1016/j.ajhg.2010.07.018; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Michaelides M, 2004, BRIT J OPHTHALMOL, V88, P291, DOI 10.1136/bjo.2003.027102; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Ozgul RK, 2011, AM J HUM GENET, V89, P253, DOI 10.1016/j.ajhg.2011.07.005; Pearson CG, 2009, J CELL BIOL, V187, P904, DOI 10.1083/jcb.200908019; Phillips JB, 2011, DIS MODEL MECH, V4, P786, DOI 10.1242/dmm.006429; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Roepman R, 2005, P NATL ACAD SCI USA, V102, P18520, DOI 10.1073/pnas.0505774102; Roosing S., 2014, PROG RETIN IN PRESS; Roosing S, 2013, AM J HUM GENET, V93, P110, DOI 10.1016/j.ajhg.2013.05.005; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Sundaram V, 2014, OPHTHALMOLOGY, V121, P234, DOI 10.1016/j.ophtha.2013.08.017; Thiadens A.A., 2009, OPHTHALMOLOGY, V116, P1984; Thiadens AAHJ, 2012, OPHTHALMOLOGY, V119, P819, DOI 10.1016/j.ophtha.2011.10.011; Thiadens AAHJ, 2010, INVEST OPHTH VIS SCI, V51, P5952, DOI 10.1167/iovs.10-5680; Thiadens AAHJ, 2009, AM J HUM GENET, V85, P240, DOI 10.1016/j.ajhg.2009.06.016; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; Venoux M, 2013, J CELL SCI, V126, P163, DOI 10.1242/jcs.111203; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE; Zach F, 2012, HUM MOL GENET, V21, P4573, DOI 10.1093/hmg/dds268; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zeitz C, 2013, AM J HUM GENET, V92, P67, DOI 10.1016/j.ajhg.2012.10.023	41	48	51	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 7	2014	95	2					131	142		10.1016/j.ajhg.2014.06.012	http://dx.doi.org/10.1016/j.ajhg.2014.06.012			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM7VE	25018096	Green Published, hybrid			2022-12-18	WOS:000340076000001
J	Shalata, A; Ramirez, MC; Desnick, RJ; Priedigkeit, N; Buettner, C; Lindtner, C; Mahroum, M; Abdul-Ghani, M; Dong, F; Arar, N; Camacho-Vanegas, O; Zhang, R; Camacho, SC; Chen, Y; Ibdah, M; DeFronzo, R; Gillespie, V; Kelley, K; Dynlacht, BD; Kim, SY; Glucksman, MJ; Borochowitz, ZU; Martignetti, JA				Shalata, Adel; Ramirez, Maria C.; Desnick, Robert J.; Priedigkeit, Nolan; Buettner, Christoph; Lindtner, Claudia; Mahroum, Mohammed; Abdul-Ghani, Muhammad; Dong, Feng; Arar, Nazik; Camacho-Vanegas, Olga; Zhang, Rui; Camacho, Sandra C.; Chen, Ying; Ibdah, Mwafaq; DeFronzo, Ralph; Gillespie, Virginia; Kelley, Kevin; Dynlacht, Brian D.; Kim, Sehyun; Glucksman, Marc J.; Borochowitz, Zvi U.; Martignetti, John A.			Morbid Obesity Resulting from Inactivation of the Ciliary Protein CEP19 in Humans and Mice	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BARDET-BIEDL-SYNDROME; BODY-MASS INDEX; FTO GENE; GENOME; CHILDHOOD; VARIANTS; WORLD	Obesity is a major public health concern, and complementary research strategies have been directed toward the identification of the underlying causative gene mutations that affect the normal pathways and networks that regulate energy balance. Here, we describe an autosomal-recessive morbid-obesity syndrome and identify the disease-causing gene defect. The average body mass index of affected family members was 48.7 (range = 36.7-61.0), and all had features of the metabolic syndrome. Homozygosity mapping localized the disease locus to a region in 3q29; we designated this region the morbid obesity 1 (MO1) locus. Sequence analysis identified a homozygous nonsense mutation in CEP19, the gene encoding the ciliary protein CEP19, in all affected family members. CEP19 is highly conserved in vertebrates and invertebrates, is expressed in multiple tissues, and localizes to the centrosome and primary cilia. Homozygous Cep19-knockout mice were morbidly obese, hyperphagic, glucose intolerant, and insulin resistant. Thus, loss of the ciliary protein CEP19 in humans and mice causes morbid obesity and defines a target for investigating the molecular pathogenesis of this disease and potential treatments for obesity and malnutrition.	[Shalata, Adel; Ramirez, Maria C.; Desnick, Robert J.; Priedigkeit, Nolan; Camacho-Vanegas, Olga; Zhang, Rui; Camacho, Sandra C.; Chen, Ying; Martignetti, John A.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Buettner, Christoph; Lindtner, Claudia] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Martignetti, John A.] Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; [Martignetti, John A.] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Gillespie, Virginia] Mt Sinai Sch Med, Ctr Comparat Med & Surg, New York, NY 10029 USA; [Kelley, Kevin] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Shalata, Adel; Mahroum, Mohammed; Ibdah, Mwafaq; Borochowitz, Zvi U.] Bnai Zion Med Ctr, Simon Winter Inst Human Genet, IL-31048 Haifa, Israel; [Shalata, Adel] Clalit Hlth Serv Grp, IL-30810 Sakhnin City, Israel; [Abdul-Ghani, Muhammad; Dong, Feng; Arar, Nazik; DeFronzo, Ralph] Univ Texas Hlth Sci Ctr San Antonio, Div Diabet, San Antonio, TX 78229 USA; [Dynlacht, Brian D.; Kim, Sehyun] NYU, Sch Med, Dept Pathol, Inst Canc, New York, NY 10016 USA; [Glucksman, Marc J.] Rosalind Franklin Univ Med & Sci, Midwest Proteome Ctr, Chicago Med Sch, Chicago, IL 60064 USA; [Glucksman, Marc J.] Rosalind Franklin Univ Med & Sci, Dept Biochem Mol Biol, Chicago Med Sch, Chicago, IL 60064 USA; [Borochowitz, Zvi U.] Technion Israel Inst Technol, Rappaport Fac Med, IL-31096 Haifa, Israel; [Borochowitz, Zvi U.] Technion Israel Inst Technol, Res Inst, IL-31096 Haifa, Israel	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Bnai Zion Medical Center; Clalit Health Services; University of Texas System; University of Texas Health San Antonio; New York University; Chicago Medical School; Rosalind Franklin University Medical & Science; Chicago Medical School; Rosalind Franklin University Medical & Science; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology	Shalata, A (corresponding author), Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA.	adelsh@clalit.org.il; john.martignetti@mssm.edu		Priedigkeit, Nolan/0000-0001-8330-5210	National Institutes of Health (NIH) [5R01DK071298]; March of Dimes award; NIH [5 R01 HD069647]; American Heart Association [10SDG4470014]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005138] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes award(March of Dimes); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank all the family members who participated in this study. J.A.M. was supported in part by a National Institutes of Health (NIH) grant (5R01DK071298), B.D.D. was supported by a March of Dimes award and by an NIH grant (5 R01 HD069647), and M.A.G. received financial support through an American Heart Association grant (10SDG4470014). J.A.M. would like to thank A. Cederbaum, C. Mobbs, and D. Leroith for their thoughtful and critical advice throughout these studies. A.S. thanks A. Ahronhiem for his generous advice and fruitful discussions of the mouse research.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Allison DB, 1996, INT J OBESITY, V20, P501; Farooqi IS, 2006, ENDOCR REV, V27, P710, DOI 10.1210/er.2006-0040; Feuillan PP, 2011, J CLIN ENDOCR METAB, V96, pE528, DOI 10.1210/jc.2010-2290; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Friedman JM, 2004, NAT MED, V10, P563, DOI 10.1038/nm0604-563; Girard D, 2011, NAT REV ENDOCRINOL, V7, P77, DOI 10.1038/nrendo.2010.210; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Marshall JD, 2005, ARCH INTERN MED, V165, P675, DOI 10.1001/archinte.165.6.675; Moore SJ, 2005, AM J MED GENET A, V132A, P352, DOI 10.1002/ajmg.a.30406; PRICE RA, 1990, INT J OBESITY, V14, P185; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Ramachandrappa S, 2011, J CLIN INVEST, V121, P2080, DOI 10.1172/JCI46044; Robbens S, 2008, J MOL EVOL, V66, P80, DOI 10.1007/s00239-007-9059-z; Rosen O M, 1979, Recent Prog Horm Res, V35, P477; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; STUNKARD AJ, 1986, NEW ENGL J MED, V314, P193, DOI 10.1056/NEJM198601233140401; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Zaghloul NA, 2009, J CLIN INVEST, V119, P428, DOI 10.1172/JCI37041	26	48	51	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 5	2013	93	6					1061	1071		10.1016/j.ajhg.2013.10.025	http://dx.doi.org/10.1016/j.ajhg.2013.10.025			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	273FS	24268657	Green Published, Bronze			2022-12-18	WOS:000328521300006
J	Steinberg, J; Webber, C				Steinberg, Julia; Webber, Caleb			The Roles of FMRP-Regulated Genes in Autism Spectrum Disorder: Single- and Multiple-Hit Genetic Etiologies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGILE-X-SYNDROME; DE-NOVO MUTATIONS; COPY-NUMBER VARIATION; RARE; PROTEIN; MOUSE; ASSOCIATION; VARIANTS; NETWORK; BIOLOGY	Autism spectrum disorder (ASD) is a highly heritable complex neurodevelopmental condition characterized by impairments in social interaction and communication and restricted and repetitive behaviors. Although roles for both de novo and familial genetic variation have been documented, the underlying disease mechanisms remain poorly elucidated. In this study, we defined and explored distinct etiologies of genetic variants that affect genes regulated by Fragile-X mental retardation protein (FMRP), thought to play a key role in neuroplasticity and neuronal translation, in ASD-affected individuals. In particular, we developed the Trend test, a pathway-association test that is able to robustly detect multiple-hit etiologies and is more powerful than existing approaches. Exploiting detailed spatiotemporal maps of gene expression within the human brain, we identified four discrete FMRP-target subpopulations that exhibit distinct functional biases and contribute to ASD via different types of genetic variation. We also demonstrated that FMRP target genes are more likely than other genes with similar expression patterns to contribute to disease. We developed the hypothesis that FMRP targets contribute to ASD via two distinct etiologies: (1) ultra-rare and highly penetrant single disruptions of embryonically upregulated FMRP targets ("single-hit etiology") or (2) the combination of multiple less penetrant disruptions of nonembryonic, synaptic FMRP targets ("multiple-hit etiology"). The Trend test provides rigorous support for a multiple-hit genetic etiology in a subset of autism cases and is easily extendible to combining information from multiple types of genetic variation (i.e., copy-number and exome variants), increasing its value to next-generation sequencing approaches.	[Steinberg, Julia; Webber, Caleb] Univ Oxford, MRC, Dept Physiol Anat & Genet, Funct Genom Unit, Oxford OX1 3QX, England; [Steinberg, Julia] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics	Webber, C (corresponding author), Univ Oxford, MRC, Dept Physiol Anat & Genet, Funct Genom Unit, Oxford OX1 3QX, England.	caleb.webber@dpag.ox.ac.uk	Steinberg, Julia/S-2007-2019	Steinberg, Julia/0000-0002-0585-2312; Webber, Caleb/0000-0001-8063-7674	Wellcome Trust [093941/Z/10/Z, 090532/Z/09/Z]; Medical Research Council; European Union [241995]; National Institute of Mental Health [1U24MH081810]; NATIONAL INSTITUTE OF MENTAL HEALTH [U24MH081810] Funding Source: NIH RePORTER; Medical Research Council [MC_UU_12021/4, MC_UP_A320_1004] Funding Source: researchfish; MRC [MC_UP_A320_1004, MC_UU_12021/4] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the anonymous reviewers for their comments and suggestions. This work was supported by the Wellcome Trust (grants 093941/Z/10/Z to J.S. and 090532/Z/09/Z to the Wellcome Trust Centre for Human Genetics), Medical Research Council (funding to C.W), and the European Union's Seventh Framework Programme project GENCODYS (grant 241995 to C.W.). We gratefully acknowledge the resources provided by the Autism Genetic Resource Exchange (AGRE) Consortium and the participating AGRE families. The AGRE is a program of Autism Speaks and is supported, in part, by grant 1U24MH081810 from the National Institute of Mental Health to Clara M. Lajonchere (principal investigator). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Baudouin SJ, 2012, SCIENCE, V338, P128, DOI 10.1126/science.1224159; Ben-David E, 2013, MOL PSYCHIATR, V18, P1054, DOI 10.1038/mp.2012.148; Ben-David E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002556; Bernier R, 2012, AUTISM RES, V5, P13, DOI 10.1002/aur.226; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Budimirovic DB, 2011, DEV NEUROSCI-BASEL, V33, P379, DOI 10.1159/000330213; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Callan MA, 2011, GENESIS, V49, P424, DOI 10.1002/dvg.20745; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; DeLorey TM, 2011, BEHAV BRAIN RES, V216, P36, DOI 10.1016/j.bbr.2010.06.032; Doetschman Thomas, 2009, V530, P423, DOI 10.1007/978-1-59745-471-1_23; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Gai X, 2012, MOL PSYCHIATR, V17, P402, DOI 10.1038/mp.2011.10; Gerdts Jennifer, 2011, Autism Res Treat, V2011, P545901, DOI 10.1155/2011/545901; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Girirajan S, 2012, NEW ENGL J MED, V367, P1321, DOI 10.1056/NEJMoa1200395; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jayaseelan S, 2012, NATURE, V492, P359, DOI 10.1038/nature11764; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Klei L, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-9; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Leblond CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002521; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McLennan Y, 2011, CURR GENOMICS, V12, P216, DOI 10.2174/138920211795677886; Muhle R, 2004, PEDIATRICS, V113, pE472, DOI 10.1542/peds.113.5.e472; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Noh HJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003523; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001097; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Shaikh TH, 2011, HUM MOL GENET, V20, P880, DOI 10.1093/hmg/ddq527; Skafidas E., 2012, MOL PSYCHIAT; Soden ME, 2010, J NEUROSCI, V30, P16910, DOI 10.1523/JNEUROSCI.3660-10.2010; State MW, 2012, SCIENCE, V337, P1301, DOI 10.1126/science.1224989; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Uher R, 2009, MOL PSYCHIATR, V14, P1072, DOI 10.1038/mp.2009.85; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wang T, 2012, CURR OPIN GENET DEV, V22, P256, DOI 10.1016/j.gde.2012.02.002; Webber C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000531; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974	56	48	49	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2013	93	5					825	839		10.1016/j.ajhg.2013.09.013	http://dx.doi.org/10.1016/j.ajhg.2013.09.013			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252HU	24207117	hybrid, Green Published, Green Accepted			2022-12-18	WOS:000326996600004
J	Koehler, K; Malik, M; Mahmood, S; Giesselmann, S; Beetz, C; Hennings, JC; Huebner, AK; Grahn, A; Reunert, J; Nurnberg, G; Thiele, H; Altmuller, J; Nurnberg, P; Mumtaz, R; Babovic-Vuksanovic, D; Basel-Vanagaite, L; Borck, G; Bramswig, J; Muhlenberg, R; Sarda, P; Sikiric, A; Anyane-Yeboa, K; Zeharia, A; Ahmad, A; Coubes, C; Wada, Y; Marquardt, T; Vanderschaeghe, D; Van Schaftingen, E; Kurth, I; Huebner, A; Hubner, CA				Koehler, Katrin; Malik, Meera; Mahmood, Saqib; Giesselmann, Sebastian; Beetz, Christian; Hennings, J. Christopher; Huebner, Antje K.; Grahn, Ammi; Reunert, Janine; Nuernberg, Gudrun; Thiele, Holger; Altmueller, Janine; Nuernberg, Peter; Mumtaz, Rizwan; Babovic-Vuksanovic, Dusica; Basel-Vanagaite, Lina; Borck, Guntram; Braemswig, Jurgen; Muehlenberg, Reinhard; Sarda, Pierre; Sikiric, Alma; Anyane-Yeboa, Kwame; Zeharia, Avraham; Ahmad, Arsalan; Coubes, Christine; Wada, Yoshinao; Marquardt, Thorsten; Vanderschaeghe, Dieter; Van Schaftingen, Emile; Kurth, Ingo; Huebner, Angela; Huebner, Christian A.			Mutations in GMPPA Cause a Glycosylation Disorder Characterized by Intellectual Disability and Autonomic Dysfunction	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GDP-MANNOSE PYROPHOSPHORYLASE; WD-REPEAT PROTEIN; TRIPLE-A SYNDROME; SACCHAROMYCES-CEREVISIAE; CONGENITAL DISORDERS; CRYSTAL-STRUCTURE; GENE; MECHANISMS; NEUROPATHY; MUTANTS	In guanosine diphosphate (GDP)-mannose pyrophosphorylase A (GMPPA), we identified a homozygous nonsense mutation that segregated with achalasia and alacrima, delayed developmental milestones, and gait abnormalities in a consanguineous Pakistani pedigree. Mutations in GMPPA were subsequently found in ten additional individuals from eight independent families affected by the combination of achalasia, alacrima, and neurological deficits. This autosomal-recessive disorder shows many similarities with triple A syndrome, which is characterized by achalasia, alacrima, and variable neurological deficits in combination with adrenal insufficiency. GMPPA is a largely uncharacterized homolog of GMPPB. GMPPB catalyzes the formation of GDP-mannose, which is an essential precursor of glycan moieties of glycoproteins and glycolipids and is associated with congenital and limb-girdle muscular dystrophies with hypoglycosylation of a-dystroglycan. Surprisingly, GDP-mannose pyrophosphorylase activity was unchanged and GDP-mannose levels were strongly increased in lymphoblasts of individuals with GMPPA mutations. This suggests that GMPPA might serve as a GMPPB regulatory subunit mediating feedback inhibition of GMPPB instead of displaying catalytic enzyme activity itself. Thus, a triple-A-like syndrome can be added to the growing list of congenital disorders of glycosylation, in which dysregulation rather than mere enzyme deficiency is the basal pathophysiological mechanism.	[Koehler, Katrin; Huebner, Angela] Tech Univ Dresden, Childrens Hosp, Div Endocrinol & Diabet, D-01307 Dresden, Germany; [Malik, Meera; Huebner, Antje K.; Mumtaz, Rizwan; Kurth, Ingo; Huebner, Christian A.] Jena Univ Hosp, Inst Human Genet, D-07743 Jena, Germany; [Mahmood, Saqib] Univ Hlth Sci, Dept Human Genet & Mol Biol, Lahore 54900, Pakistan; [Beetz, Christian] Jena Univ Hosp, Dept Clin Chem & Lab Med, D-07747 Jena, Germany; [Grahn, Ammi; Van Schaftingen, Emile] Catholic Univ Louvain, Duve Inst, B-1200 Brussels, Belgium; [Reunert, Janine; Braemswig, Jurgen; Marquardt, Thorsten] Univ Childrens Hosp, D-48149 Munster, Germany; [Nuernberg, Gudrun; Thiele, Holger; Altmueller, Janine] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Nuernberg, Peter] ATLAS Biolabs GmbH, D-10117 Berlin, Germany; [Nuernberg, Peter] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Babovic-Vuksanovic, Dusica] Mayo Clin, Rochester, MN 55905 USA; [Basel-Vanagaite, Lina] Rabin Med Ctr, Schneider Childrens Med Ctr Israel, IL-49100 Petah Tiqwa, Israel; [Basel-Vanagaite, Lina] Rabin Med Ctr, Raphael Recanati Genet Inst, IL-49100 Petah Tiqwa, Israel; [Basel-Vanagaite, Lina; Zeharia, Avraham] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Basel-Vanagaite, Lina] Rabin Med Ctr, Felsenstein Med Res Ctr, IL-49100 Petah Tiqwa, Israel; [Borck, Guntram] Univ Ulm, Inst Human Genet, D-89081 Ulm, Germany; [Muehlenberg, Reinhard] Helios Clin, D-47805 Krefeld, Germany; [Sarda, Pierre; Coubes, Christine] Hop Villeneuve, Dept Med Genet, F-34295 Montpellier, France; [Sikiric, Alma] Oslo Univ Hosp, Ulleval Hosp, Dept Neurohabiltat, N-0424 Oslo, Norway; [Anyane-Yeboa, Kwame] Columbia Univ, Med Ctr, New York, NY 10010 USA; [Zeharia, Avraham] Schneider Childrens Med Ctr Israel, Day Hospitalizat Unit, IL-49202 Petah Tiqwa, Israel; [Ahmad, Arsalan] Shifa Tameer E Millat Univ, Shifa Int Hosp, Islamabad 44000, Pakistan; [Wada, Yoshinao] Osaka Med Ctr, Osaka 5941101, Japan; [Wada, Yoshinao] Res Inst Maternal & Child Hlth, Osaka 5941101, Japan; [Vanderschaeghe, Dieter] Univ Ghent, Dept Biochem & Microbiol, B-9000 Ghent, Belgium; [Vanderschaeghe, Dieter] VIB, Dept Mol & Biomed Res, Unit Med Biotechnol, B-9052 Zwijnaarde, Belgium	Technische Universitat Dresden; Friedrich Schiller University of Jena; University of Health Science - Pakistan; Friedrich Schiller University of Jena; Universite Catholique Louvain; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster; University of Cologne; University of Cologne; Mayo Clinic; Rabin Medical Center; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Tel Aviv University; Ulm University; Universite de Montpellier; CHU de Montpellier; University of Oslo; Columbia University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Ghent University; Flanders Institute for Biotechnology (VIB)	Hubner, CA (corresponding author), Jena Univ Hosp, Inst Human Genet, D-07743 Jena, Germany.	angela.huebner@uniklinikum-dresden.de; christian.huebner@med.uni-jena.de	Thiele, Holger/ABE-6792-2020; Mahmood, Saqib/C-7837-2009; Borck, Guntram/F-1868-2015; Hübner, Christian/A-2950-2017; Van+Schaftingen, Emile/AAF-5532-2020	Thiele, Holger/0000-0002-0169-998X; Hübner, Christian/0000-0002-1030-4943; Beetz, Christian/0000-0001-7061-2895; Van Schaftingen, Emile/0000-0002-6199-7647; Kurth, Ingo/0000-0002-5642-8378; Koehler, Katrin/0000-0002-9407-1410; Basel-Vanagaite, Vanagaite, Lina/0000-0002-9076-8157; Mahmood, Saqib/0000-0003-2326-3025; Altmuller, Janine/0000-0003-4372-1521; Anyane-Yeboa, Kwame/0000-0002-4977-9719	Deutsche Forschungsgemeinschaft; ERA-Net (EURO-CDG network); Israeli Ministry of Health Chief Scientist Foundation [3-4963]; Israeli Science Foundation [558/09]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ERA-Net (EURO-CDG network); Israeli Ministry of Health Chief Scientist Foundation; Israeli Science Foundation(Israel Science Foundation)	We are grateful to the family members for their participation and support of this study. C.A.H., I.K., and A.H. are supported by the Deutsche Forschungsgemeinschaft. D.V. is a postdoctoral fellow of Fonds Wetenschappelijk Onderzoek Vlaanderen. E.V.S. and A.G. are supported by ERA-Net (EURO-CDG network). L.B.-V. is funded by the Israeli Ministry of Health Chief Scientist Foundation (grant no. 3-4963) and the Israeli Science Foundation (grant no. 558/09). We are very grateful to Markus Schuelke for fruitful strategic discussion. We kindly thank Dana Landgraf and Petra Mitzscherling for excellent technical assistance and Pierre van der Bruggen for providing us with control lymphoblasts. P.N. is a founder, chief executive officer, and shareholder of ATLAS Biolabs GmbH. ATLAS Biolabs GmbH is a service provider for genomic analysis.	BALLOU L, 1991, P NATL ACAD SCI USA, V88, P3209, DOI 10.1073/pnas.88.8.3209; Benton BK, 1996, CURR GENET, V29, P106, DOI 10.1007/BF02221573; Carss KJ, 2013, AM J HUM GENET, V93, P29, DOI 10.1016/j.ajhg.2013.05.009; de Lonlay P, 2009, BBA-MOL BASIS DIS, V1792, P841, DOI 10.1016/j.bbadis.2008.11.012; Freeman R, 2005, LANCET, V365, P1259, DOI 10.1016/S0140-6736(05)74815-7; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; Handschug K, 2001, HUM MOL GENET, V10, P283, DOI 10.1093/hmg/10.3.283; Hashimoto H, 1997, J BIOL CHEM, V272, P16308, DOI 10.1074/jbc.272.26.16308; Hermey G, 2004, J NEUROCHEM, V88, P1470, DOI 10.1046/j.1471-4159.2004.02286.x; Jaeken J, 2011, J INHERIT METAB DIS, V34, P853, DOI 10.1007/s10545-011-9299-3; Jensen SO, 1998, BBA-PROTEIN STRUCT M, V1382, P5, DOI 10.1016/S0167-4838(97)00122-2; Jin XS, 2005, EMBO J, V24, P694, DOI 10.1038/sj.emboj.7600551; Kruszewska JS, 1998, CURR GENET, V33, P445, DOI 10.1007/s002940050358; Kurth I, 2009, NAT GENET, V41, P1179, DOI 10.1038/ng.464; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Linster CL, 2003, J BIOL CHEM, V278, P36328, DOI 10.1074/jbc.M306593200; Marquardt T, 2003, EUR J PEDIATR, V162, P359, DOI 10.1007/s00431-002-1136-0; Milenkovic T, 2010, EUR J PEDIATR, V169, P1323, DOI 10.1007/s00431-010-1222-7; Niehues R, 1998, J CLIN INVEST, V101, P1414, DOI 10.1172/JCI2350; Ning BT, 2000, EUR J BIOCHEM, V267, P6866, DOI 10.1046/j.1432-1033.2000.01781.x; RAETZ CRH, 1995, SCIENCE, V270, P997, DOI 10.1126/science.270.5238.997; Rotthier A, 2012, NAT REV NEUROL, V8, P73, DOI 10.1038/nrneurol.2011.227; Rust MB, 2006, CIRC RES, V98, P549, DOI 10.1161/01.RES.0000204449.83861.22; Sivaraman J, 2002, J BIOL CHEM, V277, P44214, DOI 10.1074/jbc.M206932200; STATEVA LI, 1991, MOL CELL BIOL, V11, P4235, DOI 10.1128/MCB.11.8.4235; SZUMILO T, 1993, J BIOL CHEM, V268, P17943; Timal S, 2012, HUM MOL GENET, V21, P4151, DOI 10.1093/hmg/dds123; Tullio-Pelet A, 2000, NAT GENET, V26, P332, DOI 10.1038/81642; Vanderschaeghe D, 2009, MOL CELL PROTEOMICS, V8, P986, DOI 10.1074/mcp.M800470-MCP200; Yoda K, 2000, BIOSCI BIOTECH BIOCH, V64, P1937, DOI 10.1271/bbb.64.1937	31	48	51	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 3	2013	93	4					727	734		10.1016/j.ajhg.2013.08.002	http://dx.doi.org/10.1016/j.ajhg.2013.08.002			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	243GT	24035193	Green Published, Bronze			2022-12-18	WOS:000326305600014
J	Manes, G; Meunier, I; Avila-Fernandez, A; Banfi, S; Le Meur, G; Zanlonghi, X; Corton, M; Simonelli, F; Brabet, P; Labesse, G; Audo, I; Mohand-Said, S; Zeitz, C; Sahel, JA; Weber, M; Dollfus, H; Dhaenens, CM; Allorge, D; De Baere, E; Koenekoop, RK; Kohl, S; Cremers, FPM; Hollyfield, JG; Senechal, A; Hebrard, M; Bocquet, B; Garcia, CA; Hamel, CP				Manes, Gael; Meunier, Isabelle; Avila-Fernandez, Almudena; Banfi, Sandro; Le Meur, Guylene; Zanlonghi, Xavier; Corton, Marta; Simonelli, Francesca; Brabet, Philippe; Labesse, Gilles; Audo, Isabelle; Mohand-Said, Saddek; Zeitz, Christina; Sahel, Jose-Alain; Weber, Michel; Dollfus, Helene; Dhaenens, Claire-Marie; Allorge, Delphine; De Baere, Elfride; Koenekoop, Robert K.; Kohl, Susanne; Cremers, Frans P. M.; Hollyfield, Joe G.; Senechal, Audrey; Hebrard, Maxime; Bocquet, Beatrice; Ayuso Garcia, Carmen; Hamel, Christian P.			Mutations in IMPG1 Cause Vitelliform Macular Dystrophies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECESSIVE RETINITIS-PIGMENTOSA; BULLS-EYE MACULOPATHY; INTERPHOTORECEPTOR MATRIX; SEA DOMAIN; GENETIC-HETEROGENEITY; VMD2 GENE; PROTEOGLYCAN; PHOTORECEPTORS; DISEASE	Vitelliform macular dystrophies (VMD) are inherited retinal dystrophies characterized by yellow, round deposits visible upon fundus examination and encountered in individuals with juvenile Best macular dystrophy (BMD) or adult-onset vitelliform macular dystrophy (AVMD). Although many BMD and some AVMD cases harbor mutations in BEST1 or PRPH2, the underlying genetic cause remains unknown for many affected individuals. In a large family with autosomal-dominant VMD, gene mapping and whole-exome sequencing led to the identification of a c.713T>G (p.Leu238Arg) IMPG1 mutation, which was subsequently found in two other families with autosomal-dominant VMD and the same phenotype. IMPG1 encodes the SPACR protein, a component of the rod and cone photoreceptor extracellular matrix domains. Structural modeling indicates that the p.Leu238Arg substitution destabilizes the conserved SEA1 domain of SPACR. Screening of 144 probands who had various forms of macular dystrophy revealed three other IMPG1 mutations. Two individuals from one family affected by autosomal-recessive VMD were homozygous for the splice-site mutation c.807+1G>T, and two from another family were compound heterozygous for the mutations c.461T>C (p.Leu154Pro) and c.1519C>T (p.A1g507*). Most cases had a normal or moderately decreased electrooculogram Arden ratio. We conclude that IMPG1 mutations cause both autosomal-dominant and -recessive forms of VMD, thus indicating that impairment of the interphotoreceptor matrix might be a general cause of VMD.	[Manes, Gael; Meunier, Isabelle; Brabet, Philippe; Senechal, Audrey; Hebrard, Maxime; Bocquet, Beatrice; Hamel, Christian P.] Inst Neurosci, INSERM, U1051, F-34091 Montpellier, France; [Manes, Gael; Meunier, Isabelle; Brabet, Philippe; Senechal, Audrey; Hebrard, Maxime; Bocquet, Beatrice; Hamel, Christian P.] Univ Montpellier I, F-34091 Montpellier, France; [Manes, Gael; Meunier, Isabelle; Brabet, Philippe; Senechal, Audrey; Hebrard, Maxime; Bocquet, Beatrice; Hamel, Christian P.] Univ Montpellier 2, F-34091 Montpellier, France; [Meunier, Isabelle; Hamel, Christian P.] CHRU, F-34091 Montpellier, France; [Avila-Fernandez, Almudena; Corton, Marta; Ayuso Garcia, Carmen] Univ Hosp, Fdn Jimenez Diaz, Ctr Invest Biomed Red Enfermedades Raras, Inst Salud Carlos 3,Inst Invest Sanitaria,Dept Ge, Madrid 28040, Spain; [Banfi, Sandro] Univ Naples 2, Telethon Inst Genet & Med, I-80131 Naples, Italy; [Banfi, Sandro] Univ Naples 2, Dipartimento Biochim Biofis & Patol Generale, I-80131 Naples, Italy; [Le Meur, Guylene; Weber, Michel] CHRU, Dept Ophthalmol, F-44093 Nantes, France; [Zanlonghi, Xavier] Clin Sourdille, F-44000 Nantes, France; [Simonelli, Francesca] Univ Naples 2, Eye Clin, I-80131 Naples, Italy; [Labesse, Gilles] INSERM, U554, F-34090 Montpellier, France; [Labesse, Gilles] CNRS, Ctr Biochim Struct, UMR 5048, F-34090 Montpellier, France; [Audo, Isabelle; Mohand-Said, Saddek; Zeitz, Christina; Sahel, Jose-Alain] INSERM, U968, F-75012 Paris, France; [Audo, Isabelle; Mohand-Said, Saddek; Zeitz, Christina; Sahel, Jose-Alain] CNRS, UMR 7210, F-75012 Paris, France; [Audo, Isabelle; Mohand-Said, Saddek; Zeitz, Christina; Sahel, Jose-Alain] Univ Paris 06, Inst Vis, UMR S968, F-75012 Paris, France; [Audo, Isabelle; Mohand-Said, Saddek; Sahel, Jose-Alain] Hosp & Org Soins, Ctr Hosp Natl Ophtahmol QuinzeVingts, Ctr Invest Clin 503, INSERM, F-75012 Paris, France; [Sahel, Jose-Alain] Fdn Ophtalmol Adolphe Rotheschild, F-75019 Paris, France; [Sahel, Jose-Alain] Acad Sci Inst France, F-75006 Paris, France; [Dollfus, Helene] CHRU, Ctr Reference Affect Rares Genet Ophtalmol, F-67000 Strasbourg, France; [Dhaenens, Claire-Marie; Allorge, Delphine] CHRU Lille, UF Genopathies, Lab Biochim & Biol Mol, F-59037 Lille, France; [De Baere, Elfride] Ctr Med Genet, B-9000 Ghent, Belgium; [Koenekoop, Robert K.] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Paediat Ophthalmol Div,McGill Ocular Genet Lab, Montreal, PQ H3H 1P3, Canada; [Kohl, Susanne] Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Mol Genet Lab, D-72076 Tubingen, Germany; [Cremers, Frans P. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Hollyfield, Joe G.] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44195 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Fundacion Jimenez Diaz; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Nantes Universite; CHU de Nantes; Universita della Campania Vanvitelli; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Strasbourg; Universite de Lille - ISITE; CHU Lille; McGill University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Radboud University Nijmegen; Cleveland Clinic Foundation	Hamel, CP (corresponding author), Inst Neurosci, INSERM, U1051, F-34091 Montpellier, France.	christian.hamel@inserm.fr	Brabet, Philippe/AAO-8522-2020; Hebrard, Maxime/E-4402-2016; Banfi, Sandro/K-3963-2018; Cremers, Frans/A-5625-2014; De Baere, Elfride/E-7405-2017; Zeitz, Christina/F-2757-2017; Bocquet, Beatrice/AAY-8447-2020; Sahel, Jose-Alain/F-3172-2017; Simonelli, Francesca/AHE-7571-2022; Koenekoop, Robert/AAT-6676-2021	Brabet, Philippe/0000-0003-2739-1622; Hebrard, Maxime/0000-0003-2346-4513; Banfi, Sandro/0000-0002-6541-8833; Cremers, Frans/0000-0002-4954-5592; De Baere, Elfride/0000-0002-5609-6895; Zeitz, Christina/0000-0002-3510-1712; Bocquet, Beatrice/0000-0002-6369-4818; Sahel, Jose-Alain/0000-0002-4831-1153; Simonelli, Francesca/0000-0001-8520-6769; Labesse, Gilles/0000-0002-6861-3300; Corton, Marta/0000-0003-0087-1626; Dollfus, Helene/0000-0002-2249-895X; Audo, Isabelle/0000-0003-0698-5309; Kohl, Susanne/0000-0002-6438-6331; allorge, delphine/0000-0003-2356-3319	Retina France (the 100-Exome Project); SOS Retinite; Centre National de Genotypage; ISCIII (Fundaluce and ONCE, Spain); Italian Telethon Foundation; RP Liguria Association; INSERM; UNADEV; CIBERER	Retina France (the 100-Exome Project); SOS Retinite; Centre National de Genotypage; ISCIII (Fundaluce and ONCE, Spain); Italian Telethon Foundation(Fondazione Telethon); RP Liguria Association; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); UNADEV; CIBERER	We thank the family members who participated in this study, for which informed consent for clinical examination and genetic analysis was obtained. The project was supported by Retina France (the 100-Exome Project), SOS Retinite, Centre National de Genotypage, PI09/0459 from ISCIII (Fundaluce 2011 and ONCE 2012, Spain), the Italian Telethon Foundation, the RP Liguria Association, and INSERM. We address special thanks to UNADEV for supporting G.M. and M.H. and to CIBERER for supporting A.A.F. and M.C.. C.P.H., C.A.G., E.D.B., F.P.M.C., R.K.K., S.K., and S.B. are members of the European Retinal Disease Consortium (ERDC). At the time these studies took place, ERDC also comprised Rob W.J. Collin, Anneke I. den Hollander, Chris Ingleheam, Bart P. Leroy, Dror Sharon, Carmel Toomes, and Bernd Wissinger. We thank Ronald Roepmann and Estrada-Cuzcano for protein analysis and Britta Baumann, Marijke N. Zonneveld, and Saskia D. van der Velde-Visser for technical work. We also thank Ramon A.C. van Huet and Lies H. Hoefsloot for patient ascertainment. We thank Francesco Testa and Raffaella Brunetti-Pierri for helpful discussions, Marie-Claude Le Roy for clinical assessment, and Dr Vasiliki Kalatzis for critical reading of the manuscript. We thank the Reseau d'Histologie Experimentale de Montpellier (facility for immunofluorescence analysis.	Acharya S, 1998, GLYCOBIOLOGY, V8, P997, DOI 10.1093/glycob/8.10.997; Acharya S, 2000, J BIOL CHEM, V275, P6945, DOI 10.1074/jbc.275.10.6945; Akhavan A, 2008, FASEB J, V22, P612, DOI 10.1096/fj.07-8354com; Bandah-Rozenfeld D, 2010, AM J HUM GENET, V87, P199, DOI 10.1016/j.ajhg.2010.07.004; Best F., 1905, OPHTHALMOLOGICA, V13, P199; Boon CJF, 2007, ARCH OPHTHALMOL-CHIC, V125, P1100, DOI 10.1001/archopht.125.8.1100; Boon CJF, 2008, VISION RES, V48, P2569, DOI 10.1016/j.visres.2008.01.010; BORK P, 1995, PROTEIN SCI, V4, P1421, DOI 10.1002/pro.5560040716; Catherinot V, 2004, BIOINFORMATICS, V20, P3694, DOI 10.1093/bioinformatics/bth429; COPPETO J, 1982, AM J OPHTHALMOL, V93, P279, DOI 10.1016/0002-9394(82)90525-6; DEUTMAN AF, 1974, AM J OPHTHALMOL, V78, P384, DOI 10.1016/0002-9394(74)90225-6; Gehrig A, 1998, J MED GENET, V35, P641, DOI 10.1136/jmg.35.8.641; Gómez-Faiña P., 2007, Arch Soc Esp Oftalmol, V82, P373; Hebrard M, 2011, EUR J HUM GENET, V19, P1256, DOI 10.1038/ejhg.2011.133; HOLLYFIELD JG, 1989, RETINA-J RET VIT DIS, V9, P59, DOI 10.1097/00006982-198909010-00008; Kramer F, 2000, EUR J HUM GENET, V8, P286, DOI 10.1038/sj.ejhg.5200447; Kuehn MH, 1999, MATRIX BIOL, V18, P509, DOI 10.1016/S0945-053X(99)00043-8; Macao B, 2006, NAT STRUCT MOL BIOL, V13, P71, DOI 10.1038/nsmb1035; Maeda T, 2004, J BIOL CHEM, V279, P13174, DOI 10.1074/jbc.M309417200; MANSERGH FC, 1995, J MED GENET, V32, P855, DOI 10.1136/jmg.32.11.855; MARTYN L J, 1971, Birth Defects Original Article Series, V7, P189; Meunier I, 2011, OPHTHALMOLOGY, V118, P1130, DOI 10.1016/j.ophtha.2010.10.010; MIYAKE Y, 1989, RETINA-J RET VIT DIS, V9, P210, DOI 10.1097/00006982-198909030-00009; Perez Alvarez M.J., 2003, ARCH SOC ESP OFTALMO, V78, P451; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Salinas Alaman A., 2005, ARCH SOC ESP OFTALMO, V80, P45; Seddon JM, 2001, OPHTHALMOLOGY, V108, P2060, DOI 10.1016/S0161-6420(01)00777-1; Singh KK, 2007, VET OPHTHALMOL, V10, P274, DOI 10.1111/j.1463-5224.2007.00549.x; Sohocki MM, 1997, AM J HUM GENET, V61, P239; van Lith-Verhoeven JJC, 2004, INVEST OPHTH VIS SCI, V45, P30, DOI 10.1167/iovs.03-0392; VANDENBIESEN PR, 1985, AM J OPHTHALMOL, V100, P73, DOI 10.1016/S0002-9394(14)74986-4	31	48	51	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 5	2013	93	3					571	578		10.1016/j.ajhg.2013.07.018	http://dx.doi.org/10.1016/j.ajhg.2013.07.018			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	297QB	23993198	Green Published, Bronze			2022-12-18	WOS:000330268900017
J	Powers, NR; Eicher, JD; Butter, F; Kong, Y; Miller, LL; Ring, SM; Mann, M; Gruen, JR				Powers, Natalie R.; Eicher, John D.; Butter, Falk; Kong, Yong; Miller, Laura L.; Ring, Susan M.; Mann, Matthias; Gruen, Jeffrey R.			Alleles of a Polymorphic ETV6 Binding Site in DCDC2 Confer Risk of Reading and Language Impairment	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DYSLEXIA SUSCEPTIBILITY GENE; DNA-BINDING; KIAA0319; ASSOCIATION; EXPRESSION; TEL; TRANSCRIPTION; VARIANTS	Reading disability (RD) and language impairment (LI) are common learning disabilities that make acquisition and utilization of reading and verbal language skills, respectively, difficult for affected individuals. Both disorders have a substantial genetic component with complex inheritance. Despite decades of study, reading and language, like many other complex traits, consistently evade identification of causative and functional variants. We previously identified a putative functional risk variant, named BV677278 for its GenBank accession number, for RD in DCDC2. This variant consists of an intronic microdeletion and a highly polymorphic short tandem repeat (STR) within its breakpoints. We have also shown this STR to bind to an unknown nuclear protein with high specificity. Here, we replicate BV677278's association with RD, expand its association to LI, identify the BV677278-binding protein as the transcription factor ETV6, and provide compelling genetic evidence that BV677278 is a regulatory element that influences reading and language skills. We also provide evidence that BV677278 interacts nonadditively with KIAA0319, an RD-associated gene, to adversely affect several reading and cognitive phenotypes. On the basis of these data, we propose a new name for BV677278: "READ1" or "regulatory element associated with dyslexia 1."	[Powers, Natalie R.; Eicher, John D.; Gruen, Jeffrey R.] Yale Univ, Dept Genet, New Haven, CT 06520 USA; [Gruen, Jeffrey R.] Yale Univ, Dept Pediat, New Haven, CT 06520 USA; [Butter, Falk; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany; [Kong, Yong] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [Kong, Yong] Yale Univ, WM Keck Fdn Biotechnol Resource Lab, New Haven, CT 06510 USA; [Miller, Laura L.; Ring, Susan M.] Univ Bristol, Sch Social & Community Med, Bristol BS8 2BN, Avon, England; [Gruen, Jeffrey R.] Yale Univ, Dept Invest Med, New Haven, CT 06520 USA	Yale University; Yale University; Max Planck Society; Yale University; Yale University; University of Bristol; Yale University	Gruen, JR (corresponding author), Yale Univ, Dept Genet, 464 Congress Ave,Suite 243, New Haven, CT 06520 USA.	jeffrey.gruen@yale.edu	Mann, Matthias/A-3454-2013; Kong, Yong/B-5105-2014	Mann, Matthias/0000-0003-1292-4799; Kong, Yong/0000-0002-2881-5274; Powers, Natalie/0000-0001-6313-1719; Butter, Falk/0000-0002-7197-7279	Wellcome Trust [092731]; National Institutes of Health [R01 NSO43530, P50 HD027802, F31 DC012270]; Medical Research Council [G9815508] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD027802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC012270] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We are extremely grateful to all the families who took part in this study, the midwives for their help in recruiting them, and the whole Avon Longitudinal Study of Parents and Children (ALSPAC) team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists, and nurses. The UK Medical Research Council and the Wellcome Trust (grant 092731) and the University of Bristol provide core support for the ALSPAC. We are also grateful to the Yale Center for Gnome Analysis for SNP genotyping services and to Silvia Paracchini for her generous contribution of genotype data for rs4504469, rs2038137, and rs2143340. This research was specifically funded by the National Institutes of Health (grants R01 NSO43530 to J.R.G., P50 HD027802 to Y.K. and J.R.G., and F31 DC012270 to J.D.E.). The authors declare competing financial interests: Yale University has applied for a patent covering the complex tandem repeat and deletion in BV677278 (inventor: J.R.G.) and sublicensed it to JS Genetics Inc. J.R.G. is a founder and equity holder of JS Genetics Inc. and is a member of its scientific advisory board.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bishop DVM, 1996, J CHILD PSYCHOL PSYC, V37, P391, DOI 10.1111/j.1469-7610.1996.tb01420.x; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Butter F, 2010, EMBO REP, V11, P305, DOI 10.1038/embor.2010.6; Cope N, 2012, NEUROIMAGE, V63, P148, DOI 10.1016/j.neuroimage.2012.06.037; Dennis MY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000436; Dezso Z, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-49; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Francks C, 2004, AM J HUM GENET, V75, P1046, DOI 10.1086/426404; Fuka G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026348; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Green SM, 2010, J BIOL CHEM, V285, P18496, DOI 10.1074/jbc.M109.096958; Han B, 2008, ANN HUM GENET, V72, P834, DOI 10.1111/j.1469-1809.2008.00469.x; Handler SM, 2011, PEDIATRICS, V127, pE818, DOI 10.1542/peds.2010-3670; Harold D, 2006, MOL PSYCHIATR, V11, P1085, DOI 10.1038/sj.mp.4001904; Kim CA, 2001, EMBO J, V20, P4173, DOI 10.1093/emboj/20.15.4173; Liu JS, 2011, CURR NEUROL NEUROSCI, V11, P171, DOI 10.1007/s11910-010-0176-5; Luciano M, 2007, BIOL PSYCHIAT, V62, P811, DOI 10.1016/j.biopsych.2007.03.007; Ludwig KU, 2008, PSYCHIAT GENET, V18, P310, DOI 10.1097/YPG.0b013e3283063a78; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; Marino C, 2012, PSYCHIAT GENET, V22, P25, DOI 10.1097/YPG.0b013e32834acdb2; Meng HY, 2011, BEHAV GENET, V41, P58, DOI 10.1007/s10519-010-9408-3; Meng HY, 2005, P NATL ACAD SCI USA, V102, P17053, DOI 10.1073/pnas.0508591102; Meng HY, 2005, HUM GENET, V118, P87, DOI 10.1007/s00439-005-0017-9; Mittler G, 2009, GENOME RES, V19, P284, DOI 10.1101/gr.081711.108; Newbury DF, 2009, AM J HUM GENET, V85, P264, DOI 10.1016/j.ajhg.2009.07.004; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Paracchini S, 2006, HUM MOL GENET, V15, P1659, DOI 10.1093/hmg/ddl089; Paracchini S, 2008, AM J PSYCHIAT, V165, P1576, DOI 10.1176/appi.ajp.2008.07121872; Pennington BF, 2009, ANNU REV PSYCHOL, V60, P283, DOI 10.1146/annurev.psych.60.110707.163548; Peschansky VJ, 2010, CEREB CORTEX, V20, P884, DOI 10.1093/cercor/bhp154; Peterson RL, 2012, LANCET, V379, P1997, DOI 10.1016/S0140-6736(12)60198-6; Poelmans G, 2011, MOL PSYCHIATR, V16, P365, DOI 10.1038/mp.2010.105; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scerri TS, 2010, EUR CHILD ADOLES PSY, V19, P179, DOI 10.1007/s00787-009-0081-0; Scerri TS, 2011, BIOL PSYCHIAT, V70, P237, DOI 10.1016/j.biopsych.2011.02.005; Velayos-Baeza A, 2010, J BIOL CHEM, V285, P40148, DOI 10.1074/jbc.M110.145961; Wang LC, 1998, GENE DEV, V12, P2392, DOI 10.1101/gad.12.15.2392; Wang LL, 2001, ONCOGENE, V20, P3716, DOI 10.1038/sj.onc.1204479; Wilcke A, 2009, ANN DYSLEXIA, V59, P1, DOI 10.1007/s11881-008-0020-7; Wu Kenneth K., 2006, V338, P281; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	43	48	52	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 11	2013	93	1					19	28		10.1016/j.ajhg.2013.05.008	http://dx.doi.org/10.1016/j.ajhg.2013.05.008			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	183HG	23746548	Bronze, Green Published			2022-12-18	WOS:000321804500002
J	Mohamed, JY; Faqeih, E; Alsiddiky, A; Alshammari, MJ; Ibrahim, NA; Alkuraya, FS				Mohamed, Jawahir Y.; Faqeih, Eissa; Alsiddiky, Abdulmonem; Alshammari, Muneera J.; Ibrahim, Niema A.; Alkuraya, Fowzan S.			Mutations in MEOX1, Encoding Mesenchyme Homeobox 1, Cause Klippel-Feil Anomaly	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SNP DATA; DIFFERENTIATION; LOCALIZATION; EXPRESSION; SCLEROTOME; PROTEINS; MOX-1; LEADS; GENE	Klippel-Feil syndrome (KFS) is a segmentation malformation of the cervical spine; clinically, it manifests as a short neck with reduced mobility and a low posterior hairline. Several genes have been proposed as candidates for KFS when it is present with other associated anomalies, but the genetics of isolated KFS have been difficult to study because of the syndrome's mostly sporadic occurrence. We describe a multiplex consanguineous family in which isolated KFS maps to a single 17q21.31 locus that harbors a homozygous frame-shift deletion in MEOX1; this deletion results in complete instability of the transcript. Direct sequencing of this gene in two siblings from another consanguineous family affected by isolated KFS uncovered another homozygous truncating (nonsense) MEOX1 mutation that also leads to complete degradation of the transcript. This gene encodes a transcription factor with a well-established and nonredundant role in somite development, and homozygous null alleles of Meox1 in mice have a cervical skeletal defect that is remarkably similar to the one we observe in human individuals with MEOX1 mutations. Our data strongly suggest that KFS is the human phenotypic equivalent of the sclerotome polarity defect that results from Meox1 deficiency in mice.	[Mohamed, Jawahir Y.; Alshammari, Muneera J.; Ibrahim, Niema A.; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Faqeih, Eissa] King Fahad Med City, Dept Pediat, Riyadh 11525, Saudi Arabia; [Alsiddiky, Abdulmonem] King Khalid Univ Hosp, Dept Orthoped, Riyadh 11461, Saudi Arabia; [Alsiddiky, Abdulmonem; Alshammari, Muneera J.] King Saud Univ, Coll Med, Riyadh 11461, Saudi Arabia; [Alshammari, Muneera J.] King Khalid Univ Hosp, Dept Pediat, Riyadh 11461, Saudi Arabia; [Alkuraya, Fowzan S.] Coll Med, Dept Anat & Cell Biol, Riyadh 11533, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Fahad Medical City; King Saud University; King Saud University; King Saud University; King Khalid University Hospital	Alkuraya, FS (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.	falkuraya@kfshrc.edu.sa			King Abdulaziz City for Science and Technology grant [09-MED941-20]; Dubai-Harvard Foundation for Medical Research collaborative research grant	King Abdulaziz City for Science and Technology grant; Dubai-Harvard Foundation for Medical Research collaborative research grant	We thank the families for their enthusiastic participation. We thank the Genotyping and Sequencing Core Facilities at the King Faisal Specialist Hospital and Research Center for their technical help. This work was supported by King Abdulaziz City for Science and Technology grant 09-MED941-20 (F.S.A.) and Dubai-Harvard Foundation for Medical Research collaborative research grant (F.S.A.).	Candia AF, 1996, INT J DEV BIOL, V40, P1179; CANDIA AF, 1992, DEVELOPMENT, V116, P1123; CANDIA AF, 1995, MECH DEVELOP, V52, P27, DOI 10.1016/0925-4773(95)00384-D; Carr IM, 2006, HUM MUTAT, V27, P1041, DOI 10.1002/humu.20383; Chan D, 1998, J CLIN INVEST, V101, P1490, DOI 10.1172/JCI1976; COOPER JC, 1976, BRIT DENT J, V140, P264, DOI 10.1038/sj.bdj.4803748; DASILVA EO, 1982, J MED GENET, V19, P130; Eckalbar WL, 2012, WIRES DEV BIOL, V1, P401, DOI 10.1002/wdev.34; Gridley T, 2006, DEV DYNAM, V235, P2330, DOI 10.1002/dvdy.20850; GRIGORIOU M, 1995, GENOMICS, V26, P550, DOI 10.1016/0888-7543(95)80174-K; GUNDERSON CH, 1967, MEDICINE, V46, P491, DOI 10.1097/00005792-196711000-00003; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; Kirilenko P, 2011, MOL CELL BIOL, V31, P1301, DOI 10.1128/MCB.00705-10; Mankoo BS, 2003, DEVELOPMENT, V130, P4655, DOI 10.1242/dev.00687; MCBRIDE WZ, 1992, AM FAM PHYSICIAN, V45, P633; McGaughran JM, 2003, EUR J HUM GENET, V11, P468, DOI 10.1038/sj.ejhg.5200987; Natsuga K, 2010, HUM MUTAT, V31, pE1687, DOI 10.1002/humu.21330; Rodrigo I, 2004, MOL CELL BIOL, V24, P2757, DOI 10.1128/MCB.24.7.2757-2766.2004; Skuntz S, 2009, DEV BIOL, V332, P383, DOI 10.1016/j.ydbio.2009.06.006; Takahashi Y, 2008, DEV GROWTH DIFFER, V50, pS149, DOI 10.1111/j.1440-169X.2008.01018.x; Tassabehji M, 2008, HUM MUTAT, V29, P1017, DOI 10.1002/humu.20741; Tracy MR, 2004, CLIN ORTHOP RELAT R, P183, DOI 10.1097/01.blo.0000132067.49895.20; Ye M, 2010, HUM MOL GENET, V19, P287, DOI 10.1093/hmg/ddp496	23	48	53	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN 10	2013	92	1					157	161		10.1016/j.ajhg.2012.11.016	http://dx.doi.org/10.1016/j.ajhg.2012.11.016			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	073RA	23290072	Bronze, Green Published			2022-12-18	WOS:000313759000018
J	Xu, WY; Gu, MM; Sun, LH; Guo, WT; Zhu, HB; Ma, JF; Yuan, WT; Kuang, Y; Ji, BJ; Wu, XL; Chen, Y; Zhang, HX; Sun, FT; Huang, W; Huang, L; Chen, SD; Wang, ZG				Xu, Wang-yang; Gu, Ming-min; Sun, Lian-hua; Guo, Wen-ting; Zhu, Hou-bao; Ma, Jian-fang; Yuan, Wen-tao; Kuang, Ying; Ji, Bao-jun; Wu, Xiao-lin; Chen, Yan; Zhang, Hong-xin; Sun, Fu-ting; Huang, Wei; Huang, Lei; Chen, Sheng-di; Wang, Zhu-gang			A Nonsense Mutation in DHTKD1 Causes Charcot-Marie-Tooth Disease Type 2 in a Large Chinese Pedigree	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEFICIENCY; NEUROPATHY; PROTEINS; COMPLEX; SYSTEM; GENOME; DECAY	Charcot-Marie-Tooth (CMT) disease represents a clinically and genetically heterogeneous group of inherited neuropathies. Here, we report a five-generation family of eight affected individuals with CMT disease type 2, CMT2. Genome-wide linkage analysis showed that the disease phenotype is closely linked to chromosomal region 10p13-14, which spans 5.41 Mb between D10S585 and D10S1477. DNA-sequencing analysis revealed a nonsense mutation, c.1455T>G (p.Tyr485*), in exon 8 of dehydrogenase E1 and transketolase domain-containing 1 (DHTKD1) in all eight affected individuals, but not in other unaffected individuals in this family or in 250 unrelated normal persons. DHTKD1 mRNA expression levels in peripheral blood of affected persons were observed to be half of those in unaffected individuals. In vitro studies have shown that, compared to wild-type mRNA and DHTKD1, mutant mRNA and truncated DHTKD1 are significantly decreased by rapid mRNA decay in transfected cells. Inhibition of nonsense-mediated mRNA decay by UPF1 silencing effectively rescued the decreased levels of mutant mRNA and protein. More importantly, DHTKD1 silencing was found to lead to impaired energy production, evidenced by decreased ATP, total NAD(+) and NADH, and NADH levels. In conclusion, our data demonstrate that the heterozygous nonsense mutation in DHTKD1 is one of CMT2-causative genetic alterations, implicating an important role for DHTKD1 in mitochondrial energy production and neurological development.	[Xu, Wang-yang; Gu, Ming-min; Sun, Lian-hua; Guo, Wen-ting; Zhu, Hou-bao; Wu, Xiao-lin; Chen, Yan; Zhang, Hong-xin; Huang, Lei; Wang, Zhu-gang] Shanghai Jiao Tong Univ, Sch Med, Dept Med Genet, E Inst Shanghai Univ,State Key Lab Med Genom, Shanghai 200025, Peoples R China; [Ma, Jian-fang; Chen, Sheng-di] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Neurol, Shanghai 200025, Peoples R China; [Ma, Jian-fang; Chen, Sheng-di] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Inst Neurol, Shanghai 200025, Peoples R China; [Yuan, Wen-tao; Huang, Wei] Chinese Natl Human Genome Ctr Shanghai, Shanghai 201203, Peoples R China; [Kuang, Ying; Wang, Zhu-gang] Shanghai Res Ctr Model Organisms, Shanghai 201210, Peoples R China; [Ji, Bao-jun; Sun, Fu-ting] Weifang Peoples Hosp, Weifang 261041, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Gu, MM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Med Genet, E Inst Shanghai Univ,State Key Lab Med Genom, Shanghai 200025, Peoples R China.	gumm@sjtu.edu.cn; zhugangw@shsmu.edu.cn	Guo, Wenting/AAI-8241-2021	Guo, Wenting/0000-0003-3585-7728; Huang, Lei/0000-0002-4851-4807; Chen, Yan/0000-0001-5325-1151	Chinese National Science Fund for Distinguished Young Scholars [39925023, 30625019]; National Natural Science Foundation of China [31071107, 30530390]; Ministry of Science and Technology of China [2006BAI23B02, 2011BAI15B02]; Science and Technology Commission of Shanghai Municipality [06DZ05907, 07DZ22929, 10DZ2251500, 11DZ2292400]; E-Institutes of Shanghai Municipal Education Commission [E03003]	Chinese National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); E-Institutes of Shanghai Municipal Education Commission	We thank all members of the Charcot-Marie-Tooth-affected family for their selfless contribution to scientific discovery. We thank Professor Jian Zhang, Hui-zhen Zhang, and Hua-cheng Wu for technical assistance. This work is partially supported by grants from the Chinese National Science Fund for Distinguished Young Scholars (39925023 to Z.-g.W and 30625019 to W.H.), the National Natural Science Foundation of China (31071107 to M.-m.G. and 30530390 to Z.-g.W.), the Ministry of Science and Technology of China (2006BAI23B02 and 2011BAI15B02), the Science and Technology Commission of Shanghai Municipality (06DZ05907, 07DZ22929, 10DZ2251500, and 11DZ2292400), and the E-Institutes of Shanghai Municipal Education Commission (E03003).	Banchs I, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/985415; Bunik VI, 2008, PROTEINS, V71, P874, DOI 10.1002/prot.21766; Cassereau J, 2011, EXP NEUROL, V227, P31, DOI 10.1016/j.expneurol.2010.09.006; Cassereau J, 2009, NEUROGENETICS, V10, P145, DOI 10.1007/s10048-008-0166-9; Charcot JM, 1886, REV MED-PARIS, V6, P97; DANNELLY HK, 1992, P NATL ACAD SCI USA, V89, P11274, DOI 10.1073/pnas.89.23.11274; Gibson GE, 2000, NEUROCHEM INT, V36, P97, DOI 10.1016/S0197-0186(99)00114-X; Jansen GA, 1997, NEW ENGL J MED, V337, P133, DOI 10.1056/NEJM199707103370215; Khajavi M, 2006, EUR J HUM GENET, V14, P1074, DOI 10.1038/sj.ejhg.5201649; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; McLaughlin HM, 2012, HUM MUTAT, V33, P244, DOI 10.1002/humu.21635; Mendell JT, 2002, SCIENCE, V298, P419, DOI 10.1126/science.1074428; Murphy SM, 2011, J PERIPHER NERV SYST, V16, P191, DOI 10.1111/j.1529-8027.2011.00350.x; Niemann A, 2006, NEUROMOL MED, V8, P217, DOI 10.1385/NMM:8:1:217; Pareyson D, 2006, NEUROMOL MED, V8, P3, DOI 10.1385/NMM:8:1:3; Patzko A, 2011, CURR NEUROL NEUROSCI, V11, P78, DOI 10.1007/s11910-010-0158-7; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Puwanant A., 2011, HEREDITARY MOTOR SEN, P165; Santel A, 2001, J CELL SCI, V114, P867; Saporta ASD, 2011, ANN NEUROL, V69, P22, DOI 10.1002/ana.22166; Tooth HH, 1886, PERONEAL TYPE PROGRE; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Zuchner S, 2006, NEUROMOL MED, V8, P63, DOI 10.1385/NMM:8:1-2:63	23	48	56	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC 7	2012	91	6					1088	1094		10.1016/j.ajhg.2012.09.018	http://dx.doi.org/10.1016/j.ajhg.2012.09.018			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	055LI	23141294	Bronze, Green Published			2022-12-18	WOS:000312417400012
J	Nagamani, SCS; Campeau, PM; Shchelochkov, OA; Premkumar, MH; Guse, K; Brunetti-Pierri, N; Chen, YQ; Sun, Q; Tang, YP; Palmer, D; Reddy, AK; Li, L; Slesnick, TC; Feig, DI; Caudle, S; Harrison, D; Salviati, L; Marini, JC; Bryan, NS; Erez, A; Lee, B				Nagamani, Sandesh C. S.; Campeau, Philippe M.; Shchelochkov, Oleg A.; Premkumar, Muralidhar H.; Guse, Kilian; Brunetti-Pierri, Nicola; Chen, Yuqing; Sun, Qin; Tang, Yaoping; Palmer, Donna; Reddy, Anilkumar K.; Li, Li; Slesnick, Timothy C.; Feig, Daniel I.; Caudle, Susan; Harrison, David; Salviati, Leonardo; Marini, Juan C.; Bryan, Nathan S.; Erez, Ayelet; Lee, Brendan			Nitric-Oxide Supplementation for Treatment of Long-Term Complications in Argininosuccinic Aciduria	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEPENDENT ADENOVIRAL VECTORS; UREA CYCLE DISORDERS; SYNTHASE; LYASE; TETRAHYDROBIOPTERIN; DEFICIENCY; MICE; MECHANISMS; TOLERANCE; VESSELS	Argininosuccinate lyase (ASL) is required for the synthesis and channeling of L-arginine to nitric oxide synthase (NOS) for nitric oxide (NO) production. Congenital ASL deficiency causes argininosuccinic aciduria (ASA), the second most common urea-cycle disorder, and leads to deficiency of both ureagenesis and NO production. Subjects with ASA have been reported to develop long-term complications such as hypertension and neurocognitive deficits despite early initiation of therapy and the absence of documented hyperammonemia. In order to distinguish the relative contributions of the hepatic urea-cycle defect from those of the NO deficiency to the phenotype, we performed liver-directed gene therapy in a mouse model of ASA. Whereas the gene therapy corrected the ureagenesis defect, the systemic hypertension in mice could be corrected by treatment with an exogenous NO source. In an ASA subject with severe hypertension refractory to antihypertensive medications, monotherapy with NO supplements resulted in the long-term control of hypertension and a decrease in cardiac hypertrophy. In addition, the NO therapy was associated with an improvement in some neuropsychological parameters pertaining to verbal memory and nonverbal problem solving. Our data show that ASA, in addition to being a classical urea-cycle disorder, is also a model of congenital human NO deficiency and that ASA subjects could potentially benefit from NO supplementation. Hence, NO supplementation should be investigated for the long-term treatment of this condition.	[Nagamani, Sandesh C. S.; Campeau, Philippe M.; Shchelochkov, Oleg A.; Guse, Kilian; Brunetti-Pierri, Nicola; Chen, Yuqing; Sun, Qin; Palmer, Donna; Erez, Ayelet; Lee, Brendan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Premkumar, Muralidhar H.] Baylor Coll Med, Div Neonatol, Dept Pediat, Houston, TX 77030 USA; [Tang, Yaoping; Bryan, Nathan S.] Univ Texas Hlth Sci Ctr, Brown Fdn Inst Mol Med, Texas Therapeut Inst, Houston, TX 77030 USA; [Reddy, Anilkumar K.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Reddy, Anilkumar K.] Methodist DeBakey Heart & Vasc Ctr, Houston, TX 77030 USA; [Li, Li; Harrison, David] Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA 30322 USA; [Salviati, Leonardo] Univ Padua, Dept Pediat, Clin Genet Unit, I-35128 Padua, Italy; [Marini, Juan C.] ARS, Dept Pediat Nutr, USDA, Childrens Nutr Res Ctr,Baylor Coll Med, Houston, TX 77030 USA; [Chen, Yuqing; Lee, Brendan] Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Emory University; University of Padua; Baylor College of Medicine; United States Department of Agriculture (USDA); Howard Hughes Medical Institute	Lee, B (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	blee@bcm.edu	Campeau, Philippe/J-8614-2015; Brunetti-Pierri, Nicola/K-8465-2016; Salviati, Leonardo/L-1007-2016; Premkumar, Muralidhar/AAX-6868-2020; Reddy, Anilkumar/GLS-1391-2022	Campeau, Philippe/0000-0001-9713-7107; Brunetti-Pierri, Nicola/0000-0002-6895-8819; Salviati, Leonardo/0000-0001-5642-9963; Feig, Daniel/0000-0002-0017-6335; Nagamani, Sandesh/0000-0001-6818-7367	National Institutes of Health [DK54450, RR19453, RR00188, GM90310, GM07526, DK081735, RR024173, HL73041, HL22512]; Baylor College of Medicine Intellectual and Developmental Disabilities Research Center [HD024064]; National Urea Cycle Disorders Foundation; Canadian Institute of Health Research; Urea Cycle Disorders Consortium Rare Diseases Clinical Research Network; Deutsche Forschungsgemeinschaft from the German Research Foundation; Telethon Italy [GGP09207]; Fondazione Cariplo;  [TR01 GM90310]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064, U54HD061221] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011795, K01RR000188, K01RR024173, U54RR019453, UL1RR024148, M01RR000188] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL022512, R01HL022512, K25HL073041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK081735, R01DK054450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090310, T32GM007526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor College of Medicine Intellectual and Developmental Disabilities Research Center; National Urea Cycle Disorders Foundation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Urea Cycle Disorders Consortium Rare Diseases Clinical Research Network; Deutsche Forschungsgemeinschaft from the German Research Foundation(German Research Foundation (DFG)); Telethon Italy(Fondazione Telethon); Fondazione Cariplo(Fondazione Cariplo); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the subject and his family for their kind participation in the study. We acknowledge and thank the clinical efforts of M. Mullins, S. Carter, A. Tran, J. Stuff, and the nursing staff at the General Clinical Research Center at Texas Children's Hospital. We also thank the technical assistance of J. Zhang and H. Garg. This work was supported by the National Institutes of Health (DK54450, RR19453, RR00188, GM90310 to B. Lee, GM07526 and DK081735 to A. Erez, RR024173 to J. Marini, and HL73041 and HL22512 to A.K. Reddy), and the Baylor College of Medicine Intellectual and Developmental Disabilities Research Center (HD024064). S.C.S. Nagamani, O.A. Shchelochkov, and A. Erez are awardees of the National Urea Cycle Disorders Foundation Research Fellowship. P. Campeau is an awardee of the Canadian Institute of Health Research clinician-scientist training award. O.A. Shchelochkov and P. Campeau are awardees of the O'Malley Fellowship of the Urea Cycle Disorders Consortium Rare Diseases Clinical Research Network. K. Guse is supported by Deutsche Forschungsgemeinschaft from the German Research Foundation. N.Bryan is supported in part by subcontract TR01 GM90310. L. Salviati is supported by Telethon Italy grant GGP09207 and by Fondazione Cariplo. Neogenis Labs formulated and donated the nitric oxide dietary supplement for the study. N.S. Bryan and The University of Texas Health Science Center at Houston have financial interests in Neogenis, a company that develops, produces, and sells nitric-oxide-related products intended to improve health, develops diagnostics for nitric oxide-related metabolites, and performs commercial measurement of nitric oxide metabolites in biological samples.	BARBOSA P, 1991, J BIOL CHEM, V266, P5286; Batshaw ML, 2001, J PEDIATR-US, V138, pS46, DOI 10.1067/mpd.2001.111836; Bendall JK, 2005, CIRC RES, V97, P864, DOI 10.1161/01.RES.0000187447.03525.72; Brunetti-Pierri N, 2011, HUM MOL GENET, V20, pR7, DOI 10.1093/hmg/ddr143; Brunetti-Pierri N, 2009, MOL GENET METAB, V98, P195, DOI 10.1016/j.ymgme.2009.06.006; Brusilow SW, 2009, ONLINE METABOLIC MOL; Bryan NS, 2007, FREE RADICAL BIO MED, V43, P645, DOI 10.1016/j.freeradbiomed.2007.04.026; Bryan NS, 2011, NUTR HEALTH SER, P1, DOI 10.1007/978-1-60761-616-0; Bryan NS, 2004, P NATL ACAD SCI USA, V101, P4308, DOI 10.1073/pnas.0306706101; Chataigneau T, 1999, BRIT J PHARMACOL, V126, P219, DOI 10.1038/sj.bjp.0702300; Daiber A, 2010, ADV PHARMACOL, V60, P177, DOI [10.1016/S1054-3589(10)60003-8, 10.1016/B978-0-12-385061-4.00007-6]; Edwards TM, 2007, NEUROSCI BIOBEHAV R, V31, P413, DOI 10.1016/j.neubiorev.2006.11.001; Erez A, 2011, NAT MED, V17, P1619, DOI 10.1038/nm.2544; FAKLER CR, 1995, ACTA PAEDIATR, V84, P460, DOI 10.1111/j.1651-2227.1995.tb13673.x; Ficicioglu C, 2009, MOL GENET METAB, V98, P273, DOI 10.1016/j.ymgme.2009.06.011; Fink B, 2004, AM J PHYSIOL-CELL PH, V287, pC895, DOI 10.1152/ajpcell.00028.2004; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Kim IH, 2001, P NATL ACAD SCI USA, V98, P13282, DOI 10.1073/pnas.241506298; Li L, 2011, ARTERIOSCL THROM VAS, V31, P1547, DOI 10.1161/ATVBAHA.111.226456; Lin MI, 2003, J BIOL CHEM, V278, P44719, DOI 10.1074/jbc.M302836200; Marini JC, 2007, AM J PHYSIOL-ENDOC M, V293, pE1764, DOI 10.1152/ajpendo.00525.2007; Marini JC, 2010, AM J PHYSIOL-ENDOC M, V299, pE69, DOI 10.1152/ajpendo.00080.2010; Marley R, 2000, FREE RADICAL RES, V32, P1, DOI 10.1080/10715760000300011; McBride KL, 2007, MOL GENET METAB, V90, P217, DOI 10.1016/j.ymgme.2006.08.010; Mori M, 2004, J NUTR, V134, p2820S, DOI 10.1093/jn/134.10.2820S; Mori T, 2002, PEDIATR DEVEL PATHOL, V5, P597, DOI 10.1007/s10024-002-0109-7; Palmer D, 2003, MOL THER, V8, P846, DOI 10.1016/j.ymthe.2003.08.014; Palmer DJ, 2004, MOL THER, V10, P792, DOI 10.1016/j.ymthe.2004.06.1013; Palmer Donna J., 2008, V433, P55, DOI 10.1007/978-1-59745-237-3_4; Pickering T.G., 2005, J CLIN HYPERTENS GRE, V7, P690; Pickering Thomas G, 2005, J Clin Hypertens (Greenwich), V7, P685, DOI 10.1111/j.1524-6175.2005.04141.x; Sage PR, 2000, CIRCULATION, V102, P2810; Stokes Gordon S, 2004, J Clin Hypertens (Greenwich), V6, P192, DOI 10.1111/j.1524-6175.2004.03508.x; Stuehr D, 2001, J BIOL CHEM, V276, P14533, DOI 10.1074/jbc.R100011200; Trevisson E, 2007, HUM MUTAT, V28, P694, DOI 10.1002/humu.20498; Tuchman M, 2008, MOL GENET METAB, V94, P397, DOI 10.1016/j.ymgme.2008.05.004; Wang XD, 2006, J BIOL CHEM, V281, P26994, DOI 10.1074/jbc.M603953200; Widder JD, 2007, CIRC RES, V101, P830, DOI 10.1161/CIRCRESAHA.107.153809; Zawada RJX, 2009, BIOCHEM CELL BIOL, V87, P541, DOI [10.1139/O09-011, 10.1139/o09-011]	40	48	49	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 4	2012	90	5					836	846		10.1016/j.ajhg.2012.03.018	http://dx.doi.org/10.1016/j.ajhg.2012.03.018			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	940QG	22541557	Green Published, Bronze			2022-12-18	WOS:000303907500007
J	Torgerson, DG; Capurso, D; Mathias, RA; Graves, PE; Hernandez, RD; Beaty, TH; Bleecker, ER; Raby, BA; Meyers, DA; Barnes, KC; Weiss, ST; Martinez, FD; Nicolae, DL; Ober, C				Torgerson, Dara G.; Capurso, Daniel; Mathias, Rasika A.; Graves, Penelope E.; Hernandez, Ryan D.; Beaty, Terri H.; Bleecker, Eugene R.; Raby, Benjamin A.; Meyers, Deborah A.; Barnes, Kathleen C.; Weiss, Scott T.; Martinez, Fernando D.; Nicolae, Dan L.; Ober, Carole			Resequencing Candidate Genes Implicates Rare Variants in Asthma Susceptibility	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; NATURAL-SELECTION; CHILDHOOD ASTHMA; RESEARCH-PROGRAM; PLASMA-LEVELS; POPULATION; GENETICS; DISEASE; RISK; IDENTIFICATION	Common variation in over 100 genes has been implicated in the risk of developing asthma, but the contribution of rare variants to asthma susceptibility remains largely unexplored. We selected nine genes that showed the strongest signatures of weak purifying selection from among 53 candidate asthma-associated genes, and we sequenced the coding exons and flanking noncoding regions in 450 asthmatic cases and 515 nonasthmatic controls. We observed an overall excess of p values <0.05 (p = 0.02), and rare variants in four genes (AGT DPP10, IKBKAP, and IL12RB1) contributed to asthma susceptibility among African Americans. Rare variants in IL12RB1 were also associated with asthma susceptibility among European Americans, despite the fact that the majority of rare variants in IL12RB1 were specific to either one of the populations. The combined evidence of association with rare noncoding variants in IL12RB1 remained significant (p = 3.7 x 10(-4)) after correcting for multiple testing. Overall, the contribution of rare variants to asthma susceptibility was predominantly due to noncoding variants in sequences flanking the exons, although nonsynonymous rare variants in DPP10 and in IL12RB1 were associated with asthma in African Americans and European Americans, respectively. This study provides evidence that rare variants contribute to asthma susceptibility. Additional studies are required for testing whether prioritizing genes for resequencing on the basis of signatures of purifying selection is an efficient means of identifying novel rare variants that contribute to complex disease.	[Torgerson, Dara G.; Capurso, Daniel; Nicolae, Dan L.; Ober, Carole] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Mathias, Rasika A.; Barnes, Kathleen C.] Johns Hopkins Univ, Dept Med, Baltimore, MD 21218 USA; [Graves, Penelope E.; Martinez, Fernando D.] Univ Arizona, Arizona Resp Ctr, Tucson, AZ 85721 USA; [Graves, Penelope E.; Martinez, Fernando D.] Univ Arizona, Inst BIO5, Tucson, AZ 85721 USA; [Hernandez, Ryan D.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Beaty, Terri H.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Bleecker, Eugene R.; Meyers, Deborah A.] Wake Forest Univ, Sch Med, Ctr Genom, Winston Salem, NC 27157 USA; [Raby, Benjamin A.; Weiss, Scott T.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Raby, Benjamin A.; Weiss, Scott T.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Nicolae, Dan L.] Univ Chicago, Dept Stat, Chicago, IL 60637 USA; [Nicolae, Dan L.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago; Johns Hopkins University; University of Arizona; University of Arizona; University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Wake Forest University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Chicago; University of Chicago	Ober, C (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	c-ober@genetics.uchicago.edu	Raby, Benjamin/AAK-3866-2021	Ober, Carole/0000-0003-4626-9809; Nicolae, Dan/0000-0002-0918-4630	J. Craig Venter Institute (JCVI); National Heart, Lung, and Blood Institute (NHLBI); Mary Beryl Patch Turnbull Scholar Program; NHLBI [N01-HV-48196];  [U01 H149596];  [R01 HL072414];  [RC2 HL101651];  [R01 HL087665];  [U10 H1064307];  [U10 HL064288];  [U10 HL064295];  [U10 HL064287];  [U10 HL064305];  [U10 HL064313];  [U01 HL075419];  [U01 HL65899];  [P01 H1083069];  [R01 HL086601];  [R01 HL69167];  [HL101487];  [R01 HL087699];  [U01 11149612];  [R01 AI50024];  [R01 AI44840]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL083069, U01HL075419, RC2HL101651, R01HL072414, R01HL069167, U01HL049612, U10HL064288, U10HL064307, RC2HL101487, U10HL064305, R01HL087699, U01HL049596, R01HL087665, U10HL064295, U10HL064313, U01HL065899, R01HL086601, U10HL064287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050024, R01AI044840] Funding Source: NIH RePORTER	J. Craig Venter Institute (JCVI); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Mary Beryl Patch Turnbull Scholar Program; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors gratefully acknowledge Dana Busam and Ewen Kirkness at the J. Craig Venter Institute (JCVI), the National Heart, Lung, and Blood Institute (NHLBI)-funded Resequencing and Genotyping Service at the JCVI, and all of the patients, investigators, coordinators, and research teams for the CAMP (Childhood Asthma Management Program) Genetic Ancillary Study, the Childhood Asthma Research and Education network, the Severe Asthma Research Program network, the Collaborative Studies on the Genetics of Asthma study, and the Genomic Research on Asthma in the African Diaspora study. These studies were supported by U01 H149596 and R01 HL072414 to C.O.; RC2 HL101651 to C.O. and D.L.N.; R01 HL087665 to D.L.N.; U10 H1064307, U10 HL064288, U10 HL064295, U10 HL064287, U10 HL064305, and U10 HL064313 to F.D.M.; U01 HL075419, U01 HL65899, P01 H1083069, R01 HL086601, and RC2 HL101651 to S.T.W.; R01 HL69167 and HL101487 to D.A.M. and E.R.B.; and R01 HL087699, U01 11149612, R01 AI50024, and R01 AI44840 to K.C.B. K.C.B. was supported in part by the Mary Beryl Patch Turnbull Scholar Program. Resequencing services were provided by the JCVI under U.S. Federal Government contract number N01-HV-48196 from the NHLBI.	AGRESTI A, 2007, WILEY SERIES PROBABI; Allen M, 2003, NAT GENET, V35, P258, DOI 10.1038/ng1256; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Blekhman R, 2008, CURR BIOL, V18, P883, DOI 10.1016/j.cub.2008.04.074; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Bustamante CD, 2002, NATURE, V416, P531, DOI 10.1038/416531a; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Guilbert TW, 2004, CONTROL CLIN TRIALS, V25, P286, DOI 10.1016/j.cct.2004.03.002; Hancock DB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000623; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Hirota T, 2011, NAT GENET, V43, P893, DOI 10.1038/ng.887; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Lester LA, 2001, J ALLERGY CLIN IMMUN, V108, P357, DOI 10.1067/mai.2001.117796; Li X, 2010, J ALLERGY CLIN IMMUN, V125; Mathias RA, 2010, J ALLERGY CLIN IMMUN, V125; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Moore WC, 2007, J ALLERGY CLIN IMMUN, V119, P405, DOI 10.1016/j.jaci.2006.11.639; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Ober C, 2006, GENES IMMUN, V7, P95, DOI 10.1038/sj.gene.6364284; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Ober C, 2011, IMMUNOL REV, V242, P10, DOI 10.1111/j.1600-065X.2011.01029.x; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Proceedings of the ATS workshop on refractory asthma, 2000, AM J RESP CRIT CARE, V162, P2341, DOI DOI 10.1164/AJRCCM.162.6.ATS9-00; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Sankararaman S, 2008, AM J HUM GENET, V82, P290, DOI 10.1016/j.ajhg.2007.09.022; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Torgerson DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000592; Tzetis M, 2001, HUM GENET, V108, P216, DOI 10.1007/s004390100467; Vercelli D, 2008, J ALLERGY CLIN IMMUN, V122, P267, DOI 10.1016/j.jaci.2008.06.008; Worldwide variations in the prevalence of asthma symptoms: The International Study of Asthma and Allergies in Childhood (ISAAC), EUR RESP J, V12, P315; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; 1986, AM REV RESP DIS, V136, P225	43	48	48	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB 10	2012	90	2					273	281		10.1016/j.ajhg.2012.01.008	http://dx.doi.org/10.1016/j.ajhg.2012.01.008			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	898KV	22325360	Green Published, Bronze			2022-12-18	WOS:000300742200007
J	So, HC; Kwan, JSH; Cherny, SS; Sham, PC				So, Hon-Cheong; Kwan, Johnny S. H.; Cherny, Stacey S.; Sham, Pak C.			Risk Prediction of Complex Diseases from Family History and Known Susceptibility Loci, with Applications for Cancer Screening	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BREAST-CANCER; PROSTATE-CANCER; GENETIC SUSCEPTIBILITY; INHERITANCE; MODEL; ASSOCIATION; LIABILITY; UPDATE; AGE; PROBABILITIES	Risk prediction based on genomic profiles has raised a lot of attention recently. However, family history is usually ignored in genetic risk prediction. In this study we proposed a statistical framework for risk prediction given an individual's genotype profile and family history. Genotype information about the relatives can also be incorporated. We allow risk prediction given the current age and follow-up period and consider competing risks of mortality. The framework allows easy extension to any family size and structure. In addition, the predicted risk at any percentile and the risk distribution graphs can be computed analytically. We applied the method to risk prediction for breast and prostate cancers by using known susceptibility loci from genome-wide association studies. For breast cancer, in the population the 10-year risk at age 50 ranged from 1.1% at the 5th percentile to 4.7% at the 95th percentile. If we consider the average 10-year risk at age 50 (2.39%) as the threshold for screening, the screening age ranged from 62 at the 20th percentile to 38 at the 95th percentile (and some never reach the threshold). For women with one affected first-degree relative, the 10-year risks ranged from 2.6% (at the 5th percentile) to 8.1% (at the 95th percentile). For prostate cancer, the corresponding 10-year risks at age 60 varied from 1.8% to 14.9% in the population and from 4.2% to 23.2% in those with an affected first-degree relative. We suggest that for some diseases genetic testing that incorporates family history can stratify people into diverse risk categories and might be useful in targeted prevention and screening.	[So, Hon-Cheong; Kwan, Johnny S. H.; Cherny, Stacey S.; Sham, Pak C.] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Cherny, Stacey S.; Sham, Pak C.] Univ Hong Kong, Genome Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Cherny, Stacey S.; Sham, Pak C.] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Sham, PC (corresponding author), Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China.	pcsham@hkucc.hku.hk	Cherny, Stacey S/B-3315-2008; So, Hon-Cheong/I-1100-2016	Cherny, Stacey S/0000-0002-0269-3352; So, Hon-Cheong/0000-0002-7102-833X	Hong Kong Research Grants Council [HKU 766906M, HKU 774707M]; European Community [HEALTH-F2-2010-241909]; University of Hong Kong Strategic Research Theme of Genomics; Croucher Foundation	Hong Kong Research Grants Council(Hong Kong Research Grants Council); European Community(European Commission); University of Hong Kong Strategic Research Theme of Genomics; Croucher Foundation	The work was supported by the Hong Kong Research Grants Council General Research Fund (HKU 766906M and HKU 774707M), the European Community's Seventh Framework Programme under grant agreement No. HEALTH-F2-2010-241909 (Project EU-GEI), and the University of Hong Kong Strategic Research Theme of Genomics. H.-C.S. was supported by a Croucher Foundation Scholarship. The work was supported by the Hong Kong Research Grants Council General Research Fund.	Aitken, 1934, P EDINBURGH MATH SOC, V4, P106, DOI [DOI 10.1017/S0013091500008063, 10.1017/S0013091500008063]; American Cancer Society, 2010, DET GUID BREAST CANC; Amir E, 2010, JNCI-J NATL CANCER I, V102, P680, DOI 10.1093/jnci/djq088; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2004, BRIT J CANCER, V91, P1580, DOI 10.1038/sj.bjc.6602175; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; CLAUS EB, 1994, CANCER, V73, P643, DOI 10.1002/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; CURNOW RN, 1972, BIOMETRICS, V28, P931, DOI 10.2307/2528630; De Greve J, 2008, CURR OPIN ONCOL, V20, P605, DOI 10.1097/CCO.0b013e3283139173; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; FALCONER DS, 1967, ANN HUM GENET, V31, P1; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Gail MH, 2005, BIOSTATISTICS, V6, P227, DOI 10.1093/biostatistics/kxi005; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gail MH, 1999, J NATL CANCER I, V91, P1829, DOI 10.1093/jnci/91.21.1829; Garner C, 2007, GENET EPIDEMIOL, V31, P288, DOI 10.1002/gepi.20209; Genz A., 1992, J COMPUT GRAPH STAT, V1, P141, DOI [10.2307/1390838, DOI 10.1080/10618600.1992.10477010]; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Johnson RA, 2007, APPL MULTIVARIATE ST; Kerlikowske K, 1996, JAMA-J AM MED ASSOC, V276, P33, DOI 10.1001/jama.276.1.33; Lewis CM, 2007, J MED GENET, V44, P689, DOI 10.1136/jmg.2007.051672; Lin K, 2008, ANN INTERN MED, V149, P192, DOI 10.7326/0003-4819-149-3-200808050-00009; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Mavaddat N, 2010, MOL ONCOL, V4, P174, DOI 10.1016/j.molonc.2010.04.011; MENDELL NR, 1974, BIOMETRICS, V30, P41, DOI 10.2307/2529616; National Institute for Health and Clinical Excellence (NICE), 2010, 41 NICE; NCCN, 2011, CLIN PRACT GUID ONC; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Nelson HD, 2009, ANN INTERN MED, V151, P703, DOI [10.7326/0000605-200911170-00147, 10.7326/0003-4819-151-10-200911170-00147]; Parmigiani G, 1998, AM J HUM GENET, V62, P145, DOI 10.1086/301670; Pearson K, 1903, PHILOS T R SOC LOND, V200, P1, DOI 10.1098/rsta.1903.0001; Pepe MS, 2008, JNCI-J NATL CANCER I, V100, P978, DOI 10.1093/jnci/djn215; Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739; Rembold CM, 1998, BMJ-BRIT MED J, V317, P307, DOI 10.1136/bmj.317.7154.307; Ripperger T, 2009, EUR J HUM GENET, V17, P722, DOI 10.1038/ejhg.2008.212; Ruderfer DM, 2010, GENOME MED, V2, DOI 10.1186/gm123; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; SMITH C, 1971, AM J HUM GENET, V23, P578; So H.C., 2011, GENET EPIDEMIOL; So HC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001230; So HC, 2010, HUM HERED, V70, P205, DOI 10.1159/000319192; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Tyrer J, 2004, STAT MED, V23, P1111, DOI 10.1002/sim.1668; US Preventive Serv Task Force, 2008, ANN INTERN MED, V149, P185, DOI 10.7326/0003-4819-149-3-200808050-00008; van Asperen CJ, 2004, CANCER EPIDEM BIOMAR, V13, P87, DOI 10.1158/1055-9965.EPI-03-0090; Wolf AMD, 2010, CA-CANCER J CLIN, V60, P70, DOI 10.3322/caac.20066; YASHIN AI, 1995, GENET EPIDEMIOL, V12, P529, DOI 10.1002/gepi.1370120510; Zollner S, 2007, AM J HUM GENET, V80, P605, DOI 10.1086/512821	51	48	49	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 13	2011	88	5					548	565		10.1016/j.ajhg.2011.04.001	http://dx.doi.org/10.1016/j.ajhg.2011.04.001			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	767CE	21529750	Green Published, Bronze			2022-12-18	WOS:000290832100003
J	Kaufmann, R; Straussberg, R; Mandel, H; Fattal-Valevski, A; Ben-Zeev, B; Naamati, A; Shaag, A; Zenvirt, S; Konen, O; Mimouni-Bloch, A; Dobyns, WB; Edvardson, S; Pines, O; Elpeleg, O				Kaufmann, Rami; Straussberg, Rachel; Mandel, Hanna; Fattal-Valevski, Aviva; Ben-Zeev, Bruria; Naamati, Adi; Shaag, Avraham; Zenvirt, Shamir; Konen, Osnat; Mimouni-Bloch, Aviva; Dobyns, William B.; Edvardson, Simon; Pines, Ophry; Elpeleg, Orly			Infantile Cerebral and Cerebellar Atrophy Is Associated with a Mutation in the MED17 Subunit of the Transcription Preinitiation Mediator Complex	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								Primary microcephaly of postnatal onset is a feature of many neurological disorders, mostly associated with mental retardation seizures, and spasticity, and it typically carries a grave prognosis Five infants from four unrelated families of Caucasus Jewish origin presented soon after birth with spasticity, epilepsy and profound psychomotor retardation Head circumference percentiles declined, and brain MRI disclosed marked cereberal and cerebellar atrophy with severe myelination defect A search for a common homozygous region revealed a 2 28 Mb genomic segment on chromosome 11 that encompassed 16 protein coding genes A missense mutation in one of them, MEDI 7, segregated with I he disease state in the families and was carried by four of 79 anonymous Caucasus Jews A corresponding mutation in the homologous S cerevisiae gene SRB4 inactivated the protein according to complementation assays Screening of MED17 in additional patients with similar clinical and radiologic findings revealed four more patients, all homozygous for the p L371P mutation and all originating from Caucasus Jewish families We conclude that the p L371P mutation in MEDI 7 is a founder mutation in the Caucasus Jewish community and that homozygosity for this mutation is associated with infantile cerebral and cerebellar atrophy with poor myelination	[Kaufmann, Rami; Shaag, Avraham; Zenvirt, Shamir; Edvardson, Simon; Elpeleg, Orly] Hadassah Hebrew Univ Med Ctr, Monique & Jacques Roboh Dept Genet Res, IL-91120 Jerusalem, Israel; [Kaufmann, Rami; Shaag, Avraham; Zenvirt, Shamir; Edvardson, Simon; Elpeleg, Orly] Hadassah Hebrew Univ Med Ctr, Dept Genet & Metab Dis, IL-91120 Jerusalem, Israel; [Kaufmann, Rami; Straussberg, Rachel] Schneider Children Med Ctr, Neurogenet Clin, Dept Child Neurol, IL-49202 Petah Tiqwa, Israel; [Kaufmann, Rami; Straussberg, Rachel; Fattal-Valevski, Aviva; Ben-Zeev, Bruria; Konen, Osnat] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Mandel, Hanna] Technion Israel Inst Technol, Rambam Med Ctr, Metab Unit, Meyer Childrens Hosp,Fac Med, IL-33705 Haifa, Israel; [Fattal-Valevski, Aviva] Dana Childrens Hosp, Pediat Neurol Unit, Tel Aviv Sourasky Med Ctr, IL-64239 Tel Aviv, Israel; [Ben-Zeev, Bruria] Edmond & Lilly Safra Pediat Hosp, Pediat Neurol Unit, Chaim Sheba Med Ctr, IL-52621 Ramat Gan, Israel; [Naamati, Adi; Pines, Ophry] Hebrew Univ Jerusalem, Dept Microbiol & Mol Genet, IMRIC, Fac Med Hadassah, IL-91120 Jerusalem, Israel; [Konen, Osnat] Schneider Children Med Ctr, Dept Imaging, IL-49202 Petah Tiqwa, Israel; [Mimouni-Bloch, Aviva] Loewenstein Hosp & Rehabil Ctr, IL-43100 Raanana, Israel; [Dobyns, William B.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine; Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Chaim Sheba Medical Center; Hebrew University of Jerusalem; University of Chicago	Elpeleg, O (corresponding author), Hadassah Hebrew Univ Med Ctr, Monique & Jacques Roboh Dept Genet Res, IL-91120 Jerusalem, Israel.		Dobyns, William/AAI-2768-2020; Dobyns, William Brian/ABC-6525-2021; pines, ophry/C-4086-2011	Dobyns, William/0000-0002-7681-2844; Edvardson, Simon/0000-0003-2878-1278; Naamati, Adi/0000-0001-6989-3634; Mimouni Bloch, Aviva/0000-0001-6457-0262; pines, ophry/0000-0001-7126-2575				Boube M, 2000, GENE DEV, V14, P2906, DOI 10.1101/gad.17900; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; Kaindl AM, 2010, PROG NEUROBIOL, V90, P363, DOI 10.1016/j.pneurobio.2009.11.002; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Leal A, 2009, NEUROGENETICS, V10, P275, DOI 10.1007/s10048-009-0183-3; Risheg H, 2007, NAT GENET, V39, P451, DOI 10.1038/ng1992; Schwartz CE, 2007, J MED GENET, V44, P472, DOI 10.1136/jmg.2006.048637; Seelow D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003874; THOMPSON CM, 1995, P NATL ACAD SCI USA, V92, P4587, DOI 10.1073/pnas.92.10.4587; van Essen D, 2009, PLOS BIOL, V7, P549, DOI 10.1371/journal.pbio.1000073	10	48	52	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 12	2010	87	5					667	670		10.1016/j.ajhg.2010.09.016	http://dx.doi.org/10.1016/j.ajhg.2010.09.016			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	686AE	20950787	Bronze, Green Published			2022-12-18	WOS:000284668400012
J	Verzilli, C; Shah, T; Casas, JP; Chapman, J; Sandhu, M; Debenham, SL; Boekholdt, MS; Khaw, KT; Wareham, NJ; Judson, R; Benjamin, EJ; Kathiresan, S; Larson, MG; Rong, J; Sofat, R; Humphries, SE; Smeeth, L; Cavalleri, G; Whittaker, JC; Hingorani, AD				Verzilli, Claudio; Shah, Tina; Casas, Juan P.; Chapman, Juliet; Sandhu, Manjinder; Debenham, Sally L.; Boekholdt, Matthijs S.; Khaw, Kay Tee; Wareham, Nicholas J.; Judson, Richard; Benjamin, Emelia J.; Kathiresan, Sekar; Larson, Martin G.; Rong, Jian; Sofat, Reecha; Humphries, Steve E.; Smeeth, Liam; Cavalleri, Gianpiero; Whittaker, John C.; Hingorani, Aroon D.			Bayesian meta-analysis of genetic association studies with different sets of markers	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							C-REACTIVE PROTEIN; GENOME-WIDE ASSOCIATION; CORONARY-HEART-DISEASE; MENDELIAN RANDOMIZATION; COMPLEX DISEASES; POLYMORPHISMS; EPIDEMIOLOGY; DESIGNS; COHORT; MODEL	Robust assessment of genetic effects on quantitative traits or complex-disease risk requires synthesis of evidence from multiple studies. Frequently, studies have genotyped partially overlapping sets of SNPs within a gene or region of interest, hampering attempts to combine all the available data. By using the example of C-reactive protein (CRP) as a quantitative trait, we show how linkage disequilibrium in and around its gene facilitates use of Bayesian hierarchical models to integrate informative data from all available genetic association studies of this trait, irrespective of the SNP typed. A variable selection scheme, followed by contextualization of SNPs exhibiting independent associations within the haplotype structure of the gene, enhanced our ability to infer likely causal variants in this region with population-scale data. This strategy, based on data from a literature based systematic review and substantial new genotyping, facilitated the most comprehensive evaluation to date of the role of variants governing CRP levels, providing important information on the minimal subset of SNPs necessary for comprehensive evaluation of the likely causal relevance of elevated CRP levels for coronary-heart-disease risk by Mendelian randomization. The same method could be applied to evidence synthesis of other quantitative traits, whenever the typed SNPs vary among studies, and to assist fine mapping of causal variants.	[Verzilli, Claudio; Casas, Juan P.; Chapman, Juliet; Smeeth, Liam; Whittaker, John C.] Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; [Shah, Tina; Sofat, Reecha; Hingorani, Aroon D.] UCL, Ctr Clin Pharmacol, London WC1E 6JF, England; [Debenham, Sally L.; Khaw, Kay Tee] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England; [Boekholdt, Matthijs S.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1100 DD Amsterdam, Netherlands; [Wareham, Nicholas J.] Univ Cambridge, MRC Epidemiol Unit, Cambridge CB2 0QQ, England; [Judson, Richard] Genaissance Pharmaceut, New Haven, CT 06511 USA; [Benjamin, Emelia J.; Kathiresan, Sekar; Larson, Martin G.; Rong, Jian] Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA; [Humphries, Steve E.] UCL, Ctr Cardiovasc Genet, London WC1E 6JF, England; [Cavalleri, Gianpiero] Royal Coll Surgeons Ireland, Res Inst, Dublin 2, Ireland	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of Cambridge; University of Amsterdam; Academic Medical Center Amsterdam; University of Cambridge; Framingham Heart Study; University of London; University College London; Royal College of Surgeons - Ireland	Whittaker, JC (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England.	john.whittaker@lshtm.ac.uk	Boekholdt, Matthijs S.M./G-7562-2014; Khaw, Kay-Tee/AAZ-3209-2021; Humphries, Stephen E/C-5075-2008; Whittaker, John C/B-8609-2012; Cavalleri, Gianpiero/A-6632-2010; Smeeth, Liam/X-5862-2018; Benjamin, Emelia/E-7103-2011	Whittaker, John C/0000-0002-3529-2379; Shah, Tina/0000-0001-7724-7210; Hingorani, Aroon/0000-0001-8365-0081; Cavalleri, Gianpiero/0000-0002-9802-0506; Boekholdt, Matthijs/0000-0002-0861-0765; Smeeth, Liam/0000-0002-9168-6022; Benjamin, Emelia/0000-0003-4076-2336; Judson, Richard/0000-0002-2348-9633; Ricketts, Sally/0000-0002-5644-7958; Sofat, Reecha/0000-0002-0242-6115; Humphries, Stephen E/0000-0002-8221-6547; Larson, Martin/0000-0002-9631-1254	MRC [G0601942, G0600580] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/C509382/1] Funding Source: researchfish; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028321] Funding Source: NIH RePORTER; British Heart Foundation [PG2000/015, FS/02/086/14760, FS/05/125] Funding Source: Medline; Medical Research Council [G0601942, G0600580, MC_U106179471, G0401527] Funding Source: Medline; NHLBI NIH HHS [HL076784, N01-HC 25195, R01 HL076784, N01HC25195] Funding Source: Medline; NIA NIH HHS [AG028321, R01 AG028321] Funding Source: Medline; PHS HHS [GR076024] Funding Source: Medline; Wellcome Trust [082178] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); Wellcome Trust(Wellcome Trust)		BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Besag J, 1995, BIOMETRIKA, V82, P733, DOI 10.2307/2337341; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cambon-Thomsen A, 2003, NAT GENET, V34, P25, DOI 10.1038/ng0503-25b; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; CARLIN BP, 2002, BAYES EMPIRICAL BAYE; Carlson CS, 2005, AM J HUM GENET, V77, P64, DOI 10.1086/431366; Cirulli ET, 2007, HUM MOL GENET, V16, P1931, DOI 10.1093/hmg/ddm140; Clayton D, 2001, LANCET, V358, P1356, DOI 10.1016/S0140-6736(01)06418-2; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Day N, 1999, BRIT J CANCER, V80, P95; Denison D.G.T., 2002, BAYESIAN METHODS NON; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dominici F, 1999, J AM STAT ASSOC, V94, P16, DOI 10.2307/2669674; DUMOUCHEL WH, 1990, STAT METHODOLOGY PHA; Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.2307/2337340; Herbert A, 2007, NAT GENET, V39, P135, DOI 10.1038/ng0207-135; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hingorani A, 2005, LANCET, V366, P1906, DOI 10.1016/S0140-6736(05)67767-7; Hingorani AD, 2006, EUR HEART J, V27, P1261, DOI 10.1093/eurheartj/ehi852; Hirschfield GM, 2003, QJM-INT J MED, V96, P793, DOI 10.1093/qjmed/hcg134; Ioannidis JPA, 2006, GENET MED, V8, P583, DOI 10.1097/01.gim.0000237775.93658.0c; Ioannidis JPA, 2006, NAT GENET, V38, P3, DOI 10.1038/ng0106-3; Kardys I, 2006, EUR HEART J, V27, P1331, DOI 10.1093/eurheartj/ehl018; Kelsall J., 1999, BAYESIAN STAT; Lawson A., 2001, STAT METHODS SPATIAL; Little J, 2002, AM J EPIDEMIOL, V156, P300, DOI 10.1093/oxfordjournals.aje.a000179; Lunn DJ, 2006, GENET EPIDEMIOL, V30, P231, DOI 10.1002/gepi.20140; MacGregor AJ, 2004, CLIN CHEM, V50, P130, DOI 10.1373/clinchem.2003.028258; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Normand SLT, 1999, STAT MED, V18, P321, DOI 10.1002/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P; OHagan A., 2004, KENDALLS ADV THEOR B, V2B; Parent O, 2005, J REGIONAL SCI, V45, P747, DOI 10.1111/j.0022-4146.2005.00391.x; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Seminara D, 2007, EPIDEMIOLOGY, V18, P1, DOI 10.1097/01.ede.0000249540.17855.b7; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Thomas DC, 2004, STAT METHODS GENETIC; Verzilli CJ, 2005, J R STAT SOC C-APPL, V54, P191, DOI 10.1111/j.1467-9876.2005.00478.x; Wareham NJ, 1997, BRIT J NUTR, V78, P889, DOI 10.1079/BJN19970207; Zeggini E, 2005, NAT GENET, V37, P1320, DOI 10.1038/ng1670	42	48	49	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2008	82	4					859	872		10.1016/j.ajhg.2008.01.016	http://dx.doi.org/10.1016/j.ajhg.2008.01.016			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	290DQ	18394581	Green Published, Bronze			2022-12-18	WOS:000255103900005
J	Lu, Q; Elston, RC				Lu, Qing; Elston, Robert C.			Using the optimal receiver operating characteristic curve to design a predictive genetic test, exemplified with type 2 diabetes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; COMPLEX DISEASES; MEDICINE; RISK; LOCI	Current extensive genetic research into common complex diseases, especially with the completion of genome-wide association studies, is bringing to light many novel genetic risk loci. These new discoveries, along with previously known genetic risk variants, offer an important opportunity for researchers to improve health care. We describe a method of quick evaluation of these new findings for potential clinical practice by designing a new predictive genetic test, estimating its classification accuracy, and determining the sample size required for the verification of this accuracy. The proposed predictive test is asymptotically more powerful than tests built on any other existing method and can be extended to scenarios where loci are linked or interact. We illustrate the approach for the case of type 2 diabetes. We incorporate recently discovered risk factors into the proposed test and find a potentially better predictive genetic test. The area under the receiver operating characteristic (ROC) curve (AUC) of the proposed test is estimated to be higher (AUC = 0.671) than for the existing test (AUC = 0.580).	[Lu, Qing; Elston, Robert C.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA	Case Western Reserve University	Elston, RC (corresponding author), Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA.	rce@darwin.case.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028356, R01GM028356] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR003655, RR03655] Funding Source: Medline; NIGMS NIH HHS [R01 GM028356, R37 GM028356, GM28356] Funding Source: Medline; PHS HHS [P30CAD43703] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Baker SG, 2000, BIOMETRICS, V56, P1082, DOI 10.1111/j.0006-341X.2000.01082.x; Beaudet AL, 1999, AM J HUM GENET, V64, P1, DOI 10.1086/302217; Bell J, 1998, BMJ-BRIT MED J, V316, P618, DOI 10.1136/bmj.316.7131.618; Bookman EB, 2006, AM J MED GENET A, V140A, P1033, DOI 10.1002/ajmg.a.31195; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Christensen K, 2007, NEW ENGL J MED, V356, P1094, DOI 10.1056/NEJMp068126; Collins FS, 1999, NEW ENGL J MED, V341, P28, DOI 10.1056/NEJM199907013410106; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; EGAN JP, 1975, SIGNAL DETECTION ROC; Epstein CJ, 2006, AM J HUM GENET, V79, P434, DOI 10.1086/507610; Evans JP, 2001, BMJ-BRIT MED J, V322, P1052, DOI 10.1136/bmj.322.7293.1052; Gorelick R, 2004, GENETICS, V166, P1581, DOI 10.1534/genetics.166.3.1581; Green DM., 1966, SIGNAL DETECTION THE; HANLEY JA, 1989, CRIT REV DIAGN IMAG, V29, P307; Hastie T., 2001, ELEMENTS STAT LEARNI, P236, DOI DOI 10.1007/978-0-387-21606-5; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Janssens ACJW, 2006, EUR J EPIDEMIOL, V21, P869, DOI 10.1007/s10654-006-9084-z; Janssens ACJW, 2004, AM J HUM GENET, V74, P585, DOI 10.1086/382052; JONES M, 2000, NY TIMES        0611, P80; Khoury MJ, 2003, GENET MED, V5, P261, DOI 10.1097/01.GIM.0000076977.90682.A5; LUSTED LB, 1971, SCIENCE, V171, P1217, DOI 10.1126/science.171.3977.1217; Lyssenko V, 2005, DIABETES, V54, P166, DOI 10.2337/diabetes.54.1.166; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; MCCLISH DK, 1989, MED DECIS MAKING, V9, P190, DOI 10.1177/0272989X8900900307; McIntosh MW, 2002, BIOMETRICS, V58, P657, DOI 10.1111/j.0006-341X.2002.00657.x; Pepe M.S., 2003, STAT EVALUATION MED; Pepe MS, 2006, BIOMETRICS, V62, P221, DOI 10.1111/j.1541-0420.2005.00420.x; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Vineis P, 2001, LANCET, V357, P709, DOI 10.1016/S0140-6736(00)04136-2; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; Weinstein MC, 1980, CLIN DECISION ANAL; Yang QH, 2004, AM J HUM GENET, V74, P588, DOI 10.1086/382054; Yang QH, 2003, AM J HUM GENET, V72, P636, DOI 10.1086/367923; Yiannakouris N, 2006, EUR J EPIDEMIOL, V21, P859, DOI 10.1007/s10654-006-9070-5; ZWEIG MH, 1993, CLIN CHEM, V39, P561	36	48	50	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2008	82	3					641	651		10.1016/j.ajhg.2007.12.025	http://dx.doi.org/10.1016/j.ajhg.2007.12.025			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	275JN	18319073	Bronze, Green Published			2022-12-18	WOS:000254067800009
J	Clarimon, J; Scholz, S; Fung, HC; Hardy, J; Eerola, J; Hellstrom, O; Chen, CM; Wu, YR; Tienari, PJ; Singleton, A				Clarimon, J; Scholz, S; Fung, HC; Hardy, J; Eerola, J; Hellstrom, O; Chen, CM; Wu, YR; Tienari, PJ; Singleton, A			Conflicting results regarding the semaphorin gene (SEMA5A) and the risk for Parkinson disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									NIA, Mol Genet Sect, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; Chang Gung Univ, Chang Gung Mem Hosp, Dept Neurol, Taipei, Taiwan; Chang Gung Univ, Coll Med, Taipei, Taiwan; Univ Helsinki, Cent Hosp, Dept Neurol, FIN-00014 Helsinki, Finland; Univ Helsinki, Biomedicum, Neurosci Programme, FIN-00014 Helsinki, Finland; Seinajoki Cent Hosp, Dept Neurol, Seinajoki, Finland	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Seinajoki Central Hospital	Clarimon, J (corresponding author), NIA, Mol Genet Sect, Neurogenet Lab, NIH, Bldg 35,Room 1A1000,MSC 3707,35 Lincoln Dr, Bethesda, MD 20892 USA.	jclarimon@santpau.es	Tienari, Pentti J/A-4893-2012; Singleton, Andrew B/C-3010-2009; Scholz, Sonja W./R-5524-2017; Sander-Effron, Samuel/AAX-2231-2020; Scholz, Sonja/AAN-6601-2021; Hardy, John/C-2451-2009; Resource Center, NINDS Human Genetics/AGF-2474-2022	Scholz, Sonja W./0000-0002-6623-0429; Scholz, Sonja/0000-0002-6623-0429; Hardy, John/0000-0002-3122-0423; Clarimon, Jordi/0000-0002-6824-6942	Intramural NIH HHS Funding Source: Medline; Medical Research Council [G0701075] Funding Source: Medline; Parkinson&apos;s UK [G-0907] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [Z01AG000957, Z01AG000952] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Parkinson&apos;s UK(Parkinson&apos;s UK); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378	5	48	50	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2006	78	6					1082	1084		10.1086/504727	http://dx.doi.org/10.1086/504727			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	042TZ	16685660	Green Published, Bronze			2022-12-18	WOS:000237553800019
J	van der Maarel, SM; Frants, RR				van der Maarel, SM; Frants, RR			The D4Z4 repeat-mediated pathogenesis of facioscapulohumeral muscular dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							MENTAL-RETARDATION; DNA REARRANGEMENTS; SOMATIC MOSAICISM; 4Q SUBTELOMERE; ICF SYNDROME; HUMAN GENOME; FSHD; GENE; DISEASE; KB		Leiden Univ, Med Ctr, Ctr Human & Clin Genet, NL-2333 AL Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van der Maarel, SM (corresponding author), Leiden Univ, Med Ctr, Ctr Human & Clin Genet, NL-2333 AL Leiden, Netherlands.	maarel@lumc.nl	van der Maarel, Silvere/X-3631-2018	van der Maarel, Silvere/0000-0001-8103-711X				AGRESTI A, 1989, J MOL BIOL, V205, P625, DOI 10.1016/0022-2836(89)90308-2; BAKKER E, 1995, MUSCLE NERVE, pS39; Bakker E, 1996, J MED GENET, V33, P29, DOI 10.1136/jmg.33.1.29; Ballarati L, 2002, GENE, V296, P21, DOI 10.1016/S0378-1119(02)00858-2; Bin Sun H, 2000, BIOPHYS J, V79, P184, DOI 10.1016/S0006-3495(00)76282-5; Coppee F, 2004, FSHD - FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY: CLINICAL MEDICINE AND MOLECULAR CELL BIOLOGY, P117; DEIDDA G, 1995, EUR J HUM GENET, V3, P155; Deidda G, 1996, J MED GENET, V33, P361, DOI 10.1136/jmg.33.5.361; Ehrlich M, 2003, CLIN IMMUNOL, V109, P17, DOI 10.1016/S1521-6616(03)00201-8; Flint J, 1997, HUM MOL GENET, V6, P1305, DOI 10.1093/hmg/6.8.1305; FRANCIS F, 1994, SIGHT SOUND, V4, P3; Funakoshi M, 1998, NEUROLOGY, V50, P1791, DOI 10.1212/WNL.50.6.1791; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Gerlich D, 2003, CELL, V112, P751, DOI 10.1016/S0092-8674(03)00189-2; GILBERT JR, 1992, AM J HUM GENET, V51, P424; GILBERT JR, 1993, AM J HUM GENET, V53, P401; Goto K, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.008755; GRIGGS RC, 1993, NEUROLOGY, V43, P2369, DOI 10.1212/WNL.43.11.2369; Jiang GC, 2003, HUM MOL GENET, V12, P2909, DOI 10.1093/hmg/ddg323; Kohler J, 1996, HUM GENET, V98, P485, DOI 10.1007/s004390050244; Kondo T, 2000, HUM MOL GENET, V9, P597, DOI 10.1093/hmg/9.4.597; Lee C, 1997, HUM GENET, V100, P291, DOI 10.1007/s004390050508; LEE JH, 1995, MUSCLE NERVE, pS6; Lemmers RJFL, 2004, AM J HUM GENET, V75, P1124, DOI 10.1086/426035; Lemmers RJLF, 2004, FSHD - FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY: CLINICAL MEDICINE AND MOLECULAR CELL BIOLOGY, P211; Lemmers RJLF, 2004, AM J HUM GENET, V75, P44, DOI 10.1086/422175; Lemmers RJLF, 2004, ANN NEUROL, V55, P845, DOI 10.1002/ana.20106; Lemmers RJLF, 2003, NEUROLOGY, V61, P178, DOI 10.1212/01.WNL.0000078889.51444.81; Lemmers RJLF, 2002, NAT GENET, V32, P235, DOI 10.1038/ng999; Lemmers RJLF, 1998, HUM MOL GENET, V7, P1207, DOI 10.1093/hmg/7.8.1207; Lernmers RJLF, 2001, ANN NEUROL, V50, P816, DOI 10.1002/ana.10057; LUNT PW, 1995, HUM MOL GENET, V4, P951, DOI 10.1093/hmg/4.5.951; LYLE R, 1995, GENOMICS, V28, P389, DOI 10.1006/geno.1995.1166; MARALDI NM, 2004, J CELL PHYSL; Masny PS, 2004, HUM MOL GENET, V13, P1857, DOI 10.1093/hmg/ddh205; Matsumura T, 2002, BMC NEUROL, V2, DOI 10.1186/1471-2377-2-7; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Mefford HC, 2002, NAT REV GENET, V3, P91, DOI 10.1038/nrg727; Miura K, 1998, NEUROPEDIATRICS, V29, P239, DOI 10.1055/s-2007-973568; Padberg G W, 1991, Neuromuscul Disord, V1, P231, DOI 10.1016/0960-8966(91)90094-9; Padberg GW, 2004, FSHD - FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY: CLINICAL MEDICINE AND MOLECULAR CELL BIOLOGY, P41; Padberg GW, 1982, THESIS LEIDEN U LEID; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; Stout K, 1999, CHROMOSOME RES, V7, P323, DOI 10.1023/A:1009287111661; Tam R, 2004, J CELL BIOL, V167, P269, DOI 10.1083/jcb.200403128; Tanabe H, 2002, MUTAT RES-FUND MOL M, V504, P37, DOI 10.1016/S0027-5107(02)00077-5; Tawil R, 1996, ANN NEUROL, V39, P744, DOI 10.1002/ana.410390610; Tim R W, 2001, J Clin Neuromuscul Dis, V3, P1, DOI 10.1097/00131402-200109000-00001; Tsien F, 2001, MOL GENET METAB, V74, P322, DOI 10.1006/mgme.2001.3219; Tupler R, 1996, J MED GENET, V33, P366, DOI 10.1136/jmg.33.5.366; UPADHYAYA M, 1995, MUSCLE NERVE, pS45; van der Maarel SM, 2000, AM J HUM GENET, V66, P26, DOI 10.1086/302730; van der Maarel SM, 1999, J MED GENET, V36, P823; van Geel M, 2002, GENOMICS, V79, P210, DOI 10.1006/geno.2002.6690; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; van Overveld PGM, 2000, HUM MOL GENET, V9, P2879; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; vanDeutekom JCT, 1996, HUM MOL GENET, V5, P1997, DOI 10.1093/hmg/5.12.1997; VANDEUTEKOM JCT, 1996, THESIS LEIDEN U LEID; VOGT P, 1990, HUM GENET, V84, P301; Volpi EV, 2000, J CELL SCI, V113, P1565; WEIFFENBACH B, 1993, NAT GENET, V4, P165, DOI 10.1038/ng0693-165; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Wijmenga C, 1990, LANCET, V336, P651, DOI 10.1016/0140-6736(90)92148-B; WILKIE AOM, 1991, CELL, V64, P595, DOI 10.1016/0092-8674(91)90243-R; Winokur ST, 1994, CHROMOSOME RES, V2, P225, DOI 10.1007/BF01553323; Winokur ST, 2003, HUM MOL GENET, V12, P2895, DOI 10.1093/hmg/ddg327; Wu ZY, 2004, NEUROLOGY, V63, P581, DOI 10.1212/01.WNL.0000133210.93075.81; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yang F, 2004, CHROMOSOMA, V112, P350, DOI 10.1007/s00412-004-0280-x; ZATZ M, 1995, AM J HUM GENET, V56, P99; Zatz M, 1998, AM J MED GENET, V77, P155, DOI 10.1002/(SICI)1096-8628(19980501)77:2<155::AID-AJMG9>3.3.CO;2-G	73	48	53	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2005	76	3					375	386		10.1086/428361	http://dx.doi.org/10.1086/428361			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	895HO	15674778	Bronze, Green Published			2022-12-18	WOS:000226851900001
J	North, BV; Curtis, D; Sham, PC				North, BV; Curtis, D; Sham, PC			A note on the calculation of empirical P values from Monte Carlo procedures	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									Inst Psychiat, Dept Psychol Med, London SE5 8AF, England; St Bartholomews & Royal London Sch Med & Dent, Acad Dept Psychiat, London, England	University of London; King's College London; University of London; Queen Mary University London	Curtis, D (corresponding author), Royal London Hosp, Dept Adult Psychiat, London E1 1BB, England.		Curtis, David/HGB-3921-2022	Curtis, David/0000-0002-4089-9183				Cox DR., 1974, THEORETICAL STAT; Davison AC, 1997, BOOTSTRAP METHODS TH; North BV, 2002, AM J HUM GENET, V71, P439, DOI 10.1086/341527	3	48	49	0	13	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2003	72	2					498	499		10.1086/346173	http://dx.doi.org/10.1086/346173			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	640GK	12596795	Green Published, Bronze			2022-12-18	WOS:000180680000032
J	Palmer, CGS; Turunen, JA; Sinsheimer, JS; Minassian, S; Paunio, T; Lonnqvist, J; Peltonen, L; Woodward, JA				Palmer, CGS; Turunen, JA; Sinsheimer, JS; Minassian, S; Paunio, T; Lonnqvist, J; Peltonen, L; Woodward, JA			RHD maternal-fetal genotype incompatibility increases schizophrenia susceptibility	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CASE-PARENT TRIADS; OBSTETRIC COMPLICATIONS; HEMOLYTIC-DISEASE; TRANSMISSION/DISEQUILIBRIUM TEST; PSYCHIATRIC-DISORDERS; GENES; ABNORMALITIES; PREGNANCY; BRAIN; RISK	Fetal events and obstetric complications are associated with schizophrenia. Here we report the results of a family-based candidate-gene study that assesses the role of maternal-fetal genotype incompatibility at the RHD locus in schizophrenia. We adapted the case-parent-trio log-linear modeling approach to test for RHD maternal-fetal genotype incompatibility and to distinguish this effect from a high-risk allele at or near the RHD locus and from a direct maternal effect alone. Eighty-eight patient-parent trios, 72 patient-mother pairs, and 21 patient-father pairs were genotyped at the RHD locus. Of the 181 patients, 62% were male and 81% were second born or later. Only three patients were born after prophylaxis against maternal isoimmunization had become common practice. There was significant evidence for an RHD maternal-fetal genotype incompatibility, and the incompatibility parameter was estimated at 2.6. There was no evidence to support linkage/association with schizophrenia at or near the RHD locus nor any evidence to support the role of maternal genotype effect alone. Our results replicate previous findings that implicate the RHD locus in schizophrenia, and the candidate-gene design of this study allows the elimination of alternative explanations for the role of this locus in disease. Thus, the present study provides increasing evidence that the RHD locus increases schizophrenia risk through a maternal-fetal genotype incompatibility mechanism that increases risk of an adverse prenatal environment (e.g., Rh incompatibility) rather than through linkage/association with the disorder, linkage disequilibrium with an unknown nearby susceptibility locus, or a direct maternal effect alone. This is the first candidate-gene study to explicitly test for and provide evidence of a maternal-fetal genotype incompatibility mechanism in schizophrenia.	Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat & Behav Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biomath, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Stat, Los Angeles, CA 90095 USA; Natl Publ Hlth Inst, Dept Mol Med, Helsinki, Finland; Natl Publ Hlth Inst, Dept Mental Hlth & Alcohol Res, Helsinki, Finland	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare	Palmer, CGS (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.	cpalmer@mednet.ucla.edu; woodward@psych.ucla.edu		Turunen, Joni/0000-0002-9569-9146	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059490, R01MH059490, R21MH066001] Funding Source: NIH RePORTER; NIMH NIH HHS [MH066001, R21 MH066001, R37 MH059490, R01 MH059490, MH59490] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		*AM PSYCH ASS, 1994, DIAGN STAT MAN; AMIT Y, 1993, EXP NEUROL, V121, P248, DOI 10.1006/exnr.1993.1092; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; Bowman JM, 1998, NEW ENGL J MED, V339, P1775, DOI 10.1056/NEJM199812103392410; Cannon M, 2002, AM J PSYCHIAT, V159, P1080, DOI 10.1176/appi.ajp.159.7.1080; Cannon TD, 2000, SCHIZOPHRENIA BULL, V26, P351, DOI 10.1093/oxfordjournals.schbul.a033458; Cannon TD, 1997, INT REV PSYCHIATR, V9, P387, DOI 10.1080/09540269775259; CANNON TD, 1993, ARCH GEN PSYCHIAT, V50, P551; Cantor-Graae E, 2000, ACTA PSYCHIAT SCAND, V101, P142, DOI 10.1034/j.1600-0447.2000.90054.x; CHAVEZ GF, 1991, JAMA-J AM MED ASSOC, V265, P3270, DOI 10.1001/jama.265.24.3270; Cotter DR, 2001, BRAIN RES BULL, V55, P585, DOI 10.1016/S0361-9230(01)00527-5; Dalman C, 2001, BRIT J PSYCHIAT, V179, P403, DOI 10.1192/bjp.179.5.403; DESILVA M, 1985, VOX SANG, V48, P178; Douglas JA, 2000, AM J HUM GENET, V66, P1287, DOI 10.1086/302861; Ekelund J, 2001, HUM MOL GENET, V10, P1611, DOI 10.1093/hmg/10.15.1611; Ekelund J, 2000, HUM MOL GENET, V9, P1049, DOI 10.1093/hmg/9.7.1049; EKLUND J, 1986, ACTA OBSTET GYN SCAN, V65, P787, DOI 10.3109/00016348609161501; Geddes JR, 1999, SCHIZOPHRENIA BULL, V25, P413, DOI 10.1093/oxfordjournals.schbul.a033389; Guyton A.C., 1981, TXB MED PHYSL; HANSEN TW, 2001, INT J MENTAL HLTH, V29, P38; Hansen TWR, 2000, MOL GENET METAB, V71, P411, DOI 10.1006/mgme.2000.3028; Hollister JM, 1996, ARCH GEN PSYCHIAT, V53, P19; Hovatta I, 1999, AM J HUM GENET, V65, P1114, DOI 10.1086/302567; Hulshoff HE, 2000, AM J PSYCHIAT, V157, P1170, DOI 10.1176/appi.ajp.157.7.1170; Jurewicz I, 2001, EUR NEUROPSYCHOPHARM, V11, P395, DOI 10.1016/S0924-977X(01)00116-X; Knapp M, 1999, AM J HUM GENET, V64, P1177, DOI 10.1086/302334; LAING P, 1995, NATO ADV SCI INST SE, V275, P215; LANGE K, 1991, SEARCH RELEASE 3 0; LANGE K, 2002, MENDEL RELEASE 4 0; Lazzeroni LC, 1998, HUM HERED, V48, P67, DOI 10.1159/000022784; Lewis DA, 2000, NEURON, V28, P325, DOI 10.1016/S0896-6273(00)00111-2; Maayan-Metzger A, 2001, ARCH DIS CHILD-FETAL, V84, pF60, DOI 10.1136/fn.84.1.F60; Marcelis M, 1998, AM J MED GENET, V81, P29, DOI 10.1002/(SICI)1096-8628(19980207)81:1<29::AID-AJMG6>3.0.CO;2-I; McNeil TF, 2000, BRAIN RES REV, V31, P166, DOI 10.1016/S0165-0173(99)00034-X; Moises HW, 2002, BMC PSYCHIATRY, V2, DOI 10.1186/1471-244X-2-8; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ober C, 1998, AM J HUM GENET, V62, P1, DOI 10.1086/301692; Rhine W D, 1999, J Perinatol, V19, P206, DOI 10.1038/sj.jp.7200180; SINSHEIMER JS, IN PRESS GENET EPIDE; SINSHEIMER JS, 2002, MISMATCH RELEASE 1 0; Sobel E, 2002, AM J HUM GENET, V70, P496, DOI 10.1086/338920; STUBBS EG, 1985, J AM ACAD CHILD PSY, V24, P182, DOI 10.1016/S0002-7138(09)60445-3; THORNTON JG, 1989, BMJ-BRIT MED J, V298, P1671, DOI 10.1136/bmj.298.6689.1671; Umbach DH, 2000, AM J HUM GENET, V66, P251, DOI 10.1086/302707; vanGent T, 1997, J CHILD PSYCHOL PSYC, V38, P337; Wagner FF, 2000, BLOOD, V95, P3662; Waterworth DM, 2002, CELL MOL LIFE SCI, V59, P331, DOI 10.1007/s00018-002-8426-6; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802; Weinberg CR, 1999, AM J HUM GENET, V64, P1186, DOI 10.1086/302337; Wilcox AJ, 1998, AM J EPIDEMIOL, V148, P893; Zornberg GL, 2000, SCHIZOPHRENIA BULL, V26, P249, DOI 10.1093/oxfordjournals.schbul.a033449	51	48	51	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2002	71	6					1312	1319		10.1086/344659	http://dx.doi.org/10.1086/344659			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621KD	12439825	Green Published, Bronze			2022-12-18	WOS:000179586800006
J	Gudmundsson, G; Matthiasson, SE; Arason, H; Johannsson, H; Runarsson, F; Bjarnason, H; Helgadottir, K; Thorisdottir, S; Ingadottir, G; Lindpaintner, K; Sainz, J; Gudnason, V; Frigge, ML; Kong, A; Gulcher, JR; Stefansson, K				Gudmundsson, G; Matthiasson, SE; Arason, H; Johannsson, H; Runarsson, F; Bjarnason, H; Helgadottir, K; Thorisdottir, S; Ingadottir, G; Lindpaintner, K; Sainz, J; Gudnason, V; Frigge, ML; Kong, A; Gulcher, JR; Stefansson, K			Localization of a gene for peripheral arterial occlusive disease to chromosome 1p31	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPOINT LINKAGE ANALYSIS; COMPLEX TRAITS; TESTS	Peripheral arterial occlusive disease (PAOD) results from atherosclerosis of large and medium peripheral arteries, as well as the aorta, and has many risk factors, including smoking, diabetes, hypertension, and hyperlipidemia. PAOD often coexists with coronary artery disease and cerebrovascular disease. Cross-matching a population-based list of Icelandic patients with PAOD who had undergone angiography and/or revascularization procedures with a genealogy database of the entire Icelandic nation defined 116 extended families containing 272 patients. A genomewide scan with microsatellite markers revealed significant linkage to chromosome 1p31 with an allele-sharing LOD score of 3.93 (P = 1.04 x 10(-5)). We designate this locus as "PAOD1." Subtracting 35 patients with a history of stroke increased the LOD score to 4.93. This suggests that, although PAOD and other vascular diseases share risk factors, genetic factors specific to subtypes of vascular disease may exist.	deCODE Genet, IS-101 Reykjavik, Iceland; Natl Univ Hosp Reykjavik, Dept Surg, Reykjavik, Iceland; Genet Res Serv Ctr, Reykjavik, Iceland; Iceland Heart Assoc, Reykjavik, Iceland; F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland	Landspitali National University Hospital; Icelandic Heart Association; Roche Holding	Gulcher, JR (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.		Gudnason, Vilmundur/AAE-7126-2019; Gudnason, Vilmundur/K-6885-2015; Stefansson, Kari/AAE-7187-2019	Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; 				Daw EW, 2000, GENET EPIDEMIOL, V19, P366, DOI 10.1002/1098-2272(200012)19:4<366::AID-GEPI8>3.0.CO;2-F; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dormandy J, 1999, Semin Vasc Surg, V12, P123; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Gulcher J, 1998, CLIN CHEM LAB MED, V36, P523, DOI 10.1515/CCLM.1998.089; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; Halpern J, 1999, HUM HERED, V49, P194, DOI 10.1159/000022874; Haustein KO, 1997, INT J CLIN PHARM TH, V35, P266; HODGE S E, 1984, Genetic Epidemiology, V1, P109, DOI 10.1002/gepi.1370010203; Hooi JD, 1999, BRIT J GEN PRACT, V49, P49; Jeelani NUO, 2000, EUR J VASC ENDOVASC, V20, P25, DOI 10.1053/ejvs.2000.1141; Jonsdottir GM, 2000, AM J HUM GENET, V67, P332; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; NICOLAE DL, 1999, THESIS U CHICAGO CHI; Palsson B, 1999, GENOME RES, V9, P1002, DOI 10.1101/gr.9.10.1002; RISCH N, 1990, AM J HUM GENET, V46, P229; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Yu A, 2000, AM J HUM GENET, V67, P10	22	48	55	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2002	70	3					586	592		10.1086/339251	http://dx.doi.org/10.1086/339251			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	522DG	11833003	Bronze, Green Published			2022-12-18	WOS:000173880000003
J	Benichou, O; Cleiren, E; Gram, J; Bollerslev, J; de Vernejoul, MC; Van Hul, W				Benichou, O; Cleiren, E; Gram, J; Bollerslev, J; de Vernejoul, MC; Van Hul, W			Mapping of autosomal dominant osteopetrosis type II (Albers-Schonberg disease) to chromosome 16p13.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HETEROGENEITY; GENE; SUBUNIT	The osteopetroses are a heterogeneous group of conditions characterized by a bone-density increase due to impaired bone resorption. As well as the two or more autosomal recessive types, two autosomal dominant forms of osteopetrosis, differentiated by clinical and radiological signs, are described. Autosomal dominant osteopetrosis (ADO) type II, also known as "Albers-Schonberg disease," is characterized by sclerosis, predominantly involving the spine (vertebral end-plate thickening, or Rugger-Jersey spine), the pelvis ("bone-within-bone" structures), and the skull base. An increased fracture rate can be observed in these patients. By linkage analysis, the presence, on chromosome 1p21, of a gene causing ADO type II was previously suggested. However, analysis of further families with ADO type II indicated genetic heterogeneity within ADO type II, with the chromosome 1p21 locus being only a minor locus. We now perform a genomewide linkage scan of a French extended family with ADO type II, which allows us to localize an ADO type II gene on chromosome 16p13.3. Analysis of microsatellite markers in five further families with ADO type II could not exclude this chromosomal region. A summed maximum LOD score of 12.70 was generated with marker D16S3027, at a recombination fraction (theta) of 0. On the basis of the key recombinants in the families, a candidate region of 8.4 cM could be delineated, flanked by marker D16S521, on distal side, and marker D16S423, on the proximal side. Surprisingly, one of the families analyzed is the Danish family previously suggested to have linkage to chromosome 1p21. Linkage to chromosome 16p13.3 clearly cannot be excluded in this family, since a maximum LOD score of 4.21 at theta = 0 is generated with marker D16S3027. Because at present no other family with ADO type II has proved to have linkage to chromosome 1p21, we consider the most likely localization of the disease-causing gene in this family to be to chromosome 16p13.3. This thus reopens the possibility that ADO type II is genetically homogeneous because of a single gene on chromosome 16p13.3.	Univ Antwerp, Dept Med Genet, B-2610 Antwerp, Belgium; Hop Lariboisiere, Lab INSERM, U349, F-75475 Paris, France; Ribe Cty Hosp, Dept Med, Esbjerg, Denmark; Univ Oslo, Rikshosp, Dept Endocrinol, N-0027 Oslo, Norway	University of Antwerp; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Oslo; National Hospital Norway	Van Hul, W (corresponding author), Univ Antwerp, Dept Med Genet, Univ Pl 1, B-2610 Antwerp, Belgium.	vhul@uia.ac.be		Gram, Jeppe/0000-0003-2584-1132; Van Hul, Wim/0000-0002-5065-7858				Albers-Schonberg H.E., 1904, MUNCH MED WOCHENSCHR, V5, P365; ANDERSEN PE, 1987, RADIOLOGY, V164, P223, DOI 10.1148/radiology.164.1.3588909; Benichou OD, 2000, J BONE MINER RES, V15, P1900, DOI 10.1359/jbmr.2000.15.10.1900; Benichou OD, 2000, BONE, V26, P87, DOI 10.1016/S8756-3282(99)00244-6; BENICHOU OD, IN PRESS JOINT BONE; BOLLERSLEV J, 1989, ENDOCR REV, V10, P45, DOI 10.1210/edrv-10-1-45; BOLLERSLEV J, 1987, CLIN GENET, V31, P86; BOLLERSLEV J, 1988, BONE, V9, P7, DOI 10.1016/8756-3282(88)90021-X; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Felix R, 1996, EUR J ENDOCRINOL, V134, P143, DOI 10.1530/eje.0.1340143; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; GILLESPIE GAJ, 1991, P NATL ACAD SCI USA, V88, P4289, DOI 10.1073/pnas.88.10.4289; Johnson ML, 1997, AM J HUM GENET, V60, P1326, DOI 10.1086/515470; Kornak U, 2000, HUM MOL GENET, V9, P2059, DOI 10.1093/hmg/9.13.2059; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; LATHROP GM, 1984, AM J HUM GENET, V36, P460; SALZANO FM, 1961, ACTA GENET MED GEMEL, V10, P353, DOI 10.1017/S1120962300016954; SHAPIRO F, 1993, CLIN ORTHOP RELAT R, P34; SLY WS, 1983, P NATL ACAD SCI-BIOL, V80, P2752, DOI 10.1073/pnas.80.9.2752; Van Hul E, 2000, J BONE MINER RES, V15, pS260; VanHul W, 1997, AM J HUM GENET, V61, P363, DOI 10.1086/514844; White KE, 1999, J CLIN ENDOCR METAB, V84, P1047, DOI 10.1210/jc.84.3.1047	22	48	50	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2001	69	3					647	654		10.1086/323132	http://dx.doi.org/10.1086/323132			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	459VD	11468688	Green Published, Bronze			2022-12-18	WOS:000170271400017
J	Wohrle, D; Salat, U; Hameister, H; Vogel, W; Steinbach, P				Wohrle, D; Salat, U; Hameister, H; Vogel, W; Steinbach, P			Demethylation, reactivation, and destabilization of human fragile X full-mutation alleles in mouse embryocarcinoma cells	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CGG REPEATS; ABNORMAL METHYLATION; FETAL TISSUES; FMR1 GENE; IN-VITRO; DNA; INSTABILITY; HETEROGENEITY; PREMUTATION; REGION	The major causes of fragile X syndrome are mutational expansion of the CGG repeat in the FMR1 gene, hypermethylation, and transcriptional silencing. Most fragile X embryos develop somatic mosaicism of disease-causing "full" expansions of different lengths. Homogeneity of the mosaic patterns among multiple tissues in the same individual indicates that these previously unstable expansions acquire mitotic stability early in fetal life. Since mitotic stability is found strictly associated with hypermethylation in adult tissues, current theory has fixed the time of instability to developmental stages when fully expanded CGG repeats exist in an unmethylated state. We used murine embryocarcinoma (EC) cells (PC13) as a model system of pluripotent embryonic cells. Hypermethylated and unmethylated full expansions on human fragile X chromosomes were transferred from murine A9 hybrids into EC cells, by means of microcell fusion. As demonstrated in the present study for the first time, even full expansion alleles that were fully methylated and stable in the donors' fibroblasts and in A9 became demethylated, reactivated, and destabilized in undifferentiated EC hybrids. When destabilized expansions were reintroduced from EC cells into A9, instability was reversed to stability. Our results strongly support the idea that fully expanded alleles are initially unstable and unmethylated in the human embryo and gain stability upon genetic or epigenetic change of the embryonic cells.	Univ Hosp Ulm, Dept Human Genet, D-89073 Ulm, Germany	Ulm University	Steinbach, P (corresponding author), Univ Hosp Ulm, Dept Human Genet, Parkstr 11, D-89073 Ulm, Germany.	peter.steinbach@medizin.uni-ulm.de						Bontekoe CJM, 1997, EUR J HUM GENET, V5, P293, DOI 10.1159/000484780; Burman RW, 1999, HUM MOL GENET, V8, P2293, DOI 10.1093/hmg/8.12.2293; Chiurazzi P, 1999, HUM MOL GENET, V8, P2317, DOI 10.1093/hmg/8.12.2317; Coffee B, 1999, NAT GENET, V22, P98, DOI 10.1038/8807; DEVYS D, 1992, AM J MED GENET, V43, P208, DOI 10.1002/ajmg.1320430134; Drouin R, 1997, HUM MOL GENET, V6, P2051, DOI 10.1093/hmg/6.12.2051; EICHLER EE, 1993, HUM MOL GENET, V2, P1147, DOI 10.1093/hmg/2.8.1147; FOURNIER REK, 1981, P NATL ACAD SCI-BIOL, V78, P6349, DOI 10.1073/pnas.78.10.6349; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Glaser D, 1999, AM J MED GENET, V84, P226; Hagerman R, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P15; HEITZ D, 1992, J MED GENET, V29, P794, DOI 10.1136/jmg.29.11.794; HOOPER ML, 1977, DEV BIOL, V55, P271, DOI 10.1016/0012-1606(77)90172-5; HORNSTRA IK, 1993, HUM MOL GENET, V2, P1659; Imbert G, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P27; Islam MQ, 2000, CYTOGENET CELL GENET, V88, P110, DOI 10.1159/000015501; Jin P, 2000, HUM MOL GENET, V9, P901, DOI 10.1093/hmg/9.6.901; Lavedan C, 1998, GENOMICS, V50, P229, DOI 10.1006/geno.1998.5299; Malter HE, 1997, NAT GENET, V15, P165, DOI 10.1038/ng0297-165; McMurray CT, 1999, P NATL ACAD SCI USA, V96, P1823, DOI 10.1073/pnas.96.5.1823; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moutou C, 1997, HUM MOL GENET, V6, P971, DOI 10.1093/hmg/6.7.971; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; ROUSSEAU F, 1994, AM J HUM GENET, V55, P225; Salat U, 2000, J MED GENET, V37, P842, DOI 10.1136/jmg.37.11.842; Schwemmle S, 1997, AM J HUM GENET, V60, P1354, DOI 10.1086/515456; Steinbach P, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P509; Taylor AK, 1999, AM J MED GENET, V84, P233, DOI 10.1002/(SICI)1096-8628(19990528)84:3<233::AID-AJMG14>3.0.CO;2-6; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WOHRLE D, 1992, HUM GENET, V89, P114, DOI 10.1007/BF00207057; Wohrle D, 1998, J MED GENET, V35, P103, DOI 10.1136/jmg.35.2.103; WOHRLE D, 1993, NAT GENET, V4, P140, DOI 10.1038/ng0693-140; WOHRLE D, 1995, HUM MOL GENET, V4, P1147, DOI 10.1093/hmg/4.7.1147; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	34	48	50	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2001	69	3					504	515		10.1086/322739	http://dx.doi.org/10.1086/322739			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	459VD	11462172	Bronze, Green Published			2022-12-18	WOS:000170271400004
J	Subrahmanyan, L; Eberle, MA; Clark, AG; Kruglyak, L; Nickerson, DA				Subrahmanyan, L; Eberle, MA; Clark, AG; Kruglyak, L; Nickerson, DA			Sequence variation and linkage disequilibrium in the human T-cell receptor beta (TCRB) locus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; DNA-SEQUENCE; GENE-COMPLEX; RHEUMATOID-ARTHRITIS; STRUCTURAL BASIS; DISEASE GENES; HUMAN GENOME; POPULATIONS; RECOMBINATION; RECOGNITION	The T-cell receptor (TCR) plays a central role in the immune system, and >90% of human T cells present a receptor that consists of the a TCR subunit (TCRA) and the beta subunit (TCRB). Here we report an analysis of 63 variable genes (BV), spanning 553 kb of TCRB that yielded 279 single-nucleotide polymorphisms (SNPs). Samples were drawn from 10 individuals and represent four populations-African American, Chinese, Mexican, and Northern European. We found nine variants that produce nonfunctional BV segments, removing those genes from the TCRB genomic repertoire. There was significant heterogeneity among population samples in SNP frequency (including the BV-inactivating sites), indicating the need for multiple-population samples for adequate variant discovery. In addition, we observed considerable linkage disequilibrium (LD) (r(2) > 0.1) over distances of similar to 30 kb in TCRB, and, in general, the distribution of r(2) as a function of physical distance was in close agreement with neutral coalescent simulations. LD in TCRB showed considerable spatial variation across the locus, being concentrated in "blocks" of LD; however, coalescent simulations of the locus illustrated that the heterogeneity of LD we observed in TCRB did not differ markedly from that expected from neutral processes. Finally, examination of the extended genotypes for each subject demonstrated homozygous stretches of >100 kb in the locus of several individuals. These results provide the basis for optimization of locuswide SNP typing in TCRB for studies of genotype-phenotype association.	Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98104 USA; Penn State Univ, Inst Mol Evolutionary Genet, Dept Biol, University Pk, PA 16802 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Nickerson, DA (corresponding author), Univ Washington, Dept Mol Biotechnol, Box 357730, Seattle, WA 98195 USA.	debnick@u.washington.edu		Eberle, Michael/0000-0001-8965-1253; Clark, Andrew/0000-0001-7159-8511	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059520, R37MH059520] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG01436] Funding Source: Medline; NIAID NIH HHS [AI45279] Funding Source: Medline; NIMH NIH HHS [R37 MH059520, R01 MH059520, MH59520] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abecasis GR, 2001, AM J HUM GENET, V68, P191, DOI 10.1086/316944; Arden Bernhard, 1995, Immunogenetics, V42, P455; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Cavalli-Sforza LL, 1996, HIST GEOGRAPHY HUMAN; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; CHARMLEY P, 1995, IMMUNOGENETICS, V42, P254; CHARMLEY P, 1993, J EXP MED, V177, P135, DOI 10.1084/jem.177.1.135; CHARMLEY P, 1995, GENOMICS, V29, P760, DOI 10.1006/geno.1995.9940; Clark AG, 1999, AM J HUM GENET, V65, P1489, DOI 10.1086/302668; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DAY CE, 1994, IMMUNOGENETICS, V39, P335; DEINOCENCIO J, 1995, J IMMUNOL, V154, P4836; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Dunning AM, 2000, AM J HUM GENET, V67, P1544, DOI 10.1086/316906; Eaves IA, 2000, NAT GENET, V25, P320; Endo T, 1996, MOL BIOL EVOL, V13, P685, DOI 10.1093/oxfordjournals.molbev.a025629; Ewens W.J., 1979, MATH POPULATION GENE; Fullerton SM, 2000, AM J HUM GENET, V67, P881, DOI 10.1086/303070; Funkhouser W, 1997, MOL PHYLOGENET EVOL, V8, P51, DOI 10.1006/mpev.1997.0406; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Gilad Y, 2000, NAT GENET, V26, P221, DOI 10.1038/79957; Goddard KAB, 2000, AM J HUM GENET, V66, P216, DOI 10.1086/302727; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; HILL WG, 1974, HEREDITY, V33, P229, DOI 10.1038/hdy.1974.89; HOOD L, 1993, COLD SPRING HARB SYM, V58, P339, DOI 10.1101/SQB.1993.058.01.040; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Hudson RR, 1991, OXF SURV EVOL BIOL, V7, P1; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Huttley GA, 1999, GENETICS, V152, P1711; Jorde LB, 2000, GENOME RES, V10, P1435, DOI 10.1101/gr.144500; JORGENSEN JL, 1992, ANNU REV IMMUNOL, V10, P835, DOI 10.1146/annurev.iy.10.040192.004155; JOUVINMARCHE E, 1989, EUR J IMMUNOL, V19, P1921, DOI 10.1002/eji.1830191024; Kidd JR, 2000, AM J HUM GENET, V66, P1882, DOI 10.1086/302952; LAI E, 1988, NATURE, V331, P543, DOI 10.1038/331543a0; LEWONTIN RC, 1964, GENETICS, V49, P49; Li HM, 1999, ANNU REV IMMUNOL, V17, P435, DOI 10.1146/annurev.immunol.17.1.435; LUYRINK L, 1993, P NATL ACAD SCI USA, V90, P4369, DOI 10.1073/pnas.90.10.4369; MAKSYMOWYCH WP, 1992, IMMUNOGENETICS, V35, P257, DOI 10.1007/BF00166831; MCDERMOTT M, 1995, ANN NY ACAD SCI, V756, P173, DOI 10.1111/j.1749-6632.1995.tb44502.x; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Moffatt MF, 2000, HUM MOL GENET, V9, P1011, DOI 10.1093/hmg/9.7.1011; Nickerson DA, 2000, GENOME RES, V10, P1532, DOI 10.1101/gr.146900; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; POSNETT DN, 1994, J EXP MED, V179, P1707, DOI 10.1084/jem.179.5.1707; Przeworski M, 2000, TRENDS GENET, V16, P296, DOI 10.1016/S0168-9525(00)02030-8; Rowen L, 1996, SCIENCE, V272, P1755, DOI 10.1126/science.272.5269.1755; Ruiz M, 2000, NUCLEIC ACIDS RES, V28, P219, DOI 10.1093/nar/28.1.219; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; SEBOUN E, 1989, J EXP MED, V170, P1263, DOI 10.1084/jem.170.4.1263; Sharon D, 2000, GENE, V260, P87, DOI 10.1016/S0378-1119(00)00467-4; Su C, 2001, MOL BIOL EVOL, V18, P503, DOI 10.1093/oxfordjournals.molbev.a003829; SVED J A, 1971, Theoretical Population Biology, V2, P125; Taillon-Miller P, 2000, NAT GENET, V25, P324, DOI 10.1038/77100; TAJIMA F, 1989, GENETICS, V123, P585; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Weir B., 1996, GENETIC DATA ANAL	61	48	49	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2001	69	2					381	395		10.1086/321297	http://dx.doi.org/10.1086/321297			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XN	11438886	Green Published, Bronze			2022-12-18	WOS:000170108200013
J	Heon, E; Paterson, AD; Fraser, M; Billingsley, G; Priston, M; Balmer, A; Schorderet, DF; Verner, A; Hudson, TJ; Munier, FL				Heon, E; Paterson, AD; Fraser, M; Billingsley, G; Priston, M; Balmer, A; Schorderet, DF; Verner, A; Hudson, TJ; Munier, FL			A progressive autosomal recessive cataract locus maps to chromosome 9q13-q22	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOMINANT CONGENITAL CATARACT; MISSENSE MUTATION; MAJOR GENE; BLINDNESS; MOUSE; CLEARER	Cataracts are the leading cause of blindness in most countries. Although most hereditary cases appear to follow an autosomal dominant pattern of inheritance, autosomal recessive inheritance has been clearly documented and is probably underrecognized. We studied a large family-from a relatively isolated geographic region-whose members were affected by autosomal recessive adult-onset pulverulent cataracts. We mapped the disease locus to a 14-cM interval at a novel disease locus, 9q13-q22 (between markers D9S1123 and D9S257), with a LOD score of 4.7. The study of this progressive and age-related cataract phenotype may provide insight into the cause of the more common sporadic form of age-related cataracts.	Toronto Western Hosp UHN, Vis Sci Res Program, Toronto, ON M5T 2S8, Canada; Toronto Western Hosp UHN, Dept Ophthalmol, Toronto, ON M5T 2S8, Canada; Hosp Sick Children, Res Inst, Dept Genet, Toronto, ON M5G 1X8, Canada; McGill Univ, Ctr Hlth, Montreal Genome Ctr, Montreal, PQ, Canada; CHU Vaudois, Div Med Genet, CH-1011 Lausanne, Switzerland; Hop Jules Gonin, Ocular Genet Unit, Lausanne, Switzerland	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Heon, E (corresponding author), Toronto Western Hosp UHN, Vis Sci Res Program, 399 Bathurst St,McL Room 6-412, Toronto, ON M5T 2S8, Canada.		Paterson, Andrew D/A-4088-2011	Paterson, Andrew D/0000-0002-9169-118X; Hudson, Thomas/0000-0002-1376-4849				Arnold J, 1998, BRIT J OPHTHALMOL, V82, P593, DOI 10.1136/bjo.82.6.593; Bateman JB, 2000, INVEST OPHTH VIS SCI, V41, P2665; Betard C, 2000, AM J HUM GENET, V67, P222, DOI 10.1086/302993; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Chang B, 1996, GENOMICS, V36, P171, DOI 10.1006/geno.1996.0439; GROUP TFOES, 1994, AM J EPIDEMIOL, V140, P555; Hammond CJ, 2000, NEW ENGL J MED, V342, P1786, DOI 10.1056/NEJM200006153422404; HEIBA IM, 1993, AM J MED GENET, V47, P1208, DOI 10.1002/ajmg.1320470816; HEIBA IM, 1995, INVEST OPHTH VIS SCI, V36, P227; Hejtmancik JF, 1998, AM J HUM GENET, V62, P520, DOI 10.1086/301774; Heon E, 1999, AM J HUM GENET, V65, P1261, DOI 10.1086/302619; Iida F, 1997, EXP EYE RES, V64, P107, DOI 10.1006/exer.1996.0192; Kannabiran C, 1998, Mol Vis, V4, P21; Kramer PL, 2000, INVEST OPHTH VIS SCI, V41, P36; KRATOCHVILOVA J, 1988, MUTAT RES, V198, P295, DOI 10.1016/0027-5107(88)90006-1; LESKE MC, 1991, ARCH OPHTHALMOL-CHIC, V109, P244, DOI 10.1001/archopht.1991.01080020090051; Lim A S, 1996, Eur J Ophthalmol, V6, P95; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Mackay D, 1999, AM J HUM GENET, V64, P1357, DOI 10.1086/302383; MARAINI G, 1991, AM J EPIDEMIOL, V133, P541; MUMFORD A, 1998, BLOOD, V6, P665; Pras E, 2000, INVEST OPHTH VIS SCI, V41, P3511; Ren ZX, 2000, HUM GENET, V106, P531, DOI 10.1007/s004390050021; Shiels A, 1998, AM J HUM GENET, V62, P526, DOI 10.1086/301762; Sobel E, 1996, AM J HUM GENET, V58, P1323; Song CW, 1997, MAMM GENOME, V8, P927, DOI 10.1007/s003359900613; THYLEFORS B, 1995, B WORLD HEALTH ORGAN, V73, P115; WILSON J, 1980, WORLD BLINDNESS ITS, P7; Yorston D, 1998, BRIT J OPHTHALMOL, V82, P469, DOI 10.1136/bjo.82.5.469	29	48	49	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2001	68	3					772	777		10.1086/318798	http://dx.doi.org/10.1086/318798			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	402ND	11179024	Green Published, Bronze			2022-12-18	WOS:000166994200021
J	Sherman, SL				Sherman, SL			Premature ovarian failure among fragile X premutation carriers: Parent-of-origin effect?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material									Emory Univ, Dept Genet, Atlanta, GA 30322 USA	Emory University	Sherman, SL (corresponding author), Emory Univ, Dept Genet, 1462 Clifton Rd, Atlanta, GA 30322 USA.							Allingham-Hawkins SJ, 1999, AM J MED GENET, V83, P322, DOI 10.1002/(SICI)1096-8628(19990402)83:4<322::AID-AJMG17>3.0.CO;2-B; CRONISTER A, 1991, AM J MED GENET, V38, P269, DOI 10.1002/ajmg.1320380221; Hundscheid RDL, 2000, AM J HUM GENET, V67, P256, DOI 10.1086/302967; Hundscheid RDL, 2000, AM J HUM GENET, V66, P413, DOI 10.1086/302774; Murray A, 2000, AM J HUM GENET, V67, P253, DOI 10.1086/302963; SCHWARTZ CE, 1994, AM J MED GENET, V51, P400, DOI 10.1002/ajmg.1320510419; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Vianna-Morgante AM, 2000, AM J HUM GENET, V67, P254, DOI 10.1086/302976	8	48	48	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2000	67	1					11	13		10.1086/302985	http://dx.doi.org/10.1086/302985			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	347JY	10848491	Green Published, Bronze			2022-12-18	WOS:000088926900004
J	Kambouris, M; Bohlega, S; Al-Tahan, A; Meyer, BF				Kambouris, M; Bohlega, S; Al-Tahan, A; Meyer, BF			Localization of the gene for a novel autosomal recessive neurodegenerative Huntington-like disorder to 4p15.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRISTANOYL-COA OXIDASE; LINKAGE ANALYSIS; RECEPTOR GENE; DISEASE; CLONING; REGION	A consanguineous family affected by an autosomal recessive, progressive neurodegenerative Huntington-like disorder, was tested to rule out juvenile-onset Huntington disease (JHD). The disease manifests at similar to 3-4 years and is characterized by both pyramidal and extrapyramidal abnormalities, including chorea, dystonia, ataxia, gait instability, spasticity, seizures, mutism, and intellectual impairment. Brain magnetic resonance imaging (MRI) findings include progressive frontal cortical atrophy and bilateral caudate atrophy. Huntington CAG trinucleotide-repeat analyses ruled out JHD, since all affected individuals had repeat numbers within the normal range. The presence of only four recombinant events (theta = .2) between the disease and the Huntington locus in 20 informative meioses suggested that the disease localized to chromosome 4. Linkage was initially achieved with marker D4S2366 at 4p15.3 (LOD 3.03). High-density mapping at the linked locus resulted in homozygosity for markers D4S431 and D4S394, which span a 3-cM region. A maximum LOD score of 4.71 in the homozygous interval was obtained. Heterozygosity at the distal D4S2366 and proximal D4S2983 markers defines the maximum localization interval (7 cM). Multiple brain-related expressed sequence tags (ESTs) with no known disease association exist in the linkage interval. Among the three known genes residing in the linked interval (ACOX3, DRD5, QDPR), the most likely candidate, DRD5, encoding the dopamine receptor D5, was excluded, since all five affected family members were heterozygous for an intragenic dinucleotide repeat. The inheritance pattern and unique localization to 4p15.3 are consistent with the identification of a novel, autosomal recessive, neurodegenerative Huntington-like disorder.	King Faisal Specialist Hosp & Res Ctr, Riyadh 11211, Saudi Arabia; King Saud Univ, Riyadh, Saudi Arabia; Yale Univ, Sch Med, New Haven, CT USA	King Faisal Specialist Hospital & Research Center; King Saud University; Yale University	Kambouris, M (corresponding author), King Faisal Specialist Hosp & Res Ctr, POB 3354,MBC 03, Riyadh 11211, Saudi Arabia.							ANDREW SE, 1994, AM J HUM GENET, V54, P852; BATES GP, 1991, AM J HUM GENET, V49, P7; BEISCHLAG TV, 1995, BIOCHEMISTRY-US, V34, P5960, DOI 10.1021/bi00017a025; Bond CE, 1996, CLIN CHEM, V42, P773; BROWN RC, 1987, TOXICOL IN VITRO, V1, P67, DOI 10.1016/0887-2333(87)90002-6; EUBANKS JH, 1992, GENOMICS, V12, P510, DOI 10.1016/0888-7543(92)90442-U; FARRER LA, 1985, AM J HUM GENET, V37, P350; GRANDY DK, 1991, P NATL ACAD SCI USA, V88, P9175, DOI 10.1073/pnas.88.20.9175; KENDALL TL, 1991, ANAL BIOCHEM, V195, P74, DOI 10.1016/0003-2697(91)90297-7; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; SHERWOOD N, 1993, HUMAN PSYCHOPHARMACO, V4, P1; SMOOKER PM, 1995, J MED GENET, V32, P220, DOI 10.1136/jmg.32.3.220; VANDIJK JG, 1986, HUM GENET, V73, P235, DOI 10.1007/BF00401235; Vanhooren JCT, 1996, EUR J BIOCHEM, V239, P302, DOI 10.1111/j.1432-1033.1996.0302u.x; VANVELDHOVEN PP, 1994, EUR J BIOCHEM, V222, P795; WICHMANN T, 1997, MOVEMENT DISORDERS N, P73; Xiang FQ, 1998, AM J HUM GENET, V63, P1431, DOI 10.1086/302093	18	48	50	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					445	452		10.1086/302744	http://dx.doi.org/10.1086/302744			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677304	Green Published, Bronze			2022-12-18	WOS:000088373100011
J	Willemsen, R; Anar, B; Otero, YD; de Vries, BBA; Hilhorst-Hofstee, Y; Smits, A; van Looveren, E; Willems, PJ; Galjaard, H; Oostra, BA				Willemsen, R; Anar, B; Otero, YD; de Vries, BBA; Hilhorst-Hofstee, Y; Smits, A; van Looveren, E; Willems, PJ; Galjaard, H; Oostra, BA			Noninvasive test for fragile X syndrome, using hair root analysis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RAPID ANTIBODY-TEST; CGG REPEAT; FULL MUTATION; DIAGNOSIS; FMR-1; INSTABILITY; METHYLATION; CARRIERS; PROTEIN	Identification of the FMR1 gene and the repeat-amplification mechanism causing fragile X syndrome led to development of reliable DNA-based diagnostic methods, including Southern blot hybridization and PCR. Both methods are performed on DNA isolated from peripheral blood cells and measure the repeat size in FMR1. Using an immunocytochemical technique on blood smears, we recently developed a novel test for identification of patients with fragile X syndrome. This method, also called "antibody test," uses monoclonal antibodies against the FMR1 gene product (FMRP) and is based on absence of FMRP in patients' cells. Here we describe a new diagnostic test to identify male patients with fragile X syndrome, on the basis of lack of FMRP in their hair roots. Expression of FMRP in hair roots was studied by use of an FMRP-specific antibody test, and the percentage of FMRP-expressing hair roots in controls and in male fragile X patients was determined. Control individuals showed clear expression of FMRP in nearly every hair root, whereas male fragile X patients lacked expression of FMRP in almost all their hair roots. Mentally retarded female patients with a full mutation showed FMRP expression in only some of their hair roots (<55%), and no overlap with normal female controls was observed. The advantages of this test are (1) plucking of hair follicles does no appreciable harm to the mentally retarded patient, (2) hairs can be sent in a simple envelope to a diagnostic center, and (3) the result of the test is available within 5 h of plucking. In addition, this test enabled us to identify two fragile X patients who did not show the full mutation by analysis of DNA isolated from blood cells.	Erasmus Univ, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, Ctr Biomed Genet, NL-3000 DR Rotterdam, Netherlands; Leiden Univ, Ctr Med, Dept Clin Genet, Leiden, Netherlands; Univ Nijmegen, Dept Human Genet, Nijmegen, Netherlands	Erasmus University Rotterdam; Erasmus University Rotterdam; Leiden University; Leiden University - Excl LUMC; Radboud University Nijmegen	Oostra, BA (corresponding author), Erasmus Univ, Dept Clin Genet, POB 1738, NL-3000 DR Rotterdam, Netherlands.		de Diego Otero, Yolanda/B-7517-2016; de Diego, yolanda/I-6070-2012; Hilhorst-Hofstee, Yvonne/AAC-5120-2022	Hilhorst-Hofstee, Yvonne/0000-0003-0951-6524				BROWN WT, 1993, JAMA-J AM MED ASSOC, V270, P1569, DOI 10.1001/jama.270.13.1569; DANCIS J, 1981, HUM GENET, V58, P414, DOI 10.1007/BF00282826; DEGRAAFF E, 1995, AM J HUM GENET, V57, P609; deVries BBA, 1996, AM J HUM GENET, V58, P1025; deVries BBA, 1997, AM J HUM GENET, V61, P660, DOI 10.1086/515496; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GARTLER SM, 1971, SCIENCE, V172, P572, DOI 10.1126/science.172.3983.572; GARTLER SM, 1969, ANN HUM GENET, V33, P171, DOI 10.1111/j.1469-1809.1969.tb01642.x; KOOIJ RF, TRINUCLEOTIDE DIS IN, V1, P98; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1214; NOLIN SL, 1994, AM J MED GENET, V51, P509, DOI 10.1002/ajmg.1320510444; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; OOSTRA BA, 1993, J MED GENET, V30, P410, DOI 10.1136/jmg.30.5.410; ROUSSEAU F, 1991, J MED GENET, V28, P830, DOI 10.1136/jmg.28.12.830; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; Turner G, 1996, AM J MED GENET, V64, P196, DOI 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G; VERHEIJ C, 1993, NATURE, V363, P722, DOI 10.1038/363722a0; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VERMORKEN AJM, 1978, BRIT J DERMATOL, V98, P191, DOI 10.1111/j.1365-2133.1978.tb01621.x; Wildhagen M F, 1998, Community Genet, V1, P36, DOI 10.1159/000016133; WILLEMSEN R, 1995, LANCET, V345, P1147, DOI 10.1016/S0140-6736(95)90979-6; Willemsen R, 1997, HUM GENET, V99, P308, DOI 10.1007/s004390050363	24	48	50	0	9	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1999	65	1					98	103		10.1086/302462	http://dx.doi.org/10.1086/302462			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	212NZ	10364521	Green Published, Bronze			2022-12-18	WOS:000081224300013
J	Hamajima, N; Kouwaki, M; Vreken, P; Matsuda, K; Sumi, S; Imaeda, M; Ohba, S; Kidouchi, K; Nonaka, M; Sasaki, M; Tamaki, N; Endo, Y; De Abreu, R; Rotteveel, J; van Kuilenburg, A; van Gennip, A; Togari, H; Wada, Y				Hamajima, N; Kouwaki, M; Vreken, P; Matsuda, K; Sumi, S; Imaeda, M; Ohba, S; Kidouchi, K; Nonaka, M; Sasaki, M; Tamaki, N; Endo, Y; De Abreu, R; Rotteveel, J; van Kuilenburg, A; van Gennip, A; Togari, H; Wada, Y			Dihydropyrimidinase deficiency: Structural organization, chromosomal localization, and mutation analysis of the human dihydropyrimidinase gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEHYDROGENASE GENE; RAT-LIVER; FAMILY; IDENTIFICATION; PURIFICATION; EXPRESSION; PROTEINS; 8Q22	Dihydropyrimidinase (DHP) deficiency (MIM 222748) is characterized by dihydropyrimidinuria and is associated with a variable clinical phenotype. This disease might be associated with a risk of 5-fluorouracil toxicity, although no cases have been reported. We present here both the molecular characterization of the human DHP gene and, for the first time, the mutations causing DHP deficiency. The human DHP gene spans > 80 kb and consists of 10 exons. It has been assigned to 8q22, by FISH. We performed mutation analysis of genomic DNA in one symptomatic and five asymptomatic individuals presenting with dihydropyrimidinuria. We identified one frameshift mutation and five missense mutations. Two related Japanese adult subjects were homozygous for the Q334R substitution, whereas two other, unrelated Japanese infant subjects were heterozygous for the same mutation, but this mutation is not common in the Japanese population, A Caucasian pediatric patient exhibiting epileptic attacks, dysmorphic features, and severe developmental delay was homozygous for W360R. Using a eukaryotic expression system, we showed that all mutations reduced enzyme activity significantly, indicating that these are crucial DHP deficiency-causing mutations. There was no significant difference, in residual activity, between mutations observed in the symptomatic and those observed in the asymptomatic individuals.	Nagoya City Univ, Sch Med, Dept Pediat, Mizuho Ku, Nagoya, Aichi 4678601, Japan; Nagoya City Univ, Sch Med, Dept Biochem, Mizuho Ku, Nagoya, Aichi 4678601, Japan; Nagoya City Higashi Gen Hosp, Dept Pediat, Nagoya, Aichi, Japan; Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, NL-1105 AZ Amsterdam, Netherlands; Kobe Gakuin Univ, Fac Nutr, Kobe, Hyogo 65121, Japan; Fukushima Med Coll, Dept Biochem, Fukushima, Japan; Univ Nijmegen Hosp, Dept Pediat, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen Hosp, Dept Neurol, NL-6500 HB Nijmegen, Netherlands	Nagoya City University; Nagoya City University; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Kobe Gakuin University; Fukushima Medical University; Radboud University Nijmegen; Radboud University Nijmegen	Hamajima, N (corresponding author), Nagoya City Univ, Sch Med, Dept Pediat, Mizuho Ku, Nagoya, Aichi 4678601, Japan.		NONAKA, MASARU/G-4929-2014	De Abreu, Ronney/0000-0001-6442-5989				Assmann B, 1997, J INHERIT METAB DIS, V20, P681, DOI 10.1023/A:1005374426168; BROOKS KP, 1979, BIOCHIM BIOPHYS ACTA, V570, P213, DOI 10.1016/0005-2744(79)90216-X; BROOKS KP, 1983, ARCH BIOCHEM BIOPHYS, V226, P469, DOI 10.1016/0003-9861(83)90316-8; BRUETON LA, 1992, AM J MED GENET, V43, P612, DOI 10.1002/ajmg.1320430322; DURAN M, 1990, LANCET, V336, P817, DOI 10.1016/0140-6736(90)93288-Z; FernandezSalguero PM, 1997, PHARMACOGENETICS, V7, P161, DOI 10.1097/00008571-199704000-00012; FRITZSON P, 1957, J BIOL CHEM, V226, P229; FRITZSON P, 1957, J BIOL CHEM, V226, P223; Hamajima N, 1996, GENE, V180, P157, DOI 10.1016/S0378-1119(96)00445-3; Hayashi K, 1996, CLIN CANCER RES, V2, P1937; HENDERSON MJ, 1993, J INHERIT METAB DIS, V16, P574, DOI 10.1007/BF00711685; Holm L, 1997, PROTEINS, V28, P72, DOI 10.1002/(SICI)1097-0134(199705)28:1<72::AID-PROT7>3.0.CO;2-L; Hovnanian A, 1997, AM J HUM GENET, V61, P599, DOI 10.1086/515495; KIKUGAWA M, 1994, EUR J BIOCHEM, V219, P393, DOI 10.1111/j.1432-1033.1994.tb19951.x; Matsuda K, 1996, BBA-GENE STRUCT EXPR, V1307, P140, DOI 10.1016/0167-4781(96)00056-5; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; OHBA S, 1994, ADV EXP MED BIOL, V370, P383; Sumi S, 1996, J INHERIT METAB DIS, V19, P701, DOI 10.1007/BF01799851; SUMI S, IN PRESS AM J MED GE; TAHVANAINEN E, 1994, NAT GENET, V7, P201, DOI 10.1038/ng0694-201; TAKEDA J, 1993, CELL, V73, P703, DOI 10.1016/0092-8674(93)90250-T; TEMPLE IK, 1994, J MED GENET, V31, P735, DOI 10.1136/jmg.31.9.735; Van Kuilenburg ABP, 1997, EUR J CANCER, V33, P2258, DOI 10.1016/S0959-8049(97)00261-X; vanGennip AH, 1997, J INHERIT METAB DIS, V20, P203, DOI 10.1023/A:1005356806329; vanGennip AH, 1997, J INHERIT METAB DIS, V20, P339, DOI 10.1023/A:1005309423960; Vreken P, 1997, J INHERIT METAB DIS, V20, P335, DOI 10.1023/A:1005357307122; Vreken P, 1997, HUM GENET, V101, P333, DOI 10.1007/s004390050637; Vreken P, 1997, HUM GENET, V100, P263, DOI 10.1007/s004390050502; Wang LH, 1997, J NEUROCHEM, V69, P2261; Wei XX, 1996, J CLIN INVEST, V98, P610, DOI 10.1172/JCI118830; Wood S, 1993, Cytogenet Cell Genet, V64, P134; Zhang HF, 1996, BBA-LIPID LIPID MET, V1302, P159, DOI 10.1016/0005-2760(96)00059-8	32	48	52	0	3	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1998	63	3					717	726		10.1086/302022	http://dx.doi.org/10.1086/302022			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	119VN	9718352	Green Published, Bronze			2022-12-18	WOS:000075919000009
J	Parvari, R; Hershkovitz, E; Kanis, A; Gorodischer, R; Shalitin, S; Sheffield, VC; Carmi, R				Parvari, R; Hershkovitz, E; Kanis, A; Gorodischer, R; Shalitin, S; Sheffield, VC; Carmi, R			Homozygosity and linkage-disequilibrium mapping of the syndrome of congenital hypoparathyroidism, growth and mental retardation, and dysmorphism to a 1-cM interval on chromosome 1q42-43	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL HYPOCALCIURIC HYPERCALCEMIA; CA2+-SENSING RECEPTOR GENE; AUTOSOMAL RECESSIVE HYPOPARATHYROIDISM; NEONATAL SEVERE HYPERPARATHYROIDISM; CALCIUM-SENSING RECEPTOR; IDIOPATHIC HYPOPARATHYROIDISM; DOMINANT HYPOPARATHYROIDISM; PARATHYROID-HORMONE; DEVELOPMENTAL DELAY; MUTATIONS	The syndrome of hypoparathyroidism associated with growth retardation, developmental delay, and dysmorphism (HRD) is a newly described, autosomal recessive, congenital disorder with severe, often fatal consequences. Since the syndrome is very rare, with all parents of affected individuals being consanguineous, it is presumed to be caused by homozygous inheritance of a single recessive mutation from a common ancestor. To localize the HRD gene, we performed a genomewide screen using DNA pooling and homozygosity mapping for apparently unlinked kindreds. Analysis of a panel of 359 highly polymorphic markers revealed linkage to D1S235. The maximum LOD score obtained was 4.11 at a recombination fraction of 0. Analysis of three additional markers-GGAA6F06, D1S2678, and D1S179-in a 2-cM interval around D1S235 resulted in LOD scores >3. Analysis of additional chromosome 1 markers revealed evidence of genetic linkage disequilibrium and place the HRD locus within an similar to 1-cM interval defined by D1S1540 and D1S2678 on chromosome 1q42-43.	Ben Gurion Univ Negev, Soroka Med Ctr, Genet Inst, IL-84101 Beer Sheva, Israel; Ben Gurion Univ Negev, Soroka Med Ctr, Dept Pediat, IL-84101 Beer Sheva, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, IL-84101 Beer Sheva, Israel; Univ Iowa, Dept Pediat, Div Med Genet, Iowa City, IA 52242 USA; Schneider Childrens Med Ctr Israel, Inst Pediat Endocrinol, Petah Tiqwa, Israel	Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center; Ben Gurion University; University of Iowa	Parvari, R (corresponding author), Ben Gurion Univ Negev, Soroka Med Ctr, Genet Inst, IL-84101 Beer Sheva, Israel.	ruthi@bguvms.bgu.ac.il	Herskowitz, eli/F-1922-2012; Gorodischer, Rafael/AAQ-8132-2020	Herskowitz, eli/0000-0003-1624-1960; Sheffield, Val/0000-0002-6282-0835; Gorodischer, Rafael/0000-0002-7649-3353	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000457] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG 00457] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; AIDA K, 1995, J CLIN ENDOCR METAB, V80, P2594, DOI 10.1210/jc.80.9.2594; Alon U, 1985, Adv Pediatr, V32, P439; Barrat FJ, 1996, AM J HUM GENET, V59, P625; Barrat FJ, 1997, GENOMICS, V43, P111, DOI 10.1006/geno.1997.4785; BILOUS RW, 1992, NEW ENGL J MED, V327, P1069, DOI 10.1056/NEJM199210083271506; BROWN EM, 1995, NEW ENGL J MED, V333, P234, DOI 10.1056/NEJM199507273330407; CAREY AH, 1992, AM J HUM GENET, V51, P964; CHOU YHW, 1995, AM J HUM GENET, V56, P1075; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DRISCOLL DA, 1992, AM J MED GENET, V44, P261, DOI 10.1002/ajmg.1320440237; FANCONI S, 1986, J PEDIATR-US, V109, P469, DOI 10.1016/S0022-3476(86)80120-2; FINEGOLD DN, 1994, PEDIATR RES, V36, P414, DOI 10.1203/00006450-199409000-00024; GORODISCHER R, 1970, AM J DIS CHILD, V119, P74, DOI 10.1001/archpedi.1970.02100050076018; HEALTH H, 1996, J CLIN ENDOCR METAB, V81, P1312; HERSHKOVITZ E, 1995, ISRAEL J MED SCI, V31, P293; JANICIC N, 1995, AM J HUM GENET, V56, P880; Khan KTS, 1997, AM J MED GENET, V69, P126; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Nystuen A, 1996, HUM MOL GENET, V5, P525, DOI 10.1093/hmg/5.4.525; PARKINSON DB, 1992, NAT GENET, V1, P149, DOI 10.1038/ng0592-149; Pearce SHS, 1996, NEW ENGL J MED, V335, P1115, DOI 10.1056/NEJM199610103351505; Pearce SHS, 1995, J CLIN INVEST, V96, P2683, DOI 10.1172/JCI118335; POLLAK MR, 1993, CELL, V75, P1297, DOI 10.1016/0092-8674(93)90617-Y; RICHARDSON RJ, 1990, ARCH DIS CHILD, V65, P1113, DOI 10.1136/adc.65.10.1113; SANJAD SA, 1991, ARCH DIS CHILD, V66, P193, DOI 10.1136/adc.66.2.193; SHAW NJ, 1991, ARCH DIS CHILD, V66, P1191, DOI 10.1136/adc.66.10.1191; SHEFFIELD VC, 1995, CURR OPIN GENET DEV, V5, P335, DOI 10.1016/0959-437X(95)80048-4; SHEFFIELD VC, 1997, CURRENT PROTOCOLS HU; SMITH C, 1953, J R STAT SOC BRIT, V15, P135; THAKKER RV, 1990, J CLIN INVEST, V86, P40, DOI 10.1172/JCI114712; Wang CY, 1997, AM J HUM GENET, V60, P1461, DOI 10.1086/515469; WHYTE MP, 1981, J PEDIATR-US, V99, P608, DOI 10.1016/S0022-3476(81)80272-7; WINTER WE, 1983, J PEDIATR-US, V103, P387, DOI 10.1016/S0022-3476(83)80408-9	36	48	49	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					163	169		10.1086/301915	http://dx.doi.org/10.1086/301915			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	9634513	Bronze, Green Published			2022-12-18	WOS:000074761000024
J	Hoffmeyer, S; Nurnberg, P; Ritter, H; Fahsold, R; Leistner, W; Kaufmann, D; Krone, W				Hoffmeyer, S; Nurnberg, P; Ritter, H; Fahsold, R; Leistner, W; Kaufmann, D; Krone, W			Nearby stop codons in exons of the neurofibromatosis type 1 gene are disparate splice effectors	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRE-MESSENGER-RNA; NONSENSE MUTATIONS; SITE SELECTION; SR-PROTEINS; ENHANCER; NF1; IDENTIFICATION; RECOGNITION; EXPRESSION; SEQUENCES	Stop mutations are known to disrupt gene function in different ways. They both give rise to truncated polypeptides because of the premature-termination codons (PTCs) and frequently affect the metabolism of the corresponding mRNAs. The analysis of neurofibromin transcripts from different neurofibromatosis type 1 (NF1) patients revealed the skipping of exons containing PTCs. The phenomenon of exon skipping induced by nonsense mutations has been described for other disease genes, including the CFTR (cystic fibrosis transmembrance conductance regulator) gene and the fibrillin gene. We characterized several stop mutations localized within a few base pairs in exons 7 and 37 and noticed complete skipping of either exon in some cases. Because skipping of exon 7 and of exon 37 does not lead to a frameshift, PTCs are avoided in that way. Nuclear-scanning mechanisms for PTCs have been postulated to trigger the removal of the affected exons from the transcript. However, other stop mutations that we found in either NF1 exon did not lead to a skip, although they were localized within the same region. Calculations of minimum-free-energy structures of the respective regions suggest that both changes in the secondary structure of the mRNA and creation or disruption of exonic sequences relevant for the splicing process might in fact cause these different splice phenomena observed in the NF1 gene.	Univ Ulm, Abt Humangenet, D-89070 Ulm, Germany; Univ Klinikum Charite, Inst Med Genet, Berlin, Germany; Max Delbruck Ctr Mol Med, Berlin, Germany; Gemeinschaftspraxis B Prager & A Junge, Dresden, Germany	Ulm University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Hoffmeyer, S (corresponding author), Univ Ulm, Abt Humangenet, Albert Einstein Allee 11, D-89070 Ulm, Germany.	sven.hoffmeyer@medizin.uni-ulm.de						Aoufouchi S, 1996, CELL, V85, P415, DOI 10.1016/S0092-8674(00)81119-8; BACH G, 1993, AM J HUM GENET, V53, P330; BASERGA SJ, 1992, P NATL ACAD SCI USA, V89, P2935, DOI 10.1073/pnas.89.7.2935; Boddrich A, 1997, HUM MUTAT, V9, P374; Carter MS, 1996, EMBO J, V15, P5965, DOI 10.1002/j.1460-2075.1996.tb00983.x; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; Chiara MD, 1996, MOL CELL BIOL, V16, P3317; Cogan JD, 1997, HUM MOL GENET, V6, P909, DOI 10.1093/hmg/6.6.909; DAAR IO, 1988, MOL CELL BIOL, V8, P802, DOI 10.1128/MCB.8.2.802; DANGLOT G, 1995, HUM MOL GENET, V4, P915, DOI 10.1093/hmg/4.5.915; DIETZ HC, 1994, NAT GENET, V8, P183, DOI 10.1038/ng1094-183; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; DIETZ HC, 1992, J CLIN INVEST, V89, P1674, DOI 10.1172/JCI115766; FOJO SS, 1989, J CLIN INVEST, V84, P1215, DOI 10.1172/JCI114287; GIBSON RA, 1993, HUM MOL GENET, V2, P797, DOI 10.1093/hmg/2.6.797; HEIM RA, 1995, HUM MOL GENET, V4, P975, DOI 10.1093/hmg/4.6.975; HOFFMEYER S, 1994, HUM GENET, V93, P481; HOFFMEYER S, 1994, NAT GENET, V6, P331, DOI 10.1038/ng0494-331; HOFFMEYER S, 1995, HUM MOL GENET, V4, P126; HULL J, 1994, GENOMICS, V19, P362, DOI 10.1006/geno.1994.1070; HUSON SM, 1994, NEUROFIBROMATOSIS CL; KORF B, 1997, NNFF INT NF1 GENETIC; LAVIGUEUR A, 1993, GENE DEV, V7, P2405, DOI 10.1101/gad.7.12a.2405; LEHRMAN MA, 1987, J BIOL CHEM, V262, P401; LI Y, 1995, GENOMICS, V25, P9, DOI 10.1016/0888-7543(95)80104-T; Liu WG, 1997, NAT GENET, V16, P328, DOI 10.1038/ng0897-328; LYNCH KW, 1995, GENE DEV, V9, P284, DOI 10.1101/gad.9.3.284; Maquat LE, 1996, AM J HUM GENET, V59, P279; MAQUAT LE, 1995, RNA, V1, P453; MATSUO M, 1991, J CLIN INVEST, V87, P2127, DOI 10.1172/JCI115244; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; Messiaen L, 1997, HUM GENET, V101, P75, DOI 10.1007/s004390050590; OGASAWARA M, 1994, HUM MOL GENET, V3, P867, DOI 10.1093/hmg/3.6.867; Reed R, 1996, CURR OPIN GENET DEV, V6, P215, DOI 10.1016/S0959-437X(96)80053-0; ROBINSON PN, 1995, HUM GENET, V96, P95, DOI 10.1007/BF00214193; ROEST PAM, 1993, HUM MOL GENET, V2, P1719, DOI 10.1093/hmg/2.10.1719; SANTISTEBAN I, 1995, HUM MOL GENET, V4, P2081, DOI 10.1093/hmg/4.11.2081; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SIRANDPUGNET P, 1995, NUCLEIC ACIDS RES, V23, P3501, DOI 10.1093/nar/23.17.3501; STAKNIS D, 1994, MOL CELL BIOL, V14, P7670, DOI 10.1128/MCB.14.11.7670; STEINGRIMSDOTTI.H, 1992, NUCLEIC ACIDS RES, V6, P1201; TANAKA K, 1994, MOL CELL BIOL, V14, P1347, DOI 10.1128/MCB.14.2.1347; TURNER DH, 1988, ANNU REV BIOPHYS BIO, V17, P167; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; WAKAMATSU N, 1992, J BIOL CHEM, V267, P2406; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; WATAKABE A, 1993, GENE DEV, V7, P407, DOI 10.1101/gad.7.3.407; ZUCKER M, 1981, NUCLEIC ACIDS RES, V9, P133; 1997, HUMAN GENE MUTATION	50	48	48	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1998	62	2					269	277		10.1086/301715	http://dx.doi.org/10.1086/301715			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA927	9463322	Green Published, Bronze			2022-12-18	WOS:000072416000009
J	Gould, DB; Mears, AJ; Pearce, WG; Walter, MA				Gould, DB; Mears, AJ; Pearce, WG; Walter, MA			Autosomal dominant Axenfeld-Rieger anomaly maps to 6p25	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							FACTOR GENE; PAX6 GENE; IRIDOGONIODYSGENESIS; ANIRIDIA		UNIV ALBERTA,OCULAR GENET LAB,HERITAGE MED RES CTR 671,DEPT MED GENET,EDMONTON,AB,CANADA; UNIV ALBERTA,DEPT OPHTHALMOL,EDMONTON,AB,CANADA	University of Alberta; University of Alberta								ALWARD LM, 1995, MOL GENETICS OCULAR, P31; HEON E, 1995, HUM MOL GENET, V4, P1425; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; LEGIUS E, 1994, J MED GENET, V31, P340, DOI 10.1136/jmg.31.4.340; LEVIN H, 1986, AM J MED GENET, V25, P281, DOI 10.1002/ajmg.1320250212; Mears AJ, 1996, AM J HUM GENET, V59, P1321; MIRZAYANS F, 1995, AM J HUM GENET, V57, P539; MORTON NE, 1956, AM J HUM GENET, V8, P80; MURRAY JC, 1992, NAT GENET, V2, P46, DOI 10.1038/ng0992-46; PEARCE WG, 1983, CAN J OPHTHALMOL, V18, P7; Phillips JC, 1996, AM J HUM GENET, V59, P613; Reid CS, 1983, PEDIATR RES, V17, p217A; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Shields M B, 1983, Trans Am Ophthalmol Soc, V81, P736; Walter MA, 1996, OPHTHALMOLOGY, V103, P1907, DOI 10.1016/S0161-6420(96)30408-9	15	48	56	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1997	61	3					765	768						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY523	9326342				2022-12-18	WOS:A1997XY52300034
J	Holmans, P; Craddock, N				Holmans, P; Craddock, N			Efficient strategies for genome scanning using maximum-likelihood affected-sib-pair analysis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETICALLY COMPLEX TRAITS; PEDIGREE-MEMBER METHOD; LINKAGE ANALYSIS; MULTILOCUS MODELS; CANDIDATE GENE; TRANSMISSION; ASSOCIATION	Detection of linkage with a systematic genome scan in nuclear families including an affected sibling pair is an important initial step on the path to cloning susceptibility genes for complex genetic disorders, and it is desirable to optimize the efficiency of such studies. The aim is to maximize power while simultaneously minimizing the total number of genotypings and probability of type I error. One approach to increase efficiency, which has been investigated by other workers, is grid tightening: a sample is initially typed using a coarse grid of markers, and promising results are followed up by use of a finer grid. Another approach, not previously considered in detail in the context of an affected-sib-pair genome scan for linkage, is sample splitting: a portion of the sample is typed in the screening stage, and promising results are followed up in the whole sample. In the current study, we have used computer simulation to investigate the relative efficiency of two-stage strategies involving combinations of both grid tightening and sample splitting and found that the optimal strategy incorporates both approaches. In general, typing half the sample of affected pairs with a coarse grid of markers in the screening stage is an efficient strategy under a variety of conditions. If Hardy-Weinberg equilibrium holds, it is most efficient not to type parents in the screening stage. If Hardy-Weinberg equilibrium does not hold (e.g., because of stratification) failure to type parents in the first stage increases the amount of genotyping required, although the overall probability of type I error is not greatly increased, provided the parents are used in the final analysis.			Holmans, P (corresponding author), UNIV WALES COLL MED,DEPT PSYCHOL MED,HEATH PK,CARDIFF CF4 4XN,S GLAM,WALES.		Holmans, Peter/F-4518-2015	Holmans, Peter/0000-0003-0870-9412	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BROWN DL, 1994, AM J HUM GENET, V54, P544; Craddock N, 1996, MOL PSYCHIATR, V1, P59; Craddock N, 1996, BRIT MED BULL, V52, P434; CRADDOCK N, 1995, AM J HUM GENET, V57, P690; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; ELSTON RC, 1994, GENETIC APPROACHES M, P3; ELSTON RC, 1992, 16TH P INT BIOM C HA, P39; Hauser ER, 1996, GENET EPIDEMIOL, V13, P117, DOI 10.1002/(SICI)1098-2272(1996)13:2<117::AID-GEPI1>3.0.CO;2-5; HOLMANS P, 1993, AM J HUM GENET, V52, P362; HOLMANS P, 1995, AM J HUM GENET, V57, P1221; HOLMANS P, 1995, AM J HUM GENET; HOLMANS P, 1995, WORLD C PSYCH GEN CA; Korczak JF, 1995, GENET EPIDEMIOL, V12, P625, DOI 10.1002/gepi.1370120617; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; NEMESURE B, 1996, GENET EPIDEMIOL, V12, P653; RISCH N, 1990, AM J HUM GENET, V46, P242; RISCH N, 1990, AM J HUM GENET, V46, P222; Risch N.J., 1994, GENETIC APPROACHES M, P47; SHAM P, 1994, AM J MED GENET, V54, P154, DOI 10.1002/ajmg.1320540212; SOBELL JL, 1993, AM J MED GENET, V48, P28, DOI 10.1002/ajmg.1320480108; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; WEEKS DE, 1988, AM J HUM GENET, V42, P315	23	48	48	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1997	60	3					657	666						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK403	9042927				2022-12-18	WOS:A1997WK40300024
J	Radhakrishna, U; Blouin, JL; Mehenni, H; Patel, UC; Patel, MN; Solanki, JV; Antonarakis, SE				Radhakrishna, U; Blouin, JL; Mehenni, H; Patel, UC; Patel, MN; Solanki, JV; Antonarakis, SE			Mapping one form of autosomal dominant postaxial polydactyly type A to chromosome 7p15-q11.23 by linkage analysis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GREIG CEPHALOPOLYSYNDACTYLY SYNDROME; GENE; MAPS; REGION; LOCALIZATION; DELETION; LOCUS; 7Q36; GCPS	Postaxial polydactyly type-A (PAP-A) in humans is an autosomal dominant trait characterized by an extra digit in the ulnar and/or fibular side of the upper and/or lower extremities. The extra digit is well formed and articulates with the fifth, or extra, metacarpal/metatarsal, and thus it is usually functional. In order to map the gene responsible for PAP-A, we studied a five-generation Indian family of 37 individuals (15 of whom were affected). A genomewide search with highly informative polymorphic markers on part of the pedigree showed linkage between the PAP-A phenotype and markers on chromosome 7p15-q11.23 (no crossovers were found with D7S526, D7S795, D7S528, D7S521, D7S691, D7S667, D7S478, D7S1830, D7S803, D7S801, or ELN). The highest LOD score was obtained with marker D7S801 (Z(max)=4.21; theta=0). Haplotype analysis enabled the mapping of the PAP-A phenotype in this family between markers D7S2848 and D7S669. Analysis of additional families with PAP-A will narrow down the critical genomic region, facilitate positional cloning of the PAP-A gene, and/or uncover potential genetic heterogeneity.	UNIV GENEVA,CTR MED,SCH MED,DEPT GENET & MICROBIOL,LAB HUMAN MOL GENET,CH-1211 GENEVA,SWITZERLAND; CANTONAL HOSP,DIV MED GENET,GENEVA,SWITZERLAND; VET COLL,DEPT ANIM BREEDING & GENET,ANAND,GUJARAT,INDIA	University of Geneva; University of Geneva			Antonarakis, Stylianos E/N-8866-2014	Antonarakis, Stylianos E/0000-0001-8907-5823				BLOUIN JL, 1995, AM J HUM GENET, V57, P388; Borrow J, 1996, NAT GENET, V12, P159, DOI 10.1038/ng0296-159; BRUETON L, 1988, AM J MED GENET, V31, P799, DOI 10.1002/ajmg.1320310412; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; CANTU JM, 1974, BIRTH DEFECTS, V5, P19; CASTILLA E, 1973, AM J HUM GENET, V25, P405; Cohn MJ, 1996, TRENDS GENET, V12, P253, DOI 10.1016/0168-9525(96)10030-5; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DUBOULE D, 1994, SCIENCE, V266, P575, DOI 10.1126/science.7939709; FRAZIER TM, 1960, AM J OBSTET GYNECOL, V80, P184; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HEUTINK P, 1994, NAT GENET, V6, P287, DOI 10.1038/ng0394-287; HING AV, 1995, AM J MED GENET, V58, P128, DOI 10.1002/ajmg.1320580208; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; KRUGER G, 1989, AM J MED GENET, V32, P411, DOI 10.1002/ajmg.1320320329; KUCHERIA K, 1981, CLIN GENET, V20, P36; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEWANDOWSKI RC, 1977, NEW CHROMOSOMAL SYND, P369; MERLOB P, 1981, ACTA PAEDIATR SCAND, V70, P275, DOI 10.1111/j.1651-2227.1981.tb05557.x; MOHAN J, 1969, Journal of Medical Genetics, V6, P196, DOI 10.1136/jmg.6.2.196; MOLLICA F, 1978, J MED GENET, V15, P212, DOI 10.1136/jmg.15.3.212; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; NAKAMURA A., 1962, ANNU REP NAT I GENET, V13, P31; *NIH CEPH COLL MAP, 1992, SCIENCE, V258, P67; Odiorne JM, 1943, J HERED, V34, P45, DOI 10.1093/oxfordjournals.jhered.a105244; Polymeropoulos MH, 1996, GENOMICS, V35, P1, DOI 10.1006/geno.1996.0315; Radhakrishna U, 1996, AM J MED GENET, V66, P209, DOI 10.1002/(SICI)1096-8628(19961211)66:2<209::AID-AJMG17>3.3.CO;2-M; Sambrook J, 1989, MOL CLONING LAB MANU; SARFARAZI M, 1995, HUM MOL GENET, V4, P1453, DOI 10.1093/hmg/4.8.1453; SCOTTEMUAKPOR AB, 1976, HUM HERED, V26, P198, DOI 10.1159/000152803; Sverdrup A, 1922, J GENET, V12, P217, DOI 10.1007/BF02983978; TEMTAMY S, 1969, Birth Defects Original Article Series, V5, P125; Temtamy SA, 1990, BIRTH DEFECTS ENCY, P1397; TSUI LC, 1995, CYTOGENET CELL GENET, V71, P1, DOI 10.1159/000134055; TSUKUROV O, 1994, NAT GENET, V6, P282, DOI 10.1038/ng0394-282; VENTRUTO V, 1980, CLIN GENET, V18, P342; VORTKAMP A, 1995, HUM GENET, V95, P82; VORTKAMP A, 1992, MAMM GENOME, V3, P461, DOI 10.1007/BF00356157; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; WALKER JT, 1961, ANN HUM GENET, V25, P65, DOI 10.1111/j.1469-1809.1961.tb01498.x	42	48	55	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1997	60	3					597	604						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK403	9042919				2022-12-18	WOS:A1997WK40300016
J	Suchi, M; Mizuno, H; Kawai, Y; Tsuboi, T; Sumi, S; Okajima, K; Hodgson, ME; Ogawa, H; Wada, Y				Suchi, M; Mizuno, H; Kawai, Y; Tsuboi, T; Sumi, S; Okajima, K; Hodgson, ME; Ogawa, H; Wada, Y			Molecular cloning of the human UMP synthase gene and characterization of point mutations in two hereditary orotic aciduria families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TYROSINE AMINOTRANSFERASE GENE; LIVER-SPECIFIC GENES; DNA-BINDING PROTEIN; TRANSCRIPTION FACTOR; NUCLEOTIDE-SEQUENCE; DROSOPHILA-MELANOGASTER; PROMOTER REGIONS; EXPRESSION; CELLS; ENHANCER	Uridine monophosphate (UMP) synthase is a bifunctional enzyme catalyzing the last two steps of de novo pyrimidine biosynthesis, orotate phosphoribosyltransferase (OPRT) and orotidine-5'-monophosphate decarboxylase (ODC). Loss of either enzymatic activity results in hereditary erotic aciduria, a rare autosomal recessive disorder characterized by retarded growth, anemia, and excessive urinary excretion of erotic acid. We have isolated the UMP synthase chromosomal gene from a lambda EMBL-3 human genomic library and report a single-copy gene spanning similar to 15 kb. The UMP synthase genomic structure encodes six exons ranging; in size from 115 bp to 672 bp, and all splicing junctions adhere to the canonical GT/AG rule. Cognate promoter elements implicated in glucocorticoid- and cAMP-mediated regulation as well as in liver-, myeloid-, and lymphocyte-specific expression are located within the 5' flanking sequence. Molecular investigation of UMP synthase deficiency in a Japanese erotic aciduria patient revealed mutations R96G (A-to-G transition; nt 286) and G429R (G-to-C transversion; nt 1285) in one allele and V109G (T-to-G transversion; nt 326) in the other allele. Expression of human UMP synthase cDNAs containing these mutations in pyrimidine auxotrophic Escherichia coli and in recombinant baculovirus-infected Sf21 cells demonstrates impaired activity presumably associated with the urinary erotic acid substrate accumulations observed in vivo. We further establish the identity of two polymorphism, G213A (v=.26) and 440Gpoly (v =.27) located in exons 3 and 6, respectively, which did not significantly compromise either OPRT or ODC function.	NAGOYA CITY UNIV, SCH MED, DEPT PEDIAT, NAGOYA, AICHI 467, JAPAN; NAGOYA CITY UNIV, SCH MED, DEPT BIOREGULAT RES, NAGOYA, AICHI 467, JAPAN; NAGOYA CITY UNIV, COLL NURSING, DEPT PEDIAT NURSING, NAGOYA, AICHI 467, JAPAN; NAGOYA CITY CHILD WELF CTR, DEPT PEDIAT, NAGOYA, AICHI, JAPAN; FUJITA HLTH UNIV, SCH MED, DEPT BIOL, TOYOAKE, AICHI 47011, JAPAN	Nagoya City University; Nagoya City University; Nagoya City University; Fujita Health University								Armitage P., 2001, STAT METHODS MED RES; BAAS F, 1984, HUM GENET, V67, P301, DOI 10.1007/BF00291357; BEGUERET J, 1984, GENE, V32, P487, DOI 10.1016/0378-1119(84)90023-4; BERNSTEIN LR, 1989, SCIENCE, V244, P566, DOI 10.1126/science.2541502; BHAT NK, 1990, P NATL ACAD SCI USA, V87, P3723, DOI 10.1073/pnas.87.10.3723; BIGGIN MD, 1988, CELL, V53, P699, DOI 10.1016/0092-8674(88)90088-8; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; BRODERICK TP, 1987, P NATL ACAD SCI USA, V84, P3349, DOI 10.1073/pnas.84.10.3349; BROWN GK, 1977, BIOCHEMISTRY-US, V16, P3235, DOI 10.1021/bi00633a030; CHEN JL, 1994, CELL, V79, P93, DOI 10.1016/0092-8674(94)90403-0; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DENTON JE, 1982, CANCER RES, V42, P1176; DYNAN WS, 1986, TRENDS GENET, V2, P196, DOI 10.1016/0168-9525(86)90226-X; EISENBERG M, 1993, GENE, V124, P263, DOI 10.1016/0378-1119(93)90403-P; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; FAURE M, 1988, CELL DIFFER DEV, V22, P159, DOI 10.1016/0045-6039(88)90028-0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FINK JS, 1988, P NATL ACAD SCI USA, V85, P6662, DOI 10.1073/pnas.85.18.6662; FOX RM, 1973, AM J MED, V55, P791, DOI 10.1016/0002-9343(73)90260-X; FUCHS R, 1994, COMPUT APPL BIOSCI, V10, P171; GHOSH D, 1992, NUCLEIC ACIDS RES, V20, P2091, DOI 10.1093/nar/20.suppl.2091; GRANGE T, 1991, NUCLEIC ACIDS RES, V19, P131, DOI 10.1093/nar/19.1.131; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; HARDON EM, 1988, EMBO J, V7, P1711, DOI 10.1002/j.1460-2075.1988.tb03000.x; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; IMAEDA M, 1995, JPN SOC INHERIT META, V11, P117; JANTZEN HM, 1987, CELL, V49, P29, DOI 10.1016/0092-8674(87)90752-5; JOHNSON FB, 1992, GENE DEV, V6, P2177, DOI 10.1101/gad.6.11.2177; JONES LR, 1986, COMP BIOCHEM PHYS B, V84, P489, DOI 10.1016/0305-0491(86)90112-4; JUDD BH, 1995, GENETICS, V141, P245; KARIN M, 1984, NATURE, V308, P513, DOI 10.1038/308513a0; KROOTH RS, 1964, COLD SPRING HARB SYM, V29, P189, DOI 10.1101/SQB.1964.029.01.024; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; LIN T, 1995, SOMAT CELL MOLEC GEN, V21, P161, DOI 10.1007/BF02254768; LIN T, 1993, SOMAT CELL MOLEC GEN, V19, P193, DOI 10.1007/BF01233533; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; MARTIN ME, 1988, P NATL ACAD SCI USA, V85, P5839, DOI 10.1073/pnas.85.16.5839; MITCHELL PJ, 1991, GENE DEV, V5, P105, DOI 10.1101/gad.5.1.105; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; MORISHITA H, 1986, J JPN PEDIAT SOC, V90, P2775; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; OZTURK DH, 1995, BIOCHEMISTRY-US, V34, P10755, DOI 10.1021/bi00034a007; PAUSCH J, 1972, BIOCHIM BIOPHYS ACTA, V258, P395, DOI 10.1016/0005-2744(72)90231-8; PERRY ME, 1989, J BIOL CHEM, V264, P15522; PINSKY L, 1967, P NATL ACAD SCI USA, V57, P925, DOI 10.1073/pnas.57.4.925; POULSEN P, 1984, EMBO J, V3, P1783, DOI 10.1002/j.1460-2075.1984.tb02046.x; PROGNONEC P, 1989, ONCOGENE, V4, P691; QUMSIYEH MB, 1995, CHROMOSOME RES, V3, P455, DOI 10.1007/BF00713959; QUMSIYEH MB, 1989, GENOMICS, V5, P160, DOI 10.1016/0888-7543(89)90103-1; RAMJI DP, 1991, NUCLEIC ACIDS RES, V19, P1139, DOI 10.1093/nar/19.5.1139; RAWLS JM, 1979, COMP BIOCHEM PHYS B, V62, P207, DOI 10.1016/0305-0491(79)90201-3; REYES P, 1978, LIFE SCI, V22, P577, DOI 10.1016/0024-3205(78)90336-3; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SUCHI M, 1988, Nagoya Medical Journal, V32, P207; SUCHI M, 1989, ADV EXP MED BIOL, P511; SUGIURA Y, 1986, JPN J CANCER RES, V77, P664; SUMMERS MD, 1987, TEXAS AGR EXPT STATI, V1555, P1; SUTTLE DP, 1988, P NATL ACAD SCI USA, V85, P1754, DOI 10.1073/pnas.85.6.1754; TOMATSU S, 1989, GENE, V80, P353; TRAUT TW, 1980, BIOCHEMISTRY-US, V19, P6068, DOI 10.1021/bi00567a019; TRAUT TW, 1979, J BIOL CHEM, V254, P1143; TRUS M, 1990, MOL CELL BIOL, V10, P2418, DOI 10.1128/MCB.10.5.2418; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; TURNBOUGH CL, 1987, J BIOL CHEM, V262, P10239; WEBER G, 1981, CANCER RES, V41, P854; WEBSTER DR, 1995, METABOLIC MOL BASES, P1799; WERNER D, 1984, ANAL BIOCHEM, V141, P329, DOI 10.1016/0003-2697(84)90050-2; WINICK J, 1993, DEVELOPMENT, V119, P1055; WINKLER JK, 1988, AM J HUM GENET, V43, P86; WORTHY TE, 1974, P NATL ACAD SCI USA, V71, P3031, DOI 10.1073/pnas.71.8.3031; Yablonski MJ, 1996, J BIOL CHEM, V271, P10704, DOI 10.1074/jbc.271.18.10704; YANG Z, 1990, P NATL ACAD SCI USA, V87, P9226, DOI 10.1073/pnas.87.23.9226; YAZAKI M, 1987, TOHOKU J EXP MED, V153, P189, DOI 10.1620/tjem.153.189	76	48	50	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1997	60	3					525	539						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK403	9042911				2022-12-18	WOS:A1997WK40300008
J	Benlian, P; Foubert, L; Gagne, E; Bernard, L; DeGennes, JL; Langlois, S; Robinson, W; Hayden, M				Benlian, P; Foubert, L; Gagne, E; Bernard, L; DeGennes, JL; Langlois, S; Robinson, W; Hayden, M			Complete paternal isodisomy for chromosome 8 unmasked by lipoprotein lipase deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LPL GENE; UNIPARENTAL DISOMY; RECOMBINATION; MUTATIONS; NONDISJUNCTION; CHOLESTEROL; EXON-9; ORIGIN; MAP	Uniparental disomy (UPD)-the inheritance of two homologous chromosomes from a single parent-may be unmasked in humans by the unexpected appearance of developmental abnormalities, genetic disorders resulting from genomic imprinting, or recessive traits. Here we report a female patient with familial chylomicronemia resulting from complete lipoprotein-lipase (LPL) deficiency due to homozygosity for a frameshift mutation in exon 2 of the LPL gene. She was the normal term product of an unremarkable pregnancy and had shown normal development until her current age of 5.5 years. The father (age 33 years) and the mother (age 24 years) were unrelated and healthy, with no family history of stillbirths or malformations. The father was a heterozygous carrier of the mutation, whereas no mutation in the LPL gene was detected in the mother. Southern blotting did not reveal any LPL gene rearrangement in the proband or her parents. The proband was homozygous for 17 informative markers spanning both arms of chromosome 8 and specifically for the haplotype containing the paternally derived LPL gene. This shows that homozygosity for the defective mutation in the LPL gene resulted from a complete paternal isodisomy for chromosome 8. This is the first report of UPD for chromosome 8 unmasked by LPL deficiency and suggests that normal development can occur with two paternally derived copies of human chromosome 8.	HOP PITIE, DEPT ENDOCRINOL & METAB DIS, F-75651 PARIS, FRANCE; HOP ST ANTOINE, DEPT MOL BIOL, F-75571 PARIS, FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Benlian, P (corresponding author), UNIV BRITISH COLUMBIA, DEPT MED GENET, 2125 E MALL, VANCOUVER, BC V6T 1Z4, CANADA.		Robinson, Wendy/AAB-6420-2020; Hayden, Michael R/D-8581-2011; Robinson, Wendy P/I-9590-2014	Robinson, Wendy/0000-0002-2010-6174; Hayden, Michael R/0000-0001-5159-1419; Robinson, Wendy P/0000-0002-2010-6174				ALLAIN CC, 1974, CLIN CHEM, V20, P470; ANTONARAKIS SE, 1993, NAT GENET, V3, P146, DOI 10.1038/ng0293-146; BABIRAK SP, 1989, ARTERIOSCLEROSIS, V9, P326, DOI 10.1161/01.ATV.9.3.326; BENLIAN P, 1995, J LIPID RES, V36, P356; Brunzell J.D., 1995, METABOLIC MOL BASES, P1913; BUCOLO G, 1973, CLIN CHEM, V19, P476; CATTANACH BM, 1994, J INHERIT METAB DIS, V17, P403, DOI 10.1007/BF00711356; DEGROUCHY J, 1983, PRINCIPLES PRACTICE, P170; ENGEL E, 1995, ANN GENET-PARIS, V38, P113; FISHER JM, 1995, AM J HUM GENET, V56, P669; GAGNE E, 1994, ARTERIOSCLER THROMB, V14, P1250, DOI 10.1161/01.ATV.14.8.1250; GOLDBERG YP, 1993, HUM MOL GENET, V2, P635, DOI 10.1093/hmg/2.6.635; GORODA T, 1992, J LIPID RES, V33, P1067; HALL JG, 1990, AM J HUM GENET, V46, P857; HATA A, 1990, NUCLEIC ACIDS RES, V18, P5407, DOI 10.1093/nar/18.18.5407; Hayden M.R., 1991, CURRENT OPINION LIPI, V2, P104; HIXSON JE, 1990, J LIPID RES, V31, P545; IVERIUS PH, 1985, AM J PHYSIOL, V249, pE107, DOI 10.1152/ajpendo.1985.249.1.E107; Junien C, 1992, CURR OPIN GENET DEV, V2, P431, DOI 10.1016/S0959-437X(05)80154-6; KOTZOT D, 1995, HUM MOL GENET, V4, P583, DOI 10.1093/hmg/4.4.583; LANGLOIS S, 1989, P NATL ACAD SCI USA, V86, P948, DOI 10.1073/pnas.86.3.948; LEDBETTER DH, 1995, HUM MOL GENET, V4, P1757, DOI 10.1093/hmg/4.suppl_1.1757; LUDWIG EH, 1990, AM J HUM GENET, V47, P712; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; MCKUSICK VA, 1995, MENDELIAN INHERITANC; MONSALVE MV, 1990, J CLIN INVEST, V86, P728, DOI 10.1172/JCI114769; PEREIRA E, 1995, HUM GENET, V96, P319, DOI 10.1007/BF00210415; Robinson WP, 1996, AM J MED GENET, V61, P158, DOI 10.1002/(SICI)1096-8628(19960111)61:2<158::AID-AJMG11>3.0.CO;2-T; ROBINSON WP, 1993, AM J HUM GENET, V53, P740; ROBINSON WP, 1995, AM J HUM GENET, V56, P444; SPARKES R S, 1987, Genomics, V1, P138, DOI 10.1016/0888-7543(87)90005-X; WARNICK GR, 1978, CLIN CHEM, V24, P900; WOOD S, 1993, HUM GENET, V91, P312; ZULIANI G, 1990, NUCLEIC ACIDS RES, V18, P4958, DOI 10.1093/nar/18.16.4958-a	34	48	48	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1996	59	2					431	436						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VM288	8755931				2022-12-18	WOS:A1996VM28800020
J	Greenberg, DA; Hodge, SE; Vieland, VJ; Spence, MA				Greenberg, DA; Hodge, SE; Vieland, VJ; Spence, MA			Affecteds-only linkage methods are not a panacea	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							INFERRING MODE; LOD SCORES; INHERITANCE; EPILEPSY; LOCUS; PENETRANCE; DISEASE; TRAITS		MT SINAI MED CTR,DEPT BIOMATH,NEW YORK,NY 10029; NEW YORK STATE PSYCHIAT INST & HOSP,NEW YORK,NY; COLUMBIA UNIV,NEW YORK,NY; UNIV IOWA,COLL MED,DEPT PREVENT MED & ENVIRONM HLTH,IOWA CITY,IA; UNIV IOWA,COLL MED,DEPT PSYCHIAT,IOWA CITY,IA; UNIV CALIF IRVINE,IRVINE MED CTR,DEPT PEDIAT,ORANGE,CA 92668	Icahn School of Medicine at Mount Sinai; New York State Psychiatry Institute; Columbia University; University of Iowa; University of Iowa; University of California System; University of California Irvine	Greenberg, DA (corresponding author), MT SINAI MED CTR,DEPT PSYCHIAT,NEW YORK,NY 10029, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH036197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027941] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK31775] Funding Source: Medline; NIMH NIH HHS [MH36197] Funding Source: Medline; NINDS NIH HHS [NS27941] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BERRETTINI WH, 1994, P NATL ACAD SCI USA, V91, P5918, DOI 10.1073/pnas.91.13.5918; BLANGERO J, 1995, GENET EPIDEMIOL, V12, P684; BYERLEY W, 1995, PSYCHIATR GENET, V5, P23, DOI 10.1097/00041444-199521000-00004; CLERGETDARPOUX F, 1992, ANN HUM GENET, V56, P145, DOI 10.1111/j.1469-1809.1992.tb01140.x; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; CURTIS D, 1995, AM J HUM GENET, V57, P703; DURNER M, 1991, NEUROLOGY, V41, P1651, DOI 10.1212/WNL.41.10.1651; ELSTON RC, 1989, AM J MED GENET, V34, P487, DOI 10.1002/ajmg.1320340407; Goldin L. R., 1994, GENETIC APPROACHES M, P77; GOLDIN LR, 1993, AM J HUM GENET, V53, P908; GREENBERG DA, 1994, AM J HUM GENET, V55, P834; GREENBERG DA, 1989, GENET EPIDEMIOL, V6, P259, DOI 10.1002/gepi.1370060145; GREENBERG DA, 1989, AM J MED GENET, V34, P480, DOI 10.1002/ajmg.1320340406; GREENBERG DA, 1988, AM J MED GENET, V31, P185, DOI 10.1002/ajmg.1320310125; GREENBERG DA, 1992, ARCH GEN PSYCHIAT, V49, P745; GREENBERG DA, 1990, GENET EPIDEMIOL, V7, P467, DOI 10.1002/gepi.1370070608; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HODGE SE, 1994, GENET EPIDEMIOL, V11, P329, DOI 10.1002/gepi.1370110403; HODGE SE, 1993, AM J HUM GENET, V53, P775; KNAPP M, 1994, HUM HERED, V44, P44, DOI 10.1159/000154188; NAIR RP, 1995, HUM HERED, V45, P219, DOI 10.1159/000154293; Rice JP, 1995, GENET EPIDEMIOL, V12, P659, DOI 10.1002/gepi.1370120623; Rogus JJ, 1995, GENET EPIDEMIOL, V12, P665, DOI 10.1002/gepi.1370120624; VIELAND VJ, 1992, GENET EPIDEMIOL, V9, P45, DOI 10.1002/gepi.1370090106; VIELAND VJ, 1993, HUM HERED, V43, P329, DOI 10.1159/000154155; VIELAND VJ, 1995, AM J HUM GENET, V56, P33; VIELAND VJ, 1996, IN PRESS AM J HUM GE, V58; WEEKS DE, 1990, GENET EPIDEMIOL, V7, P237, DOI 10.1002/gepi.1370070402; WEEKS DE, 1995, HUM HERED, V45, P13, DOI 10.1159/000154250; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WILLIAMSON JA, 1990, GENET EPIDEMIOL, V7, P309, DOI 10.1002/gepi.1370070502; ZARA F, 1995, HUM MOL GENET, V4, P1201, DOI 10.1093/hmg/4.7.1201	32	48	49	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1996	58	4					892	895						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UA380	8644756				2022-12-18	WOS:A1996UA38000030
J	Ehm, MG; Kimmel, M; Cottingham, RW				Ehm, MG; Kimmel, M; Cottingham, RW			Error detection for genetic data, using likelihood methods	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; MAPS; CONSTRUCTION	As genetic maps become denser, the effect of laboratory typing errors becomes more serious. We review a general method for detecting errors in pedigree genotyping data that is a variant of the likelihood-ratio test statistic. It pinpoints individuals and loci with relatively unlikely genotypes. Power and significance studies using Monte Carlo methods are shown by using simulated data with pedigree structures similar to the CEPH pedigrees and a larger experimental pedigree used in the study of idiopathic dilated cardiomyopathy (DCM). The studies show the index detects errors for small values of theta with high power and an acceptable false positive rate. The method was also used to check for errors in DCM laboratory pedigree data and to estimate the error rate in CEPH chromosome 6 data. The errors flagged by our method in the DCM pedigree were confirmed by the laboratory, The results are consistent with estimated false-positive and false-negative rates obtained using simulation.	BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030; RICE UNIV,DEPT STAT,HOUSTON,TX 77251	Baylor College of Medicine; Rice University			Cottingham, Robert/D-2628-2014	Cottingham, Robert/0000-0002-2775-3905				Boehnke M., 1992, American Journal of Human Genetics, V51, pA183; BRZUSTOWICZ LM, 1991, AM J HUM GENET, V53, P1137; BUETOW KH, 1991, AM J HUM GENET, V49, P985; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DRACOPOLI NC, 1991, GENOMICS, V9, P686, DOI 10.1016/0888-7543(91)90362-I; Ehm Margaret Gelder, 1995, Journal of Biological Systems, V3, P13, DOI 10.1142/S0218339095000034; KEATS BJB, 1990, CYTOGENET CELL GENET, V55, P387, DOI 10.1159/000133023; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1983, AM J HUM GENET, V35, P241; LATHROP GM, 1986, GENET EPIDEMIOL, V3, P39, DOI 10.1002/gepi.1370030105; LINCOLN SE, 1992, GENOMICS, V14, P604, DOI 10.1016/S0888-7543(05)80158-2; MORTON NE, 1990, ANN HUM GENET, V54, P235, DOI 10.1111/j.1469-1809.1990.tb00381.x; OTT J, 1993, HUM HERED, V43, P25, DOI 10.1159/000154109; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Ott J., 1991, ANAL HUMAN GENETIC L; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Stuart A., 1991, KENDALLS ADV THEORY, V2; VOLZ A, 1994, GENOMICS, V21, P464, DOI 10.1006/geno.1994.1302; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204	21	48	48	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1996	58	1					225	234						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TL697	8554060				2022-12-18	WOS:A1996TL69700026
J	ZHANG, GG; RODRIGUEZ, H; FARDELLA, CE; HARRIS, DA; MILLER, WL				ZHANG, GG; RODRIGUEZ, H; FARDELLA, CE; HARRIS, DA; MILLER, WL			MUTATION T318M IN THE CYPIIB2 GENE ENCODING P450CIIAS (ALDOSTERONE SYNTHASE) CAUSES CORTICOSTERONE METHYL OXIDASE-II DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; STEROID 11-BETA-HYDROXYLASE DEFICIENCY; CRYSTAL-STRUCTURE; BIOSYNTHESIS; CYTOCHROME-P-450; CLONING; CYP11B2; CDNA; P450C11; CORTEX	Corticosterone methyl oxidase (CMO) deficiency refers to disorders of aldosterone synthesis due to mutations in the CYP11B2 gene encoding cytochrome P450c11AS, which is the adrenal aldosterone synthase. Type I CMO deficiency is associated with low concentrations of 18OH-corticosterone and aldosterone, due to severe mutations in P450c11AS; while type II CMO deficiency is associated with high concentrations of 18OH-corticosterone and low concentrations of aldosterone, due to less severe mutations of P450c11AS. A single type of mutation, compound homozygosity for R181W and V386A, has been reported as the cause of CMOII deficiency in an inbred population. We now report a patient with a typical clinical and hormonal picture of CMOII deficiency. Direct sequencing of patient and parent DNAs showed that the mother's allele contributed R181W and the deletion/frameshift mutation Delta C372, while the father's allele contributed T3318M and V386A. These mutants were recreated in cDNA expression vectors singly and in the parental pairs, showing that neither allele contributed any measurable activity. This would suggest the patient should have CMOI deficiency. These studies suggest that other factors besides P450c11AS are involved in the genesis of the distinctive CMOI and CMOII phenotypes.	UNIV CALIF SAN FRANCISCO, DEPT PEDIAT, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, METAB RES UNIT, SAN FRANCISCO, CA 94143 USA; PONTIFICIA UNIV CATOLICA CHILE, SCH MED, DEPT ENDOCRINOL, SANTIAGO, CHILE; UNIV UTAH, COLL MED, SALT LAKE CITY, UT USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Pontificia Universidad Catolica de Chile; Utah System of Higher Education; University of Utah			Miller, Walter L/J-3696-2012		FOGARTY INTERNATIONAL CENTER [F05TW004604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037922, R01DK042154] Funding Source: NIH RePORTER; FIC NIH HHS [F05-TW04604] Funding Source: Medline; NIDDK NIH HHS [DK42154, DK37922] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CHUA SC, 1987, P NATL ACAD SCI USA, V84, P7193, DOI 10.1073/pnas.84.20.7193; CURNOW KM, 1993, P NATL ACAD SCI USA, V90, P4552, DOI 10.1073/pnas.90.10.4552; CURNOW KM, 1991, MOL ENDOCRINOL, V5, P1513, DOI 10.1210/mend-5-10-1513; FARDELLA CE, 1995, J CLIN ENDOCR METAB, V80, P1040, DOI 10.1210/jc.80.3.1040; FARDELLA CE, IN PRESS J CLIN ENDO; GELEY S, 1995, J CLIN ENDOCR METAB, V80, P424, DOI 10.1210/jc.80.2.424; HASEMANN CA, 1994, J MOL BIOL, V236, P1169, DOI 10.1016/0022-2836(94)90019-1; HELMBERG A, 1992, J CLIN ENDOCR METAB, V75, P1278, DOI 10.1210/jc.75.5.1278; HUM DW, 1993, ENDOCRINOLOGY, V132, P546, DOI 10.1210/en.132.2.546; KAWAMOTO T, 1990, FEBS LETT, V269, P345, DOI 10.1016/0014-5793(90)81190-Y; KAWAMOTO T, 1990, BIOCHEM BIOPH RES CO, V173, P309, DOI 10.1016/S0006-291X(05)81058-7; KAWAMOTO T, 1992, P NATL ACAD SCI USA, V89, P1458, DOI 10.1073/pnas.89.4.1458; LAUBER M, 1989, ARCH BIOCHEM BIOPHYS, V274, P109, DOI 10.1016/0003-9861(89)90421-9; MALEE MP, 1991, P NATL ACAD SCI USA, V88, P4731, DOI 10.1073/pnas.88.11.4731; MELLON SH, 1995, J BIOL CHEM, V270, P1643, DOI 10.1074/jbc.270.4.1643; MILLER WL, 1988, ENDOCR REV, V9, P295, DOI 10.1210/edrv-9-3-295; MITSUUCHI Y, 1993, BIOCHEM BIOPH RES CO, V190, P864, DOI 10.1006/bbrc.1993.1128; MOORE CCD, 1992, MOL ENDOCRINOL, V6, P2045, DOI 10.1210/me.6.12.2045; MOREL Y, 1989, J CLIN INVEST, V83, P527, DOI 10.1172/JCI113914; MORNET E, 1989, J BIOL CHEM, V264, P20961; NELSON DR, 1993, DNA CELL BIOL, V12, P1, DOI 10.1089/dna.1993.12.1; NELSON DR, 1988, J BIOL CHEM, V263, P6038; OGISHIMA T, 1991, J BIOL CHEM, V266, P10731; OGISHIMA T, 1989, J BIOL CHEM, V264, P10935; PASCOE L, 1992, P NATL ACAD SCI USA, V89, P4996, DOI 10.1073/pnas.89.11.4996; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; RAVICHANDRAN KG, 1993, SCIENCE, V261, P731, DOI 10.1126/science.8342039; ROSLER A, 1993, J STEROID BIOCHEM, V45, P99, DOI 10.1016/0960-0760(93)90128-J; ULICK S, 1992, J CLIN ENDOCR METAB, V74, P1415, DOI 10.1210/jc.74.6.1415; WAGNER MJ, 1991, GENOMICS, V10, P114, DOI 10.1016/0888-7543(91)90491-V; WHITE PC, 1991, J CLIN INVEST, V87, P1664, DOI 10.1172/JCI115182	31	48	51	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1995	57	5					1037	1043						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TA449	7485152				2022-12-18	WOS:A1995TA44900008
J	SHIRABE, K; LANDI, MT; TAKESHITA, M; UZIEL, G; FEDRIZZI, E; BORGESE, N				SHIRABE, K; LANDI, MT; TAKESHITA, M; UZIEL, G; FEDRIZZI, E; BORGESE, N			A NOVEL POINT MUTATION IN A 3'-SPLICE-SITE OF THE NADH-CYTOCHROME-B(5) REDUCTASE GENE RESULTS IN IMMUNOLOGICALLY UNDETECTABLE ENZYME AND IMPAIRED NADH-DEPENDENT ASCORBATE REGENERATION IN CULTURED FIBROBLASTS OF A PATIENT WITH TYPE-II HEREDITARY METHEMOGLOBINEMIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE RADIOIMMUNOBLOTTING ASSAY; HUMAN NADH-CYTOCHROME-B5 REDUCTASE; MESSENGER-RNA; B5 REDUCTASE; RAT-LIVER; SEMIDEHYDROASCORBATE REDUCTASE; CONGENITAL METHEMOGLOBINEMIA; ELECTRON-TRANSFER; BINDING SITE; MEMBRANE	Hereditary met hemoglobinemia with generalized deficiency of NADH-cytochrome b(5) reductase (b(5)R) (type II) is a rare disease characterized by severe developmental abnormalities, which often lead to premature death. Although the molecular relationship between the symptoms of this condition and the enzyme deficit are not understood, it is thought that an important cause is the loss of the lipid metabolizing activities of the endoplasmic reticulum-located reductase. However, the functions of the form located on outer mitochondrial membranes have not been considered previously. In this study, we have analyzed the gene of an Italian patient and identified a novel G-->T transversion at the splice-acceptor site of the 9th exon, which results in the complete absence of immunologically detectable b(5)R in blood cells and skin fibroblasts. In cultured fibroblasts of the patient, NADH-dependent cytochrome c reductase, ferricyanide reductase, and semidehydroascorbate reductase activities were severely reduced. The latter activity is known to be due to b(5)R located on outer mitochondrial membranes. Thus, our results demonstrate that the reductase in its two membrane locations, endoplasmic reticulum and outer mitochondrial membranes, is the product of the same gene and suggest that a defect in ascorbate regeneration may contribute to the phenotype of hereditary methemoglobinemia of the generalized type.	UNIV MILAN,CNR,CTR CYTOPHARMACOL,I-20129 MILAN,ITALY; UNIV MILAN,DEPT PHARMACOL,I-20129 MILAN,ITALY; IST NEUROL CARLO BESTA,MILAN,ITALY	Consiglio Nazionale delle Ricerche (CNR); University of Milan; University of Milan; IRCCS Istituto Neurologico Besta			Borgese, Nica/GWZ-8895-2022	Borgese, Nica/0000-0002-7537-3974	Telethon [E.0081] Funding Source: Medline	Telethon(Fondazione Telethon)		BORGESE N, 1987, J CLIN INVEST, V80, P1296, DOI 10.1172/JCI113205; BORGESE N, 1993, FEBS LETT, V325, P70, DOI 10.1016/0014-5793(93)81416-W; BORGESE N, 1986, BIOCHEM J, V239, P393, DOI 10.1042/bj2390393; BORGESE N, 1993, ENDOPLASMIC RETICULU, V21, P313; BUETLER HO, 1983, METHOD ENZYMAT AN, V2, P369; DARRIGO A, 1993, J BIOL CHEM, V268, P2802; DILIBERTO EJ, 1982, J NEUROCHEM, V39, P563, DOI 10.1111/j.1471-4159.1982.tb03982.x; EIPPER BA, 1983, P NATL ACAD SCI-BIOL, V80, P5144, DOI 10.1073/pnas.80.16.5144; FISHER RA, 1977, ANN HUM GENET, V41, P151; HEGESH E, 1968, J LAB CLIN MED, V72, P339; HIRONO H, 1980, LIPIDS, V15, P272, DOI 10.1007/BF02535839; ITO A, 1981, BIOCHEM BIOPH RES CO, V101, P591, DOI 10.1016/0006-291X(81)91300-0; JAFFE ER, 1995, METABOLIC MOL BASES, P339; JULIER C, 1988, AM J HUM GENET, V42, P297; KENT UM, 1987, J BIOL CHEM, V262, P8174; LEDERER F, 1983, EUR J BIOCHEM, V132, P95, DOI 10.1111/j.1432-1033.1983.tb07330.x; LEROUX A, 1975, NATURE, V258, P619, DOI 10.1038/258619a0; LEVIN EY, 1960, J BIOL CHEM, V235, P2080; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NISHINO H, 1986, J BIOCHEM, V100, P1523, DOI 10.1093/oxfordjournals.jbchem.a121859; PADH H, 1991, NUTR REV, V49, P65, DOI 10.1111/j.1753-4887.1991.tb07407.x; PIETRINI G, 1992, J CELL BIOL, V117, P975, DOI 10.1083/jcb.117.5.975; PRCHAL JT, 1990, AM J MED, V89, P516, DOI 10.1016/0002-9343(90)90384-P; REED R, 1985, CELL, V41, P95, DOI 10.1016/0092-8674(85)90064-9; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIRABE K, 1992, J BIOL CHEM, V267, P20416; SHIRABE K, 1994, J BIOL CHEM, V269, P5952; SHIRABE K, 1991, J BIOL CHEM, V266, P7531; SKOTLAND T, 1980, BIOCHIM BIOPHYS ACTA, V630, P30, DOI 10.1016/0304-4165(80)90134-8; SMITH CWJ, 1989, NATURE, V342, P243, DOI 10.1038/342243a0; SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415; TAKESUE S, 1970, J BIOCHEM-TOKYO, V67, P259, DOI 10.1093/oxfordjournals.jbchem.a129249; TOMATSU S, 1989, GENE, V80, P353; WAKEFIELD LM, 1986, J BIOL CHEM, V261, P9746; YUBISUI T, 1991, J BIOL CHEM, V266, P66	37	48	48	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1995	57	2					302	310						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RL771	7668255				2022-12-18	WOS:A1995RL77100012
J	FRIEDLANDER, Y; ELKANA, Y; SINNREICH, R; KARK, JD				FRIEDLANDER, Y; ELKANA, Y; SINNREICH, R; KARK, JD			GENETIC AND ENVIRONMENTAL SOURCES OF FIBRINOGEN VARIABILITY IN ISRAELI FAMILIES - THE KIBBUTZIM FAMILY STUDY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ISCHEMIC-HEART-DISEASE; CARDIOVASCULAR RISK-FACTORS; PLASMA-FIBRINOGEN; SEGREGATION ANALYSIS; HEMOSTATIC FACTORS; UNIFIED MODEL; POSSIBLE LINK; SOCIAL-CLASS; FACTOR-VII; POPULATION	Genetic and environmental determinants of plasma fibrinogen were investigated in a sample of 82 kindreds residing in kibbutz settlements in Israel. The sample included 223 males and 229 females ages 15-37 years. Fibrinogen levels were first adjusted for variability in sex and age. There was a significant familial aggregation of adjusted fibrinogen levels, as indicated by inter- and intraclass correlation coefficients significantly different from zero. Commingling analysis implied that in this population a mixture of two normal distributions fit the adjusted fibrinogen levels better than did a single normal distribution. Complex segregation analysis was first applied to these sex- and age-adjusted data, Heterogeneous etiologies for individual differences were suggested. There was evidence for a nontransmitted environmental major factor in addition to polygenic genes that explained the mixture of distributions, In parallel, a single recessive locus with a major effect that explained the adjusted variation in fibrinogen could not be rejected. However, when the regression model for sex and age allowed coefficients to be ousiotype (class)-specific, the recessive genetic model was rejected and the mixed environmental one was not. These results suggested that particular ousiotypes determined by the major environmental factor are associated with a steeper increase of fibrinogen with age. While at the age of 20 years, the major environmental factor contributed 10% to fibrinogen variability, and 48% was explained by polygenic loci, at 80 years of age, the major factor explained 64% and only similar to 20% was explained by polygenic factors.	HADASSAH MED ORG, DEPT SOCIAL MED, JERUSALEM, ISRAEL; ISRAEL MINIST HLTH, DEPT EPIDEMIOL, JERUSALEM, ISRAEL	Hebrew University of Jerusalem; Hadassah University Medical Center	FRIEDLANDER, Y (corresponding author), HEBREW UNIV JERUSALEM, HADASSAH SCH PUBL HLTH, DEPT SOCIAL MED, POB 12272, IL-91120 JERUSALEM, ISRAEL.							BAKER IA, 1982, BRIT HEART J, V47, P490, DOI 10.1136/hrt.47.5.490; BALLEISEN L, 1985, THROMB HAEMOSTASIS, V54, P475; BAO WH, 1993, PEDIATR RES, V33, P323; BERG K, 1989, CLIN GENET, V36, P229; BORECKI IB, 1993, AM J HUM GENET, V53, P676; BOUCHARD C, 1994, GENETIC FACTORS CORO, P189; CLAUSS A., 1957, ACTA HAEMATOL, V17, P237; CONNOR JM, 1992, J MED GENET, V29, P480; DAY NE, 1969, BIOMETRIKA, V56, P463, DOI 10.1093/biomet/56.3.463; DEMENAIS F, 1986, AM J HUM GENET, V38, P228; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; ERNST E, 1985, BRIT MED J, V291, P1723, DOI 10.1136/bmj.291.6510.1723; FISHERRA, 1954, STATISTICAL METHODS; FOLSOM AR, 1991, ATHEROSCLEROSIS, V91, P191, DOI 10.1016/0021-9150(91)90167-2; HAMSTEN A, 1987, LANCET, V2, P988; HASTEDT SJ, 1994, PAP PEDIGREE ANAL PA; HEINRICH J, 1994, ARTERIOSCLER THROMB, V14, P54, DOI 10.1161/01.ATV.14.1.54; HUMPHRIES SE, 1987, LANCET, V1, P1452, DOI 10.1016/S0140-6736(87)92205-7; KANNEL WB, 1987, AM HEART J, V113, P1006, DOI 10.1016/0002-8703(87)90063-9; KANNEL WB, 1987, JAMA-J AM MED ASSOC, V258, P1183, DOI 10.1001/jama.258.9.1183; KARLIN S, 1981, P NATL ACAD SCI USA, V78, P2664, DOI 10.1073/pnas.78.5.2664; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LEE AJ, 1990, J CLIN EPIDEMIOL, V43, P913, DOI 10.1016/0895-4356(90)90075-Z; LOWE GDO, 1980, BRIT MED J, V280, P673, DOI 10.1136/bmj.280.6215.673; MACLEAN CJ, 1975, AM J HUM GENET, V27, P365; MACLEAN CJ, 1976, BIOMETRICS, V32, P695, DOI 10.2307/2529760; MARKOWE HLJ, 1985, BMJ-BRIT MED J, V291, P1312, DOI 10.1136/bmj.291.6505.1312; MEADE TW, 1987, LANCET, V2, P986; MEADE TW, 1979, BMJ-BRIT MED J, V1, P153, DOI 10.1136/bmj.1.6157.153; MEADE TW, 1986, LANCET, V2, P533, DOI 10.1016/S0140-6736(86)90111-X; MOLL P P, 1984, Genetic Epidemiology, V1, P301, DOI 10.1002/gepi.1370010403; MOLLER L, 1991, ARTERIOSCLER THROMB, V11, P344, DOI 10.1161/01.ATV.11.2.344; NAMBOODIRI KK, 1983, ARTERIOSCLEROSIS, V3, P616, DOI 10.1161/01.ATV.3.6.616; PERUSSE L, 1991, AM J HUM GENET, V49, P94; REED T, 1994, CLIN GENET, V45, P71; REILLY SL, 1991, AM J HUM GENET, V49, P1155; ROGERS S, 1988, EUR J CLIN NUTR, V42, P197; ROSENGREN A, 1990, BRIT MED J, V300, P634, DOI 10.1136/bmj.300.6725.634; ROSNER B, 1979, BIOMETRICS, V35, P461, DOI 10.2307/2530348; SMITH EB, 1981, LANCET, V1, P1171; STONE MC, 1985, J ROY COLL GEN PRACT, V35, P565; THOMAS AE, 1991, THROMB HAEMOSTASIS, V65, P487; TIRET L, 1992, GENET EPIDEMIOL, V9, P389, DOI 10.1002/gepi.1370090603; WILHELMSEN L, 1984, NEW ENGL J MED, V311, P501, DOI 10.1056/NEJM198408233110804; WILSON TW, 1993, AM J EPIDEMIOL, V137, P292, DOI 10.1093/oxfordjournals.aje.a116676; WOODWARD M, 1992, PREV MED, V21, P136, DOI 10.1016/0091-7435(92)90013-8	46	48	53	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1995	56	5					1194	1206						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QU586	7726177				2022-12-18	WOS:A1995QU58600024
J	ANDREWS, L; BIESECKER, BB; FOST, N; JACKSON, LG; KASS, N; LOWDEN, JA; MURRAY, TH; PAYNE, J; REILLY, PR; ROTHSTEIN, MA; STRASS, E				ANDREWS, L; BIESECKER, BB; FOST, N; JACKSON, LG; KASS, N; LOWDEN, JA; MURRAY, TH; PAYNE, J; REILLY, PR; ROTHSTEIN, MA; STRASS, E			BACKGROUND STATEMENT - GENETIC TESTING AND INSURANCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							DISCRIMINATION		AMER SOC HUMAN GENET,EXECUT OFF,BETHESDA,MD 20814; AMER BAR ASSOC,CHICAGO,IL; UNIV MICHIGAN,DEPT MOLEC & MED GENET,ANN ARBOR,MI; UNIV WISCONSIN,DEPT PEDIAT & MED ETH,MADISON,WI; THOMAS JEFFERSON UNIV,DEPT MED,DIV MED GENET,PHILADELPHIA,PA; JOHNS HOPKINS UNIV,BALTIMORE,MD; CROWN LIFE INSURANCE CO,REGINA,SK,CANADA; CASE WESTERN RESERVE UNIV,CTR BIOMED ETH,CLEVELAND,OH; HLTH INSURANCE ASSOC AMER,WASHINGTON,DC; EUNICE KENNEDY SHRIVER CTR MENTAL RETARDAT INC,WALTHAM,MA; UNIV HOUSTON,CTR LAW,HOUSTON,TX	University of Michigan System; University of Michigan; University of Wisconsin System; University of Wisconsin Madison; Jefferson University; Johns Hopkins University; Case Western Reserve University; University of Houston System; University of Houston								ANDREWS LB, 1991, YALE J BIOL MED, V64, P29; BILLINGS PR, 1992, AM J HUM GENET, V50, P476; HOLTZMAN NA, 1992, AM J HUM GENET, V50, P457; KASS NE, 1992, HASTINGS CENT REP, V22, P6, DOI 10.2307/3562940; LOWDEN JA, 1992, AM J HUM GENET, V51, P901; MITCHELL JA, 1991, REPORT ACLI HIAA TAS; MORTON GA, 1984, PRINCIPLES LIFE HLTH; Moseley Ray, 1991, Bus Prof Ethics J, V10, P69; MURRAY TH, 1992, HASTINGS CENT REP, V22, P12, DOI 10.2307/3562941; OSTRER H, 1993, AM J HUM GENET, V52, P565; Pokorski R J, 1992, J Insur Med, V24, P60; 1988, OTAH384 US C OFF TEC; 1993, NIH933686 PUBL; 1994, ASSESSING GENETIC RI; 1993, HDB DIRECTORY MED IN	15	48	48	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					327	331						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	QC101					2022-12-18	WOS:A1995QC10100042
J	RODIUS, F; DUCLOS, F; WROGEMANN, K; LEPASLIER, D; OUGEN, P; BILLAULT, A; BELAL, S; MUSENGER, C; BRICE, A; DURR, A; MIGNARD, C; SIRUGO, G; WEISSENBACH, J; COHEN, D; HENTATI, F; BENHAMIDA, M; MANDEL, JL; KOENIG, M				RODIUS, F; DUCLOS, F; WROGEMANN, K; LEPASLIER, D; OUGEN, P; BILLAULT, A; BELAL, S; MUSENGER, C; BRICE, A; DURR, A; MIGNARD, C; SIRUGO, G; WEISSENBACH, J; COHEN, D; HENTATI, F; BENHAMIDA, M; MANDEL, JL; KOENIG, M			RECOMBINATIONS IN INDIVIDUALS HOMOZYGOUS BY DESCENT LOCALIZE THE FRIEDREICH ATAXIA LOCUS IN A CLONED 450-KB INTERVAL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; GENETIC HOMOGENEITY; EXTENDED HAPLOTYPES; HUMAN GENOME; D9S15; CHROMOSOME-9; FAMILIES; REGION; MARKER; IDENTIFICATION	The locus for Friedreich ataxia (FRDA), a severe neurodegenerative disease, is tightly linked to markers D9S5 and D9S15, and analysis of rare recombination events has suggested the order cen-FRDA-D9S5-D9S15-qter. We report here the construction of a YAC contig extending 800 kb centromeric to D9S5 and the isolation of five new microsatellite markers from this region. In order to map these markers with respect to the FRDA locus, all within a 1-cM confidence interval, we sought to increase the genetic information of available FRDA families by considering homozygosity by descent and association with founder haplotypes in isolated populations. This approach allowed us to identify one phase-known recombination and one probable historic recombination on haplotypes from Reunion Island patients, both of which place three of the five markers proximal to FRDA. This represents the first identification of close FRDA flanking markers on the centromeric side. The two other markers allowed us to narrow the breakpoint of a previously identified distal recombination that is >180 kb from D9S5 (26P). Taken together, the results place the FRDA locus in a 450-kb interval, which is small enough for direct search of candidate genes. A detailed rare cutter restriction map and a cosmid contig covering this interval were constructed and should facilitate the search of genes in this region.	FAC MED STRASBOURG, INST CHIM BIOL,CNRS,GENET MOLEC LAB,INSERM,U184, F-67085 STRASBOURG, FRANCE; CTR HOSP REG & UNIV STRASBOURG, STRASBOURG, FRANCE; HOP LA PITIE SALPETRIERE, CTR ETUD POLYMORPHISME HUMAIN, PARIS, FRANCE; HOP LA PITIE SALPETRIERE, INSERM, U289, F-75651 PARIS, FRANCE; HOP LA PITIE SALPETRIERE, SERV NEUROL & NEUROPSYCHOL, PARIS, FRANCE; INST NATL NEUROL, NEUROBIOL MOLEC & NEUROPATHOL LAB, TUNIS, TUNISIA; GENETHON, EVRY, FRANCE; CTR HOSP GEN, LA REUNION, FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite de Tunis-El-Manar; Institut National de Neurologie			Sirugo, Giorgio/N-9056-2019; brice, alexis/AAE-8275-2019; Sirugo, Giorgio/L-1628-2016; Brice, Alexis/A-2170-2009	brice, alexis/0000-0002-0941-3990; Le Paslier, Denis/0000-0003-4335-9956				ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; BELAL S, 1992, AM J HUM GENET, V51, P1372; BENHAMIDA M, 1993, NEUROLOGY, V43, P2179, DOI 10.1212/WNL.43.11.2179; CHAMBERLAIN S, 1989, AM J HUM GENET, V44, P518; CHAMBERLAIN S, 1988, NATURE, V334, P248, DOI 10.1038/334248a0; CHAMBERLAIN S, 1993, AM J HUM GENET, V52, P99; DUCLOS F, 1993, P NATL ACAD SCI USA, V90, P109, DOI 10.1073/pnas.90.1.109; FUJITA R, 1991, GENOMICS, V10, P915, DOI 10.1016/0888-7543(91)90179-I; FUJITA R, 1992, HUM GENET, V89, P531, DOI 10.1007/BF00219179; FUJITA R, 1989, GENOMICS, V4, P110, DOI 10.1016/0888-7543(89)90323-6; FUJITA R, 1990, P NATL ACAD SCI USA, V87, P1796, DOI 10.1073/pnas.87.5.1796; HANAUER A, 1990, AM J HUM GENET, V46, P133; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; HEILIG R, 1987, NUCLEIC ACIDS RES, V15, P9129, DOI 10.1093/nar/15.22.9129; LAURIE DA, 1985, ANN HUM GENET, V49, P203, DOI 10.1111/j.1469-1809.1985.tb01694.x; LEGUEN M, 1979, HISTOIRE ILE REUNION; PANDOLFO M, 1990, AM J HUM GENET, V47, P228; PANDOLFO M, 1993, HUM MOL GENET, V2, P822, DOI 10.1093/hmg/2.6.822; PIERETTI M, 1991, NUCLEIC ACIDS RES, V19, P2795, DOI 10.1093/nar/19.10.2795; RICQUEBOURG CLJ, 1983, DICT GENEALOGIQUE FA, P1665; ROMEO G, 1983, AM J HUM GENET, V35, P523; SHAW J, 1990, CYTOGENET CELL GENET, V53, P221, DOI 10.1159/000132936; SIRUGO G, 1992, AM J HUM GENET, V50, P559; Sirugo G., 1993, European Journal of Human Genetics, V1, P133; SKRE H, 1980, EPIDEMIOLOGY SPINOCE; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	26	48	48	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1994	54	6					1050	1059						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NP053	8198128				2022-12-18	WOS:A1994NP05300014
J	LINDBLOM, A; SANDELIN, K; ISELIUS, L; DUMANSKI, J; WHITE, I; NORDENSKJOLD, M; LARSSON, C				LINDBLOM, A; SANDELIN, K; ISELIUS, L; DUMANSKI, J; WHITE, I; NORDENSKJOLD, M; LARSSON, C			PREDISPOSITION FOR BREAST-CANCER IN CARRIERS OF CONSTITUTIONAL TRANSLOCATION 11Q22Q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ATAXIA-TELANGIECTASIA; GENE; NEUROFIBROMATOSIS; CHROMOSOME; LOCUS; FAMILIES; HYBRIDIZATION; BREAKPOINTS; MUTATIONS; CLONING	A translocation between the long arms of chromosomes 11 and 22, t(11;22)(q23;q11), is the most frequent constitutional reciprocal translocation in man. This chromosome abnormality has not previously been reported to be associated with an increased risk for neoplasia. The observation of one patient with a constitutional translocation t(11q;22q) and breast cancer prompted us to study the relationship between these two conditions. The incidence of breast cancer was determined in carriers of t(11q;22q). The karyotypes were determined by QFQ-banding, and the breakpoints were then further characterized by fluorescent in situ hybridization. Eight families with a total of 22 balanced carriers were found. In five of these families there was one case of breast cancer each. In another family a case of an unknown malignancy was reported in one member. No other malignancies were found among these patients. The number of breast cancer cases was significantly higher than expected among the translocation carriers (P <.001). The chromosomal breakpoints showed the same localization with the markers used, in the seven families studied. The association of constitutional translocation t(11q;22q) and breast cancer identifies a subset of patients with a highly increased risk for breast cancer who would benefit from counseling and screening. It also suggests the involvement of genes on 11q and/or 22q, in the tumorigenesis of breast cancer.	KAROLINSKA HOSP, DEPT SURG, S-10401 STOCKHOLM, SWEDEN	Karolinska Institutet; Karolinska University Hospital	LINDBLOM, A (corresponding author), KAROLINSKA HOSP, DEPT CLIN GENET, S-10401 STOCKHOLM, SWEDEN.			Dumanski, Jan Piotr/0000-0002-1489-1452; Nordenskjold, Magnus/0000-0002-4974-425X				BLENNOW E, 1992, HUM GENET, V90, P371, DOI 10.1007/BF00220461; Breslow N., 1987, STATISTICAL METHODS; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; COHEN AJ, 1979, NEW ENGL J MED, V301, P592, DOI 10.1056/NEJM197909133011107; CREMER T, 1988, HUM GENET, V80, P235, DOI 10.1007/BF01790091; CURRAN ME, 1993, CELL, V73, P159, DOI 10.1016/0092-8674(93)90168-P; DEJONG PJ, 1989, CYTOGENET CELL GENET, V51, P985; EMANUEL BS, 1991, CYTOGENET CELL GENET, V58, P827, DOI 10.1159/000133182; FERTIPASSANTONOPOULOU A, 1991, CANCER GENET CYTOGEN, V51, P183, DOI 10.1016/0165-4608(91)90130-M; FRACCARO M, 1980, HUM GENET, V56, P21, DOI 10.1007/BF00281567; GRIFFIN CA, 1986, P NATL ACAD SCI USA, V83, P6122, DOI 10.1073/pnas.83.16.6122; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; ISELIUS L, 1983, HUM GENET, V64, P343, DOI 10.1007/BF00292366; JUNIEN C, 1991, CYTOGENET CELL GENET, V58, P459, DOI 10.1159/000133171; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; LAMBERT C, 1991, P NATL ACAD SCI USA, V88, P5907, DOI 10.1073/pnas.88.13.5907; LARSSON C, 1992, HUM GENET, V89, P187; LEDBETTER DH, 1989, AM J HUM GENET, V44, P20; LINDBLOM A, 1993, CANCER RES, V53, P4356; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MENON AG, 1989, GENOMICS, V5, P245, DOI 10.1016/0888-7543(89)90053-0; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; MONTEGI T, 1982, HUM GENET, V60, P193; MORRELL D, 1990, CANCER GENET CYTOGEN, V50, P119, DOI 10.1016/0165-4608(90)90245-6; NAROD SA, 1991, LANCET, V338, P82; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; Sambrook J., 1989, MOL CLONING LAB MANU; SCHMIDT MA, 1987, AM J MED GENET, V28, P771, DOI 10.1002/ajmg.1320280333; SRIVASTAVA S, 1990, NATURE, V348, P747, DOI 10.1038/348747a0; TURLEAU C, 1985, CANCER GENET CYTOGEN, V16, P321, DOI 10.1016/0165-4608(85)90240-7; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; WOOSTER R, 1992, NAT GENET, V2, P132, DOI 10.1038/ng1092-132; ZACKAI EH, 1980, AM J MED GENET, V7, P507, DOI 10.1002/ajmg.1320070412; ZUCMAN J, 1992, GENE CHROMOSOME CANC, V5, P271, DOI 10.1002/gcc.2870050402; 1989, CANCER INCIDENCE SWE	36	48	49	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1994	54	5					871	876						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NH394	8178827				2022-12-18	WOS:A1994NH39400017
J	WOLFF, DJ; SCHWARTZ, S				WOLFF, DJ; SCHWARTZ, S			CHARACTERIZATION OF ROBERTSONIAN TRANSLOCATIONS BY USING FLUORESCENCE INSITU HYBRIDIZATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACROCENTRIC CHROMOSOMES; SATELLITE DNA; SEQUENCE; REGIONS; CELLS	Fluorescence in situ hybridization with five biotin-labeled probes (three alphoid probes, a probe specific for beta-satellite sequences in all acrocentric chromosomes, and an rDNA probe) was used to characterize 30 different Robertsonian translocations, including three t(13;13); one t(15;15), four t(21;21), three t(13;14), two t(13;15), two (13;21), two t(13;22), one t(14;15), eight t(14;21), two t(14;22), and two t(21;22). Of 8 de novo homologous translocations, only one t(13;13) chromosome was interpreted as dicentric, while 19 of 22 nonhomologous Robertsonian translocations were dicentric. The three monocentric nonhomologous translocations included both of the t(13;21) and one t(21;22). Two of 26 translocations studied using the beta-satellite probe showed a positive signal, while rDNA was undetectable in 10 cases studied. These results indicate that most homologous Robertsonian translocations appear monocentric, while the bulk of nonhomologous translocations show two alphoid signals. A majority of the breakpoints localized using this analysis seem to be distal to the centromere and just proximal to the beta-satellite and nuclear-organizing regions.	UNIV MARYLAND,SCH MED,DEPT OBSTET & GYNECOL,DIV HUMAN GENET,655 W BALTIMORE ST,BALTIMORE,MD 21201; UNIV MARYLAND,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21201	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore			Slagboom, P. Eline/R-4790-2016	Slagboom, P. Eline/0000-0002-2875-4723				ANTONARAKIS SE, 1990, AM J HUM GENET, V47, P968; BOWMAN LH, 1981, NUCLEIC ACIDS RES, V9, P4951, DOI 10.1093/nar/9.19.4951; BRASCH JM, 1979, CYTOGENET CELL GENET, V24, P122, DOI 10.1159/000131365; CHEUNG SW, 1990, CYTOGENET CELL GENET, V54, P97, DOI 10.1159/000132970; CHOO KH, 1990, GENOMICS, V7, P143, DOI 10.1016/0888-7543(90)90534-2; CHOO KH, 1988, NUCLEIC ACIDS RES, V16, P1273, DOI 10.1093/nar/16.4.1273; DANIEL A, 1976, J MED GENET, V13, P381, DOI 10.1136/jmg.13.5.381; DEVILEE P, 1986, CYTOGENET CELL GENET, V41, P193, DOI 10.1159/000132229; GOSDEN JR, 1981, AM J HUM GENET, V33, P2430; GRASSO M, 1989, HUM GENET, V84, P63, DOI 10.1007/BF00210673; HAMERTON JL, 1975, CLIN GENET, V8, P223; IKEUCHI T, 1984, CYTOGENET CELL GENET, V38, P56, DOI 10.1159/000132030; JORGENSEN A L, 1988, Genomics, V3, P100, DOI 10.1016/0888-7543(88)90139-5; MATTEI MG, 1979, HUM GENET, V50, P33, DOI 10.1007/BF00295586; MIKKELSEN M, 1980, CYTOGENET CELL GENET, V26, P14, DOI 10.1159/000131416; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; NIEBUHR E, 1972, HUMANGENETIK, V16, P217, DOI 10.1007/BF00273467; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; SHAFFER LG, 1991, HUM GENET, V86, P375; VIG BK, 1984, CHROMOSOMA, V90, P39, DOI 10.1007/BF00352276; WAYE JS, 1989, P NATL ACAD SCI USA, V86, P6250, DOI 10.1073/pnas.86.16.6250; WILLARD HF, 1991, PROG CLIN BIOL RES, V360, P39	22	48	48	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1992	50	1					174	181						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HA040	1729886				2022-12-18	WOS:A1992HA04000018
J	DELFAU, MH; PICAT, C; DEROOIJ, F; VOORTMAN, G; DEYBACH, JC; NORDMANN, Y; GRANDCHAMP, B				DELFAU, MH; PICAT, C; DEROOIJ, F; VOORTMAN, G; DEYBACH, JC; NORDMANN, Y; GRANDCHAMP, B			MOLECULAR HETEROGENEITY OF ACUTE INTERMITTENT PORPHYRIA - IDENTIFICATION OF 4 ADDITIONAL MUTATIONS RESULTING IN THE CRIM-NEGATIVE SUBTYPE OF THE DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PORPHOBILINOGEN DEAMINASE GENE; DNA-POLYMERASE	Four mutations of the porphobilinogen (PBG) deaminase gene that result in cross-reacting immunological material (CRIM)-negative forms of acute intermittent porphyria (AIP) have been identified by in vitro amplification of cDNA from patients and by cloning of the amplified products in a bacterial expression vector. One mutation is a single base deletion which causes a frameshift and which is expected to result in the synthesis of a truncated protein. Two other mutations consist of single base substitutions and lead to amino acid changes. The fourth mutation is a single base substitution producing an aberrant splicing and resulting in an mRNA which would encode a protein missing three amino acids. DNAs from 16 unrelated CRIM-negative AIP patients were screened for the presence of these four mutations, by hybridization with oligonucleotides specific for each of the mutations, but none of the four mutations was identified in additional patients. The results indicate that mutations responsible for CRIM-negative AIP are highly heterogenous.	FAC XAVIER BICHAT,GENET MOLEC LAB,16 RUE H HUCHARD,F-75018 PARIS,FRANCE; HOP LOUIS MOURIER,BIOCHIM LAB,F-92701 COLOMBES,FRANCE; UNIV HOSP DIJKZIGT,DEPT INTERNAL MED,ROTTERDAM,NETHERLANDS	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; Erasmus University Rotterdam; Erasmus MC								DELFAU MH, 1990, J CLIN INVEST, V86, P1511, DOI 10.1172/JCI114869; DEROOIJ FWM, 1987, I DERMATOL S GALLICA, V33, P175; DESNICK RJ, 1985, J CLIN INVEST, V76, P865, DOI 10.1172/JCI112044; DEVERNEUIL H, 1986, SCIENCE, V234, P732, DOI 10.1126/science.3775362; DICKER AP, 1989, BIOTECHNIQUES, V7, P830; GRANDCHAMP B, 1989, P NATL ACAD SCI USA, V86, P661, DOI 10.1073/pnas.86.2.661; GRANDCHAMP B, 1989, EUR J CLIN INVEST, V19, P415, DOI 10.1111/j.1365-2362.1989.tb00252.x; GRANDCHAMP B, 1988, SEMIN HEMATOL, V25, P303; GRANDCHAMP B, 1989, NUCLEIC ACIDS RES, V17, P6637, DOI 10.1093/nar/17.16.6637; IKUTA S, 1987, NUCLEIC ACIDS RES, V15, P797, DOI 10.1093/nar/15.2.797; KAPPAS A, 1989, METABOLIC BASIS INHE, P1305; LEE JS, 1988, HUM GENET, V79, P379; LEWELLYN DH, 1987, LANCET, V2, P706; MILLER AD, 1988, BIOCHEM J, V254, P915, DOI 10.1042/bj2540915; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCOBIE GA, 1990, HUM GENET, V85, P631; TINDALL KR, 1988, BIOCHEMISTRY-US, V27, P6008, DOI 10.1021/bi00416a027; UMANOFF H, 1988, J BACTERIOL, V170, P4969, DOI 10.1128/jb.170.10.4969-4971.1988; WEATHERALL DJ, 1989, METABOLIC BASIS INHE, P2281; YOUSSOUFIAN H, 1988, AM J HUM GENET, V42, P718	20	48	49	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1991	49	2					421	428						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GA866	1714233				2022-12-18	WOS:A1991GA86600020
J	FARRAR, GJ; KENNA, P; REDMOND, R; MCWILLIAM, P; BRADLEY, DG; HUMPHRIES, MM; SHARP, EM; INGLEHEARN, CF; BASHIR, R; JAY, M; WATTY, A; LUDWIG, M; SCHINZEL, A; SAMANNS, C; GAL, A; BHATTACHARYA, S; HUMPHRIES, P				FARRAR, GJ; KENNA, P; REDMOND, R; MCWILLIAM, P; BRADLEY, DG; HUMPHRIES, MM; SHARP, EM; INGLEHEARN, CF; BASHIR, R; JAY, M; WATTY, A; LUDWIG, M; SCHINZEL, A; SAMANNS, C; GAL, A; BHATTACHARYA, S; HUMPHRIES, P			AUTOSOMAL DOMINANT RETINITIS-PIGMENTOSA - ABSENCE OF THE RHODOPSIN PROLINE-]HISTIDINE SUBSTITUTION (CODON 23) IN PEDIGREES FROM EUROPE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									QUEENS UNIV BELFAST,CITY HOSP,DEPT MED GENET,BELFAST BT7 1NN,ANTRIM,NORTH IRELAND; UNIV NEWCASTLE UPON TYNE,DEPT HUMAN GENET,MOLEC GENET UNIT,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND; MOORFIELDS EYE HOSP,DEPT OPHTHALMOL,LONDON WC1V 7AN,ENGLAND; UNIV BONN,INST HUMAN GENET,W-5300 BONN,GERMANY; UNIV BONN,INST KLIN BIOCHEM,W-5300 BONN,GERMANY; UNIV ZURICH,INST MED GENET,CH-8006 ZURICH,SWITZERLAND	Queens University Belfast; Newcastle University - UK; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Bonn; University of Bonn; University of Zurich	FARRAR, GJ (corresponding author), UNIV DUBLIN TRINITY COLL,DEPT GENET,LINCOLN PL GATE,DUBLIN 2,IRELAND.		Bradley, Daniel G/A-3240-2012; Farrar, G Jane/B-9832-2011; Bateson, Jane Farrar/AAO-6147-2020	Bradley, Daniel G/0000-0001-7335-7092	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ARDEN GB, 1983, BRIT J OPHTHALMOL, V67, P419, DOI 10.1136/bjo.67.7.419; ASAKAI R, 1989, P NATL ACAD SCI USA, V86, P7667, DOI 10.1073/pnas.86.20.7667; BLATT C, 1988, P NATL ACAD SCI USA, V85, P7642, DOI 10.1073/pnas.85.20.7642; BUNDEY S, 1984, J MED GENET, V21, P417, DOI 10.1136/jmg.21.6.417; BUNKER CH, 1984, AM J OPHTHALMOL, V97, P357, DOI 10.1016/0002-9394(84)90636-6; DEAN G, 1971, PORPHYRIAS STORY INH, P4; DEARCE MA, 1990, IN PRESS HUM GENET; DEMMER LA, 1987, J BIOL CHEM, V262, P2458; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; FARRAR GJ, IN PRESS GENOMICS; FLANNERY JG, 1989, INVEST OPHTH VIS SCI, V30, P191; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Heckenlively JR, 1988, RETINITIS PIGMENTOSA, P125; INGLEHEARN CF, 1990, GENOMICS, V6, P168, DOI 10.1016/0888-7543(90)90462-4; JIMENEZ JB, IN PRESS HUM GENET; KEMP CM, 1988, INVEST OPHTH VIS SCI, V29, P1235; LESTER DH, 1990, AM J HUM GENET, V47, P536; LYNESS AL, 1985, BRIT J OPHTHALMOL, V69, P326, DOI 10.1136/bjo.69.5.326; MASSOF RW, 1981, DOC OPHTHALMOL, V51, P328; MCWILLIAM P, 1989, GENOMICS, V5, P619, DOI 10.1016/0888-7543(89)90031-1; MYEROWITZ R, 1988, P NATL ACAD SCI USA, V85, P3955, DOI 10.1073/pnas.85.11.3955; NATHANS J, 1984, P NATL ACAD SCI-BIOL, V81, P4851, DOI 10.1073/pnas.81.15.4851; NILSSON MHL, 1988, EUR J BIOCHEM, V173, P35, DOI 10.1111/j.1432-1033.1988.tb13963.x; OLSSON JE, 1990, AM J MED GENET, V35, P595, DOI 10.1002/ajmg.1320350434; OTT J, 1990, P NATL ACAD SCI USA, V87, P701, DOI 10.1073/pnas.87.2.701; YANDELL DW, 1989, AM J HUM GENET, V45, P547	26	48	49	1	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1990	47	6					941	945						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EK400	2239971				2022-12-18	WOS:A1990EK40000009
J	BOTTEMA, CDK; KETTERLING, RP; YOON, HS; SOMMER, SS				BOTTEMA, CDK; KETTERLING, RP; YOON, HS; SOMMER, SS			THE PATTERN OF FACTOR-IX GERM-LINE MUTATION IN ASIANS IS SIMILAR TO THAT OF CAUCASIANS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MAYO CLIN & MAYO FDN,DEPT BIOCHEM & MOLEC BIOL,ROCHESTER,MN 55905	Mayo Clinic				Bottema, Cynthia/0000-0001-6245-0099; Ketterling, Rhett/0000-0001-6479-7897	NCI NIH HHS [CA15083.F1.3] Funding Source: Medline; NHLBI NIH HHS [HL39762] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA015083] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039762] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BIGGER CAH, 1989, P NATL ACAD SCI USA, V86, P2291, DOI 10.1073/pnas.86.7.2291; BOTTEMA CDK, 1989, LANCET, V2, P526; BOTTEMA CDK, 1989, NUCLEIC ACIDS RES, V17, P10139, DOI 10.1093/nar/17.23.10139; BOTTEMA CDK, 1990, NUCLEIC ACIDS RES, V18, P1924, DOI 10.1093/nar/18.7.1924; CHAKRABORTY R, 1989, P NATL ACAD SCI USA, V86, P9407, DOI 10.1073/pnas.86.23.9407; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; DIUGUID DL, 1986, P NATL ACAD SCI USA, V83, P5803, DOI 10.1073/pnas.83.16.5803; EYSTER ME, 1980, AM J HEMATOL, V9, P277, DOI 10.1002/ajh.2830090306; FRIEDBERG EC, 1985, DNA REPAIR, P1; GREEN PM, 1990, NUCLEIC ACIDS RES, V18, P3227, DOI 10.1093/nar/18.11.3227; GREEN PM, 1989, EMBO J, V8, P1067, DOI 10.1002/j.1460-2075.1989.tb03474.x; GUSTAFSON S, 1987, ANAL BIOCHEM, V165, P294, DOI 10.1016/0003-2697(87)90272-7; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; HAY CW, 1986, BLOOD, V67, P1508; HEDNER U, 1989, METABOLIC BASIS INHE, P2107; HUANG MN, 1989, BLOOD, V73, P718; JACOB M, 1989, NUCLEIC ACIDS RES, V17, P2159, DOI 10.1093/nar/17.6.2159; KOEBERL DD, 1990, AM J MED GENET, V35, P600, DOI 10.1002/ajmg.1320350435; KOEBERL DD, 1990, HUM GENET, V84, P387; KOEBERL DD, 1990, AM J HUM GENET, V47, P202; KOEBERL DD, 1989, AM J HUM GENET, V45, P448; LARSSON SA, 1985, BRIT J HAEMATOL, V59, P593, DOI 10.1111/j.1365-2141.1985.tb07353.x; LUBAHN DB, 1987, AM J HUM GENET, V40, P527; NOYES CM, 1983, P NATL ACAD SCI-BIOL, V80, P4200, DOI 10.1073/pnas.80.14.4200; SAKAI T, 1989, J BIOCHEM-TOKYO, V105, P756, DOI 10.1093/oxfordjournals.jbchem.a122740; SARKAR G, 1990, GENOMICS, V6, P133, DOI 10.1016/0888-7543(90)90458-7; SARKAR G, 1989, SCIENCE, V244, P331, DOI 10.1126/science.2565599; SOMMER SS, 1990, NATURE, V346, P22, DOI 10.1038/346022b0; STOFLET ES, 1988, SCIENCE, V239, P414; SUGIMOTO M, 1989, BRIT J HAEMATOL, V72, P216, DOI 10.1111/j.1365-2141.1989.tb07685.x; SUGIMOTO M, 1988, J BIOCHEM-TOKYO, V104, P878, DOI 10.1093/oxfordjournals.jbchem.a122575; SUZUKI DT, 1986, INTRO GENETIC ANAL, P333; TREISMAN R, 1983, NATURE, V302, P591, DOI 10.1038/302591a0; VIDAUD M, 1986, BLOOD, V68, P961; WINSHIP PR, 1989, LANCET, V1, P631; WOLFE KH, 1989, NATURE, V337, P283, DOI 10.1038/337283a0; WONG C, 1987, NATURE, V330, P384, DOI 10.1038/330384a0; YANG JL, 1987, P NATL ACAD SCI USA, V84, P3787, DOI 10.1073/pnas.84.11.3787; YOSHITAKE S, 1985, BIOCHEMISTRY-US, V24, P3736, DOI 10.1021/bi00335a049	40	48	48	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1990	47	5					835	841						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EE940	2220823				2022-12-18	WOS:A1990EE94000011
J	CONSTANTINOU, CD; PACK, M; YOUNG, SB; PROCKOP, DJ				CONSTANTINOU, CD; PACK, M; YOUNG, SB; PROCKOP, DJ			PHENOTYPIC HETEROGENEITY IN OSTEOGENESIS IMPERFECTA - THE MILDLY AFFECTED MOTHER OF A PROBAND WITH A LETHAL VARIANT HAS THE SAME MUTATION SUBSTITUTING CYSTEINE FOR ALPHA-I-GLYCINE-904 IN A TYPE-I PROCOLLAGEN GENE (COLIAI)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,JEFFERSON INST MOLEC MED,DEPT BIOCHEM & MOLEC BIOL,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,JEFFERSON INST MOLEC MED,DEPT MED,PHILADELPHIA,PA 19107	Jefferson University; Jefferson University			Deltas, Constantinos/J-9345-2013	Deltas, Constantinos/0000-0001-5549-9169				Byers P H, 1988, Ann N Y Acad Sci, V543, P117, DOI 10.1111/j.1749-6632.1988.tb55324.x; BYERS PH, 1988, AM J HUM GENET, V42, P237; CHEAH KSE, 1985, BIOCHEM J, V229, P287, DOI 10.1042/bj2290287; COHN D H, 1989, American Journal of Human Genetics, V45, pA180; CONSTANTINOU CD, 1990, ANN NY ACAD SCI, V580, P540, DOI 10.1111/j.1749-6632.1990.tb17984.x; CONSTANTINOU CD, 1989, J CLIN INVEST, V83, P574, DOI 10.1172/JCI113920; GOLDRING SR, 1990, J CLIN INVEST, V85, P798, DOI 10.1172/JCI114506; GOODSHIP J, 1988, LANCET, V1, P729; HALL JG, 1988, AM J HUM GENET, V43, P355; HAPPLE R, 1987, J AM ACAD DERMATOL, V16, P899, DOI 10.1016/S0190-9622(87)80249-9; HIGUCHI R, 1988, NATURE, V332, P543, DOI 10.1038/332543a0; KNOWLTON RG, 1989, NUCLEIC ACIDS RES, V17, P423, DOI 10.1093/nar/17.1.423; Maniatis T., 1982, MOL CLONING; MIGEON BR, 1989, AM J HUM GENET, V44, P100; MINTZ B, 1973, DEV BIOL, V31, P195, DOI 10.1016/0012-1606(73)90331-X; PROCKOP DJ, 1984, NEW ENGL J MED, V311, P376, DOI 10.1056/NEJM198408093110606; PROCKOP DJ, 1990, ANN NY ACAD SCI, V580, P330, DOI 10.1111/j.1749-6632.1990.tb17942.x; PROCKOP DJ, 1989, AM J MED GENET, V34, P60, DOI 10.1002/ajmg.1320340112; RICCARDI VM, 1988, AM J HUM GENET, V42, P284; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHUNSHIN M, 1954, J BONE JOINT SURG BR, V36, P268, DOI 10.1302/0301-620X.36B2.268; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; Smith R., 1983, BRITTLE BONE SYNDROM; SORIANO P, 1986, CELL, V46, P19, DOI 10.1016/0092-8674(86)90856-1; Stern C., 1968, GENETIC MOSAICS OTHE, P27; WALLIS G A, 1989, American Journal of Human Genetics, V45, pA228; WILKIE TM, 1986, DEV BIOL, V118, P9, DOI 10.1016/0012-1606(86)90068-0	28	48	51	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1990	47	4					670	679						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EB319	2220807				2022-12-18	WOS:A1990EB31900012
J	BROWN, WT				BROWN, WT			INVITED EDITORIAL - THE FRAGILE-X - PROGRESS TOWARD SOLVING THE PUZZLE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											BROWN, WT (corresponding author), CORNELL UNIV,N SHORE UNIV HOSP,COLL MED,DEPT PEDIAT,DIV HUMAN GENET,MANHASSET,NY 11030, USA.		Brown, William/GXN-2777-2022					ARVEILER B, 1989, GENOMICS, V4, P460, DOI 10.1016/0888-7543(89)90269-3; BELL MV, 1989, HUM GENET, V82, P27, DOI 10.1007/BF00288266; BROWN WT, 1988, HUM GENET, V78, P201, DOI 10.1007/BF00291662; BROWN WT, 1987, HUM GENET, V75, P311, DOI 10.1007/BF00284100; BROWN WT, 1987, NUCLEIC ACID PROBES, P11; BROWN WT, IN PRESS AM MED GENE; DAHL N, 1989, HUM GENET, V82, P216, DOI 10.1007/BF00291157; DAHL N, 1989, AM J HUM GENET, V45, P304; DOBKIN CS, 1988, AM J MED GENET, V30, P593, DOI 10.1002/ajmg.1320300160; FEIL R, 1990, AM J HUM GENET, V46, P720; GOONEWARDENA P, IN PRESS AM J MED GE; GUSTAVSON KH, 1986, AM J MED GENET, V23, P581, DOI 10.1002/ajmg.1320230152; HARRISON CJ, 1983, J MED GENET, V20, P280, DOI 10.1136/jmg.20.4.280; JENKINS EC, 1988, AM J MED GENET, V30, P329, DOI 10.1002/ajmg.1320300133; KHALIFA MM, 1990, AM J HUM GENET, V46, P74; KRAWCZUN MS, 1985, HUM GENET, V69, P209, DOI 10.1007/BF00293026; LAIRD CD, 1990, AM J HUM GENET, V46, P696; LAIRD CD, 1987, GENETICS, V117, P587; MACKINNON RN, 1990, AM J HUM GENET, V47, P181; NGUYEN C, 1988, AM J MED GENET, V30, P601, DOI 10.1002/ajmg.1320300161; OOSTRA BA, 1990, GENOMICS, V6, P129, DOI 10.1016/0888-7543(90)90457-6; PATTERSON M, 1987, NUCLEIC ACIDS RES, V15, P2639, DOI 10.1093/nar/15.6.2639; PATTERSON M, 1987, Genomics, V1, P297, DOI 10.1016/0888-7543(87)90028-0; PATTERSON MN, 1989, GENOMICS, V4, P570, DOI 10.1016/0888-7543(89)90281-4; PERGOLIZZI R, IN PRESS AM J MED GE; ROCCHI M, 1990, AM J HUM GENET, V46, P738; SHERMAN SL, 1985, HUM GENET, V69, P289, DOI 10.1007/BF00291644; SHERMAN SL, 1984, ANN HUM GENET, V48, P21, DOI 10.1111/j.1469-1809.1984.tb00830.x; Sutherland G, 1985, FRAGILE SITES HUMAN; SUTHERLAND GR, 1977, SCIENCE, V197, P265, DOI 10.1126/science.877551; SUTHERS GK, 1990, AM J HUM GENET, V47, P187; SUTHERS GK, 1989, SCIENCE, V246, P1298, DOI 10.1126/science.2573953; TUCKERMAN E, 1985, J MED GENET, V22, P85, DOI 10.1136/jmg.22.2.85; TURNER G, 1980, J PEDIATR-US, V96, P837, DOI 10.1016/S0022-3476(80)80552-X; VINCENT A, 1989, GENOMICS, V5, P797, DOI 10.1016/0888-7543(89)90121-3; WARREN ST, 1987, SCIENCE, V237, P420, DOI 10.1126/science.3603029; WEBB TP, 1986, AM J MED GENET, V23, P573, DOI 10.1002/ajmg.1320230151	37	48	49	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1990	47	2					175	180						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT871	1974122				2022-12-18	WOS:A1990DT87100001
J	DARRAS, BT; FRANCKE, U				DARRAS, BT; FRANCKE, U			NORMAL HUMAN GENOMIC RESTRICTION-FRAGMENT PATTERNS AND POLYMORPHISMS REVEALED BY HYBRIDIZATION WITH THE ENTIRE DYSTROPHIN CDNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									YALE UNIV,SCH MED,DEPT HUMAN GENET,333 CEDAR ST,NEW HAVEN,CT 06510	Yale University				Darras, Basil/0000-0002-1536-8145				BURMEISTER M, 1988, Genomics, V2, P189, DOI 10.1016/0888-7543(88)90002-X; DARRAS BT, 1987, NEW ENGL J MED, V316, P985, DOI 10.1056/NEJM198704163161604; DARRAS BT, 1988, AM J MED GENET, V29, P713, DOI 10.1002/ajmg.1320290341; DARRAS BT, 1988, AM J HUM GENET, V43, P620; DARRAS BT, 1988, AM J HUM GENET, V43, P126; EMERY AEH, 1987, OXFORD MONOGRAPHS ME; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FORREST SM, 1987, LANCET, V2, P1294; FORREST SM, 1987, NATURE, V329, P638, DOI 10.1038/329638a0; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KUNKEL LM, 1986, NATURE, V322, P73, DOI 10.1038/322073a0; MONACO AP, 1987, HUM GENET, V75, P221, DOI 10.1007/BF00281063; van Ommen G J, 1987, Genomics, V1, P329, DOI 10.1016/0888-7543(87)90032-2	14	48	48	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1988	43	5					612	619						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q9336	2903662				2022-12-18	WOS:A1988Q933600007
J	ZOGHBI, HY; DAIGER, SP; MCCALL, A; OBRIEN, WE; BEAUDET, AL				ZOGHBI, HY; DAIGER, SP; MCCALL, A; OBRIEN, WE; BEAUDET, AL			EXTENSIVE DNA POLYMORPHISM AT THE FACTOR-XIIIA (F13A) LOCUS AND LINKAGE TO HLA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030; UNIV TEXAS,HLTH SCI CTR,GRAD SCH BIOMED SCI,HOUSTON,TX 77225; BAYLOR COLL MED,HOWARD HUGHES MED INST,HOUSTON,TX 77030	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Howard Hughes Medical Institute	ZOGHBI, HY (corresponding author), BAYLOR COLL MED,DEPT PEDIAT,1 BAYLOR PLAZA,HOUSTON,TX 77030, USA.			Zoghbi, Huda/0000-0002-0700-3349	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K11HD000684] Funding Source: NIH RePORTER; NICHD NIH HHS [K 11HD00684-01] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BOARD PG, 1984, HUM GENET, V67, P406, DOI 10.1007/BF00291400; BOARD PG, 1979, AM J HUM GENET, V31, P116; BOARD PG, 1980, BRIT J HAEMATOL, V45, P633, DOI 10.1111/j.1365-2141.1980.tb07186.x; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; CASTLE S, 1981, BRIT J HAEMATOL, V48, P337, DOI 10.1111/j.1365-2141.1981.tb08467.x; CHAKRAVARTI A, 1984, P NATL ACAD SCI-BIOL, V81, P6085, DOI 10.1073/pnas.81.19.6085; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; EIBERG H, 1984, CLIN GENET, V26, P385; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GRAHAM JB, 1984, HUM GENET, V67, P132, DOI 10.1007/BF00272987; GRUNDMANN U, 1986, P NATL ACAD SCI USA, V83, P8024, DOI 10.1073/pnas.83.21.8024; HIGGS DR, 1986, P NATL ACAD SCI USA, V83, P5165, DOI 10.1073/pnas.83.14.5165; KEATS BJB, 1985, CYTOGENET CELL GENET, V40, P666; KOMPF J, 1985, HUM GENET, V70, P43, DOI 10.1007/BF00389457; LAMM LU, 1985, CYTOGENET CELL GENET, V40, P142; LORNAD L, 1980, PROGR HEMOSTASIS THR, V5, P245; MARX JL, 1985, SCIENCE, V229, P150, DOI 10.1126/science.2990043; McKusick V. A., 1986, MENDELIAN INHERITANC; MORTON NE, 1988, AM J HUM GENET, V42, P173; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NISHIGAKI T, 1986, HUM GENET, V72, P266, DOI 10.1007/BF00291893; OLAISEN B, 1985, AM J HUM GENET, V37, P215; OLAISEN B, 1983, 7 INT HUM GEN MAPP W; OTT J, 1985, ANAL HUMAN GENETIC L; SCHWARTZ ML, 1973, J BIOL CHEM, V248, P1395; TAKAHASHI N, 1986, P NATL ACAD SCI USA, V83, P8019, DOI 10.1073/pnas.83.21.8019; ZOGHBI HY, IN PRESS ANN NEUROL	27	48	49	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1988	42	6					877	883						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N5197	2897163				2022-12-18	WOS:A1988N519700011
J	SORGE, JA; WEST, C; KUHL, W; TREGER, L; BEUTLER, E				SORGE, JA; WEST, C; KUHL, W; TREGER, L; BEUTLER, E			THE HUMAN GLUCOCEREBROSIDASE GENE HAS 2 FUNCTIONAL ATG INITIATOR CODONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											SORGE, JA (corresponding author), SCRIPPS CLIN & RES FDN,DEPT BASIC & CLIN RES,10666 N TORREY PINES RD,LA JOLLA,CA 92037, USA.			Sorge, Joseph/0000-0002-7343-7970	NCI NIH HHS [CA 36448] Funding Source: Medline; NIADDK NIH HHS [AM 36639-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA036448] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; CHOUDARY PV, 1986, MOL BIOL MED, V3, P293; CHOUDARY PV, 1986, DNA-J MOLEC CELL BIO, V5, P78; GROS P, 1986, CELL, V47, P371, DOI 10.1016/0092-8674(86)90594-5; HOGEBOOM GH, 1955, METHOD ENZYMOL, V1, P16, DOI 10.1016/0076-6879(55)01007-0; ITAKURA K, 1984, ANNU REV BIOCHEM, V53, P323; KORNFELD S, 1986, J CLIN INVEST, V77, P1, DOI 10.1172/JCI112262; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIU CC, 1984, NATURE, V309, P82, DOI 10.1038/309082a0; RAGHAVAN SS, 1980, AM J HUM GENET, V32, P158; SORGE J, 1985, P NATL ACAD SCI USA, V82, P7289, DOI 10.1073/pnas.82.21.7289; SORGE J, 1987, P NATL ACAD SCI USA, V84, P906, DOI 10.1073/pnas.84.4.906; SORGE J, 1984, MOL CELL BIOL, V4, P1730, DOI 10.1128/MCB.4.9.1730; SORGE J, 1986, COLD SPRING HARB SYM, V51, P1041, DOI 10.1101/SQB.1986.051.01.120; TSUJIMOTO Y, 1986, P NATL ACAD SCI USA, V83, P5214, DOI 10.1073/pnas.83.14.5214; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373; 1986, STRATAGENE BLUESCRIP	19	48	51	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1987	41	6					1016	1024						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L2984	3687939				2022-12-18	WOS:A1987L298400005
J	COMINGS, DE; COMINGS, BG				COMINGS, DE; COMINGS, BG			A CONTROLLED-STUDY OF TOURETTE SYNDROME .6. EARLY DEVELOPMENT, SLEEP PROBLEMS, ALLERGIES, AND HANDEDNESS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											COMINGS, DE (corresponding author), CITY HOPE NATL MED CTR, DEPT MED GENET, 1500 E DUARTE RD, DUARTE, CA 91010 USA.							ANNETT M, 1978, BEHAV GENET, V8, P227, DOI 10.1007/BF01072826; BARABAS G, 1984, NEUROLOGY, V34, P815, DOI 10.1212/WNL.34.6.815; BARABAS G, 1984, DEV MED CHILD NEUROL, V26, P457; BOCK RD, 1985, J NEUROL NEUROSUR PS, V48, P535, DOI 10.1136/jnnp.48.6.535; BROUGHTON RJ, 1968, SCIENCE, V159, P1070, DOI 10.1126/science.159.3819.1070; COMINGS DE, 1985, AM J HUM GENET, V37, P435; COMINGS DE, 1987, AM J HUM GENET, V41, P701; COMINGS DE, 1986, P NATL ACAD SCI USA, V83, P2551, DOI 10.1073/pnas.83.8.2551; COMINGS DE, 1984, J AM ACAD CHILD PSY, V23, P138, DOI 10.1097/00004583-198403000-00004; COMINGS DE, 1987, AM J HUM GENET, V41, P839; CROOK WG, 1979, CAN YOUR CHILD READ; EGGER J, 1985, LANCET, V1, P540; FINEGOLD BF, 1975, WHY YOUR CHILD IS HY; FRIEDHOFF AJ, 1982, GILLES TOURETTE SYND; GESCHWIND N, 1982, P NATL ACAD SCI-BIOL, V79, P5097, DOI 10.1073/pnas.79.16.5097; GLAZE DG, 1982, NEUROLOGY, V32, pA153; HASHIMOTO T, 1981, BRAIN DEV-JPN, V3, P31, DOI 10.1016/S0387-7604(81)80003-4; JAGGER J, 1982, SCHIZOPHRENIA BULL, V8, P267, DOI 10.1093/schbul/8.2.267; JANKOVIC J, 1984, NEUROLOGY, V34, P688, DOI 10.1212/WNL.34.5.688; LEMOAL M, 1976, EXP NEUROL, V50, P521, DOI 10.1016/0014-4886(76)90024-8; MENDELSON WB, 1980, BIOL PSYCHIAT, V15, P339; MODOFSKY H, 1974, J NERV MENT DIS, V159, P282; NEE LE, 1980, ANN NEUROL, V7, P41, DOI 10.1002/ana.410070109; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PROAC C, 1981, LATERAL PREFERENCES; RAPP DJ, 1979, ALLERGIES HYPERACTIV; Shapiro A. K., 1978, GILLES TOURETTE SYND; SHAPIRO AK, 1972, J NERV MENT DIS, V155, P335; SHEINKIN D, 1979, FOOD MIND MOOD; SWEET RD, 1973, J NEUROL NEUROSUR PS, V36, P1, DOI 10.1136/jnnp.36.1.1; VARLEY CK, 1984, J AM ACAD CHILD PSY, V23, P182, DOI 10.1097/00004583-198403000-00009; ZARCONE V, 1972, SLEEP RES, V1, P155	32	48	49	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1987	41	5					822	838						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	K9361	3479017				2022-12-18	WOS:A1987K936100006
J	FERRARI, S; CANNIZZARO, LA; BATTINI, R; HUEBNER, K; BASERGA, R				FERRARI, S; CANNIZZARO, LA; BATTINI, R; HUEBNER, K; BASERGA, R			THE GENE ENCODING HUMAN VIMENTIN IS LOCATED ON THE SHORT ARM OF CHROMOSOME-10	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									TEMPLE UNIV,HLTH SCI CTR,SCH MED,DEPT PATHOL,PHILADELPHIA,PA 19140; WISTAR INST ANAT & BIOL,PHILADELPHIA,PA 19104; SW BIOMED RES INST,CTR GENET,SCOTTSDALE,AZ 85251	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; The Wistar Institute			Battini, Renata/F-2113-2015; Ferrari, Sergio/A-1110-2010	Battini, Renata/0000-0003-0876-4294; Ferrari, Sergio/0000-0002-4822-2521	NATIONAL CANCER INSTITUTE [P01CA021124, R01CA025898, P30CA010815] Funding Source: NIH RePORTER; NCI NIH HHS [CA25898, CA21124, CA10815] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BENZEEV A, 1984, J CELL BIOL, V99, P1424, DOI 10.1083/jcb.99.4.1424; CANNIZZARO LA, 1984, CYTOGENET CELL GENET, V38, P308, DOI 10.1159/000132079; CONNELL ND, 1983, CELL, V34, P245, DOI 10.1016/0092-8674(83)90155-1; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FERRARI S, 1986, MOL CELL BIOL, V6, P3614, DOI 10.1128/MCB.6.11.3614; GEISLER B, 1981, P NATL ACAD SCI US, V87, P4120; GIORNO R, 1985, AM J PATHOL, V120, P351; GROSS-BELLARD MM, 1973, EUR J BIOCHEM, V36, P32, DOI 10.1111/j.1432-1033.1973.tb02881.x; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; HOWLEY PM, 1979, J BIOL CHEM, V254, P4876; HUEBNER K, 1985, SCIENCE, V230, P1282, DOI 10.1126/science.2999978; HUEBNER K, 1986, P NATL ACAD SCI USA, V83, P3934, DOI 10.1073/pnas.83.11.3934; HUEBNER K, 1986, P NATL ACAD SCI USA, V83, P1403, DOI 10.1073/pnas.83.5.1403; HUEBNER K, 1986, AM J HUM GENET, V38, P819; ISOBE M, 1985, P NATL ACAD SCI USA, V82, P5836, DOI 10.1073/pnas.82.17.5836; JOHNSON LD, 1985, P NATL ACAD SCI USA, V82, P1896, DOI 10.1073/pnas.82.7.1896; KACZMAREK L, 1985, BIOCHEM BIOPH RES CO, V133, P410, DOI 10.1016/0006-291X(85)90921-0; KACZMAREK L, 1985, P NATL ACAD SCI USA, V82, P5375, DOI 10.1073/pnas.82.16.5375; LAZARIDES E, 1982, ANNU REV BIOCHEM, V51, P219, DOI 10.1146/annurev.bi.51.070182.001251; LEONARD WJ, 1985, SCIENCE, V228, P1547, DOI 10.1126/science.3925551; LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0; MARCHUK D, 1984, CELL, V39, P491, DOI 10.1016/0092-8674(84)90456-2; MCKEON FD, 1986, NATURE, V319, P463, DOI 10.1038/319463a0; NAGARAJAN L, 1986, P NATL ACAD SCI USA, V83, P2556, DOI 10.1073/pnas.83.8.2556; PETERSON RC, 1984, P NATL ACAD SCI-BIOL, V81, P4363, DOI 10.1073/pnas.81.14.4363; QUAX W, 1983, CELL, V35, P215, DOI 10.1016/0092-8674(83)90224-6; QUAX W, 1985, GENE, V38, P189, DOI 10.1016/0378-1119(85)90217-3; QUAXJEUKIN YE, 1983, P NATL ACAD SCI US, V81, P3548; SINGER PA, 1986, J BIOL CHEM, V261, P538; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0	31	48	48	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1987	41	4					616	626						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	K4621	3661560				2022-12-18	WOS:A1987K462100010
J	PALMERI, S; HOOGEVEEN, AT; VERHEIJEN, FW; GALJAARD, H				PALMERI, S; HOOGEVEEN, AT; VERHEIJEN, FW; GALJAARD, H			GALACTOSIALIDOSIS - MOLECULAR HETEROGENEITY AMONG DISTINCT CLINICAL PHENOTYPES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											PALMERI, S (corresponding author), ERASMUS UNIV,DEPT CELL BIOL & GENET,3000 DR ROTTERDAM,NETHERLANDS.							ANDRIA G, 1981, PERSPECTIVES INHERIT, V4, P379; CONZELMANN E, 1983, DEV NEUROSCI, V6, P58; DAZZO A, 1982, P NATL ACAD SCI-BIOL, V79, P4535, DOI 10.1073/pnas.79.15.4535; GALJAARD H, 1984, MOL BASIS LYSOSOMAL, P113; GALJAARD H, 1980, GENETIC METABOLIC DI; GALJAARD H, 1981, PERSPECTIVES INHERIT, V4, P317; GALJAARD H, 1984, LYSOSOM BIOL PATHOL, P315; GRAVEL RA, 1979, AM J HUM GENET, V31, P669; HASILIK A, 1980, J BIOL CHEM, V255, P4946; HASILIK A, 1980, J BIOL CHEM, V255, P4937; HOOGEVEEN AT, 1980, J BIOL CHEM, V255, P4937; KLEIJER WJ, 1979, CLIN GENET, V16, P60; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOONEN MCB, 1974, LANCET, V2, P785; LOONEN MCB, 1984, CLIN GENET, V26, P139; LOWDEN JA, 1979, AM J HUM GENET, V31, P1; NORDEN AGW, 1974, J BIOL CHEM, V249, P7969; OBRIEN JS, 1983, METABOLIC BASIS INHE, P945; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; PINSKY L, 1974, AM J HUM GENET, V26, P563; STRISCIUGLIO P, 1984, PEDIATR RES, V18, P167, DOI 10.1203/00006450-198402000-00011; SUZUKI Y, 1984, DEV BRAIN ITS DISORD, P161; SUZUKI Y, 1983, ACTA PAEDIATR JPN, V25, P31; VERHEIJEN F, 1982, BIOCHEM BIOPH RES CO, V108, P868, DOI 10.1016/0006-291X(82)90911-1; VERHEIJEN FW, 1985, EUR J BIOCHEM, V149, P315, DOI 10.1111/j.1432-1033.1985.tb08928.x; WENGER DA, 1978, BIOCHEM BIOPH RES CO, V82, P589, DOI 10.1016/0006-291X(78)90915-4	26	48	49	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1986	38	2					137	148						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	A3111	3080874				2022-12-18	WOS:A1986A311100003
J	MICHELS, VV; MEDRANO, C; VENNE, VL; RICCARDI, VM				MICHELS, VV; MEDRANO, C; VENNE, VL; RICCARDI, VM			CHROMOSOME TRANSLOCATIONS IN COUPLES WITH MULTIPLE SPONTANEOUS-ABORTIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT MED,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT OBSTET & GYNECOL,HOUSTON,TX 77030	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	MICHELS, VV (corresponding author), MAYO CLIN & MAYO FDN,DEPT GENET,ROCHESTER,MN 55901, USA.							BORTOTTO L, 1980, CLIN GENET, V17, P56; FITZGERALD PH, 1975, HUMANGENETIK, V28, P153, DOI 10.1007/BF00735748; GALLOWAY SM, 1978, CYTOGENET CELL GENET, V20, P78, DOI 10.1159/000130842; GLASS RH, 1978, FERTIL STERIL, V29, P257; HSU LYF, 1972, OBSTET GYNECOL, V40, P98; JACOBS PA, 1972, ANN HUM GENET, V35, P301, DOI 10.1111/j.1469-1809.1957.tb01403.x; KAJII T, 1978, AM J OBSTET GYNECOL, V131, P33, DOI 10.1016/0002-9378(78)90470-2; KIM HJ, 1975, NEW ENGL J MED, V293, P844, DOI 10.1056/NEJM197510232931703; NIELSEN J, 1979, BRIT J OBSTET GYNAEC, V86, P833, DOI 10.1111/j.1471-0528.1979.tb10706.x; RICCARDI VM, 1979, HUM GENET, V52, P211; ROBERTSON RD, 1981, CLIN RES, V29, pA116; SCHMIDT R, 1976, JAMA-J AM MED ASSOC, V236, P369, DOI 10.1001/jama.236.4.369; STENCHEVER MA, 1977, AM J OBSTET GYNECOL, V127, P143, DOI 10.1016/S0002-9378(16)33240-9; TSENGHI C, 1976, OBSTET GYNECOL, V47, P463; WARD BE, 1980, AM J HUM GENET, V32, P549	15	48	48	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	3					507	513						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NR133	7081226				2022-12-18	WOS:A1982NR13300016
J	WINDHAM, GC; SEVER, LE				WINDHAM, GC; SEVER, LE			NEURAL-TUBE DEFECTS AMONG TWIN BIRTHS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BATTELLE MEM INST,PACIFIC NW LABS,RICHLAND,WA 99352	Battelle Memorial Institute; United States Department of Energy (DOE); Pacific Northwest National Laboratory	WINDHAM, GC (corresponding author), NATL INST PUBL HLTH,OSLO 4,NORWAY.				NCRR NIH HHS [RR-3] Funding Source: Medline; PHS HHS [FR-3] Funding Source: Medline; BHP HRSA HHS [2A03AH00601-02] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); BHP HRSA HHS		BUCKLEY MR, 1979, J EPIDEMIOL COMMUN H, V33, P186, DOI 10.1136/jech.33.3.186; CARTER CO, 1973, J MED GENET, V10, P209, DOI 10.1136/jmg.10.3.209; CEDERBAUM SD, 1978, PREVENTION NEURAL TU, P91; ELWOOD JM, 1980, EPIDEMIOLOGY ANENCEP; EMANUEL I, 1973, TERATOLOGY, V8, P325, DOI 10.1002/tera.1420080315; FIELD B, 1974, LANCET, V2, P964; GITTELSOHN AM, 1965, GENETICS EPIDEMIOLOG, P305; GRANROTH G, 1977, BRIT J PREV SOC MED, V31, P164; GRANROTH G, 1978, TERATOLOGY, V17, P213, DOI 10.1002/tera.1420170302; GUHARAY DK, 1977, PENN MED, V80, P46; HAY S, 1970, American Journal of Human Genetics, V22, P662; JAMES WH, 1981, J MED GENET, V18, P17, DOI 10.1136/jmg.18.1.17; JAMES WH, 1979, J MED GENET, V16, P129, DOI 10.1136/jmg.16.2.129; JAMES WH, 1976, ANN HUM BIOL, V3, P401, DOI 10.1080/03014467600001661; JANERICH DT, 1978, J MED GENET, V15, P101, DOI 10.1136/jmg.15.2.101; LAYDE PM, 1980, AM J HUM GENET, V32, P69; LECK I, 1974, BRIT MED BULL, V30, P158, DOI 10.1093/oxfordjournals.bmb.a071187; MCBRIDE ML, 1979, AM J MED GENET, V3, P377, DOI 10.1002/ajmg.1320030409; Myrianthopoulos N C, 1978, Birth Defects Orig Artic Ser, V14, P151; RENWICK JH, 1972, BRIT J PREV SOC MED, V26, P67; SCHINZEL AAGL, 1979, J PEDIATR-US, V95, P921, DOI 10.1016/S0022-3476(79)80278-4; SEVER LE, 1982, TERATOLOGY, V25, P315, DOI 10.1002/tera.1420250308; SEVER LE, 1982, TERATOLOGY, V25, P323, DOI 10.1002/tera.1420250309; SEVER LE, 1976, HUM ECOL, V4, P209, DOI 10.1007/BF01534286; SEVER LE, 1978, PREVENTION NEURAL TU, P75; YEN S, 1968, LANCET, V2, P623	26	48	49	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	6					988	998						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PU211	7180853				2022-12-18	WOS:A1982PU21100017
J	WYANDT, HE; KASPRZAK, R; ENNIS, J; WILLSON, K; KOCH, V; SCHNATTERLY, P; WILSON, W; KELLY, TE				WYANDT, HE; KASPRZAK, R; ENNIS, J; WILLSON, K; KOCH, V; SCHNATTERLY, P; WILSON, W; KELLY, TE			INTERSTITIAL 3P DELETION IN A CHILD DUE TO PATERNAL PARACENTRIC INSERTED INVERSION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											WYANDT, HE (corresponding author), UNIV VIRGINIA,MED CTR,DEPT PEDIAT,DIV MED GENET,CHARLOTTESVILLE,VA 22908, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM125244] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-25244] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		HOEGERMAN SF, 1979, SCIENCE, V205, P1035, DOI 10.1126/science.472726; KELLY TE, 1979, AM J HUM GENET, V31, pA100; PALMER CG, 1977, AM J HUM GENET, V29, P371; SPARKES RS, 1979, SCIENCE, V203, P1027, DOI 10.1126/science.424728; VERJAAL M, 1979, AM J DIS CHILD, V132, P43	5	48	48	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	5					731	735						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KJ795	7424912				2022-12-18	WOS:A1980KJ79500012
J	PASSARGE, E				PASSARGE, E			HEITZ,EMIL AND THE CONCEPT OF HETEROCHROMATIN - LONGITUDINAL CHROMOSOME DIFFERENTIATION WAS RECOGNIZED 50 YEARS AGO	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review											PASSARGE, E (corresponding author), UNIV KLINIKUM ESSEN,INST HUMANGENET,D-4300 ESSEN 1,FED REP GER.							ARRIGHI FE, 1971, CYTOGENETICS, V10, P81, DOI 10.1159/000130130; BOVERI T, 1888, Z NATURWISS, V22, P685; Bridges CB, 1935, J HERED, V26, P60, DOI 10.1093/oxfordjournals.jhered.a104022; BROWN SW, 1966, SCIENCE, V151, P417, DOI 10.1126/science.151.3709.417; CHEN TR, 1971, CHROMOSOMA, V34, P51, DOI 10.1007/BF00285516; Comings D E, 1972, Adv Hum Genet, V3, P237; Heitz E., 1933, Zeitschrift fuer Zellforschung, V17, P67, DOI 10.1007/BF00403356; Heitz E., 1935, Zeitschrift fuer Induktive Abstammungs- und Vererbungslehre, V70, P402, DOI 10.1007/BF01741657; HEITZ E., 1933, Zeitschrift fur Zellforschung und Mikroskopische Anatomie, V19, P720, DOI 10.1007/BF02450275; HEITZ E., 1933, ZEITSCHR WISS BIOL ABT B ZEITSCHR ZELLFORSCH U MIKROSK ANAT, V20, P237, DOI 10.1007/BF00374027; HEITZ E., 1929, BER DEUTSCH BOT GES, V47, P274; HEITZ E, 1956, C CHROMOSOMES, P5; HEITZ E, 1928, Z BOT, V18, P625; Heitz E., 1928, JAHRB WISS BOT, V69, P762; JACHIMSKY HUGO, 1935, JAHRB WISS BOT, V81, P203; McCLINTOCK BARBARA, 1934, ZEITSCHR ZELLJORSCH U MIKROSK ANAT, V21, P294, DOI 10.1007/BF00374060; McClung CE, 1902, BIOL BULL-US, V3, P43, DOI 10.2307/1535527; MORGAN TH, 1915, MECHANISM MENDELIAN; Muller H. J., 1932, Zeitschrift fuer Induktive Abstammungs- und Vererbungslehre, V62, P316, DOI 10.1007/BF01948610; Muller HJ, 1935, P NATL ACAD SCI USA, V21, P69, DOI 10.1073/pnas.21.2.69; Muller HJ, 1935, P NATL ACAD SCI USA, V21, P16, DOI 10.1073/pnas.21.1.16; Muller HJ, 1929, AM NAT, V63, P193, DOI 10.1086/280253; Painter TS, 1933, SCIENCE, V78, P585, DOI 10.1126/science.78.2034.585; RESENDE F, 1962, PORT ACTA BIOL     E, V6; RESENDE F, 1964, PORT ACTA BIOL     E, V7; SCHMID W, 1967, Archiv der Julius Klaus-Stiftung fuer Vererbungsforschung Sozialanthropologie und Rassenhygiene, V42, P1; SCHWARZACHER HG, 1976, CHROMOSOMES MITOSIS; Sutton WS, 1903, BIOL BULL-US, V4, P231, DOI 10.2307/1535741; YUNIS JJ, 1971, NATURE, V231, P532, DOI 10.1038/231532a0; [No title captured], DOI DOI 10.2307/1005428	31	48	50	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	2					106	115						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GZ386	377956				2022-12-18	WOS:A1979GZ38600002
J	FISHMAN, PM; SUAREZ, B; HODGE, SE; REICH, T				FISHMAN, PM; SUAREZ, B; HODGE, SE; REICH, T			ROBUST METHOD FOR DETECTION OF LINKAGE IN FAMILIAL DISEASES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WASHINGTON UNIV,DEPT PSYCHIAT,ST LOUIS,MO 63110; JEWISH HOSP ST LOUIS,ST LOUIS,MO 63110	Washington University (WUSTL); Barnes-Jewish Hospital								Bailey NTJ, 1961, MATH THEORY GENETIC; DAY NE, 1976, TISSUE ANTIGENS, V8, P109; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; GREEN JR, 1977, TISSUE ANTIGENS, V9, P31; HALDANE JBS, 1947, ANN EUGENIC, V14, P10, DOI 10.1111/j.1469-1809.1947.tb02374.x; HASEMAN JK, 1972, BEHAV GENET, V2, P1; HILL AP, 1975, ANN HUM GENET, V38, P439, DOI 10.1111/j.1469-1809.1975.tb00633.x; JAYAKAR SD, 1970, BIOMETRICS, V26, P451, DOI 10.2307/2529101; MORTON NE, 1955, AM J HUM GENET, V7, P277; OTT J, 1974, AM J HUM GENET, V26, P588; PENROSE LS, 1953, ANN EUGENIC, V18, P120; ROBERTSON A, 1973, BEHAV GENET, V3, P389, DOI 10.1007/BF01070222; SMITH CAB, 1953, J R STAT SOC B, V15, P153; SMITH CAB, 1975, ANN HUM GENET, V38, P451, DOI 10.1111/j.1469-1809.1975.tb00634.x	14	48	48	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	3					308	321						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	FE044	677128				2022-12-18	WOS:A1978FE04400009
J	OMOTO, K; MISAWA, S; HARADA, S; SUMPAICO, JS; MEDADO, PM; OGONUKI, H				OMOTO, K; MISAWA, S; HARADA, S; SUMPAICO, JS; MEDADO, PM; OGONUKI, H			POPULATION GENETIC STUDIES OF PHILIPPINE NEGRITOS .1. PILOT SURVEY OF RED-CELL ENZYME AND SERUM-PROTEIN GROUPS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TSUKUBA,SCH MED,DEPT COMMUNITY MED,TSUKUBA,JAPAN; DEPT HLTH,BUR RES & LABS,MANILA,PHILIPPINES; JAPAN INT COOPERAT AGCY,MANILA,PHILIPPINES	University of Tsukuba; Philippine Department Health	OMOTO, K (corresponding author), UNIV TOKYO,FAC SCI,DEPT ANTHROPOL,TOKYO 113,JAPAN.							BARGAGNA M, 1975, HUMANGENETIK, V29, P251, DOI 10.1007/BF00297631; BENDER K, 1974, HUMANGENETIK, V23, P315, DOI 10.1007/BF00272516; BERG K, 1976, HUM GENET, V32, P81, DOI 10.1007/BF00569980; BLAKE NM, 1976, HUM GENET, V35, P91, DOI 10.1007/BF00295623; BLAKE NM, 1975, ANN HUM GENET, V38, P251, DOI 10.1111/j.1469-1809.1975.tb00610.x; CLEVE H, 1973, ISRAEL J MED SCI, V9, P1133; Giblett ER., 1969, GENETIC MARKERS HUMA; GROVE E, 1926, COMMUNICATION; GROVE E, 1976, DISTRIBUTION HUMAN B; HARADA S, 1975, JPN J HUM GENET, V20, P141; HARADA S, 1975, HUMANGENETIK, V29, P255, DOI 10.1007/BF00297632; HARADA S, 1976, KYORIN MED J, V7, P21; Harris, 1976, HDB ENZYME ELECTROPH; Howells, 1973, PACIFIC ISLANDERS; ISHIMOTO G, 1975, ANTHR GENETIC STUDIE, P109; JOHNSON AM, 1975, AM J HUM GENET, V27, P728; KARP GW, 1967, AM J HUM GENET, V19, P54; KIRK RL, 1976, ORIGIN AUSTR, P329; LIEINJO LE, 1976, ORIGIN AUSTR, P277; Mourant AE, 1976, DISTRIBUTION HUMAN B; OMOTO K, 1975, HUM HERED, V25, P378, DOI 10.1159/000152749; OMOTO K, 1975, ANTHR GENETIC STUD 2, P141; OMOTO K, UNPUBLISHED; PASCASIO F M, 1974, Birth Defects Original Article Series, V10, P220; SAHA N, 1974, HUM HERED, V24, P198, DOI 10.1159/000152653; SCHEBESTA P, 1952, COMMUNICATION; SCHEBESTA P, 1976, DISTRIBUTION HUMAN B; SIMMONS RT, 1965, ENCYCLOPAEDIA BRITAN; YAMBOT E, 1975, PHILIPPINE ALMANAC H	29	48	48	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	2					190	201						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV595	655166				2022-12-18	WOS:A1978EV59500011
J	JACOBS, PA; MAYER, M; MORTON, NE				JACOBS, PA; MAYER, M; MORTON, NE			ACROCENTRIC CHROMOSOME ASSOCIATIONS IN MAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV HAWAII, DEPT ANAT, HONOLULU, HI USA; UNIV HAWAII, POPULATION GENET LAB, HONOLULU, HI USA	University of Hawaii System; University of Hawaii System								COHEN MM, 1967, ANN HUM GENET, V31, P129, DOI 10.1111/j.1469-1809.1967.tb00544.x; COOKE P, 1972, CHROMOSOMA, V36, P221; CURTIS DJ, 1974, HUMANGENETIK, V22, P17, DOI 10.1007/BF00338131; DITTES H, 1975, HUMANGENETIK, V26, P47, DOI 10.1007/BF00280284; EVANS HJ, 1974, CHROMOSOMA, V48, P405, DOI 10.1007/BF00290996; FERGUS.MA, 1961, LANCET, V1, P638, DOI 10.1016/S0140-6736(61)91655-5; GALLIMORE PH, 1973, CHROMOSOMA, V41, P259, DOI 10.1007/BF00344020; HANSSON A, 1970, HEREDITAS-GENETISK A, V66, P21; HANSSON A, 1970, HEREDITAS-GENETISK A, V66, P31; HENDERSON AS, 1972, P NATL ACAD SCI USA, V69, P3394, DOI 10.1073/pnas.69.11.3394; ING P, 1973, AM J HUM GENET, V25, pA34; JACOBS PA, 1974, ANN HUM GENET, V37, P359, DOI 10.1111/j.1469-1809.1974.tb01843.x; MATTEI JF, 1974, HUMANGENETIK, V25, P29; MORTON NE, 1968, VOX SANG, V15, P15, DOI 10.1111/j.1423-0410.1968.tb04443.x; OHNO S, 1961, LANCET, V2, P123; PATIL SR, 1971, HUMANGENETIK, V13, P157, DOI 10.1007/BF00295797; RAO DC, 1974, AM J HUM GENET, V26, P444; SCHMID M, 1974, HUMANGENETIK, V23, P267, DOI 10.1007/BF00272510; Wright S, 1921, GENETICS, V6, P124; ZANG KD, 1968, CYTOGENETICS, V7, P455, DOI 10.1159/000130006; ZANKL H, 1974, HUMANGENETIK, V23, P259, DOI 10.1007/BF00272509; 1971, BIRTH DEFECTS OAS	22	48	48	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1976	28	6					567	576						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CQ152	795295				2022-12-18	WOS:A1976CQ15200004
J	MERRITT, AD; LOVRIEN, EW; RIVAS, ML; CONNEALLY, PM				MERRITT, AD; LOVRIEN, EW; RIVAS, ML; CONNEALLY, PM			HUMAN AMYLASE LOCI - GENETIC LINKAGE WITH DUFFY BLOOD-GROUP LOCUS AND ASSIGNMENT TO LINKAGE GROUP-I	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									INDIANA UNIV, MED CTR, DEPT MED GENET, INDIANAPOLIS, IN 46202 USA; UNIV OREGON, MED SCH, DIV MED GENET, CRIPPLED CHILDRENS DIV, PORTLAND, OR 97201 USA; RUTGERS STATE UNIV, DOUGLASS COLL, DEPT BIOL SCI, NEW BRUNSWICK, NJ 08903 USA	Indiana University System; Indiana University-Purdue University Indianapolis; University of Oregon; Rutgers State University New Brunswick								ALTMAN PL, 1972, BIOLOGY DATA BOOK, V1; CARTER TC, 1951, J GENET, V50, P307, DOI 10.1007/BF02996226; COOK PJL, 1972, ANN HUM GENET, V35, P239, DOI 10.1111/j.1469-1809.1957.tb01397.x; COOK PJL, 1972, ANN HUM GENET, V36, P89, DOI 10.1111/j.1469-1809.1972.tb00584.x; COOPER HL, 1963, AM J HUM GENET, V15, P465; DONAHUE RP, 1968, P NATL ACAD SCI USA, V61, P949, DOI 10.1073/pnas.61.3.949; GEDDEDAHL T, 1967, ACTA GENET STAT MED, V17, P482; GEDDEDAHL T, 1968, ACTA GENET STAT MED, V18, P420; HILL CJ, 1972, NATURE, V235, P162, DOI 10.1038/235162a0; JACOBS PA, 1970, ANN HUM GENET, V33, P325, DOI 10.1111/j.1469-1809.1970.tb01658.x; KAMARYT J, 1971, HUMANGENETIK, V11, P213, DOI 10.1007/BF00274740; KAMARYT J, 1965, HUMANGENETIK, V1, P579; KAMARYT J, 1971, EXCERPTA MEDICA  233, P98; LAMM LU, 1970, HUM HERED, V20, P305, DOI 10.1159/000152326; MERRITT A D, 1972, Clinical Research, V20, P782; MERRITT AD, 1972, NATURE-NEW BIOL, V239, P243, DOI 10.1038/newbio239243a0; MERRITT AD, 1973, AM J HUM GENET, V25, P510; MORTON NE, 1956, AM J HUM GENET, V8, P80; MORTON NE, 1955, AM J HUM GENET, V7, P277; PHILIP J, 1965, CYTOGENETICS, V4, P329, DOI 10.1159/000129870; RENWICK J H, 1970, Journal of Medical Genetics, V7, P239, DOI 10.1136/jmg.7.3.239; RENWICK JH, 1971, ANNU REV GENET, V5, P81, DOI 10.1146/annurev.ge.05.120171.000501; RENWICK JH, 1963, ANN HUM GENET, V27, P67, DOI 10.1111/j.1469-1809.1963.tb00782.x; RENWICK JH, 1971, NATURE, V234, P475, DOI 10.1038/234475a0; RIVAS ML, 1972, AM J HUM GENET, V24, pA40; ROBSON EB, 1972, HUMAN GENETICS; RUDDLE F, 1972, SCIENCE, V176, P1429, DOI 10.1126/science.176.4042.1429; SANTACHI.AS, 1970, NATURE, V227, P248, DOI 10.1038/227248a0; VANCONG N, 1971, CR HEBD ACAD SCI, V272, P485; WARD JC, 1971, AM J HUM GENET, V23, P403; WEITKAMP LR, 1970, AM J HUM GENET, V22, P216; WEITKAMP LR, 1971, AM J HUM GENET, V23, P462; WESTERVELD A, 1972, NATURE, V236, P30, DOI 10.1038/236030a0; YING KL, 1968, CAN J GENET CYTOL, V10, P575, DOI 10.1139/g68-076	34	48	48	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1973	25	5					523	538						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q7858	4741847				2022-12-18	WOS:A1973Q785800005
J	HSU, LYF; GERTNER, M; LEITER, E; HIRSCHHORN, K				HSU, LYF; GERTNER, M; LEITER, E; HIRSCHHORN, K			PATERNAL TRISOMY-21 MOSAICISM AND DOWNS SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		AARSKOG D, 1969, ACTA PAEDIATR SCAND, V58, P609, DOI 10.1111/j.1651-2227.1969.tb04769.x; BLANK CE, 1962, BRIT MED J, P378, DOI 10.1136/bmj.2.5301.378; EVANS EP, 1964, CYTOGENETICS, V3, P289, DOI 10.1159/000129818; FERRIER S, 1964, J GENET HUM, V13, P315; FORSSMAN H, 1962, ACTA PAEDIATR SCAND, V51, P180, DOI 10.1111/j.1651-2227.1962.tb06527.x; FRACCARO M, 1960, LANCET, V1, P724; HAMERTON JL, 1961, LANCET, V2, P788; HSU LYF, 1970, ANN HUM GENET, V33, P343, DOI 10.1111/j.1469-1809.1970.tb01660.x; Macklin MT, 1929, AM J MED SCI, V178, P315, DOI 10.1097/00000441-192909000-00002; MIKKELSEN M, 1966, ANN HUM GENET, V30, P125, DOI 10.1111/j.1469-1809.1966.tb00013.x; Oster J., 1953, MONGOLISM; Penrose L.S., 1966, DOWNS ANOMALY; PENROSE LS, 1951, J MENT SCI, V97, P738, DOI 10.1192/bjp.97.409.738; PENROSE LS, 1954, LANCET, V2, P505; PENROSE LS, 1960, LANCET, V2, P409; PENROSE LS, 1963, BIOLOGY MENTAL DEFEC; SMITH DW, 1962, AM J DIS CHILD, V104, P534; SOLTAN HC, 1964, ACTA GENET STAT MED, V14, P251; VERRESEN H, 1964, LANCET, V1, P526; WALKER FA, 1969, LANCET, V1, P374; WEINSTEIN ED, 1963, J PEDIATR-US, V63, P599, DOI 10.1016/S0022-3476(63)80370-4	21	48	50	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1971	23	6					592	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L2014	4257130				2022-12-18	WOS:A1971L201400006
J	JARVIK, LF; KATO, T				JARVIK, LF; KATO, T			CHROMOSOME EXAMINATIONS IN AGED TWINS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALTSHULER KZ, 1967, EXCERPTA MEDICA  134, P111; BLOOM AD, 1967, NATURE, V216, P487, DOI 10.1038/216487a0; COHEN MM, 1967, SCIENCE, V155, P1417, DOI 10.1126/science.155.3768.1417; COURTBROWN WM, 1966, CHROMOSOME STUDIES A; FEINGOLD L, 1950, THESIS COLUMBIA U; GOODMAN RM, 1969, AM J MED SCI, V258, P26, DOI 10.1097/00000441-196907000-00004; HAMERTON JL, 1965, NATURE, V206, P1232, DOI 10.1038/2061232a0; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; HAYFLICK L, 1966, PERSPECTIVES EXPERIM, P195; JACOBS PA, 1964, ANN HUM GENET, V27, P353; JACOBS PA, 1963, NATURE, V197, P1080, DOI 10.1038/1971080a0; JACOBS PA, 1961, NATURE, V191, P1178, DOI 10.1038/1911178a0; Jarvik L F, 1967, Symp Soc Exp Biol, V21, P463; JARVIK LF, 1960, AM J HUM GENET, V12, P170; JARVIK LF, 1962, J GERONTOL, V17, P289, DOI 10.1093/geronj/17.3.289; JARVIK LF, 1969, BRIT J PSYCHIAT, V115, P1193, DOI 10.1192/bjp.115.527.1193; JARVIK LF, 1963, LANCET, V1, P114; KALLMANN FJ, 1948, J HERED, V39, P349, DOI 10.1093/oxfordjournals.jhered.a105785; KATO T, 1969, DIS NERV SYST, V30, P42; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; NEURATH P, 1970, NATURE, V225, P281, DOI 10.1038/225281a0; NIELSEN J, 1968, BRIT J PSYCHIAT, V114, P303, DOI 10.1192/bjp.114.508.303; SANDBERG AA, 1967, AM J HUM GENET, V19, P633; 1966, STANDARDIZATION HUMA	25	48	48	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1970	22	5					562	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	H6097	5534561				2022-12-18	WOS:A1970H609700007
J	NEEL, JV; SCHULL, WJ; YAMAMOTO, M; UCHIDA, S; YANASE, T; FUJIKI, N				NEEL, JV; SCHULL, WJ; YAMAMOTO, M; UCHIDA, S; YANASE, T; FUJIKI, N			EFFECTS OF PARENTAL CONSANGUINITY AND INBREEDING IN HIRADO, JAPAN .2. PHYSICAL DEVELOPMENT, TAPPING RATE, BLOOD PRESSURE, INTELLIGENCE QUOTIENT, AND SCHOOL PERFORMANCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BARRAI I, 1964, HEREDITY, V19, P651, DOI 10.1038/hdy.1964.76; MANGE AP, 1964, HUM BIOL, V36, P104; MORTON NE, 1958, AM J HUM GENET, V10, P344; NEEL JV, 1956, 461 NAT RES COUNC PU; Pearson K., 1903, BIOMETRIKA, V2, P357; SCHULL WJ, 1970, AM J HUM GENET, V22, P239; SCHULL WJ, 1958, AM J HUM GENET, V10, P294; SCHULL WJ, 1962, EUGEN QUART, V9, P14, DOI 10.1080/19485565.1962.9987496; SCHULL WJ, 1968, P NATL ACAD SCI USA, V59, P671, DOI 10.1073/pnas.59.3.671; Schull WJ, 1965, EFFECTS INBREEDING J; [No title captured]	11	48	48	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1970	22	3					263	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	G6436	5444999				2022-12-18	WOS:A1970G643600002
J	ROBINSON, A; GOAD, WB; PUCK, TT; HARRIS, JS				ROBINSON, A; GOAD, WB; PUCK, TT; HARRIS, JS			STUDIES ON CHROMOSOMAL NONDISJUNCTION IN MAN .3.	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BARR ML, 1949, NATURE, V163, P676, DOI 10.1038/163676a0; BROWN W M C, 1968, Journal of Medical Genetics, V5, P341, DOI 10.1136/jmg.5.4.341; BROWN WMC, 1967, HUMAN POPULATION CYT; DALES S, 1965, AM J MED, V38, P699, DOI 10.1016/0002-9343(65)90191-9; FROLAND A, 1967, LANCET, V2, P771; FULGINITI VA, 1966, J PEDIATR-US, V68, P723, DOI 10.1016/S0022-3476(66)80444-4; MIKAMO K, 1968, OBSTET GYNECOL, V32, P688; ROBINSON A, 1965, SCIENCE, V148, P83, DOI 10.1126/science.148.3666.83; ROBINSON A, 1967, AM J HUM GENET, V19, P112; SEVER JL, 1968, OBSTET GYNECOL, V32, P365; TAYLOR A I, 1968, Journal of Medical Genetics, V5, P227, DOI 10.1136/jmg.5.3.227; TUNTE W, 1968, LANCET, V1, P641	12	48	48	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1969	21	5					466	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	E7549	5387720				2022-12-18	WOS:A1969E754900006
J	CONEN, PE; ERKMAN, B				CONEN, PE; ERKMAN, B			FREQUENCY AND OCCURRENCE OF CHROMOSOMAL SYNDROMES .I. D-TRISOMY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ATKINS L, 1961, NEW ENGL J MED, V265, P314, DOI 10.1056/NEJM196108172650703; BLANCK C, 1964, ACTA PATHOL MIC SC, V60, P36, DOI 10.1111/apm.1964.60.1.36; BUHLER VE, 1962, ANN PEDIAT, V199, P198; CARR DH, 1965, OBSTET GYNECOL, V26, P308; CONEN PE, 1966, AM J HUM GENET, V18, P387; CONEN PE, 1966, AM J DIS CHILD, V111, P236, DOI 10.1001/archpedi.1966.02090060046002; CONEN PE, 1964, LANCET, V1, P665; CONEN PE, 1962, CAN MED ASSOC J, V87, P709; DAY RW, 1966, AM J HUM GENET, V18, P70; DEMEYER W, 1963, NEUROLOGY, V13, P913; ELLIS JR, 1961, LANCET, V2, P263; ERKMAN B, 1965, J PEDIATR-US, V67, P270, DOI 10.1016/S0022-3476(65)80251-7; HUEHNS ER, 1964, LANCET, V1, P589; JONGBLOET P, 1964, HELV PAEDIATR ACTA, V19, P121; KOENIG EU, 1962, YALE J BIOL MED, V35, P189; LUBS HA, 1961, LANCET, V2, P1001; MARDEN PM, 1964, J PEDIATR-US, V64, P357, DOI 10.1016/S0022-3476(64)80188-8; MARINPADILLA M, 1964, CYTOGENETICS, V3, P258, DOI 10.1159/000129816; MARSHALL R, 1964, LANCET, V1, P556; MILLER JQ, 1963, NEW ENGL J MED, V268, P120, DOI 10.1056/NEJM196301172680302; MILLER M, 1963, AM J OPHTHALMOL, V55, P901, DOI 10.1016/0002-9394(63)90367-2; NORTHCUTT R, 1962, SOUTHERN MED J, V55, P835; PEARSON ES, 1962, BIOMETRIKA TABLES ST, P203; POWARS D, 1964, LANCET, V1, P1363; PRADER VA, 1962, HELV MED ACTA, V29, P403; ROSENFIELD RL, 1962, AM J MED SCI, V244, P763; SCHARER D, 1962, HELV MED ACTA, V29, P423; SERGOVICH F, 1963, CAN MED ASSOC J, V89, P151; SHAW MW, 1961, CITED INDIRECTLY; SMITH D W, 1963, J Pediatr, V62, P326, DOI 10.1016/S0022-3476(63)80129-8; SMITH DW, 1964, AM J OBSTET GYNECOL, V90, P1055, DOI 10.1016/0002-9378(64)90835-X; TAYLOR ANGELA I., 1964, GUY S HOSP REP, V113, P231; TELLER W, 1964, Z Kinderheilkd, V89, P36, DOI 10.1007/BF02473346; THERMAN E, 1961, AM J HUM GENET, V13, P193; TOWNES PL, 1962, J PEDIATR-US, V60, P528, DOI 10.1016/S0022-3476(62)80113-9; UCHIDA IA, 1962, AM J HUM GENET, V14, P345; WARBURG M, 1963, ACTA OPHTHALMOL, V41, P321; YUNIS JJ, 1964, LANCET, V2, P935; 1960, 91 94 OFF REG GEN RE	39	48	48	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1966	18	4					374	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	81309	5945953				2022-12-18	WOS:A19668130900004
J	AXELSSON, U; LAURELL, CB				AXELSSON, U; LAURELL, CB			HEREDITARY VARIANTS OF SERUM ALPHA1-ANTITRYPSIN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ERIKSSON S, 1963, ACTA CHEM SCAND, V17, P150, DOI 10.3891/acta.chem.scand.17s-0150; ERIKSSON S, 1965, ACTA MED SCAND  S175, V177; ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X; JACOBSSON K, 1955, SCAND J CLIN LAB S14, P55; LAURELL CB, 1965, ANAL BIOCHEM, V10, P358, DOI 10.1016/0003-2697(65)90278-2; LAURELL CB, 1965, CLIN CHIM ACTA, V11, P395, DOI 10.1016/0009-8981(65)90184-1; LAURELL CB, 1965, SCAND J CLIN LAB INV, V17, P1; SCHULTZE HE, 1962, KLIN WOCHENSCHR, V40, P427, DOI 10.1007/BF01732842	8	48	50	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1965	17	6					466	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	69652	4158556				2022-12-18	WOS:A19656965200002
J	Micheletti, SJ; Bryc, K; Esselmann, SGA; Freyman, WA; Moreno, ME; Poznik, GD; Shastri, AJ; Beleza, S; Mountain, JL				Micheletti, Steven J.; Bryc, Kasia; Esselmann, Samantha G. Ancona; Freyman, William A.; Moreno, Meghan E.; Poznik, G. David; Shastri, Anjali J.; Beleza, Sandra; Mountain, Joanna L.		23andMe Res Team	Genetic Consequences of the Transatlantic Slave Trade in the Americas	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ADMIXTURE; POPULATION; DIVERSITY; ANCESTRY; HISTORY; ASSOCIATION; HAPLOGROUP; IDENTITY; AFRICANS; ORIGINS	According to historical records of transatlantic slavery, traders forcibly deported an estimated 12.5 million people from ports along the Atlantic coastline of Africa between the 16th and 19th centuries, with global impacts reaching to the present day, more than a century and a half after slavery's abolition. Such records have fueled a broad understanding of the forced migration from Africa to the Americas yet remain underexplored in concert with genetic data. Here, we analyzed genotype array data from 50,281 research participants, which-combined with historical shipping documents-illustrate that the current genetic landscape of the Americas is largely concordant with expectations derived from documentation of slave voyages. For instance, genetic connections between people in slave trading regions of Africa and disembarkation regions of the Americas generally mirror the proportion of individuals forcibly moved between those regions. While some discordances can be explained by additional records of deportations within the Americas, other discordances yield insights into variable survival rates and timing of arrival of enslaved people from specific regions of Africa. Furthermore, the greater contribution of African women to the gene pool compared to African men varies across the Americas, consistent with literature documenting regional differences in slavery practices. This investigation of the transatlantic slave trade, which is broad in scope in terms of both datasets and analyses, establishes genetic links between individuals in the Americas and populations across Atlantic Africa, yielding a more comprehensive understanding of the African roots of peoples of the Americas.	[Micheletti, Steven J.; Bryc, Kasia; Esselmann, Samantha G. Ancona; Freyman, William A.; Moreno, Meghan E.; Poznik, G. David; Shastri, Anjali J.; Mountain, Joanna L.; 23andMe Res Team] 23andMe Inc, Sunnyvale, CA 94043 USA; [Beleza, Sandra] Univ Leicester, Leicester LE1 7RH, Leics, England	University of Leicester	Micheletti, SJ (corresponding author), 23andMe Inc, Sunnyvale, CA 94043 USA.	smicheletti@ucdavis.edu		Freyman, William/0000-0002-3463-2044	23andMe	23andMe	We thank the customers and others who consented to participate in research for enabling this study. We acknowledge other employees of 23andMe who contributed to the development of the infrastructure that made this research possible, and the suggestions of Scott Hadly, Altovise Ewing, Vence Bonham, Alvin Tillery, John Thornton, Linda Heywood, BeatrizMarcheco-Teruel, Richard Roberts, David Robinson, David Eltis, the slavevoyages.org ScholarsGroup, and two anonymous reviewers. We also thank those who made additional samples available and provided guidance and discussion around those samples: Nathan Nunn (DRC), Bert Ely (Sierra Leone), and Brenna Henn (Khoe-San speakers). Finally, we would like to acknowledge the many people who were taken from Africa but never made it to the Americas, whose DNA is not directly part of this paper. Funding for this research was provided by 23andMe.	Acemoglu D, 2005, AM ECON REV, V95, P546, DOI 10.1257/0002828054201305; Agier M., 1995, B LAT AM RES, V14, P245, DOI [10.1111/j.1470-9856.1995.tb00010.x, DOI 10.1111/J.1470-9856.1995.TB00010.X]; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Auton A., 2015, NATURE, V7571, P68, DOI 10.1038/nature15393; Baharian S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006059; Baptist EE, 2001, AM HIST REV, V106, P1619, DOI 10.2307/2692741; Baum Robert M., 1999, SHRINES SLAVE TRADE; Beleza S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051103; Bergad Laird W, 2007, COMP HIST SLAVERY BR; Bethell Leslie, 2009, ABOLITION BRAZILIAN; Borucki A, 2015, AM HIST REV, V120, P433, DOI 10.1093/ahr/120.2.433; Browning BL, 2013, GENETICS, V194, P459, DOI 10.1534/genetics.113.150029; Browning SR, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007385; Bryc K, 2015, AM J HUM GENET, V96, P37, DOI 10.1016/j.ajhg.2014.11.010; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; Busby GBJ, 2016, ELIFE, V5, DOI 10.7554/eLife.15266; Cann HM, 2002, SCIENCE, V296, P261; Carney J, 2000, ECUMENE, V7, P125, DOI 10.1177/096746080000700201; Cash F.G., 1853, SLAVERY SYSTEM INHER; Conomos MP, 2016, AM J HUM GENET, V98, P165, DOI 10.1016/j.ajhg.2015.12.001; DeFrancesco L, 2015, NAT BIOTECHNOL, V33, P1220, DOI 10.1038/nbt1215-1220; Deyle Steven, 2005, CARRY ME BACK DOMEST; Do C., 2016, SCALABLE PIPELINE LO; Durand EY, 2014, BIORXIV; Edwards Laura F, 1996, LAW HIST REV, V14, P81; Ellis N, 2002, GENOME RES, V12, P339; Eltis D., 2007, BRIEF OVERVIEW TRANS; Eltis D., 2010, ATLAS TRANSATLANTIC; Eltis D, 2001, WILLIAM MARY QUART, V58, P17, DOI 10.2307/2674417; Eriksson N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000993; Fortes-Lima C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29851-3; Gates H. L., 2011, LIFE THESE SHORES LO; Goldberg A, 2015, GENETICS, V201, P263, DOI 10.1534/genetics.115.178509; Goldberg A, 2014, GENETICS, V198, P1209, DOI 10.1534/genetics.114.166793; Gouveia MH, 2020, MOL BIOL EVOL, V37, P1647, DOI 10.1093/molbev/msaa033; GRAHAM R, 1976, J SOC HIST, V9, P382, DOI 10.1353/jsh/9.3.382; Haber M, 2019, GENETICS, V212, P1421, DOI 10.1534/genetics.119.302368; Hall G. M., 2005, SLAVERY AFRICAN ETHN; Head D, 2013, J EARLY REPUBL, V33, P433, DOI 10.1353/jer.2013.0061; Henderson G., 1995, MIGRANTS IMMIGRANTS; Henn BM, 2011, P NATL ACAD SCI USA, V108, P5154, DOI 10.1073/pnas.1017511108; Heywood LM, 2007, CENTRAL AFRICANS, ATLANTIC CREOLES, AND THE FOUNDATION OF THE AMERICAS, 1585-1660, P1; Holt K, 2005, INT REV SOC HIST, V50, P25, DOI 10.1017/S0020859005002051; Jackson BA, 2005, AM J PHYS ANTHROPOL, V128, P156, DOI 10.1002/ajpa.20040; James Melville, 2020, Arxiv, DOI arXiv:1802.03426; Keller Albert G., 1908, COLONIZATION STUDY F; King Wilma., 2011, STOLEN CHILDHOOD SLA; Kivisild T, 2015, INVESTIG GENET, V6, DOI 10.1186/s13323-015-0022-2; Klimentidis YC, 2009, AM J PHYS ANTHROPOL, V138, P375, DOI 10.1002/ajpa.20945; Knight A, 2003, CURR BIOL, V13, P464, DOI 10.1016/S0960-9822(03)00130-1; LAVEIST TA, 1993, MILBANK Q, V71, P41, DOI 10.2307/3350274; Lind JM, 2007, HUM GENET, V120, P713, DOI 10.1007/s00439-006-0261-7; Loh PR, 2016, NAT GENET, V48, P811, DOI 10.1038/ng.3571; Malarek V., 2011, NATASHAS HORRIFIC IN; MANNING P, 1981, CAN J AFR STUD, V15, P499, DOI 10.2307/484732; Marable M., 2015, CAPITALISM UNDER; Marcheco-Teruel B, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004488; MARTINS RB, 1982, J ECON HIST, V42, P222, DOI 10.1017/S0022050700027133; Meade TA., 2016, HIST MODERN LATIN AM, V2; Montalvo FrankF., 2001, ETHNICITIES, V1, P321, DOI DOI 10.1177/146879680100100303; Murdock G.P., 1959, AFRICA ITS PEOPLES T; National Research Council, 1996, LOST CROPS AFR, VI; OMalley GE, 2014, FINAL PASSAGES: THE INTERCOLONIAL SLAVE TRADE OF BRITISH AMERICA, 1619-1807, P1, DOI 10.5149/northcarolina/9781469615349.001.0001; Ongaro L, 2019, CURR BIOL, V29, P3974, DOI 10.1016/j.cub.2019.09.076; Palamara PF, 2012, AM J HUM GENET, V91, P809, DOI 10.1016/j.ajhg.2012.08.030; Powell JE, 2010, NAT REV GENET, V11, P800, DOI 10.1038/nrg2865; Poznik GD., 2016, BIORXIV, P088716, DOI [10.1101/088716, DOI 10.1101/088716]; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rotimi CN, 2016, CURR OPIN GENET DEV, V41, P77, DOI 10.1016/j.gde.2016.08.005; Rucker W.C., 2008, RIVER FLOWS BLACK RE; Santos HC, 2016, EUR J HUM GENET, V24, P725, DOI 10.1038/ejhg.2015.187; Schneider D., 2014, SLAVERY AM; Skidmore Thomas E., 1993, BLACK WHITE RACE NAT; Snyder TL, 2010, J AM HIST, V97, P39, DOI 10.2307/jahist/97.1.39; van Dorp L, 2019, P NATL ACAD SCI USA, V116, P593, DOI 10.1073/pnas.1811211115; VANSINA J, 1995, J AFR HIST, V36, P173, DOI 10.1017/S0021853700034101; Wang S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000037; Weissensteiner H, 2016, NUCLEIC ACIDS RES, V44, pW58, DOI 10.1093/nar/gkw233	78	47	47	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 6	2020	107	2					265	277		10.1016/j.ajhg.2020.06.012	http://dx.doi.org/10.1016/j.ajhg.2020.06.012			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	MY5YF	32707084	Green Published, hybrid			2022-12-18	WOS:000558491800008
J	Chen, H; Huffman, JE; Brody, JA; Wang, CL; Lee, S; Li, ZL; Gogarten, SM; Sofer, T; Bielak, LF; Bis, JC; Blangero, J; Bowler, RP; Cade, BE; Cho, MH; Correa, A; Curran, JE; de Vries, PS; Glahn, DC; Guo, XQ; Johnson, AD; Kardia, S; Kooperberg, C; Lewis, JP; Liu, XM; Mathias, RA; Mitchell, BD; O'Connell, JR; Peyser, PA; Post, WS; Reiner, AP; Rich, SS; Rotter, JI; Silverman, EK; Smith, JA; Vasan, RS; Wilson, JG; Yanek, LR; Redline, S; Smith, NL; Boerwinkle, E; Borecki, IB; Cupples, LA; Laurie, CC; Morrison, AC; Rice, KM; Lin, XH				Chen, Han; Huffman, Jennifer E.; Brody, Jennifer A.; Wang, Chaolong; Lee, Seunggeun; Li, Zilin; Gogarten, Stephanie M.; Sofer, Tamar; Bielak, Lawrence F.; Bis, Joshua C.; Blangero, John; Bowler, Russell P.; Cade, Brian E.; Cho, Michael H.; Correa, Adolfo; Curran, Joanne E.; de Vries, Paul S.; Glahn, David C.; Guo, Xiuqing; Johnson, Andrew D.; Kardia, Sharon; Kooperberg, Charles; Lewis, Joshua P.; Liu, Xiaoming; Mathias, Rasika A.; Mitchell, Braxton D.; O'Connell, Jeffrey R.; Peyser, Patricia A.; Post, Wendy S.; Reiner, Alex P.; Rich, Stephen S.; Rotter, Jerome I.; Silverman, Edwin K.; Smith, Jennifer A.; Vasan, Ramachandran S.; Wilson, James G.; Yanek, Lisa R.; Redline, Susan; Smith, Nicholas L.; Boerwinkle, Eric; Borecki, Ingrid B.; Cupples, L. Adrienne; Laurie, Cathy C.; Morrison, Alanna C.; Rice, Kenneth M.; Lin, Xihong		NHLBI Trans-Omics Precision Med; TOPMED Hematology Hemostasis	Efficient Variant Set Mixed Model Association Tests for Continuous and Binary Traits in Large-Scale Whole-Genome Sequencing Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RARE VARIANTS; POPULATION-STRUCTURE; QUANTITATIVE TRAITS; GENERAL FRAMEWORK; COMMON DISEASES; METAANALYSIS; ANNOTATIONS; PREDICTION; INFERENCE; POWERFUL	With advances in whole-genome sequencing (WGS) technology, more advanced statistical methods for testing genetic association with rare variants are being developed. Methods in which variants are grouped for analysis are also known as variant-set, gene-based, and aggregate unit tests. The burden test and sequence kernel association test (SKAT) are two widely used variant-set tests, which were originally developed for samples of unrelated individuals and later have been extended to family data with known pedigree structures. However, computationally efficient and powerful variant-set tests are needed to make analyses tractable in large-scale WGS studies with complex study samples. In this paper, we propose the variant-set mixed model association tests (SMMAT) for continuous and binary traits using the generalized linear mixed model framework. These tests can be applied to large-scale WGS studies involving samples with population structure and relatedness, such as in the National Heart, Lung, and Blood Institute's Trans-Omics for Precision Medicine (TOPMed) program. SMMATs share the same null model for different variant sets, and a virtue of this null model, which includes covariates only, is that it needs to be fit only once for all tests in each genome-wide analysis. Simulation studies show that all the proposed SMMATs correctly control type I error rates for both continuous and binary traits in the presence of population structure and relatedness. We also illustrate our tests in a real data example of analysis of plasma fibrinogen levels in the TOPMed program (n = 23,763), using the Analysis Commons, a cloud-based computing platform.	[Chen, Han; de Vries, Paul S.; Boerwinkle, Eric; Morrison, Alanna C.] Univ Texas Hlth Sci Ctr Houston, Dept Epidemiol Human Genet & Environm Sci, Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA; [Chen, Han] Univ Texas Hlth Sci Ctr Houston, Ctr Precis Hlth, Sch Publ Hlth, Houston, TX 77030 USA; [Chen, Han] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Houston, TX 77030 USA; [Huffman, Jennifer E.] VA Boston Healthcare Syst, Ctr Populat Genom, Jamaica Plain, MA 02130 USA; [Brody, Jennifer A.; Bis, Joshua C.; Smith, Nicholas L.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Wang, Chaolong] Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Sch Publ Hlth, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China; [Lee, Seunggeun] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Li, Zilin; Lin, Xihong] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Gogarten, Stephanie M.; Borecki, Ingrid B.; Laurie, Cathy C.; Rice, Kenneth M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Sofer, Tamar; Cade, Brian E.; Redline, Susan] Brigham & Womens Hosp, Div Sleep & Circadian Disorders, 75 Francis St, Boston, MA 02115 USA; [Sofer, Tamar; Cade, Brian E.; Redline, Susan] Harvard Med Sch, Div Sleep Med, Boston, MA 02115 USA; [Bielak, Lawrence F.; Kardia, Sharon; Peyser, Patricia A.; Smith, Jennifer A.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Blangero, John; Curran, Joanne E.] Univ Texas Rio Grande Valley, Dept Human Genet, Sch Med, Brownsville, TX 78520 USA; [Blangero, John; Curran, Joanne E.] Univ Texas Rio Grande Valley, South Texas Diabet & Obes Inst, Sch Med, Brownsville, TX 78520 USA; [Bowler, Russell P.] Natl Jewish Hlth, Div Pulm Med, Dept Med, Denver, CO 80206 USA; [Cho, Michael H.; Silverman, Edwin K.] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Cho, Michael H.; Silverman, Edwin K.] Harvard Med Sch, Div Pulm & Crit Care Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Correa, Adolfo] Univ Mississippi, Med Ctr, Dept Med, Jackson Heart Study, Jackson, MS 39216 USA; [Glahn, David C.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA; [Glahn, David C.] Hartford Hosp, Olin Neuropsychiat Res Ctr, Inst Living, Hartford, CT 06106 USA; [Guo, Xiuqing; Rotter, Jerome I.] Harbor UCLA Med Ctr, Inst Translat Genom & Populat Sci, Dept Pediat, Los Angeles Biomed Res Inst, Torrance, CA 90502 USA; [Johnson, Andrew D.; Vasan, Ramachandran S.; Cupples, L. Adrienne] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; [Johnson, Andrew D.; Vasan, Ramachandran S.; Cupples, L. Adrienne] Boston Univ, Framingham, MA 01702 USA; [Kooperberg, Charles; Reiner, Alex P.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Lewis, Joshua P.; Mitchell, Braxton D.; O'Connell, Jeffrey R.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Liu, Xiaoming] Univ S Florida, USF Genom, Coll Publ Hlth, Tampa, FL 33612 USA; [Mathias, Rasika A.; Yanek, Lisa R.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21287 USA; [Mitchell, Braxton D.] Baltimore VA Med Ctr, Geriatr Res & Educ Clin Ctr, Baltimore, MD 21201 USA; [Post, Wendy S.] Johns Hopkins Univ, Div Cardiol, Baltimore, MD 21287 USA; [Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Dept Med, Sect Prevent Med & Epidemiol, Boston, MA 02118 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Dept Med, Cardiol Sect, Boston, MA 02118 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02118 USA; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Redline, Susan] Beth Israel Deaconess Med Ctr, Div Pulm Crit Care & Sleep Med, Boston, MA 02115 USA; [Smith, Nicholas L.] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA 98101 USA; [Smith, Nicholas L.] Dept Vet Affairs Off Res & Dev, Seattle Epidemiol Res & Informat Ctr, Seattle, WA 98108 USA; [Smith, Nicholas L.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Lin, Xihong] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; University of Washington; University of Washington Seattle; Huazhong University of Science & Technology; University of Michigan System; University of Michigan; Harvard University; Harvard T.H. Chan School of Public Health; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Michigan System; University of Michigan; University of Texas System; University of Texas Rio Grande Valley; University of Texas System; University of Texas Rio Grande Valley; National Jewish Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Mississippi; University of Mississippi Medical Center; Yale University; Hartford Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Fred Hutchinson Cancer Center; University System of Maryland; University of Maryland Baltimore; State University System of Florida; University of South Florida; Johns Hopkins University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; Johns Hopkins University; University of Virginia; Boston University; Boston University; Boston University; University of Mississippi; University of Mississippi Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Kaiser Permanente; University of Washington; University of Washington Seattle; Baylor College of Medicine; Boston University; Harvard University	Lin, XH (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.; Lin, XH (corresponding author), Harvard Univ, Dept Stat, Cambridge, MA 02138 USA.	xlin@hsph.harvard.edu	Blangero, John/ABA-7175-2021; Mitchell, Braxton/CAF-0876-2022; Johnson, Andrew D/G-6520-2013; Rotter, Jerome/AAY-6598-2021; Li, Zilin/AAB-1216-2019; Cade, Brian/J-6770-2019; Ramachandran, Vasan/Y-2527-2019; Li, Zilin/AAG-8038-2021; Liu, Xiaoming/C-2743-2008	Johnson, Andrew D/0000-0001-6369-5178; Cade, Brian/0000-0003-1424-0673; Ramachandran, Vasan/0000-0001-7357-5970; Li, Zilin/0000-0003-1521-8945; Lewis, Joshua/0000-0002-4107-6066; Curran, Joanne/0000-0002-6898-155X; Smith, Jennifer Ann/0000-0002-3575-5468; Sofer, Tamar/0000-0001-8520-8860; Liu, Xiaoming/0000-0001-8285-5528; Gogarten, Stephanie/0000-0002-7231-9745; Blangero, John/0000-0001-6250-5723; Chen, Han/0000-0002-9510-4923; Rich, Stephen/0000-0003-3872-7793	National Institutes of Health [R00 HL130593, U01 HL120393, R35 CA197449, P01-CA134294, U01-HG009088, U19-CA203654, R01-HL113338]; NIH [R01 HL131136, R01 HL139553]; NATIONAL CANCER INSTITUTE [P01CA134294, U19CA203654, R35CA197449] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL120393, R00HL130593, R01HL131136, R35HL135818, R01HL113338, R01HL137922, R01HL139553, ZIAHL006170, K01HL135405] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG009088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB015611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM115428, P20GM121334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R00 HL130593 (to H.C.), U01 HL120393 (to H.C. and J.E.H.), and R35 CA197449, P01-CA134294, U01-HG009088, U19-CA203654, and R01-HL113338 (to X. Lin). The authors acknowledge the Texas Advanced Computing Center (TACC, https://www.tacc.utexas.edu) at The University of Texas at Austin for providing high performance computing (HPC) resources that have contributed to the research results reported within this paper. Whole-genome sequence analysis of fibrinogen levels in TOPMed was performed in the Analysis Commons on DNAnexus, a hosting platform that uses AmazonWeb Services (AWS) to provide a cloud data management and computing environment for large genomic data projects. The Analysis Commons was funded by NIH R01 HL131136. Phenotype harmonization and aggregation of the fibrinogen levels across TOPMed studies were supported in part by NIH R01 HL139553. Detailed TOPMed and study-specific acknowledgments can be found in Supplemental Acknowledgments. The views expressed in this manuscript are those of the authors and do not necessarily represent the views of the National Heart, Lung, and Blood Institute, the National Institutes of Health, or the U.S. Department of Health and Human Services. We thank the referees for their helpful comments that have helped improve the paper.	Bates D, 2018, MATRIX SPARSE DENSE; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Brody JA, 2017, NAT GENET, V49, P1560, DOI 10.1038/ng.3968; Chen H, 2016, AM J HUM GENET, V98, P653, DOI 10.1016/j.ajhg.2016.02.012; Chen H, 2013, GENET EPIDEMIOL, V37, P196, DOI 10.1002/gepi.21703; Chen J, 2016, GENET EPIDEMIOL, V40, P5, DOI 10.1002/gepi.21934; Conomos MP, 2016, AM J HUM GENET, V98, P165, DOI 10.1016/j.ajhg.2015.12.001; Conomos MP, 2015, GENET EPIDEMIOL, V39, P276, DOI 10.1002/gepi.21896; Dey R, 2017, AM J HUM GENET, V101, P37, DOI 10.1016/j.ajhg.2017.05.014; Feng S, 2015, GENET EPIDEMIOL, V39, P227, DOI 10.1002/gepi.21892; He ZH, 2017, AM J HUM GENET, V101, P340, DOI 10.1016/j.ajhg.2017.07.011; Huffman JE, 2015, BLOOD, V126, pE19, DOI 10.1182/blood-2015-02-624551; Ionita-Laza I, 2016, NAT GENET, V48, P214, DOI 10.1038/ng.3477; Ionita-Laza I, 2013, AM J HUM GENET, V92, P841, DOI 10.1016/j.ajhg.2013.04.015; Jiang D, 2014, GENET EPIDEMIOL, V38, P10, DOI 10.1002/gepi.21775; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; KOZIOL JA, 1978, J AM STAT ASSOC, V73, P753, DOI 10.2307/2286276; Lee S, 2013, AM J HUM GENET, V93, P42, DOI 10.1016/j.ajhg.2013.05.010; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/NMETH.1681, 10.1038/nmeth.1681]; Liu DJJ, 2014, NAT GENET, V46, P200, DOI 10.1038/ng.2852; Loh PR, 2018, NAT GENET, V50, P906, DOI 10.1038/s41588-018-0144-6; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Lu QS, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005947; Lumley T, 2018, GENET EPIDEMIOL, V42, P516, DOI 10.1002/gepi.22136; MACCLUER JW, 1986, ZOO BIOL, V5, P147, DOI 10.1002/zoo.1430050209; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Morrison AC, 2017, AM J HUM GENET, V100, P205, DOI 10.1016/j.ajhg.2016.12.009; Oualkacha K, 2013, GENET EPIDEMIOL, V37, P366, DOI 10.1002/gepi.21725; Pan W, 2014, GENETICS, V197, P1081, DOI 10.1534/genetics.114.165035; Park JY, 2018, BEHAV GENET, V48, P55, DOI 10.1007/s10519-017-9883-x; Pirinen M, 2013, ANN APPL STAT, V7, P369, DOI 10.1214/12-AOAS586; Rice K, 2018, J R STAT SOC A STAT, V181, P205, DOI 10.1111/rssa.12275; Rogers MF, 2018, BIOINFORMATICS, V34, P511, DOI 10.1093/bioinformatics/btx536; Schifano ED, 2012, GENET EPIDEMIOL, V36, P797, DOI 10.1002/gepi.21676; Su YR, 2018, AM J HUM GENET, V102, P904, DOI 10.1016/j.ajhg.2018.03.019; Sun JP, 2013, GENET EPIDEMIOL, V37, P334, DOI 10.1002/gepi.21717; Wang XF, 2013, GENET EPIDEMIOL, V37, P778, DOI 10.1002/gepi.21763; Wu MC, 2013, GENET EPIDEMIOL, V37, P267, DOI 10.1002/gepi.21715; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yan Q, 2015, HUM HERED, V79, P60, DOI 10.1159/000375409; Zhan XW, 2016, BIOINFORMATICS, V32, P1423, DOI 10.1093/bioinformatics/btw079; Zhou JJ, 2016, GENETICS, V204, P921, DOI 10.1534/genetics.116.190454; Zhou W, 2018, NAT GENET, V50, P1335, DOI 10.1038/s41588-018-0184-y; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	50	47	49	4	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 7	2019	104	2					260	274		10.1016/j.ajhg.2018.12.012	http://dx.doi.org/10.1016/j.ajhg.2018.12.012			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HL2SW	30639324	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000458557800007
J	Weissbrod, O; Flint, J; Rosset, S				Weissbrod, Omer; Flint, Jonathan; Rosset, Saharon			Estimating SNP-Based Heritability and Genetic Correlation in Case-Control Studies Directly and with Summary Statistics	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; MISSING HERITABILITY; SUSCEPTIBILITY LOCI; DISEASES; PROPORTION; REGRESSION; IDENTIFY; TRAITS	Methods that estimate SNP-based heritability and genetic correlations from genome-wide association studies have proven to be powerful tools for investigating the genetic architecture of common diseases and exposing unexpected relationships between disorders. Many relevant studies employ a case-control design, yet most methods are primarily geared toward analyzing quantitative traits. Here we investigate the validity of three common methods for estimating SNP-based heritability and genetic correlation between diseases. We find that the phenotype-correlation-genotype-correlation (PCGC) approach is the only method that can estimate both quantities accurately in the presence of important non-genetic risk factors, such as age and sex. We extend PCGC to work with arbitrary genetic architectures and with summary statistics that take the case-control sampling into account, and we demonstrate that our new method, PCGC-s, accurately estimates both SNP-based heritability and genetic correlations and can be applied to large datasets without requiring individual-level genotypic or phenotypic information. Finally, we use PCGC-s to estimate the genetic correlation between schizophrenia and bipolar disorder and demonstrate that previous estimates are biased, partially due to incorrect handling of sex as a strong risk factor.	[Weissbrod, Omer; Rosset, Saharon] Tel Aviv Univ, Stat Dept, IL-6997801 Ramat Aviv, Israel; [Weissbrod, Omer] Technion Israel Inst Technol, Comp Sci Dept, IL-3200003 Haifa, Israel; [Flint, Jonathan] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90405 USA; [Weissbrod, Omer] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Tel Aviv University; Technion Israel Institute of Technology; University of California System; University of California Los Angeles; Harvard University; Harvard T.H. Chan School of Public Health	Weissbrod, O; Rosset, S (corresponding author), Tel Aviv Univ, Stat Dept, IL-6997801 Ramat Aviv, Israel.; Weissbrod, O (corresponding author), Technion Israel Inst Technol, Comp Sci Dept, IL-3200003 Haifa, Israel.; Weissbrod, O (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	oweissbrod@hsphharvard.edu; saharon@post.tau.ac.il		Weissbrod, Omer/0000-0001-9860-0626	Wellcome Trust [076113, 085475, 090355]; Israeli Science Foundation [1804/16]; NIH [GM112625]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM112625] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); Israeli Science Foundation(Israel Science Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study makes use of data generated by the Wellcome Trust Case Control Consortium. A full list of the investigators who contributed to the generation of the data is available from httrys://www.wtccc.org.uk. Funding for the project was provided by the Wellcome Trust under awards 076113, 085475, and 090355. We wish to thank the Swedish Bipolar Collection (SWEBIC, PI Mikael Landen) for making data available. The authors thank Noah Zaitlen, Joel Mefford, and Na Cai for useful discussions.; This work was supported by the Israeli Science Foundation grant 1804/16. This collaboration started at the Computational Genomics Summer Institute funded by NIH grant GM112625. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anttila V, 2018, SCIENCE, V360, P1313, DOI 10.1126/science.aap8757; Bhatia G., 2016, BIORXIV; Bonnet A., 2018, ELECTRON J STAT, V12, P1002; Bulik-Sullivan B., 2015, 018283 BIORXIV; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Charney AW, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.242; Chen GB, 2014, HUM MOL GENET, V23, P4710, DOI 10.1093/hmg/ddu174; Chen GB, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00107; Day Felix R, 2017, Nat Genet, V49, P834, DOI 10.1038/ng.3841; DEMPSTER ER, 1950, GENETICS, V35, P212; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Ferreira MA, 2017, NAT GENET, V49, P1752, DOI 10.1038/ng.3985; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Gazal S., 2018, BIORXIV; Golan D, 2014, P NATL ACAD SCI USA, V111, pE5272, DOI 10.1073/pnas.1419064111; Goodson N, 2002, CURR OPIN RHEUMATOL, V14, P115, DOI 10.1097/00002281-200203000-00007; Hammerschlag AR, 2017, NAT GENET, V49, P1584, DOI 10.1038/ng.3888; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Hayeck TJ, 2015, AM J HUM GENET, V96, P720, DOI 10.1016/j.ajhg.2015.03.004; Hobbs BD, 2017, NAT GENET, V49, P426, DOI 10.1038/ng.3752; Ji SG, 2017, NAT GENET, V49, P269, DOI 10.1038/ng.3745; Kanai M, 2018, NAT GENET, V50, P390, DOI 10.1038/s41588-018-0047-6; Kemp JP, 2017, NAT GENET, V49, P1468, DOI 10.1038/ng.3949; Lane JM, 2017, NAT GENET, V49, P274, DOI 10.1038/ng.3749; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Li ZQ, 2017, NAT GENET, V49, P1576, DOI 10.1038/ng.3973; Lo MT, 2017, NAT GENET, V49, P152, DOI 10.1038/ng.3736; Loh PR, 2015, NAT GENET, V47, P1385, DOI 10.1038/ng.3431; Luciano M, 2018, NAT GENET, V50, P6, DOI 10.1038/s41588-017-0013-8; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P722, DOI 10.1002/art.20878; McKay JD, 2017, NAT GENET, V49, P1126, DOI 10.1038/ng.3892; Orchard TJ, 2006, DIABETES CARE, V29, P2528, DOI 10.2337/dc06-1161; Palla L, 2015, AM J HUM GENET, V97, P250, DOI 10.1016/j.ajhg.2015.06.005; Pardinas AF, 2018, NAT GENET, V50, P381, DOI 10.1038/s41588-018-0059-2; Pasaniuc B, 2017, NAT REV GENET, V18, P117, DOI 10.1038/nrg.2016.142; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Robinson EB, 2016, NAT GENET, V48, P552, DOI 10.1038/ng.3529; Sanchez-Roige S, 2018, NAT NEUROSCI, V21, P16, DOI 10.1038/s41593-017-0032-x; Shi H, 2016, AM J HUM GENET, V99, P139, DOI 10.1016/j.ajhg.2016.05.013; Sniekers S, 2017, NAT GENET, V49, P1107, DOI 10.1038/ng.3869; Speed D., 2018, BIORXIV; Speed D, 2017, NAT GENET, V49, P986, DOI 10.1038/ng.3865; Yang J, 2017, NAT GENET, V49, P1304, DOI 10.1038/ng.3941; Yang J, 2015, NAT GENET, V47, P1114, DOI 10.1038/ng.3390; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhou X, 2017, ANN APPL STAT, V11, P2027, DOI 10.1214/17-AOAS1052; Zhu X, 2017, ANN APPL STAT, V11, P1561, DOI 10.1214/17-AOAS1046; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	53	47	47	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 5	2018	103	1					89	99		10.1016/j.ajhg.2018.06.002	http://dx.doi.org/10.1016/j.ajhg.2018.06.002			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GM5IG	29979983	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000438168800007
J	De Tomasi, L; David, P; Humbert, C; Silbermann, F; Arrondel, C; Tores, F; Fouquet, S; Desgrange, A; Niel, O; Bole-Feysot, C; Nitschke, P; Roume, J; Cordier, MP; Pietrement, C; Isidor, B; Van Kien, PK; Gonzales, M; Saint-Frison, MH; Martinovic, J; Novo, R; Piard, J; Cabrol, C; Verma, IC; Puri, R; Journel, H; Aziza, J; Gavard, L; Said-Menthon, MH; Heidet, L; Saunier, S; Jeanpierre, C				De Tomasi, Lara; David, Pierre; Humbert, Camille; Silbermann, Flora; Arrondel, Christelle; Tores, Frederic; Fouquet, Stephane; Desgrange, Audrey; Niel, Olivier; Bole-Feysot, Christine; Nitschke, Patrick; Roume, Joelle; Cordier, Marie-Pierre; Pietrement, Christine; Isidor, Bertrand; Van Kien, Philippe Khau; Gonzales, Marie; Saint-Frison, Marie-Helene; Martinovic, Jelena; Novo, Robert; Piard, Juliette; Cabrol, Christelle; Verma, Ishwar C.; Puri, Ratna; Journel, Hubert; Aziza, Jacqueline; Gavard, Laurent; Said-Menthon, Marie-Helene; Heidet, Laurence; Saunier, Sophie; Jeanpierre, Cecile			Mutations in GREB1L Cause Bilateral Kidney Agenesis in Humans and Mice	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL-ANOMALIES; URINARY-TRACT; RENAL AGENESIS; GENE; RARE; GENERATION; VARIANTS; FAMILIES; SEQUENCE; SYSTEM	Congenital anomalies of the kidney and urinary tract (CAKUT) constitute a major cause of chronic kidney disease in children and 20% of prenatally detected anomalies. CAKUT encompass a spectrum of developmental kidney defects, including renal agenesis, hypoplasia, and cystic and non-cystic dysplasia. More than 50 genes have been reported as mutated in CAKUT-affected case subjects. However, the pathophysiological mechanisms leading to bilateral kidney agenesis (BKA) remain largely elusive. Whole-exome or targeted exome sequencing of 183 unrelated familial and/or severe CAKUT-affected case subjects, including 54 fetuses with BKA, led to the identification of 16 heterozygous variants in GREB1L (growth regulation by estrogen in breast cancer 1-like), a gene reported as a target of retinoic acid signaling. Four loss-of-function and 12 damaging missense variants, 14 being absent from GnomAD, were identified. Twelve of them were present in familial or simplex BKA-affected case subjects. Female BKA-affected fetuses also displayed uterus agenesis. We demonstrated a significant association between GREB1L variants and BKA. By in situ hybridization, we showed expression of Greb1l in the nephrogenic zone in developing mouse kidney. We generated a Greb1l knock-out mouse model by CRISPR-Cas9. Analysis at E13.5 revealed lack of kidneys and genital tract anomalies in male and female Greb1l(-/-) embryos and a slight decrease in ureteric bud branching in Greb1l(+/-) embryos. We showed that Greb1l invalidation in mIMCD3 cells affected tubulomorphogenesis in 3D-collagen culture, a phenotype rescued by expression of the wild-type human protein. This demonstrates that GREB1L plays a major role in early metanephros and genital development in mice and humans.	[De Tomasi, Lara; Humbert, Camille; Silbermann, Flora; Arrondel, Christelle; Saunier, Sophie; Jeanpierre, Cecile] Imagine Inst, Lab Hereditary Kidney Dis, INSERM UMR 1163, F-75015 Paris, France; [De Tomasi, Lara; Humbert, Camille; Arrondel, Christelle; Desgrange, Audrey; Saunier, Sophie; Jeanpierre, Cecile] Paris Descartes Sorbonne Paris Cite Univ, Imagine Inst, F-75015 Paris, France; [De Tomasi, Lara] Paris Diderot Univ, F-75013 Paris, France; [David, Pierre] Struct Federat Rech Necker INSERM US24 CNRS UMS36, Imagine Inst, LEAT, Transgenesis Platform, F-75015 Paris, France; [Tores, Frederic] Paris Descartes Sorbonne Paris Cite Univ, Imagine Inst, Bioinformat Platform, INSERM UMR 1163, F-75015 Paris, France; [Fouquet, Stephane] Sorbonne Univ, Imaging Platform, UPMC Univ Paris 06, INSERM UMR S968, F-75012 Paris, France; [Fouquet, Stephane] CNRS, UMR7210, Inst Vis, F-75012 Paris, France; [Desgrange, Audrey] Imagine Inst Pasteur Inst, Lab Heart Morphogenesis, INSERM UMR 1163, F-75015 Paris, France; [Niel, Olivier] Hop Robert Debre, AP HP, Pediat Nephrol Dept, F-75019 Paris, France; [Bole-Feysot, Christine] Paris Descartes Sorbonne Paris Cite Univ, Imagine Inst, Genom Platform, INSERM UMR 1163, F-75015 Paris, France; [Roume, Joelle] CHI Poissy St Germain Laye, Unite Genet Med, Ctr Reference Malad Rarer Dev AnD Rare, F-78300 Poissy, France; [Cordier, Marie-Pierre] Grp Hosp Est, Serv Genet, F-69677 Bron, France; [Pietrement, Christine] CHU Reims, Unit Nephrol Pediatr, F-51100 Reims, France; [Isidor, Bertrand] CHU Nantes, Serv Genet Med, F-44093 Nantes, France; [Van Kien, Philippe Khau] CHU Caremeau, Nimes Hosp Univ, Unite Genet Med, F-30900 Nimes, France; [Gonzales, Marie] Univ Paris 06, Dept Med Genet, AP HP, Hop Armand Trousseau, F-75571 Paris, France; [Gonzales, Marie] Hop Necker Enfants Malad, AP HP, Unite Embryofoetopathol, Serv Histol Embryol Cytogenet, F-75015 Paris, France; [Saint-Frison, Marie-Helene] Hop Robert Debre, AP HP, Unite Foetopathol, Dept Genet, F-75019 Paris, France; [Martinovic, Jelena] Antoine Beclere Hosp, Unit Fetal Pathol, AP HP, F-92140 Clamart, France; [Novo, Robert] Ctr Hosp Univ Lille, Serv Nephrol Pediat, Hop Jeanne Flandre, F-59000 Lille, France; [Piard, Juliette; Cabrol, Christelle] CHU Besancon, Univ Franche Comte, Ctr Human Genet, F-25000 Besancon, France; [Verma, Ishwar C.; Puri, Ratna] Sir Ganga Ram Hosp, Inst Med Genet & Genom, New Delhi 110060, India; [Journel, Hubert] Hop Chubert, Serv Genet Med, F-56000 Vannes, France; [Aziza, Jacqueline] IUCT Oncopole, Dept Anatomie & Cytol Patholog, F-31100 Toulouse, France; [Gavard, Laurent] Hop Louis Mourier, Serv Gynecol Obstet, F-92700 Colombes, France; [Said-Menthon, Marie-Helene] Hop Leman, Serv Pediat, F-74203 Thonon Les Bains, France; [Heidet, Laurence] Hop Necker Enfants Malad, AP HP, Ctr Reference Malad Renales Hereditaires Enfant &, F-75015 Paris, France; [Heidet, Laurence] Hop Necker Enfants Malad, AP HP, Serv Nephrol Pediatr, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Cote d'Azur; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Hospital Chi of Poissy Saint Germain; Assistance Publique Hopitaux Paris (APHP); CHU Lyon; CHU de Reims; Universite de Reims Champagne-Ardenne; Nantes Universite; CHU de Nantes; Universite de Montpellier; CHU de Nimes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Universite de Lille - ISITE; CHU Lille; Universite de Franche-Comte; CHU Besancon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Jeanpierre, C (corresponding author), Imagine Inst, Lab Hereditary Kidney Dis, INSERM UMR 1163, F-75015 Paris, France.; Jeanpierre, C (corresponding author), Paris Descartes Sorbonne Paris Cite Univ, Imagine Inst, F-75015 Paris, France.	cecile.jeanpierre@inserm.fr	Desgrange, Audrey/AAA-8094-2020; Puri, Ratna Dua/AAY-5849-2021; Isidor, Bertrand/AAJ-3456-2021; Saunier, Sophie/G-6044-2015; Desgrange, Audrey/I-3295-2017	Desgrange, Audrey/0000-0001-9716-755X; Isidor, Bertrand/0000-0001-6480-126X; Saunier, Sophie/0000-0002-1069-0047; Desgrange, Audrey/0000-0001-9716-755X; KHAU VAN KIEN, Philippe/0000-0001-7754-969X; Piard, Juliette/0000-0001-5244-5325	European Union's Seventh Framework Programme (FP7) [305608]; EURenOmics; GIS-Institut des Maladies Rares [AMA11025KSA]; Fondation pour la Recherche Medicale [DEQ20130326532]; Agence Nationale de la Recherche under "Investissements d'avenir'' program [ANR-10-IAHU-01]	European Union's Seventh Framework Programme (FP7); EURenOmics; GIS-Institut des Maladies Rares; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche under "Investissements d'avenir'' program(French National Research Agency (ANR))	We thank affected individuals and families for their participation. We also thank the foetopathologists of the SOcieteFrancaise de FOETopatholgie (SOFFOET) for providing us with fetal tissue samples, and the pediatric nephrologists from the French Society of Pediatric Nephrology and geneticists for referring the patients. We specifically thank Drs. Dominique Gaillard and Martine Doco. We are very grateful to Yuliya Petrov and Anrifati Harouna for providing us with family 5 grandparents' DNAs. We thank Drs. Lorrie le Page and Nicole Joyefor providing us with clinical information for some of the families. We warmly thank Marie-Claire Gubler for her precious help with histology analysis of fetal kidneys as well as Brigitte Lelongt for her help in dissection of mouse embryos. We are grateful to Sophie Berissi and Sophie Bernard (Small Animal Histology and Morphology platform, Necker) for tissue sections and slide scans. We acknowledge Meriem Garfa-Traoreand Nicolas Goudin (Necker Cell Imaging Platform), Emilie Panafieu, Laetitia Duhamel, Alexandra Levostre, Yann Zimmermann, and Cristian Dicu (LEAT, Animal facility) and Lotfi Slimani and Jeremy Sadoine (Platform Imagerie du Vivant, UniversiteParis Descartes) for their excellent technical assistance. We are also grateful to Marion Delous who introduced us to the embryo clearing technique. The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) grant 305608 (EURenOmics). C.H. was funded by EURenOmics. This work was also supported by GIS-Institut des Maladies Rares (AMA11025KSA to C.J.), Fondation pour la Recherche Medicale (DEQ20130326532 to S.S.), and state funding from the Agence Nationale de la Recherche under "Investissements d'avenir'' program (ANR-10-IAHU-01 to S.S.).	Ardissino G, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e382; Barak H, 2012, DEV CELL, V22, P1191, DOI 10.1016/j.devcel.2012.04.018; Belle M, 2017, CELL, V169, DOI 10.1016/j.cell.2017.03.008; Berry R, 2011, HUM MOL GENET, V20, P917, DOI 10.1093/hmg/ddq530; Brophy PD, 2017, GENETICS, V207, P215, DOI 10.1534/genetics.117.1125; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; Degenhardt K, 2010, CIRC-CARDIOVASC IMAG, V3, P314, DOI 10.1161/CIRCIMAGING.109.918482; Dekel B, 2006, CANCER RES, V66, P6040, DOI 10.1158/0008-5472.CAN-05-4528; Deschenes J, 2007, J BIOL CHEM, V282, P17335, DOI 10.1074/jbc.C700030200; DRESSLER GR, 1990, DEVELOPMENT, V109, P787; Garne E, 2012, BIRTH DEFECTS RES A, V94, P134, DOI 10.1002/bdra.22886; Guzeltas A, 2013, PEDIATR CARDIOL, V34, P2096, DOI 10.1007/s00246-013-0656-x; Harewood L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012375; Heidet L, 1997, LAB INVEST, V76, P233; Heidet L, 2017, J AM SOC NEPHROL, V28, P2901, DOI 10.1681/ASN.2017010043; Humbert C, 2014, AM J HUM GENET, V94, P288, DOI 10.1016/j.ajhg.2013.12.017; Jeanpierre C, 2011, J MED GENET, V48, P497, DOI 10.1136/jmg.2010.088526; Kanwar YS, 2003, KIDNEY INT, V63, P1658, DOI 10.1046/j.1523-1755.2003.00905.x; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Little MH, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008300; Loane M, 2011, BIRTH DEFECTS RES A, V91, pS31, DOI 10.1002/bdra.20778; Mai WY, 2005, MOL BIOL CELL, V16, P4398, DOI 10.1091/mbc.E04-11-1019; Ochsner SA, 2012, PHYSIOL GENOMICS, V44, P853, DOI 10.1152/physiolgenomics.00033.2012; Oram RA, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.05.022; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rosselot C, 2010, DEVELOPMENT, V137, P283, DOI 10.1242/dev.040287; San Lucas FA, 2012, BIOINFORMATICS, V28, P421, DOI 10.1093/bioinformatics/btr667; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; Simandi Z, 2016, MOL CELL, V63, P647, DOI 10.1016/j.molcel.2016.06.039; Skinner MA, 2008, AM J HUM GENET, V82, P344, DOI 10.1016/j.ajhg.2007.10.008; Torres M, 1995, DEVELOPMENT, V121, P4057; Uy N, 2016, J PEDIATR GENET, V5, P51, DOI 10.1055/s-0035-1558423; van Haelst MM, 2008, AM J MED GENET A, V146A, P2252, DOI 10.1002/ajmg.a.32440; Vivante A, 2017, J AM SOC NEPHROL, V28, P2364, DOI 10.1681/ASN.2016060694; Vivante A, 2017, J AM SOC NEPHROL, V28, P69, DOI 10.1681/ASN.2015080962; Vivante A, 2014, PEDIATR NEPHROL, V29, P695, DOI 10.1007/s00467-013-2684-4; Wang GT, 2014, AM J HUM GENET, V94, P770, DOI 10.1016/j.ajhg.2014.04.004	39	47	51	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2017	101	5					803	814		10.1016/j.ajhg.2017.09.026	http://dx.doi.org/10.1016/j.ajhg.2017.09.026			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FL5DL	29100091	Green Published, Bronze			2022-12-18	WOS:000414251600011
J	Heinz, L; Kim, GJ; Marrakchi, S; Christiansen, J; Turki, H; Rauschendorf, MA; Lathrop, M; Hausser, I; Zimmer, AD; Fischer, J				Heinz, Lisa; Kim, Gwang-Jin; Marrakchi, Slaheddine; Christiansen, Julie; Turki, Hamida; Rauschendorf, Marc-Alexander; Lathrop, Mark; Hausser, Ingrid; Zimmer, Andreas D.; Fischer, Judith			Mutations in SULT2B1 Cause Autosomal-Recessive Congenital Ichthyosis in Humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHOLESTEROL SULFOTRANSFERASE SULT2B1B; STRATUM-CORNEUM LIPIDS; X-LINKED ICHTHYOSIS; LAMELLAR ICHTHYOSIS; EPIDERMAL LIPIDS; PREVENTS HYPERKERATOSIS; CELL-PROLIFERATION; SEQUENCING DATA; HUMAN SKIN; GENE	Ichthyoses are a clinically and genetically heterogeneous group of genodermatoses associated with abnormal scaling of the skin over the whole body. Mutations in nine genes are known to cause non-syndromic forms of autosomal-recessive congenital ichthyosis (ARCI). However, not all genetic causes for ARCI have been discovered to date. Using whole-exome sequencing (WES) and multigene panel screening, we identified 6 ARCI-affected individuals from three unrelated families with mutations in Sulfotransferase family 2B member 1 (SULT2B1), showing their causative association with ARCI. Cytosolic sulfotransferases form a large family of enzymes that are involved in the synthesis and metabolism of several steroids in humans. We identified four distinct mutations including missense, nonsense, and splice site mutations. We demonstrated the loss of SULT2B1 expression at RNA and protein levels in keratinocytes from individuals with ARCI by functional analyses. Furthermore, we succeeded in reconstructing the morphologic skin alterations in a 3D organotypic tissue culture model with SULT2B1-deficient keratinocytes and fibroblasts. By thin layer chromatography (TLC) of extracts from these organotypic cultures, we could show the absence of cholesterol sulfate, the metabolite of SULT2B1, and an increased level of cholesterol, indicating a disturbed cholesterol metabolism of the skin upon loss-of-function mutation in SULT2B1. In conclusion, our study reveals an essential role for SULT2B1 in the proper development of healthy human skin. Mutation in SULT2B1 leads to an ARCI phenotype via increased proliferation of human keratinocytes, thickening of epithelial layers, and altered epidermal cholesterol metabolism.	[Heinz, Lisa; Kim, Gwang-Jin; Rauschendorf, Marc-Alexander; Zimmer, Andreas D.; Fischer, Judith] Univ Freiburg, Inst Human Genet, Med Ctr, Fac Med, D-79106 Freiburg, Germany; [Heinz, Lisa] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Kim, Gwang-Jin] Albert Ludwigs Univ, Inst Pharmaceut Sci, Pharmaceut Bioinformat, D-79104 Freiburg, Germany; [Marrakchi, Slaheddine; Turki, Hamida] Hedi Chaker Univ Hosp, Dept Dermatol, Sfax 3029, Tunisia; [Christiansen, Julie] Skanes Univ Hosp, Dept Dermatol & Venereol, S-22185 Lund, Sweden; [Lathrop, Mark] McGill Univ, Montreal, PQ H3A 0G1, Canada; [Lathrop, Mark] Genome Quebec Innovat Ctr, Montreal, PQ H3A 0G1, Canada; [Hausser, Ingrid] Univ Hosp Heidelberg, Inst Pathol, D-69120 Heidelberg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; Universite de Sfax; Hopital Hedi Chaker; McGill University; Ruprecht Karls University Heidelberg	Fischer, J (corresponding author), Univ Freiburg, Inst Human Genet, Med Ctr, Fac Med, D-79106 Freiburg, Germany.	judith.fischer@uniklinik-freiburg.de	Fischer, Judith/E-6327-2016	Fischer, Judith/0000-0002-8580-8118; Zimmer, Andreas/0000-0002-5595-9388; Rauschendorf, Marc-Alexander/0000-0003-0940-0521	German research foundation DFG [FI1767/3-1]	German research foundation DFG(German Research Foundation (DFG))	The authors wish to express grateful thanks to Dr. Pavel Salavei and Dr. Susan Lauw for their technical support, to Prof. Dr. Stefan Gunther for contributing the structural visualization, to Dr. Franz Radner for providing valuable advice for the performance of TLC, and to Prof. Dr. Dieter Metze for helpful comments about histological findings. We also wish to thank Dr. Susan Cure for critical reading of the manuscript, Dr. Sabine Rosenberger for helpful suggestions in performing 3D organotypic tissue culture models, Dr. Emmanuelle Bourrat and Dr. Anne-Marie Calza for providing clinical data, and Dr. Abderrahmen Masmoudi for cooperation. We are very grateful to all the individuals and probands who provided DNA samples and/or skin biopsy specimens. This study was supported by a grant from the German research foundation DFG (FI1767/3-1).	ABRAHAM W, 1987, J INVEST DERMATOL, V88, P212, DOI 10.1111/1523-1747.ep12525375; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aufenvenne K, 2013, AM J HUM GENET, V93, P620, DOI 10.1016/j.ajhg.2013.08.003; Baskaran K, 2014, BMC STRUCT BIOL, V14, DOI 10.1186/s12900-014-0022-0; BERGNER EA, 1981, J CLIN ENDOCR METAB, V53, P221, DOI 10.1210/jcem-53-1-220; Breiden B, 2007, EUR J CELL BIOL, V86, P657, DOI 10.1016/j.ejcb.2007.02.006; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Eckl KM, 2013, J INVEST DERMATOL, V133, P2202, DOI 10.1038/jid.2013.153; Eckl KM, 2011, J INVEST DERMATOL, V131, P1938, DOI 10.1038/jid.2011.126; Elias PM, 2014, BBA-MOL CELL BIOL L, V1841, P353, DOI 10.1016/j.bbalip.2013.11.009; EPSTEIN EH, 1984, J AM ACAD DERMATOL, V10, P866, DOI 10.1016/S0190-9622(84)80144-9; Eyles SJ, 2000, J MOL BIOL, V301, P737, DOI 10.1006/jmbi.2000.4002; Feingold KR, 2007, J LIPID RES, V48, P2531, DOI 10.1194/jlr.R700013-JLR200; Fischer J, 2014, MED GENET-BERLIN, V26, P427, DOI 10.1007/s11825-014-0017-z; Fischer J, 2009, J INVEST DERMATOL, V129, P1319, DOI 10.1038/jid.2009.57; Grall A, 2012, NAT GENET, V44, P140, DOI 10.1038/ng.1056; Grond S, 2017, J INVEST DERMATOL, V137, P394, DOI 10.1016/j.jid.2016.08.036; Guerra L, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0336-4; Hatfield RM, 1999, BIOCHEMISTRY-US, V38, P784, DOI 10.1021/bi981421k; He DN, 2005, BBA-GEN SUBJECTS, V1724, P119, DOI 10.1016/j.bbagen.2005.03.018; He DN, 2004, BIOCHEM J, V379, P533, DOI 10.1042/BJ20031524; He DN, 2007, PROSTATE, V67, P1318, DOI 10.1002/pros.20615; Her C, 1998, GENOMICS, V53, P284, DOI 10.1006/geno.1998.5518; Higashi Y, 2004, J INVEST DERMATOL, V122, P1207, DOI 10.1111/j.0022-202X.2004.22416.x; Hotz A, 2016, ACTA DERM-VENEREOL, V96, P473, DOI 10.2340/00015555-2299; HUBER M, 1995, SCIENCE, V267, P525, DOI 10.1126/science.7824952; Javitt NB, 2001, ENDOCRINOLOGY, V142, P2978, DOI 10.1210/en.142.7.2978; Ji Y, 2007, J PHARMACOL EXP THER, V322, P529, DOI 10.1124/jpet.107.122895; Jobard F, 2002, HUM MOL GENET, V11, P107, DOI 10.1093/hmg/11.1.107; Kiritsi D, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-33; Kurogi K, 2010, FEBS J, V277, P3804, DOI 10.1111/j.1742-4658.2010.07781.x; Lee KA, 2003, J BIOL CHEM, V278, P44593, DOI 10.1074/jbc.M308312200; Lefevre C, 2006, HUM MOL GENET, V15, P767, DOI 10.1093/hmg/ddi491; Lefevre C, 2004, HUM MOL GENET, V13, P2473, DOI 10.1093/hmg/ddh263; Lefevre C, 2003, HUM MOL GENET, V12, P2369, DOI 10.1093/hmg/ddg235; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Maltman DJ, 2010, BIOCHEM SOC T, V38, P1072, DOI 10.1042/BST0381072; Meloche CA, 2001, J STEROID BIOCHEM, V77, P261, DOI 10.1016/S0960-0760(01)00064-4; Mildner M, 2006, BIOCHEM BIOPH RES CO, V348, P76, DOI 10.1016/j.bbrc.2006.07.035; O'Shaughnessy RFL, 2010, HUM MOL GENET, V19, P2594, DOI 10.1093/hmg/ddq145; Oji V, 2010, J AM ACAD DERMATOL, V63, P607, DOI 10.1016/j.jaad.2009.11.020; Paller AS, 2011, J INVEST DERMATOL, V131, P2242, DOI 10.1038/jid.2011.189; Radner FPW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003536; Radner FPW, 2010, J BIOL CHEM, V285, P7300, DOI 10.1074/jbc.M109.081877; Ren SL, 2014, AM J PHYSIOL-ENDOC M, V306, pE123, DOI 10.1152/ajpendo.00552.2013; Rosenberger S, 2014, BRIT J DERMATOL, V171, P1347, DOI 10.1111/bjd.13308; RUSSELL LJ, 1995, NAT GENET, V9, P279, DOI 10.1038/ng0395-279; SCHURER NY, 1991, ADV LIPID RES, V24, P27; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Sethuraman G, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1313; Shigehara Y, 2016, HUM MOL GENET, V25, P4484, DOI 10.1093/hmg/ddw277; Strott CA, 2003, J LIPID RES, V44, P1268, DOI 10.1194/jlr.R300005-JLR200; Thomas AC, 2009, AM J PATHOL, V174, P970, DOI 10.2353/ajpath.2009.080860; TRAUPE H, 1986, J AM ACAD DERMATOL, V14, P1000, DOI 10.1016/S0190-9622(86)70123-0; Traupe H, 2014, J DTSCH DERMATOL GES, V12, P109, DOI 10.1111/ddg.12229; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; WERTZ PW, 1992, SEMIN DERMATOL, V11, P106; WILLIAMS ML, 1981, J CLIN INVEST, V68, P1404, DOI 10.1172/JCI110391; YAMAZOE Y, 1994, ENVIRON HEALTH PERSP, V102, P99, DOI 10.2307/3432160; Youssef G, 2014, J INVEST DERMATOL, V134, P858, DOI 10.1038/jid.2013.374; Zhang ZG, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-23	63	47	50	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 1	2017	100	6					926	939		10.1016/j.ajhg.2017.05.007	http://dx.doi.org/10.1016/j.ajhg.2017.05.007			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EW7NL	28575648	Green Published, Bronze			2022-12-18	WOS:000402700600008
J	Barbe, L; Lanni, S; Lopez-Castel, A; Franck, S; Spits, C; Keymolen, K; Seneca, S; Tome, S; Miron, I; Letourneau, J; Liang, M; Choufani, S; Weksberg, R; Wilson, MD; Sedlacek, Z; Gagnon, C; Musova, Z; Chitayat, D; Shannon, P; Mathieu, J; Sermon, K; Pearson, CE				Barbe, Lise; Lanni, Stella; Lopez-Castel, Arturo; Franck, Silvie; Spits, Claudia; Keymolen, Kathelijn; Seneca, Sara; Tome, Stephanie; Miron, Ioana; Letourneau, Julie; Liang, Minggao; Choufani, Sanaa; Weksberg, Rosanna; Wilson, Michael D.; Sedlacek, Zdenek; Gagnon, Cynthia; Musova, Zuzana; Chitayat, David; Shannon, Patrick; Mathieu, Jean; Sermon, Karen; Pearson, Christopher E.			CpG Methylation, a Parent-of-Origin Effect for Maternal-Biased Transmission of Congenital Myotonic Dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CTG REPEAT; TRINUCLEOTIDE REPEAT; PATERNAL TRANSMISSION; DNA METHYLATION; SKELETAL-MUSCLE; MESSENGER-RNA; DMPK GENE; SOMATIC INSTABILITY; PRENATAL-DIAGNOSIS; REDUCES EXPRESSION	CTG repeat expansions in DMPK cause myotonic dystrophy (DM1) with a continuum of severity and ages of onset. Congenital DM1 (CDM1), the most severe form, presents distinct clinical features, large expansions, and almost exclusive maternal transmission. The correlation between CDM1 and expansion size is not absolute, suggesting contributions of other factors. We determined CpG methylation flanking the CTG repeat in 79 blood samples from 2,0 CDM1-affected individuals; 21, 27, and 11 individuals with DM1 but not CDM1 (henceforth non-CDM1) with maternal, paternal, and unknown inheritance; and collections of maternally and paternally derived chorionic villus samples (7 CVSs) and human embryonic stem cells (4 hESC5). All but two CDM1-affected individuals showed high levels of methylation upstream and downstream of the repeat, greater than non-CDM1 individuals (p = 7.04958 x 10(-12)). Most non-CDM1 individuals were devoid of methylation, where one in six showed downstream methylation. Only two non-CDM1 individuals showed upstream methylation, and these were maternally derived childhood onset, suggesting a continuum of methylation with age of onset. Only maternally derived hESCs and CVSs showed upstream methylation. In contrast, paternally derived samples (27 blood samples, 3 CVSs, and 2 hESCs) never showed upstream methylation. CTG tract length did not strictly correlate with CDM1 or methylation. Thus, methylation patterns flanking the CTG repeat are stronger indicators of CDM1 than repeat size. Spermatogonia with upstream methylation may not survive due to methylation-induced reduced expression of the adjacent SIXS, thereby protecting DM1-affected fathers from having CDM1-affected children. Thus, DMPK methylation may account for the maternal bias for CDM1 transmission, larger maternal CTG expansions, age of onset, and clinical continuum, and may serve as a diagnostic indicator.	[Barbe, Lise; Franck, Silvie; Spits, Claudia; Sermon, Karen] Vrije Univ Brussel, Dept Reprod & Genet, B-1090 Brussels, Belgium; [Lanni, Stella; Lopez-Castel, Arturo; Tome, Stephanie; Liang, Minggao; Choufani, Sanaa; Weksberg, Rosanna; Wilson, Michael D.; Pearson, Christopher E.] Hosp Sick Children, Genet & Genome Biol, Toronto, ON M5G 0A4, Canada; [Keymolen, Kathelijn; Seneca, Sara] Univ Ziekenhuis Brussel, Ctr Med Genet, B-1090 Brussels, Belgium; [Miron, Ioana; Chitayat, David] Univ Toronto, Dept Obstet & Gynecol, Prenatal Diag & Med Genet Program, Toronto, ON M5G 1E2, Canada; [Letourneau, Julie; Gagnon, Cynthia; Mathieu, Jean] Grp Rech Interdisciplinaire Malad Neuromusculaire, Saguenay, PQ 75204, Canada; [Liang, Minggao; Weksberg, Rosanna; Wilson, Michael D.; Pearson, Christopher E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Weksberg, Rosanna; Chitayat, David] Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Weksberg, Rosanna] Univ Toronto, Sch Grad Studies, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Weksberg, Rosanna] Univ Toronto, Dept Pediat, Toronto, ON M5S 1A1, Canada; [Sedlacek, Zdenek; Musova, Zuzana] Charles Univ Prague, Dept Biol & Med Genet, Prague 12800, Czech Republic; [Shannon, Patrick] Univ Toronto, Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Lopez-Castel, Arturo] Genera Biotech, Valencia 46980, Spain; [Tome, Stephanie] INSERM, Lab CTG Repeat Instabil & Myoton Dystrophy, F-75654 Paris, France	Vrije Universiteit Brussel; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University Hospital Brussels; Vrije Universiteit Brussel; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Charles University Prague; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Institut National de la Sante et de la Recherche Medicale (Inserm)	Sermon, K (corresponding author), Vrije Univ Brussel, Dept Reprod & Genet, B-1090 Brussels, Belgium.; Pearson, CE (corresponding author), Hosp Sick Children, Genet & Genome Biol, Toronto, ON M5G 0A4, Canada.; Pearson, CE (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada.	karen.sermon@uzbrussel.be; cepearson.sickkids@gmail.com	Spits, Claudia/J-1964-2014; Choufani, Sanaa/GWC-1820-2022; Castel, Arturo López/AAL-9778-2020; Lanni, Stella/K-8901-2019; Tomé, Stephanie/G-9456-2017; Wilson, Michael D/K-6294-2014; gagnon, cynthia/AAM-7292-2021	Spits, Claudia/0000-0002-0187-5138; Choufani, Sanaa/0000-0002-5241-2213; Tomé, Stephanie/0000-0002-0135-9256; Wilson, Michael D/0000-0002-4015-3066; gagnon, cynthia/0000-0003-2829-8470; Seneca, Sara/0000-0002-0853-9890; Sermon, Karen/0000-0002-2311-9034; Franck, Silvie/0000-0002-7433-8587; Keymolen, Kathelijn/0000-0002-7349-641X; Pearson, Christopher/0000-0001-9545-4205; Lanni, Stella/0000-0003-3233-9204	Canadian Institutes of Health Research [FRN94966, FRN291634]; Muscular Dystrophy Canada; Tribute Communities; Kazman Family Fund; Marigold Foundation; Petroff Family; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen; Leerstoel Mireille Aerens; Methusalem grant; Association Beige contre les Maladies neuro-Musculaires fund [2013/10]; Canada Research Chair; Hospital for Sick Children Foundation Student Scholarship Program; NSERC [436194-2013]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Muscular Dystrophy Canada(Muscular Dystrophy Association); Tribute Communities; Kazman Family Fund; Marigold Foundation; Petroff Family; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen(FWO); Leerstoel Mireille Aerens; Methusalem grant; Association Beige contre les Maladies neuro-Musculaires fund; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Hospital for Sick Children Foundation Student Scholarship Program; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was partially supported by the Canadian Institutes of Health Research (FRN94966 and FRN291634) (C.E.P.), the Muscular Dystrophy Canada (C.E.P.), Tribute Communities (C.E.P.), the Kazman Family Fund (C.E.P.), The Marigold Foundation (C.E.P.), the Petroff Family (C.E.P.), the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (K.S.), the Leerstoel Mireille Aerens (K.S.), the Methusalem grant (K.S.), and Association Beige contre les Maladies neuro-Musculaires fund (Projet 2013/10) (K.S.). Saguenay-Lac-St-Jean DM1 Biobank was supported by The Marigold Foundation (C.E.P. and C.G.). M.D.W. was supported by a Canada Research Chair. M.L. was supported by Hospital for Sick Children Foundation Student Scholarship Program and NSERC grant 436194-2013. S.L. was supported by Tribute Communities, the Kazman Family Fund, and The Marigold Foundation. L.B. was funded by a PhD grant from Leerstoel Mireille Aerens. L.B.'s exchange visit to the Pearson Lab was covered in part by Association Beige contre les Maladies neuro-Musculaires fund ("Prijs Denys Bourgeois"). We acknowledge the technical support by Dr. Lisa Yu, Mila Mirceta, Neha Thakkar, Kimberly Dee, Pierre Hilven, and the team of the BRIGHTCore for the Miseq Analyses. We acknowledge Pieter-Jan Van de Maele for his informatics expertise in writing the script used for analysis of the MPBS data. We acknowledge Olivia Shea for support in producing figures.	AFIFI AM, 1992, AM J OBSTET GYNECOL, V166, P929, DOI 10.1016/0002-9378(92)91365-H; Alwazzan M, 1999, HUM MOL GENET, V8, P1491, DOI 10.1093/hmg/8.8.1491; ASHIZAWA T, 1992, NEUROLOGY, V42, P1871; ASHIZAWA T, 1994, AM J HUM GENET, V54, P414; ASHIZAWA T, 1992, NEUROLOGY, V42, P1877; ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BARCELO JM, 1994, AM J HUM GENET, V54, P1124; Barua S, 2015, EPIGENOMICS-UK, V7, P85, DOI [10.2217/EPI.14.71, 10.2217/epi.14.71]; BERGOFFEN J, 1994, J MED GENET, V31, P518, DOI 10.1136/jmg.31.7.518; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; BOUCHER CA, 1995, HUM MOL GENET, V4, P1919, DOI 10.1093/hmg/4.10.1919; BROOK, 1992, CELL, V69, P385; Brouwer JR, 2013, J NUCLEIC ACIDS, V2013, DOI 10.1155/2013/567435; BRUNNER HG, 1993, AM J HUM GENET, V53, P1016; Brykczynska U, 2016, STEM CELL REP, V7, P1059, DOI 10.1016/j.stemcr.2016.10.004; Buckley L, 2016, EPIGENOMICS-UK, V8, P13, DOI 10.2217/epi.15.104; Campbell C, 2013, J PEDIATR-US, V163, P120, DOI 10.1016/j.jpeds.2012.12.070; Castel AL, 2011, HUM MOL GENET, V20, P1, DOI 10.1093/hmg/ddq427; Cho DH, 2005, MOL CELL, V20, P483, DOI 10.1016/j.molcel.2005.09.002; Clark C, 1998, CLIN EXP DERMATOL, V23, P47; Clarke HJ, 2015, SEMIN CELL DEV BIOL, V43, P106, DOI 10.1016/j.semcdb.2015.07.003; Cleary JD, 2010, NAT STRUCT MOL BIOL, V17, P1079, DOI 10.1038/nsmb.1876; COBO AM, 1993, LANCET, V341, P1159, DOI 10.1016/0140-6736(93)93186-5; COBO AM, 1995, J MED GENET, V32, P105, DOI 10.1136/jmg.32.2.105; DALPHIN ML, 1992, PEDIATRIE, V47, P677; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; De Antonio M, 2016, REV NEUROL-FRANCE, V172, P572, DOI 10.1016/j.neurol.2016.08.003; De Temmerman N, 2008, MOL HUM REPROD, V14, P405, DOI 10.1093/molehr/gan034; deDieSmulders CEM, 1997, J MED GENET, V34, P930, DOI 10.1136/jmg.34.11.930; DEMUNAIN AL, 1995, J MED GENET, V32, P689, DOI 10.1136/jmg.32.9.689; Depardon F, 2001, ARCH MED RES, V32, P123, DOI 10.1016/S0188-4409(01)00263-6; Di Costanzo A, 2009, BRAIN DEV-JPN, V31, P79, DOI 10.1016/j.braindev.2008.04.008; DiRocco M, 1996, EUR J PEDIATR, V155, P995, DOI 10.1007/BF02282900; Echenne B, 2013, HAND CLINIC, V113, P1387, DOI 10.1016/B978-0-444-59565-2.00009-5; Ekstrom AB, 2008, AM J MED GENET B, V147B, P918, DOI 10.1002/ajmg.b.30698; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; FU YH, 1993, SCIENCE, V260, P235, DOI 10.1126/science.8469976; Geifman-Holtzman O, 1998, AM J MED GENET, V78, P250, DOI 10.1002/(SICI)1096-8628(19980707)78:3<250::AID-AJMG8>3.0.CO;2-T; Hamshere MG, 1997, P NATL ACAD SCI USA, V94, P7394, DOI 10.1073/pnas.94.14.7394; HARLEY HG, 1993, AM J HUM GENET, V52, P1164; HARPER PS, 1972, LANCET, V2, P53; Hilbert JE, 2013, J PEDIATR-US, V163, P12, DOI 10.1016/j.jpeds.2013.02.022; HOFMANNRADVANYI H, 1993, HUM MOL GENET, V2, P1263, DOI 10.1093/hmg/2.8.1263; HOJO K, 1995, AM J PERINAT, V12, P195, DOI 10.1055/s-2007-994451; HSU CD, 1993, FETAL DIAGN THER, V8, P200, DOI 10.1159/000263825; Inukai A, 2000, MUSCLE NERVE, V23, P1421, DOI 10.1002/1097-4598(200009)23:9<1421::AID-MUS14>3.3.CO;2-P; Jacobs K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5227; JANSEN G, 1994, AM J HUM GENET, V54, P575; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; Johnson NE, 2016, DEV MED CHILD NEUROL, V58, P698, DOI 10.1111/dmcn.12948; Joseph JT, 1997, NEUROLOGY, V49, P1457, DOI 10.1212/WNL.49.5.1457; Klesert TR, 1997, NAT GENET, V16, P402, DOI 10.1038/ng0897-402; KOCH MC, 1991, AM J HUM GENET, V48, P1084; Langley AR, 2016, NUCLEIC ACIDS RES, V44, P10230, DOI 10.1093/nar/gkw760; LAVEDAN C, 1993, AM J HUM GENET, V52, P875; Liu GQ, 2012, MOL CELL BIOL, V32, P1618, DOI 10.1128/MCB.06727-11; Lucifero D, 2002, GENOMICS, V79, P530, DOI 10.1006/geno.2002.6732; Ly L, 2015, SEMIN CELL DEV BIOL, V43, P96, DOI 10.1016/j.semcdb.2015.07.006; Maatouk DM, 2003, DEV BIOL, V258, P201, DOI 10.1016/S0012-1606(03)00110-6; Malter HE, 1997, NAT GENET, V15, P165, DOI 10.1038/ng0297-165; Martorell L, 1998, HUM MOL GENET, V7, P307, DOI 10.1093/hmg/7.2.307; Martorell L, 2000, EUR J HUM GENET, V8, P423, DOI 10.1038/sj.ejhg.5200478; Martorell L, 2004, NEUROLOGY, V62, P269, DOI 10.1212/WNL.62.2.269; MASSARI A, 1995, J NEUROL, V242, P379, DOI 10.1007/BF00868393; Mateizel I, 2008, REPROD BIOMED ONLINE, V16, P741, DOI 10.1016/S1472-6483(10)60490-7; Michel L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137620; MONCKTON DG, 1995, HUM MOL GENET, V4, P1; Morales F, 2015, EUR J HUM GENET, V23, P646, DOI 10.1038/ejhg.2014.138; Morales F, 2012, HUM MOL GENET, V21, P3558, DOI 10.1093/hmg/dds185; Musova Z, 2009, AM J MED GENET A, V149A, P1365, DOI 10.1002/ajmg.a.32987; MYRING J, 1992, J MED GENET, V29, P785, DOI 10.1136/jmg.29.11.785; Narang MA, 2000, EUR J HUM GENET, V8, P507, DOI 10.1038/sj.ejhg.5200490; NOVELLI G, 1995, NEUROMUSCULAR DISORD, V5, P157, DOI 10.1016/0960-8966(94)00044-A; OHYA K, 1994, NEUROLOGY, V44, P1958, DOI 10.1212/WNL.44.10.1958; Ohya K, 1995, JPN J HUM GENET, V40, P319, DOI 10.1007/BF01900598; Pearson CE, 2003, TRENDS MOL MED, V9, P490, DOI 10.1016/j.molmed.2003.09.006; POULTON J, 1995, J MED GENET, V32, P732, DOI 10.1136/jmg.32.9.732; Pratte A, 2015, AM J MED GENET A, V167, P708, DOI 10.1002/ajmg.a.36950; REDMAN JB, 1993, JAMA-J AM MED ASSOC, V269, P1960, DOI 10.1001/jama.269.15.1960; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Reik W, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a019422; Roifman M, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0238-x; Rudnik-Schoneborn S, 1998, AM J MED GENET, V80, P314, DOI 10.1002/(SICI)1096-8628(19981204)80:4<314::AID-AJMG3>3.0.CO;2-I; SABOURI LA, 1993, NAT GENET, V4, P233, DOI 10.1038/ng0793-233; Salat U, 2000, J MED GENET, V37, P842, DOI 10.1136/jmg.37.11.842; Salehi LB, 2007, GENET TEST, V11, P84, DOI 10.1089/gte.2006.0511; Sambrook Joseph, 2006, CSH Protoc, V2006, DOI [10.1101/pdb.prot4056, 10.1101/pdb.prot4453, 10.1101/pdb.prot3825, 10.1101/pdb.prot3972, 10.1101/pdb.prot4027, 10.1101/pdb.prot4022, 10.1101/pdb.prot3871, 10.1101/pdb.prot3723, 10.1101/pdb.prot4085, 10.1101/pdb.prot3966, 10.1101/pdb.prot4050, 10.1101/pdb.prot4455, 10.1101/pdb.prot4044]; Sarkar PS, 2004, HUM MOL GENET, V13, P1421, DOI 10.1093/hmg/ddh161; Schmidt MHM, 2016, DNA REPAIR, V38, P117, DOI 10.1016/j.dnarep.2015.11.008; Seriola A, 2011, HUM MOL GENET, V20, P176, DOI 10.1093/hmg/ddq456; SHAW DJ, 1993, J MED GENET, V30, P189, DOI 10.1136/jmg.30.3.189; Spranger M, 1999, NERVENARZT, V70, P131, DOI 10.1007/s001150050413; Steinbach P, 1998, AM J HUM GENET, V62, P278, DOI 10.1086/301711; Steyaert J, 1997, CLIN GENET, V52, P135; Stuart AAV, 2000, J PERINAT MED, V28, P497; Sun YJ, 1999, AM J MED GENET, V86, P162, DOI 10.1002/(SICI)1096-8628(19990910)86:2<162::AID-AJMG14>3.0.CO;2-D; TACHI N, 1995, PEDIATR NEUROL, V12, P81, DOI 10.1016/0887-8994(94)00112-F; Tanaka Y, 2000, BRAIN DEV-JPN, V22, P132, DOI 10.1016/S0387-7604(99)00128-X; THORNTON CA, 1994, ANN NEUROL, V35, P104, DOI 10.1002/ana.410350116; Thornton CA, 1997, NAT GENET, V16, P407, DOI 10.1038/ng0897-407; TSILFIDIS C, 1992, NAT GENET, V1, P192, DOI 10.1038/ng0692-192; Turner C, 2010, J NEUROL NEUROSUR PS, V81, P358, DOI 10.1136/jnnp.2008.158261; VAZQUEZ JA, 1990, J ENDOCRINOL INVEST, V13, P375, DOI 10.1007/BF03350681; WEBB D, 1978, AM J OBSTET GYNECOL, V132, P265, DOI 10.1016/0002-9378(78)90891-8; Willemsen R, 2002, HUM GENET, V110, P601, DOI 10.1007/s00439-002-0723-5; Winblad S, 2016, EUR J NEUROL, V23, P1471, DOI 10.1111/ene.13062; Wong LJC, 1997, AM J HUM GENET, V61, P1445, DOI 10.1086/301654; Yanovsky-Dagan S, 2015, STEM CELL REP, V5, P221, DOI 10.1016/j.stemcr.2015.06.003; Zaki M, 2007, ULTRASOUND OBST GYN, V29, P284, DOI 10.1002/uog.3859; ZATZ M, 1995, HUM MOL GENET, V4, P401, DOI 10.1093/hmg/4.3.401; Zeesman S, 2002, AM J MED GENET, V107, P222, DOI 10.1002/ajmg.10141	111	47	49	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 2	2017	100	3					488	505		10.1016/j.ajhg.2017.01.033	http://dx.doi.org/10.1016/j.ajhg.2017.01.033			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EN2PH	28257691	hybrid, Green Published			2022-12-18	WOS:000395851900014
J	Paolini, NA; Attwood, M; Sondalle, SB; Vieira, CMD; van Adrichem, AM; di Summa, FM; O'Donohue, MF; Gleizes, PE; Rachuri, S; Briggs, JW; Fischer, R; Ratcliffe, PJ; Wlodarski, MW; Houtkooper, RH; von Lindern, M; Kuijpers, TW; Dinman, JD; Baserga, SJ; Cockman, ME; MacInnes, AW				Paolini, Nahuel A.; Attwood, Martin; Sondalle, Samuel B.; Vieira, Carolina Marques dos Santos; van Adrichem, Anita M.; di Summa, Franca M.; O'Donohue, Marie-Francoise; Gleizes, Pierre-Emmanuel; Rachuri, Swaksha; Briggs, Joseph W.; Fischer, Roman; Ratcliffe, Peter J.; Wlodarski, Marcin W.; Houtkooper, Riekelt H.; von Lindern, Marieke; Kuijpers, Taco W.; Dinman, Jonathan D.; Baserga, Susan J.; Cockman, Matthew E.; MacInnes, Alyson W.			A Ribosomopathy Reveals Decoding Defective Ribosomes Driving Human Dysmorphism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DIAMOND-BLACKFAN ANEMIA; TRANSFER-RNA; PROTEIN; TRANSLATION; ACCURACY; MUTATION; RECOGNITION; GENE; S12	Ribosomal protein (RP) gene mutations, mostly associated with inherited or acquired bone marrow failure, are believed to drive disease by slowing the rate of protein synthesis. Here de novo missense mutations in the RPS23 gene, which codes for uS12, are reported in two unrelated individuals with microcephaly, hearing loss, and overlapping dysmorphic features. One individual additionally presents with intellectual disability and autism spectrum disorder. The amino acid substitutions lie in two highly conserved loop regions of uS12 with known roles in maintaining the accuracy of mRNA codon translation. Primary cells revealed one substitution severely impaired OGFOD1-dependent hydroxylation of a neighboring proline residue resulting in 40S ribosomal subunits that were blocked from poly some formation. The other disrupted a predicted pi-pi stacking interaction between two phenylalanine residues leading to a destabilized uS12 that was poorly tolerated in 40S subunit biogenesis. Despite no evidence of a reduction in the rate of mRNA translation, these uS12 variants impaired the accuracy of mRNA translation and rendered cells highly sensitive to oxidative stress. These discoveries describe a ribosomopathy linked to uS12 and reveal mechanistic distinctions between RP gene mutations driving hematopoietic disease and those resulting in developmental disorders.	[Paolini, Nahuel A.; di Summa, Franca M.; von Lindern, Marieke; MacInnes, Alyson W.] Sanquin, Dept Hematopoiesis, NL-1066 CX Amsterdam, Netherlands; [Paolini, Nahuel A.; di Summa, Franca M.; von Lindern, Marieke; MacInnes, Alyson W.] UvA, AMC, Landsteiner Lab, NL-1066 CX Amsterdam, Netherlands; [Attwood, Martin; Fischer, Roman; Ratcliffe, Peter J.; Cockman, Matthew E.] Univ Oxford, Target Discovery Inst, Oxford OX3 7FZ, England; [Sondalle, Samuel B.] Yale Univ, Sch Med, Dept Genet, 333 Cedar St, New Haven, CT 06520 USA; [Vieira, Carolina Marques dos Santos; Rachuri, Swaksha; Briggs, Joseph W.; Dinman, Jonathan D.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [van Adrichem, Anita M.; Houtkooper, Riekelt H.; MacInnes, Alyson W.] Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [O'Donohue, Marie-Francoise; Gleizes, Pierre-Emmanuel] Univ Toulouse, CNRS, UPS, LBME,Ctr Biol Integrat, F-31000 Toulouse, France; [Wlodarski, Marcin W.] Univ Freiburg, Dept Pediat & Adolescent Med, Div Pediat Hematol & Oncol, Med Ctr,Fac Med, Freiburg, Germany; [Kuijpers, Taco W.] Emma Childrens Hosp, Acad Med Ctr, Dept Pediat Hematol Immunol & Infect Dis, NL-1105 AZ Amsterdam, Netherlands; [Baserga, Susan J.] Yale Univ, Sch Med, Dept Mol Biophys & Biochem Genet & Therapeut Radi, 333 Cedar St, New Haven, CT 06520 USA	University of Amsterdam; Academic Medical Center Amsterdam; University of Oxford; Yale University; University System of Maryland; University of Maryland College Park; University of Amsterdam; Academic Medical Center Amsterdam; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Freiburg; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Yale University	MacInnes, AW (corresponding author), Sanquin, Dept Hematopoiesis, NL-1066 CX Amsterdam, Netherlands.; MacInnes, AW (corresponding author), UvA, AMC, Landsteiner Lab, NL-1066 CX Amsterdam, Netherlands.; MacInnes, AW (corresponding author), Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands.	a.w.macinnes@amc.nl	Sondalle, Samuel/C-1283-2014; von Lindern, Marieke/AAH-2350-2020; Fischer, Roman/N-4408-2017; Cockman, Matthew/V-9619-2019; Houtkooper, Riekelt/P-5001-2019; Gleizes, Pierre-Emmanuel/H-3821-2014; Gleizes, Pierre-Emmanuel/ABB-9653-2021	Sondalle, Samuel/0000-0002-4144-9897; Fischer, Roman/0000-0002-9715-5951; Cockman, Matthew/0000-0002-3310-4821; Gleizes, Pierre-Emmanuel/0000-0003-0830-7341; Gleizes, Pierre-Emmanuel/0000-0003-0830-7341; von Lindern, Marieke/0000-0001-6162-6320; Dinman, Jonathan/0000-0002-2402-9698; O'Donohue, Marie-Francoise/0000-0002-1204-8285; Houtkooper, Riekelt/0000-0001-9961-0842; Ratcliffe, Peter/0000-0002-2853-806X	E-Rare-2, ERA-Net for Research on Rare Diseases (ZonMW in the Netherlands) [113301205, 40-44000-98-1008]; E-Rare-2, ERA-Net for Research on Rare Diseases (Germany) [BMBF 01GM1301]; E-Rare-2, ERA-Net for Research on Rare Diseases (France) [ANR-15-RAR3-0007-04]; Landsteiner Foundation for Blood Transfusion Research [1239]; National Institutes of Health (NIH) / National Heart Lung Blood Institute [R01HL119439]; NIH / General Medical Sciences [R01GM115710]; National Institutes of Health (NIH) / Diabetes and Digestive and Kidney Diseases / General Medical Sciences / Child Health and Human Development [F30DK109582, T32GM07205, T32HD007149]; Ludwig Institute of Cancer Research; Agence National de la Recherche (project DBA-Multigenes); The Francis Crick Institute [10501] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007149] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK109582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117177, T32GM007205, R01GM115710] Funding Source: NIH RePORTER	E-Rare-2, ERA-Net for Research on Rare Diseases (ZonMW in the Netherlands); E-Rare-2, ERA-Net for Research on Rare Diseases (Germany); E-Rare-2, ERA-Net for Research on Rare Diseases (France); Landsteiner Foundation for Blood Transfusion Research; National Institutes of Health (NIH) / National Heart Lung Blood Institute; NIH / General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health (NIH) / Diabetes and Digestive and Kidney Diseases / General Medical Sciences / Child Health and Human Development; Ludwig Institute of Cancer Research; Agence National de la Recherche (project DBA-Multigenes); The Francis Crick Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Very special thanks go to all the individuals in this study and their families. We thank Professor Han Brunner of the Radboud University Nijmegen Medical Centre and Professor Nine Knoers of the University Medical Center Utrecht for performing the exome sequencing as well as Daisy Picavet and the AMC Cellular Imaging Core Facility for assistance with the confocal microscopy. Mass spectrometry analysis was performed in the TDI MS laboratory led by Benedict M. Kessler. A.W.M., A.M.v.A., M.W.W., P.E.G., and M.F.O.D. are supported under the frame of E-Rare-2, ERA-Net for Research on Rare Diseases (ZonMW #113301205 and #40-44000-98-1008 in the Netherlands, #BMBF 01GM1301 in Germany, #ANR-15-RAR3-0007-04 in France). The Landsteiner Foundation for Blood Transfusion Research (#1239) supported N.A.P. and F.M.d.S.. C.M.d.S.V. was supported by the National Institutes of Health (NIH) / National Heart Lung Blood Institute (R01HL119439 to JD). S.J.B. was supported by NIH / General Medical Sciences (R01GM115710). S.B.S. was supported by National Institutes of Health (NIH) / Diabetes and Digestive and Kidney Diseases / General Medical Sciences / Child Health and Human Development (F30DK109582, T32GM07205, and T32HD007149 to SS). The Ludwig Institute of Cancer Research supported M.A., M.E.C., and P.J.R. P.E.G. and M.F.O.D. were supported by the Agence National de la Recherche (project DBA-Multigenes).	Advani VM, 2013, TRANSLATION, V1, DOI 10.4161/trla.24418; Alsop RJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149619; ANTHONY RA, 1995, GENETICS, V140, P1247; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Bolze A, 2013, SCIENCE, V340, P976, DOI 10.1126/science.1234864; Boria I, 2010, HUM MUTAT, V31, P1269, DOI 10.1002/humu.21383; Brooks SS, 2014, GENETICS, V198, P723, DOI 10.1534/genetics.114.168211; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cukras AR, 2003, MOL CELL, V12, P321, DOI 10.1016/S1097-2765(03)00275-2; De Keersmaecker K, 2013, NAT GENET, V45, P186, DOI 10.1038/ng.2508; Dinman JD, 2012, WIRES RNA, V3, P661, DOI 10.1002/wrna.1126; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Harger JW, 2003, RNA, V9, P1019, DOI 10.1261/rna.5930803; Heijnen HF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004371; Hui-Yuen J, 2011, JOVE-J VIS EXP, DOI 10.3791/3321; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jacobs JL, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh157; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Khatter H, 2015, NATURE, V520, P640, DOI 10.1038/nature14427; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; O'Donohue MF, 2010, J CELL BIOL, V190, P853, DOI 10.1083/jcb.201005117; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Ozgen H, 2011, J AUTISM DEV DISORD, V41, P23, DOI 10.1007/s10803-010-1018-7; Paganin-Gioanni A, 2011, P NATL ACAD SCI USA, V108, P10443, DOI 10.1073/pnas.1103519108; Pereboom TC, 2014, EXP HEMATOL, V42, P394, DOI 10.1016/j.exphem.2013.12.010; Pereboom TC, 2011, BLOOD, V118, P5458, DOI 10.1182/blood-2011-04-351460; Plant EP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000517; Rakwalska M, 2004, MOL CELL BIOL, V24, P9186, DOI 10.1128/MCB.24.20.9186-9197.2004; Sharma D, 2007, J MOL BIOL, V374, P1065, DOI 10.1016/j.jmb.2007.10.003; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singleton RS, 2014, P NATL ACAD SCI USA, V111, P4031, DOI 10.1073/pnas.1314482111; Stark H, 2002, NAT STRUCT BIOL, V9, P849, DOI 10.1038/nsb859; Synetos D, 1996, BBA-GENE STRUCT EXPR, V1309, P156, DOI 10.1016/S0167-4781(96)00128-5; Taggart L., 2014, HLTH PROMOTION PEOPL; Thevenon J, 2015, AM J MED GENET A, V167, P1908, DOI 10.1002/ajmg.a.37094; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Vlachos A, 2008, BRIT J HAEMATOL, V142, P859, DOI 10.1111/j.1365-2141.2008.07269.x; Wang MS, 2014, NUCLEIC ACIDS RES, V42, P11180, DOI 10.1093/nar/gku787; Wolozin B, 2014, DISCOV MED, V17, P47; Zakari M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005308; Zanni G, 2015, HUM MUTAT, V36, P1155, DOI 10.1002/humu.22860	45	47	48	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 2	2017	100	3					506	522		10.1016/j.ajhg.2017.01.034	http://dx.doi.org/10.1016/j.ajhg.2017.01.034			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EN2PH	28257692	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000395851900015
J	Harel, T; Yesil, G; Bayram, Y; Coban-Akdemir, Z; Charng, WL; Karaca, E; Al Asmari, A; Eldomery, MK; Hunter, JV; Jhangiani, SN; Rosenfeld, JA; Pehlivan, D; El-Hattab, AW; Saleh, MA; Leduc, CA; Muzny, D; Boerwinkle, E; Gibbs, RA; Chung, WK; Yang, YP; Belmont, JW; Lupski, JR				Harel, Tamar; Yesil, Gozde; Bayram, Yavuz; Coban-Akdemir, Zeynep; Charng, Wu-Lin; Karaca, Ender; Al Asmari, Ali; Eldomery, Mohammad K.; Hunter, Jill V.; Jhangiani, Shalini N.; Rosenfeld, Jill A.; Pehlivan, Davut; El-Hattab, Ayman W.; Saleh, Mohammed A.; LeDuc, Charles A.; Muzny, Donna; Boerwinkle, Eric; Gibbs, Richard A.; Chung, Wendy K.; Yang, Yaping; Belmont, John W.; Lupski, James R.		Baylor-Hopkins Ctr Mendelian Genom	Monoallelic and Biallelic Variants in EMC1 Identified in Individuals with Global Developmental Delay, Hypotonia, Scoliosis, and Cerebellar Atrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTELLECTUAL DISABILITY; ENDOPLASMIC-RETICULUM; PARKINSONS-DISEASE; MISSENSE MUTATIONS; ALPHA-SYNUCLEIN; SEQUENCING DATA; ER MEMBRANES; DOMINANT; GENE; NEURODEGENERATION	The paradigm of a single gene associated with one specific phenotype and mode of inheritance has been repeatedly challenged. Genotype-phenotype correlations can often be traced to different mutation types, localization of the variants in distinct protein domains, or the trigger of or escape from nonsense-mediated decay. Using whole-exome sequencing, we identified homozygous variants in EMC1 that segregated with a phenotype of developmental delay, hypotonia, scoliosis, and cerebellar atrophy in three families. In addition, a de novo heterozygous EMC1 variant was seen in an individual with a similar clinical and MRI imaging phenotype. EMC1 encodes a member of the endoplasmic reticulum (ER)-membrane protein complex (EMC), an evolutionarily conserved complex that has been proposed to have multiple roles in ER-associated degradation, ER-mitochondria tethering, and proper assembly of multi-pass transmembrane proteins. Perturbations of protein folding and organelle crosstalk have been implicated in neurodegenerative processes including cerebellar atrophy. We propose EMC1 as a gene in which either biallelic or monoallelic variants might lead to a syndrome including intellectual disability and preferential degeneration of the cerebellum.	[Harel, Tamar; Bayram, Yavuz; Coban-Akdemir, Zeynep; Charng, Wu-Lin; Karaca, Ender; Eldomery, Mohammad K.; Rosenfeld, Jill A.; Pehlivan, Davut; Gibbs, Richard A.; Yang, Yaping; Belmont, John W.; Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Yesil, Gozde] Bezmialem Univ, Dept Med Genet, TR-34093 Istanbul, Turkey; [Al Asmari, Ali; Saleh, Mohammed A.] King Fahad Med City, Childrens Specialist Hosp, Med Genet Sect, Riyadh 11525, Saudi Arabia; [Hunter, Jill V.] Texas Childrens Hosp, Dept Pediat Radiol, Houston, TX 77030 USA; [Jhangiani, Shalini N.; Muzny, Donna; Boerwinkle, Eric; Gibbs, Richard A.; Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Rosenfeld, Jill A.; Yang, Yaping] Baylor Coll Med, Baylor Miraca Genet Labs, Houston, TX 77030 USA; [El-Hattab, Ayman W.] Tawam Hosp, Dept Pediat, Div Clin Genet & Metab Disorders, Al Ain 15258, U Arab Emirates; [LeDuc, Charles A.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Chung, Wendy K.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; [Chung, Wendy K.] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Bezmialem Vakif University; King Fahad Medical City; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Columbia University; University of Texas System; University of Texas Health Science Center Houston; Columbia University; Columbia University; Baylor College of Medicine; Baylor College of Medicine	Harel, T (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	tamar.harel@bcm.edu	Pehlivan, Davut/I-3235-2019; Belmont, John W/AAI-2494-2019; Belmont, John/AAH-6084-2021; YESIL, GOZDE/ABE-1615-2020	Belmont, John W/0000-0001-7409-3578; YESIL, GOZDE/0000-0003-1964-6306; LeDuc, Charles/0000-0002-2073-5050	US National Human Genome Research Institute; National Heart Lung and Blood Institute [U54HG006542]; National Institute of Neurological Disorders and Stroke [RO1 NS058529]; NIH Medical Genetics Research Fellowship Program [T32 GM07526]; Cancer Prevention & Research Institute of Texas Training Program [RP140102]; BioReference Laboratories; Regeneron Pharmaceuticals; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058529] Funding Source: NIH RePORTER	US National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH Medical Genetics Research Fellowship Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention & Research Institute of Texas Training Program; BioReference Laboratories; Regeneron Pharmaceuticals(Regeneron); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the families for participation in this study. This work was supported in part by a US National Human Genome Research Institute and National Heart Lung and Blood Institute grant (U54HG006542) to the Baylor-Hopkins Center for Mendelian Genomics and a National Institute of Neurological Disorders and Stroke grant (RO1 NS058529) to J.R.L. T.H. is supported by the NIH Medical Genetics Research Fellowship Program (T32 GM07526). W.-L. C. is supported by the Cancer Prevention & Research Institute of Texas Training Program (RP140102). We thank Dr. Hugo Bellen and Dr. Hector Sandoval for critical review of the manuscript. J.R.L. has stock ownership in 23andMe, is a paid consultant for Regeneron Pharmaceuticals, has stock options in Lasergen, is a member of the Scientific Advisory Board of Baylor Miraca Genetics Laboratories, and is a co-inventor on multiple United States and European patents related to molecular diagnostics for inherited neuropathies, eye diseases, and bacterial genomic fingerprinting. The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from the chromosomal microarray analysis and clinical exome sequencing offered in the Baylor Miraca Genetics Laboratory (http://www.bmgl.com). W.K.C. is a paid consultant to BioReference Laboratories and for Regeneron Pharmaceuticals. J.W.B. is an employee of Illumina.	Abu-Safieh L, 2013, GENOME RES, V23, P236, DOI 10.1101/gr.144105.112; Anderrson JF, 2011, J MOL BIOL, V411, P870, DOI 10.1016/j.jmb.2011.06.016; Area-Gomez E, 2014, J CHILD NEUROL, V29, P1208, DOI 10.1177/0883073814539561; Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Ben-Shachar S, 2009, CLIN GENET, V75, P394, DOI 10.1111/j.1399-0004.2008.01114.x; Benedetti S, 2007, NEUROLOGY, V69, P1285, DOI 10.1212/01.wnl.0000261254.87181.80; Burrage LC, 2015, AM J HUM GENET, V97, P904, DOI 10.1016/j.ajhg.2015.11.006; Challis D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-8; Chojnowski A, 2015, CELL TISSUE RES, V360, P621, DOI 10.1007/s00441-014-2069-4; Chong JX, 2015, AM J HUM GENET, V96, P462, DOI 10.1016/j.ajhg.2015.01.003; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Credle JJ, 2015, NEUROBIOL DIS, V76, P112, DOI 10.1016/j.nbd.2015.02.005; El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314; Faqeih EA, 2014, AM J MED GENET A, V164, P1565, DOI 10.1002/ajmg.a.36482; Fogel BL, 2007, LANCET NEUROL, V6, P245, DOI 10.1016/S1474-4422(07)70054-6; Guardia-Laguarta C, 2014, J NEUROSCI, V34, P249, DOI 10.1523/JNEUROSCI.2507-13.2014; Guardia-Laguarta C, 2015, MOVEMENT DISORD, V30, P1026, DOI 10.1002/mds.26239; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Karaca E, 2014, CELL, V157, P636, DOI 10.1016/j.cell.2014.02.058; Khajavi M, 2006, EUR J HUM GENET, V14, P1074, DOI 10.1038/sj.ejhg.5201649; Lahiri S, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001969; Lalani SR, 2016, AM J HUM GENET, V98, P347, DOI 10.1016/j.ajhg.2015.12.008; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liu L, 2015, CELL, V160, P177, DOI 10.1016/j.cell.2014.12.019; Lupski JR, 2013, GENOME MED, V5, DOI 10.1186/gm461; Muntoni F, 2006, BRAIN, V129, P1260, DOI 10.1093/brain/awl062; Nieh SE, 2015, ANN CLIN TRANSL NEUR, V2, P623, DOI 10.1002/acn3.198; Poretti A, 2015, NEUROPEDIATRICS, V46, P359, DOI 10.1055/s-0035-1564620; Poretti Andrea, 2015, Cerebellum Ataxias, V2, P8, DOI 10.1186/s40673-015-0027-x; Rainger J, 2014, AM J HUM GENET, V94, P915, DOI 10.1016/j.ajhg.2014.05.005; Rajab A, 2015, J MED GENET, V52, P607, DOI 10.1136/jmedgenet-2015-103083; Rankin J, 2008, AM J MED GENET A, V146A, P1530, DOI 10.1002/ajmg.a.32331; Reid JG, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-30; Richard G, 2002, AM J HUM GENET, V70, P1341, DOI 10.1086/339986; Richard M, 2013, P NATL ACAD SCI USA, V110, pE1055, DOI 10.1073/pnas.1216154110; Rodriguez S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025472; Roman-Sanchez R, 2016, EXP EYE RES, V145, P444, DOI 10.1016/j.exer.2015.09.013; Rudnik-Schoneborn S, 2014, AM J MED GENET C, V166, P173, DOI 10.1002/ajmg.c.31403; Satoh T, 2015, ELIFE, V4, DOI 10.7554/eLife.06306; Schaffer AE, 2014, CELL, V157, P651, DOI 10.1016/j.cell.2014.03.049; Schon EA, 2013, MOL CELL NEUROSCI, V55, P26, DOI 10.1016/j.mcn.2012.07.011; Shy ME, 2006, ANN NEUROL, V59, P358, DOI 10.1002/ana.20777; Simons C, 2015, AM J HUM GENET, V96, P675, DOI 10.1016/j.ajhg.2015.02.012; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Srour M, 2013, AM J HUM GENET, V93, P765, DOI 10.1016/j.ajhg.2013.08.014; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Warner LE, 1999, HUM MOL GENET, V8, P1245, DOI 10.1093/hmg/8.7.1245; Warner LE, 1998, NAT GENET, V18, P382, DOI 10.1038/ng0498-382; Watkin LB, 2015, NAT GENET, V47, P654, DOI 10.1038/ng.3279; Xia YX, 2014, J NEUROCHEM, V129, P99, DOI 10.1111/jnc.12606; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Yatsenko AN, 2001, HUM GENET, V108, P346, DOI 10.1007/s004390100493	54	47	49	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 3	2016	98	3					562	570		10.1016/j.ajhg.2016.01.011	http://dx.doi.org/10.1016/j.ajhg.2016.01.011			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DG9DN	26942288	Green Published, Bronze			2022-12-18	WOS:000372383100018
J	Kishita, Y; Pajak, A; Bolar, NA; Marobbio, CMT; Maffezzini, C; Miniero, DV; Monne, M; Kohda, M; Stranneheim, H; Murayama, K; Naess, K; Lesko, N; Bruhn, H; Mourier, A; Wibom, R; Nennesmo, I; Jespers, A; Goyaert, P; Ohtake, A; Van Laer, L; Loeys, BL; Freyer, C; Palmieri, F; Wredenberg, A; Okazaki, Y; Wedell, A				Kishita, Yoshihito; Pajak, Aleksandra; Bolar, Nikhita Ajit; Marobbio, Carlo M. T.; Maffezzini, Camilla; Miniero, Daniela V.; Monne, Magnus; Kohda, Masakazu; Stranneheim, Henrik; Murayama, Kei; Naess, Karin; Lesko, Nicole; Bruhn, Helene; Mourier, Arnaud; Wibom, Rolf; Nennesmo, Inger; Jespers, Ann; Goyaert, Paul; Ohtake, Akira; Van Laer, Lut; Loeys, Bart L.; Freyer, Christoph; Palmieri, Ferdinando; Wredenberg, Anna; Okazaki, Yasushi; Wedell, Anna			Intra-mitochondrial Methylation Deficiency Due to Mutations in SLC25A26	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							S-ADENOSYLMETHIONINE TRANSPORTER; RIBOSOMAL-RNA; FUNCTIONAL-CHARACTERIZATION; MITOCHONDRIAL RIBOSOME; BACTERIAL EXPRESSION; ESCHERICHIA-COLI; IDENTIFICATION; RECONSTITUTION; CARRIER; BIOSYNTHESIS	S-adenosylmethionine (SAM) is the predominant methyl group donor and has a large spectrum of target substrates. As such, it is essential for nearly all biological methylation reactions. SAM is synthesized by methionine adenosyltransferase from methionine and ATP in the cytoplasm and subsequently distributed throughout the different cellular compartments, including mitochondria, where methylation is mostly required for nucleic-acid modifications and respiratory-chain function. We report a syndrome in three families affected by reduced intra-mitochondrial methylation caused by recessive mutations in the gene encoding the only known mitochondrial SAM transporter, SLC25A26. Clinical findings ranged from neonatal mortality resulting from respiratory insufficiency and hydrops to childhood acute episodes of cardiopulmonary failure and slowly progressive muscle weakness. We show that SLC25A26 mutations cause various mitochondrial defects, including those affecting RNA stability, protein modification, mitochondrial translation, and the biosynthesis of CoQ10 and lipoic acid.	[Kishita, Yoshihito; Okazaki, Yasushi] Saitama Med Univ, Res Ctr Genom Med, Div Funct Genom & Syst Med, Saitama 3501241, Japan; [Pajak, Aleksandra; Maffezzini, Camilla; Freyer, Christoph; Wredenberg, Anna; Wedell, Anna] Karolinska Inst, Dept Lab Med, Div Metab Dis, Max Planck Inst Biol Ageing,Karolinska Inst Lab, S-17177 Stockholm, Sweden; [Bolar, Nikhita Ajit; Van Laer, Lut; Loeys, Bart L.] Univ Antwerp, Univ Antwerp Hosp, Fac Med & Hlth Sci, Dept Med Genet, B-2650 Antwerp, Belgium; [Marobbio, Carlo M. T.; Miniero, Daniela V.; Monne, Magnus; Palmieri, Ferdinando] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, I-70125 Bari, Italy; [Monne, Magnus] Univ Basilicata, Dept Sci, I-85100 Potenza, Italy; [Kohda, Masakazu; Okazaki, Yasushi] Saitama Med Univ, Res Ctr Genom Med, Div Translat Res, Saitama 3501241, Japan; [Stranneheim, Henrik; Naess, Karin; Lesko, Nicole; Bruhn, Helene; Wibom, Rolf; Freyer, Christoph; Wredenberg, Anna; Wedell, Anna] Karolinska Univ Hosp, Ctr Inherited Metab Dis, S-17176 Stockholm, Sweden; [Stranneheim, Henrik; Wedell, Anna] Karolinska Inst, Sci Life Lab, S-17176 Stockholm, Sweden; [Stranneheim, Henrik; Wedell, Anna] Karolinska Inst, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Murayama, Kei] Chiba Childrens Hosp, Dept Metab, Midori Ku, Chiba 2660007, Japan; [Naess, Karin; Lesko, Nicole; Bruhn, Helene; Wibom, Rolf] Karolinska Inst, Dept Lab Med, S-17177 Stockholm, Sweden; [Mourier, Arnaud] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany; [Nennesmo, Inger] Karolinska Univ Hosp, Dept Pathol, S-17177 Stockholm, Sweden; [Jespers, Ann; Goyaert, Paul] Paola Childrens Hosp, ZNA Middelheim, B-2650 Antwerp, Belgium; [Ohtake, Akira] Saitama Med Univ, Dept Pediat, Saitama 3500495, Japan; [Loeys, Bart L.] Radboud Univ Nijmegen, Med Ctr, Dept Genet, NL-6525 GA Nijmegen, Netherlands	Saitama Medical University; Karolinska Institutet; University of Antwerp; Universita degli Studi di Bari Aldo Moro; Italfarmaco; University of Basilicata; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Chiba Children's Hospital; Karolinska Institutet; Max Planck Society; Karolinska Institutet; Karolinska University Hospital; ZNA Middelheim Hospital; Saitama Medical University; Radboud University Nijmegen	Palmieri, F (corresponding author), Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Via Edoardo Orabona 4, I-70125 Bari, Italy.	ferdinando.palmieri@uniba.it; anna.wredenberg@ki.se	Loeys, Bart/B-3236-2017; MOURIER, Arnaud/F-9657-2019; Monné, Magnus/D-5642-2012; Miniero, Daniela Valeria/P-9786-2019	Loeys, Bart/0000-0003-3703-9518; MOURIER, Arnaud/0000-0002-5413-611X; Monné, Magnus/0000-0003-2344-3878; Miniero, Daniela Valeria/0000-0002-3324-9692; Ohtake, Akira/0000-0003-1147-3113; Maffezzini, Camilla/0000-0002-0397-1609; Naess, Karin/0000-0003-4310-7927; KOHDA, Masakazu/0000-0001-5970-2224; Pajak, Aleksandra/0000-0001-8294-9620; Okazaki, Yasushi/0000-0003-3241-5502; Wredenberg, Anna/0000-0002-2500-6121; Freyer, Christoph/0000-0003-0418-1673; Kishita, Yoshihito/0000-0003-4978-1680	Japanese Ministry of Education, Culture, Sports, Science, and Technology; Takeda Science Foundation; Japan Society for the Promotion of Science KAKENHI [20634398]; Ministry of Health, Labor, and Welfare of Japan; Japan Agency for Medical Research and Development; Swedish Research Council [VR12198, VR521-2012-2571]; Karolinska Institutet [2013fobi38557, 2013fobi37932]; Ake Wiberg Foundation [738762088, 367990950]; Stockholm County Council [20140053, K0176-2012]; Swedish Foundation for Strategic Research [ICA 12-0017]; Knut & Alice Wallenberg Foundation [KAW 20130026]; Comitato Telethon Fondazione Onlus [GGP11139]; Italian Human ProteomeNet [RBRNO7BMCT-009]; Fund for Scientific Research, Flanders (FWO, Belgium), a European Research Council (ERC); FWO [G.0221.12]; ERC	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Ake Wiberg Foundation; Stockholm County Council(Stockholm County Council); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Knut & Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Comitato Telethon Fondazione Onlus(Fondazione Telethon); Italian Human ProteomeNet; Fund for Scientific Research, Flanders (FWO, Belgium), a European Research Council (ERC); FWO(FWO); ERC(European Research Council (ERC)European Commission)	We thank the families who participated in this study; Y. Mogami, K. Tominaga, Y. Tokuzawa, H. Nyuzuki, Y. Yatsuka, S. Tamaru, C. Shimizu, and S. Suzuki for technical assistance; and H. Miyoshi of Keio University and RIKEN BioResource Center for the CS-CA-MCS plasmid. This work was supported by the Japanese Ministry of Education, Culture, Sports, Science, and Technology (Innovative Cell Biology by Innovative Technology and Strategic Research Centers at private universities) and the Takeda Science Foundation to Y.O.; Japan Society for the Promotion of Science KAKENHI 20634398 to Y.K.; Research on Intractable Diseases (Mitochondrial Disorder) from the Ministry of Health, Labor, and Welfare of Japan to A.O.; and Grants-in-Aid for the Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development to K.M. Support was also given by the Swedish Research Council (A. Wedell [VR12198]; A. Wredenberg [VR521-2012-2571]); Karolinska Institutet (A. Wredenberg [2013fobi38557]; C.F. [2013fobi37932]); Ake Wiberg Foundation (A. Wredenberg [738762088]; C.F. [367990950]); Stockholm County Council (A. Wedell [20140053]; A. Wredenberg [K0176-2012]); Swedish Foundation for Strategic Research (A. Wredenberg [ICA 12-0017]); and Knut & Alice Wallenberg Foundation (A. Wedell and A. Wredenberg [KAW 20130026]). A. Wredenberg is a Ragnar Soderberg fellow (M77/13). F.P. received grants from the Comitato Telethon Fondazione Onlus (GGP11139) and Italian Human ProteomeNet (RBRNO7BMCT-009). B.L.L. is a senior clinical investigator of the Fund for Scientific Research, Flanders (FWO, Belgium), holds a European Research Council (ERC) starting grant, and received additional support from the FWO (G.0221.12) and ERC.	Agrimi G, 2004, BIOCHEM J, V379, P183, DOI 10.1042/BJ20031664; Booker SJ, 2007, CURR OPIN CHEM BIOL, V11, P543, DOI 10.1016/j.cbpa.2007.08.028; Capobianco L, 1996, BIOCHEMISTRY-US, V35, P8974, DOI 10.1021/bi960258v; Carrasco M, 2014, HIPPOCAMPUS, V24, P840, DOI 10.1002/hipo.22274; Clarke SG, 2013, TRENDS BIOCHEM SCI, V38, P243, DOI 10.1016/j.tibs.2013.02.004; Freyer C., 2015, J MED GENET; Haack TB, 2015, ANN CLIN TRANSL NEUR, V2, P492, DOI 10.1002/acn3.189; HELSER TL, 1971, NATURE-NEW BIOL, V233, P12, DOI 10.1038/newbio233012a0; Infantino V, 2011, MOL GENET METAB, V102, P378, DOI 10.1016/j.ymgme.2010.11.166; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; Laredj LN, 2014, BIOCHIMIE, V100, P78, DOI 10.1016/j.biochi.2013.12.006; Leary SC, 2009, METHODS MOL BIOL, V554, P143, DOI 10.1007/978-1-59745-521-3_10; Marobbio CMT, 2003, EMBO J, V22, P5975, DOI 10.1093/emboj/cdg574; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; Mourier A, 2015, J CELL BIOL, V208, P429, DOI 10.1083/jcb.201411100; Ohtake A, 2014, BBA-GEN SUBJECTS, V1840, P1355, DOI 10.1016/j.bbagen.2014.01.025; Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3; Palmieri F, 1979, Methods Enzymol, V56, P279; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; Palmieri L, 1997, FEBS LETT, V410, P447, DOI 10.1016/S0014-5793(97)00630-3; Palmieri L, 2006, PLANT PHYSIOL, V142, P855, DOI 10.1104/pp.106.086975; Pierri CL, 2014, CELL MOL LIFE SCI, V71, P349, DOI 10.1007/s00018-013-1389-y; POLDERMANS B, 1979, J BIOL CHEM, V254, P9090; Rhein VF, 2014, J BIOL CHEM, V289, P24640, DOI 10.1074/jbc.M114.580464; Rhein VF, 2013, J BIOL CHEM, V288, P33016, DOI 10.1074/jbc.M113.518803; Rio D.C., 2011, RNA LAB MANUAL; Rorbach J, 2014, MOL BIOL CELL, V25, P2542, DOI 10.1091/mbc.E14-01-0014; Scharpf RB, 2008, ANN APPL STAT, V2, P687, DOI 10.1214/07-AOAS155; Stranneheim H., 2014, MUTATION IDENTIFICAT; Stranneheim H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1090; Vandeweyer G, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-4; Wibom R, 2002, ANAL BIOCHEM, V311, P139, DOI 10.1016/S0003-2697(02)00424-4	32	47	50	2	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 5	2015	97	5					761	768		10.1016/j.ajhg.2015.09.013	http://dx.doi.org/10.1016/j.ajhg.2015.09.013			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CW2ED	26522469	hybrid, Green Published			2022-12-18	WOS:000364803000012
J	Munns, CF; Fahiminiya, S; Poudel, N; Munteanu, MC; Majewski, J; Sillence, DO; Metcalf, JP; Biggin, A; Glorieux, F; Fassier, F; Rauch, F; Hinsdale, ME				Munns, Craig F.; Fahiminiya, Somayyeh; Poudel, Nabin; Munteanu, Maria Cristina; Majewski, Jacek; Sillence, David O.; Metcalf, Jordan P.; Biggin, Andrew; Glorieux, Francis; Fassier, Francois; Rauch, Frank; Hinsdale, Myron E.			Homozygosity for Frameshift Mutations in XYLT2 Result in a Spondylo-Ocular Syndrome with Bone Fragility, Cataracts, and Hearing Defects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME; XYLOSYLTRANSFERASE-II; HEPARAN-SULFATE; PROTEOGLYCANS; BIOSYNTHESIS; INITIATION; DISORDERS; SPECTRUM; DISEASE; B3GALT6	Heparan and chondroitin/dermatan sulfated proteoglycans have a wide range of roles in cellular and tissue homeostasis including growth factor function, morphogen gradient formation, and co-receptor activity. Proteoglycan assembly initiates with a xylose monosaccharide covalently attached by either xylosyltransferase I or II. Three individuals from two families were found that exhibited similar phenotypes. The index case subjects were two brothers, individuals 1 and 2, who presented with osteoporosis, cataracts, sensorineural hearing loss, and mild learning defects. Whole exome sequence analyses showed that both individuals had a homozygous c.692dup mutation (GenBank: NM_022167.3) in the xylosyltransferase II locus (XYLT2) (MIM: 608125), causing reduced XYLT2 mRNA and low circulating xylosyltransferase (XylT) activity. In an unrelated boy (individual 3) from the second family, we noted low serum XylT activity. Sanger sequencing of XYLT2 in this individual revealed a c.520del mutation in exon 2 that resulted in a frameshift and premature stop codon (p.Ala174Profs*35). Fibroblasts from individuals 1 and 2 showed a range of defects including reduced XylT activity, GAG incorporation of (SO4)-S-35, and heparan sulfate proteoglycan assembly. These studies demonstrate that human XylT2 deficiency results in vertebral compression fractures, sensorineural hearing loss, eye defects, and heart defects, a phenotype that is similar to the autosomal-recessive disorder spondylo-ocular syndrome of unknown cause. This phenotype is different from what has been reported in individuals with other linker enzyme deficiencies. These studies illustrate that the cells of the lens, retina, heart muscle, inner ear, and bone are dependent on XylT2 for proteoglycan assembly in humans.	[Munns, Craig F.; Biggin, Andrew] Childrens Hosp Westmead, Inst Endocrinol & Diabet, Westmead, NSW 2145, Australia; [Fahiminiya, Somayyeh; Majewski, Jacek] McGill Univ, Dept Human Genet, Fac Med, Montreal, PQ H3A 1B1, Canada; [Fahiminiya, Somayyeh; Majewski, Jacek] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1B1, Canada; [Poudel, Nabin; Munteanu, Maria Cristina; Hinsdale, Myron E.] Oklahoma State Univ, Dept Physiol Sci, Stillwater, OK 74078 USA; [Sillence, David O.] Childrens Hosp Westmead, Discipline Genet Med, Sch Clin, Sydney Med, Westmead, NSW 2145, Australia; [Metcalf, Jordan P.] Univ Oklahoma, Dept Med, Hlth Sci Ctr, Oklahoma City, OK 73126 USA; [Glorieux, Francis; Fassier, Francois; Rauch, Frank] Shriners Hosp Children, Montreal, PQ H3G 1A6, Canada; [Hinsdale, Myron E.] Univ Oklahoma, Dept Cell Biol, Hlth Sci Ctr, Oklahoma City, OK 73126 USA	University of Sydney; McGill University; Oklahoma State University System; Oklahoma State University - Stillwater; University of Sydney; University of Oklahoma System; University of Oklahoma Health Sciences Center; McGill University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Hinsdale, ME (corresponding author), Oklahoma State Univ, Dept Physiol Sci, Stillwater, OK 74078 USA.	myron.hinsdale@okstate.edu	Munns, Craig F/A-8719-2015; Poudel, Nabin/H-9394-2019; Poudel, Nabin/K-1270-2019; Rauch, Frank/D-1554-2009	Munns, Craig F/0000-0001-5898-5808; Biggin, Andrew/0000-0002-3443-9359; Rauch, Frank/0000-0002-6261-0360; Poudel, Nabin/0000-0002-9389-3850	Shriners of North America; Chercheur-Boursier Clinicien program of the Fonds de recherche du Quebec - Sante; NIH [AI062629, GM103648, DK087989]; Department of Veterans Affairs; Research Advisory Committee grant, Oklahoma State University College of Veterinary Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI062629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103648] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001937] Funding Source: NIH RePORTER	Shriners of North America; Chercheur-Boursier Clinicien program of the Fonds de recherche du Quebec - Sante; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Research Advisory Committee grant, Oklahoma State University College of Veterinary Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	We are grateful for the involvement of the study individuals and their families. We acknowledge the contribution of the general pediatrician, Dr. David McDonald of Port Macquarie, NSW, who referred and coordinated the care of the extraskeletal features including their learning disabilities and hearing impairment and supervised their interval Pamidronate therapy. We are indebted to Patty Mason for technical assistance, to Mark Lepik for preparing the figures, and to Michaela Durigova for providing clinical information. The authors wish to acknowledge the McGill University and Genome Quebec Innovation Centre, Montreal, Canada for performing the exome sequencing and Sanger sequencing analyses. We also thank Phillip A. Wood for critical reading of the manuscript. This work was supported by the Shriners of North America. F.R. received support from the Chercheur-Boursier Clinicien program of the Fonds de recherche du Quebec - Sante. J.P.M. is supported by the NIH grants AI062629 and GM103648 and by the Merit Review Program of the Department of Veterans Affairs. M.E.H., N.P., and M.C.M. are supported by a Research Advisory Committee grant, Oklahoma State University College of Veterinary Medicine, and NIH DK087989. The findings herein are the views and conclusions of the authors and not the NIH.	Alanay Y, 2006, AM J MED GENET A, V140A, P652, DOI 10.1002/ajmg.a.31119; Baasanjav S, 2011, AM J HUM GENET, V89, P15, DOI 10.1016/j.ajhg.2011.05.021; Condac E, 2007, P NATL ACAD SCI USA, V104, P9416, DOI 10.1073/pnas.0700908104; Condac E, 2009, GLYCOBIOLOGY, V19, P829, DOI 10.1093/glycob/cwp058; Couchman JR, 2012, J HISTOCHEM CYTOCHEM, V60, P885, DOI 10.1369/0022155412464638; Cuellar K, 2007, J BIOL CHEM, V282, P5195, DOI 10.1074/jbc.M611048200; DEPAEPE A, 1993, AM J MED GENET, V45, P30, DOI 10.1002/ajmg.1320450110; Eames BF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002246; Esko J.D., 2009, ESSENTIALS GLYCOBIOL; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; Hinsdale ME., 2014, HDB GLYCOSYLTRANSFER, P873; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Malfait F, 2013, AM J HUM GENET, V92, P935, DOI 10.1016/j.ajhg.2013.04.016; Mis E.K., 2014, DEV BIOL, V385, P67; Morello LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029174; Nakajima M, 2013, AM J HUM GENET, V92, P927, DOI 10.1016/j.ajhg.2013.04.003; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Roch C, 2010, BIOCHEM BIOPH RES CO, V391, P685, DOI 10.1016/j.bbrc.2009.11.121; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; Schmidt H, 2001, CLIN GENET, V59, P99, DOI 10.1034/j.1399-0004.2001.590206.x; Schreml J, 2014, HUM GENET, V133, P29, DOI 10.1007/s00439-013-1351-y; Shimokawa N, 2010, EMBO J, V29, P2421, DOI 10.1038/emboj.2010.120; SOMER H, 1988, J MED GENET, V25, P543, DOI 10.1136/jmg.25.8.543; TEEBI AS, 1988, J MED GENET, V25, P32, DOI 10.1136/jmg.25.1.32; ZHANG LJ, 1995, J BIOL CHEM, V270, P27127, DOI 10.1074/jbc.270.45.27127	25	47	50	1	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 4	2015	96	6					971	978		10.1016/j.ajhg.2015.04.017	http://dx.doi.org/10.1016/j.ajhg.2015.04.017			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CK0YH	26027496	Green Published, Bronze			2022-12-18	WOS:000355931200011
J	Wieczorek, D; Newman, WG; Wieland, T; Berulava, T; Kaffe, M; Falkenstein, D; Beetz, C; Graf, E; Schwarzmayr, T; Douzgou, S; Clayton-Smith, J; Daly, SB; Williams, SG; Bhaskar, SS; Urquhart, JE; Anderson, B; O'Sullivan, J; Boute, O; Gundlach, J; Czeschik, JC; van Essen, AJ; Hazan, F; Park, S; Hing, A; Kuechler, A; Lohmann, DR; Ludwig, KU; Mangold, E; Steenpass, L; Zeschnigk, M; Lemke, JR; Lourenco, CM; Hehr, U; Prott, EC; Waldenberger, M; Bohmer, AC; Horsthemke, B; O'Keefe, RT; Meitinger, T; Bum, J; Luedecke, HJ; Strom, TM				Wieczorek, Dagmar; Newman, William G.; Wieland, Thomas; Berulava, Tea; Kaffe, Maria; Falkenstein, Daniela; Beetz, Christian; Graf, Elisabeth; Schwarzmayr, Thomas; Douzgou, Sofia; Clayton-Smith, Jill; Daly, Sarah B.; Williams, Simon G.; Bhaskar, Sanjeev S.; Urquhart, Jill E.; Anderson, Beverley; O'Sullivan, James; Boute, Odile; Gundlach, Jasmin; Czeschik, Johanna Christina; van Essen, Anthonie J.; Hazan, Filiz; Park, Sarah; Hing, Anne; Kuechler, Alma; Lohmann, Dietmar R.; Ludwig, Kerstin U.; Mangold, Elisabeth; Steenpass, Laura; Zeschnigk, Michael; Lemke, Johannes R.; Lourenco, Charles Marques; Hehr, Ute; Prott, Eva-Christina; Waldenberger, Melanie; Boehmer, Anne C.; Horsthemke, Bernhard; O'Keefe, Raymond T.; Meitinger, Thomas; Bum, John; Luedecke, Hermann-Josef; Strom, Tim M.			Compound Heterozygosity of Low-Frequency Promoter Deletions and Rare Loss-of-Function Mutations in TXNL4A Causes Burn-McKeown Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NONSYNDROMIC CLEFT-LIP; OTO-FACIAL DYSPLASIA; CHOANAL ATRESIA; PALATE; HAPLOINSUFFICIENCY; INHERITANCE; COMPLEX; PROTEIN; SNRNP	Mutations in components of the major spliceosome have been described in disorders with craniofacial anomalies, e.g., Nager syndrome and mandibulofacial dysostosis type Guion-Almeida. The US spliceosomal complex of eight highly conserved proteins is critical for premRNA splicing. We identified biallelic mutations in TXNL4A, a member of this complex, in individuals with Burn-McKeown syndrome (BMKS). This rare condition is characterized by bilateral choanal atresia, hearing loss, cleft lip and/or palate, and other craniofacial dysmorphisms. Mutations were found in 9 of 11 affected families. In 8 families, affected individuals carried a rare loss-of-function mutation (nonsense, frameshift, or microdeletion) on one allele and a low-frequency 34 bp deletion (allele frequency 0.76%) in the core promoter region on the other allele. In a single highly consanguineous family, formerly diagnosed as oculo-oto-facial dysplasia, the four affected individuals were homozygous for a 34 bp promoter deletion, which differed from the promoter deletion in the other families. Reporter gene and in vivo assays showed that the promoter deletions led to reduced expression of TXNL4A. Depletion of TXNL4A (Dibl) in yeast demonstrated reduced assembly of the tri-snRNP complex. Our results indicate that BMKS is an autosomal-recessive condition, which is frequently caused by compound heterozygosity of low-frequency promoter deletions in combination with very rare loss-of-function mutations.	[Wieczorek, Dagmar; Berulava, Tea; Falkenstein, Daniela; Czeschik, Johanna Christina; Kuechler, Alma; Lohmann, Dietmar R.; Steenpass, Laura; Zeschnigk, Michael; Prott, Eva-Christina; Horsthemke, Bernhard; Luedecke, Hermann-Josef] Univ Duisburg Essen, Univ Klinikum Essen, Inst Humangenet, D-45122 Essen, Germany; [Newman, William G.; Douzgou, Sofia; Clayton-Smith, Jill; Daly, Sarah B.; Williams, Simon G.; Bhaskar, Sanjeev S.; Urquhart, Jill E.; Anderson, Beverley; O'Sullivan, James] Univ Manchester, Fac Med & Human Sci, Manchester Ctr Genom Med, Inst Human Dev, Manchester M13 9WL, Lancs, England; [Newman, William G.; Douzgou, Sofia; Clayton-Smith, Jill; Daly, Sarah B.; Williams, Simon G.; Bhaskar, Sanjeev S.; Urquhart, Jill E.; Anderson, Beverley; O'Sullivan, James] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester M13 9WL, Lancs, England; [Wieland, Thomas; Kaffe, Maria; Graf, Elisabeth; Schwarzmayr, Thomas; Gundlach, Jasmin; Meitinger, Thomas; Strom, Tim M.] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Kaffe, Maria] Schon Klin Munchen Schwabing, Ctr Parkinsons Dis & Movement Disorders, Dept Neurol & Clin Neurophysiol, D-80804 Munich, Germany; [Beetz, Christian] Univ Hosp Jena, Inst Clin Chem & Lab Diagnost, D-07747 Jena, Germany; [Boute, Odile] CHU Lille, Ctr Genet, F-59037 Lille, France; [van Essen, Anthonie J.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 Groningen, Netherlands; [Hazan, Filiz] Dr Behcet Uz Childrens Hosp, Dept Med Genet, TR-35210 Izmir, Turkey; [Park, Sarah] Seattle Childrens Hosp, Craniofacial Ctr, Seattle, WA 98105 USA; [Hing, Anne] Seattle Childrens Hosp, Seattle, WA 98105 USA; [Ludwig, Kerstin U.; Mangold, Elisabeth; Boehmer, Anne C.] Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany; [Ludwig, Kerstin U.; Boehmer, Anne C.] Univ Bonn, Life & Brain Ctr, Dept Genom, D-53127 Bonn, Germany; [Lemke, Johannes R.] Univ Klinikum Leipzig, Inst Humangenet, D-04103 Leipzig, Germany; [Lemke, Johannes R.] Inselspital Bern, Univ Klin Kinderheilkunde, Abt Humangenet, CH-3010 Bern, Switzerland; [Lourenco, Charles Marques] Univ Sao Paulo, Clin Hosp Ribeirao Preto, Neurogenet Unit, BR-14048900 Sao Paulo, Brazil; [Hehr, Ute] Univ Regensburg, Ctr & Dept Human Genet, D-93053 Regensburg, Germany; [Prott, Eva-Christina; Strom, Tim M.] Inst Praenatale Med & Humangenet, D-42103 Wuppertal, Germany; [Waldenberger, Melanie] Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, D-85764 Neuherberg, Germany; [Waldenberger, Melanie] Helmholtz Zentrum Munchen, Inst Epidemiol 2, D-85764 Neuherberg, Germany; [O'Keefe, Raymond T.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Bum, John] Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England	University of Duisburg Essen; University of Manchester; University of Manchester; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Friedrich Schiller University of Jena; Universite de Lille - ISITE; CHU Lille; University of Groningen; Izmir Dr Behcet Uz Children's Disease & Surgery Training & Research Hospital; Seattle Children's Hospital; Seattle Children's Hospital; University of Bonn; University of Bonn; Leipzig University; University of Bern; University Hospital of Bern; Universidade de Sao Paulo; University of Regensburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Manchester; Technical University of Munich; Newcastle University - UK	Wieczorek, D (corresponding author), Univ Duisburg Essen, Univ Klinikum Essen, Inst Humangenet, D-45122 Essen, Germany.	dagmar.wieczorek@uni-due.de	Ludwig, Kerstin U/H-7828-2019; Lohmann, Dietmar R/B-4041-2013; Waldenberger, Melanie/B-5355-2014; Meitinger, Thomas/O-1318-2015; Houge, Sofia Douzgou/I-2049-2019; Lohmann, Dietmar R./X-4895-2019; Wieczorek, Dagmar/AAU-6008-2021; Urquhart, Jill/G-2282-2015	Ludwig, Kerstin U/0000-0002-8541-2519; Lohmann, Dietmar R/0000-0002-2624-9889; Waldenberger, Melanie/0000-0003-0583-5093; Houge, Sofia Douzgou/0000-0001-8890-7544; Lohmann, Dietmar R./0000-0002-2624-9889; Wieczorek, Dagmar/0000-0003-2812-6492; Urquhart, Jill/0000-0002-5788-5511; Meitinger, Thomas/0000-0002-8838-8403; Burn, John/0000-0002-9823-2322; Newman, William/0000-0002-6382-4678; Beetz, Christian/0000-0001-7061-2895; Williams, Simon/0000-0001-7396-4108	German Ministry of Education and Research; FACE consortium (BMBF) [01GM1211B, 01GM1109B]; Manchester Biomedical Research Centre; BBSRC [019510]; Wellcome Trust [094225]; BBSRC [BB/I019510/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I019510/1] Funding Source: researchfish; Cancer Research UK [15934] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10282] Funding Source: researchfish	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); FACE consortium (BMBF)(Federal Ministry of Education & Research (BMBF)); Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank families for participating in this study and Michaela Hiber for excellent technical assistance. This work was supported by the German Ministry of Education and Research for the CRANIRARE, to D.W., the FACE consortium to D.W. and H.-J.L. (BMBF 01GM1211B and 01GM1109B), and the Manchester Biomedical Research Centre to W.G.N. R.T.O. is supported by the BBSRC (019510) and the Wellcome Trust (094225).	Albers CA, 2012, NAT GENET, V44, P435, DOI 10.1038/ng.1083; Aldhorae KA, 2014, BIRTH DEFECTS RES A, V100, P307, DOI 10.1002/bdra.23221; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Beetz C, 2006, NEUROLOGY, V67, P1926, DOI 10.1212/01.wnl.0000244413.49258.f5; Bernier FP, 2012, AM J HUM GENET, V90, P925, DOI 10.1016/j.ajhg.2012.04.004; Birnbaum S, 2009, NAT GENET, V41, P473, DOI 10.1038/ng.333; Burn J, 1992, Clin Dysmorphol, V1, P137; Gouya L, 1996, AM J HUM GENET, V58, P292; Hing AV, 2006, AM J MED GENET A, V140A, P804, DOI 10.1002/ajmg.a.31160; Lines MA, 2012, AM J HUM GENET, V90, P369, DOI 10.1016/j.ajhg.2011.12.023; Liu SB, 2006, RNA, V12, P1418, DOI 10.1261/rna.55406; Mangold E, 2012, EUR J ORAL SCI, V120, P373, DOI 10.1111/j.1600-0722.2012.00991.x; Opitz JM, 2006, AM J MED GENET A, V140A, P2385, DOI 10.1002/ajmg.a.31476; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Reuter K, 1999, J MOL BIOL, V294, P515, DOI 10.1006/jmbi.1999.3258; Teber OA, 2004, EUR J HUM GENET, V12, P879, DOI 10.1038/sj.ejhg.5201260; Toriello HV, 1999, CLIN DYSMORPHOL, V8, P143; Wieczorek D, 2003, CLIN DYSMORPHOL, V12, P171, DOI 10.1097/01.mcd.0000072163.33788.c4; Wieczorek D, 2006, AM J MED GENET A, V140A, P2381, DOI 10.1002/ajmg.a.31478	19	47	48	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 4	2014	95	6					698	707		10.1016/j.ajhg.2014.10.014	http://dx.doi.org/10.1016/j.ajhg.2014.10.014			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AX0DH	25434003	Green Published, Bronze			2022-12-18	WOS:000346623100006
J	Bhatia, G; Tandon, A; Patterson, N; Aldrich, MC; Ambrosone, CB; Amos, C; Bandera, EV; Berndt, SI; Bernstein, L; Blot, WJ; Bock, CH; Caporaso, N; Casey, G; Deming, SL; Diver, WR; Gapstur, SM; Gillanders, EM; Harris, CC; Henderson, BE; Ingles, SA; Isaacs, W; De Jager, PL; John, EM; Kittles, RA; Larkin, E; McNeill, LH; Millikan, RC; Murphy, A; Neslund-Dudas, C; Nyante, S; Press, MF; Rodriguez-Gil, JL; Rybicki, BA; Schwartz, AG; Signorello, LB; Spitz, M; Strom, SS; Tucker, MA; Wiencke, JK; Witte, JS; Wu, X; Yamamura, Y; Zanetti, KA; Zheng, W; Ziegler, RG; Chanock, SJ; Haiman, CA; Reich, D; Price, AL				Bhatia, Gaurav; Tandon, Arti; Patterson, Nick; Aldrich, Melinda C.; Ambrosone, Christine B.; Amos, Christopher; Bandera, Elisa V.; Berndt, Sonja I.; Bernstein, Leslie; Blot, William J.; Bock, Cathryn H.; Caporaso, Neil; Casey, Graham; Deming, Sandra L.; Diver, W. Ryan; Gapstur, Susan M.; Gillanders, Elizabeth M.; Harris, Curtis C.; Henderson, Brian E.; Ingles, Sue A.; Isaacs, William; De Jager, Phillip L.; John, Esther M.; Kittles, Rick A.; Larkin, Emma; McNeill, Lorna H.; Millikan, Robert C.; Murphy, Adam; Neslund-Dudas, Christine; Nyante, Sarah; Press, Michael F.; Rodriguez-Gil, Jorge L.; Rybicki, Benjamin A.; Schwartz, Ann G.; Signorello, Lisa B.; Spitz, Margaret; Strom, Sara S.; Tucker, Margaret A.; Wiencke, John K.; Witte, John S.; Wu, Xifeng; Yamamura, Yuko; Zanetti, Krista A.; Zheng, Wei; Ziegler, Regina G.; Chanock, Stephen J.; Haiman, Christopher A.; Reich, David; Price, Alkes L.			Genome-wide Scan of 29,141 African Americans Finds No Evidence of Directional Selection since Admixture	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ESTIMATING F-STATISTICS; NATURAL-SELECTION; POSITIVE SELECTION; LOCAL-ANCESTRY; POPULATION-STRUCTURE; ALTITUDE ADAPTATION; LATINO POPULATIONS; VARIANTS; GENE; SIGNALS	The extent of recent selection in admixed populations is currently an unresolved question. We scanned the genomes of 29,141 African Americans and failed to find any genome-wide-significant deviations in local ancestry, indicating no evidence of selection influencing ancestry after admixture. A recent analysis of data from 1,890 African Americans reported that there was evidence of selection in African Americans after their ancestors left Africa, both before and after admixture. Selection after admixture was reported on the basis of deviations in local ancestry, and selection before admixture was reported on the basis of allele-frequency differences between African Americans and African populations. The local-ancestry deviations reported by the previous study did not replicate in our very large sample, and we show that such deviations were expected purely by chance, given the number of hypotheses tested. We further show that the previous study's conclusion of selection in African Americans before admixture is also subject to doubt. This is because the F-ST statistics they used were inflated and because true signals of unusual allele-frequency differences between African Americans and African populations would be best explained by selection that occurred in Africa prior to migration to the Americas.	[Bhatia, Gaurav] Harvard MIT Program Hlth Sci & Technol, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Bhatia, Gaurav; Tandon, Arti; Patterson, Nick; De Jager, Phillip L.; Reich, David; Price, Alkes L.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Tandon, Arti; De Jager, Phillip L.; Reich, David] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Aldrich, Melinda C.; Blot, William J.; Deming, Sandra L.; Signorello, Lisa B.; Zheng, Wei] Vanderbilt Epidemiol Ctr, Div Epidemiol, Dept Med, Nashville, TN 37203 USA; [Aldrich, Melinda C.; Blot, William J.; Deming, Sandra L.; Signorello, Lisa B.; Zheng, Wei] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Sch Med, Nashville, TN 37203 USA; [Aldrich, Melinda C.] Vanderbilt Univ, Dept Thorac Surg, Sch Med, Nashville, TN 37203 USA; [Ambrosone, Christine B.] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Amos, Christopher; Spitz, Margaret; Wu, Xifeng] Dartmouth Coll, Geisel Sch Med, Sect Biostat & Epidemiol Community & Family Med, Hanover, NH 03766 USA; [Bandera, Elisa V.] Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Berndt, Sonja I.; Caporaso, Neil; Tucker, Margaret A.; Ziegler, Regina G.; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Bernstein, Leslie] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Div Canc Etiol, Duarte, CA 91010 USA; [Blot, William J.; Signorello, Lisa B.] Int Epidemiol Inst, Rockville, MD 20850 USA; [Bock, Cathryn H.; Schwartz, Ann G.] Wayne State Univ Med, Karmanos Canc Inst, Detroit, MI 48201 USA; [Bock, Cathryn H.; Schwartz, Ann G.] Wayne State Univ Med, Dept Oncol, Detroit, MI 48201 USA; [Casey, Graham; Henderson, Brian E.; Ingles, Sue A.; Press, Michael F.; Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Casey, Graham; Henderson, Brian E.; Ingles, Sue A.; Press, Michael F.; Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Dept Pathol, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Diver, W. Ryan; Gapstur, Susan M.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30303 USA; [Gillanders, Elizabeth M.; Zanetti, Krista A.] NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA; [Harris, Curtis C.; Zanetti, Krista A.] NCI, Lab Human Carcinogenesis, Ctr Canc Res, Bethesda, MD 20892 USA; [Isaacs, William] Johns Hopkins Hosp & Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD 21287 USA; [De Jager, Phillip L.] Brigham & Womens Hosp, Inst Neurosci, Dept Neurol, Program Translat NeuroPsychiat Genom, Boston, MA 02115 USA; [John, Esther M.] Canc Prevent Inst Calif, Fremont, CA 94538 USA; [John, Esther M.] Stanford Med, Stanford Canc Ctr, Stanford, CA 94305 USA; [Kittles, Rick A.] Univ Illinois, Dept Med, Chicago, IL 60607 USA; [Larkin, Emma] Vanderbilt Univ Sch Med, Dept Med, Div Allergy Pulm & Crit Care, Nashville, TN 37232 USA; [McNeill, Lorna H.] Univ Texas MD Anderson Canc Ctr, Dept Hlth Dispar Res Canc Prevent & Populat Sci, Houston, TX 77030 USA; [McNeill, Lorna H.] Univ Texas MD Anderson Canc Ctr, Duncan Family Inst, Ctr Community Implementat & Disseminat Res, Houston, TX 77030 USA; [Millikan, Robert C.; Nyante, Sarah] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Millikan, Robert C.; Nyante, Sarah] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Murphy, Adam] Northwestern Univ, Dept Urol, Chicago, IL 60611 USA; [Neslund-Dudas, Christine; Rybicki, Benjamin A.] Henry Ford Hosp, Dept Publ Hlth Sci, Detroit, MI 48202 USA; [Rodriguez-Gil, Jorge L.] Univ Miami, Sylvester Comprehens Canc Ctr, Miller Sch Med, Miami, FL 33136 USA; [Rodriguez-Gil, Jorge L.] Univ Miami, Dept Epidemiol & Publ Hlth, Miller Sch Med, Miami, FL 33136 USA; [Strom, Sara S.; Yamamura, Yuko] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Wiencke, John K.] Univ Calif San Francisco, San Francisco, CA 94158 USA; [Witte, John S.] Univ Calif San Francisco, Inst Human Genet, Dept Epidemiol & Biostat, San Francisco, CA 94158 USA; [Witte, John S.] Univ Calif San Francisco, Inst Human Genet, Dept Urol, San Francisco, CA 94158 USA; [Price, Alkes L.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Price, Alkes L.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Vanderbilt University; Vanderbilt University; Vanderbilt University; Roswell Park Cancer Institute; Dartmouth College; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); City of Hope; Beckman Research Institute of City of Hope; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; University of Southern California; University of Southern California; American Cancer Society; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Brigham & Women's Hospital; Cancer Prevention Institute of California; Stanford Cancer Institute; Stanford University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Vanderbilt University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Northwestern University; Henry Ford Health System; Henry Ford Hospital; University of Miami; University of Miami; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Bhatia, G (corresponding author), Harvard MIT Program Hlth Sci & Technol, Div Hlth Sci & Technol, Cambridge, MA 02139 USA.	gbhatia@mit.edu	Berndt, Sonja I/J-8423-2016; Jorge L. Rodriguez-Gil, D.Phil/AAD-3523-2020; Zheng, Wei/O-3351-2013; Rybicki, Benjamin/L-4614-2019; Diver, Ryan/AAG-3469-2019; Bandera, Elisa V/M-4169-2014; Tucker, Margaret A/B-4297-2015; zhang, weihua/GXV-1334-2022	Jorge L. Rodriguez-Gil, D.Phil/0000-0002-1125-1281; Zheng, Wei/0000-0003-1226-070X; Rybicki, Benjamin/0000-0003-3190-3467; Diver, Ryan/0000-0002-5418-9000; Bandera, Elisa V/0000-0002-8789-2755; Nyante, Sarah/0000-0002-1770-5993	NIH [R01 HG006399]; NATIONAL CANCER INSTITUTE [UM1CA164920, ZIACP010201, K07CA172294, P30CA016672, R01CA092447, ZIABC011495] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100233, T32GM008692] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Carlos Bustamante, Bogdan Pasaniuc, and Amy L. Williams for helpful discussions and Richard Cooper for sharing data from 756 Yoruba samples. This research was funded by NIH grant R01 HG006399.	Aidoo M, 2002, LANCET, V359, P1311, DOI 10.1016/S0140-6736(02)08273-9; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Auer PL, 2012, AM J HUM GENET, V91, P794, DOI 10.1016/j.ajhg.2012.08.031; Ayodo G, 2007, AM J HUM GENET, V81, P234, DOI 10.1086/519221; Baran Y, 2012, BIOINFORMATICS, V28, P1359, DOI 10.1093/bioinformatics/bts144; Bhatia G, 2013, GENOME RES, V23, P1514, DOI 10.1101/gr.154831.113; Bhatia G, 2011, AM J HUM GENET, V89, P368, DOI 10.1016/j.ajhg.2011.07.025; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; Chen H, 2010, GENOME RES, V20, P393, DOI 10.1101/gr.100545.109; Churchhouse C, 2013, GENET EPIDEMIOL, V37, P1, DOI 10.1002/gepi.21692; Engelken J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004128; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Guan YT, 2014, GENETICS, V196, P625, DOI 10.1534/genetics.113.160697; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; HUDSON RR, 1992, GENETICS, V132, P583; Huerta-Sanchez E, 2014, NATURE, V512, P194, DOI 10.1038/nature13408; Huerta-Sanchez E, 2013, MOL BIOL EVOL, V30, P1877, DOI 10.1093/molbev/mst089; Jeong CW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4281; Jin WF, 2012, GENOME RES, V22, P519, DOI 10.1101/gr.124784.111; LEWONTIN RC, 1973, GENETICS, V74, P175; Maples BK, 2013, AM J HUM GENET, V93, P278, DOI 10.1016/j.ajhg.2013.06.020; McEvoy BP, 2009, GENOME RES, V19, P804, DOI 10.1101/gr.083394.108; Pasaniuc B, 2013, BIOINFORMATICS, V29, P1407, DOI 10.1093/bioinformatics/btt166; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Peter BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003011; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000505; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000519; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Seldin MF, 2011, NAT REV GENET, V12, P523, DOI 10.1038/nrg3002; Smith MW, 2005, NAT REV GENET, V6, P623, DOI 10.1038/nrg1657; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Teo YY, 2009, GENOME RES, V19, P2154, DOI 10.1101/gr.095000.109; Vernot B, 2014, SCIENCE, V343, P1017, DOI 10.1126/science.1245938; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	41	47	47	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 2	2014	95	4					437	444		10.1016/j.ajhg.2014.08.011	http://dx.doi.org/10.1016/j.ajhg.2014.08.011			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AQ2XW	25242497	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000342654300008
J	Wang, GT; Peng, B; Leal, SM				Wang, Gao T.; Peng, Bo; Leal, Suzanne M.			Variant Association Tools for Quality Control and Analysis of Large-Scale Sequence and Genotyping Array Data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; RARE VARIANTS; GENERAL FRAMEWORK; DISEASE ASSOCIATION; COMMON DISEASES; LOW-FREQUENCY; METAANALYSIS; CONTRIBUTE; IMPUTATION; INFERENCE	Currently there is great interest in detecting associations between complex traits and rare variants. In this report, we describe Variant Association Tools (VAT) and the VAT pipeline, which implements best practices for rare-variant association studies. Highlights of VAT include variant-site and call-level quality control (QC), summary statistics, phenotype- and genotype-based sample selection, variant annotation, selection of variants for association analysis, and a collection of rare-variant association methods for analyzing qualitative and quantitative traits. The association testing framework for VAT is regression based, which readily allows for flexible construction of association models with multiple covariates and weighting themes based on allele frequencies or predicted functionality. Additionally, pathway analyses, conditional analyses, and analyses of gene-gene and gene-environment interactions can be performed. VAT is capable of rapidly scanning through data by using multi-process computation, adaptive permutation, and simultaneously conducting association analysis via multiple methods. Results are available in text or graphic file formats and additionally can be output to relational databases for further annotation and filtering. An interface to R language also facilitates user implementation of novel association methods. The VAT's data QC and association-analysis pipeline can be applied to sequence, imputed, and genotyping array, e.g., "exome chip," data, providing a reliable and reproducible computational environment in which to analyze small- to large-scale studies with data from the latest genotyping and sequencing technologies. Application of the VAT pipeline is demonstrated through analysis of data from the 1000 Genomes project.	[Wang, Gao T.; Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Ctr Stat Genet, Houston, TX 77030 USA; [Peng, Bo] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Leal, SM (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Ctr Stat Genet, Houston, TX 77030 USA.	sleal@bcm.edu		Peng, Bo/0000-0001-8225-2284	National Institutes of Health [HL102926, MD005964, HG006493, 1R01HG005859]; Lyda Hill Foundation; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [RC4MD005964] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005859, UM1HG006493, U54HG006493] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lyda Hill Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We would like to thank Mengyuan Kan, Kristine Bucasas, Biao Li, and Regie Santos-Cortez for their useful suggestions. This work was supported by National Institutes of Health grants HL102926 (to S.M.L), MD005964 (to S.M.L), HG006493 (to S.M.L) and 1R01HG005859 (to B.P). Additional support for this work was provided by the Lyda Hill Foundation (to B.P.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agarwala V, 2013, NAT GENET, V45, P1418, DOI 10.1038/ng.2804; Auer PL, 2013, GENET EPIDEMIOL, V37, P529, DOI 10.1002/gepi.21736; Basu S, 2011, GENET EPIDEMIOL, V35, P606, DOI 10.1002/gepi.20609; Bhatia G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000954; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Challis D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-8; Chang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021097; Cheung YH, 2012, GENET EPIDEMIOL, V36, P675, DOI 10.1002/gepi.21662; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Cooper GM, 2010, NAT METHODS, V7, P250, DOI 10.1038/nmeth0410-250; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Devlin B, 2001, GENET EPIDEMIOL, V21, P273, DOI 10.1002/gepi.1034; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huyghe JR, 2013, NAT GENET, V45, P197, DOI 10.1038/ng.2507; Ionita-Laza I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001289; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kutner M, 2005, APPL LINEAR STAT MOD, VFifth; Ladouceur M, 2013, EUR J HUM GENET, V21, P1027, DOI 10.1038/ejhg.2012.284; Ladouceur M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002496; Leal SM, 2005, GENET EPIDEMIOL, V29, P204, DOI 10.1002/gepi.20086; Lee S, 2013, AM J HUM GENET, V93, P42, DOI 10.1016/j.ajhg.2013.05.010; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lin DY, 2011, AM J HUM GENET, V89, P354, DOI [10.1016/j.ajhg.2011.07.015, 10.1016/j.ajhg.2011.07.015.]; Liu DJJ, 2014, NAT GENET, V46, P200, DOI 10.1038/ng.2852; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Peloso GM, 2014, AM J HUM GENET, V94, P223, DOI 10.1016/j.ajhg.2014.01.009; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; San Lucas FA, 2012, BIOINFORMATICS, V28, P421, DOI 10.1093/bioinformatics/btr667; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029	52	47	48	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 1	2014	94	5					770	783		10.1016/j.ajhg.2014.04.004	http://dx.doi.org/10.1016/j.ajhg.2014.04.004			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG5VB	24791902	Green Published, Bronze			2022-12-18	WOS:000335485700011
J	Guthridge, JM; Lu, RF; Sun, H; Sun, CL; Wiley, GB; Dominguez, N; Macwana, SR; Lessard, CJ; Kim-Howard, X; Cobb, BL; Kaufman, KM; Kelly, JA; Langefeld, CD; Adler, AJ; Harley, ITW; Merrill, JT; Gilkeson, GS; Kamen, DL; Niewold, TB; Brown, EE; Edberg, JC; Petri, MA; Ramsey-Goldman, R; Reveille, JD; Vila, LM; Kimberly, RP; Freedman, BI; Stevens, AM; Boackle, SA; Criswell, LA; Vyse, TJ; Behrens, TW; Jacob, CO; Alarcon-Riquelme, ME; Sivils, KL; Choi, J; Joo, YB; Bang, SY; Lee, HS; Bae, SC; Shen, N; Qian, XX; Tsao, BP; Scofield, RH; Harley, JB; Webb, CF; Wakeland, EK; James, JA; Nath, SK; Graham, RR; Gaffney, PM				Guthridge, Joel M.; Lu, Rufei; Sun, Harry; Sun, Celi; Wiley, Graham B.; Dominguez, Nicolas; Macwana, Susan R.; Lessard, Christopher J.; Kim-Howard, Xana; Cobb, Beth L.; Kaufman, Kenneth M.; Kelly, Jennifer A.; Langefeld, Carl D.; Adler, Adam J.; Harley, Isaac T. W.; Merrill, Joan T.; Gilkeson, Gary S.; Kamen, Diane L.; Niewold, Timothy B.; Brown, Elizabeth E.; Edberg, Jeffery C.; Petri, Michelle A.; Ramsey-Goldman, Rosalind; Reveille, John D.; Vila, Luis M.; Kimberly, Robert P.; Freedman, Barry I.; Stevens, Anne M.; Boackle, Susan A.; Criswell, Lindsey A.; Vyse, Tim J.; Behrens, Timothy W.; Jacob, Chaim O.; Alarcon-Riquelme, Marta E.; Sivils, Kathy L.; Choi, Jiyoung; Joo, Young Bin; Bang, So-Young; Lee, Hye-Soon; Bae, Sang-Cheol; Shen, Nan; Qian, Xiaoxia; Tsao, Betty P.; Scofield, R. Hal; Harley, John B.; Webb, Carol F.; Wakeland, Edward K.; James, Judith A.; Nath, Swapan K.; Graham, Robert R.; Gaffney, Patrick M.		BIOLUPUS Network	Two Functional Lupus-Associated BLK Promoter Variants Control Cell-Type- and Developmental-Stage-Specific Transcription	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; B LYMPHOID KINASE; SUSCEPTIBILITY LOCI; SJOGRENS-SYNDROME; GENOTYPE DATA; CHINESE HAN; ERYTHEMATOSUS; GENE; PROTEIN; EXPRESSION	Efforts to identify lupus-associated causal variants in the FAM167A/BLK locus on 8p21 are hampered by highly associated noncausal variants. In this report, we used a trans-population mapping and sequencing strategy to identify a common variant (rs922483) in the proximal BLK promoter and a tri-allelic variant (rs1382568) in the upstream alternative BLK promoter as putative causal variants for association with systemic lupus erythematosus. The risk allele (T) at rs922483 reduced proximal promoter activity and modulated alternative promoter usage. Allelic differences at rs1382568 resulted in altered promoter activity in B progenitor cell lines. Thus, our results demonstrated that both lupus-associated functional variants contribute to the autoimmune disease association by modulating transcription of BLK in B cells and thus potentially altering immune responses.	[Guthridge, Joel M.; Lu, Rufei; Sun, Celi; Wiley, Graham B.; Dominguez, Nicolas; Macwana, Susan R.; Lessard, Christopher J.; Kim-Howard, Xana; Kelly, Jennifer A.; Adler, Adam J.; Alarcon-Riquelme, Marta E.; Sivils, Kathy L.; Scofield, R. Hal; James, Judith A.; Nath, Swapan K.; Gaffney, Patrick M.] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Program, Oklahoma City, OK 73104 USA; [Lu, Rufei; James, Judith A.] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA; [Sun, Harry; Behrens, Timothy W.; Graham, Robert R.] Genentech Inc, Immune & Tissue Growth & Repair, San Francisco, CA 94080 USA; [Sun, Harry; Behrens, Timothy W.; Graham, Robert R.] Genentech Inc, Dept Human Genet, San Francisco, CA 94080 USA; [Cobb, Beth L.; Kaufman, Kenneth M.; Harley, John B.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Kaufman, Kenneth M.; Harley, John B.] Cincinnati Vet Affairs Med Ctr, Cincinnati, OH 45220 USA; [Langefeld, Carl D.] Wake Forest Univ, Dept Biostat Sci, Winston Salem, NC 27106 USA; [Harley, Isaac T. W.] Cincinnati Childrens Hosp Res Fdn, Div Mol Immunol, Cincinnati, OH 45229 USA; [Harley, Isaac T. W.] Cincinnati Childrens Hosp Res Fdn, Grad Program Immunobiol, Cincinnati, OH 45229 USA; [Merrill, Joan T.] Oklahoma Med Res Fdn, Dept Clin Pharmacol, Oklahoma City, OK 73104 USA; [Gilkeson, Gary S.; Kamen, Diane L.] Med Univ S Carolina, Div Rheumatol, Dept Med, Charleston, SC 29425 USA; [Niewold, Timothy B.] Mayo Clin, Div Rheumatol, Rochester, MN 55902 USA; [Niewold, Timothy B.] Mayo Clin, Dept Immunol, Rochester, MN 55902 USA; [Brown, Elizabeth E.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA; [Brown, Elizabeth E.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Edberg, Jeffery C.; Kimberly, Robert P.] Univ Alabama Birmingham, Sch Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA; [Petri, Michelle A.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Ramsey-Goldman, Rosalind] Northwestern Univ, Feinberg Sch Med, Div Rheumatol, Chicago, IL 60611 USA; [Reveille, John D.] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Vila, Luis M.] Univ Puerto Rico, Div Rheumatol, Dept Med, San Juan, PR 00921 USA; [Freedman, Barry I.] Wake Forest Sch Med, Dept Internal Med, Winston Salem, NC 27106 USA; [Stevens, Anne M.] Univ Washington, Ctr Immun & Immunotherapies, Seattle Childrens Res Inst, Div Rheumatol,Dept Pediat, Seattle, WA 98101 USA; [Boackle, Susan A.] Univ Colorado Denver, Div Rheumatol, Aurora, CO 80045 USA; [Criswell, Lindsey A.] Univ Calif San Francisco, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94143 USA; [Vyse, Tim J.] Univ London Imperial Coll Sci Technol & Med, Div Med, London SW7 2AZ, England; [Jacob, Chaim O.] Univ So Calif, Dept Med, Los Angeles, CA 90089 USA; [Alarcon-Riquelme, Marta E.] Pfizer Univ Granada Junta de Andalucia, Ctr Genom & Invest Oncol GENYO, Granada 18016, Spain; [Choi, Jiyoung; Joo, Young Bin; Bang, So-Young; Lee, Hye-Soon; Bae, Sang-Cheol] Hanyang Univ, Hosp Rheumat Dis, Dept Rheumatol, Seoul 133791, South Korea; [Shen, Nan; Qian, Xiaoxia] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Mol Rheumatol Lab, Shanghai 200025, Peoples R China; [Shen, Nan; Qian, Xiaoxia] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200025, Peoples R China; [Tsao, Betty P.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; [Webb, Carol F.] Oklahoma Med Res Fdn, Immunobiol & Canc Program, Oklahoma City, OK 73104 USA; [Webb, Carol F.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Webb, Carol F.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA; [Wakeland, Edward K.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75235 USA; [Scofield, R. Hal; James, Judith A.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73105 USA; [Scofield, R. Hal] US Dept Vet Affairs Med Ctr, Oklahoma City, OK 73105 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; Roche Holding; Genentech; Roche Holding; Genentech; Cincinnati Children's Hospital Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; Wake Forest University; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Oklahoma Medical Research Foundation; Medical University of South Carolina; Mayo Clinic; Mayo Clinic; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Johns Hopkins University; Northwestern University; Feinberg School of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Wake Forest University; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California San Francisco; Imperial College London; University of Southern California; Pfizer; University of Granada; Hanyang University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; University of California System; University of California Los Angeles; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Guthridge, JM (corresponding author), Oklahoma Med Res Fdn, Arthrit & Clin Immunol Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	guthridgej@omrf.org	Alarcón-Riquelme, Marta E./ABF-8163-2020; Shen, Nan/AGK-6807-2022; Merrill, Joan/HDL-9141-2022; Scofield, Robert Hal/AEJ-8314-2022; Bae, Sang-Cheol/P-2051-2015; Niewold, Timothy/D-2669-2018	Alarcón-Riquelme, Marta E./0000-0002-7632-4154; Kelly, Jennifer/0000-0002-3203-2467; Bae, Sang-Cheol/0000-0003-4658-1093; Kimberly, Robert/0000-0002-5330-3086; Tsao, Betty/0000-0001-7938-5975; Lessard, Christopher J./0000-0003-2440-3843; Gaffney, Patrick/0000-0002-1580-869X; Guthridge, Joel/0000-0002-9308-237X; Niewold, Timothy/0000-0003-3532-6660; Harley, Isaac/0000-0003-1282-5395; Shen, Nan/0000-0002-5875-4417	NIH; NATIONAL CANCER INSTITUTE [P30CA046934, R01CA141700] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079, UL1TR000150, UL1TR000154, UL1TR001082, UL1TR000371] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000079, P20RR020143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI101934, U19AI082714, P01AI083194, K24AI078004, R21AI070304, R01AI063274, R21AI090343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [RC1AR058621, P60AR062755, K24AR002138, R01AR043274, P01AR049084, P60AR053308, R01AR056360, P30AR053483, R01AR042460, P60AR049459, R01AR064820, R01AR051545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE018209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104938, P30GM103510] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001834] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	The authors declare the following competing financial interests: H.S., T.W.B., and R.R.G. are full-time employees of Genentech. We thank all individuals who participated in this study and the research assistants, coordinators, and physicians who helped in the recruitment of subjects. We thank Peter K. Gregersen for providing genotyping controls and cases and controls from the ABCoN and NYCP collections. We thank the members of the BIOLUPUS Network (see consortium section) for providing samples used in this study. We thank Mary C. Comeau; Miranda C. Marion; Paula S. Ramos; Adam Adler; Stuart Glenn, and Mai Li Zhu for assistance in genotyping, quality-control analyses, and clinical-data management; J. Donald Capra for critical reading of the manuscript; Julie M. Robertson for scientific editing; and the staff of the Oklahoma Rheumatic Disease Resources Cores Center for collecting and maintaining the samples. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or any other funding organization. Specific NIH grant numbers and other funding information can be found in the supplemental materials.	Akerblad P, 1999, J IMMUNOL, V163, P5453; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bernal-Quiros M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059842; Cao W, 2007, PLOS BIOL, V5, P2190, DOI 10.1371/journal.pbio.0050248; Delgado-Vega AM, 2012, ANN RHEUM DIS, V71, P1219, DOI 10.1136/annrheumdis-2011-200987; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Goris A, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007260; Gourh P, 2010, J AUTOIMMUN, V34, P155, DOI 10.1016/j.jaut.2009.08.014; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hoffjan S, 2010, MOL CELL PROBE, V24, P237, DOI 10.1016/j.mcp.2010.04.006; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Ice JA, 2012, J AUTOIMMUN, V39, P57, DOI 10.1016/j.jaut.2012.01.008; Kozyrev SV, 2012, GENES IMMUN, V13, P129, DOI 10.1038/gene.2011.62; Laird RM, 2010, J IMMUNOL, V185, P6518, DOI 10.4049/jimmunol.1002766; Lessard CJ, 2013, NAT GENET, V45, P1284, DOI 10.1038/ng.2792; Lessard CJ, 2012, AM J HUM GENET, V90, P648, DOI 10.1016/j.ajhg.2012.02.023; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; LIN YH, 1995, J BIOL CHEM, V270, P25968, DOI 10.1074/jbc.270.43.25968; MEULIA T, 1992, MOL CELL BIOL, V12, P4590, DOI 10.1128/MCB.12.10.4590; Perricone C, 2011, AUTOIMMUN REV, V10, P599, DOI 10.1016/j.autrev.2011.04.021; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Purcell S, 2007, BIOINFORMATICS, V23, P255, DOI 10.1093/bioinformatics/btl580; Rullo OJ, 2013, ANN RHEUM DIS, V72, P56, DOI 10.1136/annrheumdis-2012-202351; Samuelson EM, 2012, IMMUNOL CELL BIOL, V90, P620, DOI 10.1038/icb.2011.76; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Simpfendorfer KR, 2012, HUM MOL GENET, V21, P3918, DOI 10.1093/hmg/dds220; Tsuchiya Naoyuki, 2010, Nihon Rinsho Meneki Gakkai Kaishi, V33, P57; Wiebolt J, 2010, EUR J CLIN INVEST, V40, P1144, DOI 10.1111/j.1365-2362.2010.02366.x; Yarden G, 2009, NUCLEIC ACIDS RES, V37, P4234, DOI 10.1093/nar/gkp315; Yin H, 2009, ARTHRITIS RHEUM-US, V60, P2468, DOI 10.1002/art.24701; Zhang Z, 2010, ARCH DERMATOL RES, V302, P619, DOI 10.1007/s00403-010-1029-4; Zielger A., 2010, STAT APPROACH GENETI	34	47	48	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 3	2014	94	4					586	598		10.1016/j.ajhg.2014.03.008	http://dx.doi.org/10.1016/j.ajhg.2014.03.008			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AE1XC	24702955	Green Published, Bronze			2022-12-18	WOS:000333765300009
J	Caussy, C; Charriere, S; Marcais, C; Di Filippo, M; Sassolas, A; Delay, M; Euthine, V; Jalabert, A; Lefai, E; Rome, S; Moulin, P				Caussy, Cyrielle; Charriere, Sybil; Marcais, Christophe; Di Filippo, Mathilde; Sassolas, Agnes; Delay, Mireille; Euthine, Vanessa; Jalabert, Audrey; Lefai, Etienne; Rome, Sophie; Moulin, Philippe			An APOA5 3 ' UTR Variant Associated with Plasma Triglycerides Triggers APOA5 Downregulation by Creating a Functional miR-485-5p Binding Site	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							APOLIPOPROTEIN-A-V; GENOME-WIDE ASSOCIATION; RICH LIPOPROTEINS; WEB SERVER; HYPERTRIGLYCERIDEMIA; DETERMINANTS; -1131T-GREATER-THAN-C; HYPERCHYLOMICRONEMIA; IDENTIFICATION; POLYMORPHISM	APOA5 c.*158C>T (rs2266788), located in the 3' UTR, belongs to APOA5 haplotype 2 (APOA5*2), which is strongly associated with plasma triglyceride levels and modulates the occurrence of both moderate and severe hypertriglyceridemia. Individuals with APOA5*2 display reduced APOA5 expression at the posttranscriptional level. However, the functionality of this haplotype remains unclear. We hypothesized that the hypertriglyceridemic effects of APOA5*2 could involve miRNA regulation in the APOA5 3' UTR. Bioinformatic studies have identified the creation of a potential miRNA binding site for liver-expressed miR-485-5p (MIRN485-5p) in the mutant APOA5 3' UTR with the c.*158C allele. In human embryonic kidney 293T (HEK293T) cells cotransfected with an APOA5 3' UTR luciferase reporter vector and a miR485-5p precursor, c.*158C allele expression was significantly decreased. Moreover, in HuH-7 cells endogenously expressing miR-485-5p, we observed that luciferase activity was significantly lower in the presence of the c.*158C allele than in the presence of the c.*158T allele, which was completely reversed by a miR-485-5p inhibitor. We demonstrated that the rare c.*158C APOA5 allele creates a functional target site for liver-expressed miR-485-5p. Therefore, we propose that the well-documented hypertriglyceridemic effect of APOA5*2 involves an APOA5 posttranscriptional downregulation mediated by miR-485-5p.	[Caussy, Cyrielle; Charriere, Sybil; Moulin, Philippe] Hosp Civils Lyon, Hop Louis Pradel, Federat Endocrinol Malad Metabol Diabete & Nutr, F-69677 Bron, France; [Caussy, Cyrielle; Charriere, Sybil; Marcais, Christophe; Di Filippo, Mathilde; Sassolas, Agnes; Euthine, Vanessa; Jalabert, Audrey; Lefai, Etienne; Rome, Sophie; Moulin, Philippe] Univ Lyon 1, INRA, Inst Natl Sci Appl Lyon, INSERM,U1060,Lab Carmen,U1235, F-69621 Villeurbanne, France; [Marcais, Christophe; Delay, Mireille] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Ctr Biol Sud, Lab Biochim Mol & Metab, F-69495 Pierre Benite, France; [Di Filippo, Mathilde; Sassolas, Agnes] Hosp Civils Lyon, Ctr Biol & Pathol Est, Dept Biochim & Biol Mol, F-69677 Bron, France	CHU Lyon; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; CHU Lyon	Charriere, S (corresponding author), Hosp Civils Lyon, Hop Louis Pradel, Federat Endocrinol Malad Metabol Diabete & Nutr, F-69677 Bron, France.	sybil.charriere@chu-lyon.fr	Carmen, Team2/Y-7383-2019; Carmen, Team1/Y-7382-2019; Lefai, Etienne/L-7961-2019; Di Filippo, Mathilde/C-2234-2016; Lefai, Etienne/E-9615-2019; charriere, sybil/AAG-1603-2021	Carmen, Team2/0000-0001-9867-5724; Carmen, Team1/0000-0003-4234-1746; Lefai, Etienne/0000-0002-3042-7801; Di Filippo, Mathilde/0000-0001-6206-5908; Lefai, Etienne/0000-0002-3042-7801; Lab, Carmen/0000-0002-5935-3236	Societe Francaise d'Endocrinologie; Institut National de la Sante et de la Recherche Medicale; Universite Claude Bernard Lyon 1; Fondation pour le Recherche Medicale; Fondation de France	Societe Francaise d'Endocrinologie; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Claude Bernard Lyon 1; Fondation pour le Recherche Medicale(Fondation pour la Recherche Medicale); Fondation de France(Fondation de France)	The authors would like to acknowledge Michel Lagarde and Hubert Vidal for their helpful discussions, the nurses for blood drawing, and the Societe Francaise d'Endocrinologie, Institut National de la Sante et de la Recherche Medicale, and Universite Claude Bernard Lyon 1 for their support ("BQR accueil EC 2013" grants). S.R. received grants from the Fondation pour le Recherche Medicale, and P.M. received grants from the Fondation de France.	Ahituv N, 2007, GENOMICS, V90, P674, DOI 10.1016/j.ygeno.2007.08.003; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Charriere S, 2009, ATHEROSCLEROSIS, V207, P150, DOI 10.1016/j.atherosclerosis.2009.04.021; Charriere S, 2008, CLIN CHIM ACTA, V394, P99, DOI 10.1016/j.cca.2008.04.013; Cohen JE, 2011, P NATL ACAD SCI USA, V108, P11650, DOI 10.1073/pnas.1017576108; Comuzzie AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051954; Costa FF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025114; Dallinga-Thie GM, 2006, DIABETOLOGIA, V49, P1505, DOI 10.1007/s00125-006-0261-0; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Fruchart-Najib J, 2004, BIOCHEM BIOPH RES CO, V319, P397, DOI 10.1016/j.bbrc.2004.05.003; Fu HJ, 2005, FEBS LETT, V579, P3849, DOI 10.1016/j.febslet.2005.05.064; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grosskopf I, 2005, ARTERIOSCL THROM VAS, V25, P2573, DOI 10.1161/01.ATV.0000186189.26141.12; Hahne P, 2008, J INTERN MED, V264, P452, DOI 10.1111/j.1365-2796.2008.01987.x; Huang HY, 2006, NUCLEIC ACIDS RES, V34, pW429, DOI 10.1093/nar/gkl333; Ishihara M, 2005, J LIPID RES, V46, P2015, DOI 10.1194/jlr.D500018-JLR200; Johansen CT, 2011, J LIPID RES, V52, P189, DOI 10.1194/jlr.R009720; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kettunen J, 2012, NAT GENET, V44, P269, DOI 10.1038/ng.1073; Kim JY, 2013, J CLIN LIPIDOL, V7, P94, DOI 10.1016/j.jacl.2012.06.002; Kim TH, 2010, HISTOPATHOLOGY, V57, P734, DOI 10.1111/j.1365-2559.2010.03686.x; Kraja AT, 2011, DIABETES, V60, P1329, DOI 10.2337/db10-1011; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Maragkakis M, 2011, NUCLEIC ACIDS RES, V39, pW145, DOI 10.1093/nar/gkr294; Marcais C, 2005, J CLIN INVEST, V115, P2862, DOI 10.1172/JCI24471; Marcais C, 2000, DIABETOLOGIA, V43, P1346, DOI 10.1007/s001250051537; Merkel M, 2005, J BIOL CHEM, V280, P21553, DOI 10.1074/jbc.M411412200; Oliva CP, 2005, ARTERIOSCL THROM VAS, V25, P411, DOI 10.1161/01.ATV.0000153087.36428.dd; Olivier M, 2004, GENOMICS, V83, P912, DOI 10.1016/j.ygeno.2003.11.016; Palmen J, 2008, BBA-MOL BASIS DIS, V1782, P447, DOI 10.1016/j.bbadis.2008.03.003; Pennacchio LA, 2002, HUM MOL GENET, V11, P3031, DOI 10.1093/hmg/11.24.3031; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Richardson K, 2013, AM J HUM GENET, V92, P5, DOI 10.1016/j.ajhg.2012.10.020; Staats M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028448; Talmud PJ, 2005, J BIOL CHEM, V280, P28215, DOI 10.1074/jbc.M502144200; Tan AH, 2012, HUM MOL GENET, V21, P1658, DOI 10.1093/hmg/ddr587; Vaessen SFC, 2006, J LIPID RES, V47, P2064, DOI 10.1194/jlr.M600233-JLR200; van der Vliet HN, 2002, BIOCHEM BIOPH RES CO, V295, P1156, DOI 10.1016/S0006-291X(02)00808-2; Wang J, 2008, NAT CLIN PRACT CARD, V5, P730, DOI 10.1038/ncpcardio1326; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Wynendaele J, 2010, CANCER RES, V70, P9641, DOI 10.1158/0008-5472.CAN-10-0527	43	47	49	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 2	2014	94	1					129	134		10.1016/j.ajhg.2013.12.001	http://dx.doi.org/10.1016/j.ajhg.2013.12.001			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	292FU	24387992	Green Published, Bronze			2022-12-18	WOS:000329888400014
J	He, ZX; O'Roak, BJ; Smith, JD; Wang, G; Hooker, S; Santos-Cortez, RLP; Li, B; Kan, MY; Krumm, N; Nickerson, DA; Shendure, J; Eichler, EE; Leal, SM				He, Zongxiao; O'Roak, Brian J.; Smith, Joshua D.; Wang, Gao; Hooker, Stanley; Santos-Cortez, Regie Lyn P.; Li, Biao; Kan, Mengyuan; Krumm, Nik; Nickerson, Deborah A.; Shendure, Jay; Eichler, Evan E.; Leal, Suzanne M.			Rare-Variant Extensions of the Transmission Disequilibrium Test: Application to Autism Exome Sequence Data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WHOLE-GENOME ASSOCIATION; HAPLOTYPE RELATIVE RISK; FAMILY-BASED DESIGNS; DE-NOVO MUTATIONS; LINKAGE DISEQUILIBRIUM; MISSING-DATA; UNRELATED INDIVIDUALS; GENETIC ASSOCIATION; SPECTRUM DISORDERS; ALZHEIMERS-DISEASE	Many population-based rare-variant (RV) association tests, which aggregate variants across a region, have been developed to analyze sequence data. A drawback of analyzing population-based data is that it is difficult to adequately control for population substructure and admixture, and spurious associations can occur. For RVs, this problem can be substantial, because the spectrum of rare variation can differ greatly between populations. A solution is to analyze parent-child trio data, by using the transmission disequilibrium test (TDT), which is robust to population substructure and admixture. We extended the TDT to test for RV associations using four commonly used methods. We demonstrate that for all RV-TDT methods, using proper analysis strategies, type I error is well-controlled even when there are high levels of population substructure or admixture. For trio data, unlike for population-based data, RV allele-counting association methods will lead to inflated type I errors. However type I errors can be properly controlled by obtaining p values empirically through haplotype permutation. The power of the RV-TDT methods was evaluated and compared to the analysis of case-control data with a number of genetic and disease models. The RV-TDT was also used to analyze exome data from 199 Simons Simplex Collection autism trios and an association was observed with variants in ABCA7. Given the problem of adequately controlling for population substructure and admixture in RV association studies and the growing number of sequence-based trio studies, the RV-TDT is extremely beneficial to elucidate the involvement of RVs in the etiology of complex traits.	[He, Zongxiao; Wang, Gao; Hooker, Stanley; Santos-Cortez, Regie Lyn P.; Li, Biao; Kan, Mengyuan; Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Ctr Stat Genet, Houston, TX 77030 USA; [O'Roak, Brian J.; Smith, Joshua D.; Krumm, Nik; Nickerson, Deborah A.; Shendure, Jay; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA	Baylor College of Medicine; University of Washington; University of Washington Seattle	Leal, SM (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Ctr Stat Genet, Houston, TX 77030 USA.	sleal@bcm.edu	Shendure, Jay/AAU-3684-2021	Shendure, Jay/0000-0002-1516-1865; O'Roak, Brian/0000-0002-4141-0095	Simons Foundation Autism Research Initiative [SFARI 137578, 191889]; National Institutes of Health [HD065285, HL102926, MD005964, HG006493]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD065285] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [RC4MD005964] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266, T32GM008307] Funding Source: NIH RePORTER	Simons Foundation Autism Research Initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to all of the families at the participating Simons Simplex Collection (SSC) sites, as well as the principal investigators (A. Beaudet, R. Bernier, J. Constantino, E. Cook, E. Fombonne, D. Geschwind, E. Hanson, D. Grice, A. Klin, R. Kochel, D. Ledbetter, C. Lord, C. Martin, D. Martin, R. Maxim, J. Miles, O. Ousley, K. Pelphrey, B. Peterson, J. Piggot, C. Saulnier, M. State, W. Stone, J. Sutcliffe, C. Walsh, Z. Warren, and E. Wijsman). We appreciate obtaining access to phenotypic data on SEAM Base. This work was supported by the Simons Foundation Autism Research Initiative (SFARI 137578 and 191889 to E.E.E. and J.S.). E.E.E. is an Investigator of the Howard Hughes Medical Institute. This study was also funded by the National Institutes of Health grants HD065285, HL102926, MD005964, and HG006493.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Auer PL, 2013, GENET EPIDEMIOL, V37, P529, DOI 10.1002/gepi.21736; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Bhatia G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000954; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Buchovecky CM, 2013, NAT GENET, V45, P1013, DOI 10.1038/ng.2714; Buxbaum JD, 2004, MOL PSYCHIATR, V9, P144, DOI 10.1038/sj.mp.4001465; Chen W, 2013, GENOME RES, V23, P142, DOI 10.1101/gr.142455.112; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Hernandez RD, 2008, BIOINFORMATICS, V24, P2786, DOI 10.1093/bioinformatics/btn522; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Ionita-Laza I, 2013, EUR J HUM GENET, V21, P1158, DOI 10.1038/ejhg.2012.308; Karch CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050976; Kazeem GR, 2005, ANN HUM GENET, V69, P329, DOI 10.1046/j.1529-8817.2005.00156.x; Kilpinen H, 2009, HUM MOL GENET, V18, P2912, DOI 10.1093/hmg/ddp229; Kim WS, 2013, J NEUROSCI, V33, P4387, DOI 10.1523/JNEUROSCI.4165-12.2013; Kryukov GV, 2009, P NATL ACAD SCI USA, V106, P3871, DOI 10.1073/pnas.0812824106; Ladouceur M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002496; Laird NM, 2006, NAT REV GENET, V7, P385, DOI 10.1038/nrg1839; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li BS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002944; Lin DY, 2011, AM J HUM GENET, V89, P354, DOI [10.1016/j.ajhg.2011.07.015, 10.1016/j.ajhg.2011.07.015.]; Liu DJJ, 2012, HUM HERED, V73, P105, DOI 10.1159/000336293; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Liu JH, 2013, AM J EPIDEMIOL, V177, P351, DOI 10.1093/aje/kws234; Liu JJ, 2001, AM J HUM GENET, V69, P327, DOI 10.1086/321980; Madsen B.E., 2009, PLOS GENET, V5; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; Mellon SH, 2002, TRENDS ENDOCRIN MET, V13, P35, DOI 10.1016/S1043-2760(01)00503-3; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; OTT J, 1989, GENET EPIDEMIOL, V6, P127, DOI 10.1002/gepi.1370060124; Ott J, 2011, NAT REV GENET, V12, P465, DOI 10.1038/nrg2989; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ray B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020405; Reitz C, 2013, JAMA-J AM MED ASSOC, V309, P1483, DOI 10.1001/jama.2013.2973; RISCH N, 1990, AM J HUM GENET, V46, P222; Shackleton C, 2002, J STEROID BIOCHEM, V82, P225, DOI 10.1016/S0960-0760(02)00155-3; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; State MW, 2011, NAT NEUROSCI, V14, P1499, DOI 10.1038/nn.2924; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Tamiji J, 2010, NEUROSIGNALS, V18, P98, DOI 10.1159/000323189; Tanaka N, 2011, J ATHEROSCLER THROMB, V18, P274, DOI 10.5551/jat.6726; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wegiel J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035414; Zook JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041356	59	47	48	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 2	2014	94	1					33	46		10.1016/j.ajhg.2013.11.021	http://dx.doi.org/10.1016/j.ajhg.2013.11.021			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	292FU	24360806	Green Published, Bronze			2022-12-18	WOS:000329888400004
J	Mueller, M; Barros, P; Witherden, AS; Roberts, AL; Zhang, Z; Schaschl, H; Yu, CY; Hurles, ME; Schaffner, C; Floto, RA; Game, L; Steinberg, KM; Wilson, RK; Graves, TA; Eichler, EE; Cook, HT; Vyse, TJ; Aitman, TJ				Mueller, Michael; Barros, Paula; Witherden, Abigail S.; Roberts, Amy L.; Zhang, Zhou; Schaschl, Helmut; Yu, Chack-Yung; Hurles, Matthew E.; Schaffner, Catherine; Floto, R. Andres; Game, Laurence; Steinberg, Karyn Meltz; Wilson, Richard K.; Graves, Tina A.; Eichler, Evan E.; Cook, H. Terence; Vyse, Timothy J.; Aitman, Timothy J.			Genomic Pathology of SLE-Associated Copy-Number Variation at the FCGR2C/FCGR3B/FCGR2B Locus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; NATURAL-KILLER-CELLS; FC-GAMMA-RIIB; NK CELLS; READ ALIGNMENT; RECEPTOR; POLYMORPHISM; FCGR3B; EXPRESSION; DISEASE	Reduced FCGR3B copy number is associated with increased risk of systemic lupus erythematosus (SLE). The five FCGR2/FCGR3 genes are arranged across two highly paralogous genomic segments on chromosome 1q23. Previous studies have suggested mechanisms for structural rearrangements at the FCGR2/FCGR3 locus and have proposed mechanisms whereby altered FCGR3B copy number predisposes to autoimmunity, but the high degree of sequence similarity between paralogous segments has prevented precise definition of the molecular events and their functional consequences. To pursue the genomic pathology associated with FCGR3B copy-number variation, we integrated sequencing data from fosmid and bacterial artificial chromosome clones and sequence-captured DNA from FCGR3B-deleted genomes to establish a detailed map of allelic and paralogous sequence variation across the FCGR2/FCGR3 locus. This analysis identified two highly paralogous 24.5 kb blocks within the FCGR2C/FCGR3B/FCGR2B locus that are devoid of nonpolymorphic paralogous sequence variations and that define the limits of the genomic regions in which nonallelic homologous recombination leads to FCGR2C/FCGR3B copy-number variation. Further, the data showed evidence of swapping of haplotype blocks between these highly paralogous blocks that most likely arose from sequential ancestral recombination events across the region. Functionally, we found by flow cytometry, immunoblotting and cDNA sequencing that individuals with FCGR3B-deleted alleles show ectopic presence of Fc gamma RIlb on natural killer (NK) cells. We conclude that FCGR3B deletion juxtaposes the 5'-regulatory sequences of FCGR2C with the coding sequence of FCGR2B, creating a chimeric gene that results in an ectopic accumulation of Fc gamma RIlb on NK cells and provides an explanation for SLE risk associated with reduced FCGR3B gene copy number.	[Mueller, Michael; Zhang, Zhou; Aitman, Timothy J.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Ctr Clin Sci, Physiol Genom & Med Grp,MRC, London W12 0NN, England; [Barros, Paula; Witherden, Abigail S.; Roberts, Amy L.; Schaschl, Helmut; Vyse, Timothy J.] Kings Coll London, Dept Med & Mol Genet, Guys Hosp, London SE1 9RT, England; [Yu, Chack-Yung] Nationwide Childrens Hosp, Ctr Mol & Human Genet, Columbus, OH 43205 USA; [Yu, Chack-Yung] Ohio State Univ, Dept Pediat, Columbus, OH 43205 USA; [Hurles, Matthew E.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Schaffner, Catherine; Floto, R. Andres] Univ Cambridge, Cambridge Inst Med Res, Dept Med, Cambridge CB2 0XY, England; [Game, Laurence] MRC, Ctr Clin Sci, Genom Core Lab, London W12 0NN, England; [Steinberg, Karyn Meltz; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Steinberg, Karyn Meltz; Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA 98195 USA; [Wilson, Richard K.; Graves, Tina A.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63110 USA; [Cook, H. Terence] Univ London Imperial Coll Sci Technol & Med, Dept Med, Ctr Complement & Inflammat Res, London W12 0NN, England	Imperial College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Wellcome Trust Sanger Institute; University of Cambridge; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; Washington University (WUSTL); Imperial College London	Vyse, TJ (corresponding author), Kings Coll London, Dept Med & Mol Genet, Guys Hosp, London SE1 9RT, England.	timothy.vyse@kcl.ac.uk	Wilson, Richard K./AAF-4139-2019; Yu, Chack-Yung/E-4360-2011	Wilson, Richard K./0000-0002-1992-1358; Aitman, Timothy/0000-0002-7875-4502; Meltz Steinberg, Karyn/0000-0002-8676-3337; Roberts, Amy/0000-0002-5704-9249; Yu, Chack-Yung/0000-0002-5218-7503; Schaschl, Helmut/0000-0003-2826-8773	Wellcome Trust; MRC; Imperial NIHR-funded Biomedical Research Centre; Medical Research Council [MC_U120061454] Funding Source: researchfish; MRC [MC_U120061454] Funding Source: UKRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG004120] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Imperial NIHR-funded Biomedical Research Centre; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We acknowledge support from the Wellcome Trust to H.T.C., T.J.V. and T.J.A., from the MRC to T.J.A., and from the Imperial NIHR-funded Biomedical Research Centre to T.J.A. and T.J.V.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Antonacci F, 2010, NAT GENET, V42, P745, DOI 10.1038/ng.643; Blanco P, 2000, J MED GENET, V37, P752, DOI 10.1136/jmg.37.10.752; Breunis WB, 2009, HUM MUTAT, V30, pE640, DOI 10.1002/humu.20997; CASSEL DL, 1993, MOL IMMUNOL, V30, P451, DOI 10.1016/0161-5890(93)90113-P; Conigliaro P, 2011, AUTOIMMUN REV, V10, P577, DOI 10.1016/j.autrev.2011.04.017; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; Deng Y, 2010, NAT REV RHEUMATOL, V6, P683, DOI 10.1038/nrrheum.2010.176; Dutertre CA, 2008, J LEUKOCYTE BIOL, V84, P1511, DOI 10.1189/jlb.0608343; Fanciulli M, 2008, CYTOGENET GENOME RES, V123, P161, DOI 10.1159/000184704; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Floto RA, 2005, NAT MED, V11, P1056, DOI 10.1038/nm1288; Fossati G, 2002, ARTHRITIS RHEUM, V46, P1351, DOI 10.1002/art.10230; Green MRJ, 2005, CLIN EXP IMMUNOL, V141, P165, DOI 10.1111/j.1365-2249.2005.02822.x; Hagberg N, 2011, J IMMUNOL, V186, P5085, DOI 10.4049/jimmunol.1003349; HENDRICH C, 1991, ARTHRITIS RHEUM-US, V34, P423, DOI 10.1002/art.1780340407; Hindorff L, 2012, CATALOG PUBLISHED GE; Hollox EJ, 2009, HUM MUTAT, V30, P477, DOI 10.1002/humu.20911; JOHNSON AE, 1995, ARTHRITIS RHEUM, V38, P551, DOI 10.1002/art.1780380415; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kidd JM, 2008, GENOME RES, V18, P2016, DOI 10.1101/gr.081786.108; Kondadasula SV, 2008, BLOOD, V111, P4173, DOI 10.1182/blood-2007-01-068908; Kono H, 2005, HUM MOL GENET, V14, P2881, DOI 10.1093/hmg/ddi320; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin QS, 2006, J IMMUNOL, V177, P1646, DOI 10.4049/jimmunol.177.3.1646; Machado LR, 2012, AM J HUM GENET, V90, P973, DOI 10.1016/j.ajhg.2012.04.018; McKinney C, 2010, ANN RHEUM DIS, V69, P1711, DOI 10.1136/ard.2009.123588; Metes D, 1998, BLOOD, V91, P2369, DOI 10.1182/blood.V91.7.2369.2369_2369_2380; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Morris DL, 2010, EUR J HUM GENET, V18, P1027, DOI 10.1038/ejhg.2010.56; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; NAGARAJAN S, 1995, J BIOL CHEM, V270, P25762, DOI 10.1074/jbc.270.43.25762; Niederer HA, 2010, HUM MOL GENET, V19, P3282, DOI 10.1093/hmg/ddq216; Park YW, 2009, ARTHRITIS RHEUM-US, V60, P1753, DOI 10.1002/art.24556; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Robinson JI, 2012, HUM MUTAT, V33, P741, DOI 10.1002/humu.22031; Su K, 2002, GENES IMMUN, V3, pS51, DOI 10.1038/sj.gene.6363879; Su KH, 2007, J IMMUNOL, V178, P3272, DOI 10.4049/jimmunol.178.5.3272; TSOKOS GC, 1982, CLIN EXP IMMUNOL, V50, P239; Tsuboi N, 2008, IMMUNITY, V28, P833, DOI 10.1016/j.immuni.2008.04.013; van der Heijden J, 2012, J IMMUNOL, V188, P1318, DOI 10.4049/jimmunol.1003945; Veri MC, 2007, IMMUNOLOGY, V121, P392, DOI 10.1111/j.1365-2567.2007.02588.x; WARMERDAM PAM, 1993, J BIOL CHEM, V268, P7346; Willcocks LC, 2008, J EXP MED, V205, P1573, DOI 10.1084/jem.20072413; Willcocks LC, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001161; Wu JM, 1997, J CLIN INVEST, V100, P1059, DOI 10.1172/JCI119616; Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80	49	47	48	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 10	2013	92	1					28	40		10.1016/j.ajhg.2012.11.013	http://dx.doi.org/10.1016/j.ajhg.2012.11.013			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	073RA	23261299	Green Published, Bronze			2022-12-18	WOS:000313759000003
J	McGrath, JA; Stone, KL; Begum, R; Simpson, MA; Dopping-Hepenstal, PJ; Liu, L; McMillan, JR; South, AP; Pourreyron, C; McLean, WHI; Martinez, AE; Mellerio, JE; Parsons, M				McGrath, John A.; Stone, Kristina L.; Begum, Rumena; Simpson, Michael A.; Dopping-Hepenstal, Patricia J.; Liu, Lu; McMillan, James R.; South, Andrew P.; Pourreyron, Celine; McLean, W. H. Irwin; Martinez, Anna E.; Mellerio, Jemima E.; Parsons, Maddy			Germline Mutation in EXPH5 Implicates the Rab27B Effector Protein Slac2-b in Inherited Skin Fragility	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GRISCELLI-SYNDROME; EXOSOMES; MELANOPHILIN; TRAFFICKING; ASSOCIATION; MEMBRANE; GRANULES; GTPASES; CELLS; MYO5A	The Rab GTPase Rab27B and one of its effector proteins, Slac2-b (also known as EXPH5, exophilin-5), have putative roles in intracellular vesicle trafficking but their relevance to human disease is not known. By using whole-exome sequencing, we identified a homozygous frameshift mutation in EXPH5 in three siblings with inherited skin fragility born to consanguineous Iraqi parents. All three individuals harbor the mutation c.5786delC (p.Pro1929Leufs*8) in EXPH5, which truncates the 1,989 amino acid Slac2-b protein by 52 residues. The clinical features comprised generalized scale-crusts and occasional blisters, mostly induced by trauma, as well as mild diffuse pigmentary mottling on the trunk and proximal limbs. There was no increased bleeding tendency, no neurologic abnormalities, and no increased incidence of infection. Analysis of an affected person's skin showed loss of Slac2-b immunostaining (C-terminal antibody), disruption of keratinocyte adhesion within the lower epidermis, and an increased number of perinuclear vesicles. A role for Slac2-b in keratinocyte biology was supported by findings of cytoskeletal disruption (mainly keratin intermediate filaments) and decreased keratinocyte adhesion in both keratinocytes from an affected subject and after shRNA knockdown of Slac2-b in normal keratinocytes. Slac2-b was also shown to colocalize with Rab27B and beta 4 integrin to early adhesion initiation sites in spreading normal keratinocytes. Collectively, our findings identify an unexpected role for Slac2-b in inherited skin fragility and expand the clinical spectrum of human disorders of GTPase effector proteins.	[McGrath, John A.; Stone, Kristina L.; Begum, Rumena; Mellerio, Jemima E.] Kings Coll London, St Johns Inst Dermatol, London SE1 9RT, England; [Stone, Kristina L.; Simpson, Michael A.] Kings Coll London, Dept Med & Mol Genet, London SE1 9RT, England; [Begum, Rumena; Parsons, Maddy] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 9RT, England; [Dopping-Hepenstal, Patricia J.; Liu, Lu; McMillan, James R.] St Thomas Hosp, GSTS Pathol, London SE1 7EH, England; [South, Andrew P.; Pourreyron, Celine] Univ Dundee, Div Canc Res, Coll Life Sci & Med, Dundee DD1 5EH, Scotland; [South, Andrew P.; Pourreyron, Celine] Univ Dundee, Div Canc Res, Coll Dent, Dundee DD1 5EH, Scotland; [South, Andrew P.; Pourreyron, Celine] Univ Dundee, Div Canc Res, Coll Nursing, Dundee DD1 5EH, Scotland; [Martinez, Anna E.; Mellerio, Jemima E.] Great Ormond St Hosp Sick Children, Dept Paediat Dermatol, London WC1N 3JH, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of Dundee; University of Dundee; University of Dundee; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	McGrath, JA (corresponding author), Kings Coll London, St Johns Inst Dermatol, Guys Campus, London SE1 9RT, England.	john.mcgrath@kcl.ac.uk	Simpson, Michael/F-4737-2011; Mellerio, Jemima/G-3681-2012; McGrath, John/N-3529-2019; Stone, Kristina/A-4700-2013; McMillan, James R/C-6657-2009; Parsons, Maddy/B-2203-2013; Pourreyron, Celine/AAE-7362-2020; McGrath, John/D-6824-2012	Simpson, Michael/0000-0002-8539-8753; Mellerio, Jemima/0000-0002-2670-8117; Parsons, Maddy/0000-0002-2021-8379; McGrath, John/0000-0002-3708-9964; McLean, William Henry Irwin/0000-0001-5539-5757	UK National Institute for Health Research (NIHR) Biomedical Research Centre; Dystrophic Epidermolysis Bullosa Research Association (DebRA UK); Dystrophic Epidermolysis Bullosa Research Association (DebRA Austria); Royal Society; MRC [G0802780] Funding Source: UKRI; Medical Research Council [G0802780] Funding Source: researchfish	UK National Institute for Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR)); Dystrophic Epidermolysis Bullosa Research Association (DebRA UK); Dystrophic Epidermolysis Bullosa Research Association (DebRA Austria); Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by the UK National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. We acknowledge financial support from the Dystrophic Epidermolysis Bullosa Research Association (DebRA UK and Austria) and the Royal Society. We also thank Jananan Pathmanathan and Panos Karagiannis for helpful discussions on protein structure and modeling.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Anikster Y, 2002, AM J HUM GENET, V71, P407, DOI 10.1086/341606; Chaput N, 2011, SEMIN IMMUNOPATHOL, V33, P419, DOI 10.1007/s00281-010-0233-9; Chavez-Munoz C, 2009, J CELL PHYSIOL, V221, P221, DOI 10.1002/jcp.21847; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Fine JD, 2008, J AM ACAD DERMATOL, V58, P931, DOI 10.1016/j.jaad.2008.02.004; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukuda M, 2005, J BIOCHEM, V137, P9, DOI 10.1093/jb/mvi002; Gomi H, 2007, MOL BIOL CELL, V18, P4377, DOI 10.1091/mbc.E07-05-0409; Iero M, 2008, CELL DEATH DIFFER, V15, P80, DOI 10.1038/sj.cdd.4402237; Lakkaraju A, 2008, TRENDS CELL BIOL, V18, P199, DOI 10.1016/j.tcb.2008.03.002; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Menasche G, 2003, J CLIN INVEST, V112, P450, DOI 10.1172/JCI200318264; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Pastural E, 1997, NAT GENET, V16, P289, DOI 10.1038/ng0797-289; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Simpson MA, 2011, NAT GENET, V43, P303, DOI 10.1038/ng.779; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Styers ML, 2004, MOL BIOL CELL, V15, P5369, DOI 10.1091/mbc.E04-03-0272; Toivola DM, 2005, TRENDS CELL BIOL, V15, P608, DOI 10.1016/j.tcb.2005.09.004; Tolmachova T, 2007, P NATL ACAD SCI USA, V104, P5872, DOI 10.1073/pnas.0609879104; Van Gele M, 2009, PIGM CELL MELANOMA R, V22, P268, DOI 10.1111/j.1755-148X.2009.00558.x; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wiley RD, 2006, P NATL ACAD SCI USA, V103, P738, DOI 10.1073/pnas.0507995103; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Wu XS, 2005, J CELL BIOL, V171, P201, DOI 10.1083/jcb.200503028	28	47	50	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 7	2012	91	6					1115	1121		10.1016/j.ajhg.2012.10.012	http://dx.doi.org/10.1016/j.ajhg.2012.10.012			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	055LI	23176819	Bronze, Green Published			2022-12-18	WOS:000312417400016
J	Twigg, SRF; Lloyd, D; Jenkins, D; Elcioglu, NE; Cooper, CDO; Al-Sannaa, N; Annagur, A; Gillessen-Kaesbach, G; Huning, I; Knight, SJL; Goodship, JA; Keavney, BD; Beales, PL; Gileadi, O; McGowan, SJ; Wilkie, AOM				Twigg, Stephen R. F.; Lloyd, Deborah; Jenkins, Dagan; Elcioglu, Nurse E.; Cooper, Christopher D. O.; Al-Sannaa, Nouriya; Annagur, Ali; Gillessen-Kaesbach, Gabriele; Huening, Irina; Knight, Samantha J. L.; Goodship, Judith A.; Keavney, Bernard D.; Beales, Philip L.; Gileadi, Opher; McGowan, Simon J.; Wilkie, Andrew O. M.			Mutations in Multidomain Protein MEGF8 Identify a Carpenter Syndrome Subtype Associated with Defective Lateralization	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EPIDERMAL-GROWTH-FACTOR; CRYSTAL-STRUCTURE; KELCH DOMAIN; OPEN BRAIN; RAB23; MOUSE; SYNOSTOSIS; SPECTRUM; GTPASES; GLI3	Carpenter syndrome is an autosomal-recessive multiple-congenital-malformation disorder characterized by multisuture craniosynostosis and polysyndactyly of the hands and feet; many other clinical features occur, and the most frequent include obesity, umbilical hernia, cryptorchidism, and congenital heart disease. Mutations of RAB23, encoding a small GTPase that regulates vesicular transport, are present in the majority of cases. Here, we describe a disorder caused by mutations in multiple epidermal-growth-factor-like-domains 8 (MEGF8), which exhibits substantial clinical overlap with Carpenter syndrome but is frequently associated with abnormal left-right patterning. We describe five affected individuals with similar dysmorphic facies, and three of them had either complete situs inversus, dextrocardia, or transposition of the great arteries; similar cardiac abnormalities were previously identified in a mouse mutant for the orthologous Megf8. The mutant alleles comprise one nonsense, three missense, and two splice-site mutations; we demonstrate in zebrafish that, in contrast to the wild-type protein, the proteins containing all three missense alterations provide only weak rescue of an early gastrulation phenotype induced by Megf8 knockdown. We conclude that mutations in MEGF8 cause a Carpenter syndrome subtype frequently associated with defective left-right patterning, probably through perturbation of signaling by hedgehog and nodal family members. We did not observe any subject with biallelic loss-of function mutations, suggesting that some residual MEGF8 function might be necessary for survival and might influence the phenotypes observed.	[Twigg, Stephen R. F.; Lloyd, Deborah; Wilkie, Andrew O. M.] Univ Oxford, Weatherall Inst Mol Med, Clin Genet Grp, Oxford OX3 9DS, England; [Jenkins, Dagan; Beales, Philip L.] UCL, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; [Elcioglu, Nurse E.] Marmara Univ, Fac Med, Dept Pediat Genet, TR-34660 Istanbul, Turkey; [Cooper, Christopher D. O.; Gileadi, Opher] Struct Genom Consortium, Oxford OX3 7DQ, England; [Al-Sannaa, Nouriya] Saudi Aramco Med Serv Org, Dhahran Hlth Ctr, Pediat Serv Div, Dhahran 31311, Saudi Arabia; [Annagur, Ali] Selcuk Univ, Fac Med, Div Neonatol, TR-42075 Konya, Turkey; [Gillessen-Kaesbach, Gabriele; Huening, Irina] Med Univ Lubeck, Inst Humangenet, D-23538 Lubeck, Germany; [Knight, Samantha J. L.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Knight, Samantha J. L.] Natl Inst Hlth Res, Biomed Res Ctr, Oxford, England; [Goodship, Judith A.; Keavney, Bernard D.] Univ Newcastle, Int Ctr Life, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [McGowan, Simon J.] Univ Oxford, Weatherall Inst Mol Med, Computat Biol Res Grp, Oxford OX3 9DS, England	University of Oxford; University of London; University College London; Marmara University; University of Oxford; Selcuk University; University of Lubeck; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Newcastle University - UK; University of Oxford	Wilkie, AOM (corresponding author), Univ Oxford, Weatherall Inst Mol Med, Clin Genet Grp, Oxford OX3 9DS, England.	andrew.wilkie@imm.ox.ac.uk	Wilkie, Andrew/AAC-3820-2020; Twigg, Stephen/AAU-1135-2021; Gileadi, Opher/F-1105-2013; Cooper, Chris/G-9982-2014; Beales, Philip L/C-7367-2009; Cooper, Christopher/E-8392-2013	Wilkie, Andrew/0000-0002-2972-5481; Twigg, Stephen/0000-0001-5024-049X; Gileadi, Opher/0000-0001-6886-898X; Cooper, Chris/0000-0002-9197-8041; McGowan, Simon/0000-0001-9720-1914; Keavney, Bernard/0000-0001-9573-0812; Knight, Samantha/0000-0002-6047-3462	National Institute for Health Research (NIHR) Biomedical Research Centre, Oxford; Department of Health's NIHR Biomedical Research Centre's funding scheme; European Union [241955-2-SYSCILIA]; Wellcome Trust [090532/Z/09/Z, 093329]; Newlife Foundation for Disabled Children [10-11/04]; British Heart Foundation [RG/08/012/25941, FS/10/008/28146] Funding Source: researchfish; Medical Research Council [G0601260] Funding Source: researchfish; MRC [G0601260] Funding Source: UKRI	National Institute for Health Research (NIHR) Biomedical Research Centre, Oxford(National Institute for Health Research (NIHR)); Department of Health's NIHR Biomedical Research Centre's funding scheme(National Institute for Health Research (NIHR)); European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Newlife Foundation for Disabled Children; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are very grateful to the families for their participation in this study. We thank John O'Sullivan and Anna Topf for help with sample recruitment; Tracy Lester for coordinating diagnostic genetic analysis; Lorna Gregory and the staff at the High-Throughput Genomics facility at the Wellcome Trust Centre for Human Genetics (Oxford) for exome sequencing; Sue Butler, John Frank land, and Tim Rostron for help with cell culture and DNA sequencing; and Ekim Taskiran and Nurten Akarsu (Hacettepe University Medical Faculty, Department of Medical Genetics, Ankara, Turkey) for analysis of Turkish control samples. This work was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre, Oxford and received funding from the Department of Health's NIHR Biomedical Research Centre's funding scheme (to S.J.L.K. and A.O.M.W.), the European Union (FP7-HEALTH grant 241955-2-SYSCILIA to P.L.B.), the Wellcome Trust (University College London School of Life and Medical Sciences funding to D.J., Senior Research Fellowship in Clinical Science to P.L.B., Core Award 090532/Z/09/Z to S.J.L.K., and Project Grant 093329 to A.O.M.W and S.R.F.T.), and the Newlife Foundation for Disabled Children (10-11/04 to A.O.M.W. and S.R.F.T.). The views expressed in this publication are those of the authors and are not necessarily those of the Department of Health.	Alessandri JL, 2010, AM J MED GENET A, V152A, P982, DOI 10.1002/ajmg.a.33327; Altunhan H, 2011, TURK KLIN TIP BILIM, V31, P464, DOI 10.5336/medsci.2010-19822; Aune CN, 2008, PEDIATR RES, V63, P9, DOI 10.1203/PDR.0b013e31815b6926; Beamer LJ, 2005, ACTA CRYSTALLOGR D, V61, P1335, DOI [10.1107/S0907444905022626, 10.1107/S090744905022626]; Boehlke C, 2010, J CELL SCI, V123, P1460, DOI 10.1242/jcs.058883; Carpenter G, 1909, Proc R Soc Med, V2, P45; Carpenter G., 1901, REP SOC STUDY DIS CH, V1, P110; Chi SM, 2012, CELL SIGNAL, V24, P1222, DOI 10.1016/j.cellsig.2012.02.004; COHEN DM, 1987, AM J MED GENET, V28, P311, DOI 10.1002/ajmg.1320280208; Eggenschwiler JT, 2000, DEV BIOL, V227, P648, DOI 10.1006/dbio.2000.9918; Eggenschwiler JT, 2006, DEV BIOL, V290, P1, DOI 10.1016/j.ydbio.2005.09.022; Eggenschwiler JT, 2001, NATURE, V412, P194, DOI 10.1038/35084089; Gileadi Opher, 2008, V426, P221, DOI 10.1007/978-1-60327-058-8_14; Gorlin R.J., 2001, SYNDROMES HEAD NECK, P666; GUNTHER T, 1994, DEVELOPMENT, V120, P3119; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Hildebrandt F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000353; Hurst JA, 2011, EUR J HUM GENET, V19, P757, DOI 10.1038/ejhg.2011.13; Jenkins D, 2007, AM J HUM GENET, V80, P1162, DOI 10.1086/518047; Jenkins D, 2011, HUM MUTAT, V32, pE2069, DOI 10.1002/humu.21457; Klopocki E, 2011, AM J HUM GENET, V88, P70, DOI 10.1016/j.ajhg.2010.11.006; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lenton K, 2011, GENESIS, V49, P784, DOI 10.1002/dvg.20768; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li XC, 2004, J BIOL CHEM, V279, P54750, DOI 10.1074/jbc.M410073200; Lim YS, 2011, BIOL CELL, V103, P209, DOI 10.1042/BC20100150; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Lu HS, 2001, J BIOL CHEM, V276, P34913, DOI 10.1074/jbc.M102874200; Mougou-Zerelli S, 2009, HUM MUTAT, V30, P1574, DOI 10.1002/humu.21116; Nakayama M, 1998, GENOMICS, V51, P27, DOI 10.1006/geno.1998.5341; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Overton JD, 2011, J BIOL CHEM, V286, P18914, DOI 10.1074/jbc.M111.224592; Periz J, 2005, MOL BIOCHEM PARASIT, V143, P192, DOI 10.1016/j.molbiopara.2005.06.003; Rice DPC, 2010, HUM MOL GENET, V19, P3457, DOI 10.1093/hmg/ddq258; Stetefeld J, 1996, J MOL BIOL, V257, P644, DOI 10.1006/jmbi.1996.0191; TEMTAMY SA, 1966, J PEDIATR-US, V69, P111, DOI 10.1016/S0022-3476(66)80368-2; Veistinen L, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00121; Woods CG, 2006, AM J HUM GENET, V78, P889, DOI 10.1086/503875; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047; Zhang Z, 2009, P NATL ACAD SCI USA, V106, P3219, DOI 10.1073/pnas.0813400106	41	47	51	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2012	91	5					897	905		10.1016/j.ajhg.2012.08.027	http://dx.doi.org/10.1016/j.ajhg.2012.08.027			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	036FI	23063620	hybrid, Green Published, Green Accepted, Green Submitted			2022-12-18	WOS:000311011400012
J	Behar, DM; Harmant, C; Manry, J; van Oven, M; Haak, W; Martinez-Cruz, B; Salaberria, J; Oyharcabal, B; Bauduer, F; Comas, D; Quintana-Murci, L				Behar, Doron M.; Harmant, Christine; Manry, Jeremy; van Oven, Mannis; Haak, Wolfgang; Martinez-Cruz, Begona; Salaberria, Jasone; Oyharcabal, Bernard; Bauduer, Frederic; Comas, David; Quintana-Murci, Lluis		Genographic Consortium	The Basque Paradigm: Genetic Evidence of a Maternal Continuity in the Franco-Cantabrian Region since Pre-Neolithic Times	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA; EUROPEAN POPULATION; IBERIAN PENINSULA; MTDNA ANALYSIS; HAPLOGROUP-H; NEAR-EASTERN; DIVERSITY; LINEAGES; EXPANSION; HISTORY	Different lines of evidence point to the resettlement of much of western and central Europe by populations from the Franco-Cantabrian region during the Late Glacial and Postglacial periods. In this context, the study of the genetic diversity of contemporary Basques, a population located at the epicenter of the Franco-Cantabrian region, is particularly useful because they speak a non-Indo-European language that is considered to be a linguistic isolate. In contrast with genome-wide analysis and Y chromosome data, where the problem of poor time estimates remains, a new timescale has been established for the human mtDNA and makes this genome the most informative marker for studying European prehistory. Here, we aim to increase knowledge of the origins of the Basque people and, more generally, of the role of the Franco-Cantabrian refuge in the postglacial repopulation of Europe. We thus characterize the maternal ancestry of 908 Basque and non-Basque individuals from the Basque Country and immediate adjacent regions and, by sequencing 420 complete mtDNA genomes, we focused on haplogroup H. We identified six mtDNA haplogroups, H1j1, H1t1., H2a5a1, H1av1, H3c2a, and H1e1a1, which are autochthonous to the Franco-Cantabrian region and, more specifically, to Basque-speaking populations. We detected signals of the expansion of these haplogroups at similar to 4,000 years before present (YBP) and estimated their separation from the pan-European gene pool at similar to 8,000 YBP, antedating the Indo-European arrival to the region. Our results clearly support the hypothesis of a partial genetic continuity of contemporary Basques with the preceding Paleolithic/Mesolithic settlers of their homeland.	[Behar, Doron M.; Harmant, Christine; Manry, Jeremy; Quintana-Murci, Lluis] Inst Pasteur, Unit Human Evolutionary Genet, Dept Genomes & Genet, F-75015 Paris, France; [Behar, Doron M.] Rambam Hlth Care Campus, Mol Med Lab, IL-31096 Haifa, Israel; [Harmant, Christine; Manry, Jeremy; Quintana-Murci, Lluis] Ctr Natl Rech Sci, URA3012, F-75015 Paris, France; [van Oven, Mannis] Univ Med Ctr, Erasmus MC, Dept Forens Mol Biol, NL-3000 Rotterdam, Netherlands; [Haak, Wolfgang] Univ Adelaide, Australian Ctr Ancient DNA, Adelaide, SA 5005, Australia; [Martinez-Cruz, Begona; Comas, David] Univ Pompeu Fabra, Inst Biol Evolut, Consejo Super Invest Cient, Dept Ciencies Expt & Salut, Barcelona 08003, Spain; [Salaberria, Jasone; Oyharcabal, Bernard] Ctr Rech Langue & Textes Basques, Ctr Natl Rech Sci, Unite Mixte Rech 5478, F-64100 Bayonne, France; [Bauduer, Frederic] Univ Bordeaux, EA 4576, F-33076 Bordeaux, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Rambam Health Care Campus; Centre National de la Recherche Scientifique (CNRS); Erasmus University Rotterdam; Erasmus MC; University of Adelaide; Consejo Superior de Investigaciones Cientificas (CSIC); Pompeu Fabra University; Centre National de la Recherche Scientifique (CNRS); Universite Bordeaux-Montaigne; Universite de Pau et des Pays de l'Adour; UDICE-French Research Universities; Universite de Bordeaux	Quintana-Murci, L (corresponding author), Inst Pasteur, Unit Human Evolutionary Genet, Dept Genomes & Genet, 25-28 Rue Dr Roux, F-75015 Paris, France.	quintana@pasteur.fr	Haak, Wolfgang/C-2362-2014; Cooper, Alan/E-8171-2012; Santos, Fabrício Rodrigues/H-2370-2011; Quintana-Murci, Lluis/AAB-7468-2022; Haak, Wolfgang/Z-4947-2019; Comas, David/D-5382-2014	Haak, Wolfgang/0000-0003-2475-2007; Cooper, Alan/0000-0002-7738-7851; Santos, Fabrício Rodrigues/0000-0001-9088-1750; Haak, Wolfgang/0000-0003-2475-2007; Comas, David/0000-0002-5075-0956; Martinez-Cruz, Begona/0000-0003-1268-6620; Manry, Jeremy/0000-0001-5998-2051; van Oven, Mannis/0000-0003-0026-7998; Quintana-Murci, Lluis/0000-0003-2429-6320	Institut Pasteur; Histoire des populations et variation linguistique dans les Pyrenees de l'Ouest project; Conseil Regional d'Aquitane; Conseil General des Pyrenees-Atlantiques; Centre National de la Recherche Scientifique interdisciplinary; Department of Hematology, Centre Hospitalier de la Cote Basque, in Bayonne; Association Sang [64]; National Geographic; Conseil des Elus du Pays-Basque; des Langues et du Langage	Institut Pasteur(European Commission); Histoire des populations et variation linguistique dans les Pyrenees de l'Ouest project; Conseil Regional d'Aquitane; Conseil General des Pyrenees-Atlantiques(Region Nouvelle-Aquitaine); Centre National de la Recherche Scientifique interdisciplinary; Department of Hematology, Centre Hospitalier de la Cote Basque, in Bayonne; Association Sang; National Geographic(National Geographic Society); Conseil des Elus du Pays-Basque; des Langues et du Langage	We warmly thank all study participants. This work was supported by the Institut Pasteur, National Geographic, and the Histoire des populations et variation linguistique dans les Pyrenees de l'Ouest project, which received funding from the Conseil Regional d'Aquitane, the Conseil General des Pyrenees-Atlantiques, the Conseil des Elus du Pays-Basque, and the Centre National de la Recherche Scientifique interdisciplinary program Origine de l'Homme, des Langues et du Langage. This study also benefited from the support of Department of Hematology, Centre Hospitalier de la Cote Basque, in Bayonne, and Association Sang 64. We are grateful to the many contributors for their valuable help with the recruitment of samples, especially to Estibaliz Montoya, and to David Basterot and Tristan Carrere for technical assistance.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; Adams SM, 2008, AM J HUM GENET, V83, P725, DOI 10.1016/j.ajhg.2008.11.007; Alfonso-Sanchez MA, 2008, AM J HUM BIOL, V20, P154, DOI 10.1002/ajhb.20706; Alonso S, 2005, EUR J HUM GENET, V13, P1293, DOI 10.1038/sj.ejhg.5201482; Alvarez-Iglesias V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005112; Auton A, 2009, GENOME RES, V19, P795, DOI 10.1101/gr.088898.108; Balaresque P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000285; Bauchet M, 2007, AM J HUM GENET, V80, P948, DOI 10.1086/513477; Behar DM, 2007, PLOS GENET, V3, P1083, DOI 10.1371/journal.pgen.0030104; Behar DM, 2010, NATURE, V466, P238, DOI 10.1038/nature09103; BERTRANPETIT J, 1991, ANN HUM GENET, V55, P51, DOI 10.1111/j.1469-1809.1991.tb00398.x; BERTRANPETIT J, 1995, ANN HUM GENET, V59, P63, DOI 10.1111/j.1469-1809.1995.tb01606.x; CALAFELL F, 1994, AM J PHYS ANTHROPOL, V93, P201, DOI 10.1002/ajpa.1330930205; CALAFELL F, 1994, HUM BIOL, V66, P823; Catelli ML, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-77; Cherni L, 2009, AM J PHYS ANTHROPOL, V139, P253, DOI 10.1002/ajpa.20979; Cruciani F, 2011, FORENSIC SCI INT-GEN, V5, pE49, DOI 10.1016/j.fsigen.2010.07.006; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; Gamble C, 2005, CAMB ARCHAEOL J, V15, P193, DOI 10.1017/S0959774305000107; Gamble C, 2004, PHILOS T R SOC B, V359, P243, DOI 10.1098/rstb.2003.1396; Garcia O, 2011, HEREDITY, V106, P37, DOI 10.1038/hdy.2010.47; Gomez-Carballa A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018348; Gonzalez AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-124; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718; Laayouni H, 2010, HUM GENET, V127, P455, DOI 10.1007/s00439-010-0798-3; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Myres NM, 2011, EUR J HUM GENET, V19, P95, DOI 10.1038/ejhg.2010.146; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Ottoni C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013378; Pala M, 2009, AM J HUM GENET, V84, P814, DOI 10.1016/j.ajhg.2009.05.004; Pereira L, 2005, GENOME RES, V15, P19, DOI 10.1101/gr.3182305; Prieto L, 2011, FORENSIC SCI INT-GEN, V5, P146, DOI 10.1016/j.fsigen.2010.10.013; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 1996, AM J HUM GENET, V59, P185; Rodriguez-Ezpeleta N, 2010, HUM GENET, V128, P113, DOI 10.1007/s00439-010-0833-4; Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173; Salas A, 1998, EUR J HUM GENET, V6, P365, DOI 10.1038/sj.ejhg.5200202; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; TORRONI A, 1993, AM J HUM GENET, V53, P563; Zlojutro M, 2006, HUM BIOL, V78, P599, DOI 10.1353/hub.2007.0007; Zuazo K., 2010, EL EUSKERA SUS DIALE	48	47	47	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR 9	2012	90	3					486	493		10.1016/j.ajhg.2012.01.002	http://dx.doi.org/10.1016/j.ajhg.2012.01.002			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911ZI	22365151	Bronze, Green Published			2022-12-18	WOS:000301762800014
J	Boteva, L; Morris, DL; Cortes-Hernandez, J; Martin, J; Vyse, TJ; Fernando, MMA				Boteva, Lora; Morris, David L.; Cortes-Hernandez, Josefina; Martin, Javier; Vyse, Timothy J.; Fernando, Michelle M. A.			Genetically Determined Partial Complement C4 Deficiency States Are Not Independent Risk Factors for SLE in UK and Spanish Populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; GENOME-WIDE ASSOCIATION; MAJOR HISTOCOMPATIBILITY COMPLEX; COMPONENT C4; SUSCEPTIBILITY VARIANTS; COPY-NUMBER; DISEASE; NULL; LOCI; REGION	Systemic lupus erythematosus (SLE) is a chronic, multisystem autoimmune disease. Complete deficiency of complement component C4 confers strong genetic risk for SLE. Partial C4 deficiency states have also shown association with SLE, but despite much effort over the last 30 years, it has not been established whether this association is primarily causal or secondary to long-range linkage disequilibrium. The complement C4 locus, located in the major histocompatibility complex (MHC) class III region, exhibits copy-number variation (CNV) and C4 itself exists as two paralogs, C4A and C4B. In order to determine whether partial C4 deficiency is an independent genetic risk factor for SLE, we investigated C4 CNV in the context of HLA-DRB1 and MFIC region SNP polymorphism in the largest and most comprehensive complement C4 study to date. Specifically, we genotyped 2,207 subjects of northern and southern European ancestry (1,028 SLE cases and 1,179 controls) for total C4, C4A, and C4B gene copy numbers, and the loss-of-function C4 exon 29 CT indel. We used multiple logistic regression to determine the independence of C4 CNV from known SNP and HLA-DRB1 associations. We clearly demonstrate that genetically determined partial C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations. These results are further corroborated by the lack of association shown by the C4A exon 29 CT insertion in either cohort. Thus, although complete homozygous deficiency of complement C4 is one of the strongest genetic risk factors for SLE, partial C4 deficiency states do not independently predispose to the disease.	[Boteva, Lora; Morris, David L.; Vyse, Timothy J.; Fernando, Michelle M. A.] Kings Coll London, Div Genet & Mol Med, Guys Hosp, London SE1 9RT, England; [Boteva, Lora; Morris, David L.; Vyse, Timothy J.; Fernando, Michelle M. A.] Kings Coll London, Div Immunol Infect & Inflammatory Dis, Guys Hosp, London SE1 9RT, England; [Cortes-Hernandez, Josefina] Univ Autonoma Barcelona, Autoimmune Dis Res Unit, Vall dHebron Univ Hosp, Res Inst, Barcelona 08035, Spain; [Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada 18100, Spain	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN)	Fernando, MMA (corresponding author), Kings Coll London, Div Genet & Mol Med, Guys Hosp, London SE1 9RT, England.	michelle.fernando@kcl.ac.uk	Martin, Javier/B-8141-2008; Martín, Javier/AAV-5209-2021; Fernando, Michelle/F-5554-2012; Martín, María/HDL-9512-2022	Martin, Javier/0000-0002-2202-0622; Morris, David/0000-0002-1754-8932	Arthritis Research UK [18239]; National Institutes of Allergy and Infectious Diseases [A1067152]; Medical Research Council [G0000934]; Wellcome Trust [068545/Z/02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067152] Funding Source: NIH RePORTER; MRC [G0000934] Funding Source: UKRI	Arthritis Research UK(Versus Arthritis); National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	M.M.A.F. and L.B. were funded through an Arthritis Research UK grant (18239). The International MHC and Autoimmunity Genetics Network (IMAGEN) participated in this research (John D. Rioux, Philippe Goyette, Timothy J. Vyse, Lennart Hammarstrom, Michelle M.A. Fernando, Todd Green, Philip L. De Jager, Sylvain Foisy, Joanne Wang, Paul I.W. de Bakker, Stephen Leslie, Gilean McVean, Leonid Padyukov, Lars Alfredsson, Vito Annese, David A. Hafler, Qiang Pan-Hammarstrom, Ritva Matell, Stephen J. Sawcer, Alastair D. Compston, Bruce A.C. Cree, Daniel B. Mirel, Mark J. Daly, Tim W. Behrens, Lars Klareskog, Peter K. Gregersen, Jorge R. Oksenberg, and Stephen L. Hauser) and was supported by grant A1067152 from the National Institutes of Allergy and Infectious Diseases. The clinicians who provided Spanish samples were Norberto Ortego Centeno, Department of Internal Medicine, Hospital San Cecilio, Granada; Juan Jimenez Alonso, Department of Internal Medicine, Hospital Virgen de las Nieves, Granada; Enrique de Ramon Garrido and Maria Teresa Camps Garcia, Department of Internal Medicine, Hospital Carlos Haya, Malaga; Julio Sanchez Roman, Department of Internal Medicine, Hospital Virgen del Rocio, Seville, Spain. Spanish HLA typing was done by Maria Francisca Gonzalez-Escribano, Department of Immunology, Hospital Virgen del Rocio, Seville, Spain, and Miguel Angel Lopez-Nevot, Department of Immunology, Hospital Virgen de las Nieves, Granada, Spain. We acknowledge use of DNA from the 1958 British Birth Cohort (D. Strachan, S. Ring, W. McArdle, and M. Pembrey) funded by the Medical Research Council grant G0000934 and Wellcome Trust grant 068545/Z/02. We thank all individuals who participated in the study.	Auton A, 2009, GENOME RES, V19, P795, DOI 10.1101/gr.088898.108; BARBA G, 1993, J CLIN INVEST, V91, P1681, DOI 10.1172/JCI116377; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boteva L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022128; Carroll MC, 2004, NAT REV IMMUNOL, V4, P825, DOI 10.1038/nri1456; CHRISTIANSEN FT, 1983, AUST NZ J MED, V13, P483, DOI 10.1111/j.1445-5994.1983.tb02699.x; Cook HT, 2006, NAT CLIN PRACT RHEUM, V2, P330, DOI 10.1038/ncprheum0191; Dodds AW, 1996, NATURE, V379, P177, DOI 10.1038/379177a0; Dorak MT, 2006, GENES IMMUN, V7, P450, DOI 10.1038/sj.gene.6364315; Fernando MMA, 2007, PLOS GENET, V3, P2109, DOI 10.1371/journal.pgen.0030192; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Fernando MMA, 2012, ANN RHEUM DIS, V71, P777, DOI 10.1136/annrheumdis-2011-200808; Fernando MMA, 2010, HUM MUTAT, V31, P866, DOI 10.1002/humu.21259; FIELDER AHL, 1983, BMJ-BRIT MED J, V286, P425, DOI 10.1136/bmj.286.6363.425; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; GRUMET FC, 1971, NEW ENGL J MED, V285, P193, DOI 10.1056/NEJM197107222850403; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; HAUPTMANN G, 1974, B I SIEROTER MILAN, V53, P228; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; LAW SKA, 1984, EMBO J, V3, P1819, DOI 10.1002/j.1460-2075.1984.tb02052.x; MOULDS JM, 1993, J RHEUMATOL, V20, P443; Naves M, 1998, EUR J IMMUNOGENET, V25, P317, DOI 10.1046/j.1365-2370.1998.00110.x; Pickering M C, 2000, Adv Immunol, V76, P227; Pickering MC, 2000, RHEUMATOLOGY, V39, P133, DOI 10.1093/rheumatology/39.2.133; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rioux JD, 2009, P NATL ACAD SCI USA, V106, P18680, DOI 10.1073/pnas.0909307106; SHEN LM, 1994, J BIOL CHEM, V269, P8466; Soto K, 2010, CLIN IMMUNOL, V137, P166, DOI 10.1016/j.clim.2010.06.003; WATERS H, 1971, Tissue Antigens, V1, P68; Wu YL, 2009, GENES IMMUN, V10, P433, DOI 10.1038/gene.2009.10; Yang WL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000841; Yang Y, 2004, CURR DIRECT AUTOIMMU, V7, P98; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257; YU CY, 1986, EMBO J, V5, P2873, DOI 10.1002/j.1460-2075.1986.tb04582.x	37	47	50	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR 9	2012	90	3					445	456		10.1016/j.ajhg.2012.01.012	http://dx.doi.org/10.1016/j.ajhg.2012.01.012			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911ZI	22387014	Green Published, hybrid			2022-12-18	WOS:000301762800010
J	Lee, JM; Gillis, T; Mysore, JS; Ramos, EM; Myers, RH; Hayden, MR; Morrison, PJ; Nance, M; Ross, CA; Margolis, RL; Squitieri, F; Griguoli, A; Di Donato, S; Gomez-Tortosa, E; Ayuso, C; Suchowersky, O; Trent, RJ; McCusker, E; Novelletto, A; Frontali, M; Jones, R; Ashizawa, T; Frank, S; Saint-Hilaire, MH; Hersch, SM; Rosas, HD; Lucente, D; Harrison, MB; Zanko, A; Abramson, RK; Marder, K; Sequeiros, J; MacDonald, ME; Gusella, JF				Lee, Jong-Min; Gillis, Tammy; Mysore, Jayalakshmi Srinidhi; Ramos, Eliana Marisa; Myers, Richard H.; Hayden, Michael R.; Morrison, Patrick J.; Nance, Martha; Ross, Christopher A.; Margolis, Russell L.; Squitieri, Ferdinando; Griguoli, Annamaria; Di Donato, Stefano; Gomez-Tortosa, Estrella; Ayuso, Carmen; Suchowersky, Oksana; Trent, Ronald J.; McCusker, Elizabeth; Novelletto, Andrea; Frontali, Marina; Jones, Randi; Ashizawa, Tetsuo; Frank, Samuel; Saint-Hilaire, Marie-Helene; Hersch, Steven M.; Rosas, Herminia D.; Lucente, Diane; Harrison, Madaline B.; Zanko, Andrea; Abramson, Ruth K.; Marder, Karen; Sequeiros, Jorge; MacDonald, Marcy E.; Gusella, James F.			Common SNP-Based Haplotype Analysis of the 4p16.3 Huntington Disease Gene Region	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EXPANDED CAG REPEAT; AGE-OF-ONSET; TRINUCLEOTIDE REPEAT; HD; ASSOCIATION; EXPANSION; MODIFIER; LENGTH	Age at the onset of motor symptoms in Huntington disease (HD) is determined largely by the length of a GAG repeat expansion in HIT but is also influenced by other genetic factors. We tested whether common genetic variation near the mutation site is associated with differences in the distribution of expanded GAG alleles or age at the onset of motor symptoms. To define disease-associated single-nucleotide polymorphisms (SNPs), we compared 4p16.3 SNPs in HD subjects with population controls in a case:control strategy, which revealed that the strongest signals occurred at a great distance from the HD mutation as a result of "synthetic association" with SNP alleles that are of low frequency in population controls. Detailed analysis delineated a prominent ancestral haplotype that accounted for similar to 50% of HD chromosomes and extended to at least 938 kb on about half of these. Together, the seven most abundant haplotypes accounted for similar to 83% of HD chromosomes. Neither the extended shared haplotype nor the individual local HTT haplotypes were associated with altered GAG-repeat length distribution or residual age at the onset of motor symptoms, arguing against modification of these disease features by common cis-regulatory elements. Similarly, the 11 most frequent control haplotypes showed no trans-modifier effect on age at the onset of motor symptoms. Our results argue against common local regulatory variation as a factor influencing HD pathogenesis, suggesting that genetic modifiers be sought elsewhere in the genome. They also indicate that genome-wide association analysis with a small number of cases can be effective for regional localization of genetic defects, even when a founder effect accounts for only a fraction of the disorder.	[Lee, Jong-Min; Gillis, Tammy; Mysore, Jayalakshmi Srinidhi; Ramos, Eliana Marisa; Lucente, Diane; MacDonald, Marcy E.; Gusella, James F.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Lee, Jong-Min; MacDonald, Marcy E.; Gusella, James F.] Broad Inst Harvard & Massachusetts Inst Technol, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Ramos, Eliana Marisa; Sequeiros, Jorge] Univ Porto, UnIGENe, Inst Mol & Cell Biol, P-4150180 Oporto, Portugal; [Myers, Richard H.; Frank, Samuel; Saint-Hilaire, Marie-Helene] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Hayden, Michael R.] Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada; [Morrison, Patrick J.] Belfast Hlth & Social Care Trust, Reg Med Genet Ctr, Belfast BT9 7AB, Antrim, North Ireland; [Morrison, Patrick J.] Univ Ulster, Coleraine BT52 1SA, Londonderry, North Ireland; [Nance, Martha] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA; [Ross, Christopher A.; Margolis, Russell L.] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Baltimore, MD 21287 USA; [Squitieri, Ferdinando; Griguoli, Annamaria] Inst Ricovero & Cura Carattere Sci Neuromed, Neurogenet Unit, I-86077 Pozzilli, IS, Italy; [Squitieri, Ferdinando; Griguoli, Annamaria] Inst Ricovero & Cura Carattere Sci Neuromed, Ctr Rare Dis, I-86077 Pozzilli, IS, Italy; [Di Donato, Stefano] Fdn IRCCS, Ist Nazl Neurol C Besta, I-20133 Milan, Italy; [Gomez-Tortosa, Estrella] Fdn Jimenez Diaz, Dept Neurol, E-28040 Madrid, Spain; [Ayuso, Carmen] Fdn Jimenez Diaz, Dept Genet, IIS, CIBERER, E-28040 Madrid, Spain; [Suchowersky, Oksana] Univ Alberta, Dept Med Neurol, Edmonton, AB T6G 2B7, Canada; [Suchowersky, Oksana] Univ Alberta, Dept Med Genet, Edmonton, AB T6G 2B7, Canada; [Trent, Ronald J.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [McCusker, Elizabeth] Westmead Hosp, Dept Neurol, Sydney, NSW 2145, Australia; [Novelletto, Andrea] Univ Tor Vergata, Dept Biol, I-00133 Rome, Italy; [Frontali, Marina] CNR, Ist Farmacol Traslaz, I-00133 Rome, Italy; [Jones, Randi] Emory Univ, Dept Neurol, Atlanta, GA 30329 USA; [Ashizawa, Tetsuo] Univ Florida, Dept Neurol, Gainesville, FL 32610 USA; [Hersch, Steven M.; Rosas, Herminia D.] Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Charlestown, MA 02129 USA; [Harrison, Madaline B.] Univ Virginia, Dept Neurol, Charlottesville, VA 22908 USA; [Zanko, Andrea] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Abramson, Ruth K.] Univ S Carolina, Sch Med, Dept Neuropsychiat & Behav Sci, Columbia, SC 29209 USA; [Marder, Karen] Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; [Sequeiros, Jorge] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4099003 Oporto, Portugal	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Universidade do Porto; Boston University; University of British Columbia; Ulster University; Hennepin County Medical Center; Johns Hopkins University; IRCCS Neuromed; IRCCS Neuromed; IRCCS Istituto Neurologico Besta; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Fundacion Jimenez Diaz; University of Alberta; University of Alberta; University of Sydney; University of Sydney; University of Rome Tor Vergata; Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR); Emory University; State University System of Florida; University of Florida; Harvard University; Massachusetts General Hospital; University of Virginia; University of California System; University of California San Francisco; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Columbia University; Universidade do Porto	Gusella, JF (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	gusella@helix.mgh.harvard.edu	Di Donato, Stefano/B-9717-2012; Squitieri, Ferdinando/N-1852-2019; Hayden, Michael R/D-8581-2011; Ross, Christopher A/H-8395-2013	Squitieri, Ferdinando/0000-0002-7397-1727; Hayden, Michael R/0000-0001-5159-1419; Ayuso, Carmen/0000-0002-9242-7065; Myers, Richard/0000-0002-8365-2674; Novelletto, Andrea/0000-0002-1146-7680; Sequeiros, Jorge/0000-0002-9846-1037; Saint-Hilaire, Marie-Helene/0000-0002-2355-5979	U.S. National Institutes of Health; National Heart, Lung, and Blood Institute [R01 HL087676]; National Center for Research Resources [U54 RR020278]; National Institute of Neurological Disorders and Stroke [NS16367, NS32765]; CHDI Foundation; Huntington's Disease Society of America's Coalition for the Cure; Fundacao para a Ciencia e a Tecnologia of Portugal [SFRH/BD/44335/2008]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016367, R01NS032765, P50NS016367] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); CHDI Foundation; Huntington's Disease Society of America's Coalition for the Cure; Fundacao para a Ciencia e a Tecnologia of Portugal(Portuguese Foundation for Science and Technology); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the HD research participants and their families, who made this work possible; the Harvard Brain Tissue Resource Center; the COHORT Study of the Huntington Study Group; and the Myocardial Infarction Genetics Consortium (MIGen) study, which was funded by grants from the U.S. National Institutes of Health and National Heart, Lung, and Blood Institute's STAMPEED genomics research program (R01 HL087676) and the National Center for Research Resources (U54 RR020278). We also thank investigators anti contributors to the I-ID-MAPS study: Alexandra Durr, Adam Rosenblatt, Luigi Frati, Susan Perlman, P. Michael Conneally, Mary Lou Klimek, Melissa Diggin, Tiffany Hadzi, and Ayana Duckett. This work was supported by grants from the National Institute of Neurological Disorders and Stroke (NS16367) (Huntington's Disease Center Without Walls) and NS32765, the CHDI Foundation, and the Huntington's Disease Society of America's Coalition for the Cure. E.M.R. received a scholarship from the Fundacao para a Ciencia e a Tecnologia of Portugal (SFRH/BD/44335/2008).	AMBROSE CM, 1994, SOMAT CELL MOLEC GEN, V20, P27, DOI 10.1007/BF02257483; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Djousse L, 2004, NEUROGENETICS, V5, P109, DOI 10.1007/s10048-004-0175-2; Djousse L, 2003, AM J MED GENET A, V119A, P279, DOI 10.1002/ajmg.a.20190; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; FARRER LA, 1993, AM J HUM GENET, V53, P125; Frontali M, 1996, ANN HUM GENET, V60, P423, DOI 10.1111/j.1469-1809.1996.tb00440.x; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Lee J.M., 2012, NEUROLOGY IN PRESS; Li JL, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-71; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MACDONALD ME, 1991, AM J HUM GENET, V49, P723; MACDONALD ME, 1989, NEURON, V3, P183, DOI 10.1016/0896-6273(89)90031-7; MYERS RH, 1993, NAT GENET, V5, P168, DOI 10.1038/ng1093-168; Persichetti F, 1994, Neurobiol Dis, V1, P159, DOI 10.1006/nbdi.1994.0019; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; Warby SC, 2011, EUR J HUM GENET, V19, P561, DOI 10.1038/ejhg.2010.229; Warby SC, 2009, AM J HUM GENET, V84, P351, DOI 10.1016/j.ajhg.2009.02.003; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101	24	47	48	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR 9	2012	90	3					434	444		10.1016/j.ajhg.2012.01.005	http://dx.doi.org/10.1016/j.ajhg.2012.01.005			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911ZI	22387017	Green Published, Bronze			2022-12-18	WOS:000301762800009
J	Ghassibe-Sabbagh, M; Desmyter, L; Langenberg, T; Claes, F; Boute, O; Bayet, B; Pellerin, P; Hermans, K; Backx, L; Mansilla, MA; Imoehl, S; Nowak, S; Ludwig, KU; Baluardo, C; Ferrian, M; Mossey, PA; Noethen, M; Dewerchin, M; Francois, G; Revencu, N; Vanwijck, R; Hecht, J; Mangold, E; Murray, J; Rubini, M; Vermeesch, JR; Poirel, HA; Carmeliet, P; Vikkula, M				Ghassibe-Sabbagh, Michella; Desmyter, Laurence; Langenberg, Tobias; Claes, Filip; Boute, Odile; Bayet, Benedicte; Pellerin, Philippe; Hermans, Karlien; Backx, Liesbeth; Mansilla, Maria Adela; Imoehl, Sandra; Nowak, Stefanie; Ludwig, Kerstin U.; Baluardo, Carlotta; Ferrian, Melissa; Mossey, Peter A.; Noethen, Markus; Dewerchin, Mieke; Francois, Genevieve; Revencu, Nicole; Vanwijck, Romain; Hecht, Jacqueline; Mangold, Elisabeth; Murray, Jeffrey; Rubini, Michele; Vermeesch, Joris R.; Poirel, Helene A.; Carmeliet, Peter; Vikkula, Miikka			FAF1, a Gene that Is Disrupted in Cleft Palate and Has Conserved Function in Zebrafish	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POPLITEAL PTERYGIUM SYNDROME; PIERRE-ROBIN-SEQUENCE; NEURAL CREST; CHONDROCYTE DIFFERENTIATION; MICE LACKING; IRF6 GENE; IKK-ALPHA; WILD-TYPE; KAPPA-B; EXPRESSION	Cranial neural crest (CNC) is a multipotent migratory cell population that gives rise to most of the craniofacial bones. An intricate network mediates CNC formation, epithelial-mesenchymal transition, migration along distinct paths, and differentiation. Errors in these processes lead to craniofacial abnormalities, including cleft lip and palate. Clefts are the most common congenital craniofacial defects. Patients have complications with feeding, speech, hearing, and dental and psychological development. Affected by both genetic predisposition and environmental factors, the complex etiology of clefts remains largely unknown. Here we show that Fas-associated factor-1 (FAF1) is disrupted and that its expression is decreased in a Pierre Robin family with an inherited translocation. Furthermore, the locus is strongly associated with cleft palate and shows an increased relative risk. Expression studies show that faf1 is highly expressed in zebrafish cartilages during embryogenesis. Knockdown of zebrafish faf1 leads to pharyngeal cartilage defects and jaw abnormality as a result of a failure of CNC to differentiate into and express cartilage-specific markers, such as sox9a and col2a1. Administration of faf1 mRNA rescues this phenotype. Our findings therefore identify FAF1 as a regulator of CNC differentiation and show that it predisposes humans to cleft palate and is necessary for lower jaw development in zebrafish.	[Ghassibe-Sabbagh, Michella; Desmyter, Laurence; Revencu, Nicole; Poirel, Helene A.; Vikkula, Miikka] Catholic Univ Louvain, Lab Human Mol Genet, de Duve Inst, B-1200 Brussels, Belgium; [Langenberg, Tobias; Claes, Filip; Hermans, Karlien; Dewerchin, Mieke; Carmeliet, Peter] Katholieke Univ Leuven, Vesalius Res Ctr, B-3000 Louvain, Belgium; [Langenberg, Tobias; Claes, Filip; Hermans, Karlien; Dewerchin, Mieke; Carmeliet, Peter] Flanders Inst Biotechnol, Vesalius Res Ctr, B-3000 Louvain, Belgium; [Boute, Odile] CHU Lille, Ctr Genet, F-59037 Lille, France; [Bayet, Benedicte; Francois, Genevieve; Vanwijck, Romain] Clin Univ St Luc, Ctr Labiopalatin, Serv Chirurg Plast, B-1200 Brussels, Belgium; [Pellerin, Philippe] CHU Lille, Serv Chirurg Plast & Reconstruct, F-59037 Lille, France; [Backx, Liesbeth; Vermeesch, Joris R.] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; [Mansilla, Maria Adela; Imoehl, Sandra; Murray, Jeffrey] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Nowak, Stefanie; Noethen, Markus; Mangold, Elisabeth] Univ Bonn, Inst Human Genet, D-53012 Bonn, Germany; [Ludwig, Kerstin U.; Noethen, Markus] Univ Bonn, Dept Genom, Life & Brain Ctr, D-53012 Bonn, Germany; [Baluardo, Carlotta; Ferrian, Melissa; Rubini, Michele] Univ Ferrara, Med Genet Unit, Dept Expt & Diagnost Med, I-44121 Ferrara, Italy; [Mossey, Peter A.] Univ Dundee, Orthodont Unit, Dent Hosp & Sch, Dundee DD1 4HR, Scotland; [Revencu, Nicole; Poirel, Helene A.] Catholic Univ Louvain, Clin Univ St Luc, Ctr Human Genet, B-1200 Brussels, Belgium; [Hecht, Jacqueline] Univ Texas Houston, Dept Pediat, Med Sch Houston, Houston, TX 77030 USA	Universite Catholique Louvain; KU Leuven; Flanders Institute for Biotechnology (VIB); Universite de Lille - ISITE; CHU Lille; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite de Lille - ISITE; CHU Lille; KU Leuven; University of Iowa; University of Bonn; University of Bonn; University of Ferrara; University of Dundee; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; University of Texas System; University of Texas Health Science Center Houston	Vikkula, M (corresponding author), Catholic Univ Louvain, Lab Human Mol Genet, de Duve Inst, B-1200 Brussels, Belgium.	miikka.vikkula@uclouvain.be	Carmeliet, Peter/AAQ-5140-2020; Ghassibe, Michella/A-7256-2011; Ghassibe-Sabbagh, Michella/AAG-5710-2019; Vikkula, Miikka/Q-1038-2018; Rubini, Michele/AFF-8477-2022; Ludwig, Kerstin U/H-7828-2019	Carmeliet, Peter/0000-0001-7961-1821; Ghassibe-Sabbagh, Michella/0000-0003-2107-9929; Vikkula, Miikka/0000-0002-6236-338X; Rubini, Michele/0000-0003-1448-9516; Ludwig, Kerstin U/0000-0002-8541-2519; Mossey, Peter/0000-0002-9914-6901; Ferrian, Melissa/0000-0002-3746-4576; Vermeesch, Joris/0000-0002-3071-1191; Nothen, Markus/0000-0002-8770-2464	Interuniversity Attraction Poles [6/05, 7/11]; Belgian French Community Ministry [02/07-276, 07/12-005]; Fonds de la Recherche Scientifique; Flemish Government; Deutsche Forschungsgemeinschaft [FOR 423, MA 2546/3-1, KR 1912/7-1, NO 246/6-1, WI 1555/5-1]; Universite catholique de Louvain (UCL); IWT (Institute for the Promotion of Innovation by Science and Technology in Flanders); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE008559] Funding Source: NIH RePORTER	Interuniversity Attraction Poles(Belgian Federal Science Policy Office); Belgian French Community Ministry; Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Flemish Government(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Universite catholique de Louvain (UCL); IWT (Institute for the Promotion of Innovation by Science and Technology in Flanders)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We are grateful to all the families for their participation in the study. The studies were partially supported by the Interuniversity Attraction Poles initiated by the Belgian Federal Science Policy, networks 6/05 and 7/11; Concerted Research Actions (A.R.C.), Conventions 02/07-276 and 07/12-005 of the Belgian French Community Ministry; and the F.R.S.-FNRS (Fonds de la Recherche Scientifique) (all to MV.). P.C. is supported by long-term structural funding "Methusalem funding by the Flemish Government"; E.M. was supported by the Deutsche Forschungsgemeinschaft (FOR 423 and individual grants MA 2546/3-1, KR 1912/7-1, NO 246/6-1, and WI 1555/5-1); M.G. was a postdoctoral researcher of F.R.S.-FNRS; M.G. and L.D. were supported by a fellowship from F.R.I.A. (Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture); M.G. was also supported by a "Patrimoine de la Faculte de Medecine" fellowship from the Universite catholique de Louvain (UCL); and K. H. was supported by a predoctoral fellowship of IWT (Institute for the Promotion of Innovation by Science and Technology in Flanders). The authors thank Khadija Bahloula, Bieke Tembuyser, and Anne Van Egeren for their expert technical assistance and Liliana Niculescu for secretarial help.	AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; Appel B, 1995, DEVELOPMENT, V121, P4117; Backx L, 2007, CYTOGENET GENOME RES, V116, P158, DOI 10.1159/000098181; Barbieri O, 2003, AM J PHYSIOL-CELL PH, V285, pC1504, DOI 10.1152/ajpcell.00579.2002; Benko S, 2009, NAT GENET, V41, P359, DOI 10.1038/ng.329; Bi WM, 2001, P NATL ACAD SCI USA, V98, P6698, DOI 10.1073/pnas.111092198; Birnbaum S, 2009, NAT GENET, V41, P473, DOI 10.1038/ng.333; Chiang EFL, 2001, DEV BIOL, V231, P149, DOI 10.1006/dbio.2000.0129; Desmyter L, 2010, MOL SYNDROMOL, V1, P67, DOI 10.1159/000313786; Dutton KA, 2001, DEVELOPMENT, V128, P4113; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Faber J, 2000, J MED GENET, V37, P318, DOI 10.1136/jmg.37.4.318; de Lima RLLF, 2009, GENET MED, V11, P241, DOI 10.1097/GIM.0b013e318197a49a; Ghassibe M, 2006, B-ENT, P20; Ghassibe M, 2005, EUR J HUM GENET, V13, P1239, DOI 10.1038/sj.ejhg.5201486; Ghassibe M, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.009274; Hargus G, 2008, INT J DEV BIOL, V52, P323, DOI 10.1387/ijdb.072490gh; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; Jakobsen LP, 2006, CLEFT PALATE-CRAN J, V43, P155, DOI 10.1597/05-008.1; Kelsh RN, 2000, MECH DEVELOP, V93, P161, DOI 10.1016/S0925-4773(00)00250-1; Kulesa P, 2004, DEV DYNAM, V229, P14, DOI 10.1002/dvdy.10485; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Luo RS, 2001, DEV DYNAM, V220, P169, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1097>3.0.CO;2-1; Mager AM, 1998, INT J DEV BIOL, V42, P561; Mangold E, 2010, NAT GENET, V42, P24, DOI 10.1038/ng.506; MEYER D, 1993, MECH DEVELOP, V44, P109, DOI 10.1016/0925-4773(93)90061-2; Murakami S, 2000, J BIOL CHEM, V275, P3687, DOI 10.1074/jbc.275.5.3687; Murray JC, 2002, CLIN GENET, V61, P248, DOI 10.1034/j.1399-0004.2002.610402.x; Myllyharju J, 2001, ANN MED, V33, P7, DOI 10.3109/07853890109002055; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; Park MY, 2004, J BIOL CHEM, V279, P2544, DOI 10.1074/jbc.M304565200; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; SADEWITZ VL, 1992, CLEFT PALATE-CRAN J, V29, P246, DOI 10.1597/1545-1569(1992)029<0246:RSCITL>2.3.CO;2; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; SCHILLING TF, 1994, DEVELOPMENT, V120, P483; Stalmans I, 2003, NAT MED, V9, P173, DOI 10.1038/nm819; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; THISSE C, 1995, DEV BIOL, V172, P86, DOI 10.1006/dbio.1995.0007; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; VIKKULA M, 1995, CELL, V80, P431, DOI 10.1016/0092-8674(95)90493-X; Weinberg ES, 1996, DEVELOPMENT, V122, P271; YAN YL, 1995, DEV DYNAM, V203, P363, DOI 10.1002/aja.1002030308; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406; Zucchero TM, 2004, NEW ENGL J MED, V351, P769, DOI 10.1056/NEJMoa032909	48	47	49	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 11	2011	88	2					150	161		10.1016/j.ajhg.2011.01.003	http://dx.doi.org/10.1016/j.ajhg.2011.01.003			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	725YZ	21295280	Green Published, Bronze			2022-12-18	WOS:000287684100003
J	Tukel, T; Sosic, D; Al-Gazali, LI; Erazo, M; Casasnovas, J; Franco, HL; Richardson, JA; Olson, EN; Cadilla, CL; Desnick, RJ				Tukel, Turgut; Sosic, Drazen; Al-Gazali, Lihadh I.; Erazo, Monica; Casasnovas, Jose; Franco, Hector L.; Richardson, James A.; Olson, Eric N.; Cadilla, Carmen L.; Desnick, Robert J.			Homozygous Nonsense Mutations in TWIST2 Cause Setleis Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL-DOMINANT INHERITANCE; FACIAL DERMAL DYSPLASIA; FORCEPS MARKS SYNDROME; FAMILY; DIFFERENTIATION; MORPHOGENESIS; EXPRESSION	The focal facial dermal dysplasias (FFDDs) are a group of inherited developmental disorders in which the characteristic diagnostic feature is bitemporal scar-like lesions that resemble forceps marks. To date, the genetic defects underlying these ectodermal dysplasias have not been determined. To identify the gene defect causing autosomal-recessive Setleis syndrome (type III FFDD), homozygosity mapping was performed with genomic DNAs from five affected individuals and 26 members of the consanguineous Puerto Rican (PR) family originally described by Setleis and colleagues. Microsatellites D2S1397 and D2S2968 were homozygous in all affected individuals, mapping the disease locus to 2q37.3. Haplotype analyses of additional markers in the PR family and a consanguineous Arab family further limited the disease locus to similar to 3 Mb between D2S2949 and D2S2253. Of the 29 candidate genes in this region, the bHLH transcription factor, TWIST2, was initially sequenced on the basis of its known involvement in murine facial development. Homozygous TWIST2 nonsense mutations, c.324C>T and c.486C>T, were identified in the affected members of the Arab and PR families, respectively. Characterization of the expressed mutant proteins, p.Q65X and p.Q119X, by electrophoretic mobility shift assays and immunoblot analyses indicated that they were truncated and unstable. Notably, Setleis syndrome patients and Twist2 knockout mice have similar facial features, indicating the gene's conserved role in mammalian development. Although human TWIST2 and TWIST] encode highly homologous bHLH transcription factors, the finding that TWIST2 recessive mutations cause an FFDD and dominant TWIST1 mutations cause Saethre-Chotzen craniocynostosis suggests that they function independently in skin and bone development.	[Tukel, Turgut; Erazo, Monica; Desnick, Robert J.] NYU, Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Sosic, Drazen; Richardson, James A.; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Al-Gazali, Lihadh I.] United Arab Emirates Univ, Dept Pediat, Fac Med & Hlth Sci, Al Ain, U Arab Emirates; [Casasnovas, Jose; Franco, Hector L.; Cadilla, Carmen L.] Univ Puerto Rico, Sch Med, Dept Biochem, San Juan, PR 00936 USA	Icahn School of Medicine at Mount Sinai; New York University; University of Texas System; University of Texas Southwestern Medical Center Dallas; United Arab Emirates University; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Desnick, RJ (corresponding author), NYU, Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA.	robert.desnick@mssm.edu		Franco, Hector/0000-0001-9354-0679	NIH [R25GM061838, G12RR03051]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR011126, G12RR003051] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL053351, R01HL093039, R01HL077439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061838] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was partially supported by NIH grants R25GM061838 and G12RR03051. The study was approved by the institutional review boards of Mount Sinai School of Medicine and the University of Puerto Rico Medical Sciences Campus. All experimental procedures involving animals in this study were reviewed and approved by the Institutional Care and Research Advisory Committee at the University of Texas Southwestern Medical Center.	AlGazali LI, 1996, CLIN DYSMORPHOL, V5, P249; Artlich A, 1992, Clin Dysmorphol, V1, P157; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; BOTET MV, 1989, P R HEALTH SCI J, V8, P259; Brauer A, 1929, DERMATOL WOCHENSCHR, V89, P1163; Browning VL, 2001, GENOMICS, V73, P291, DOI 10.1006/geno.2001.6523; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; DILERNIA V, 1991, J AM ACAD DERMATOL, V25, P389, DOI 10.1016/0190-9622(91)70211-J; Garcia-Minaur S, 1995, Clin Dysmorphol, V4, P173; Gelb BD, 1996, SCIENCE, V273, P1236, DOI 10.1126/science.273.5279.1236; Gitelman I, 2007, MOL BIOL EVOL, V24, P1912, DOI 10.1093/molbev/msm120; Graul-Neumann LM, 2009, AM J MED GENET A, V149A, P746, DOI 10.1002/ajmg.a.32728; Kao WWY, 2006, CORNEA, V25, pS7, DOI 10.1097/01.ico.0000247207.55520.a4; Kaplan P., 1995, American Journal of Human Genetics, V57, pA93; KOWALSKI DC, 1992, J AM ACAD DERMATOL, V27, P575, DOI 10.1016/0190-9622(92)70225-5; Kress W, 2006, EUR J HUM GENET, V14, P39, DOI 10.1038/sj.ejhg.5201507; LI L, 1995, DEV BIOL, V172, P280, DOI 10.1006/dbio.1995.0023; MAGID ML, 1988, J AM ACAD DERMATOL, V18, P1203, DOI 10.1016/S0190-9622(88)70125-5; MARION RW, 1987, AM J DIS CHILD, V141, P895, DOI 10.1001/archpedi.1987.04460080081033; MASUNO M, 1995, AM J MED GENET, V57, P57, DOI 10.1002/ajmg.1320570113; MATSUMOTO S, 1991, Acta Paediatrica Japonica, V33, P186; McGaughran J, 2002, AM J MED GENET, V111, P376, DOI 10.1002/ajmg.10632; SETLEIS H, 1963, PEDIATRICS, V32, P540; Sobel E, 2001, HUM HERED, V52, P121, DOI 10.1159/000053366; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; Suner IJ, 1997, J PEDIAT OPHTH STRAB, V34, P378; Terwilliger J., 1994, HDB HUMAN GENETIC LI; WARD KA, 1994, BRIT J DERMATOL, V130, P645, DOI 10.1111/j.1365-2133.1994.tb13113.x; Yoshida T, 2008, MECH DEVELOP, V125, P797, DOI 10.1016/j.mod.2008.06.007	29	47	50	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 13	2010	87	2					289	296		10.1016/j.ajhg.2010.07.009	http://dx.doi.org/10.1016/j.ajhg.2010.07.009			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641EG	20691403	Green Published, Bronze			2022-12-18	WOS:000281107000014
J	Ortiz-Abalia, J; Sahun, I; Altafaj, X; Andreu, N; Estivill, X; Dierssen, M; Fillat, C				Ortiz-Abalia, Jon; Sahun, Ignasi; Altafaj, Xavier; Andreu, Nuria; Estivill, Xavier; Dierssen, Mara; Fillat, Cristina			Targeting Dyrk1A with AAVshRNA Attenuates Motor Alterations in TgDyrk1A, a Mouse Model of Down Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PREPULSE INHIBITION; REGULATED KINASE-1A; MICE; GENE; EXPRESSION; MINIBRAIN; BRAIN; SPECIFICITY; DEFICITS; HAPLOINSUFFICIENCY	Genetic-dissection studies carried out with Down syndrome (DS) murine models point to the critical contribution of Dyrk] A overexpression to the motor abnormalities and cognitive deficits displayed in DS individuals. In the present study we have used a murine model overexpressing Dyrk1A (TgDyrk1A mice) to evaluate whether functional CNS defects could be corrected with an inhibitory RNA against Dyrk]A, delivered by bilateral intrastriatal injections of adeno-associated virus type 2 (AAVshDyrk1A). We report that AAVshDyrk1A efficiently transduced HEK293 cells and primary neuronal cultures, triggering the specific inhibition of Dyrk1A expression. Injecting the vector into the striata of TgDyrk1A mice resulted in a restricted, long-term transduction of the striatum. This gene therapy was found to be devoid of toxicity and succeeded in normalizing Dyrk1A protein levels in TgDyrk1A mice. Importantly, the behavioral studies of the adult TgDyrk1A mice treated showed a reversal of corticostriatal-dependent phenotypes, as revealed by the attenuation of their hyperactive behavior, the restoration of motor-coordination defects, and an improvement in sensorimotor gating. Taken together, the data demonstrate that normalizing Dyrk1A gene expression in the striatum of adult TgDyrk1A mice, by means of AAVshRNA, clearly reverses motor impairment. Furthermore, these results identify Dyrk1A as a potential target for therapy in DS.	[Ortiz-Abalia, Jon; Sahun, Ignasi; Altafaj, Xavier; Andreu, Nuria; Estivill, Xavier; Dierssen, Mara; Fillat, Cristina] UPF, CRG, Programa Gens & Malaltia, Barcelona 08003, Spain; [Ortiz-Abalia, Jon; Sahun, Ignasi; Altafaj, Xavier; Andreu, Nuria; Dierssen, Mara; Fillat, Cristina] Ctr Invest Biomed Red Enfermedades Raras, Barcelona 08003, Spain; [Estivill, Xavier] Ctr Invest Biomed Red Epidemiol & Salud Publ, Barcelona 08003, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Fillat, C (corresponding author), UPF, CRG, Programa Gens & Malaltia, PRBB, Barcelona 08003, Spain.	cristina.fillat@crg.es	Fillat, Cristina/ABH-1674-2020; Estivill, Xavier/A-3125-2013; Dierssen, Mara/G-3552-2015; Altafaj, Xavier/K-9257-2014; Andreu, Nuria/H-2576-2015; Estivill, Xavier/E-2957-2012; Sahun, Ignasi/H-6892-2015	Estivill, Xavier/0000-0002-0723-2256; Dierssen, Mara/0000-0003-0853-6865; Altafaj, Xavier/0000-0002-7595-0647; Andreu, Nuria/0000-0003-1999-8483; Fillat, Cristina/0000-0002-0801-3338; Sahun, Ignasi/0000-0002-4257-9255	Spanish Ministry of Health [FIS PI041559]; Jerome Lejeune Foundation; EU FP6-2005-LIFESCIHEALTH-6 ANEUPLOIDY [037627]; Instituto de Salud Carlos III [CP07/00323]	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Jerome Lejeune Foundation; EU FP6-2005-LIFESCIHEALTH-6 ANEUPLOIDY(European Commission); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work has been supported by grants from Spanish Ministry of Health (FIS PI041559), Jerome Lejeune Foundation, EU FP6-2005-LIFESCIHEALTH-6 ANEUPLOIDY No.037627. The CIBER de Enfermedades Raras is an initiative of the ISCIII. X.A. is partially financed by the Instituto de Salud Carlos III (CP07/00323). We acknowledge the UPV-CBATEG and the Association Francaise contre les Myopathies for the AAV vector production.	Ahn KJ, 2006, NEUROBIOL DIS, V22, P463, DOI 10.1016/j.nbd.2005.12.006; Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Antonarakis SE, 2006, TRENDS MOL MED, V12, P473, DOI 10.1016/j.molmed.2006.08.005; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Becker W, 1998, J BIOL CHEM, V273, P25893, DOI 10.1074/jbc.273.40.25893; Brooks AR, 2004, J GENE MED, V6, P395, DOI 10.1002/jgm.516; Campbell LE, 2007, EUR J NEUROSCI, V26, P2327, DOI 10.1111/j.1460-9568.2007.05858.x; Costa ACS, 2008, NEUROPSYCHOPHARMACOL, V33, P1624, DOI 10.1038/sj.npp.1301535; de Lagran MM, 2007, GENES BRAIN BEHAV, V6, P569, DOI 10.1111/j.1601-183X.2006.00285.x; de Lagran MM, 2004, NEUROBIOL DIS, V15, P132, DOI 10.1016/j.nbd.2003.10.002; Dierssen M, 2006, THESCIENTIFICWORLDJO, V6, P1911, DOI 10.1100/tsw.2006.319; Dowjat WK, 2007, NEUROSCI LETT, V413, P77, DOI 10.1016/j.neulet.2006.11.026; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Fotaki V, 2004, BEHAV NEUROSCI, V118, P815, DOI 10.1037/0735-7044.118.4.815; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Fujita Y, 1999, MOL BRAIN RES, V63, P316, DOI 10.1016/S0169-328X(98)00299-X; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; Guimera J, 1999, GENOMICS, V57, P407, DOI 10.1006/geno.1999.5775; Hallett PJ, 2006, J NEUROSCI, V26, P4690, DOI 10.1523/JNEUROSCI.0792-06.2006; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Marti E, 2003, BRAIN RES, V964, P250, DOI 10.1016/S0006-8993(02)04069-6; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Moller RS, 2008, AM J HUM GENET, V82, P1165, DOI 10.1016/j.ajhg.2008.03.001; Okui M, 1999, GENOMICS, V62, P165, DOI 10.1006/geno.1999.5998; Salvetti A, 1998, HUM GENE THER, V9, P695, DOI 10.1089/hum.1998.9.5-695; Smith DJ, 1997, NAT GENET, V16, P28, DOI 10.1038/ng0597-28; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; Warrington KH, 2006, HUM GENET, V119, P571, DOI 10.1007/s00439-006-0165-6	29	47	48	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 10	2008	83	4					479	488		10.1016/j.ajhg.2008.09.010	http://dx.doi.org/10.1016/j.ajhg.2008.09.010			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	363AV	18940310	Green Published, Bronze			2022-12-18	WOS:000260239200005
J	Hillmer, AM; Flaquer, A; Hanneken, S; Eigelshoven, S; Korttum, AK; Brockschmidt, FF; Golla, A; Metzen, C; Thiele, H; Kolberg, S; Reinartz, R; Betz, RC; Ruzicka, T; Hennies, HC; Kruse, R; Noethen, MM				Hillmer, Axel M.; Flaquer, Antonia; Hanneken, Sandra; Eigelshoven, Sibylle; Korttuem, Anne-Katrin; Brockschmidt, Felix F.; Golla, Astrid; Metzen, Christine; Thiele, Holger; Kolberg, Susanne; Reinartz, Roman; Betz, Regina C.; Ruzicka, Thomas; Hennies, Hans Christian; Kruse, Roland; Noethen, Markus M.			Genome-wide scan and fine-mapping linkage study of androgenetic alopecia reveals a locus on chromosome 3q26	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MALE PATTERN BALDNESS; CORONARY-HEART-DISEASE; RECEPTOR GENE; EARLY-ONSET; PROSTATE-CANCER; ELDERLY-MEN; HAIR LOSS; ASSOCIATION; SUSCEPTIBILITY; PROGRAM	Androgenetic alopecia (AGA, male pattern baldness) is the most common form of hair loss. The origin of AGA is genetic, with the X chromosome located androgen receptor gene (AR) being the only risk gene identified to date. We present the results of a genomewide linkage study of 95 families and linkage fine mapping of the 3q21-q29, 11q14-q25, 18p11-q23, and 19p13-q13 regions in an extended sample of 125 families of German descent. The locus with strongest evidence for linkage was mapped to 3q26 with a nonparametric linkage (NPL) score of 3.97 (empirical p value = 0.00055). This is the first step toward the identification of new susceptibility genes in AGA, a process which will provide important insights into the molecular and cellular basis of scalp hair loss.	[Hillmer, Axel M.; Brockschmidt, Felix F.; Reinartz, Roman; Noethen, Markus M.] Univ Bonn, Dept Genom Life & Brain Ctr, D-53127 Bonn, Germany; [Flaquer, Antonia; Golla, Astrid] Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-53127 Bonn, Germany; [Thiele, Holger; Kolberg, Susanne; Hennies, Hans Christian] Univ Cologne, Div Dermatogenet, Cologne Ctr Genom, D-50674 Cologne, Germany; [Betz, Regina C.; Noethen, Markus M.] Univ Bonn, Inst Human Genet, D-53111 Bonn, Germany; [Ruzicka, Thomas] Univ Munich, Dept Dermatol, D-80337 Munich, Germany; [Hennies, Hans Christian] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Hanneken, Sandra; Eigelshoven, Sibylle; Korttuem, Anne-Katrin; Metzen, Christine; Ruzicka, Thomas; Kruse, Roland] Univ Dusseldorf, Dept Dermatol, D-40225 Dusseldorf, Germany	University of Bonn; University of Bonn; University of Cologne; University of Bonn; University of Munich; University of Cologne; Heinrich Heine University Dusseldorf	Hillmer, AM (corresponding author), Univ Bonn, Dept Genom Life & Brain Ctr, D-53127 Bonn, Germany.	axel.hillmer@uni-bonn.de	Thiele, Holger/ABE-6792-2020; Hillmer, Axel M/B-7485-2015; Hennies, Hans C/G-9424-2014; Nöthen, Markus/B-2027-2009; Betz, Regina C/E-8591-2011; Hillmer, Axel M/N-2927-2014	Thiele, Holger/0000-0002-0169-998X; Hillmer, Axel M/0000-0002-3381-7266; Hennies, Hans C/0000-0001-7210-2389; Nöthen, Markus/0000-0002-8770-2464; Betz, Regina C/0000-0001-5024-3623; Hillmer, Axel M/0000-0002-3381-7266; Reinartz, Roman/0000-0002-6417-9156				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Ahouansou S, 2007, EUR J DERMATOL, V17, P220; Baessler A, 2005, DIABETES, V54, P259, DOI 10.2337/diabetes.54.1.259; Birch MP, 2001, EUR J DERMATOL, V11, P309; Bjornsson A, 2003, AM J HUM GENET, V73, P986, DOI 10.1086/378417; COOKE NT, 1979, BRIT J DERMATOL, V101, P455, DOI 10.1111/j.1365-2133.1979.tb00026.x; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; Duffy DL, 2006, BEHAV GENET, V36, P4, DOI 10.1007/s10519-005-9015-x; Ellis JA, 1998, J INVEST DERMATOL, V110, P849, DOI 10.1046/j.1523-1747.1998.00224.x; Ellis JA, 2001, CLIN SCI, V100, P401, DOI 10.1042/CS20000203; Ellis JA, 2001, J INVEST DERMATOL, V116, P452, DOI 10.1046/j.1523-1747.2001.01261.x; Garcia CK, 2007, NUCLEIC ACIDS RES, V35, P7406, DOI 10.1093/nar/gkm644; Giles GG, 2002, CANCER EPIDEM BIOMAR, V11, P549; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; HAMILTON JB, 1951, ANN NY ACAD SCI, V53, P708, DOI 10.1111/j.1749-6632.1951.tb31971.x; Hawk E, 2000, CANCER EPIDEM BIOMAR, V9, P523; HERRERA CR, 1995, AM J EPIDEMIOL, V142, P828, DOI 10.1093/oxfordjournals.aje.a117722; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Hillmer AM, 2005, AM J HUM GENET, V77, P140, DOI 10.1086/431425; Hirsso Paivi, 2006, Central European Journal of Public Health, V14, P78; Hirsso P, 2007, DERMATOLOGY, V214, P125, DOI 10.1159/000098570; JAMRA AR, 2007, AM J HUM GENET, V81, P974; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; KUSTER W, 1984, J AM ACAD DERMATOL, V11, P921, DOI 10.1016/S0190-9622(84)80498-3; Lange K, 2001, AM J HUM GENET, V69, P504; Lee YA, 2000, AM J HUM GENET, V67, P1020, DOI 10.1086/303075; Lotufo PA, 2000, ARCH INTERN MED, V160, P165, DOI 10.1001/archinte.160.2.165; Matilainen V, 2000, LANCET, V356, P1165, DOI 10.1016/S0140-6736(00)02763-X; Matilainen VA, 2001, J CARDIOVASC RISK, V8, P147, DOI 10.1097/00043798-200106000-00005; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NORWOOD OT, 1975, SOUTHERN MED J, V68, P1359, DOI 10.1097/00007611-197511000-00009; Nyholt DR, 2003, J INVEST DERMATOL, V121, P1561, DOI 10.1111/j.1523-1747.2003.12615.x; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Oh BR, 1998, UROLOGY, V51, P744, DOI 10.1016/S0090-4295(98)00108-3; Rexbye H, 2005, J GERONTOL A-BIOL, V60, P1077, DOI 10.1093/gerona/60.8.1077; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911	38	47	51	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2008	82	3					737	743		10.1016/j.ajhg.2007.11.014	http://dx.doi.org/10.1016/j.ajhg.2007.11.014			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	275JN	18304493	Green Published, Bronze			2022-12-18	WOS:000254067800017
J	Zaykin, DV; Shibata, K				Zaykin, Dmitri V.; Shibata, Kyoko			Genetic flip-flop without an accompanying change in linkage disequilibrium	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							PATTERNS		[Zaykin, Dmitri V.; Shibata, Kyoko] Natl Inst Environm Hlth Sci, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Zaykin, DV (corresponding author), Natl Inst Environm Hlth Sci, NIH, Res Triangle Pk, NC 27709 USA.	zaykind@niehs.nih.gov	Zaykin, Dmitri/C-3752-2019	Zaykin, Dmitri/0000-0002-9444-2859	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101866] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		LEWONTIN RC, 1964, GENETICS, V49, P49; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; SCHRODI SJ, 2007, FUR J HUM GENET, V15, P212; Terwilliger JD, 2006, EUR J HUM GENET, V14, P426, DOI 10.1038/sj.ejhg.5201583; Wang T, 2007, AM J HUM GENET, V80, P911, DOI 10.1086/516794; Weir BS, 1996, SINAUER ASS SUNDERL; Zaykin DV, 2006, AM J HUM GENET, V78, P737, DOI 10.1086/503710; Zhao JY, 2006, AM J HUM GENET, V79, P831, DOI 10.1086/508571	8	47	47	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2008	82	3					794	796		10.1016/j.ajhg.2008.02.001	http://dx.doi.org/10.1016/j.ajhg.2008.02.001			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	275JN	18319078	Green Published, Bronze			2022-12-18	WOS:000254067800025
J	Costa, MF; Oliveira, AGF; Feitosa-Santana, C; Zatz, M; Ventura, DF				Costa, Marcelo Fernandes; Oliveira, Andre Gustavo Fernandes; Feitosa-Santana, Claudia; Zatz, Mayana; Ventura, Dora Fix			Red-green color vision impairment in Duchenne muscular dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISCRIMINATION ELLIPSES; CONTRAST SENSITIVITY; BETA-DYSTROGLYCAN; ELECTRORETINOGRAM; PHENOTYPE; RETINA; ERG; MOUSE; LOCALIZATION; GLYCOPROTEIN	The present study evaluated the color vision of 44 patients with Duchenne muscular dystrophy (DMD) (mean age 14.8 years; SD 4.9) who were submitted to a battery of four different color tests: Cambridge Colour Test (CCT), Neitz Anomaloscope, Ishihara, and American Optical Hardy-Rand-Rittler (AO H-R-R). Patients were divided into two groups according to the region of deletion in the dystrophin gene: upstream of exon 30 (n = 12) and downstream of exon 30 (n = 32). The control group was composed of 70 age-matched healthy male subjects with no ophthalmological complaints plaints. Of the patients with DMD, 47% (21/44) had a red-green color vision defect in the CCT, confirmed by the Neitz Anomaloscope with statistical agreement (P < .001). The Ishihara and the AO H-R-R had a lower capacity to detect color defects -5% and 7%, respectively, with no statistical similarity between the results of these two tests nor between CCT and Anomaloscope results (P < .05). Of the patients with deletion downstream of exon 30, 66% had a red-green color defect. No color defect was found in the patients with deletion upstream of exon 30. A negative correlation between the color thresholds and age was found for the controls and patients with DMD, suggesting a nonprogressive color defect. The percentage (66%) of patients with a red- green defect was significantly higher than the expected < 10% for the normal male population (P < .001). In contrast, patients with DMD with deletion upstream of exon 30 had normal color vision. This color defect might be partially explained by a retina impairment related to dystrophin isoform Dp260.	Univ Sao Paulo, Dept Psicol Expt, Inst Psicol, Lab Visao, BR-05508900 Sao Paulo, Brazil; Univ Sao Paulo, Ctr Estudos Genoma Humano, Inst Biociencias, BR-05508900 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Costa, MF (corresponding author), Univ Sao Paulo, Dept Psicol Expt, Inst Psicol, Lab Visao, Ave Prof Mello Moraes,1721, BR-05508900 Sao Paulo, Brazil.	costamf@usp.br	Zatz, Mayana/M-5338-2015; Costa, Marcelo F/C-5776-2013; Ventura, Dora F/B-9071-2012; Feitosa-Santana, Claudia/M-4777-2016	Zatz, Mayana/0000-0003-3970-8025; Costa, Marcelo F/0000-0002-3944-8457; Ventura, Dora F/0000-0002-7616-4031; Feitosa-Santana, Claudia/0000-0002-1669-361X				BEGGS AH, 1990, HUM GENET, V86, P45; Birch E E, 2001, Semin Neonatol, V6, P487, DOI 10.1053/siny.2001.0077; Birch J., 2001, DIAGNOSIS DEFECTIVE; Calkins DJ, 2001, PROG RETIN EYE RES, V20, P255, DOI 10.1016/S1350-9462(00)00026-4; Castelo-Branco M, 2004, INVEST OPHTH VIS SCI, V45, P499, DOI 10.1167/iovs.03-0815; CHAMBERLAIN JS, 1988, NUCLEIC ACIDS RES, V16, P11141, DOI 10.1093/nar/16.23.11141; CIBIS GW, 1993, INVEST OPHTH VIS SCI, V34, P3646; Claudepierre T, 2000, J CELL SCI, V113, P3409; Claudepierre T, 2000, INVEST OPHTH VIS SCI, V41, P294; Connors NC, 2002, J NEUROSCI, V22, P4321, DOI 10.1523/JNEUROSCI.22-11-04321.2002; Costa MF, 2006, VISUAL NEUROSCI, V23, P461, DOI 10.1017/S095252380623311X; Dacey DM, 2003, CURR OPIN NEUROBIOL, V13, P421, DOI 10.1016/S0959-4388(03)00103-X; De Valois RL, 2000, P NATL ACAD SCI USA, V97, P4997, DOI 10.1073/pnas.97.9.4997; DEBECKER I, 1994, BRIT J OPHTHALMOL, V78, P719, DOI 10.1136/bjo.78.9.719; DEVALOIS RL, 1966, J OPT SOC AM, V56, P966, DOI 10.1364/JOSA.56.000966; Diller L, 2004, J NEUROSCI, V24, P1079, DOI 10.1523/JNEUROSCI.3828-03.2004; Dobkins KR, 2000, VISION RES, V40, P613, DOI 10.1016/S0042-6989(99)00211-4; Drenckhahn D, 1996, NEUROSCIENCE, V73, P605, DOI 10.1016/0306-4522(96)00069-3; DSOUZA VN, 1995, HUM MOL GENET, V4, P837, DOI 10.1093/hmg/4.5.837; Fitzgerald KM, 1999, J MED GENET, V36, P316; FITZGERALD KM, 1994, J CLIN INVEST, V93, P2425, DOI 10.1172/JCI117250; FITZGERALD KM, 1993, INVEST OPHTH VIS SCI, V34, P1076; FITZSIMMONS JS, 1980, J MED GENET, V17, P165, DOI 10.1136/jmg.17.3.165; Girlanda P, 1997, J NEUROL SCI, V146, P127, DOI 10.1016/S0022-510X(96)00292-4; Green DG, 2004, VISUAL NEUROSCI, V21, P739, DOI 10.1017/S0952523804215085; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Ino-ue M, 1997, EXP EYE RES, V65, P861, DOI 10.1006/exer.1997.0389; Knoblauch K, 2001, VISION RES, V41, P23, DOI 10.1016/S0042-6989(00)00205-4; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; Lee Barry B, 2004, Clin Exp Optom, V87, P239; Matsuo M, 1996, BRAIN DEV-JPN, V18, P167, DOI 10.1016/0387-7604(96)00007-1; MOLLON JD, 1989, J PHYSL, V414, P5; Neitz M, 2000, ARCH OPHTHALMOL-CHIC, V118, P691; Nobile C, 1997, GENOMICS, V45, P421, DOI 10.1006/geno.1997.4911; O'Brien KF, 2001, MOL GENET METAB, V74, P75, DOI 10.1006/mgme.2001.3220; Pascual SIP, 1998, PEDIATR NEUROL, V18, P315, DOI 10.1016/S0887-8994(97)00208-7; Pillers DAH, 1999, HUM GENET, V105, P2, DOI 10.1007/s004390051056; Pillers DAM, 1999, MOL GENET METAB, V66, P100, DOI 10.1006/mgme.1998.2784; PILLERS DAM, 1993, NAT GENET, V4, P82, DOI 10.1038/ng0593-82; PILLERS DAM, 1995, INVEST OPHTH VIS SCI, V36, P462; PILLERS DM, 1993, AM J HUM GENET, V53, P146; POKORNY J, 1981, 41 NAT RES COUNC COM; REGAN BC, 1994, VISION RES, V34, P1279, DOI 10.1016/0042-6989(94)90203-8; Regan BC, 1998, VISION RES, V38, P3427, DOI 10.1016/S0042-6989(97)00402-1; Schiller PH, 1995, PROG RETIN EYE RES, V15, P173, DOI 10.1016/1350-9462(95)00009-7; Schmitz F, 1997, PROG NEUROBIOL, V53, P547, DOI 10.1016/S0301-0082(97)00047-6; Schmitz F, 1997, HISTOCHEM CELL BIOL, V108, P249, DOI 10.1007/s004180050165; SIEGEL IM, 1981, SURV OPHTHALMOL, V25, P312, DOI 10.1016/S0039-6257(81)80001-X; SIGESMUND DA, 1994, OPHTHALMOLOGY, V101, P856; SIGESMUND DA, 1993, INVEST OPHTH VIS SCI, V34, P1463; Simunovic MP, 1998, VISION RES, V38, P3413, DOI 10.1016/S0042-6989(98)00094-7; TREMBLAY F, 1994, CAN J OPHTHALMOL, V29, P280; Ueda H, 1997, HISTOCHEM CELL BIOL, V108, P243, DOI 10.1007/s004180050164; UEDA H, 1995, OPHTHALMIC RES, V27, P219, DOI 10.1159/000267709; Ventura D. F., 2003, NORMAL DEFECTIVE COL, P395, DOI [10.1093/acprof:oso/9780198525301.003.0042, DOI 10.1093/ACPROF:OSO/9780198525301.003.0042]; Ventura DF, 2005, ENVIRON TOXICOL PHAR, V19, P523, DOI 10.1016/j.etap.2004.12.016; Ventura DF, 2005, INVEST OPHTH VIS SCI, V46, P4809, DOI 10.1167/iovs.05-0455; Ventura DF, 2004, VISUAL NEUROSCI, V21, P421, DOI 10.1017/S0952523804213372; Ventura DF, 2007, INVEST OPHTH VIS SCI, V48, P2362, DOI 10.1167/iovs.06-0331; VETURA DF, 2004, ARQ BRAS OFTALMOL, V66, P9; VIGNOS PJ, 1967, J BONE JOINT SURG AM, VA 49, P1212, DOI 10.2106/00004623-196749060-00023; Yang Y, 2001, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V18, P32; ZATZ M, 1974, J MED GENET, V11, P321, DOI 10.1136/jmg.11.4.321	63	47	54	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2007	80	6					1064	1075		10.1086/518127	http://dx.doi.org/10.1086/518127			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	168WD	17503325	Green Published, Bronze			2022-12-18	WOS:000246553800006
J	Li, Y; Sung, WK; Liu, JJ				Li, Yi; Sung, Wing-Kin; Liu, Jian Jun			Association mapping via regularized regression analysis of single-nucleotide-polymorphism haplotypes in variable-sized sliding windows	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE-DISEQUILIBRIUM; HUMAN GENOME; UNRELATED INDIVIDUALS; MODEL SELECTION; GENOTYPE DATA; TAGGING SNPS; TESTS; ALGORITHM; SAMPLES; BLOCKS	Large-scale haplotype association analysis, especially at the whole-genome level, is still a very challenging task without an optimal solution. In this study, we propose a new approach for haplotype association analysis that is based on a variable-sized sliding-window framework and employs regularized regression analysis to tackle the problem of multiple degrees of freedom in the haplotype test. Our method can handle a large number of haplotypes in association analyses more efficiently and effectively than do currently available approaches. We implement a procedure in which the maximum size of a sliding window is determined by local haplotype diversity and sample size, an attractive feature for large-scale haplotype analyses, such as a whole-genome scan, in which linkage disequilibrium patterns are expected to vary widely. We compare the performance of our method with that of three other methods - a test based on a single-nucleotide polymorphism, a cladistic analysis of haplotypes, and variable-length Markov chains - with use of both simulated and experimental data. By analyzing data sets simulated under different disease models, we demonstrate that our method consistently outperforms the other three methods, especially when the region under study has high haplotype diversity. Built on the regression analysis framework, our method can incorporate other risk-factor information into haplotype-based association analysis, which is becoming an increasingly necessary step for studying common disorders to which both genetic and environmental risk factors contribute.	Genome Inst Singapore, Singapore 138672, Singapore; Natl Univ Singapore, Sch Computing, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore	Sung, WK (corresponding author), Genome Inst Singapore, 60 Biopolis St,02-01 Genome, Singapore 138672, Singapore.	sungk@gis.a-star.edu.sg		Liu, Jianjun/0000-0002-3255-3019; Sung, Wing-Kin/0000-0001-7806-7086				Akey J, 2001, EUR J HUM GENET, V9, P291, DOI 10.1038/sj.ejhg.5200619; ALBERT JH, 1993, J AM STAT ASSOC, V88, P669, DOI 10.2307/2290350; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barton NH, 2000, HEREDITY, V84, P373, DOI 10.1046/j.1365-2540.2000.00683.x; Bourgain C, 2000, ANN HUM GENET, V64, P255, DOI 10.1046/j.1469-1809.2000.6430255.x; Browning SR, 2006, AM J HUM GENET, V78, P903, DOI 10.1086/503876; Clayton D, 1999, AM J HUM GENET, V65, P1161, DOI 10.1086/302566; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Draper NR, 1980, APPL REGRESSION ANAL; Durrant C, 2004, AM J HUM GENET, V75, P35, DOI 10.1086/422174; Efron B, 2004, J AM STAT ASSOC, V99, P619, DOI 10.1198/016214504000000692; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Hastie T., 2001, ELEMENTS STAT LEARNI, P236, DOI DOI 10.1007/978-0-387-21606-5; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Lin S, 2004, NAT GENET, V36, P1181, DOI 10.1038/ng1457; Low YL, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1511; MacLean CJ, 2000, AM J HUM GENET, V66, P1062, DOI 10.1086/302796; Molitor J, 2003, AM J HUM GENET, V73, P1368, DOI 10.1086/380415; Morris RW, 2002, GENET EPIDEMIOL, V23, P221, DOI 10.1002/gepi.10200; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Qin ZHS, 2002, AM J HUM GENET, V71, P1242, DOI 10.1086/344207; Ron D, 1998, J COMPUT SYST SCI, V56, P133, DOI 10.1006/jcss.1997.1555; Seltman H, 2001, AM J HUM GENET, V68, P1250, DOI 10.1086/320110; SEVICE SK, 1999, AM J HUM GENET, V64, P1728; Shen XT, 2002, J AM STAT ASSOC, V97, P210, DOI 10.1198/016214502753479356; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202; Stram DO, 2003, HUM HERED, V55, P27, DOI 10.1159/000071807; Tanck MWT, 2003, ANN HUM GENET, V67, P175, DOI 10.1046/j.1469-1809.2003.00021.x; Toivonen HTT, 2000, AM J HUM GENET, V67, P133, DOI 10.1086/302954; Weale ME, 2003, AM J HUM GENET, V73, P551, DOI 10.1086/378098; Wessel J, 2006, AM J HUM GENET, V79, P792, DOI 10.1086/508346; Ye JM, 1998, J AM STAT ASSOC, V93, P120, DOI 10.2307/2669609; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Zhang K, 2002, P NATL ACAD SCI USA, V99, P7335, DOI 10.1073/pnas.102186799; Zhao HY, 2003, PHARMACOGENOMICS, V4, P171, DOI 10.1517/phgs.4.2.171.22636; Zollner S, 2000, AM J HUM GENET, V66, P615, DOI 10.1086/302766	37	47	51	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2007	80	4					705	715		10.1086/513205	http://dx.doi.org/10.1086/513205			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	153VV	17357076	Bronze, Green Published			2022-12-18	WOS:000245465200011
J	McMaster, ML; Goldin, LR; Bai, Y; Ter-Minassian, M; Boehringer, S; Giambarresi, TR; Vasquez, LG; Tucker, MA				McMaster, Mary L.; Goldin, Lynn R.; Bai, Yan; Ter-Minassian, Monica; Boehringer, Stefan; Giambarresi, Therese R.; Vasquez, Linda G.; Tucker, Margaret A.			Genomewide linkage screen for Waldenstrom macroglobulinemia susceptibility loci in high-risk families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NON-HODGKIN-LYMPHOMA; MONOCLONAL GAMMOPATHY; AGGREGATION; IDENTIFICATION; ABNORMALITIES; STATISTICS; DISEASE; TUMORS; IGM	Waldenstroom macroglobulinemia (WM), a distinctive subtype of non-Hodgkin lymphoma that features overproduction of immunoglobulin M (IgM), clearly has a familial component; however, no susceptibility genes have yet been identified. We performed a genomewide linkage analysis in 11 high-risk families with WM that were informative for linkage, for a total of 122 individuals with DNA samples, including 34 patients with WM and 10 patients with IgM monoclonal gammopathy of undetermined significance (IgM MGUS). We genotyped 1,058 microsatellite markers ( average spacing 3.5 cM), performed both nonparametric and parametric linkage analysis, and computed both two-point and multipoint linkage statistics. The strongest evidence of linkage was found on chromosomes 1q and 4q when patients with WM and with IgM MGUS were both considered affected; nonparametric linkage scores were 2.5 (P = .0089) and 3.1 (P = .004), respectively. Other locations suggestive of linkage were found on chromosomes 3 and 6. Results of two- locus linkage analysis were consistent with independent effects. The findings from this first linkage analysis of families at high risk for WM represent important progress toward identifying gene(s) that modulate susceptibility to WM and toward understanding its complex etiology.	NCI, DCEG, DHHS, Genet Epidemiol Branch,NIH, Bethesda, MD 20892 USA; NCI, DCEG, DHHS, Biostat Branch,NIH, Bethesda, MD 20892 USA; Univ Klinikum Essen, Inst Human Genet, Essen, Germany; Westat Res Inc, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Duisburg Essen; Westat	McMaster, ML (corresponding author), NCI, DCEG, DHHS, Genet Epidemiol Branch,NIH, 6120 Execut Blvd,MSC 7236, Bethesda, MD 20892 USA.	mcmastem@mail.nih.gov	Boehringer, Stefan/Y-2442-2018; Tucker, Margaret A/B-4297-2015	Boehringer, Stefan/0000-0001-9108-9212; Ter-Minassian, Monica/0000-0002-9497-2585	Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [N02-CP-01108] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01CP004410] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Altieri A, 2005, LEUKEMIA, V19, P2342, DOI 10.1038/sj.leu.2403991; Berger R, 2001, PATHOLOGY GENETICS T, P132; Cohen HJ, 1998, AM J MED, V104, P439, DOI 10.1016/S0002-9343(98)00080-1; Dimopoulos MA, 2003, ANN ONCOL, V14, P1299, DOI 10.1093/annonc/mdg334; ELVES M W, 1968, Journal of Medical Genetics, V5, P118, DOI 10.1136/jmg.5.2.118; FINE JM, 1982, ACTA MED SCAND, V211, P237; Fisher SG, 2004, ONCOGENE, V23, P6524, DOI 10.1038/sj.onc.1207843; GOBBI PG, 1994, BLOOD, V83, P2939, DOI 10.1182/blood.V83.10.2939.2939; Goldin LR, 2004, BLOOD, V104, P1850, DOI 10.1182/blood-2004-01-0341; Goldin LR, 2005, CANCER EPIDEM BIOMAR, V14, P2402, DOI 10.1158/1055-9965.EPI-05-0346; Goldin LR, 2005, J MED GENET, V42, P595, DOI 10.1136/jmg.2004.027433; Goldin LR, 2004, CANCER-AM CANCER SOC, V100, P1902, DOI 10.1002/cncr.20189; Jaffe ES, 2001, PATHOLOGY GENETICS T; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; JOHANSSON B, 1995, LEUKEMIA, V9, P1136; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kyle RA, 2003, BLOOD, V102, P3759, DOI 10.1182/blood-2003-03-0801; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Mansoor A, 2001, AM J CLIN PATHOL, V116, P543; McMaster ML, 2005, CLIN LYMPHOMA, V5, P230, DOI 10.3816/CLM.2005.n.005; McMaster ML, 2003, SEMIN ONCOL, V30, P146, DOI 10.1053/sonc.2003.50063; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Owen R G, 2000, Clin Lymphoma, V1, P39, DOI 10.3816/CLM.2000.n.003; PALKA G, 1987, CANCER GENET CYTOGEN, V29, P261, DOI 10.1016/0165-4608(87)90237-8; Pangalis GA, 2005, CLIN LYMPHOMA, V5, P235, DOI 10.3816/CLM.2005.n.006; Schop RFJ, 2002, BLOOD, V100, P2996, DOI 10.1182/blood.V100.8.2996; SELIGMANN M, 1967, AM J MED, V43, P66, DOI 10.1016/0002-9343(67)90149-0; Sobel E, 2001, HUM HERED, V52, P121, DOI 10.1159/000053366; Sobel E, 1996, AM J HUM GENET, V58, P1323; Sobel E, 2002, AM J HUM GENET, V70, P496, DOI 10.1086/338920; Strauch K, 2003, HUM HERED, V56, P200, DOI 10.1159/000076394; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; TALEB N, 1991, ACTA ONCOL, V30, P703, DOI 10.3109/02841869109092443; Treon SP, 2006, ANN ONCOL, V17, P488, DOI 10.1093/annonc/mdj111; YOUINOU P, 1978, BIOMEDICINE, V28, P226	36	47	48	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2006	79	4					695	701		10.1086/507687	http://dx.doi.org/10.1086/507687			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	089BV	16960805	Bronze, Green Published			2022-12-18	WOS:000240855900010
J	Verzilli, CJ; Stallard, N; Whittaker, JC				Verzilli, Claudio J.; Stallard, Nigel; Whittaker, John C.			Bayesian graphical models for genomewide association studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM PATTERNS	As the extent of human genetic variation becomes more fully characterized, the research community is faced with the challenging task of using this information to dissect the heritable components of complex traits. Genomewide association studies offer great promise in this respect, but their analysis poses formidable difficulties. In this article, we describe a computationally efficient approach to mining genotype-phenotype associations that scales to the size of the data sets currently being collected in such studies. We use discrete graphical models as a data-mining tool, searching for single- or multilocus patterns of association around a causative site. The approach is fully Bayesian, allowing us to incorporate prior knowledge on the spatial dependencies around each marker due to linkage disequilibrium, which reduces considerably the number of possible graphical structures. A Markov chain-Monte Carlo scheme is developed that yields samples from the posterior distribution of graphs conditional on the data from which probabilistic statements about the strength of any genotype-phenotype association can be made. Using data simulated under scenarios that vary in marker density, genotype relative risk of a causative allele, and mode of inheritance, we show that the proposed approach has better localization properties and leads to lower false-positive rates than do single- locus analyses. Finally, we present an application of our method to a quasi-synthetic data set in which data from the CYP2D6 region are embedded within simulated data on 100K single- nucleotide polymorphisms. Analysis is quick (< 5 min), and we are able to localize the causative site to a very short interval.	Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; Univ Warwick, Sch Med, Div Hlth Community, Warwick, England	University of London; London School of Hygiene & Tropical Medicine; University of Warwick	Verzilli, CJ (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	claudio.verzilli@lshtm.ac.uk	Whittaker, John C/B-8609-2012	Whittaker, John C/0000-0002-3529-2379; Stallard, Nigel/0000-0001-7781-1512	Wellcome Trust [GR 068213] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Borgelt C., 2002, GRAPHICAL MODELS MET; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; COWELL RG, 1999, PROBABILISTIC NETWOR; DAWID AP, 1993, ANN STAT, V21, P1272, DOI 10.1214/aos/1176349260; Dawson E, 2002, NATURE, V418, P544, DOI 10.1038/nature00864; Dellaportas P, 1999, BIOMETRIKA, V86, P615, DOI 10.1093/biomet/86.3.615; Denison D.G.T., 2002, BAYESIAN METHODS NON; Durrant C, 2004, AM J HUM GENET, V75, P35, DOI 10.1086/422174; Evans DM, 2005, AM J HUM GENET, V76, P681, DOI 10.1086/429274; Farrall M, 2005, HUM MOL GENET, V14, pR157, DOI 10.1093/hmg/ddi273; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; GIUDICI P, 1999, EFFICIENT MODEL DETE; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hosking L. K., 2002, Pharmacogenomics Journal, V2, P165, DOI 10.1038/sj.tpj.6500096; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Lawrence RW, 2005, PHILOS T R SOC B, V360, P1589, DOI 10.1098/rstb.2005.1689; Little RJ, 1987, STAT ANAL MISSING DA; MADIGAN D, 1995, INT STAT REV, V63, P215, DOI 10.2307/1403615; Maniatis N, 2005, HUM MOL GENET, V14, P145, DOI 10.1093/hmg/ddi019; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Monti S., 1999, LEARNING GRAPHICAL M; Morris AP, 2005, GENET EPIDEMIOL, V29, P91, DOI 10.1002/gepi.20080; Morris AP, 2003, P NATL ACAD SCI USA, V100, P13442, DOI 10.1073/pnas.2235031100; Mueller JC, 2005, AM J HUM GENET, V76, P387, DOI 10.1086/427925; MURRAY I, 2004, P 20 ANN C UNC ART I; OHagan A., 2004, KENDALLS ADV THEOR B, V2B; R Development Core Team, 2004, R LANG ENV STAT COMP; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rodin AS, 2005, BIOINFORMATICS, V21, P3273, DOI 10.1093/bioinformatics/bti505; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sebastiani P, 2005, NAT GENET, V37, P435, DOI 10.1038/ng1533; Tarantola C, 2004, STAT MODEL, V4, P39, DOI 10.1191/1471082X04st063oa; Thomas A, 2005, GENET EPIDEMIOL, V29, P23, DOI 10.1002/gepi.20076; Thomas A, 2004, AM J HUM GENET, V74, P1088, DOI 10.1086/421249; Thomas DC, 2005, AM J HUM GENET, V77, P337, DOI 10.1086/432962; Thomas DC, 2003, HUM HERED, V56, P32, DOI 10.1159/000073730; Verzilli CJ, 2005, GENET EPIDEMIOL, V28, P313, DOI 10.1002/gepi.20072; Viallefont V, 2001, STAT MED, V20, P3215, DOI 10.1002/sim.976.abs; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Zollner S, 2005, GENETICS, V169, P1071, DOI 10.1534/genetics.104.031799; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	43	47	47	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2006	79	1					100	112		10.1086/505313	http://dx.doi.org/10.1086/505313			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	053YD	16773569	Green Published, Bronze			2022-12-18	WOS:000238341200010
J	Wang, L; Wang, XB; Laird, N; Zuckerman, B; Stubblefield, P; Xu, X				Wang, L; Wang, XB; Laird, N; Zuckerman, B; Stubblefield, P; Xu, X			Polymorphism in maternal LRP8 gene is associated with fetal growth	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							E RECEPTOR 2; BIRTH-WEIGHT; INTRAUTERINE GROWTH; APOLIPOPROTEIN-E; POPULATION STRATIFICATION; AGE; HYPERTENSION; PREGNANCY; ULTRASOUND; SEVERITY	Fetal growth restriction (FGR) affects 1200,000 pregnancies in the United States annually and is associated with increased perinatal mortality and morbidity, as well as poorer long-term health for infants with FGR compared with infants without FGR. FGR appears to be a complex trait, but the role of genetic factors in the development of FGR is largely unknown. We conducted a candidate-gene association study of birth weight and FGR in two independent study samples obtained at the Boston Medical Center. We first investigated the association between maternal genotypes of 68 single-nucleotide polymorphisms (SNPs) from 41 candidate genes and fetal growth in a sample of 204 black women selected for a previous study of preeclampsia, 92 of whom had preeclampsia (characterized by high blood pressure and the presence of protein in the urine). We found significant association between SNP rs2297660 in the LRP8 gene and birth weight. Subsequently, we replicated the association in a larger independent sample of 1,094 black women; similar association between LRP8 and FGR was observed in this sample. The "A" allele at rs2297660 was associated with a higher standardized birth weight and a lower risk of FGR. Under the additive genetic model, each additional copy of the "A" allele reduced the risk of FGR by 33% (P < .05). In conclusion, results from the two independent samples of black women provide consistent evidence that SNP rs2297660 in LRP8 is associated with fetal growth.	Harvard Univ, Sch Publ Hlth, Program Populat Genet, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Boston Univ, Med Ctr, Dept Pediat, Boston, MA USA; Boston Univ, Med Ctr, Dept Obstet & Gynecol, Boston, MA USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; Childrens Mem Hosp, Mary Ann & J Milburn Smith Child Hlth Res Program, Childrens Mem Res Ctr, Chicago, IL 60614 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Boston University; Boston University; University of California System; University of California Los Angeles; Ann & Robert H. Lurie Children's Hospital of Chicago	Xu, X (corresponding author), Harvard Univ, Sch Publ Hlth, Program Populat Genet, 665 Huntington Ave FXB-101, Boston, MA 02115 USA.	xin_xu@harvard.edu	Xu, Xin/A-1687-2016	Xu, Xin/0000-0002-6324-5211; Zuckerman, Barry/0000-0002-0044-2592	NICHD NIH HHS [R01 HD041702, R01 HD41702] Funding Source: Medline; NIEHS NIH HHS [R01ES11682, R21 ES011666, R21 ES11666, P30 ES000002, ES-00002, R01 ES011682] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD041702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES011666, P30ES000002, R01ES011682] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Alexander G R, 1999, Matern Child Health J, V3, P71, DOI 10.1023/A:1021849209722; ALLEN MC, 1984, SEMIN PERINATOL, V8, P123; Anteby EY, 2004, EUR J OBSTET GYN R B, V113, P31, DOI 10.1016/j.ejogrb.2003.05.002; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bracken MB, 2003, OBSTET GYNECOL, V102, P739, DOI 10.1016/S0029-7844(03)00621-5; BRENNER WE, 1976, AM J OBSTET GYNECOL, V126, P555, DOI 10.1016/0002-9378(76)90748-1; CALLAN NA, 1990, INT J GYNECOL OBSTET, V33, P215, DOI 10.1016/0020-7292(90)90004-5; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Clausson B, 2002, AM J EPIDEMIOL, V155, P429, DOI 10.1093/aje/155.5.429; CNATTINGIUS S, 1985, OBSTET GYNECOL, V66, P449; Creasy R.K., 1994, MATERNAL FETAL MED P, V3rd ed., P558; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; GALBRAITH RS, 1979, AM J OBSTET GYNECOL, V133, P281, DOI 10.1016/0002-9378(79)90679-3; Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; GOLDENBERG RL, 1990, AM J OBSTET GYNECOL, V162, P1626, DOI 10.1016/0002-9378(90)90932-W; Hao K, 2004, HUM MOL GENET, V13, P683, DOI 10.1093/hmg/ddh091; HUGHEY MJ, 1984, OBSTET GYNECOL, V64, P101; Kim DH, 1997, J BIOL CHEM, V272, P8498, DOI 10.1074/jbc.272.13.8498; Kim DH, 1996, J BIOL CHEM, V271, P8373, DOI 10.1074/jbc.271.14.8373; KURJAK A, 1980, OBSTET GYNECOL, V56, P281; Li HJ, 2003, AM J CLIN NUTR, V77, P1498, DOI 10.1093/ajcn/77.6.1498; Loos RJF, 2002, AM J CLIN NUTR, V75, P676, DOI 10.1093/ajcn/75.4.676; LUBCHENCO LO, 1963, PEDIATRICS, V32, P793; Lucas A, 1999, BRIT MED J, V319, P245, DOI 10.1136/bmj.319.7204.245; MABIE WC, 1986, OBSTET GYNECOL, V67, P197, DOI 10.1097/00006250-198602000-00008; Mahley RW, 1999, CURR OPIN LIPIDOL, V10, P207, DOI 10.1097/00041433-199906000-00003; MCCANCE DR, 1994, BRIT MED J, V308, P942, DOI 10.1136/bmj.308.6934.942; Roberts JM, 2003, HYPERTENSION, V41, P437, DOI 10.1161/01.HYP.0000054981.03589.E9; Robinson WP, 1997, AM J HUM GENET, V60, P917; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; SIBAI BM, 1983, OBSTET GYNECOL, V61, P571; SIBAI BM, 1986, OBSTET GYNECOL, V67, P517; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Vickers MH, 2001, J ENDOCRINOL, V170, P323, DOI 10.1677/joe.0.1700323; Wang XB, 2002, JAMA-J AM MED ASSOC, V287, P195, DOI 10.1001/jama.287.2.195; WENNERGREN M, 1988, OBSTET GYNECOL, V72, P615; ZHANG J, 1995, OBSTET GYNECOL, V86, P200, DOI 10.1016/0029-7844(95)00142-E	39	47	50	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2006	78	5					770	777		10.1086/503712	http://dx.doi.org/10.1086/503712			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032EH	16642433	Bronze, Green Published			2022-12-18	WOS:000236756200004
J	Du, H; Levine, M; Ganesa, C; Witte, DP; Cole, ES; Grabowski, GA				Du, H; Levine, M; Ganesa, C; Witte, DP; Cole, ES; Grabowski, GA			The role of mannosylated enzyme and the mannose receptor in enzyme replacement therapy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LYSOSOMAL ACID LIPASE; ESTER STORAGE DISEASE; YEAST PICHIA-PASTORIS; CHOLESTERYL ESTER; METHYLOTROPHIC YEAST; LINKED GLYCOSYLATION; WOLMAN-DISEASE; RAT-LIVER; IN-SITU; DEFICIENCY	Lysosomal acid lipase (LAL) is the critical enzyme for the hydrolysis of triglycerides (TGs) and cholesteryl esters (CEs) in lysosomes. LAL defects cause Wolman disease (WD) and CE storage disease (CESD). An LAL null (lal(-/-)) mouse model closely mimics human WD/CESD, with hepatocellular, Kupffer cell and other macrophage, and adrenal cortical storage of CEs and TGs. The effect on the cellular targeting of high-mannose and complex oligosaccharide-type oligosaccharide chains was tested with human LAL expressed in Pichia pastoris (phLAL) and CHO cells (chLAL), respectively. Only chLAL was internalized by cultured fibroblasts, whereas both chLAL and phLAL were taken up by macrophage mannose receptor (MMR)-positive J774E cells. After intraperitoneal injection into lal(-/-) mice, phLAL and chLAL distributed to macrophages and macrophage-derived cells of various organs. chLAL was also detected in hepatocytes. Ten injections of either enzyme over 30 d into 2- and 2.5-mo-old lal(-/-) mice produced normalization of hepatic color, decreased liver weight (50%-58%), and diminished hepatic cholesterol and TG storage. Lipid accumulations in macrophages were diminished with either enzyme. Only chLAL cleared lipids in hepatocytes. Mice double homozygous for the LAL and MMR deficiences (lal(-/-); MMR-/-) showed phLAL uptake into Kupffer cells and hepatocytes, reversal of macrophage histopathology and lipid storage in all tissues, and clearance of hepatocytes. These results implicate MMR-independent and mannose 6-phosphate receptor-independent pathways in phLAL uptake and delivery to lysosomes in vivo. In addition, these studies show specific cellular targeting and physiologic effects of differentially oligosaccharide-modified human LALs mediated by MMR and that lysosomal targeting of mannose-terminated glycoproteins occurs and storage can be eliminated effectively without MMR.	Childrens Hosp Res Fdn, Div & Program Human Genet, Cincinnati, OH 45229 USA; Childrens Hosp Res Fdn, Div Pathol, Cincinnati, OH 45229 USA; Genzyme, Cambridge, MA USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Sanofi-Aventis; Genzyme Corporation	Grabowski, GA (corresponding author), Childrens Hosp Res Fdn, Div & Program Human Genet, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	grey.grabowski@cchmc.org			NIDDK NIH HHS [DK 54930, DK36729, R01 DK036729] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054930, R01DK036729] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anumula KR, 1998, GLYCOBIOLOGY, V8, P685, DOI 10.1093/glycob/8.7.685; Aslanidis C, 1996, GENOMICS, V33, P85, DOI 10.1006/geno.1996.0162; BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; BEAUDET AL, 1977, J PEDIATR-US, V90, P910, DOI 10.1016/S0022-3476(77)80557-X; Boven LA, 2004, AM J CLIN PATHOL, V122, P359, DOI 10.1309/BG5VA8JRDQH1M7HN; Du H, 1996, J LIPID RES, V37, P937; Du H, 1998, HUM MOL GENET, V7, P1347, DOI 10.1093/hmg/7.9.1347; Du H, 1998, MOL GENET METAB, V64, P126, DOI 10.1006/mgme.1998.2707; Du H, 2002, HUM GENE THER, V13, P1361, DOI 10.1089/104303402760128586; Du H, 2001, J LIPID RES, V42, P489; Du H, 2001, HUM MOL GENET, V10, P1639, DOI 10.1093/hmg/10.16.1639; FOLCH J, 1957, J BIOL CHEM, V226, P497; GEUZE HJ, 1984, J CELL BIOL, V98, P2047, DOI 10.1083/jcb.98.6.2047; GINSBERG HN, 1987, J CLIN INVEST, V80, P1692, DOI 10.1172/JCI113259; GOLDSTEIN JL, 1975, J BIOL CHEM, V250, P8487; GRABOWSKI GA, 2003, PEDIAT GASTROINTESTI; HALBERG DF, 1987, J BIOL CHEM, V262, P9828; Henriksson H, 2003, BIOCHEM J, V375, P61, DOI 10.1042/BJ20030485; Hirose M, 2002, YEAST, V19, P1191, DOI 10.1002/yea.914; HUDGIN RL, 1974, J BIOL CHEM, V249, P5536; Kalidas C, 2001, PROTEIN ENG, V14, P201, DOI 10.1093/protein/14.3.201; Krivit W, 2000, BONE MARROW TRANSPL, V26, P567, DOI 10.1038/sj.bmt.1702557; Lee K, 2003, GLYCOBIOLOGY, V13, P305, DOI 10.1093/glycob/cwg034; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; Lerouge P, 1998, PLANT MOL BIOL, V38, P31, DOI 10.1023/A:1006012005654; MATSUO H, 1994, J DRUG TARGET, V2, P141, DOI 10.3109/10611869409015902; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Montesino R, 1998, PROTEIN EXPRES PURIF, V14, P197, DOI 10.1006/prep.1998.0933; RedonnetVernhet I, 1997, BIOCHEM MOL MED, V62, P42, DOI 10.1006/bmme.1997.2626; RUDEL LL, 1973, J LIPID RES, V14, P364; SHERIFF S, 1995, J BIOL CHEM, V270, P27766, DOI 10.1074/jbc.270.46.27766; Trimble RB, 2004, GLYCOBIOLOGY, V14, P265, DOI 10.1093/glycob/cwh036; VANDONGEN JM, 1984, HISTOCHEM J, V16, P941, DOI 10.1007/BF01003850; YAMADA M, 1994, BBA-PROTEIN STRUCT M, V1206, P279, DOI 10.1016/0167-4838(94)90219-4	35	47	54	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2005	77	6					1061	1074		10.1086/498652	http://dx.doi.org/10.1086/498652			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	983OE	16380916	Green Published, Bronze			2022-12-18	WOS:000233241200014
J	Shaw, CJ; Withers, MA; Lupski, JR				Shaw, CJ; Withers, MA; Lupski, JR			Uncommon deletions of the Smith-Magenis syndrome region can be recurrent when alternate low-copy repeats act as homologous recombination substrates	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME ARCHITECTURE; CHROMOSOME 17P11.2; STRAND EXCHANGE; HUMAN-DISEASE; DNA; REARRANGEMENTS; DISORDERS; HOTSPOT; SEQUENCE; DUPLICATION	Several homologous recombination "hotspots," or sites of positional preference for strand exchanges, associated with recurrent deletions and duplications have been reported within large low-copy repeats (LCRs). Recently, such a hotspot was identified in patients with the Smith-Magenis syndrome (SMS) common deletion of similar to4 Mb or a reciprocal duplication within the KER gene cluster of the SMS-REP LCRs, in which 50% of analyzed strand exchanges resulting in deletion and 23% of those resulting in duplication occurred. Here, we report an additional recombination hotspot within LCR17pA and LCR17pD, which serve as alternative substrates for nonallelic homologous recombination that results in large (similar to5 Mb) deletions of 17p11.2, which include the SMS region. Using polymerase-chain-reaction mapping of somatic cell hybrid lines, we refined the breakpoints of six deletions within these LCRs. Sequence analysis of the recombinant junctions revealed that all six strand exchanges occurred within a 524-bp interval, and four of them occurred within an AluSq/x element. This interval represents only 0.5% of the 124-kb stretch of 98.6% sequence identity between LCR17pA and LCR17pD. A search for potentially stimulating sequence motifs revealed short AT-rich segments flanking the recombination hotspot. Our findings indicate that alternative LCRs can mediate rearrangements, resulting in haploinsufficiency of the SMS critical region, and reimplicate homologous recombination as a major mechanism for genomic disorders.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lupski, JR (corresponding author), 1 Baylor Plaza,Room 604B, Houston, TX 77030 USA.	jlupski@bcm.tmc.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD039420] Funding Source: NIH RePORTER; NICHD NIH HHS [HD24064, P01 HD039420, P30 HD024064, P01 HD39420] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abeysinghe SS, 2003, HUM MUTAT, V22, P229, DOI 10.1002/humu.10254; BARAN N, 1987, MOL CELL BIOL, V7, P2636, DOI 10.1128/MCB.7.7.2636; Bayes M, 2003, AM J HUM GENET, V73, P131, DOI 10.1086/376565; Bi WM, 2003, AM J HUM GENET, V73, P1302, DOI 10.1086/379979; Bi WM, 2002, GENOME RES, V12, P713, DOI 10.1101/gr.73702; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; CULLEN M, 1995, AM J HUM GENET, V56, P1350; Cullen M, 1997, AM J HUM GENET, V60, P397; DAYN A, 1992, P NATL ACAD SCI USA, V89, P11406, DOI 10.1073/pnas.89.23.11406; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; GARNER MM, 1987, J MOL BIOL, V196, P581, DOI 10.1016/0022-2836(87)90034-9; GREENBERG F, 1991, AM J HUM GENET, V49, P1207; HANIFORD DB, 1983, NATURE, V302, P632, DOI 10.1038/302632a0; Herbert JM, 1996, J BIOL CHEM, V271, P25928; Juyal RC, 1996, AM J HUM GENET, V58, P998; Kolomietz E, 2002, GENE CHROMOSOME CANC, V35, P97, DOI 10.1002/gcc.10111; LAPIDOT A, 1989, NUCLEIC ACIDS RES, V17, P883, DOI 10.1093/nar/17.3.883; Lopes J, 1999, HUM MOL GENET, V8, P2285, DOI 10.1093/hmg/8.12.2285; Lopez-Correa C, 2001, HUM MOL GENET, V10, P1387, DOI 10.1093/hmg/10.13.1387; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; LYAMICHEV VI, 1985, J BIOMOL STRUCT DYN, V3, P327, DOI 10.1080/07391102.1985.10508420; MIRKIN SM, 1987, NATURE, V330, P495, DOI 10.1038/330495a0; PECK LJ, 1985, CELL, V40, P129, DOI 10.1016/0092-8674(85)90316-2; Potocki L, 2003, GENET MED, V5, P430, DOI 10.1097/01.GIM.0000095625.14160.AB; Reiter LT, 1996, NAT GENET, V12, P288, DOI 10.1038/ng0396-288; Reiter LT, 1998, AM J HUM GENET, V62, P1023, DOI 10.1086/301827; RUDIGER NS, 1995, NUCLEIC ACIDS RES, V23, P256, DOI 10.1093/nar/23.2.256; Shaw CJ, 2004, J MED GENET, V41, P113, DOI 10.1136/jmg.2003.012831; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Shaw CJ, 2002, AM J HUM GENET, V71, P1072, DOI 10.1086/344346; SPITZNER JR, 1990, NUCLEIC ACIDS RES, V18, P1, DOI 10.1093/nar/18.1.1; Stankiewicz P, 2003, AM J HUM GENET, V72, P1101, DOI 10.1086/374385; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Vlangos CN, 2003, MOL GENET METAB, V79, P134, DOI 10.1016/S1096-7192(03)00048-9	34	47	47	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2004	75	1					75	81		10.1086/422016	http://dx.doi.org/10.1086/422016			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	829FG	15148657	Bronze, Green Published			2022-12-18	WOS:000222031300009
J	Lutz, SM; Vincent, BJ; Kazazian, HH; Balzer, MA; Moran, JV				Lutz, SM; Vincent, BJ; Kazazian, HH; Balzer, MA; Moran, JV			Allelic heterogeneity in LINE-1 retrotransposition activity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							REVERSE TRANSCRIPTION; GENOMIC DNA; MECHANISM; SEQUENCES; PROTEIN; RNA; TRANSDUCTION; ELEMENTS	De novo LINE-1 (long interspersed element-1, or L1) retrotransposition events are responsible for similar to1/1,000 disease-causing mutations in humans. Previously, L1.2 was identified as the likely progenitor of a mutagenic insertion in the factor VIII gene in a patient with hemophilia A. It subsequently was shown to be one of a small number of active Us in the human genome. Here, we demonstrate that L1.2 is present at an intermediate insertion allele frequency in worldwide human populations and that common alleles (L1.2A and L1.2B) exhibit an similar to16-fold difference in their ability to retrotranspose in cultured human HeLa cells. Chimera analysis revealed that two amino acid substitutions (S1259L and I1220M) downstream of the conserved cysteine-rich motif in Ll open reading frame 2 are largely responsible for the observed reduction in L1.2A retrotransposition efficiency. Thus, common Ll alleles can vary widely in their retrotransposition potential. We propose that such allelic heterogeneity can influence the potential L1 mutational load present in an individual genome.	Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; Louisiana State Univ, Dept Biol Sci, Biol Computat & Visualizat Ctr, Baton Rouge, LA 70803 USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Louisiana State University System; Louisiana State University; University of Pennsylvania	Moran, JV (corresponding author), Univ Michigan, Sch Med, Dept Human Genet, 1241 E Catherine St, Ann Arbor, MI 48109 USA.	moranj@umich.edu		Lutz, Sheila/0000-0002-6729-4598	NIGMS NIH HHS [GM60518, R01 GM059290, GM45398, R01 GM045398, R01 GM060518, GM59290] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059290, R01GM060518] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boeke JD, 1997, NAT GENET, V16, P6, DOI 10.1038/ng0597-6; Boissinot S, 2000, MOL BIOL EVOL, V17, P915, DOI 10.1093/oxfordjournals.molbev.a026372; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Choi Y, 1999, ANIM GENET, V30, P51, DOI 10.1046/j.1365-2052.1999.00400.x; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; DOMBROSKI BA, 1993, P NATL ACAD SCI USA, V90, P6513, DOI 10.1073/pnas.90.14.6513; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; Ejima Y, 2003, HUM MOL GENET, V12, P1321, DOI 10.1093/hmg/ddg138; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; FANNING T, 1987, NUCLEIC ACIDS RES, V15, P2251, DOI 10.1093/nar/15.5.2251; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Goodier JL, 2000, HUM MOL GENET, V9, P653, DOI 10.1093/hmg/9.4.653; GUO SW, 1992, AM J HUM GENET, V51, P1111; Hohjoh H, 1997, EMBO J, V16, P6034, DOI 10.1093/emboj/16.19.6034; Hohjoh H, 1996, EMBO J, V15, P630, DOI 10.1002/j.1460-2075.1996.tb00395.x; HOLMES SE, 1992, J BIOL CHEM, V267, P19765; HOLMES SE, 1994, NAT GENET, V7, P143, DOI 10.1038/ng0694-143; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; Kubo Y, 2001, MOL BIOL EVOL, V18, P848, DOI 10.1093/oxfordjournals.molbev.a003866; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; LUAN DD, 1995, MOL CELL BIOL, V15, P3882; MATHIAS SL, 1991, SCIENCE, V254, P1808, DOI 10.1126/science.1722352; Moran J.V., 2002, MOBILE DNA, P836; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Myers JS, 2002, AM J HUM GENET, V71, P312, DOI 10.1086/341718; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Ovchinnikov I, 2001, GENOME RES, V11, P2050, DOI 10.1101/gr.194701; Pickeral OK, 2000, GENOME RES, V10, P411, DOI 10.1101/gr.10.4.411; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; SCOTT A F, 1987, Genomics, V1, P113, DOI 10.1016/0888-7543(87)90003-6; Sheen FM, 2000, GENOME RES, V10, P1496, DOI 10.1101/gr.149400; SKOWRONSKI J, 1988, MOL CELL BIOL, V8, P1385, DOI 10.1128/MCB.8.4.1385; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; Wei W, 2000, ANAL BIOCHEM, V284, P435, DOI 10.1006/abio.2000.4675; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001	38	47	48	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2003	73	6					1431	1437		10.1086/379744	http://dx.doi.org/10.1086/379744			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	756PW	14610717	Bronze, Green Published			2022-12-18	WOS:000187491100017
J	Zietkiewicz, E; Yotova, V; Gehl, D; Wambach, T; Arrieta, I; Batzer, M; Cole, DEC; Hechtman, P; Kaplan, F; Modiano, D; Moisan, JP; Michalski, R; Labuda, D				Zietkiewicz, E; Yotova, V; Gehl, D; Wambach, T; Arrieta, I; Batzer, M; Cole, DEC; Hechtman, P; Kaplan, F; Modiano, D; Moisan, JP; Michalski, R; Labuda, D			Haplotypes in the dystrophin DNA segment point to a mosaic origin of modern human diversity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							Y-CHROMOSOME HAPLOTYPES; LINKAGE DISEQUILIBRIUM; SEQUENCE VARIATION; HUMAN-EVOLUTION; HUMAN-POPULATIONS; HIGH-RESOLUTION; RECOMBINATION EVENTS; MITOCHONDRIAL-DNA; GENETIC-STRUCTURE; FRENCH-CANADIANS	Although Africa has played a central role in human evolutionary history, certain studies have suggested that not all contemporary human genetic diversity is of recent African origin. We investigated 35 simple polymorphic sites and one T-n microsatellite in an 8-kb segment of the dystrophin gene. We found 86 haplotypes in 1,343 chromosomes from around the world. Although a classical out-of-Africa topology was observed in trees based on the variant frequencies, the tree of haplotype sequences reveals three lineages accounting for present-day diversity. The proportion of new recombinants and the diversity of the T-n microsatellite were used to estimate the age of haplotype lineages and the time of colonization events. The lineage that underwent the great expansion originated in Africa prior to the Upper Paleolithic (27,000-56,000 years ago). A second group, of structurally distinct haplotypes that occupy a central position on the tree, has never left Africa. The third lineage is represented by the haplotype that lies closest to the root, is virtually absent in Africa, and appears older than the recent out-of-Africa expansion. We propose that this lineage could have left Africa before the expansion (as early as 160,000 years ago) and admixed, outside of Africa, with the expanding lineage. Contemporary human diversity, although dominated by the recently expanded African lineage, thus represents a mosaic of different contributions.	Hop St Justine, Ctr Rech, Montreal, PQ H3T 1C5, Canada; McGill Univ, Ctr Human Genet, Montreal, PQ, Canada; McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; Univ Montreal, Dept Pediat, Montreal, PQ H3C 3J7, Canada; Polish Acad Sci, Inst Human Genet, PL-60479 Poznan, Poland; Univ Basque Country, Dept Biol Anim & Genet, E-48080 Bilbao, Spain; Louisiana State Univ, Biol Computat & Visualizat Ctr, Dept Biol Sci, Baton Rouge, LA 70803 USA; Univ Toronto, Dept Lab Med & Pathol, Toronto, ON, Canada; Univ Roma La Sapienza, Ist Parassitol, Fdn Pasteur Cenci Bolognetti, Rome, Italy; Ctr Hosp Reg & Univ, Nantes, France; Victoria Hosp, Prince Albert Parkland Hlth Reg, Prince Albert, SK, Canada	Universite de Montreal; McGill University; McGill University; Universite de Montreal; Polish Academy of Sciences; Institute of Human Genetics of the Polish Academy of Sciences; University of Basque Country; Louisiana State University System; Louisiana State University; University of Toronto; Fondazione Cenci Bolognetti; Sapienza University Rome; Nantes Universite; CHU de Nantes; University of Victoria	Labuda, D (corresponding author), Hop St Justine, Ctr Rech, 3175 Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	damian.labuda@umontreal.ca	Zietkiewicz, Ewa/ABP-3539-2022	Zietkiewicz, Ewa/0000-0003-2437-5088				Baird DM, 2000, AM J HUM GENET, V66, P235, DOI 10.1086/302721; BATZER MA, 1994, P NATL ACAD SCI USA, V91, P12288, DOI 10.1073/pnas.91.25.12288; Bianchi NO, 1998, AM J HUM GENET, V63, P1862, DOI 10.1086/302141; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; CHEN YS, 1995, AM J HUM GENET, V57, P133; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Colombo R, 2000, AM J HUM GENET, V66, P692, DOI 10.1086/302757; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Di Rienzo A, 1998, GENETICS, V148, P1269; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Fan JB, 2002, GENOMICS, V80, P351, DOI 10.1006/geno.2002.6832; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Hammer MF, 1998, MOL BIOL EVOL, V15, P427, DOI 10.1093/oxfordjournals.molbev.a025939; Hammer MF, 1997, GENETICS, V145, P787; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; Harding RM, 1997, AM J HUM GENET, V60, P772; Harris EE, 1999, P NATL ACAD SCI USA, V96, P3320, DOI 10.1073/pnas.96.6.3320; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HUDSON RR, 1985, GENETICS, V111, P147; Jaruzelska J, 1999, GENETICS, V152, P1091; Jin L, 1999, P NATL ACAD SCI USA, V96, P3796, DOI 10.1073/pnas.96.7.3796; Jorde LB, 1997, P NATL ACAD SCI USA, V94, P3100, DOI 10.1073/pnas.94.7.3100; Kaessmann H, 1999, NAT GENET, V22, P78, DOI 10.1038/8785; Kidd JR, 2000, AM J HUM GENET, V66, P1882, DOI 10.1086/302952; Kimmel M, 1998, GENETICS, V148, P1921; Kivisild T, 1999, CURR BIOL, V9, P1331, DOI 10.1016/S0960-9822(00)80057-3; KLEIN R, 1999, HUMAN CAREER HUM BIO; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Labuda D, 2000, GENETICS, V156, P799; Labuda D, 1997, AM J HUM GENET, V61, P768, DOI 10.1016/S0002-9297(07)64341-9; Labuda M, 1996, AM J HUM GENET, V59, P633; Lahr Marta Mirazon, 1994, Evolutionary Anthropology, V3, P48, DOI 10.1002/evan.1360030206; Lahr MM, 1998, YEARB PHYS ANTHROPOL, V41, P137; Luria SE, 1943, GENETICS, V28, P491; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; Pritchard JK, 1996, THEOR POPUL BIOL, V50, P325, DOI 10.1006/tpbi.1996.0034; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Relethford John H., 1995, Evolutionary Anthropology, V4, P53, DOI 10.1002/evan.1360040207; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Satta Y, 2002, BIOESSAYS, V24, P871, DOI 10.1002/bies.10166; SCHNEIDER S, 1997, ARLEQUIN VERSION 1 1; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; Slatkin M, 2000, ANNU REV GENOM HUM G, V1, P225, DOI 10.1146/annurev.genom.1.1.225; STEPHENS JC, 1986, GENETICS, V112, P923; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stiner MC, 1999, SCIENCE, V283, P190, DOI 10.1126/science.283.5399.190; Stoneking M, 1997, GENOME RES, V7, P1061, DOI 10.1101/gr.7.11.1061; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; TAKAHATA N, 1994, MOL BIOL EVOL, V11, P803; TATTERSALL I, 2000, EXTINCT HUMANS; Tattersall Ian, 1995, FOSSIL TRAIL WE KNOW; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; TORRONI A, 1993, AM J HUM GENET, V53, P563; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Verrelli BC, 2002, AM J HUM GENET, V71, P1112, DOI 10.1086/344345; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503; WATTERSON GA, 1978, GENETICS, V88, P405; White TD, 2003, NATURE, V423, P742, DOI 10.1038/nature01669; Yu N, 2001, MOL BIOL EVOL, V18, P214, DOI 10.1093/oxfordjournals.molbev.a003795; Zietkiewicz E, 2001, NATO SCI S A LIF SCI, V310, P79; Zietkiewicz E, 1997, GENE, V205, P161; Zietkiewicz E, 1998, J MOL EVOL, V47, P146, DOI 10.1007/PL00006371	70	47	48	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2003	73	5					994	1015		10.1086/378777	http://dx.doi.org/10.1086/378777			22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	742AR	14513410	Bronze, Green Published			2022-12-18	WOS:000186493400003
J	Abalkhail, H; Mitchell, J; Habgood, J; Orrell, R; de Belleroche, J				Abalkhail, H; Mitchell, J; Habgood, J; Orrell, R; de Belleroche, J			A new familial amyotrophic lateral sclerosis locus on chromosome 16q12.1-16q12.2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUPEROXIDE-DISMUTASE; GENE; LINKAGE; FORM; MUTATIONS; DEATH; ALS/; 9Q34	Familial amyotrophic lateral sclerosis (FALS) affects 5% - 10% of cases of amyotrophic lateral sclerosis (ALS) and is inherited as an autosomal dominant condition with incomplete penetrance. One-fifth of these cases of FALS are associated with mutations in copper/zinc-dependent superoxide dismutase (SOD1), but the gene defect in the remaining 80% of familial cases is, as yet, unknown. We have carried out a preliminary genome screen, using a U. K. resource of families lacking SOD1 mutations, to identify other potential disease loci and have identified a putative locus on chromosome 16q12.1-q12.2. The region associated with disease was further refined in the major family that contributed to this result and was localized to D16S409-D16S3032, a 14.74-cM genetic interval that corresponds to a physical distance of 6.6 Mb, which coincides with a region independently identified by two further research groups in the United States and the United Kingdom.	Charing Cross Hosp, Imperial Coll, Fac Med, Dept Neuromuscular Dis,Div Neurosci & Psychol Med, London W6 8RF, England; Royal Free & UCL, Dept Clin Neurosci, London, England	Imperial College London; University of London; University College London	de Belleroche, J (corresponding author), Charing Cross Hosp, Imperial Coll, Fac Med, Dept Neuromuscular Dis,Div Neurosci & Psychol Med, Fulham Palace Rd, London W6 8RF, England.	j.belleroche@ic.ac.uk	Orrell, Richard/L-2123-2013					Beckman JS, 2001, TRENDS NEUROSCI, V24, pS15, DOI 10.1016/S0166-2236(00)01981-0; Blair IP, 2000, NEUROGENETICS, V3, P1; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Chance PF, 1998, AM J HUM GENET, V62, P633, DOI 10.1086/301769; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; deBelleroche J, 1996, J NEUROPATH EXP NEUR, V55, P747; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Hand CK, 2002, AM J HUM GENET, V70, P251, DOI 10.1086/337945; Hentati A, 1998, NEUROGENETICS, V2, P55, DOI 10.1007/s100480050052; HENTATI A, 1994, NAT GENET, V7, P425, DOI 10.1038/ng0794-425; Hosler BA, 2000, JAMA-J AM MED ASSOC, V284, P1664, DOI 10.1001/jama.284.13.1664; Orrell RW, 1997, NEUROLOGY, V48, P746, DOI 10.1212/WNL.48.3.746; PLOUGHMAN LM, 1989, AM J HUM GENET, V44, P543; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160	15	47	51	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2003	73	2					383	389		10.1086/377156	http://dx.doi.org/10.1086/377156			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	702KW	12830400	Green Published, Bronze			2022-12-18	WOS:000184223900014
J	Derenko, MV; Grzybowski, T; Malyarchuk, BA; Czarny, J; Miscicka-Sliwka, D; Zakharov, IA				Derenko, MV; Grzybowski, T; Malyarchuk, BA; Czarny, J; Miscicka-Sliwka, D; Zakharov, IA			The presence of mitochondrial haplogroup X in Altaians from South Siberia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							DNA VARIATION; NATIVE-AMERICAN; MTDNA; POPULATION; SEQUENCE; ORIGIN; POLYMORPHISMS; INDIVIDUALS; HISTORY; ASIA		Inst Biol Problems N, Genet Lab, Magadan 685000, Russia; Ludwik Rydygier Med Univ Bydgoszcz, Inst Forens Med, Bydgoszcz, Poland; NI Vavilov Gen Genet Res Inst, Anim Comparat Genet Lab, Moscow 117809, Russia	Institute of Biological Problems of the North; Nicolaus Copernicus University; Russian Academy of Sciences; Vavilov Institute of General Genetics	Derenko, MV (corresponding author), Inst Biol Problems N, Genet Lab, Portovaya St 18, Magadan 685000, Russia.		Grzybowski, Tomasz/A-1676-2015; Malyarchuk, Boris/D-5783-2018; Derenko, Miroslava/J-1495-2018	Grzybowski, Tomasz/0000-0001-6228-6460; Malyarchuk, Boris/0000-0002-0304-0652; Derenko, Miroslava/0000-0002-1849-784X				Alexeev VP, 1984, ANTHR ASIATIC PART U; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BANDELT HJ, 1995, GENETICS, V141, P743; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; Calafell F, 1996, ANN HUM GENET, V60, P35, DOI 10.1111/j.1469-1809.1996.tb01170.x; Comas D, 1998, AM J HUM GENET, V63, P1824, DOI 10.1086/302133; Derenko MV, 2000, HUM BIOL, V72, P945; Helgason A, 2000, AM J HUM GENET, V66, P999, DOI 10.1086/302816; Karafet TM, 1999, AM J HUM GENET, V64, P817, DOI 10.1086/302282; Lalueza C, 1997, HUM MOL GENET, V6, P41, DOI 10.1093/hmg/6.1.41; Lell JT, 1997, HUM GENET, V100, P536, DOI 10.1007/s004390050548; Lutz S, 1998, INT J LEGAL MED, V111, P67, DOI 10.1007/s004140050117; LUZINA FA, 1987, THESIS MOSCOW STATE; Malyarchuk B, 2000, AM J HUM GENET, V67, P216; MALYARCHUK BA, 2000, ARCHAEOGENETICS DNA, P249; Orekhov V, 1999, FEBS LETT, V445, P197, DOI 10.1016/S0014-5793(99)00115-5; Osipova LP, 1997, GENETIKA+, V33, P1559; Parson W, 1998, INT J LEGAL MED, V111, P124, DOI 10.1007/s004140050132; PIERCY R, 1993, INT J LEGAL MED, V106, P85, DOI 10.1007/BF01225046; Potapov L.P., 1969, ETHNICAL STRUCTURE O; Rousselet F, 1998, INT J LEGAL MED, V111, P292, DOI 10.1007/s004140050174; Santos FR, 1999, AM J HUM GENET, V64, P619, DOI 10.1086/302242; Stone AC, 1998, AM J HUM GENET, V62, P1153, DOI 10.1086/301838; Sukernik RI, 1996, GENETIKA+, V32, P432; Torroni A, 1996, GENETICS, V144, P1835; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196; WALLACE DC, 1995, AM J HUM GENET, V57, P201	27	47	49	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2001	69	1					237	241		10.1086/321266	http://dx.doi.org/10.1086/321266			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XM	11410843	Green Published, Bronze			2022-12-18	WOS:000170108100026
J	Klein, C; Schilling, K; Saunders-Pullman, RJ; Garrels, J; Breakefield, XO; Brin, MF; deLeon, D; Doheny, D; Fahn, S; Fink, JS; Forsgren, L; Friedman, J; Frucht, S; Harris, J; Holmgren, G; Kis, B; Kurlan, R; Kyllerman, M; Lang, AE; Leung, J; Raymond, D; Robishaw, JD; Sanner, G; Schwinger, E; Tabamo, RE; Tagliati, M; Vieregge, P; Wahlstrom, J; Wendt, KJ; Kramer, PL; Bressman, SB; Ozelius, LJ				Klein, C; Schilling, K; Saunders-Pullman, RJ; Garrels, J; Breakefield, XO; Brin, MF; deLeon, D; Doheny, D; Fahn, S; Fink, JS; Forsgren, L; Friedman, J; Frucht, S; Harris, J; Holmgren, G; Kis, B; Kurlan, R; Kyllerman, M; Lang, AE; Leung, J; Raymond, D; Robishaw, JD; Sanner, G; Schwinger, E; Tabamo, RE; Tagliati, M; Vieregge, P; Wahlstrom, J; Wendt, KJ; Kramer, PL; Bressman, SB; Ozelius, LJ			A major locus for myoclonus-dystonia maps to chromosome 7q in eight families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOMINANT INHERITANCE	Myoclonus-dystonia (M-D) is an autosomal dominant disorder characterized by myoclonic and dystonic muscle contractions that are often responsive to alcohol. The dopamine D2 receptor gene (DRD2) on chromosome 11q has been implicated in one family with this syndrome, and linkage to a 28-cM region on 7q has been reported in another. We performed genetic studies, using eight additional families with M-D, to assess these two loci. No evidence for linkage was found for 11q markers. However, all eight of these families showed linkage to chromosome 7 markers, with a combined multipoint LOD score of 11.71. Recombination events in the families define the disease gene within a 14-cM interval flanked by D7S2212 and D7S821. These data provide evidence for a major locus for M-D on chromosome 7q21.	Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany; Med Univ Lubeck, Dept Human Genet, D-23538 Lubeck, Germany; Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; Beth Israel Deaconess Med Ctr, Dept Neurol, New York, NY 10003 USA; Mt Sinai Sch Med, Dept Neurol, New York, NY 10003 USA; Columbia Univ, Dept Neurol, New York, NY 10027 USA; Massachusetts Gen Hosp, Neurol Serv, Mol Neurogenet Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Umea Univ, Dept Neurol, S-90187 Umea, Sweden; Umea Univ, Dept Clin Genet, S-90187 Umea, Sweden; Univ Rochester, Sch Med, Dept Neurol, Rochester, NY 14627 USA; Univ Gothenburg, Dept Pediat, Gothenburg, Sweden; Univ Gothenburg, Dept Clin Genet, Gothenburg, Sweden; Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada; Toronto Western Hosp, Toronto, ON M5T 2S8, Canada; Penn State Coll Med, Henry Hood Res Program, Danville, PA USA; Cent Hosp Karlstad, Child Habilitat Ctr, Karlstad, Sweden	University of Lubeck; University of Lubeck; Oregon Health & Science University; Harvard University; Beth Israel Deaconess Medical Center; Icahn School of Medicine at Mount Sinai; Columbia University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Umea University; Umea University; University of Rochester; University of Gothenburg; University of Gothenburg; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Ozelius, LJ (corresponding author), Albert Einstein Coll Med, Dept Mol Genet, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	ozelius@aecom.yu.edu	Lang, Anthony/ABF-8114-2021; Kis, Bernhard/A-8731-2008	Kis, Bernhard/0000-0003-3244-9737; Lang, Anthony/0000-0003-1229-3667; Frucht, Steven/0000-0002-4653-0491; Tagliati, Michele/0000-0002-6722-8208; Klein, Christine/0000-0003-2102-3431	NINDS NIH HHS [R01 NS028384, R01 NS026656, NS28384, NS26656] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026656, R01NS028384] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bouffard GG, 1997, GENOME RES, V7, P673, DOI 10.1101/gr.7.7.673; BRESSMAN SB, 1989, ANN NEUROL, V26, P612, DOI 10.1002/ana.410260505; Durr A, 2000, ANN NEUROL, V48, P127; Fahn S, 1998, Adv Neurol, V78, P1; Gasser T, 1998, Adv Neurol, V78, P325; Klein C, 1999, P NATL ACAD SCI USA, V96, P5173, DOI 10.1073/pnas.96.9.5173; Klein C, 2000, ANN NEUROL, V47, P369, DOI 10.1002/1531-8249(200003)47:3<369::AID-ANA14>3.3.CO;2-0; Kurlan R, 1988, Adv Neurol, V50, P385; KYLLERMAN M, 1990, MOVEMENT DISORD, V5, P270, DOI 10.1002/mds.870050403; Lang AE, 1997, MOVEMENT DISORD, V12, P127, DOI 10.1002/mds.870120126; MAHLOUDJI M, 1967, BRAIN, V90, P669, DOI 10.1093/brain/90.3.669; Nygaard TG, 1999, ANN NEUROL, V46, P794, DOI 10.1002/1531-8249(199911)46:5<794::AID-ANA19>3.0.CO;2-2; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Quinn NP, 1996, MOVEMENT DISORD, V11, P119, DOI 10.1002/mds.870110202	14	47	49	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1314	1319						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	369WW	11022010				2022-12-18	WOS:000165091600028
J	Moore, FL; Reijo-Pera, RA				Moore, FL; Reijo-Pera, RA			Male sperm motility dictated by mother's mtDNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							HEREDITARY OPTIC NEUROPATHY; Y-CHROMOSOME; MITOCHONDRIAL-DNA; MALE-INFERTILITY; NUCLEAR-DNA; GENE; DISEASE; SPERMATOZOA; EXPRESSION; INHIBITION		Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Moore, FL (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, 513 Parnassus Ave,Bldg HSW,Room 1475, San Francisco, CA 94143 USA.	flmoor@itsa.ucsf.edu		Reijo Pera, Renee/0000-0002-6487-1329				BAKER HWG, 1994, REPROD FERT DEVELOP, V6, P9, DOI 10.1071/RD9940009; BAKER HWG, 1986, MALE REPRODUCTIVE DY, P341; Brown GM, 1998, HUM MOL GENET, V7, P97, DOI 10.1093/hmg/7.1.97; Brown MD, 1997, AM J HUM GENET, V60, P381; CARDULLO RA, 1991, CELL MOTIL CYTOSKEL, V19, P180, DOI 10.1002/cm.970190306; CLAYTON DA, 1974, P NATL ACAD SCI USA, V71, P2777, DOI 10.1073/pnas.71.7.2777; Elliott DJ, 1997, BIOESSAYS, V19, P801, DOI 10.1002/bies.950190910; FOLGERO T, 1993, HUM REPROD, V8, P1863, DOI 10.1093/oxfordjournals.humrep.a137950; FORD WCL, 1981, J REPROD FERTIL, V63, P271; Frank SA, 1996, NATURE, V383, P224, DOI 10.1038/383224a0; FUKUNAGA M, 1979, BIOCHEM BIOPH RES CO, V90, P582, DOI 10.1016/0006-291X(79)91275-0; HALANGK W, 1985, BIOCHIM BIOPHYS ACTA, V808, P316, DOI 10.1016/0005-2728(85)90014-3; Hofmann S, 1997, GENOMICS, V39, P8, DOI 10.1006/geno.1996.4474; Hofmann S, 1997, HUM MOL GENET, V6, P1835, DOI 10.1093/hmg/6.11.1835; John JCS, 1997, NAT MED, V3, P124, DOI 10.1038/nm0297-124c; JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007; KAO SH, 1995, BIOL REPROD, V52, P729, DOI 10.1095/biolreprod52.4.729; MA K, 1993, CELL, V75, P1287, DOI 10.1016/0092-8674(93)90616-X; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; MITCHELL J A, 1976, P83; MUNDY AJ, 1995, HUM REPROD, V10, P116, DOI 10.1093/humrep/10.1.116; Nagley Phillip, 1993, P137; Nudell D, 2000, HUM REPROD, V15, P1289, DOI 10.1093/humrep/15.6.1289; Oates R, 1998, C AM SOC REPR MED MA; Pascual ML, 1996, BIOSCIENCE REP, V16, P35, DOI 10.1007/BF01200999; Pryor JL, 1997, NEW ENGL J MED, V336, P534, DOI 10.1056/NEJM199702203360802; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Reijo R, 1996, LANCET, V347, P1290, DOI 10.1016/S0140-6736(96)90938-1; Richards M, 1996, AM J HUM GENET, V59, P185; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; Ruiz-Pesini E, 1998, CLIN CHEM, V44, P1616; Torroni A, 1996, GENETICS, V144, P1835; Torroni A, 1997, AM J HUM GENET, V60, P1107; WALLACE DC, 1995, AM J HUM GENET, V57, P201; WEINBERG JB, 1995, FERTIL STERIL, V64, P408; World Health Organization, 1992, WHO LAB MAN EX HUM S, V3rd; ZAMBONI L, 1991, J ELECTRON MICR TECH, V17, P412, DOI 10.1002/jemt.1060170405; Zeviani M, 1997, MOL HUM REPROD, V3, P133, DOI 10.1093/molehr/3.2.133	38	47	51	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2000	67	3					543	548		10.1086/303061	http://dx.doi.org/10.1086/303061			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	348TJ	10936105	Green Published, Bronze			2022-12-18	WOS:000089002300001
J	Rogers, T; Chandler, D; Angelicheva, D; Thomas, PK; Youl, B; Tournev, I; Gergelcheva, V; Kalaydjieva, L				Rogers, T; Chandler, D; Angelicheva, D; Thomas, PK; Youl, B; Tournev, I; Gergelcheva, V; Kalaydjieva, L			A novel locus for autosomal recessive peripheral neuropathy in the EGR2 region on 10q23	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MARIE-TOOTH-DISEASE; DEMYELINATING NEUROPATHY; SENSORY NEUROPATHY; HEREDITARY MOTOR; GENE; GYPSIES; FORM; MUTATION; MAPS; MYELINOPATHIES	During our studies of Romany (Gypsy) families with hereditary motor and sensory neuropathy-Lom, we have identified a large kindred with two independently segregating autosomal recessive neuropathies. The novel disorder, named "hereditary motor and sensory neuropathy-Russe" (HMSNR), presented as a severe disabling form of Charcot-Marie-Tooth disease with prominent sensory loss, moderately reduced motor nerve conduction velocity, and a high threshold for electrical nerve stimulation. A genome scan in two branches of the large kindred detected linkage to the 10q22-q23 region containing the early growth response 2 gene (EGR2), a transcription factor with a key role in peripheral nerve myelination. The results of sequence analysis and the detection of an intragenic polymorphism allowed us to exclude EGR2 as the HMSNR gene. Further analysis done using linkage and recombination mapping refined the position of the HMSNR gene to a small interval on 10q23.2, flanked by markers D10S581 and D10S1742, telomeric to EGR2. In this interval, a conserved seven-marker haplotype is shared by all disease chromosomes, suggesting a single founder mutation. The homozygosity region is contained in bacterial-artificial-chromosome contig 1570 of the Sanger Centre physical map and has an estimated physical size of similar to 500 kb.	Edith Cowan Univ, Ctr Human Genet, Perth, WA 6027, Australia; Western Australian Inst Med Res, Perth, WA, Australia; UCL, Inst Neurol, London, England; Med Univ, Dept Neurol, Sofia, Bulgaria	Edith Cowan University; University of Western Australia; University of London; University College London; Medical University Sofia	Kalaydjieva, L (corresponding author), Edith Cowan Univ, Ctr Human Genet, Joondalup Campus, Perth, WA 6027, Australia.	L.Kalaydjieva@cowan.edu.au						Abicht A, 1999, NEUROLOGY, V53, P1564, DOI 10.1212/WNL.53.7.1564; Angelicheva D, 1999, EUR J HUM GENET, V7, P560, DOI 10.1038/sj.ejhg.5200319; Ben Othmane K, 1999, GENOMICS, V62, P344, DOI 10.1006/geno.1999.6028; Bolino A, 2000, NAT GENET, V25, P17, DOI 10.1038/75542; Bolino A, 1996, HUM MOL GENET, V5, P1051, DOI 10.1093/hmg/5.7.1051; Bouhouche A, 1999, AM J HUM GENET, V65, P722, DOI 10.1086/302542; Casaubon LK, 1996, AM J HUM GENET, V58, P28; Delague V, 2000, AM J HUM GENET, V67, P236, DOI 10.1086/302980; GABREELSFESTEN AAWM, 1991, BRAIN, V114, P1855, DOI 10.1093/brain/114.4.1855; GABREELSFESTEN AAWM, 1990, BRAIN, V113, P1629, DOI 10.1093/brain/113.6.1629; Gambardella A, 1997, BRAIN, V120, P2113, DOI 10.1093/brain/120.11.2113; Goodman R. M., 1979, GENETIC DISORDERS JE; JOSEPH LJ, 1988, P NATL ACAD SCI USA, V85, P7164, DOI 10.1073/pnas.85.19.7164; Kalaydjieva L, 2000, AM J HUM GENET, V67, P47, DOI 10.1086/302978; Kalaydjieva L, 1996, NAT GENET, V14, P214, DOI 10.1038/ng1096-214; Kalaydjieva L, 1998, BRAIN, V121, P399, DOI 10.1093/brain/121.3.399; Keller MP, 1999, BRAIN PATHOL, V9, P327; Kessali M, 1997, NEUROLOGY, V48, P867, DOI 10.1212/WNL.48.4.867; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LeGuern E, 1996, HUM MOL GENET, V5, P1685, DOI 10.1093/hmg/5.10.1685; Lupski JR, 1998, MOL MED, V4, P3, DOI 10.1007/BF03401724; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOTULSKY AG, 1995, NAT GENET, V9, P99, DOI 10.1038/ng0295-99; OHNISHI A, 1989, MUSCLE NERVE, V12, P568, DOI 10.1002/mus.880120707; OTHMANE KB, 1993, HUM MOL GENET, V2, P1625, DOI 10.1093/hmg/2.10.1625; Ott J., 1991, ANAL HUMAN GENETIC L; Piccolo F, 1996, HUM MOL GENET, V5, P2019, DOI 10.1093/hmg/5.12.2019; Plasilova M, 1998, HUM HERED, V48, P30; Schenone A, 1999, CURR OPIN NEUROL, V12, P603, DOI 10.1097/00019052-199910000-00015; THOMAS PK, 2000, IN PRESS CURR OPIN N; Timmerman V, 1999, NEUROLOGY, V52, P1827, DOI 10.1212/WNL.52.9.1827; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Tournev I, 1999, ANN NEUROL, V45, P742; Warner LE, 1999, HUM MOL GENET, V8, P1245, DOI 10.1093/hmg/8.7.1245; Warner LE, 1998, NAT GENET, V18, P382, DOI 10.1038/ng0498-382	35	47	49	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2000	67	3					664	671		10.1086/303053	http://dx.doi.org/10.1086/303053			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	348TJ	10915613	Bronze, Green Published			2022-12-18	WOS:000089002300013
J	Edelmann, L; Spiteri, E; McCain, N; Goldberg, R; Pandita, RK; Duong, S; Fox, J; Blumenthal, D; Lalani, SR; Shaffer, LG; Morrow, BE				Edelmann, L; Spiteri, E; McCain, N; Goldberg, R; Pandita, RK; Duong, S; Fox, J; Blumenthal, D; Lalani, SR; Shaffer, LG; Morrow, BE			A common breakpoint on 11q23 in carriers of the constitutional t(11;22) translocation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CAT-EYE SYNDROME; 3-1 MEIOTIC DISJUNCTION; CARDIO-FACIAL-SYNDROME; MOLECULAR CHARACTERIZATION; 22Q11 DELETIONS; GENE; RECOMBINATION; POLYMORPHISM; DELINEATION; CHROMOSOMES	Structural chromosomal rearrangements occur commonly in the general population. Individuals that carry a balanced translocation are at risk of having unbalanced offspring; therefore, the frequency of translocations in couples with recurrent spontaneous abortions is higher than that in the general population. The constitutional t(11;22) translocation is the most common recurrent non-Robertsonian translocation in humans and may serve as a model to determine the mechanism that causes recurrent meiotic translocations. We previously localized the t(11;22) translocation breakpoint to a region on 22q11 within a low-copy repeat, termed "LCR22." To define the breakpoint on 11q23 and to ascertain whether this region shares homology with LCR22 sequences, we performed haplotype analysis on patients with der(22) syndrome. We found that the breakpoint on 11q23 occurred between two genetic markers, D11S1340 and APOC3-tetra, both being present within a single bacterial-artificial-chromosome clone. To determine whether the breakpoint occurred within the same region among a larger set of carriers, we per formed FISH mapping studies. The breakpoints were all within the same clone, suggesting that this region may harbor sequences that are prone to breakage. We narrowed the breakpoint interval, in both derivative chromosomes from two unrelated carriers, to a 190-bp, AT-rich repeat, which indicates that this repeat may mediate recombination events on chromosome 11. Interestingly, the LCR22s harbor AT-rich repeats, suggesting that this sequence motif may mediate recombination events in nonhomologous chromosomes during meiosis.	Yeshiva Univ Albert Einstein Coll Med, Dept Med Genet, Bronx, NY 10461 USA; Long Isl Jewish Med Ctr, Schneider Childrens Hosp, New Hyde Park, NY USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Yeshiva University; Albert Einstein College of Medicine; Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York; Baylor College of Medicine	Morrow, BE (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Med Genet, 1300 Morris Pk Ave, Bronx, NY 10461 USA.		Lalani, Seema/AAI-5090-2020	Morrow, Bernice/0000-0002-8076-4726	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD034980] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009060] Funding Source: NIH RePORTER; NCI NIH HHS [T32CA09060, T32 CA009060] Funding Source: Medline; NICHD NIH HHS [P0-1HD34980-3] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Baumer A, 1998, HUM MOL GENET, V7, P887, DOI 10.1093/hmg/7.5.887; BHATTACHARYA S, 1991, NUCLEIC ACIDS RES, V19, P4799, DOI 10.1093/nar/19.17.4799; Boan F, 1998, J MOL BIOL, V278, P499, DOI 10.1006/jmbi.1998.1714; CAMPANA M, 1986, AM J MED GENET, V24, P341, DOI 10.1002/ajmg.1320240214; Carlson C, 1997, AM J HUM GENET, V61, P620, DOI 10.1086/515508; Edelmann L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/hmg/8.7.1157; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; FRACCARO M, 1980, HUM GENET, V56, P21, DOI 10.1007/BF00281567; Funke B, 1999, AM J HUM GENET, V64, P747, DOI 10.1086/302284; GalchevaGargova Z, 1996, SCIENCE, V272, P1797, DOI 10.1126/science.272.5269.1797; JEFFREYS AJ, 1990, CELL, V60, P473, DOI 10.1016/0092-8674(90)90598-9; Jeffreys AJ, 1998, MOL CELL, V2, P267, DOI 10.1016/S1097-2765(00)80138-0; JONES CPJ, 1995, MICRON, V2, P145; KARATHANASIS SK, 1985, P NATL ACAD SCI USA, V82, P6374, DOI 10.1073/pnas.82.19.6374; KehrerSawatzki H, 1997, HUM GENET, V99, P237, DOI 10.1007/s004390050346; Laake K, 1997, GENE CHROMOSOME CANC, V18, P175, DOI 10.1002/(SICI)1098-2264(199703)18:3<175::AID-GCC4>3.0.CO;2-Z; Launonen V, 1998, GYNECOL ONCOL, V71, P299, DOI 10.1006/gyno.1998.5186; LIN AE, 1986, CLIN GENET, V29, P269; McTaggart KE, 1998, CYTOGENET CELL GENET, V81, P222, DOI 10.1159/000015035; MEARS AJ, 1994, AM J HUM GENET, V55, P134; MEARS AJ, 1995, AM J HUM GENET, V57, P667; Michaelis RC, 1998, AM J MED GENET, V76, P222, DOI 10.1002/(SICI)1096-8628(19980319)76:3<222::AID-AJMG5>3.0.CO;2-S; MICHELS VV, 1982, AM J HUM GENET, V34, P507; MIETUSSNYDER M, 1990, GENOMICS, V7, P633, DOI 10.1016/0888-7543(90)90211-C; MORROW B, 1995, AM J HUM GENET, V56, P1391; Murray J, 1999, GENOME RES, V9, P130; Ning Y, 1996, HUM GENET, V97, P765; REISS JA, 1985, AM J MED GENET, V20, P165, DOI 10.1002/ajmg.1320200120; SCHINZEL A, 1981, HUM GENET, V56, P249, DOI 10.1007/BF00274675; SCHMID M, 1986, HUM GENET, V74, P67; SHAFFER LG, 1994, AM J HUM GENET, V55, P968; Sutherland GR, 1999, AM J HUM GENET, V64, P354, DOI 10.1086/302267; SUTHERLAND GR, 1995, CURR OPIN GENET DEV, V5, P323, DOI 10.1016/0959-437X(95)80046-8; Tunnacliffe A, 1999, GENOME RES, V9, P44; Uzawa K, 1996, INT J CANCER, V67, P510, DOI 10.1002/(SICI)1097-0215(19960807)67:4<510::AID-IJC8>3.3.CO;2-R; Wang SSQ, 1999, GENE CHROMOSOME CANC, V25, P154, DOI 10.1002/(SICI)1098-2264(199906)25:2<154::AID-GCC11>3.3.CO;2-N; WARBURTON D, 1991, AM J HUM GENET, V49, P995; Yu S, 1997, CELL, V88, P367, DOI 10.1016/S0092-8674(00)81875-9; ZACKAI EH, 1980, AM J MED GENET, V7, P507, DOI 10.1002/ajmg.1320070412	39	47	47	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1608	1616		10.1086/302689	http://dx.doi.org/10.1086/302689			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577914	Bronze, Green Published			2022-12-18	WOS:000084282500015
J	Tesoriero, A; Andersen, C; Southey, M; Somers, G; McKay, M; Armes, J; McCredie, M; Giles, G; Hopper, JL; Venter, D				Tesoriero, A; Andersen, C; Southey, M; Somers, G; McKay, M; Armes, J; McCredie, M; Giles, G; Hopper, JL; Venter, D			De novo BRCA1 mutation in a patient with breast cancer and an inherited BRCA2 mutation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							MEIOTIC CELLS; DNA-REPAIR; WOMEN; ASHKENAZI; GENES; RAD51; MICE; AGE		Peter MacCallum Canc Inst, Dept Pathol, Melbourne, Vic, Australia; Peter MacCallum Canc Inst, Early Detect Lab, Melbourne, Vic, Australia; Peter MacCallum Canc Inst, Trescowthick Res Labs, Melbourne, Vic, Australia; Peter MacCallum Canc Inst, Div Radiat Oncol, Melbourne, Vic, Australia; Peter MacCallum Canc Inst, Victorian Breast Canc Res Consortium, Mol Pathol Lab, Melbourne, Vic, Australia; New S Wales Canc Council, Canc & Epidemiol Res Unit, Sydney, NSW, Australia; Univ Otago, Dept Social & Prevent Med, Dunedin, New Zealand; Anti Canc Council Victoria, Canc Epidemiol Ctr, Parkville, Vic, Australia; Univ Melbourne, Ctr Genet Epidemiol, Parkville, Vic 3052, Australia; Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; Cancer Council New South Wales; University of Otago; Cancer Council Victoria; University of Melbourne; University of Melbourne	Venter, D (corresponding author), Peter MacCallum Canc Inst, Dept Pathol, Locked Bag 1,A Beckett St, Melbourne, Vic, Australia.		McKay, Michael/ABA-9029-2021; Armes, Jane/D-6396-2012	Armes, Jane/0000-0002-2215-0347; Southey, Melissa/0000-0002-6313-9005; Giles, Graham/0000-0003-4946-9099				Berman DB, 1996, CANCER RES, V56, P3409; Bertwistle D, 1998, CURR OPIN GENET DEV, V8, P14, DOI 10.1016/S0959-437X(98)80056-7; Blackshear PE, 1998, ONCOGENE, V16, P61, DOI 10.1038/sj.onc.1201506; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Connor F, 1997, NAT GENET, V17, P423, DOI 10.1038/ng1297-423; Cooper D. N., 1993, HUMAN GENE MUTATION; DEBOER JG, 1984, P NATL ACAD SCI-BIOL, V81, P5528; Liede A, 1998, AM J HUM GENET, V62, P1543, DOI 10.1086/301889; Marmorstein LY, 1998, P NATL ACAD SCI USA, V95, P13869, DOI 10.1073/pnas.95.23.13869; McCredie MRE, 1998, CANCER CAUSE CONTROL, V9, P189, DOI 10.1023/A:1008886328352; Neuhausen S, 1996, NAT GENET, V13, P126, DOI 10.1038/ng0596-126; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Rajan JV, 1996, P NATL ACAD SCI USA, V93, P13078, DOI 10.1073/pnas.93.23.13078; Ramus SJ, 1997, NAT GENET, V15, P14, DOI 10.1038/ng0197-14; Rosche WA, 1998, J MOL BIOL, V284, P633, DOI 10.1006/jmbi.1998.2193; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; Southey MC, 1999, BRIT J CANCER, V79, P34, DOI 10.1038/sj.bjc.6690008; Southey MC, 1998, J NATL CANCER I, V90, P532, DOI 10.1093/jnci/90.7.532	19	47	47	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1999	65	2					567	569		10.1086/302503	http://dx.doi.org/10.1086/302503			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	223JA	10417300	Green Published, Bronze			2022-12-18	WOS:000081836900033
J	Brown, KD; Barlow, C; Wynshaw-Boris, A				Brown, KD; Barlow, C; Wynshaw-Boris, A			Multiple ATM-dependent pathways: An explanation for pleiotropy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							ATAXIA-TELANGIECTASIA GENE; CELL-CYCLE CHECKPOINT; REPLICATION PROTEIN-A; DEFICIENT MICE; INDUCED PHOSPHORYLATION; IONIZING-RADIATION; DNA-DAMAGE; C-ABL; PRODUCT; P53		Louisiana State Univ, Med Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; Louisiana State Univ, Med Ctr, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA; Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; Natl Human Genome Res Inst, Genet Dis Res Branch, NIH, Bethesda, MD USA	Louisiana State University System; Louisiana State University System; Salk Institute; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Brown, KD (corresponding author), Louisiana State Univ, Med Ctr, Dept Biochem & Mol Biol, 1901 Perdido St, New Orleans, LA 70112 USA.							Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Barlow C, 1997, NAT GENET, V17, P462, DOI 10.1038/ng1297-462; Barlow C, 1997, NAT GENET, V17, P453, DOI 10.1038/ng1297-453; Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; Brown KD, 1997, P NATL ACAD SCI USA, V94, P1840, DOI 10.1073/pnas.94.5.1840; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chen G, 1996, J BIOL CHEM, V271, P33693, DOI 10.1074/jbc.271.52.33693; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; FISCELLA M, 1993, ONCOGENE, V8, P1519; Gately DP, 1998, MOL BIOL CELL, V9, P2361, DOI 10.1091/mbc.9.9.2361; Gilad S, 1996, HUM MOL GENET, V5, P433, DOI 10.1093/hmg/5.4.433; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; Herzog KH, 1998, SCIENCE, V280, P1089, DOI 10.1126/science.280.5366.1089; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Keegan KS, 1996, GENE DEV, V10, P2423, DOI 10.1101/gad.10.19.2423; Lakin ND, 1996, ONCOGENE, V13, P2707; Lim DS, 1998, P NATL ACAD SCI USA, V95, P10146, DOI 10.1073/pnas.95.17.10146; LIU VF, 1993, MOL CELL BIOL, V13, P7222, DOI 10.1128/MCB.13.12.7222; Morgan SE, 1997, CANCER RES, V57, P3386; Oka A, 1998, NEUROSCI LETT, V252, P195, DOI 10.1016/S0304-3940(98)00576-X; Pecker I, 1996, GENOMICS, V35, P39, DOI 10.1006/geno.1996.0320; Rotman G, 1998, HUM MOL GENET, V7, P1555, DOI 10.1093/hmg/7.10.1555; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; SICILIANO JD, 1997, GENE DEV, V11, P3471; Watters D, 1997, ONCOGENE, V14, P1911, DOI 10.1038/sj.onc.1201037; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; ZAKIAN VA, 1995, CELL, V82, P685, DOI 10.1016/0092-8674(95)90463-8; Zhang N, 1998, ONCOGENE, V17, P811, DOI 10.1038/sj.onc.1202007; Zhang N, 1997, P NATL ACAD SCI USA, V94, P8021, DOI 10.1073/pnas.94.15.8021; Ziv Y, 1997, ONCOGENE, V15, P159, DOI 10.1038/sj.onc.1201319	36	47	48	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					46	50		10.1086/302223	http://dx.doi.org/10.1086/302223			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164RM	9915942	Bronze, Green Published			2022-12-18	WOS:000078477400008
J	Dermaut, B; Cruts, M; Slooter, AJC; Van Gestel, S; De Jonghe, C; Vanderstichele, H; Vanmechelen, E; Breteler, MM; Hofman, A; van Duijn, CM; Van Broeckhoven, C				Dermaut, B; Cruts, M; Slooter, AJC; Van Gestel, S; De Jonghe, C; Vanderstichele, H; Vanmechelen, E; Breteler, MM; Hofman, A; van Duijn, CM; Van Broeckhoven, C			The Glu318Gly substitution in presenilin 1 is not causally related to Alzheimer disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							MISSENSE MUTATIONS; VASCULAR DEMENTIA; GENE; ROTTERDAM		Univ Antwerp VIB, Dept Biochem, Born Bunge Fdn, Lab Neurogenet, B-2020 Antwerp, Belgium; Erasmus Univ, Sch Med, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; Innogenet NV, Swijnaarde, Belgium	Flanders Institute for Biotechnology (VIB); University of Antwerp; Erasmus University Rotterdam; Innogenetics NV	Van Broeckhoven, C (corresponding author), Univ Antwerp VIB, Dept Biochem, Born Bunge Fdn, Lab Neurogenet, B-2020 Antwerp, Belgium.	cvbroeck@uia.ua.ac.be	Breteler, Monique M.B./J-5058-2014; Cruts, Marc/J-6161-2013; Dermaut, Bart/AAM-2483-2020; Van Broeckhoven, Christine/G-8362-2017; Vanderstichele, Hugo/AAD-2601-2019; Van Broeckhoven, Christine/M-7853-2019; , Otto/P-4127-2018	Breteler, Monique M.B./0000-0002-0626-9305; Cruts, Marc/0000-0002-1338-992X; Van Broeckhoven, Christine/0000-0003-0183-7665; Van Broeckhoven, Christine/0000-0003-0183-7665; , Otto/0000-0003-2101-4105; Vanmechelen, Eugeen/0000-0002-9466-5366				American Psychiatric Association, 1987, DIAGN STAT MAN MENT; BAKER M, 1998, NEUROBIOL AGING S, V19, pS87; CRUTCHER LA, 1995, IEEE PARALL DISTRIB, V3, P4, DOI 10.1109/88.393226; Cruts M, 1998, HUM MOL GENET, V7, P43, DOI 10.1093/hmg/7.1.43; Cruts M, 1998, HUM MUTAT, V11, P183, DOI 10.1002/(SICI)1098-1004(1998)11:3<183::AID-HUMU1>3.3.CO;2-M; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Forsell C, 1997, NEUROSCI LETT, V234, P3, DOI 10.1016/S0304-3940(97)00603-4; FORSELL C, 1998, NEUROBIOL AGING S, V19, pS88; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; HELISALMI S, 1998, NEUROBIOL AGING S, V19, pS88; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; MATTILA KM, 1998, NEUROBIOL AGING S, V19, pS88; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; OTT A, 1995, BRIT MED J, V310, P970, DOI 10.1136/bmj.310.6985.970; Ott A, 1998, AM J EPIDEMIOL, V147, P574; PERICAKVANCE MA, 1995, TRENDS GENET, V11, P504, DOI 10.1016/S0168-9525(00)89161-1; RAO VS, 1994, AM J HUM GENET, V55, P991; Reznik-Wolf H, 1998, EUR J HUM GENET, V6, P176, DOI 10.1038/sj.ejhg.5200160; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Sandbrink R, 1996, ANN NEUROL, V40, P265, DOI 10.1002/ana.410400225; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; TORRES O, 1998, NEUROBIOL AGING S, V19, pS88; Van Broeckhoven C, 1995, NAT GENET, V11, P230	23	47	50	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					290	292		10.1086/302200	http://dx.doi.org/10.1086/302200			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164RM	9915968	Green Published, Bronze			2022-12-18	WOS:000078477400034
J	Goodman, SI; Elsas, LJ; Rosenblatt, DS				Goodman, SI; Elsas, LJ; Rosenblatt, DS		Amer Soc Human Genetics Amer Coll Med Genetics; Technology Transfer Comm Working Grp	ASHG/ACMG STATEMENT - Measurement and use of total plasma homocysteine	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; FLUORESCENCE DETECTION; SERUM; COBALAMIN; RISK; DEFICIENCY	Hyperhomocysteinemia, which is a recognized independent risk factor for premature vascular occlusion, is defined as a fasting total plasma homocysteine (tHcy) level >15 mu M. There may also be graded increased risks for persons with tHcy concentrations of 10-15 mu M. The measurement of tHcy requires precise sample collection, immediate separation and freezing of plasma, and referral to a specialized laboratory. The etiologies of hyperhomocysteinemia are complex and involve both genetic and environmental factors. Because the inappropriate supplementation of involved cofactors can be harmful, it is important to identify the cause of hyperhomocysteinemia prior to treatment.	Univ Colorado, Sch Med, Dept Pediat, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Goodman, SI (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Box C233,4200 E 9th Ave, Denver, CO 80262 USA.							ARAKI A, 1987, J CHROMATOGR-BIOMED, V422, P43, DOI 10.1016/0378-4347(87)80438-3; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; JACOBSEN DW, 1989, ANAL BIOCHEM, V178, P208, DOI 10.1016/0003-2697(89)90381-3; JACOBSEN DW, 1994, CLIN CHEM, V40, P873; NYGARD O, 1995, JAMA-J AM MED ASSOC, V274, P1526, DOI 10.1001/jama.274.19.1526; SAVAGE DG, 1995, BAILLIERE CLIN HAEM, V8, P657, DOI 10.1016/S0950-3536(05)80225-2; STABLER SP, 1993, BLOOD, V81, P3404; STABLER SP, 1987, ANAL BIOCHEM, V162, P185, DOI 10.1016/0003-2697(87)90026-1; STAMPFER MJ, 1992, JAMA-J AM MED ASSOC, V268, P877, DOI 10.1001/jama.268.7.877; UELAND PM, 1993, CLIN CHEM, V39, P1764	10	47	48	1	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1998	63	5					1541	1543						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	138QZ					2022-12-18	WOS:000076985200030
J	Engel, E				Engel, E			Uniparental disomies in unselected populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							PRADER-WILLI-SYNDROME; PATERNAL ISODISOMY; MATERNAL HETERODISOMY; GROWTH-RETARDATION; ANGELMAN SYNDROME; 2 ISOCHROMOSOMES; CHROMOSOME; PATIENT; PHENOTYPE; MOSAICISM		Univ Geneva, Div Med Genet, Geneva, Switzerland	University of Geneva	Engel, E (corresponding author), CMU, 1 Rue Michel Servet, CH-1211 Geneva, Switzerland.							ABRAMOWICZ MJ, 1994, J CLIN INVEST, V94, P418, DOI 10.1172/JCI117339; ANTONARAKIS SE, 1993, AM J HUM GENET, V52, P1145; BELDJORD C, 1992, BLOOD, V80, P287; Benlian P, 1996, AM J HUM GENET, V59, P431; Bernasconi F, 1996, AM J HUM GENET, V59, P1114; Bittencourt MC, 1997, J MED GENET, V34, P77, DOI 10.1136/jmg.34.1.77; BOTTANI A, 1994, AM J MED GENET, V51, P35, DOI 10.1002/ajmg.1320510109; BRZUSTOWICZ LM, 1994, AM J HUM GENET, V54, P482; CASSIDY SB, 1992, AM J HUM GENET, V51, P701; Cotter PD, 1997, AM J MED GENET, V70, P74, DOI 10.1002/(SICI)1096-8628(19970502)70:1<74::AID-AJMG14>3.0.CO;2-U; DeLozier-Blanchet CD, 1997, AM J HUM GENET, V61, pA151; EGGERDING FA, 1994, AM J HUM GENET, V55, P253; ENGEL E, 1980, AM J MED GENET, V6, P137, DOI 10.1002/ajmg.1320060207; Engel E, 1998, EUR J HUM GENET, V6, P29; Field LL, 1998, AM J HUM GENET, V63, P1216, DOI 10.1086/302050; FREEMAN SB, 1993, AM J MED GENET, V45, P625, DOI 10.1002/ajmg.1320450522; Gelb BD, 1998, AM J HUM GENET, V62, P848, DOI 10.1086/301795; HARRISON K, 1995, AM J MED GENET, V58, P147, DOI 10.1002/ajmg.1320580211; Henry I., 1993, European Journal of Human Genetics, V1, P19; HENRY I, 1991, NATURE, V351, P665, DOI 10.1038/351665a0; HOGLUND P, 1994, AM J HUM GENET, V55, P747; James R. S., 1994, European Journal of Human Genetics, V2, P83; JAMES RS, 1995, EUR J HUM GENET, V3, P21; Johnston K. M., 1996, American Journal of Human Genetics, V59, pA95; KALOUSEK DK, 1993, AM J HUM GENET, V52, P8; Korenstein A., 1994, American Journal of Human Genetics, V55, pA109; KOTZOT D, 1995, HUM MOL GENET, V4, P583, DOI 10.1093/hmg/4.4.583; LEDBETTER DH, 1995, HUM MOL GENET, V4, P1757, DOI 10.1093/hmg/4.suppl_1.1757; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; NGO KY, 1993, AM J HUM GENET, V53, P1207; NICHOLLS RD, 1991, AM J MED GENET, V41, P273, DOI 10.1002/ajmg.1320410233; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; Pan YZ, 1998, AM J HUM GENET, V62, P1551, DOI 10.1086/301857; PENTAO L, 1992, AM J HUM GENET, V50, P690; Pulkkinen L, 1997, AM J HUM GENET, V61, P611, DOI 10.1086/515524; Quan F, 1997, AM J HUM GENET, V60, P160; ROBINSON WP, 1993, J MED GENET, V30, P756, DOI 10.1136/jmg.30.9.756; Robinson WP, 1996, PRENATAL DIAG, V16, P837, DOI 10.1002/(SICI)1097-0223(199609)16:9<837::AID-PD956>3.0.CO;2-7; SCHINZEL AA, 1991, AM J HUM GENET, V48, P424; Schneider AS, 1996, AM J MED GENET, V66, P204, DOI 10.1002/(SICI)1096-8628(19961211)66:2<204::AID-AJMG16>3.0.CO;2-X; Shaffer LG, 1997, AM J HUM GENET, V61, P461; SPENCE JE, 1988, AM J HUM GENET, V42, P217; SPOTILA LD, 1992, AM J HUM GENET, V51, P1396; Sulisalo T, 1997, EUR J HUM GENET, V5, P35, DOI 10.1159/000484729; TEMPLE IK, 1995, NAT GENET, V9, P110, DOI 10.1038/ng0295-110; Temple IK, 1996, HUM MOL GENET, V5, P1117, DOI 10.1093/hmg/5.8.1117; Temple K, 1998, EUR J HUM GENET, V6, P153; Van Opstal D, 1998, PRENATAL DIAG, V18, P35; vandenBergLoonen EM, 1996, HUM IMMUNOL, V45, P46, DOI 10.1016/0198-8859(95)00148-4; VAUGHAN J, 1994, PRENATAL DIAG, V14, P751, DOI 10.1002/pd.1970140817; VIDAUD D, 1989, American Journal of Human Genetics, V45, pA226; VOSS R, 1989, AM J HUM GENET, V45, P373; WARBURTON D, 1988, AM J HUM GENET, V42, P215; WELCH TR, 1990, J CLIN INVEST, V86, P675, DOI 10.1172/JCI114760; WIEDEMANN HR, 1997, CLIN SYNDROMES, P148; WILLATT LR, 1992, J MED GENET, V29, P742, DOI 10.1136/jmg.29.10.742; WOODAGE T, 1994, AM J HUM GENET, V55, P74	57	47	47	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					962	966		10.1086/302074	http://dx.doi.org/10.1086/302074			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9758632	Green Published, Bronze			2022-12-18	WOS:000076577800007
J	Wijmenga, C; van den Heuvel, LPWJ; Strengman, E; Luyten, JAFM; van der Burgt, IJAM; de Groot, R; Smeets, DFCM; Draaisma, JMT; van Dongen, JJ; De Abreu, RA; Pearson, PL; Sandkuijl, LA; Weemaes, CMR				Wijmenga, C; van den Heuvel, LPWJ; Strengman, E; Luyten, JAFM; van der Burgt, IJAM; de Groot, R; Smeets, DFCM; Draaisma, JMT; van Dongen, JJ; De Abreu, RA; Pearson, PL; Sandkuijl, LA; Weemaes, CMR			Localization of the ICF syndrome to chromosome 20 by homozygosity mapping	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							S-ADENOSYLHOMOCYSTEINE HYDROLASE; CENTROMERIC INSTABILITY; FACIAL ANOMALIES; RECESSIVE TRAITS; DNA; IMMUNODEFICIENCY; GENE; MAP	Immunodeficiency in association with centromere instability of chromosomes 1, 9, and 16 and facial anomalies (ICF syndrome) is a rare autosomal recessive disorder. ICF patients show marked hypomethylation of their DNA; undermethylation of classical satellites II and III is thought to be associated with the centromere instability. We used DNA from three consanguineous families with a total of four ICF patients and performed a total genome screen, to localize the ICF syndrome gene by homozygosity mapping. One chromosomal region (20q11-q13) was consistently found to be homozygous in ICF patients, whereas all healthy sibs showed a heterozygous pattern. Comparison of the regions of homozygosity in the four ICF patients localized the ICF locus to a 9-cM region between the markers D20S477 and D20S850. Analysis of more families will be required, to refine the map location further. Isolation of the gene associated with the ICF syndrome not only will give insight into the etiology of the ICF syndrome but will also broaden our understanding of DNA methylation processes.	Univ Utrecht, Dept Human Genet, NL-3508 TA Utrecht, Netherlands; Univ Nijmegen Hosp, Dept Pediat, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen Hosp, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Sophia Childrens Hosp, Dept Pediat, Rotterdam, Netherlands; Erasmus Univ, Dept Immunol, NL-3000 DR Rotterdam, Netherlands; St Elisabeth Hosp, Dept Pediat, Tilburg, Netherlands	Utrecht University; Radboud University Nijmegen; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Elisabeth-TweeSteden Ziekenhuis (ETZ)	Wijmenga, C (corresponding author), Univ Utrecht, Dept Human Genet, POB 80030, NL-3508 TA Utrecht, Netherlands.		Weemaes, C.M.R./L-4747-2015; Wijmenga, Cisca/D-2173-2009; Wijmenga, Cisca/AAE-7719-2019; Draaisma, J.M.T./L-4283-2015; van den Heuvel, Lambertus/AAM-1772-2021; van den Heuvel, L.P.W.J./H-8044-2014; van Dongen, Jacques J.M./F-8537-2015; de Groot, R./H-8039-2014; Smeets, D.F.C.M./L-4653-2015	Wijmenga, Cisca/0000-0002-5635-1614; van den Heuvel, Lambertus/0000-0003-3917-6727; van den Heuvel, L.P.W.J./0000-0003-3917-6727; van Dongen, Jacques J.M./0000-0001-7686-0021; van Dongen, Jacques J.M./0000-0002-3650-7087; Draaisma, Jos/0000-0003-4829-6173				BROWN DC, 1995, HUM GENET, V96, P411; Buetow K H, 1994, Science, V265, P2055, DOI 10.1126/science.8091228; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FRANCESCHINI P, 1995, EUR J PEDIATR, V154, P840, DOI 10.1007/BF01959794; HULTEN M, 1978, CLIN GENET, V14, P294; JEANPIERRE M, 1993, HUM MOL GENET, V2, P731, DOI 10.1093/hmg/2.6.731; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; MILLER MW, 1994, EMBO J, V13, P1806, DOI 10.1002/j.1460-2075.1994.tb06449.x; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Miniou P, 1997, CYTOGENET CELL GENET, V77, P308, DOI 10.1159/000134605; Neufeld EJ, 1997, AM J HUM GENET, V61, P1335, DOI 10.1086/301642; SCHUFFENHAUER S, 1995, HUM GENET, V96, P562, DOI 10.1007/BF00197412; SMEETS DFCM, 1994, HUM GENET, V94, P240; Taylor TD, 1996, NAT GENET, V14, P479, DOI 10.1038/ng1296-479; Terwilliger JD, 1997, AM J HUM GENET, V61, P430, DOI 10.1086/514855; TIEPOLO L, 1979, HUM GENET, V51, P127, DOI 10.1007/BF00287166; UELAND PM, 1982, PHARMACOL REV, V34, P223; VALKOVA G, 1987, CLIN GENET, V31, P119; Wang CY, 1997, AM J HUM GENET, V60, P1461, DOI 10.1086/515469	20	47	49	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1998	63	3					803	809		10.1086/302021	http://dx.doi.org/10.1086/302021			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	119VN	9718351	Bronze, Green Published			2022-12-18	WOS:000075919000018
J	Tamary, H; Shalmon, L; Shalev, H; Halil, A; Dobrushin, D; Ashkenazi, N; Zoldan, M; Resnitzky, P; Korostishevsky, M; Bonne-Tamir, B; Zaizov, R				Tamary, H; Shalmon, L; Shalev, H; Halil, A; Dobrushin, D; Ashkenazi, N; Zoldan, M; Resnitzky, P; Korostishevsky, M; Bonne-Tamir, B; Zaizov, R			Localization of the gene for congenital dyserythropoietic anemia type I to a < 1-cM interval on chromosome 15q15.1-15.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN-4.2; MAP	Congenital dyserythropoietic anemias (CDA) are a rare group of red-blood-cell disorders of unknown etiology that are characterized by ineffective erythropoiesis, pathognomonic cytopathology of the nucleated red blood cells in the bone marrow, and secondary hemochromatosis. In CDA type I, bone-marrow electron microscopy reveals characteristic findings in erythroid precursors, including spongy heterochromatin and enlarged nuclear pores. Since the genetic basis of CDA type I is not evident, we used homozygosity and linkage mapping to localize the genetic defect responsible for CDA type I in 25 Bedouins from four large consanguineous families. We report the linkage of this disease to markers on chromosome 15 located at q15.1-q15.3. Fourteen markers within a 12-cM interval were typed in the relevant family members. Nine of the markers yielded maximum LOD scores of 1.625-12.928 at a recombination fraction of .00. Linkage disequilibrium was found only with marker D15S779. Haplotype analysis revealed eight different carrier haplotypes and highlighted the existence of a founder haplotype. Identification of historical crossover events further narrowed the gene location to between D15S779 and D15S778. The data suggest localization of the CDA type I gene within a 0.5-cM interval. The founder mutation probably occurred greater than or equal to 400 years ago. Sequence analysis of the coding region of protein 4.2, the only known erythroid-specific gene in the locus, did not reveal any change in the CDA type I patients. Future analysis of this locus may lead to the identification of a gene essential to normal erythropoiesis.	Schneider Childrens Med Ctr Israel, Pediat Hematol Oncol Ctr, IL-49202 Petah Tiqwa, Israel; Felsenstein Med Res Ctr, Pediat Hematol Oncol Res Lab, IL-49202 Petah Tiqwa, Israel; Soroka Med Ctr, Div Pediat, IL-84101 Beer Sheva, Israel; Kaplan Hosp, Efrati Res Inst Blood Cells & Cytol, IL-76100 Rehovot, Israel; Tel Aviv Univ, Sackler Sch Med, Dept Human Genet, Tel Aviv, Israel	Tel Aviv University; Ben Gurion University; Soroka Medical Center; Hebrew University of Jerusalem; Kaplan Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Tamary, H (corresponding author), Schneider Childrens Med Ctr Israel, Pediat Hematol Oncol Ctr, Beilinson Campus, IL-49202 Petah Tiqwa, Israel.	eytamary@netivision.net.il						ALLAMAND V, 1995, AM J HUM GENET, V56, P1417; Allamand V, 1997, HUM HERED, V47, P237, DOI 10.1159/000154418; ALTER BP, 1998, HEMATOLOGY INFANCY C, V1, P301; BONNETAMIR B, 1997, COLD SPRING HARB LAB; CHIANNILKULCHAI N, 1995, HUM MOL GENET, V4, P717, DOI 10.1093/hmg/4.4.717; FUKUDA MN, 1992, BRIT J HAEMATOL, V82, P745, DOI 10.1111/j.1365-2141.1992.tb06953.x; GALLAGHER PG, 1998, HEMATOLOGY INFANCY C, V1, P544; Gasparini P, 1997, AM J HUM GENET, V61, P1112, DOI 10.1086/301609; HEIMPEL H, 1968, HELV MED ACTA, V34, P103; HEIMPEL H, 1998, CIBA FOUND S, V37, P544; Iolascon A, 1997, BLOOD, V90, P4197, DOI 10.1182/blood.V90.10.4197; KORSGREN C, 1991, P NATL ACAD SCI USA, V88, P4840, DOI 10.1073/pnas.88.11.4840; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LEWIS SM, 1973, CIBA F SYMP, V37, P171; LIND L, 1995, HUM MOL GENET, V4, P109, DOI 10.1093/hmg/4.1.109; Marx E., 1967, BEDOUINS NEGEV; NAJFELD V, 1992, AM J HUM GENET, V50, P71; OTT J, 1974, AM J HUM GENET, V26, P588; PONCZ M, 1982, HEMOGLOBIN, V6, P27, DOI 10.3109/03630268208996930; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; Shalev H, 1997, J PEDIATR-US, V131, P95, DOI 10.1016/S0022-3476(97)70130-6; Tamary H, 1996, BLOOD, V87, P1763; Wickramasinghe SN, 1997, BRIT J HAEMATOL, V98, P785, DOI 10.1046/j.1365-2141.1997.2513065.x	24	47	48	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1998	62	5					1062	1069		10.1086/301834	http://dx.doi.org/10.1086/301834			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZL922	9545404	Bronze, Green Published			2022-12-18	WOS:000073487000009
J	Savino, M; Ianzano, L; Strippoli, P; Ramenghi, U; Arslanian, A; Bagnara, GP; Joenje, H; Zelante, L; Savoia, A				Savino, M; Ianzano, L; Strippoli, P; Ramenghi, U; Arslanian, A; Bagnara, GP; Joenje, H; Zelante, L; Savoia, A			Mutations of the Fanconi anemia group A gene (FAA) in Italian patients	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEMENTATION GROUP-A; GROUP-C GENE; FACC; DIAGNOSIS	Fanconi anemia (FA) is an autosomal recessive disease characterized by progressive pancytopenia, congenital malformations, and predisposition to acute myeloid leukemia. At least five complementation groups (FA-A-FA-E) have been identified, The relative prevalence of FA-A has been estimated at an average of similar to 65% but may widely vary according to ethnic background. In Italy, 11 of 12 patients analyzed by cell-fusion studies were assigned to group FA-A, suggesting an unusually high relative prevalence of this FA subtype in patients of Italian ancestry. We have screened the 43 exons of the FAA gene and their flanking intronic sequences in 38 Italian FA patients, using RNA-SSCP. Ten different mutations were detected: three nonsense and one missense substitutions, four putative splice mutations, an insertion, and a duplication. Most of the mutations are expected to cause a premature termination of the FAA protein at various sites throughout the molecule. Four protein variants were also found, three of which were polymorphisms. The missense mutation D1359Y, not found in chromosomes from healthy unrelated individuals, was responsible for a local alteration of hydrophobicity in the FAA protein, and it was likely to be pathogenic. Thus, the mutations so far encountered in the FAA gene are essentially all different. Since screening based on the analysis of single exons by genomic DNA amplification apparently detects only a minority of the mutations, methods designed to detect alterations in the genomic structure of the gene or in the FAA polypeptide may be helpful in the identification of FAA mutations.	Osped CSS, IRCCS, Serv Genet Med, Foggia, Italy; Univ Bologna, Ist Embriol & Istol, Bologna, Italy; Univ Turin, Dipartimento Sci Pediat & Adolescenza, Turin, Italy; EO Galliera, Ctr Reg Genet Umana, Genoa, Italy; Free Univ Amsterdam, Dept Human Genet, Amsterdam, Netherlands	IRCCS Casa Sollievo Della Sofferenza; University of Bologna; University of Turin; Ente Ospedaliero Ospedali Galliera; Vrije Universiteit Amsterdam	Savoia, A (corresponding author), Osped CSS, IRCCS, Serv Genet Med, I-71013 San Giovanni Rotondo, Italy.	genetcss@g.nettuno.it	Savoia, Anna/AIC-4560-2022; Savoia, Anna/B-6463-2014	Savoia, Anna/0000-0002-2407-2696; Savoia, Anna/0000-0002-2407-2696; STRIPPOLI, PIERLUIGI/0000-0001-8769-8832	Telethon [E.0364] Funding Source: Medline	Telethon(Fondazione Telethon)		Apostolou S, 1996, NAT GENET, V14, P324, DOI 10.1038/ng1196-324; AUERBACH AD, 1993, EXP HEMATOL, V21, P731; BUCHWALD M, 1995, NAT GENET, V11, P228, DOI 10.1038/ng1195-228; BUTTURINI A, 1994, BLOOD, V84, P1650, DOI 10.1182/blood.V84.5.1650.bloodjournal8451650; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; FOE JRL, IN PRESS HUM MUTAT; FOE LT, 1996, HUM MUTAT, V7, P264; Gibson RA, 1996, HUM MUTAT, V8, P140, DOI 10.1002/(SICI)1098-1004(1996)8:2<140::AID-HUMU6>3.0.CO;2-F; GIBSON RA, 1993, HUM MOL GENET, V2, P797, DOI 10.1093/hmg/2.6.797; Gschwend M, 1996, AM J HUM GENET, V59, P377; Ianzano L, 1997, GENOMICS, V41, P309, DOI 10.1006/geno.1997.4675; JOENJE H, 1995, BLOOD, V86, P2156, DOI 10.1182/blood.V86.6.2156.bloodjournal8662156; LoTenFoe JR, 1996, NAT GENET, V14, P320, DOI 10.1038/ng1196-320; MURERORLANDO M, 1993, LANCET, V342, P686, DOI 10.1016/0140-6736(93)91800-2; PRONK JC, 1995, NAT GENET, V11, P338, DOI 10.1038/ng1195-338; SAKAR G, 1992, NUCLEIC ACIDS RES, V20, P871; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; Savoia A, 1996, HUM GENET, V97, P599; Savoia A, 1997, HUM GENET, V99, P93; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; STRATHDEE CA, 1992, NAT GENET, V1, P196, DOI 10.1038/ng0692-196; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; VERLANDER PC, 1994, AM J HUM GENET, V54, P595; WHITNEY MA, 1993, NAT GENET, V4, P202, DOI 10.1038/ng0693-202	24	47	50	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1997	61	6					1246	1253		10.1086/301632	http://dx.doi.org/10.1086/301632			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YT019	9399890	Bronze, Green Published			2022-12-18	WOS:000071555900006
J	Schwarze, U; Goldstein, JA; Byers, PH				Schwarze, U; Goldstein, JA; Byers, PH			Splicing defects in the COL3A1 gene: Marked preference for 5 ' (donor) splice-site mutations in patients with exon-skipping mutations and Ehlers-Danlos syndrome type IV	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRE-MESSENGER-RNA; COL1A1 NULL ALLELES; IMPERFECTA TYPE-I; III PROCOLLAGEN; OSTEOGENESIS IMPERFECTA; UNRELATED PATIENTS; BASE SUBSTITUTION; AORTIC-ANEURYSMS; COLLAGEN; INTRON	Ehlers-Danlos syndrome (EDS) type IV results from mutations in the COL3A1 gene, which encodes the constituent chains of type III procollagen. We have identified, in 33 unrelated individuals or families with EDS type IV, mutations that affect splicing, of which 30 are point mutations at splice junctions and 3 are small deletions that remove splice-junction sequences and partial exon sequences. Except for one point mutation at a donor site, which ileads to partial intron inclusion, and a single base-pair substitution at an acceptor site, which gives rise to inclusion of the complete upstream intron into the mature mRNA, all mutations result in deletion of a single exon as the only splice alteration. Of the exonskipping mutations that are due to single base substitutions, which we have identified in 28 separate individuals, only two affect the splice-acceptor site. The underrepresentation of splice acceptor-site mutations suggests that the favored consequence of 31 mutations is the use of an alternative acceptor site that creates a null allele with a premature-termination codon. The phenotypes of those mutations may differ, with respect to either their severity or their symptomatic range, from the usual presentation of EDS type IV and thus have been excluded from analysis.	Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Byers, PH (corresponding author), Univ Washington, Dept Pathol, Box 357470, Seattle, WA 98195 USA.	pbyers@u.washington.edu		Byers, Peter H./0000-0001-7786-7030				ALAKOKKO L, 1989, BIOCHEM J, V260, P509, DOI 10.1042/bj2600509; Anderson D. W., 1993, Matrix, V13, P33; BENSONCHANDA V, 1989, GENE, V78, P255, DOI 10.1016/0378-1119(89)90228-X; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; BONADIO J, 1985, J BIOL CHEM, V260, P1734; Byers PH, 1997, AM J MED GENET, V72, P94, DOI 10.1002/(SICI)1096-8628(19971003)72:1<94::AID-AJMG20>3.0.CO;2-O; Carter MS, 1996, EMBO J, V15, P5965, DOI 10.1002/j.1460-2075.1996.tb00983.x; CHIODO AA, 1995, BIOCHEM J, V311, P939, DOI 10.1042/bj3110939; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chu Mon-Li, 1993, P149; Cogan J. D., 1996, American Journal of Human Genetics, V59, pA10; COLE WG, 1990, J BIOL CHEM, V265, P17070; DelGatto F, 1996, NUCLEIC ACIDS RES, V24, P2017, DOI 10.1093/nar/24.11.2017; EFSTRATIADIS A, 1980, CELL, V21, P653, DOI 10.1016/0092-8674(80)90429-8; ESTES PA, 1992, J BIOL CHEM, V267, P14902; HAWKINS JD, 1988, NUCLEIC ACIDS RES, V16, P9893, DOI 10.1093/nar/16.21.9893; KINNANE J, 1995, PEDIATR EMERG CARE, V11, P230, DOI 10.1097/00006565-199508000-00010; KONTUSAARI S, 1990, AM J HUM GENET, V47, P112; KRAWCZAK M, 1992, HUM GENET, V90, P41; KUIVANIEMI H, 1995, J INVEST DERMATOL, V105, P352, DOI 10.1111/1523-1747.ep12320704; KUIVANIEMI H, 1993, NEUROLOGY, V43, P2652, DOI 10.1212/WNL.43.12.2652; Kuivaniemi H, 1997, HUM MUTAT, V9, P300, DOI 10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9; KUIVANIEMI H, 1990, J BIOL CHEM, V265, P12067; LEE B, 1991, J BIOL CHEM, V266, P5256; Liu X, 1997, P NATL ACAD SCI USA, V94, P1852, DOI 10.1073/pnas.94.5.1852; LLOYD J, 1993, J MED GENET, V30, P376, DOI 10.1136/jmg.30.5.376; MacMillan AM, 1997, P NATL ACAD SCI USA, V94, P133, DOI 10.1073/pnas.94.1.133; Maquat LE, 1996, AM J HUM GENET, V59, P279; MAQUAT LE, 1995, RNA, V1, P453; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.biochem.55.1.1119; PETERSON ML, 1994, MOL CELL BIOL, V14, P77, DOI 10.1128/MCB.14.1.77; Pope FM, 1996, BRIT J DERMATOL, V135, P163, DOI 10.1046/j.1365-2133.1996.d01-971.x; RedfordBadwal DA, 1996, J CLIN INVEST, V97, P1035, DOI 10.1172/JCI118495; RICHARDS AJ, 1994, HUM MOL GENET, V3, P1901, DOI 10.1093/hmg/3.10.1901; ROBBERSON BL, 1990, MOL CELL BIOL, V10, P84, DOI 10.1128/MCB.10.1.84; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; SIRANDPUGNET P, 1995, NUCLEIC ACIDS RES, V23, P3501, DOI 10.1093/nar/23.17.3501; Smith LT, 1997, J INVEST DERMATOL, V108, P241, DOI 10.1111/1523-1747.ep12286441; Steinmann Beat, 1993, P351; STERNER DA, 1993, MOL CELL BIOL, V13, P2677, DOI 10.1128/MCB.13.5.2677; STOVER ML, 1993, J CLIN INVEST, V92, P1994, DOI 10.1172/JCI116794; THAKKERVARIA S, 1995, HUM MUTAT, V6, P116, DOI 10.1002/humu.1380060204; TROMP G, 1993, J CLIN INVEST, V91, P2539, DOI 10.1172/JCI116490; TSIPOURAS P, 1986, HUM GENET, V74, P41; Valcarcel J, 1996, SCIENCE, V273, P1706, DOI 10.1126/science.273.5282.1706; VANOERS CCM, 1994, MOL CELL BIOL, V14, P951, DOI 10.1128/MCB.14.2.951; Wang J, 1996, GENE DEV, V10, P2588, DOI 10.1101/gad.10.20.2588; WEINBAUM PJ, 1987, AM J PERINAT, V4, P134, DOI 10.1055/s-2007-999756; WILLING MC, 1994, AM J HUM GENET, V55, P638; Willing MC, 1996, AM J HUM GENET, V59, P799; WU YL, 1993, HUM MUTAT, V2, P28, DOI 10.1002/humu.1380020106	54	47	49	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1997	61	6					1276	1286		10.1086/301641	http://dx.doi.org/10.1086/301641			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YT019	9399899	Bronze, Green Published			2022-12-18	WOS:000071555900010
J	VanHul, W; Bollerslev, J; Gram, J; VanHul, E; Wuyts, W; Benichou, O; Vanhoenacker, F; Willems, PJ				VanHul, W; Bollerslev, J; Gram, J; VanHul, E; Wuyts, W; Benichou, O; Vanhoenacker, F; Willems, PJ			Localization of a gene for autosomal dominant osteopetrosis (Albers-Schonberg disease) to chromosome 1p21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECESSIVE SKELETAL MUTATION; STIMULATING FACTOR GENE; RENAL TUBULAR-ACIDOSIS; HORMONAL ASPECTS; BONE METABOLISM; HUMAN CSF-1; C-FOS; MOUSE; MICE; CALCIFICATION	Albers-Schonberg disease, the classical form of osteopetrosis, is an autosomal dominant condition with generalized increased skeletal density due to reduced bone resorption. Characteristic radiological findings are generalized osteosclerosis, with, most typically, endplate sandwichlike thickening of the vertebrae (Rugger-Jersey spine) and the bone-within-bone (endobones) phenomenon. We studied an extended kindred with Albers-Schonberg disease and found linkage with several markers from chromosome 1p21. The Albers-Schonberg gene is located in a candidate region of similar to 8.5 cM flanked by markers D1S486 and D1S2792. A maximum LOD score (Z(max)) of 4.09 was obtained in multipoint analysis at loci D1S233/D1S248. Possible linkage of osteopetrosis to this chromosomal region was analyzed because the CSF-1 gene, which is mutated in the op/op mouse model for osteopetrosis, is located in 1p21. However, SSCP and mutation analysis in patients did not reveal any abnormality, which excludes the CSF-1 gene as the disease-causing gene. This was confirmed by refined physical mapping of the CSF-1 gene outside the candidate region for the Albers-Schonberg gene. The identification of the molecular defect underlying Albers-Schonberg disease will therefore be dependent on the isolation of other genes from an 8.5-cM candidate region on chromosome 1p21.	UNIV ANTWERP HOSP, DEPT RADIOL, ANTWERP, BELGIUM; NATL UNIV HOSP, DEPT ENDOCRINOL, OSLO, NORWAY; ODENSE UNIV HOSP, DEPT ENDOCRINOL, DK-5000 ODENSE, DENMARK; HOP LARIBOISIERE, LAB INSERM U349, DEPT ENDOCRINOL, F-75475 PARIS, FRANCE	University of Antwerp; University of Oslo; National Hospital Norway; University of Southern Denmark; Odense University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	VanHul, W (corresponding author), UNIV ANTWERP, DEPT MED GENET, UNIV PLEIN 1, B-2010 ANTWERP, BELGIUM.		wuyts, wim/B-6262-2017; wuyts, wim/B-1346-2012	wuyts, wim/0000-0002-4349-9038; wuyts, wim/0000-0002-4349-9038; Van Hul, Wim/0000-0002-5065-7858; Gram, Jeppe/0000-0003-2584-1132				Albers-Schonberg H.E., 1904, MUNCH MED WOCHENSCHR, V5, P365; BARKER PE, 1984, P NATL ACAD SCI-BIOL, V81, P5826, DOI 10.1073/pnas.81.18.5826; BEIGHTON P, 1977, POSTGRAD MED J, V53, P507, DOI 10.1136/pgmj.53.622.507; BOLLERSLEV J, 1993, BONE, V14, P865, DOI 10.1016/8756-3282(93)90316-3; BOLLERSLEV J, 1989, ENDOCR REV, V10, P45, DOI 10.1210/edrv-10-1-45; BOLLERSLEV J, 1987, CLIN GENET, V31, P86; BOLLERSLEV J, 1988, BONE, V9, P7, DOI 10.1016/8756-3282(88)90021-X; BOLLERSLEV J, 1995, ENDOCRINE REV MONOGR, V4, P365; CRUTS M, 1995, HUM MOL GENET, V4, P2363, DOI 10.1093/hmg/4.12.2363; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DRACOPOLI NC, 1990, GENOMICS, V7, P97, DOI 10.1016/0888-7543(90)90523-W; GERRITSEN EJA, 1994, PEDIATRICS, V93, P247; GISSELBRECHT S, 1989, BLOOD, V73, P1742; Gruneberg H, 1935, PROC R SOC SER B-BIO, V118, P321, DOI 10.1098/rspb.1935.0060; GRUNEBERG H, 1948, J GENET, V49, P1, DOI 10.1007/BF02986377; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Hayman AR, 1996, DEVELOPMENT, V122, P3151; HEINZMANN C, 1989, NUCLEIC ACIDS RES, V17, P6425, DOI 10.1093/nar/17.15.6425; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; HORTON WA, 1980, J PEDIATR-US, V97, P580, DOI 10.1016/S0022-3476(80)80012-6; HUGHES AE, 1994, NAT GENET, V7, P509, DOI 10.1038/ng0894-509; JOHNSTON CC, 1968, MEDICINE, V47, P149, DOI 10.1097/00005792-196803000-00004; KAHLER SG, 1984, AM J MED GENET, V17, P451, DOI 10.1002/ajmg.1320170208; Karshner RG, 1926, AM J ROENTGENOL RADI, V16, P405; KAWASAKI ES, 1985, SCIENCE, V230, P291, DOI 10.1126/science.2996129; LADNER MB, 1987, EMBO J, V6, P2693, DOI 10.1002/j.1460-2075.1987.tb02561.x; LANDEGENT JE, 1992, ANN HEMATOL, V64, P110, DOI 10.1007/BF01715356; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LORIACORTES R, 1977, J PEDIATR-US, V91, P43, DOI 10.1016/S0022-3476(77)80441-1; MARKS SC, 1977, AM J ANAT, V149, P289, DOI 10.1002/aja.1001490212; MARKS SC, 1989, AM J MED GENET, V34, P43, DOI 10.1002/ajmg.1320340110; MARKS SC, 1976, J HERED, V67, P11, DOI 10.1093/oxfordjournals.jhered.a108657; MARKS SC, 1973, AM J ANAT, V138, P165, DOI 10.1002/aja.1001380204; MARKS SC, 1985, J HERED, V76, P171, DOI 10.1093/oxfordjournals.jhered.a110059; MORRIS CM, 1989, BLOOD, V74, P1768; MOSELEY WS, 1989, GENOMICS, V5, P899, DOI 10.1016/0888-7543(89)90132-8; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; PEARCE L, 1948, J EXP MED, V88, P579, DOI 10.1084/jem.88.6.579; RISER WH, 1970, J AM VET RADIOL SOC, V11, P29; SHAPIRO F, 1993, CLIN ORTHOP RELAT R, V294, P34; SLY WS, 1985, NEW ENGL J MED, V313, P139, DOI 10.1056/NEJM198507183130302; SLY WS, 1983, P NATL ACAD SCI-BIOL, V80, P2752, DOI 10.1073/pnas.80.9.2752; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; TACHIBANA M, 1994, HUM MOL GENET, V3, P553, DOI 10.1093/hmg/3.4.553; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; THOMSON RG, 1966, PATHOL VET, V3, P234, DOI 10.1177/030098586600300307; TONDRAVI MM, 1995, J BONE MINER RES, V10, pS175; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; WHYTE MP, 1980, AM J MED, V69, P64, DOI 10.1016/0002-9343(80)90501-X; XIANG K, 1991, NUCLEIC ACIDS RES, V19, P6967, DOI 10.1093/nar/19.24.6967-a; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0	51	47	48	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1997	61	2					363	369		10.1086/514844	http://dx.doi.org/10.1086/514844			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XX701	9311741	Green Published, Bronze			2022-12-18	WOS:A1997XX70100014
J	ODonnell, H; McKeown, C; Gould, C; Morrow, B; Scambler, P				ODonnell, H; McKeown, C; Gould, C; Morrow, B; Scambler, P			Detection of an atypical 22q11 deletion that has no overlap with the DiGeorge syndrome critical region	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							BALANCED TRANSLOCATION BREAKPOINT; CONGENITAL HEART-DISEASE; CARDIO-FACIAL SYNDROME; MICRODELETIONS; GENE; CHROMOSOME-22Q11; VICINITY; CLONING		INST CHILD HLTH,MOL MED UNIT,LONDON WC1N 1EH,ENGLAND; BIRMINGHAM MATERN HOSP,W MIDLANDS REG CLIN GENET SERV,BIRMINGHAM,W MIDLANDS,ENGLAND; HEARTLANDS HOSP,DEPT CYTOGENET,BIRMINGHAM,W MIDLANDS,ENGLAND; ALBERT EINSTEIN COLL MED,BRONX,NY 10467	University of London; University College London; Heart of England NHS Foundation Trust; Yeshiva University; Albert Einstein College of Medicine			Scambler, Peter/AAZ-6026-2020; Scambler, Peter J/C-4998-2008	Scambler, Peter/0000-0002-1487-4628; Scambler, Peter J/0000-0002-1487-4628; Morrow, Bernice/0000-0002-8076-4726				BUDARF ML, 1995, NAT GENET, V10, P269, DOI 10.1038/ng0795-269; BURN J, 1993, J MED GENET, V30, P822, DOI 10.1136/jmg.30.10.822; COLLINS JE, 1995, NATURE, V377, P367; DEMCZUK S, 1995, HUM MOL GENET, V4, P551, DOI 10.1093/hmg/4.4.551; DRISCOLL DA, 1992, AM J MED GENET, V44, P261, DOI 10.1002/ajmg.1320440237; DRISCOLL DA, 1992, AM J HUM GENET, V50, P924; Gong WK, 1996, HUM MOL GENET, V5, P789, DOI 10.1093/hmg/5.6.789; HALFORD S, 1993, HUM MOL GENET, V2, P2099, DOI 10.1093/hmg/2.12.2099; Kurahashi H, 1996, AM J HUM GENET, V58, P1377; LEVY A, 1995, HUM MOL GENET, V4, P2417, DOI 10.1093/hmg/4.12.2417; MCDONALDMCGINN DM, 1995, AM J MED GENET, V59, P103, DOI 10.1002/ajmg.1320590122; MORROW B, 1995, AM J HUM GENET, V56, P1379; SCAMBLER PJ, 1991, GENOMICS, V10, P201, DOI 10.1016/0888-7543(91)90501-5; SCAMBLER PJ, 1992, LANCET, V339, P1138, DOI 10.1016/0140-6736(92)90734-K; Sutherland HF, 1996, AM J HUM GENET, V59, P23; WADEY R, 1995, HUM MOL GENET, V4, P1027, DOI 10.1093/hmg/4.6.1027; WILSON DI, 1992, LANCET, V340, P573, DOI 10.1016/0140-6736(92)92107-Q	17	47	47	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1997	60	6					1544	1548						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XE294	9199579				2022-12-18	WOS:A1997XE29400036
J	Schwemmle, S; deGraaff, E; Deissler, H; Glaser, D; Wohrle, D; Kennerknecht, I; Just, W; Oostra, BA; Dorfler, W; Vogel, W; Steinbach, P				Schwemmle, S; deGraaff, E; Deissler, H; Glaser, D; Wohrle, D; Kennerknecht, I; Just, W; Oostra, BA; Dorfler, W; Vogel, W; Steinbach, P			Characterization of FMR1 promoter elements by in vivo - Footprinting analysis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGILE-X-SYNDROME; LIGATION MEDIATED PCR; C-MYC PROTEIN; TRANSCRIPTION FACTOR; METHYLATION ANALYSIS; CGG REPEAT; DNA-BINDING; GENE FMR-1; EXPRESSION; INSTABILITY	Fragile X syndrome is associated with silencing of the FMR1 gene, We studied the transcriptional regulation, by analysis of the FMR1 promoter region for the presence of in vivo protein/DNA interactions and for cytosine methylation at the single-nucleotide level. Four protein-binding sites were present in the unmethylated promoter of the active FMR1 gene. In the methylated promoter of inactive genes no footprints were detected, and no evidence of active repression was found in the region investigated. We propose that the silencing of FMR1 gene transcription results from a lack of transcription-factor binding.	ERASMUS UNIV ROTTERDAM, DEPT CLIN GENET, NL-3000 DR ROTTERDAM, NETHERLANDS; UNIV COLOGNE, INST GENET, D-5000 COLOGNE, GERMANY	Erasmus University Rotterdam; University of Cologne	Schwemmle, S (corresponding author), UNIV ULM, ABT MED GENET, PK STR 11, D-89073 ULM, GERMANY.		de Graaff, Esther/D-3287-2011	Deissler, Heidrun/0000-0003-0086-7811				ARIGA H, 1989, EMBO J, V8, P4273, DOI 10.1002/j.1460-2075.1989.tb08613.x; BELL MV, 1991, CELL, V64, P861, DOI 10.1016/0092-8674(91)90514-Y; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11366, DOI 10.1073/pnas.90.23.11366; DANG CV, 1991, MOL CELL BIOL, V11, P954, DOI 10.1128/MCB.11.2.954; DEGRAAFF E, 1995, AM J HUM GENET, V57, P609; Ehrlich M., 1993, Experientia Supplementum (Basel), V64, P145; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Graessmann M, 1993, EXS, V64, P404; HANSEN RS, 1992, HUM MOL GENET, V1, P571, DOI 10.1093/hmg/1.8.571; HARRINGTON MA, 1988, P NATL ACAD SCI USA, V85, P2066, DOI 10.1073/pnas.85.7.2066; HEGERSBERG M, 1995, HUM MOL GENET, V4, P359; HOLLER M, 1988, GENE DEV, V2, P1127, DOI 10.1101/gad.2.9.1127; HORNSTRA IK, 1993, HUM MOL GENET, V2, P1659; HWU WL, 1993, BIOCHEM BIOPH RES CO, V193, P324, DOI 10.1006/bbrc.1993.1627; JACOB WF, 1989, J BIOL CHEM, V264, P20372; LATCHMAN DS, 1991, EUKARYOTIC TRANSCRIP; LATHANGUE NB, 1988, TRANSCRIPTION SPLICI, P3; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; NAKAHORI Y, 1991, NUCLEIC ACIDS RES, V19, P4355, DOI 10.1093/nar/19.16.4355; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Pfeifer G P, 1993, Methods Mol Biol, V23, P169; PFEIFER GP, 1989, SCIENCE, V246, P810, DOI 10.1126/science.2814502; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; RICHARDS RI, 1993, HUM MOL GENET, V2, P1429, DOI 10.1093/hmg/2.9.1429; SMEETS HJM, 1995, HUM MOL GENET, V4, P2103, DOI 10.1093/hmg/4.11.2103; STEINBACH P, 1993, HUM GENET, V92, P491, DOI 10.1007/BF00216457; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; VERHEIJ C, 1993, NATURE, V363, P722, DOI 10.1038/363722a0; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VINCENT A, 1991, NATURE, V349, P624, DOI 10.1038/349624a0; WASYLYK B, 1988, BIOCHIM BIOPHYS ACTA, V951, P17, DOI 10.1016/0167-4781(88)90021-8; Zhong N., 1995, American Journal of Human Genetics, V57, pA155	36	47	50	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1997	60	6					1354	1362		10.1086/515456	http://dx.doi.org/10.1086/515456			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XE294	9199556	Green Published, Bronze			2022-12-18	WOS:A1997XE29400013
J	Sherman, SL; DeFries, JC; Gottesman, II; Loehlin, JC; Meyer, JM; Pelias, MZ; Rice, J; Waldman, I				Sherman, SL; DeFries, JC; Gottesman, II; Loehlin, JC; Meyer, JM; Pelias, MZ; Rice, J; Waldman, I			ASHG statement - Recent developments in human behavioral genetics: Past accomplishments and future directions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPLE-REGRESSION ANALYSIS; SCHIZOPHRENIA SUSCEPTIBILITY; CHROMOSOME 6P24-22; TWIN DATA; PERSONALITY; VULNERABILITY; RELATIVES; ADOPTEES; MODELS; FAMILY	The field of behavioral genetics has enormous potential to uncover both genetic and environmental influences on normal and deviant behavior. Behavioral-genetic methods are based on a solid foundation of theories and methods that successfully have delineated components of complex traits in plants and animals. New resources are now available to dissect the genetic component of these complex traits. As specific genes are identified, we can begin to explore how these interact with environmental factors in development. How we interpret such findings, how we ask new questions, how we celebrate the knowledge, and how we use or misuse this knowledge are all important considerations. These issues are pervasive in all areas of human research, and they are. especially salient in human behavioral genetics.	EMORY UNIV, DEPT PSYCHOL, ATLANTA, GA 30322 USA; UNIV COLORADO, INST BEHAV GENET, BOULDER, CO 80309 USA; UNIV VIRGINIA, DEPT PSYCHOL, CHARLOTTESVILLE, VA 22903 USA; UNIV TEXAS, DEPT PSYCHOL, AUSTIN, TX 78712 USA; MILLENNIUM PHARMACEUT INC, CAMBRIDGE, MA USA; LOUISIANA STATE UNIV, DEPT BIOMETRY & GENET, NEW ORLEANS, LA 70112 USA; WASHINGTON UNIV, DEPT PSYCHIAT, ST LOUIS, MO USA	Emory University; University of Colorado System; University of Colorado Boulder; University of Virginia; University of Texas System; University of Texas Austin; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Louisiana State University System; Washington University (WUSTL)	Sherman, SL (corresponding author), EMORY UNIV, SCH MED, DEPT GENET, 1461 CLIFTON RD NE, ATLANTA, GA 30322 USA.		Loehlin, John C./H-3794-2019; G, I/D-8042-2011					ANTONARAKIS SE, 1995, NAT GENET, V11, P235, DOI 10.1038/ng1195-235; BOOMSMA DI, 1987, BEHAV GENET, V17, P111, DOI 10.1007/BF01065991; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; DEFRIES JC, 1988, ACTA GENET MED GEMEL, V37, P205, DOI 10.1017/S0001566000003810; DEFRIES JC, 1985, BEHAV GENET, V15, P467, DOI 10.1007/BF01066239; DiLalla DL, 1996, J ABNORM PSYCHOL, V105, P491, DOI 10.1037/0021-843X.105.4.491; Eaves L, 1989, GENES CULTURE PERSON; EAVES LJ, 1986, BEHAV GENET, V16, P143, DOI 10.1007/BF01065484; Eysenck H. J., 1975, MANUAL EYSENCK PERSO; FLINT J, 1995, SCIENCE, V269, P1432, DOI 10.1126/science.7660127; FLODERUS B, 1995, NORD HYG TIDSKR S, V6; FLODERUSMYRHED B, 1980, BEHAV GENET, V10, P153, DOI 10.1007/BF01066265; GOTTESMAN II, 1989, ARCH GEN PSYCHIAT, V46, P867; Gottesman II, 1996, AM J MED GENET, V67, P317; GOTTESMAN II, 1991, SCHIZOPHRENIA GENETI; GOTTESMAN II, 1993, NATURE NURTURE PSYCH, P231; GURLING H, 1995, NAT GENET, V11, P234, DOI 10.1038/ng1195-234; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; HATHAWAY SR, 1983, MMPI MANUAL; HESTON LL, 1966, BRIT J PSYCHIAT, V112, P819, DOI 10.1192/bjp.112.489.819; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; JINKS JL, 1970, PSYCHOL BULL, V73, P311, DOI 10.1037/h0029135; KENDLER KS, 1994, ARCH GEN PSYCHIAT, V51, P456; KETY SS, 1994, ARCH GEN PSYCHIAT, V51, P442; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANGINVAINIO H, 1984, ACTA GENET MED GEMEL, V33, P259, DOI 10.1017/S0001566000007303; Li G, 1996, GENET EPIDEMIOL, V13, P285, DOI 10.1002/(SICI)1098-2272(1996)13:3<285::AID-GEPI5>3.0.CO;2-5; Loehlin J., 1976, HEREDITY ENV PERSONA, DOI DOI 10.7560/730038; Loehlin J.C., 1992, GENES ENV PERSONALIT; Lush J.L., 1937, ANIMAL BREEDING PLAN; MARTIN NG, 1977, HEREDITY, V38, P79, DOI 10.1038/hdy.1977.9; Martin NG., 1986, HANS EYSENCK CONSENS, P13; Mather K., 1949, BIOMETRICAL GENETICS; MCARDLE JJ, 1986, BEHAV GENET, V16, P163, DOI 10.1007/BF01065485; MCCARTNEY K, 1990, PSYCHOL BULL, V107, P226, DOI 10.1037/0033-2909.107.2.226; Megargee EI., 1972, CALIFORNIA PSYCHOL I; MOISES HW, 1995, NAT GENET, V11, P321, DOI 10.1038/ng1195-321; MOWRY BJ, 1995, NAT GENET, V11, P233, DOI 10.1038/ng1195-233; PEDERSEN NL, 1988, J PERS SOC PSYCHOL, V55, P950, DOI 10.1037/0022-3514.55.6.950; PELIAS MZ, 1991, AM J MED GENET, V39, P347, DOI 10.1002/ajmg.1320390320; Pennington BF, 1997, AM J HUM GENET, V60, P13; PLOMIN R, 1987, BEHAV BRAIN SCI, V10, P1, DOI 10.1017/S0140525X00055941; PLOMIN R, 1990, BEHAVIORAL GENETICS; PLOMIN R, 1988, NATURE NURTURE INFAN; Roses AD, 1996, NAT MED, V2, P267, DOI 10.1038/nm0396-267; ROWE DC, 1994, PSYCHOL REV, V101, P396, DOI 10.1037/0033-295X.101.3.396; SCHWAB SG, 1995, NAT GENET, V11, P325, DOI 10.1038/ng1195-325; Shields J, 1982, SCHIZOPHRENIA EPIGEN; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; TELLEGEN A, 1988, J PERS SOC PSYCHOL, V54, P1031, DOI 10.1037/0022-3514.54.6.1031; TIENARI P, 1991, ACTA PSYCHIAT SCAND, V84, P460, DOI 10.1111/j.1600-0447.1991.tb03178.x; Torrey E. F., 1994, SCHIZOPHRENIA MANIC; VIKEN RJ, 1994, J PERS SOC PSYCHOL, V66, P722, DOI 10.1037/0022-3514.66.4.722	53	47	47	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1997	60	6					1265	1275		10.1086/515473	http://dx.doi.org/10.1086/515473			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	XE294	9199545	Bronze, Green Published			2022-12-18	WOS:A1997XE29400002
J	Kaul, R; Gao, GP; Matalon, R; Aloya, M; Su, Q; Jin, M; Johnson, AB; Schutgens, RBH; Clarke, JTR				Kaul, R; Gao, GP; Matalon, R; Aloya, M; Su, Q; Jin, M; Johnson, AB; Schutgens, RBH; Clarke, JTR			Identification and expression of eight novel mutations among non-Jewish patients with Canavan disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASPARTOACYLASE DEFICIENCY; MISSENSE MUTATION; MOLECULAR-BASIS; GENE	Canavan disease is inherited as an autosomal recessive trait that is caused by the deficiency of aspartoacylase (ASPA). The majority of patients with Canavan disease are from an Ashkenazi Jewish background. Mutations in ASPA that lead to loss of enzymatic activity have been identified, and E285A and Y231X are the two predominant mutations that account for 97% of the mutant chromosomes in Ashkenazi Jewish patients. The current study was aimed at finding the molecular basis of Canavan disease in 25 independent patients of non-Jewish background. Eight novel and three previously characterized mutations accounted for 80% (40/50) of mutant chromosomes. The A305E missense mutation accounted for 48% (24/50) of mutant chromosomes in patients of western European descent, while the two predominant Jewish mutations each accounted for a single mutant chromosome. The eight novel mutations identified included 1- and 4-bp deletions (32 Delta T and 876 Delta AGAA, respectively) and I16T, G27R, D114E, G123E, C152Y, and R168C missense mutations. The homozygous 32 Delta T deletion was identified in the only known patient of African-American origin with Canavan disease. The heterozygosity for 876 Delta AGAA mutation was identified in three independent patients from England. Six single-base changes leading to missense mutations were identified in patients from Turkey (D114E, R168C), The Netherlands (I16T), Germany (G27R), Ireland (C152Y), and Canada (G123E). A PCR-based protocol is described that was used to introduce mutations in wild-type cDNA. In vitro expression of mutant cDNA clones demonstrated that all of these mutations led to a deficiency of ASPA and should therefore result in Canavan disease.	MIAMI CHILDRENS HOSP,RES INST,MIAMI,FL; ALBERT EINSTEIN COLL MED,DEPT PATHOL,BRONX,NY 10467; FREE UNIV AMSTERDAM HOSP,DEPT PEDIAT,NL-1081 HV AMSTERDAM,NETHERLANDS; HOSP SICK CHILDREN,DIV CLIN GENET,TORONTO,ON M5G 1X8,CANADA	Yeshiva University; Albert Einstein College of Medicine; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)				Kaul, Rajinder/0000-0002-7895-9284				BIRNBAUM SM, 1955, METHOD ENZYMOL, V2, P115, DOI 10.1016/S0076-6879(55)02176-9; ELPELEG ON, 1994, AM J HUM GENET, V55, P287; GOLDSTEIN FB, 1969, J BIOL CHEM, V244, P4257; GOLDSTEIN FB, 1959, J BIOL CHEM, V243, P2702; KAUL R, 1993, NAT GENET, V5, P118, DOI 10.1038/ng1093-118; KAUL R, 1994, AM J HUM GENET, V55, P34; KAUL R, 1994, GENOMICS, V21, P364, DOI 10.1006/geno.1994.1278; KAUL R, 1994, J INHERIT METAB DIS, V17, P295, DOI 10.1007/BF00711811; KAUL R, 1995, HUM MUTAT, V5, P269, DOI 10.1002/humu.1380050313; KAUL RK, 1994, AM J HUM GENET S, V55, P212; KRONN D, 1995, AM J HUM GENET, V57, P1250; MATALON R, 1995, J PEDIATR-US, V127, P511, DOI 10.1016/S0022-3476(95)70105-2; MATALON R, 1988, AM J MED GENET, V29, P463, DOI 10.1002/ajmg.1320290234; MATALON R, 1994, AM J HUM GENET S, V55, P908; SHAAG A, 1995, AM J HUM GENET, V57, P572; van Bogaert L., 1949, ACTA NEUROL BELG, V49, P572	16	47	50	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1996	59	1					95	102						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL455	8659549				2022-12-18	WOS:A1996VL45500014
J	Santos, FR; RodriguezDelfin, L; Pena, SDJ; Moore, J; Weiss, KM				Santos, FR; RodriguezDelfin, L; Pena, SDJ; Moore, J; Weiss, KM			North and South Amerindians may have the same major founder Y chromosome haplotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									UNIV FED MINAS GERAIS,DEPT BIOQUIM,BR-30161970 BELO HORIZONT,MG,BRAZIL; UNIV FLORIDA,DEPT ANTHROPOL,GAINESVILLE,FL 32611; PENN STATE UNIV,DEPT ANTHROPOL,UNIVERSITY PK,PA 16802	Universidade Federal de Minas Gerais; State University System of Florida; University of Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park			Santos, Fabrício Rodrigues/H-2370-2011	Santos, Fabrício Rodrigues/0000-0001-9088-1750				LITTLEFIELD D, 1979, AFRICANS CREEKS; PENA SDJ, 1995, NAT GENET, V11, P15, DOI 10.1038/ng0995-15; PRICE R, 1979, MAROON SOC REBEL SLA; Santos FR, 1996, HUM GENET, V97, P309, DOI 10.1007/BF02185760; SANTOS FR, 1993, HUM GENET, V90, P655; SANTOS FR, 1995, GENE, V165, P191, DOI 10.1016/0378-1119(95)00501-V; Santos FR, 1995, BRAZ J GENET, V18, P669; SWANTON JR, 1922, B BUREAU AM ETHNOLOG, V73	8	47	49	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1996	58	6					1369	1370						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UM271	8651314				2022-12-18	WOS:A1996UM27100030
J	Knight, SJL; Ritchie, RJ; Chakrabarti, L; Cross, G; Taylor, GR; Mueller, RF; Hurst, J; Paterson, J; Yates, JRW; Dow, DJ; Davies, KE				Knight, SJL; Ritchie, RJ; Chakrabarti, L; Cross, G; Taylor, GR; Mueller, RF; Hurst, J; Paterson, J; Yates, JRW; Dow, DJ; Davies, KE			A study of FRAXE in mentally retarded individuals referred for fragile X syndrome (FRAXA) testing in the United Kingdom	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							2 FAMILIES; SITE; IDENTIFICATION; RETARDATION	The folate-sensitive fragile site FRAXE is located in proximal Xq28 of the human X chromosome and lies similar to 600 kb distal to the fragile X syndrome (FRAXA) fragile sire at Xq27.3. The cytogenetic expression of FRAXE is thought to be associated with mental handicap, but this is usually mild compared to that of the more common fragile X syndrome that is associated with the expression of the FRAXA fragile site. The exact incidence of FRAXE mental retardation is uncertain. We describe here the results of a U.K. survey designed to assess the frequency of FRAXE in a population of individuals referred for fragile X syndrome testing and found to be negative for expansion events at the FRAXA locus. No FRAXE expansion events were found in 362 cytogenetically negative males studied, and one expansion event was identified in a sample of 534 males for whom cytogenetic analyses were either unrecorded or not performed. Further FRAXE expansion events were detected in two related females known to be cytogenetically positive for a fragile site in Xq27.3-28. To gain insight into the FRAXE phenotype, the clinical details of the identified FRAXE male plus three other FRAXE individuals identified through previous referrals for fragile X syndrome testing are presented. For the population studied, we conclude that FRAXE mental retardation is a relatively rare but significant form of mental retardation for which genetic diagnosis would be appropriate.	JOHN RADCLIFFE HOSP,INST MOLEC MED,OXFORD OX3 9DU,ENGLAND; CHURCHILL HOSP,DEPT MED GENET,OXFORD OX3 7LJ,ENGLAND; CITY HOSP,CTR GENET MED,DEPT MOLEC GENET,NOTTINGHAM NG5 1PB,ENGLAND; ST JAMESS UNIV HOSP,REG GENET UNIT,YORKSHIRE REG DNA LAB,LEEDS,W YORKSHIRE,ENGLAND; ST JAMESS UNIV HOSP,DEPT CLIN GENET,LEEDS,W YORKSHIRE,ENGLAND; ADDENBROOKES NHS TRUST,DEPT CLIN GENET,CAMBRIDGE,ENGLAND; ADDENBROOKES NHS TRUST,MOLEC GENET LAB,CAMBRIDGE,ENGLAND	University of Oxford; University of Oxford; University of Nottingham; Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Leeds; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital			Chakrabarti, Lisa/G-4236-2011	Knight, Samantha/0000-0002-6047-3462; Chakrabarti, Lisa/0000-0001-7213-6837				ALLINGHAMHAWKIN.DJ, 1995, AM J HUM GENET, V57, P72; BROWN WT, 1990, AM J HUM GENET, V47, P175; DENNIS NR, 1992, AM J MED GENET, V43, P232, DOI 10.1002/ajmg.1320430137; DONNELLY J, 1994, J MED GENET, V31, P173; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; FLYNN GA, 1993, J MED GENET, V30, P97, DOI 10.1136/jmg.30.2.97; HAMEL BCJ, 1994, AM J HUM GENET, V55, P923; HIRST MC, 1993, HUM MOL GENET, V2, P197, DOI 10.1093/hmg/2.2.197; KNIGHT SJL, 1994, AM J HUM GENET, V55, P81; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; LUBS HA, 1969, AM J HUM GENET, V21, P231; MULLEY JC, 1995, J MED GENET, V32, P162, DOI 10.1136/jmg.32.3.162; NAKAHORI Y, 1991, NUCLEIC ACIDS RES, V19, P4355, DOI 10.1093/nar/19.16.4355; NANCARROW JK, 1995, HUM MOL GENET, V4, P367, DOI 10.1093/hmg/4.3.367; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; PARRISH JE, 1994, NAT GENET, V8, P229, DOI 10.1038/ng1194-229; RITCHIE RJ, 1994, HUM MOL GENET, V3, P2115, DOI 10.1093/hmg/3.12.2115; RUBINSZTEIN DC, 1995, NAT GENET, V10, P337, DOI 10.1038/ng0795-337; Sutherland Grant R., 1992, Human Molecular Genetics, V1, P111, DOI 10.1093/hmg/1.2.111; WANG Q, 1995, J MED GENET, V32, P170, DOI 10.1136/jmg.32.3.170; WANG Q, 1993, LANCET, V242, P1025	21	47	48	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1996	58	5					906	913						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH192	8651274				2022-12-18	WOS:A1996UH19200002
J	Ghosh, SS; Fahy, E; BodisWollner, I; Sherman, J; Howell, N				Ghosh, SS; Fahy, E; BodisWollner, I; Sherman, J; Howell, N			Longitudinal study of a heteroplasmic 3460 Leber hereditary optic neuropathy family by multiplexed primer-extension analysis and nucleotide sequencing	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA MUTATION; SEGREGATION; ORGANIZATION; GENETICS; LINEAGE	Nucleotide-sequencing and multiplexed primer-extension assays have been used to quantitate the mutant-allele frequency in 14 maternal relatives, spanning three generations, from a family that is heteroplasmic for the primary Leber hereditary optic neuropathy (LHON) mutation at nucleotide 3460 of the mitochondrial genome. There was excellent agreement between the values that were obtained with the two different methods. The longitudinal study shows that the mutant-allele frequency was constant within individual family members over a sampling period of 3.5 years. Second, although there was an overall increase in the mutant-allele frequency in successive generations, segregation in the direction of the mutant allele was not invariant, and there was one instance in which there was a significant decrease in the frequency from parent to offspring. From these two sets of results, and from previous studies of heteroplasmic LHON families, we conclude that there is no evidence for a marked selective pressure that determines the replication, segregation, or transmission of primary LHON mutations to white blood cells and platelets. Instead, the mtDNA molecules are most likely to replicate and segregate under conditions of random drift at the cellular level. Finally, the pattern of transmission in this maternal lineage is compatible with a developmental bottleneck model in which the number of mitochondrial units of segregation in the female germ line is relatively small in relation to the number of mtDNA molecules within a cell. However, this is not an invariant pattern for humans, and simple models of mitochondrial gene transmission are inappropriate at the present time.	UNIV TEXAS,MED BRANCH,DEPT RADIAT THERAPY,BIOL DIV 0656,DEPT HUMAN BIOL CHEM & GENET,GALVESTON,TX 77555; APPL GENET,SAN DIEGO,CA; SUNY HLTH SCI CTR,DEPT NEUROL,BROOKLYN,NY; SUNY COLL OPTOMETRY,SCHNURMACHER INST VIS RES,NEW YORK,NY 10010	University of Texas System; University of Texas Medical Branch Galveston; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; SUNY Optometry			bodis-wollner, ivan/AAH-2631-2020		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD008315] Funding Source: NIH RePORTER; NICHD NIH HHS [P01 HD08315] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ASHLEY MV, 1989, NUCLEIC ACIDS RES, V17, P7325, DOI 10.1093/nar/17.18.7325; BROWN MD, 1994, CLIN NEUROSCI, V2, P138; HAEN PJ, 1995, PRINCIPLES HEMATOLOG, P25; HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686; HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739; HOWELL N, 1994, CLIN NEUROSCI, V2, P130; HOWELL N, 1992, HUM GENET, V90, P117; HOWELL N, 1994, AM J HUM GENET, V55, P203; HOWELL N, 1991, AM J HUM GENET, V49, P939; HOWELL N, 1992, AM J HUM GENET, V50, P443; HUOPONEN K, 1994, HUM MUTAT, V3, P29, DOI 10.1002/humu.1380030106; HUTCHIN T, 1995, P NATL ACAD SCI USA, V92, P6892, DOI 10.1073/pnas.92.15.6892; JOHNS DR, 1994, CLIN NEUROSCI, V2, P146; JUVONEN V, 1994, HUM GENET, V93, P16; KOEHLER CM, 1991, GENETICS, V129, P247; LOTT MT, 1990, AM J OPHTHALMOL, V109, P625, DOI 10.1016/S0002-9394(14)72429-8; MACKEY DA, 1994, CLIN NEUROSCI, V2, P162; MACKEY DA, 1992, AUST NZ J OPHTHALMOL, V20, P177, DOI 10.1111/j.1442-9071.1992.tb00937.x; MASHIMA Y, 1995, INVEST OPHTH VIS SCI, V36, P1714; MATTHEWS PM, 1995, HUM GENET, V96, P261; NASS MMK, 1969, J MOL BIOL, V42, P521, DOI 10.1016/0022-2836(69)90240-X; NEWMAN NJ, 1993, ARCH NEUROL-CHICAGO, V50, P540, DOI 10.1001/archneur.1993.00540050082021; NIGUCHI Y, 1995, J BIOL CHEM, V270, P7950; NIKOSKELAINEN EK, 1994, CLIN NEUROSCI, V2, P115; POULTON J, 1993, ANN NEUROL, V34, P116, DOI 10.1002/ana.410340124; RAND DM, 1986, GENETICS, V114, P955; RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319; SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9; SHERMAN J, 1994, CLIN NEUROSCI, V2, P121; SMITH KH, 1993, ARCH OPHTHALMOL-CHIC, V111, P1486, DOI 10.1001/archopht.1993.01090110052022; SOLIGNAC M, 1984, MOL GEN GENET, V197, P183, DOI 10.1007/BF00330961; Steel R.G.D., 1960, PRINCIPLES PROCEDURE, P99; TORRONI A, 1994, J BIOENERG BIOMEMBR, V26, P261, DOI 10.1007/BF00763098; VILKKI J, 1990, AM J HUM GENET, V47, P95; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; ZHU DP, 1992, AM J MED GENET, V42, P173, DOI 10.1002/ajmg.1320420208	37	47	48	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1996	58	2					325	334						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TR791	8571959				2022-12-18	WOS:A1996TR79100009
J	Milani, N; Dalpra, L; delPrete, A; Zanini, R; Larizza, L				Milani, N; Dalpra, L; delPrete, A; Zanini, R; Larizza, L			A novel mutation (Gln266->His) in the alpha1 subunit of the inhibitory glycine-receptor gene (GLRA1) in hereditary hyperekplexia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									UNIV MILAN,FAC MED,DIPARTIMENTO BIOL & GENET SCI MED,MILAN,ITALY; OSPED CIRCOLI,DIV PATOL NEONATALE,DIPARTIMENTO PEDIAT,LECCO,ITALY	University of Milan								BORMANN J, 1993, EMBO J, V12, P3729, DOI 10.1002/j.1460-2075.1993.tb06050.x; BUCKWALTER MS, 1994, HUM MOL GENET, V3, P2025, DOI 10.1093/hmg/3.11.2025; Elmslie F. V., 1994, American Journal of Human Genetics, V55, pA358; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; GRENNINGLOH G, 1990, EMBO J, V9, P771, DOI 10.1002/j.1460-2075.1990.tb08172.x; KINGSMORE SF, 1994, NAT GENET, V7, P136, DOI 10.1038/ng0694-136; LANGOSCH D, 1994, EMBO J, V13, P4223, DOI 10.1002/j.1460-2075.1994.tb06742.x; RAJENDRA S, 1994, J BIOL CHEM, V269, P18739; REES MI, 1994, HUM MOL GENET, V3, P2175, DOI 10.1093/hmg/3.12.2175; RYAN SG, 1992, AM J HUM GENET, V51, P1334; RYAN SG, 1994, NAT GENET, V7, P131, DOI 10.1038/ng0694-131; SCHORDERET DF, 1994, HUM MOL GENET, V3, P1201; SHIANG R, 1993, NAT GENET, V5, P351, DOI 10.1038/ng1293-351; Shiang R., 1994, American Journal of Human Genetics, V55, pA242; Warrington J. A., 1992, American Journal of Human Genetics, V51, pA248	15	47	49	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1996	58	2					420	422						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TR791	8571969				2022-12-18	WOS:A1996TR79100019
J	MEARS, AJ; ELSHANTI, H; MURRAY, JC; MCDERMID, HE; PATIL, SR				MEARS, AJ; ELSHANTI, H; MURRAY, JC; MCDERMID, HE; PATIL, SR			MINUTE SUPERNUMERARY RING CHROMOSOME-22 ASSOCIATED WITH CAT EYE SYNDROME - FURTHER DELINEATION OF THE CRITICAL REGION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSLOCATION; MICRODELETIONS; ETIOLOGY; DIGEORGE; MOTHER; CHILD	Cat eye syndrome (CES) is typically associated with a supernumerary bisatellited marker chromosome (inv dup 22pter-22q11.2) resulting in four copies of this region. We describe an individual showing the inheritance of a minute supernumerary double ring chromosome 22, which resulted in expression of all cardinal features of CES. The size of the ring was determined by DNA dosage analysis and FISH analysis for five loci mapping to 22q11.2. The probes to the loci D22S9, D22S43, and ATP6E were present in four copies, whereas D22S57 and D22S181 were present in two copies. This finding further delineates the distal boundary of the critical region of CES, with ATP6E being the most distal duplicated locus identified. The phenotypically normal father and grandfather of the patient each had a small supernumerary ring chromosome and demonstrated three copies for the loci D22S9, D22S43, and ATP6E. Although three copies of this region have been reported in other cases with CES features, it is possible that the presence of four copies leads to greater susceptibility.	UNIV ALBERTA,DEPT BIOL SCI,EDMONTON,AB T6G 2E9,CANADA; UNIV IOWA HOSP & CLIN,DEPT PEDIAT,DIV MED GENET,IOWA CITY,IA 52242; JORDAN UNIV SCI & TECHNOL,DEPT PEDIAT,IRBID,JORDAN	University of Alberta; University of Iowa; Jordan University of Science & Technology			El-Shanti, Hatem/O-5990-2014	El-Shanti, Hatem/0000-0001-6230-8316				BAUD V, 1994, HUM MOL GENET, V3, P335, DOI 10.1093/hmg/3.2.335; Benn P.A., 1986, HUMAN CYTOGENETICS C, VVolume 1, P91; BUDARF ML, 1991, GENOMICS, V10, P996, DOI 10.1016/0888-7543(91)90190-P; CANTU ES, 1989, CLIN GENET, V36, P189; DALLAPICCOLA B, 1982, ANN GENET-PARIS, V25, P56; DEALMEIDA JCC, 1983, ANN GENET-PARIS, V26, P112; DEPREZ RHL, 1991, NUCLEIC ACIDS RES, V19, P686; DRISCOLL DA, 1992, AM J HUM GENET, V50, P924; DRISCOLL DA, 1993, J MED GENET, V30, P813, DOI 10.1136/jmg.30.10.813; DUCKETT DP, 1992, ANN GENET-PARIS, V35, P113; ELSHANTI H, 1993, AM J HUM GENET S, V53, pA126; FIBISON WJ, 1990, AM J HUM GENET, V47, pA178; ING P S, 1985, American Journal of Human Genetics, V37, pA98; JALAL SM, 1990, ANN GENET-PARIS, V33, P173; KNOLL JHM, 1994, IN PRESS AM J MED GE; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; LULECI G, 1989, HEREDITAS, V111, P7, DOI 10.1111/j.1601-5223.1989.tb00369.x; MCDERMID HE, 1986, SCIENCE, V232, P646, DOI 10.1126/science.3961499; MCGINNISS MJ, 1992, AM J HUM GENET, V50, P15; MEARS AJ, 1994, AM J HUM GENET, V55, P134; MEARS AJ, 1995, THESIS U ALBERTA EDM; NERI G, 1983, AM J MED GENET, V14, P307, DOI 10.1002/ajmg.1320140211; NOEL B, 1976, J GENET HUM, V24, P279; OHASHI H, 1993, AM J HUM GENET S, V53, pA586; ORYE E, 1974, HUM HERED, V24, P253, DOI 10.1159/000152658; PANGALOS C, 1984, ANN GENET-PARIS, V27, P38; REISS JA, 1985, AM J MED GENET, V20, P165, DOI 10.1002/ajmg.1320200120; SCHACHENMANN G, 1965, LANCET, V2, P290; SCHINZEL A, 1981, HUM GENET, V57, P148; SPINNER NB, 1989, AM J HUM GENET, V44, P631; STEWART GD, 1985, NUCLEIC ACIDS RES, V13, P4125, DOI 10.1093/nar/13.11.4125; STEWART GD, 1985, NUCLEIC ACIDS RES, V19, P7168; SUTHERLAND GR, 1989, LEUKEMIA, V3, P9; URIOSTE M, 1994, AM J MED GENET, V49, P77, DOI 10.1002/ajmg.1320490114; XIE YG, 1994, HUM GENET, V94, P339	35	47	49	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1995	57	3					667	673						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR605	7668296				2022-12-18	WOS:A1995RR60500017
J	SHAAG, A; ANIKSTER, Y; CHRISTENSEN, E; GLUSTEIN, JZ; FOIS, A; MICHELAKAKIS, H; NIGRO, F; PRONICKA, E; RIBES, A; ZABOT, MT; ELPELEG, ON				SHAAG, A; ANIKSTER, Y; CHRISTENSEN, E; GLUSTEIN, JZ; FOIS, A; MICHELAKAKIS, H; NIGRO, F; PRONICKA, E; RIBES, A; ZABOT, MT; ELPELEG, ON			THE MOLECULAR-BASIS OF CANAVAN (ASPARTOACYLASE DEFICIENCY) DISEASE IN EUROPEAN NON-JEWISH PATIENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							N-ACETYLASPARTIC ACIDURIA; DIAGNOSIS	Canavan disease is an infantile neurodegenerative disease that is due to aspartoacylase deficiency. The disease has been reported mainly in Ashkenazi Jews but also occurs in other ethnic groups. Determination of enzymatic activity for carrier detection and prenatal diagnosis is considered unreliable. In the present study, nine mutations were found in the aspartoacylase gene of 19 non-Jewish patients. These included four point mutations (A305E [39.5% of the mutated alleles], C218X [15.8%], F295S [2.6%], and G274R [5.3%]); four deletion mutations (827 delGT [5.3%], 870de14 [2.6%], 566del7 [2.6%], and 527del6 [2.6%]); and one exon skip (527 del108 [5.3%]). The A305E mutation is panEuropean and probably the most ancient mutation, identified in patients of Greek, Polish, Danish, French, Spanish, Italian, and British origin. In contrast, the G274R and 527 del108 mutations were found only in patients of Turkish origin, and the C218X mutation was identified only in patients of Gypsy origin. Homozygosity for the A305E mutation was identified in patients with both the severe and the mild forms of Canavan disease. Mutations were identified in 31 of the 38 alleles, resulting in an overall detection rate of 81.6%. All nine mutations identified in non-Jewish patients reside in exons 4-6 of the aspartoacylase gene. The results would enable accurate genetic counseling in the families of 13 (68.4%) of 19 patients, in whom two mutations were identified in the aspartoacylase cDNA.	SHAARE ZEDEK MED CTR,METABOL UNIT,IL-91031 JERUSALEM,ISRAEL; RIGSHOSP,DEPT CLIN GENET,DK-2100 COPENHAGEN,DENMARK; UNIV SIENA,I-53100 SIENA,ITALY; AGHIA SOPHIA CHILDRENS HOSP,INST CHILD HLTH,DIV ENZYMOL & CELLULAR FUNCT,ATHENS,GREECE; UNIV CATANIA,PEDIAT CLIN,CATANIA,ITALY; CHILD HLTH CTR,DEPT METAB DIS,WARSAW,POLAND; CORP SANITARIA,INST BIOQUIM CLIN,BARCELONA,SPAIN; HOP DEBROUSSE,SERV BIOCHEM,UNITE CULTURE CELLULAIRE,LYON,FRANCE	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Rigshospitalet; University of Copenhagen; University of Siena; The Aghia Sophia Children's Hospital; University of Catania; Children's Memorial Health Institute; CHU Lyon				Pronicka, Ewa/0000-0002-5705-4814				BARTALINI G, 1992, CHILD NERV SYST, V8, P468, DOI 10.1007/BF00274411; BENNETT MJ, 1993, J INHERIT METAB DIS, V16, P831, DOI 10.1007/BF00714274; DIVRY P, 1988, J INHERIT METAB DIS, V11, P307, DOI 10.1007/BF01800378; ELPELEG ON, 1994, J INHERIT METAB DIS, V17, P664, DOI 10.1007/BF00712008; ELPELEG ON, 1994, AM J HUM GENET, V55, P287; GOODHUE WW, 1979, ARCH NEUROL-CHICAGO, V36, P481, DOI 10.1001/archneur.1979.00500440051009; JELLINGER K, 1969, ACTA NEUROPATHOL, V13, P276, DOI 10.1007/BF00690647; KAUL R, 1993, NAT GENET, V5, P118, DOI 10.1038/ng1093-118; KAUL R, 1994, AM J HUM GENET, V55, P34; KAUL R, 1994, GENOMICS, V21, P364, DOI 10.1006/geno.1994.1278; KRAWCZAK M, 1992, HUM GENET, V90, P41; MATALON R, 1988, AM J MED GENET, V29, P463, DOI 10.1002/ajmg.1320290234; MICHELAKAKIS H, 1991, J INHERIT METAB DIS, V14, P267, DOI 10.1007/BF01800603; NIGRO F, 1991, 29TH M SOC STYD INB, pP148; ROLLAND MO, 1994, J INHERIT METAB DIS, V17, P748, DOI 10.1007/BF00712018; Sambrook J., 1989, MOL CLONING; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TOFT PB, 1993, EUR J PEDIATR, V152, P750, DOI 10.1007/BF01953994; VANBOGAERT L, 1970, HDB CLIN NEUROLOGY, V10, P203	19	47	48	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1995	57	3					572	580						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR605	7668285				2022-12-18	WOS:A1995RR60500006
J	MCGUIRE, RE; SULLIVAN, LS; BLANTON, SH; CHURCH, MW; HECKENLIVELY, JR; DAIGER, SP				MCGUIRE, RE; SULLIVAN, LS; BLANTON, SH; CHURCH, MW; HECKENLIVELY, JR; DAIGER, SP			X-LINKED DOMINANT CONE-ROD DEGENERATION - LINKAGE MAPPING OF A NEW LOCUS FOR RETINITIS-PIGMENTOSA (RP15) TO XP22.13-P22.11	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC-LINKAGE; CARRIERS; COMPUTATIONS	Retinitis pigmentosa is the name given to a heterogeneous group of hereditary retinal degenerations characterized by progressive visual field loss, pigmentary changes of the retina, abnormal electroretinograms, and, frequently, night blindness. In this study, we investigated a family with dominant cone-rod degeneration, a variant form of retinitis pigmentosa. We used microsatellite markers to test for linkage to the disease locus and excluded ail mapped autosomal loci. However, a marker from the short arm of the X chromosome, DXS989, showed 0% recombination to the disease locus, with a maximum lod (log-odds) score of 3.3. On the basis of this marker, the odds favoring X-linked dominant versus autosomal dominant inheritance are > 10(5):1. Haplotype analysis using an additional nine microsatellite markers places the disease locus in the Xp22.13-p22.11 region and excludes other X-linked disease loci causing retinal degeneration. The clinical expression of the retinal degeneration is consistent with X-linked dominant inheritance with milder, variable effects of Lyonization affecting expression in females. On the basis of these data we propose that this family has a novel form of dominant, X-linked cone-rod degeneration with the gene symbol "RP15."	UNIV TEXAS, HLTH SCI CTR, SCH PUBL HLTH, CTR HUMAN GENET, HOUSTON, TX 77225 USA; UNIV TEXAS, HLTH SCI CTR, DEPT OPHTHALMOL & VISUAL SCI, HOUSTON, TX USA; UNIV VIRGINIA, DEPT PEDIAT, CHARLOTTESVILLE, VA USA; WAYNE STATE UNIV, SCH MED, DEPT OBSTET GYNECOL, DETROIT, MI USA; UNIV CALIF LOS ANGELES, JULES STEIN EYE INST, LOS ANGELES, CA 90024 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Virginia; Wayne State University; University of California System; University of California Los Angeles			Blanton, Susan Halloran/ABF-1323-2021		NEI NIH HHS [EY07024, EY06467, R01 EY007142] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY006467, R01EY007142] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BHATTACHARYA SS, 1984, NATURE, V309, P253, DOI 10.1038/309253a0; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DAIGER SP, 1995, IN PRESS BEHAV BRAIN; FISHMAN GA, 1986, ARCH OPHTHALMOL-CHIC, V104, P1329, DOI 10.1001/archopht.1986.01050210083030; FRIEDRICH U, 1993, HUM GENET, V92, P359, DOI 10.1007/BF01247335; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Heckenlively J. R., 1988, RETINITIS PIGMENTOSA; HECKENLIVELY JR, 1981, ARCH OPHTHALMOL-CHIC, V99, P1983; HECKENLIVELY JR, 1981, DOC OPHTHALMOL P SER, V27, P183; LATHROP GM, 1988, AM J HUM GENET, V42, P498; MARMOR MF, 1983, OPHTHALMOLOGY, V90, P126; McGuire R. E., 1994, American Journal of Human Genetics, V55, pA195; OTT J, 1990, P NATL ACAD SCI USA, V87, P701, DOI 10.1073/pnas.87.2.701; PEACHEY NS, 1988, OPHTHALMOLOGY, V95, P677; PEARSON PL, 1992, NUCLEIC ACIDS RES, V20, P2201, DOI 10.1093/nar/20.suppl.2201; WEBER JL, 1989, AM J HUM GENET, V44, P388; WILLARD HF, 1994, CYTOGENET CELL GENET, V67, P296	17	47	48	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1995	57	1					87	94						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RE629	7611300				2022-12-18	WOS:A1995RE62900011
J	QUAN, F; ZONANA, J; GUNTER, K; PETERSON, KL; MAGENIS, RE; POPOVICH, BW				QUAN, F; ZONANA, J; GUNTER, K; PETERSON, KL; MAGENIS, RE; POPOVICH, BW			AN ATYPICAL CASE OF FRAGILE-X SYNDROME CAUSED BY A DELETION THAT INCLUDES THE FMRI GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MENTAL-RETARDATION; CGG REPEAT; REGION; DNA; SITE; INSTABILITY; METHYLATION; HYPERMETHYLATION; AMPLIFICATION; RESOLUTION	Fragile X syndrome is the most common form of inherited mental retardation and results from the transcriptional inactivation of the FMR1 gene. In the vast majority of cases, this is caused by the expansion of an unstable CGG repeat in the first exon of the FMR1 gene. We describe here a phenotypically atypical case of fragile X syndrome, caused by a deletion that includes the entire FMR1 gene and greater than or equal to 9.0 Mb of flanking DNA. The proband, RK, was a 6-year-old mentally retarded male with obesity and anal atresia. A diagnosis of fragile X syndrome was established by the failure of RK's DNA to hybridize to a 558-bp PstI-XhoI fragment (pfxa3) specific for the 5'-end of the FMR1 gene. The analysis of Banking markers in the interval from Xq26.3-q28 indicated a deletion extending from between 160-500 kb distal and 9.0 Mb proximal to the FMR1 gene. High-resolution chromosome banding confirmed a deletion with breakpoints in Xq26.3 and Xq27.3. This deletion was maternally transmitted and arose as a new mutation on the grandpaternal X chromosome. The maternal transmission of the deletion was confirmed by FISH using a 34-kb cosmid (c31.4) containing most of the FMR1 gene. These results indicated that RK carried a deletion of the FMR1 region with the most proximal breakpoint described to date. This patient's unusual clinical presentation may indicate the presence of genes located in the deleted interval proximal to the FMR1 locus that are able to modify the fragile X syndrome phenotype.	OREGON HLTH SCI UNIV,DNA DIAGNOST LAB,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT MOLEC & MED GENET,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,CTR CHILD DEV & REHABIL,PORTLAND,OR 97201; SHRINERS HOSP CRIPPLED CHILDREN,PORTLAND,OR 97201	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University			Quan, Fu-Shi/V-1826-2019					ALBRIGHT SG, 1994, AM J MED GENET, V51, P294, DOI 10.1002/ajmg.1320510403; ARVEILER B, 1988, AM J HUM GENET, V42, P380; BELL MV, 1991, CELL, V64, P861, DOI 10.1016/0092-8674(91)90514-Y; BOGGS BA, 1984, SOMAT CELL MOLEC GEN, V10, P607, DOI 10.1007/BF01535226; BROWN WT, 1993, JAMA-J AM MED ASSOC, V270, P1569, DOI 10.1001/jama.270.13.1569; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; DEVRIES BBA, 1994, J MED GENET, V30, P761; EICHLER EE, 1993, HUM MOL GENET, V2, P1147, DOI 10.1093/hmg/2.8.1147; FRYNS JP, 1987, CLIN GENET, V32, P388; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GEDEON AK, 1992, NAT GENET, V1, P341, DOI 10.1038/ng0892-341; GU YH, 1994, HUM MOL GENET, V3, P1705, DOI 10.1093/hmg/3.9.1705; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HAGERMAN RJ, 1991, FRAGILE X SYNDROME; HEITZ D, 1992, J MED GENET, V29, P794, DOI 10.1136/jmg.29.11.794; HIRST MC, 1991, NUCLEIC ACIDS RES, V19, P3283, DOI 10.1093/nar/19.12.3283; HOLM VA, 1993, PEDIATRICS, V91, P398; HORNSTRA IK, 1993, HUM MOL GENET, V2, P1659; KNIGHT SJL, 1994, AM J HUM GENET, V55, P81; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; KNIGHT SJL, 1994, CELL, V55, P81; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; LUBS HA, 1969, AM J HUM GENET, V21, P231; MEIJER H, 1994, HUM MOL GENET, V3, P615; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; OOSTRA BA, 1990, GENOMICS, V6, P129, DOI 10.1016/0888-7543(90)90457-6; OOSTRA BA, 1993, J MED GENET, V30, P410, DOI 10.1136/jmg.30.5.410; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; SUTHERLAND GR, 1977, SCIENCE, V197, P265, DOI 10.1126/science.877551; TARLETON J, 1993, HUM MOL GENET, V2, P1973, DOI 10.1093/hmg/2.11.1973; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WARREN ST, 1994, JAMA-J AM MED ASSOC, V271, P536, DOI 10.1001/jama.271.7.536; WEBB TP, 1986, AM J MED GENET, V23, P573, DOI 10.1002/ajmg.1320230151; WILLARD HF, 1994, CYTOGENET CELL GENET, V67, P296; WOHRLE D, 1992, AM J HUM GENET, V51, P299; YU S, 1992, AM J HUM GENET, V50, P968; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	37	47	49	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1995	56	5					1042	1051						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QU586	7726157				2022-12-18	WOS:A1995QU58600004
J	GEDEON, AK; KEINANEN, M; ADES, LC; KAARIAINEN, H; GECZ, J; BAKER, E; SUTHERLAND, GR; MULLEY, JC				GEDEON, AK; KEINANEN, M; ADES, LC; KAARIAINEN, H; GECZ, J; BAKER, E; SUTHERLAND, GR; MULLEY, JC			OVERLAPPING SUBMICROSCOPIC DELETIONS IN XQ28 IN 2 UNRELATED BOYS WITH DEVELOPMENTAL DISORDERS - IDENTIFICATION OF A GENE NEAR FRAXE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGILE-X-SYNDROME; MENTAL-RETARDATION; FMR-1 GENE; DNA; HYPERMETHYLATION; AMPLIFICATION; INACTIVATION; EXPRESSION; PHENOTYPE; SEQUENCE	Two unrelated boys are described with delay in development and submicroscopic deletions in Xq28, near FRAXE. Molecular diagnosis to exclude the fragile X (FRAXA) syndrome used the direct probe pfxa3, together with a control probe pS8 (DXS296), against PstI restriction digests of DNA. Deletions were detected initially by the control probe pS8, which is an anonymous fragment subcloned from YAC 539, within 1 Mb distal to FRAXA. Further molecular analyses determined that the maximum size of the deletion is <100 kb in one boy (MK) and is wholly overlapped by the deletion of up to similar to 200 kb in the other (CB). These deletions lie between the sequences detected by the probe VK21C (DXS296) and a dinucleotide repeat VK18AC (DXS295). The patient MK had only speech delay with otherwise normal development, while patient CB had global developmental delay that included speech delay. Detection of overlapping deletions in these two cases led to speculation that coding sequences of a gene(s) important in language development may be affected. Hybridization of the pS8 and VK21A probes to zoo-blots revealed cross-species homology. This conservation during evolution suggested that this region contains sequences with functional significance in normal development. The VK21A probe detected a 9.5-kb transcript in placenta and brain and a smaller, 2.5-kb, transcript in other tissues analyzed.	WOMENS & CHILDRENS HOSP,CTR GENET MED,DEPT MED GENET,ADELAIDE,SA,AUSTRALIA; UNIV ADELAIDE,DEPT GENET,ADELAIDE,SA,AUSTRALIA; UNIV ADELAIDE,DEPT PEDIAT,ADELAIDE,SA,AUSTRALIA; CLIN LAB MEDIX,ESPOO,FINLAND; UNIV HELSINKI,DEPT MED GENET,HELSINKI,FINLAND	Womens & Childrens Hospital Australia; University of Adelaide; University of Adelaide; University of Helsinki	GEDEON, AK (corresponding author), WOMENS & CHILDRENS HOSP,CTR GENET MED,DEPT CYTOGENET & MOLEC GENET,ADELAIDE,SA 5006,AUSTRALIA.		Gedeon, Agi/G-7890-2011; Sutherland, Grant Robert/D-2606-2012; Gecz, Jozef/X-3469-2019	Gecz, Jozef/0000-0002-7884-6861				ALBRIGHT SG, 1994, AM J MED GENET, V51, P294, DOI 10.1002/ajmg.1320510403; BELL MV, 1991, CELL, V64, P861, DOI 10.1016/0092-8674(91)90514-Y; CALLEN DF, 1990, ANN GENET, V33, P419; CHOO KH, 1987, DNA-J MOLEC CELL BIO, V6, P297, DOI 10.1089/dna.1987.6.297; CLARKE JTR, 1991, AM J HUM GENET, V49, P289; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; EICHLER EE, 1993, HUM MOL GENET, V2, P1147, DOI 10.1093/hmg/2.8.1147; GEDEON AK, 1992, NAT GENET, V1, P341, DOI 10.1038/ng0892-341; KALATZIS V, 1991, THESIS U ADELAIDE AD; KETTERLING RP, 1994, AM J HUM GENET, V54, P201; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; MEIJER H, 1994, HUM MOL GENET, V3, P615; MULLEY JC, IN PRESS J MED GENET; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; PARRISH JE, 1994, NAT GENET, V8, P229, DOI 10.1038/ng1194-229; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; SCHMIDT M, 1990, HUM GENET, V84, P347, DOI 10.1007/BF00196232; SUTHERLAND GR, 1991, NEW ENGL J MED, V325, P1720, DOI 10.1056/NEJM199112123252407; SUTHERS GK, 1990, AM J HUM GENET, V47, P187; TARLETON J, 1993, HUM MOL GENET, V2, P1973, DOI 10.1093/hmg/2.11.1973; TROTTIER Y, 1994, AM J MED GENET, V51, P454, DOI 10.1002/ajmg.1320510431; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WILSON PJ, 1991, HUM GENET, V86, P505; WOHRLE D, 1992, AM J HUM GENET, V51, P299; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179; YU S, 1992, THESIS U ADELAIDE AD	26	47	47	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1995	56	4					907	914						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QP663	7536393				2022-12-18	WOS:A1995QP66300012
J	LALWANI, AK; BRISTER, JR; FEX, J; GRUNDFAST, KM; PLOPLIS, B; SANAGUSTIN, TB; WILCOX, ER				LALWANI, AK; BRISTER, JR; FEX, J; GRUNDFAST, KM; PLOPLIS, B; SANAGUSTIN, TB; WILCOX, ER			FURTHER ELUCIDATION OF THE GENOMIC STRUCTURE OF PAX3, AND IDENTIFICATION OF 2 DIFFERENT POINT MUTATIONS WITHIN THE PAX3 HOMEOBOX THAT CAUSE WAARDENBURG SYNDROME TYPE-I IN 2 FAMILIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TUMOR ALVEOLAR RHABDOMYOSARCOMA; MAGNETIC-RESONANCE SPECTROSCOPY; HOMEODOMAIN-DNA INTERACTIONS; HUP2 PAIRED DOMAIN; MOUSE MUTANT; CRYSTAL-STRUCTURE; BINDING DOMAIN; HUMAN HOMOLOG; BOX GENE; DROSOPHILA	Waardenburg syndrome is an autosomal dominant disorder characterized by sensorineural deafness and pigmentary disturbances. Previous work has linked the disease to PAX3 on chromosome 2, and several mutations within the highly conserved paired-box and octapeptide motifs, but not the homeobox, have been reported. In this report, we have used the published cDNA sequence to further define the genomic structure of PAX3, using inverse PCR. We have identified exon/intron boundaries between exons 5 and 6 and between exons 6 and 7. Further, we have identified the first two mutations within the homeobox in two different families with type 1 Waardenburg syndrome. The first is a point mutation (G-->T) at the first base of exon 6, which substitutes phenylalanine for valine. In another family, we have identified a point mutation (C-->G) within the homeobox, in exon 6, which substitutes a glycine for arginine at a highly conserved site. The homeodomain is important in binding of DNA and in effecting transcriptional control. These mutations likely result in structural change within the homeodomain that either change the DNA-binding specificity of the homeodomain or reduce the affinity of the PAX3 protein for DNA. These homeodomain mutations should aid in elucidating the role of the homeodomain in the function of the PAX3 protein.	NIDOCD,MOLEC BIOL LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)								ARIAS S, 1993, NAT GENET, V5, P8, DOI 10.1038/ng0993-8a; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BARR FG, 1993, NAT GENET, V3, P113, DOI 10.1038/ng0293-113; BASTIAN H, 1990, EMBO J, V9, P1839, DOI 10.1002/j.1460-2075.1990.tb08309.x; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BILLETER M, 1990, J MOL BIOL, V214, P183, DOI 10.1016/0022-2836(90)90155-F; BOPP D, 1986, CELL, V47, P1033, DOI 10.1016/0092-8674(86)90818-4; BURRI M, 1989, EMBO J, V8, P1183, DOI 10.1002/j.1460-2075.1989.tb03490.x; BUTT J, 1994, HUM MOL GENET, V3, P197, DOI 10.1093/hmg/3.1.197; COLLINS FS, 1984, P NATL ACAD SCI-BIOL, V81, P6812, DOI 10.1073/pnas.81.21.6812; EPSTEIN DJ, 1993, P NATL ACAD SCI USA, V90, P532, DOI 10.1073/pnas.90.2.532; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; FARRER LA, 1994, AM J HUM GENET, V55, P728; FREYD G, 1990, NATURE, V344, P876, DOI 10.1038/344876a0; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; GOULDING M, 1993, GENOMICS, V17, P355, DOI 10.1006/geno.1993.1332; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; GRUNDFAST KM, 1992, OTOLARYNG CLIN N AM, V25, P935; GRUSS P, 1992, CELL, V69, P719, DOI 10.1016/0092-8674(92)90281-G; HOLLAND PWH, 1991, GENE, V98, P253, DOI 10.1016/0378-1119(91)90182-B; HOTH CF, 1993, AM J HUM GENET, V52, P455; JOSTES B, 1991, MECH DEVELOP, V33, P27; KESSEL M, 1990, SCIENCE, V249, P374, DOI 10.1126/science.1974085; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; MARTIN P, 1992, ONCOGENE, V7, P1721; MCGINNIS W, 1984, NATURE, V308, P428, DOI 10.1038/308428a0; MCGINNIS W, 1984, CELL, V38, P675, DOI 10.1016/0092-8674(84)90262-9; McKusick V. A. E., 1991, MENDELIAN INHERITANC; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; MORELL R, 1993, HUM MOL GENET, V9, P1487; Morell Robert, 1992, Human Molecular Genetics, V1, P243, DOI 10.1093/hmg/1.4.243; NASMYTH KA, 1981, NATURE, V289, P244, DOI 10.1038/289244a0; OCHMAN H, 1988, GENETICS, V120, P621; OKAYAMA H, 1989, J LAB CLIN MED, V114, P105; OTTING G, 1990, EMBO J, V9, P3085, DOI 10.1002/j.1460-2075.1990.tb07505.x; READ AP, 1993, NAT GENET, V5, P8, DOI 10.1038/ng0993-8b; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; TASSABEHJI M, 1993, NAT GENET, V3, P26, DOI 10.1038/ng0193-26; TREISMAN J, 1991, GENE DEV, V5, P594, DOI 10.1101/gad.5.4.594; TRIGLIA T, 1988, NUCLEIC ACIDS RES, V16, P8186, DOI 10.1093/nar/16.16.8186; VOGAN KJ, 1993, GENOMICS, V17, P364, DOI 10.1006/geno.1993.1333; WAARDENBURG PJ, 1951, AM J HUM GENET, V3, P195; WOLBERGER C, 1991, CELL, V67, P517, DOI 10.1016/0092-8674(91)90526-5	46	47	49	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					75	83						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825605				2022-12-18	WOS:A1995QC10100010
J	LALWANI, AK; BRISTER, JR; FEX, J; GRUNDFAST, KM; PIKUS, AT; PLOPLIS, B; SANAGUSTIN, T; SKARKA, H; WILCOX, ER				LALWANI, AK; BRISTER, JR; FEX, J; GRUNDFAST, KM; PIKUS, AT; PLOPLIS, B; SANAGUSTIN, T; SKARKA, H; WILCOX, ER			NEW NONSYNDROMIC X-LINKED SENSORINEURAL HEARING IMPAIRMENT LINKED TO XP21.2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; CONGENITAL ADRENAL HYPOPLASIA; MENTAL-RETARDATION; DMD GENE; INTRAGENIC RECOMBINATION; LINKAGE ANALYSIS; HIGH-FREQUENCY; DEAFNESS; DEFICIENCY; DELETIONS	X-linked deafness is a rare cause of hereditary hearing impairment. We have identified a family with X-linked dominant sensorineural hearing impairment, characterized by incomplete penetrance and variable expressivity in carrier females, that is linked to the Xp21.2, which contains the Duchenne muscular dystrophy (DMD) locus. The auditory impairment in affected males was congenital, bilateral, profound, sensorineural, affecting all frequencies, and without evidence of radiographic abnormality of the temporal bone. Adult carrier females manifested bilateral, mild-to-moderate high-frequency sensorineural hearing impairment of delayed onset during adulthood. Eighteen commercially available polymorphic markers from the X chromosome, generating a 10-15-cM map, were initially used for identification of a candidate region. DXS997, located within the DMD gene, generated a two-point LOD score of 2.91 at theta = 0, with every carrier mother heterozygous at this locus. Recombination events at DXS332 (located within the DMD locus, 3' to exon 50 of the dystrophin gene) and at DXS1068 (5' to the brain promoter of the dystrophin gene) were observed. No recombination events were noted with the following markers within the DMD locus: 5'DYS II, intron 44, DXS997, and intron 50. There was no clinical evidence of Duchenne or Becker muscular dystrophy in any family member. It is likely that this family represents a new locus on the X chromosome, which when mutated results in nonsyndromic sensorineural hearing loss and is distinct from the heterogeneous group of X-linked hearing losses that have been previously described.	NIDCD,PUBL HLTH SERV,GENET MOLEC LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); United States Public Health Service								ABBS S, 1990, GENOMICS, V7, P602, DOI 10.1016/0888-7543(90)90205-9; AHN AH, 1993, NAT GENET, V3, P283, DOI 10.1038/ng0493-283; ALLEN NR, 1973, DEV MED CHILD NEUROL, V15, P500; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; AZIBI K, 1993, HUM MOL GENET, V2, P1423; BACH I, 1992, AM J HUM GENET, V51, P38; BEGGS AH, 1990, NUCLEIC ACIDS RES, V18, P1931, DOI 10.1093/nar/18.7.1931; BODURTHA JN, 1988, OTOLOGIC MED SURGERY, V1, P831; BURMEISTER M, 1988, Genomics, V2, P189, DOI 10.1016/0888-7543(88)90002-X; CLEMENS PR, 1991, AM J HUM GENET, V49, P951; DAVIES KE, 1988, J MED GENET, V25, P9, DOI 10.1136/jmg.25.1.9; DENDUNNEN JT, 1989, AM J HUM GENET, V45, P835; DONNELLY A, IN PRESS GENOMICS; FEENER CA, 1991, AM J HUM GENET, V48, P621; FRANCKE U, 1987, AM J HUM GENET, V40, P212; FRASER GR, 1965, ANN HUM GENET, V29, P171, DOI 10.1111/j.1469-1809.1965.tb00512.x; FRIES MH, 1993, AM J MED GENET, V46, P363, DOI 10.1002/ajmg.1320460404; Grundfast Kenneth M., 1992, Ear Nose and Throat Journal, V71, P479; GUILFORD P, 1994, NAT GENET, V6, P24, DOI 10.1038/ng0194-24; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; KEMP DT, 1978, J ACOUST SOC AM, V64, P1386, DOI 10.1121/1.382104; KENWRICK S, 1987, CELL, V48, P351, DOI 10.1016/0092-8674(87)90438-7; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KUNKEL LM, 1986, NATURE, V322, P73, DOI 10.1038/322073a0; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEON PE, 1992, P NATL ACAD SCI USA, V89, P5181, DOI 10.1073/pnas.89.11.5181; LIVAN M, 1961, ARCH ITAL OTOL, V72, P331; MALMGREN H, 1993, AM J HUM GENET, V52, P1046; MARAZITA ML, 1993, AM J MED GENET, V46, P486, DOI 10.1002/ajmg.1320460504; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; MATSUMURA K, 1992, NATURE, V359, P320, DOI 10.1038/359320a0; MATTEI JF, 1983, CLIN GENET, V23, P70; MCKUSICK VA, 1993, MENDELIAN INHERITANC; MOHR JAN, 1960, ACTA GENET ET STATIST MED, V10, P54; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; MUNTONI F, 1993, NEW ENGL J MED, V329, P921, DOI 10.1056/NEJM199309233291304; MYHRE SA, 1982, CLIN GENET, V22, P299; NANCE W E, 1971, Birth Defects Original Article Series, V7, P64; NANCE WE, 1970, S MED B, V58, P41; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; OUDET C, 1992, HUM MOL GENET, V1, P599, DOI 10.1093/hmg/1.8.599; OUDET C, 1990, HUM GENET, V84, P283; OUDET C, 1991, AM J HUM GENET, V49, P311; PELLETIER LP, 1975, AM J HUM GENET, V27, P609; PILLERS DM, 1993, AM J HUM GENET, V53, P146; REARDON W, 1991, GENOMICS, V11, P885, DOI 10.1016/0888-7543(91)90011-3; REARDON W, 1992, British Journal of Audiology, V26, P109, DOI 10.3109/03005369209077878; REARDON W, 1992, AM J MED GENET, V44, P513, DOI 10.1002/ajmg.1320440427; SAUGIERVEBER P, 1993, AM J HUM GENET, V52, P1040; van Ommen G J, 1987, Genomics, V1, P329, DOI 10.1016/0888-7543(87)90032-2; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WELLESLEY D, 1992, CLIN GENET, V41, P79; ZACHMANN M, 1992, EUR J PEDIATR, V151, P167, DOI 10.1007/BF01954375; 1992, SCIENCE, V258, P148	57	47	52	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1994	55	4					685	694						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PJ027	7942846				2022-12-18	WOS:A1994PJ02700011
J	TSUJINO, S; SERVIDEI, S; TONIN, P; SHANSKE, S; AZAN, G; DIMAURO, S				TSUJINO, S; SERVIDEI, S; TONIN, P; SHANSKE, S; AZAN, G; DIMAURO, S			IDENTIFICATION OF 3 NOVEL MUTATIONS IN NON-ASHKENAZI ITALIAN PATIENTS WITH MUSCLE PHOSPHOFRUCTOKINASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LIVER-TYPE PHOSPHOFRUCTOKINASE; MESSENGER-RNA; TISSUE-SPECIFICITY; GENE; EXPRESSION; CDNA; CLONING; DEFECT; REGION; ACID	We have identified three novel mutations in four non-Ashkenazi Italian patients with muscle phosphofructokinase (PFK-M) deficiency (Tarui disease). Patient 1 was homozygous for an A-to-C substitution at the 3' end of intron 6 of the PFK-M gene, changing the consensus splice-junction sequence AG to CG. The mutation leads to activation of two cryptic splice sites in exon 7, resulting in one 5 bp- and one 12 bp-deleted transcript. An affected brother was also homozygous, and both parents were heterozygous, for the splice-junction mutation. Patient 2 was homozygous for a G-to-C substitution at codon 39, changing an encoded arginine (CGA) to proline (CCA). Patient 3 was heterozygous for an A-to-C substitution at codon 543, changing an encoded aspartate (GAC) to alanine (GCC); the PFK-M gene on the other allele was not expressed, but sequencing of the reported regulatory region of the gene did not reveal any mutation.	COLUMBIA PRESBYTERIAN MED CTR, H HOUSTON MERRITT CLIN RES MUSCULAR DYSTROPHY & R, DEPT NEUROL, NEW YORK, NY 10032 USA; UNIV CATTOLICA SACRO CUORE, IST NEUROL, I-00168 ROME, ITALY; UNIV VERONA, IST NEUROL, I-37100 VERONA, ITALY; IST OASI, TROINA, GREECE	Columbia University; NewYork-Presbyterian Hospital; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Verona			Servidei, Serenella/ABC-4262-2021	SERVIDEI, Serenella/0000-0001-8478-2799	NINDS NIH HHS [NS 11766] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS011766, P50NS011766] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BELGRADER P, 1993, P NATL ACAD SCI USA, V90, P482, DOI 10.1073/pnas.90.2.482; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; EVANS PR, 1981, PHILOS T ROY SOC B, V293, P53, DOI 10.1098/rstb.1981.0059; GEHNRICH SC, 1988, J BIOL CHEM, V263, P11755; GLISIN V, 1974, BIOCHEMISTRY-US, V13, P2633, DOI 10.1021/bi00709a025; HOTTA K, 1991, EUR J BIOCHEM, V202, P293, DOI 10.1111/j.1432-1033.1991.tb16375.x; KONO N, 1986, NEUROLOGY, V36, P106, DOI 10.1212/WNL.36.1.106; KRAWCZAK M, 1992, HUM GENET, V90, P41; LEE CP, 1987, J BIOL CHEM, V262, P4195; LEVANON D, 1989, DNA-J MOLEC CELL BIO, V8, P733, DOI 10.1089/dna.1989.8.733; MASHIMA Y, 1992, AM J HUM GENET, V51, P81; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NAKAJIMA H, 1990, BIOCHEM BIOPH RES CO, V166, P637, DOI 10.1016/0006-291X(90)90856-I; NAKAJIMA H, 1990, BIOCHEM BIOPH RES CO, V173, P1317, DOI 10.1016/S0006-291X(05)80931-3; NAKAJIMA H, 1987, FEBS LETT, V223, P113, DOI 10.1016/0014-5793(87)80519-7; NAKAJIMA H, 1990, J BIOL CHEM, V265, P9392; POORMAN RA, 1984, NATURE, V309, P467, DOI 10.1038/309467a0; RABEN N, 1993, J BIOL CHEM, V268, P4963; RABEN N, 1993, AM J HUM GENET, V53, P942; ROWLAND LP, 1986, PHOSPHOFRUCTOKINASE, P1603; SERVIDEI S, 1986, NEUROLOGY, V36, P1465, DOI 10.1212/WNL.36.11.1465; SHANSKE S, 1987, J BIOL CHEM, V262, P14612; SHARMA PM, 1989, GENE, V77, P177, DOI 10.1016/0378-1119(89)90372-7; SHARMA PM, 1990, J BIOL CHEM, V265, P9006; SIMPSON CJ, 1991, BIOCHEM BIOPH RES CO, V180, P197, DOI 10.1016/S0006-291X(05)81276-8; TARUI S, 1965, BIOCHEM BIOPH RES CO, V19, P517, DOI 10.1016/0006-291X(65)90156-7; TSUJINO S, 1994, AM J HUM GENET, V54, P44; TSUJINO S, 1993, NEW ENGL J MED, V329, P241, DOI 10.1056/NEJM199307223290404; Uyeda K, 1979, Adv Enzymol Relat Areas Mol Biol, V48, P193; VORA S, 1987, J CLIN INVEST, V80, P1479, DOI 10.1172/JCI113229; VORA S, 1982, ISOZYMES-CURR T BIOL, V6, P119; VORA S, 1982, SOMAT CELL GENET, V8, P95, DOI 10.1007/BF01538653; YAMASAKI T, 1991, GENE, V104, P277, DOI 10.1016/0378-1119(91)90262-A	34	47	48	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1994	54	5					812	819						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NH394	7513946				2022-12-18	WOS:A1994NH39400010
J	KWIATKOWSKI, DJ; DIB, C; SLAUGENHAUPT, SA; POVEY, S; GUSELLA, JF; HAINES, JL				KWIATKOWSKI, DJ; DIB, C; SLAUGENHAUPT, SA; POVEY, S; GUSELLA, JF; HAINES, JL			AN INDEX MARKER MAP OF CHROMOSOME-9 PROVIDES STRONG EVIDENCE FOR POSITIVE INTERFERENCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; GENETIC-LINKAGE MAP; HUMAN GENOME; LOCUS; IDENTIFICATION; PROGRAM; 9Q32-34	An index marker map of chromosome 9 has been constructed using the Centre d'Etude du Polymorphisme Humain reference pedigrees. The map comprises 26 markers, with a maximum intermarker interval of 13.1 cM and only two intervals >10 cM. Placement of all but one marker into the map was achieved with >10,000:1 odds. The sex-equal length is 151 cM, with male length of 121 cM and female length of 185 cM. The map extends to within 2%-3% of physical length at the telomeres, and its coverage therefore is expected to be within 20-30 cM of full map length. The markers are all of the GT/CA repeat type and have average heterozygosity .77, with a range of .60-.89. The map shows both marked contraction of genetic distance relative to physical distance in the pericentromeric region and expansion in the telomeric regions. Genotypic data were carefully examined for errors by using the crossover routine of the program DATAMAN. Five new mutations were observed among 17,316 meiotic events examined. There were two double-crossover events occurring within an interval of 0-10 cM, and another eight were observed within an interval of 10-20 cM. Many of these could be due to additional mutational events in which one parental allele converted to the other by either gene conversion or random strand slippage. When there was no correction for these possible mutational events, the number of crossovers displayed by the maternal and paternal chromosomes was significantly different (P<.001) from that predicted by the Poisson distribution, which would be expected in the absence of interference. In addition, the observed crossover distribution for paternally derived chromosomes was similar to that predicted from cytogenetic chiasma frequency observations. In all, the data strongly support the occurrence of strong positive interference on human chromosome 9 and suggest that flanking markers at an interval of less than or equal to 20 cM are generally sufficient for disease gene inheritance predictions in presymptomatic genetic counseling by Linkage analysis.	HARVARD UNIV, BRIGHAM & WOMENS HOSP, SCH MED, DIV EXPTL MED & HEMATOL ONCOL, BOSTON, MA 02115 USA; MASSACHUSETTS GEN HOSP, NEUROGENET LAB, BOSTON, MA 02114 USA; GENETHON, EVRY, FRANCE; UCL, MRC, HUMAN BIOCHEM GENET UNIT, LONDON, ENGLAND	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of London; University College London			Haines, Jonathan/C-3374-2012	Haines, Jonathan/0000-0002-4351-4728	NHGRI NIH HHS [HG00598, HG00169, HG00324] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000598, R01HG000324] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BUETOW KH, 1991, AM J HUM GENET, V49, P985; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; FOUNTAIN JW, 1992, GENOMICS, V14, P105, DOI 10.1016/S0888-7543(05)80290-3; GRAW SL, 1993, HUM MOL GENET, V2, P614, DOI 10.1093/hmg/2.5.614-a; GRAW SL, 1992, SOMAT CELL MOLEC GEN, V18, P269, DOI 10.1007/BF01233863; HAINES JL, 1992, GENOMICS, V14, P517, DOI 10.1016/S0888-7543(05)80257-5; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; HULTEN M, 1974, HEREDITAS, V76, P55; Kwiatkowski David J., 1993, Cytogenetics and Cell Genetics, V64, P93, DOI 10.1159/000133566; KWIATKOWSKI DJ, 1992, HUM MOL GENET, V1, P658, DOI 10.1093/hmg/1.8.658-a; KWIATKOWSKI DJ, 1991, AM J HUM GENET, V48, P121; KWIATKOWSKI DJ, 1991, NUCLEIC ACIDS RES, V19, P967, DOI 10.1093/nar/19.4.967; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LATHROP GM, 1988, GENOMICS, V3, P361; LAURIE DA, 1985, ANN HUM GENET, V49, P189, DOI 10.1111/j.1469-1809.1985.tb01693.x; LINCOLN SE, 1992, GENOMICS, V14, P604, DOI 10.1016/S0888-7543(05)80158-2; MORTON NE, 1991, P NATL ACAD SCI USA, V88, P7474, DOI 10.1073/pnas.88.17.7474; Nahmias Joseph, 1992, Human Molecular Genetics, V1, P286, DOI 10.1093/hmg/1.4.286; Ozelius L., 1992, Human Molecular Genetics, V1, P141, DOI 10.1093/hmg/1.2.141-a; OZELIUS LJ, 1992, GENOMICS, V14, P715, DOI 10.1016/S0888-7543(05)80173-9; POVEY S, 1992, ANN HUM GENET, V56, P167, DOI 10.1111/j.1469-1809.1992.tb01145.x; SHARMA V, 1991, NUCLEIC ACIDS RES, V19, P4023, DOI 10.1093/nar/19.14.4023-a; TROFATTER JA, 1986, AM J HUM GENET, V39, P147; WALLIS J, 1990, HUM GENET, V85, P98; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WILKIE PJ, 1992, GENOMICS, V12, P607, DOI 10.1016/0888-7543(92)90456-3	27	47	47	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1993	53	6					1279	1288						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MJ818	8250044				2022-12-18	WOS:A1993MJ81800015
J	CHANG, ML; ARTYMIUK, PJ; WU, XY; HOLLAN, S; LAMMI, A; MAQUAT, LE				CHANG, ML; ARTYMIUK, PJ; WU, XY; HOLLAN, S; LAMMI, A; MAQUAT, LE			HUMAN TRIOSEPHOSPHATE ISOMERASE DEFICIENCY RESULTING FROM MUTATION OF PHE-240	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRIOSE-PHOSPHATE ISOMERASE; AMINO-ACID SEQUENCE; ESCHERICHIA-COLI; CHICKEN MUSCLE; MESSENGER-RNA; ACTIVE-SITE; ENZYME; RESOLUTION; FRAGMENTS; TPI	Triosephosphate isomerase (TPI; D-glyceraldehyde-3-phosphate ketolisomerase [E.C.5.3.1.1]) deficiency is an autosomal recessive disorder that typically results in chronic, nonspherocytic hemolytic anemia and in neuromuscular impairment. The molecular basis of this disease was analyzed for one Hungarian family and for two Australian families by localizing the defects in TPI cDNA and by determining how each defect affects TPI gene expression. The Hungarian family is noteworthy in having the first reported case of an individual, A. Jo., who harbors two defective TPI alleles but who does not manifest neuromuscular disabilities. This family was characterized by two mutations that have never been described. One is a missense mutation within codon 240 (TTC [Phe]-->CTC [Leu]), which creates a thermolabile protein, as indicated by the results of enzyme activity assays using cell extracts. This substitution, which changes a phylogenetically conserved amino acid, may affect enzyme activity by disrupting intersubunit contacts or substrate binding, as deduced from enzyme structural studies. The other mutation has yet to be localized but reduces the abundance of TPI mRNA 10-20-fold. Each of the Australian families was characterized by a previously described mutation within codon 104 (GAG [Glu]-->GAC [Asp]), which also results in thermolabile protein.	ROSWELL PK CANC INST,DEPT HUMAN GENET,ELM & CARLTON ST,BUFFALO,NY 14263; UNIV SHEFFIELD,DEPT BIOCHEM,SHEFFIELD S10 2TN,S YORKSHIRE,ENGLAND; NATL INST HAEMATOL & BLOOD TRANSFUS,BUDAPEST,HUNGARY; CHILDRENS HOSP,DEPT HEMATOL,CAMPERDOWN,SYDNEY,AUSTRALIA	Roswell Park Cancer Institute; University of Sheffield				Maquat, Lynne/0000-0002-2789-2075				ALBER T, 1982, Journal of Molecular and Applied Genetics, V1, P419; ARTAVANISTSAKONAS S, 1980, EUR J BIOCHEM, V108, P599, DOI 10.1111/j.1432-1033.1980.tb04755.x; BANNER DW, 1975, NATURE, V255, P609, DOI 10.1038/255609a0; BANNER DW, 1976, BIOCHEM BIOPH RES CO, V72, P146, DOI 10.1016/0006-291X(76)90972-4; BARDOSI A, 1990, ACTA NEUROPATHOL, V79, P387, DOI 10.1007/BF00308714; BEUTLER E, 1986, METHODS HEMATOLOGY R, P57; CHENG J, 1990, Molecular and Cellular Biology, V10, P5215; CHENG J, 1993, MOL CELL BIOL, V13, P1892, DOI 10.1128/MCB.13.3.1892; CLARK ACL, 1986, AUST PAEDIATR J, V22, P135; CLAY SA, 1982, AM J DIS CHILD, V139, P800; CRAIG LC, 1991, GENE, V99, P217, DOI 10.1016/0378-1119(91)90130-4; DAAR IO, 1988, MOL CELL BIOL, V8, P802, DOI 10.1128/MCB.8.2.802; DAAR IO, 1986, P NATL ACAD SCI USA, V83, P7903, DOI 10.1073/pnas.83.20.7903; EBER SW, 1979, EUR J CLIN INVEST, V9, P195, DOI 10.1111/j.1365-2362.1979.tb00923.x; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Freycon F, 1975, Pediatrie, V30, P55; FURTH AJ, 1974, BIOCHEM J, V139, P11, DOI 10.1042/bj1390011; GRACY RW, 1982, ISOZYMES-CURR T BIOL, V6, P169; HARRIS SR, 1970, CLIN RES, V18, P529; Hendrickson W. A., 1981, BIOMOLECULAR STRUCTU, V1, P43; HOLLAN S, 1990, BLOOD S, V76, pA35; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; KNOWLES JR, 1977, ACCOUNTS CHEM RES, V10, P105, DOI 10.1021/ar50112a001; KOLB E, 1974, BIOCHEM J, V137, P185, DOI 10.1042/bj1370185; LOLIS E, 1990, BIOCHEMISTRY-US, V29, P6609, DOI 10.1021/bi00480a009; LU HS, 1984, J BIOL CHEM, V259, P1958; MERKLE S, 1989, GENETICS, V123, P837; MOHRENWEISER HW, 1987, HUM GENET, V77, P241, DOI 10.1007/BF00284477; MOHRENWEISER HW, 1982, PEDIATR RES, V16, P960, DOI 10.1203/00006450-198211000-00012; NICKBARG EB, 1988, BIOCHEMISTRY-US, V27, P5939, DOI 10.1021/bi00416a018; NOBLE MEM, 1991, PROTEINS, V10, P50, DOI 10.1002/prot.340100106; PERRY BA, 1992, HUM GENET, V88, P634, DOI 10.1007/BF02265287; PHILLIPS DC, 1978, J MOL BIOL, V119, P329, DOI 10.1016/0022-2836(78)90440-0; PICHERSKY E, 1984, MOL GEN GENET, V195, P314, DOI 10.1007/BF00332765; ROSA R, 1985, HUM GENET, V71, P235, DOI 10.1007/BF00284582; ROSE IA, 1990, BIOCHEMISTRY-US, V29, P4312, DOI 10.1021/bi00470a008; ROSS J, 1976, J MOL BIOL, V106, P403, DOI 10.1016/0022-2836(76)90093-0; SAMBROOK J, 1989, MOL CLONING LABORATO, V1; SCHNEIDER AS, 1965, NEW ENGL J MED, V272, P229, DOI 10.1056/NEJM196502042720503; SCHNEIDER AS, 1968, HERED DISORD, P273; SCHNEIDER AS, 1968, HERED DISORD, P265; SKALA H, 1977, BIOCHEM MED METAB B, V18, P226, DOI 10.1016/0006-2944(77)90094-1; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STRAUS D, 1985, P NATL ACAD SCI USA, V82, P2014, DOI 10.1073/pnas.82.7.2014; TANAKA KR, 1990, SEMIN HEMATOL, V27, P165; VIVESCORRONS JL, 1978, HUM GENET, V42, P171, DOI 10.1007/BF00283637; WIERENGA RK, 1987, J MOL BIOL, V198, P109, DOI 10.1016/0022-2836(87)90461-X; ZANELLA A, 1985, SCAND J HAEMATOL, V34, P417	49	47	49	0	13	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1993	52	6					1260	1269						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LG133	8503454				2022-12-18	WOS:A1993LG13300027
J	MCCLATCHEY, AI; TROFATTER, J; MCKENNAYASEK, D; RASKIND, W; BIRD, T; PERICAKVANCE, M; GILCHRIST, J; ARAHATA, K; RADOSAVLJEVIC, D; WORTHEN, HG; VANDENBERGH, P; HAINES, JL; GUSELLA, JF; BROWN, RH				MCCLATCHEY, AI; TROFATTER, J; MCKENNAYASEK, D; RASKIND, W; BIRD, T; PERICAKVANCE, M; GILCHRIST, J; ARAHATA, K; RADOSAVLJEVIC, D; WORTHEN, HG; VANDENBERGH, P; HAINES, JL; GUSELLA, JF; BROWN, RH			DINUCLEOTIDE REPEAT POLYMORPHISMS AT THE SCN4A LOCUS SUGGEST ALLELIC HETEROGENEITY OF HYPERKALEMIC PERIODIC PARALYSIS AND PARAMYOTONIA-CONGENITA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; CHANNEL ALPHA-SUBUNIT; MUSCLE SODIUM-CHANNEL; RAT-BRAIN; SKELETAL-MUSCLE; EXPRESSION; MYOTONIA; HUMANS; GENE; CDNA	Two polymorphic dinucleotide repeats - one (dGdA)n and one (dGdT)n - have been identified at the SCN4A locus, encoding the alpha-subunit of the adult skeletal muscle sodium channel. When typed using PCR, the dinucleotide repeats display 4 and 10 alleles, respectively, with a predicted heterozygosity of .81 for the combined haplotype. We have applied these polymorphisms to the investigation of hyperkalemic periodic paralysis and paramyotonia congenita, distinct neuromuscular disorders both of which are thought to involve mutation at SCN4A. Our data confirm the genetic linkage of both disorders with SCN4A. Haplotype analysis also indicates the strong likelihood of allelic heterogeneity in both disorders.	MASSACHUSETTS GEN HOSP, MOLEC NEUROGENET LAB, 13TH ST, BOSTON, MA 02114 USA; MASSACHUSETTS GEN HOSP, DAY NEUROMUSCULAR RES, BOSTON, MA 02114 USA; HARVARD MED SCH, BOSTON, MA USA; UNIV WASHINGTON, DEPT MED, SEATTLE, WA 98195 USA; VET AFFAIRS HOSP, DIV NEUROL, SEATTLE, WA USA; DUKE UNIV, DEPT MED, DIV NEUROL, DURHAM, NC 27706 USA; BROWN UNIV, RHODE ISL HOSP, DEPT NEUROL, PROVIDENCE, RI 02903 USA; NATL CTR NEUROL & PSYCHIAT, NATL INST NEUROSCI, KODAIRA, TOKYO, JAPAN; INST MOLEC GENET & GENET ENGN, BELGRADE, YUGOSLAVIA; CAMBRIDGE FAMILY HLTH, CAMBRIDGE, MA USA; CATHOLIC UNIV LOUVAIN CLIN, DEPT NEUROL, B-1200 BRUSSELS, BELGIUM	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; Duke University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; National Center for Neurology & Psychiatry - Japan; Universite Catholique Louvain; Universite Catholique Louvain Hospital			Haines, Jonathan/C-3374-2012	Haines, Jonathan/0000-0002-4351-4728	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022224, P01NS024279, P01NS026630] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; BARCHI RL, 1988, ANNU REV NEUROSCI, V11, P455, DOI 10.1146/annurev.ne.11.030188.002323; CANNON SC, 1991, NEURON, V6, P619, DOI 10.1016/0896-6273(91)90064-7; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; ENGEL AG, 1986, MYOLOGY, P1843; FONTAINE B, 1990, SCIENCE, V250, P1000, DOI 10.1126/science.2173143; GEORGE AL, 1991, GENOMICS, V9, P555, DOI 10.1016/0888-7543(91)90425-E; GUSELLA J, 1979, P NATL ACAD SCI USA, V76, P5239, DOI 10.1073/pnas.76.10.5239; Iaizzo P A, 1991, Neuromuscul Disord, V1, P47, DOI 10.1016/0960-8966(91)90042-Q; KALLEN RG, 1990, NEURON, V4, P233, DOI 10.1016/0896-6273(90)90098-Z; KAYANO T, 1988, FEBS LETT, V228, P187, DOI 10.1016/0014-5793(88)80614-8; KOCH MC, 1991, HUM GENET, V88, P71, DOI 10.1007/BF00204932; KOCH MC, 1991, J MED GENET, V28, P583, DOI 10.1136/jmg.28.9.583; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEHMANNHORN F, 1990, MUSCLE NERVE, V13, P528, DOI 10.1002/mus.880130609; LEHMANNHORN F, 1987, MUSCLE NERVE, V10, P363, DOI 10.1002/mus.880100414; LEHMANNHORN F, 1987, MUSCLE NERVE, V10, P633, DOI 10.1002/mus.880100709; LEHMANNHORN F, 1991, PFLUG ARCH EUR J PHY, V418, P297, DOI 10.1007/BF00370530; NODA M, 1986, NATURE, V322, P826, DOI 10.1038/322826a0; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; PTACEK LJ, 1991, AM J HUM GENET, V49, P851; PTACEK LJ, 1991, AM J HUM GENET, V49, P378; RASKIND WH, 1991, AM J HUM GENET, V48, P335; ROGART RB, 1989, P NATL ACAD SCI USA, V86, P8170, DOI 10.1073/pnas.86.20.8170; ROJAS CV, 1991, NATURE, V354, P387, DOI 10.1038/354387a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEIZINGER BR, 1986, NATURE, V322, P644, DOI 10.1038/322644a0; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X	30	47	47	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1992	50	5					896	901						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HR473	1315122				2022-12-18	WOS:A1992HR47300003
J	CALLEN, DF; BAKER, E; LANE, S; NANCARROW, J; THOMPSON, A; WHITMORE, SA; MACLENNAN, DH; BERGER, R; CHERIF, D; JARVELA, I; PELTONEN, L; SUTHERLAND, GR; GARDINER, RM				CALLEN, DF; BAKER, E; LANE, S; NANCARROW, J; THOMPSON, A; WHITMORE, SA; MACLENNAN, DH; BERGER, R; CHERIF, D; JARVELA, I; PELTONEN, L; SUTHERLAND, GR; GARDINER, RM			REGIONAL MAPPING OF THE BATTEN DISEASE LOCUS (CLN3) TO HUMAN CHROMOSOME-16P12	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE; HYBRIDIZATION; PROBES; MAP	The gene for Batten disease (CLN3) has been mapped to human chromosome 16 by demonstration of linkage to the haptoglobin locus, and its localization has been further refined using a panel of DNA markers. The aim of this work was to refine the genetic and physical mapping of this disease locus. Genetic linkage analysis was carried out in a larger group of families by using markers for five linked loci. Multipoint analysis indicated a most likely location for CLN3 in the interval between D16S67 and D16S148 (Z = 12.S). Physical mapping of linked markers was carried out using somatic cell hybrid analysis and in situ hybridization. A mouse/human hybrid cell panel containing various segments of chromosome 16 has been constructed. The relative order and physical location of breakpoints in the proximal portion of 16p were determined. Physical mapping in this panel of the markers for the loci flanking CLN3 positioned them to the bands 16p12.1 --> 16p12.3. Fluorescent in situ hybridization of metaphase chromosomes by using these markers positioned them to the region 16p11.2-16p12.1. These results localize CLN3 to an interval of about 2 cM in the region 16p12.	UNIV COLL & MIDDLESEX SCH MED,RAYNE INST,DEPT PAEDIAT,UNIV ST,LONDON WC1E 6JJ,ENGLAND; ADELAIDE CHILDRENS HOSP INC,DEPT CYTOGENET & MOLEC GENET,ADELAIDE,SA 5006,AUSTRALIA; UNIV TORONTO,CHARLES H BEST INST,DEPT MED RES,TORONTO M5G 1L6,ONTARIO,CANADA; INST GENET MOLEC,INSERM,U301,PARIS,FRANCE; NATL PUBL HLTH INST,SF-00280 HELSINKI 28,FINLAND	University of London; King's College London; University College London; University of Toronto; Institut National de la Sante et de la Recherche Medicale (Inserm); Finland National Institute for Health & Welfare	GARDINER, RM (corresponding author), UNIV COLL & MIDDLESEX SCH MED,RAYNE INST,DEPT PAEDIAT,UNIV ST,LONDON WC1E 6JJ,ENGLAND.		Sutherland, Grant Robert/D-2606-2012; Callen, David F/G-1975-2012; Jarvela, Irma E/L-5836-2013	Jarvela, Irma E/0000-0002-1770-6187; Callen, David/0000-0002-6189-9991				CALLEN D F, 1988, Genomics, V2, P144, DOI 10.1016/0888-7543(88)90096-1; CALLEN DF, 1986, ANN GENET-PARIS, V29, P235; CALLEN DF, 1989, GENOMICS, V4, P348, DOI 10.1016/0888-7543(89)90341-8; CALLEN DF, IN PRESS ANN GENET; CHERIF D, 1990, P NATL ACAD SCI USA, V87, P6639, DOI 10.1073/pnas.87.17.6639; EIBERG H, 1989, CLIN GENET, V36, P217; GARDINER M, 1990, GENOMICS, V8, P387, DOI 10.1016/0888-7543(90)90297-8; HORI T, 1988, CANCER GENET CYTOGEN, V34, P177, DOI 10.1016/0165-4608(88)90257-9; HYLAND VJ, 1988, AM J HUM GENET, V42, P373; JULIER C, 1990, GENOMICS, V6, P419, DOI 10.1016/0888-7543(90)90471-6; KEITH TP, 1990, P NATL ACAD SCI USA, V87, P5754, DOI 10.1073/pnas.87.15.5754; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MACLENNAN DH, 1987, SOMAT CELL MOLEC GEN, V13, P441; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; PRITCHARD MA, IN PRESS GENOMICS; RICHARDS RI, IN PRESS GENOMICS; SEALEY PG, 1985, NUCLEIC ACIDS RES, V13, P1905, DOI 10.1093/nar/13.6.1905; STALLINGS RL, 1990, P NATL ACAD SCI USA, V87, P6218, DOI 10.1073/pnas.87.16.6218	18	47	48	1	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1991	49	6					1372	1377						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GU672	1746562				2022-12-18	WOS:A1991GU67200025
J	AGUIRRE, A; VICARIO, A; MAZON, LI; ESTOMBA, A; DEPANCORBO, MM; PICO, VA; ELORTONDO, FP; LOSTAO, CM				AGUIRRE, A; VICARIO, A; MAZON, LI; ESTOMBA, A; DEPANCORBO, MM; PICO, VA; ELORTONDO, FP; LOSTAO, CM			ARE THE BASQUES A SINGLE AND A UNIQUE POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CELL ENZYME POLYMORPHISMS; GALICIA NW SPAIN; GROUP SYSTEMS; BOMBAY; POLAND	Different analyses of genetic polymorphisms performed on the Basque population have suggested a possible heterogeneity of the Basques and a singularity of their genetic characteristics. In this paper, both aspects are analyzed by means of the genetic study of seven polymorphic systems - ACP, ADA, AK, ESD, PGD, GC, and HP - in 854 autochthonous individuals from the province of Vizcaya. The individuals were classified as being from the regions of Arratia, Guernica, Durango, Uribe, Marquina, Lea, and Bilbao, on the basis of the birthplaces of their four grandparents. Analyses for heterogeneity of the gene frequencies distribution suggest that there is a moderate genetic heterogeneity, probably produced by centuries of geographical and administrative isolation of these regions. The comparison with caucasoid populations, performed using the principal components analysis and Cavalli-Sforza and Edwards are distance, indicates that the subpopulations of the province of Vizcaya have experienced little genetic exchange with other caucasoids and that the distribution of their genetic frequencies differentiates them from other populations.	UNIV BASQUE COUNTRY,FAC MED,DEPT CELLULAR BIOL & MORPHOL SCI,E-48080 BILBAO,SPAIN	University of Basque Country	AGUIRRE, A (corresponding author), UNIV BASQUE COUNTRY,FAC SCI,DEPT ANIM BIOL & GENET,GENET LAB,APTO 644,E-48080 BILBAO,SPAIN.			AGUIRRE ESCOBAL, ANA ISABEL/0000-0002-5624-443X; M. de Pancorbo, Marian/0000-0002-8081-0702; Estonba, Andone/0000-0003-2851-5201				Aguirre A I, 1989, Gene Geogr, V3, P41; AMORIM S, 1982, HUM HERED, V32, P298; ANDERSON TW, 1963, ANN MATH STAT, V34, P122, DOI 10.1214/aoms/1177704248; BECKER PE, 1980, GENETICA HUMANA, V1; BLAKE NM, 1970, HUM HERED, V20, P409, DOI 10.1159/000152337; BLAKE NM, 1976, HUM GENET, V35, P91, DOI 10.1007/BF00295623; Bonaparte L. L., 1869, VERBE BASQUE TABLEAU; Bonaparte L. L., 1863, CARTE SEPT PROVINCES; BONAPARTE LL, 1858, CANTICUM TRIUM PUERO; BROCTEUR J, 1980, HUM HERED, V32, P147; CARRACEDO A, 1983, HUM HERED, V33, P160, DOI 10.1159/000153368; CARRACEDO A, 1982, Z RECHTSMED, V88, P143; Cavalli-Sforza LL, 1988, MUNIBE S, V6, P129; CAVALLISFORZA LL, 1967, EVOLUTION, V21, P550, DOI 10.1111/j.1558-5646.1967.tb03411.x; COLLINS R, 1986, JBASQUES; CONSTANS J, 1979, HUM GENET, V48, P143, DOI 10.1007/BF00286897; CONSTANS J, 1975, COMMUNICATION; CUADRAS CM, 1981, METODOS ANAL MULTIVA; DEPANCORBO MM, 1986, ANN HUM BIOL, V13, P297, DOI 10.1080/03014468600008471; DETTER J C, 1970, Journal of Medical Genetics, V7, P356, DOI 10.1136/jmg.7.4.356; DISSING J, 1984, HUM HERED, V34, P148, DOI 10.1159/000153452; DOBOSZ T, 1983, HUM HERED, V33, P55, DOI 10.1159/000153348; FLORIS R, 1985, HUM HERED, V35, P339, DOI 10.1159/000153573; Giblett ER., 1969, GENETIC MARKERS HUMA; GOEDDE HW, 1972, HUM HERED, V22, P552, DOI 10.1159/000152537; GRUPPIONI G, 1982, RIV ANTROPOL, V62, P57; Harris, 1976, HDB ENZYME ELECTROPH; KARP GW, 1967, AM J HUM GENET, V19, P54; Lebart L., 1977, TECHNIQUES DESCRIPTI; LEVENE H, 1949, ANN MATH STAT, V20, P91, DOI 10.1214/aoms/1177730093; LEWONTIN RC, 1973, GENETICS, V74, P175; LI CC, 1968, POPULATION GENETICS; MARTELL M, 1986, HUM HERED, V36, P41, DOI 10.1159/000153598; MITCHELL RJ, 1982, ANN HUM BIOL, V9, P57, DOI 10.1080/03014468200005491; MORAL P, 1984, TRABAJOS ANTROPOLOGI, V19, P193; MORAL P, 1986, THESIS U BARCELONA B; MORAL P, 1986, TRAB ANTROPOL, V20, P351; MORENO P, 1981, REV MEX EST ANTROPOL, V27, P80; MOURANT AE, 1976, HUM GENET, V33, P307, DOI 10.1007/BF00286857; Mourant AE, 1976, DISTRIBUTION HUMAN B; MOURANT AE, 1983, BLOOD RELATIONS; PALSSON JOP, 1970, HUM HERED, V20, P231, DOI 10.1159/000152315; Piazza A, 1988, MUNIBE S, V6, P169; SMITHIES O, 1959, BIOCHEM J, V71, P585, DOI 10.1042/bj0710585; SWOFFORD D, 1989, BIOSYS 1 COMPUTER PR; TILLS D, 1983, AM J PHYS ANTHROPOL, V61, P145, DOI 10.1002/ajpa.1330610203; TILLS D, 1971, HUM HERED, V21, P305, DOI 10.1159/000152418; UNDEVIA JV, 1972, HUM HERED, V22, P274, DOI 10.1159/000152499; VERGNES H, 1980, HUM HERED, V30, P232, DOI 10.1159/000153134; VERGNES H, 1980, HUM HERED, V30, P171, DOI 10.1159/000153123; WEISSMANN J, 1982, HUM HERED, V32, P344, DOI 10.1159/000153321; WOKMAN PL, 1970, AM J HUM GENET, V22, P24; WOLANSKI N, 1983, HUM HERED, V33, P270, DOI 10.1159/000153390; Wright S., 1978, EVOLUTION GENETICS P, V4; WRIGHT S, 1965, EVOLUTION, V19, P195	55	47	48	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1991	49	2					450	458						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GA866	1867201				2022-12-18	WOS:A1991GA86600024
J	BROOKS, DA; MCCOURT, PAG; GIBSON, GJ; ASHTON, LJ; SHUTTER, M; HOPWOOD, JJ				BROOKS, DA; MCCOURT, PAG; GIBSON, GJ; ASHTON, LJ; SHUTTER, M; HOPWOOD, JJ			ANALYSIS OF N-ACETYLGALACTOSAMINE-4-SULFATASE PROTEIN AND KINETICS IN MUCOPOLYSACCHARIDOSIS TYPE-VI PATIENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAROTEAUX-LAMY SYNDROME; ARYLSULFATASE-A; DIAGNOSIS; CELLS; PURIFICATION; SULFATASE	A sensitive and specific, monoclonal antibody-based immunoquantification assay has facilitated determination of the N-acetylgalactosamine-4-sulfatase (4-sulfatase) protein content in cultured fibroblasts from normal controls and mucopolysaccharidosis type VI (MPS VI) patients. The assay enabled the quantification of 4-sulfatase protein by using a panel of seven monoclonal antibodies and has shown that fibroblasts from 16 MPS VI patients contained less-than-or-equal-to 5% of the level determined for normal controls. Fibroblasts from the most severely affected patients contained the lowest levels of 4-sulfatase protein, usually with few epitopes detected, while fibroblasts from mildly affected patients had higher levels of 4-sulfatase protein, with all seven epitopes detected. The pattern of epitope expression is proposed to reflect the conformational changes in the 4-sulfatase protein that arise from different mutations in the 4-sulfatase gene. Immunoquantification in combination with a specific and highly sensitive 4-sulfated trisaccharide-based assay of enzyme activity in these MPS VI patient fibroblasts enabled the determination of residual 4-sulfatase catalytic efficiency (k(cat)/K(m)). The capacity of fibroblasts to degrade substrate (catalytic capacity) was calculated as the product of 4-sulfatase catalytic efficiency and the content of 4-sulfatase in fibroblasts. One patient, 2357, with no clinical signs of MPS VI but with reduced 4-sulfatase activity and protein (both 5% of normal) and dermatansulfaturia, had 5% of normal catalytic capacity. The other 15 MPS VI patient fibroblasts had 0%-1.4% of the catalytic capacity of fibroblasts from normal controls and were representative of the spectrum of MPS VI clinical phenotypes, from severe to mild. It is proposed that an enzyme-replacement therapy achieving a correction of > 5% of normal catalytic capacity is required to avoid the onset of MPS VI clinical phenotype. Moreover, it is suggested that the restored catalytic capacity must be correctly localized within the lysosomal compartment to enable effective treatment of MPS VI.			BROOKS, DA (corresponding author), ADELAIDE MED CTR WOMEN & CHILDREN, DEPT CHEM PATHOL, LYSOSOMAL DIS RES UNIT, KING WILLIAM RD, ADELAIDE, SA 5006, AUSTRALIA.		McCourt, Peter/B-3043-2009; Brooks, Doug A/K-6714-2012	McCourt, Peter/0000-0001-5072-4590; Brooks, Doug/0000-0001-9098-3626				BROOKS DA, 1990, J INHERIT METAB DIS, V13, P108, DOI 10.1007/BF01799338; BROOKS DA, IN PRESS J INHERITED; CHANG PL, 1981, ANAL BIOCHEM, V117, P382, DOI 10.1016/0003-2697(81)90795-8; CLEMENTS PR, 1989, BIOCHEM J, V259, P199, DOI 10.1042/bj2590199; DEGROEN PC, 1989, BIOCHEM J, V264, P115, DOI 10.1042/bj2640115; DELVIN EE, 1976, BIOCHEM J, V157, P353, DOI 10.1042/bj1570353; GIBSON GJ, 1987, BIOCHEM J, V248, P755, DOI 10.1042/bj2480755; GOLDBERG AL, 1976, ANNU REV BIOCHEM, V45, P747, DOI 10.1146/annurev.bi.45.070176.003531; HOPWOOD JJ, 1986, BIOCHEM J, V234, P507, DOI 10.1042/bj2340507; HOPWOOD JJ, 1982, MED J AUSTRALIA, V1, P257, DOI 10.5694/j.1326-5377.1982.tb132293.x; HOPWOOD JJ, 1982, ANAL BIOCHEM, V119, P120, DOI 10.1016/0003-2697(82)90674-1; HOSLI P, 1977, CLIN CHEM, V23, P1476; LEABACK DH, 1961, BIOCHEM J, V78, P151, DOI 10.1042/bj0780151; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATALON R, 1974, BIOCHEM BIOPH RES CO, V61, P1450, DOI 10.1016/S0006-291X(74)80446-8; Neufeld EF, 1989, METABOLIC BASIS INHE, P1565; PETERS C, 1990, J BIOL CHEM, V265, P3374; ROSE JK, 1988, ANNU REV CELL BIOL, V4, P257, DOI 10.1146/annurev.cellbio.4.1.257; SCHUCHMAN EH, 1990, GENOMICS, V6, P149, DOI 10.1016/0888-7543(90)90460-C; TAYLOR JA, 1990, BIOCHEM J, V268, P379, DOI 10.1042/bj2680379	20	47	48	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1991	48	4					710	719						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK478	1901688				2022-12-18	WOS:A1991FK47800010
J	XIONG, WJ; LI, WH; POSNER, I; YAMAMURA, T; YAMAMOTO, A; GOTTO, AM; CHAN, L				XIONG, WJ; LI, WH; POSNER, I; YAMAMURA, T; YAMAMOTO, A; GOTTO, AM; CHAN, L			NO SEVERE BOTTLENECK DURING HUMAN-EVOLUTION - EVIDENCE FROM 2 APOLIPOPROTEIN-C-II DEFICIENCY ALLELES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA; MUTATION; GENE; POLYMORPHISM; PATIENT; CII; HYPERLIPOPROTEINEMIA; SEQUENCES	The DNA sequences of a Japanese and a Venezuelan apolipoprotein (apo) C-II-deficiency allele, of a normal Japanese apo C-II gene, and of a chimpanzee apo C-II gene were amplified by PCR, and their nucleotide sequences were determined on multiple clones of the PCR products. The normal Japanese sequence is identical to-and the chimpanzee sequence differs by only three nucleotides from-a previously published normal Caucasian sequence. In contrast, the two human mutant sequences each differ from the normal apo C-II gene sequence by several nucleotides, including deletions. The data suggest that both mutant alleles arose >500,000 years ago. It is shown that a defective allele can persist in a population for only a short time if a bottleneck occurs. Therefore, the antiquity of the two alleles suggests no severe bottleneck during human evolution. Moreover, the fact that one allele is from Japan and the other is from a Venezuelan Caucasian family is more consistent with the multiregional evolution model of modern human origins than with the complete replacement or "out of Africa" model.	UNIV TEXAS,CTR DEMOG & POPULAT GENET,POB 20334,HOUSTON,TX 77225; BAYLOR UNIV,DEPT MED,HOUSTON,TX 77030; BAYLOR UNIV,DEPT CELL BIOL,HOUSTON,TX 77030; HEBREW UNIV JERUSALEM,DEPT BIOL CHEM,IL-91904 JERUSALEM,ISRAEL; NATL CARDIOVASC CTR,RES INST,SUITA,OSAKA 565,JAPAN	University of Texas System; University of Texas Health Science Center Houston; Baylor University; Baylor University; Hebrew University of Jerusalem; National Cerebral & Cardiovascular Center - Japan				Li, Wen-Hsiung/0000-0003-1086-1456	NHLBI NIH HHS [HL-16512] Funding Source: Medline; NIGMS NIH HHS [GM-30998, GM-39927] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016512, R37HL016512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039927, R01GM030998, R37GM030998] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRECKENRIDGE WC, 1978, NEW ENGL J MED, V298, P1265, DOI 10.1056/NEJM197806082982301; BROWN WM, 1980, P NATL ACAD SCI-BIOL, V77, P3605, DOI 10.1073/pnas.77.6.3605; Brunzell JD, 1989, METABOLIC BASIS INHE, P1165; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CONNELLY PW, 1987, P NATL ACAD SCI USA, V84, P270, DOI 10.1073/pnas.84.1.270; CONNELLY PW, 1987, J CLIN INVEST, V80, P1597, DOI 10.1172/JCI113246; FIGUEROA F, 1988, NATURE, V335, P265, DOI 10.1038/335265a0; FOJO SS, 1988, J CLIN INVEST, V82, P1489, DOI 10.1172/JCI113756; FOJO SS, 1989, J BIOL CHEM, V264, P20839; FOJO SS, 1988, J BIOL CHEM, V263, P17913; HAIGH J, 1972, GENET RES, V19, P73, DOI 10.1017/S0016672300014282; JONES JS, 1986, NATURE, V319, P449, DOI 10.1038/319449b0; KASHYAP ML, 1977, J CLIN INVEST, V60, P171, DOI 10.1172/JCI108753; KASHYAP ML, 1980, J LAB CLIN MED, V95, P180; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; LI WH, 1972, AM J HUM GENET, V24, P667; LI WH, 1987, NATURE, V326, P93, DOI 10.1038/326093a0; LITTLE JA, 1980, ATHEROSCLEROSIS, V5, P671; Maniatis T., 1982, MOL CLONING; MAYER WE, 1988, EMBO J, V7, P2765, DOI 10.1002/j.1460-2075.1988.tb03131.x; NEI M, 1984, EVOL BIOL, V17, P73; NEI M, 1975, GENET RES, V26, P31, DOI 10.1017/S0016672300015822; NEI M, 1966, HEREDITY, V21, P183, DOI 10.1038/hdy.1966.17; NIKKILA EA, 1983, METABOLIC BASIS INHE, P622; POSNER I, 1986, IRCS MED SCI-BIOCHEM, V14, P1155; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARICH VM, 1967, SCIENCE, V158, P1200, DOI 10.1126/science.158.3805.1200; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; WEI CF, 1985, J BIOL CHEM, V260, P5211; Wolpoff M.H., 1984, P411; YAMAMURA T, 1979, ATHEROSCLEROSIS, V34, P53, DOI 10.1016/0021-9150(79)90106-0	33	47	47	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1991	48	2					383	389						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV744	1990844				2022-12-18	WOS:A1991EV74400023
J	SANAL, O; WEI, S; FOROUD, T; MALHOTRA, U; CONCANNON, P; CHARMLEY, P; SALSER, W; LANGE, K; GATTI, RA				SANAL, O; WEI, S; FOROUD, T; MALHOTRA, U; CONCANNON, P; CHARMLEY, P; SALSER, W; LANGE, K; GATTI, RA			FURTHER MAPPING OF AN ATAXIA-TELANGIECTASIA LOCUS TO THE CHROMOSOME-IIQ23 REGION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF LOS ANGELES,SCH MED,DEPT PATHOL,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,DEPT BIOL,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,DEPT BIOMATH,LOS ANGELES,CA 90024; VIRGINIA MASON RES CTR,SEATTLE,WA 98101; HACETTEPE UNIV,DEPT PEDIAT,ANKARA,TURKEY	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Virginia Mason Medical Center; Hacettepe University				Malhotra, Uma/0000-0003-0132-0885; Concannon, Patrick/0000-0002-5801-1859	NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NCI NIH HHS [CA 16042] Funding Source: Medline; NIGMS NIH HHS [GM07104] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BODER E, 1985, ATAXIA TELANGIECTASI, P1; CARLSON M, 1988, NUCLEIC ACIDS RES, V16, P378, DOI 10.1093/nar/16.1.378; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; CHARMLEY P, 1990, GENOMICS, V6, P316, DOI 10.1016/0888-7543(90)90572-C; CHARMLEY P, 1989, NUCLEIC ACIDS RES, V17, P2372, DOI 10.1093/nar/17.6.2372; CONCANNON P, 1989, AM J HUM GENET, V46, P789; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GATTI RA, 1987, CYTOGENET CELL GENET, V46, P618; GATTI RA, 1988, HUM IMMUNOL, V22, P145, DOI 10.1016/0198-8859(88)90023-7; GATTI RA, 1988, NATURE, V336, P577, DOI 10.1038/336577a0; GATTI RA, 1990, AM J HUM GENET S, V47, pA179; JASPERS NGJ, 1988, CYTOGENET CELL GENET, V49, P259, DOI 10.1159/000132673; JASPERS NGJ, 1982, P NATL ACAD SCI-BIOL, V79, P2641, DOI 10.1073/pnas.79.8.2641; JULIER C, 1990, GENOMICS, V7, P335, DOI 10.1016/0888-7543(90)90167-S; KOMATSU K, 1990, MUTAT RES, V235, P59, DOI 10.1016/0921-8777(90)90058-D; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEPERT M, 1987, CYTOGENET CELL GENET, V46, P648; LLEWELLYN DH, 1987, NUCLEIC ACIDS RES, V15, P1349, DOI 10.1093/nar/15.3.1349; Maslen CL, 1988, GENOMICS, V2, P66, DOI 10.1016/0888-7543(88)90110-3; MCCONVILLE CM, 1990, NUCLEIC ACIDS RES, V18, P4335, DOI 10.1093/nar/18.15.4335; MCCONVILLE CM, 1990, HUM GENET, V85, P215; MURNANE JP, 1982, P NATL ACAD SCI-BIOL, V79, P1960, DOI 10.1073/pnas.79.6.1960; OTT J, 1985, ANAL HUMAN GENETIC L; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7207, DOI 10.1093/nar/13.20.7207; SHILOH Y, 1989, HUM GENET, V45, pA161; SPURR N K, 1988, Genomics, V2, P119, DOI 10.1016/0888-7543(88)90093-6; WARNICH L, 1986, NUCLEIC ACIDS RES, V14, P1920, DOI 10.1093/nar/14.4.1920; WEI S, 1990, CANCER GENET CYTOGEN, V46, P1, DOI 10.1016/0165-4608(90)90002-R	30	47	48	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1990	47	5					860	866						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EE940	2220826				2022-12-18	WOS:A1990EE94000014
J	NAVON, R; KOLODNY, EH; MITSUMOTO, H; THOMAS, GH; PROIA, RL				NAVON, R; KOLODNY, EH; MITSUMOTO, H; THOMAS, GH; PROIA, RL			ASHKENAZI-JEWISH AND NON-JEWISH ADULT GM2 GANGLIOSIDOSIS PATIENTS SHARE A COMMON GENETIC-DEFECT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									SHRIVER CTR MENTAL RETARDAT,WALTHAM,MA; CLEVELAND CLIN EDUC FDN,DEPT NEUROL,CLEVELAND,OH 44106; KENNEDY INST,BALTIMORE,MD; NIDDKD,GENET & BIOCHEM BRANCH,BETHESDA,MD	Cleveland Clinic Foundation; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)			Proia, Richard L/A-7908-2012	Proia, Richard/0000-0003-0456-1270	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024061] Funding Source: NIH RePORTER; NICHD NIH HHS [HD24061] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARPAIA E, 1988, NATURE, V333, P85, DOI 10.1038/333085a0; CONZELMANN E, 1984, DEV NEUROSCI-BASEL, V6, P58, DOI 10.1159/000112332; CONZELMANN E, 1983, AM J HUM GENET, V35, P900; GREENBERG DA, 1982, AM J HUM GENET, V34, P444; Maniatis T., 1982, MOL CLONING; MITSUMOTO H, 1985, ANN NEUROL, V17, P378, DOI 10.1002/ana.410170413; MYEROWITZ R, 1988, J BIOL CHEM, V263, P18587; MYEROWITZ R, 1988, P NATL ACAD SCI USA, V85, P3955, DOI 10.1073/pnas.85.11.3955; NAVON R, 1985, AM J HUM GENET, V37, P1031; NAVON R, 1986, AM J MED GENET, V24, P179, DOI 10.1002/ajmg.1320240123; NAVON R, 1989, SCIENCE, V243, P1471, DOI 10.1126/science.2522679; NEUFELD EF, 1989, J BIOL CHEM, V264, P10927; OHNO K, 1988, BIOCHEM BIOPH RES CO, V153, P463, DOI 10.1016/S0006-291X(88)81247-6; PAW BH, 1989, P NATL ACAD SCI USA, V86, P2413, DOI 10.1073/pnas.86.7.2413; PROIA RL, 1987, J BIOL CHEM, V262, P5677; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SNADHOFF K, 1989, METABOLIC BASIS INHE, P1807	17	47	48	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1990	46	4					817	821						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	CW549	2278539				2022-12-18	WOS:A1990CW54900021
J	JOHN, SWM; ROZEN, R; LAFRAMBOISE, R; LABERGE, C; SCRIVER, CR				JOHN, SWM; ROZEN, R; LAFRAMBOISE, R; LABERGE, C; SCRIVER, CR			NOVEL PKU MUTATION ON HAPLOTYPE-2 IN FRENCH-CANADIANS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CHU LAVAL,CTR GENET HUMAINE,QUEBEC CITY G1V 4G2,QUEBEC,CANADA; MCGILL UNIV,DEPT BIOL,MRC,HUMAN GENET GRP,MONTREAL H3A 2T5,QUEBEC,CANADA; MCGILL UNIV,DEPT PEDIAT,MONTREAL H3A 2T5,QUEBEC,CANADA; MCGILL UNIV,CTR HUMAN GENET,MONTREAL H3A 2T5,QUEBEC,CANADA	Laval University; McGill University; McGill University; McGill University			Rozen, Rima/AAE-9294-2020					AVIGAD S, 1987, American Journal of Human Genetics, V41, pA205; DILELLA AG, 1988, LANCET, V1, P497; DILELLA AG, 1987, NATURE, V327, P333, DOI 10.1038/327333a0; DILELLA AG, 1986, NATURE, V322, P799, DOI 10.1038/322799a0; DILELLA AG, 1986, BIOCHEMISTRY-US, V25, P743, DOI 10.1021/bi00352a001; KWOK SCM, 1985, BIOCHEMISTRY-US, V24, P556, DOI 10.1021/bi00324a002; LABERGE C, 1987, Archives Francaises de Pediatrie, V44, P643; LEDLEY FD, 1986, NEW ENGL J MED, V314, P1276, DOI 10.1056/NEJM198605153142002; LICHTERKONECKI U, 1988, BIOCHEMISTRY-US, V27, P2881, DOI 10.1021/bi00408a032; LIDSKY AS, 1985, AM J HUM GENET, V37, P619; LYONNET S, 1988, M S-MED SCI, V4, P544, DOI 10.4267/10608/3878; LYONNET S, 1989, AM J HUM GENET, V44, P511; REY F, 1988, AM J HUM GENET, V43, P9124; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SCRIVER CR, 1988, ANNU REV GENET, V22, P301; WONG C, 1987, NATURE, V330, P384, DOI 10.1038/330384a0; WOO SLC, 1988, AM J HUM GENET, V43, P781; WOO SLC, 1983, NATURE, V306, P151, DOI 10.1038/306151a0; [No title captured]	20	47	47	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1989	45	6					905	909						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CF403	2574002				2022-12-18	WOS:A1989CF40300009
J	OVERHAUSER, J; BENGTSSON, U; MCMAHON, J; ULM, J; BUTLER, MG; SANTIAGO, L; WASMUTH, JJ				OVERHAUSER, J; BENGTSSON, U; MCMAHON, J; ULM, J; BUTLER, MG; SANTIAGO, L; WASMUTH, JJ			PRENATAL-DIAGNOSIS AND CARRIER DETECTION OF A CRYPTIC TRANSLOCATION BY USING DNA MARKERS FROM THE SHORT ARM OF CHROMOSOME-5	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									THOMAS JEFFERSON UNIV HOSP & MED COLL,DEPT BIOCHEM & MOLEC BIOL,PHILADELPHIA,PA; VANDERBILT UNIV,MED CTR,SCH MED,DEPT PEDIAT,NASHVILLE,TN 37232	Jefferson University; Vanderbilt University	OVERHAUSER, J (corresponding author), UNIV CALIF IRVINE,COLL MED,DEPT BIOL CHEM,D240,IRVINE,CA 92717, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018642] Funding Source: NIH RePORTER; NICHD NIH HHS [HD18642] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		CAVANEE WK, 1983, NATURE, V305, P779; DANA S, 1982, MOL CELL BIOL, V2, P1220, DOI 10.1128/MCB.2.10.1220; DAVIES KE, 1984, HUM GENET, V66, P54, DOI 10.1007/BF00275186; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; NIEBUHR E, 1978, HUM GENET, V44, P227, DOI 10.1007/BF00394291; NIEBUHR E, 1978, HUM GENET, V42, P142; Old JM, 1986, HUMAN GENETIC DISEAS, P1; OVERHAUSER J, 1986, AM J HUM GENET, V39, P562; OVERHAUSER J, 1986, AM J HUM GENET, V39, P1; OVERHAUSER J, 1987, NUCLEIC ACIDS RES, V15, P4617, DOI 10.1093/nar/15.11.4617; SCHWARTZ CE, 1988, AM J HUM GENET, V43, P597; STEWART GD, 1988, AM J HUM GENET, V42, P227; VANTUINEN P, 1988, AM J HUM GENET, V43, P587	14	47	47	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1989	45	2					296	303						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK380	2667351				2022-12-18	WOS:A1989AK38000012
J	ROBBINS, C; THEILMANN, J; YOUNGMAN, S; HAINES, J; ALTHERR, MJ; HARPER, PS; PAYNE, C; JUNKER, A; WASMUTH, J; HAYDEN, MR				ROBBINS, C; THEILMANN, J; YOUNGMAN, S; HAINES, J; ALTHERR, MJ; HARPER, PS; PAYNE, C; JUNKER, A; WASMUTH, J; HAYDEN, MR			EVIDENCE FROM FAMILY STUDIES THAT THE GENE CAUSING HUNTINGTON DISEASE IS TELOMERIC TO D4S95 AND D4S90	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV HOSP BRITISH COLUMBIA,DEPT MED GENET,ROOM F168,2211 WESBROOK MALL,VANCOUVER V6T 2B5,BC,CANADA; UNIV BRITISH COLUMBIA,DEPT MED GENET,VANCOUVER V6T 1W5,BC,CANADA; MASSACHUSETTS GEN HOSP,DIV NEUROGENET,BOSTON,MA 02114; UNIV BRITISH COLUMBIA,DEPT PAEDIAT,VANCOUVER V6T 1W5,BC,CANADA; DUKE UNIV,DEPT NEUROL,DURHAM,NC 27706; UNIV CARDIFF,DIV MED GENET,CARDIFF,WALES; UNIV CALIF IRVINE,DEPT BIOL CHEM,IRVINE,CA 92717	University of British Columbia; University of British Columbia; Harvard University; Massachusetts General Hospital; University of British Columbia; Duke University; Cardiff University; University of California System; University of California Irvine			Haines, Jonathan/C-3374-2012; Hayden, Michael R/D-8581-2011	Haines, Jonathan/0000-0002-4351-4728; Hayden, Michael R/0000-0001-5159-1419				CONNEALLY P M, 1984, Genetic Epidemiology, V1, P81, DOI 10.1002/gepi.1370010110; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GILLIAM TC, 1987, SCIENCE, V238, P950, DOI 10.1126/science.2890209; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HAYDEN MR, 1988, AM J HUM GENET, V42, P125; HAYDEN MR, 1987, AM J HUM GENET, V40, P421; RICHARDS JE, 1988, P NATL ACAD SCI USA, V85, P6437, DOI 10.1073/pnas.85.17.6437; SMITH B, 1988, AM J HUM GENET, V42, P335; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WASMUTH JJ, 1986, AM J HUM GENET, V39, P397; WASMUTH JJ, 1988, NATURE, V332, P734, DOI 10.1038/332734a0; YOUNGMAN S, 1988, NUCLEIC ACIDS RES, V16, P1648, DOI 10.1093/nar/16.4.1648	12	47	47	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1989	44	3					422	425						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T3535	2521771				2022-12-18	WOS:A1989T353500016
J	HAYDEN, MR; ROBBINS, C; ALLARD, D; HAINES, J; FOX, S; WASMUTH, J; FAHY, M; BLOCH, M				HAYDEN, MR; ROBBINS, C; ALLARD, D; HAINES, J; FOX, S; WASMUTH, J; FAHY, M; BLOCH, M			IMPROVED PREDICTIVE TESTING FOR HUNTINGTON DISEASE BY USING 3 LINKED DNA MARKERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MASSACHUSETTS GEN HOSP,DIV NEUROGENET,BOSTON,MA 02114; UNIV CALIF IRVINE,DEPT BIOL CHEM,IRVINE,CA 92717	Harvard University; Massachusetts General Hospital; University of California System; University of California Irvine	HAYDEN, MR (corresponding author), UNIV BRITISH COLUMBIA,DEPT MED GENET,HOSP HLTH SCI CTR,ROOM F168-2211 WESBROOK MALL,VANCOUVER V6T 2B5,BC,CANADA.		Haines, Jonathan/C-3374-2012; Hayden, Michael R/D-8581-2011	Haines, Jonathan/0000-0002-4351-4728; Hayden, Michael R/0000-0001-5159-1419				BLOCH M, UNPUB AM J MED GENET; CONNEALLY P M, 1984, Genetic Epidemiology, V1, P81, DOI 10.1002/gepi.1370010110; FARRER LA, IN PRESS J MED GENET; FOX S, UNPUB AM J MED GENET; GILLIAM TC, 1987, SCIENCE, V238, P950, DOI 10.1126/science.2890209; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HAINES J, 1986, American Journal of Human Genetics, V39, pA156; HARPER PS, 1985, BRIT MED J, V290, P1929, DOI 10.1136/bmj.290.6486.1929; HAYDEN MR, 1988, AM J HUM GENET, V42, P125; HAYDEN MR, 1987, AM J HUM GENET, V40, P421; HAYDEN MR, 1987, LANCET, V1, P1284; HAYDEN MR, 1981, HUNTINGTON CHOREA; MEISSEN GJ, 1988, NEW ENGL J MED, V318, P535, DOI 10.1056/NEJM198803033180903; QUARRELL OWJ, 1987, LANCET, V1, P1281; WASMUTH JJ, 1988, NATURE, V332, P734, DOI 10.1038/332734a0	15	47	47	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1988	43	5					689	694						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q9336	2973229				2022-12-18	WOS:A1988Q933600015
J	FARRALL, M; WAINWRIGHT, BJ; FELDMAN, GL; BEAUDET, A; SRETENOVIC, Z; HALLEY, D; SIMON, M; DICKERMAN, L; DEVOTO, M; ROMEO, G; KAPLAN, JC; KITZIS, A; WILLIAMSON, R				FARRALL, M; WAINWRIGHT, BJ; FELDMAN, GL; BEAUDET, A; SRETENOVIC, Z; HALLEY, D; SIMON, M; DICKERMAN, L; DEVOTO, M; ROMEO, G; KAPLAN, JC; KITZIS, A; WILLIAMSON, R			RECOMBINATIONS BETWEEN IRP AND CYSTIC-FIBROSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV LONDON, ST MARYS HOSP, SCH MED, DEPT BIOCHEM & MOLEC GENETS, LONDON W2 1PG, ENGLAND; BAYLOR COLL MED, INST MOLEC GENET, HOUSTON, TX 77030 USA; INST SERBIA, DEPT GYNAECOL MOTHER & CHILD HLTH, BEOGRAD, YUGOSLAVIA; ERASMUS UNIV, FAC GENEESKUNDE, 3000 DR ROTTERDAM, NETHERLANDS; COLLABORAT RES INC, BEDFORD, MA USA; CASE WESTERN RESERVE UNIV, CTR GENET, CLEVELAND, OH 44106 USA; IST GIANNINA GASLINI, I-16148 GENOA, ITALY; INST PATHOL MOLEC, BIOCHIM GENET LAB, PARIS, FRANCE	Imperial College London; University of London; Baylor College of Medicine; Erasmus University Rotterdam; Case Western Reserve University; University of Genoa; IRCCS Istituto Giannina Gaslini			Devoto, Marcella/AAP-7595-2021	DEVOTO, MARCELLA/0000-0002-4431-5114; Wainwright, Brandon/0000-0003-0406-2092				BARKER D, 1987, P NATL ACAD SCI USA, V84, P8006, DOI 10.1073/pnas.84.22.8006; BEAUDET A, 1986, AM J HUM GENET, V39, P681; BEAUDET AL, 1988, NEW ENGL J MED, V318, P50; BERGER W, 1987, HUM GENET, V77, P197, DOI 10.1007/BF00272392; BOUE A, 1986, HUM GENET, V74, P288; CARBARNS NJB, 1983, LANCET, V1, P329; COOPER DN, 1985, HUM GENET, V69, P201, DOI 10.1007/BF00293024; EIBERG H, 1985, CLIN GENET, V28, P265; ESTIVILL X, 1987, Genomics, V1, P257, DOI 10.1016/0888-7543(87)90052-8; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; KNOWLTON RG, 1985, NATURE, V318, P380, DOI 10.1038/318380a0; LATHROP GM, 1988, AM J HUM GENET, V42, P38; LI M, 1988, NATURE, V331, P358, DOI 10.1038/331358a0; POUSTKA A, IN PRESS GENOMICS; SCAMBLER PJ, 1986, NUCLEIC ACIDS RES, V14, P1951, DOI 10.1093/nar/14.5.1951; TSUI LC, 1985, SCIENCE, V230, P1054, DOI 10.1126/science.2997931; WAINWRIGHT BJ, 1985, NATURE, V318, P384, DOI 10.1038/318384a0; WAINWRIGHT BJ, 1988, EMBO J, V7, P1743, DOI 10.1002/j.1460-2075.1988.tb03003.x; WHITE R, 1985, NATURE, V318, P382, DOI 10.1038/318382a0	19	47	51	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1988	43	4					471	475						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q4736	2902786				2022-12-18	WOS:A1988Q473600014
J	LITTLE, RE; SING, CF				LITTLE, RE; SING, CF			GENETIC AND ENVIRONMENTAL-INFLUENCES ON HUMAN BIRTH-WEIGHT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MICHIGAN,DEPT HUMAN GENET,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan	LITTLE, RE (corresponding author), UNIV WASHINGTON,DEPT EPIDEMIOL,SEATTLE,WA 98195, USA.			Sing, Charles/0000-0001-5872-7956	NICHD NIH HHS [HD06608] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Cochran W.G, 1957, STAT METHODS, V6th ed; DONNER A, 1984, AM J EPIDEMIOL, V119, P642, DOI 10.1093/oxfordjournals.aje.a113780; DOUGHERTY CRS, 1982, AM J OBSTET GYNECOL, V144, P190, DOI 10.1016/0002-9378(82)90627-5; EAVES LJ, 1980, CAUSES EFFECTS SMOKI, P236; EISNER V, 1979, AM J PUBLIC HEALTH, V69, P887, DOI 10.2105/AJPH.69.9.887; EVERSON RB, 1986, SCIENCE, V231, P54, DOI 10.1126/science.3941892; GUERRERO R, 1975, STUD FAMILY PLANN, V6, P367, DOI 10.2307/1964917; HARLAP S, 1985, AM J HUM GENET, V37, P1206; HOOK EB, 1985, AM J HUM GENET, V37, P1216; KARN MN, 1951, ANN EUGENIC, V16, P147, DOI 10.1111/j.1469-1809.1951.tb02469.x; LITTLE RE, 1986, SOC SCI MED, V22, P91, DOI 10.1016/0277-9536(86)90312-6; LITTLE RE, 1984, AM J EPIDEMIOL, V120, P794, DOI 10.1093/oxfordjournals.aje.a113949; LITTLE RE, 1986, AM J PUBLIC HEALTH, V76, P1350, DOI 10.2105/AJPH.76.11.1350; LITTLE RE, 1986, NEW ENGL J MED, V314, P1644, DOI 10.1056/NEJM198606193142516; LITTLE RE, 1986, AM J EPIDEMIOL, V123, P270, DOI 10.1093/oxfordjournals.aje.a114235; MAGNUS P, 1984, CLIN GENET, V25, P15; MAGNUS P, 1984, CLIN GENET, V26, P289; MAGNUS P, 1984, CLIN GENET, V26, P397; MILLS JL, 1984, JAMA-J AM MED ASSOC, V252, P1875, DOI 10.1001/jama.252.14.1875; MOORE KL, 1960, ANAT REC, V136, P247; MORTON NE, 1955, ANN HUM GENET, V20, P125; NANCE WE, 1983, AM J HUM GENET, V35, P1211; NANCE WE, 1978, GENETIC EPIDEMIOLOGY, P87; PENROSE LS, 1954, PROPHYLAXIE GYNECOLO, P638; RAO DC, 1979, GENET RES, V33, P175, DOI 10.1017/S0016672300018310; RAO DC, 1974, AM J HUM GENET, V26, P331; RAVENHOLT RT, 1965, LANCET, V1, P961; Robson E., 1978, HUMAN GROWTH, V1, P285; SING CF, 1978, AM J HUM GENET, V30, P491; WEATHERSBEE PS, 1980, J REPROD MED, V25, P243; WEISS W, 1969, PERINATAL FACTORS AF, P54; [No title captured]	32	47	48	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1987	40	6					512	526						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	H9693	3591799				2022-12-18	WOS:A1987H969300004
J	SCRIVER, CR; MAHON, B; LEVY, HL; CLOW, CL; READE, TM; KRONICK, J; LEMIEUX, B; LABERGE, C				SCRIVER, CR; MAHON, B; LEVY, HL; CLOW, CL; READE, TM; KRONICK, J; LEMIEUX, B; LABERGE, C			THE HARTNUP PHENOTYPE - MENDELIAN TRANSPORT DISORDER, MULTIFACTORIAL DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MCGILL UNIV, CTR HUMAN GENET, MONTREAL H3A 2T5, QUEBEC, CANADA; MASSACHUSETTS GEN HOSP, NEUROL SERV, JOSEPH P KENNEDY JR LABS, BOSTON, MA 02114 USA; HARVARD UNIV, SCH MED, DEPT NEUROL, BOSTON, MA 02115 USA; MASSACHUSETTS DEPT PUBL HLTH, STATE LAB INST, BOSTON, MA 02130 USA; CHU SHERBROOKE, SHERBROOKE J1H 5N4, QUEBEC, CANADA; CHU LAVAL, ST FOY, QUEBEC, CANADA	McGill University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Department of Public Health; University of Sherbrooke; Laval University					NINDS NIH HHS [NS 05096] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS005096] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		[Anonymous], 1980, INT CLASSIFICATION I; BARON DN, 1956, LANCET, V271, P421; BOERWINKLE E, 1986, AM J HUM GENET, V39, P137; CHILDS B, 1986, PERSPECT BIOL MED, V29, P437; CHILDS B, 1968, NEW ENGL J MED, V279, P1205, DOI 10.1056/NEJM196811282792206; COLLISS JE, 1963, BMJ-BRIT MED J, P590, DOI 10.1136/bmj.1.5330.590; DENT CE, 1948, BIOCHEM J, V43, P169, DOI 10.1042/bj0430169; Garrod A.E., 1909, INBORN ERRORS METABO; GARROD AE, 1931, INBORN FACTORS DISEA; GROTH U, 1972, J CLIN INVEST, V51, P2130, DOI 10.1172/JCI107020; HILLMAN RE, 1986, PEDIATR RES, V20, pA265; JEPSON B, 1978, METABOLIC BASIS INHE, P1563; KACSER H, 1981, GENETICS, V97, P639; Levy H.L., 1980, NEONATAL SCREENING I, P89; POMEROY J, 1968, NEW ENGL J MED, V278, P1214, DOI 10.1056/NEJM196805302782207; SCRIVER CR, 1985, METABOLISM, V34, P868, DOI 10.1016/0026-0495(85)90112-X; SCRIVER CR, 1984, PROC R SOC SER B-BIO, V220, P273, DOI 10.1098/rspb.1984.0001; SCRIVER CR, 1965, NEW ENGL J MED, V273, P530, DOI 10.1056/NEJM196509022731005; SCRIVER CR, 1978, SCIENCE, V200, P946, DOI 10.1126/science.644337; SCRIVER CR, 1961, J LAB CLIN MED, V58, P908; SCRIVER CR, 1973, AMINO ACID METABOLIS, P39; SCRIVER CR, IN PRESS HDB PHYSL; SEAKINS JWT, 1967, ARCH DIS CHILD, V42, P682, DOI 10.1136/adc.42.226.682; SHIH VE, 1971, GASTROENTEROLOGY, V61, P445; SPENCER N, 1964, NATURE, V201, P299, DOI 10.1038/201299a0; SRIKANTIA SG, 1964, BRIT MED J, V1, P282, DOI 10.1136/bmj.1.5378.282; TARLOW MJ, 1972, ARCH DIS CHILD, V47, P798, DOI 10.1136/adc.47.255.798; VOGEL F, 1979, HUMAN GENETICS PROBL, P568; WILCKEN B, 1977, ARCH DIS CHILD, V52, P38, DOI 10.1136/adc.52.1.38	29	47	47	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1987	40	5					401	412						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	H5759	3578280				2022-12-18	WOS:A1987H575900002
J	POPOVICH, BW; ROSENBLATT, DS; KENDALL, AG; NISHIOKA, Y				POPOVICH, BW; ROSENBLATT, DS; KENDALL, AG; NISHIOKA, Y			MOLECULAR CHARACTERIZATION OF AN ATYPICAL BETA-THALASSEMIA CAUSED BY A LARGE DELETION IN THE 5' BETA-GLOBIN GENE REGION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MCGILL UNIV,DEPT BIOL,MONTREAL H3A 1B1,QUEBEC,CANADA; MCGILL UNIV,DEPT PEDIAT,MONTREAL H3A 1B1,QUEBEC,CANADA; MCGILL UNIV,DEPT MED,MONTREAL H3A 1B1,QUEBEC,CANADA; MCGILL UNIV,CTR HUMAN GENET,MONTREAL H3A 1B1,QUEBEC,CANADA	McGill University; McGill University; McGill University; McGill University								ALTER BP, 1976, NEW ENGL J MED, V295, P1437, DOI 10.1056/NEJM197612232952601; BETKE K, 1959, NATURE, V184, P1877, DOI 10.1038/1841877a0; Bunn HF, 1977, HUMAN HEMOGLOBINS; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; CHOMCZYNSKI P, 1984, BIOCHEM BIOPH RES CO, V122, P340, DOI 10.1016/0006-291X(84)90480-7; COLLINS FS, 1984, PROG NUCLEIC ACID RE, V31, P315, DOI 10.1016/S0079-6603(08)60382-7; CONGOTE LF, 1982, ANAL BIOCHEM, V123, P124, DOI 10.1016/0003-2697(82)90632-7; DENTE L, 1983, NUCLEIC ACIDS RES, V11, P1645, DOI 10.1093/nar/11.6.1645; EFSTRATIADIS A, 1980, CELL, V21, P653, DOI 10.1016/0092-8674(80)90429-8; FARABAUGH PJ, 1978, J MOL BIOL, V126, P847, DOI 10.1016/0022-2836(78)90023-2; GILMAN JG, 1984, BRIT J HAEMATOL, V56, P339, DOI 10.1111/j.1365-2141.1984.tb03961.x; HUISMAN TH, 1961, BLOOD, V17, P747, DOI 10.1182/blood.V17.6.747.747; KAN YW, 1980, NEW ENGL J MED, V302, P185, DOI 10.1056/NEJM198001243020401; LAWN RM, 1978, CELL, V15, P1157, DOI 10.1016/0092-8674(78)90043-0; MANIATIS T, 1982, MOL CLONING LABORATO; MAROTTA CA, 1977, J BIOL CHEM, V252, P5040; ORKIN SH, 1979, P NATL ACAD SCI USA, V76, P2400, DOI 10.1073/pnas.76.5.2400; ORKIN SH, 1984, ANNU REV GENET, V18, P131; PADANILAM BJ, 1984, BLOOD, V64, P941; PEARSON HA, 1965, AM J HUM GENET, V17, P125; PONCZ M, 1983, J BIOL CHEM, V258, P1599; RIPLEY LS, 1982, COLD SPRING HARB SYM, V47, P851; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SPRITZ RA, 1982, NUCLEIC ACIDS RES, V10, P8025, DOI 10.1093/nar/10.24.8025; STEINBERG MH, 1982, J LAB CLIN MED, V100, P548; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; WEATHERALL DJ, 1976, J MED GENET, V13, P20, DOI 10.1136/jmg.13.1.20; Weatherall DJ, 1981, THALASSEMIA SYNDROME	28	47	47	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1986	39	6					797	810						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	F5414	3799598				2022-12-18	WOS:A1986F541400014
J	SAUNDERS, ME; SHERWOOD, WG; DUTHIE, M; SURH, L; GRAVEL, RA				SAUNDERS, ME; SHERWOOD, WG; DUTHIE, M; SURH, L; GRAVEL, RA			EVIDENCE FOR A DEFECT OF HOLOCARBOXYLASE SYNTHETASE-ACTIVITY IN CULTURED LYMPHOBLASTS FROM A PATIENT WITH BIOTIN-RESPONSIVE MULTIPLE CARBOXYLASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											SAUNDERS, ME (corresponding author), HOSP SICK CHILDREN, RES INST, TORONTO M5S 1A8, ONTARIO, CANADA.							BARTLETT K, 1978, CLIN CHIM ACTA, V84, P399, DOI 10.1016/0009-8981(78)90255-3; BURRI BJ, 1981, J CLIN INVEST, V68, P1491, DOI 10.1172/JCI110402; CHALMERS RA, 1974, CLIN CHIM ACTA, V52, P43, DOI 10.1016/0009-8981(74)90386-6; CHARLES BM, 1979, LANCET, V2, P118; COWAN MJ, 1979, LANCET, V2, P115; FELDMAN GL, 1980, BIOCHEM GENET, V18, P617, DOI 10.1007/BF00484405; FELDMAN GL, 1981, CLIN CHIM ACTA, V111, P147, DOI 10.1016/0009-8981(81)90181-9; FORSGREN A, 1966, J IMMUNOL, V97, P822; GLADE PR, 1971, IN VITRO METHODS CEL, P561; GOMPERTZ D, 1973, ARCH DIS CHILD, V48, P975, DOI 10.1136/adc.48.12.975; GOMPERTZ D, 1971, LANCET, V2, P22; GRAVEL RA, 1977, AM J HUM GENET, V29, P378; GRAVEL RA, 1980, ARCH BIOCHEM BIOPHYS, V201, P669, DOI 10.1016/0003-9861(80)90557-3; GREEN NM, 1963, BIOCHEM J, V89, P585, DOI 10.1042/bj0890585; LEHNERT W, 1979, EUR J PEDIATR, V132, P107, DOI 10.1007/BF00447377; MCKEON C, 1980, CLIN CHIM ACTA, V101, P217, DOI 10.1016/0009-8981(80)90246-6; MUNNICH A, 1980, LANCET, V1, P1080; MURTHY PNA, 1972, J SCI IND RES INDIA, V31, P554; ROTH K, 1976, J PEDIATR-US, V88, P229, DOI 10.1016/S0022-3476(76)80987-0; SAUNDERS M, 1979, J CLIN INVEST, V64, P1695, DOI 10.1172/JCI109632; STANNERS CP, 1971, NATURE-NEW BIOL, V230, P52, DOI 10.1038/newbio230052a0; SWEETMAN L, 1977, PEDIATR RES, V11, P1144, DOI 10.1203/00006450-197711000-00006; WEYLER W, 1977, CLIN CHIM ACTA, V76, P321, DOI 10.1016/0009-8981(77)90158-9	23	47	47	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1982	34	4					590	601						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NY863	7102675				2022-12-18	WOS:A1982NY86300006
J	RUBINSTEIN, P; GINSBERGFELLNER, F; FALK, C				RUBINSTEIN, P; GINSBERGFELLNER, F; FALK, C			GENETICS OF TYPE-I DIABETES-MELLITUS - A SINGLE, RECESSIVE PREDISPOSITION GENE-MAPPING BETWEEN HLA-B AND GLO	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CUNY MT SINAI SCH MED,DEPT PEDIAT,DIV PEDIAT ENDOCRINOL,NEW YORK,NY 10029	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	RUBINSTEIN, P (corresponding author), NEW YORK BLOOD CTR,LINDSLEY F KIMBALL RES INST,310 E 67TH ST,NEW YORK,NY 10021, USA.				NHLBI NIH HHS [HL-09011] Funding Source: Medline; NIADDK NIH HHS [AM-19631] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM019631] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL009011] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARNAIZVILLENA A, 1980, NEW ENGL J MED, V303, P1065; BARBOSA J, 1980, J CLIN INVEST, V65, P592, DOI 10.1172/JCI109704; BARBOSA J, 1977, J CLIN INVEST, V60, P989, DOI 10.1172/JCI108879; BARBOSA J, 1978, J CLIN INVEST, V62, P492, DOI 10.1172/JCI109151; BERTRAMS J, 1976, TISSUE ANTIGENS, V8, P13; BERTRAMS J, 1980, HISTOCOMPATIBILITY T, P949; BOTTAZZO GF, 1978, BRIT MED J, V2, P1253, DOI 10.1136/bmj.2.6147.1253; CAHILL GF, 1979, GENETIC ANAL COMMON, P113; Christy M, 1979, Diabetes Care, V2, P209, DOI 10.2337/diacare.2.2.209; CHRISTY M, 1976, LANCET, V2, P142; CUDWORTH AG, 1978, DIABETOLOGIA, V14, P281, DOI 10.1007/BF01223018; CUDWORTH AG, 1977, LANCET, V1, P385; CUDWORTH AG, 1976, BRIT MED J, V2, P846, DOI 10.1136/bmj.2.6040.846; CUDWORTH AG, 1975, BRIT MED J, V3, P133, DOI 10.1136/bmj.3.5976.133; DEGNBOL B, 1978, ANN HUM GENET, V42, P25, DOI 10.1111/j.1469-1809.1978.tb00929.x; EFF C, 1978, DIABETOLOGIA, V15, P169, DOI 10.1007/BF00421234; Falk C T, 1975, Ser Haematol, V8, P153; FALK CT, 1978, CYTOGENET CELL GENET, V22, P298, DOI 10.1159/000130958; FALK CT, 1980, ANN HUM GENET, V43, P295; GORWITZ K, 1976, DIABETES, V25, P122, DOI 10.2337/diabetes.25.2.122; IRVINE WJ, 1978, J CLIN LAB IMMUNOL, V1, P107; KIDD CJ, 1978, DIABETES, V27, P57; KOMPF J, 1975, HUMANGENETIK, V27, P141; LAMM LU, 1978, TISSUE ANTIGENS, V11, P132, DOI 10.1111/j.1399-0039.1978.tb01237.x; LENDRUM R, 1976, BRIT MED J, V1, P1565, DOI 10.1136/bmj.1.6025.1565; LUDWIG H, 1977, DIABETES METAB, V3, P43; MACDONALD MJ, 1980, DIABETES, V29, P110, DOI 10.2337/diab.29.2.110; MADSBAD S, 1980, DIABETOLOGIA, V18, P45, DOI 10.1007/BF01228301; MARTEL JL, 1974, VOX SANG, V27, P13, DOI 10.1111/j.1423-0410.1974.tb02384.x; MORRIS PJ, 1976, LANCET, V2, P652; MORTON NE, 1956, AM J HUM GENET, V8, P80; MORTON NE, 1955, AM J HUM GENET, V7, P277; NELSON PG, 1975, LANCET, V2, P193; NERUP J, 1974, LANCET, V2, P864; OTT J, 1974, AM J HUM GENET, V26, P588; REITNAUER PJ, 1980, NEW ENGL J MED, V302, P406; RICHENS ER, 1979, CLIN EXP IMMUNOL, V36, P198; RODEY GE, 1979, N ENGL J MED, V301, P369; ROTTER JI, 1978, DIABETES, V27, P599, DOI 10.2337/diabetes.27.5.599; ROTTER JI, 1980, DIABETES, V29, P115, DOI 10.2337/diabetes.29.2.115; RUBINSTEIN P, 1976, J EXP MED, V143, P1277, DOI 10.1084/jem.143.5.1277; RUBINSTEIN P, 1977, NEW ENGL J MED, V297, P1036, DOI 10.1056/NEJM197711102971905; Rubinstein P, 1979, Adv Exp Med Biol, V119, P33; RUBINSTEIN P, 1980, IMMUNOLOGY DIABETES, P109; RYDER LP, 1979, TREATMENT EARLY DIAB, V119, P41; SCHERNTHANER G, 1979, J CLIN ENDOCR METAB, V48, P403, DOI 10.1210/jcem-48-3-403; SCHERNTHANER G, 1976, NEW ENGL J MED, V295, P622; SINGAL DP, 1973, DIABETES, V22, P429, DOI 10.2337/diab.22.6.429; SPENCE MA, 1980, AM J HUM GENET, V32, pA151; SPIELMAN RS, 1980, ANN HUM GENET, V44, P135, DOI 10.1111/j.1469-1809.1980.tb00954.x; SUCIUFOCA N, 1979, TRANSPLANT P, V11, P1309; SVEJGAARD A, 1980, HISTOCOMPATIBILITY T, P638; TATTERSALL RB, 1972, LANCET, V2, P1120; Thomson G, 1977, HLA DISEASE, P84; ZEIDLER A, 1980, DIABETES, V29, P247, DOI 10.2337/diabetes.29.4.247	55	47	47	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	6					865	882						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MV199	7034534				2022-12-18	WOS:A1981MV19900003
J	KENNAWAY, NG; WELEBER, RG; BUIST, NRM				KENNAWAY, NG; WELEBER, RG; BUIST, NRM			GYRATE ATROPHY OF THE CHOROID AND RETINA WITH HYPERORNITHINEMIA - BIOCHEMICAL AND HISTOLOGIC-STUDIES AND RESPONSE TO VITAMIN-B6	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV OREGON,HLTH SCI CTR,DEPT OPHTHALMOL,PORTLAND,OR 97201; UNIV OREGON,HLTH SCI CTR,DEPT PEDIAT,PORTLAND,OR 97201	University of Oregon; University of Oregon	KENNAWAY, NG (corresponding author), UNIV OREGON,HLTH SCI CTR,DIV MED GENET,PORTLAND,OR 97201, USA.							ARSHINOFF S, 1977, CLIN RES, V25, pA321; BARBER GW, 1969, J PEDIATR, V75, P463, DOI 10.1016/S0022-3476(69)80274-X; BARTOS D, 1975, CANCER RES, V35, P2056; BARTOS F, 1978, RES COMMUN CHEM PATH, V19, P295; BERSON EL, 1976, BRIT J OPHTHALMOL, V60, P142, DOI 10.1136/bjo.60.2.142; BERSON EL, 1978, OPHTHALMOLOGY, V85, P1018; CABALLERO MLR, 1975, ARCH OPHTALMOL PARIS, V35, P973; CHEN TR, 1977, EXP CELL RES, V104, P255, DOI 10.1016/0014-4827(77)90089-1; ENGEL WK, 1970, J ULTRA MOL STRUCT R, V31, P507, DOI 10.1016/S0022-5320(70)90166-8; FOWLER B, 1978, J CLIN INVEST, V61, P645, DOI 10.1172/JCI108976; FRIMPTER GW, 1965, SCIENCE, V149, P1095, DOI 10.1126/science.149.3688.1095; HERZFELD A, 1968, J BIOL CHEM, V243, P3327; KAISERKUPFER MI, 1978, AM J OPHTHALMOL, V85, P200, DOI 10.1016/S0002-9394(14)75948-3; KENNAWAY NG, 1977, AM J HUM GENET, V29, pA61; KENNAWAY NG, 1977, NEW ENGL J MED, V297, P1180; LOGAN A, 1968, AM J SURG, V115, P112, DOI 10.1016/0002-9610(68)90138-4; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARON BJ, 1974, J MOL CELL CARDIOL, V6, P249, DOI 10.1016/0022-2828(74)90054-6; MCCULLOCH C, 1975, AM J OPHTHALMOL, V80, P1047, DOI 10.1016/0002-9394(75)90335-9; MCCULLOCH JC, 1978, OPHTHALMOLOGY, V85, P918; MORROW G, 1975, PEDIATR RES, V9, P641, DOI 10.1203/00006450-197508000-00006; MUDD SH, 1971, FED PROC, V30, P970; ODONNELL JJ, 1977, BIOCHEM BIOPH RES CO, V79, P396, DOI 10.1016/0006-291X(77)90170-X; ODONNELL JJ, 1978, SCIENCE, V200, P200, DOI 10.1126/science.635581; OLSON W, 1972, ARCH NEUROL-CHICAGO, V26, P193, DOI 10.1001/archneur.1972.00490090019001; SCHIAFFINO S, 1977, LAB INVEST, V37, P223; SENGERS RCA, 1976, PEDIATR RES, V10, P894, DOI 10.1203/00006450-197610000-00135; SHIH VE, 1970, CLIN CHIM ACTA, V27, P73, DOI 10.1016/0009-8981(70)90376-1; SHIH VE, 1978, AM J HUM GENET, V30, P174; SHIH VE, 1977, AM J HUM GENET, V29, pA98; SIMELL O, 1973, LANCET, V1, P1031; SIPILA I, 1979, NEUROLOGY, V29, P996, DOI 10.1212/WNL.29.7.996; STEIN WH, 1953, J BIOL CHEM, V201, P45; STOPPOLONI G, 1978, HELV PAEDIATR ACTA, V33, P429; TAKKI K, 1974, BRIT J OPHTHALMOL, V58, P3, DOI 10.1136/bjo.58.1.3; TAKKI K, 1974, BRIT J OPHTHALMOL, V58, P907, DOI 10.1136/bjo.58.11.907; Takki K, 1976, Birth Defects Orig Artic Ser, V12, P373; TRIJBELS JMF, 1977, CLIN CHIM ACTA, V79, P371; VALLE D, 1979, PEDIATR RES, V13, P483; VALLE D, 1977, P NATL ACAD SCI USA, V74, P5159, DOI 10.1073/pnas.74.11.5159; WELEBER RG, 1978, LANCET, V2, P1213	41	47	47	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	4					529	541						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KB522	7395865				2022-12-18	WOS:A1980KB52200006
J	SPECTOR, EB; KIERNAN, M; BERNARD, B; CEDERBAUM, SD				SPECTOR, EB; KIERNAN, M; BERNARD, B; CEDERBAUM, SD			PROPERTIES OF FETAL AND ADULT RED-BLOOD-CELL ARGINASE - POSSIBLE PRENATAL DIAGNOSTIC-TEST FOR ARGINASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF LOS ANGELES,SCH MED,DEPT PSYCHIAT,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,DEPT PEDIAT,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	SPECTOR, EB (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,MENTAL RETARDAT RES CTR,LOS ANGELES,CA 90024, USA.							ALTER BP, 1976, NEW ENGL J MED, V295, P1437, DOI 10.1056/NEJM197612232952601; ALTER BP, 1978, CLIN HAEMATOL, V7, P195; BOYER SH, 1976, BLOOD, V47, P883; CABELLO J, 1961, BIOCHIM BIOPHYS ACTA, V48, P148, DOI 10.1016/0006-3002(61)90525-X; CABELLO JULIO, 1965, BIOCHIM BIOPHYS ACTA, V105, P583; CEDERBAUM SD, 1979, PEDIATR RES, V13, P827, DOI 10.1203/00006450-197907000-00007; CEDERBAUM SD, 1977, J PEDIATR-US, V90, P569, DOI 10.1016/S0022-3476(77)80368-5; CORNISHBOWDEN A, 1976, PRINCIPLES ENZYME KI, P23; GREENGARD O, 1977, PEDIATR RES, V11, P669, DOI 10.1203/00006450-197705000-00009; HERZFELD A, 1976, PEDIATR RES, V10, P960, DOI 10.1203/00006450-197612000-00002; HOBBINS JC, 1974, NEW ENGL J MED, V290, P1065, DOI 10.1056/NEJM197405092901908; HUISMAN TH, 1969, BIOCH METHODS RED CE, P454; KAN YW, 1974, LANCET, V1, P79; KAN YW, 1974, BLOOD, V43, P411, DOI 10.1182/blood.V43.3.411.411; MICHELS VV, 1978, CLIN GENET, V13, P61; RICE SCH, 1978, AM J HUM GENET, V30, pA39; SCHIMKE RT, 1964, J BIOL CHEM, V239, P136; SNYDERMAN SE, 1977, J PEDIATR-US, V90, P563, DOI 10.1016/S0022-3476(77)80367-3; TERHEGGEN HG, 1975, ARCH DIS CHILD, V50, P57, DOI 10.1136/adc.50.1.57; TERHEGGEN HG, 1969, LANCET, V2, P748; Wintrobe MM, 1974, CLIN HEMATOLOGY, P114	21	47	52	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	1					79	87						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JH296	7361766				2022-12-18	WOS:A1980JH29600010
J	JACKSON, CE; BLOCK, MA; GREENAWALD, KA; TASHJIAN, AH				JACKSON, CE; BLOCK, MA; GREENAWALD, KA; TASHJIAN, AH			2-MUTATIONAL-EVENT THEORY IN MEDULLARY-THYROID CANCER	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HENRY FORD HOSP,DEPT SURG,DETROIT,MI 48202; HENRY FORD HOSP,DEPT PATHOL,DETROIT,MI 48202; HARVARD UNIV,SCH MED,DEPT PHARMACOL,BOSTON,MA 02115; HARVARD UNIV,SCH PUBL HLTH,TOXICOL LAB,BOSTON,MA 02115	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	JACKSON, CE (corresponding author), HENRY FORD HOSP,DEPT MED,DETROIT,MI 48202, USA.							BAYLIN SB, 1976, SCIENCE, V193, P321, DOI 10.1126/science.935869; BAYLIN SB, 1978, SCIENCE, V199, P429, DOI 10.1126/science.619463; BLOCK MA, 1972, ARCH SURG-CHICAGO, V104, P579; BLOCK MA, ARCH SURG; CARNEY JA, 1976, AM J CLIN PATHOL, V66, P279; DELELLIS RA, 1976, AM J PATHOL, V83, P177; FIALKOW PJ, 1977, NEW ENGL J MED, V297, P696, DOI 10.1056/NEJM197709292971304; Gagel R F, 1975, Trans Assoc Am Physicians, V88, P177; JACKSON CE, 1973, ANN INTERN MED, V78, P845, DOI 10.7326/0003-4819-78-6-845; Knudson A G Jr, 1977, Adv Hum Genet, V8, P1; KNUDSON AG, 1972, AM J HUM GENET, V24, P514; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; MELVIN KEW, 1971, NEW ENGL J MED, V285, P1115, DOI 10.1056/NEJM197111112852004; SIZEMORE GW, 1977, SURG CLIN N AM, V57, P633; STEINER AL, 1968, MEDICINE, V47, P371, DOI 10.1097/00005792-196809000-00001; TASHJIAN AH, 1970, NEW ENGL J MED, V283, P890, DOI 10.1056/NEJM197010222831702; WELLS SA, 1975, ANN SURG, V182, P362, DOI 10.1097/00000658-197510000-00002; WOLFE HJ, 1973, NEW ENGL J MED, V289, P437, DOI 10.1056/NEJM197308302890901	18	47	48	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	6					704	710						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HZ742	517520				2022-12-18	WOS:A1979HZ74200006
J	HOAR, DI; WAGHORNE, C				HOAR, DI; WAGHORNE, C			DNA-REPAIR IN COCKAYNE SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											HOAR, DI (corresponding author), UNIV TORONTO,DEPT MED GENET,TORONTO M5S 1A8,ONTARIO,CANADA.							ANDREWS AD, 1976, CLIN RES, V24, pA624; ARLETT CF, 1975, MUTAT RES, V33, P341, DOI 10.1016/0027-5107(75)90209-2; BERGSMA D, 1973, BIRTH DEFECTS ATLAS; BOYD JB, 1976, GENETICS, V84, P507; Buhl S N, 1975, Basic Life Sci, V5B, P627; CHU EHY, 1975, AM J HUM GENET, V27, pA26; COLE RS, 1976, J MOL BIOL, V103, P39, DOI 10.1016/0022-2836(76)90051-6; COLE RS, 1973, P NATL ACAD SCI USA, V70, P1064, DOI 10.1073/pnas.70.4.1064; ELKIND MM, 1970, BIOPHYS J, V10, P237, DOI 10.1016/S0006-3495(70)86296-8; GOLDSTEIN S, 1969, DIABETES, V18, P545, DOI 10.2337/diab.18.8.545; HOAR DI, 1976, NATURE, V261, P590, DOI 10.1038/261590a0; HOAR DI, 1976, EXCERPTA MED INT 397, P30; IYER VN, 1963, P NATL ACAD SCI USA, V50, P355, DOI 10.1073/pnas.50.2.355; LAWLEY PD, 1968, BIOCHEM J, V109, P433, DOI 10.1042/bj1090433; LEHMANN AR, 1975, P NATL ACAD SCI USA, V72, P219, DOI 10.1073/pnas.72.1.219; MORTELMANS K, 1976, P NATL ACAD SCI USA, V73, P2757, DOI 10.1073/pnas.73.8.2757; PATERSON MC, 1976, NATURE, V260, P444, DOI 10.1038/260444a0; REGAN JD, 1974, CANCER RES, V34, P3318; ROBBINS JH, 1974, ANN INTERN MED, V80, P221, DOI 10.7326/0003-4819-80-2-221; SCHMICKEL RD, 1977, PEDIATRICS, V60, P135; SODERHALL S, 1975, J BIOL CHEM, V250, P8438; TIMSON J, 1975, MUTAT RES, V32, P115, DOI 10.1016/0165-1110(75)90002-0; YOAKUM GH, 1976, BIOPHYS J, V16, pA182	23	47	47	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	6					590	601						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GK656	747187				2022-12-18	WOS:A1978GK65600003
J	ALVESALO, L; KARI, M				ALVESALO, L; KARI, M			SIZES OF DECIDUOUS TEETH IN 47,XYY MALES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TURKU,INST DENT,SF-20520 TURKU 52,FINLAND	University of Turku								ALVESALO L, 1975, AM J HUM GENET, V27, P53; LUNT RC, 1974, J AM DENT ASSOC, V89, P599, DOI 10.14219/jada.archive.1974.0446; OWEN DR, 1972, PSYCHOL BULL, V78, P209, DOI 10.1037/h0033068; [No title captured]	4	47	47	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1977	29	5					486	489						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DV673	900123				2022-12-18	WOS:A1977DV67300007
J	VANDYKE, DL; WEISS, L; LOGAN, M; PAI, GS				VANDYKE, DL; WEISS, L; LOGAN, M; PAI, GS			ORIGIN AND BEHAVIOR OF 2 ISODICENTRIC BISATELLITED CHROMOSOMES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HENRY FORD HOSP, DEPT PATHOL, DETROIT, MI 48202 USA; HENRY FORD HOSP, DEPT PEDIAT, DETROIT, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital								BALICEK P, 1976, CLIN GENET, V9, P192; BREG WR, 1974, AM J HUM GENET, V26, pA17; CENTERWALL WR, 1975, HUM HERED, V25, P442, DOI 10.1159/000152759; CHAPELLE AD, 1974, HEREDITAS, V76, P259; CRANDALL BF, 1973, AM J MENT DEF, V77, P571; DEGUTIERREZ AC, 1975, ANN GENET, V18, P45; DISTECHE C, 1972, CLIN GENET, V3, P388; FRIEDRICH U, 1974, CLIN GENET, V6, P23; GERALD PS, 1970, HUMAN POPULATION CYT, P143; GERMAN J, 1970, Clinical Genetics, V1, P15; HOWARD RN, 1974, AM J HUM GENET, V26, pA41; KAKATI S, 1973, HUM HERED, V23, P313, DOI 10.1159/000152592; LEWANDOWSKI RC, 1975, AM J DIS CHILD, V129, P515, DOI 10.1001/archpedi.1975.02120410075021; LIN CC, 1973, TISSUE CULTURE METHO, P778; Lubs H A, 1973, Methods Cell Biol, V6, P345, DOI 10.1016/S0091-679X(08)60057-6; MAGENIS RE, 1972, LANCET, V2, P1365; NIELSEN J, 1974, ANN GENET-PARIS, V17, P129; NIELSEN J, 1973, HUMANGENETIK, V19, P271, DOI 10.1007/BF00278401; Palmer C G, 1969, J Med Genet, V6, P166, DOI 10.1136/jmg.6.2.166; PARKER CE, 1972, LANCET, V1, P1073; PENROSE LS, 1960, LANCET, V2, P409; PRIEST JH, 1975, J MED GENET, V12, P378, DOI 10.1136/jmg.12.4.378; ROHDE RUSSELL A., 1965, J MED GENET, V2, P243, DOI 10.1136/jmg.2.4.243; SMITH KD, 1965, CYTOGENETICS, V4, P219, DOI 10.1159/000129858; SOUDEK D, 1973, ANN GENET-PARIS, V16, P101; TANGHERONI W, 1973, HUMANGENETIK, V18, P291, DOI 10.1007/BF00291125; TAYLOR KM, 1975, CLIN GENET, V8, P364; THERMAN E, 1974, AM J HUM GENET, V26, P83; WATSON EJ, 1974, J MED GENET, V11, P400, DOI 10.1136/jmg.11.4.400; WEBB GC, 1971, J MED GENET, V8, P522, DOI 10.1136/jmg.8.4.522; YANAGISAWA S, 1975, CLIN GENET, V7, P299	31	47	47	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1977	29	3					294	300						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DG794	868876				2022-12-18	WOS:A1977DG79400009
J	RINGELHANN, B; HATHORN, MKS; JILLY, P; GRANT, F; PARNICZKY, G				RINGELHANN, B; HATHORN, MKS; JILLY, P; GRANT, F; PARNICZKY, G			NEW LOOK AT PROTECTION OF HEMOGLOBIN-AS AND HEMOGLOBIN-AC GENOTYPES AGAINST PLASMODIUM-FALCIPARUM INFECTION - CENSUS TRACT APPROACH	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									GHANA ACAD SCI NATL INST HLTH & MED RES, ACCRA, GHANA; LONDON HOSP COLL, DEPT PHYSIOL, LONDON, ENGLAND; HOWARD UNIV, COLL MED, DEPT PATHOL, WASHINGTON, DC USA; MINIST HLTH, ACCRA, GHANA; UN CONFER TRADE & DEV, DEPT STATISTICS, GENEVA, SWITZERLAND	Howard University								ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; ALLISON AC, 1961, ANN NY ACAD SCI, V91, P710, DOI 10.1111/j.1749-6632.1961.tb31102.x; BIENZLE U, 1972, Z TROPENMED PARASIT, V23, P56; BOYO AE, 1972, AM J TROP MED HYG, V21, P863, DOI 10.4269/ajtmh.1972.21.863; COLBOURNE M J, 1954, J Trop Med Hyg, V57, P203; Deming E., 1960, SAMPLE DESIGN BUSINE; EDINGTON GM, 1957, BMJ-BRIT MED J, V2, P143, DOI 10.1136/bmj.2.5037.143; EDINGTON GM, 1965, ABNORMAL HAEMOGLOBIN, P393; FOY H, 1955, BMJ-BRIT MED J, V2, P1116, DOI 10.1136/bmj.2.4948.1116; GARLICK J. P., 1960, TRANS ROY SOC TROP MED AND HYG, V54, P146, DOI 10.1016/0035-9203(60)90051-1; GILLES HM, 1967, LANCET, V1, P138; Lambotte-Legrand J., 1958, Annales de la Societe Belge de Medecine Tropicale, V38, P45; LEHMANN H, 1956, BRIT MED J, V2, P333, DOI 10.1136/bmj.2.4988.333; LUZZATTO L, 1970, LANCET, V1, P319; McGregor I A, 1974, Trop Doct, V4, P104; MILTENYI K, 1967, REGISTERED BIRTHS DE; MOORE RA, 1954, BRIT MED J, V2, P630, DOI 10.1136/bmj.2.4888.630; MOTULSKY AG, 1964, AM J TROP MED HYG, V13, P147, DOI 10.4269/ajtmh.1964.13.147; MOTULSKY AG, 1966, AM J HUM GENET, V18, P514; RAPER AB, 1955, BRIT MED J, V1, P1186, DOI 10.1136/bmj.1.4923.1186; RINGELHANN B, 1968, Ghana Medical Journal, V7, P120; ROBERTS DF, 1960, ANN HUM GENET, V24, P375, DOI 10.1111/j.1469-1809.1960.tb01750.x; Rucknagel D. L., 1961, PROGR MED GENETICS, P158; THOMPSON GR, 1963, BMJ-BRIT MED J, P976, DOI 10.1136/bmj.2.5363.976; THOMPSON GR, 1962, BMJ-BRIT MED J, P682, DOI 10.1136/bmj.1.5279.682; TRENT R. D., 1965, Ghana Medical Journal, V4, P141; VANDEPITTE J, 1957, Ann Soc Belg Med Trop (1920), V37, P703; VANDEPITTE JM, 1955, ANN SOC BELG MED TR, V39, P711; WALTERS J. H., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P204, DOI 10.1016/0035-9203(56)90024-4; WENT LN, 1961, NATURE, V192, P382, DOI 10.1038/192382a0; 1968, WHO396 TECHN REP SER	31	47	50	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1976	28	3					270	279						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	BS306	773175				2022-12-18	WOS:A1976BS30600009
J	MORTON, NE; KLEIN, D; HUSSELS, IE; DODINVAL, P; TODOROV, A; LEW, R; YEE, S				MORTON, NE; KLEIN, D; HUSSELS, IE; DODINVAL, P; TODOROV, A; LEW, R; YEE, S			GENETIC STRUCTURE OF SWITZERLAND	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV HAWAII, POPULATION GENET LAB, HONOLULU, HI 96822 USA; UNIV GENEVA, HOP CANTONAL, INST GENET MED, GENEVA 8, SWITZERLAND; JOHNS HOPKINS UNIV, SCH MED, DIV MED GENET, BALTIMORE, MD 21205 USA; UNIV LIEGE, SERV GENET HUMAINE, LIEGE, BELGIUM; UNIV GENEVA, GENEVA, SWITZERLAND	University of Hawaii System; University of Geneva; Johns Hopkins University; University of Liege; University of Geneva								AMMANN F, 1962, J GENET HUM, V11, P221; AZEVEDO E, 1969, AM J HUM GENET, V21, P1; BARTELS ED, 1941, HEREDITY GRAVES DISE; BODMER WF, 1968, GENETICS, V59, P565; CAVALLISFORZA LL, 1969, COMPUTER APPLICATION; CROW JF, 1965, EUGEN QUART, V12, P199, DOI 10.1080/19485565.1965.9987630; Darwin G., 1875, J STAT SOC, V38, P153; DODINVAL P, 1962, J GENET HUM, V11, P1; DODINVAL P, IN PRESS; FRIEDLAENDER JS, 1971, P NATL ACAD SCI USA, V68, P704, DOI 10.1073/pnas.68.4.704; HANHART E., 1960, ARCH JULIUS KLAUS STIFT, V35, P1; HARPENDING H, 1971, AM J HUM GENET, V23, P536; HUSSELS I, 1969, HUM BIOL, V41, P469; HUSSELS IE, IN PRESS; IMAIZUMI Y, 1970, GENETICS, V66, P569; IMAIZUMI Y, 1970, ARCHAEOLOGY PHYSICAL, V5, P218; KIMURA M, 1964, GENETICS, V49, P561; MALECOT G, 1969, Annales de Genetique et de Selection Animale, V1, P237, DOI 10.1186/1297-9686-1-3-237; MALECOT G, 1972, Annales de Genetique et de Selection Animale, V4, P385, DOI 10.1186/1297-9686-4-3-385; Malecot G, 1948, MATH HEREDITE; MALECOT G, 1950, ANN U LYON SCIENCE A, V13, P37; MORONI A, 1964, ATTI ASSOC GENET IT, V9, P207; MORTON N E, 1971, Theoretical Population Biology, V2, P507, DOI 10.1016/0040-5809(71)90038-4; MORTON NE, 1970, HUM BIOL, V42, P65; MORTON NE, 1971, AM J HUM GENET, V23, P339; MORTON NE, 1968, AM J HUM GENET, V20, P411; MORTON NE, 1971, AM J HUM GENET, V23, P538; MORTON NE, 1971, AM J HUM GENET, V23, P350; MORTON NE, 1968, AM J HUM GENET, V20, P420; MORTON NE, 1969, COMPUTER APPLICATION; MORTON NE, IN PRESS; ROSIN S, 1956, ARCH KLAUSSTIFT VERE, V31, P1; Sutter J, 1955, POPULATION, V10, P645, DOI 10.2307/1525257; TODOROV A, 1970, J GENET HUM, V18, P387; TWIESSELMANN F, 1962, POPULATION, V17, P241, DOI 10.2307/1527067; YASUDA N, 1967, 3RD P INT C HUM GEN, P249; ZURBRIGGEN J, 1961, FAMILIENSTATISTIK SA; 1920, EIDGENOSSISCHE VOLKS, V1; 1925, SCHWEIZERISCHE STATI, V6, P148	39	47	47	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1973	25	4					347	361						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q0158	4716654				2022-12-18	WOS:A1973Q015800001
J	WEITKAMP, LR; GUTTORMSEN, SA; GREENDYKE, RM				WEITKAMP, LR; GUTTORMSEN, SA; GREENDYKE, RM			GENETIC LINKAGE BETWEEN A LOCUS FOR 6-PGD AND RH LOCUS - EVALUATION OF POSSIBLE HETEROGENEITY IN RECOMBINATION FRACTION BETWEEN SEXES AND AMONG FAMILIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BANNERMAN RM, 1962, ANN HUM GENET, V26, P23, DOI 10.1111/j.1469-1809.1962.tb01306.x; BROWNE WG, 1969, ANN HUM GENET, V32, P271, DOI 10.1111/j.1469-1809.1969.tb00076.x; CARTER TC, 1951, J GENET, V50, P307, DOI 10.1007/BF02996226; COOK PJL, 1965, ANN HUM GENET, V28, P393; DUNN LC, 1967, GENET RES, V9, P211, DOI 10.1017/S0016672300010491; GEERDINK RA, 1967, ANN HUM GENET, V30, P363, DOI 10.1111/j.1469-1809.1967.tb00038.x; Giblett ER., 1969, GENETIC MARKERS HUMA; HALDANE JBS, 1947, ANN EUGENIC, V14, P10, DOI 10.1111/j.1469-1809.1947.tb02374.x; MORTON NE, 1956, AM J HUM GENET, V8, P80; MORTON NE, 1955, AM J HUM GENET, V7, P277; RAPLEY S, 1967, ANN HUM GENET, V31, P237; RENWICK JH, 1964, AM J HUM GENET, V16, P410; RENWICK JH, 1969, BRIT MED BULL, V25, P65, DOI 10.1093/oxfordjournals.bmb.a070673; RENWICK JH, 1965, ANN HUM GENET, V28, P379, DOI 10.1111/j.1469-1809.1965.tb00493.x; RENWICK JH, 1968, EUROPEAN SOCIETY HUM, V2, P7; RITTER H, 1969, HUMANGENETIK, V7, P1, DOI 10.1007/BF00278686; ROBSON EB, 1966, ANN HUM GENET, V29, P325, DOI 10.1111/j.1469-1809.1966.tb00528.x; SCHLEUTERMANN DA, 1969, AM J HUM GENET, V21, P606; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; SMITH CAB, 1959, AM J HUM GENET, V11, P289; TUCHINDA S, 1968, BIOCHEM GENET, V2, P253, DOI 10.1007/BF01474765; WEITKAMP L, 1970, American Journal of Human Genetics, V22, p57A; WEITKAMP LR, 1969, AM J HUM GENET, V21, P600; WEITKAMP LR, 1970, AM J HUM GENET, V22, P216; WEITKAMP LR, 1969, ANN HUM GENET, V33, P53, DOI 10.1111/j.1469-1809.1969.tb01629.x; WEITKAMP LR, 1970, CLIN RES, V18, P396	26	47	47	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1971	23	5					462	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	K4744	4999137				2022-12-18	WOS:A1971K474400004
J	SCHROEDER, WA; HUISMAN, THJ; SHELTON, JR; SHELTON, JB; APELL, G; BOUVER, N				SCHROEDER, WA; HUISMAN, THJ; SHELTON, JR; SHELTON, JB; APELL, G; BOUVER, N			HETEROGENEITY OF FETAL HEMOGLOBIN IN BETA-THALASSEMIA OF NEGRO	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BETKE K, 1959, NATURE, V184, P1877, DOI 10.1038/1841877a0; DOZY AM, 1968, J CHROMATOGR, V32, P723, DOI 10.1016/S0021-9673(01)80551-3; FESSAS P, 1968, 12 C INT SOC HEM NEW, P52; HELLER P, 1966, ANN INTERN MED, V64, P52, DOI 10.7326/0003-4819-64-1-52; HUISMAN THJ, 1965, J CHROMATOGR, V19, P160, DOI 10.1016/S0021-9673(01)99434-8; HUISMAN THJ, 1963, ADV CLIN CHEM, V6, P231, DOI 10.1016/S0065-2423(08)60240-1; HUISMAN THJ, 1969, ANN NY ACAD SCI, V165, P320, DOI 10.1111/j.1749-6632.1969.tb27802.x; HUISMAN THJ, 1970, J CLIN INVEST, V49, P1035, DOI 10.1172/JCI106303; MOTULSKY AG, 1964, COLD SPRING HARB SYM, V29, P399, DOI 10.1101/SQB.1964.029.01.042; SCHOKKER RC, 1966, NATURE, V209, P44, DOI 10.1038/209044a0; SCHROEDER WA, 1970, ANAL BIOCHEM, V35, P235, DOI 10.1016/0003-2697(70)90030-8; SCHROEDER WA, 1968, P NATL ACAD SCI USA, V60, P537, DOI 10.1073/pnas.60.2.537; SCHROEDER WA, 1969, 17 COLL PROT BIOL FL; SMITHIES O, 1964, COLD SPRING HARB SYM, V29, P309, DOI 10.1101/SQB.1964.029.01.033; WEATHERALL D J, 1967, Seminars in Hematology, V4, P72; WEATHERALL DJ, 1969, BRIT MED BULL, V25, P24, DOI 10.1093/oxfordjournals.bmb.a070665; WEATHERALL DJ, 1965, THALASSAEMIA SYNDROM; WINTROBE MM, 1962, CLINICAL HEMATOLOGY	18	47	47	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1970	22	5					505	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	H6097	5516235				2022-12-18	WOS:A1970H609700002
J	UCHIDA, IA; RAY, M; MCRAE, KN; BESANT, DF				UCHIDA, IA; RAY, M; MCRAE, KN; BESANT, DF			FAMILIAL OCCURRENCE OF TRISOMY 22	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BACK F, 1967, LANCET, V1, P1228; BROWN WMC, 1965, LANCET, V2, P561; BROWN WMC, 1966, CHROMOSOME STUDIES A; CRAWFURD MD, 1965, ANN HUM GENET, V29, P199, DOI 10.1111/j.1469-1809.1965.tb00514.x; DE LA CHAPELLE A., 1963, CYTOGENETICS [BASEL], V2, P129, DOI 10.1159/000129774; ELLIS JR, 1963, ANN HUM GENET, V26, P287, DOI 10.1111/j.1469-1809.1963.tb01985.x; FERGUSON J, 1963, MED J AUSTRALIA, V1, P546, DOI 10.5694/j.1326-5377.1963.tb23263.x; FRACCARO M, 1967, MONGOLISM, P62; GIORGI PL, 1967, HELV PAEDIATR ACTA, V22, P28; GUSTAVSON K. -H., 1962, CYTOGENETICS, V1, P32, DOI 10.1159/000129711; HECHT F, 1967, LANCET, V2, P467; ISHMAEL J, 1965, J Med Genet, V2, P136, DOI 10.1136/jmg.2.2.136; KOULISCHER L, 1962, Bull Acad R Med Belg, V2, P329; MCKENZIE J, 1966, DEV MED CHILD NEUROL, V8, P55; MOSS MH, 1964, AM J DIS CHILD, V107, P304, DOI 10.1001/archpedi.1964.02080060306016; ROTHFELS KH, 1958, STAIN TECHNOL, V33, P73, DOI 10.3109/10520295809111827; SCHACHENMANN G, 1965, LANCET, V2, P290; SCHMID W., 1963, CYTOGENETICS [BASEL], V2, P175, DOI 10.1159/000129778; SCHMID W., 1962, CYTOGENETICS, V1, P199, DOI 10.1159/000129729; THERKELSEN AJ, 1964, CYTOGENETICS, V3, P441, DOI 10.1159/000129832; YUNIS JJ, 1965, AM J HUM GENET, V17, P191	21	47	47	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1968	20	2					107	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	B2183	5643178				2022-12-18	WOS:A1968B218300003
J	BARRAI, I; MI, MP; MORTON, NE; YASUDA, N				BARRAI, I; MI, MP; MORTON, NE; YASUDA, N			ESTIMATION OF PREVALENCE UNDER INCOMPLETE SELECTION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BURDETTE WJ, 1962, METHODOLOGY HUMAN ED, P17; BURDETTE WJ, 1962, HUMAN GENETICS, P3; CHUNG CS, 1959, ANN HUM GENET, V23, P357, DOI 10.1111/j.1469-1809.1959.tb01479.x; CHUNG CS, 1960, AM J HUM GENET, V13, P9; CHUNG CS, 1960, JPN J HUM GENET, V5, P124; DAHLBERG G, 1948, MATHEMATICAL METHODS; DEWEY WJ, 1965, AM J HUM GENET, V17, P237; Fisher RA, 1941, ANN EUGENIC, V11, P182, DOI 10.1111/j.1469-1809.1941.tb02284.x; FURUSHO T, 1957, JPN J HUM GENET, V2, P35; GITTELSOHN AM, 1960, AM J HUM GENET, V12, P425; Greenwood M, 1920, J ROY STATIST SOC  A, V83, P255; JAMES WH, 1963, AM J HUM GENET, V15, P223; KENDALL MG, 1958, ADVANCED THEORY STAT; KIMURA M, 1958, JPN J HUM GENET, V3, P51; Kiser CV, 1944, MILBANK MEML FUND Q, V22, P72, DOI 10.2307/3348215; KOJIMA KI, 1962, AM NAT, V96, P329, DOI 10.1086/282242; LILIENFELD AM, 1962, HUMAN GENETICS, P3; MACKLIN MT, 1960, AM J HUM GENET, V12, P1; MORTON NE, 1960, AM J HUM GENET, V12, P348; MORTON NE, 1959, AM J HUM GENET, V11, P1; MORTON NE, 1959, AM J HUM GENET, V11, P360; MORTON NE, 1962, AM J HUM GENET, V14, P170; MORTON NE, 1964, 11 P INT C GEN HAG, P935; MORTON NE, 1962, METHODOLOGY HUMAN GE, P17; NEI M, 1963, AM J HUM GENET, V15, P86; RAINER JD, 1963, DEAF POPULATION, P28; SANK D, 1963, DEAF POPULATION, P28; SMITH CAB, 1957, ANN HUM GENET, V21, P254, DOI 10.1111/j.1469-1809.1972.tb00287.x	28	47	47	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1965	17	3					221	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	65219	14295492				2022-12-18	WOS:A19656521900004
J	ROBERTS, DF				ROBERTS, DF			DYNAMICS OF RACIAL INTERMIXTURE IN THE AMERICAN NEGRO - SOME ANTHROPOLOGICAL CONSIDERATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALLEN FH, 1951, NATURE, V167, P482, DOI 10.1038/167482b0; Armattoe REG, 1951, AM J PHYS ANTHROP-NE, V9, P371, DOI 10.1002/ajpa.1330090313; ARMATTOE R. E. G., 1953, WEST AFRICAN MED JOUR, V2, P89; BARNICOT NA, 1950, ANN EUGENIC, V15, P248; CHALMERS JNM, 1953, ANN EUGENIC, V17, P168; GLASS B, 1953, AM J HUM GENET, V5, P1; HERSKOVITS M, 1930, COLUMBIA U CONTR ANT, P11; HERSKOVITS MJ, 1933, SOCIAL FORCES, V12, P252; HERSKOWITS MJ, 1928, AM NEGRO STUDY RACIA; HERSKOWITS MJ, 1942, MYTH NEGRO PAST; IKIN E. W., 1952, MAN, V52, P21; LAMBOTTE-LEGRAND J, 1950, Ann Soc Belg Med Trop (1920), V30, P547; LEE B. F., 1934, OHIO JOUR SCI, V34, P337; Meier A, 1949, AM J PHYS ANTHROP-NE, V7, P227, DOI 10.1002/ajpa.1330070206; Miller EB, 1951, AM J PHYS ANTHROP-NE, V9, P115, DOI 10.1002/ajpa.1330090202; Moore RE, 1955, AM J PHYS ANTHROP-NE, V13, P121, DOI 10.1002/ajpa.1330130109; Mourant A., 1954, DISTRIBUTION HUMAN B; NEEL JV, 1951, GENETICS, V36, P84; ROSENFIELD RE, 1953, AM J CLIN PATHOL, V23, P1222; SNYDER LAURENCE H., 1932, OHIO JOUR SCI, V32, P436; STERN C, 1953, Acta Genet Stat Med, V4, P281; UNGER LJ, 1946, AM J CLIN PATHOL, V16, P498, DOI 10.1093/ajcp/16.8.498; WIENER A S, 1953, Acta Genet Med Gemellol (Roma), V2, P391; WIENER AS, 1945, AM J CLIN PATHOL, V15, P106	24	47	48	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1955	7	4					361	367						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA213	13275459				2022-12-18	WOS:A1955WA21300002
J	Fang, HY; Hui, Q; Lynch, J; Honerlaw, J; Assimes, TL; Huang, J; Vujkovic, M; Damrauer, SM; Pyarajan, S; Gaziano, JM; DuVall, SL; O'Donnell, CJ; Cho, K; Chang, KM; Wilson, PWF; Tsao, PS; Sun, YV; Tang, H				Fang, Huaying; Hui, Qin; Lynch, Julie; Honerlaw, Jacqueline; Assimes, Themistocles L.; Huang, Jie; Vujkovic, Marijana; Damrauer, Scott M.; Pyarajan, Saiju; Gaziano, J. Michael; DuVall, Scott L.; O'Donnell, Christopher J.; Cho, Kelly; Chang, Kyong-Mi; Wilson, Peter W. F.; Tsao, Philip S.; Sun, Yan V.; Tang, Hua		VA Million Vet Program	Harmonizing Genetic Ancestry and Self-identified Race/Ethnicity in Genome-wide Association Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POPULATION-STRUCTURE; AFRICAN-AMERICANS; HEALTH; STRATIFICATION; COMPONENTS; INFERENCE; GENOTYPE; RESOURCE; BIOBANK; MODEL	Large-scale multi-ethnic cohorts offer unprecedented opportunities to elucidate the genetic factors influencing complex traits related to health and disease among minority populations. At the same time, the genetic diversity in these cohorts presents new challenges for analysis and interpretation. We consider the utility of race and/or ethnicity categories in genome-wide association studies (GWASs) of multi-ethnic cohorts. We demonstrate that race/ethnicity information enhances the ability to understand population-specific genetic architecture. To address the practical issue that self-identified racial/ethnic information may be incomplete, we propose a machine learning algorithm that produces a surrogate variable, termed HARE. We use height as a model trait to demonstrate the utility of HARE and ethnicity-specific GWASs.	[Fang, Huaying; Tang, Hua] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Fang, Huaying; Assimes, Themistocles L.; Tsao, Philip S.; Tang, Hua] VA Palo Alto Hlth Care Syst, VA Palo Alto Epidemiol Res & Informat Ctr Genom, Palo Alto, CA 94304 USA; [Hui, Qin; Sun, Yan V.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Hui, Qin; Wilson, Peter W. F.; Sun, Yan V.] Atlanta VA Med Ctr, Atlanta, GA 30033 USA; [Lynch, Julie] Edith Norse Rogers Mem VA Med Ctr, Bedford, MA 01730 USA; [Lynch, Julie] Univ Massachusetts, Coll Nursing & Hlth Sci, Boston, MA 02125 USA; [Honerlaw, Jacqueline; Huang, Jie; Pyarajan, Saiju; Gaziano, J. Michael; O'Donnell, Christopher J.; Cho, Kelly] VA Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr MA, Boston, MA 02130 USA; [Assimes, Themistocles L.; Tsao, Philip S.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Huang, Jie; O'Donnell, Christopher J.] Harvard Med Sch, Cardiovasc Med Div, Dept Med, Boston, MA 02115 USA; [Vujkovic, Marijana; Damrauer, Scott M.; Chang, Kyong-Mi] Corporal Michael J Crescenz VA Med Ctr, Philadelphia, PA 19104 USA; [Vujkovic, Marijana] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA; [Damrauer, Scott M.] Univ Penn, Dept Surg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Pyarajan, Saiju; Gaziano, J. Michael; Cho, Kelly] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Pyarajan, Saiju; Gaziano, J. Michael; Cho, Kelly] Harvard Med Sch, Boston, MA 02115 USA; [Lynch, Julie; DuVall, Scott L.] VA Salt Lake City Hlth Care Syst, VA Informat & Comp Infrastruct, Salt Lake City, UT 84148 USA; [DuVall, Scott L.] Univ Utah, Sch Med, Salt Lake City, UT 84132 USA; [Chang, Kyong-Mi] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Wilson, Peter W. F.] Emory Univ, Sch Med, Dept Med, Atlanta, GA 30322 USA; [Sun, Yan V.] Emory Univ, Sch Med, Dept Biomed Informat, Atlanta, GA 30322 USA; [Huang, Jie] Peking Univ, Sch Publ Hlth, Dept Global Hlth, Beijing 100191, Peoples R China	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Emory University; Rollins School Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; University of Massachusetts System; University of Massachusetts Boston; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Stanford University; Harvard University; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; University of Pennsylvania; Pennsylvania Medicine; Emory University; Emory University; Peking University	Tang, H (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.; Tang, H (corresponding author), VA Palo Alto Hlth Care Syst, VA Palo Alto Epidemiol Res & Informat Ctr Genom, Palo Alto, CA 94304 USA.; Sun, YV (corresponding author), Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.; Sun, YV (corresponding author), Atlanta VA Med Ctr, Atlanta, GA 30033 USA.; Sun, YV (corresponding author), Emory Univ, Sch Med, Dept Biomed Informat, Atlanta, GA 30322 USA.	yvsun@emory.edu; huatang@stanford.edu	Vujković, Marijana/S-9414-2019; Assimes, Themistocles Leonard/D-9696-2015	Vujković, Marijana/0000-0003-4924-5714; Assimes, Themistocles Leonard/0000-0003-2349-0009; Chang, Kyong-Mi/0000-0001-6811-9364; Hauser, Elizabeth/0000-0003-0367-9189; Fang, Huaying/0000-0002-7693-8260; Whittle, Jeff/0000-0002-9544-838X; DuVall, Scott/0000-0002-4898-3865; Ballas, Zuhair/0000-0001-5569-1230; Knaack, Aaron/0000-0001-7712-1415	Department of Veterans Affairs Office of Research and Development, Million Veteran Program [I01-BX003362, I01-BX003340, I01-BX002641]; US National Institutes of Health [R01 GM073059, R35 GM127063, R01 NR013520]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073059, R35GM127063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR013520] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003340, I01BX003362, I01BX002641] Funding Source: NIH RePORTER	Department of Veterans Affairs Office of Research and Development, Million Veteran Program(US Department of Veterans Affairs); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); Veterans Affairs(US Department of Veterans Affairs)	This research is supported by funding from the Department of Veterans Affairs Office of Research and Development, Million Veteran Program Grant I01-BX003362 (PIs P.S.T. and K.-M.C.), I01-BX003340 (PIs P.W.F.W. and K.C.), and I01-BX002641 (PI P.S.T.). Additionally, H.F. and H.T. are supported by US National Institutes of Health grants R01 GM073059 and R35 GM127063 and Y.V.S. is supported by R01 NR013520. This publication does not represent the views of the Department of Veterans Affairs or the United States Government. A list of MVP investigators can be found in Supplemental Acknowledgments.	Abraham G, 2017, BIOINFORMATICS, V33, P2776, DOI 10.1093/bioinformatics/btx299; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Banda Y, 2015, GENETICS, V200, P1285, DOI 10.1534/genetics.115.178616; Bryc K, 2015, AM J HUM GENET, V96, P37, DOI 10.1016/j.ajhg.2014.11.010; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Canela-Xandri O, 2018, NAT GENET, V50, P1593, DOI 10.1038/s41588-018-0248-z; Carty CL, 2012, HUM MOL GENET, V21, P711, DOI 10.1093/hmg/ddr489; Conomos MP, 2016, AM J HUM GENET, V98, P165, DOI 10.1016/j.ajhg.2015.12.001; Conomos MP, 2015, GENET EPIDEMIOL, V39, P276, DOI 10.1002/gepi.21896; Coram MA, 2017, AM J HUM GENET, V101, P218, DOI 10.1016/j.ajhg.2017.06.015; Coram MA, 2013, AM J HUM GENET, V92, P904, DOI 10.1016/j.ajhg.2013.04.025; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Gaziano JM, 2016, J CLIN EPIDEMIOL, V70, P214, DOI 10.1016/j.jclinepi.2015.09.016; Grinde KE, 2019, GENET EPIDEMIOL, V43, P50, DOI 10.1002/gepi.22166; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Klarin D, 2018, NAT GENET, V50, P1514, DOI 10.1038/s41588-018-0222-9; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Liu MY, 2014, SCI REP-UK, V4, DOI 10.1038/srep04383; Morris AP, 2011, GENET EPIDEMIOL, V35, P809, DOI 10.1002/gepi.20630; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Risch N, 2002, GENOME BIOL, V3, DOI [10.1186/GB-2002-3-7-COMMENT2007, DOI 10.1186/GB-2002-3-7-C0MMENT2007, 10.1186/gb-2002-3-7-comment2007]; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Scutari M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006288; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; van Rooij FJA, 2017, AM J HUM GENET, V100, P51, DOI 10.1016/j.ajhg.2016.11.016; Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108; Wu TF, 2004, J MACH LEARN RES, V5, P975; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	34	46	46	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 3	2019	105	4					763	772		10.1016/j.ajhg.2019.08.012	http://dx.doi.org/10.1016/j.ajhg.2019.08.012			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC0EX	31564439	Green Published, Bronze			2022-12-18	WOS:000488953400007
J	Carvill, GL; Engel, KL; Ramamurthy, A; Cochran, JN; Roovers, J; Stamberger, H; Lim, N; Schneider, AL; Hollingsworth, G; Holder, DH; Regan, BM; Lawlor, J; Lagae, L; Ceulemans, B; Bebin, EM; Nguyen, J; Barsh, GS; Weckhuysen, S; Meisler, M; Berkovic, SE; De Jonghe, P; Scheffer, IE; Myers, RM; Cooper, GM; Mefford, HC				Carvill, Gemma L.; Engel, Krysta L.; Ramamurthy, Aishwarya; Cochran, J. Nicholas; Roovers, Jolien; Stamberger, Hannah; Lim, Nicholas; Schneider, Amy L.; Hollingsworth, Georgie; Holder, Dylan H.; Regan, Brigid M.; Lawlor, James; Lagae, Lieven; Ceulemans, Berten; Bebin, E. Martina; Nguyen, John; Barsh, Gregory S.; Weckhuysen, Sarah; Meisler, Miriam; Berkovic, Samuel E.; De Jonghe, Peter; Scheffer, Ingrid E.; Myers, Richard M.; Cooper, Gregory M.; Mefford, Heather C.		EuroEPINOMICS Rare Epilepsy Syndro	Aberrant Inclusion of a Poison Exon Causes Dravet Syndrome and Related SCN1A-Associated Genetic Epilepsies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DE-NOVO MUTATIONS; NEURONAL SODIUM-CHANNEL; SPLICE VARIANTS; SCN1A; PROTEIN; REGULATOR; BRAIN	Developmental and epileptic encephalopathies (DEEs) are a group of severe epilepsies characterized by refractory seizures and developmental impairment. Sequencing approaches have identified causal genetic variants in only about 50% of individuals with DEEs.(1-3) This suggests that unknown genetic etiologies exist, potentially in the similar to 98% of human genomes not covered by exome sequencing (ES). Here we describe seven likely pathogenic variants in regions outside of the annotated coding exons of the most frequently implicated epilepsy gene, SCN1A, encoding the alpha-1 sodium channel subunit. We provide evidence that five of these variants promote inclusion of a "poison" exon that leads to reduced amounts of full-length SCN1A protein. This mechanism is likely to be broadly relevant to human disease; transcriptome studies have revealed hundreds of poison exons,(4,5) including some present within genes encoding other sodium channels and in genes involved in neurodevelopment more broadly.(6) Future research on the mechanisms that govern neuronal-specific splicing behavior might allow researchers to co-opt this system for RNA therapeutics.	[Carvill, Gemma L.; Ramamurthy, Aishwarya] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60610 USA; [Engel, Krysta L.; Cochran, J. Nicholas; Holder, Dylan H.; Lawlor, James; Barsh, Gregory S.; Myers, Richard M.; Cooper, Gregory M.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Engel, Krysta L.] Univ Colorado, Anschutz Sch Med, Dept Biochem & Mol Genet, Denver, CO 80204 USA; [Roovers, Jolien; Stamberger, Hannah; Weckhuysen, Sarah; De Jonghe, Peter] Univ Antwerp, Inst Born Bunge, Lab Neurogenet, B-2610 Antwerp, Belgium; [Roovers, Jolien; Stamberger, Hannah; Weckhuysen, Sarah; De Jonghe, Peter] VIB, Ctr Mol Neurol, Neurogenet Grp, B-2610 Antwerp, Belgium; [Roovers, Jolien; Stamberger, Hannah; Weckhuysen, Sarah; De Jonghe, Peter; Scheffer, Ingrid E.] Univ Hosp Antwerp, Dept Neurol, B-2610 Antwerp, Belgium; [Lim, Nicholas; Nguyen, John; Mefford, Heather C.] Univ Washington, Dept Pediat, Div Genet Med, Seattle, WA 98195 USA; [Schneider, Amy L.; Hollingsworth, Georgie; Regan, Brigid M.; Berkovic, Samuel E.] Univ Melbourne, Epilepsy Res Ctr, Dept Med, Austin Hlth, Heidelberg, Vic 3084, Australia; [Lagae, Lieven] Univ Hosp KU Leuven, Dept Dev & Regenerat, Sect Pediat Neurol, B-3000 Leuven, Belgium; [Ceulemans, Berten] Univ Antwerp, Dept Pediat Neurol, B-2610 Antwerp, Belgium; [Ceulemans, Berten] Univ Hosp Antwerp, B-2610 Antwerp, Belgium; [Bebin, E. Martina] Univ Alabama Birmingham, Birmingham, AL 35294 USA; [Meisler, Miriam] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Scheffer, Ingrid E.] Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Florey Inst, Melbourne, Vic 3084, Australia	Northwestern University; Feinberg School of Medicine; HudsonAlpha Institute for Biotechnology; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Antwerp; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Washington; University of Washington Seattle; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; KU Leuven; University Hospital Leuven; University of Antwerp; University of Antwerp; University of Alabama System; University of Alabama Birmingham; University of Michigan System; University of Michigan; Florey Institute of Neuroscience & Mental Health; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne	Cooper, GM (corresponding author), HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA.; Mefford, HC (corresponding author), Univ Washington, Dept Pediat, Div Genet Med, Seattle, WA 98195 USA.	gcooper@hudsonalpha.org; hmefford@uw.edu	Stamberger, Hannah/ABD-1814-2020; Scheffer, Ingrid E/G-1668-2013; jiang, yu/HGU-0029-2022; Marini, Carla/AAC-2413-2022; Craiu, Dana/ABE-4886-2020; Weckhuysen, Sarah/HGB-9957-2022; Cooper, Gregory/D-6914-2011	Scheffer, Ingrid E/0000-0002-2311-2174; Marini, Carla/0000-0002-9212-2691; Weckhuysen, Sarah/0000-0003-2878-1147; Depienne, Christel/0000-0002-7212-9554; Berkovic, Samuel/0000-0003-4580-841X; Guerrini, Renzo/0000-0002-7272-7079; Lawlor, James/0000-0003-1735-1766; Selmer, Kaja Kristine/0000-0003-4871-112X; Moller, Rikke S./0000-0002-9664-1448; Cooper, Gregory/0000-0001-5509-9923; Ceulemans, Berten/0000-0001-7818-0679; Stamberger, Hannah/0000-0001-8308-9511	NIH [NINDS R01 NS069605]; American Epilepsy Society; Epilepsy Foundation; National Health and Medical Research Council of Australia; National Human Genome Research Institute [UM1HG007301]; National Cancer Institute [R01CA197139]; NIH (NINDS) [R01 NS069605]; NATIONAL CANCER INSTITUTE [R01CA197139] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069605, R00NS089858] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Epilepsy Society; Epilepsy Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the affected individuals and their families for participating in our research programs. G.L.C. is supported by the NIH (NINDS R00 NS089858) and the Junior Investigator Kevin's Fellows Award sponsored by the American Epilepsy Society and the Epilepsy Foundation. H.C.M. is supported by the NIH (NINDS R01 NS069605). I.E.S. and S.F.B. are supported by funding from the National Health and Medical Research Council of Australia. Work by authors at HudsonAlpha was supported by grants from the National Human Genome Research Institute (UM1HG007301) and National Cancer Institute (R01CA197139).	Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Bowling KM, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0433-1; Buratti E, 2007, NUCLEIC ACIDS RES, V35, P4359, DOI 10.1093/nar/gkm444; Carvill GL, 2014, NEUROLOGY, V82, P1245, DOI 10.1212/WNL.0000000000000291; Carvill GL, 2013, NAT GENET, V45, P825, DOI 10.1038/ng.2646; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Gazina EV, 2010, NEUROSCIENCE, V166, P195, DOI 10.1016/j.neuroscience.2009.12.011; Gehman LT, 2012, GENE DEV, V26, P445, DOI 10.1101/gad.182477.111; Gokben S, 2017, ACTA NEUROL BELG, V117, P131, DOI 10.1007/s13760-016-0709-z; Han JH, 2011, MOL CELL BIOL, V31, P793, DOI 10.1128/MCB.01117-10; Howell KB, 2018, EPILEPSIA, V59, P1177, DOI 10.1111/epi.14087; Ibrahim EC, 2005, P NATL ACAD SCI USA, V102, P5002, DOI 10.1073/pnas.0500543102; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kumakura A, 2009, BRAIN DEV-JPN, V31, P179, DOI 10.1016/j.braindev.2008.06.001; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Linares AJ, 2015, ELIFE, V4, DOI 10.7554/eLife.09268; Martin MS, 2007, GENOMICS, V90, P225, DOI 10.1016/j.ygeno.2007.04.006; Meisler MH, 2005, J CLIN INVEST, V115, P2010, DOI 10.1172/JCI25466; Meisler MH, 2010, J PHYSIOL-LONDON, V588, P1841, DOI 10.1113/jphysiol.2010.188482; Meng H, 2015, HUM MUTAT, V36, P573, DOI 10.1002/humu.22782; Nakayama T, 2010, HUM MUTAT, V31, P820, DOI 10.1002/humu.21275; O'Brien JE, 2012, MOL CELL NEUROSCI, V49, P120, DOI 10.1016/j.mcn.2011.10.005; Oh Y, 1998, NEUROREPORT, V9, P1267, DOI 10.1097/00001756-199805110-00002; Plummer NW, 1997, J BIOL CHEM, V272, P24008, DOI 10.1074/jbc.272.38.24008; Scheffer IE, 1997, BRAIN, V120, P479, DOI 10.1093/brain/120.3.479; Suls A, 2010, NEUROLOGY, V75, P72, DOI 10.1212/WNL.0b013e3181e62088; Villate O, 2014, NUCLEIC ACIDS RES, V42, P11818, DOI 10.1093/nar/gku861; Yan QH, 2015, P NATL ACAD SCI USA, V112, P3445, DOI 10.1073/pnas.1502849112; Yu MJ, 2010, SEIZURE-EUR J EPILEP, V19, P443, DOI 10.1016/j.seizure.2010.06.010; Zhang Q, 2017, CLIN GENET, V91, P717, DOI 10.1111/cge.12901; Zhang XC, 2016, CELL, V166, P1147, DOI 10.1016/j.cell.2016.07.025; Zhang YH, 2017, NEUROLOGY, V89, P1210, DOI 10.1212/WNL.0000000000004384; Zubovic L, 2012, NUCLEIC ACIDS RES, V40, P6255, DOI 10.1093/nar/gks249	36	46	51	2	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 6	2018	103	6					1022	1029		10.1016/j.ajhg.2018.10.023	http://dx.doi.org/10.1016/j.ajhg.2018.10.023			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HD4YX	30526861	Green Accepted, Bronze, Green Published			2022-12-18	WOS:000452535600015
J	Boyden, LM; Vincent, NG; Zhou, J; Hu, RH; Craiglow, BG; Bayliss, SJ; Rosman, IS; Lucky, AW; Diaz, LA; Goldsmith, LA; Paller, AS; Lifton, RP; Baserga, SJ; Choate, KA				Boyden, Lynn M.; Vincent, Nicholas G.; Zhou, Jing; Hu, Ronghua; Craiglow, Brittany G.; Bayliss, Susan J.; Rosman, Ilana S.; Lucky, Anne W.; Diaz, Luis A.; Goldsmith, Lowell A.; Paller, Amy S.; Lifton, Richard P.; Baserga, Susan J.; Choate, Keith A.			Mutations in KDSR Cause Recessive Progressive Symmetric Erythrokeratoderma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACTIVE-SITE; CERAMIDE; YEAST; GENE; EXPRESSION; FEATURES; VECTORS	The discovery of new genetic determinants of inherited skin disorders has been instrumental to the understanding of epidermal function, differentiation, and renewal. Here, we show that mutations in KDSR (3-ketodihydrosphingosine reductase), encoding an enzyme in the ceramide synthesis pathway, lead to a previously undescribed recessive Mendelian disorder in the progressive symmetric erythrokeratoderma spectrum. This disorder is characterized by severe lesions of thick scaly skin on the face and genitals and thickened, red, and scaly skin on the hands and feet. Although exome sequencing revealed several of the KDSR mutations, we employed genome sequencing to discover a pathogenic 346 kb inversion in multiple probands, and cDNA sequencing and a splicing assay established that two mutations, including a recurrent silent third base change, cause exon skipping. Immunohistochemistry and yeast complementation studies demonstrated that the mutations cause defects in KDSR function. Systemic isotretinoin therapy has achieved nearly complete resolution in the two probands in whom it has been applied, consistent with the effects of retinoic acid on alternative pathways for ceramide generation.	[Boyden, Lynn M.; Lifton, Richard P.; Baserga, Susan J.; Choate, Keith A.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Vincent, Nicholas G.] Yale Univ, Sch Med, Dept Microbiol, New Haven, CT 06510 USA; [Zhou, Jing; Hu, Ronghua; Craiglow, Brittany G.; Choate, Keith A.] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Bayliss, Susan J.; Rosman, Ilana S.] Washington Univ, Sch Med, Div Dermatol, St Louis, MO 63110 USA; [Lucky, Anne W.] Dermatologists Southwest Ohio, Cincinnati, OH 45247 USA; [Diaz, Luis A.; Goldsmith, Lowell A.] Univ N Carolina, Sch Med, Dept Dermatol, Chapel Hill, NC 27516 USA; [Paller, Amy S.] Northwestern Univ, Dept Dermatol, Feinberg Sch Med, Chicago, IL 60611 USA; [Baserga, Susan J.] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA; [Baserga, Susan J.] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [Choate, Keith A.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Washington University (WUSTL); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Northwestern University; Feinberg School of Medicine; Yale University; Yale University; Yale University	Choate, KA (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.; Choate, KA (corresponding author), Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA.; Choate, KA (corresponding author), Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA.	keith.choate@yale.edu	Lucky, Anne W/ABH-1415-2021; Wang, Guilin/G-8794-2018	Rosman, Ilana/0000-0001-5842-5691	Clinician Scientist Development Award from the Doris Duke Charitable Foundation; Foundation for Ichthyosis and Related Skin Types; National Institutes of Health [R01 AR068392, R01 GM115710]; National Institutes of Health (Yale Center for Mendelian Genomics) [U54 HG006504]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR068392, R01AR032599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115710, T32GM007223] Funding Source: NIH RePORTER	Clinician Scientist Development Award from the Doris Duke Charitable Foundation; Foundation for Ichthyosis and Related Skin Types; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (Yale Center for Mendelian Genomics); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the study subjects, their families, and the health-care professionals whose participation made this work possible. We also thank Erin Loring, Carol Nelson-Williams, Irina Tikhonova, Christopher Castaldi, Kaya Bilguvar, James Knight, and Bill Rizzo for technical assistance. This work was supported in part by a Clinician Scientist Development Award from the Doris Duke Charitable Foundation to K.A.C., the Foundation for Ichthyosis and Related Skin Types, and the National Institutes of Health (R01 AR068392 to K.A.C., R01 GM115710 to S.J. Baserga, and the Yale Center for Mendelian Genomics U54 HG006504).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; ALBALAT R, 1992, FEBS LETT, V308, P235; Borodzicz S, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0178-7; Boyden LM, 2016, HUM MOL GENET, V25, P348, DOI 10.1093/hmg/ddv481; Boyden LM, 2015, J INVEST DERMATOL, V135, P1540, DOI 10.1038/jid.2014.485; Eckl KM, 2013, J INVEST DERMATOL, V133, P2202, DOI 10.1038/jid.2013.153; ENSOR CM, 1994, BBA-PROTEIN STRUCT M, V1208, P151, DOI 10.1016/0167-4838(94)90172-4; Gupta SD, 2009, J LIPID RES, V50, P1630, DOI 10.1194/jlr.M800580-JLR200; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; KALEN A, 1992, BIOCHIM BIOPHYS ACTA, V1125, P90, DOI 10.1016/0005-2760(92)90160-W; Kihara A, 2004, J BIOL CHEM, V279, P49243, DOI 10.1074/jbc.M405915200; Kihara A, 2016, PROG LIPID RES, V63, P50, DOI 10.1016/j.plipres.2016.04.001; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kraveka JM, 2003, ARCH BIOCHEM BIOPHYS, V419, P110, DOI 10.1016/j.abb.2003.08.034; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Macari F, 2000, AM J HUM GENET, V67, P1296; Maestrini E, 1996, NAT GENET, V13, P70, DOI 10.1038/ng0596-70; McAleer MA, 2015, J ALLERGY CLIN IMMUN, V136, P1268, DOI 10.1016/j.jaci.2015.05.002; Mirza H, 2015, J INVEST DERMATOL, V135, P3041, DOI 10.1038/jid.2015.284; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; OBEID J, 1992, BIOCHEM BIOPH RES CO, V188, P222, DOI 10.1016/0006-291X(92)92373-6; Radner FPW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003536; RIBONI L, 1995, J BIOL CHEM, V270, P26868, DOI 10.1074/jbc.270.45.26868; Richard G, 1998, NAT GENET, V20, P366, DOI 10.1038/3840; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; SIKORSKI RS, 1989, GENETICS, V122, P19; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Uchida Y, 2014, BBA-MOL CELL BIOL L, V1841, P453, DOI 10.1016/j.bbalip.2013.09.003; Zhang MQ, 1998, HUM MOL GENET, V7, P919, DOI 10.1093/hmg/7.5.919	29	46	52	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 1	2017	100	6					978	984		10.1016/j.ajhg.2017.05.003	http://dx.doi.org/10.1016/j.ajhg.2017.05.003			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EW7NL	28575652	Green Published, Bronze			2022-12-18	WOS:000402700600013
J	Yao, C; Joehanes, R; Johnson, AD; Huan, TX; Liu, CY; Freedman, JE; Munson, PJ; Hill, DE; Vidal, M; Levy, D				Yao, Chen; Joehanes, Roby; Johnson, Andrew D.; Huan, Tianxiao; Liu, Chunyu; Freedman, Jane E.; Munson, Peter J.; Hill, David E.; Vidal, Marc; Levy, Daniel			Dynamic Role of trans Regulation of Gene Expression in Relation to Complex Traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CARDIOVASCULAR-DISEASE; WIDE ASSOCIATION; VARIANTS; RESOURCE; GWAS; IDENTIFICATION; TRANSCRIPTOME; DISCOVERY; NETWORKS; UPDATE	Identifying causal genetic variants and understanding their mechanisms of effect on traits remains a challenge in genome-wide association studies (GWASs). In particular, how genetic variants (i.e., trans-eQTLs) affect expression of remote genes (i.e., trans-eGenes) remains unknown. We hypothesized that some trans-eQTLs regulate expression of distant genes by altering the expression of near by genes (cis-eGenes). Using published GWAS datasets with 39,165 single-nucleotide polymorphisms (SNPs) associated with 1,960 traits, we explored whole blood gene expression associations of trait-associated SNPs in 5,257 individuals from the Framingham Heart Study. We identified 2,350 trans-eQTLs (at p < 10(-7)); more than 80% of them were found to have cis-associated eGenes. Mediation testing suggested that for 35% of trans-eQTL-trans-eGene pairs in different chromosomes and 90% pairs in the same chromosome, the disease-associated SNP may alter expression of the trans-eGene via cis-eGene expression. In addition, we identified 13 trans-eQTL hotspots, affecting from ten to hundreds of genes, suggesting the existence of master genetic regulators. Using causal inference testing, we searched causal variants across eight cardiometabolic traits (BMI, systolic and diastolic blood pressure, LDL cholesterol, HDL cholesterol, total cholesterol, triglycerides, and fasting blood glucose) and identified several cis-eGenes (ALDH2 for systolic and diastolic blood pressure, MCM6 and DARS for total cholesterol, and TRIB1 for triglycerides) that were causal mediators for the corresponding traits, as well as examples of trans-mediators (TAGAP for LDL cholesterol). The finding of extensive evidence of genome-wide mediation effects suggests a critical role of cryptic gene regulation underlying many disease traits.	[Yao, Chen; Joehanes, Roby; Johnson, Andrew D.; Huan, Tianxiao; Liu, Chunyu; Levy, Daniel] Framingham Heart Dis Epidemiol Study, 73 Mt Wayte Ave, Framingham, MA 01702 USA; [Yao, Chen; Joehanes, Roby; Johnson, Andrew D.; Huan, Tianxiao; Liu, Chunyu; Levy, Daniel] NHLBI, Populat Sci Branch, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Joehanes, Roby] Hebrew Senior Life, 1200 Ctr St Room 609, Boston, MA 02131 USA; [Freedman, Jane E.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01655 USA; [Munson, Peter J.] NIH, Ctr Informat Technol, Math & Stat Comp Lab, Bethesda, MD 20817 USA; [Hill, David E.; Vidal, Marc] CCSB, Boston, MA 02215 USA; [Hill, David E.; Vidal, Marc] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Hill, David E.; Vidal, Marc] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA	Framingham Heart Study; Harvard University; Hebrew SeniorLife; University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Levy, D (corresponding author), Framingham Heart Dis Epidemiol Study, 73 Mt Wayte Ave, Framingham, MA 01702 USA.; Levy, D (corresponding author), NHLBI, Populat Sci Branch, Div Intramural Res, NIH, Bethesda, MD 20892 USA.	levyd@nhlbi.nih.gov	Vidal, Marc/Y-2466-2019; Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021; Johnson, Andrew D/G-6520-2013; Huan, Tianxiao/AAF-3577-2021	Vidal, Marc/0000-0003-3391-5410; Levy, Daniel/0000-0003-1843-8724; Johnson, Andrew D/0000-0001-6369-5178; Huan, Tianxiao/0000-0001-5840-9413	NIH [N01-HC-25195]; Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH; American Heart Association (AHA) Cardiovascular Genome-Phenome Study (CVGPS) grant [15CVGPS23430000]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006170, ZIAHL006001] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association (AHA) Cardiovascular Genome-Phenome Study (CVGPS) grant(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank all of the study participants who helped to create this valuable resource and supported this work. We thank the data management group of FHS for organizing and providing these data. We thank the NIH Fellows Editorial Board members for their valuable edits and comments. This study used the high-performance computational capabilities of the Biowulf Linux cluster at the NIH. The FHS is funded by NIH contract N01-HC-25195. The laboratory work for this investigation was funded by the Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH. The analytical component of this project was funded by American Heart Association (AHA) Cardiovascular Genome-Phenome Study (CVGPS) grant 15CVGPS23430000. The views expressed in this manuscript are those of the authors and do not necessarily represent the views of the National Heart, Lung, and Blood Institute; the NIH; or the U.S. Department of Health and Human Services.	Arvind P, 2015, J GENET, V94, P601, DOI 10.1007/s12041-015-0548-3; Atanasovska B, 2015, TRENDS ENDOCRIN MET, V26, P722, DOI 10.1016/j.tem.2015.10.004; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breitling R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000232; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Eicher JD, 2015, NUCLEIC ACIDS RES, V43, pD799, DOI 10.1093/nar/gku1202; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Huan TX, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005035; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Joehanes R, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1142-6; Joehanes R, 2012, PHYSIOL GENOMICS, V44, P59, DOI 10.1152/physiolgenomics.00130.2011; Kobayashi KS, 2012, NAT REV IMMUNOL, V12, P813, DOI 10.1038/nri3339; Lemaitre RN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002193; Lizio M, 2017, NUCLEIC ACIDS RES, V45, pD737, DOI 10.1093/nar/gkw995; Lu WS, 2015, HUM MOL GENET, V24, P2390, DOI 10.1093/hmg/ddu731; Mahmood SS, 2014, LANCET, V383, P999, DOI 10.1016/S0140-6736(13)61752-3; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McKenzie M, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-31; Meissner TB, 2012, J IMMUNOL, V188, P4951, DOI 10.4049/jimmunol.1103160; Michaelson JJ, 2009, METHODS, V48, P265, DOI 10.1016/j.ymeth.2009.03.004; Millstein J, 2016, BIOINFORMATICS, V32, P2364, DOI 10.1093/bioinformatics/btw135; Millstein J, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-23; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Orozco LD, 2015, CELL METAB, V21, P905, DOI 10.1016/j.cmet.2015.04.025; Pierce BL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004818; Powell DR, 2016, DIABETES METAB SYNDR, V9, P185, DOI 10.2147/DMSO.S106653; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Simon LM, 2016, AM J HUM GENET, V98, P883, DOI 10.1016/j.ajhg.2016.03.007; Stegle O, 2012, NAT PROTOC, V7, P500, DOI 10.1038/nprot.2011.457; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thompson D, 2015, ANNU REV CELL DEV BI, V31, P399, DOI 10.1146/annurev-cellbio-100913-012908; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wang K, 2010, AM J HUM GENET, V86, P730, DOI 10.1016/j.ajhg.2010.04.003; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Welter Danielle, 2014, Nucleic Acids Res, V42, pD1001, DOI 10.1093/nar/gkt1229; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Won HH, 2012, J MOL MED, V90, P201, DOI 10.1007/s00109-011-0818-3; Yao C, 2015, CIRCULATION, V131, P536, DOI 10.1161/CIRCULATIONAHA.114.010696; Yu-Poth S, 2005, J NUTR, V135, P2541, DOI 10.1093/jn/135.11.2541; Zhang XL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-532	48	46	46	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 6	2017	100	4					571	580		10.1016/j.ajhg.2017.02.003	http://dx.doi.org/10.1016/j.ajhg.2017.02.003			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EQ9FK	28285768	Green Published, Bronze			2022-12-18	WOS:000398389600001
J	Yan, KZ; Rousseau, J; Littlejohn, RO; Kiss, C; Lehman, A; Rosenfeld, JA; Stumpel, CTR; Stegmann, APA; Robak, L; Scaglia, F; Nguyen, TTM; Fu, H; Ajeawung, NF; Camurri, MV; Li, L; Gardham, A; Panis, B; Almannai, M; Sacoto, MJG; Baskin, B; Ruivenkamp, C; Xia, F; Bi, W; Cho, MT; Potjer, TP; Santen, GWE; Parker, MJ; Canham, N; McKinnon, M; Potocki, L; MacKenzie, JJ; Roeder, ER; Campeau, PM; Yang, XJ				Yan, Kezhi; Rousseau, Justine; Littlejohn, Rebecca Okashah; Kiss, Courtney; Lehman, Anna; Rosenfeld, Jill A.; Stumpel, Constance T. R.; Stegmann, Alexander P. A.; Robak, Laurie; Scaglia, Fernando; Thi Tuyet Mai Nguyen; Fu, He; Ajeawung, Norbert F.; Camurri, Maria Vittoria; Li, Lin; Gardham, Alice; Panis, Bianca; Almannai, Mohammed; Sacoto, Maria J. Guillen; Baskin, Berivan; Ruivenkamp, Claudia; Xia, Fan; Bi, Weimin; Cho, Megan T.; Potjer, Thomas P.; Santen, Gijs W. E.; Parker, Michael J.; Canham, Natalie; McKinnon, Margaret; Potocki, Lorraine; MacKenzie, Jennifer J.; Roeder, Elizabeth R.; Campeau, Philippe M.; Yang, Xiang-Jiao		DDD Study; CAUSES Study	Mutations in the Chromatin Regulator Gene BRPF1 Cause Syndromic Intellectual Disability and Deficient Histone Acetylation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEMATOPOIETIC STEM-CELLS; ZINC-FINGER PROTEIN; CAUSE GENITOPATELLAR SYNDROME; DE-NOVO MUTATIONS; CAENORHABDITIS-ELEGANS; HBO1 ACETYLTRANSFERASE; PHD FINGER; PZP DOMAIN; KAT6B; EXPRESSION	Identification of over 500 epigenetic regulators in humans raises an interesting question regarding how chromatin dysregulation contributes to different diseases. Bromodomain and PHD finger-containing protein 1 (BRPF1) is a multivalent chromatin regulator possessing three histone-binding domains, one non-specific DNA-binding module, and several motifs for interacting with and activating three lysine acetyltransferases. Genetic analyses of fish brpf1 and mouse Brpf1 have uncovered an important role in skeletal, hematopoietic, and brain development, but it remains unclear how BRPF1 is linked to human development and disease. Here, we describe an intellectual disability disorder in ten individuals with inherited or de novo monoallelic BRPF1 mutations. Syrhptoms include infantile hypotonia, global developmental delay, intellectual disability, expressive language impairment, and facial dysmorphisms. Central nervous system and spinal abnormalities are also seen in some individuals. These clinical features overlap with but are not identical to those reported for persons with KAT6A or KAT6B mutations, suggesting that BRPF1 targets these two acetyltransferases and additional partners in humans. Functional assays showed that the resulting BRPF1 variants are pathogenic and impair acetylation of histone H3 at lysine 23, an abundant but poorly characterized epigenetic mark. We also found a similar deficiency in different lines of Brpf1-knockout mice. These data indicate that aberrations in the chromatin regulator gene BRPF1 cause histone H3 acetylation deficiency and a previously unrecognized intellectual disability syndrome.	[Yan, Kezhi; Li, Lin; Yang, Xiang-Jiao] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Yan, Kezhi; Li, Lin; Yang, Xiang-Jiao] McGill Univ, Dept Med, Montreal, PQ H3A 1A3, Canada; [Rousseau, Justine; Thi Tuyet Mai Nguyen; Fu, He; Ajeawung, Norbert F.; Camurri, Maria Vittoria; Campeau, Philippe M.] CHU St Justine, CHUSJ Res Ctr, Montreal, PQ H3T 1J4, Canada; [Littlejohn, Rebecca Okashah; Roeder, Elizabeth R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Kiss, Courtney; MacKenzie, Jennifer J.] Kingston Gen Hosp, 76 Stuart St,Armstrong 4, Kingston, ON K7L 2V7, Canada; [Lehman, Anna; McKinnon, Margaret; CAUSES Study] Univ British Columbia, Dept Med Genet, 4500 Oak St, Vancouver, BC V6H 3N1, Canada; [Rosenfeld, Jill A.; Robak, Laurie; Scaglia, Fernando; Almannai, Mohammed; Xia, Fan; Bi, Weimin; Potocki, Lorraine; Roeder, Elizabeth R.] Baylor Coll Med, Dept Mol & Human Genet, One Baylor Plaza, Houston, TX 77030 USA; [Stumpel, Constance T. R.; Stegmann, Alexander P. A.] Maastricht Univ, Med Ctr, Dept Clin Genet, NL-6229 Maastricht, Netherlands; [Stumpel, Constance T. R.; Stegmann, Alexander P. A.] Maastricht Univ, Med Ctr, Sch Oncol & Dev Biol, NL-6229 Maastricht, Netherlands; [Gardham, Alice; Canham, Natalie] Northwick Pk Hosp & Clin Res Ctr, London North West Healthcare NHS Trust, North West Thames Reg Genet Serv, Watford Rd, Harrow HA1 3UJ, Middx, England; [Panis, Bianca] Zuyderland Med Ctr, Dept Pediat, Heerlen, Netherlands; [Panis, Bianca] Zuyderland Med Ctr, Dept Pediat, NL-6419 Sittard, Netherlands; [Sacoto, Maria J. Guillen; Baskin, Berivan; Cho, Megan T.] GeneDx, 207 Perry Pkwy, Gaithersburg, MD 20877 USA; [Ruivenkamp, Claudia; Potjer, Thomas P.; Santen, Gijs W. E.] Leiden Univ, Med Ctr, Dept Clin Genet, NL-2300 RC Leiden, Netherlands; [DDD Study] Wellcome Trust Sanger Inst, Decipher Dev Disorder Study, Wellcome Genome Campus, Hinxton CB10 1SA, England; [Parker, Michael J.] Northern Gen Hosp, OPD2, Sheffield Clin Genet Serv, Herries Rd, Sheffield S5 7AU, S Yorkshire, England; [MacKenzie, Jennifer J.] McMaster Univ, Dept Pediat, Div Clin Genet, Hamilton, ON L8S 4K1, Canada; [Campeau, Philippe M.] Hop St Justine, Dept Pediat, Montreal, PQ H3T 1J4, Canada; [Campeau, Philippe M.] Univ Montreal, Montreal, PQ H3T 1J4, Canada; [Yang, Xiang-Jiao] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Yang, Xiang-Jiao] McGill Univ, Ctr Hlth, Montreal, PQ H3A 1A3, Canada	McGill University; McGill University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Baylor College of Medicine; Queens University - Canada; University of British Columbia; Baylor College of Medicine; Maastricht University; Maastricht University; Imperial College London; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Wellcome Trust Sanger Institute; Northern General Hospital; McMaster University; Universite de Montreal; Universite de Montreal; McGill University; McGill University	Yang, XJ (corresponding author), McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada.; Yang, XJ (corresponding author), McGill Univ, Dept Med, Montreal, PQ H3A 1A3, Canada.; Campeau, PM (corresponding author), CHU St Justine, CHUSJ Res Ctr, Montreal, PQ H3T 1J4, Canada.; Campeau, PM (corresponding author), Hop St Justine, Dept Pediat, Montreal, PQ H3T 1J4, Canada.; Campeau, PM (corresponding author), Univ Montreal, Montreal, PQ H3T 1J4, Canada.; Yang, XJ (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada.; Yang, XJ (corresponding author), McGill Univ, Ctr Hlth, Montreal, PQ H3A 1A3, Canada.	p.campeau@umontreal.ca; xiang-jiao.yang@mcgill.ca	Campeau, Philippe/J-8614-2015; Potjer, Thomas/AAC-3499-2022; Lehman, Anna/R-6706-2017	Campeau, Philippe/0000-0001-9713-7107; Potjer, Thomas/0000-0002-3831-6022; Lehman, Anna/0000-0003-0636-123X; Rousseau, Justine/0000-0002-3554-2673; MacKenzie, Jennifer/0000-0002-3374-8619; Stegmann, Alexander/0000-0002-9736-7137; McKinnon, Margaret/0000-0002-3161-414X	Canadian Institutes of Health Research [RN324373, RN315908, MOP-142252]; Natural Sciences and Engineering Research Council of Canada [342146-12]; Mining for Miracles, British Columbia Hospital Foundation; Wellcome Trust [HICF-1009-003]; UK Department of Health [HICF-1009-003]; Wellcome Trust Sanger Institute [WT098051]; National Institute for Health Research, through the Comprehensive Clinical Research Network	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Mining for Miracles, British Columbia Hospital Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); UK Department of Health; Wellcome Trust Sanger Institute(Wellcome Trust); National Institute for Health Research, through the Comprehensive Clinical Research Network(National Institute for Health Research (NIHR))	This project was supported in part by operating grants from the Canadian Institutes of Health Research (RN324373 and RN315908 to P.M.C. and MOP-142252 X.J.Y.) and the Natural Sciences and Engineering Research Council of Canada (342146-12 to X.J.Y.). Funding for the CAUSES Study was from Mining for Miracles, British Columbia Hospital Foundation. The DDD Study presents independent research commissioned by the Health Innovation Challenge Fund (grant no. HICF-1009-003), a parallel funding partnership between the Wellcome Trust and the UK Department of Health, and the Wellcome Trust Sanger Institute (grant no. WT098051). The views expressed in this publication are those of the author(s) and not necessarily those of the Wellcome Trust or the Department of Health. The study has UK Research Ethics Committee (REC) approval (10/H0305/83, granted by the Cambridge South REC, and GEN/284/12, granted by the Republic of Ireland REC). The research team acknowledges the support of the National Institute for Health Research, through the Comprehensive Clinical Research Network. M.G., B.B. and M.T.C. are employees of GeneDx.	Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; Arboleda VA, 2015, AM J HUM GENET, V96, P498, DOI 10.1016/j.ajhg.2015.01.017; Berdasco M, 2013, HUM GENET, V132, P359, DOI 10.1007/s00439-013-1271-x; Berger J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000085; Bernier R, 2014, CELL, V158, P263, DOI 10.1016/j.cell.2014.06.017; Campeau PM, 2012, AM J HUM GENET, V90, P282, DOI 10.1016/j.ajhg.2011.11.023; Champagne N, 1999, J BIOL CHEM, V274, P28528, DOI 10.1074/jbc.274.40.28528; Chen SD, 2015, MOL CELL, V60, P319, DOI 10.1016/j.molcel.2015.08.019; Clayton-Smith J, 2011, AM J HUM GENET, V89, P675, DOI 10.1016/j.ajhg.2011.10.008; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Feng YM, 2016, ITAL J PURE APPL MAT, P1; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Huang F, 2016, GENE DEV, V30, P1198, DOI 10.1101/gad.271429.115; Huang F, 2014, GENE DEV, V28, P2750, DOI 10.1101/gad.249730.114; Katsumoto T, 2006, GENE DEV, V20, P1321, DOI 10.1101/gad.1393106; Klein BJ, 2016, NUCLEIC ACIDS RES, V44, P472, DOI 10.1093/nar/gkv1321; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kraft M, 2011, J CLIN INVEST, V121, P3479, DOI 10.1172/JCI43428; Lalonde ME, 2013, GENE DEV, V27, P2009, DOI 10.1101/gad.223396.113; Laue K, 2008, DEVELOPMENT, V135, P1935, DOI 10.1242/dev.017160; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Ling PD, 2005, CURR PROTOC MOL BIOL, V28, DOI 10.1002/0471142727.mb2802s70; Liu L, 2012, J STRUCT BIOL, V180, P165, DOI 10.1016/j.jsb.2012.06.014; Miller CT, 2004, DEVELOPMENT, V131, P2443, DOI 10.1242/dev.01134; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Nishiyama A, 2013, NATURE, V502, P249, DOI 10.1038/nature12488; O'Meara MM, 2010, GENETICS, V186, P1497, DOI 10.1534/genetics.110.123661; Papazyan R, 2014, ELIFE, V3, DOI 10.7554/eLife.02996; Poplawski A, 2014, J MOL BIOL, V426, P1661, DOI 10.1016/j.jmb.2013.12.007; Qin S, 2011, J BIOL CHEM, V286, P36944, DOI 10.1074/jbc.M111.244400; Scott EK, 2001, CURR BIOL, V11, P99, DOI 10.1016/S0960-9822(01)00020-3; Simo-Riudalbas L, 2015, CANCER RES, V75, P3936, DOI 10.1158/0008-5472.CAN-14-3702; Simpson MA, 2012, AM J HUM GENET, V90, P290, DOI 10.1016/j.ajhg.2011.11.024; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Strubbe G, 2011, P NATL ACAD SCI USA, V108, P5572, DOI 10.1073/pnas.1007916108; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Tham E, 2015, AM J HUM GENET, V96, P507, DOI 10.1016/j.ajhg.2015.01.016; Thomas T, 2006, GENE DEV, V20, P1175, DOI 10.1101/gad.1382606; Thomas T, 2000, DEVELOPMENT, V127, P2537; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Ullah M, 2008, MOL CELL BIOL, V28, P6828, DOI 10.1128/MCB.01297-08; Vandamme J, 2015, NUCLEIC ACIDS RES, V43, P9694, DOI 10.1093/nar/gkv1063; Vega H, 2005, NAT GENET, V37, P468, DOI 10.1038/ng1548; Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797; Weiss K, 2016, AM J HUM GENET, V99, P934, DOI 10.1016/j.ajhg.2016.08.001; Williams SR, 2010, AM J HUM GENET, V87, P219, DOI 10.1016/j.ajhg.2010.07.011; Wu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018919; Yan KZ, 2016, J BIOL CHEM, V291, P2647, DOI 10.1074/jbc.M115.703041; Yang XJ, 2015, BBA-MOL CELL RES, V1853, P1818, DOI 10.1016/j.bbamcr.2015.04.014; You LY, 2016, J CLIN INVEST, V126, P3247, DOI 10.1172/JCI80711; You LY, 2015, J BIOL CHEM, V290, P11349, DOI 10.1074/jbc.M115.643189; You LY, 2015, J BIOL CHEM, V290, P7114, DOI 10.1074/jbc.M114.635250; You LY, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005034; You LY, 2014, EPIGENETICS-US, V9, P860, DOI 10.4161/epi.28530; Yu HC, 2014, AM J MED GENET A, V164, P950, DOI 10.1002/ajmg.a.36379; Zhou T, 2016, J PROTEOME RES, V15, P1103, DOI 10.1021/acs.jproteome.5b01097	57	46	47	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 5	2017	100	1					91	104		10.1016/j.ajhg.2016.11.011	http://dx.doi.org/10.1016/j.ajhg.2016.11.011			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EH6UX	27939640	Green Published, Bronze			2022-12-18	WOS:000391910500008
J	Bello, L; Flanigan, KM; Weiss, RB; Spitali, P; Aartsma-Rus, A; Muntoni, F; Zaharieva, I; Ferlini, A; Mercuri, E; Tuffery-Giraud, S; Claustres, M; Straub, V; Lochmuller, H; Barp, A; Vianello, S; Pegoraro, E; Punetha, J; Gordish-Dressman, H; Giri, M; McDonald, CM; Hoffman, EP				Bello, Luca; Flanigan, Kevin M.; Weiss, Robert B.; Spitali, Pietro; Aartsma-Rus, Annemieke; Muntoni, Francesco; Zaharieva, Irina; Ferlini, Alessandra; Mercuri, Eugenio; Tuffery-Giraud, Sylvie; Claustres, Mireille; Straub, Volker; Lochmuller, Hanns; Barp, Andrea; Vianello, Sara; Pegoraro, Elena; Punetha, Jaya; Gordish-Dressman, Heather; Giri, Mamta; McDonald, Craig M.; Hoffman, Eric P.		United Dystrophinopathy Project; Cooperative Int Neuromuscular Res	Association Study of Exon Variants in the NF-kappa B and TGF beta Pathways Identifies CD40 as a Modifier of Duchenne Muscular Dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NATURAL-HISTORY; T-LYMPHOCYTE; CLINICAL-TRIALS; MUSCLE; FIBROSIS; MOUSE; DISEASE; REGENERATION; AMBULATION; DEPLETION	The expressivity of Mendelian diseases can be influenced by factors independent from the pathogenic mutation: in Duchenne muscular dystrophy (DMD), for instance, age at loss of ambulation (LoA) varies between individuals whose DMD mutations all abolish dystrophin expression. This suggests the existence of trans-acting variants in modifier genes. Common single nucleotide polymorphisms (SNPs) in candidate genes (SPP1, encoding osteopontin, and LTBP4, encoding latent transforming growth factor beta [TGF beta]-binding protein 4) have been established as DMD modifiers. We performed a genome-wide association study of age at LoA in a sub-cohort of European or European American ancestry (n = 109) from the Cooperative International Research Group Duchenne Natural History Study (CINRG-DNHS). We focused on protein-altering variants (Exome Chip) and included glucocorticoid treatment as a covariate. As expected, due to the small population size, no SNPs displayed an exome-wide significant p value (< 1.8 x 10(-6)). Subsequently, we prioritized 438 SNPs in the vicinities of 384 genes implicated in DMD-related pathways, i.e., the nuclear-factor-kappa B and TGF beta pathways. The minor allele at rs1883832, in the 5'-untranslated region of CD40, was associated with earlier LoA (p = 3.5 x 10(-5)). This allele diminishes the expression of CD40, a co-stimulatory molecule for T cell polarization. We validated this association in multiple independent DMD cohorts (United Dystrophinopathy Project, Bio-NMD, and Padova, total n = 660), establishing this locus as a DMD modifier. This finding points to cell-mediated immunity as a relevant pathogenetic mechanism and potential therapeutic target in DMD.	[Bello, Luca; Punetha, Jaya; Gordish-Dressman, Heather; Giri, Mamta; Hoffman, Eric P.] Childrens Natl Med Ctr, Ctr Genet Med Res, Washington, DC 20010 USA; [Bello, Luca; Barp, Andrea; Vianello, Sara; Pegoraro, Elena] Univ Padua, Dept Neurosci, I-35128 Padua, Italy; [Flanigan, Kevin M.] Ohio State Univ, Nationwide Childrens Hosp, Ctr Gene Therapy, Columbus, OH 43205 USA; [Flanigan, Kevin M.] Ohio State Univ, Dept Pediat, Columbus, OH 43205 USA; [Flanigan, Kevin M.] Ohio State Univ, Dept Neurol, Columbus, OH 43205 USA; [Weiss, Robert B.] Univ Utah, Dept Human Genet, Sch Med, Salt Lake City, UT 84112 USA; [Spitali, Pietro; Aartsma-Rus, Annemieke] Leiden Univ, Dept Human Genet, Med Ctr, NL-2333 ZA Leiden, Netherlands; [Aartsma-Rus, Annemieke; Straub, Volker; Lochmuller, Hanns] Newcastle Univ, Int Ctr Life, John Walton Muscular Dystrophy Res Ctr, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Muntoni, Francesco; Zaharieva, Irina] UCL, Inst Child Hlth, Dubowitz Neuromuscular Ctr, London WC1N 1EH, England; [Ferlini, Alessandra] Univ Ferrara, Dept Med Sci, UOL Med Genet, I-44121 Ferrara, Italy; [Mercuri, Eugenio] Catholic Univ, Paediat Neuropsychiat Unit, Policlin Gemelli, I-00168 Rome, Italy; [Tuffery-Giraud, Sylvie; Claustres, Mireille] Univ Montpellier, EA 7402, Lab Genet Rare Dis, F-34093 Montpellier, France; [McDonald, Craig M.] Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA; [Hoffman, Eric P.] SUNY Binghamton, Sch Pharm & Pharmaceut Sci, POB 6000, Binghamton, NY 13902 USA	Children's National Health System; University of Padua; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Utah System of Higher Education; University of Utah; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Newcastle University - UK; University of London; University College London; University of Ferrara; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Universite de Montpellier; University of California System; University of California Davis; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Hoffman, EP (corresponding author), Childrens Natl Med Ctr, Ctr Genet Med Res, Washington, DC 20010 USA.; Hoffman, EP (corresponding author), SUNY Binghamton, Sch Pharm & Pharmaceut Sci, POB 6000, Binghamton, NY 13902 USA.	ehoffman@binghamton.edu	giri, mamta/ABC-2895-2020; TUFFERY-GIRAUD, Sylvie/A-9228-2008; Spitali, Pietro/Y-2948-2018; Mercuri, Eugenio/G-1351-2015	Spitali, Pietro/0000-0003-2783-688X; Flanigan, Kevin/0000-0001-6440-3376; Duong, Tina/0000-0003-3177-4722; Ryan, Monique/0000-0001-6397-1910; mathews, katherine/0000-0003-4160-0435; Aartsma-Rus, Annemieke/0000-0003-1565-654X; FERLINI, ALESSANDRA/0000-0001-8385-9870; Lowes, Linda/0000-0003-4206-0557; Alfano, Lindsay/0000-0002-2263-7569; Punetha, Jaya/0000-0002-6774-4464; Swoboda, Kathryn/0000-0002-4593-6342; Tuffery-Giraud, Sylvie/0000-0001-9369-7780; Mercuri, Eugenio/0000-0002-9851-5365; Straub, Volker/0000-0001-9046-3540; Bello, Luca/0000-0002-3075-6525; Kuntz, Nancy L/0000-0003-2253-5156; Hoffman, Eric/0000-0001-6470-5139	Italian Ministry of Education PhD grant for the Doctorate School of Medical, Clinical, and Experimental Science at the University of Padova; Association Francaise contre les Myopathies [15092, 17724]; Dutch Duchenne Parent Project; European Union [241665, 305121, 305444]; Italian Duchenne Parent Project; Medical Research council Centre for Neuromuscular Diseases Biobanks; Telethon Italy Foundation [GTB12001D]; U.S. Department of Defense [W81XWH-12-1-0417]; U.S. Department of Education/NIDRR [H133B031118, H133B090001]; U.S. National Institutes of Health/NIAMS [R01AR061875]; Medical Research Council [MR/N027302/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085238] Funding Source: NIH RePORTER	Italian Ministry of Education PhD grant for the Doctorate School of Medical, Clinical, and Experimental Science at the University of Padova; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Dutch Duchenne Parent Project; European Union(European Commission); Italian Duchenne Parent Project; Medical Research council Centre for Neuromuscular Diseases Biobanks(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Telethon Italy Foundation(Fondazione Telethon); U.S. Department of Defense(United States Department of Defense); U.S. Department of Education/NIDRR(US Department of Education); U.S. National Institutes of Health/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank all participants and their families. We gratefully acknowledge Stanley F. Nelson and Richard T. Wang (UCLA) for generating Exome Chip data, Akanchha Kesari (Children's National Medical Center) for help with genotyping, Bruno F. Gavassini (University of Padova) for technical help with immunoblot experiments, Michela Guglieri and Kate Bushby (Newcastle University) for providing clinical data, and biobank staff Dan Cox and Mojgan Reza (Newcastle University) for processing samples. L.B. was supported by an Italian Ministry of Education PhD grant for the Doctorate School of Medical, Clinical, and Experimental Science at the University of Padova. We acknowledge funding from Association Francaise contre les Myopathies (support to Bio-NMD, grants 15092 and 17724); Dutch Duchenne Parent Project (support to P.S.); the European Union (support to Bio-NMD grant 241665, Neuromics grant 305121, RD-Connect grant 305444); the Italian Duchenne Parent Project (support to A.F.); the Medical Research council Centre for Neuromuscular Diseases Biobanks (support to London and Newcastle Biobanks), part of Eurobiobank; National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children, NHS Foundation Trust, and University College London; Telethon Italy Foundation (support to Nemo Centers and Padova Neuromuscular Biobank, grant GTB12001D); the U.S. Department of Defense (support to CINRG, grant #W81XWH-12-1-0417); the U.S. Department of Education/NIDRR (support to CINRG, grants H133B031118 and H133B090001); and the U.S. National Institutes of Health/NIAMS (support to CINRG, grant R01AR061875).	Bello L, 2016, NEUROLOGY, V87, P401, DOI 10.1212/WNL.0000000000002891; Bello L, 2015, NEUROLOGY, V85, P1048, DOI 10.1212/WNL.0000000000001950; Bello L, 2015, ANN NEUROL, V77, P684, DOI 10.1002/ana.24370; Bello L, 2012, NEUROLOGY, V79, P159, DOI 10.1212/WNL.0b013e31825f04ea; Cascabulho CM, 2012, AM J PATHOL, V181, P593, DOI 10.1016/j.ajpath.2012.04.023; Ceco E, 2013, FEBS J, V280, P4198, DOI 10.1111/febs.12266; Chen YW, 2005, NEUROLOGY, V65, P826, DOI 10.1212/01.wnl.0000173836.09176.c4; Dadgar S, 2014, J CELL BIOL, V207, P139, DOI 10.1083/jcb.201402079; Emond MJ, 2012, NAT GENET, V44, P886, DOI 10.1038/ng.2344; Farini A, 2007, J PATHOL, V213, P229, DOI 10.1002/path.2213; Flanigan KM, 2013, ANN NEUROL, V73, P481, DOI 10.1002/ana.23819; Gandhi KS, 2010, HUM MOL GENET, V19, P2134, DOI 10.1093/hmg/ddq090; Giacopelli F, 2004, PHYSIOL GENOMICS, V20, P87, DOI 10.1152/physiolgenomics.00138.2004; GUSSONI E, 1994, J IMMUNOL, V153, P4798; Henricson EK, 2013, MUSCLE NERVE, V48, P55, DOI 10.1002/mus.23808; Heydemann A, 2009, J CLIN INVEST, V119, P3703, DOI 10.1172/JCI39845; HOFFMAN EP, 1989, NEUROLOGY, V39, P1011, DOI 10.1212/WNL.39.8.1011; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hoffman EP, 2013, MED SCI SPORT EXER, V45, P1060, DOI 10.1249/MSS.0b013e31828093c1; Humbertclaude V, 2012, EUR J PAEDIATR NEURO, V16, P149, DOI 10.1016/j.ejpn.2011.07.001; Jacobson EM, 2005, ENDOCRINOLOGY, V146, P2684, DOI 10.1210/en.2004-1617; Jimenez C, 2015, NEUROMUSCULAR DISORD, V25, pS201, DOI 10.1016/j.nmd.2015.06.066; KISSEL JT, 1991, NEUROLOGY, V41, P667, DOI 10.1212/WNL.41.5.667; McDonald CM, 2013, MUSCLE NERVE, V48, P32, DOI 10.1002/mus.23807; Morrison J, 2005, AM J PATHOL, V166, P1701, DOI 10.1016/S0002-9440(10)62480-7; Morrison J, 2000, LAB INVEST, V80, P881, DOI 10.1038/labinvest.3780092; Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220; Pegoraro E, 2011, NEUROLOGY, V76, P219, DOI 10.1212/WNL.0b013e318207afeb; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosenberg AS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa7322; Schork AJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003449; Sugiura T, 2000, J IMMUNOL, V164, P6593, DOI 10.4049/jimmunol.164.12.6593; Turner S. D., 2014, BIORXIV, DOI DOI 10.1101/005165; Uaesoontrachoon K, 2013, DIS MODEL MECH, V6, P197, DOI 10.1242/dmm.009993; van den Bergen JC, 2015, J NEUROL NEUROSUR PS, V86, P1060, DOI 10.1136/jnnp-2014-308409; Vetrone SA, 2009, J CLIN INVEST, V119, P1583, DOI 10.1172/JCI37662; Villalta SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009925	37	46	46	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 3	2016	99	5					1163	1171		10.1016/j.ajhg.2016.08.023	http://dx.doi.org/10.1016/j.ajhg.2016.08.023			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EB6XT	27745838	Green Published, Bronze			2022-12-18	WOS:000387529600013
